|
Code
|
Display
|
|
76090-0
|
Erythrocytes.hyperchromic/100 erythrocytes in Blood by Automated count |
|
76069-4
|
Erythrocytes.hypochromic/100 erythrocytes in Blood by Automated count |
|
38486-7
|
Homocystine [Presence] in DBS |
|
54302-5
|
Homocystine [Moles/volume] in DBS |
|
55879-1
|
Homocystine [Moles/volume] in Body fluid |
|
44378-8
|
Homocystine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56682-8
|
Homocystine/Creatinine [Ratio] in 24 hour Urine |
|
38699-5
|
1,1-Dichloroethane [Mass/volume] in Air |
|
62290-2
|
1,25-Dihydroxyvitamin D [Mass/volume] in Serum or Plasma |
|
62291-0
|
1,25-Dihydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
|
1649-3
|
Calcitriol [Mass/volume] in Serum or Plasma |
|
14566-4
|
Calcitriol [Moles/volume] in Serum or Plasma |
|
80630-7
|
1,2-Dichloroethane [Mass/volume] in Blood |
|
54935-2
|
1,2-Dichloroethane [Mass/volume] in Serum or Plasma |
|
38756-3
|
1,2-Dimethylbenzene [Mass/volume] in Air |
|
13650-7
|
1,2-Dimethylbenzene [Mass/volume] in Blood |
|
29144-3
|
1,2-Dimethylbenzene [Mass/volume] in Serum or Plasma |
|
35578-4
|
1,2-Glyceryl dinitrate [Mass/volume] in Blood |
|
88923-8
|
1,3 beta glucan [Mass/volume] in Lower respiratory specimen |
|
42176-8
|
1,3 beta glucan [Mass/volume] in Serum |
|
62468-4
|
1,3 beta glucan [Mass/volume] in Unspecified specimen |
|
80631-5
|
1,3-Dimethylbenzene+1,4-Dimethylbenzene [Mass/volume] in Blood |
|
38642-5
|
1,3-Butadiene [Mass/volume] in Air |
|
74642-0
|
1,3-Dichlorobenzene [Mass/volume] in Serum or Plasma |
|
38757-1
|
1,3-Dimethylbenzene [Mass/volume] in Air |
|
13644-0
|
1,3-Dimethylbenzene [Mass/volume] in Blood |
|
29145-0
|
1,3-Dimethylbenzene [Mass/volume] in Serum or Plasma |
|
38719-1
|
1,3-Propane sultone [Mass/volume] in Air |
|
38723-3
|
1,4-Benzoquinone [Mass/volume] in Air |
|
79513-8
|
1,4-Cyclohexanediol [Moles/volume] in Serum or Plasma |
|
79471-9
|
1,4-Cyclohexanediol/Creatinine [Molar ratio] in Urine |
|
38593-0
|
1,4-Dioxane [Mass/volume] in Air |
|
14033-5
|
1,4-Dioxane [Mass/volume] in Blood by Gas chromatography |
|
14258-8
|
1,4-Dioxane [Mass/volume] in Blood |
|
27423-3
|
1,4-Dioxane [Presence] in Serum or Plasma |
|
12997-3
|
1,4-Dioxane [Mass/volume] in Serum or Plasma |
|
16292-5
|
1,4-Dioxane [Mass/volume] in Urine |
|
38758-9
|
1,4-Dimethylbenzene [Mass/volume] in Air |
|
13651-5
|
1,4-Dimethylbenzene [Mass/volume] in Blood |
|
29143-5
|
1,4-Dimethylbenzene [Mass/volume] in Serum or Plasma |
|
53835-5
|
1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma |
|
48332-1
|
10 minute Apgar panel |
|
60035-3
|
10-Hydroxycarbazepine [Mass/volume] in Blood |
|
31019-3
|
10-Hydroxycarbazepine [Mass/volume] in Serum or Plasma |
|
48348-7
|
10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma |
|
87766-2
|
10-Hydroxycarbazepine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
13872-7
|
11-Deoxycortisol [Mass/time] in 24 hour Urine |
|
34204-8
|
11-Deoxycortisol [Moles/volume] in 24 hour Urine |
|
25315-3
|
11-Deoxycortisol [Moles/time] in 24 hour Urine |
|
21035-1
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --morning specimen |
|
55809-8
|
11-Deoxycortisol [Mass/volume] in Amniotic fluid |
|
50071-0
|
11-Deoxycortisol [Moles/volume] in Amniotic fluid |
|
40810-4
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --baseline |
|
53338-0
|
11-Deoxycortisol [Mass/volume] in DBS |
|
53339-8
|
11-Deoxycortisol [Moles/volume] in DBS |
|
21034-4
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma --evening specimen |
|
93773-0
|
11-Deoxycortisol [Moles/volume] in Saliva (oral fluid) |
|
1657-6
|
11-Deoxycortisol [Mass/volume] in Serum or Plasma |
|
14567-2
|
11-Deoxycortisol [Moles/volume] in Serum or Plasma |
|
42572-8
|
11-Deoxycortisol [Mass/volume] in Urine |
|
34205-5
|
11-Deoxycortisol [Moles/volume] in Urine |
|
16293-3
|
11-Deoxycorticosteroids [Mass/volume] in Plasma |
|
11061-9
|
11-Dehydro thromboxane beta 2 [Mass/time] in 24 hour Urine |
|
33351-8
|
11-Dehydro thromboxane beta 2 [Mass/volume] in Urine |
|
49734-7
|
11-Dehydro thromboxane beta 2/Creatinine [Mass Ratio] in Urine |
|
82846-7
|
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine |
|
82847-5
|
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Androsterone+etiocholanolone [Molar ratio] in Urine |
|
82849-1
|
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82848-3
|
11-Dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
16110-9
|
11-Deoxycorticosterone [Mass/time] in 24 hour Urine |
|
40818-7
|
11-Deoxycorticosterone [Moles/volume] in 24 hour Urine |
|
55808-0
|
11-Deoxycorticosterone [Moles/time] in 24 hour Urine |
|
53347-1
|
11-Deoxycorticosterone [Mass/volume] in DBS |
|
53348-9
|
11-Deoxycorticosterone [Moles/volume] in DBS |
|
40811-2
|
11-Deoxycorticosterone [Presence] in Serum or Plasma |
|
1656-8
|
11-Deoxycorticosterone [Mass/volume] in Serum or Plasma |
|
25561-2
|
11-Deoxycorticosterone [Moles/volume] in Serum or Plasma |
|
42855-7
|
11-Deoxycorticosterone [Mass/volume] in Urine |
|
26943-1
|
11-Ketoandrosterone [Mass/volume] in 24 hour Urine |
|
6702-5
|
11-Ketoandrosterone [Mass/time] in 24 hour Urine |
|
34213-9
|
11-Ketoandrosterone [Moles/volume] in 24 hour Urine |
|
15005-2
|
11-Ketoandrosterone [Moles/time] in 24 hour Urine |
|
1661-8
|
11-Ketoandrosterone [Mass/volume] in Serum |
|
26944-9
|
11-Ketoandrosterone [Mass/volume] in Urine |
|
34214-7
|
11-Ketoandrosterone [Moles/volume] in Urine |
|
40814-6
|
11-Ketoandrosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
34215-4
|
11-Ketoandrosterone/Creatinine [Molar ratio] in Urine |
|
43359-9
|
11-Ketoetiocholanolone [Mass/volume] in 24 hour Urine |
|
6703-3
|
11-Ketoetiocholanolone [Mass/time] in 24 hour Urine |
|
34216-2
|
11-Ketoetiocholanolone [Moles/volume] in 24 hour Urine |
|
15006-0
|
11-Ketoetiocholanolone [Moles/time] in 24 hour Urine |
|
1662-6
|
11-Ketoetiocholanolone [Mass/volume] in Serum |
|
34217-0
|
11-Ketoetiocholanolone [Moles/volume] in Urine |
|
40815-3
|
11-Ketoetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
|
34396-2
|
11-Ketoetiocholanolone/Creatinine [Molar ratio] in Urine |
|
6704-1
|
11-Ketopregnanetriol [Mass/time] in 24 hour Urine |
|
93242-6
|
11-Ketotestosterone [Mass/volume] in Serum or Plasma |
|
50067-8
|
11-Hydroxyandrostenedione [Moles/volume] in Body fluid |
|
1658-4
|
11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma |
|
47086-4
|
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma |
|
6701-7
|
11-Hydroxyandrosterone [Mass/time] in 24 hour Urine |
|
34207-1
|
11-Hydroxyandrosterone [Moles/volume] in 24 hour Urine |
|
15003-7
|
11-Hydroxyandrosterone [Moles/time] in 24 hour Urine |
|
16296-6
|
11-Hydroxyandrosterone [Mass/volume] in Serum or Plasma |
|
1659-2
|
11-Hydroxyandrosterone [Mass/volume] in Urine |
|
34208-9
|
11-Hydroxyandrosterone [Moles/volume] in Urine |
|
40812-0
|
11-Hydroxyandrosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
34209-7
|
11-Hydroxyandrosterone/Creatinine [Molar ratio] in Urine |
|
6700-9
|
11-Hydroxyetiocholanolone [Mass/time] in 24 hour Urine |
|
34210-5
|
11-Hydroxyetiocholanolone [Moles/volume] in 24 hour Urine |
|
15004-5
|
11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine |
|
1660-0
|
11-Hydroxyetiocholanolone [Mass/volume] in Serum |
|
26950-6
|
11-Hydroxyetiocholanolone [Mass/volume] in Urine |
|
34211-3
|
11-Hydroxyetiocholanolone [Moles/volume] in Urine |
|
40813-8
|
11-Hydroxyetiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
|
34212-1
|
11-Hydroxyetiocholanolone/Creatinine [Molar ratio] in Urine |
|
93243-4
|
11-Hydroxytestosterone [Mass/volume] in Serum or Plasma |
|
80111-8
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Blood by Confirmatory method |
|
70178-9
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood |
|
80112-6
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Body fluid by Confirmatory method |
|
78752-3
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Body fluid by Screen method |
|
78751-5
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/mass] in Hair |
|
78753-1
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method |
|
80113-4
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
|
78754-9
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Urine by Screen method |
|
48935-1
|
11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Unspecified specimen |
|
48934-4
|
11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Unspecified specimen |
|
40865-8
|
11-Oxo-Androsterone [Mass/time] in 24 hour Urine |
|
40866-6
|
11-Oxo-Androsterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
60547-7
|
11-Oxo-Androsterone/Creatinine [Mass Ratio] in Urine |
|
40867-4
|
11-Oxo-Etiocholanolone [Mass/time] in 24 hour Urine |
|
40868-2
|
11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
|
60548-5
|
11-Oxo-Etiocholanolone/Creatinine [Mass Ratio] in Urine |
|
9445-8
|
11-Oxopregnanetriol [Mass/time] in 24 hour Urine |
|
1663-4
|
11-Oxycorticosterone [Mass/volume] in Serum |
|
34534-8
|
EKG 12 channel panel |
|
82256-9
|
Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH |
|
27072-8
|
14-3-3 Ag [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31989-7
|
14-3-3 Ag [Presence] in Cerebral spinal fluid |
|
24031-7
|
14-3-3 Ag [Presence] in Cerebral spinal fluid by Immunoblot |
|
31990-5
|
14-3-3 Ag [Units/volume] in Cerebral spinal fluid |
|
36924-9
|
14-3-3 Ag [Mass/volume] in Cerebral spinal fluid |
|
75880-5
|
14-3-3 eta Ag [Mass/volume] in Serum by Immunoassay |
|
91065-3
|
14-3-3 protein [Presence] in Tissue by NAA with probe detection |
|
80607-5
|
14-Hydroxyclarithromycin [Mass/volume] in DBS |
|
80606-7
|
14-Hydroxyclarithromycin [Mass/volume] in Serum or Plasma |
|
44277-2
|
15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine [Mass Ratio] in Urine |
|
73846-8
|
16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine |
|
73845-0
|
16-Alpha hydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine |
|
73844-3
|
16-Alpha hydroxydehydroepiandrosterone [Moles/volume] in Urine |
|
44278-0
|
16-Alpha hydroxydehydroepiandrosterone/Creatinine [Mass Ratio] in Urine |
|
81801-3
|
16-Alpha hydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine |
|
74508-3
|
16-Alpha hydroxypregnenolone [Moles/volume] in 24 hour Urine |
|
74506-7
|
16-Alpha hydroxypregnenolone [Moles/time] in 24 hour Urine |
|
74507-5
|
16-Alpha hydroxypregnenolone [Moles/volume] in Urine |
|
44279-8
|
16-Alpha hydroxypregnenolone/16-Alpha hydroxydehydroepiandrosterone [Mass Ratio] in Urine |
|
43688-1
|
16-Alpha hydroxypregnenolone/Creatinine [Mass Ratio] in Urine |
|
81799-9
|
16-Alpha hydroxypregnenolone/Creatinine [Molar ratio] in Urine |
|
49825-3
|
16-Alpha hydroxyestrone [Mass/volume] in Serum or Plasma |
|
74504-2
|
16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in 24 hour Urine |
|
74505-9
|
16-Beta,18-dihydroxydehydroepiandrosterone [Moles/time] in 24 hour Urine |
|
74503-4
|
16-Beta,18-dihydroxydehydroepiandrosterone [Moles/volume] in Urine |
|
81802-1
|
16-Beta,18-dihydroxydehydroepiandrosterone/Creatinine [Molar ratio] in Urine |
|
73847-6
|
16-Ketoandrostenediol [Moles/volume] in 24 hour Urine |
|
73848-4
|
16-Ketoandrostenediol [Moles/time] in 24 hour Urine |
|
73849-2
|
16-Ketoandrostenediol [Moles/volume] in Urine |
|
81800-5
|
16-Ketoandrostenediol/Creatinine [Molar ratio] in Urine |
|
61106-1
|
16p11.2 chromosome region deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
44280-6
|
17 Alpha-hydroxypregnanolone/Creatinine [Mass Ratio] in Urine |
|
43726-9
|
17-Ketogenic steroids [Presence] in 24 hour Urine |
|
27866-3
|
17-Ketogenic steroids [Mass/volume] in 24 hour Urine |
|
1673-3
|
17-Ketogenic steroids [Mass/time] in 24 hour Urine |
|
50798-8
|
17-Ketogenic steroids [Moles/volume] in 24 hour Urine |
|
27979-4
|
17-Ketogenic steroids [Moles/time] in 24 hour Urine |
|
16300-6
|
17-Ketogenic steroids [Mass/time] in 72 hour Urine |
|
1671-7
|
17-Ketogenic steroids [Mass/volume] in Blood |
|
21038-5
|
17-Ketosteroids [Mass/volume] in 24 hour Urine |
|
6766-0
|
17-Ketosteroids [Mass/time] in 24 hour Urine |
|
25317-9
|
17-Ketosteroids [Moles/volume] in 24 hour Urine |
|
14572-2
|
17-Ketosteroids [Moles/time] in 24 hour Urine |
|
29353-0
|
17-Ketosteroids.total neutral [Mass/time] in 12 hour Urine |
|
12769-6
|
17-Ketosteroids.total neutral [Mass/time] in 24 hour Urine |
|
47978-2
|
17-Ketosteroids [Mass/volume] in Serum |
|
34222-0
|
17-Ketosteroids [Moles/volume] in Urine |
|
44281-4
|
17-Ketosteroids/Creatinine [Mass Ratio] in 24 hour Urine |
|
33347-6
|
17-Ketosteroids/Creatinine [Mass Ratio] in Urine |
|
34223-8
|
17-Ketosteroids/Creatinine [Molar ratio] in Urine |
|
43135-3
|
17-Ketosteroids and 17-Ketogenic steroids panel - 24 hour Urine |
|
6866-8
|
17-Hydroxycorticosteroids [Mass/volume] in 24 hour Urine |
|
21036-9
|
17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine |
|
25852-5
|
17-Hydroxycorticosteroids [Moles/volume] in 24 hour Urine |
|
14568-0
|
17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine |
|
1664-2
|
17-Hydroxycorticosteroids [Mass/volume] in Amniotic fluid |
|
1665-9
|
17-Hydroxycorticosteroids [Mass/volume] in Plasma |
|
1666-7
|
17-Hydroxycorticosteroids [Mass/volume] in Urine |
|
34218-8
|
17-Hydroxycorticosteroids [Moles/volume] in Urine |
|
41404-5
|
17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in 24 hour Urine |
|
38472-7
|
17-Hydroxycorticosteroids/Creatinine [Mass Ratio] in Urine |
|
34219-6
|
17-Hydroxycorticosteroids/Creatinine [Molar ratio] in Urine |
|
53336-4
|
17-Hydroxyprogesterone+Androstenedione/Cortisol [Mass Ratio] in DBS |
|
53337-2
|
17-Hydroxyprogesterone+Androstenedione/Cortisol [Molar ratio] in DBS |
|
32152-1
|
17-Hydroxyketosteroids [Mass/time] in 24 hour Urine |
|
1667-5
|
17-Hydroxyketosteroids [Mass/volume] in Urine |
|
74350-0
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --20M post dose corticotropin |
|
9616-4
|
17-Hydroxyprogesterone [Mass/time] in 24 hour Urine |
|
34220-4
|
17-Hydroxyprogesterone [Moles/volume] in 24 hour Urine |
|
14571-4
|
17-Hydroxyprogesterone [Moles/time] in 24 hour Urine |
|
40754-4
|
17-Hydroxyprogesterone [Mass/volume] in Amniotic fluid |
|
69796-1
|
17-Hydroxyprogesterone [Moles/volume] in Amniotic fluid |
|
92726-9
|
17-Hydroxyprogesterone [Mass/volume] in DBS by LC/MS/MS |
|
32854-2
|
17-Hydroxyprogesterone [Presence] in DBS |
|
48616-7
|
17-Hydroxyprogesterone [Units/volume] in DBS |
|
38473-5
|
17-Hydroxyprogesterone [Mass/volume] in DBS |
|
53340-6
|
17-Hydroxyprogesterone [Moles/volume] in DBS |
|
72490-6
|
17-Hydroxyprogesterone [Moles/volume] in Saliva (oral fluid) |
|
1668-3
|
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma |
|
14569-8
|
17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma |
|
26908-4
|
17-Hydroxyprogesterone [Units/volume] in Urine |
|
1670-9
|
17-Hydroxyprogesterone [Mass/volume] in Urine |
|
14570-6
|
17-Hydroxyprogesterone [Moles/volume] in Urine |
|
63042-6
|
17-Hydroxyprogesterone/Creatinine [Mass Ratio] in Urine |
|
34221-2
|
17-Hydroxyprogesterone/Creatinine [Molar ratio] in Urine |
|
21037-7
|
17-Hydroxypregnenolone [Mass/time] in 24 hour Urine |
|
50249-2
|
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
|
6765-2
|
17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma |
|
25316-1
|
17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma |
|
16297-4
|
17-Hydroxypregnenolone [Mass/volume] in Urine |
|
83138-8
|
17-Hydroxypregnenetriol [Moles/time] in 24 hour Urine |
|
83140-4
|
17-Hydroxypregnenetriol [Moles/volume] in Urine |
|
83139-6
|
17-Hydroxypregnenetriol/Creatinine [Molar ratio] in Urine |
|
9639-6
|
18-Hydroxycorticosterone [Mass/time] in 24 hour Urine |
|
1674-1
|
18-Hydroxycorticosterone [Mass/volume] in Serum or Plasma |
|
50082-7
|
18-Hydroxycorticosterone [Moles/volume] in Serum or Plasma |
|
42573-6
|
18-Hydroxycorticosterone [Mass/volume] in Urine |
|
21039-3
|
18-Hydroxycortisol [Mass/volume] in 24 hour Urine |
|
14148-1
|
18-Hydroxycortisol [Mass/time] in 24 hour Urine |
|
55812-2
|
18-Hydroxycortisol [Moles/volume] in 24 hour Urine |
|
55811-4
|
18-Hydroxycortisol [Moles/time] in 24 hour Urine |
|
55810-6
|
18-Hydroxycortisol [Moles/volume] in Serum or Plasma |
|
27199-9
|
18-Hydroxycortisol/Creatinine [Mass Ratio] in 24 hour Urine |
|
6767-8
|
18-Hydroxycorticosteroids [Mass/volume] in Serum |
|
26988-6
|
18-Hydroxydeoxycorticosterone [Mass/time] in 24 hour Urine |
|
11206-0
|
18-Hydroxydeoxycorticosterone [Mass/volume] in Serum or Plasma |
|
50081-9
|
18-Hydroxydeoxycorticosterone [Moles/volume] in Serum or Plasma |
|
46108-7
|
18q chromosome deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38692-0
|
1-Butene oxide [Mass/volume] in Air |
|
48334-7
|
1 minute Apgar panel |
|
50065-2
|
1-Methylhistidine [Moles/volume] in DBS |
|
50066-0
|
1-Methylhistidine [Moles/volume] in Body fluid |
|
70179-7
|
1-Methylhistidine [Moles/volume] in Serum or Plasma from Fetus |
|
56666-1
|
1-Methylhistidine/Creatinine [Ratio] in 24 hour Urine |
|
1654-3
|
1-Naphthalene [Mass/volume] in Urine |
|
60036-1
|
1-Naphthol [Mass/volume] in Blood |
|
60037-9
|
1-Naphthol [Mass/volume] in Body fluid |
|
9681-8
|
1-Naphthol [Mass/volume] in Serum or Plasma |
|
60038-7
|
1-Naphthol [Mass/mass] in Tissue |
|
42574-4
|
1-Naphthol [Presence] in Urine |
|
35480-3
|
1-Naphthol [Mass/volume] in Urine |
|
78755-6
|
1-Hydroxymidazolam [Mass/volume] in Blood |
|
79131-9
|
1-Hydroxymidazolam [Mass/volume] in Body fluid |
|
59588-4
|
1-Hydroxymidazolam [Mass/mass] in Meconium |
|
69797-9
|
1-Hydroxymidazolam [Mass/volume] in Serum or Plasma |
|
59590-0
|
1-Hydroxymidazolam [Mass/volume] in Urine by Confirmatory method |
|
94108-8
|
1-Hydroxymidazolam [Presence] in Urine by Screen method |
|
59589-2
|
1-Hydroxymidazolam [Mass/volume] in Urine |
|
82250-2
|
Chromosome region 1p subtelomere and 1p36 deletion and 1q25 rearrangement in Blood or Tissue by FISH |
|
42634-6
|
1p and 19q chromosome deletion [Presence] in Fixed tissue by Molecular genetics method |
|
14259-6
|
1-Pentanol [Mass/volume] in Blood |
|
48798-3
|
First trimester maternal screen panel - Serum or Plasma |
|
49086-2
|
First trimester maternal screen with nuchal translucency panel |
|
62443-7
|
Single view Teeth Document XR |
|
73987-0
|
2,2',3,4,4',5-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
74375-7
|
2,2',3,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
74376-5
|
2,2',4,4',5,5'-Hexachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73988-8
|
2,2',4,5,5'-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73991-2
|
2,2',5,5'-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73992-0
|
2,2',5-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73989-6
|
2,3',4,4',5-Pentachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73990-4
|
2,3',4',5-Tetrachlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
87651-6
|
2,3,5-trimethylphenyl methylcarbamate [Mass/mass] in Unspecified specimen |
|
1675-8
|
2,3-Diphosphoglycerate [Mass/volume] in Red Blood Cells |
|
15007-8
|
2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells |
|
49217-3
|
2,3-Diphosphoglycerate [Moles/mass] in Red Blood Cells |
|
1676-6
|
2,3-Diphosphoglycerate [Mass/volume] in Serum |
|
74374-0
|
2,4,4'-Trichlorobiphenyl (PCB) [Mass/volume] in Serum or Plasma by Confirmatory method |
|
38729-0
|
2,4,5-Trichlorophenol [Mass/volume] in Air |
|
38730-8
|
2,4,6-Trichlorophenol [Mass/volume] in Air |
|
43725-1
|
2,4-Dichlorophenol [Presence] in Urine |
|
38741-5
|
2,4-Dinitrophenol [Mass/volume] in Air |
|
38742-3
|
2,4-Dinitrotoluene [Mass/volume] in Air |
|
38754-8
|
2,4-Toluene diisocyanate [Mass/volume] in Air |
|
43724-4
|
2,5-Dichlorophenol [Presence] in Urine |
|
69798-7
|
2,5-dimethoxy-4-bromoamphetamine [Presence] in Urine |
|
79475-0
|
2,5-Furandicarboxylate [Moles/volume] in Serum or Plasma |
|
79522-9
|
2,5-Furandicarboxylate/Creatinine [Molar ratio] in Urine |
|
1678-2
|
20-Hydroxyprogesterone [Mass/volume] in Serum |
|
53628-4
|
20q chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
|
50093-4
|
21-Deoxycortisol [Moles/volume] in Amniotic fluid |
|
53341-4
|
21-Deoxycortisol [Mass/volume] in DBS |
|
53342-2
|
21-Deoxycortisol [Moles/volume] in DBS |
|
74872-3
|
21-Deoxycortisol [Mass/volume] in Serum or Plasma |
|
50250-0
|
21-Deoxycortisol [Moles/volume] in Serum or Plasma |
|
69799-5
|
21-Deoxycorticosterone [Moles/volume] in Serum or Plasma |
|
85363-0
|
21-Hydroxylase Ab [Presence] in Serum |
|
17781-6
|
21-Hydroxylase Ab [Units/volume] in Serum |
|
1679-0
|
24r-Hydroxycalcidiol [Mass/volume] in Serum or Plasma |
|
49054-0
|
25-Hydroxycalciferol [Mass/volume] in Serum or Plasma |
|
46269-7
|
25-Hydroxycalciferol [Moles/volume] in Serum or Plasma |
|
86918-0
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 goal [Mass/volume] Serum or Plasma |
|
83070-3
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma by Immunoassay |
|
83071-1
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Moles/volume] in Serum or Plasma by Immunoassay |
|
62292-8
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma |
|
68438-1
|
25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Moles/volume] in Serum or Plasma |
|
55814-8
|
Calcidiol [Moles/volume] in Cord blood |
|
1989-3
|
Calcidiol [Mass/volume] in Serum or Plasma |
|
35196-5
|
Calcidiol [Mass or Moles/volume] in Serum or Plasma |
|
14635-7
|
Calcidiol [Moles/volume] in Serum or Plasma |
|
73998-7
|
25H-NBOMe [Presence] in Urine by Confirmatory method |
|
74000-1
|
25I-NBOMe [Presence] in Urine by Confirmatory method |
|
80159-7
|
27-Norcholestanehexol/Creatinine [Ratio] in Urine |
|
38687-0
|
2-Acetylaminofluorene [Mass/volume] in Air |
|
80165-4
|
2-Amino-4-hydroxypteridine [Moles/volume] in Cerebral spinal fluid |
|
80166-2
|
2-Amino-4-hydroxypteridine [Moles/volume] in Serum or Plasma |
|
80167-0
|
2-Amino-4-hydroxypteridine/Creatinine [Molar ratio] in Serum or Plasma |
|
38728-2
|
2-Aminotoluene [Mass/volume] in Air |
|
35585-9
|
2-Butoxyacetate [Mass/volume] in Urine |
|
38655-7
|
2-Chloroacetophenone [Mass/volume] in Air |
|
38651-6
|
2-Chloro-1,3-Butadiene [Mass/volume] in Air |
|
73999-5
|
2C-C-NBOMe [Presence] in Urine by Confirmatory method |
|
34552-0
|
2D echocardiogram panel |
|
69805-0
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --12 hours post dose ifosfamide |
|
69810-0
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --1 day post dose ifosfamide |
|
69809-2
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --1 day post dose ifosfamide |
|
50266-6
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide |
|
69812-6
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --2 days post dose ifosfamide |
|
69811-8
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --2 days post dose ifosfamide |
|
50267-4
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide |
|
69814-2
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --3 days post dose ifosfamide |
|
69813-4
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --3 days post dose ifosfamide |
|
50268-2
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide |
|
50271-6
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide |
|
69816-7
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --4 days post dose ifosfamide |
|
69815-9
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --4 days post dose ifosfamide |
|
50269-0
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide |
|
69818-3
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --5 days post dose ifosfamide |
|
69817-5
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --5 days post dose ifosfamide |
|
50270-8
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide |
|
69821-7
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --6 days post dose ifosfamide |
|
69820-9
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --6 days post dose ifosfamide |
|
69819-1
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide |
|
50272-4
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide |
|
69824-1
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --7 days post dose ifosfamide |
|
69823-3
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --7 days post dose ifosfamide |
|
69822-5
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --7 days post dose ifosfamide |
|
69806-8
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --post dose ifosfamide |
|
69808-4
|
2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --pre dose ifosfamide |
|
69807-6
|
2-Dechloroethylifosfamide [Mass/time] in 24 hour Urine --pre dose ifosfamide |
|
50265-8
|
2-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide |
|
47807-3
|
2-Deoxytetronate/Creatinine [Molar ratio] in Urine |
|
35587-5
|
2-Ethoxyacetate [Mass/volume] in Urine |
|
69825-8
|
2-Ethylhydracrylate [Moles/volume] in Cerebral spinal fluid |
|
69826-6
|
2-Ethylhydracrylate [Moles/volume] in Serum or Plasma |
|
47808-1
|
2-Ethylhydracrylate/Creatinine [Molar ratio] in Urine |
|
59190-9
|
2-Hydroxycaproate/Creatinine [Molar ratio] in Urine |
|
17683-4
|
2-Methyl-2-Propanol [Mass/volume] in Blood |
|
9683-4
|
2-Methyl-2-Propanol [Mass/volume] in Unspecified specimen |
|
69788-8
|
2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Cerebral spinal fluid |
|
69789-6
|
2-methyl-3-hydroxybutyrate (C5-OH) [Moles/volume] in Serum or Plasma |
|
50087-6
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid |
|
50088-4
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid |
|
50086-8
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in DBS |
|
50090-0
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
|
50089-2
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Urine |
|
50091-8
|
2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine |
|
47810-7
|
2-Methyl-3-Hydroxyvalerate [Moles/volume] in Plasma |
|
50085-0
|
2-Methyl-3-Hydroxyvalerate/Creatinine [Molar ratio] in Urine |
|
47811-5
|
2-Methyl-3-Oxobutyrate/Creatinine [Molar ratio] in Urine |
|
69790-4
|
2-Methylbutyrylglycine [Moles/volume] in Serum or Plasma |
|
50092-6
|
2-Methylcitrate [Moles/volume] in Cerebral spinal fluid |
|
82386-4
|
2-Methylcitrate [Moles/volume] in DBS |
|
44284-8
|
2-Methylcitrate/Creatinine [Molar ratio] in 24 hour Urine |
|
47812-3
|
2-Methylglutaconate/Creatinine [Molar ratio] in Urine |
|
69827-4
|
2-Methylglutarate [Moles/volume] in Serum or Plasma |
|
47813-1
|
2-Methylglutarate/Creatinine [Molar ratio] in Urine |
|
17276-7
|
2-Methylpentane [Mass/volume] in Blood |
|
16305-5
|
2-Methoxyethanol [Mass/volume] in Blood |
|
69786-2
|
2-Methylacetoacetate [Moles/volume] in Cerebral spinal fluid |
|
69787-0
|
2-Methylacetoacetate [Moles/volume] in Serum or Plasma |
|
59377-2
|
2-Methylacetoacetate/Creatinine [Molar ratio] in Urine |
|
80894-9
|
2-Methyltyrosine/Creatinine [Molar ratio] in Urine |
|
83143-8
|
2-Minute Walk Endurance Test [NIH Toolbox] |
|
35086-8
|
Second trimester triple maternal screen panel - Serum or Plasma |
|
48800-7
|
Second trimester quad maternal screen panel - Serum or Plasma |
|
48799-1
|
Second trimester penta maternal screen panel - Serum or Plasma |
|
38711-8
|
2-Nitropropane [Mass/volume] in Air |
|
49828-7
|
2-Hydroxyestrone and 16-Alpha hydroxyestrone panel - Serum or Plasma |
|
69838-1
|
2-Hydroxy-3-Methylvalerate [Moles/volume] in Cerebral spinal fluid |
|
69839-9
|
2-Hydroxy-3-Methylvalerate [Moles/volume] in Serum or Plasma |
|
69840-7
|
2-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid |
|
69841-5
|
2-Hydroxyadipate [Moles/volume] in Serum or Plasma |
|
49826-1
|
2-Hydroxyestrone [Mass/volume] in Serum or Plasma |
|
94110-4
|
2-Hydroxyethylflurazepam [Presence] in Urine by Screen method |
|
43635-2
|
2-Hydroxyglutarate [Presence] in 24 hour Urine |
|
75036-4
|
2-Hydroxyglutarate [Moles/volume] in Amniotic fluid |
|
69844-9
|
2-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
|
75037-2
|
2-Hydroxyglutarate [Moles/volume] in DBS |
|
69845-6
|
2-Hydroxyglutarate [Moles/volume] in Serum or Plasma |
|
69846-4
|
2-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid |
|
69847-2
|
2-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma |
|
69848-0
|
2-Hydroxyisocaproate [Moles/volume] in Cerebral spinal fluid |
|
69849-8
|
2-Hydroxyisocaproate [Moles/volume] in Serum or Plasma |
|
43226-0
|
2-Hydroxyisocaproate [Presence] in Urine |
|
44282-2
|
2-Hydroxyisocaproate/Creatinine [Mass Ratio] in 24 hour Urine |
|
69780-5
|
2-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid |
|
69781-3
|
2-Hydroxyisovalerate [Moles/volume] in Serum or Plasma |
|
69782-1
|
2-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid |
|
69783-9
|
2-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma |
|
29883-6
|
2-Hydroxyphenylacetate [Presence] in Urine |
|
44283-0
|
2-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine |
|
47534-3
|
2-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
|
69784-7
|
2-Hydroxysebacate [Moles/volume] in Cerebral spinal fluid |
|
69785-4
|
2-Hydroxysebacate [Moles/volume] in Serum or Plasma |
|
47809-9
|
2-Hydroxysebacate/Creatinine [Molar ratio] in Urine |
|
48608-4
|
2-Hydroxyvalerate/Creatinine [Mass Ratio] in Urine |
|
35869-7
|
2-Oxo,3-Methylvalerate [Moles/volume] in Serum or Plasma |
|
29864-6
|
2-Oxo,3-Methylvalerate [Presence] in Urine |
|
13676-2
|
2-Oxo,3-Methylvalerate/Creatinine [Mass Ratio] in Urine |
|
25083-7
|
2-Oxo,3-Methylvalerate/Creatinine [Molar ratio] in Urine |
|
80114-2
|
2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Blood by Confirmatory method |
|
78756-4
|
2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Blood by Screen method |
|
78757-2
|
2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Screen method |
|
45185-6
|
2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Urine |
|
69801-9
|
2-Oxoadipate [Moles/volume] in Cerebral spinal fluid |
|
69768-0
|
2-Oxoadipate [Moles/volume] in Serum or Plasma |
|
69804-3
|
2-Oxoisocaproate [Moles/volume] in Cerebral spinal fluid |
|
3291-2
|
2-Pyridone [Mass/volume] in Serum or Plasma |
|
3292-0
|
2-Pyridone/N'-methylnicotinamide [Mass Ratio] in Serum or Plasma |
|
86504-8
|
These questions three panel |
|
38667-2
|
3,3'-Dimethoxybenzidine [Mass/volume] in Air |
|
87737-3
|
3,4,5-trimethylphenyl methylcarbamate [Mass/mass] in Unspecified specimen |
|
79480-0
|
3,4-Dihydroxyhydrocinnamate [Moles/volume] in Serum or Plasma |
|
79490-9
|
3,4-Dihydroxyhydrocinnamate/Creatinine [Molar ratio] in Urine |
|
79488-3
|
3,4-Dihydroxybutyrate [Moles/volume] in Serum or Plasma |
|
79474-3
|
3,4-Dihydroxybutyrate/Creatinine [Molar ratio] in Urine |
|
69830-8
|
3,4-Dihydroxyphenylacetate [Moles/volume] in 24 hour Urine |
|
53548-4
|
3,4-Dihydroxyphenylacetate [Moles/time] in 24 hour Urine |
|
53544-3
|
3,4-Dihydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid |
|
53547-6
|
3,4-Dihydroxyphenylacetate [Moles/volume] in Serum or Plasma |
|
55816-3
|
3,4-Dihydroxyphenylacetate [Moles/volume] in Urine |
|
53551-8
|
3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in 24 hour Urine |
|
69831-6
|
3,4-Dihydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
|
47814-9
|
3,4-Dihydroxyphenyllactate/Creatinine [Molar ratio] in Urine |
|
47815-6
|
3,4-Hydroxymandelate/Creatinine [Molar ratio] in Urine |
|
79526-0
|
3,5-Dihydroxybenzoate [Moles/volume] in Serum or Plasma |
|
79486-7
|
3,5-Dihydroxybenzoate/Creatinine [Molar ratio] in Urine |
|
48078-0
|
3,6-Epoxydecanedioate/Creatinine [Molar ratio] in Urine |
|
48079-8
|
3,6-Epoxydodecanedioate/Creatinine [Molar ratio] in Urine |
|
48080-6
|
3,6-Epoxyoctanedioate/Creatinine [Molar ratio] in Urine |
|
48081-4
|
3,6-Epoxytetradecanedioate/Creatinine [Molar ratio] in Urine |
|
82865-7
|
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in 24 hour Urine |
|
82864-0
|
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/time] in 24 hour Urine |
|
82863-2
|
3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone [Moles/volume] in Urine |
|
34224-6
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in 24 hour Urine |
|
25855-8
|
3-Alpha-Androstanediol glucuronide [Moles/time] in 24 hour Urine |
|
1680-8
|
3-Alpha-Androstanediol glucuronide [Mass/volume] in Serum |
|
15008-6
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum |
|
34225-3
|
3-Alpha-Androstanediol glucuronide [Moles/volume] in Urine |
|
34226-1
|
3-Alpha-Androstanediol glucuronide/Creatinine [Molar ratio] in Urine |
|
13610-1
|
3-Beta-Androstanediol [Mass/volume] in Serum or Plasma |
|
47816-4
|
3-Deoxytetronate/Creatinine [Molar ratio] in Urine |
|
50285-6
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide |
|
50286-4
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide |
|
50287-2
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide |
|
50290-6
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide |
|
50288-0
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide |
|
50289-8
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --6 days post dose ifosfamide |
|
50291-4
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide |
|
50145-2
|
3-Dechloroethylifosfamide [Mass/volume] in Blood --pre dose ifosfamide |
|
72404-7
|
3-epi-25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma |
|
72403-9
|
3-epi-25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma |
|
75088-5
|
3-Indolelactate [Moles/volume] in Serum or Plasma |
|
47821-4
|
3-Indolelactate/Creatinine [Molar ratio] in Urine |
|
50392-0
|
3-Keto n-Valerate [Moles/volume] in Cerebral spinal fluid |
|
53467-7
|
3-Keto n-Valerate [Moles/volume] in Serum or Plasma |
|
50393-8
|
3-Keto n-Valerate/Creatinine [Molar ratio] in Urine |
|
59376-4
|
3-Keto, 2-Methylvalerate/Creatinine [Molar ratio] in Urine |
|
82218-9
|
3-Methylcrotonyl-CoA carboxylase [Enzymatic activity/mass] in Fibroblast |
|
21043-5
|
3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in 24 hour Urine |
|
9695-8
|
3-Methoxy-4-Hydroxyphenylglycol [Mass/time] in 24 hour Urine |
|
53496-6
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in 24 hour Urine |
|
53098-0
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/time] in 24 hour Urine |
|
47538-4
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Cerebral spinal fluid |
|
50135-3
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Serum or Plasma |
|
43634-5
|
3-Methoxy-4-Hydroxyphenylglycol [Presence] in Urine |
|
1684-0
|
3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in Urine |
|
50136-1
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/volume] in Urine |
|
50137-9
|
3-Methoxy-4-Hydroxyphenylglycol [Moles/time] in Urine |
|
50138-7
|
3-Methoxy-4-Hydroxyphenylglycol/Creatinine [Molar ratio] in Urine |
|
72441-9
|
3-Methylcrotonylglycine [Moles/volume] in Amniotic fluid |
|
72442-7
|
3-Methylcrotonylglycine [Moles/volume] in Cerebral spinal fluid |
|
41039-9
|
3-Methylcrotonylglycine [Moles/volume] in Serum or Plasma |
|
44285-5
|
3-Methylcrotonylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
93465-3
|
3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
72440-1
|
3-Methylglutaconate [Moles/volume] in Cerebral spinal fluid |
|
72438-5
|
3-Methylglutarate [Moles/volume] in Cerebral spinal fluid |
|
72439-3
|
3-Methylglutarate [Moles/volume] in Serum or Plasma |
|
72423-7
|
3-Methylhistidine [Moles/volume] in Blood from Fetus |
|
47539-2
|
3-Methylhistidine [Moles/volume] in DBS |
|
47540-0
|
3-Methylhistidine [Moles/volume] in Body fluid |
|
72424-5
|
3-Methylhistidine/Amino acids.total in Serum or Plasma |
|
44286-3
|
3-Methylhistidine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56667-9
|
3-Methylhistidine/Creatinine [Ratio] in 24 hour Urine |
|
10973-6
|
3 methoxy O desmethylencainide [Mass/volume] in Serum or Plasma |
|
72443-5
|
3-Methyladipate [Moles/volume] in Serum or Plasma |
|
47822-2
|
3-Methyladipate/Creatinine [Molar ratio] in Urine |
|
54344-7
|
3-Methoxytyramine [Mass/volume] in 24 hour Urine |
|
32618-1
|
3-Methoxytyramine [Mass/time] in 24 hour Urine |
|
48380-0
|
3-Methoxytyramine [Moles/volume] in 24 hour Urine |
|
40409-5
|
3-Methoxytyramine [Moles/time] in 24 hour Urine |
|
50139-5
|
3-Methoxytyramine [Moles/volume] in Cerebral spinal fluid |
|
50140-3
|
3-Methoxytyramine [Moles/volume] in Serum or Plasma |
|
54343-9
|
3-Methoxytyramine/Creatinine [Mass Ratio] in 24 hour Urine |
|
48381-8
|
3-Methoxytyramine/Creatinine [Molar ratio] in 24 hour Urine |
|
80156-3
|
3-Methoxytyramine/Creatinine [Molar ratio] in Urine |
|
82219-7
|
3-Methylglutaconyl-CoA hydratase [Enzymatic activity/mass] in Fibroblast |
|
48760-3
|
3-Hydroxy fatty acid panel - Serum or Plasma |
|
69833-2
|
3-Hydroxy,3-Methylglutarate [Moles/volume] in Amniotic fluid |
|
69832-4
|
3-Hydroxy,3-Methylglutarate [Moles/volume] in Cerebral spinal fluid |
|
69834-0
|
3-Hydroxy,3-Methylglutarate [Moles/volume] in Serum or Plasma |
|
29867-9
|
3-Hydroxy,3-Methylglutarate [Presence] in Urine |
|
13682-0
|
3-Hydroxy,3-Methylglutarate/Creatinine [Mass Ratio] in Urine |
|
26583-5
|
3-Hydroxy,3-Methylglutarate/Creatinine [Molar ratio] in Urine |
|
47817-2
|
3-Hydroxy,4-Methoxybenzoate/Creatinine [Molar ratio] in Urine |
|
79479-2
|
3-Hydroxyadipate 3,6-lactone [Moles/volume] in Serum or Plasma |
|
48082-2
|
3-Hydroxyadipate 3,6-lactone/Creatinine [Molar ratio] in Urine |
|
69835-7
|
3-Hydroxyadipate [Moles/volume] in Cerebral spinal fluid |
|
69836-5
|
3-Hydroxyadipate [Moles/volume] in Serum or Plasma |
|
55888-2
|
3-Hydroxyanthranilate [Moles/time] in 24 hour Urine |
|
55887-4
|
3-Hydroxyanthranilate [Moles/volume] in Serum or Plasma |
|
55889-0
|
3-Hydroxyanthranilate [Moles/volume] in Urine |
|
79497-4
|
3-Hydroxybenzoate [Moles/volume] in Serum or Plasma |
|
79518-7
|
3-Hydroxybenzoate/Creatinine [Molar ratio] in Urine |
|
50103-1
|
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Amniotic fluid |
|
50101-5
|
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Cerebral spinal fluid |
|
50102-3
|
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS |
|
74595-0
|
3-Hydroxybutyrylcarnitine (C4-OH) [Enzymatic activity/mass] in Fibroblast |
|
53105-3
|
3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Urine |
|
50251-8
|
3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine |
|
69012-3
|
3-Hydroxybenzoylecgonine [Mass/mass] in Meconium by Confirmatory method |
|
40901-1
|
3-Hydroxybenzoylecgonine [Mass/mass] in Meconium |
|
50593-3
|
3-Hydroxybenzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
50594-1
|
3-Hydroxybenzoylecgonine [Mass/volume] in Urine by Confirmatory method |
|
48763-7
|
3-Hydroxydecanoate (3-OH-C10:0) [Moles/volume] in Serum or Plasma |
|
48755-3
|
3-Hydroxydecanoate.free (3-OH-C10:0) [Moles/volume] in Serum or Plasma |
|
81811-2
|
3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS |
|
74509-1
|
3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma |
|
81810-4
|
3-Hydroxydecanoylcarnitine (C10-OH)/Creatinine [Molar ratio] in Urine |
|
53182-2
|
3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in DBS |
|
82478-9
|
3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Serum or Plasma |
|
48083-0
|
3-Hydroxydodecanedienedioate/Creatinine [Molar ratio] in Urine |
|
48084-8
|
3-Hydroxydodecanedioate (3-OH-D-C12)/Creatinine [Molar ratio] in Urine |
|
48754-6
|
3-Hydroxydodecanoate (3-OH-C12:0) [Moles/volume] in Serum or Plasma |
|
48753-8
|
3-Hydroxydodecanoate.free (3-OH-C12:0) [Moles/volume] in Serum or Plasma |
|
75078-6
|
3-Hydroxydodecanoate (3-OH-C12:0)/Creatinine [Molar ratio] in Urine |
|
53189-7
|
3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS |
|
81809-6
|
3-Hydroxydodecanoylcarnitine (C12-OH)/Creatinine [Molar ratio] in Urine |
|
48085-5
|
3-Hydroxydodecenedioate/Creatinine [Molar ratio] in Urine |
|
53188-9
|
3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in DBS |
|
59195-8
|
3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Serum or Plasma |
|
74510-9
|
3-Hydroxyeicosanoylcarnitine (C20-OH) [Moles/volume] in Serum or Plasma |
|
69850-6
|
3-Hydroxyglutarate [Moles/volume] in Amniotic fluid |
|
69837-3
|
3-Hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
|
82505-9
|
3-Hydroxyglutarate [Moles/volume] in DBS |
|
69851-4
|
3-Hydroxyglutarate [Moles/volume] in Serum or Plasma |
|
48759-5
|
3-Hydroxyhexanoate (3-OH-C6:0) [Moles/volume] in Serum or Plasma |
|
48758-7
|
3-Hydroxyhexanoate.free (3-OH-C6:0) [Moles/volume] in Serum or Plasma |
|
47818-0
|
3-Hydroxyhexanoate (3-OH-C6:0)/Creatinine [Molar ratio] in Urine |
|
53173-1
|
3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS |
|
79510-4
|
3-Hydroxyhippurate [Moles/volume] in Serum or Plasma |
|
79501-3
|
3-Hydroxyhippurate/Creatinine [Molar ratio] in Urine |
|
69852-2
|
3-Hydroxyisobutyrate [Moles/volume] in Cerebral spinal fluid |
|
69853-0
|
3-Hydroxyisobutyrate [Moles/volume] in Serum or Plasma |
|
72449-2
|
3-Hydroxyisovalerate [Moles/volume] in Cerebral spinal fluid |
|
72450-0
|
3-Hydroxyisovalerate [Moles/volume] in Serum or Plasma |
|
50105-6
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Amniotic fluid |
|
50104-9
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Cerebral spinal fluid |
|
50106-4
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS |
|
50107-2
|
3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Urine |
|
53171-5
|
3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) [Molar ratio] in DBS |
|
53172-3
|
3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
|
50252-6
|
3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine |
|
51412-5
|
3-Hydroxyisovalerylcarnitine+2-Methyl,3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
|
74930-9
|
3-Hydroxykynurenin [Moles/volume] in Cerebral spinal fluid |
|
74430-0
|
3-Hydroxykynurenin [Moles/volume] in Serum or Plasma |
|
50111-4
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Amniotic fluid |
|
50110-6
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Cerebral spinal fluid |
|
50109-8
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS |
|
50108-0
|
3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Urine |
|
50112-2
|
3-Hydroxylinoleoylcarnitine (C18:2-OH)/Creatinine [Molar ratio] in Urine |
|
48762-9
|
3-Hydroxymyristate (3-OH-C14:0) [Moles/volume] in Serum or Plasma |
|
48752-0
|
3-Hydroxymyristate.free (3-OH-C14:0) [Moles/volume] in Serum or Plasma |
|
50274-0
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Amniotic fluid |
|
50276-5
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Cerebral spinal fluid |
|
50275-7
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in DBS |
|
74604-0
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Enzymatic activity/mass] in Fibroblast |
|
50277-3
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Serum or Plasma |
|
50273-2
|
3-Hydroxymyristoleylcarnitine (C14:1-OH) [Moles/volume] in Urine |
|
50278-1
|
3-Hydroxymyristoleylcarnitine (C14:1-OH)/Creatinine [Molar ratio] in Urine |
|
48757-9
|
3-Hydroxyoctanoate (3-OH-C8:0) [Moles/volume] in Serum or Plasma |
|
48756-1
|
3-Hydroxyoctanoate.free (3-OH-C8:0) [Moles/volume] in Serum or Plasma |
|
53178-0
|
3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBS |
|
53179-8
|
3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
|
50115-5
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Amniotic fluid |
|
50114-8
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Cerebral spinal fluid |
|
50113-0
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS |
|
50116-3
|
3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Urine |
|
50117-1
|
3-Hydroxyoleoylcarnitine (C18:1-OH)/Creatinine [Molar ratio] in Urine |
|
48761-1
|
3-Hydroxypalmitate (3-OH-C16:0) [Moles/volume] in Serum or Plasma |
|
48751-2
|
3-Hydroxypalmitate.free (3-OH-C16:0) [Moles/volume] in Serum or Plasma |
|
50120-5
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Amniotic fluid |
|
50119-7
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Cerebral spinal fluid |
|
50121-3
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS |
|
74599-2
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Enzymatic activity/mass] in Fibroblast |
|
50118-9
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Urine |
|
50122-1
|
3-Hydroxypalmitoleylcarnitine (C16:1-OH)/Creatinine [Molar ratio] in Urine |
|
50126-2
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Amniotic fluid |
|
41041-5
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Blood |
|
50124-7
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Cerebral spinal fluid |
|
50125-4
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS |
|
74597-6
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Enzymatic activity/mass] in Fibroblast |
|
50123-9
|
3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Urine |
|
53201-0
|
3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
59196-6
|
3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma |
|
50127-0
|
3-Hydroxypalmitoylcarnitine (C16-OH)/Creatinine [Molar ratio] in Urine |
|
79491-7
|
3-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma |
|
44427-3
|
3-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine |
|
44426-5
|
3-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
|
50129-6
|
3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Amniotic fluid |
|
50128-8
|
3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Cerebral spinal fluid |
|
47536-8
|
3-Hydroxypropionate (3-OH-C3) [Moles/volume] in Plasma |
|
72447-6
|
3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Cerebral spinal fluid |
|
72448-4
|
3-Hydroxysebacate ( 3-OH-C8) [Moles/volume] in Serum or Plasma |
|
79525-2
|
3-Hydroxysebacate (3-OH-C8) unsaturated [Moles/volume] in Serum or Plasma |
|
49931-9
|
3-Hydroxysebacate (3-OH-C8) unsaturated/Creatinine [Molar ratio] in Urine |
|
47537-6
|
3-Hydroxysebacate ( 3-OH-C8)/Creatinine [Molar ratio] in Urine |
|
50133-8
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Amniotic fluid |
|
50131-2
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Cerebral spinal fluid |
|
50132-0
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS |
|
50130-4
|
3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Urine |
|
50134-6
|
3-Hydroxystearoylcarnitine (C18-OH)/Creatinine [Molar ratio] in Urine |
|
72445-0
|
3-Hydroxysuberate [Moles/volume] in Cerebral spinal fluid |
|
72446-8
|
3-Hydroxysuberate [Moles/volume] in Serum or Plasma |
|
79493-3
|
3-Hydroxysuberate.unsaturated [Moles/volume] in Serum or Plasma |
|
49932-7
|
3-Hydroxysuberate.unsaturated/Creatinine [Molar ratio] in Urine |
|
47819-8
|
3-Hydroxysuberate/Creatinine [Molar ratio] in Urine |
|
48086-3
|
3-Hydroxytetradecadienedioate/Creatinine [Molar ratio] in Urine |
|
53196-2
|
3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS |
|
72444-3
|
3-Hydroxytetradecanedioate [Moles/volume] in Serum or Plasma |
|
48087-1
|
3-Hydroxytetradecanedioate/Creatinine [Molar ratio] in Urine |
|
50282-3
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Amniotic fluid |
|
50280-7
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Cerebral spinal fluid |
|
50281-5
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS |
|
74602-4
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Enzymatic activity/mass] in Fibroblast |
|
50279-9
|
3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Urine |
|
50284-9
|
3-Hydroxytetradecanoylcarnitine (C14-OH)/Creatinine [Molar ratio] in Urine |
|
48088-9
|
3-Hydroxytetradecenedioate/Creatinine [Molar ratio] in Urine |
|
53197-0
|
3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS |
|
79269-7
|
3-Hydroxytrimethyl-L-lysine [Moles/volume] in Cerebral spinal fluid |
|
79270-5
|
3-Hydroxytrimethyl-L-lysine [Moles/volume] in DBS |
|
79268-9
|
3-Hydroxytrimethyl-L-lysine [Moles/volume] in Serum or Plasma |
|
79271-3
|
3-Hydroxytrimethyl-L-lysine/Creatinine [Molar ratio] in Urine |
|
79272-1
|
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid |
|
79273-9
|
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in DBS |
|
79274-7
|
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Serum or Plasma |
|
79275-4
|
3-Hydroxytrimethyl-L-lysine/Trimethyllysine [Molar ratio] in Urine |
|
50098-3
|
3-Hydroxyvalerate [Moles/volume] in Cerebral spinal fluid |
|
47820-6
|
3-Hydroxyvalerate [Moles/volume] in Plasma |
|
53488-3
|
3-O-Methyldopa [Moles/volume] in 24 hour Urine |
|
53097-2
|
3-O-Methyldopa [Moles/time] in 24 hour Urine |
|
34596-7
|
3-O-Methyldopa [Moles/volume] in Cerebral spinal fluid |
|
11229-2
|
3-O-Methyldopa [Mass/volume] in Serum or Plasma |
|
50141-1
|
3-O-Methyldopa [Moles/volume] in Serum or Plasma |
|
50142-9
|
3-O-Methyldopa [Moles/volume] in Urine |
|
50143-7
|
3-O-Methyldopa [Moles/time] in Urine |
|
50144-5
|
3-O-Methyldopa/Creatinine [Molar ratio] in Urine |
|
48133-3
|
3-Oxovalerate [Moles/volume] in Plasma |
|
78982-6
|
D-3-phosphoglycerate dehydrogenase [Enzymatic activity/mass] in Fibroblast |
|
85095-8
|
D-3-phosphoglycerate dehydrogenase IgG Ab [Presence] in Serum by Line blot |
|
92876-2
|
Human coronavirus 229E+HKU1+NL63+OC43 and Parainfluenza virus 1+2+3+4 RNA panel - Lower respiratory specimen by NAA with probe detection |
|
92877-0
|
Human coronavirus 229E+HKU1+NL63+OC43 and Parainfluenza virus 1+2+3+4 RNA panel - Upper respiratory specimen by NAA with probe detection |
|
92878-8
|
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
92879-6
|
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
83144-6
|
4-Meter Walk Gait Speed Test [NIH Toolbox] |
|
38746-4
|
4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Air |
|
10913-2
|
4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine |
|
38748-0
|
Methylenedianiline [Mass/volume] in Air |
|
17272-6
|
Methylenedianiline [Mass/volume] in Blood |
|
33646-1
|
Methylenedianiline [Mass/volume] in Serum or Plasma |
|
27409-2
|
Methylenedianiline [Mass/volume] in Urine |
|
72435-1
|
4,5-Dihydroxyhexanoate [Moles/volume] in Serum or Plasma |
|
48137-4
|
4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine |
|
72434-4
|
4,5-Dihydroxyhexanolactone [Moles/volume] in Serum or Plasma |
|
48106-9
|
4,5-Dihydroxyhexanolactone/Creatinine [Molar ratio] in Urine |
|
38690-4
|
4,6-Dinitro-O-Cresol [Mass/volume] in Air |
|
38632-6
|
4-Biphenylamine [Mass/volume] in Air |
|
79520-3
|
4-Deoxythreonate [Moles/volume] in Serum or Plasma |
|
79527-8
|
4-Deoxythreonate/Creatinine [Molar ratio] in Urine |
|
93469-5
|
4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
93464-6
|
p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method |
|
86192-2
|
4-Methylethcathinone [Mass/volume] in Urine by Confirmatory method |
|
93461-2
|
4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
93472-9
|
4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
78983-4
|
4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Cerebral spinal fluid |
|
79505-4
|
4-Hydroxy-3-Methoxyphenyllactate [Moles/volume] in Serum or Plasma |
|
47823-0
|
4-Hydroxy-3-Methoxyphenyllactate/Creatinine [Molar ratio] in Urine |
|
90749-3
|
4-Hydroxyatomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
43733-5
|
4-Hydroxybenzoate [Presence] in 24 hour Urine |
|
75075-2
|
4-Hydroxybenzoate [Moles/volume] in Serum or Plasma |
|
43732-7
|
4-Hydroxybenzoate [Presence] in Urine |
|
47541-8
|
4-Hydroxybenzoate/Creatinine [Molar ratio] in Urine |
|
51189-9
|
4-Hydroxybupivacaine [Mass/volume] in Serum or Plasma |
|
74109-0
|
4-hydroxycoumarins [Presence] in Unspecified specimen by Screen method |
|
29869-5
|
4-Hydroxycyclohexylacetate [Presence] in Urine |
|
79178-0
|
4-Hydroxycyclohexylacetate/Creatinine [Molar ratio] in Urine |
|
93772-2
|
4-hydroxyglutamate/Creatinine [Molar ratio] in Urine |
|
13544-2
|
4-Hydroxyglutethimide [Presence] in Serum or Plasma |
|
35637-8
|
4-Hydroxyglutethimide [Mass/volume] in Serum or Plasma by Screen method |
|
79503-9
|
4-Hydroxyhippurate [Moles/volume] in Serum or Plasma |
|
79498-2
|
4-Hydroxyhippurate/Creatinine [Molar ratio] in Urine |
|
50293-0
|
4-Hydroxyifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide |
|
50294-8
|
4-Hydroxyifosfamide [Mass/volume] in Blood --2 days post dose ifosfamide |
|
50295-5
|
4-Hydroxyifosfamide [Mass/volume] in Blood --3 days post dose ifosfamide |
|
50298-9
|
4-Hydroxyifosfamide [Mass/volume] in Blood --3 hours post dose ifosfamide |
|
50296-3
|
4-Hydroxyifosfamide [Mass/volume] in Blood --4 days post dose ifosfamide |
|
50297-1
|
4-Hydroxyifosfamide [Mass/volume] in Blood --5 days post dose ifosfamide |
|
50299-7
|
4-Hydroxyifosfamide [Mass/volume] in Blood --6 hours post dose ifosfamide |
|
50292-2
|
4-Hydroxyifosfamide [Mass/volume] in Blood --pre dose ifosfamide |
|
79508-8
|
4-Hydroxymandelate [Moles/volume] in Serum or Plasma |
|
44861-3
|
4-Hydroxymandelate/Creatinine [Mass Ratio] in Urine |
|
47543-4
|
4-Hydroxymandelate/Creatinine [Molar ratio] in Urine |
|
79132-7
|
4-Hydroxymidazolam [Mass/volume] in Body fluid |
|
54402-3
|
4-Hydroxymidazolam [Mass/volume] in Serum or Plasma |
|
78758-0
|
4-Hydroxymidazolam [Mass/volume] in Urine |
|
72431-0
|
4-Hydroxyphenylacetate [Moles/volume] in Cerebral spinal fluid |
|
72432-8
|
4-Hydroxyphenylacetate [Moles/volume] in Serum or Plasma |
|
27270-8
|
4-Hydroxyphenylacetate [Presence] in Urine |
|
13696-0
|
4-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine |
|
28585-8
|
4-Hydroxyphenylacetate/Creatinine [Ratio] in Urine |
|
25088-6
|
4-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
|
72429-4
|
4-Hydroxyphenyllactate [Moles/volume] in Cerebral spinal fluid |
|
72430-2
|
4-Hydroxyphenyllactate [Moles/volume] in Serum or Plasma |
|
72427-8
|
4-Hydroxyphenylpyruvate [Moles/volume] in Cerebral spinal fluid |
|
72428-6
|
4-Hydroxyphenylpyruvate [Moles/volume] in Serum or Plasma |
|
59346-7
|
4-Hydroxy-Tamoxifen [Mass/volume] in Blood |
|
59350-9
|
4-Hydroxy-Tamoxifen [Mass/volume] in Serum or Plasma |
|
79502-1
|
4-Hydroxyvalerate [Moles/volume] in Serum or Plasma |
|
79485-9
|
4-Hydroxyvalerate/Creatinine [Molar ratio] in Urine |
|
73749-4
|
4p16.3 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
|
1688-1
|
4-Pyridoxate [Mass/volume] in Serum or Plasma |
|
78201-1
|
4q12 chromosome region rearrangements [Identifier] in Blood or Tissue by FISH Nominal |
|
92936-4
|
4q25 g.111710169C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
92935-6
|
4q25 g.111720761T>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
35586-7
|
4-Tert-Butylphenol [Mass/volume] in Urine |
|
44862-1
|
5-Alpha tetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine |
|
21044-3
|
5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine |
|
80161-3
|
5-beta-cholestane-3-alpha,7-alpha,12-alpha,24,25-pentol/Creatinine [Ratio] in Urine |
|
80160-5
|
5-beta-cholestane-3-alpha,7-alpha,12-alpha,23-tetrol/Creatinine [Ratio] in Urine |
|
43722-8
|
5-Ethyl-5-Phenylhydantoin [Presence] in Unspecified specimen |
|
90746-9
|
5F-ADB-M7 (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
88022-9
|
5-F PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
25142-1
|
5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak |
|
3639-2
|
5-Fluorocytosine [Mass/volume] in Serum or Plasma |
|
46218-4
|
5-Fluorocytosine [Moles/volume] in Serum or Plasma |
|
25143-9
|
5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough |
|
10974-4
|
5-Fluorocytosine [Mass/volume] in Urine |
|
23805-5
|
5-Fluorocytosine [Mass/volume] in Unspecified specimen |
|
44907-4
|
5-Hydroxyindoleacetate panel - 24 hour Urine |
|
48333-9
|
5 minute Apgar panel |
|
33274-2
|
5-Methyltetrahydrofolate [Presence] in Cerebral spinal fluid |
|
34637-9
|
5-Methyltetrahydrofolate [Mass/volume] in Cerebral spinal fluid |
|
47547-5
|
5-Methyltetrahydrofolate [Moles/volume] in Cerebral spinal fluid |
|
50153-6
|
5-Methyltetrahydrofolate [Moles/volume] in Serum or Plasma |
|
50039-7
|
5-Methyltetrahydrofolate/Folate in Serum or Plasma |
|
1696-4
|
5-Methyltetrahydrofolate homocysteine methyltransferase [Enzymatic activity/volume] in Serum |
|
1689-9
|
5'-Nucleotidase [Enzymatic activity/volume] in Amniotic fluid |
|
1690-7
|
5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma |
|
72426-0
|
5-Hydroxyhexanoate [Moles/volume] in Serum or Plasma |
|
44287-1
|
5-Hydroxyhexanoate/Creatinine [Mass Ratio] in 24 hour Urine |
|
12172-3
|
5-Hydroxyindoleacetate [Presence] in 24 hour Urine |
|
31203-3
|
5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine |
|
1695-6
|
5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine |
|
25971-3
|
5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine |
|
14573-0
|
5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine |
|
1692-3
|
5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid |
|
47544-2
|
5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid |
|
74769-1
|
5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma |
|
1693-1
|
5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma |
|
50149-4
|
5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma |
|
72820-4
|
5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method |
|
48168-9
|
5-Hydroxyindoleacetate [Presence] in Urine |
|
1694-9
|
5-Hydroxyindoleacetate [Mass/volume] in Urine |
|
15009-4
|
5-Hydroxyindoleacetate [Moles/volume] in Urine |
|
44288-9
|
5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in 24 hour Urine |
|
47545-9
|
5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine |
|
11145-0
|
5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine |
|
29520-4
|
5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine |
|
79528-6
|
5-Hydroxymethyl-2-Furoate [Moles/volume] in Serum or Plasma |
|
44836-5
|
5-Hydroxymethyl-2-Furoate [Presence] in Urine |
|
79477-6
|
5-Hydroxymethyl-2-Furoate/Creatinine [Molar ratio] in Urine |
|
78690-5
|
5-Hydroxymethyluracil/Creatinine [Molar ratio] in Urine |
|
26046-3
|
5-Hydroxypropafenone [Moles/volume] in Serum or Plasma |
|
58794-9
|
5-Hydroxytryptophan [Mass/volume] in 24 hour Urine |
|
21045-0
|
5-Hydroxytryptophan [Mass/time] in 24 hour Urine |
|
53497-4
|
5-Hydroxytryptophan [Moles/volume] in 24 hour Urine |
|
56663-8
|
5-Hydroxytryptophan [Moles/time] in 24 hour Urine |
|
47546-7
|
5-Hydroxytryptophan [Moles/volume] in Cerebral spinal fluid |
|
74768-3
|
5-Hydroxytryptophan [Moles/volume] in Platelet rich plasma |
|
50150-2
|
5-Hydroxytryptophan [Moles/volume] in Serum or Plasma |
|
56525-9
|
5-Hydroxytryptophan [Mass/volume] in Urine |
|
50151-0
|
5-Hydroxytryptophan [Moles/volume] in Urine |
|
53110-3
|
5-Hydroxytryptophan/Creatinine [Molar ratio] in 24 hour Urine |
|
50152-8
|
5-Hydroxytryptophan/Creatinine [Molar ratio] in Urine |
|
43633-7
|
5-Oxoproline [Presence] in 24 hour Urine |
|
75089-3
|
5-Oxoproline [Moles/volume] in Serum or Plasma |
|
53232-5
|
5-Oxoproline+Pipecolate [Moles/volume] in DBS |
|
73751-0
|
5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
|
60514-7
|
6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method |
|
44863-9
|
6-alpha-hydroxytetrahydro-11-Dehydrocorticosterone/Creatinine [Mass Ratio] in Urine |
|
44864-7
|
6-Alpha hydroxytetrahydro-11-Deoxycortisol/Creatinine [Mass Ratio] in Urine |
|
87824-9
|
6-Beta naltrexol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
82526-5
|
6-Beta naltrexol [Mass/volume] in Serum or Plasma |
|
82524-0
|
6-Beta naltrexol [Mass/volume] in Urine by Confirmatory method |
|
82527-3
|
6-Beta naltrexol/Creatinine [Mass Ratio] in Urine |
|
13611-9
|
6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine |
|
80115-9
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Blood by Confirmatory method |
|
78759-8
|
6-Monoacetylmorphine (6-MAM) [Presence] in Blood by Screen method |
|
80116-7
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Body fluid by Confirmatory method |
|
78760-6
|
6-Monoacetylmorphine (6-MAM) [Presence] in Body fluid by Screen method |
|
73941-7
|
6-monoacetylmorphine free [Mass/volume] in Blood |
|
46263-0
|
6-monoacetylmorphine free [Presence] in Serum or Plasma |
|
49749-5
|
6-monoacetylmorphine free [Mass/volume] in Serum or Plasma |
|
47004-7
|
6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method |
|
51740-9
|
6-monoacetylmorphine free [Mass/volume] in Urine |
|
14843-7
|
6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid |
|
26721-1
|
6-Monoacetylmorphine (6-MAM) [Mass/mass] in Hair |
|
29345-6
|
6-Monoacetylmorphine (6-MAM) [Mass/mass] in Meconium |
|
72763-6
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74677-6
|
6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Confirmatory method |
|
87816-5
|
6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Screen method |
|
57300-6
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) |
|
14844-5
|
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma |
|
43184-1
|
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method |
|
18343-4
|
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method |
|
74130-6
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum, Plasma or Blood |
|
12788-6
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma |
|
19593-3
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method |
|
70197-9
|
6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method |
|
10976-9
|
6-Monoacetylmorphine (6-MAM) [Presence] in Urine |
|
19322-7
|
6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method |
|
19321-9
|
6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method |
|
10975-1
|
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine |
|
55520-1
|
6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine |
|
32099-4
|
6-Monoacetylmorphine (6-MAM) [Presence] in Unspecified specimen |
|
58384-9
|
6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine |
|
32654-6
|
6-Methylmercaptopurine [Entitic substance] in Red Blood Cells |
|
43631-1
|
6-Methylmercaptopurine metabolite [Presence] in Red Blood Cells |
|
43632-9
|
6-Methylmercaptopurine [Presence] in Red Blood Cells |
|
50300-3
|
6-Hydroxyheptanoate [Moles/volume] in Urine |
|
76065-2
|
6p25 and 6q23 and 11q and 8q24 and 9p21 chromosome partial aneuploidy in Blood or Tissue by FISH |
|
1697-2
|
6-Phosphogluconate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
48998-9
|
6-Phosphogluconate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells |
|
82869-9
|
6-Thioguanine and 6-methylmercaptopurine panel - Red Blood Cells |
|
32660-3
|
6-Thioguanine [Entitic substance] in Red Blood Cells |
|
43630-3
|
6-Thioguanine [Presence] in Red Blood Cells |
|
79276-2
|
7,8-Dihydrobiopterin [Moles/volume] in Cerebral spinal fluid |
|
59592-6
|
7-Aminoclonazepam [Mass/volume] in Blood by Confirmatory method |
|
59591-8
|
7-Aminoclonazepam [Mass/volume] in Blood |
|
59594-2
|
7-Aminoclonazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59593-4
|
7-Aminoclonazepam [Mass/volume] in Body fluid |
|
61070-9
|
7-Aminoclonazepam [Presence] in Gastric fluid |
|
78761-4
|
7-Aminoclonazepam [Mass/mass] in Hair |
|
73563-9
|
7-Aminoclonazepam [Mass/mass] in Meconium by Confirmatory method |
|
59595-9
|
7-Aminoclonazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61029-5
|
7-Aminoclonazepam [Presence] in Serum or Plasma |
|
59597-5
|
7-Aminoclonazepam [Mass/mass] in Tissue by Confirmatory method |
|
59596-7
|
7-Aminoclonazepam [Mass/mass] in Tissue |
|
51776-3
|
7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method |
|
61030-3
|
7-Aminoclonazepam [Presence] in Urine |
|
58365-8
|
7-Aminoclonazepam [Presence] in Urine by Confirmatory method |
|
94112-0
|
7-Aminoclonazepam [Presence] in Urine by Screen method |
|
61031-1
|
7-Aminoclonazepam [Presence] in Unspecified specimen |
|
58364-1
|
7-Aminoclonazepam/Creatinine [Mass Ratio] in Urine |
|
80117-5
|
7-Aminoflunitrazepam [Mass/volume] in Body fluid by Confirmatory method |
|
61071-7
|
7-Aminoflunitrazepam [Presence] in Gastric fluid |
|
78762-2
|
7-Aminoflunitrazepam [Mass/mass] in Hair |
|
61032-9
|
7-Aminoflunitrazepam [Presence] in Serum or Plasma |
|
73829-4
|
7-Aminoflunitrazepam [Mass/volume] in Serum, Plasma or Blood |
|
21046-8
|
7-Aminoflunitrazepam [Mass/volume] in Serum or Plasma |
|
51777-1
|
7-Aminoflunitrazepam [Mass/volume] in Urine by Confirmatory method |
|
61033-7
|
7-Aminoflunitrazepam [Presence] in Urine |
|
94111-2
|
7-Aminoflunitrazepam [Presence] in Urine by Screen method |
|
27084-3
|
7-Aminoflunitrazepam [Mass/volume] in Urine |
|
61034-5
|
7-Aminoflunitrazepam [Presence] in Unspecified specimen |
|
57303-0
|
7-Aminonitrazepam [Mass/volume] in Saliva (oral fluid) |
|
31182-9
|
7-Aminonitrazepam [Mass/volume] in Serum or Plasma |
|
40597-7
|
7-Dehydrocholesterol [Presence] in Amniotic fluid |
|
48610-0
|
7-Dehydrocholesterol [Mass/volume] in Amniotic fluid |
|
46700-1
|
7-Dehydrocholesterol [Moles/volume] in Amniotic fluid |
|
50799-6
|
7-Dehydrocholesterol [Moles/volume] in Body fluid |
|
22676-1
|
7-Dehydrocholesterol [Presence] in Serum or Plasma |
|
33275-9
|
7-Dehydrocholesterol [Mass/volume] in Serum or Plasma |
|
32289-1
|
7-Dehydrocholesterol [Moles/volume] in Serum or Plasma |
|
73852-6
|
7-Dehydrocholesterol and 8-Dehydrocholesterol panel - Serum or Plasma |
|
79323-2
|
7-Isobiopterin/Creatinine [Molar ratio] in Urine |
|
79277-0
|
7-lathosterol [Moles/volume] in Serum or Plasma |
|
89976-5
|
7-Hydroxychlorpromazine [Mass/volume] in Urine by Confirmatory method |
|
89977-3
|
7-Hydroxychlorpromazine [Presence] in Urine by Screen method |
|
89973-2
|
7-Hydroxyfluphenazine [Mass/volume] in Urine by Confirmatory method |
|
89974-0
|
7-Hydroxyfluphenazine [Presence] in Urine by Screen method |
|
72731-3
|
7-Hydroxymitragynine [Mass/volume] in Urine by Confirmatory method |
|
75643-7
|
7-Hydroxymitragynine [Presence] in Urine by Confirmatory method |
|
72729-7
|
7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine |
|
72425-2
|
7-Hydroxyoctanoate [Moles/volume] in Serum or Plasma |
|
47825-5
|
7-Hydroxyoctanoate/Creatinine [Molar ratio] in Urine |
|
77757-3
|
7-Hydroxyquetiapine [Mass/volume] in Urine by Confirmatory method |
|
76022-3
|
8(9)-Cholestenol [Moles/volume] in Serum or Plasma |
|
34671-8
|
8-Dehydrocholesterol [Mass/volume] in Serum or Plasma |
|
56535-8
|
8-Dehydrocholesterol [Moles/volume] in Serum or Plasma |
|
79278-8
|
8-lathosterol [Moles/volume] in Serum or Plasma |
|
43629-5
|
8-Hydroxyamoxapine [Presence] in Serum or Plasma |
|
1698-0
|
8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
|
14574-8
|
8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
|
75226-1
|
8-Hydroxyamoxapine [Presence] in Urine |
|
18360-8
|
8-Hydroxyamoxapine [Mass/volume] in Urine |
|
34575-1
|
8-Hydroxyloxapine [Presence] in Serum, Plasma or Blood |
|
9696-6
|
8-Hydroxyloxapine [Mass/volume] in Serum or Plasma |
|
89971-6
|
8-Hydroxyloxapine [Presence] in Urine by Screen method |
|
21047-6
|
8-Hydroxyloxapine [Mass/volume] in Urine |
|
87777-9
|
8-Hydroxyloxapine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
60115-3
|
9-Hydroxyrisperidone [Mass/volume] in Blood |
|
79133-5
|
9-Hydroxyrisperidone [Mass/volume] in Body fluid |
|
78771-3
|
9-Hydroxyrisperidone [Mass/mass] in Hair |
|
89982-3
|
9-Hydroxyrisperidone [Presence] in Serum or Plasma by Screen method |
|
9383-1
|
9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma |
|
39455-1
|
9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma |
|
92654-3
|
9-Hydroxyrisperidone [Mass/volume] in Urine by Confirmatory method |
|
90471-4
|
9-Hydroxyrisperidone [Presence] in Urine by Screen method |
|
60116-1
|
9-Hydroxyrisperidone [Mass/volume] in Urine |
|
57906-0
|
9p21 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
|
92934-9
|
9p21 g.22124478A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
92933-1
|
9p21 g.22125503G>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
78202-9
|
9q34 chromosome region deletion [Presence] in Blood or Tissue by FISH |
|
38358-8
|
A Ab [Titer] in Serum or Plasma by Antihuman globulin |
|
38359-6
|
A Ab [Titer] in Serum or Plasma by Immediate spin |
|
820-1
|
A Ag [Presence] on Red Blood Cells |
|
58774-1
|
Alternaria alternata recombinant (rAlt a) 1 IgE Ab [Units/volume] in Serum |
|
64977-2
|
Alternaria alternata recombinant (rAlt a) 6 IgE Ab [Units/volume] in Serum |
|
45163-3
|
Alternaria alternata Ab [Presence] in Serum |
|
57033-3
|
Alternaria alternata Ab [Presence] in Serum by Immune diffusion (ID) |
|
39578-0
|
Alternaria alternata Ab [Mass/volume] in Serum |
|
7077-1
|
Alternaria alternata triggered histamine release [Units/volume] in Blood |
|
6020-2
|
Alternaria alternata IgE Ab [Units/volume] in Serum |
|
40996-1
|
Alternaria alternata IgE Ab/IgE total in Serum |
|
51540-3
|
Alternaria alternata IgG Ab [Presence] in Serum |
|
7076-3
|
Alternaria alternata IgG Ab [Units/volume] in Serum |
|
26951-4
|
Alternaria alternata IgG Ab [Mass/volume] in Serum |
|
26403-6
|
Alternaria alternata IgG4 Ab [Units/volume] in Serum |
|
56170-4
|
Alternaria alternata IgG4 Ab [Mass/volume] in Serum |
|
48239-8
|
Alternaria alternata triggered leukotriene release [Mass/volume] by Leukocytes |
|
30037-6
|
Alternaria alternata+American house dust mite IgE Ab [Presence] in Serum by Multidisk |
|
30031-9
|
Alternaria alternata+American house dust mite IgG Ab [Presence] in Serum by Multidisk |
|
63196-0
|
Alternaria alternata+American house dust mite IgG Ab [Mass/volume] in Serum by Multidisk |
|
16414-5
|
Aspergillus amstelodami Ab [Units/volume] in Serum |
|
6023-6
|
Aspergillus amstelodami IgE Ab [Units/volume] in Serum |
|
63168-9
|
Aspergillus amstelodami IgG Ab [Mass/volume] in Serum |
|
92989-3
|
Acinetobacter baumannii DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85770-6
|
Acinetobacter baumannii DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92988-5
|
Acinetobacter baumannii DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61360-4
|
Acinetobacter baumannii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43621-2
|
Actinomyces bovis Ab [Presence] in Serum |
|
43094-2
|
Angiostrongylus cantonensis Ab [Presence] in Unspecified specimen |
|
41411-0
|
Angiostrongylus cantonensis Ab [Presence] in Unspecified specimen by Immunoblot |
|
41430-0
|
Angiostrongylus cantonensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91667-6
|
Aspergillus clavatus Ab [Units/volume] in Serum |
|
31228-0
|
Aspergillus clavatus Ab [Presence] in Serum |
|
24507-6
|
Aspergillus clavatus Ab [Presence] in Serum by Immune diffusion (ID) |
|
26669-2
|
Absidia corymbifera Ab [Presence] in Serum |
|
43093-4
|
Angiostrongylus costaricensis Ab [Presence] in Serum |
|
41412-8
|
Angiostrongylus costaricensis Ab [Presence] in Serum by Agglutination |
|
41431-8
|
Angiostrongylus costaricensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32662-9
|
Afipia felis IgG Ab [Presence] in Serum |
|
31218-1
|
Afipia felis IgG Ab [Units/volume] in Serum |
|
22081-4
|
Afipia felis IgG Ab [Titer] in Serum |
|
9582-8
|
Afipia felis IgG Ab [Titer] in Serum by Immunofluorescence |
|
32663-7
|
Afipia felis IgM Ab [Presence] in Serum |
|
31219-9
|
Afipia felis IgM Ab [Units/volume] in Serum |
|
22082-2
|
Afipia felis IgM Ab [Titer] in Serum |
|
9583-6
|
Afipia felis IgM Ab [Titer] in Serum by Immunofluorescence |
|
16415-2
|
Aspergillus flavus Ab [Presence] in Cerebral spinal fluid |
|
21084-9
|
Aspergillus flavus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
13193-8
|
Aspergillus flavus Ab [Units/volume] in Cerebral spinal fluid |
|
31229-8
|
Aspergillus flavus Ab [Presence] in Body fluid |
|
27377-1
|
Aspergillus flavus Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
9490-4
|
Aspergillus flavus Ab [Presence] in Serum |
|
23820-4
|
Aspergillus flavus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31230-6
|
Aspergillus flavus Ab [Units/volume] in Serum |
|
43090-0
|
Aspergillus flavus Ab [Titer] in Serum |
|
27309-4
|
Aspergillus flavus Ab [Titer] in Serum by Immune diffusion (ID) |
|
47421-3
|
Aspergillus flavus B Ab [Presence] in Serum |
|
44025-5
|
Aspergillus flavus B Ab [Presence] in Serum by Immune diffusion (ID) |
|
47422-1
|
Aspergillus flavus H Ab [Presence] in Serum |
|
44026-3
|
Aspergillus flavus H Ab [Presence] in Serum by Immune diffusion (ID) |
|
6024-4
|
Aspergillus flavus IgE Ab [Units/volume] in Serum |
|
19725-1
|
Aspergillus flavus IgG Ab [Presence] in Serum |
|
30986-4
|
Aspergillus fumigatus recombinant (rAsp f) 1 IgE Ab [Units/volume] in Serum |
|
30990-6
|
Aspergillus fumigatus recombinant (rAsp f) 2 IgE Ab [Units/volume] in Serum |
|
30991-4
|
Aspergillus fumigatus recombinant (rAsp f) 3 IgE Ab [Units/volume] in Serum |
|
30992-2
|
Aspergillus fumigatus recombinant (rAsp f) 4 IgE Ab [Units/volume] in Serum |
|
30993-0
|
Aspergillus fumigatus recombinant (rAsp f) 6 IgE Ab [Units/volume] in Serum |
|
18468-9
|
Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid |
|
21085-6
|
Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
40828-6
|
Aspergillus fumigatus Ab [Presence] in Body fluid |
|
27375-5
|
Aspergillus fumigatus Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
9632-1
|
Aspergillus fumigatus Ab [Presence] in Serum |
|
23821-2
|
Aspergillus fumigatus Ab [Presence] in Serum by Immune diffusion (ID) |
|
5050-0
|
Aspergillus fumigatus Ab [Units/volume] in Serum |
|
54435-3
|
Aspergillus fumigatus Ab [Titer] in Serum |
|
10645-0
|
Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |
|
47423-9
|
Aspergillus fumigatus B Ab [Presence] in Serum |
|
44027-1
|
Aspergillus fumigatus B Ab [Presence] in Serum by Immune diffusion (ID) |
|
7104-3
|
Aspergillus fumigatus triggered histamine release [Units/volume] in Blood |
|
62478-3
|
Aspergillus fumigatus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47424-7
|
Aspergillus fumigatus H Ab [Presence] in Serum |
|
44028-9
|
Aspergillus fumigatus H Ab [Presence] in Serum by Immune diffusion (ID) |
|
6025-1
|
Aspergillus fumigatus IgE Ab [Units/volume] in Serum |
|
38438-8
|
Aspergillus fumigatus IgE Ab/IgE total in Serum |
|
7103-5
|
Aspergillus fumigatus IgG Ab [Units/volume] in Serum |
|
19726-9
|
Aspergillus fumigatus IgG Ab [Presence] in Serum |
|
26954-8
|
Aspergillus fumigatus IgG Ab [Mass/volume] in Serum |
|
26405-1
|
Aspergillus fumigatus IgG4 Ab [Units/volume] in Serum |
|
56180-3
|
Aspergillus fumigatus IgG4 Ab [Mass/volume] in Serum |
|
42579-3
|
Aspergillus fumigatus IgM Ab [Units/volume] in Serum |
|
48241-4
|
Aspergillus fumigatus triggered leukotriene release [Mass/volume] by Leukocytes |
|
44045-3
|
Aspergillus fumigatus O Ab [Presence] in Serum |
|
11030-4
|
Aspergillus fumigatus+Aspergillus niger IgE Ab [Units/volume] in Serum |
|
42486-1
|
Aspergillus fumigatus 1 Ab [Presence] in Cerebral spinal fluid |
|
11583-2
|
Aspergillus fumigatus 1 Ab [Presence] in Serum |
|
6808-0
|
Aspergillus fumigatus 1 Ab [Presence] in Serum by Immune diffusion (ID) |
|
44438-0
|
Aspergillus fumigatus 1 Ab [Units/volume] in Serum |
|
29334-0
|
Aspergillus fumigatus 2 Ab [Presence] in Serum |
|
30036-8
|
Aspergillus fumigatus 2 Ab [Presence] in Serum by Immune diffusion (ID) |
|
22085-5
|
Aspergillus fumigatus 3 Ab [Presence] in Serum |
|
15151-4
|
Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) |
|
44439-8
|
Aspergillus fumigatus 3 Ab [Units/volume] in Serum |
|
42487-9
|
Aspergillus fumigatus 6 Ab [Presence] in Cerebral spinal fluid |
|
11592-3
|
Aspergillus fumigatus 6 Ab [Presence] in Serum |
|
6809-8
|
Aspergillus fumigatus 6 Ab [Presence] in Serum by Immune diffusion (ID) |
|
44440-6
|
Aspergillus fumigatus 6 Ab [Units/volume] in Serum |
|
87553-4
|
Aspergillus fumigatus and Saccharopolyspora rectivirgula and Thermoactinomyces vulgaris IgG panel - Serum |
|
46157-4
|
Aspergillus glaucus Ab [Presence] in Serum |
|
43823-4
|
Aspergillus glaucus Ab [Presence] in Serum by Immune diffusion (ID) |
|
13194-6
|
Aspergillus glaucus Ab [Units/volume] in Serum |
|
50761-6
|
A IgG Ab [Titer] in Serum or Plasma |
|
50762-4
|
A IgM Ab [Titer] in Serum or Plasma |
|
43620-4
|
Actinomyces israelii Ab [Presence] in Serum |
|
5049-2
|
Ascaris lumbricoides Ab [Units/volume] in Serum by Immunoassay |
|
7806-3
|
Ascaris lumbricoides Ab [Units/volume] in Serum |
|
21075-7
|
Ascaris lumbricoides IgE Ab [Units/volume] in Serum |
|
40607-4
|
Ascaris lumbricoides IgG Ab [Units/volume] in Serum by Immunoassay |
|
41161-1
|
Ascaris lumbricoides IgG Ab [Units/volume] in Serum |
|
40608-2
|
Ascaris lumbricoides IgM Ab [Units/volume] in Serum by Immunoassay |
|
41160-3
|
Ascaris lumbricoides IgM Ab [Units/volume] in Serum |
|
44436-4
|
Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum by Immunoassay |
|
46156-6
|
Ascaris lumbricoides larva IgG Ab [Units/volume] in Serum |
|
44435-6
|
Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum by Immunoassay |
|
46155-8
|
Ascaris lumbricoides adult IgG Ab [Units/volume] in Serum |
|
22084-8
|
Anaplasma marginale Ab [Presence] in Serum |
|
15433-6
|
Anaplasma marginale Ab [Presence] in Serum by Agglutination |
|
20685-4
|
Anaplasma marginale Ab [Presence] in Serum by Card agglutination |
|
20686-2
|
Anaplasma marginale Ab [Presence] in Serum by Complement fixation |
|
22795-9
|
Anaplasma marginale Ab [Presence] in Serum by Immunoassay |
|
22794-2
|
Anaplasma marginale Ab [Presence] in Serum by Immunofluorescence |
|
31222-3
|
Anaplasma marginale Ab [Units/volume] in Serum |
|
43095-9
|
Anaplasma marginale Ab [Titer] in Serum |
|
23657-0
|
Anaplasma marginale Ab [Titer] in Serum by Complement fixation |
|
22796-7
|
Anaplasma marginale Ag [Presence] in Tissue by Immunofluorescence |
|
22797-5
|
Anaplasma marginale DNA [Presence] in Tissue by NAA with probe detection |
|
22798-3
|
Anaplasma marginale rRNA [Presence] in Tissue by Probe |
|
31231-4
|
Aspergillus nidulans Ab [Presence] in Serum |
|
24508-4
|
Aspergillus nidulans Ab [Presence] in Serum by Immune diffusion (ID) |
|
47425-4
|
Aspergillus nidulans B Ab [Presence] in Serum |
|
44029-7
|
Aspergillus nidulans B Ab [Presence] in Serum by Immune diffusion (ID) |
|
47426-2
|
Aspergillus nidulans H Ab [Presence] in Serum |
|
44030-5
|
Aspergillus nidulans H Ab [Presence] in Serum by Immune diffusion (ID) |
|
7105-0
|
Aspergillus nidulans IgE Ab [Units/volume] in Serum |
|
18416-8
|
Aspergillus nidulans IgG Ab [Units/volume] in Serum |
|
63169-7
|
Aspergillus nidulans IgG Ab [Mass/volume] in Serum |
|
18395-4
|
Aspergillus niger Ab [Presence] in Cerebral spinal fluid |
|
21086-4
|
Aspergillus niger Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
31232-2
|
Aspergillus niger Ab [Presence] in Body fluid |
|
27364-9
|
Aspergillus niger Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
44441-4
|
Aspergillus niger Ab [Units/volume] in Serum by Complement fixation |
|
22086-3
|
Aspergillus niger Ab [Presence] in Serum |
|
10894-4
|
Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID) |
|
5051-8
|
Aspergillus niger Ab [Units/volume] in Serum |
|
43089-2
|
Aspergillus niger Ab [Titer] in Serum |
|
27313-6
|
Aspergillus niger Ab [Titer] in Serum by Immune diffusion (ID) |
|
47427-0
|
Aspergillus niger B Ab [Presence] in Serum |
|
44031-3
|
Aspergillus niger B Ab [Presence] in Serum by Immune diffusion (ID) |
|
47428-8
|
Aspergillus niger H Ab [Presence] in Serum |
|
44032-1
|
Aspergillus niger H Ab [Presence] in Serum by Immune diffusion (ID) |
|
6830-4
|
Aspergillus niger IgE Ab [Units/volume] in Serum |
|
61221-8
|
Aspergillus niger IgE Ab/IgE total in Serum |
|
19727-7
|
Aspergillus niger IgG Ab [Presence] in Serum |
|
58914-3
|
Aspergillus niger IgG Ab [Mass/volume] in Serum |
|
56181-1
|
Aspergillus niger IgG4 Ab [Mass/volume] in Serum |
|
87548-4
|
Anaplasma phagocytophilum and Ehrlichia sp DNA panel - Blood Qualitative by NAA with non-probe detection |
|
87558-3
|
Anaplasma phagocytophilum groEL gene [Presence] in Blood by NAA with non-probe detection |
|
77165-9
|
Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG panel [Titer] - Serum |
|
91899-5
|
Anaplasma phagocytophilum and Ehrlichia chaffeensis DNA panel - Blood |
|
93370-5
|
Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG and IgM panel - Serum |
|
7877-4
|
Anaplasma phagocytophilum Ab [Presence] in Serum |
|
6403-0
|
Anaplasma phagocytophilum Ab [Presence] in Serum by Immunoassay |
|
31363-5
|
Anaplasma phagocytophilum Ab [Units/volume] in Serum |
|
33609-9
|
Anaplasma phagocytophilum Ab [Titer] in Serum |
|
30338-8
|
Anaplasma phagocytophilum Ab [Titer] in Serum by Immunofluorescence |
|
54034-4
|
Anaplasma phagocytophilum Ag [Presence] in Tissue by Immune stain |
|
30039-2
|
Anaplasma phagocytophilum DNA [Presence] in Blood by NAA with probe detection |
|
29560-0
|
Anaplasma phagocytophilum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
29844-8
|
Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid |
|
29806-7
|
Anaplasma phagocytophilum IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
29856-2
|
Anaplasma phagocytophilum IgG Ab [Presence] in Serum |
|
29819-0
|
Anaplasma phagocytophilum IgG Ab [Presence] in Serum by Immunoblot |
|
16808-8
|
Anaplasma phagocytophilum IgG Ab [Units/volume] in Serum |
|
49213-2
|
Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid |
|
48877-5
|
Anaplasma phagocytophilum IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
32691-8
|
Anaplasma phagocytophilum IgG Ab [Titer] in Serum |
|
23877-4
|
Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence |
|
29832-3
|
Anaplasma phagocytophilum IgG Ab [Presence] in Unspecified specimen |
|
29793-7
|
Anaplasma phagocytophilum IgG Ab [Presence] in Unspecified specimen by Immunoblot |
|
55150-7
|
Anaplasma phagocytophilum IgG and IgM panel - Serum Qualitative |
|
29845-5
|
Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid |
|
29807-5
|
Anaplasma phagocytophilum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
29857-0
|
Anaplasma phagocytophilum IgM Ab [Presence] in Serum |
|
29820-8
|
Anaplasma phagocytophilum IgM Ab [Presence] in Serum by Immunoblot |
|
16809-6
|
Anaplasma phagocytophilum IgM Ab [Units/volume] in Serum |
|
49214-0
|
Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid |
|
48876-7
|
Anaplasma phagocytophilum IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
32692-6
|
Anaplasma phagocytophilum IgM Ab [Titer] in Serum |
|
23878-2
|
Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence |
|
29833-1
|
Anaplasma phagocytophilum IgM Ab [Presence] in Unspecified specimen |
|
29794-5
|
Anaplasma phagocytophilum IgM Ab [Presence] in Unspecified specimen by Immunoblot |
|
48872-6
|
Anaplasma phagocytophilum [Presence] in Unspecified specimen by Organism specific culture |
|
31212-4
|
Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum |
|
23644-8
|
Actinobacillus pleuropneumoniae serotype 1 Ab [Presence] in Serum by Immunoassay |
|
86717-6
|
Actinobacillus pleuropneumoniae serotype 1 Ab [Titer] in Serum by Complement fixation |
|
87362-0
|
Actinobacillus pleuropneumoniae serotypes 1+2+9+11 Ab/Positive control in Serum by Immunoassay |
|
87366-1
|
Actinobacillus pleuropneumoniae serotypes 1+9+11 Ab/Positive control in Serum by Immunoassay |
|
87355-4
|
Actinobacillus pleuropneumoniae serotype 10 Ab/Positive control in Serum by Immunoassay |
|
87368-7
|
Actinobacillus pleuropneumoniae serotypes 10+12 Ab/Positive control in Serum by Immunoassay |
|
87356-2
|
Actinobacillus pleuropneumoniae serotype 12 Ab/Positive control in Serum by Immunoassay |
|
87357-0
|
Actinobacillus pleuropneumoniae serotype 2 Ab/Positive control in Serum by Immunoassay |
|
31213-2
|
Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum |
|
23645-5
|
Actinobacillus pleuropneumoniae serotype 3 Ab [Presence] in Serum by Immunoassay |
|
86718-4
|
Actinobacillus pleuropneumoniae serotype 3 Ab [Titer] in Serum by Complement fixation |
|
87359-6
|
Actinobacillus pleuropneumoniae serotypes 3+6+8 Ab/Positive control in Serum by Immunoassay |
|
87363-8
|
Actinobacillus pleuropneumoniae serotypes 3+6+8+15 Ab/Positive control in Serum by Immunoassay |
|
87360-4
|
Actinobacillus pleuropneumoniae serotypes 4+5+7 Ab/Positive control in Serum by Immunoassay |
|
87365-3
|
Actinobacillus pleuropneumoniae serotypes 4+7 Ab/Positive control in Serum by Immunoassay |
|
31214-0
|
Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum |
|
23646-3
|
Actinobacillus pleuropneumoniae serotype 5 Ab [Presence] in Serum by Immunoassay |
|
86719-2
|
Actinobacillus pleuropneumoniae serotype 5 Ab [Titer] in Serum by Complement fixation |
|
87358-8
|
Actinobacillus pleuropneumoniae serotype 5 Ab/Positive control in Serum by Immunoassay |
|
31215-7
|
Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum |
|
23647-1
|
Actinobacillus pleuropneumoniae serotype 7 Ab [Presence] in Serum by Immunoassay |
|
86720-0
|
Actinobacillus pleuropneumoniae serotype 7 Ab [Titer] in Serum by Complement fixation |
|
20673-0
|
Actinobacillus pleuropneumoniae Ab [Presence] in Serum |
|
22764-5
|
Actinobacillus pleuropneumoniae Ab [Presence] in Serum by Complement fixation |
|
31216-5
|
Actinobacillus pleuropneumoniae Ab [Units/volume] in Serum |
|
23648-9
|
Actinobacillus pleuropneumoniae Ab [Titer] in Serum |
|
86715-0
|
Actinobacillus pleuropneumoniae Ab [Titer] in Serum by Complement fixation |
|
87354-7
|
Actinobacillus pleuropneumoniae Ab/Positive control in Serum or Plasma by Immunoassay |
|
23649-7
|
Actinobacillus pleuropneumoniae biovar 2 serotype [Identifier] in Unspecified specimen by Agglutination |
|
86716-8
|
Actinobacillus pleuropneumoniae DNA [Cycle Threshold #] in Isolate by NAA with probe detection |
|
88364-5
|
Actinobacillus pleuropneumoniae IgG Ab/Positive control in Saliva (oral fluid) by Immunoassay |
|
20672-2
|
Actinobacillus pleuropneumoniae serotype [Identifier] in Isolate |
|
86721-8
|
Actinobacillus pleuropneumoniae serotype identified in Isolate by NAA with probe detection |
|
23650-5
|
Actinobacillus pleuropneumoniae serotype [Identifier] in Unspecified specimen by Agglutination |
|
42489-5
|
Aureobasidium pullulans Ab [Presence] in Cerebral spinal fluid |
|
11584-0
|
Aureobasidium pullulans Ab [Presence] in Serum |
|
6810-6
|
Aureobasidium pullulans Ab [Presence] in Serum by Immune diffusion (ID) |
|
6029-3
|
Aureobasidium pullulans IgE Ab [Units/volume] in Serum |
|
61225-9
|
Aureobasidium pullulans IgE Ab/IgE total in Serum |
|
31235-5
|
Aureobasidium pullulans IgG Ab [Units/volume] in Serum |
|
33572-9
|
Aureobasidium pullulans IgG Ab [Presence] in Serum |
|
26955-5
|
Aureobasidium pullulans IgG Ab [Mass/volume] in Serum |
|
23652-1
|
Aeromonas salmonicida DNA [Presence] in Tissue by NAA with probe detection |
|
24406-1
|
Aeromonas salmonicida serotype [Identifier] in Isolate |
|
24405-3
|
Aeromonas salmonicida [Presence] in Unspecified specimen |
|
6254-7
|
Acarus siro IgE Ab [Units/volume] in Serum |
|
48234-9
|
Acarus siro triggered leukotriene release [Mass/volume] by Leukocytes |
|
86723-4
|
Actinobacillus suis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86722-6
|
Actinobacillus suis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23651-3
|
Actinobacillus suis serotype [Identifier] in Isolate by Agglutination |
|
16416-0
|
Aspergillus terreus Ab [Units/volume] in Serum |
|
31234-8
|
Aspergillus terreus Ab [Presence] in Serum |
|
24509-2
|
Aspergillus terreus Ab [Presence] in Serum by Immune diffusion (ID) |
|
62479-1
|
Aspergillus terreus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6026-9
|
Aspergillus terreus IgE Ab [Units/volume] in Serum |
|
63166-3
|
Aspergillus terreus IgG Ab [Mass/volume] in Serum |
|
74667-7
|
Atopobium vaginae DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
|
69565-0
|
Atopobium vaginae DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
43911-7
|
Aspergillus versicolor Ab [Presence] in Serum |
|
16417-8
|
Aspergillus versicolor Ab [Units/volume] in Serum |
|
6027-7
|
Aspergillus versicolor IgE Ab [Units/volume] in Serum |
|
51542-9
|
Aspergillus versicolor IgG Ab [Presence] in Serum |
|
56182-9
|
Aspergillus versicolor IgG4 Ab [Mass/volume] in Serum |
|
59382-2
|
Aspergillus versicolor IgG Ab [Mass/volume] in Serum |
|
880-5
|
A,B Ag [Presence] on Red Blood Cells |
|
91668-4
|
Aspergillus oryzae Ab [Units/volume] in Serum |
|
93847-2
|
Aspergillus oryzae IgE Ab [Units/volume] in Serum |
|
78354-8
|
Arterial-alveolar oxygen Partial pressure ratio |
|
69370-5
|
A1 Ab [Presence] in Cord blood |
|
844-1
|
A1 Ag [Presence] on Red Blood Cells |
|
850-8
|
A1 B Ag [Presence] on Red Blood Cells |
|
48414-7
|
Alpha-1-Microglobulin [Mass/time] in 24 hour Urine |
|
50385-4
|
Alpha-1-Microglobulin.placental [Presence] in Vaginal fluid |
|
48413-9
|
Alpha-1-Microglobulin [Mass/volume] in Serum or Plasma |
|
46723-3
|
Alpha-1-Microglobulin [Mass/volume] in Urine |
|
77163-4
|
Alpha-1-Microglobulin [Moles/volume] in Urine |
|
48415-4
|
Alpha-1-Microglobulin/Creatinine [Mass Ratio] in Urine |
|
2684-9
|
Alpha-1-acid glycoprotein [Mass/volume] in Cerebral spinal fluid |
|
48416-2
|
Alpha-1-acid glycoprotein [Mass/volume] in Body fluid |
|
40601-7
|
Alpha-1-acid glycoprotein [Presence] in Serum or Plasma by Immunoelectrophoresis |
|
2685-6
|
Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma |
|
33781-6
|
Alpha-1-acid glycoprotein [Moles/volume] in Serum or Plasma |
|
40600-9
|
Alpha-1-acid glycoprotein [Presence] in Urine by Immunoelectrophoresis |
|
76688-1
|
Alpha-1-acid glycoprotein/Creatinine [Mass Ratio] in Urine |
|
10461-2
|
Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
|
1824-2
|
Alpha-1-Antichymotrypsin [Mass/volume] in Serum |
|
27915-8
|
Alpha-1-Antichymotrypsin [Units/volume] in Stool |
|
46429-7
|
Alpha 1 antitrypsin [Mass/mass] in 24 hour Stool |
|
74990-3
|
Alpha 1 antitrypsin [Mass/time] in 24 hour Stool |
|
46430-5
|
Alpha 1 antitrypsin [Mass/mass] in 48 hour Stool |
|
46431-3
|
Alpha 1 antitrypsin [Mass/mass] in 72 hour Stool |
|
10462-0
|
Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
|
12466-9
|
Alpha 1 antitrypsin [Mass/volume] in Amniotic fluid by Nephelometry |
|
18271-7
|
Alpha 1 antitrypsin fecal clearance in 24 hour |
|
93419-0
|
Alpha 1 antitrypsin fecal clearance panel - Serum or Plasma and Stool |
|
12960-1
|
Alpha 1 antitrypsin fecal clearance |
|
29146-8
|
Alpha 1 antitrypsin [Mass/volume] in Body fluid |
|
6770-2
|
Alpha 1 antitrypsin phenotyping [Identifier] in Serum or Plasma by Immunofixation |
|
6771-0
|
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry |
|
40603-3
|
Alpha 1 antitrypsin [Presence] in Serum or Plasma by Immunoelectrophoresis |
|
1825-9
|
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma |
|
76481-1
|
Alpha 1 antitrypsin [Moles/volume] in Serum or Plasma |
|
9407-8
|
Alpha 1 antitrypsin [Mass/volume] in Stool |
|
25303-9
|
Alpha 1 antitrypsin [Mass/mass] in Stool |
|
74997-8
|
Alpha 1 antitrypsin [Mass/mass] in Stool.dried |
|
40602-5
|
Alpha 1 antitrypsin [Presence] in Urine by Immunoelectrophoresis |
|
856-5
|
A2 Ag [Presence] on Red Blood Cells |
|
862-3
|
A2 B Ag [Presence] on Red Blood Cells |
|
42660-1
|
Alpha 2 laminin [Presence] in Tissue by Immune stain |
|
40605-8
|
Alpha-2-Macroglobulin [Presence] in Serum by Immunoelectrophoresis |
|
1835-8
|
Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma |
|
40604-1
|
Alpha-2-Macroglobulin [Presence] in Urine by Immunoelectrophoresis |
|
29944-6
|
Alpha-2-Macroglobulin [Mass/volume] in Unspecified specimen |
|
50748-3
|
Alpha-2-Macroglobulin/Creatinine [Mass Ratio] in Urine |
|
31151-4
|
Alpha-2-Microglobulin [Mass/volume] in 24 hour Urine |
|
868-0
|
A3 Ag [Presence] on Red Blood Cells |
|
874-8
|
A3 B Ag [Presence] on Red Blood Cells |
|
75110-7
|
Arachidonate (C20:4w6) [Entitic substance] in Red Blood Cells |
|
53261-4
|
Amino acid newborn screen panel |
|
1847-3
|
Amyloid associated protein [Mass/volume] in Serum |
|
88994-9
|
Arachidonate (C20:4w6)/Fatty acids.C14-C24 in Serum or Plasma |
|
50083-5
|
Alpha aminoadipate [Moles/volume] in DBS |
|
50084-3
|
Alpha aminoadipate [Moles/volume] in Body fluid |
|
1785-5
|
Alpha amino acid nitrogen [Mass/time] in 24 hour Urine |
|
1784-8
|
Alpha amino acid nitrogen [Mass/volume] in Plasma |
|
70180-5
|
Alpha aminoadipate [Moles/volume] in Serum or Plasma from Fetus |
|
56668-7
|
Alpha aminoadipate/Creatinine [Ratio] in 24 hour Urine |
|
47559-0
|
Alpha aminobutyrate [Moles/volume] in DBS |
|
70181-3
|
Alpha aminobutyrate [Moles/volume] in Serum or Plasma from Fetus |
|
44296-2
|
Alpha aminobutyrate/Creatinine [Mass Ratio] in 24 hour Urine |
|
1740-0
|
Alanine aminopeptidase [Mass/volume] in Serum |
|
33353-4
|
Alanine aminopeptidase [Enzymatic activity/volume] in Urine |
|
77109-7
|
AARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77108-9
|
AARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
22091-3
|
Avian hemorrhagic enteritis virus Ab [Presence] in Serum |
|
15438-5
|
Avian hemorrhagic enteritis virus Ab [Presence] in Serum by Immunoassay |
|
23819-6
|
Antibody coated bacteria [Presence] in Urine by Immunofluorescence |
|
50335-9
|
Alpha-beta crystallin Ag [Presence] in Tissue by Immune stain |
|
78772-1
|
Abacavir [Mass/volume] in Amniotic fluid |
|
80118-3
|
Abacavir [Mass/volume] in Cord blood |
|
79134-3
|
Abacavir [Mass/volume] in Cerebral spinal fluid |
|
29113-8
|
Abacavir [Units/volume] in Serum or Plasma |
|
78773-9
|
Abacavir [Mass/volume] in Serum or Plasma |
|
19724-4
|
Abachi Wood Dust IgE Ab [Units/volume] in Serum |
|
7060-7
|
Abalone IgE Ab [Units/volume] in Serum |
|
46225-9
|
ABCA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72506-9
|
ABCB1 gene c.3435C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
74004-3
|
ABCB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
91672-6
|
ABCB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49874-1
|
ABCB4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
51476-0
|
ABCB4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38891-8
|
ABCC8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38918-9
|
ABCC8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79568-2
|
ABCD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53836-3
|
ABCD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87495-8
|
AB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
87494-1
|
AB-CHMINACA hydroxycyclohexyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73553-0
|
Abciximab induced platelet Ab [Interpretation] in Serum or Plasma |
|
73555-5
|
Abciximab induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73554-8
|
Abciximab induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
87493-3
|
AB-FUBINACA oxobutanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
12472-7
|
Amino beta guanidinopropionate [Mass/volume] in 24 hour Urine |
|
26700-5
|
Amino beta guanidinopropionate [Moles/time] in 24 hour Urine |
|
13382-7
|
Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid |
|
26852-4
|
Amino beta guanidinopropionate [Moles/volume] in Amniotic fluid |
|
13365-2
|
Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid |
|
27337-5
|
Amino beta guanidinopropionate [Moles/volume] in Cerebral spinal fluid |
|
16355-0
|
Amino beta guanidinopropionate [Presence] in Plasma |
|
13364-5
|
Amino beta guanidinopropionate [Mass/volume] in Plasma |
|
30060-8
|
Amino beta guanidinopropionate [Moles/volume] in Serum or Plasma |
|
16353-5
|
Amino beta guanidinopropionate [Presence] in Urine |
|
12471-9
|
Amino beta guanidinopropionate [Mass/volume] in Urine |
|
39582-2
|
Amino beta guanidinopropionate/Creatinine [Molar ratio] in 24 hour Urine |
|
28591-6
|
Amino beta guanidinopropionate/Creatinine [Ratio] in Urine |
|
27254-2
|
Amino beta guanidinopropionate/Creatinine [Molar ratio] in Urine |
|
77194-9
|
Ankle-brachial index |
|
23381-7
|
Abnormal Prion Protein [Presence] in Brain by Electron microscopy |
|
37425-6
|
Abnormal Prion Protein [Presence] in Brain by Immunoassay |
|
23379-1
|
Abnormal Prion Protein [Presence] in Brain by Immunoblot |
|
23380-9
|
Abnormal Prion Protein [Presence] in Brain by Immune stain |
|
74036-5
|
Abnormal Prion Protein [Identifier] in Tissue by Immunoblot |
|
74035-7
|
Abnormal Prion Protein [Identifier] in Tissue by Immune stain |
|
39021-1
|
Abnormal Prion Protein [Presence] in Tissue by Immunoassay |
|
39320-7
|
Abnormal Prion Protein [Presence] in Tissue by Immunoblot |
|
39020-3
|
Abnormal Prion Protein [Presence] in Tissue by Immune stain |
|
49587-9
|
Protein.abnormal band [Mass/volume] in Serum |
|
55235-6
|
Abnormal hemoglobin gene panel - Blood by Molecular genetics method |
|
90046-4
|
Spermatozoa.abnormal principal pieces/100 spermatozoa in Semen |
|
882-1
|
ABO and Rh group [Type] in Blood |
|
77397-8
|
ABO and Rh group [Type] in Blood by Confirmatory method |
|
90906-9
|
Father's ABO and Rh group Type |
|
54417-1
|
ABO and Rh group [Type] in Blood from Fetus |
|
90905-1
|
Mother's ABO and Rh group Type |
|
19057-9
|
ABO and Rh group [Type] in Blood from Newborn |
|
884-7
|
ABO and Rh group [Type] in Capillary blood |
|
34474-7
|
ABO and Rh group [Type] in Cord blood |
|
93906-6
|
ABO and Rh group [Type] in Blood--during infancy |
|
93932-2
|
ABO and Rh group [Type] in Blood--post hematopoietic stem cell transplant |
|
90039-9
|
ABO and Rh group [Type] in Blood--after transfusion reaction |
|
46268-9
|
ABO and Rh group [Type] in Blood from Blood product unit--after transfusion reaction |
|
50773-1
|
ABO and Rh group [Type] in Blood from Newborn--after transfusion reaction |
|
34530-6
|
ABO and Rh group panel - Blood |
|
93916-5
|
ABO and Rh group panel - Blood from Blood product unit |
|
93949-6
|
ABO and Rh group panel - Cord blood |
|
93923-1
|
ABO and Rh group post transfusion reaction panel - Blood |
|
883-9
|
ABO group [Type] in Blood |
|
57743-7
|
ABO group [Type] in Blood by Confirmatory method |
|
52793-7
|
Father's ABO group Type |
|
14580-5
|
ABO group [Type] in Blood from Newborn |
|
51892-8
|
ABO group [Type] in Cord blood |
|
93905-8
|
ABO group [Type] in Blood--during infancy |
|
93931-4
|
ABO group [Type] in Blood--post hematopoietic stem cell transplant |
|
46270-5
|
ABO group [Type] in Blood--after transfusion reaction |
|
85504-9
|
Presumptive ABO group [Type] in Saliva (oral fluid) by Molecular genetics method |
|
93941-3
|
ABO and Rh group during infancy panel - Blood |
|
93933-0
|
ABO and Rh group post hematopoietic stem cell transplant panel - Blood |
|
52027-0
|
Abortion consent Document |
|
87492-5
|
AB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
92846-5
|
Ambulatory blood pressure monitor study report |
|
54933-7
|
Abrine [Mass/volume] in Urine |
|
82288-2
|
Absolute aerobic exercise intensity |
|
1718-6
|
Acyl CoA dehydrogenase [Enzymatic activity/volume] in Serum |
|
77044-6
|
ACAD8 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77043-8
|
ACAD8 gene full mutation analysis in Blood or Tissue by Sequencing |
|
75141-2
|
Acadesine [Moles/volume] in Cerebral spinal fluid |
|
75137-0
|
Acadesine [Moles/volume] in Serum or Plasma |
|
48135-8
|
Acadesine [Presence] in Urine |
|
75151-1
|
Acadesine/Creatinine [Molar ratio] in Urine |
|
32628-0
|
ACADM gene c.985A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
43242-7
|
ACADM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
78360-5
|
Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] myristate substrate |
|
78358-9
|
Acyl CoA dehydrogenases [Enzymatic activity/mass] in Fibroblast by [9,10-3H] palmitate substrate |
|
41121-5
|
ACADS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34498-6
|
ACADS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77046-1
|
ACADSB gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77045-3
|
ACADSB gene full mutation analysis in Blood or Tissue by Sequencing |
|
73736-1
|
ACADVL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
73735-3
|
ACADVL gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
74697-4
|
Acamprosate [Mass/volume] in Serum or Plasma |
|
22077-2
|
Acanthamoeba sp Ab [Presence] in Cornea |
|
6618-3
|
Acanthamoeba sp Ab [Presence] in Cornea by Immunofluorescence |
|
22078-0
|
Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid |
|
6620-9
|
Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
6619-1
|
Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
7803-0
|
Acanthamoeba sp Ab [Presence] in Serum |
|
87991-6
|
Acanthamoeba sp identified in Contact lens by Organism specific culture |
|
88162-3
|
Acanthamoeba sp identified in Cornea or Conjunctiva by Organism specific culture |
|
87990-8
|
Acanthamoeba sp identified in Cerebral spinal fluid by Organism specific culture |
|
87988-2
|
Acanthamoeba sp DNA [Presence] in Contact lens by NAA with probe detection |
|
88163-1
|
Acanthamoeba sp DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88570-7
|
Acanthamoeba sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
88914-7
|
Acanthamoeba sp DNA [Presence] in Tissue by NAA with probe detection |
|
41429-2
|
Acanthamoeba sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10635-1
|
Acanthamoeba sp identified in Eye by Organism specific culture |
|
10636-9
|
Acanthamoeba sp identified in Eye by Wet preparation |
|
9781-6
|
Acanthamoeba sp identified in Unspecified specimen by Organism specific culture |
|
91135-4
|
Acanthocytes [Presence] in Urine sediment by Light microscopy |
|
73551-4
|
Acarbose induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73550-6
|
Acarbose induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
93768-0
|
Acarboxyprothrombin [Units/volume] in Serum or Plasma |
|
34444-0
|
Acarboxyprothrombin [Mass/volume] in Serum or Plasma |
|
27078-5
|
Carotene.alpha [Moles/volume] in Plasma |
|
56669-5
|
Carotene.alpha [Mass/volume] in Serum |
|
74833-5
|
ACAT1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
46035-2
|
Accidents Set |
|
24043-2
|
Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Fibroblast |
|
24044-0
|
Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Leukocytes |
|
1857-2
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Blood |
|
12480-0
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid |
|
56022-7
|
ACE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
51835-7
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid |
|
53581-5
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid |
|
2742-5
|
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma |
|
3295-3
|
Acebutolol [Mass/time] in 24 hour Urine |
|
60039-5
|
Acebutolol [Mass/volume] in Blood |
|
79135-0
|
Acebutolol [Mass/volume] in Body fluid |
|
80119-1
|
Acebutolol [Mass/mass] in Hair by Confirmatory method |
|
73549-8
|
Acebutolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73548-0
|
Acebutolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60040-3
|
Acebutolol [Mass/volume] in Serum or Plasma |
|
60041-1
|
Acebutolol [Mass/mass] in Tissue |
|
3293-8
|
Acebutolol [Presence] in Urine |
|
3294-6
|
Acebutolol [Mass/volume] in Urine |
|
18188-3
|
Acebutolol [Mass/volume] in Unspecified specimen |
|
55521-9
|
Acebutolol [Moles/volume] in Unspecified specimen |
|
78774-7
|
Acenocoumarol [Mass/volume] in Blood |
|
79152-5
|
Acenocoumarol [Mass/volume] in Body fluid |
|
80120-9
|
Acenocoumarol [Mass/mass] in Hair |
|
35102-3
|
Acenocoumarol [Mass/volume] in Serum or Plasma |
|
78775-4
|
Acenocoumarol [Mass/volume] in Urine |
|
60043-7
|
Acepromazine [Mass/volume] in Blood |
|
79136-8
|
Acepromazine [Mass/volume] in Body fluid |
|
78776-2
|
Acepromazine [Mass/mass] in Hair |
|
3296-1
|
Acepromazine [Mass/volume] in Serum or Plasma |
|
60044-5
|
Acepromazine [Mass/volume] in Urine |
|
38584-9
|
Acetaldehyde [Mass/volume] in Air |
|
39531-9
|
Acetaldehyde [Presence] in Blood |
|
1700-4
|
Acetaldehyde [Mass/volume] in Blood |
|
60045-2
|
Acetaldehyde [Mass/volume] in Body fluid |
|
49514-3
|
Acetaldehyde [Presence] in Gastric fluid |
|
60046-0
|
Acetaldehyde [Mass/volume] in Red Blood Cells |
|
35118-9
|
Acetaldehyde [Presence] in Serum or Plasma |
|
1701-2
|
Acetaldehyde [Mass/volume] in Serum or Plasma |
|
60047-8
|
Acetaldehyde [Mass/mass] in Tissue |
|
21048-4
|
Acetaldehyde [Mass/volume] in Urine |
|
43105-6
|
Acetaldehyde and Paraldehyde panel [Mass/volume] - Serum or Plasma |
|
38629-2
|
Acetamide [Mass/volume] in Air |
|
43720-2
|
Acetaminophen+Codeine [Presence] in Serum or Plasma |
|
43719-4
|
Acetaminophen+oxyCODONE [Presence] in Serum or Plasma |
|
43721-0
|
Acetaldehyde+Paraldehyde [Presence] in Serum or Plasma |
|
33277-5
|
Acetaminophen+Phenacetin [Presence] in Urine by Screen method |
|
53781-1
|
Acetaminophen and Propoxyphene panel [Mass/volume] - Urine |
|
38658-1
|
Acetate [Mass/volume] in Air |
|
16307-1
|
Acetate [Mass/volume] in Dialysis fluid |
|
3303-5
|
Acetazolamide [Mass/time] in 24 hour Urine |
|
59598-3
|
Acetazolamide [Mass/volume] in Blood |
|
43627-9
|
Acetazolamide [Presence] in Serum or Plasma |
|
16308-9
|
Acetazolamide [Units/volume] in Serum or Plasma |
|
3300-1
|
Acetazolamide [Mass/volume] in Serum or Plasma |
|
55522-7
|
Acetazolamide [Moles/volume] in Serum or Plasma |
|
3301-9
|
Acetazolamide [Presence] in Urine |
|
16309-7
|
Acetazolamide [Units/volume] in Urine |
|
3302-7
|
Acetazolamide [Mass/volume] in Urine |
|
74431-8
|
Acetoacetate [Moles/volume] in Blood |
|
1703-8
|
Acetoacetate [Mass/volume] in Cerebral spinal fluid |
|
50154-4
|
Acetoacetate [Moles/volume] in Cerebral spinal fluid |
|
72415-3
|
Acetoacetate [Moles/volume] in Blood --post meal |
|
72414-6
|
Acetoacetate [Moles/volume] in Blood --pre-meal |
|
1704-6
|
Acetoacetate [Presence] in Serum or Plasma |
|
1705-3
|
Acetoacetate [Mass/volume] in Serum or Plasma |
|
35867-1
|
Acetoacetate [Moles/volume] in Serum or Plasma |
|
27132-0
|
Acetoacetate [Presence] in Urine |
|
1702-0
|
Acetoacetate [Mass/volume] in Urine |
|
33918-4
|
Acetoacetate [Moles/volume] in Urine |
|
13701-8
|
Acetoacetate/Creatinine [Mass Ratio] in Urine |
|
29524-6
|
Acetoacetate/Creatinine [Molar ratio] in Urine |
|
30574-8
|
Acetoacetate+Acetone [Mass/volume] in Serum or Plasma |
|
43626-1
|
Acetohexamide [Presence] in Serum or Plasma |
|
27007-4
|
Acetohexamide [Mass/volume] in Serum or Plasma |
|
27164-3
|
Acetohexamide [Mass/volume] in Urine |
|
48322-2
|
Acetohexamide [Presence] in Unspecified specimen |
|
6943-5
|
Acetohexamide [Mass/volume] in Unspecified specimen |
|
35665-9
|
Acetone [Mass/volume] in Urine collected for unspecified duration |
|
18189-1
|
Acetone [Mass/time] in 24 hour Urine |
|
38585-6
|
Acetone [Mass/volume] in Air |
|
39529-3
|
Acetone [Presence] in Blood |
|
9425-0
|
Acetone [Mass/volume] in Blood |
|
76524-8
|
Acetone [Moles/volume] in Blood |
|
5566-5
|
Acetone [Presence] in Exhaled gas |
|
16310-5
|
Acetone [Presence] in Body fluid |
|
15146-4
|
Acetone [Units/volume] in Body fluid |
|
16311-3
|
Acetone [Mass/volume] in Body fluid |
|
50800-2
|
Acetone [Moles/volume] in Body fluid |
|
40598-5
|
Acetone [Presence] in Gastric fluid |
|
59864-9
|
Acetone [Moles/volume] in Gastric fluid |
|
5567-3
|
Acetone [Presence] in Serum or Plasma |
|
20469-3
|
Acetone [Presence] in Serum or Plasma by Screen method |
|
5568-1
|
Acetone [Mass/volume] in Serum or Plasma |
|
14582-1
|
Acetone [Moles/volume] in Serum or Plasma |
|
21049-2
|
Acetone [Mass/mass] in Tissue |
|
5569-9
|
Acetone [Presence] in Urine |
|
5570-7
|
Acetone [Mass/volume] in Urine |
|
32291-7
|
Acetone [Moles/volume] in Urine |
|
32290-9
|
Acetone [Presence] in Unspecified specimen |
|
32292-5
|
Acetone [Moles/volume] in Unspecified specimen |
|
58803-8
|
Acetone/Creatinine [Mass Ratio] in Urine |
|
38586-4
|
Acetonitrile [Mass/volume] in Air |
|
1706-1
|
Acetonitrile [Mass/volume] in Blood |
|
16312-1
|
Acetonitrile [Mass/volume] in Serum or Plasma |
|
12987-4
|
Acetonitrile [Mass/volume] in Urine |
|
60051-0
|
Acetophenazine [Mass/volume] in Blood |
|
26925-8
|
Acetophenazine [Presence] in Serum or Plasma |
|
10528-8
|
Acetophenazine [Mass/volume] in Serum or Plasma |
|
38659-9
|
Acetophenone [Mass/volume] in Air |
|
74810-3
|
Acetyl fentaNYL [Presence] in Urine by Confirmatory method |
|
74372-4
|
Acetyl fentaNYL [Mass/volume] in Urine |
|
86223-5
|
Acetyl norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
93471-1
|
Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method |
|
50156-9
|
Acetylcarnitine (C2) [Moles/volume] in Amniotic fluid |
|
50155-1
|
Acetylcarnitine (C2) [Moles/volume] in Cerebral spinal fluid |
|
50157-7
|
Acetylcarnitine (C2) [Moles/volume] in DBS |
|
18436-6
|
Acetylcarnitine (C2) [Mass/volume] in Serum or Plasma |
|
30191-1
|
Acetylcarnitine (C2) [Moles/volume] in Serum or Plasma |
|
54345-4
|
Acetylcarnitine (C2) [Moles/volume] in Semen |
|
50158-5
|
Acetylcarnitine (C2) [Moles/volume] in Urine |
|
50159-3
|
Acetylcarnitine (C2)/Creatinine [Molar ratio] in Urine |
|
3304-3
|
Acetyldigitoxin [Mass/volume] in Serum or Plasma |
|
38660-7
|
Acetylene [Mass/volume] in Air |
|
16313-9
|
Acetylene [Mass/volume] in Blood |
|
12899-1
|
Acetylene [Mass/volume] in Serum or Plasma |
|
73058-0
|
Acetylsalicylate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73057-2
|
Acetylsalicylate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7108-4
|
Acetylsalicylate IgE Ab [Units/volume] in Serum |
|
73518-3
|
Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73519-1
|
Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3305-0
|
Acetylsalicylate [Presence] in Serum or Plasma |
|
3306-8
|
Acetylsalicylate [Mass/volume] in Serum or Plasma |
|
74970-5
|
Acetylsalicylate [Mass/volume] in Serum or Plasma --trough |
|
16314-7
|
Acetylsalicylate [Presence] in Urine |
|
1707-9
|
Acetylcholine [Mass/volume] in Serum |
|
30106-9
|
Acetylcholinesterase [Presence] in Amniotic fluid |
|
1708-7
|
Acetylcholinesterase [Enzymatic activity/volume] in Amniotic fluid |
|
30244-8
|
Acetylcholinesterase [Enzymatic activity/volume] in Blood |
|
76478-7
|
Acetylcholinesterase panel - Amniotic fluid |
|
1709-5
|
Acetylcholinesterase [Enzymatic activity/volume] in Red Blood Cells |
|
49230-6
|
Acetylcholinesterase [Enzymatic activity/mass] in Red Blood Cells |
|
1710-3
|
Acetylcholinesterase [Enzymatic activity/volume] in Serum or Plasma |
|
35701-2
|
Acetylcholinesterase [Enzymatic activity/volume] in Unspecified specimen |
|
16347-7
|
Alpha chlordane [Mass/volume] in Blood |
|
11091-6
|
Alpha chlordane [Mass/volume] in Serum or Plasma |
|
16346-9
|
Alpha chlordane [Mass/volume] in Urine |
|
68937-2
|
Acetylcholine receptor Ab [Moles/volume] in Serum by Immunoassay |
|
43625-3
|
Acetylcholine receptor Ab [Presence] in Serum |
|
8058-0
|
Acetylcholine receptor Ab [Units/volume] in Serum |
|
20427-1
|
Acetylcholine receptor Ab [Moles/volume] in Serum |
|
43624-6
|
Acetylcholine receptor binding Ab [Presence] in Serum |
|
11560-0
|
Acetylcholine receptor binding Ab [Units/volume] in Serum |
|
11034-6
|
Acetylcholine receptor binding Ab [Moles/volume] in Serum |
|
5037-7
|
Acetylcholine receptor binding Ab [Titer] in Serum by Immunofluorescence |
|
43623-8
|
Acetylcholine receptor blocking Ab [Presence] in Serum |
|
11561-8
|
Acetylcholine receptor blocking Ab [Units/volume] in Serum |
|
33278-3
|
Acetylcholine receptor blocking Ab [Moles/volume] in Serum |
|
5038-5
|
Acetylcholine receptor blocking Ab [Titer] in Serum by Immunofluorescence |
|
42937-3
|
Acetylcholine receptor blocking Ab/Acetylcholine Ab.total in Serum |
|
11562-6
|
Acetylcholine receptor modulation Ab [Units/volume] in Serum |
|
33279-1
|
Acetylcholine receptor modulation Ab [Moles/volume] in Serum |
|
5039-3
|
Acetylcholine receptor modulation Ab [Titer] in Serum by Immunofluorescence |
|
30192-9
|
Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum |
|
67562-9
|
Achromobacter sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76323-5
|
Aorta acceleration index |
|
21064-1
|
Acid alpha glucosidase [Enzymatic activity/volume] in Amniotic fluid |
|
55827-0
|
Acid alpha glucosidase [Enzymatic activity/volume] in DBS |
|
24050-7
|
Acid alpha glucosidase [Enzymatic activity/mass] in Fibroblast |
|
38475-0
|
Acid alpha glucosidase [Enzymatic activity/volume] in Serum or Plasma |
|
1814-3
|
Acid alpha glucosidase [Enzymatic activity/volume] in Semen |
|
1815-0
|
Acid alpha glucosidase [Enzymatic activity/mass] in Tissue |
|
30315-6
|
Acid alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue |
|
1816-8
|
Acid alpha glucosidase [Enzymatic activity/volume] in Leukocytes |
|
24051-5
|
Acid alpha glucosidase [Enzymatic activity/mass] in Leukocytes |
|
88152-4
|
Microscopic observation [Identifier] in Cervix by Acid fast stain.Kinyoun |
|
640-3
|
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun |
|
88631-7
|
Microscopic observation [Presence] in Lower respiratory specimen by Acid fast stain.Kinyoun |
|
645-2
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun |
|
6655-5
|
Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun |
|
650-2
|
Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun |
|
654-4
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain.Kinyoun |
|
641-1
|
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Kinyoun modified |
|
14353-7
|
Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Kinyoun modified |
|
646-0
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Kinyoun modified |
|
6656-3
|
Microscopic observation [Identifier] in Tissue by Acid fast stain.Kinyoun modified |
|
651-0
|
Microscopic observation [Identifier] in Urine by Acid fast stain.Kinyoun modified |
|
14354-5
|
Microscopic observation [Identifier] in Wound by Acid fast stain.Kinyoun modified |
|
655-1
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain.Kinyoun modified |
|
88156-5
|
Microscopic observation [Identifier] in Amniotic fluid by Acid fast stain |
|
88159-9
|
Microscopic observation [Identifier] in Aspirate by Acid fast stain |
|
88231-6
|
Microscopic observation [Identifier] in Bile fluid by Acid fast stain |
|
32699-1
|
Microscopic observation [Identifier] in Blood by Acid fast stain |
|
24002-8
|
Microscopic observation [Identifier] in Bronchial specimen by Acid fast stain |
|
88171-4
|
Microscopic observation [Presence] in Cornea or Conjunctiva by Acid fast stain |
|
32188-5
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain |
|
32189-3
|
Microscopic observation [Identifier] in Body fluid by Acid fast stain |
|
11476-9
|
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain |
|
88148-2
|
Microscopic observation [Identifier] in Genital specimen by Acid fast stain |
|
89660-5
|
Microscopic observation [Identifier] in Implanted device by Acid fast stain |
|
88172-2
|
Microscopic observation [Presence] in Isolate by Acid fast stain |
|
89662-1
|
Microscopic observation [Identifier] in Lower respiratory specimen by Acid fast stain |
|
88153-2
|
Microscopic observation [Identifier] in Bone marrow by Acid fast stain |
|
90269-2
|
Microscopic observation [Identifier] in Milk by Acid fast stain |
|
88155-7
|
Microscopic observation [Identifier] in Ocular fluid by Acid fast stain |
|
88145-8
|
Microscopic observation [Identifier] in Pericardial fluid by Acid fast stain |
|
88173-0
|
Microscopic observation [Presence] in Pleural fluid by Acid fast stain |
|
88144-1
|
Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain |
|
88154-0
|
Microscopic observation [Identifier] in Sinus by Acid fast stain |
|
88157-3
|
Microscopic observation [Identifier] in Semen by Acid fast stain |
|
88234-0
|
Microscopic observation [Presence] in Synovial fluid by Acid fast stain |
|
11477-7
|
Microscopic observation [Identifier] in Sputum by Acid fast stain |
|
11478-5
|
Microscopic observation [Identifier] in Stool by Acid fast stain |
|
11479-3
|
Microscopic observation [Identifier] in Tissue by Acid fast stain |
|
89661-3
|
Microscopic observation [Identifier] in Upper respiratory specimen by Acid fast stain |
|
11480-1
|
Microscopic observation [Identifier] in Urine by Acid fast stain |
|
88366-0
|
Microscopic observation [Presence] in Vomitus by Acid fast stain |
|
88151-6
|
Microscopic observation [Identifier] in Wound by Acid fast stain |
|
11545-1
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain |
|
72357-7
|
Microscopic observation [Presence] in Unspecified specimen by Acid fast stain |
|
52126-0
|
Acid glycerol lysis [Time] in Red Blood Cells |
|
13533-5
|
Acid hemolysis [Presence] of Blood |
|
35702-0
|
Acid hemolysis fraction in Blood |
|
18297-2
|
Acid hemolysis [Mass/volume] of Red Blood Cells |
|
21536-8
|
Acid sphingomyelinase [Enzymatic activity/volume] in Blood |
|
62316-5
|
Acid sphingomyelinase [Enzymatic activity/volume] in DBS |
|
24100-0
|
Acid sphingomyelinase [Enzymatic activity/mass] in Fibroblast |
|
24101-8
|
Acid sphingomyelinase [Enzymatic activity/mass] in Leukocytes |
|
88244-9
|
Acinetobacter sp rpsA gene [Presence] by Probe in Positive blood culture |
|
90003-5
|
Acinetobacter sp identified in Unspecified specimen by Organism specific culture |
|
43622-0
|
Aconitate [Presence] in 24 hour Urine |
|
75083-6
|
Aconitate [Moles/volume] in Serum or Plasma |
|
26832-6
|
Aconitate [Presence] in Urine |
|
13702-6
|
Aconitate/Creatinine [Mass Ratio] in Urine |
|
29525-3
|
Aconitate/Creatinine [Molar ratio] in Urine |
|
55905-4
|
Alpha cortol [Mass/volume] in 24 hour Urine |
|
53629-2
|
Alpha cortol [Mass/time] in 24 hour Urine |
|
73869-0
|
Alpha cortol [Moles/volume] in 24 hour Urine |
|
73867-4
|
Alpha cortol [Moles/time] in 24 hour Urine |
|
73868-2
|
Alpha cortol [Moles/volume] in Urine |
|
53630-0
|
Alpha cortol/Creatinine [Mass Ratio] in 24 hour Urine |
|
53631-8
|
Alpha cortol/Creatinine [Mass Ratio] in Urine |
|
81807-0
|
Alpha cortol/Creatinine [Molar ratio] in Urine |
|
55907-0
|
Alpha cortolone [Mass/volume] in 24 hour Urine |
|
73872-4
|
Alpha cortolone [Moles/volume] in 24 hour Urine |
|
73870-8
|
Alpha cortolone [Moles/time] in 24 hour Urine |
|
73871-6
|
Alpha cortolone [Moles/volume] in Urine |
|
44430-7
|
Alpha cortolone/Creatinine [Mass Ratio] in Urine |
|
81806-2
|
Alpha cortolone/Creatinine [Molar ratio] in Urine |
|
16315-4
|
Acid phosphatase [Enzymatic activity/volume] in Blood by Tartrate inhibited |
|
1711-1
|
Acid phosphatase [Enzymatic activity/volume] in Blood |
|
12804-1
|
Acid phosphatase [Enzymatic activity/volume] in Body fluid |
|
12173-1
|
Non prostatic acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
|
1715-2
|
Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
|
21391-8
|
Microscopic observation [Identifier] in Bone by Acid phosphatase stain |
|
44835-7
|
Acid phosphatase tartrate resistant [Presence] in Blood |
|
16316-2
|
Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Blood |
|
44834-0
|
Acid phosphatase tartrate resistant [Presence] in Bone marrow |
|
17837-6
|
Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Serum |
|
18190-9
|
Acid phosphatase tartrate resistant [Presence] in Unspecified specimen |
|
45160-9
|
Acremonium sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
6066-5
|
Acremonium sp IgE Ab [Units/volume] in Serum |
|
61207-7
|
Acremonium sp IgE Ab/IgE total in Serum |
|
56214-0
|
Acremonium sp IgG4 Ab [Mass/volume] in Serum |
|
63177-0
|
Acremonium sp IgG Ab [Mass/volume] in Serum |
|
38587-2
|
Acrylaldehyde [Mass/volume] in Air |
|
21051-8
|
Acrylaldehyde [Mass/volume] in Serum or Plasma |
|
38573-2
|
Acrylamide [Mass/volume] in Air |
|
12988-2
|
Acrylamide [Mass/volume] in Blood |
|
16319-6
|
Acrylamide [Mass/volume] in Serum or Plasma |
|
16318-8
|
Acrylamide [Mass/volume] in Urine |
|
38630-0
|
Acrylate [Mass/volume] in Air |
|
93468-7
|
Acrylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
38588-0
|
Acrylonitrile [Mass/volume] in Air |
|
5571-5
|
Acrylonitrile [Mass/volume] in Blood |
|
53237-4
|
Acrylylcarnitine (C3:1) [Moles/volume] in DBS |
|
43235-1
|
Acrylylcarnitine (C3:1) [Moles/volume] in Serum or Plasma |
|
77048-7
|
ACSF3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77047-9
|
ACSF3 gene full mutation analysis in Blood or Tissue by Sequencing |
|
61110-3
|
ACSL4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
3184-9
|
Activated clotting time (ACT) of Blood by Coagulation assay |
|
80658-8
|
Activated clotting time (ACT) of Blood induced by Diatomaceous earth |
|
80659-6
|
Activated clotting time (ACT) of Blood induced by Kaolin |
|
82271-8
|
Activity metabolic rate/Standard resting metabolic rate [Relative Energy/Time] adjusted for age+sex+race+BMI 1 minute mean Estimated |
|
48344-6
|
Activated clotting time (ACT) of Platelet poor plasma by Kaolin induced method |
|
44700-3
|
ACTA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48091-3
|
Corticotropin [Mass/volume] in Plasma --12 AM specimen |
|
48092-1
|
Corticotropin [Mass/volume] in Plasma --12 PM specimen |
|
48095-4
|
Corticotropin [Mass/volume] in Plasma --4 PM specimen |
|
48097-0
|
Corticotropin [Mass/volume] in Plasma --8 PM specimen |
|
10475-2
|
Corticotropin Ag [Presence] in Tissue by Immune stain |
|
56913-7
|
Corticotropin [Mass/volume] in Plasma --morning specimen |
|
16652-0
|
Corticotropin [Mass/volume] in Amniotic fluid by Radioimmunoassay (RIA) |
|
2140-2
|
Corticotropin [Mass/volume] in Amniotic fluid |
|
14149-9
|
Corticotropin Big Fragment [Mass/volume] in Serum or Plasma |
|
16653-8
|
Corticotropin Canine [Mass/volume] in Plasma |
|
56914-5
|
Corticotropin [Mass/volume] in Plasma --evening specimen |
|
6016-0
|
Corticotropin IgE Ab [Units/volume] in Serum |
|
56167-0
|
Corticotropin IgG4 Ab [Mass/volume] in Serum |
|
50414-2
|
Corticotropin [Mass/volume] in Plasma --post 1 mg dexamethasone PO overnight |
|
91707-0
|
Corticotropin post CRH stimulation panel - Plasma |
|
47843-8
|
Corticotropin [Mass/volume] in Plasma --post dose dexamethasone |
|
6879-1
|
Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) |
|
2141-0
|
Corticotropin [Mass/volume] in Plasma |
|
66732-9
|
Corticotropin [Mass or Moles/volume] in Plasma |
|
14674-6
|
Corticotropin [Moles/volume] in Plasma |
|
12283-8
|
Corticotropin releasing hormone [Units/volume] in Serum or Plasma |
|
11213-6
|
Corticotropin releasing hormone [Mass/volume] in Serum or Plasma |
|
37990-9
|
Corticotropin releasing hormone [Moles/volume] in Serum or Plasma |
|
15042-5
|
Corticotropin [Units/volume] in Serum |
|
34541-3
|
ACTH stimulation test using IM corticosteroids in Serum or Plasma |
|
34542-1
|
ACTH stimulation test using IV corticosteroids in Serum or Plasma |
|
53979-1
|
Actin Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
53980-9
|
Actin Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
10457-0
|
Actin Ag [Presence] in Tissue by Immune stain |
|
34661-9
|
Actin IgG Ab [Units/volume] in Serum or Plasma |
|
29885-1
|
Actinobacillus sp identified in Unspecified specimen by Organism specific culture |
|
43619-6
|
Actinomyces sp Ab [Presence] in Serum |
|
7804-8
|
Actinomyces sp Ab [Units/volume] in Serum |
|
22079-8
|
Actinomyces sp Ab [Titer] in Serum |
|
5040-1
|
Actinomyces sp Ab [Titer] in Serum by Immunofluorescence |
|
89634-0
|
Actinomyces sp identified in Implanted device by Organism specific culture |
|
89633-2
|
Actinomyces sp identified in Lower respiratory specimen by Organism specific culture |
|
9816-0
|
Actinomyces sp identified in Unspecified specimen by Organism specific culture |
|
57461-6
|
Activated T cells lymphocytes/100 lymphocytes.small in Bronchial specimen |
|
41359-1
|
Active range of motion panel Quantitative |
|
46052-7
|
Activity pursuit patterns section |
|
85237-6
|
Acupuncture Consult note |
|
85220-2
|
Acupuncture Note |
|
85221-0
|
Acupuncture Nurse Note |
|
24363-4
|
Acute hepatitis 2000 panel - Serum |
|
88993-1
|
Acute kidney injury risk [Likelihood] by Calculated by NephroCheck |
|
45270-6
|
Acute leukemia panel - Unspecified specimen by Flow cytometry (FC) |
|
72103-5
|
Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method |
|
43395-3
|
Cholesterol in VLDL acylated [Mass/volume] in Serum or Plasma |
|
47961-8
|
ACVRL1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
69481-0
|
ACVRL1 gene+ENG gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
80121-7
|
Acyclovir [Mass/volume] in Cerebral spinal fluid |
|
73544-9
|
Acyclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73545-6
|
Acyclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73574-6
|
Acyclovir [Susceptibility] by Genotype method |
|
35104-9
|
Acyclovir [Mass/volume] in Serum or Plasma --peak |
|
9416-9
|
Acyclovir [Mass/volume] in Serum or Plasma |
|
8-Jan
|
Acyclovir [Susceptibility] |
|
35103-1
|
Acyclovir [Mass/volume] in Serum or Plasma --trough |
|
50162-7
|
Acylcarnitine [Moles/volume] in Amniotic fluid |
|
43715-2
|
Acylcarnitine [Presence] in Blood |
|
50163-5
|
Acylcarnitine [Moles/volume] in Cerebral spinal fluid |
|
43717-8
|
Acylcarnitine [Presence] in DBS |
|
58092-8
|
Acylcarnitine newborn screen panel |
|
43433-2
|
Acylcarnitine panel - Serum or Plasma |
|
38552-6
|
Acylcarnitine short chain [Moles/volume] in Serum or Plasma |
|
31991-3
|
Acylcarnitine [Presence] in Serum or Plasma |
|
14282-8
|
Acylcarnitine [Moles/volume] in Serum or Plasma |
|
43716-0
|
Acylcarnitine [Presence] in Urine |
|
59249-3
|
Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in DBS |
|
59254-3
|
Acylcarnitine/Acylcarnitine+Carnitine Free (C0) [Molar ratio] in Serum or Plasma |
|
50334-2
|
Acylglycines panel [Mass Ratio] - Urine |
|
74914-3
|
Acylglycines panel [Molar ratio] - Urine |
|
32280-0
|
Acylglycines [Presence] in Urine |
|
90779-0
|
Adalimumab Ab [Units/volume] in Serum by Immunoassay |
|
86895-0
|
Adalimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
87742-3
|
Adalimumab Ab [Units/volume] in Serum or Plasma |
|
74116-5
|
Adalimumab Ab [Mass/volume] in Serum or Plasma |
|
92765-7
|
Adalimumab neutralizing antibody [Titer] in Serum by Bioassay |
|
86894-3
|
Adalimumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
74117-3
|
Adalimumab [Mass/volume] in Serum or Plasma |
|
89070-7
|
ADAPTABLE patient reported item set [ADAPTABLE] |
|
87491-7
|
ADBICA N-4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
87485-9
|
ADBICA N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
87490-9
|
ADB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
87251-5
|
Addiction medicine Administrative note |
|
87252-3
|
Addiction medicine Admission evaluation note |
|
88361-1
|
Addiction medicine Alert |
|
86212-8
|
Addiction medicine Attending Note |
|
87261-4
|
Addiction medicine Case manager Note |
|
87254-9
|
Addiction medicine Consult note |
|
87255-6
|
Addiction medicine Counseling note |
|
87245-7
|
Addiction medicine Custodial care facility Note |
|
87256-4
|
Addiction medicine Discharge summary |
|
87248-1
|
Addiction medicine Education note |
|
87257-2
|
Addiction medicine Group counseling note |
|
87259-8
|
Addiction medicine History and physical note |
|
87246-5
|
Addiction medicine Hospital Note |
|
87260-6
|
Addiction medicine Initial evaluation note |
|
86211-0
|
Addiction medicine Physician Note |
|
87247-3
|
Addiction medicine Medication management note |
|
34857-3
|
Addiction medicine Note |
|
87262-2
|
Addiction medicine Nurse Note |
|
87249-9
|
Addiction medicine Outpatient Note |
|
87244-0
|
Addiction medicine Telephone encounter Note |
|
87253-1
|
Addiction medicine Plan of care note |
|
93892-8
|
Addiction medicine Progress note |
|
87250-7
|
Addiction medicine Referral note |
|
87258-0
|
Addiction medicine Risk assessment and screening note |
|
90760-0
|
Addiction medicine Social worker Note |
|
87263-0
|
Addiction medicine Team Note |
|
87264-8
|
Addiction medicine Therapist Note |
|
75422-6
|
Addiction psychiatry Group counseling note |
|
75423-4
|
Addiction psychiatry Note |
|
77599-9
|
Additional documentation |
|
72259-5
|
Adefovir [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
75133-9
|
Adenine [Moles/volume] in Cerebral spinal fluid |
|
1719-4
|
Adenine [Mass/volume] in Serum |
|
75131-3
|
Adenine [Moles/volume] in Serum or Plasma |
|
80374-2
|
Adenovirus and Norovirus and Rotavirus Ag panel - Stool by Rapid immunoassay |
|
1722-8
|
Adenosine deaminase [Enzymatic activity/volume] in Blood |
|
47996-4
|
Adenosine deaminase binding protein [Units/volume] in Urine |
|
1723-6
|
Adenosine deaminase binding protein [Mass/volume] in Urine |
|
35703-8
|
Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
79404-0
|
Adenosine deaminase [Enzymatic activity/substance] in Red Blood Cells |
|
50395-3
|
Adenosine deaminase [Enzymatic activity/mass] in Chorionic villus sample |
|
75052-1
|
Adenosine deaminase [Enzymatic activity/volume] in DBS |
|
59023-2
|
Adenosine deaminase [Enzymatic activity/volume] in Peritoneal dialysis fluid |
|
47548-3
|
Adenosine deaminase [Enzymatic activity/mass] in Fibroblast |
|
9404-5
|
Adenosine deaminase [Enzymatic activity/volume] in Body fluid |
|
49760-2
|
Adenosine deaminase [Enzymatic activity/volume] in Pericardial fluid |
|
35704-6
|
Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid |
|
49759-4
|
Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid |
|
47549-1
|
Adenosine deaminase [Enzymatic activity/mass] in Red Blood Cells |
|
47826-3
|
Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma |
|
51799-5
|
Adenosine deaminase [Enzymatic activity/volume] in Synovial fluid |
|
50591-7
|
Adenosine deaminase [Enzymatic activity/mass] in Trophoblasts |
|
47550-9
|
Adenosine deaminase [Entitic Catalytic Activity] in Leukocytes |
|
79451-1
|
Adenosine deaminase [Enzymatic activity/mass] in Leukocytes |
|
47827-1
|
Adenosyl homocysteine hydrolase [Enzymatic activity/mass] in Red Blood Cells |
|
80586-1
|
Adenovirus hexon gene [Presence] in Nasopharynx by NAA with probe detection |
|
24126-5
|
Adenovirus type [Identifier] in Unspecified specimen by Neutralization test |
|
9782-4
|
Adenovirus sp identified in Unspecified specimen by Organism specific culture |
|
11035-3
|
Adenylate kinase [Enzymatic activity/volume] in Red Blood Cells |
|
44051-1
|
Adenylate kinase [Enzymatic activity/mass] in Red Blood Cells |
|
1731-9
|
Adenylate kinase [Enzymatic activity/volume] in Serum |
|
78689-7
|
Adenylosuccinate/Creatinine [Molar ratio] in Urine |
|
75294-9
|
Adequacy of breastmilk andor formula |
|
79453-7
|
Alcohol dehydrogenase [Enzymatic activity/mass] in Liver |
|
1760-8
|
Alcohol dehydrogenase [Enzymatic activity/volume] in Serum |
|
74155-3
|
ADHD action plan |
|
94018-9
|
ADHD screening report |
|
43609-7
|
Adipate [Presence] in 24 hour Urine |
|
75087-7
|
Adipate [Moles/volume] in Serum or Plasma |
|
26751-8
|
Adipate [Presence] in Urine |
|
1733-5
|
Adipate [Mass/volume] in Urine |
|
49933-5
|
Adipate.unsaturated/Creatinine [Molar ratio] in Urine |
|
13703-4
|
Adipate/Creatinine [Mass Ratio] in Urine |
|
29859-6
|
Adipate/Creatinine [Molar ratio] in Urine |
|
49934-3
|
Adipolactone/Creatinine [Molar ratio] in Urine |
|
47828-9
|
Adiponectin [Mass/volume] in Serum or Plasma |
|
55819-7
|
Adiponectin.high molecular weight [Mass/volume] in Serum or Plasma |
|
50302-9
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Amniotic fluid |
|
50303-7
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Cerebral spinal fluid |
|
50304-5
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS |
|
50166-8
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Serum or Plasma |
|
50301-1
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC) [Moles/volume] in Urine |
|
50305-2
|
Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine |
|
74628-9
|
Adipoylcarnitine (C6-DC) [Moles/volume] in DBS |
|
74593-5
|
Adipoylcarnitine (C6-DC) [Enzymatic activity/mass] in Fibroblast |
|
81769-2
|
Adipoylcarnitine (C6-DC)/Creatinine [Molar ratio] in Urine |
|
46013-9
|
ADL functional rehabilitation potential Set |
|
45979-2
|
ADL patterns Set |
|
46007-1
|
ADL self performance or support Set |
|
51851-4
|
Administrative note |
|
52455-3
|
Admission date |
|
86532-9
|
Admission notification note |
|
67851-6
|
Admission evaluation note |
|
51849-8
|
Admission history and physical note |
|
57909-4
|
ADNFLE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75136-2
|
Adenosine [Moles/volume] in Cerebral spinal fluid |
|
75142-0
|
Adenosine [Moles/volume] in Serum or Plasma |
|
75160-2
|
Adenosine/Creatinine [Molar ratio] in Urine |
|
90709-7
|
Adolescent medicine Consult note |
|
68611-3
|
Adolescent medicine Diagnostic study note |
|
68612-1
|
Adolescent medicine Discharge summary |
|
68614-7
|
Adolescent medicine History and physical note |
|
68619-6
|
Adolescent medicine Hospital Consult note |
|
68620-4
|
Adolescent medicine Hospital Letter |
|
68615-4
|
Adolescent medicine Note |
|
89878-3
|
Adolescent medicine Outpatient Note |
|
68616-2
|
Adolescent medicine Preoperative evaluation and management note |
|
68617-0
|
Adolescent medicine Progress note |
|
89887-4
|
Adolescent medicine Telehealth Note |
|
68618-8
|
Adolescent medicine Transfer summary note |
|
82871-5
|
Adenosine diphosphate [Entitic substance] in Platelets |
|
1724-4
|
Adenosine diphosphate [Mass/volume] in Serum |
|
14232-3
|
Adrenal Ab [Presence] in Serum |
|
57745-2
|
Adrenal Ab [Presence] in Serum by Immunofluorescence |
|
8059-8
|
Adrenal Ab [Units/volume] in Serum |
|
32661-1
|
Adrenal Ab [Titer] in Serum |
|
5043-5
|
Adrenal Ab [Titer] in Serum by Immunofluorescence |
|
6923-7
|
Adrenal cortex Ab [Units/volume] in Serum by Immunofluorescence |
|
43608-9
|
Adrenal cortex Ab [Presence] in Serum |
|
5044-3
|
Adrenal cortex Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
8060-6
|
Adrenal cortex Ab [Units/volume] in Serum |
|
25499-5
|
Adrenal cortex Ab [Titer] in Serum by Immunofluorescence |
|
74967-1
|
Adrenal cortex IgG Ab [Presence] in Serum by Immunofluorescence |
|
56670-3
|
Adrenal cortex IgG Ab [Units/volume] in Serum |
|
66122-3
|
Adrenal gland Pathology biopsy report |
|
79452-9
|
Adenylosuccinate lyase [Enzymatic activity/substance] in Red Blood Cells |
|
1732-7
|
Adenylosuccinate lyase [Enzymatic activity/volume] in Serum |
|
22765-2
|
Adult fly identified in Unspecified specimen |
|
58715-4
|
Adulterants panel - Urine |
|
61363-8
|
Adenovirus 3+4+7+21 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31709-9
|
Adenovirus 40+41 Ag [Presence] in Stool |
|
6306-5
|
Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay |
|
82209-8
|
Adenovirus 40+41 DNA [Presence] in Stool by NAA with non-probe detection |
|
92690-7
|
Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection |
|
80674-5
|
Adenovirus 40+41fiber protein gene [Presence] in Stool by NAA with probe detection |
|
22793-4
|
Aleutian disease virus Ab [Presence] in Serum |
|
22792-6
|
Aleutian disease virus Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
|
86330-8
|
Adenovirus B(11) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86331-6
|
Adenovirus B(14) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86329-0
|
Adenovirus B(16) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86328-2
|
Adenovirus B(21) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86334-0
|
Adenovirus B(3) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86332-4
|
Adenovirus B(7) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
92136-1
|
Adenovirus B+C+E DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
73755-1
|
Adenovirus B+E DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92828-3
|
Adenovirus B+E DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
73754-4
|
Adenovirus C DNA [Presence] in Nasopharynx by NAA with probe detection |
|
86333-2
|
Adenovirus E(4) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85810-0
|
Adenovirus serotype DNA panel - Unspecified specimen by NAA with probe detection |
|
75791-4
|
Advance directive - request for antibiotics |
|
75787-2
|
Advance directive - request for intubation |
|
75790-6
|
Advance directive - request for IV fluid and support |
|
75789-8
|
Advance directive - request for life support |
|
75792-2
|
Advance directive - request for resuscitation that differs from cardiopulmonary resuscitation |
|
75788-0
|
Advance directive - request for tube feeding |
|
93442-2
|
Advance directive document format |
|
42348-3
|
Advance directives |
|
75772-4
|
Advance directives panel [ADVault] |
|
75911-8
|
Advance directives panel |
|
45986-7
|
Advance directives Set |
|
53243-2
|
Advanced beneficiary notice |
|
82608-1
|
Advancing care information for population |
|
82813-7
|
Adverse Childhood Experiences [ACE] |
|
85893-6
|
Adverse event note |
|
81426-9
|
Microscopic observation [Identifier] in Venous blood by Acetate esterase stain |
|
81423-6
|
Microscopic observation [Identifier] in Bone marrow by Acetate esterase stain |
|
10765-6
|
Microscopic observation [Identifier] in Tissue by Acetate esterase stain |
|
32818-7
|
Microscopic observation [Identifier] in Unspecified specimen by Acetate esterase stain |
|
10429-9
|
AE 1 Ag [Presence] in Tissue by Immune stain |
|
10430-7
|
AE 3 Ag [Presence] in Tissue by Immune stain |
|
7500-2
|
Aedes mosquito triggered histamine release [Units/volume] in Blood |
|
6177-0
|
Aedes mosquito IgE Ab [Units/volume] in Serum |
|
61208-5
|
Aedes mosquito IgE Ab/IgE total in Serum |
|
56322-1
|
Aedes mosquito IgG4 Ab [Mass/volume] in Serum |
|
92909-1
|
Aerodigestive medicine Outpatient Note |
|
30122-6
|
Aeromonas sp [Presence] in Unspecified specimen by Organism specific culture |
|
85587-4
|
Aerospace medicine Note |
|
73873-2
|
Androstenetriol [Moles/volume] in 24 hour Urine |
|
73874-0
|
Androstenetriol [Moles/time] in 24 hour Urine |
|
73875-7
|
Androstenetriol [Moles/volume] in Urine |
|
81808-8
|
Androstenetriol/Creatinine [Molar ratio] in Urine |
|
43908-3
|
Avian encephalomyelitis virus Ab [Presence] in Cerebral spinal fluid |
|
22090-5
|
Avian encephalomyelitis virus Ab [Presence] in Serum |
|
15436-9
|
Avian encephalomyelitis virus Ab [Presence] in Serum by Immunoassay |
|
15437-7
|
Avian encephalomyelitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
87584-9
|
Aflatoxin B1 [Mass/mass] in Unspecified specimen |
|
87583-1
|
Aflatoxin B2 [Mass/mass] in Unspecified specimen |
|
23654-7
|
Aflatoxin [Mass/mass] in Feed |
|
87582-3
|
Aflatoxin G1 [Mass/mass] in Unspecified specimen |
|
87581-5
|
Aflatoxin G2 [Mass/mass] in Unspecified specimen |
|
32657-9
|
Aflatoxin IgA Ab [Units/volume] in Serum or Plasma |
|
32659-5
|
Aflatoxin IgE Ab [Units/volume] in Serum or Plasma |
|
32656-1
|
Aflatoxin IgG Ab [Units/volume] in Serum or Plasma |
|
32658-7
|
Aflatoxin IgM Ab [Units/volume] in Serum or Plasma |
|
87580-7
|
Aflatoxin M1 [Mass/mass] in Unspecified specimen |
|
23655-4
|
Aflatoxin [Mass/mass] in Tissue |
|
23653-9
|
Aflatoxin [Mass/volume] in Unspecified specimen |
|
90290-8
|
Alpha-1-Fetoprotein Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
10459-6
|
Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
|
83074-5
|
Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid by Immunoassay |
|
83075-2
|
Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid by Immunoassay |
|
43798-8
|
Alpha-1-Fetoprotein [Presence] in Amniotic fluid |
|
19171-8
|
Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid |
|
1832-5
|
Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid |
|
15019-3
|
Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid |
|
54348-8
|
Alpha-1-Fetoprotein [Mass/volume] in Cord blood |
|
59564-5
|
Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid |
|
1833-3
|
Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid |
|
44910-8
|
Alpha-1-Fetoprotein [Units/volume] in Body fluid |
|
11207-8
|
Alpha-1-Fetoprotein [Mass/volume] in Body fluid |
|
42332-7
|
Alpha-1-Fetoprotein L3/Alpha-1-fetoprotein.total in Serum or Plasma |
|
19172-6
|
Alpha-1-Fetoprotein [Units/volume] in Pleural fluid |
|
49762-8
|
Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid |
|
19173-4
|
Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid |
|
58735-2
|
Alpha-1-Fetoprotein panel - Amniotic fluid |
|
48802-3
|
Alpha-1-Fetoprotein panel - Serum or Plasma |
|
49761-0
|
Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid |
|
83072-9
|
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay |
|
83073-7
|
Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay |
|
31993-9
|
Alpha-1-Fetoprotein [Presence] in Serum or Plasma |
|
19176-7
|
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma |
|
1834-1
|
Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
|
19177-5
|
Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma |
|
53961-9
|
Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma |
|
53962-7
|
Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma |
|
53960-1
|
Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma |
|
10481-0
|
Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
|
27140-3
|
Follitropin.alpha subunit [Mass/volume] in Serum or Plasma |
|
2288-9
|
Follitropin.alpha subunit [Moles/volume] in Serum or Plasma |
|
17839-2
|
Alpha fucosidase [Enzymatic activity/volume] in Blood |
|
79454-5
|
Alpha fucosidase [Enzymatic activity/volume] in DBS |
|
24046-5
|
Alpha fucosidase [Enzymatic activity/mass] in Fibroblast |
|
24045-7
|
Alpha fucosidase [Enzymatic activity/volume] in Serum or Plasma |
|
1812-7
|
Alpha fucosidase [Enzymatic activity/mass] in Tissue |
|
23810-5
|
Alpha fucosidase [Units/volume] in Leukocytes |
|
24047-3
|
Alpha fucosidase [Enzymatic activity/mass] in Leukocytes |
|
77069-3
|
AGA gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
24058-0
|
Aspartylglucosaminidase [Enzymatic activity/mass] in Fibroblast |
|
77068-5
|
AGA gene full mutation analysis in Blood or Tissue by Sequencing |
|
24059-8
|
Aspartylglucosaminidase [Enzymatic activity/mass] in Leukocytes |
|
86449-6
|
Against medical advice note |
|
55908-8
|
Alpha galactosidase A [Enzymatic activity/volume] in DBS |
|
24048-1
|
Alpha galactosidase A [Enzymatic activity/mass] in Fibroblast |
|
1813-5
|
Alpha galactosidase A [Enzymatic activity/volume] in Serum or Plasma |
|
24049-9
|
Alpha galactosidase A [Enzymatic activity/mass] in Leukocytes |
|
87296-0
|
Age--at delivery Father |
|
90740-2
|
Aggressive prostate cancer risk [Likelihood] in Serum or Plasma by Calculated.4Kscore |
|
81830-2
|
AGL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
1846-5
|
Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells |
|
82222-1
|
Amylo-alpha-1,6-glucosidase [Enzymatic activity/mass] in Leukocytes |
|
80570-5
|
Agreement |
|
59245-1
|
Alanine glyoxylate aminotransferase [Enzymatic activity/mass] in Tissue |
|
69478-6
|
AGXT gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
69384-6
|
AGXT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
69383-8
|
AGXT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
13087-2
|
Complement alternate pathway AH50 [Units/volume] in Serum or Plasma |
|
93460-4
|
AH-7921 [Mass/volume] in Urine by Confirmatory method |
|
93457-0
|
AH-8529 [Mass/volume] in Urine by Confirmatory method |
|
93458-8
|
AH-8533 [Mass/volume] in Urine by Confirmatory method |
|
30206-7
|
Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma |
|
2108-9
|
Choriogonadotropin.alpha subunit [Presence] in Serum or Plasma |
|
27252-6
|
Choriogonadotropin.alpha subunit [Mass/volume] in Serum or Plasma |
|
2109-7
|
Choriogonadotropin.alpha subunit [Moles/volume] in Serum or Plasma |
|
77066-9
|
AHCY gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77065-1
|
AHCY gene full mutation analysis in Blood or Tissue by Sequencing |
|
22771-0
|
African horse sickness virus Ab [Presence] in Serum |
|
22768-6
|
African horse sickness virus Ab [Presence] in Serum by Complement fixation |
|
22766-0
|
African horse sickness virus Ab [Presence] in Serum by Immunoassay |
|
22767-8
|
African horse sickness virus Ab [Presence] in Serum by Immunoblot |
|
34885-4
|
African horse sickness virus Ab [Presence] in Serum by Immunofluorescence |
|
31220-7
|
African horse sickness virus Ab [Units/volume] in Serum |
|
22770-2
|
African horse sickness virus Ab [Titer] in Serum |
|
22769-4
|
African horse sickness virus Ab [Titer] in Serum by Neutralization test |
|
22772-8
|
African horse sickness virus Ag [Presence] in Tissue by Immunoassay |
|
31715-6
|
African horse sickness virus Ag [Presence] in Unspecified specimen |
|
22773-6
|
African horse sickness virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
22774-4
|
African horse sickness virus RNA [Presence] in Tissue by NAA with probe detection |
|
22775-1
|
African horse sickness virus serotype [Identifier] in Serum by Neutralization test |
|
22776-9
|
African horse sickness virus serotype [Identifier] in Unspecified specimen by Neutralization test |
|
22083-0
|
Alcelaphine herpesvirus 1 Ab [Presence] in Serum |
|
22787-6
|
Alcelaphine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
|
20873-6
|
Alcelaphine herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
|
31221-5
|
Alcelaphine herpesvirus 1 Ab [Units/volume] in Serum |
|
22786-8
|
Alcelaphine herpesvirus 1 Ab [Titer] in Serum |
|
22788-4
|
Alcelaphine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
|
31717-2
|
Alcelaphine herpesvirus 1 Ag [Presence] in Unspecified specimen |
|
22789-2
|
Alcelaphine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22790-0
|
Alcelaphine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immune stain |
|
22791-8
|
Alcelaphine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection |
|
90320-3
|
Aichivirus C RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
90321-1
|
Aichivirus C RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
53152-5
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline [Moles/volume] in DBS |
|
53154-1
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [Molar ratio] in DBS |
|
53153-3
|
Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [Molar ratio] in DBS |
|
34893-8
|
Aino virus Ab [Titer] in Serum |
|
34888-8
|
Aino virus Ab [Titer] in Serum by Neutralization test |
|
75396-2
|
AIP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
75395-4
|
AIP gene full mutation analysis in Blood or Tissue by Sequencing |
|
75915-9
|
Air curtain status Infant microenvironment.incubator |
|
75984-5
|
Air delivered during case [Volume] from Gas delivery system |
|
75985-2
|
Air delivered.total [Volume] in Reporting period from Gas delivery system |
|
57908-6
|
AIRE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
76004-1
|
Airway occlusion pressure |
|
75946-4
|
Airway resistance |
|
75947-2
|
Airway resistance --during expiration |
|
75948-0
|
Airway resistance --during inspiration |
|
91981-1
|
Airway resistance measured/predicted by Plethysmograph body box |
|
81442-6
|
Airway resistance --post bronchodilation |
|
81443-4
|
Airway resistance --pre bronchodilation |
|
60955-2
|
Airway temperature |
|
76067-8
|
Abbreviated Injury Scale panel AAAM |
|
34894-6
|
Akabane virus Ab [Titer] in Serum |
|
34889-6
|
Akabane virus Ab [Titer] in Serum by Neutralization test |
|
87489-1
|
AKB48 N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
69802-7
|
Alpha ketoglutarate [Moles/volume] in Cerebral spinal fluid |
|
1817-6
|
Alpha ketoglutarate [Mass/volume] in Serum or Plasma |
|
69803-5
|
Alpha ketoglutarate [Moles/volume] in Serum or Plasma |
|
27271-6
|
Alpha ketoglutarate [Presence] in Urine |
|
13678-8
|
Alpha ketoglutarate/Creatinine [Mass Ratio] in Urine |
|
29507-1
|
Alpha ketoglutarate/Creatinine [Molar ratio] in Urine |
|
42777-3
|
AKT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74127-2
|
Akt1 phosphate Ag [Presence] in Tissue by Immune stain |
|
70072-4
|
Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid |
|
70073-2
|
Amyloid beta 40 peptide [Mass/volume] in Plasma |
|
33203-1
|
Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid |
|
33200-7
|
Amyloid beta 42 peptide [Mass/volume] in Plasma |
|
55828-8
|
Aliphatic carboxylate, C14-C26.esters [Presence] in Stool |
|
10465-3
|
Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
|
10463-8
|
Amyloid A component Ag [Presence] in Tissue by Immune stain |
|
53150-9
|
Alanine+Beta Alanine+Sarcosine [Moles/volume] in DBS |
|
15137-3
|
Alanine+Ethanolamine [Presence] in Serum or Plasma |
|
15142-3
|
Alanine+Ethanolamine [Presence] in Urine |
|
10460-4
|
Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
|
25453-2
|
Lactalbumin alpha IgA Ab [Units/volume] in Serum |
|
7445-0
|
Lactalbumin alpha IgE Ab [Units/volume] in Serum |
|
61213-5
|
Lactalbumin alpha IgE Ab/IgE total in Serum |
|
51530-4
|
Lactalbumin alpha IgG Ab [Presence] in Serum |
|
11176-5
|
Lactalbumin alpha IgG Ab [Units/volume] in Serum |
|
26425-9
|
Lactalbumin alpha IgG4 Ab [Units/volume] in Serum |
|
56301-5
|
Lactalbumin alpha IgG4 Ab [Mass/volume] in Serum |
|
63418-8
|
Lactalbumin alpha IgG Ab [Mass/volume] in Serum |
|
48206-7
|
Lactalbumin alpha triggered leukotriene release [Mass/volume] by Leukocytes |
|
47551-7
|
Alanine [Moles/volume] in DBS |
|
47554-1
|
Alanine/Amino acids.total in Amniotic fluid |
|
47553-3
|
Alanine/Amino acids.total in Cerebral spinal fluid |
|
47556-6
|
Alanine/Amino acids.total in DBS |
|
47552-5
|
Alanine/Amino acids.total in Hair |
|
47555-8
|
Alanine/Amino acids.total in Serum or Plasma |
|
47557-4
|
Alanine/Amino acids.total in Unspecified specimen |
|
44291-3
|
Alanine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56671-1
|
Alanine/Creatinine [Ratio] in 24 hour Urine |
|
88018-7
|
Alanine/Lysine [Mass Ratio] in DBS |
|
59067-9
|
ALAS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82458-1
|
Alaska pollock roe IgE Ab [Units/volume] in Serum |
|
1756-6
|
Albumin in CSF/Albumin in Serum or Plasma |
|
75222-0
|
Microscopic observation [Identifier] in Throat by Alberts stain |
|
49002-9
|
Albumin [Mass/time] in Urine collected for unspecified duration |
|
29946-1
|
Albumin [Presence] in 24 hour Urine by Electrophoresis |
|
21059-1
|
Albumin [Mass/volume] in 24 hour Urine |
|
1745-9
|
Albumin [Mass/volume] in Amniotic fluid |
|
76631-1
|
Albumin [Mass/volume] in Blood by Bromocresol purple (BCP) dye binding method |
|
1757-4
|
Albumin renal clearance in 24 hour Urine and Serum or Plasma |
|
43711-1
|
Albumin [Presence] in Cerebral spinal fluid |
|
1746-7
|
Albumin [Mass/volume] in Cerebral spinal fluid |
|
76480-3
|
Albumin [Moles/volume] in Cerebral spinal fluid |
|
40599-3
|
Albumin [Mass/volume] in Peritoneal dialysis fluid |
|
43713-7
|
Albumin [Presence] in Body fluid |
|
1747-5
|
Albumin [Mass/volume] in Body fluid |
|
1758-2
|
Albumin.glycated [Mass/volume] in Serum or Plasma |
|
86921-4
|
Albumin goal [Mass/volume] Serum or Plasma |
|
54464-3
|
Albumin/Protein.total in Dialysis fluid by Electrophoresis |
|
51693-0
|
Albumin [Mass/volume] in Pericardial fluid |
|
1748-3
|
Albumin [Mass/volume] in Pleural fluid |
|
1749-1
|
Albumin [Mass/volume] in Peritoneal fluid |
|
72646-3
|
Albumin in serum - albumin in pericardial fluid [Mass concentration difference] |
|
61151-7
|
Albumin [Mass/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method |
|
62235-7
|
Albumin [Moles/volume] in Serum or Plasma by Bromocresol green (BCG) dye binding method |
|
61152-5
|
Albumin [Mass/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method |
|
62234-0
|
Albumin [Moles/volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method |
|
61195-4
|
Albumin [Mass/volume] in Serum or Plasma from Fetus |
|
43712-9
|
Albumin [Presence] in Serum or Plasma |
|
77148-5
|
Albumin [Mass/volume] in Serum, Plasma or Blood by Bromocresol purple (BCP) dye binding method |
|
1751-7
|
Albumin [Mass/volume] in Serum or Plasma |
|
72647-1
|
Albumin in serum - albumin in pleural fluid [Mass concentration difference] |
|
54347-0
|
Albumin [Moles/volume] in Serum or Plasma |
|
63549-0
|
Albumin in serum - albumin in peritoneal fluid [Mass concentration difference] |
|
1750-9
|
Albumin [Mass/volume] in Semen |
|
10558-5
|
Albumin [Moles/volume] in Semen |
|
1752-5
|
Albumin [Mass/volume] in Synovial fluid |
|
54346-2
|
Albumin [Mass/volume] in Stool |
|
50209-6
|
Albumin [Mass/time] in Urine collected for unspecified duration --supine |
|
6942-7
|
Albumin [Mass/volume] in Urine by Electrophoresis |
|
61196-2
|
Albumin [Mass/volume] in Urine from Fetus |
|
1753-3
|
Albumin [Presence] in Urine |
|
50949-7
|
Albumin [Presence] in Urine by Test strip |
|
1754-1
|
Albumin [Mass/volume] in Urine |
|
32293-3
|
Albumin [Mass/volume] in Unspecified specimen |
|
13705-9
|
Albumin/Creatinine [Mass Ratio] in 24 hour Urine |
|
76401-9
|
Albumin/Creatinine [Ratio] in 24 hour Urine |
|
9318-7
|
Albumin/Creatinine [Mass Ratio] in Urine |
|
20621-9
|
Albumin/Creatinine [Presence] in Urine by Test strip |
|
32294-1
|
Albumin/Creatinine [Ratio] in Urine |
|
14585-4
|
Albumin/Creatinine [Molar ratio] in Urine |
|
44294-7
|
Albumin/Globulin [Mass Ratio] in 24 hour Urine by Electrophoresis |
|
88709-1
|
Albumin/Globulin [Mass Ratio] in Body fluid by Electrophoresis |
|
44429-9
|
Albumin/Globulin [Mass Ratio] in Serum or Plasma by Electrophoresis |
|
44293-9
|
Albumin/Globulin [Mass Ratio] in Urine by Electrophoresis |
|
73543-1
|
Albuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73542-3
|
Albuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9311-2
|
Albuterol [Mass/volume] in Serum or Plasma |
|
29635-0
|
Albuterol [Presence] in Urine |
|
74043-1
|
Alcohol abuse or dependence HL7.VMR-CDS |
|
80439-3
|
Alcohol intake panel |
|
50022-3
|
Ethanol+Methanol+Isopropyl alcohol+Acetone [Presence] in Serum, Plasma or Blood |
|
48342-0
|
Ethanol+Methanol+Isopropyl alcohol+Acetone [Moles/volume] in Serum or Plasma |
|
81833-6
|
ALDH3A2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
53646-6
|
Aldicarb [Presence] in Gastric fluid |
|
80634-9
|
Aldicarb sulfone [Mass/volume] in Urine |
|
87635-9
|
Aldicarb sulfone [Mass/mass] in Unspecified specimen |
|
80635-6
|
Aldicarb sulfoxide [Mass/volume] in Urine |
|
80633-1
|
Aldicarb [Mass/volume] in Urine |
|
87634-2
|
Aldicarb [Mass/mass] in Unspecified specimen |
|
41120-7
|
ALDOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
36918-1
|
ALDOB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49724-8
|
Aldolase [Enzymatic activity/volume] in Body fluid |
|
44801-9
|
Aldolase [Enzymatic activity/volume] in Pleural fluid |
|
2299-6
|
Aldolase [Enzymatic activity/volume] in Red Blood Cells |
|
72655-4
|
Aldolase [Enzymatic activity/mass] in Red Blood Cells |
|
1761-6
|
Aldolase [Enzymatic activity/volume] in Serum or Plasma |
|
41023-3
|
Aldosterone [Molar amount] in Urine collected for unspecified duration |
|
15345-2
|
Aldosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
31992-1
|
Aldosterone [Mass/volume] in 24 hour Urine |
|
1765-7
|
Aldosterone [Mass/time] in 24 hour Urine |
|
25845-9
|
Aldosterone [Moles/volume] in 24 hour Urine |
|
14587-0
|
Aldosterone [Moles/time] in 24 hour Urine |
|
1762-4
|
Aldosterone [Mass/volume] in Blood |
|
1734-3
|
Aldosterone renal clearance in 24 hour Urine and Serum or Plasma |
|
23808-9
|
Aldosterone free [Mass/time] in 24 hour Urine |
|
92897-8
|
Aldosterone [Mass/volume] in Serum or Plasma by Immunoassay |
|
92896-0
|
Aldosterone [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
1763-2
|
Aldosterone [Mass/volume] in Serum or Plasma |
|
35185-8
|
Aldosterone [Mass or Moles/volume] in Serum or Plasma |
|
14586-2
|
Aldosterone [Moles/volume] in Serum or Plasma |
|
1767-3
|
Aldosterone [Mass/volume] in Serum or Plasma --supine |
|
35187-4
|
Aldosterone [Mass or Moles/volume] in Serum or Plasma --supine |
|
15011-0
|
Aldosterone [Moles/volume] in Serum or Plasma --supine |
|
1768-1
|
Aldosterone [Mass/volume] in Serum or Plasma --upright |
|
35188-2
|
Aldosterone [Mass or Moles/volume] in Serum or Plasma --upright |
|
15012-8
|
Aldosterone [Moles/volume] in Serum or Plasma --upright |
|
1764-0
|
Aldosterone [Mass/volume] in Urine |
|
35186-6
|
Aldosterone [Mass or Moles/volume] in Urine |
|
15010-2
|
Aldosterone [Moles/volume] in Urine |
|
44295-4
|
Aldosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
13482-5
|
Aldosterone/Creatinine [Mass Ratio] in Urine |
|
34231-1
|
Aldosterone/Creatinine [Molar ratio] in Urine |
|
30894-0
|
Aldosterone/Renin [Ratio] in Plasma |
|
73853-4
|
Aldosterone-18-glucuronide [Moles/volume] in 24 hour Urine |
|
73854-2
|
Aldosterone-18-glucuronide [Moles/time] in 24 hour Urine |
|
43640-2
|
Aldosterone-18-glucuronide [Units/volume] in Urine |
|
73855-9
|
Aldosterone-18-glucuronide [Moles/volume] in Urine |
|
78960-2
|
Aldosterone and renin concentration panel - Plasma |
|
55151-5
|
Aldosterone and renin activity panel - Plasma |
|
74729-5
|
Adrenoleukodystrophy protein (ALDP) [Presence] in Fibroblast by Immune stain |
|
38661-5
|
Aldrin [Mass/volume] in Air |
|
16333-7
|
Aldrin [Mass/volume] in Blood |
|
87668-0
|
Aldrin [Mass/mass] in Unspecified specimen |
|
73072-1
|
Alendronate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73071-3
|
Alendronate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73541-5
|
Alendronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73540-7
|
Alendronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
7065-6
|
Alfalfa IgE Ab [Units/volume] in Serum |
|
7066-4
|
Alfalfa IgG Ab [Units/volume] in Serum |
|
63194-5
|
Alfalfa IgG Ab [Mass/volume] in Serum |
|
7067-2
|
Alfalfa Pollen IgE Ab [Units/volume] in Serum |
|
80122-5
|
Alfentanil [Mass/volume] in Blood by Confirmatory method |
|
78778-8
|
Alfentanil [Presence] in Blood by Screen method |
|
79153-3
|
Alfentanil [Mass/volume] in Body fluid |
|
78777-0
|
Alfentanil [Mass/mass] in Hair |
|
3307-6
|
Alfentanil [Mass/volume] in Serum or Plasma |
|
18383-0
|
Alfentanil [Presence] in Urine |
|
16334-5
|
Alfentanil [Mass/volume] in Urine |
|
86604-6
|
Alfentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
7068-0
|
Algae IgE Ab [Units/volume] in Serum |
|
63176-2
|
Algae IgG Ab [Mass/volume] in Serum |
|
2582-5
|
Lutropin.alpha subunit [Moles/volume] in Serum or Plasma |
|
17840-0
|
Alpha-L-iduronidase [Enzymatic activity/volume] in Blood |
|
55909-6
|
Alpha-L-iduronidase [Enzymatic activity/volume] in DBS |
|
24056-4
|
Alpha-L-iduronidase [Enzymatic activity/mass] in Fibroblast |
|
75053-9
|
Alpha-L-iduronidase [Enzymatic activity/volume] in Serum or Plasma |
|
1699-8
|
Alpha-L-iduronidase [Enzymatic activity/mass] in Tissue |
|
24057-2
|
Alpha-L-iduronidase [Enzymatic activity/mass] in Leukocytes |
|
75113-1
|
Alpha linolenate (C18:3w3) [Entitic substance] in Red Blood Cells |
|
16335-2
|
Hydrocarbons Aliphatic [Identifier] in Blood |
|
78779-6
|
Alizapride [Mass/volume] in Blood |
|
79154-1
|
Alizapride [Mass/volume] in Body fluid |
|
80123-3
|
Alizapride [Mass/mass] in Hair |
|
80201-7
|
Alizapride [Mass/volume] in Urine |
|
47303-3
|
Anaplastic lymphoma kinase Ag [Presence] in Tissue by Immune stain |
|
78210-2
|
ALK gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
78205-2
|
ALK gene rearrangements [Presence] in Blood or Tissue by FISH |
|
11159-1
|
Alkalase IgE Ab [Units/volume] in Serum |
|
20680-5
|
Alkaloid identified in Ingesta by Thin layer chromatography (TLC) |
|
20679-7
|
Alkaloid identified in Plant by Thin layer chromatography (TLC) |
|
20678-9
|
Alkaloid identified in Urine by Thin layer chromatography (TLC) |
|
82220-5
|
Alkyl-dihydroxyacetonephosphate synthase [Enzymatic activity/mass] in Fibroblast |
|
54493-2
|
Allantoine [Moles/time] in 24 hour Urine by Electrophoresis |
|
75140-4
|
Allantoine [Moles/volume] in Cerebral spinal fluid |
|
75158-6
|
Allantoine [Moles/volume] in Serum or Plasma |
|
50306-0
|
Allantoine [Moles/volume] in Urine |
|
75155-2
|
Allantoine/Creatinine [Molar ratio] in Urine |
|
19058-7
|
Allergens identified in Serum |
|
20662-3
|
Allergens tested for in Serum |
|
79151-7
|
Known allergies to food or environmental agents |
|
83320-2
|
Allergy and Immunology Adverse event note |
|
77429-9
|
Allergy and Immunology Consult note |
|
68625-3
|
Allergy and Immunology Diagnostic study note |
|
68626-1
|
Allergy and Immunology Discharge summary |
|
77430-7
|
Allergy and Immunology Education note |
|
77438-0
|
Allergy and Immunology Flowsheet |
|
68628-7
|
Allergy and Immunology History and physical note |
|
68633-7
|
Allergy and Immunology Hospital Consult note |
|
68634-5
|
Allergy and Immunology Hospital Letter |
|
77431-5
|
Allergy and Immunology Initial evaluation note |
|
68629-5
|
Allergy and Immunology Note |
|
83565-2
|
Allergy and Immunology Nurse Note |
|
83566-0
|
Allergy and Immunology Nurse Outpatient Note |
|
84057-9
|
Allergy and Immunology Outpatient Note |
|
77443-0
|
Allergy and Immunology Plan of care note |
|
68630-3
|
Allergy and Immunology procedure note |
|
68631-1
|
Allergy and Immunology Progress note |
|
77432-3
|
Allergy and Immunology Referral note |
|
89895-7
|
Allergy and Immunology Telehealth Note |
|
68632-9
|
Allergy and Immunology Transfer summary note |
|
21062-5
|
Allobarbital [Mass/volume] in Serum or Plasma |
|
25560-4
|
Allobarbital [Moles/volume] in Serum or Plasma |
|
12502-1
|
Allobarbital [Presence] in Stool |
|
50174-2
|
Alloisoleucine [Moles/volume] in Amniotic fluid |
|
50175-9
|
Alloisoleucine [Moles/volume] in Body fluid |
|
74875-6
|
Alloisoleucine [Moles/volume] in DBS --post therapeutic diet |
|
41398-9
|
Alloisoleucine [Presence] in Serum or Plasma |
|
59212-1
|
Alloisoleucine [Moles/volume] in Urine |
|
73908-6
|
Alloisoleucine/Creatinine [Ratio] in Urine |
|
55821-3
|
Allo-pregnanediol [Mass/volume] in 24 hour Urine |
|
55820-5
|
Allo-pregnanediol [Mass/time] in 24 hour Urine |
|
73858-3
|
Allo-pregnanediol [Moles/volume] in 24 hour Urine |
|
73857-5
|
Allo-pregnanediol [Moles/time] in 24 hour Urine |
|
73856-7
|
Allo-pregnanediol [Moles/volume] in Urine |
|
83136-2
|
Allo-pregnanediol/Creatinine [Molar ratio] in Urine |
|
82867-3
|
Allo-pregnanediolone [Moles/volume] in 24 hour Urine |
|
82866-5
|
Allo-pregnanediolone [Moles/time] in 24 hour Urine |
|
82868-1
|
Allo-pregnanediolone [Moles/volume] in Urine |
|
83135-4
|
Allo-pregnanediolone/Creatinine [Molar ratio] in Urine |
|
73070-5
|
Allopurinol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73069-7
|
Allopurinol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73538-1
|
Allopurinol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73539-9
|
Allopurinol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9736-0
|
Allopurinol [Mass/volume] in Serum or Plasma |
|
74928-3
|
Allopurinol [Mass/volume] in Serum or Plasma --trough |
|
43133-8
|
Allopurinol and Oxipurinol panel [Mass/volume] - Serum or Plasma |
|
55825-4
|
Allo-tetrahydrocorticosterone [Mass/volume] in 24 hour Urine |
|
55824-7
|
Allo-tetrahydrocorticosterone [Mass/time] in 24 hour Urine |
|
73860-9
|
Allo-tetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
|
73861-7
|
Allo-tetrahydrocorticosterone [Moles/time] in 24 hour Urine |
|
73859-1
|
Allo-tetrahydrocorticosterone [Moles/volume] in Urine |
|
81805-4
|
Allo-tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
|
55823-9
|
Allo-tetrahydrodeoxycortisol [Mass/volume] in 24 hour Urine |
|
55822-1
|
Allo-tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine |
|
55826-2
|
Allo-tetrahydrocortisol [Mass/volume] in 24 hour Urine |
|
6869-2
|
Allo-tetrahydrocortisol [Mass/time] in 24 hour Urine |
|
73864-1
|
Allo-tetrahydrocortisol [Moles/volume] in 24 hour Urine |
|
73862-5
|
Allo-tetrahydrocortisol [Moles/time] in 24 hour Urine |
|
73863-3
|
Allo-tetrahydrocortisol [Moles/volume] in Urine |
|
81804-7
|
Allo-tetrahydrocortisol/Creatinine [Molar ratio] in Urine |
|
7690-1
|
Allscale IgE Ab [Units/volume] in Serum |
|
7069-8
|
Allspice IgE Ab [Units/volume] in Serum |
|
56168-8
|
Allspice IgG4 Ab [Mass/volume] in Serum |
|
63136-6
|
Allspice IgG Ab [Mass/volume] in Serum |
|
16327-9
|
Allyl alcohol [Mass/volume] in Blood |
|
27017-3
|
Allyl alcohol [Presence] in Serum or Plasma |
|
12989-0
|
Allyl alcohol [Mass/volume] in Serum or Plasma |
|
38631-8
|
Allyl chloride [Mass/volume] in Air |
|
78780-4
|
Alminoprofen [Mass/volume] in Blood |
|
78806-7
|
Alminoprofen [Mass/volume] in Body fluid |
|
80124-1
|
Alminoprofen [Mass/mass] in Hair |
|
7071-4
|
Almond triggered histamine release [Units/volume] in Blood |
|
6019-4
|
Almond IgE Ab [Units/volume] in Serum |
|
39542-6
|
Almond IgE Ab/IgE total in Serum |
|
7070-6
|
Almond IgG Ab [Units/volume] in Serum |
|
56169-6
|
Almond IgG4 Ab [Mass/volume] in Serum |
|
60348-0
|
Almond IgG Ab [Mass/volume] in Serum |
|
7072-2
|
Almond Tree IgE Ab [Units/volume] in Serum |
|
44606-2
|
ALOX3+ALOX12B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
10464-6
|
Amyloid P component Ag [Presence] in Tissue by Immune stain |
|
54907-1
|
Alkaline phosphatase [Enzymatic activity/volume] in Amniotic fluid |
|
1783-0
|
Alkaline phosphatase [Enzymatic activity/volume] in Blood |
|
55971-6
|
Alkaline phosphatase [Enzymatic activity/volume] in Cord blood |
|
40797-3
|
Alkaline phosphatase.bone [Presence] in Serum or Plasma |
|
1777-2
|
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma |
|
17838-4
|
Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma |
|
74996-0
|
Alkaline phosphatase.bone [Z-score] in Serum or Plasma |
|
59164-4
|
Alkaline phosphatase [Enzymatic activity/volume] in Dialysis fluid |
|
34568-6
|
Alkaline phosphatase [Presence] in Body fluid |
|
15148-0
|
Alkaline phosphatase [Enzymatic activity/volume] in Body fluid |
|
1775-6
|
Alkaline phosphatase [Mass/volume] in Body fluid |
|
32351-9
|
Alkaline phosphatase.heat labile [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
|
32352-7
|
Alkaline phosphatase.heat stable [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
|
40794-0
|
Alkaline phosphatase.intestinal [Presence] in Serum or Plasma |
|
24332-9
|
Alkaline phosphatase isoenz panel - Serum or Plasma |
|
12805-8
|
Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma |
|
16182-8
|
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
|
33063-9
|
Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Levamisole inhibition |
|
43939-8
|
Alkaline phosphatase.liver [Presence] in Serum or Plasma |
|
49924-4
|
Alkaline phosphatase.macro/Alkaline phosphatase.total in Serum or Plasma |
|
10458-8
|
Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
|
59188-3
|
Alkaline phosphatase.placental [Enzymatic activity/volume] in Cerebral spinal fluid |
|
40410-3
|
Alkaline phosphatase [Enzymatic activity/volume] in Peritoneal fluid |
|
77141-0
|
Alkaline phosphatase [Enzymatic activity/volume] in Serum, Plasma or Blood |
|
6768-6
|
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma |
|
29639-2
|
Alkaline phosphatase [Enzymatic activity/mass] in Tissue |
|
16337-8
|
Alkaline phosphatase [Enzymatic activity/volume] in Urine |
|
1776-4
|
Alkaline phosphatase [Mass/volume] in Urine |
|
87667-2
|
Alpha benzene hexachloride [Mass/mass] in Unspecified specimen |
|
60848-9
|
Alpha frequency relative power on EEG |
|
90040-7
|
Alpha globin gene cluster and HS-40 region deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
|
42234-5
|
Alpha subunit free [Units/volume] in Serum or Plasma |
|
30316-4
|
Alpha subunit free [Mass/volume] in Serum or Plasma |
|
12728-2
|
Alpha subunit [Units/volume] in Serum or Plasma |
|
30199-4
|
Alpha subunit [Mass/volume] in Serum or Plasma |
|
55234-9
|
Alpha thalassemia gene panel - Blood by Molecular genetics method |
|
88985-7
|
Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Serum or Plasma |
|
74104-1
|
Alpha-Amanitin + gamma-Amanitin [Mass/volume] in Urine by Immunoassay |
|
54465-0
|
Alpha 1 globulin/Protein.total in Dialysis fluid by Electrophoresis |
|
54466-8
|
Alpha 2 globulin/Protein.total in Dialysis fluid by Electrophoresis |
|
79280-4
|
Alpha-aminoadipic semialdehyde [Moles/volume] in Cerebral spinal fluid |
|
79279-6
|
Alpha-aminoadipic semialdehyde [Moles/volume] in Serum or Plasma |
|
79346-3
|
Alpha-aminoadipic semialdehyde/Creatinine [Molar ratio] in Urine |
|
80636-4
|
Alpha-amanitin [Mass/volume] in Urine |
|
73837-7
|
Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum |
|
49486-4
|
Alphapinene [Presence] in Blood |
|
60052-8
|
Alphapinene [Mass/volume] in Blood |
|
3311-8
|
Alphaprodine [Mass/time] in 24 hour Urine |
|
3308-4
|
Alphaprodine [Mass/volume] in Serum or Plasma |
|
3309-2
|
Alphaprodine [Presence] in Urine |
|
3310-0
|
Alphaprodine [Mass/volume] in Urine |
|
51663-3
|
Alphavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77085-9
|
ALPL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77084-2
|
ALPL gene full mutation analysis in Blood or Tissue by Sequencing |
|
59607-2
|
ALPRAZolam [Mass/volume] in Blood by Confirmatory method |
|
10977-7
|
ALPRAZolam [Mass/volume] in Blood |
|
59609-8
|
ALPRAZolam [Mass/volume] in Body fluid by Confirmatory method |
|
59608-0
|
ALPRAZolam [Mass/volume] in Body fluid |
|
61073-3
|
ALPRAZolam [Presence] in Gastric fluid |
|
29348-0
|
ALPRAZolam [Mass/volume] in Gastric fluid |
|
26886-2
|
ALPRAZolam [Mass/mass] in Hair |
|
73537-3
|
ALPRAZolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73536-5
|
ALPRAZolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59610-6
|
ALPRAZolam [Mass/mass] in Meconium by Confirmatory method |
|
26911-8
|
ALPRAZolam [Mass/mass] in Meconium |
|
72756-0
|
ALPRAZolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72612-5
|
ALPRAZolam [Presence] in Saliva (oral fluid) |
|
72381-7
|
ALPRAZolam [Mass/volume] in Saliva (oral fluid) |
|
59611-4
|
ALPRAZolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13545-9
|
ALPRAZolam [Presence] in Serum or Plasma |
|
3312-6
|
ALPRAZolam [Mass/volume] in Serum or Plasma |
|
14591-2
|
ALPRAZolam [Moles/volume] in Serum or Plasma |
|
59612-2
|
ALPRAZolam [Mass/mass] in Stool by Confirmatory method |
|
16187-7
|
ALPRAZolam [Mass/volume] in Stool |
|
59614-8
|
ALPRAZolam [Mass/mass] in Tissue by Confirmatory method |
|
59613-0
|
ALPRAZolam [Mass/mass] in Tissue |
|
74985-3
|
ALPRAZolam [Mass/volume] in Serum or Plasma --trough |
|
59615-5
|
ALPRAZolam [Mass/volume] in Urine by Confirmatory method |
|
9351-8
|
ALPRAZolam [Presence] in Urine |
|
16203-2
|
ALPRAZolam [Presence] in Urine by Confirmatory method |
|
94116-1
|
ALPRAZolam [Presence] in Urine by Screen method |
|
3313-4
|
ALPRAZolam [Mass/volume] in Urine |
|
26878-9
|
ALPRAZolam [Mass/volume] in Vitreous fluid |
|
61038-6
|
ALPRAZolam [Presence] in Unspecified specimen |
|
48938-5
|
ALPRAZolam [Mass/volume] in Unspecified specimen |
|
60282-1
|
ALPRAZolam [Moles/volume] in Unspecified specimen |
|
86224-3
|
ALPRAZolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
3314-2
|
Alprenolol [Mass/volume] in Serum or Plasma |
|
3315-9
|
Alprenolol [Presence] in Urine |
|
3316-7
|
Alprenolol [Mass/volume] in Urine |
|
77630-2
|
ALS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
44705-2
|
ALS4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
1741-8
|
Alanine aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
|
50168-4
|
Alanine aminotransferase [Enzymatic activity/volume] in Dialysis fluid |
|
25302-1
|
Alanine aminotransferase [Enzymatic activity/volume] in Body fluid |
|
54492-4
|
Alanine aminotransferase [Enzymatic activity/volume] in Pleural fluid |
|
54491-6
|
Alanine aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
|
16324-6
|
Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
|
1743-4
|
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
|
1744-2
|
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P |
|
77144-4
|
Alanine aminotransferase [Enzymatic activity/volume] in Serum, Plasma or Blood |
|
1742-6
|
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
|
48134-1
|
Alanine aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
|
16325-3
|
Alanine aminotransferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma |
|
7074-8
|
Alternaria sp IgE Ab [Units/volume] in Serum |
|
34233-7
|
Alternaria sp IgG Ab [Presence] in Serum by Immune diffusion (ID) |
|
7075-5
|
Alternaria sp IgG Ab [Units/volume] in Serum |
|
40837-7
|
Alternaria sp IgG Ab [Presence] in Serum |
|
39570-7
|
Alternaria sp IgG Ab [Mass/volume] in Serum |
|
30926-0
|
Aluminum [Mass/volume] in Urine collected for unspecified duration |
|
6929-4
|
Aluminum [Mass/volume] in 24 hour Urine |
|
26707-0
|
Aluminum [Mass/time] in 24 hour Urine |
|
14592-0
|
Aluminum [Moles/volume] in 24 hour Urine |
|
32295-8
|
Aluminum [Moles/time] in 24 hour Urine |
|
38759-7
|
Aluminum [Mass/volume] in Air |
|
82463-1
|
Aluminum [Moles/volume] in Blood |
|
27264-1
|
Aluminum [Mass/volume] in Cerebral spinal fluid |
|
80127-4
|
Aluminum [Moles/volume] in Cerebral spinal fluid |
|
5572-3
|
Aluminum [Mass/volume] in Dialysis fluid |
|
15113-4
|
Aluminum [Moles/volume] in Dialysis fluid |
|
16349-3
|
Aluminum [Mass/volume] in Body fluid |
|
80126-6
|
Aluminum [Moles/volume] in Body fluid |
|
5573-1
|
Aluminum [Mass/mass] in Hair |
|
50801-0
|
Aluminum [Moles/mass] in Hair |
|
38662-3
|
Aluminum oxide [Mass/volume] in Air |
|
5575-6
|
Aluminum [Mass/volume] in Red Blood Cells |
|
47096-3
|
Aluminum [Moles/volume] in Red Blood Cells |
|
5574-9
|
Aluminum [Mass/volume] in Serum or Plasma |
|
14593-8
|
Aluminum [Moles/volume] in Serum or Plasma |
|
80125-8
|
Aluminum [Mass/mass] in Tissue |
|
52892-7
|
Aluminum [Moles/mass] in Tissue |
|
5577-2
|
Aluminum [Mass/volume] in Urine |
|
52915-6
|
Aluminum [Moles/volume] in Urine |
|
9462-3
|
Aluminum [Mass/volume] in Water |
|
78782-0
|
Aluminum [Moles/volume] in Water |
|
29937-0
|
Aluminum/Creatinine [Mass Ratio] in 24 hour Urine |
|
52944-6
|
Aluminum/Creatinine [Molar ratio] in 24 hour Urine |
|
13470-0
|
Aluminum/Creatinine [Mass Ratio] in Urine |
|
52943-8
|
Aluminum/Creatinine [Molar ratio] in Urine |
|
31723-0
|
Avian leukosis virus Ag [Units/volume] in Egg yolk |
|
31724-8
|
Avian leukosis virus Ag [Units/volume] in Serum |
|
15446-8
|
Avian leukosis virus Ag [Titer] in Egg yolk by Immunoassay |
|
15445-0
|
Avian leukosis virus Ag [Titer] in Serum by Immunoassay |
|
829-2
|
Am Ag [Presence] on Red Blood Cells |
|
64980-6
|
American house dust mite recombinant (rDer f) 2 IgE Ab [Units/volume] in Serum |
|
73528-2
|
amLODIPine+Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73529-0
|
amLODIPine+Benazepril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73925-0
|
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72817-0
|
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72463-3
|
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
72818-8
|
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73952-4
|
AM-2201 (synthetic cannabinoid) [Presence] in Blood |
|
87488-3
|
AM694 N-5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
82221-3
|
Alpha-methylacyl CoA racemase [Enzymatic activity/mass] in Fibroblast |
|
55910-4
|
Alpha mannosidase [Enzymatic activity/volume] in DBS |
|
24052-3
|
Alpha mannosidase [Enzymatic activity/mass] in Fibroblast |
|
1818-4
|
Alpha mannosidase [Enzymatic activity/volume] in Serum or Plasma |
|
1819-2
|
Alpha mannosidase [Enzymatic activity/mass] in Tissue |
|
24053-1
|
Alpha mannosidase [Enzymatic activity/mass] in Leukocytes |
|
3317-5
|
Amantadine [Mass/volume] in Serum or Plasma |
|
23814-7
|
Amantadine [Mass/volume] in Urine |
|
18682-5
|
Ambulance records |
|
3318-3
|
Amdinocillin [Mass/volume] in Serum or Plasma |
|
6038-4
|
American Beech IgE Ab [Units/volume] in Serum |
|
61263-0
|
American Beech IgE Ab/IgE total in Serum |
|
56171-2
|
American Beech IgG4 Ab [Mass/volume] in Serum |
|
30170-5
|
American Cockroach IgE Ab [Units/volume] in Serum |
|
56173-8
|
American Cockroach IgG4 Ab [Mass/volume] in Serum |
|
6263-8
|
American Sycamore IgE Ab [Units/volume] in Serum |
|
58043-1
|
American Sycamore IgE Ab/IgE total in Serum |
|
24145-5
|
American Sycamore IgG Ab [Units/volume] in Serum |
|
56175-3
|
American Sycamore IgG4 Ab [Mass/volume] in Serum |
|
7201-7
|
American Cheese IgE Ab [Units/volume] in Serum |
|
7202-5
|
American Cheese IgG Ab [Units/volume] in Serum |
|
56172-0
|
American Cheese IgG4 Ab [Mass/volume] in Serum |
|
63099-6
|
American Cheese IgG Ab [Mass/volume] in Serum |
|
77547-8
|
American National Adult Reading Test (AmNART) panel |
|
80883-2
|
American Urological Association Symptom Index [AUASI] |
|
38653-2
|
Amiben [Mass/volume] in Air |
|
49579-6
|
Aminocaproate [Presence] in Serum or Plasma |
|
9312-0
|
Aminocaproate [Mass/volume] in Serum or Plasma |
|
3326-6
|
Aminocaproate [Mass/volume] in Serum or Plasma --trough |
|
17798-0
|
Amikacin [Mass/volume] in Cerebral spinal fluid |
|
13546-7
|
Amikacin [Mass/volume] in Body fluid |
|
80972-3
|
Amikacin free [Mass/volume] in Serum or Plasma |
|
89484-0
|
Amikacin [Susceptibility] by Genotype method |
|
59378-0
|
Amikacin [Mass/volume] in Serum or Plasma --post dialysis |
|
3319-1
|
Amikacin [Mass/volume] in Serum or Plasma --peak |
|
50802-8
|
Amikacin [Moles/volume] in Serum or Plasma --peak |
|
31097-9
|
Amikacin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
|
31099-5
|
Amikacin [Mass/volume] in Serum or Plasma --random post extended interval dosing |
|
3320-9
|
Amikacin [Mass/volume] in Serum or Plasma --random |
|
15098-7
|
Amikacin [Moles/volume] in Serum or Plasma --random |
|
35669-1
|
Amikacin [Mass/volume] in Serum or Plasma |
|
56628-1
|
Amikacin [Moles/volume] in Serum or Plasma |
|
31098-7
|
Amikacin [Mass/volume] in Serum or Plasma --trough post extended interval dosing |
|
3321-7
|
Amikacin [Mass/volume] in Serum or Plasma --trough |
|
50803-6
|
Amikacin [Moles/volume] in Serum or Plasma --trough |
|
3325-8
|
aMILoride [Mass/time] in 24 hour Urine |
|
60053-6
|
aMILoride [Mass/volume] in Blood |
|
16351-9
|
aMILoride [Units/volume] in Serum or Plasma |
|
3322-5
|
aMILoride [Mass/volume] in Serum or Plasma |
|
3323-3
|
aMILoride [Presence] in Urine |
|
16352-7
|
aMILoride [Units/volume] in Urine |
|
3324-1
|
aMILoride [Mass/volume] in Urine |
|
34397-0
|
Amilsulpride [Mass/volume] in Serum or Plasma |
|
81913-6
|
Essential amino acid intake panel |
|
81912-8
|
Amino acid intake panel |
|
81931-8
|
Nonessential amino acid intake panel |
|
18191-7
|
Amino acids [Identifier] in 24 hour Urine |
|
32611-6
|
Amino acids [Moles/volume] in Amniotic fluid |
|
27336-7
|
Amino acids [Identifier] in Blood |
|
34616-3
|
Amino acids [Identifier] in Cerebral spinal fluid |
|
32610-8
|
Amino acids [Moles/volume] in Cerebral spinal fluid |
|
32609-0
|
Amino acids [Moles/volume] in Body fluid |
|
55817-1
|
Amino acids [Moles/mass] in Hair |
|
21056-7
|
Alanine+Cystine+Histidine+Homocysteine+Leucine+Phenylalanine+Tyrosine [Presence] in Urine |
|
21057-5
|
Alanine+Histidine+Leucine+Phenylalanine+Tyrosine [Presence] in Serum or Plasma |
|
15136-5
|
Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma |
|
15140-7
|
Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine |
|
15135-7
|
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma |
|
15143-1
|
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine |
|
15133-2
|
Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma |
|
15139-9
|
Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine |
|
35509-9
|
Amino acids panel [Moles/time] - 24 hour Urine |
|
35508-1
|
Amino acids panel [Moles/volume] - Amniotic fluid |
|
35507-3
|
Amino acids panel [Moles/volume] - Cerebral spinal fluid |
|
35083-5
|
Amino acids panel [Moles/volume] - Serum or Plasma |
|
35087-6
|
Amino acids panel - Urine |
|
74514-1
|
Amino acids panel [Moles/volume] - Urine |
|
74991-1
|
Amino acids panel [Molar ratio] - Urine |
|
12468-5
|
Amino acids [Identifier] in Serum or Plasma |
|
12176-4
|
Amino acids [Moles/volume] in Serum or Plasma |
|
12467-7
|
Amino acids [Identifier] in Urine |
|
32612-4
|
Amino acids [Moles/volume] in Vitreous fluid |
|
12177-2
|
Amino acids/Creatinine [Ratio] in Urine |
|
9408-6
|
Aminobenzoate [Mass/volume] in Serum or Plasma |
|
89490-7
|
Aminoglycoside [Susceptibility] by Genotype method |
|
3327-4
|
Aminopyrine [Mass/volume] in Exhaled gas |
|
3328-2
|
Aminopyrine [Mass/volume] in Serum or Plasma |
|
3329-0
|
Aminosalicylate [Mass/volume] in Serum or Plasma |
|
73068-9
|
Amiodarone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73067-1
|
Amiodarone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55152-3
|
Amiodarone and Desethylamiodarone panel [Mass/volume] - Serum or Plasma |
|
60054-4
|
Amiodarone [Mass/volume] in Blood |
|
29207-8
|
Amiodarone [Mass/volume] in Body fluid |
|
79230-9
|
Amiodarone [Mass/mass] in Hair |
|
73534-0
|
Amiodarone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73535-7
|
Amiodarone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
40755-1
|
Amiodarone [Mass/volume] in Serum or Plasma --peak |
|
3330-8
|
Amiodarone [Mass/volume] in Serum or Plasma |
|
15099-5
|
Amiodarone [Moles/volume] in Serum or Plasma |
|
40756-9
|
Amiodarone [Mass/volume] in Serum or Plasma --trough |
|
78784-6
|
Amiodarone [Mass/volume] in Urine |
|
3331-6
|
Amiodarone+Desethylamiodarone [Mass/volume] in Serum or Plasma |
|
80129-0
|
Amisulpride [Mass/volume] in Blood |
|
80130-8
|
Amisulpride [Mass/volume] in Body fluid |
|
80128-2
|
Amisulpride [Mass/mass] in Hair |
|
85384-6
|
Amisulpride [Mass/volume] in Serum or Plasma |
|
80131-6
|
Amisulpride [Mass/volume] in Urine |
|
73066-3
|
Amitriptyline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73065-5
|
Amitriptyline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3336-5
|
Amitriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose |
|
78786-1
|
Amitriptyline [Mass/volume] in Blood |
|
80558-0
|
Amitriptyline [Mass/volume] in DBS |
|
79229-1
|
Amitriptyline [Mass/volume] in Body fluid |
|
40411-1
|
Amitriptyline [Presence] in Gastric fluid |
|
29406-6
|
Amitriptyline [Mass/volume] in Gastric fluid |
|
50805-1
|
Amitriptyline [Moles/volume] in Gastric fluid |
|
78785-3
|
Amitriptyline [Mass/mass] in Hair |
|
73532-4
|
Amitriptyline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73533-2
|
Amitriptyline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16360-0
|
Amitriptyline [Mass/volume] in Serum or Plasma --peak |
|
3332-4
|
Amitriptyline [Presence] in Serum or Plasma |
|
35636-0
|
Amitriptyline [Mass/volume] in Serum or Plasma by Screen method |
|
3333-2
|
Amitriptyline [Mass/volume] in Serum or Plasma |
|
14597-9
|
Amitriptyline [Moles/volume] in Serum or Plasma |
|
16361-8
|
Amitriptyline [Mass/volume] in Serum or Plasma --trough |
|
20515-3
|
Amitriptyline [Mass/volume] in Urine by Confirmatory method |
|
3334-0
|
Amitriptyline [Presence] in Urine |
|
16225-5
|
Amitriptyline [Presence] in Urine by Confirmatory method |
|
19331-8
|
Amitriptyline [Presence] in Urine by Screen method |
|
16114-1
|
Amitriptyline [Mass/volume] in Urine |
|
50804-4
|
Amitriptyline [Moles/volume] in Urine |
|
60283-9
|
Amitriptyline [Moles/volume] in Unspecified specimen |
|
61407-3
|
Amitriptyline/Creatinine [Mass Ratio] in Urine |
|
14594-6
|
Amitriptyline+Nortriptyline [Presence] in Gastric fluid |
|
81207-3
|
Amitriptyline and Nortriptyline panel - Gastric fluid |
|
43106-4
|
Amitriptyline and Nortriptyline panel - Serum or Plasma |
|
81208-1
|
Amitriptyline and Nortriptyline panel - Urine |
|
81211-5
|
Amitriptyline and Nortriptyline panel - Unspecified specimen |
|
14595-3
|
Amitriptyline+Nortriptyline [Presence] in Serum or Plasma |
|
3335-7
|
Amitriptyline+Nortriptyline [Mass/volume] in Serum or Plasma |
|
14598-7
|
Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma |
|
20516-1
|
Amitriptyline+Nortriptyline [Mass/volume] in Urine by Confirmatory method |
|
14596-1
|
Amitriptyline+Nortriptyline [Presence] in Urine |
|
19336-7
|
Amitriptyline+Nortriptyline [Presence] in Urine by Confirmatory method |
|
19335-9
|
Amitriptyline+Nortriptyline [Presence] in Urine by Screen method |
|
10978-5
|
Amitriptyline+Nortriptyline [Mass/volume] in Urine |
|
32048-1
|
Amitriptyline+Nortriptyline [Presence] in Unspecified specimen |
|
77322-6
|
Amitriptyline+Nortriptyline [Moles/volume] in Unspecified specimen |
|
42712-0
|
AML/MDS gene 7q31 deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
42713-8
|
AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics method |
|
73064-8
|
amLODIPine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73063-0
|
amLODIPine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
78787-9
|
amLODIPine [Mass/volume] in Blood |
|
79228-3
|
amLODIPine [Mass/volume] in Body fluid |
|
80132-4
|
amLODIPine [Mass/mass] in Hair |
|
73531-6
|
amLODIPine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73530-8
|
amLODIPine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
28064-4
|
amLODIPine [Mass/volume] in Serum or Plasma |
|
78788-7
|
amLODIPine [Mass/volume] in Urine |
|
27039-7
|
Ammonia [Mass/volume] in 24 hour Urine |
|
9309-6
|
Ammonia [Mass/time] in 24 hour Urine |
|
25850-9
|
Ammonia [Moles/volume] in 24 hour Urine |
|
25308-8
|
Ammonia [Moles/time] in 24 hour Urine |
|
38589-8
|
Ammonia [Mass/volume] in Air |
|
32664-5
|
Ammonia [Mass/volume] in Blood |
|
1839-0
|
Ammonia [Moles/volume] in Blood |
|
1840-8
|
Ammonia [Moles/volume] in Cerebral spinal fluid |
|
54349-6
|
Ammonia [Mass/volume] in Dialysis fluid |
|
53081-6
|
Ammonia [Moles/volume] in Dialysis fluid |
|
15149-8
|
Ammonia [Moles/volume] in Body fluid |
|
20683-9
|
Ammonia [Mass/volume] in Ingesta |
|
1843-2
|
Ammonia nitrogen [Mass/time] in 24 hour Urine |
|
87562-5
|
Ammonia nitrogen [Mass/mass] in Feed |
|
22763-7
|
Ammonia [Mass/volume] in Plasma |
|
35254-2
|
Ammonia [Mass or Moles/volume] in Plasma |
|
16362-6
|
Ammonia [Moles/volume] in Plasma |
|
20684-7
|
Ammonia [Mass/volume] in Serum |
|
1841-6
|
Ammonia [Moles/volume] in Serum |
|
16363-4
|
Ammonia [Moles/mass] in Tissue |
|
20682-1
|
Ammonia [Mass/volume] in Urine |
|
1842-4
|
Ammonia [Moles/volume] in Urine |
|
53500-5
|
Ammonia [Moles/volume] in Water |
|
23656-2
|
Ammonia [Mass/volume] in Unspecified specimen |
|
25851-7
|
Ammonia/Creatinine [Molar ratio] in 24 hour Urine |
|
1844-0
|
Ammonium ion [Moles/volume] in Arterial blood |
|
1845-7
|
Ammonium ion [Moles/volume] in Plasma |
|
14599-5
|
Ammonium [Presence] in Stone |
|
72399-9
|
Amobarbital [Mass/volume] in Blood by Confirmatory method |
|
19341-7
|
Amobarbital cutoff [Mass/volume] in Urine for Screen method |
|
79227-5
|
Amobarbital [Mass/volume] in Body fluid |
|
12485-9
|
Amobarbital [Presence] in Gastric fluid |
|
16364-2
|
Amobarbital [Mass/volume] in Gastric fluid |
|
59866-4
|
Amobarbital [Moles/volume] in Gastric fluid |
|
26920-9
|
Amobarbital [Mass/mass] in Hair |
|
27324-3
|
Amobarbital [Mass/mass] in Meconium |
|
72455-9
|
Amobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72631-5
|
Amobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3337-3
|
Amobarbital [Presence] in Serum or Plasma |
|
82973-9
|
Amobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3338-1
|
Amobarbital [Mass/volume] in Serum or Plasma |
|
25309-6
|
Amobarbital [Moles/volume] in Serum or Plasma |
|
12494-1
|
Amobarbital [Presence] in Stool |
|
27245-0
|
Amobarbital [Mass/mass] in Stool |
|
16239-6
|
Amobarbital [Mass/volume] in Urine by Confirmatory method |
|
3339-9
|
Amobarbital [Presence] in Urine |
|
16190-1
|
Amobarbital [Presence] in Urine by Confirmatory method |
|
19339-1
|
Amobarbital [Presence] in Urine by Screen method |
|
11230-0
|
Amobarbital [Mass/volume] in Urine |
|
59865-6
|
Amobarbital [Moles/volume] in Urine |
|
26687-4
|
Amobarbital [Mass/volume] in Vitreous fluid |
|
32049-9
|
Amobarbital [Presence] in Unspecified specimen |
|
60284-7
|
Amobarbital [Moles/volume] in Unspecified specimen |
|
64128-2
|
Amobarbital/Creatinine [Mass Ratio] in Urine |
|
18305-3
|
Amoeba identified in Aspirate by Iron hematoxylin stain |
|
10641-9
|
Amoeba identified in Aspirate by Immune stain |
|
10642-7
|
Amoeba identified in Aspirate by Wet preparation |
|
10643-5
|
Amoeba identified in Stool by Organism specific culture |
|
87998-1
|
Amoeba identified in Stool by Wet preparation |
|
6594-6
|
Amoeba identified in Unspecified specimen by Organism specific culture |
|
79231-7
|
Amoxapine [Mass/volume] in Body fluid |
|
59868-0
|
Amoxapine [Moles/volume] in Gastric fluid |
|
78789-5
|
Amoxapine [Mass/mass] in Hair |
|
10529-6
|
Amoxapine metabolite [Mass/volume] in Serum or Plasma |
|
3340-7
|
Amoxapine [Presence] in Serum or Plasma |
|
3341-5
|
Amoxapine [Mass/volume] in Serum or Plasma |
|
14600-1
|
Amoxapine [Moles/volume] in Serum or Plasma |
|
3342-3
|
Amoxapine [Presence] in Urine |
|
3343-1
|
Amoxapine [Mass/volume] in Urine |
|
59867-2
|
Amoxapine [Moles/volume] in Urine |
|
60285-4
|
Amoxapine [Moles/volume] in Unspecified specimen |
|
9625-5
|
Amoxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
|
14601-9
|
Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
|
73062-2
|
Amoxicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73061-4
|
Amoxicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80133-2
|
Amoxicillin [Mass/volume] in Cerebral spinal fluid |
|
6829-6
|
Amoxicillin IgE Ab [Units/volume] in Serum |
|
42575-1
|
Amoxicillin IgE Ab/IgE total in Serum |
|
73527-4
|
Amoxicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73526-6
|
Amoxicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48198-6
|
Amoxicillin triggered leukotriene release [Mass/volume] by Leukocytes |
|
3344-9
|
Amoxicillin [Mass/volume] in Serum or Plasma |
|
25274-2
|
Amoxicillin [Mass/volume] in Unspecified specimen |
|
73525-8
|
Amoxicillin+Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73524-1
|
Amoxicillin+Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
1725-1
|
Adenosine monophosphate deaminase [Enzymatic activity/volume] in Serum |
|
82732-9
|
AMPAR1+AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82733-7
|
AMPAR1+AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
90811-1
|
AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93869-6
|
AMPAR1 Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
84929-9
|
AMPAR1 Ab [Presence] in Serum by Immunofluorescence |
|
90812-9
|
AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82735-2
|
AMPAR1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82734-5
|
AMPAR1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
90813-7
|
AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93868-8
|
AMPAR2 Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
84930-7
|
AMPAR2 Ab [Presence] in Serum by Immunofluorescence |
|
90814-5
|
AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93491-9
|
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82987-9
|
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
93489-3
|
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding assay immunofluorescent assay |
|
82980-4
|
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
93492-7
|
AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
93490-1
|
AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
85046-1
|
AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio [Presence] by ARD gradient strip |
|
40876-5
|
AMPD1 gene p.Gln12Ter and p.Pro48Leu [Presence] in Blood or Tissue by Molecular genetics method |
|
42576-9
|
Amphetamine [Mass/volume] in Blood by Confirmatory method |
|
80135-7
|
Amphetamine [Mass/volume] in Body fluid by Confirmatory method |
|
78790-3
|
Amphetamine [Presence] in Body fluid by Screen method |
|
80134-0
|
Amphetamine [Mass/mass] in Hair by Confirmatory method |
|
73425-1
|
Amphetamine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73424-4
|
Amphetamine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26959-7
|
Amphetamine [Mass/mass] in Meconium |
|
72758-6
|
Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74680-0
|
Amphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
29592-3
|
Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
66127-2
|
Amphetamine [Presence] in Serum or Plasma by Confirmatory method |
|
82967-1
|
Amphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
30112-7
|
Amphetamine [Mass/volume] in Serum or Plasma |
|
26791-4
|
Amphetamine [Mass/mass] in Stool |
|
16234-7
|
Amphetamine [Mass/volume] in Urine by Confirmatory method |
|
19344-1
|
Amphetamine [Presence] in Urine by Confirmatory method |
|
19343-3
|
Amphetamine [Presence] in Urine by Screen method |
|
19346-6
|
Amphetamine [Mass/volume] in Urine |
|
52957-8
|
Amphetamine [Moles/volume] in Urine |
|
58357-5
|
Amphetamine/Creatinine [Mass Ratio] in Urine |
|
75644-5
|
Amphetamine+Methamphetamine [Presence] in Blood by Confirmatory method |
|
43860-6
|
Amphetamine+Methamphetamine [Presence] in Gastric fluid by Screen method |
|
40421-0
|
Amphetamine+Methamphetamine [Presence] in Serum or Plasma |
|
40419-4
|
Amphetamine+Methamphetamine [Presence] in Urine |
|
76492-8
|
Amphetamine+Methamphetamine [Presence] in Urine by Screen method |
|
33280-9
|
Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method |
|
56120-9
|
Amphetamine+Methamphetamine [Mass/volume] in Urine |
|
40420-2
|
Amphetamine+Methamphetamine [Presence] in Unspecified specimen |
|
51690-6
|
Amphetamines [Presence] in Blood by Screen method |
|
8140-6
|
Amphetamines [Presence] in Gastric fluid |
|
8141-4
|
Amphetamines [Presence] in Gastric fluid by Confirmatory method |
|
8142-2
|
Amphetamines [Presence] in Gastric fluid by Screen method |
|
8139-8
|
Amphetamines [Mass/volume] in Gastric fluid |
|
40529-0
|
Amphetamines [Presence] in Hair |
|
40798-1
|
Amphetamines [Presence] in Hair by Screen method |
|
9352-6
|
Amphetamines [Mass/mass] in Hair |
|
43934-9
|
Amphetamines [Mass/mass] in Meconium by Confirmatory method |
|
8144-8
|
Amphetamines [Presence] in Meconium |
|
8145-5
|
Amphetamines [Presence] in Meconium by Confirmatory method |
|
8146-3
|
Amphetamines [Presence] in Meconium by Screen method |
|
8143-0
|
Amphetamines [Mass/volume] in Meconium |
|
26895-3
|
Amphetamines [Mass/mass] in Meconium |
|
27105-6
|
Amphetamines [Mass/volume] in Milk |
|
69021-4
|
Amphetamines panel - Meconium by Confirmatory method |
|
74681-8
|
Amphetamines [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40799-9
|
Amphetamines [Presence] in Saliva (oral fluid) by Screen method |
|
3348-0
|
Amphetamines [Presence] in Serum or Plasma |
|
8148-9
|
Amphetamines [Presence] in Serum or Plasma by Confirmatory method |
|
8149-7
|
Amphetamines [Presence] in Serum or Plasma by Screen method |
|
8147-1
|
Amphetamines [Mass/volume] in Serum or Plasma |
|
12350-5
|
Amphetamines [Presence] in Stool |
|
18431-7
|
Amphetamines [Presence] in Stool by Screen method |
|
20410-7
|
Amphetamines [Mass/volume] in Urine by Confirmatory method |
|
3349-8
|
Amphetamines [Presence] in Urine |
|
16369-1
|
Amphetamines [Presence] in Urine by Confirmatory method |
|
14309-9
|
Amphetamines [Presence] in Urine by Confirm method >200 ng/mL |
|
8151-3
|
Amphetamines [Presence] in Urine by SAMHSA confirm method |
|
8152-1
|
Amphetamines [Presence] in Urine by SAMHSA screen method |
|
19261-7
|
Amphetamines [Presence] in Urine by Screen method |
|
14308-1
|
Amphetamines [Presence] in Urine by Screen method >1000 ng/mL |
|
43983-6
|
Amphetamines [Presence] in Urine by Screen method >500 ng/mL |
|
70138-3
|
Amphetamines [Mass/volume] in Urine by Screen method |
|
8150-5
|
Amphetamines [Mass/volume] in Urine |
|
8154-7
|
Amphetamines [Presence] in Unknown substance |
|
8155-4
|
Amphetamines [Presence] in Unknown substance by Confirmatory method |
|
8156-2
|
Amphetamines [Presence] in Unknown substance by Screen method |
|
8153-9
|
Amphetamines [Mass/volume] in Unknown substance |
|
27205-4
|
Amphetamines [Presence] in Vitreous fluid |
|
27263-3
|
Amphetamines [Mass/volume] in Vitreous fluid |
|
29530-3
|
Amphetamines [Presence] in Unspecified specimen |
|
48939-3
|
Amphetamines [Mass/volume] in Unspecified specimen |
|
41464-9
|
Amphetamines/Creatinine [Mass Ratio] in Urine |
|
3352-2
|
Amphetaminil [Mass/time] in 24 hour Urine |
|
3350-6
|
Amphetaminil [Presence] in Urine |
|
3351-4
|
Amphetaminil [Mass/volume] in Urine |
|
90816-0
|
Amphiphysin Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
63383-4
|
Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
90815-2
|
Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
33422-7
|
Amphiphysin Ab [Presence] in Serum |
|
33423-5
|
Amphiphysin Ab [Units/volume] in Serum |
|
35142-9
|
Amphiphysin Ab [Titer] in Cerebral spinal fluid |
|
56531-7
|
Amphiphysin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
33927-5
|
Amphiphysin Ab [Titer] in Serum |
|
72327-0
|
Amphiphysin IgG Ab [Presence] in Serum by Immunoassay |
|
3353-0
|
Amphotericin B [Mass/volume] in Cerebral spinal fluid |
|
40707-2
|
Amphotericin B [Mass/volume] in Serum or Plasma --peak |
|
3354-8
|
Amphotericin B [Mass/volume] in Serum or Plasma |
|
40757-7
|
Amphotericin B [Mass/volume] in Serum or Plasma --trough |
|
16370-9
|
Amphotericin B [Mass/volume] in Urine |
|
49859-2
|
Amphotericin B [Mass/volume] in Unspecified specimen |
|
73060-6
|
Ampicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73059-8
|
Ampicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6712-4
|
Ampicillin IgE Ab [Units/volume] in Serum |
|
42577-7
|
Ampicillin IgE Ab/IgE total in Serum |
|
34234-5
|
Ampicillin IgG Ab [Units/volume] in Serum |
|
7078-9
|
Ampicillin IgM Ab [Units/volume] in Serum |
|
73523-3
|
Ampicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73522-5
|
Ampicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48199-4
|
Ampicillin triggered leukotriene release [Mass/volume] by Leukocytes |
|
33562-0
|
Ampicillin [Mass/volume] in Serum or Plasma --peak |
|
43883-8
|
Ampicillin [Presence] in Serum or Plasma |
|
3355-5
|
Ampicillin [Mass/volume] in Serum or Plasma |
|
33919-2
|
Ampicillin [Mass/volume] in Serum or Plasma --trough |
|
43884-6
|
Ampicillin [Presence] in Urine |
|
21066-6
|
Ampicillin [Mass/volume] in Unspecified specimen |
|
87604-5
|
Ampicillin [Mass/mass] in Unspecified specimen |
|
29114-6
|
Amprenavir [Units/volume] in Serum or Plasma |
|
31028-4
|
Amprenavir [Mass/volume] in Serum or Plasma |
|
49623-2
|
Amprenavir or Fosamprenavir [Susceptibility] by Genotype method |
|
43349-0
|
Avian metapneumovirus A Ab [Presence] in Serum |
|
43318-5
|
Avian metapneumovirus A Ab [Presence] in Serum by Immunofluorescence |
|
43350-8
|
Avian metapneumovirus A Ab [Titer] in Serum |
|
43319-3
|
Avian metapneumovirus A Ab [Titer] in Serum by Immunoassay |
|
22834-6
|
Avian metapneumovirus Ab [Presence] in Serum |
|
43351-6
|
Avian metapneumovirus B Ab [Presence] in Serum |
|
43320-1
|
Avian metapneumovirus B Ab [Presence] in Serum by Immunofluorescence |
|
43352-4
|
Avian metapneumovirus B Ab [Titer] in Serum |
|
43321-9
|
Avian metapneumovirus B Ab [Titer] in Serum by Immunoassay |
|
43353-2
|
Avian metapneumovirus C Ab [Presence] in Serum |
|
43322-7
|
Avian metapneumovirus C Ab [Presence] in Serum by Immunofluorescence |
|
43354-0
|
Avian metapneumovirus C Ab [Titer] in Serum |
|
43323-5
|
Avian metapneumovirus C Ab [Titer] in Serum by Immunoassay |
|
1820-0
|
Alpha melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
|
16373-3
|
Amyl ether [Presence] in Blood |
|
16173-7
|
Amyl ether [Mass/volume] in Blood |
|
12535-1
|
Amyl nitrite [Presence] in Blood |
|
16374-1
|
Amyl nitrite [Mass/volume] in Serum or Plasma |
|
33245-2
|
Amylase [Catalytic Activity] in Urine collected for unspecified duration |
|
33599-2
|
Amylase [Enzymatic activity/volume] in Urine collected for unspecified duration |
|
38193-9
|
Amylase [Enzymatic activity/time] in Urine collected for unspecified duration |
|
44789-6
|
Amylase and Creatinine clearance panel - Urine and Serum or Plasma |
|
38991-6
|
Amylase [Enzymatic activity/volume] in 12 hour Urine |
|
17841-8
|
Amylase [Enzymatic activity/time] in 12 hour Urine |
|
59001-8
|
Amylase [Enzymatic activity/time] in 18 hour Urine |
|
30124-2
|
Amylase [Enzymatic activity/time] in 1 hour Urine |
|
43821-8
|
Amylase [Presence] in 24 hour Urine |
|
38992-4
|
Amylase [Units/volume] in 24 hour Urine |
|
25311-2
|
Amylase [Enzymatic activity/volume] in 24 hour Urine |
|
1800-2
|
Amylase [Enzymatic activity/time] in 24 hour Urine |
|
38192-1
|
Amylase [Enzymatic activity/volume] in 2 hour Urine |
|
15350-2
|
Amylase [Enzymatic activity/time] in 2 hour Urine |
|
14392-5
|
Amylase [Enzymatic activity/volume] in Amniotic fluid |
|
76630-3
|
Amylase [Enzymatic activity/volume] in Blood |
|
14389-1
|
Amylase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
59039-8
|
Amylase [Enzymatic activity/volume] in Peritoneal dialysis fluid |
|
14390-9
|
Amylase [Enzymatic activity/volume] in Dialysis fluid |
|
1794-7
|
Amylase [Enzymatic activity/volume] in Duodenal fluid |
|
43816-8
|
Amylase [Presence] in Body fluid |
|
1795-4
|
Amylase [Enzymatic activity/volume] in Body fluid |
|
14391-7
|
Amylase [Enzymatic activity/volume] in Gastric fluid |
|
7073-0
|
Amylase IgE Ab [Units/volume] in Serum |
|
24333-7
|
Amylase isoenzyme 3 panel - Serum or Plasma |
|
24334-5
|
Amylase isoenzyme 7 panel - Serum |
|
48186-1
|
Amylase triggered leukotriene release [Mass/volume] by Leukocytes |
|
88710-9
|
Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal dialysis fluid |
|
48996-3
|
Amylase.pancreatic [Enzymatic activity/volume] in Body fluid |
|
70270-4
|
Amylase.pancreatic [Enzymatic activity/volume] in Pleural fluid |
|
70258-9
|
Amylase.pancreatic [Enzymatic activity/volume] in Peritoneal fluid |
|
69951-2
|
Amylase.pancreatic/Creatinine [Ratio] in Urine |
|
33368-2
|
Amylase [Enzymatic activity/volume] in Pericardial fluid |
|
1796-2
|
Amylase [Enzymatic activity/volume] in Pleural fluid |
|
1797-0
|
Amylase [Enzymatic activity/volume] in Peritoneal fluid |
|
56776-8
|
Amylase S3+S4/Amylase.total in Serum or Plasma |
|
74992-9
|
Amylase [Enzymatic activity/volume] in Saliva (oral fluid) |
|
77146-9
|
Amylase [Enzymatic activity/volume] in Serum, Plasma or Blood |
|
1798-8
|
Amylase [Enzymatic activity/volume] in Serum or Plasma |
|
14388-3
|
Amylase [Enzymatic activity/volume] in Synovial fluid |
|
1799-6
|
Amylase [Enzymatic activity/volume] in Urine |
|
32298-2
|
Amylase [Enzymatic activity/volume] in Unspecified specimen |
|
70262-1
|
Amylase in peritoneal fluid/Amylase in serum |
|
30077-2
|
Amylase/Creatinine renal clearance [Ratio] in Urine and Serum or Plasma |
|
72272-8
|
Amylase and triacylglycerol lipase panel - Serum or Plasma |
|
48498-0
|
Amyloid A [Mass/volume] in Serum or Plasma |
|
81773-4
|
Amyloid A [Mass/mass] in Tissue |
|
72341-1
|
Amyloid bodies [Presence] in Prostatic fluid by Light microscopy |
|
82954-9
|
Amyotrophic lateral sclerosis functional rating scale - revised [ALSFRS-R] |
|
82850-9
|
Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82851-7
|
Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
63295-0
|
Nuclear Ab [Presence] in Cerebral spinal fluid by Hep2 substrate |
|
63294-3
|
Nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
53002-2
|
Fine speckled nuclear Ab pattern [Titer] in Serum by Immunofluorescence |
|
13066-6
|
Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence |
|
14607-6
|
Nuclear Ab [Presence] in Body fluid |
|
16394-9
|
Nuclear Ab [Presence] in Body fluid by Immunofluorescence |
|
31540-8
|
Nuclear Ab [Units/volume] in Body fluid |
|
17380-7
|
Nuclear Ab.histone reactive [Presence] in Serum |
|
20398-4
|
Homogenous nuclear Ab pattern [Titer] in Serum |
|
85085-9
|
Centrosomal nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85084-2
|
Coarse speckled nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85083-4
|
Homogeneous nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85081-8
|
Multiple nuclear dots nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85082-6
|
Nuclear membrane pores nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85080-0
|
Nucleolar nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
85079-2
|
Other nuclear IgG pattern [Titer] in Serum by Immunofluorescence |
|
42212-1
|
Nucleolar nuclear Ab pattern [Titer] in Body fluid |
|
20399-2
|
Nucleolar nuclear Ab pattern [Titer] in Serum |
|
14611-8
|
Nuclear Ab pattern [Interpretation] in Serum |
|
68369-8
|
Nuclear Ab [Presence] in Pericardial fluid by Immunofluorescence |
|
31541-6
|
Nuclear Ab [Units/volume] in Pericardial fluid |
|
14608-4
|
Nuclear Ab [Presence] in Pleural fluid |
|
57010-1
|
Nuclear Ab [Presence] in Pleural fluid by Immunoassay |
|
68370-6
|
Nuclear Ab [Presence] in Pleural fluid by Immunofluorescence |
|
31542-4
|
Nuclear Ab [Units/volume] in Pleural fluid |
|
14609-2
|
Nuclear Ab [Presence] in Peritoneal fluid |
|
68371-4
|
Nuclear Ab [Presence] in Peritoneal fluid by Immunofluorescence |
|
31543-2
|
Nuclear Ab [Units/volume] in Peritoneal fluid |
|
42213-9
|
Rim nuclear Ab pattern [Titer] in Body fluid |
|
20400-8
|
Rim nuclear Ab pattern [Titer] in Serum |
|
5047-6
|
Nuclear Ab [Units/volume] in Serum by Immunoassay |
|
44752-4
|
Nuclear Ab [Units/volume] in Serum by Immunofluorescence (IF) rat kidney |
|
9423-5
|
Nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8061-4
|
Nuclear Ab [Presence] in Serum |
|
59069-5
|
Nuclear Ab [Presence] in Serum by Hep2 substrate |
|
47383-5
|
Nuclear Ab [Presence] in Serum by Immunoassay |
|
42254-3
|
Nuclear Ab [Presence] in Serum by Immunofluorescence |
|
44751-6
|
Nuclear Ab [Presence] in Serum by Immunofluorescence (IF) rat kidney |
|
16392-3
|
Nuclear Ab [Presence] in Serum by Rodent substrate |
|
16393-1
|
Nuclear Ab [Units/volume] in Serum by Rodent substrate |
|
27200-5
|
Nuclear Ab [Units/volume] in Serum |
|
14610-0
|
Nuclear Ab [Presence] in Synovial fluid |
|
68372-2
|
Nuclear Ab [Presence] in Synovial fluid by Immunofluorescence |
|
31544-0
|
Nuclear Ab [Units/volume] in Synovial fluid |
|
42214-7
|
Speckled nuclear Ab pattern [Titer] in Body fluid |
|
20401-6
|
Speckled nuclear Ab pattern [Titer] in Serum |
|
63297-6
|
Nuclear Ab [Titer] in Cerebral spinal fluid by Hep2 substrate |
|
63296-8
|
Nuclear Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
14613-4
|
Nuclear Ab [Titer] in Body fluid |
|
68376-3
|
Nuclear Ab [Titer] in Body fluid by Immunofluorescence |
|
14612-6
|
Nuclear Ab [Titer] in Pericardial fluid |
|
68373-0
|
Nuclear Ab [Titer] in Pericardial fluid by Immunofluorescence |
|
14614-2
|
Nuclear Ab [Titer] in Pleural fluid |
|
68374-8
|
Nuclear Ab [Titer] in Pleural fluid by Immunofluorescence |
|
14615-9
|
Nuclear Ab [Titer] in Peritoneal fluid |
|
68375-5
|
Nuclear Ab [Titer] in Peritoneal fluid by Immunofluorescence |
|
29953-7
|
Nuclear Ab [Titer] in Serum |
|
33253-6
|
Nuclear Ab [Titer] in Serum by Hep2 substrate |
|
40655-3
|
Nuclear Ab [Titer] in Serum by Immunoassay |
|
5048-4
|
Nuclear Ab [Titer] in Serum by Immunofluorescence |
|
21423-9
|
Nuclear Ab [Titer] in Serum by Immunofluorescence (IF) rat liver |
|
14616-7
|
Nuclear Ab [Titer] in Synovial fluid |
|
6822-1
|
Nuclear Ab [Titer] in Synovial fluid by Immunofluorescence |
|
33915-0
|
Anabasine [Mass/volume] in Urine |
|
46095-6
|
Anabolic steroids [Moles/volume] in Serum or Plasma |
|
9409-4
|
Anabolic steroids [Identifier] in Urine |
|
43977-8
|
Anabolic steroids [Presence] in Urine |
|
24091-1
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Fibroblast |
|
1837-4
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Serum or Plasma |
|
1838-2
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue |
|
2644-3
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Urine |
|
24092-9
|
Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Leukocytes |
|
79455-2
|
Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in DBS |
|
24054-9
|
Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Fibroblast |
|
11037-9
|
Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in Serum or Plasma |
|
24055-6
|
Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Leukocytes |
|
78792-9
|
Anakinra [Mass/volume] in Serum or Plasma |
|
44035-4
|
Analgesics Non-narcotic [Presence] in Serum or Plasma |
|
44036-2
|
Analgesics Non-narcotic [Presence] in Urine |
|
34175-0
|
Analgesics [Identifier] in Serum or Plasma |
|
53416-4
|
Alpha naphthylesterase [Enzymatic activity/volume] in Blood |
|
53417-2
|
Alpha naphthylesterase [Enzymatic activity/volume] in Bone marrow |
|
1821-8
|
Alpha naphthylesterase [Enzymatic activity/volume] in Serum |
|
74152-0
|
Anaphylaxis action plan |
|
22800-7
|
Anaplasma sp identified in Blood by Modified Giemsa stain |
|
22799-1
|
Anaplasma sp identified in Tissue by Modified Giemsa stain |
|
48981-5
|
Anaplasma sp [Presence] in Unspecified specimen by Light microscopy |
|
49122-5
|
Anaplasma sp identified in Unspecified specimen by Sequencing |
|
21419-7
|
Neutrophil cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence |
|
45151-8
|
Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunoassay |
|
5262-1
|
Neutrophil cytoplasmic Ab [Units/volume] in Serum by Immunofluorescence |
|
17351-8
|
Neutrophil cytoplasmic Ab [Presence] in Serum |
|
35279-9
|
Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence |
|
5128-4
|
Neutrophil cytoplasmic Ab [Units/volume] in Serum |
|
63293-5
|
Neutrophil cytoplasmic Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63292-7
|
Neutrophil cytoplasmic Ab [Titer] in Body fluid by Immunofluorescence |
|
21023-7
|
Neutrophil cytoplasmic Ab [Titer] in Serum |
|
51924-9
|
Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence |
|
17354-2
|
Neutrophil cytoplasmic IgA Ab [Presence] in Serum |
|
18329-3
|
Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum |
|
87551-8
|
Neutrophil cytoplasmic Ab.IgG and Saccharomyces cerevisiae IgA and IgG in Serum |
|
17355-9
|
Neutrophil cytoplasmic IgG Ab [Presence] in Serum |
|
18330-1
|
Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum |
|
29967-7
|
Neutrophil cytoplasmic IgG Ab [Titer] in Serum by Immunofluorescence |
|
17356-7
|
Neutrophil cytoplasmic IgM Ab [Presence] in Serum |
|
18331-9
|
Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum |
|
87427-1
|
Neutrophil cytoplasmic Ab panel - Serum by Immunofluorescence |
|
7079-7
|
Anchovy IgE Ab [Units/volume] in Serum |
|
7080-5
|
Anchovy IgG Ab [Units/volume] in Serum |
|
5045-0
|
Ancylostoma sp Ab [Units/volume] in Serum |
|
9310-4
|
Androstenedione [Mass/time] in 24 hour Urine |
|
34239-4
|
Androstenedione [Moles/volume] in 24 hour Urine |
|
15028-4
|
Androstenedione [Moles/time] in 24 hour Urine |
|
1851-5
|
Androstenedione [Mass/volume] in Amniotic fluid |
|
93731-8
|
Androstenedione [Moles/volume] in Amniotic fluid |
|
1852-3
|
Androstenedione [Mass/volume] in Capillary blood |
|
53343-0
|
Androstenedione [Mass/volume] in DBS |
|
53344-8
|
Androstenedione [Moles/volume] in DBS |
|
72489-8
|
Androstenedione [Moles/volume] in Saliva (oral fluid) |
|
43817-6
|
Androstenedione [Presence] in Serum or Plasma |
|
1854-9
|
Androstenedione [Mass/volume] in Serum or Plasma |
|
35190-8
|
Androstenedione [Mass or Moles/volume] in Serum or Plasma |
|
14603-5
|
Androstenedione [Moles/volume] in Serum or Plasma |
|
1853-1
|
Androstenedione [Mass/volume] in Semen |
|
1855-6
|
Androstenedione [Mass/volume] in Urine |
|
15027-6
|
Androstenedione [Moles/volume] in Urine |
|
34240-2
|
Androstenedione/Creatinine [Molar ratio] in Urine |
|
23815-4
|
Androstanediol [Mass/time] in 24 hour Urine |
|
9640-4
|
Androstanediol [Mass/volume] in Serum or Plasma |
|
15026-8
|
Androstanediol [Moles/volume] in Serum or Plasma |
|
1850-7
|
Androstanediol [Mass/volume] in Urine |
|
14047-5
|
Androstanolone Free [Mass/volume] in Serum or Plasma |
|
43826-7
|
Androstanolone [Presence] in Serum or Plasma |
|
1848-1
|
Androstanolone [Mass/volume] in Serum or Plasma |
|
35189-0
|
Androstanolone [Mass or Moles/volume] in Serum or Plasma |
|
15057-3
|
Androstanolone [Moles/volume] in Serum or Plasma |
|
1849-9
|
Androstanolone [Mass/volume] in Semen |
|
56033-4
|
Androstenediol [Mass/time] in 24 hour Urine |
|
34237-8
|
Androstenediol [Moles/volume] in 24 hour Urine |
|
25314-6
|
Androstenediol [Moles/time] in 24 hour Urine |
|
55851-0
|
Androstenediol [Moles/volume] in Serum or Plasma |
|
34236-0
|
Androstenediol [Moles/volume] in Urine |
|
34238-6
|
Androstenediol/Creatinine [Molar ratio] in Urine |
|
56487-2
|
Androsterone [Mass/volume] in 24 hour Urine |
|
6705-8
|
Androsterone [Mass/time] in 24 hour Urine |
|
34241-0
|
Androsterone [Moles/volume] in 24 hour Urine |
|
15030-0
|
Androsterone [Moles/time] in 24 hour Urine |
|
1856-4
|
Androsterone [Mass/volume] in Serum or Plasma |
|
15029-2
|
Androsterone [Moles/volume] in Serum or Plasma |
|
27110-6
|
Androsterone [Mass/volume] in Urine |
|
12479-2
|
Androsterone [Mass/time] in Urine |
|
34242-8
|
Androsterone [Moles/volume] in Urine |
|
44297-0
|
Androsterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
30509-4
|
Androsterone/Creatinine [Mass Ratio] in Urine |
|
34243-6
|
Androsterone/Creatinine [Molar ratio] in Urine |
|
61359-6
|
Anesthesia consent Document |
|
11485-0
|
Anesthesia records |
|
77401-8
|
Anesthesiology Admission history and physical note |
|
83680-9
|
Anesthesiology Attending Note |
|
83681-7
|
Anesthesiology Attending Preoperative evaluation and management note |
|
78495-9
|
Anesthesiology Checklist |
|
77403-4
|
Anesthesiology Consult note |
|
77404-2
|
Anesthesiology Education note |
|
84058-7
|
Anesthesiology Flowsheet |
|
84059-5
|
Anesthesiology Hospital Note |
|
34123-0
|
Anesthesiology Hospital Preoperative evaluation and management note |
|
34750-0
|
Anesthesiology Note |
|
83567-8
|
Anesthesiology Nurse Note |
|
34749-2
|
Anesthesiology Outpatient Consult note |
|
84060-3
|
Anesthesiology Outpatient Note |
|
84063-7
|
Anesthesiology Telephone encounter Note |
|
84061-1
|
Anesthesiology Postoperative evaluation and management note |
|
34751-8
|
Anesthesiology Preoperative evaluation and management note |
|
84062-9
|
Anesthesiology procedure note |
|
89811-4
|
Anesthesiology Progress note |
|
85849-8
|
Anesthesiology Recovery room Discharge summary |
|
77405-9
|
Anesthesiology Referral note |
|
77436-4
|
Anesthesiology Summary note |
|
89794-2
|
Anesthesiology Team Conference note |
|
77406-7
|
Anesthesiology Transfer summary note |
|
76059-5
|
Anesthetic agent.XXX Airway adaptor |
|
60874-5
|
Anesthetic agent.XXX Airway adaptor --during inspiration |
|
60873-7
|
Anesthetic agent.XXX Airway adaptor --at end expiration |
|
30915-3
|
Aneuploid cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
|
31114-2
|
Aneuploid cell population 1/100 cells in Unspecified specimen |
|
31115-9
|
Aneuploid cell population 2/100 cells in Unspecified specimen |
|
1921-6
|
Atrial natriuretic factor [Mass/volume] in Arterial blood |
|
11208-6
|
Atrial natriuretic factor [Mass/volume] in Plasma |
|
33783-2
|
Atrial natriuretic factor [Moles/volume] in Plasma |
|
77632-8
|
ANG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85105-5
|
Anger-Affect Survey - CAT item bank - age 18+ [NIH Toolbox] |
|
1858-0
|
Angiotensin I [Mass/volume] in Plasma |
|
15031-8
|
Angiotensin I [Moles/volume] in Plasma |
|
1859-8
|
Angiotensin II [Mass/volume] in Cerebral spinal fluid |
|
1860-6
|
Angiotensin II [Mass/volume] in Plasma |
|
15032-6
|
Angiotensin II [Moles/volume] in Plasma |
|
70074-0
|
Angiotensin II [Mass/volume] in Plasma --supine |
|
25562-0
|
Angiotensin II [Moles/volume] in Plasma --supine |
|
51836-5
|
Angiotensin II [Mass/volume] in Plasma --upright |
|
25563-8
|
Angiotensin II [Moles/volume] in Plasma --upright |
|
1861-4
|
Angiotensinogen [Mass/volume] in Plasma |
|
47087-2
|
Angiotensinogen [Moles/volume] in Plasma |
|
54916-2
|
Angler IgE Ab [Units/volume] in Serum |
|
77162-6
|
Anidulafungin [Susceptibility] by Gradient strip |
|
55343-8
|
Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
58420-1
|
Anidulafungin [Mass/volume] in Serum or Plasma |
|
3359-7
|
Anileridine [Moles/volume] in 24 hour Urine |
|
3356-3
|
Anileridine [Mass/volume] in Serum or Plasma |
|
55523-5
|
Anileridine [Moles/volume] in Serum or Plasma |
|
3357-1
|
Anileridine [Presence] in Urine |
|
38567-4
|
Aniline [Mass/volume] in Air |
|
35584-2
|
Aniline [Mass/volume] in Blood |
|
1862-2
|
Aniline [Mass/volume] in Serum or Plasma |
|
35590-9
|
Aniline [Mass/volume] in Urine |
|
38736-5
|
Animal hair+Epithelium [Mass/volume] in Air |
|
47561-6
|
Anion gap in Body fluid |
|
42485-3
|
Anion gap in Vitreous fluid |
|
73581-1
|
Anion gap 4 in Arterial blood |
|
73577-9
|
Anion gap 4 in Arterial cord blood |
|
73576-1
|
Anion gap 4 in Venous cord blood |
|
73580-3
|
Anion gap 4 in Capillary blood |
|
73579-5
|
Anion gap 4 in Mixed venous blood |
|
73582-9
|
Anion gap 4 in Blood |
|
73578-7
|
Anion gap 4 in Venous blood |
|
64985-5
|
Anisakis recombinant (rAni s) 1 IgE Ab [Units/volume] in Serum |
|
64986-3
|
Anisakis recombinant (rAni s) 3 IgE Ab [Units/volume] in Serum |
|
10919-9
|
Anisakis IgE Ab [Units/volume] in Serum |
|
7081-3
|
Anise IgE Ab [Units/volume] in Serum |
|
58468-0
|
Anise IgG4 Ab [Mass/volume] in Serum |
|
50638-6
|
Annatto seed IgE Ab [Units/volume] in Serum |
|
49458-3
|
Annexin 1 Ag [Presence] in Tissue by Immune stain |
|
44431-5
|
Annexin V IgG Ab [Units/volume] in Serum or Plasma |
|
44432-3
|
Annexin V IgM Ab [Units/volume] in Serum or Plasma |
|
7355-1
|
Annual blue grass IgE Ab [Units/volume] in Serum |
|
84064-5
|
Annual evaluation note |
|
66449-0
|
Annual mercury recombinant (rMer a) 1 IgE Ab [Units/volume] in Serum |
|
7687-7
|
Annual Saltbush IgE Ab [Units/volume] in Serum |
|
43906-7
|
Anserine [Presence] in Urine |
|
57055-6
|
Antepartum summary note |
|
53478-4
|
Anthranilate [Moles/time] in 24 hour Urine |
|
53468-5
|
Anthranilate [Moles/volume] in Serum or Plasma |
|
53498-2
|
Anthranilate [Moles/volume] in Urine |
|
53513-8
|
Anthranilate/Creatinine [Molar ratio] in Urine |
|
3363-9
|
Anthraquinone [Mass/volume] in Serum or Plasma |
|
9417-7
|
Anthraquinone [Mass/mass] in Stool |
|
43929-9
|
Anthraquinone [Mass/volume] in Urine |
|
32665-2
|
Anticonvulsants [Identifier] in Serum or Plasma |
|
16388-1
|
Anticonvulsants [Identifier] in Urine |
|
38194-7
|
Antidepressants [Identifier] in Gastric fluid |
|
16389-9
|
Antidepressants [Identifier] in Serum or Plasma |
|
32136-4
|
Antidepressants [Presence] in Urine |
|
16390-7
|
Antidiuretics [Identifier] in Urine |
|
80136-5
|
Antihistamines [Presence] in Blood by Screen method |
|
80137-3
|
Antihistamines [Presence] in Body fluid by Screen method |
|
38195-4
|
Antihistamines [Presence] in Gastric fluid |
|
75814-4
|
Antihistamines panel - Serum or Plasma or Urine by Screen method |
|
80197-7
|
Antihistamines [Presence] in Serum or Plasma by Screen method |
|
12332-3
|
Antihistamines [Identifier] in Urine |
|
18335-0
|
Antihistamines [Presence] in Urine by Confirmatory method |
|
35699-8
|
Anti-hyperglycemics [Identifier] in Serum or Plasma by Screen method |
|
30910-4
|
Antimicrobials [Presence] in Urine |
|
43876-2
|
Antimony [Presence] in 24 hour Urine |
|
21071-6
|
Antimony [Mass/volume] in 24 hour Urine |
|
14097-0
|
Antimony [Mass/time] in 24 hour Urine |
|
50808-5
|
Antimony [Moles/volume] in 24 hour Urine |
|
5578-0
|
Antimony [Mass/volume] in Blood |
|
50809-3
|
Antimony [Moles/volume] in Blood |
|
51191-5
|
Antimony [Mass/volume] in Body fluid |
|
80140-7
|
Antimony [Moles/volume] in Body fluid |
|
26765-8
|
Antimony [Presence] in Hair |
|
5579-8
|
Antimony [Mass/mass] in Hair |
|
50810-1
|
Antimony [Moles/mass] in Hair |
|
27137-9
|
Antimony [Mass/mass] in Red Blood Cells |
|
50811-9
|
Antimony [Moles/volume] in Red Blood Cells |
|
12702-7
|
Antimony [Presence] in Serum or Plasma |
|
5580-6
|
Antimony [Mass/volume] in Serum or Plasma |
|
25321-1
|
Antimony [Moles/volume] in Serum or Plasma |
|
80138-1
|
Antimony [Mass/mass] in Tissue |
|
80139-9
|
Antimony [Moles/mass] in Tissue |
|
16391-5
|
Antimony [Presence] in Urine |
|
5581-4
|
Antimony [Mass/volume] in Urine |
|
50807-7
|
Antimony [Moles/volume] in Urine |
|
87563-3
|
Antimony [Mass/mass] in Unspecified specimen |
|
29941-2
|
Antimony/Creatinine [Mass Ratio] in 24 hour Urine |
|
52942-0
|
Antimony/Creatinine [Molar ratio] in 24 hour Urine |
|
13823-0
|
Antimony/Creatinine [Mass Ratio] in Urine |
|
52941-2
|
Antimony/Creatinine [Molar ratio] in Urine |
|
55219-0
|
Antioxidants [Moles/volume] in Serum or Plasma |
|
75815-1
|
Antipsychotics drug panel - Blood or Urine by Screen method |
|
76659-2
|
Antipsychotics drug panel - Urine by Screen method |
|
12344-8
|
Antipsychotics [Identifier] in Serum or Plasma |
|
16395-6
|
Antipsychotics [Identifier] in Urine |
|
75242-8
|
Antipsychotics [Presence] in Urine by Screen method |
|
3365-4
|
Antipyrine renal clearance in 24 hour Urine and Serum or Plasma |
|
3364-7
|
Antipyrine [Mass/volume] in Serum or Plasma |
|
47248-0
|
HIV Antiretroviral therapy Antiretroviral therapy status section |
|
82872-3
|
AnWj Ab [Presence] in Serum or Plasma |
|
94017-1
|
Anxiety screening report |
|
89558-1
|
Anxiety symptoms score [CUBS] |
|
59474-7
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Acridine orange stain |
|
6658-9
|
Microscopic observation [Identifier] in Tissue by Acridine orange stain |
|
657-7
|
Microscopic observation [Identifier] in Unspecified specimen by Acridine orange stain |
|
59600-7
|
Alpha hydroxyalprazolam [Mass/volume] in Blood by Confirmatory method |
|
59599-1
|
Alpha hydroxyalprazolam [Mass/volume] in Blood |
|
59602-3
|
Alpha hydroxyalprazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59601-5
|
Alpha hydroxyalprazolam [Mass/volume] in Body fluid |
|
61072-5
|
Alpha hydroxyalprazolam [Presence] in Gastric fluid |
|
94115-3
|
Alpha hydroxyalprazolam glucuronide [Presence] in Urine by Screen method |
|
26887-0
|
Alpha hydroxyalprazolam [Mass/mass] in Hair |
|
59603-1
|
Alpha hydroxyalprazolam [Mass/mass] in Meconium by Confirmatory method |
|
26910-0
|
Alpha hydroxyalprazolam [Mass/mass] in Meconium |
|
59604-9
|
Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61035-2
|
Alpha hydroxyalprazolam [Presence] in Serum or Plasma |
|
27921-6
|
Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma |
|
27439-9
|
Alpha hydroxyalprazolam [Mass/mass] in Stool |
|
59606-4
|
Alpha hydroxyalprazolam [Mass/mass] in Tissue by Confirmatory method |
|
59605-6
|
Alpha hydroxyalprazolam [Mass/mass] in Tissue |
|
16348-5
|
Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
|
61036-0
|
Alpha hydroxyalprazolam [Presence] in Urine |
|
19326-8
|
Alpha hydroxyalprazolam [Presence] in Urine by Confirmatory method |
|
19325-0
|
Alpha hydroxyalprazolam [Presence] in Urine by Screen method |
|
19328-4
|
Alpha hydroxyalprazolam [Mass/volume] in Urine |
|
61037-8
|
Alpha hydroxyalprazolam [Presence] in Unspecified specimen |
|
48937-7
|
Alpha hydroxyalprazolam [Mass/volume] in Unspecified specimen |
|
58363-3
|
Alpha hydroxyalprazolam/Creatinine [Mass Ratio] in Urine |
|
69842-3
|
Alpha hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
|
1677-4
|
Alpha hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
69843-1
|
Alpha hydroxybutyrate [Moles/volume] in Serum or Plasma |
|
26797-1
|
Alpha hydroxybutyrate [Presence] in Urine |
|
13671-3
|
Alpha hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
|
29858-8
|
Alpha hydroxybutyrate/Creatinine [Molar ratio] in Urine |
|
73564-7
|
Alpha hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method |
|
53816-5
|
Alpha hydroxytriazolam [Mass/volume] in Serum |
|
49876-6
|
Alpha hydroxytriazolam [Mass/volume] in Urine by Confirmatory method |
|
94105-4
|
Alpha hydroxytriazolam [Presence] in Urine by Screen method |
|
60677-2
|
Alpha hydroxytriazolam [Mass/volume] in Urine |
|
86605-3
|
Alpha hydroxytriazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
60981-8
|
Aorta blood pressure |
|
60982-6
|
Aorta Diastolic blood pressure |
|
60983-4
|
Aorta Mean blood pressure |
|
60984-2
|
Aorta Systolic blood pressure |
|
73073-9
|
Acetaminophen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73074-7
|
Acetaminophen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
31089-6
|
Acetaminophen [Presence] in Bile fluid |
|
88059-1
|
Acetaminophen [Presence] in Blood by Screen method |
|
60048-6
|
Acetaminophen [Mass/volume] in Blood |
|
18265-9
|
Acetaminophen [Presence] in Body fluid |
|
60049-4
|
Acetaminophen [Mass/volume] in Body fluid |
|
80964-0
|
Acetaminophen free [Mass/volume] in Serum or Plasma |
|
29389-4
|
Acetaminophen [Presence] in Gastric fluid |
|
35700-4
|
Acetaminophen [Mass/volume] in Gastric fluid |
|
47095-5
|
Acetaminophen [Moles/volume] in Gastric fluid |
|
6711-6
|
Acetaminophen IgE Ab [Units/volume] in Serum |
|
73546-4
|
Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73547-2
|
Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48277-8
|
Acetaminophen triggered leukotriene release [Mass/volume] by Leukocytes |
|
3297-9
|
Acetaminophen [Presence] in Serum or Plasma |
|
35595-8
|
Acetaminophen [Mass/volume] in Serum or Plasma by Screen method |
|
70198-7
|
Acetaminophen [Moles/volume] in Serum or Plasma by Screen method |
|
3298-7
|
Acetaminophen [Mass/volume] in Serum or Plasma |
|
14581-3
|
Acetaminophen [Moles/volume] in Serum or Plasma |
|
60050-2
|
Acetaminophen [Mass/mass] in Tissue |
|
3299-5
|
Acetaminophen [Presence] in Urine |
|
59384-8
|
Acetaminophen [Presence] in Urine by Screen method |
|
16282-6
|
Acetaminophen [Units/volume] in Urine |
|
13622-6
|
Acetaminophen [Mass/volume] in Urine |
|
39456-9
|
Acetaminophen [Moles/volume] in Urine |
|
29529-5
|
Acetaminophen [Presence] in Unspecified specimen |
|
12442-0
|
Acetaminophen [Mass/volume] in Unspecified specimen |
|
22736-3
|
Acetaminophen [Moles/volume] in Unspecified specimen |
|
72819-6
|
Acetaminophen/Creatinine [Mass Ratio] in Urine |
|
75071-1
|
Acetaminophen/Creatinine [Molar ratio] in Urine |
|
93972-8
|
Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma |
|
66503-4
|
APC gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
20990-8
|
APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21617-6
|
APC gene p.Ile1307Lys [Presence] in Blood or Tissue by Molecular genetics method |
|
13589-7
|
Activated protein C resistance [Presence] in Blood by NAA with probe detection |
|
48596-1
|
Activated protein C resistance panel - Platelet poor plasma |
|
13590-5
|
Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay |
|
52750-7
|
Activated protein C resistance [Presence] in Platelet poor plasma by Coagulation assay |
|
25505-9
|
Pituitary glycoprotein hormone.alpha subunit [Units/volume] in Serum |
|
14170-5
|
Pituitary glycoprotein hormone.alpha subunit [Mass/volume] in Serum |
|
74214-8
|
Apixaban [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
74218-9
|
Apixaban [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
72608-3
|
Apixaban [Mass/volume] in Serum or Plasma |
|
74368-2
|
Apelin [Mass/volume] in Serum or Plasma |
|
37982-6
|
Avian paramyxovirus [Presence] in Unspecified specimen by Organism specific culture |
|
22097-0
|
Avian paramyxovirus 1 Ab [Presence] in Serum |
|
22829-6
|
Avian paramyxovirus 1 Ab [Presence] in Serum by Hemagglutination inhibition |
|
15447-6
|
Avian paramyxovirus 1 Ab [Presence] in Serum by Immunoassay |
|
31242-1
|
Avian paramyxovirus 1 Ab [Units/volume] in Serum |
|
22098-8
|
Avian paramyxovirus 1 Ab [Titer] in Serum |
|
22830-4
|
Avian paramyxovirus 1 Ab [Titer] in Serum by Agglutination |
|
15448-4
|
Avian paramyxovirus 1 Ab [Titer] in Serum by Hemagglutination inhibition |
|
23661-2
|
Avian paramyxovirus 1 Ab [Titer] in Serum by Immunoassay |
|
31725-5
|
Avian paramyxovirus 1 Ag [Presence] in Unspecified specimen |
|
22831-2
|
Avian paramyxovirus 1 Ag [Presence] in Unspecified specimen by Hemagglutination inhibition |
|
44267-3
|
Avian paramyxovirus 1 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
34486-1
|
Avian paramyxovirus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
34488-7
|
Avian paramyxovirus 1 subtype [Identifier] in Isolate by NAA with probe detection |
|
22832-0
|
Avian paramyxovirus 1 identified in Unspecified specimen by Bioassay |
|
22833-8
|
Avian paramyxovirus 1 [Units/volume] in Unspecified specimen by Bioassay |
|
31243-9
|
Avian paramyxovirus 2 Ab [Units/volume] in Serum |
|
22099-6
|
Avian paramyxovirus 2 Ab [Titer] in Serum |
|
15449-2
|
Avian paramyxovirus 2 Ab [Titer] in Serum by Hemagglutination inhibition |
|
22100-2
|
Avian paramyxovirus 3 Ab [Titer] in Serum |
|
15450-0
|
Avian paramyxovirus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
|
43345-8
|
Avian paramyxovirus 6 Ab [Titer] in Serum |
|
43314-4
|
Avian paramyxovirus 6 Ab [Titer] in Serum by Hemagglutination inhibition |
|
43346-6
|
Avian paramyxovirus 7 Ab [Titer] in Serum |
|
43315-1
|
Avian paramyxovirus 7 Ab [Titer] in Serum by Hemagglutination inhibition |
|
43347-4
|
Avian paramyxovirus 8 Ab [Titer] in Serum |
|
43316-9
|
Avian paramyxovirus 8 Ab [Titer] in Serum by Hemagglutination inhibition |
|
43348-2
|
Avian paramyxovirus 9 Ab [Titer] in Serum |
|
43317-7
|
Avian paramyxovirus 9 Ab [Titer] in Serum by Hemagglutination inhibition |
|
60821-6
|
Apnea duration |
|
1883-8
|
Apolipoprotein A [Mass/volume] in Serum or Plasma |
|
1869-7
|
Apolipoprotein A-I [Mass/volume] in Serum or Plasma |
|
76483-7
|
Apolipoprotein A-I [Moles/volume] in Serum or Plasma |
|
1870-5
|
Apolipoprotein A-II [Mass/volume] in Serum or Plasma |
|
1878-8
|
Apolipoprotein A-III [Mass/volume] in Serum or Plasma |
|
1884-6
|
Apolipoprotein B [Mass/volume] in Serum or Plasma |
|
76482-9
|
Apolipoprotein B [Moles/volume] in Serum or Plasma |
|
56036-7
|
Apolipoprotein B/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
|
1871-3
|
Apolipoprotein B-100 [Mass/volume] in Serum or Plasma |
|
1885-3
|
Apolipoprotein C [Mass/volume] in Serum or Plasma |
|
1875-4
|
Apolipoprotein C-I [Mass/volume] in Serum or Plasma |
|
1876-2
|
Apolipoprotein C-II [Mass/volume] in Serum or Plasma |
|
1877-0
|
Apolipoprotein C-III [Mass/volume] in Serum or Plasma |
|
90419-3
|
Apolipoprotein CIII-0/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma |
|
90421-9
|
Apolipoprotein CIII-1/Apolipoprotein CIII-2 [Mass Ratio] in Serum or Plasma |
|
34438-2
|
Apolipoprotein E phenotyping [Identifier] in Blood |
|
43835-8
|
Apolipoprotein E [Presence] in Serum or Plasma |
|
1886-1
|
Apolipoprotein E [Mass/volume] in Serum or Plasma |
|
48619-1
|
Apolipoprotein E1 [Presence] in Blood |
|
15351-0
|
Apolipoprotein E2 [Presence] in Blood |
|
1879-6
|
Apolipoprotein E2 [Mass/volume] in Serum or Plasma |
|
15352-8
|
Apolipoprotein E3 [Presence] in Blood |
|
15353-6
|
Apolipoprotein E4 [Presence] in Blood |
|
1881-2
|
Apolipoprotein LPA [Mass/volume] in Serum or Plasma |
|
1882-0
|
Apolipoprotein LPQ [Mass/volume] in Serum or Plasma |
|
93420-8
|
APOA1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
89323-0
|
APOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
73748-6
|
APOB gene p.Arg3500Gln and p.Arg3500Trp [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
56752-9
|
APOB gene+LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
68467-0
|
APOB+LDLR+PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
42315-2
|
APOE gene alleles e2 and e3 and e4 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21619-2
|
APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
72157-1
|
Apo-transcobalamin II [Moles/volume] in Serum |
|
55724-9
|
Apolipoprotein A-I and A-II and B and C panel [Mass/volume] - Serum or Plasma |
|
92636-0
|
APOL1 inferred genotype [Identifier] in Plasma from Donor |
|
72158-9
|
Apo-transcobalamin I [Moles/volume] in Serum |
|
49459-1
|
Alzheimer precursor protein Ag [Presence] in Tissue by Immune stain |
|
75390-5
|
APP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
52032-0
|
Appeal denial letter |
|
68455-5
|
Appearance of Spun Vitreous fluid |
|
76675-8
|
Appearance of Cerebral spinal fluid--1st tube |
|
76676-6
|
Appearance of Cerebral spinal fluid--2nd tube |
|
76677-4
|
Appearance of Cerebral spinal fluid--3rd tube |
|
76678-2
|
Appearance of Cerebral spinal fluid--4th tube |
|
68436-5
|
Appearance of Vitreous fluid |
|
64961-6
|
Apple recombinant (rMal d) 1 IgE Ab [Units/volume] in Serum |
|
81791-6
|
Apple recombinant (rMal d) 3 IgE Ab [Units/volume] in Serum |
|
79171-5
|
Apple recombinant (rMal d) 4 IgE Ab [Units/volume] in Serum |
|
7089-6
|
Apple triggered histamine release [Units/volume] in Serum |
|
6021-0
|
Apple IgE Ab [Units/volume] in Serum |
|
43596-6
|
Apple IgE Ab/IgE total in Serum |
|
7088-8
|
Apple IgG Ab [Units/volume] in Serum |
|
56176-1
|
Apple IgG4 Ab [Mass/volume] in Serum |
|
60349-8
|
Apple IgG Ab [Mass/volume] in Serum |
|
7090-4
|
Apple Tree IgE Ab [Units/volume] in Serum |
|
93752-4
|
Atypical porcine pestivirus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
86465-2
|
AST to platelet ratio index in Serum and Blood by calculation |
|
7091-2
|
Apricot IgE Ab [Units/volume] in Serum |
|
7092-0
|
Apricot IgG Ab [Units/volume] in Serum |
|
56177-9
|
Apricot IgG4 Ab [Mass/volume] in Serum |
|
60350-6
|
Apricot IgG Ab [Mass/volume] in Serum |
|
10530-4
|
Aprobarbital [Mass/volume] in Serum or Plasma |
|
20517-9
|
Aprobarbital [Mass/volume] in Urine by Confirmatory method |
|
12313-3
|
Aprobarbital [Presence] in Urine |
|
19350-8
|
Aprobarbital [Presence] in Urine by Confirmatory method |
|
19349-0
|
Aprobarbital [Presence] in Urine by Screen method |
|
14183-8
|
Aprobarbital [Mass/volume] in Urine |
|
43975-2
|
Aprobarbital [Presence] in Unspecified specimen |
|
50165-0
|
Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Amniotic fluid cells |
|
79450-3
|
Adenine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells |
|
50394-6
|
Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Chorionic villus sample |
|
1720-2
|
Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
|
74358-3
|
Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Serum or Plasma |
|
50590-9
|
Adenine phosphoribosyltransferase [Enzymatic activity/mass] in Trophoblasts |
|
76452-2
|
APTA Registry patient registration panel |
|
76464-7
|
American Physical Therapy Association registry panel |
|
75507-4
|
aPTT.lupus sensitive W excess phospholipid percent correction |
|
49844-4
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with 1:4 normal plasma |
|
30322-2
|
aPTT.factor substitution in Platelet poor plasma --1 hour post incubation |
|
49843-6
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --2H post incubation with 1:4 normal plasma |
|
63561-5
|
aPTT actual/normal in Platelet poor plasma by Coagulation assay |
|
3173-2
|
aPTT in Blood by Coagulation assay |
|
16631-4
|
aPTT in Blood by Coagulation 1:1 saline |
|
49058-1
|
aPTT in Blood drawn from CRRT circuit by Coagulation assay |
|
3282-1
|
aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay |
|
91119-8
|
aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma |
|
15362-7
|
aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay |
|
50197-3
|
aPTT panel - Platelet poor plasma |
|
14979-9
|
aPTT in Platelet poor plasma by Coagulation assay |
|
61191-3
|
aPTT in Platelet poor plasma from Fetus by Coagulation assay |
|
52766-3
|
aPTT in Platelet poor plasma by Coagulation assay -- after addition of protein C activator + Factor V depleted plasma/aPTT |
|
52751-5
|
aPTT.factor sensitive in Platelet poor plasma by Coagulation assay |
|
50760-8
|
aPTT.lupus sensitive.factor substitution in Platelet poor plasma by Coagulation assay --1H post incubation with normal plasma |
|
52755-6
|
aPTT.lupus sensitive [Presence] in Platelet poor plasma by Coagulation assay |
|
52767-1
|
Activated partial thromboplastin time (aPTT) in Platelet poor plasma by Coagulation assay -- after addition of protein C activator/Activated partial thromboplastin time (aPTT) |
|
40434-3
|
APTX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41119-9
|
APTX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
90817-8
|
Aquaporin 4 water channel Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
61430-5
|
Aquaporin 4 water channel Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
46718-3
|
Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid |
|
90818-6
|
Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
68548-7
|
Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
43752-5
|
Aquaporin 4 water channel IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
|
43638-6
|
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma |
|
63439-4
|
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
61117-8
|
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma by Immune stain |
|
90819-4
|
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
86240-9
|
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Flow cytometry (FC) |
|
88056-7
|
Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
86241-7
|
Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Flow cytometry (FC) |
|
44794-6
|
Aquaporin 4 water channel IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
49457-5
|
Androgen receptor Ag [Presence] in Tissue by Immune stain |
|
21754-7
|
AR gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
41118-1
|
AR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35359-9
|
AR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79281-2
|
Arabinose/Creatinine [Molar ratio] in Urine |
|
47829-7
|
Arabitol/Creatinine [Molar ratio] in Urine |
|
75108-1
|
Arachidate (C20:0) [Entitic substance] in Red Blood Cells |
|
54173-0
|
Arbekacin [Susceptibility] by Disk diffusion (KB) |
|
53818-1
|
Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
36899-3
|
Arbovirus Ab [Identifier] in Unspecified specimen |
|
36895-1
|
Arbovirus Ab [Identifier] in Unspecified specimen by Immunofluorescence |
|
50034-8
|
Arbovirus Ab [Identifier] in Unspecified specimen by Neutralization test |
|
6309-9
|
Arbovirus identified in Blood by Organism specific culture |
|
53804-1
|
Arbovirus IgG panel - Serum by Immunofluorescence |
|
43905-9
|
Arbovirus IgG Ab [Presence] in Serum |
|
49094-6
|
Arbovirus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
|
49093-8
|
Arbovirus IgG and IgM panel - Serum by Immunofluorescence |
|
74032-4
|
Arbovirus IgM panel - Serum |
|
40584-5
|
Arbovirus IgM Ab [Presence] in Serum |
|
74033-2
|
Arbovirus IgM Ab [Presence] in Serum by Immunofluorescence |
|
31223-1
|
Arbovirus NOS Ab [Units/volume] in Serum |
|
43092-6
|
Arbovirus NOS Ab [Titer] in Serum |
|
26014-1
|
Arbovirus NOS Ab [Titer] in Serum by Complement fixation |
|
6310-7
|
Arbovirus identified in Unspecified specimen by Organism specific culture |
|
89260-4
|
Area of wound |
|
41621-4
|
Arenavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
73520-9
|
Argatroban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73521-7
|
Argatroban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
68981-0
|
Argatroban [Units/volume] in Platelet poor plasma by Chromogenic method |
|
55363-6
|
Argatroban [Mass/volume] in Platelet poor plasma |
|
1890-3
|
Arginase [Enzymatic activity/volume] in Red Blood Cells |
|
79456-0
|
Arginase [Enzymatic activity/mass] in Red Blood Cells |
|
77620-3
|
Arginase-1 [Mass/volume] in Serum by Immunoassay |
|
41168-6
|
Arginine [Presence] in Blood |
|
43927-3
|
Arginine [Presence] in DBS |
|
47562-4
|
Arginine [Moles/volume] in DBS |
|
55911-2
|
Arginine [Moles/mass] in Hair |
|
74876-4
|
Arginine [Moles/volume] in DBS --post therapeutic diet |
|
47566-5
|
Arginine/Amino acids.total in Amniotic fluid |
|
47565-7
|
Arginine/Amino acids.total in Cerebral spinal fluid |
|
47567-3
|
Arginine/Amino acids.total in DBS |
|
47564-0
|
Arginine/Amino acids.total in Hair |
|
47563-2
|
Arginine/Amino acids.total in Serum or Plasma |
|
47568-1
|
Arginine/Amino acids.total in Unspecified specimen |
|
44299-6
|
Arginine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56672-9
|
Arginine/Creatinine [Ratio] in 24 hour Urine |
|
75214-7
|
Arginine/Ornithine [Molar ratio] in DBS |
|
32228-9
|
Argininosuccinate [Moles/volume] in Amniotic fluid |
|
40838-5
|
Argininosuccinate [Moles/volume] in Cerebral spinal fluid |
|
53062-6
|
Argininosuccinate [Moles/volume] in DBS |
|
53067-5
|
Argininosuccinate [Moles/volume] in Body fluid |
|
74877-2
|
Argininosuccinate [Moles/volume] in DBS --post therapeutic diet |
|
43907-5
|
Argininosuccinate [Presence] in Serum or Plasma |
|
1896-0
|
Argininosuccinate [Mass/volume] in Serum or Plasma |
|
32227-1
|
Argininosuccinate [Moles/volume] in Serum or Plasma |
|
27134-6
|
Argininosuccinate [Presence] in Urine |
|
1897-8
|
Argininosuccinate [Mass/volume] in Urine |
|
74484-7
|
Argininosuccinate [Moles/volume] in Urine |
|
53200-2
|
Argininosuccinate/Arginine [Molar ratio] in DBS |
|
13709-1
|
Argininosuccinate/Creatinine [Mass Ratio] in Urine |
|
32229-7
|
Argininosuccinate/Creatinine [Ratio] in Urine |
|
29878-6
|
Argininosuccinate/Creatinine [Molar ratio] in Urine |
|
60915-6
|
Argon [VFr/PPres] Airway adaptor --during expiration |
|
76129-6
|
Argon [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60916-4
|
Argon [VFr/PPres] Airway adaptor --during inspiration |
|
76128-8
|
Argon [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60918-0
|
Argon [VFr/PPres] Airway adaptor --at end expiration |
|
60914-9
|
Argon [VFr/PPres] Airway adaptor |
|
76127-0
|
Argon [VFr/PPres] Gas delivery system |
|
78794-5
|
ARIPiprazole [Mass/volume] in Blood |
|
79226-7
|
ARIPiprazole [Mass/volume] in Body fluid |
|
78793-7
|
ARIPiprazole [Mass/mass] in Hair |
|
89985-6
|
ARIPiprazole [Presence] in Serum or Plasma by Screen method |
|
38893-4
|
ARIPiprazole [Mass/volume] in Serum or Plasma |
|
48354-5
|
ARIPiprazole [Moles/volume] in Serum or Plasma |
|
74931-7
|
ARIPiprazole [Mass/volume] in Serum or Plasma --trough |
|
77761-5
|
ARIPiprazole [Mass/volume] in Urine by Confirmatory method |
|
89978-1
|
ARIPiprazole [Presence] in Urine by Screen method |
|
87781-1
|
ARIPiprazole/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
7095-3
|
Arizona Ash IgE Ab [Units/volume] in Serum |
|
65778-3
|
Arizona Cypress native (nCup a) 1 IgE Ab [Units/volume] in Serum |
|
11168-2
|
Arizona Cypress IgE Ab [Units/volume] in Serum |
|
61253-1
|
Arizona Cypress IgE Ab/IgE total in Serum |
|
16402-0
|
Aromatic solvents [Identifier] in Blood |
|
74132-2
|
Aromatic solvents [Presence] in Blood |
|
40700-7
|
Aromatic solvents [Identifier] in Serum or Plasma |
|
74643-8
|
Aromatic solvents [Presence] in Urine |
|
76281-5
|
Type of arrhythmia on EKG |
|
7093-8
|
Arrowroot IgE Ab [Units/volume] in Serum |
|
76035-5
|
ARSA gene full mutation analysis in Blood or Tissue by Sequencing |
|
49706-5
|
ARSA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35453-0
|
ARSA gene PD allele [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
18405-1
|
Arsenate [Mass/volume] in Urine |
|
30924-5
|
Arsenic [Mass/volume] in Urine collected for unspecified duration |
|
13958-4
|
Arsenic [Presence] in 24 hour Urine |
|
21074-0
|
Arsenic [Mass/volume] in 24 hour Urine |
|
5587-1
|
Arsenic [Mass/time] in 24 hour Urine |
|
34245-1
|
Arsenic [Moles/volume] in 24 hour Urine |
|
34244-4
|
Arsenic [Moles/time] in 24 hour Urine |
|
38569-0
|
Arsenic [Mass/volume] in Air |
|
5582-2
|
Arsenic [Presence] in Blood |
|
5583-0
|
Arsenic [Mass/volume] in Blood |
|
15114-2
|
Arsenic [Moles/volume] in Blood |
|
40701-5
|
Arsenic [Mass/volume] in Dialysis fluid |
|
9489-6
|
Arsenic [Mass/volume] in Body fluid |
|
80141-5
|
Arsenic [Moles/volume] in Body fluid |
|
54454-4
|
Arsenic fractions panel - Urine |
|
43825-9
|
Arsenic [Presence] in Gastric fluid |
|
20687-0
|
Arsenic [Mass/volume] in Gastric fluid |
|
5584-8
|
Arsenic [Mass/mass] in Hair |
|
46096-4
|
Arsenic [Moles/mass] in Hair |
|
8157-0
|
Arsenic [Mass/mass] in Nail |
|
50813-5
|
Arsenic [Moles/mass] in Nail |
|
43181-7
|
Arsenic organic [Mass/volume] in 24 hour Urine |
|
53839-7
|
Arsenic organic [Mass/time] in 24 hour Urine |
|
53778-7
|
Arsenic organic [Mass/volume] in Urine |
|
50816-8
|
Arsenic organic [Moles/volume] in Urine |
|
27127-0
|
Arsenic [Mass/mass] in Red Blood Cells |
|
50812-7
|
Arsenic [Moles/volume] in Red Blood Cells |
|
16403-8
|
Arsenic [Presence] in Serum or Plasma |
|
5585-5
|
Arsenic [Mass/volume] in Serum or Plasma |
|
25323-7
|
Arsenic [Moles/volume] in Serum or Plasma |
|
43809-3
|
Arsenic [Presence] in Tissue |
|
8158-8
|
Arsenic [Mass/mass] in Tissue |
|
78795-2
|
Arsenic [Moles/mass] in Tissue |
|
18406-9
|
Arsenic trioxide [Mass/volume] in Urine |
|
16404-6
|
Arsenic [Presence] in Urine |
|
5586-3
|
Arsenic [Mass/volume] in Urine |
|
29914-9
|
Arsenic [Mass/time] in Urine |
|
15115-9
|
Arsenic [Moles/volume] in Urine |
|
9463-1
|
Arsenic [Mass/volume] in Water |
|
43815-0
|
Arsenic [Presence] in Unspecified specimen |
|
9366-6
|
Arsenic [Mass/mass] in Unspecified specimen |
|
53779-5
|
Arsenic.methylated [Mass/volume] in Urine |
|
13824-8
|
Arsenic/Creatinine [Mass Ratio] in 24 hour Urine |
|
50817-6
|
Arsenic/Creatinine [Molar ratio] in 24 hour Urine |
|
13463-5
|
Arsenic/Creatinine [Mass Ratio] in Urine |
|
56652-1
|
Arsenic/Creatinine [Ratio] in Urine |
|
25324-5
|
Arsenic/Creatinine [Molar ratio] in Urine |
|
60835-6
|
Arterial blood temperature |
|
85794-6
|
Arthralgia/arthritis [Presence] in Mother |
|
18742-7
|
Arthroscopy study |
|
56778-4
|
Articaine IgE Ab [Units/volume] in Serum |
|
7094-6
|
Artichoke IgE Ab [Units/volume] in Serum |
|
30162-2
|
Artichoke IgG Ab [Units/volume] in Serum |
|
56178-7
|
Artichoke IgG4 Ab [Mass/volume] in Serum |
|
60351-4
|
Artichoke IgG Ab [Mass/volume] in Serum |
|
22820-5
|
Avian orthoreovirus Ag [Presence] in Unspecified specimen |
|
38537-7
|
ARX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
1900-0
|
Arylamidase [Enzymatic activity/volume] in Serum |
|
16405-3
|
Arylamidase [Presence] in Urine |
|
16406-1
|
Arylamidase [Enzymatic activity/volume] in Urine |
|
42726-0
|
Cerebroside sulfatase [Enzymatic activity/volume] in 24 hour Urine |
|
9341-9
|
Cerebroside sulfatase [Mass/time] in 24 hour Urine |
|
24077-0
|
Cerebroside sulfatase [Enzymatic activity/mass] in Fibroblast |
|
2059-4
|
Cerebroside sulfatase [Presence] in Serum or Plasma |
|
24076-2
|
Cerebroside sulfatase [Enzymatic activity/volume] in Serum or Plasma |
|
2060-2
|
Cerebroside sulfatase [Enzymatic activity/mass] in Tissue |
|
2061-0
|
Cerebroside sulfatase [Enzymatic activity/volume] in Urine |
|
2062-8
|
Cerebroside sulfatase [Presence] in Leukocytes |
|
2063-6
|
Cerebroside sulfatase [Enzymatic activity/volume] in Leukocytes |
|
24078-8
|
Cerebroside sulfatase [Enzymatic activity/mass] in Leukocytes |
|
55725-6
|
Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/volume] - Serum or Plasma |
|
74978-8
|
Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/mass] - Leukocytes |
|
2645-0
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Amniotic fluid |
|
79463-6
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in DBS |
|
24093-7
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Fibroblast |
|
2646-8
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Serum |
|
2647-6
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Tissue |
|
21413-0
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Urine |
|
2648-4
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Leukocytes |
|
24094-5
|
N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Leukocytes |
|
93852-2
|
N-Acetylgalactosamine-4-Sulfatase/N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity ratio] in Urine |
|
76025-6
|
Arylsulfatase C [Enzymatic activity/mass] in Fibroblast |
|
59244-4
|
Arylsulfatase C [Enzymatic activity/mass] in Leukocytes |
|
55912-0
|
Arylsulfatase [Enzymatic activity/volume] in DBS |
|
1901-8
|
Arylsulfatase [Enzymatic activity/volume] in Serum or Plasma |
|
48024-4
|
AS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50623-8
|
AS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41117-3
|
AS+PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35466-2
|
AS+PWS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53435-4
|
Argininosuccinate lyase [Enzymatic activity/mass] in Chorionic villus sample |
|
47570-7
|
Argininosuccinate lyase [Enzymatic activity/mass] in Fibroblast |
|
53439-6
|
Argininosuccinate lyase [Enzymatic activity/mass] in Liver from Fetus |
|
47569-9
|
Argininosuccinate lyase [Enzymatic activity/mass] in Liver |
|
32627-2
|
Argininosuccinate lyase [Enzymatic activity/mass] in Red Blood Cells |
|
1898-6
|
Argininosuccinate lyase [Enzymatic activity/volume] in Serum |
|
47831-3
|
Argininosuccinate synthase [Enzymatic activity/mass] in Amniotic fluid cells |
|
47830-5
|
Argininosuccinate synthase [Enzymatic activity/mass] in Chorionic villus sample |
|
47571-5
|
Argininosuccinate synthase [Enzymatic activity/mass] in Fibroblast |
|
53440-4
|
Argininosuccinate synthase [Enzymatic activity/mass] in Liver from Fetus |
|
1899-4
|
Argininosuccinate synthase [Enzymatic activity/mass] in Tissue |
|
38568-2
|
Asbestos [Mass/volume] in Air |
|
16407-9
|
Asbestos identified in Sputum by Light microscopy |
|
26671-8
|
Ascaris sp Ab [Presence] in Serum |
|
31224-9
|
Ascaris sp Ab [Units/volume] in Serum |
|
43091-8
|
Ascaris sp Ab [Titer] in Serum |
|
27924-0
|
Ascaris sp Ab [Titer] in Serum by Immunoassay |
|
6022-8
|
Ascaris sp IgE Ab [Units/volume] in Serum |
|
25325-2
|
Ascaris sp IgE Ab [Units/volume] in Serum by Immunoassay |
|
61220-0
|
Ascaris sp IgE Ab/IgE total in Serum |
|
74815-2
|
Ascaris sp IgG Ab [Presence] in Serum by Immunoassay |
|
44437-2
|
Ascaris sp IgG Ab [Units/volume] in Serum |
|
43910-9
|
Ascaris sp IgM Ab [Presence] in Serum |
|
91665-0
|
Ascorbate oxidase IgE Ab [Units/volume] in Serum |
|
91666-8
|
Ascorbate oxidase IgE Ab RAST class [Presence] in Serum |
|
22778-5
|
African swine fever virus Ab [Presence] in Body fluid |
|
22777-7
|
African swine fever virus Ab [Presence] in Body fluid by Immunoassay |
|
22779-3
|
African swine fever virus Ab [Presence] in Serum |
|
22780-1
|
African swine fever virus Ab [Presence] in Serum by Immunoassay |
|
23592-9
|
African swine fever virus Ab [Presence] in Serum by Immune stain |
|
22782-7
|
African swine fever virus Ag [Presence] in Tissue by Agglutination |
|
22783-5
|
African swine fever virus Ag [Presence] in Tissue by Immunofluorescence |
|
31716-4
|
African swine fever virus Ag [Presence] in Unspecified specimen |
|
22781-9
|
African swine fever virus Ag [Presence] in Unspecified specimen by Agglutination |
|
22784-3
|
African swine fever virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
73693-4
|
African swine fever virus DNA [Cycle Threshold #] in Tissue by NAA with probe detection |
|
22785-0
|
African swine fever virus DNA [Presence] in Tissue by NAA with probe detection |
|
56532-5
|
Asialoglycoprotein receptor Ab [Units/volume] in Serum by Immunoassay |
|
55220-8
|
Asialoglycoprotein receptor Ab [Units/volume] in Serum |
|
50639-4
|
Asian ladybug IgE Ab [Units/volume] in Serum |
|
29208-6
|
Streptolysin O Ab [Units/volume] in Body fluid |
|
25788-1
|
Streptolysin O Ab [Units/volume] in Serum by Latex agglutination |
|
9788-1
|
Streptolysin O Ab [Presence] in Serum |
|
45228-4
|
Streptolysin O Ab [Mass/volume] in Serum |
|
5370-2
|
Streptolysin O Ab [Units/volume] in Serum or Plasma |
|
17657-8
|
Streptolysin O Ab [Units/volume] in Synovial fluid |
|
30149-9
|
Streptolysin O Ab [Units/volume] in Serum --1st specimen |
|
30150-7
|
Streptolysin O Ab [Units/volume] in Serum --2nd specimen |
|
22568-0
|
Streptolysin O Ab [Titer] in Serum |
|
5371-0
|
Streptolysin O Ab [Titer] in Serum by Latex agglutination |
|
46990-8
|
ASPA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21081-5
|
ASPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35341-7
|
ASPA gene p.Ala305Glu [Presence] in Blood or Tissue by Molecular genetics method |
|
21622-6
|
ASPA gene p.Glu285Ala [Presence] in Blood or Tissue by Molecular genetics method |
|
35340-9
|
ASPA gene p.Tyr231Ter [Presence] in Blood or Tissue by Molecular genetics method |
|
47572-3
|
Asparagine [Moles/volume] in DBS |
|
53505-4
|
Asparagine/Amino acids.total in Serum or Plasma |
|
44301-0
|
Asparagine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56643-0
|
Asparagine/Creatinine [Ratio] in 24 hour Urine |
|
7099-5
|
Asparagus IgE Ab [Units/volume] in Serum |
|
7100-1
|
Asparagus IgG Ab [Units/volume] in Serum |
|
56179-5
|
Asparagus IgG4 Ab [Mass/volume] in Serum |
|
60362-1
|
Asparagus IgG Ab [Mass/volume] in Serum |
|
47573-1
|
Aspartate [Moles/volume] in DBS |
|
55913-8
|
Aspartate [Moles/mass] in Hair |
|
47576-4
|
Aspartate/Amino acids.total in Amniotic fluid |
|
47575-6
|
Aspartate/Amino acids.total in Cerebral spinal fluid |
|
47578-0
|
Aspartate/Amino acids.total in DBS |
|
47574-9
|
Aspartate/Amino acids.total in Hair |
|
47577-2
|
Aspartate/Amino acids.total in Serum or Plasma |
|
44302-8
|
Aspartate/Creatinine [Mass Ratio] in 24 hour Urine |
|
56640-6
|
Aspartate/Creatinine [Ratio] in 24 hour Urine |
|
7101-9
|
Aspen IgE Ab [Units/volume] in Serum |
|
7102-7
|
Aspen IgG Ab [Units/volume] in Serum |
|
63205-9
|
Aspen IgG Ab [Mass/volume] in Serum |
|
18426-7
|
Aspergillus sp Ab [Presence] in Cerebral spinal fluid |
|
49730-5
|
Aspergillus sp Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
31233-0
|
Aspergillus sp Ab [Units/volume] in Cerebral spinal fluid |
|
7808-9
|
Aspergillus sp Ab [Presence] in Serum |
|
43870-5
|
Aspergillus sp Ab [Presence] in Serum by Complement fixation |
|
5052-6
|
Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
7807-1
|
Aspergillus sp Ab [Units/volume] in Serum |
|
23956-6
|
Aspergillus sp Ab [Titer] in Cerebral spinal fluid |
|
23953-3
|
Aspergillus sp Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43088-4
|
Aspergillus sp Ab [Titer] in Pleural fluid |
|
42488-7
|
Aspergillus sp Ab [Titer] in Pleural fluid by Complement fixation |
|
22087-1
|
Aspergillus sp Ab [Titer] in Serum |
|
5053-4
|
Aspergillus sp Ab [Titer] in Serum by Complement fixation |
|
58808-7
|
Aspergillus sp Ab [Titer] in Serum by Hemagglutination |
|
23660-4
|
Aspergillus sp Ab [Titer] in Serum by Immunoassay |
|
33266-8
|
Aspergillus sp Ab [Titer] in Urine |
|
48335-4
|
Aspergillus sp Ag [Presence] in Tissue by Immune stain |
|
76071-0
|
Aspergillus sp DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
90340-1
|
Aspergillus sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
90339-3
|
Aspergillus sp DNA [Presence] in Tissue by NAA with probe detection |
|
49863-4
|
Aspergillus sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43871-3
|
Aspergillus sp IgA Ab [Presence] in Serum |
|
9491-2
|
Aspergillus sp IgA Ab [Units/volume] in Serum |
|
7106-8
|
Aspergillus sp IgE Ab [Units/volume] in Serum |
|
61222-6
|
Aspergillus sp IgE Ab/IgE total in Serum |
|
7107-6
|
Aspergillus sp IgG Ab [Units/volume] in Serum |
|
43872-1
|
Aspergillus sp IgG Ab [Presence] in Serum |
|
33267-6
|
Aspergillus sp IgG Ab [Presence] in Urine |
|
43873-9
|
Aspergillus sp IgM Ab [Presence] in Serum |
|
9492-0
|
Aspergillus sp IgM Ab [Units/volume] in Serum |
|
20688-8
|
Aspergillus sp identified in Litter by Organism specific culture |
|
75007-5
|
Aspergillus restrictus native (nAsp r) 1 IgE Ab [Units/volume] in Serum |
|
43979-4
|
Aspergillus sp identified in Unspecified specimen by Organism specific culture |
|
38761-3
|
Asphalt [Mass/volume] in Air |
|
81820-3
|
ASS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46070-9
|
Assessment information section |
|
45983-4
|
Assessment reference date Set |
|
78933-9
|
Assisted circulation procedures performed panel |
|
1917-4
|
Aspartate aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
|
1918-2
|
Aspartate aminotransferase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
14414-7
|
Aspartate aminotransferase [Enzymatic activity/volume] in Dialysis fluid |
|
43822-6
|
Aspartate aminotransferase [Presence] in Body fluid |
|
1919-0
|
Aspartate aminotransferase [Enzymatic activity/volume] in Body fluid |
|
14412-1
|
Aspartate aminotransferase [Enzymatic activity/volume] in Gastric fluid |
|
48136-6
|
Aspartate aminotransferase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
|
54500-4
|
Aspartate aminotransferase.macromolecular/Aspartate aminotransferase.total in Serum or Plasma |
|
14409-7
|
Aspartate aminotransferase [Enzymatic activity/volume] in Pleural fluid |
|
14410-5
|
Aspartate aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
|
16412-9
|
Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
|
27344-1
|
Aspartate aminotransferase [Presence] in Serum or Plasma |
|
30239-8
|
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
|
88112-8
|
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P |
|
1920-8
|
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
|
14411-3
|
Aspartate aminotransferase [Enzymatic activity/volume] in Synovial fluid |
|
14413-9
|
Aspartate aminotransferase [Enzymatic activity/volume] in Urine |
|
60055-1
|
Astemizole [Mass/volume] in Body fluid |
|
11231-8
|
Astemizole [Mass/volume] in Serum or Plasma |
|
60056-9
|
Astemizole [Mass/mass] in Tissue |
|
69981-9
|
Asthma action plan |
|
82674-3
|
Asthma Control Test [ACT] |
|
55403-0
|
Asthma tracking panel |
|
82210-6
|
Astrovirus subtypes 1-8 RNA [Presence] in Stool by NAA with non-probe detection |
|
49456-7
|
Alpha synuclein Ag [Presence] in Tissue by Immune stain |
|
27811-9
|
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method |
|
27812-7
|
Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3175-7
|
Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
1868-9
|
Antithrombin Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3177-3
|
Antithrombin Ag [Moles/volume] in Platelet poor plasma by Immunoassay |
|
43869-7
|
Antithrombin Ag [Presence] in Platelet poor plasma by Immunoassay |
|
3174-0
|
Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3176-5
|
Antithrombin [Moles/volume] in Platelet poor plasma by Chromogenic method |
|
65318-8
|
At sup(a) Ab [Presence] in Serum or Plasma |
|
78796-0
|
Atazanavir [Mass/volume] in Amniotic fluid |
|
80143-1
|
Atazanavir [Mass/volume] in Cord blood |
|
80142-3
|
Atazanavir [Mass/volume] in Cerebral spinal fluid by Confirmatory method |
|
49668-7
|
Atazanavir [Susceptibility] by Phenotype method |
|
41470-6
|
Atazanavir [Mass/volume] in Serum or Plasma |
|
78797-8
|
Atazanavir [Mass/volume] in Serum or Plasma --trough |
|
49618-2
|
Atazanavir+Ritonavir [Susceptibility] by Genotype method |
|
57907-8
|
Atazanavir+Ritonavir [Susceptibility] by Phenotype method |
|
73056-4
|
Atenolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73055-6
|
Atenolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3362-1
|
Atenolol [Mass/time] in 24 hour Urine |
|
78799-4
|
Atenolol [Mass/volume] in Blood |
|
79223-4
|
Atenolol [Mass/volume] in Body fluid |
|
78798-6
|
Atenolol [Mass/mass] in Hair |
|
73516-7
|
Atenolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73517-5
|
Atenolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3366-2
|
Atenolol [Mass/volume] in Serum or Plasma |
|
3360-5
|
Atenolol [Presence] in Urine |
|
3361-3
|
Atenolol [Mass/volume] in Urine |
|
57855-9
|
Atenolol [Moles/volume] in Unspecified specimen |
|
1822-6
|
Alpha thymosin [Mass/volume] in Serum |
|
21624-2
|
ATM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49631-5
|
ATN1 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49632-3
|
ATN1 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21756-2
|
ATN1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
74513-3
|
Alpha tocopherol [Entitic substance] in Red Blood Cells |
|
1823-4
|
Alpha tocopherol [Mass/volume] in Serum or Plasma |
|
14590-4
|
Alpha tocopherol [Moles/volume] in Serum or Plasma |
|
20681-3
|
Alpha tocopherol [Mass/mass] in Tissue |
|
73515-9
|
Atomoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73514-2
|
Atomoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
90748-5
|
Atomoxetine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
35667-5
|
Atomoxetine [Mass/volume] in Serum or Plasma |
|
87761-3
|
Atomoxetine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73054-9
|
Atorvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73053-1
|
Atorvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73513-4
|
Atorvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73512-6
|
Atorvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73684-3
|
Atovaquone [Mass/volume] in Serum or Plasma |
|
1721-0
|
Adenosine triphosphate [Mass/volume] in Blood |
|
46701-9
|
Adenosine triphosphate [Moles/volume] in Red Blood Cells |
|
10557-7
|
Adenosine triphosphate [Moles/volume] in Semen |
|
73675-1
|
Adenosine triphosphate/Adenosine diphosphate [Entitic molar ratio] in Platelets |
|
69364-8
|
ATP1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77073-5
|
ATP5A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77072-7
|
ATP5A1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
41116-5
|
ATP7A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34659-3
|
ATP7A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21630-9
|
ATP7B gene c.1711G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
21627-5
|
ATP7B gene c.2010_2016del [Presence] in Blood or Tissue by Molecular genetics method |
|
21628-3
|
ATP7B gene c.2337delC [Presence] in Blood or Tissue by Molecular genetics method |
|
21629-1
|
ATP7B gene c.2487insT [Presence] in Blood or Tissue by Molecular genetics method |
|
75382-2
|
ATP7B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
21626-7
|
ATP7B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
51756-5
|
ATP7B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21631-7
|
ATP7B gene p.Gly1267Arg [Presence] in Blood or Tissue by Molecular genetics method |
|
21632-5
|
ATP7B gene p.His1070Gln [Presence] in Blood or Tissue by Molecular genetics method |
|
21633-3
|
ATP7B gene p.His714Gln [Presence] in Blood or Tissue by Molecular genetics method |
|
21634-1
|
ATP7B gene p.Asn915Ser [Presence] in Blood or Tissue by Molecular genetics method |
|
21635-8
|
ATP7B gene p.Arg778Leu [Presence] in Blood or Tissue by Molecular genetics method |
|
1729-3
|
Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells |
|
1730-1
|
Adenosine triphosphatase [Enzymatic activity/volume] in Semen |
|
48282-8
|
Atracurium triggered leukotriene release [Mass/volume] by Leukocytes |
|
78801-8
|
Atropine [Mass/volume] in Blood |
|
78800-0
|
Atropine [Mass/mass] in Hair |
|
56698-4
|
Atropine IgE Ab [Units/volume] in Serum |
|
3367-0
|
Atropine [Mass/volume] in Serum or Plasma |
|
55524-3
|
Atropine [Moles/volume] in Serum or Plasma |
|
14184-6
|
Atropine [Presence] in Urine |
|
10840-7
|
Atropine [Mass/volume] in Urine |
|
53841-3
|
ATRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
83824-3
|
Attending Admission evaluation note |
|
28655-9
|
Attending Discharge summary |
|
83818-5
|
Attending Emergency department Note |
|
83819-3
|
Attending History and physical note |
|
83822-7
|
Attending Hospital Note |
|
83816-9
|
Attending Intensive care unit Admission evaluation note |
|
83817-7
|
Attending Intensive care unit Note |
|
28654-2
|
Attending Initial evaluation note |
|
83823-5
|
Attending Long term care facility Note |
|
75471-3
|
Attending Note |
|
83821-9
|
Attending Outpatient Note |
|
34134-7
|
Attending Outpatient Supervisory note |
|
83815-1
|
Attending Surgical operation note |
|
83820-1
|
Attending Preoperative evaluation and management note |
|
18733-6
|
Attending Progress note |
|
3074-2
|
Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma |
|
34939-9
|
Tumor necrosis factor.alpha [Moles/volume] in Serum or Plasma |
|
29641-8
|
Neutrophil Cytoplasmic Ab atypical [Presence] in Serum by Immunofluorescence |
|
17358-3
|
Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum |
|
53012-1
|
Neutrophil Cytoplasmic Ab atypical [Titer] in Serum by Immunofluorescence |
|
29642-6
|
Neutrophil cytoplasmic Ab.classic.atypical [Presence] in Serum by Immunofluorescence |
|
90439-1
|
Atypical pneumonia pathogens panel - Respiratory specimen by NAA with probe detection |
|
826-8
|
Au sup(a) Ag [Presence] on Red Blood Cells |
|
82870-7
|
Au sup(b) Ab [Presence] in Serum or Plasma |
|
93908-2
|
Au sup(b) Ag [Presence] on Red Blood Cells |
|
84065-2
|
Audiology Administrative note |
|
75424-2
|
Audiology Consult note |
|
68635-2
|
Audiology Diagnostic study note |
|
77423-2
|
Audiology Education note |
|
77439-8
|
Audiology Flowsheet |
|
68637-8
|
Audiology History and physical note |
|
68639-4
|
Audiology Hospital Consult note |
|
68640-2
|
Audiology Hospital Diagnostic study note |
|
77424-0
|
Audiology Initial evaluation note |
|
88362-9
|
Audiology Medical equipment or product note |
|
68636-0
|
Audiology Note |
|
84066-0
|
Audiology Telephone encounter Note |
|
77444-8
|
Audiology Plan of care note |
|
68638-6
|
Audiology Preoperative evaluation and management note |
|
77425-7
|
Audiology procedure note |
|
77426-5
|
Audiology Progress note |
|
77427-3
|
Audiology Referral note |
|
28615-3
|
Audiology study |
|
87243-2
|
Microscopic observation [Presence] in Unspecified specimen by Auramine fluorochrome stain |
|
6032-7
|
Australian pine IgE Ab [Units/volume] in Serum |
|
50351-6
|
Australian pine IgE Ab/IgE total in Serum |
|
56183-7
|
Australian pine IgG4 Ab [Mass/volume] in Serum |
|
74154-6
|
Autism action plan |
|
57023-4
|
Auto Differential panel - Blood |
|
88883-4
|
Autoimmune connective tissue Ab panel - Serum by Line blot |
|
52065-0
|
Automobile liability attachment |
|
18743-5
|
Autopsy report |
|
85691-4
|
Autopsy result Narrative |
|
81392-3
|
Aortic valve Orifice area/Body surface area [Area/Area] by US.2D+Measured by planimetry |
|
6033-5
|
Avocado IgE Ab [Units/volume] in Serum |
|
61294-5
|
Avocado IgE Ab/IgE total in Serum |
|
7109-2
|
Avocado IgG Ab [Units/volume] in Serum |
|
56184-5
|
Avocado IgG4 Ab [Mass/volume] in Serum |
|
60398-5
|
Avocado IgG Ab [Mass/volume] in Serum |
|
22102-8
|
Avian reovirus Ab [Presence] in Serum |
|
15453-4
|
Avian reovirus Ab [Presence] in Serum by Immunoassay |
|
15452-6
|
Avian reovirus Ab [Presence] in Serum by Immune diffusion (ID) |
|
43324-3
|
Avian reovirus Ab [Presence] in Serum by Immunofluorescence |
|
76151-0
|
Airway pressure backup setting Ventilator |
|
76152-8
|
Airway pressure delta setting Ventilator |
|
838-3
|
Ax Ag [Presence] on Red Blood Cells |
|
75734-4
|
AXIN2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
75733-6
|
AXIN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
86421-5
|
XR Abdomen and RF Gastrointestinal tract upper W air contrast PO and W barium contrast PO |
|
86424-9
|
XR Abdomen and RF Gastrointestinal tract upper W barium contrast PO |
|
86423-1
|
XR Abdomen and RF Gastrointestinal tract upper W contrast PO |
|
86422-3
|
XR Abdomen and RF Gastrointestinal tract upper W water soluble contrast PO |
|
27236-9
|
Azatadine [Mass/volume] in Serum or Plasma |
|
16418-6
|
Azatadine [Presence] in Urine |
|
27276-5
|
Azatadine [Mass/volume] in Urine |
|
43924-0
|
azaTHIOprine [Presence] in Serum or Plasma |
|
16419-4
|
azaTHIOprine [Mass/volume] in Serum or Plasma |
|
79495-8
|
Azelate [Moles/volume] in Serum or Plasma |
|
13712-5
|
Azelate/Creatinine [Mass Ratio] in Urine |
|
29526-1
|
Azelate/Creatinine [Molar ratio] in Urine |
|
38570-8
|
Azinphos-methyl [Mass/volume] in Air |
|
43902-6
|
Azinphos-methyl [Presence] in Blood |
|
23822-0
|
Azinphos-methyl [Mass/volume] in Blood |
|
43903-4
|
Azinphos-methyl [Presence] in Serum or Plasma |
|
35490-2
|
Azinphos-methyl [Mass/volume] in Serum or Plasma |
|
43904-2
|
Azinphos-methyl [Presence] in Urine |
|
21088-0
|
Azinphos-methyl [Mass/volume] in Urine |
|
56747-9
|
Azithromycin IgE Ab [Units/volume] in Serum |
|
73511-8
|
Azithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73510-0
|
Azithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
89480-8
|
Azithromycin [Susceptibility] by Genotype method |
|
16420-2
|
Azithromycin [Mass/volume] in Serum or Plasma |
|
25233-8
|
Azithromycin [Mass/volume] in Unspecified specimen |
|
3368-8
|
Azlocillin [Mass/volume] in Serum or Plasma |
|
16422-8
|
Azlocillin [Mass/volume] in Urine |
|
73509-2
|
Aztreonam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73508-4
|
Aztreonam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3369-6
|
Aztreonam [Mass/volume] in Serum or Plasma |
|
16423-6
|
Aztreonam [Mass/volume] in Urine |
|
25234-6
|
Aztreonam [Mass/volume] in Unspecified specimen |
|
54015-3
|
Azurocidin Ab [Presence] in Serum |
|
69371-3
|
B Ab [Presence] in Cord blood |
|
49196-9
|
Brucella abortus Ab [Presence] in Cerebral spinal fluid |
|
51832-4
|
Brucella abortus Ab [Presence] in Cerebral spinal fluid by Acidified buffered plate agglutination |
|
48967-4
|
Brucella abortus Ab [Presence] in Cerebral spinal fluid by Card agglutination |
|
22146-5
|
Brucella abortus Ab [Presence] in Milk |
|
71714-0
|
Brucella abortus Ab [Presence] in Milk by Heat-inactivation ring test |
|
20725-8
|
Brucella abortus Ab [Presence] in Milk by Ring agglutination |
|
20720-9
|
Brucella abortus Ab [Presence] in Milk by Serial ring agglutination |
|
22921-1
|
Brucella abortus Ab [Units/volume] in Serum by Agglutination |
|
19243-5
|
Brucella abortus Ab [Units/volume] in Serum by Immunoassay |
|
22147-3
|
Brucella abortus Ab [Presence] in Serum |
|
20727-4
|
Brucella abortus Ab [Presence] in Serum by Acidified buffered plate agglutination |
|
20726-6
|
Brucella abortus Ab [Presence] in Serum by Card agglutination |
|
20728-2
|
Brucella abortus Ab [Presence] in Serum by Complement fixation |
|
20731-6
|
Brucella abortus Ab [Presence] in Serum by Immunoassay (EIA) RST |
|
20730-8
|
Brucella abortus Ab [Presence] in Serum by Immunoassay |
|
22920-3
|
Brucella abortus Ab [Presence] in Serum by Immunofluorescence |
|
5066-6
|
Brucella abortus Ab [Presence] in Serum by Latex agglutination |
|
20723-3
|
Brucella abortus Ab [Presence] in Serum by Rapid agglutination |
|
11586-5
|
Brucella abortus Ab [Units/volume] in Serum |
|
22148-1
|
Brucella abortus Ab [Presence] in Semen |
|
20721-7
|
Brucella abortus Ab [Presence] in Semen by Agglutination |
|
33945-7
|
Brucella abortus Ab [Titer] in Cerebral spinal fluid |
|
63435-2
|
Brucella abortus Ab [Titer] in Cerebral spinal fluid by Antihuman globulin |
|
22150-7
|
Brucella abortus Ab [Titer] in Serum |
|
6324-8
|
Brucella abortus Ab [Titer] in Serum by Agglutination |
|
63437-8
|
Brucella abortus Ab [Titer] in Serum by Antihuman globulin |
|
6325-5
|
Brucella abortus Ab [Titer] in Serum by Complement fixation |
|
5067-4
|
Brucella abortus Ab [Titer] in Serum by Latex agglutination |
|
20729-0
|
Brucella abortus Ab [Titer] in Serum by Plate agglutination |
|
20722-5
|
Brucella abortus Ab [Titer] in Serum by Rivanol agglutination |
|
20719-1
|
Brucella abortus Ab [Titer] in Serum by Tube agglutination |
|
22149-9
|
Brucella abortus Ab [Presence] in Whey |
|
20724-1
|
Brucella abortus Ab [Presence] in Whey by Ring agglutination |
|
22927-8
|
Brucella abortus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6910-4
|
Brucella abortus IgA Ab [Units/volume] in Serum |
|
16486-3
|
Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum |
|
42592-6
|
Brucella abortus IgG Ab [Presence] in Cerebral spinal fluid |
|
13212-6
|
Brucella abortus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
16487-1
|
Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination |
|
16488-9
|
Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation |
|
43843-2
|
Brucella abortus IgG Ab [Units/volume] in Serum by Immunoassay |
|
44818-3
|
Brucella abortus IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
38243-2
|
Brucella abortus IgG Ab [Presence] in Serum |
|
6911-2
|
Brucella abortus IgG Ab [Units/volume] in Serum |
|
23963-2
|
Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid |
|
23986-3
|
Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
16119-0
|
Brucella abortus IgG Ab [Titer] in Serum |
|
80151-4
|
Brucella abortus IgG Ab [Titer] in Serum by Agglutination |
|
43129-6
|
Brucella abortus IgG and IgM panel - Serum |
|
44458-8
|
Brucella abortus IgG+IgM Ab [Units/volume] in Serum |
|
22925-2
|
Brucella abortus IgG1 Ab [Presence] in Milk |
|
22923-7
|
Brucella abortus IgG1 Ab [Presence] in Milk by Immunoassay |
|
22924-5
|
Brucella abortus IgG1 Ab [Presence] in Serum |
|
22922-9
|
Brucella abortus IgG1 Ab [Presence] in Serum by Immunoassay |
|
71715-7
|
Brucella abortus IgG1 and IgG2 Ab [Presence] in Serum by Immunoassay |
|
13213-4
|
Brucella abortus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
6326-3
|
Brucella abortus IgM Ab [Units/volume] in Serum by Immunoassay |
|
44815-9
|
Brucella abortus IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
38244-0
|
Brucella abortus IgM Ab [Presence] in Serum |
|
22151-5
|
Brucella abortus IgM Ab [Units/volume] in Serum |
|
23964-0
|
Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid |
|
23987-1
|
Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
16120-8
|
Brucella abortus IgM Ab [Titer] in Serum |
|
22926-0
|
Brucella abortus rRNA [Presence] in Unspecified specimen by Probe |
|
92812-7
|
Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
92813-5
|
Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
92810-1
|
Borrelia afzelii+burgdorferi+garinii IgG Ab [Units/volume] in Serum by Immunoassay |
|
92814-3
|
Borrelia afzelii+burgdorferi+garinii IgG Ab [Presence] in Serum by Immunoassay |
|
87274-7
|
Borrelia afzelii+burgdorferi+garinii IgG and IgM panel - Serum by Line blot |
|
48360-2
|
Borrelia afzelii IgG Ab [Presence] in Serum by Immunoblot |
|
916-7
|
B Ag [Presence] on Red Blood Cells |
|
5055-9
|
Bacillus anthracis Ab [Units/volume] in Serum by Hemagglutination |
|
11467-8
|
Bacillus anthracis Ab [Units/volume] in Serum by Immunoblot |
|
22860-1
|
Bacillus anthracis Ab [Presence] in Serum |
|
22862-7
|
Bacillus anthracis Ab [Presence] in Serum by Agglutination |
|
22864-3
|
Bacillus anthracis Ab [Presence] in Serum by Complement fixation |
|
22863-5
|
Bacillus anthracis Ab [Presence] in Serum by Immunoassay |
|
22861-9
|
Bacillus anthracis Ab [Presence] in Serum by Immune diffusion (ID) |
|
7814-7
|
Bacillus anthracis Ab [Units/volume] in Serum |
|
22859-3
|
Bacillus anthracis Ab [Titer] in Serum |
|
22865-0
|
Bacillus anthracis Ab [Titer] in Serum by Immune diffusion (ID) |
|
11468-6
|
Bacillus anthracis Ab [Units/volume] in Unspecified specimen by Immunofluorescence |
|
22109-3
|
Bacillus anthracis Ab [Units/volume] in Unspecified specimen |
|
33697-4
|
Bacillus anthracis Ag [Presence] in Isolate by Immunofluorescence |
|
22866-8
|
Bacillus anthracis Ag [Presence] in Tissue by Immunofluorescence |
|
31726-3
|
Bacillus anthracis Ag [Presence] in Unspecified specimen |
|
22867-6
|
Bacillus anthracis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
51976-9
|
Bacillus anthracis capsule Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
44269-9
|
Bacillus anthracis cell wall Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41622-2
|
Bacillus anthracis DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
41623-0
|
Bacillus anthracis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
33698-2
|
Bacillus anthracis [Presence] in Isolate by Phage lysis |
|
44270-7
|
Bacillus anthracis spore Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
11469-4
|
Bacillus anthracis [Presence] in Unspecified specimen by Organism specific culture |
|
22114-3
|
Bordetella avium Ab [Presence] in Serum |
|
15458-3
|
Bordetella avium Ab [Presence] in Serum by Immunoassay |
|
31265-2
|
Bordetella avium Ab [Units/volume] in Serum |
|
22115-0
|
Bordetella avium Ab [Titer] in Serum |
|
15457-5
|
Bordetella avium Ab [Titer] in Serum by Agglutination |
|
49210-8
|
Bartonella bacilliformis IgG Ab [Titer] in Body fluid |
|
48878-3
|
Bartonella bacilliformis IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49212-4
|
Bartonella bacilliformis IgG Ab [Titer] in Serum |
|
48842-9
|
Bartonella bacilliformis IgG Ab [Titer] in Serum by Immunofluorescence |
|
49209-0
|
Bartonella bacilliformis IgM Ab [Titer] in Body fluid |
|
48879-1
|
Bartonella bacilliformis IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49211-6
|
Bartonella bacilliformis IgM Ab [Titer] in Serum |
|
48843-7
|
Bartonella bacilliformis IgM Ab [Titer] in Serum by Immunofluorescence |
|
22844-5
|
Babesia bigemina Ab [Presence] in Serum |
|
23662-0
|
Babesia bigemina Ab [Presence] in Serum by Complement fixation |
|
22846-0
|
Babesia bigemina Ab [Presence] in Serum by Immunoassay |
|
22845-2
|
Babesia bigemina Ab [Presence] in Serum by Immunofluorescence |
|
22847-8
|
Babesia bovis Ab [Presence] in Serum |
|
23663-8
|
Babesia bovis Ab [Presence] in Serum by Complement fixation |
|
22848-6
|
Babesia bovis Ab [Presence] in Serum by Immunoassay |
|
22849-4
|
Babesia bovis Ab [Presence] in Serum by Immunofluorescence |
|
22886-6
|
Bordetella bronchiseptica Ab [Presence] in Serum |
|
22887-4
|
Bordetella bronchiseptica Ab [Presence] in Serum by Agglutination |
|
31735-4
|
Bordetella bronchiseptica Ag [Presence] in Unspecified specimen |
|
22888-2
|
Bordetella bronchiseptica Ag [Presence] in Unspecified specimen by Agglutination |
|
45271-4
|
Bordetella bronchiseptica DNA [Presence] in Nasopharynx by NAA with probe detection |
|
45294-6
|
Bordetella bronchiseptica DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
60342-3
|
Borrelia burgdorferi IgG panel - Serum by Immunoblot |
|
60343-1
|
Borrelia burgdorferi IgM panel - Serum by Immunoblot |
|
90893-9
|
Borrelia burgdorferi bba64 gene [Presence] in Blood by NAA with non-probe detection |
|
51744-1
|
Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum by Immunoassay |
|
53362-0
|
Borrelia burgdorferi 49736 IgA Ab [Units/volume] in Serum |
|
51743-3
|
Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum by Immunoassay |
|
51746-6
|
Borrelia burgdorferi 49736 IgG Ab [Presence] in Serum by Immunoblot |
|
53363-8
|
Borrelia burgdorferi 49736 IgG Ab [Units/volume] in Serum |
|
51742-5
|
Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum by Immunoassay |
|
53364-6
|
Borrelia burgdorferi 49736 IgM Ab [Units/volume] in Serum |
|
6318-0
|
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
44453-9
|
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoblot |
|
22118-4
|
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid |
|
16475-6
|
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
45189-8
|
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
22119-2
|
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid |
|
6319-8
|
Borrelia burgdorferi Ab [Units/volume] in Body fluid by Immunoassay |
|
16477-2
|
Borrelia burgdorferi Ab [Presence] in Body fluid |
|
16476-4
|
Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay |
|
22120-0
|
Borrelia burgdorferi Ab [Units/volume] in Body fluid |
|
23833-7
|
Borrelia burgdorferi Ab index [Presence] in Serum and CSF |
|
5060-9
|
Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay |
|
44452-1
|
Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoblot |
|
11006-4
|
Borrelia burgdorferi Ab [Presence] in Serum |
|
26006-7
|
Borrelia burgdorferi Ab [Presence] in Serum by Hemagglutination |
|
20449-5
|
Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay |
|
23676-0
|
Borrelia burgdorferi Ab [Presence] in Serum by Immunofluorescence |
|
22121-8
|
Borrelia burgdorferi Ab [Units/volume] in Serum |
|
44020-6
|
Borrelia burgdorferi Ab [Presence] in Synovial fluid by Immunoblot |
|
44454-7
|
Borrelia burgdorferi Ab [Units/volume] in Synovial fluid |
|
44455-4
|
Borrelia burgdorferi Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
44456-2
|
Borrelia burgdorferi Ab [Units/volume] in Serum --1st specimen |
|
30128-3
|
Borrelia burgdorferi Ab [Units/volume] in Serum --2nd specimen |
|
33932-5
|
Borrelia burgdorferi Ab [Titer] in Cerebral spinal fluid |
|
22122-6
|
Borrelia burgdorferi Ab [Titer] in Serum |
|
43842-4
|
Borrelia burgdorferi Ab [Titer] in Serum by Immunoassay |
|
5061-7
|
Borrelia burgdorferi Ab [Titer] in Serum by Immunofluorescence |
|
31155-5
|
Borrelia burgdorferi Ab [Units/volume] in Unspecified specimen by Immunoassay |
|
43077-7
|
Borrelia burgdorferi Ab [Units/volume] in Unspecified specimen |
|
6322-2
|
Borrelia burgdorferi Ag [Units/volume] in Serum |
|
29952-9
|
Borrelia burgdorferi Ag [Mass/volume] in Urine by Immunoassay |
|
11007-2
|
Borrelia burgdorferi Ag [Units/volume] in Urine |
|
31738-8
|
Borrelia burgdorferi Ag [Presence] in Unspecified specimen |
|
23977-2
|
Borrelia burgdorferi Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
43074-4
|
Borrelia burgdorferi C6 Ab [Units/volume] in Cerebral spinal fluid |
|
57916-9
|
Borrelia burgdorferi C6 Ab [Presence] in Serum |
|
43075-1
|
Borrelia burgdorferi C6 Ab [Units/volume] in Serum |
|
32667-8
|
Borrelia burgdorferi DNA [Presence] in Blood by NAA with probe detection |
|
10846-4
|
Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification |
|
32668-6
|
Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
11551-9
|
Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by Probe with amplification |
|
42589-2
|
Borrelia burgdorferi DNA [Presence] in Body fluid by NAA with probe detection |
|
10847-2
|
Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification |
|
32669-4
|
Borrelia burgdorferi DNA [Presence] in Synovial fluid by NAA with probe detection |
|
42236-0
|
Borrelia burgdorferi DNA [Presence] in Tick by NAA with probe detection |
|
35638-6
|
Borrelia burgdorferi DNA [Presence] in Tissue by NAA with probe detection |
|
21120-1
|
Borrelia burgdorferi DNA [Presence] in Urine by NAA with probe detection |
|
19052-0
|
Borrelia burgdorferi DNA [Presence] in Urine by Probe with amplification |
|
4991-6
|
Borrelia burgdorferi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
51745-8
|
Borrelia burgdorferi G39/40 IgG Ab [Presence] in Serum by Immunoblot |
|
53730-8
|
Borrelia burgdorferi G39/40 IgG Ab [Units/volume] in Serum or Plasma |
|
22123-4
|
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid |
|
16479-8
|
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
18202-2
|
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
45165-8
|
Borrelia burgdorferi IgA Ab [Units/volume] in Serum by Immunofluorescence |
|
22124-2
|
Borrelia burgdorferi IgA Ab [Presence] in Serum |
|
16478-0
|
Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay |
|
18201-4
|
Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoblot |
|
46174-9
|
Borrelia burgdorferi IgA Ab [Units/volume] in Serum |
|
55726-4
|
Borrelia burgdorferi IgA and IgG and IgM panel - Cerebral spinal fluid |
|
14077-2
|
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
13204-3
|
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
22125-9
|
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid |
|
83080-2
|
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13202-7
|
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
79709-2
|
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
22126-7
|
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid |
|
16481-4
|
Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
23980-6
|
Borrelia burgdorferi IgG Ab [Presence] in Body fluid by Immunoblot |
|
22127-5
|
Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid |
|
47304-1
|
Borrelia burgdorferi IgG Ab index [Units/volume] in Serum and CSF |
|
5062-5
|
Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay |
|
22128-3
|
Borrelia burgdorferi IgG Ab [Presence] in Serum |
|
6320-6
|
Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoblot |
|
7817-0
|
Borrelia burgdorferi IgG Ab [Units/volume] in Serum |
|
16480-6
|
Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
79708-4
|
Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
22129-1
|
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid |
|
21118-5
|
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoassay |
|
13206-8
|
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoblot |
|
23966-5
|
Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid |
|
23978-0
|
Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22130-9
|
Borrelia burgdorferi IgG Ab [Titer] in Serum |
|
5063-3
|
Borrelia burgdorferi IgG Ab [Titer] in Serum by Immunofluorescence |
|
31268-6
|
Borrelia burgdorferi IgG Ab [Presence] in Unspecified specimen |
|
29898-4
|
Borrelia burgdorferi IgG Ab [Presence] in Unspecified specimen by Immunoblot |
|
34943-1
|
Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid |
|
87423-0
|
Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid by Immunoblot |
|
34942-3
|
Borrelia burgdorferi IgG and IgM panel - Serum |
|
22131-7
|
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum |
|
83081-0
|
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
18203-0
|
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoblot |
|
34148-7
|
Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum |
|
62341-3
|
Borrelia burgdorferi IgG+IgM with reflex to immune blot panel - Serum |
|
14078-0
|
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
43573-5
|
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoblot |
|
13205-0
|
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
22132-5
|
Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid |
|
13203-5
|
Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
22133-3
|
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid |
|
16482-2
|
Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
31269-4
|
Borrelia burgdorferi IgM Ab [Presence] in Body fluid |
|
23982-2
|
Borrelia burgdorferi IgM Ab [Presence] in Body fluid by Immunoblot |
|
22134-1
|
Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid |
|
5064-1
|
Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay |
|
22135-8
|
Borrelia burgdorferi IgM Ab [Presence] in Serum |
|
6321-4
|
Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunoblot |
|
30526-8
|
Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunofluorescence |
|
7818-8
|
Borrelia burgdorferi IgM Ab [Units/volume] in Serum |
|
40612-4
|
Borrelia burgdorferi IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
22136-6
|
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid |
|
21119-3
|
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoassay |
|
13207-6
|
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoblot |
|
43076-9
|
Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid |
|
23984-8
|
Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22137-4
|
Borrelia burgdorferi IgM Ab [Titer] in Serum |
|
5065-8
|
Borrelia burgdorferi IgM Ab [Titer] in Serum by Immunofluorescence |
|
11550-1
|
Borrelia burgdorferi [Presence] in Unspecified specimen by Organism specific culture |
|
22104-4
|
Babesia caballi Ab [Presence] in Serum |
|
20689-6
|
Babesia caballi Ab [Presence] in Serum by Complement fixation |
|
22850-2
|
Babesia caballi Ab [Presence] in Serum by Immunoassay |
|
22851-0
|
Babesia caballi Ab [Presence] in Serum by Immunofluorescence |
|
22853-6
|
Babesia caballi rRNA [Presence] in Blood by Probe |
|
6327-1
|
Brucella canis Ab [Units/volume] in Serum by Immunoassay |
|
22928-6
|
Brucella canis Ab [Presence] in Serum |
|
22930-2
|
Brucella canis Ab [Presence] in Serum by Agglutination |
|
22929-4
|
Brucella canis Ab [Presence] in Serum by Immune diffusion (ID) |
|
23681-0
|
Brucella canis Ab [Presence] in Serum by Immunofluorescence |
|
24410-3
|
Brucella canis Ab [Presence] in Serum by Plate agglutination |
|
11587-3
|
Brucella canis Ab [Units/volume] in Serum |
|
43087-6
|
Babesia canis Ab [Titer] in Serum |
|
22152-3
|
Brucella canis Ab [Titer] in Serum |
|
23682-8
|
Brucella canis Ab [Titer] in Serum by Agglutination |
|
23683-6
|
Brucella canis Ab [Titer] in Serum by Immunofluorescence |
|
23664-6
|
Babesia canis Ab [Titer] in Serum by Immunofluorescence |
|
5068-2
|
Brucella canis Ab [Titer] in Serum by Latex agglutination |
|
24408-7
|
Babesia canis [Presence] in Blood by Giemsa stain |
|
13214-2
|
Brucella canis IgG Ab [Units/volume] in Cerebral spinal fluid |
|
9495-3
|
Brucella canis IgG Ab [Units/volume] in Serum by Immunoassay |
|
38245-7
|
Brucella canis IgG Ab [Presence] in Serum |
|
22153-1
|
Brucella canis IgG Ab [Units/volume] in Serum |
|
43072-8
|
Brucella canis IgG Ab [Titer] in Cerebral spinal fluid |
|
30092-1
|
Brucella canis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22154-9
|
Brucella canis IgG Ab [Titer] in Serum |
|
14079-8
|
Brucella canis IgG Ab [Titer] in Serum by Immunofluorescence |
|
13215-9
|
Brucella canis IgM Ab [Units/volume] in Cerebral spinal fluid |
|
9496-1
|
Brucella canis IgM Ab [Units/volume] in Serum by Immunoassay |
|
38246-5
|
Brucella canis IgM Ab [Presence] in Serum |
|
22155-6
|
Brucella canis IgM Ab [Units/volume] in Serum |
|
43071-0
|
Brucella canis IgM Ab [Titer] in Cerebral spinal fluid |
|
30093-9
|
Brucella canis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22156-4
|
Brucella canis IgM Ab [Titer] in Serum |
|
14080-6
|
Brucella canis IgM Ab [Titer] in Serum by Immunofluorescence |
|
10431-5
|
B-cell Ag [Presence] in Tissue by Immune stain |
|
48390-9
|
B cell crossmatch [Presence] in Blood from Donor |
|
46715-9
|
B cell crossmatch [Presence] in Blood |
|
20692-0
|
Bacillus cereus [Presence] in Food by Culture FDA method |
|
77495-0
|
Bacillus cereus [Presence] in Unspecified specimen by Organism specific culture |
|
6049-1
|
Botrytis cinerea IgE Ab [Units/volume] in Serum |
|
61231-7
|
Botrytis cinerea IgE Ab/IgE total in Serum |
|
30022-8
|
Botrytis cinerea IgG Ab [Units/volume] in Serum |
|
42591-8
|
Botrytis cinerea IgG Ab [Mass/volume] in Serum |
|
7149-8
|
Bipolanis curvularia IgE Ab [Units/volume] in Serum |
|
81653-8
|
Blastomyces dermatitidis drk1 and Histoplasma capsulatum gapdh genes [Identifier] in Unspecified specimen by NAA with probe detection |
|
18197-4
|
Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid |
|
43900-0
|
Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
51741-7
|
Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
13201-9
|
Blastomyces dermatitidis Ab [Units/volume] in Cerebral spinal fluid |
|
31259-5
|
Blastomyces dermatitidis Ab [Presence] in Body fluid |
|
27386-2
|
Blastomyces dermatitidis Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
44451-3
|
Blastomyces dermatitidis Ab [Units/volume] in Serum by Complement fixation |
|
7816-2
|
Blastomyces dermatitidis Ab [Presence] in Serum |
|
16470-7
|
Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation |
|
5058-3
|
Blastomyces dermatitidis Ab [Presence] in Serum by Immune diffusion (ID) |
|
16471-5
|
Blastomyces dermatitidis Ab [Units/volume] in Serum |
|
23959-0
|
Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid |
|
23976-4
|
Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43084-3
|
Blastomyces dermatitidis Ab [Titer] in Pleural fluid |
|
42490-3
|
Blastomyces dermatitidis Ab [Titer] in Pleural fluid by Complement fixation |
|
22112-7
|
Blastomyces dermatitidis Ab [Titer] in Serum |
|
5057-5
|
Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation |
|
51787-0
|
Blastomyces dermatitidis Ab [Titer] in Serum by Immune diffusion (ID) |
|
54455-1
|
Blastomyces dermatitidis Ag [Units/volume] in Body fluid |
|
31731-3
|
Blastomyces dermatitidis Ag [Presence] in Serum |
|
6313-1
|
Blastomyces dermatitidis Ag [Presence] in Serum by Immunoassay |
|
41746-9
|
Blastomyces dermatitidis Ag [Presence] in Urine by Immunoassay |
|
18198-2
|
Blastomyces dermatitidis IgE Ab [Presence] in Serum |
|
46160-8
|
Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid |
|
43864-8
|
Blastomyces dermatitidis IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
18199-0
|
Blastomyces dermatitidis IgG Ab [Presence] in Serum |
|
43865-5
|
Blastomyces dermatitidis IgG Ab [Presence] in Serum by Immunoassay |
|
9494-6
|
Blastomyces dermatitidis IgG Ab [Units/volume] in Serum |
|
18200-6
|
Blastomyces dermatitidis IgM Ab [Presence] in Serum |
|
38443-8
|
Blastomyces dermatitidis IgM Ab [Presence] in Serum by Immunoassay |
|
16472-3
|
Blastomyces dermatitidis rRNA [Presence] in Serum by Probe |
|
4990-8
|
Blastomyces dermatitidis rRNA [Presence] in Unspecified specimen by Probe |
|
14197-8
|
Blastomyces dermatitidis exoantigen [Identifier] in Isolate |
|
88450-2
|
Babesia divergens+MO-1 strain 18S rRNA gene [Presence] in Blood by NAA with non-probe detection |
|
22855-1
|
Babesia divergens Ab [Presence] in Serum |
|
23665-3
|
Babesia divergens Ab [Presence] in Serum by Complement fixation |
|
22854-4
|
Babesia divergens Ab [Presence] in Serum by Immunofluorescence |
|
43086-8
|
Babesia divergens Ab [Titer] in Serum |
|
41413-6
|
Babesia divergens Ab [Titer] in Serum by Immunofluorescence |
|
88451-0
|
Babesia duncani 18S rRNA gene [Presence] in Blood by NAA with non-probe detection |
|
26622-1
|
Babesia duncani Ab [Presence] in Serum |
|
43085-0
|
Babesia duncani Ab [Titer] in Serum |
|
41415-1
|
Babesia duncani Ab [Titer] in Serum by Immunofluorescence |
|
93776-3
|
Babesia duncani IgG Ab [Titer] in Serum by Immunofluorescence |
|
26678-3
|
Bartonella elizabethae Ab [Presence] in Serum |
|
49206-6
|
Bartonella elizabethae IgG Ab [Titer] in Body fluid |
|
48880-9
|
Bartonella elizabethae IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49208-2
|
Bartonella elizabethae IgG Ab [Titer] in Serum |
|
48844-5
|
Bartonella elizabethae IgG Ab [Titer] in Serum by Immunofluorescence |
|
49205-8
|
Bartonella elizabethae IgM Ab [Titer] in Body fluid |
|
48881-7
|
Bartonella elizabethae IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49207-4
|
Bartonella elizabethae IgM Ab [Titer] in Serum |
|
48845-2
|
Bartonella elizabethae IgM Ab [Titer] in Serum by Immunofluorescence |
|
31727-1
|
Bacteroides fragilis Ag [Presence] in Unspecified specimen |
|
544-7
|
Bacteroides fragilis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
70020-3
|
Bacteroides fragilis DNA [Presence] in Blood by NAA with probe detection |
|
26766-6
|
Bacteroides fragilis IgG Ab [Units/volume] in Serum |
|
27905-9
|
Bacteroides fragilis IgM Ab [Units/volume] in Serum |
|
82471-4
|
Borrelia garinii+afzelii oppA1 gene [Presence] in Blood by NAA with non-probe detection |
|
82472-2
|
Borrelia garinii+afzelii oppA1 gene [Presence] in Unspecified specimen by NAA with non-probe detection |
|
34251-9
|
Borrelia garinii IgG Ab [Presence] in Serum by Immunoblot |
|
34252-7
|
Borrelia garinii IgM Ab [Presence] in Serum by Immunoblot |
|
87283-8
|
Brachyspira hampsonii DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
44442-2
|
Bartonella henselae Ab [Units/volume] in Serum by Immunoassay |
|
26676-7
|
Bartonella henselae Ab [Presence] in Serum |
|
35269-0
|
Bartonella henselae Ab [Presence] in Serum by Immunofluorescence |
|
31249-6
|
Bartonella henselae Ab [Units/volume] in Serum |
|
23668-7
|
Bartonella henselae Ab [Titer] in Serum |
|
34433-3
|
Bartonella henselae Ab [Titer] in Serum by Flow cytometry (FC) |
|
91864-9
|
Bartonella henselae DNA [Presence] in Aspirate by NAA with probe detection |
|
16276-8
|
Bartonella henselae DNA [Presence] in Blood by NAA with probe detection |
|
89645-6
|
Bartonella henselae DNA [Presence] in Implanted device by NAA with probe detection |
|
33985-3
|
Bartonella henselae DNA [Presence] in Tissue by NAA with probe detection |
|
33986-1
|
Bartonella henselae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16174-5
|
Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid |
|
31250-4
|
Bartonella henselae IgG Ab [Units/volume] in Cerebral spinal fluid |
|
7815-4
|
Bartonella henselae IgG Ab [Units/volume] in Serum by Immunoassay |
|
48721-5
|
Bartonella henselae IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
32575-3
|
Bartonella henselae IgG Ab [Presence] in Serum |
|
5326-4
|
Bartonella henselae IgG Ab [Units/volume] in Serum |
|
23957-4
|
Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid |
|
23954-1
|
Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49203-3
|
Bartonella henselae IgG Ab [Titer] in Body fluid |
|
48883-3
|
Bartonella henselae IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
22110-1
|
Bartonella henselae IgG Ab [Titer] in Serum |
|
6954-2
|
Bartonella henselae IgG Ab [Titer] in Serum by Immunofluorescence |
|
41478-9
|
Bartonella henselae IgG and IgM panel - Serum |
|
16175-2
|
Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid |
|
31251-2
|
Bartonella henselae IgM Ab [Units/volume] in Cerebral spinal fluid |
|
6312-3
|
Bartonella henselae IgM Ab [Units/volume] in Serum by Immunoassay |
|
32576-1
|
Bartonella henselae IgM Ab [Presence] in Serum |
|
5327-2
|
Bartonella henselae IgM Ab [Units/volume] in Serum |
|
23962-4
|
Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid |
|
23955-8
|
Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49204-1
|
Bartonella henselae IgM Ab [Titer] in Body fluid |
|
48882-5
|
Bartonella henselae IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
22111-9
|
Bartonella henselae IgM Ab [Titer] in Serum |
|
6955-9
|
Bartonella henselae IgM Ab [Titer] in Serum by Immunofluorescence |
|
43436-5
|
Bartonella henselae and Bartonella quintana IgG panel - Cerebral spinal fluid |
|
43439-9
|
Bartonella henselae and Bartonella quintana IgG panel [Titer] - Serum |
|
43437-3
|
Bartonella henselae and Bartonella quintana IgG and IgM panel - Cerebral spinal fluid |
|
43438-1
|
Bartonella henselae and Bartonella quintana IgG and IgM panel - Serum |
|
90251-0
|
Bartonella henselae and Bartonella quintana IgG and IgM panel [Titer] - Serum |
|
43435-7
|
Bartonella henselae and Bartonella quintana IgM panel - Cerebral spinal fluid |
|
43440-7
|
Bartonella henselae and Bartonella quintana IgM panel [Titer] - Serum |
|
26631-2
|
Borrelia hermsii Ab [Presence] in Serum |
|
13208-4
|
Borrelia hermsii IgG Ab [Units/volume] in Serum |
|
22138-2
|
Borrelia hermsii IgG Ab [Titer] in Serum |
|
21121-9
|
Borrelia hermsii IgG Ab [Titer] in Serum by Immunofluorescence |
|
60522-0
|
Borrelia hermsii IgG+IgM Ab [Presence] in Serum |
|
13209-2
|
Borrelia hermsii IgM Ab [Units/volume] in Serum |
|
22139-0
|
Borrelia hermsii IgM Ab [Titer] in Serum |
|
21122-7
|
Borrelia hermsii IgM Ab [Titer] in Serum by Immunofluorescence |
|
16483-0
|
Borrelia hermsii [Presence] in Unspecified specimen by Organism specific culture |
|
86326-6
|
Bordetella holmesii hIS1001 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
88576-4
|
Bordetella holmesii hIS1001 DNA [Presence] in Nasopharynx by NAA with probe detection |
|
91840-9
|
Bordetella holmesii DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91867-2
|
Bordetella holmesii DNA [Presence] in Throat by NAA with probe detection |
|
91817-7
|
Bordetella holmesii DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
62427-0
|
Bordetella holmesii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
70292-8
|
Blastocystis hominis DNA [Presence] in Stool by NAA with probe detection |
|
87282-0
|
Brachyspira hyodysenteriae DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87284-6
|
Brachyspira hyodysenteriae DNA [Presence] in Isolate by NAA with probe detection |
|
87411-5
|
Brachyspira hyodysenteriae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80612-5
|
B IgG Ab [Presence] in Serum or Plasma |
|
50764-0
|
B IgG Ab [Titer] in Serum or Plasma |
|
50763-2
|
B IgM Ab [Titer] in Serum or Plasma |
|
7819-6
|
Brugia malayi Ab [Presence] in Serum |
|
6606-8
|
Brugia malayi Ab [Presence] in Serum by Immunoassay |
|
22956-7
|
Burkholderia mallei Ab [Presence] in Serum |
|
22959-1
|
Burkholderia mallei Ab [Presence] in Serum by Complement fixation |
|
22958-3
|
Burkholderia mallei Ab [Presence] in Serum by Immunoassay |
|
70854-5
|
Burkholderia mallei Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
70853-7
|
Burkholderia mallei DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
70850-3
|
Burkholderia mallei [Presence] in Unspecified specimen by Organism specific culture |
|
41432-6
|
Balamuthia mandrillaris DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82473-0
|
Borrelia mayonii oppA1 gene [Presence] in Blood by NAA with non-probe detection |
|
82474-8
|
Borrelia mayonii oppA1 gene [Presence] in Unspecified specimen by NAA with non-probe detection |
|
31728-9
|
Bacteroides melaninogenicus Ag [Presence] in Unspecified specimen |
|
545-4
|
Bacteroides melaninogenicus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22934-4
|
Brucella melitensis Ab [Units/volume] in Serum by Complement fixation |
|
16489-7
|
Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination |
|
22931-0
|
Brucella melitensis Ab [Presence] in Serum |
|
22933-6
|
Brucella melitensis Ab [Presence] in Serum by Agglutination |
|
22935-1
|
Brucella melitensis Ab [Presence] in Serum by Complement fixation |
|
22932-8
|
Brucella melitensis Ab [Presence] in Serum by Immunoassay |
|
11588-1
|
Brucella melitensis Ab [Units/volume] in Serum |
|
22157-2
|
Brucella melitensis Ab [Titer] in Serum |
|
5069-0
|
Brucella melitensis Ab [Titer] in Serum by Latex agglutination |
|
22936-9
|
Brucella melitensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
57670-2
|
Brucella melitensis IgG Ab [Units/volume] in Serum by Immunoassay |
|
57671-0
|
Brucella melitensis IgM Ab [Units/volume] in Serum by Immunoassay |
|
88452-8
|
Babesia microti 18S rRNA gene [Presence] in Blood by NAA with non-probe detection |
|
6311-5
|
Babesia microti Ab [Units/volume] in Serum by Immunoassay |
|
43918-2
|
Babesia microti Ab [Presence] in Serum |
|
7812-1
|
Babesia microti Ab [Units/volume] in Serum |
|
16427-7
|
Babesia microti Ab [Titer] in Serum |
|
41414-4
|
Babesia microti Ab [Titer] in Serum by Immunofluorescence |
|
10347-3
|
Babesia microti identified in Blood by Light microscopy |
|
21089-8
|
Babesia microti DNA [Presence] in Blood by NAA with probe detection |
|
47396-7
|
Babesia microti DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43893-7
|
Babesia microti IgG Ab [Presence] in Serum |
|
82747-7
|
Babesia microti IgG Ab [Presence] in Serum by Immunoblot |
|
31244-7
|
Babesia microti IgG Ab [Units/volume] in Serum |
|
47071-6
|
Babesia microti IgG Ab [Titer] in Cerebral spinal fluid |
|
16117-4
|
Babesia microti IgG Ab [Titer] in Serum |
|
34940-7
|
Babesia microti IgG and IgM panel - Serum |
|
88728-1
|
Babesia microti IgG and IgM panel - Serum by Immunofluorescence |
|
60521-2
|
Babesia microti IgG+IgM Ab [Presence] in Serum |
|
88700-0
|
Babesia microti IgG and IgM [Interpretation] in Serum |
|
27965-3
|
Babesia microti IgM Ab [Presence] in Serum |
|
31245-4
|
Babesia microti IgM Ab [Units/volume] in Serum |
|
47073-2
|
Babesia microti IgM Ab [Titer] in Cerebral spinal fluid |
|
16118-2
|
Babesia microti IgM Ab [Titer] in Serum |
|
82475-5
|
Borrelia miyamotoi glpQ gene [Presence] in Blood by NAA with non-probe detection |
|
82476-3
|
Borrelia miyamotoi glpQ gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
82780-8
|
Borrelia miyamotoi flaB gene [Presence] in Tick by NAA with probe detection |
|
82781-6
|
Borrelia miyamotoi flaB gene [Presence] in Unspecified specimen by NAA with probe detection |
|
93873-8
|
Borrelia miyamotoi IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
93874-6
|
Borrelia miyamotoi IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
22937-7
|
Brucella ovis Ab [Units/volume] in Serum by Complement fixation |
|
22158-0
|
Brucella ovis Ab [Presence] in Serum |
|
22938-5
|
Brucella ovis Ab [Presence] in Serum by Agglutination |
|
20733-2
|
Brucella ovis Ab [Presence] in Serum by Complement fixation |
|
20732-4
|
Brucella ovis Ab [Presence] in Serum by Immunoassay |
|
22940-1
|
Brucella ovis Ab [Presence] in Serum by Immune diffusion (ID) |
|
22939-3
|
Brucella ovis Ab [Units/volume] in Serum |
|
23684-4
|
Brucella ovis Ab [Titer] in Serum |
|
86327-4
|
Bordetella parapertussis IS1001 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
92855-6
|
Bordetella parapertussis IS1001 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
87621-9
|
Bordetella parapertussis IS1001 DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
92856-4
|
Bordetella parapertussis IS1001 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
44019-8
|
Bordetella parapertussis Ab [Presence] in Body fluid |
|
51825-8
|
Bordetella parapertussis Ab [Units/volume] in Serum by Immunoassay |
|
10348-1
|
Bordetella parapertussis Ab [Presence] in Serum |
|
16473-1
|
Bordetella parapertussis Ab [Units/volume] in Serum |
|
38197-0
|
Bordetella parapertussis Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31736-2
|
Bordetella parapertussis Ag [Presence] in Unspecified specimen |
|
13916-2
|
Bordetella parapertussis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
42588-4
|
Bordetella parapertussis DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92129-6
|
Bordetella parapertussis DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91868-0
|
Bordetella parapertussis DNA [Presence] in Throat by NAA with probe detection |
|
91816-9
|
Bordetella parapertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29723-4
|
Bordetella parapertussis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
69948-8
|
Bordetella parapertussis IgG Ab [Presence] in Serum by Immunoassay |
|
53361-2
|
Bordetella parapertussis IgG Ab [Titer] in Serum |
|
51837-3
|
Bordetella parapertussis IgG Ab [Titer] in Serum by Immunofluorescence |
|
56636-4
|
Bordetella parapertussis IgM Ab [Titer] in Serum by Immunofluorescence |
|
43879-6
|
Bordetella parapertussis [Presence] in Nasopharynx by Organism specific culture |
|
43925-7
|
Bordetella parapertussis [Presence] in Unspecified specimen by Organism specific culture |
|
85809-2
|
Bordetella pertussis and parapertussis and holmesii DNA panel - Unspecified specimen by NAA with probe detection |
|
85799-5
|
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
16474-9
|
Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation |
|
5059-1
|
Bordetella pertussis Ab [Units/volume] in Serum by Immunoassay |
|
31998-8
|
Bordetella pertussis Ab [Presence] in Serum |
|
11585-7
|
Bordetella pertussis Ab [Units/volume] in Serum |
|
22116-8
|
Bordetella pertussis Ab [Titer] in Serum |
|
6315-6
|
Bordetella pertussis Ab [Titer] in Serum by Agglutination |
|
6316-4
|
Bordetella pertussis Ab [Titer] in Serum by Complement fixation |
|
22117-6
|
Bordetella pertussis Ab [Titer] in Unspecified specimen |
|
6314-9
|
Bordetella pertussis Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
20992-4
|
Bordetella pertussis Ab [Presence] in Unspecified specimen |
|
43381-3
|
Bordetella pertussis Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
31266-0
|
Bordetella pertussis Ab [Units/volume] in Unspecified specimen |
|
43909-1
|
Bordetella pertussis Ag [Presence] in Nasopharynx |
|
38198-8
|
Bordetella pertussis Ag [Presence] in Nasopharynx by Immunofluorescence |
|
43891-1
|
Bordetella pertussis Ag [Presence] in Sputum by Immunofluorescence |
|
31737-0
|
Bordetella pertussis Ag [Presence] in Unspecified specimen |
|
550-4
|
Bordetella pertussis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
43913-3
|
Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92128-8
|
Bordetella pertussis DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91869-8
|
Bordetella pertussis DNA [Presence] in Throat by NAA with probe detection |
|
91815-1
|
Bordetella pertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
23826-1
|
Bordetella pertussis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
24034-1
|
Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum by Immunoassay |
|
43880-4
|
Bordetella pertussis filamentous hemagglutinin IgA Ab [Presence] in Serum |
|
23827-9
|
Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum |
|
24033-3
|
Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunoassay |
|
46253-1
|
Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
43881-2
|
Bordetella pertussis filamentous hemagglutinin IgG Ab [Presence] in Serum |
|
23828-7
|
Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum |
|
24035-8
|
Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum by Immunoassay |
|
43882-0
|
Bordetella pertussis filamentous hemagglutinin IgM Ab [Presence] in Serum |
|
23829-5
|
Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum |
|
44046-1
|
Bordetella pertussis Higashi-Hama Ab [Units/volume] in Serum |
|
42328-5
|
Bordetella pertussis IgA Ab [Units/volume] in Serum by Immunoassay |
|
29672-3
|
Bordetella pertussis IgA Ab [Presence] in Serum |
|
29657-4
|
Bordetella pertussis IgA Ab [Presence] in Serum by Immunoassay |
|
69366-3
|
Bordetella pertussis IgA Ab [Presence] in Serum by Immunoblot |
|
9362-5
|
Bordetella pertussis IgA Ab [Units/volume] in Serum |
|
55161-4
|
Bordetella pertussis IgA and IgG panel - Serum by Immunoassay |
|
41877-2
|
Bordetella pertussis IgA and IgG and IgM panel [Units/volume] - Serum by Immunoassay |
|
42330-1
|
Bordetella pertussis IgG Ab [Units/volume] in Serum by Immunoassay |
|
29674-9
|
Bordetella pertussis IgG Ab [Presence] in Serum |
|
29659-0
|
Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay |
|
69367-1
|
Bordetella pertussis IgG Ab [Presence] in Serum by Immunoblot |
|
9363-3
|
Bordetella pertussis IgG Ab [Units/volume] in Serum |
|
25331-0
|
Bordetella pertussis IgG Ab [Titer] in Serum |
|
25352-6
|
Bordetella pertussis IgG Ab [Titer] in Serum by Immunofluorescence |
|
34941-5
|
Bordetella pertussis IgG and IgM panel - Serum |
|
42329-3
|
Bordetella pertussis IgM Ab [Units/volume] in Serum by Immunoassay |
|
29673-1
|
Bordetella pertussis IgM Ab [Presence] in Serum |
|
29658-2
|
Bordetella pertussis IgM Ab [Presence] in Serum by Immunoassay |
|
9364-1
|
Bordetella pertussis IgM Ab [Units/volume] in Serum |
|
25332-8
|
Bordetella pertussis IgM Ab [Titer] in Serum |
|
25353-4
|
Bordetella pertussis IgM Ab [Titer] in Serum by Immunofluorescence |
|
48741-3
|
Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture |
|
43896-0
|
Bordetella pertussis [Presence] in Pleural fluid by Organism specific culture |
|
31267-8
|
Bordetella pertussis secretory IgA Ab [Presence] in Unspecified specimen |
|
24130-7
|
Bordetella pertussis secretory IgA Ab [Presence] in Unspecified specimen by Immunoassay |
|
43890-3
|
Bordetella pertussis [Presence] in Sputum by Organism specific culture |
|
548-8
|
Bordetella pertussis [Presence] in Throat by Organism specific culture |
|
549-6
|
Bordetella pertussis [Presence] in Unspecified specimen by Organism specific culture |
|
44047-9
|
Bordetella pertussis Yamaguchi Ab [Presence] in Serum |
|
74766-7
|
Bordetella pertussis.pertussis toxin 100 IgG Ab [Presence] in Serum by Line blot |
|
24128-1
|
Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum by Immunoassay |
|
74765-9
|
Bordetella pertussis.pertussis toxin IgA Ab [Presence] in Serum by Line blot |
|
23830-3
|
Bordetella pertussis.pertussis toxin IgA Ab [Units/volume] in Serum |
|
24127-3
|
Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunoassay |
|
46254-9
|
Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
85684-9
|
Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Immunoassay |
|
69755-7
|
Bordetella pertussis.pertussis toxin IgG Ab [Presence] in Serum by Line blot |
|
23831-1
|
Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum |
|
33268-4
|
Bordetella pertussis.pertussis toxin IgG Ab [Mass/volume] in Serum |
|
24129-9
|
Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum by Immunoassay |
|
23832-9
|
Bordetella pertussis.pertussis toxin IgM Ab [Units/volume] in Serum |
|
82179-3
|
Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with non-probe detection |
|
92857-2
|
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
85360-6
|
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
92858-0
|
Bordetella pertussis+bronchiseptica+holmesii IS481 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
69753-2
|
Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgA Ab [Presence] in Serum by Line blot |
|
69754-0
|
Bordetella pertussis+Bordetella parapertussis filamentous hemagglutinin IgG Ab [Presence] in Serum by Line blot |
|
86325-8
|
Bordetella pertussis+parapertussis ptxS1 gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
90441-7
|
Bordetella pertussis and Bordetella parapertussis DNA panel - Nasopharynx |
|
41875-6
|
Bordetella pertussis and Bordetella parapertussis DNA panel - Unspecified specimen by NAA with probe detection |
|
78921-4
|
Bordetella pertussis and Bordetella parapertussis DNA and culture panel - Nasopharynx |
|
87401-6
|
Brachyspira pilosicoli DNA [Presence] in Isolate by NAA with probe detection |
|
87285-3
|
Brachyspira pilosicoli DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5287-8
|
Burkholderia pseudomallei Ab [Units/volume] in Serum by Hemagglutination |
|
11604-6
|
Burkholderia pseudomallei Ab [Units/volume] in Serum |
|
70855-2
|
Burkholderia pseudomallei Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
70852-9
|
Burkholderia pseudomallei DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
7988-9
|
Burkholderia pseudomallei IgG Ab [Units/volume] in Serum |
|
23965-7
|
Burkholderia pseudomallei IgG Ab [Titer] in Serum |
|
23988-9
|
Burkholderia pseudomallei IgG Ab [Titer] in Serum by Immunofluorescence |
|
43070-2
|
Burkholderia pseudomallei IgG Ab [Titer] in Unspecified specimen |
|
30090-5
|
Burkholderia pseudomallei IgG Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
31276-9
|
Burkholderia pseudomallei IgG Ab [Units/volume] in Unspecified specimen |
|
35683-2
|
Burkholderia pseudomallei IgG and IgM panel - Serum |
|
41839-2
|
Burkholderia pseudomallei IgG and IgM panel - Serum by Immunofluorescence |
|
7989-7
|
Burkholderia pseudomallei IgM Ab [Units/volume] in Serum |
|
23973-1
|
Burkholderia pseudomallei IgM Ab [Titer] in Serum |
|
23989-7
|
Burkholderia pseudomallei IgM Ab [Titer] in Serum by Immunofluorescence |
|
43069-4
|
Burkholderia pseudomallei IgM Ab [Titer] in Unspecified specimen |
|
30091-3
|
Burkholderia pseudomallei IgM Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
31277-7
|
Burkholderia pseudomallei IgM Ab [Units/volume] in Unspecified specimen |
|
70851-1
|
Burkholderia pseudomallei [Presence] in Unspecified specimen by Organism specific culture |
|
26677-5
|
Bartonella quintana Ab [Presence] in Serum |
|
91863-1
|
Bartonella quintana DNA [Presence] in Aspirate by NAA with probe detection |
|
16277-6
|
Bartonella quintana DNA [Presence] in Blood by NAA with probe detection |
|
89646-4
|
Bartonella quintana DNA [Presence] in Implanted device by NAA with probe detection |
|
89592-0
|
Bartonella quintana DNA [Presence] in Tissue by NAA with probe detection |
|
57910-2
|
Bartonella quintana DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17544-8
|
Bartonella quintana IgG Ab [Presence] in Cerebral spinal fluid |
|
16176-0
|
Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid |
|
51816-7
|
Bartonella quintana IgG Ab [Units/volume] in Serum by Immunoassay |
|
32577-9
|
Bartonella quintana IgG Ab [Presence] in Serum |
|
8009-3
|
Bartonella quintana IgG Ab [Units/volume] in Serum |
|
48713-2
|
Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
|
51451-3
|
Bartonella quintana IgG Ab [Units/volume] in Serum or Plasma |
|
23961-6
|
Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid |
|
23974-9
|
Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49202-5
|
Bartonella quintana IgG Ab [Titer] in Body fluid |
|
48884-1
|
Bartonella quintana IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
9360-9
|
Bartonella quintana IgG Ab [Titer] in Serum |
|
44827-4
|
Bartonella quintana IgG Ab [Titer] in Serum by Immunofluorescence |
|
17545-5
|
Bartonella quintana IgM Ab [Presence] in Cerebral spinal fluid |
|
16177-8
|
Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51821-7
|
Bartonella quintana IgM Ab [Units/volume] in Serum by Immunoassay |
|
44823-3
|
Bartonella quintana IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
32578-7
|
Bartonella quintana IgM Ab [Presence] in Serum |
|
8010-1
|
Bartonella quintana IgM Ab [Units/volume] in Serum |
|
23960-8
|
Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid |
|
23975-6
|
Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49201-7
|
Bartonella quintana IgM Ab [Titer] in Body fluid |
|
48885-8
|
Bartonella quintana IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
9361-7
|
Bartonella quintana IgM Ab [Titer] in Serum |
|
44825-8
|
Bartonella quintana IgM Ab [Titer] in Serum by Immunofluorescence |
|
17546-3
|
Bartonella quintana rRNA [Presence] in Unspecified specimen by Probe |
|
90892-1
|
Borrelia sp panel - Blood by NAA with non-probe detection |
|
30023-6
|
Bacillus subtilis IgE Ab [Units/volume] in Serum |
|
22953-4
|
Brucella suis Ab [Units/volume] in Serum by Complement fixation |
|
16490-5
|
Brucella suis Ab [Units/volume] in Serum by Latex agglutination |
|
22951-8
|
Brucella suis Ab [Presence] in Serum |
|
22952-6
|
Brucella suis Ab [Presence] in Serum by Immunoassay |
|
22950-0
|
Brucella suis Ab [Presence] in Serum by Plate agglutination |
|
11589-9
|
Brucella suis Ab [Units/volume] in Serum |
|
22160-6
|
Brucella suis Ab [Titer] in Serum |
|
5071-6
|
Brucella suis Ab [Titer] in Serum by Latex agglutination |
|
71717-3
|
Brucella suis Ab [Titer] in Serum by Plate agglutination |
|
71716-5
|
Brucella suis Ab [Titer] in Serum by Tube agglutination |
|
22955-9
|
Brucella suis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22954-2
|
Brucella suis rRNA [Presence] in Unspecified specimen by Probe |
|
64979-8
|
Blomia tropicalis recombinant (rBlo t) 5 IgE Ab [Units/volume] in Serum |
|
10921-5
|
Blomia tropicalis IgE Ab [Units/volume] in Serum |
|
48361-0
|
Borrelia valaisiana IgG Ab [Presence] in Serum by Immunoblot |
|
49197-7
|
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid |
|
48887-4
|
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49199-3
|
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum |
|
48847-8
|
Bartonella vinsonii berkhoffii IgG Ab [Titer] in Serum by Immunofluorescence |
|
49198-5
|
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid |
|
48886-6
|
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49200-9
|
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum |
|
48846-0
|
Bartonella vinsonii berkhoffii IgM Ab [Titer] in Serum by Immunofluorescence |
|
73809-6
|
B cell+T cell crossmatch [Interpretation] Qualitative by Complement dependent cytotoxicity |
|
73807-0
|
B cell+T cell crossmatch.autologous [Interpretation] Qualitative by Complement dependent cytotoxicity |
|
5272-0
|
Parvovirus B19 Ab [Units/volume] in Serum by Immunoassay |
|
7982-2
|
Parvovirus B19 Ab [Units/volume] in Serum |
|
49427-8
|
Parvovirus B19 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49428-6
|
Parvovirus B19 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49431-0
|
Parvovirus B19 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49430-2
|
Parvovirus B19 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49429-4
|
Parvovirus B19 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49434-4
|
Parvovirus B19 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49435-1
|
Parvovirus B19 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
91797-1
|
Parvovirus B19 DNA [#/volume] (viral load) in Upper respiratory specimen by NAA with probe detection |
|
49433-6
|
Parvovirus B19 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49432-8
|
Parvovirus B19 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
50349-0
|
Parvovirus B19 DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
50348-2
|
Parvovirus B19 DNA [Presence] in Blood by NAA with probe detection |
|
50346-6
|
Parvovirus B19 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
50344-1
|
Parvovirus B19 DNA [Presence] in Body fluid by NAA with probe detection |
|
50347-4
|
Parvovirus B19 DNA [Presence] in Bone marrow by NAA with probe detection |
|
75541-3
|
Parvovirus B19 DNA [log units/volume] (viral load) in Plasma from Donor by NAA with probe detection |
|
9572-9
|
Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection |
|
74420-1
|
Parvovirus B19 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
74419-3
|
Parvovirus B19 DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
69355-6
|
Parvovirus B19 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
91796-3
|
Parvovirus B19 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
50345-8
|
Parvovirus B19 DNA [Presence] in Urine by NAA with probe detection |
|
9571-1
|
Parvovirus B19 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
58757-6
|
Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31557-2
|
Parvovirus B19 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
53885-0
|
Parvovirus B19 IgG Ab [Units/volume] in Body fluid |
|
5273-8
|
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay |
|
29675-6
|
Parvovirus B19 IgG Ab [Presence] in Serum |
|
29660-8
|
Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay |
|
40657-9
|
Parvovirus B19 IgG Ab [Presence] in Serum by Immunofluorescence |
|
7983-0
|
Parvovirus B19 IgG Ab [Units/volume] in Serum |
|
32826-0
|
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
32836-9
|
Parvovirus B19 IgG Ab [Units/volume] in Serum --1st specimen |
|
32792-4
|
Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
32837-7
|
Parvovirus B19 IgG Ab [Units/volume] in Serum --2nd specimen |
|
27095-9
|
Parvovirus B19 IgG Ab [Titer] in Cerebral spinal fluid |
|
25630-5
|
Parvovirus B19 IgG Ab [Titer] in Serum |
|
25729-5
|
Parvovirus B19 IgG Ab [Titer] in Serum by Immunofluorescence |
|
34950-6
|
Parvovirus B19 IgG and IgM panel - Serum |
|
17422-7
|
Parvovirus B19 IgG+IgM Ab [Units/volume] in Serum |
|
58756-8
|
Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31558-0
|
Parvovirus B19 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
53886-8
|
Parvovirus B19 IgM Ab [Units/volume] in Body fluid |
|
5274-6
|
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay |
|
7981-4
|
Parvovirus B19 IgM Ab [Presence] in Serum |
|
40658-7
|
Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay |
|
6517-7
|
Parvovirus B19 IgM Ab [Presence] in Serum by Immunoblot |
|
40659-5
|
Parvovirus B19 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7984-8
|
Parvovirus B19 IgM Ab [Units/volume] in Serum |
|
32794-0
|
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
41129-8
|
Parvovirus B19 IgM Ab [Units/volume] in Serum --1st specimen |
|
32795-7
|
Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
32839-3
|
Parvovirus B19 IgM Ab [Units/volume] in Serum --2nd specimen |
|
27115-5
|
Parvovirus B19 IgM Ab [Titer] in Cerebral spinal fluid |
|
25631-3
|
Parvovirus B19 IgM Ab [Titer] in Serum |
|
25730-3
|
Parvovirus B19 IgM Ab [Titer] in Serum by Immunofluorescence |
|
5030-2
|
Parvovirus B19 RNA [Presence] in Blood by NAA with probe detection |
|
5031-0
|
Parvovirus B19 RNA [Presence] in Tissue by NAA with probe detection |
|
5032-8
|
Parvovirus B19 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
56152-2
|
Beta 2 glycoprotein 1 Ab IgA and IgG and IgM panel - Serum |
|
72488-0
|
Beta 2 glycoprotein 1 IgG and IgM panel - Serum |
|
56538-2
|
Beta 2 glycoprotein 1 Ab [Units/volume] in Serum by Immunoassay |
|
31256-1
|
Beta 2 glycoprotein 1 Ab [Presence] in Serum |
|
27817-6
|
Beta 2 glycoprotein 1 Ab [Presence] in Serum by Immunoassay |
|
40456-6
|
Beta 2 glycoprotein 1 Ab [Units/volume] in Serum |
|
43915-8
|
Beta 2 glycoprotein 1 IgA Ab [Presence] in Serum |
|
21108-6
|
Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum |
|
44447-1
|
Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
55396-6
|
Beta 2 glycoprotein 1 IgA and IgG panel - Serum |
|
43914-1
|
Beta 2 glycoprotein 1 IgG Ab [Presence] in Serum |
|
16135-6
|
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum |
|
44448-9
|
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
43916-6
|
Beta 2 glycoprotein 1 IgM Ab [Presence] in Serum |
|
16136-4
|
Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum |
|
44449-7
|
Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
1880-4
|
Beta 2 glycoprotein 1 [Mass/volume] in Serum or Plasma |
|
54356-1
|
Beta-2-Microglobulin [Mass/volume] in 24 hour Urine |
|
10873-8
|
Beta-2-Microglobulin [Mass/time] in 24 hour Urine |
|
50824-2
|
Beta-2-Microglobulin [Moles/volume] in 24 hour Urine |
|
56662-0
|
Beta-2-Microglobulin [Moles/time] in 24 hour Urine |
|
43919-0
|
Beta-2-Microglobulin [Presence] in Cerebral spinal fluid |
|
1951-3
|
Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid |
|
32301-4
|
Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid |
|
88711-7
|
Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid |
|
49081-3
|
Beta-2-Microglobulin [Mass/volume] in Dialysis fluid |
|
48166-3
|
Beta-2-Microglobulin [Mass/volume] in Body fluid |
|
39458-5
|
Beta-2-Microglobulin [Moles/volume] in Body fluid |
|
87708-4
|
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis |
|
59218-8
|
Beta-2-Microglobulin [Mass/volume] in Pleural fluid |
|
59217-0
|
Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid |
|
43818-4
|
Beta-2-Microglobulin [Presence] in Serum |
|
83076-0
|
Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay |
|
83078-6
|
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay |
|
1952-1
|
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma |
|
76484-5
|
Beta-2-Microglobulin [Moles/volume] in Serum or Plasma |
|
14626-6
|
Beta-2-Microglobulin [Moles/volume] in Serum |
|
56786-7
|
Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum |
|
83079-4
|
Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay |
|
83077-8
|
Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay |
|
43819-2
|
Beta-2-Microglobulin [Presence] in Urine |
|
1953-9
|
Beta-2-Microglobulin [Mass/volume] in Urine |
|
32302-2
|
Beta-2-Microglobulin [Moles/volume] in Urine |
|
44303-6
|
Beta-2-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine |
|
93729-2
|
Beta-2-Microglobulin/Creatinine [Ratio] in 24 hour Urine |
|
13485-8
|
Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine |
|
59177-6
|
Beta-2-Microglobulin/Creatinine [Ratio] in Urine |
|
39773-7
|
Beta-2-Microglobulin/Creatinine [Molar ratio] in Urine |
|
40610-8
|
Beta-2 transferrin [Presence] in Cerebral spinal fluid |
|
53559-1
|
Beta-2 transferrin [Mass/volume] in Cerebral spinal fluid |
|
13876-8
|
Beta-2 transferrin [Presence] in Body fluid |
|
51831-6
|
Beta-2 transferrin [Mass/volume] in Body fluid |
|
43867-1
|
Beta-2 transferrin [Presence] in Serum |
|
43858-0
|
Beta-2 transferrin [Presence] in Unspecified specimen |
|
56149-8
|
Beta 2 glycoprotein and Cardiolipin Ab and Phosphatidylserine panel - Serum |
|
10467-9
|
Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
|
89342-0
|
Babesia sp 18S rRNA [Presence] in Blood by NAA with probe detection |
|
43926-5
|
Babesia sp Ab [Presence] in Serum |
|
7813-9
|
Babesia sp Ab [Units/volume] in Serum |
|
22106-9
|
Babesia sp Ab [Titer] in Serum |
|
23666-1
|
Babesia sp Ab [Titer] in Serum by Complement fixation |
|
5054-2
|
Babesia sp Ab [Titer] in Serum by Immunofluorescence |
|
10647-6
|
Babesia sp identified in Blood by Thick film |
|
10648-4
|
Babesia sp identified in Blood by Thin film |
|
88233-2
|
Babesia sp DNA [Presence] in Blood by NAA with probe detection |
|
22857-7
|
Babesia sp DNA [Presence] in Tissue by NAA with probe detection |
|
42641-1
|
Babesia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
67866-4
|
Babesia identification panel - Unspecified specimen |
|
42581-9
|
Babesia sp IgG Ab [Presence] in Serum |
|
31246-2
|
Babesia sp IgG Ab [Units/volume] in Serum |
|
22107-7
|
Babesia sp IgG Ab [Titer] in Serum |
|
9584-4
|
Babesia sp IgG Ab [Titer] in Serum by Immunofluorescence |
|
16425-1
|
Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
42580-1
|
Babesia sp IgM Ab [Presence] in Serum |
|
22108-5
|
Babesia sp IgM Ab [Units/volume] in Serum |
|
16426-9
|
Babesia sp IgM Ab [Titer] in Serum |
|
9585-1
|
Babesia sp IgM Ab [Titer] in Serum by Immunofluorescence |
|
22856-9
|
Babesia sp rRNA [Presence] in Tissue by Probe |
|
88461-9
|
Babesia microti and B. divergens+MO-1 and B. duncani 18S rRNA gene panel - Blood by NAA with non-probe detection |
|
22858-5
|
Babesia sp identified in Tissue by Giemsa stain |
|
16428-5
|
Bacitracin [Mass/volume] in Serum or Plasma |
|
87603-7
|
Bacitracin zinc [Mass/mass] in Unspecified specimen |
|
74391-4
|
Baclofen [Mass/volume] in Blood |
|
79224-2
|
Baclofen [Mass/volume] in Body fluid |
|
78802-6
|
Baclofen [Mass/mass] in Hair |
|
43897-8
|
Baclofen [Presence] in Serum or Plasma |
|
9353-4
|
Baclofen [Mass/volume] in Serum or Plasma |
|
75227-9
|
Baclofen [Mass/volume] in Urine |
|
74377-3
|
Baclofen [Mass/volume] in Unknown substance |
|
74390-6
|
Baclofen [Mass/mass] in Unspecified specimen |
|
87773-8
|
Baclofen/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
89314-9
|
Bacterial 23S rRNA gene azithromycin resistance mutation [Presence] by Molecular method |
|
85421-6
|
Bacterial identification and susceptibility panel - Isolate |
|
20695-3
|
Bacteria [#/volume] in Mother's milk |
|
13315-7
|
Bacteria identified in 24 hour Urine by Culture |
|
595-9
|
Bacteria identified in Abscess by Aerobe culture |
|
75357-4
|
Bacteria identified in Abscess by Anaerobe+Aerobe culture |
|
87929-6
|
Bacteria identified in Amniotic fluid by Aerobe culture |
|
87933-8
|
Bacteria identified in Amniotic fluid by Anaerobe culture |
|
596-7
|
Bacteria identified in Amniotic fluid by Culture |
|
52966-9
|
Bacteria identified in Anal by Culture |
|
597-5
|
Bacteria identified in Aspirate by Aerobe culture |
|
598-3
|
Bacteria identified in Aspirate by Anaerobe culture |
|
43411-8
|
Bacteria identified in Aspirate by Culture |
|
43441-5
|
Bacteria identified in Bronchoalveolar lavage by Aerobe culture |
|
88683-8
|
Bacteria identified in Bronchoalveolar lavage by Anaerobe culture |
|
90270-0
|
Bacteria identified in Bile fluid by Aerobe culture |
|
87934-6
|
Bacteria identified in Bile fluid by Anaerobe culture |
|
53911-4
|
Bacteria identified in Bile fluid by Culture |
|
17928-3
|
Bacteria identified in Blood by Aerobe culture |
|
45275-5
|
Bacteria identified in Blood by Aerobe culture 25 degree C incubation |
|
17934-1
|
Bacteria identified in Blood by Anaerobe culture |
|
45276-3
|
Bacteria identified in Blood by Anaerobe culture 25 degree C incubation |
|
600-7
|
Bacteria identified in Blood by Culture |
|
48727-2
|
Bacteria # 2 identified in Blood by Culture |
|
87954-4
|
Bacteria identified in Cord blood by Aerobe culture |
|
87955-1
|
Bacteria identified in Cord blood by Anaerobe culture |
|
602-3
|
Bacteria identified in Bone by Aerobe culture |
|
75358-2
|
Bacteria identified in Bone by Anaerobe+Aerobe culture |
|
74348-4
|
Bacteria identified in Bone from Donor by Aerobe culture |
|
599-1
|
Bacteria identified in Blood product unit by Aerobe culture |
|
87935-3
|
Bacteria identified in Blood product unit by Anaerobe culture |
|
68366-4
|
Bacteria identified in Blood product unit by Culture |
|
76693-1
|
Bacteria identified in Blood product unit.autologous by Culture |
|
43442-3
|
Bacteria identified in Bronchial brush by Aerobe culture |
|
32810-4
|
Bacteria identified in Bronchial specimen |
|
604-9
|
Bacteria identified in Bronchial specimen by Aerobe culture |
|
87930-4
|
Bacteria identified in Burn by Aerobe culture |
|
87936-1
|
Bacteria identified in Burn by Anaerobe culture |
|
603-1
|
Bacteria identified in Burn by Culture |
|
605-6
|
Bacteria identified in Cannula specimen by Aerobe culture |
|
90274-2
|
Bacteria identified in Catheter tip by Aerobe culture |
|
90273-4
|
Bacteria identified in Catheter tip by Anaerobe culture |
|
19128-8
|
Bacteria identified in Catheter tip by Culture |
|
56714-9
|
Bacteria identified in Contact lens by Culture |
|
88142-5
|
Bacteria identified in Cornea or Conjunctiva by Aerobe culture |
|
60257-3
|
Bacteria identified in Cornea by Culture |
|
88236-5
|
Bacteria identified in Cerebral spinal fluid by Aerobe culture |
|
87937-9
|
Bacteria identified in Cerebral spinal fluid by Anaerobe culture |
|
606-4
|
Bacteria identified in Cerebral spinal fluid by Culture |
|
75518-1
|
Bacteria identified in Cerebral spinal fluid by Latex agglutination |
|
41602-4
|
Bacteria [Presence] in Cerebral spinal fluid by Light microscopy |
|
14475-8
|
Bacteria identified in Cervix by Aerobe culture |
|
12281-2
|
Bacteria identified in Cervix by Anaerobe culture |
|
43410-0
|
Bacteria identified in Cervix by Culture |
|
44022-2
|
Bacteria [Presence] in Cervix by Wet preparation |
|
17909-3
|
Bacteria identified in Wound deep by Aerobe culture |
|
17925-9
|
Bacteria identified in Wound deep by Anaerobe culture |
|
43407-6
|
Bacteria identified in Wound deep by Culture |
|
90280-9
|
Bacteria identified in Peritoneal dialysis fluid by Aerobe culture |
|
90277-5
|
Bacteria identified in Peritoneal dialysis fluid by Anaerobe culture |
|
60032-0
|
Bacteria identified in Peritoneal dialysis fluid by Culture |
|
9822-8
|
Bacteria identified in Dialysis fluid by Culture |
|
607-2
|
Bacteria identified in Drain by Aerobe culture |
|
53617-7
|
Bacteria identified in Duodenal fluid by Aerobe culture |
|
53614-4
|
Bacteria # 2 identified in Duodenal fluid by Aerobe culture |
|
53615-1
|
Bacteria # 3 identified in Duodenal fluid by Aerobe culture |
|
53616-9
|
Bacteria # 4 identified in Duodenal fluid by Aerobe culture |
|
608-0
|
Bacteria identified in Ear by Aerobe culture |
|
20694-6
|
Bacteria identified in Embryo by Aerobe culture |
|
53908-0
|
Bacteria identified in Esophageal brushing by Culture |
|
609-8
|
Bacteria identified in Eye by Aerobe culture |
|
44039-6
|
Bacteria [Presence] in Eye by Light microscopy |
|
610-6
|
Bacteria identified in Body fluid by Aerobe culture |
|
17956-4
|
Bacteria identified in Body fluid by Anaerobe culture |
|
611-4
|
Bacteria identified in Body fluid by Culture |
|
41599-2
|
Bacteria [Presence] in Body fluid by Light microscopy |
|
6459-2
|
Bacteria identified in Food by Culture |
|
52967-7
|
Bacteria identified in Gastric fluid by Culture |
|
10352-3
|
Bacteria identified in Genital specimen by Aerobe culture |
|
91865-6
|
Bacteria identified in Genital specimen by Anaerobe culture |
|
12178-0
|
Bacteria [Presence] in Genital specimen by Wet preparation |
|
87931-2
|
Bacteria identified in Implanted device by Aerobe culture |
|
87938-7
|
Bacteria identified in Implanted device by Anaerobe culture |
|
42803-7
|
Bacteria identified in Isolate |
|
32367-5
|
Bacteria identified in Isolate by Aerobe culture |
|
20878-5
|
Bacteria identified in Isolate by Anaerobe culture |
|
20877-7
|
Bacteria identified in Isolate by Animal inoculation |
|
43409-2
|
Bacteria identified in Isolate by Culture |
|
75756-7
|
Bacteria identified in Isolate by MS.MALDI-TOF |
|
42661-9
|
Bacteria identified in Isolate by Pulsed-Field Gel Electrophoresis (PFGE) |
|
612-2
|
Bacterial strain [Type] in Isolate by Bacteria subtyping |
|
616-3
|
Bacteria identified in Line specimen by IV Line culture |
|
20693-8
|
Bacteria identified in Litter by Aerobe culture |
|
89643-1
|
Bacteria identified in Lower respiratory specimen by Aerobe culture |
|
89644-9
|
Bacteria identified in Lower respiratory specimen by Anaerobe culture |
|
79425-5
|
Bacteria identified in Lower respiratory specimen by Cystic fibrosis respiratory culture |
|
19126-2
|
Bacteria identified in Bone marrow by Aerobe culture |
|
60258-1
|
Bacteria identified in Bone marrow by Culture |
|
20879-3
|
Bacteria identified in Milk by Aerobe culture |
|
91866-4
|
Bacteria identified in Mouth by Aerobe culture |
|
10353-1
|
Bacteria identified in Nose by Aerobe culture |
|
18192-5
|
Bacteria [Presence] in Nose by Light microscopy |
|
43426-6
|
Bacteria identified in Nasopharynx by Aerobe culture |
|
43214-6
|
Bacteria identified in Nasopharynx by Culture |
|
88141-7
|
Bacteria identified in Ocular fluid by Aerobe culture |
|
88139-1
|
Bacteria identified in Ocular fluid by Anaerobe culture |
|
90271-8
|
Bacteria identified in Pericardial fluid by Aerobe culture |
|
87939-5
|
Bacteria identified in Pericardial fluid by Anaerobe culture |
|
56715-6
|
Bacteria identified in Pericardial fluid by Culture |
|
41598-4
|
Bacteria [Presence] in Pericardial fluid by Light microscopy |
|
14478-2
|
Bacteria identified in Penis by Aerobe culture |
|
617-1
|
Bacteria identified in Placenta by Aerobe culture |
|
87941-1
|
Bacteria identified in Placenta by Anaerobe culture |
|
17279-1
|
Bacteria identified in Pleural fluid by Aerobe culture |
|
87942-9
|
Bacteria identified in Pleural fluid by Anaerobe culture |
|
618-9
|
Bacteria identified in Pleural fluid by Culture |
|
41603-2
|
Bacteria [Presence] in Pleural fluid by Light microscopy |
|
91063-8
|
Bacteria identified in Platelets from Blood product unit by Aerobe culture |
|
91062-0
|
Bacteria identified in Platelets from Blood product unit by Anaerobe culture |
|
72340-3
|
Bacteria [Presence] in Prostatic fluid by Light microscopy |
|
90281-7
|
Bacteria identified in Peritoneal fluid by Aerobe culture |
|
87940-3
|
Bacteria identified in Peritoneal fluid by Anaerobe culture |
|
619-7
|
Bacteria identified in Peritoneal fluid by Culture |
|
41601-6
|
Bacteria [Presence] in Peritoneal fluid by Light microscopy |
|
17915-0
|
Bacteria identified in Wound shallow by Aerobe culture |
|
87932-0
|
Bacteria identified in Sinus by Aerobe culture |
|
87943-7
|
Bacteria identified in Sinus by Anaerobe culture |
|
43307-8
|
Bacteria identified in Sinus by Culture |
|
620-5
|
Bacteria identified in Skin by Aerobe culture |
|
13314-0
|
Bacteria identified in Semen |
|
90279-1
|
Bacteria identified in Semen by Aerobe culture |
|
90276-7
|
Bacteria identified in Semen by Anaerobe culture |
|
53558-3
|
Bacteria identified in Semen by Culture |
|
90278-3
|
Bacteria identified in Synovial fluid by Aerobe culture |
|
87944-5
|
Bacteria identified in Synovial fluid by Anaerobe culture |
|
621-3
|
Bacteria identified in Synovial fluid by Culture |
|
41600-8
|
Bacteria [Presence] in Synovial fluid by Light microscopy |
|
622-1
|
Bacteria identified in Sputum by Aerobe culture |
|
19127-0
|
Bacteria identified in Sputum by Acute Respiratoy Distress (ARDS) culture |
|
623-9
|
Bacteria identified in Sputum by Cystic fibrosis respiratory culture |
|
6460-0
|
Bacteria identified in Sputum by Culture |
|
624-7
|
Bacteria identified in Sputum by Respiratory culture |
|
52973-5
|
Bacteria identified in Sputum tracheal aspirate by Culture |
|
6461-8
|
Bacteria identified in Stool by Anaerobe culture |
|
625-4
|
Bacteria identified in Stool by Culture |
|
17898-8
|
Bacteria identified in Throat by Aerobe culture |
|
626-2
|
Bacteria identified in Throat by Culture |
|
627-0
|
Bacteria identified in Tissue by Aerobe culture |
|
628-8
|
Bacteria identified in Tissue by Anaerobe culture |
|
20474-3
|
Bacteria identified in Tissue by Biopsy culture |
|
43408-4
|
Bacteria identified in Tissue by Culture |
|
58940-8
|
Bacteria identified in Total parental nutrition by Culture |
|
91819-3
|
Bacteria identified in Upper respiratory specimen by Aerobe culture |
|
91818-5
|
Bacteria identified in Upper respiratory specimen by Anaerobe culture |
|
630-4
|
Bacteria identified in Urine by Culture |
|
87829-8
|
Bacteria [Presence] in Urine |
|
14477-4
|
Bacteria identified in Urethra by Aerobe culture |
|
10354-9
|
Bacteria identified in Urethra by Culture |
|
631-2
|
Bacteria identified in Unknown substance by Aerobe culture |
|
77193-1
|
Bacteria identified in Uterus by Culture |
|
11261-5
|
Bacteria identified in Vaginal fluid by Aerobe culture |
|
44023-0
|
Bacteria [Presence] in Vaginal fluid by Wet preparation |
|
44243-4
|
Bacteria [#/area] in Vaginal fluid by Wet preparation |
|
74356-7
|
Bacteria identified in Ventriculoperitoneal (VP) shunt by Culture |
|
14093-9
|
Bacteria identified in Water by Culture |
|
632-0
|
Bacteria identified in Wound by Aerobe culture |
|
633-8
|
Bacteria identified in Wound by Anaerobe culture |
|
6462-6
|
Bacteria identified in Wound by Culture |
|
23667-9
|
Bacteria identified in Unspecified specimen |
|
634-6
|
Bacteria identified in Unspecified specimen by Aerobe culture |
|
635-3
|
Bacteria identified in Unspecified specimen by Anaerobe culture |
|
21020-3
|
Bacteria identified in Unspecified specimen by Anaerobe+Aerobe culture |
|
636-1
|
Bacteria identified in Unspecified specimen by Sterile body fluid culture |
|
6463-4
|
Bacteria identified in Unspecified specimen by Culture |
|
14325-5
|
Bacteria identified in Unspecified specimen by Environmental culture |
|
44038-8
|
Bacteria [Presence] in Unspecified specimen |
|
32763-5
|
Bacteria [Presence] in Unspecified specimen by Wet preparation |
|
32355-0
|
Bacteria identified in Unspecified specimen by Respiratory culture |
|
73834-4
|
Bacteria.carbapenem resistant identified in Anal by Organism specific culture |
|
73835-1
|
Bacteria.extended spectrum beta lactamase resistant identified in Anal by Organism specific culture |
|
73836-9
|
Bacteria.fluoroquinolone resistant identified in Anal by Organism specific culture |
|
43131-2
|
Bacterial Ag panel - Cerebral spinal fluid |
|
43434-0
|
Bacterial Ag panel - Serum |
|
43443-1
|
Bacterial Ag panel - Urine |
|
94057-7
|
Bacterial ahpC gene drug resistance mutation [Identifier] by Molecular method |
|
94065-0
|
Bacterial rpoB gene drug resistance mutation [Identifier] by Molecular method |
|
66885-5
|
Bacterial 16S rRNA sequencing [Identifier] in Unspecified specimen |
|
41477-1
|
Bacterial sialidase [Presence] in Unspecified specimen |
|
91895-3
|
Bacterial strain [Type] in Isolate by Sequencing |
|
92894-5
|
Microbiology - bacterial studies |
|
29576-6
|
Bacterial susceptibility panel |
|
49589-5
|
Bacterial susceptibility panel by Gradient strip |
|
50546-1
|
Bacterial susceptibility panel by Disk diffusion (KB) |
|
50545-3
|
Bacterial susceptibility panel by Minimum inhibitory concentration (MIC) |
|
87927-0
|
Bacterial susceptibility panel - Isolate by Minimum lethal concentration (MLC) |
|
90246-0
|
Bacterial whole genome [Nucleotide sequence] in Isolate by Sequencing |
|
20675-5
|
Bovine adenovirus 3 Ag [Presence] in Tissue by Immunofluorescence |
|
20676-3
|
Bovine adenovirus 5 Ag [Presence] in Tissue by Immunofluorescence |
|
90418-5
|
BAFF-R cells/100 CD19 cells in Blood |
|
7111-8
|
Bahia grass triggered histamine release [Units/volume] in Blood |
|
6034-3
|
Bahia grass IgE Ab [Units/volume] in Serum |
|
50354-0
|
Bahia grass IgE Ab/IgE total in Serum |
|
13181-3
|
Bahia grass IgG Ab [Units/volume] in Serum |
|
56185-2
|
Bahia grass IgG4 Ab [Mass/volume] in Serum |
|
63156-4
|
Bahia grass IgG Ab [Mass/volume] in Serum |
|
53064-2
|
Beta aminoisobutyrate [Moles/volume] in DBS |
|
53463-6
|
Beta aminoisobutyrate [Moles/volume] in Body fluid |
|
56673-7
|
Beta aminoisobutyrate/Creatinine [Ratio] in 24 hour Urine |
|
53024-6
|
Baker's yeast Ab [Presence] in Serum |
|
56785-9
|
Baker's yeast Ab [Units/volume] in Serum |
|
68936-4
|
Baker's yeast Ab [Units/volume] in Serum by Immunoassay |
|
56761-0
|
Baker's yeast Ab [Titer] in Serum by Immunofluorescence |
|
7784-2
|
Baker's yeast triggered histamine release [Units/volume] in Blood |
|
63330-5
|
Baker's yeast IgA Ab [Units/volume] in Body fluid by Immunoassay |
|
57415-2
|
Baker's yeast IgA Ab [Presence] in Serum by Immunoassay |
|
63331-3
|
Baker's yeast IgA Ab [Presence] in Serum by Immunofluorescence |
|
31032-6
|
Baker's yeast IgA Ab [Units/volume] in Serum |
|
47320-7
|
Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay |
|
43189-0
|
Baker's yeast IgA Ab [Titer] in Serum |
|
6287-7
|
Baker's yeast IgE Ab [Units/volume] in Serum |
|
41202-3
|
Baker's yeast IgE Ab/IgE total in Serum |
|
63332-1
|
Baker's yeast IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
81421-0
|
Baker's yeast IgG Ab [Presence] in Serum by Immunoassay |
|
63333-9
|
Baker's yeast IgG Ab [Presence] in Serum by Immunofluorescence |
|
6713-2
|
Baker's yeast IgG Ab [Units/volume] in Serum |
|
47321-5
|
Baker's yeast IgG Ab [Units/volume] in Serum by Immunoassay |
|
56449-2
|
Baker's yeast IgG4 Ab [Mass/volume] in Serum |
|
35538-8
|
Baker's yeast IgG Ab [Mass/volume] in Serum |
|
48208-3
|
Baker's yeast triggered leukotriene release [Mass/volume] by Leukocytes |
|
79603-7
|
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Cerebral spinal fluid |
|
79650-8
|
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Serum or Plasma |
|
79584-9
|
Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Urine |
|
53063-4
|
Beta alanine [Moles/volume] in DBS |
|
53068-3
|
Beta alanine [Moles/volume] in Body fluid |
|
56674-5
|
Beta alanine/Creatinine [Ratio] in 24 hour Urine |
|
7272-8
|
Bald Cypress IgE Ab [Units/volume] in Serum |
|
93741-7
|
Balm IgE Ab [Units/volume] in Serum |
|
50634-5
|
Balsam poplar IgE Ab [Units/volume] in Serum |
|
87602-9
|
Bambermycins [Mass/mass] in Unspecified specimen |
|
10920-7
|
Bamboo shoot IgE Ab [Units/volume] in Serum |
|
7113-4
|
Banana triggered histamine release [Units/volume] in Blood |
|
6035-0
|
Banana IgE Ab [Units/volume] in Serum |
|
61287-9
|
Banana IgE Ab/IgE total in Serum |
|
7112-6
|
Banana IgG Ab [Units/volume] in Serum |
|
56186-0
|
Banana IgG4 Ab [Mass/volume] in Serum |
|
60352-2
|
Banana IgG Ab [Mass/volume] in Serum |
|
26652-8
|
Banzi virus Ab [Presence] in Serum |
|
38628-4
|
Benzo alpha pyrene [Mass/volume] in Air |
|
78804-2
|
Barbital [Mass/volume] in Blood |
|
79225-9
|
Barbital [Mass/volume] in Body fluid |
|
52950-3
|
Barbital [Presence] in Gastric fluid |
|
78803-4
|
Barbital [Mass/mass] in Hair |
|
14623-3
|
Barbital [Presence] in Serum or Plasma |
|
3370-4
|
Barbital [Mass/volume] in Serum or Plasma |
|
32050-7
|
Barbital [Moles/volume] in Serum or Plasma |
|
12495-8
|
Barbital [Presence] in Stool |
|
20518-7
|
Barbital [Mass/volume] in Urine by Confirmatory method |
|
12360-4
|
Barbital [Presence] in Urine |
|
19354-0
|
Barbital [Presence] in Urine by Confirmatory method |
|
19353-2
|
Barbital [Presence] in Urine by Screen method |
|
3371-2
|
Barbital [Mass/volume] in Urine |
|
32051-5
|
Barbital [Presence] in Unspecified specimen |
|
42582-7
|
Barbiturates [Mass/volume] in Blood by Confirmatory method |
|
91028-1
|
Barbiturates [Presence] in Body fluid by Screen method |
|
14624-1
|
Barbiturates [Presence] in Gastric fluid |
|
9427-6
|
Barbiturates [Mass/volume] in Gastric fluid |
|
40413-7
|
Barbiturates [Presence] in Hair |
|
91047-1
|
Barbiturates [Presence] in Hair by Screen method |
|
11092-4
|
Barbiturates [Mass/mass] in Hair |
|
40412-9
|
Barbiturates [Presence] in Meconium |
|
38439-6
|
Barbiturates [Presence] in Meconium by Confirmatory method |
|
34578-5
|
Barbiturates [Presence] in Meconium by Screen method |
|
11022-1
|
Barbiturates [Mass/volume] in Meconium |
|
29161-7
|
Barbiturates [Mass/mass] in Meconium |
|
72480-7
|
Barbiturates panel - Blood by Confirmatory method |
|
73663-7
|
Barbiturates panel - Saliva (oral fluid) by Confirmatory method |
|
53746-4
|
Barbiturates panel - Urine |
|
72451-8
|
Barbiturates [Presence] in Saliva (oral fluid) by Confirmatory method |
|
72627-3
|
Barbiturates [Presence] in Saliva (oral fluid) by Screen method |
|
74168-6
|
Barbiturates [Mass/volume] in Saliva (oral fluid) by Screen method |
|
20421-4
|
Barbiturates [Presence] in Serum or Plasma by Screen method |
|
30249-7
|
Barbiturates [Mass/volume] in Serum or Plasma by Screen method |
|
3376-1
|
Barbiturates [Presence] in Serum, Plasma or Blood |
|
10338-2
|
Barbiturates [Mass/volume] in Serum or Plasma |
|
15100-1
|
Barbiturates [Moles/volume] in Serum or Plasma |
|
12358-8
|
Barbiturates [Presence] in Stool |
|
20411-5
|
Barbiturates [Mass/volume] in Urine by Confirmatory method |
|
3377-9
|
Barbiturates [Presence] in Urine |
|
16429-3
|
Barbiturates [Presence] in Urine by Confirmatory method |
|
19270-8
|
Barbiturates [Presence] in Urine by Screen method |
|
70155-7
|
Barbiturates [Presence] in Urine by Screen method >200 ng/mL |
|
70139-1
|
Barbiturates [Presence] in Urine by Screen method >300 ng/mL |
|
20664-9
|
Barbiturates [Mass/volume] in Urine by Screen method |
|
16430-1
|
Barbiturates [Units/volume] in Urine |
|
9426-8
|
Barbiturates [Mass/volume] in Urine |
|
52956-0
|
Barbiturates [Moles/volume] in Urine |
|
27224-5
|
Barbiturates [Presence] in Vitreous fluid |
|
10363-0
|
Barbiturates [Presence] in Unspecified specimen |
|
61067-5
|
Barbiturates [Presence] in Unspecified specimen by Screen method |
|
43827-5
|
Barbiturates [Mass/volume] in Unspecified specimen |
|
41468-0
|
Barbiturates/Creatinine [Mass Ratio] in Urine |
|
85517-1
|
Bariatric surgery Consult note |
|
85514-8
|
Bariatric surgery Discharge summary |
|
85522-1
|
Bariatric surgery Initial evaluation note |
|
85516-3
|
Bariatric surgery Note |
|
85515-5
|
Bariatric surgery Progress note |
|
43901-8
|
Barium [Presence] in 24 hour Urine |
|
29985-9
|
Barium [Mass/volume] in 24 hour Urine |
|
18194-1
|
Barium [Mass/time] in 24 hour Urine |
|
50819-2
|
Barium [Moles/time] in 24 hour Urine |
|
38571-6
|
Barium [Mass/volume] in Air |
|
16432-7
|
Barium [Mass/volume] in Blood |
|
78890-1
|
Barium [Moles/volume] in Blood |
|
51192-3
|
Barium [Mass/volume] in Body fluid |
|
80209-0
|
Barium [Moles/volume] in Body fluid |
|
76653-5
|
Barium [Mass/mass] in Hair |
|
50818-4
|
Barium [Moles/mass] in Hair |
|
5588-9
|
Barium [Presence] in Serum or Plasma |
|
5589-7
|
Barium [Mass/volume] in Serum or Plasma |
|
78807-5
|
Barium [Moles/volume] in Serum or Plasma |
|
78805-9
|
Barium [Moles/mass] in Tissue |
|
16431-9
|
Barium [Presence] in Urine |
|
5590-5
|
Barium [Mass/volume] in Urine |
|
72924-4
|
Barium [Moles/volume] in Urine |
|
87619-3
|
Barium [Mass/mass] in Unspecified specimen |
|
29986-7
|
Barium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52937-0
|
Barium/Creatinine [Molar ratio] in 24 hour Urine |
|
13826-3
|
Barium/Creatinine [Mass Ratio] in Urine |
|
52938-8
|
Barium/Creatinine [Molar ratio] in Urine |
|
7115-9
|
Barley triggered histamine release [Units/volume] in Blood |
|
6037-6
|
Barley IgE Ab [Units/volume] in Serum |
|
61273-9
|
Barley IgE Ab/IgE total in Serum |
|
7114-2
|
Barley IgG Ab [Units/volume] in Serum |
|
56187-8
|
Barley IgG4 Ab [Mass/volume] in Serum |
|
51917-3
|
Barley IgG Ab [Mass/volume] in Serum |
|
48221-6
|
Barley triggered leukotriene release [Mass/volume] by Leukocytes |
|
7116-7
|
Barley Pollen IgE Ab [Units/volume] in Serum |
|
46721-7
|
Barley smut IgE Ab [Units/volume] in Serum |
|
14104-4
|
Barley smut+Wheat smut IgE Ab [Units/volume] in Serum |
|
75371-5
|
Bartlett score of Sputum Qualitative by Light microscopy |
|
43866-3
|
Bartonella sp Ab [Presence] in Serum |
|
13325-6
|
Bartonella sp identified in Blood by Light microscopy |
|
91862-3
|
Bartonella sp DNA [Presence] in Aspirate by NAA with probe detection |
|
16275-0
|
Bartonella sp DNA [Presence] in Blood by NAA with probe detection |
|
89647-2
|
Bartonella sp DNA [Presence] in Implanted device by NAA with probe detection |
|
89593-8
|
Bartonella sp DNA [Presence] in Tissue by NAA with probe detection |
|
48864-3
|
Bartonella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44443-0
|
Bartonella sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
43920-8
|
Bartonella sp IgG Ab [Presence] in Serum |
|
46158-2
|
Bartonella sp IgG Ab [Units/volume] in Serum |
|
43425-8
|
Bartonella sp IgG Ab [Titer] in Cerebral spinal fluid |
|
44444-8
|
Bartonella sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
43921-6
|
Bartonella sp IgM Ab [Presence] in Serum |
|
46159-0
|
Bartonella sp IgM Ab [Units/volume] in Serum |
|
43424-1
|
Bartonella sp IgM Ab [Titer] in Cerebral spinal fluid |
|
38354-7
|
Bartonella sp identified in Unspecified specimen by Organism specific culture |
|
49123-3
|
Bartonella sp identified in Unspecified specimen by Sequencing |
|
24320-4
|
Basic metabolic 1998 panel - Serum or Plasma |
|
24321-2
|
Basic metabolic 2000 panel - Serum or Plasma |
|
70219-1
|
Basic metabolic 2008 panel with ionized calcium - Serum or Plasma |
|
51990-0
|
Basic metabolic panel - Blood |
|
50820-0
|
Base excess in Capillary blood from Fetus by calculation |
|
60840-6
|
Base excess in Extracellular fluid by calculation |
|
53085-7
|
Base excess in Nonbiological fluid by calculation |
|
89044-2
|
Basic metabolic and albumin panel - Serum or Plasma |
|
7118-3
|
Basil IgE Ab [Units/volume] in Serum |
|
61288-7
|
Basil IgE Ab/IgE total in Serum |
|
7119-1
|
Basil IgG Ab [Units/volume] in Serum |
|
56188-6
|
Basil IgG4 Ab [Mass/volume] in Serum |
|
63124-2
|
Basil IgG Ab [Mass/volume] in Serum |
|
66142-1
|
Basophils [#/volume] in Blood from Fetus by Manual count |
|
68393-8
|
Basophils [#/volume] in Pericardial fluid by Manual count |
|
68394-6
|
Basophils [#/volume] in Pleural fluid by Manual count |
|
68392-0
|
Basophils [#/volume] in Peritoneal fluid by Manual count |
|
68395-3
|
Basophils [#/volume] in Synovial fluid by Manual count |
|
68397-9
|
Basophils [#/volume] in Vitreous fluid by Manual count |
|
44048-7
|
Basophils [Presence] in Nose by Light microscopy |
|
53516-1
|
Basophils/100 leukocytes in Dialysis fluid by Manual count |
|
68396-1
|
Basophils/100 leukocytes in Vitreous fluid by Manual count |
|
7120-9
|
Bass, Black IgE Ab [Units/volume] in Serum |
|
61285-3
|
Bass, Black IgE Ab/IgE total in Serum |
|
56192-8
|
Bass, Black IgG4 Ab [Mass/volume] in Serum |
|
63142-4
|
Bass, Black IgG Ab [Mass/volume] in Serum |
|
7121-7
|
Bassiai IgE Ab [Units/volume] in Serum |
|
7122-5
|
Basswood IgE Ab [Units/volume] in Serum |
|
7123-3
|
Bayberry IgE Ab [Units/volume] in Serum |
|
7124-1
|
Bayberry Pollen IgE Ab [Units/volume] in Serum |
|
7125-8
|
Bayleaf IgE Ab [Units/volume] in Serum |
|
7126-6
|
Bayleaf IgG Ab [Units/volume] in Serum |
|
56189-4
|
Bayleaf IgG4 Ab [Mass/volume] in Serum |
|
63128-3
|
Bayleaf IgG Ab [Mass/volume] in Serum |
|
74843-4
|
Baylisascaris sp IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
74844-2
|
Baylisascaris sp IgG Ab [Presence] in Serum by Immunoassay |
|
87484-2
|
BB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
41743-6
|
BBS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81822-9
|
BBS10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48598-7
|
BBS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53632-6
|
Breast Cancer Ag 225 [Presence] in Tissue by Immune stain |
|
49460-9
|
Beta catenin Ag [Presence] in Tissue by Immune stain |
|
38664-9
|
Bis(2-Chloroethyl) ether [Mass/volume] in Air |
|
80717-2
|
B-cell CD27 and IgD subsets panel - Blood |
|
90414-4
|
B-cell phenotyping panel - Blood |
|
90415-1
|
B-cell TACI and BAFF-R subsets panel - Blood |
|
79571-6
|
BCHE gene full mutation analysis in Blood or Tissue by Sequencing |
|
56883-2
|
BCHE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
33359-1
|
Branched chain keto-acid dehydrogenase complex [Identifier] in Blood |
|
38479-2
|
Branched chain keto-acid dehydrogenase complex [Presence] in DBS |
|
81842-7
|
BCKDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53633-4
|
BCL1 Ag [Presence] in Tissue by Immune stain |
|
50307-8
|
BCL10 Ag [Presence] in Tissue by Immune stain |
|
33054-8
|
BCL2 Ag [Presence] in Tissue by Immune stain |
|
21095-5
|
BCL2 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
78218-5
|
BCL2 gene rearrangements [Presence] in Blood or Tissue by FISH |
|
47009-6
|
BCL6 Ag [Presence] in Tissue by Immune stain |
|
21746-3
|
BCL6 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
78203-7
|
BCL6 gene rearrangements [Presence] in Blood or Tissue by FISH |
|
38637-5
|
Bis(Chloromethyl) Ether [Mass/volume] in Air |
|
73878-1
|
Beta cortolone [Moles/volume] in 24 hour Urine |
|
73877-3
|
Beta cortolone [Moles/time] in 24 hour Urine |
|
73876-5
|
Beta cortolone [Moles/volume] in Urine |
|
50336-7
|
Beta cortolone/Cortisol [Mass Ratio] in Urine |
|
44450-5
|
Beta cortolone/Creatinine [Mass Ratio] in Urine |
|
81803-9
|
Beta cortolone/Creatinine [Molar ratio] in Urine |
|
85502-3
|
Carbapenemase resistance genes panel by Molecular genetics method |
|
55135-8
|
BCR-ABL1 kinase domain mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49491-4
|
BCR-ABL1 b3a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
|
47397-5
|
BCS1L gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
20779-5
|
Bovine coronavirus Ag [Presence] in Tissue by Immunofluorescence |
|
35095-9
|
Body temperature panel |
|
75539-7
|
Body temperature - Temporal artery |
|
13512-9
|
Microscopic observation [Identifier] in Bone marrow by Butyrate esterase stain |
|
10778-9
|
Microscopic observation [Identifier] in Tissue by Butyrate esterase stain |
|
7139-9
|
Bean string IgG Ab [Units/volume] in Serum |
|
26662-7
|
Bebaru virus Ab [Presence] in Serum |
|
89211-7
|
Beck Depression Inventory Fast Screen [BDI] |
|
89208-3
|
Beck Depression Inventory Fast Screen total score [BDI] |
|
89210-9
|
Beck Depression Inventory II [BDI] |
|
89209-1
|
Beck Depression Inventory II total score [BDI] |
|
41744-4
|
Beclomethasone dipropionate [Mass/volume] in Serum or Plasma |
|
46945-2
|
Beclomethasone dipropionate [Mass/volume] in Urine |
|
92203-9
|
Bed category panel Facility |
|
75917-5
|
Bed state Infant microenvironment.incubator |
|
80409-6
|
Bed type |
|
75916-7
|
Bed type Infant microenvironment |
|
92204-7
|
Bed type panel Facility |
|
88704-2
|
Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteria |
|
80637-2
|
Bedaquiline [Mass/volume] in Serum or Plasma |
|
7143-1
|
Beef triggered histamine release [Units/volume] in Blood |
|
6039-2
|
Beef IgE Ab [Units/volume] in Serum |
|
61331-5
|
Beef IgE Ab/IgE total in Serum |
|
6714-0
|
Beef IgG Ab [Units/volume] in Serum |
|
56438-5
|
Beef IgG4 Ab [Mass/volume] in Serum |
|
35529-7
|
Beef IgG Ab [Mass/volume] in Serum |
|
48211-7
|
Beef triggered leukotriene release [Mass/volume] by Leukocytes |
|
19728-5
|
Beet IgE Ab [Units/volume] in Serum |
|
7145-6
|
Beet IgG Ab [Units/volume] in Serum |
|
42584-3
|
Beet IgG Ab [Mass/volume] in Serum |
|
46001-4
|
Behavioral symptoms Set |
|
7586-1
|
Bell Pepper IgE Ab [Units/volume] in Serum |
|
7587-9
|
Bell Pepper IgG Ab [Units/volume] in Serum |
|
73506-8
|
Benazepril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73507-6
|
Benazepril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9684-2
|
Bendiocarb [Mass/volume] in Serum or Plasma |
|
42585-0
|
Bendiocarb [Presence] in Urine |
|
21107-8
|
Bendiocarb [Mass/volume] in Urine |
|
43922-4
|
Beta endorphin [Presence] in Serum or Plasma |
|
1937-2
|
Beta endorphin [Mass/volume] in Serum or Plasma |
|
41019-1
|
Beta endorphin [Moles/volume] in Serum or Plasma |
|
3380-3
|
Bendroflumethiazide [Mass/time] in 24 hour Urine |
|
3378-7
|
Bendroflumethiazide [Presence] in Urine |
|
16437-6
|
Bendroflumethiazide [Units/volume] in Urine |
|
3379-5
|
Bendroflumethiazide [Mass/volume] in Urine |
|
78968-5
|
Benperidol [Mass/volume] in Serum or Plasma |
|
27012-4
|
Benzaldehyde [Presence] in Serum or Plasma |
|
16438-4
|
Benzaldehyde [Presence] in Urine |
|
38627-6
|
Benzene [Mass/volume] in Air |
|
16439-2
|
Benzene [Presence] in Blood |
|
9330-2
|
Benzene [Mass/volume] in Blood |
|
16440-0
|
Benzene ring IgE Ab [Units/volume] in Serum |
|
16441-8
|
Benzene ring IgG Ab [Units/volume] in Serum |
|
16442-6
|
Benzene ring IgM Ab [Units/volume] in Serum |
|
5591-3
|
Benzene [Presence] in Serum or Plasma |
|
5592-1
|
Benzene [Mass/volume] in Serum or Plasma |
|
43917-4
|
Benzene [Presence] in Urine |
|
9465-6
|
Benzene [Mass/volume] in Urine |
|
3384-5
|
Benzfetamine [Mass/time] in 24 hour Urine |
|
3381-1
|
Benzfetamine [Mass/volume] in Blood |
|
27004-1
|
Benzfetamine [Mass/mass] in Meconium |
|
26993-6
|
Benzfetamine [Mass/volume] in Milk |
|
29600-4
|
Benzfetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
26773-2
|
Benzfetamine [Mass/mass] in Stool |
|
3382-9
|
Benzfetamine [Presence] in Urine |
|
3383-7
|
Benzfetamine [Mass/volume] in Urine |
|
27346-6
|
Benzfetamine [Mass/volume] in Vitreous fluid |
|
38572-4
|
Benzidine [Mass/volume] in Air |
|
18321-0
|
Benzidine [Mass/volume] in Serum or Plasma |
|
10909-0
|
Benzidine [Mass/volume] in Urine |
|
1930-7
|
Benzoate [Mass/volume] in Serum or Plasma |
|
75065-3
|
Benzoate [Moles/volume] in Serum or Plasma |
|
13713-3
|
Benzoate/Creatinine [Mass Ratio] in Urine |
|
28587-4
|
Benzoate/Creatinine [Ratio] in Urine |
|
25090-2
|
Benzoate/Creatinine [Molar ratio] in Urine |
|
42586-8
|
Benzodiazepines [Mass/volume] in Blood by Confirmatory method |
|
42662-7
|
Benzodiazepines [Presence] in Blood |
|
79222-6
|
Benzodiazepines [Presence] in Body fluid by Screen method |
|
29209-4
|
Benzodiazepines [Mass/volume] in Body fluid |
|
12364-6
|
Benzodiazepines [Presence] in Gastric fluid |
|
33560-4
|
Benzodiazepines [Mass/volume] in Gastric fluid |
|
40415-2
|
Benzodiazepines [Presence] in Hair |
|
13933-7
|
Benzodiazepines [Mass/mass] in Hair |
|
40414-5
|
Benzodiazepines [Presence] in Meconium |
|
38441-2
|
Benzodiazepines [Presence] in Meconium by Confirmatory method |
|
31081-3
|
Benzodiazepines [Presence] in Meconium by Screen method |
|
11023-9
|
Benzodiazepines [Mass/volume] in Meconium |
|
29160-9
|
Benzodiazepines [Mass/mass] in Meconium |
|
42235-2
|
Benzodiazepine metabolites [Presence] in Urine by Screen method |
|
72616-6
|
Benzodiazepines [Presence] in Saliva (oral fluid) |
|
72456-7
|
Benzodiazepines [Presence] in Saliva (oral fluid) by Confirmatory method |
|
72633-1
|
Benzodiazepines [Presence] in Saliva (oral fluid) by Screen method |
|
72757-8
|
Benzodiazepines [Mass/volume] in Saliva (oral fluid) by Screen method |
|
46977-5
|
Benzodiazepines [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3389-4
|
Benzodiazepines [Presence] in Serum or Plasma |
|
46976-7
|
Benzodiazepines [Presence] in Serum or Plasma by Screen method |
|
78808-3
|
Benzodiazepines [Presence] in Serum or Plasma by Screen method >200 ng/mL |
|
30250-5
|
Benzodiazepines [Mass/volume] in Serum or Plasma by Screen method |
|
11024-7
|
Benzodiazepines [Mass/volume] in Serum or Plasma |
|
32052-3
|
Benzodiazepines [Moles/volume] in Serum or Plasma |
|
12359-6
|
Benzodiazepines [Presence] in Stool |
|
27063-7
|
Benzodiazepines [Mass/mass] in Stool |
|
91036-4
|
Benzodiazepines [Presence] in Tissue by Screen method |
|
20412-3
|
Benzodiazepines [Mass/volume] in Urine by Confirmatory method |
|
3390-2
|
Benzodiazepines [Presence] in Urine |
|
16195-0
|
Benzodiazepines [Presence] in Urine by Confirmatory method |
|
14316-4
|
Benzodiazepines [Presence] in Urine by Screen method |
|
70141-7
|
Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL |
|
70142-5
|
Benzodiazepines [Presence] in Urine by Screen method >300 ng/mL |
|
70140-9
|
Benzodiazepines [Mass/volume] in Urine by Screen method |
|
9428-4
|
Benzodiazepines [Mass/volume] in Urine |
|
52955-2
|
Benzodiazepines [Moles/volume] in Urine |
|
27197-3
|
Benzodiazepines [Presence] in Vitreous fluid |
|
48940-1
|
Benzodiazepines [Mass/volume] in Unspecified specimen by Confirmatory method |
|
43828-3
|
Benzodiazepines [Presence] in Unspecified specimen |
|
48941-9
|
Benzodiazepines [Mass/volume] in Unspecified specimen |
|
41467-2
|
Benzodiazepines/Creatinine [Mass Ratio] in Urine |
|
73662-9
|
Benzodiazepines panel - Saliva (oral fluid) by Screen method |
|
53745-6
|
Benzodiazepines panel - Urine |
|
90890-5
|
Benzodiazepines panel - Urine by Confirmatory method |
|
94117-9
|
Benzodiazepines panel [Presence] - Urine by Screen method |
|
16443-4
|
Benzonatate [Mass/volume] in Serum |
|
16444-2
|
Benzophenone [Mass/volume] in Serum or Plasma |
|
38633-4
|
Benzotrichloride [Mass/volume] in Air |
|
53613-6
|
Benzoylcarnitine (BzCn) [Moles/volume] in DBS |
|
43863-0
|
Benzthiazide [Presence] in 24 hour Urine |
|
3401-7
|
Benzthiazide [Mass/time] in 24 hour Urine |
|
16449-1
|
Benzthiazide [Mass/volume] in Serum or Plasma |
|
3399-3
|
Benzthiazide [Presence] in Urine |
|
3400-9
|
Benzthiazide [Mass/volume] in Urine |
|
59871-4
|
Benztropine [Moles/volume] in Gastric fluid |
|
73504-3
|
Benztropine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73505-0
|
Benztropine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
43857-2
|
Benztropine [Presence] in Serum or Plasma |
|
9384-9
|
Benztropine [Mass/volume] in Serum or Plasma |
|
59869-8
|
Benztropine [Moles/volume] in Serum or Plasma |
|
43265-8
|
Benztropine [Presence] in Urine |
|
9354-2
|
Benztropine [Mass/volume] in Urine |
|
59870-6
|
Benztropine [Moles/volume] in Urine |
|
60287-0
|
Benztropine [Moles/volume] in Unspecified specimen |
|
16328-7
|
Benzyl alcohol [Presence] in Blood |
|
12304-2
|
Benzyl alcohol [Presence] in Serum or Plasma |
|
38634-2
|
Benzyl chloride [Mass/volume] in Air |
|
16450-9
|
Benzylhydrazine [Mass/volume] in Serum or Plasma |
|
59285-7
|
Benzylpiperazine [Mass/volume] in Blood |
|
79137-6
|
Benzylpiperazine [Mass/volume] in Body fluid |
|
78809-1
|
Benzylpiperazine [Mass/mass] in Hair |
|
59286-5
|
Benzylpiperazine [Mass/volume] in Serum or Plasma |
|
59135-4
|
Benzylpiperazine [Mass/volume] in Urine by Confirmatory method |
|
64233-0
|
Benzylpiperazine [Presence] in Urine by Confirmatory method |
|
59287-3
|
Benzylpiperazine [Mass/volume] in Urine |
|
47010-4
|
Ber-EP4 Ag [Presence] in Tissue by Immune stain |
|
15339-5
|
Berlin Beetle IgE Ab [Units/volume] in Serum |
|
65775-9
|
Bermuda grass native (nCyn d) 1 IgE Ab [Units/volume] in Serum |
|
7354-4
|
Bermuda grass triggered histamine release [Units/volume] in Blood |
|
6041-8
|
Bermuda grass IgE Ab [Units/volume] in Serum |
|
61255-6
|
Bermuda grass IgE Ab/IgE total in Serum |
|
7353-6
|
Bermuda grass IgG Ab [Units/volume] in Serum |
|
56190-2
|
Bermuda grass IgG4 Ab [Mass/volume] in Serum |
|
63152-3
|
Bermuda grass IgG Ab [Mass/volume] in Serum |
|
48264-6
|
Bermuda grass triggered leukotriene release [Mass/volume] by Leukocytes |
|
7704-0
|
Bermuda grass smut IgE Ab [Units/volume] in Serum |
|
58034-0
|
Bermuda grass smut IgE Ab/IgE total in Serum |
|
7148-0
|
Berry IgE Ab [Units/volume] in Serum |
|
29927-1
|
Beryllium [Mass/volume] in 24 hour Urine |
|
5596-2
|
Beryllium [Mass/time] in 24 hour Urine |
|
50822-6
|
Beryllium [Moles/time] in 24 hour Urine |
|
38574-0
|
Beryllium [Mass/volume] in Air |
|
8159-6
|
Beryllium [Mass/volume] in Blood |
|
80210-8
|
Beryllium [Mass/volume] in Body fluid |
|
80211-6
|
Beryllium [Moles/volume] in Body fluid |
|
76654-3
|
Beryllium [Mass/mass] in Hair |
|
50823-4
|
Beryllium [Moles/mass] in Hair |
|
8160-4
|
Beryllium [Mass/volume] in Saliva (oral fluid) |
|
5593-9
|
Beryllium [Presence] in Serum or Plasma |
|
5594-7
|
Beryllium [Mass/volume] in Serum or Plasma |
|
52899-2
|
Beryllium [Moles/volume] in Serum or Plasma |
|
16178-6
|
Beryllium [Mass/mass] in Tissue |
|
78810-9
|
Beryllium [Moles/mass] in Tissue |
|
16451-7
|
Beryllium [Presence] in Urine |
|
5595-4
|
Beryllium [Mass/volume] in Urine |
|
50821-8
|
Beryllium [Moles/volume] in Urine |
|
43885-3
|
Beryllium [Presence] in Unspecified specimen |
|
29920-6
|
Beryllium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52936-2
|
Beryllium/Creatinine [Molar ratio] in 24 hour Urine |
|
13827-1
|
Beryllium/Creatinine [Mass Ratio] in Urine |
|
52935-4
|
Beryllium/Creatinine [Molar ratio] in Urine |
|
80213-2
|
Beta blockers [Presence] in Blood by Screen method |
|
80215-7
|
Beta blockers [Presence] in Body fluid by Screen method |
|
80212-4
|
Beta blockers [Presence] in Hair by Screen method |
|
80214-0
|
Beta blockers [Presence] in Serum or Plasma by Screen method |
|
12328-1
|
Beta blockers [Identifier] in Urine |
|
53634-2
|
Beta cortol [Mass/time] in 24 hour Urine |
|
53635-9
|
Beta cortol/Creatinine [Mass Ratio] in 24 hour Urine |
|
53636-7
|
Beta cortol/Creatinine [Mass Ratio] in Urine |
|
56042-5
|
Beta defensin [Mass/mass] in Stool.dried |
|
49554-9
|
Beta F1 Ag [Presence] in Tissue by Immune stain |
|
60849-7
|
Beta frequency relative power on EEG |
|
11038-7
|
Beta+gamma tocopherol [Mass/volume] in Serum or Plasma |
|
54353-8
|
Beta 1 globulin [Mass/volume] in Urine by Electrophoresis |
|
57837-7
|
Beta-1 transferrin [Presence] in Body fluid |
|
54354-6
|
Beta 2 globulin [Mass/volume] in Urine by Electrophoresis |
|
77347-3
|
Beta-2 transferrin panel - Serum or Plasma and CSF |
|
80638-0
|
Beta-amanitin [Mass/volume] in Urine |
|
41745-1
|
Betamethasone [Mass/volume] in Serum or Plasma |
|
46946-0
|
Betamethasone [Mass/volume] in Urine |
|
48493-1
|
Beta-trace protein [Mass/volume] in Cerebral spinal fluid |
|
72660-4
|
Beta-trace protein [Mass/volume] in Ear fluid |
|
57733-8
|
Beta-trace protein [Mass/volume] in Body fluid |
|
60224-3
|
Beta-trace protein [Mass/volume] in Nasal fluid |
|
48499-8
|
Beta-trace protein [Mass/volume] in Serum or Plasma |
|
81199-2
|
Beta-ureidopropionase [Enzymatic activity/mass] in Liver |
|
16458-2
|
Bethanechol [Mass/volume] in Serum or Plasma |
|
1938-0
|
Beta fructofuranosidase [Enzymatic activity/volume] in Red Blood Cells |
|
1939-8
|
Beta fructofuranosidase [Enzymatic activity/volume] in Serum |
|
46427-1
|
Beta fructofuranosidase [Enzymatic activity/mass] in Tissue |
|
10482-8
|
Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
|
26874-8
|
Follitropin.beta subunit [Mass/volume] in Serum or Plasma |
|
2289-7
|
Follitropin.beta subunit [Moles/volume] in Serum or Plasma |
|
81120-8
|
Barmah forest virus Ab [Titer] in Serum |
|
31247-0
|
Barmah forest virus IgG Ab [Presence] in Serum |
|
24121-6
|
Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay |
|
31248-8
|
Barmah forest virus IgM Ab [Presence] in Serum |
|
24118-2
|
Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay |
|
81688-4
|
Barmah forest virus RNA [Presence] in Blood by NAA with probe detection |
|
74124-9
|
Blood group 8 (BG8) Ag [Presence] in Tissue by Immune stain |
|
34192-5
|
Beta galactosidase [Presence] in Amniotic fluid cells |
|
38185-5
|
Beta galactosidase [Presence] in Blood |
|
16454-1
|
Beta galactosidase [Enzymatic activity/volume] in Blood |
|
55916-1
|
Beta galactosidase [Enzymatic activity/volume] in DBS |
|
24060-6
|
Beta galactosidase [Enzymatic activity/mass] in Fibroblast |
|
11178-1
|
Beta galactosidase IgE Ab [Units/volume] in Serum |
|
1940-6
|
Beta galactosidase [Enzymatic activity/volume] in Red Blood Cells |
|
1941-4
|
Beta galactosidase [Enzymatic activity/volume] in Serum or Plasma |
|
1942-2
|
Beta galactosidase [Enzymatic activity/mass] in Tissue |
|
30319-8
|
Beta galactosidase [Enzymatic activity/mass] in Small intestine Tissue |
|
33653-7
|
Beta galactosidase [Entitic Catalytic Activity] in Leukocytes |
|
12915-5
|
Beta galactosidase [Enzymatic activity/volume] in Leukocytes |
|
24061-4
|
Beta galactosidase [Enzymatic activity/mass] in Leukocytes |
|
43836-6
|
Beta globulin [Presence] in Serum or Plasma by Electrophoresis |
|
11209-4
|
Beta glucuronidase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
79457-8
|
Beta glucuronidase [Enzymatic activity/volume] in DBS |
|
24064-8
|
Beta glucuronidase [Enzymatic activity/mass] in Fibroblast |
|
13962-6
|
Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma |
|
14284-4
|
Beta glucuronidase [Moles/volume] in Serum or Plasma |
|
1944-8
|
Beta glucuronidase [Enzymatic activity/mass] in Tissue |
|
1945-5
|
Beta glucuronidase [Enzymatic activity/volume] in Urine |
|
24065-5
|
Beta glucuronidase [Enzymatic activity/mass] in Leukocytes |
|
34191-7
|
Beta glucuronidase [Enzymatic activity/volume] in Unspecified specimen |
|
56497-1
|
Choriogonadotropin.beta subunit [Units] in 24 hour Urine |
|
2113-9
|
Choriogonadotropin.beta subunit [Mass/time] in 24 hour Urine |
|
47024-5
|
Choriogonadotropin.beta subunit Ag [Presence] in Tissue by Immune stain |
|
19174-2
|
Choriogonadotropin.beta subunit [Units/volume] in Amniotic fluid |
|
19175-9
|
Choriogonadotropin.beta subunit [Moles/volume] in Amniotic fluid |
|
43800-2
|
Choriogonadotropin.beta subunit [Presence] in Cerebral spinal fluid |
|
14041-8
|
Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid |
|
29154-2
|
Choriogonadotropin.beta subunit [Units/volume] in Body fluid |
|
19178-3
|
Choriogonadotropin.beta subunit free [Units/volume] in Amniotic fluid |
|
19179-1
|
Choriogonadotropin.beta subunit free [Moles/volume] in Amniotic fluid |
|
55866-8
|
Choriogonadotropin.beta subunit free [Mass/volume] in Cerebral spinal fluid |
|
47601-0
|
Choriogonadotropin.beta subunit free [Units/volume] in Body fluid |
|
55867-6
|
Choriogonadotropin.beta subunit free [Mass/volume] in Body fluid |
|
19180-9
|
Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma |
|
25373-2
|
Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma |
|
2115-4
|
Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma |
|
55868-4
|
Choriogonadotropin.beta subunit [Multiple of the median] in Serum or Plasma |
|
66762-6
|
Choriogonadotropin.beta subunit [Units/volume] in Pleural fluid |
|
2110-5
|
Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma |
|
2112-1
|
Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine |
|
66763-4
|
Choriogonadotropin.beta subunit [Units/volume] in Peritoneal fluid |
|
20415-6
|
Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma by Immunoassay (EIA) 3rd IS |
|
21198-7
|
Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma |
|
55869-2
|
Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma |
|
2111-3
|
Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma |
|
2114-7
|
Choriogonadotropin.beta subunit [Moles/volume] in Urine |
|
43799-6
|
Choriogonadotropin.beta subunit [Presence] in Unspecified specimen |
|
44701-1
|
BHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
11267-2
|
Streptococcus.beta-hemolytic [Presence] in Genital specimen by Organism specific culture |
|
73666-0
|
Streptococcus.beta-hemolytic [Type] in Isolate by Latex agglutination |
|
546-2
|
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture |
|
547-0
|
Streptococcus.beta-hemolytic [Presence] in Unspecified specimen by Organism specific culture |
|
90080-3
|
Bictegravir [Susceptibility] by Genotype method |
|
20696-1
|
Bifidobacterium sp [#/volume] in Milk by Organism specific culture |
|
72693-5
|
Insulin-like growth factor-II.high molecular weight [Mass/volume] in Serum or Plasma |
|
74515-8
|
Bile acid [Moles/mass] in 24 hour Stool |
|
72679-4
|
Bile acid [Moles/time] in 24 hour Stool |
|
27931-5
|
Bile acid [Moles/volume] in Serum --2 hours post meal |
|
93336-6
|
Bile acid [Moles/time] in 48 hour Stool |
|
43888-7
|
Bile acid [Presence] in Bile fluid |
|
16464-0
|
Bile acid [Units/volume] in Exhaled gas |
|
1966-1
|
Bile acid [Mass/volume] in Exhaled gas |
|
34640-3
|
Bile acid [Mass/volume] in Body fluid |
|
50825-9
|
Bile acid [Moles/volume] in Body fluid |
|
35562-8
|
Bile acid [Moles/volume] in Serum --fasting |
|
43877-0
|
Bile acid [Presence] in Serum |
|
1967-9
|
Bile acid [Mass/volume] in Serum |
|
14628-2
|
Bile acid [Moles/volume] in Serum or Plasma |
|
72491-4
|
Bile acid [Moles/volume] in Stool |
|
43889-5
|
Bile acid [Presence] in Urine |
|
16465-7
|
Bile acid [Mass/volume] in Urine |
|
73722-1
|
Bile acid [Moles/volume] in Urine |
|
43130-4
|
Bile acid fractions panel [Moles/volume] - Serum or Plasma |
|
73725-4
|
Bile acid panel - 24 hour Stool |
|
93338-2
|
Bile acid panel - 48 hour Stool |
|
80163-9
|
Bile alcohols panel - Urine |
|
80162-1
|
Bile alcohols [Interpretation] in Urine Qualitative |
|
44034-7
|
Bile canalicular Ab [Presence] in Serum |
|
44016-4
|
Bile [Presence] in Body fluid |
|
1965-3
|
Bile [Presence] in Stool |
|
59166-9
|
Bilirubin.total [Moles/time] in 24 hour Stool |
|
44033-9
|
Bilirubin.total [Presence] in 24 hour Urine by Test strip |
|
13877-6
|
Bilirubin.total [Presence] in Amniotic fluid |
|
43887-9
|
Bilirubin.total [Presence] in Amniotic fluid by Spectrophotometry direct |
|
27198-1
|
Bilirubin.total [Units/volume] in Amniotic fluid by Spectrophotometry direct |
|
12476-8
|
Bilirubin.total [Mass/volume] in Amniotic fluid by Spectrophotometry direct |
|
1972-9
|
Bilirubin.total [Mass/volume] in Amniotic fluid |
|
72925-1
|
Bilirubin.total [Moles/volume] in Amniotic fluid |
|
59827-6
|
Bilirubin.total [Mass/volume] in Arterial blood |
|
89872-6
|
Bilirubin.total [Moles/volume] in Arterial blood |
|
48624-1
|
Bilirubin.total [Mass/volume] in Cord blood |
|
47994-9
|
Bilirubin.total [Moles/volume] in Cord blood |
|
42719-5
|
Bilirubin.total [Mass/volume] in Blood |
|
54363-7
|
Bilirubin.total [Moles/volume] in Blood |
|
59828-4
|
Bilirubin.total [Mass/volume] in Venous blood |
|
89871-8
|
Bilirubin.total [Moles/volume] in Venous blood |
|
1969-5
|
Bilirubin.total renal clearance in 24 hour Urine and Serum or Plasma |
|
53083-2
|
Bilirubin.conjugated [Moles/volume] in Dialysis fluid |
|
33458-1
|
Bilirubin.conjugated [Mass/volume] in Body fluid |
|
39462-7
|
Bilirubin.conjugated [Moles/volume] in Body fluid |
|
78441-3
|
Bilirubin.conjugated [Moles/volume] in Peritoneal fluid |
|
15152-2
|
Bilirubin.conjugated [Mass/volume] in Serum or Plasma |
|
29760-6
|
Bilirubin.conjugated [Moles/volume] in Serum or Plasma |
|
33898-8
|
Bilirubin.conjugated+indirect [Mass/volume] in Serum or Plasma |
|
33899-6
|
Bilirubin.conjugated+indirect [Moles/volume] in Serum or Plasma |
|
53415-6
|
Bilirubin.total [Presence] in Cerebral spinal fluid |
|
1973-7
|
Bilirubin.total [Mass/volume] in Cerebral spinal fluid |
|
74906-9
|
Bilirubin.total [Moles/volume] in Cerebral spinal fluid |
|
1970-3
|
Bilirubin.delta [Mass/volume] in Serum or Plasma |
|
22665-4
|
Bilirubin.delta [Moles/volume] in Serum or Plasma |
|
14420-4
|
Bilirubin.total [Mass/volume] in Dialysis fluid |
|
54362-9
|
Bilirubin.total [Moles/volume] in Dialysis fluid |
|
48623-3
|
Bilirubin.direct [Mass/volume] in Cord blood |
|
14152-3
|
Bilirubin.direct [Mass/volume] in Body fluid |
|
25564-6
|
Bilirubin.direct [Moles/volume] in Body fluid |
|
56905-3
|
Bilirubin.direct [Mass/volume] in Pleural fluid |
|
56906-1
|
Bilirubin.direct [Mass/volume] in Peritoneal fluid |
|
43820-0
|
Bilirubin.direct [Presence] in Serum or Plasma |
|
1968-7
|
Bilirubin.direct [Mass/volume] in Serum or Plasma |
|
35191-6
|
Bilirubin.direct [Mass or Moles/volume] in Serum or Plasma |
|
14629-0
|
Bilirubin.direct [Moles/volume] in Serum or Plasma |
|
43824-2
|
Bilirubin.total [Presence] in Body fluid |
|
1974-5
|
Bilirubin.total [Mass/volume] in Body fluid |
|
35193-2
|
Bilirubin.total [Mass or Moles/volume] in Body fluid |
|
29767-1
|
Bilirubin.total [Moles/volume] in Body fluid |
|
14424-6
|
Bilirubin.total [Mass/volume] in Gastric fluid |
|
64082-1
|
Bilirubin.indirect [Mass/volume] in Cord blood |
|
29210-2
|
Bilirubin.indirect [Mass/volume] in Body fluid |
|
39463-5
|
Bilirubin.indirect [Moles/volume] in Body fluid |
|
78442-1
|
Bilirubin.indirect [Moles/volume] in Peritoneal fluid |
|
1971-1
|
Bilirubin.indirect [Mass/volume] in Serum or Plasma |
|
35192-4
|
Bilirubin.indirect [Mass or Moles/volume] in Serum or Plasma |
|
14630-8
|
Bilirubin.indirect [Moles/volume] in Serum or Plasma |
|
74434-2
|
Bilirubin.total/Total in Stone by Infrared spectroscopy |
|
49763-6
|
Bilirubin.total [Mass/volume] in Pericardial fluid |
|
14421-2
|
Bilirubin.total [Mass/volume] in Pleural fluid |
|
77452-1
|
Bilirubin [Presence] in Peritoneal fluid |
|
14422-0
|
Bilirubin.total [Mass/volume] in Peritoneal fluid |
|
39461-9
|
Bilirubin.total [Moles/volume] in Peritoneal fluid |
|
77137-8
|
Bilirubin.total [Moles/volume] in Serum, Plasma or Blood |
|
1975-2
|
Bilirubin.total [Mass/volume] in Serum or Plasma |
|
35194-0
|
Bilirubin.total [Mass or Moles/volume] in Serum or Plasma |
|
14631-6
|
Bilirubin.total [Moles/volume] in Serum or Plasma |
|
58941-6
|
Bilirubin [Mass/volume] in Skin |
|
72898-0
|
Bilirubin [Moles/volume] in Skin |
|
14423-8
|
Bilirubin.total [Mass/volume] in Synovial fluid |
|
1976-0
|
Bilirubin.total [Presence] in Stool |
|
1977-8
|
Bilirubin.total [Presence] in Urine |
|
58450-8
|
Bilirubin [Presence] in Urine by Confirmatory method |
|
41016-7
|
Bilirubin.total [Moles/volume] in Urine by Test strip |
|
1978-6
|
Bilirubin.total [Mass/volume] in Urine |
|
70199-5
|
Bilirubin.total [Moles/volume] in Urine |
|
33870-7
|
Bilirubin.total [Presence] in Unspecified specimen |
|
32303-0
|
Bilirubin.total [Moles/volume] in Unspecified specimen |
|
34543-9
|
Bilirubin direct and total panel [Mass/volume] - Serum or Plasma |
|
75697-3
|
Bilirubin fractions panel [Moles/volume] - Serum or Plasma |
|
43428-2
|
Bilirubin.microscopic observation [Identifier] in Tissue by Hall's stain |
|
57087-9
|
Biotinidase newborn screening panel |
|
80440-1
|
Bioactive compound intake panel |
|
23669-5
|
Biochanin A [Mass/volume] in Serum or Plasma |
|
20697-9
|
Amines.biogenic [Mass/mass] in Feed |
|
1979-4
|
Biopterin [Mass/volume] in 24 hour Urine |
|
47581-4
|
Biopterin [Moles/volume] in Cerebral spinal fluid |
|
59247-7
|
Tetrahydrobiopterin [Moles/volume] in Cerebral spinal fluid |
|
75039-8
|
Biopterin [Moles/volume] in Serum or Plasma |
|
34170-1
|
Biopterin [Moles/volume] in Urine |
|
79282-0
|
Biopterin/Biopterin+Neopterin [Molar ratio] in Urine |
|
47582-2
|
Biopterin/Creatinine [Molar ratio] in Urine |
|
31997-0
|
Biotin [Presence] in Blood |
|
1980-2
|
Biotin [Mass/volume] in Serum or Plasma |
|
34398-8
|
Biotin [Moles/volume] in Serum or Plasma |
|
1981-0
|
Biotinidase [Presence] in Blood |
|
38478-4
|
Biotinidase [Presence] in DBS |
|
75217-0
|
Biotinidase [Enzymatic activity/volume] in DBS |
|
55153-1
|
Biotinidase panel - Serum or Plasma |
|
54457-7
|
Biotinidase [Enzymatic activity/volume] in Serum or Plasma from Normal control |
|
32619-9
|
Biotinidase [Presence] in Serum or Plasma |
|
1982-8
|
Biotinidase [Enzymatic activity/volume] in Serum or Plasma |
|
80370-0
|
Biotinidase [Enzymatic activity/mass] in Serum or Plasma |
|
75162-8
|
Biphasic positive airway pressure (BIPAP) activity Ventilator |
|
16322-0
|
Biperiden [Mass/volume] in Serum or Plasma |
|
38635-9
|
Biphenyl [Mass/volume] in Air |
|
94019-7
|
Bipolar screening report |
|
85103-0
|
Bipolar Spectrum Diagnostic Scale [BSDS] |
|
87286-1
|
Birth attendant [Extended Identifier] |
|
71230-7
|
Birth certificate |
|
87287-9
|
Birth certifier [Extended Identifier] |
|
77963-7
|
Birth defects diagnosis Narrative |
|
85580-9
|
Birth defects Hospital Registry report |
|
75609-8
|
Birth defects Outpatient Registry report |
|
87297-8
|
Birth registration date |
|
49515-0
|
Bisacodyl [Mass/volume] in Stool |
|
10889-4
|
Bisacodyl [Mass/mass] in Stool |
|
43912-5
|
Bisacodyl [Presence] in Urine |
|
27180-9
|
Bisacodyl [Mass/volume] in Urine |
|
43878-8
|
Bismuth [Presence] in 24 hour Urine |
|
21113-6
|
Bismuth [Mass/volume] in 24 hour Urine |
|
29918-0
|
Bismuth [Mass/time] in 24 hour Urine |
|
52887-7
|
Bismuth [Moles/time] in 24 hour Urine |
|
16467-3
|
Bismuth [Presence] in Blood |
|
8161-2
|
Bismuth [Mass/volume] in Blood |
|
81429-3
|
Bismuth [Moles/volume] in Blood |
|
9493-8
|
Bismuth [Mass/volume] in Body fluid |
|
60057-7
|
Bismuth [Mass/mass] in Hair |
|
50826-7
|
Bismuth [Moles/mass] in Hair |
|
60058-5
|
Bismuth [Mass/volume] in Red Blood Cells |
|
43894-5
|
Bismuth [Presence] in Serum or Plasma |
|
5597-0
|
Bismuth [Mass/volume] in Serum or Plasma |
|
25351-8
|
Bismuth [Moles/volume] in Serum or Plasma |
|
60059-3
|
Bismuth [Mass/mass] in Tissue |
|
16468-1
|
Bismuth [Presence] in Urine |
|
5598-8
|
Bismuth [Mass/volume] in Urine |
|
52898-4
|
Bismuth [Moles/volume] in Urine |
|
43886-1
|
Bismuth [Presence] in Unspecified specimen |
|
29940-4
|
Bismuth/Creatinine [Mass Ratio] in 24 hour Urine |
|
52906-5
|
Bismuth/Creatinine [Molar ratio] in 24 hour Urine |
|
16469-9
|
Bismuth/Creatinine [Mass Ratio] in Urine |
|
52907-3
|
Bismuth/Creatinine [Molar ratio] in Urine |
|
75918-3
|
Bispectral index Cerebral cortex Electroencephalogram (EEG) |
|
59288-1
|
Bisphenol A [Mass/volume] in Urine |
|
50714-5
|
Bitter dock IgE Ab [Units/volume] in Serum |
|
73503-5
|
Bivalirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73502-7
|
Bivalirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
31152-2
|
Immunoglobulin light chains [Presence] in 24 hour Urine |
|
17793-1
|
Immunoglobulin light chains [Mass/volume] in 24 hour Urine |
|
46084-0
|
Immunoglobulin light chains [Mass/time] in 24 hour Urine |
|
51406-7
|
Immunoglobulin light chains.free [Mass/time] in 24 hour Urine |
|
56125-8
|
Immunoglobulin light chains.free [Presence] in Serum |
|
55897-3
|
Immunoglobulin light chains.free [Presence] in Serum by Immunoelectrophoresis |
|
55898-1
|
Immunoglobulin light chains.free [Presence] in Serum by Immunofixation |
|
14977-3
|
Immunoglobulin light chains.free [Type] in Urine |
|
55899-9
|
Immunoglobulin light chains.free [Presence] in Urine by Electrophoresis |
|
55900-5
|
Immunoglobulin light chains.free [Presence] in Urine by Immunofixation |
|
11219-3
|
Immunoglobulin light chains [Presence] in Serum |
|
1928-1
|
Immunoglobulin light chains [Presence] in Urine |
|
1929-9
|
Immunoglobulin light chains [Mass/volume] in Urine |
|
79234-1
|
Butylone [Mass/volume] in Urine by Confirmatory method |
|
79243-2
|
Ethylone [Mass/volume] in Urine by Confirmatory method |
|
26645-2
|
BK virus Ab [Presence] in Serum |
|
49346-0
|
BK virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49345-2
|
BK virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49344-5
|
BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49343-7
|
BK virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
41479-7
|
BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49342-9
|
BK virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
41480-5
|
BK virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
48309-9
|
BK virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
63475-8
|
BK virus DNA [Presence] in Blood |
|
46970-0
|
BK virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
32284-2
|
BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
44805-0
|
BK virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
32362-6
|
BK virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
32285-9
|
BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection |
|
90924-2
|
BK virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
|
33978-8
|
BK virus DNA [Presence] in Urine by NAA with probe detection |
|
42587-6
|
BK virus DNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
43201-3
|
BK virus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
47251-4
|
BK virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
62466-8
|
BK virus IgG Ab [Presence] in Serum or Plasma |
|
72484-9
|
BK virus subtype in Blood by NAA with probe detection |
|
72483-1
|
BK virus subtype in Serum or Plasma by NAA with probe detection |
|
72482-3
|
BK virus subtype in Tissue by NAA with probe detection |
|
72412-0
|
BK virus subtype in Urine by NAA with probe detection |
|
72413-8
|
BK virus subtype in Unspecified specimen by NAA with probe detection |
|
90440-9
|
BK virus + JC virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
64967-3
|
Black Alder recombinant (rAln g) 1 IgE Ab [Units/volume] in Serum |
|
7083-9
|
Black Ant triggered histamine release [Units/volume] in Blood |
|
6044-2
|
Black Ant IgE Ab [Units/volume] in Serum |
|
7082-1
|
Black Ant IgG Ab [Units/volume] in Serum |
|
21077-3
|
Black Ash IgE Ab [Units/volume] in Serum |
|
21096-3
|
Black Bean IgE Ab [Units/volume] in Serum |
|
18417-6
|
Black Bean IgG Ab [Units/volume] in Serum |
|
7254-6
|
Black Cottonwood IgE Ab [Units/volume] in Serum |
|
15341-1
|
Black Fly IgE Ab [Units/volume] in Serum |
|
7086-2
|
Black Imported Fire Ant IgE Ab [Units/volume] in Serum |
|
7473-2
|
Black Locust IgE Ab [Units/volume] in Serum |
|
7528-3
|
Black Oak IgE Ab [Units/volume] in Serum |
|
7589-5
|
Black Pepper triggered histamine release [Units/volume] in Blood |
|
6045-9
|
Black Pepper IgE Ab [Units/volume] in Serum |
|
50364-9
|
Black Pepper IgE Ab/IgE total in Serum |
|
7588-7
|
Black Pepper IgG Ab [Units/volume] in Serum |
|
56450-0
|
Black Pepper IgG4 Ab [Mass/volume] in Serum |
|
60392-8
|
Black Pepper IgG Ab [Mass/volume] in Serum |
|
7763-6
|
Black Walnut IgE Ab [Units/volume] in Serum |
|
24136-4
|
Black Walnut IgG Ab [Units/volume] in Serum |
|
6046-7
|
Black Walnut Pollen IgE Ab [Units/volume] in Serum |
|
7764-4
|
Black Western Walnut IgE Ab [Units/volume] in Serum |
|
6862-7
|
Black Willow IgE Ab [Units/volume] in Serum |
|
56193-6
|
Black Willow IgG4 Ab [Mass/volume] in Serum |
|
7151-4
|
Blackberry IgE Ab [Units/volume] in Serum |
|
45227-6
|
Blackberry IgE Ab/IgE total in Serum |
|
56194-4
|
Blackberry IgG4 Ab [Mass/volume] in Serum |
|
63112-7
|
Blackberry IgG Ab [Mass/volume] in Serum |
|
7571-3
|
Black-eye pea IgE Ab [Units/volume] in Serum |
|
7572-1
|
Black-eye pea IgG Ab [Units/volume] in Serum |
|
56195-1
|
Black-eye pea IgG4 Ab [Mass/volume] in Serum |
|
63100-2
|
Black-eye pea IgG Ab [Mass/volume] in Serum |
|
11177-3
|
Lactalbumin beta IgE Ab [Units/volume] in Serum |
|
20423-0
|
Beta lactamase organism identified in Isolate |
|
41397-1
|
Beta lactoglobulin IgE Ab [Units/volume] in Serum |
|
57914-4
|
Beta lactoglobulin IgE Ab/IgE total in Serum |
|
51531-2
|
Beta lactoglobulin IgG Ab [Presence] in Serum |
|
11160-9
|
Beta lactoglobulin IgG Ab [Units/volume] in Serum |
|
56302-3
|
Beta lactoglobulin IgG4 Ab [Mass/volume] in Serum |
|
63090-5
|
Beta lactoglobulin IgG Ab [Mass/volume] in Serum |
|
48205-9
|
Beta lactoglobulin triggered leukotriene release [Mass/volume] by Leukocytes |
|
6042-6
|
Beta lactoglobulin MF77 IgE Ab [Units/volume] in Serum |
|
88250-6
|
Cephalosporin resistance blaCTX-M gene [Presence] by Molecular method |
|
66125-6
|
Urinary bladder Pathology biopsy report |
|
76278-1
|
Bladder temperature via Foley |
|
28551-0
|
Bladder tumor Ag [Units/volume] in Urine by Immunoassay |
|
31729-7
|
Bladder tumor Ag [Presence] in Urine |
|
28078-4
|
Bladder tumor Ag [Presence] in Urine by Immunoassay |
|
80386-6
|
Bladder tumor Ag [Presence] in Urine by Rapid immunoassay |
|
31730-5
|
Bladder tumor Ag [Units/volume] in Urine |
|
88245-6
|
Carbapenem resistance blaIMP gene [Presence] by Probe in Positive blood culture |
|
85788-8
|
Carbapenem resistance blaKPC gene [Presence] by NAA with non-probe detection in Positive blood culture |
|
88246-4
|
Carbapenem resistance blaKPC gene [Presence] by Probe in Positive blood culture |
|
49617-4
|
Carbapenem resistance blaKPC gene [Presence] by Molecular method |
|
88247-2
|
Carbapenem resistance blaNDM gene [Presence] by Probe in Positive blood culture |
|
73982-1
|
Carbapenem resistance blaNDM gene [Presence] by Molecular method |
|
88248-0
|
Carbapenem resistance blaOXA gene [Presence] by Probe in Positive blood culture |
|
86712-7
|
Carbapenem resistance blaOXA gene [Presence] by Molecular method |
|
86713-5
|
Carbapenem resistance blaOXA-134-like gene [Presence] by Molecular method |
|
86220-1
|
Carbapenem resistance blaOXA-48 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
86714-3
|
Carbapenem resistance blaOXA-51-like gene [Presence] by Molecular method |
|
93432-3
|
Blastomyces sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay |
|
93431-5
|
Blastomyces sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay |
|
93430-7
|
Blastomyces sp Ag [Mass/volume] in Serum or Plasma by Immunoassay |
|
93429-9
|
Blastomyces sp Ag [Mass/volume] in Urine by Immunoassay |
|
66134-8
|
Blasts [#/volume] in Blood from Fetus by Manual count |
|
88249-8
|
Carbapenem resistance blaVIM gene [Presence] by Probe in Positive blood culture |
|
80736-2
|
Blood banking and transfusion medicine Consult note |
|
84067-8
|
Blood banking and transfusion medicine Note |
|
83620-5
|
Blood banking and transfusion medicine Nurse Note |
|
89797-5
|
Blood banking and transfusion medicine Telephone encounter Note |
|
89796-7
|
Blood banking and transfusion medicine procedure note |
|
89795-9
|
Blood banking and transfusion medicine Progress note |
|
76283-1
|
Blood flow rate Pulmonary capillaries |
|
92805-1
|
Blood Fungal Pathogens Panel by NAA with probe detection in Positive blood culture |
|
14575-5
|
Blood group antibody investigation [Interpretation] in Plasma or RBC |
|
69369-7
|
Blood group antibody screen [Presence] in Cord blood |
|
46271-3
|
Blood group antibody screen [Presence] in Serum or Plasma --after transfusion reaction |
|
18273-3
|
Blood group antibody screen [Presence] in Serum or Plasma from Blood product unit |
|
18274-1
|
Blood group antibody screen [Presence] in Serum or Plasma from Donor |
|
890-4
|
Blood group antibody screen [Presence] in Serum or Plasma |
|
75263-4
|
Blood group antibody screen [Presence] in Serum or Plasma by GEL |
|
75264-2
|
Blood group antibody screen [Presence] in Serum or Plasma by Low ionic strength saline (LISS) |
|
75265-9
|
Blood group antibody screen [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method |
|
15343-7
|
Blood group antibody screen [Titer] in Serum or Plasma |
|
93914-0
|
Blood group antigens panel - Red Blood Cells |
|
72264-5
|
Bilirubin excess and oxyhemoglobin and methemoglobin and xanthochromia and albumin quotient panel - Serum and CSF |
|
5909-7
|
Blood smear finding [Identifier] in Blood by Light microscopy |
|
11067-6
|
Bleeding time |
|
3178-1
|
Bleeding time by Duke method |
|
3179-9
|
Bleeding time by Ivy method |
|
26823-5
|
Lutropin.beta subunit [Mass/volume] in Serum or Plasma |
|
2583-3
|
Lutropin.beta subunit [Moles/volume] in Serum or Plasma |
|
43899-4
|
Beta lipotropin [Presence] in Serum or Plasma |
|
1949-7
|
Beta lipotropin [Mass/volume] in Serum or Plasma |
|
46991-6
|
BLM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
32640-5
|
BLM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48331-3
|
BLM gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
33720-4
|
Blood bank consult |
|
43153-6
|
Blood coagulation device panel |
|
52041-1
|
Blood glucose monitor attachment |
|
92552-9
|
Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue from Donor by Molecular genetics method |
|
92514-9
|
Blood group Ag and Hemoglobin S inferred panel - Blood or Tissue by Molecular genetics method |
|
889-6
|
Blood group antibodies identified in Blood product unit |
|
888-8
|
Blood group antibodies identified in Serum or Plasma |
|
85762-3
|
Blood pathogens panel by NAA with non-probe detection in Positive blood culture |
|
79569-0
|
Blood product given [Type] |
|
60834-9
|
Blood temperature |
|
6047-5
|
Bloodworm IgE Ab [Units/volume] in Serum |
|
7203-3
|
Blue Cheese IgE Ab [Units/volume] in Serum |
|
7520-0
|
Blue mussel triggered histamine release [Units/volume] in Blood |
|
6048-3
|
Blue mussel IgE Ab [Units/volume] in Serum |
|
39596-2
|
Blue mussel IgE Ab/IgE total in Serum |
|
7519-2
|
Blue mussel IgG Ab [Units/volume] in Serum |
|
56327-0
|
Blue mussel IgG4 Ab [Mass/volume] in Serum |
|
63085-5
|
Blue mussel IgG Ab [Mass/volume] in Serum |
|
19729-3
|
Blue vetch IgE Ab [Units/volume] in Serum |
|
7154-8
|
Blueberry triggered histamine release [Units/volume] in Blood |
|
7152-2
|
Blueberry IgE Ab [Units/volume] in Serum |
|
39609-3
|
Blueberry IgE Ab/IgE total in Serum |
|
7153-0
|
Blueberry IgG Ab [Units/volume] in Serum |
|
56196-9
|
Blueberry IgG4 Ab [Mass/volume] in Serum |
|
58035-7
|
Blueberry IgG Ab [Mass/volume] in Serum |
|
22915-3
|
Bovine leukemia virus Ab [Presence] in Milk |
|
22916-1
|
Bovine leukemia virus Ab [Presence] in Milk by Immunoassay |
|
22144-0
|
Bovine leukemia virus Ab [Presence] in Serum |
|
15460-9
|
Bovine leukemia virus Ab [Presence] in Serum by Immunoassay |
|
15461-7
|
Bovine leukemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31274-4
|
Bovine leukemia virus Ab [Units/volume] in Serum |
|
43073-6
|
Bovine leukemia virus Ab [Titer] in Serum |
|
23677-8
|
Bovine leukemia virus Ab [Titer] in Serum by Complement fixation |
|
22917-9
|
Bovine leukemia virus Ag [Presence] in Unspecified specimen |
|
23593-7
|
Bovine leukemia virus [Presence] in Blood by Organism specific culture |
|
22918-7
|
Bovine leukemia virus RNA [Presence] in Blood by NAA with probe detection |
|
22919-5
|
Bovine leukemia virus RNA [Presence] in Tissue by NAA with probe detection |
|
9329-4
|
Basement membrane Ab [Units/volume] in Serum by Immunoassay |
|
16434-3
|
Basement membrane Ab [Units/volume] in Serum by Immunofluorescence |
|
16433-5
|
Basement membrane Ab [Presence] in Serum |
|
5056-7
|
Basement membrane Ab [Presence] in Serum by Immunofluorescence |
|
31252-0
|
Basement membrane Ab [Units/volume] in Serum |
|
10862-1
|
Basement membrane Ab [Titer] in Serum |
|
57737-9
|
Basement membrane Ab [Titer] in Serum by Immunofluorescence |
|
31253-8
|
Basement membrane IgA Ab [Presence] in Serum |
|
29995-8
|
Basement membrane IgA Ab [Presence] in Serum by Immunofluorescence |
|
44445-5
|
Basement membrane IgA Ab [Units/volume] in Serum |
|
29997-4
|
Basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
|
44446-3
|
Basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
31255-3
|
Basement membrane IgG Ab [Presence] in Serum |
|
43814-3
|
Basement membrane IgG Ab [Presence] in Serum by Immunoassay |
|
29994-1
|
Basement membrane IgG Ab [Presence] in Serum by Immunofluorescence |
|
31254-6
|
Basement membrane IgG Ab [Units/volume] in Serum |
|
43875-4
|
Basement membrane IgM Ab [Presence] in Serum |
|
47398-3
|
Beta mannosidase actual/normal in Leukocytes |
|
24067-1
|
Beta mannosidase [Enzymatic activity/mass] in Fibroblast |
|
24066-3
|
Beta mannosidase [Enzymatic activity/volume] in Serum or Plasma |
|
24068-9
|
Beta mannosidase [Enzymatic activity/mass] in Leukocytes |
|
83311-1
|
DXA Bone density quantitative measurement panel |
|
89270-3
|
Body mass index (BMI) [Ratio] Estimated |
|
75735-1
|
BMPR1A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
87756-3
|
BMPR1A and SMAD4 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
1950-5
|
Beta melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
|
38440-4
|
Basement membrane zone Ab [Presence] in Serum |
|
38410-7
|
Basement membrane zone Ab [Titer] in Serum |
|
92671-7
|
Basement membrane zone BP180 and BP230 IgG panel - Serum or Plasma |
|
57738-7
|
Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay |
|
45188-0
|
Basement membrane zone BP180 Ab [Units/volume] in Serum |
|
53842-1
|
Basement membrane zone BP180 IgG Ab [Units/volume] in Serum or Plasma |
|
57911-0
|
Basement membrane zone BP230 Ab [Units/volume] in Serum or Plasma |
|
53807-4
|
Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
53843-9
|
Basement membrane zone BP230 IgG Ab [Units/volume] in Serum or Plasma |
|
45178-1
|
Basement membrane zone IgG Ab [Presence] in Serum by Immunofluorescence |
|
2643-5
|
N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Serum |
|
33354-2
|
N-acetyl-beta-glucosaminidase [Enzymatic activity/volume] in Urine |
|
48995-5
|
N-acetyl-beta-glucosaminidase/Creatinine [Ratio] in Urine |
|
29542-8
|
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Amniotic fluid cells |
|
79458-6
|
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in DBS |
|
24074-7
|
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Fibroblast |
|
18344-2
|
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Platelets |
|
1954-7
|
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Serum or Plasma |
|
1955-4
|
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Tissue |
|
12913-0
|
Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Leukocytes |
|
24075-4
|
Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Leukocytes |
|
33655-2
|
Beta-N-acetylhexosaminidase [Moles/volume] in Leukocytes |
|
40460-8
|
Phenytoin.bound [Mass/volume] in Serum or Plasma |
|
42637-9
|
Natriuretic peptide B [Mass/volume] in Blood |
|
30934-4
|
Natriuretic peptide B [Mass/volume] in Serum or Plasma |
|
35257-5
|
Natriuretic peptide B [Mass or Moles/volume] in Serum or Plasma |
|
47092-2
|
Natriuretic peptide B [Moles/volume] in Serum or Plasma |
|
53637-5
|
BOB1 Ag [Presence] in Tissue by Immune stain |
|
72859-2
|
Boceprevir [Susceptibility] by Genotype method |
|
89269-5
|
Body height Measured --at birth |
|
3137-7
|
Body height Measured |
|
91370-7
|
Body height --used for drug calculation |
|
73964-9
|
Body muscle mass Calculated |
|
73965-6
|
Body muscle mass/Body weight Measured |
|
74727-9
|
Body condition score Jefferies |
|
72369-2
|
Body site identification panel |
|
61008-9
|
Body surface temperature |
|
93473-7
|
Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method |
|
43898-6
|
Beta hydroxybutyrate [Presence] in 24 hour Urine |
|
66441-7
|
Beta hydroxybutyrate [Moles/volume] in Blood by Test strip |
|
1946-3
|
Beta hydroxybutyrate [Mass/volume] in Cerebral spinal fluid |
|
16455-8
|
Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
|
1681-6
|
Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Blood |
|
1682-4
|
Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
72416-1
|
Beta hydroxybutyrate [Moles/volume] in Blood --post meal |
|
72417-9
|
Beta hydroxybutyrate [Moles/volume] in Blood --pre-meal |
|
43923-2
|
Beta hydroxybutyrate [Presence] in Serum or Plasma |
|
29512-1
|
Beta hydroxybutyrate [Mass/volume] in Serum or Plasma |
|
35255-9
|
Beta hydroxybutyrate [Mass or Moles/volume] in Serum or Plasma |
|
6873-4
|
Beta hydroxybutyrate [Moles/volume] in Serum or Plasma |
|
29622-8
|
Beta hydroxybutyrate [Presence] in Urine |
|
1947-1
|
Beta hydroxybutyrate [Mass/volume] in Urine |
|
16456-6
|
Beta hydroxybutyrate [Moles/volume] in Urine |
|
58685-9
|
Beta hydroxybutyrate [Moles/volume] in Vitreous fluid |
|
50099-1
|
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood |
|
50100-7
|
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Cerebral spinal fluid |
|
72419-5
|
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --post meal |
|
72418-7
|
Beta hydroxybutyrate/Acetoacetate [Molar ratio] in Blood --pre-meal |
|
72603-4
|
Beta hydroxybutyrate + Acetoacetate [Moles/volume] in Blood |
|
41269-2
|
Beta hydroxybutyrate + Gamma aminobutyrate [Moles/volume] in Serum or Plasma |
|
22905-4
|
Bovine herpesvirus 1 Ab [Presence] in Milk |
|
22903-9
|
Bovine herpesvirus 1 Ab [Presence] in Milk by Immunoassay |
|
22142-4
|
Bovine herpesvirus 1 Ab [Presence] in Serum |
|
30034-3
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Complement fixation |
|
20845-4
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Immunoassay |
|
22902-1
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Immune diffusion (ID) |
|
22901-3
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
|
22904-7
|
Bovine herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
|
31273-6
|
Bovine herpesvirus 1 Ab [Units/volume] in Serum |
|
22143-2
|
Bovine herpesvirus 1 Ab [Titer] in Serum |
|
15459-1
|
Bovine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
|
31744-6
|
Bovine herpesvirus 1 Ag [Presence] in Genital specimen |
|
22911-2
|
Bovine herpesvirus 1 Ag [Presence] in Genital specimen by Immunofluorescence |
|
31745-3
|
Bovine herpesvirus 1 Ag [Presence] in Nose |
|
22907-0
|
Bovine herpesvirus 1 Ag [Presence] in Nose by Immunofluorescence |
|
20846-2
|
Bovine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
|
22912-0
|
Bovine herpesvirus 1 Ag [Presence] in Tissue by Immune stain |
|
22908-8
|
Bovine herpesvirus 1 Ag [Units/volume] in Unspecified specimen by Neutralization test |
|
31746-1
|
Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen |
|
22906-2
|
Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunoassay |
|
22910-4
|
Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22909-6
|
Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immune stain |
|
31747-9
|
Bovine herpesvirus 1 Ag [Units/volume] in Unspecified specimen |
|
22913-8
|
Bovine herpesvirus 1 DNA [Presence] in Semen by NAA with probe detection |
|
22914-6
|
Bovine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection |
|
31748-7
|
Bovine herpesvirus 2 Ag [Presence] in Exudate |
|
20847-0
|
Bovine herpesvirus 2 Ag [Presence] in Exudate by Immunofluorescence |
|
20848-8
|
Bovine herpesvirus 2 Ag [Presence] in Tissue by Immunofluorescence |
|
31749-5
|
Bovine herpesvirus 4 Ag [Presence] in Body fluid |
|
20849-6
|
Bovine herpesvirus 4 Ag [Presence] in Body fluid by Immunofluorescence |
|
20850-4
|
Bovine herpesvirus 4 Ag [Presence] in Tissue by Immunofluorescence |
|
20851-2
|
Bovine herpesvirus 5 Ag [Presence] in Tissue by Immunofluorescence |
|
3404-1
|
Bolasterone [Mass/time] in 24 hour Urine |
|
3402-5
|
Bolasterone [Presence] in Urine |
|
3403-3
|
Bolasterone [Mass/volume] in Urine |
|
43859-8
|
Bolasterone [Presence] in Unspecified specimen |
|
5601-0
|
Boldenone [Mass/time] in 24 hour Urine |
|
5599-6
|
Boldenone [Presence] in Urine |
|
5600-2
|
Boldenone [Mass/volume] in Urine |
|
44024-8
|
Boldenone [Presence] in Unspecified specimen |
|
15354-4
|
Bombesin Ag [Presence] in Tissue by Immune stain |
|
10874-6
|
Bombesin [Mass/volume] in Plasma |
|
58478-9
|
Bombus sp IgG Ab [Mass/volume] in Serum |
|
93187-3
|
Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel |
|
87480-0
|
Bone ash/Bone.total in Bone |
|
48807-2
|
Bone marrow aspiration report |
|
66108-2
|
Bone Pathology biopsy report |
|
5603-6
|
Borate [Mass/time] in 24 hour Urine |
|
43892-9
|
Borate [Presence] in Blood |
|
5602-8
|
Borate [Mass/volume] in Serum or Plasma |
|
10910-8
|
Borate [Mass/volume] in Urine |
|
9367-4
|
Borate [Mass/volume] in Unspecified specimen |
|
69756-5
|
Bordetella sp filamentous hemagglutinin and pertussis toxin Ab.IgA and IgG panel - Serum by Line blot |
|
22875-9
|
Border disease virus Ab [Units/volume] in Serum by Immunoassay |
|
22876-7
|
Border disease virus Ab [Units/volume] in Serum |
|
22877-5
|
Border disease virus Ab [Titer] in Serum |
|
22878-3
|
Border disease virus Ab [Titer] in Serum by Neutralization test |
|
31733-9
|
Border disease virus Ag [Presence] in Blood |
|
22882-5
|
Border disease virus Ag [Presence] in Blood by Immunoassay |
|
20704-3
|
Border disease virus Ag [Presence] in Blood by Immunofluorescence |
|
22881-7
|
Border disease virus Ag [Presence] in Tissue by Immunoassay |
|
20703-5
|
Border disease virus Ag [Presence] in Tissue by Immunofluorescence |
|
31734-7
|
Border disease virus Ag [Presence] in Unspecified specimen |
|
22879-1
|
Border disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22880-9
|
Border disease virus Ag [Presence] in Unspecified specimen by Immune stain |
|
22885-8
|
Border disease virus RNA [Presence] in Blood by NAA with probe detection |
|
22883-3
|
Border disease virus RNA [Presence] in Tissue from Fetus by NAA with probe detection |
|
22884-1
|
Border disease virus RNA [Presence] in Tissue by NAA with probe detection |
|
72719-8
|
Borderline symptom list - 23 item [BSL-23] |
|
72718-0
|
Borderline symptom list - behavior supplement [BSL-SUPP] |
|
91839-1
|
Bordetella sp Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
91870-6
|
Bordetella sp Ag [Presence] in Throat by Immunofluorescence |
|
91814-4
|
Bordetella sp Ag [Presence] in Upper respiratory specimen by Immunofluorescence |
|
43360-7
|
Bordetella sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
91838-3
|
Bordetella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection |
|
88583-0
|
Bordetella sp DNA [Identifier] in Nasopharynx by NAA with probe detection |
|
62426-2
|
Bordetella sp DNA panel - Unspecified specimen by NAA with probe detection |
|
91871-4
|
Bordetella sp DNA [Identifier] in Throat by NAA with probe detection |
|
91813-6
|
Bordetella sp DNA [Identifier] in Upper respiratory specimen by NAA with probe detection |
|
62428-8
|
Bordetella sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
63431-1
|
Bordetella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91775-7
|
Bordetella sp identified in Lower respiratory specimen by Organism specific culture |
|
88582-2
|
Bordetella sp identified in Nasopharynx by Organism specific culture |
|
91872-2
|
Bordetella sp identified in Throat by Organism specific culture |
|
91777-3
|
Bordetella sp identified in Upper respiratory specimen by Organism specific culture |
|
6317-2
|
Bordetella sp identified in Unspecified specimen by Organism specific culture |
|
49112-6
|
Borna disease virus Ab [Units/volume] in Serum |
|
29926-3
|
Boron [Mass/volume] in 24 hour Urine |
|
29921-4
|
Boron [Mass/time] in 24 hour Urine |
|
50829-1
|
Boron [Moles/time] in 24 hour Urine |
|
5604-4
|
Boron [Mass/volume] in Blood |
|
5605-1
|
Boron [Mass/volume] in Body fluid |
|
50827-5
|
Boron [Moles/volume] in Body fluid |
|
77178-2
|
Boron [Mass/mass] in Hair |
|
50828-3
|
Boron [Moles/mass] in Hair |
|
38638-3
|
Boron oxide [Mass/volume] in Air |
|
5606-9
|
Boron [Mass/volume] in Red Blood Cells |
|
5607-7
|
Boron [Mass/volume] in Serum or Plasma |
|
52914-9
|
Boron [Moles/volume] in Serum or Plasma |
|
60060-1
|
Boron [Mass/mass] in Tissue |
|
38639-1
|
Boron trifluoride [Mass/volume] in Air |
|
9331-0
|
Boron [Mass/volume] in Urine |
|
50830-9
|
Boron [Moles/volume] in Urine |
|
9368-2
|
Boron [Mass/volume] in Unspecified specimen |
|
29922-2
|
Boron/Creatinine [Mass Ratio] in 24 hour Urine |
|
50831-7
|
Boron/Creatinine [Molar ratio] in 24 hour Urine |
|
50832-5
|
Boron/Creatinine [Molar ratio] in Urine |
|
44457-0
|
Borrelia sp Ab [Units/volume] in Serum |
|
42590-0
|
Borrelia sp Ab [Titer] in Serum |
|
92815-0
|
Borrelia afzelii+burgdorferi+garinii IgG panel - Serum and CSF |
|
31739-6
|
Borrelia sp Ag [Presence] in Unspecified specimen |
|
24036-6
|
Borrelia sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
87945-2
|
Borrelia sp identified in Cerebral spinal fluid by Organism specific culture |
|
88581-4
|
Borrelia sp DNA [Identifier] in Cerebral spinal fluid by NAA with probe detection |
|
90042-3
|
Borrelia sp DNA [Presence] in Tick by NAA with probe detection |
|
87947-8
|
Borrelia sp DNA identified in Tissue by NAA with probe detection |
|
49615-8
|
Borrelia sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
87946-0
|
Borrelia sp identified in Tissue by Organism specific culture |
|
6323-0
|
Borrelia sp identified in Unspecified specimen by Organism specific culture |
|
25565-3
|
Bougainvillea IgE Ab [Units/volume] in Serum |
|
31750-3
|
Bovine inner ear Ag [Presence] in Serum or Plasma |
|
12852-0
|
Bovine inner ear Ag [Presence] in Serum or Plasma by Immunoblot |
|
16102-6
|
Bovine Gelatin IgE Ab [Units/volume] in Serum |
|
90742-8
|
Bovine Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay |
|
46016-2
|
Bowel elimination pattern Set |
|
7155-5
|
Boxelder IgE Ab [Units/volume] in Serum |
|
61206-9
|
Boxelder IgE Ab/IgE total in Serum |
|
7156-3
|
Boxelder IgG Ab [Units/volume] in Serum |
|
56315-5
|
Boxelder IgG4 Ab [Mass/volume] in Serum |
|
16484-8
|
Boysenberry IgE Ab [Units/volume] in Serum |
|
43152-8
|
Blood pressure device panel |
|
75995-1
|
Diastolic blood pressure by Continuous non-invasive monitoring |
|
86909-9
|
Diastolic blood pressure goal |
|
89281-0
|
Diastolic blood pressure--during anesthesia |
|
89267-9
|
Diastolic blood pressure--lying in L-lateral position |
|
87736-5
|
Diastolic blood pressure--post exercise |
|
87740-7
|
Diastolic blood pressure--W exercise |
|
75996-9
|
Mean blood pressure by Continuous non-invasive monitoring |
|
35094-2
|
Blood pressure panel |
|
85354-9
|
Blood pressure panel with all children optional |
|
75997-7
|
Systolic blood pressure by Continuous non-invasive monitoring |
|
86908-1
|
Systolic blood pressure goal |
|
89280-2
|
Systolic blood pressure--during anesthesia |
|
89268-7
|
Systolic blood pressure--lying in L-lateral position |
|
87741-5
|
Systolic blood pressure--post exercise |
|
87739-9
|
Systolic blood pressure--W exercise |
|
75161-0
|
Bilevel positive airway pressure (BPAP) activity Ventilator |
|
72663-8
|
Bisphosphoglycerate mutase [Enzymatic activity/mass] in Red Blood Cells |
|
63214-1
|
Bactericidal permeability increasing protein Ab [Presence] in Body fluid by Immunoassay |
|
63213-3
|
Bactericidal permeability increasing protein Ab [Units/volume] in Serum by Immunoassay |
|
53013-9
|
Bactericidal permeability increasing protein Ab [Presence] in Serum |
|
58771-7
|
Bactericidal permeability increasing protein Ab [Units/volume] in Serum |
|
33573-7
|
Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum by Immunoassay |
|
33603-2
|
Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum |
|
23678-6
|
Bovine parainfluenza virus 3 Ag [Presence] in Tissue by Immunofluorescence |
|
38720-9
|
Beta-propiolactone [Mass/volume] in Air |
|
20708-4
|
Bovine papular stomatitis virus Ag [Presence] in Tissue by Immunofluorescence |
|
20934-6
|
Bovine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
|
10433-1
|
BR-2 Ag [Presence] in Tissue by Immune stain |
|
87400-8
|
Brachyspira sp Ag [Presence] in Tissue by Immune stain |
|
87398-4
|
Brachyspira sp DNA [Presence] in Isolate by NAA with probe detection |
|
87413-1
|
Brachyspira sp [Type] in Isolate by Sequencing |
|
87412-3
|
Brachyspira sp nox gene [Nucleotide sequence] in Isolate by Sequencing |
|
24409-5
|
Brachyspira sp identified in Unspecified specimen by Organism specific culture |
|
38228-3
|
Braden scale skin assessment panel |
|
1983-6
|
Bradykinin [Mass/volume] in Serum or Plasma |
|
58483-9
|
BRAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53844-7
|
BRAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
83061-2
|
BRAF gene [VCF] in Cancer specimen by Sequencing |
|
93690-6
|
BRAF gene V600 mutations [Identifier] in Plasma cell-free DNA by Molecular genetics method Nominal |
|
85101-4
|
BRAF gene p.Val600Glu [Presence] in Bone marrow by Molecular genetics method |
|
58415-1
|
BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method |
|
87627-6
|
Brain injury Consult note |
|
87628-4
|
Brain injury Note |
|
87629-2
|
Brain injury Plan of care note |
|
66109-0
|
Brain Pathology biopsy report |
|
82873-1
|
Brallobarbital [Mass/volume] in Serum or Plasma |
|
92281-5
|
Brand name of cigarettes smoked most often 30 days |
|
77371-3
|
Brassicasterol [Moles/volume] in Serum or Plasma |
|
7670-3
|
Brazilian Rubber Tree IgE Ab [Units/volume] in Serum |
|
64963-2
|
Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum |
|
7158-9
|
Brazil Nut triggered histamine release [Units/volume] in Blood |
|
6050-9
|
Brazil Nut IgE Ab [Units/volume] in Serum |
|
39592-1
|
Brazil Nut IgE Ab/IgE total in Serum |
|
7157-1
|
Brazil Nut IgG Ab [Units/volume] in Serum |
|
56198-5
|
Brazil Nut IgG4 Ab [Mass/volume] in Serum |
|
63081-4
|
Brazil Nut IgG Ab [Mass/volume] in Serum |
|
42778-1
|
BRCA1 Ag [Presence] in Tissue by Immune stain |
|
21637-4
|
BRCA1 gene.c.185 del AG [presence] in Blood or Tissue by Molecular genetics method |
|
21638-2
|
BRCA1 gene c.5382insC [Presence] in Blood or Tissue by Molecular genetics method |
|
79207-7
|
BRCA1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
21636-6
|
BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50995-0
|
BRCA1+BRCA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
42779-9
|
BRCA2 Ag [Presence] in Tissue by Immune stain |
|
21640-8
|
BRCA2 gene c.6174delT [Presence] in Blood or Tissue by Molecular genetics method |
|
79208-5
|
BRCA2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
38530-2
|
BRCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
80441-9
|
Breast milk andor formula intake panel |
|
80442-7
|
Breast milk intake panel |
|
88439-5
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose fructose PO |
|
88440-3
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --10M post dose lactose PO |
|
48613-4
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose lactose PO |
|
88441-1
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20M post dose fructose PO |
|
88446-0
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --20 minutes post dose lactose PO |
|
88443-7
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40M post dose fructose PO |
|
88442-9
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --40 minutes post dose lactose PO |
|
88444-5
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose fructose PO |
|
88445-2
|
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --50M post dose lactose PO |
|
10531-2
|
Bretylium [Mass/volume] in Serum or Plasma |
|
7785-9
|
Brewer's yeast triggered histamine release [Units/volume] in Blood |
|
6051-7
|
Brewer's yeast IgE Ab [Units/volume] in Serum |
|
6715-7
|
Brewer's yeast IgG Ab [Units/volume] in Serum |
|
56199-3
|
Brewer's yeast IgG4 Ab [Mass/volume] in Serum |
|
60413-2
|
Brewer's yeast IgG Ab [Mass/volume] in Serum |
|
82152-0
|
BRFSS ACE Module [ACE.BRFSS] |
|
52491-8
|
Brief interview for mental status [BIMS] |
|
77564-3
|
Brief Pain Inventory Short Form - pain interference panel |
|
48303-2
|
Brilliant black BN triggered leukotriene release [Mass/volume] by Leukocytes |
|
29776-2
|
Microscopic observation [Identifier] in Blood by Brilliant cresyl blue |
|
88894-1
|
Brivaracetam [Mass/volume] in Serum or Plasma |
|
6052-5
|
Broccoli IgE Ab [Units/volume] in Serum |
|
61234-1
|
Broccoli IgE Ab/IgE total in Serum |
|
7159-7
|
Broccoli IgG Ab [Units/volume] in Serum |
|
56200-9
|
Broccoli IgG4 Ab [Mass/volume] in Serum |
|
60356-3
|
Broccoli IgG Ab [Mass/volume] in Serum |
|
40705-6
|
Brodifacoum [Mass/volume] in Blood |
|
12426-3
|
Brodifacoum [Mass/volume] in Serum or Plasma |
|
74111-6
|
Brodifacoum [Presence] in Unspecified specimen by Screen method |
|
87612-8
|
Brodifacoum [Mass/mass] in Unspecified specimen |
|
74112-4
|
Bromadiolone [Presence] in Unspecified specimen by Screen method |
|
87611-0
|
Bromadiolone [Mass/mass] in Unspecified specimen |
|
59873-0
|
Bromazepam [Moles/volume] in Gastric fluid |
|
3405-8
|
Bromazepam [Mass/volume] in Serum or Plasma |
|
32124-0
|
Bromazepam [Moles/volume] in Serum or Plasma |
|
20520-3
|
Bromazepam [Mass/volume] in Urine by Confirmatory method |
|
19365-6
|
Bromazepam [Presence] in Urine by Confirmatory method |
|
19364-9
|
Bromazepam [Presence] in Urine by Screen method |
|
3406-6
|
Bromazepam [Mass/volume] in Urine |
|
59872-2
|
Bromazepam [Moles/volume] in Urine |
|
60288-8
|
Bromazepam [Moles/volume] in Unspecified specimen |
|
6053-3
|
Brome IgE Ab [Units/volume] in Serum |
|
61235-8
|
Brome IgE Ab/IgE total in Serum |
|
24144-8
|
Brome IgG Ab [Units/volume] in Serum |
|
40847-6
|
Brome IgG4 Ab [Mass/volume] in Serum |
|
10923-1
|
Bromelin IgE Ab [Units/volume] in Serum |
|
58984-6
|
Bromelin MUXF3 IgE Ab [Units/volume] in Serum |
|
38444-6
|
Bromide [Presence] in 24 hour Urine |
|
42725-2
|
Bromide [Mass/volume] in Blood |
|
25171-0
|
Bromide [Moles/volume] in Blood |
|
20718-3
|
Bromide [Mass/volume] in Ocular fluid |
|
1984-4
|
Bromide [Mass/volume] in Serum or Plasma |
|
15034-2
|
Bromide [Moles/volume] in Serum or Plasma |
|
1985-1
|
Bromide [Mass/volume] in Urine |
|
43169-2
|
Bromide [Moles/volume] in Urine |
|
23680-2
|
Bromide [Mass/volume] in Unspecified specimen |
|
56655-4
|
Bromide/Creatinine [Ratio] in Urine |
|
38640-9
|
Bromine [Mass/volume] in Air |
|
11232-6
|
Bromocriptine [Mass/volume] in Serum or Plasma |
|
30516-9
|
Bromodiphenhydramine [Mass/volume] in Serum or Plasma |
|
16485-5
|
Bromodiphenhydramine [Mass/volume] in Urine |
|
38575-7
|
Bromoform [Mass/volume] in Air |
|
14260-4
|
Bromoform [Mass/volume] in Blood |
|
35105-6
|
Bromperidol [Mass/volume] in Serum or Plasma |
|
82917-6
|
Bromperidol [Mass/volume] in Serum or Plasma --trough |
|
59875-5
|
Brompheniramine [Moles/volume] in Gastric fluid |
|
75758-3
|
Brompheniramine [Presence] in Serum or Plasma or Urine by Screen method |
|
3407-4
|
Brompheniramine [Presence] in Serum or Plasma |
|
11233-4
|
Brompheniramine [Mass/volume] in Serum or Plasma |
|
55526-8
|
Brompheniramine [Moles/volume] in Serum or Plasma |
|
3408-2
|
Brompheniramine [Presence] in Urine |
|
27284-9
|
Brompheniramine [Mass/volume] in Urine |
|
59874-8
|
Brompheniramine [Moles/volume] in Urine |
|
60289-6
|
Brompheniramine [Moles/volume] in Unspecified specimen |
|
1371-4
|
Bromsulphthalein [Mass/volume] in Serum or Plasma |
|
18744-3
|
Bronchoscopy study |
|
47305-8
|
BRST 2 Ag [Presence] in Tissue by Immune stain |
|
76544-6
|
Breast cancer 10-year risk of distant recurrence score Calculated by Prosigna |
|
76546-1
|
Breast cancer 10-year risk of distant recurrence panel by Prosigna |
|
66110-8
|
Breast Pathology biopsy report |
|
31751-1
|
Bovine respiratory syncytial virus Ag [Presence] in Lung |
|
20944-5
|
Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunoassay |
|
20945-2
|
Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunofluorescence |
|
20943-7
|
Bovine respiratory syncytial virus Ag [Presence] in Lung by Immune stain |
|
23679-4
|
Bovine respiratory syncytial virus Ag [Presence] in Unspecified specimen |
|
30202-6
|
Brucella sp Ab [Presence] in Serum |
|
40614-0
|
Brucella sp Ab [Presence] in Serum by Agglutination |
|
86455-3
|
Brucella sp Ab [Presence] in Serum by Acidified buffered plate agglutination |
|
86456-1
|
Brucella sp Ab [Presence] in Serum by Card agglutination |
|
40613-2
|
Brucella sp Ab [Presence] in Serum by Complement fixation |
|
86457-9
|
Brucella sp Ab [Presence] in Serum by Fluorescent polarization assay |
|
10349-9
|
Brucella sp Ab [Units/volume] in Serum |
|
30129-1
|
Brucella sp Ab [Presence] in Serum --1st specimen |
|
29250-8
|
Brucella sp Ab [Titer] in Serum --1st specimen |
|
30130-9
|
Brucella sp Ab [Presence] in Serum --2nd specimen |
|
29251-6
|
Brucella sp Ab [Titer] in Serum --2nd specimen |
|
58806-1
|
Brucella sp Ab [Titer] in Cerebral spinal fluid by Agglutination |
|
22159-8
|
Brucella sp Ab [Titer] in Serum |
|
19053-8
|
Brucella sp Ab [Titer] in Serum by Agglutination |
|
91876-3
|
Brucella sp Ab [Titer] in Serum by Immunocapture agglutination |
|
6328-9
|
Brucella sp Ab [Titer] in Serum by Immunofluorescence |
|
86459-5
|
Brucella sp Ab [Titer] in Serum by Plate agglutination |
|
86458-7
|
Brucella sp Ab [Titer] in Serum by Rivanol agglutination |
|
51671-6
|
Brucella sp Ab [Titer] in Serum by Tube agglutination |
|
31754-5
|
Brucella sp Ag [Presence] in Placenta |
|
22943-5
|
Brucella sp Ag [Presence] in Placenta by Immunofluorescence |
|
22949-2
|
Brucella sp Ag [Presence] in Placenta by Immune stain |
|
22946-8
|
Brucella sp Ag [Presence] in Tissue from Fetus by Immunofluorescence |
|
22948-4
|
Brucella sp Ag [Presence] in Tissue from Fetus by Immune stain |
|
22945-0
|
Brucella sp Ag [Presence] in Tissue by Immune stain |
|
31753-7
|
Brucella sp Ag [Presence] in Vaginal fluid |
|
22947-6
|
Brucella sp Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
22944-3
|
Brucella sp Ag [Presence] in Vaginal fluid by Immune stain |
|
44271-5
|
Brucella sp Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
47001-3
|
Brucella sp Ag [Presence] in Unspecified specimen by Agglutination |
|
41624-8
|
Brucella sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
551-2
|
Brucella sp identified in Blood by Organism specific culture |
|
63465-9
|
Brucella sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
53604-5
|
Brucella sp DNA [Identifier] in Serum by NAA with probe detection |
|
41625-5
|
Brucella sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
41626-3
|
Brucella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
13211-8
|
Brucella sp IgA Ab [Units/volume] in Serum |
|
56630-7
|
Brucella sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
24396-4
|
Brucella sp IgG Ab [Presence] in Serum |
|
24387-3
|
Brucella sp IgG Ab [Presence] in Serum by Immunoassay |
|
13210-0
|
Brucella sp IgG Ab [Units/volume] in Serum |
|
72308-0
|
Brucella sp IgG Ab [Titer] in Serum --1st specimen |
|
72307-2
|
Brucella sp IgG Ab [Titer] in Serum --2nd specimen |
|
38247-3
|
Brucella sp IgG Ab [Titer] in Serum |
|
35739-2
|
Brucella sp IgG and IgM panel - Serum |
|
56631-5
|
Brucella sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
24397-2
|
Brucella sp IgM Ab [Presence] in Serum |
|
24388-1
|
Brucella sp IgM Ab [Presence] in Serum by Immunoassay |
|
5070-8
|
Brucella sp IgM Ab [Units/volume] in Serum |
|
38248-1
|
Brucella sp IgM Ab [Titer] in Serum |
|
24003-6
|
Brucella sp identified in Bone marrow by Organism specific culture |
|
20735-7
|
Brucella sp identified in Milk by Organism specific culture |
|
23594-5
|
Brucella sp identified in Semen by Organism specific culture |
|
91140-4
|
Brucella sp IgG and IgM panel - Serum Qualitative |
|
20734-0
|
Brucella sp identified in Tissue by Organism specific culture |
|
552-0
|
Brucella sp identified in Unspecified specimen by Organism specific culture |
|
44797-9
|
Brucella sp [Presence] in Unspecified specimen by Organism specific culture |
|
31275-1
|
Brush border Ab [Presence] in Serum |
|
16491-3
|
Brush border Ab [Presence] in Serum by Immunofluorescence |
|
5072-4
|
Brush border Ab [Units/volume] in Serum |
|
21125-0
|
Brush border Ab [Titer] in Serum by Immunofluorescence |
|
7160-5
|
Brussel Sprouts IgE Ab [Units/volume] in Serum |
|
7161-3
|
Brussel Sprouts IgG Ab [Units/volume] in Serum |
|
56201-7
|
Brussel Sprouts IgG4 Ab [Mass/volume] in Serum |
|
60357-1
|
Brussel Sprouts IgG Ab [Mass/volume] in Serum |
|
20950-2
|
Bovine rotavirus Ag [Presence] in Tissue by Immunofluorescence |
|
10922-3
|
Bovine serum albumin (BSA) IgE Ab [Units/volume] in Serum |
|
48228-1
|
Bovine serum albumin (BSA) triggered leukotriene release [Mass/volume] by Leukocytes |
|
75741-9
|
Beta sitosterol [Mass/volume] in Serum or Plasma |
|
74907-7
|
Beta sitosterol [Moles/volume] in Serum or Plasma |
|
53845-4
|
BTD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
75708-8
|
Bruton tyrosine kinase [Interpretation] in B cells+monocytes by Flow cytometry (FC) Narrative |
|
69479-4
|
BTK gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
35295-5
|
BTK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
31257-9
|
Beta tubulin IgG Ab [Units/volume] in Serum |
|
14233-1
|
Beta tubulin IgG Ab [Titer] in Serum |
|
82737-8
|
Beta tubulin IgG Ab [Titer] in Serum by Immunoassay |
|
44739-1
|
Beta tubulin IgM Ab [Presence] in Serum |
|
31258-7
|
Beta tubulin IgM Ab [Units/volume] in Serum |
|
14234-9
|
Beta tubulin IgM Ab [Titer] in Serum |
|
22113-5
|
Bluetongue virus Ab [Presence] in Serum |
|
20699-5
|
Bluetongue virus Ab [Presence] in Serum by Complement fixation |
|
15456-7
|
Bluetongue virus Ab [Presence] in Serum by Immunoassay |
|
15455-9
|
Bluetongue virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
22868-4
|
Bluetongue virus Ab [Presence] in Serum by Neutralization test |
|
22872-6
|
Bluetongue virus Ag [Presence] in Blood |
|
20701-9
|
Bluetongue virus Ag [Presence] in Tissue by Immunofluorescence |
|
31732-1
|
Bluetongue virus Ag [Presence] in Unspecified specimen |
|
22870-0
|
Bluetongue virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
22869-2
|
Bluetongue virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22873-4
|
Bluetongue virus Ag [Presence] in Unspecified specimen by Immune stain |
|
22871-8
|
Bluetongue virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
20700-1
|
Bluetongue virus RNA [Presence] in Tissue by NAA with probe detection |
|
20698-7
|
Bluetongue virus serotype [Identifier] in Isolate |
|
22874-2
|
Bluetongue virus serotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
20702-7
|
Bluetongue virus [Presence] in Unspecified specimen by Organism specific culture |
|
31260-3
|
Bluetongue virus 10 Ab [Units/volume] in Serum |
|
43082-7
|
Bluetongue virus 10 Ab [Titer] in Serum |
|
23671-1
|
Bluetongue virus 10 Ab [Titer] in Serum by Neutralization test |
|
31261-1
|
Bluetongue virus 11 Ab [Units/volume] in Serum |
|
43081-9
|
Bluetongue virus 11 Ab [Titer] in Serum |
|
23672-9
|
Bluetongue virus 11 Ab [Titer] in Serum by Neutralization test |
|
31262-9
|
Bluetongue virus 13 Ab [Units/volume] in Serum |
|
43080-1
|
Bluetongue virus 13 Ab [Titer] in Serum |
|
23673-7
|
Bluetongue virus 13 Ab [Titer] in Serum by Neutralization test |
|
31263-7
|
Bluetongue virus 17 Ab [Units/volume] in Serum |
|
43079-3
|
Bluetongue virus 17 Ab [Titer] in Serum |
|
23674-5
|
Bluetongue virus 17 Ab [Titer] in Serum by Neutralization test |
|
31264-5
|
Bluetongue virus 2 Ab [Units/volume] in Serum |
|
43078-5
|
Bluetongue virus 2 Ab [Titer] in Serum |
|
23675-2
|
Bluetongue virus 2 Ab [Titer] in Serum by Neutralization test |
|
34399-6
|
Buccal mucosa Ab [Titer] in Serum by Immunofluorescence |
|
65773-4
|
Buckwheat native (nFag e) 2 IgE Ab [Units/volume] in Serum |
|
6054-1
|
Buckwheat IgE Ab [Units/volume] in Serum |
|
61262-2
|
Buckwheat IgE Ab/IgE total in Serum |
|
7162-1
|
Buckwheat IgG Ab [Units/volume] in Serum |
|
56202-5
|
Buckwheat IgG4 Ab [Mass/volume] in Serum |
|
63078-0
|
Buckwheat IgG Ab [Mass/volume] in Serum |
|
73501-9
|
Budesonide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73500-1
|
Budesonide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41747-7
|
Budesonide [Mass/volume] in Serum or Plasma |
|
46947-8
|
Budesonide [Mass/volume] in Urine |
|
6304-0
|
Budgerigar droppings IgE Ab [Units/volume] in Serum |
|
61236-6
|
Budgerigar droppings IgE Ab/IgE total in Serum |
|
51545-2
|
Budgerigar droppings IgG Ab [Presence] in Serum |
|
57917-7
|
Budgerigar droppings IgG Ab [Units/volume] in Serum |
|
55589-6
|
Budgerigar feather IgE Ab [Presence] in Serum |
|
6030-1
|
Budgerigar feather IgE Ab [Units/volume] in Serum |
|
61237-4
|
Budgerigar feather IgE Ab/IgE total in Serum |
|
51858-9
|
Budgerigar serum proteins+feathers+droppings IgG Ab [Presence] in Serum |
|
78385-2
|
Budgerigar serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum |
|
6031-9
|
Budgerigar serum proteins IgE Ab [Units/volume] in Serum |
|
87743-1
|
Bufencarb [Mass/mass] in Unspecified specimen |
|
16493-9
|
Bufotenine [Units/volume] in Serum or Plasma |
|
12433-9
|
Bufotenine [Mass/volume] in Serum or Plasma |
|
16492-1
|
Bufotenine [Units/volume] in Urine |
|
5608-5
|
Bufotenine [Mass/volume] in Urine |
|
6056-6
|
Bumble Bee IgE Ab [Units/volume] in Serum |
|
57915-1
|
Bumble Bee IgE Ab/IgE total in Serum |
|
3411-6
|
Bumetanide [Mass/time] in 24 hour Urine |
|
73499-6
|
Bumetanide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73498-8
|
Bumetanide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9355-9
|
Bumetanide [Mass/volume] in Serum or Plasma |
|
3409-0
|
Bumetanide [Presence] in Urine |
|
16494-7
|
Bumetanide [Units/volume] in Urine |
|
3410-8
|
Bumetanide [Mass/volume] in Urine |
|
12961-9
|
Urea nitrogen [Mass/volume] in Arterial blood |
|
6299-2
|
Urea nitrogen [Mass/volume] in Blood |
|
12963-5
|
Urea nitrogen [Mass/volume] in Peripheral blood |
|
59570-2
|
Urea nitrogen [Moles/volume] in Blood |
|
12962-7
|
Urea nitrogen [Mass/volume] in Venous blood |
|
17759-2
|
Urea nitrogen [Mass/volume] in Arterial blood --post dialysis |
|
48639-9
|
Urea nitrogen [Mass/volume] in Peripheral blood --post dialysis |
|
48629-0
|
Urea nitrogen [Mass/volume] in Venous blood --post dialysis |
|
11064-3
|
Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis |
|
72270-2
|
Urea nitrogen [Mass/volume] in Serum or Plasma --pre contrast |
|
17760-0
|
Urea nitrogen [Mass/volume] in Venous blood --pre dialysis |
|
11065-0
|
Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis |
|
3094-0
|
Urea nitrogen [Mass/volume] in Serum or Plasma |
|
35234-4
|
Urea nitrogen [Mass or Moles/volume] in Serum or Plasma |
|
14937-7
|
Urea nitrogen [Moles/volume] in Serum or Plasma |
|
3097-3
|
Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma |
|
56699-2
|
Bupivacaine IgE Ab [Units/volume] in Serum |
|
3412-4
|
Bupivacaine [Mass/volume] in Serum or Plasma |
|
32053-1
|
Bupivacaine [Moles/volume] in Serum or Plasma |
|
74382-3
|
Bupivacaine [Mass/volume] in Unknown substance |
|
87786-0
|
Bupivacaine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
3416-5
|
Buprenorphine [Mass/time] in 24 hour Urine |
|
79138-4
|
Buprenorphine [Presence] in Blood by Confirmatory method |
|
79139-2
|
Buprenorphine [Presence] in Blood by Screen method |
|
82372-4
|
Buprenorphine [Presence] in Gastric fluid by Screen method |
|
75367-3
|
Buprenorphine [Mass/mass] in Meconium by Confirmatory method |
|
77205-3
|
Buprenorphine [Presence] in Meconium by Screen method |
|
72762-8
|
Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
73942-5
|
Buprenorphine [Presence] in Saliva (oral fluid) by Screen method |
|
53846-2
|
Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
82369-0
|
Buprenorphine [Presence] in Serum or Plasma by Screen method |
|
16495-4
|
Buprenorphine [Units/volume] in Serum or Plasma |
|
75368-1
|
Buprenorphine [Mass/volume] in Serum, Plasma or Blood |
|
3413-2
|
Buprenorphine [Mass/volume] in Serum or Plasma |
|
49752-9
|
Buprenorphine [Mass/volume] in Urine by Confirmatory method |
|
3414-0
|
Buprenorphine [Presence] in Urine |
|
16208-1
|
Buprenorphine [Presence] in Urine by Confirmatory method |
|
93494-3
|
Buprenorphine [Presence] in Urine by Screen method |
|
16496-2
|
Buprenorphine [Units/volume] in Urine |
|
3415-7
|
Buprenorphine [Mass/volume] in Urine |
|
82373-2
|
Buprenorphine [Presence] in Unspecified specimen by Screen method |
|
58360-9
|
Buprenorphine/Creatinine [Mass Ratio] in Urine |
|
69033-9
|
Buprenorphine and Norbuprenorphine panel - Urine |
|
77201-2
|
Buprenorphine+Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
38373-7
|
Buprenorphine+Norbuprenorphine [Presence] in Urine |
|
58359-1
|
Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method |
|
73052-3
|
Bupropion induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73051-5
|
Bupropion induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60061-9
|
Bupropion [Mass/volume] in Blood |
|
60062-7
|
Bupropion [Mass/volume] in Body fluid |
|
73496-2
|
Bupropion induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73497-0
|
Bupropion induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6706-6
|
Bupropion [Mass/volume] in Serum or Plasma |
|
55527-6
|
Bupropion [Moles/volume] in Serum or Plasma |
|
60063-5
|
Bupropion [Mass/mass] in Tissue |
|
59169-3
|
Bupropion [Presence] in Urine |
|
60064-3
|
Bupropion [Mass/volume] in Urine |
|
41627-1
|
Burkholderia sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41629-7
|
Burkholderia sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
41628-9
|
Burkholderia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88580-6
|
Burkholderia sp identified in Lower respiratory specimen by Organism specific culture |
|
44798-7
|
Burkholderia sp identified in Unspecified specimen by Organism specific culture |
|
44800-1
|
Burkholderia sp [Presence] in Unspecified specimen by Organism specific culture |
|
90012-6
|
Burn management Consult note |
|
93150-1
|
Burn management procedure note |
|
90014-2
|
Burn management Progress note |
|
7164-7
|
Burrobrush IgE Ab [Units/volume] in Serum |
|
7166-2
|
Burweed IgE Ab [Units/volume] in Serum |
|
7484-9
|
Burweed marshelder IgE Ab [Units/volume] in Serum |
|
7485-6
|
Burweed marshelder IgG Ab [Units/volume] in Serum |
|
73495-4
|
Buspirone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73494-7
|
Buspirone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9356-7
|
Buspirone [Mass/volume] in Serum or Plasma |
|
74943-2
|
Buspirone [Mass/volume] in Serum or Plasma --trough |
|
60471-0
|
Buspirone [Mass/volume] in Urine |
|
93435-6
|
Busulfan [Mass/volume] in Plasma --1 hour post busulfan infusion completion |
|
93434-9
|
Busulfan [Mass/volume] in Plasma --2 hours post busulfan infusion completion |
|
93433-1
|
Busulfan [Mass/volume] in Plasma --4 hours post busulfan infusion completion |
|
93478-6
|
Busulfan area under the curve panel - Plasma |
|
93436-4
|
Busulfan [Mass/volume] in Plasma --immediately post busulfan infusion completion |
|
93476-0
|
Busulfan [Area under the curve] in Plasma |
|
15363-5
|
Busulfan [Mass/volume] in Serum or Plasma |
|
22666-2
|
Busulfan [Moles/volume] in Serum or Plasma |
|
73683-5
|
Busulfan [Mass/volume] in Serum or Plasma --trough |
|
75645-2
|
Butabarbital [Mass/volume] in Blood by Confirmatory method |
|
12486-7
|
Butabarbital [Presence] in Gastric fluid |
|
16497-0
|
Butabarbital [Mass/volume] in Gastric fluid |
|
26923-3
|
Butabarbital [Mass/mass] in Hair |
|
27061-1
|
Butabarbital [Mass/mass] in Meconium |
|
18384-8
|
Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3417-3
|
Butabarbital [Presence] in Serum or Plasma |
|
82972-1
|
Butabarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3418-1
|
Butabarbital [Mass/volume] in Serum or Plasma |
|
25357-5
|
Butabarbital [Moles/volume] in Serum or Plasma |
|
12496-6
|
Butabarbital [Presence] in Stool |
|
26733-6
|
Butabarbital [Mass/mass] in Stool |
|
16236-2
|
Butabarbital [Mass/volume] in Urine by Confirmatory method |
|
3419-9
|
Butabarbital [Presence] in Urine |
|
16191-9
|
Butabarbital [Presence] in Urine by Confirmatory method |
|
19368-0
|
Butabarbital [Presence] in Urine by Screen method |
|
19370-6
|
Butabarbital [Mass/volume] in Urine |
|
26689-0
|
Butabarbital [Mass/volume] in Vitreous fluid |
|
32054-9
|
Butabarbital [Presence] in Unspecified specimen |
|
73493-9
|
Butalbital+Acetylsalicylate+Caffeine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73492-1
|
Butalbital+Acetylsalicylate+Caffeine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72398-1
|
Butalbital [Mass/volume] in Blood by Confirmatory method |
|
12487-5
|
Butalbital [Presence] in Gastric fluid |
|
16498-8
|
Butalbital [Units/volume] in Gastric fluid |
|
27912-5
|
Butalbital [Mass/mass] in Hair |
|
27962-0
|
Butalbital [Mass/mass] in Meconium |
|
72454-2
|
Butalbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72632-3
|
Butalbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3420-7
|
Butalbital [Presence] in Serum or Plasma |
|
35598-2
|
Butalbital [Mass/volume] in Serum or Plasma by Screen method |
|
82971-3
|
Butalbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
6895-7
|
Butalbital [Mass/volume] in Serum or Plasma |
|
32055-6
|
Butalbital [Moles/volume] in Serum or Plasma |
|
12497-4
|
Butalbital [Presence] in Stool |
|
27246-8
|
Butalbital [Mass/mass] in Stool |
|
16237-0
|
Butalbital [Mass/volume] in Urine by Confirmatory method |
|
3421-5
|
Butalbital [Presence] in Urine |
|
18385-5
|
Butalbital [Presence] in Urine by Confirmatory method |
|
19373-0
|
Butalbital [Presence] in Urine by Screen method |
|
11071-8
|
Butalbital [Mass/volume] in Urine |
|
32056-4
|
Butalbital [Moles/volume] in Urine |
|
27927-3
|
Butalbital [Mass/volume] in Vitreous fluid |
|
32057-2
|
Butalbital [Presence] in Unspecified specimen |
|
64139-9
|
Butalbital/Creatinine [Mass Ratio] in Urine |
|
38576-5
|
Butane [Mass/volume] in Air |
|
9497-9
|
Butane [Mass/volume] in Blood |
|
13934-5
|
Butanol [Mass/volume] in Blood |
|
9685-9
|
Butanol [Mass/volume] in Unspecified specimen |
|
9313-8
|
Butorphanol [Mass/volume] in Body fluid |
|
12394-3
|
Butorphanol [Mass/volume] in Serum or Plasma |
|
16499-6
|
Butorphanol [Mass/volume] in Urine by Confirmatory method |
|
12333-1
|
Butorphanol [Presence] in Urine |
|
19378-9
|
Butorphanol [Presence] in Urine by Confirmatory method |
|
19377-1
|
Butorphanol [Presence] in Urine by Screen method |
|
12395-0
|
Butorphanol [Mass/volume] in Urine |
|
13547-5
|
Butriptyline [Presence] in Serum or Plasma |
|
7167-0
|
Butterfly IgE Ab [Units/volume] in Serum |
|
7168-8
|
Buttermilk triggered histamine release [Units/volume] in Blood |
|
14268-7
|
Butyl acetate [Mass/volume] in Blood |
|
12536-9
|
Butyl nitrate [Presence] in Blood |
|
51413-3
|
Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in Serum or Plasma |
|
53167-3
|
Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
53168-1
|
Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBS |
|
53169-9
|
Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
|
53060-0
|
Butyrylcarnitine (C4) [Moles/volume] in Amniotic fluid |
|
53070-9
|
Butyrylcarnitine (C4) [Moles/volume] in Cerebral spinal fluid |
|
53065-9
|
Butyrylcarnitine (C4) [Moles/volume] in DBS |
|
74596-8
|
Butyrylcarnitine (C4) [Enzymatic activity/mass] in Fibroblast |
|
53106-1
|
Butyrylcarnitine (C4) [Moles/volume] in Urine |
|
53111-1
|
Butyrylcarnitine (C4)/Creatinine [Molar ratio] in Urine |
|
93467-9
|
Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
92702-0
|
Lactobacillus crispatus+jensenii + Gardnerella vaginalis + Atopobium vaginae + Bacterial Vaginosis Associated Bacteria-2 + Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
69571-8
|
Bacterial vaginosis DNA and score panel - Vaginal fluid by NAA with probe detection |
|
74635-4
|
Bacterial vaginosis DNA panel - Vaginal fluid by NAA with probe detection |
|
69566-8
|
Bacterial vaginosis associated bacterium 2 DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
22889-0
|
Bovine diarrhea virus Ab [Presence] in Milk |
|
22890-8
|
Bovine diarrhea virus Ab [Presence] in Milk by Immunoassay |
|
22895-7
|
Bovine diarrhea virus Ab [Presence] in Serum |
|
22894-0
|
Bovine diarrhea virus Ab [Presence] in Serum by Immunoassay |
|
22893-2
|
Bovine diarrhea virus Ab [Presence] in Serum by Neutralization test |
|
31272-8
|
Bovine diarrhea virus Ab [Units/volume] in Serum |
|
22891-6
|
Bovine diarrhea virus Ab [Titer] in Serum |
|
22892-4
|
Bovine diarrhea virus Ab [Titer] in Serum by Neutralization test |
|
31740-4
|
Bovine diarrhea virus Ag [Presence] in Blood |
|
22896-5
|
Bovine diarrhea virus Ag [Presence] in Blood by Immunoassay |
|
20713-4
|
Bovine diarrhea virus Ag [Presence] in Blood by Immunofluorescence |
|
31741-2
|
Bovine diarrhea virus Ag [Presence] in Nose |
|
20711-8
|
Bovine diarrhea virus Ag [Presence] in Nose by Immunofluorescence |
|
20715-9
|
Bovine diarrhea virus Ag [Presence] in Serum by Immune stain |
|
31742-0
|
Bovine diarrhea virus Ag [Presence] in Stool |
|
20714-2
|
Bovine diarrhea virus Ag [Presence] in Stool by Immunofluorescence |
|
20712-6
|
Bovine diarrhea virus Ag [Presence] in Tissue by Immunofluorescence |
|
31743-8
|
Bovine diarrhea virus Ag [Presence] in Unspecified specimen |
|
22898-1
|
Bovine diarrhea virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22897-3
|
Bovine diarrhea virus Ag [Presence] in Unspecified specimen by Immune stain |
|
20710-0
|
Bovine diarrhea virus RNA [Presence] in Serum by NAA with probe detection |
|
20709-2
|
Bovine diarrhea virus RNA [Presence] in Tissue by NAA with probe detection |
|
22899-9
|
Bovine diarrhea virus RNA [Presence] in Tissue by Probe |
|
22900-5
|
Bovine diarrhea virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20716-7
|
Bovine diarrhea virus [Presence] in Serum by Organism specific culture |
|
31270-2
|
Bovine diarrhea virus 1 Ab [Units/volume] in Serum |
|
22140-8
|
Bovine diarrhea virus 1 Ab [Titer] in Serum |
|
15462-5
|
Bovine diarrhea virus 1 Ab [Titer] in Serum by Neutralization test |
|
31271-0
|
Bovine diarrhea virus 2 Ab [Units/volume] in Serum |
|
22141-6
|
Bovine diarrhea virus 2 Ab [Titer] in Serum |
|
15463-3
|
Bovine diarrhea virus 2 Ab [Titer] in Serum by Neutralization test |
|
20717-5
|
Bovine diarrhea virus 2 Ag [Presence] in Tissue by Immunofluorescence |
|
42856-5
|
Benzoylecgonine [Mass/volume] in Blood by Confirmatory method |
|
72407-0
|
Benzoylecgonine [Presence] in Blood by Screen method |
|
8183-6
|
Benzoylecgonine [Presence] in Gastric fluid |
|
8184-4
|
Benzoylecgonine [Presence] in Gastric fluid by Confirmatory method |
|
8185-1
|
Benzoylecgonine [Presence] in Gastric fluid by Screen method |
|
8182-8
|
Benzoylecgonine [Mass/volume] in Gastric fluid |
|
5938-6
|
Benzoylecgonine [Presence] in Hair |
|
5936-0
|
Benzoylecgonine [Mass/mass] in Hair |
|
69010-7
|
Benzoylecgonine [Mass/mass] in Meconium by Confirmatory method |
|
8187-7
|
Benzoylecgonine [Presence] in Meconium |
|
8188-5
|
Benzoylecgonine [Presence] in Meconium by Confirmatory method |
|
8189-3
|
Benzoylecgonine [Presence] in Meconium by Screen method |
|
8186-9
|
Benzoylecgonine [Mass/volume] in Meconium |
|
27026-4
|
Benzoylecgonine [Mass/mass] in Meconium |
|
87809-0
|
Benzoylecgonine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74679-2
|
Benzoylecgonine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
57301-4
|
Benzoylecgonine [Mass/volume] in Saliva (oral fluid) |
|
59616-3
|
Benzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3391-0
|
Benzoylecgonine [Presence] in Serum or Plasma |
|
16446-7
|
Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method |
|
3392-8
|
Benzoylecgonine [Mass/volume] in Serum or Plasma |
|
55525-0
|
Benzoylecgonine [Moles/volume] in Serum or Plasma |
|
12352-1
|
Benzoylecgonine [Presence] in Stool |
|
27248-4
|
Benzoylecgonine [Mass/mass] in Stool |
|
16226-3
|
Benzoylecgonine [Mass/volume] in Urine by Confirmatory method |
|
3393-6
|
Benzoylecgonine [Presence] in Urine |
|
14315-6
|
Benzoylecgonine [Presence] in Urine by Confirmatory method |
|
8192-7
|
Benzoylecgonine [Presence] in Urine by SAMHSA confirm method |
|
8193-5
|
Benzoylecgonine [Presence] in Urine by SAMHSA screen method |
|
14314-9
|
Benzoylecgonine [Presence] in Urine by Screen method |
|
43984-4
|
Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL |
|
43985-1
|
Benzoylecgonine [Presence] in Urine by Screen method >300 ng/mL |
|
70146-6
|
Benzoylecgonine [Mass/volume] in Urine by Screen method |
|
3394-4
|
Benzoylecgonine [Mass/volume] in Urine |
|
27358-1
|
Benzoylecgonine [Mass/volume] in Vitreous fluid |
|
40609-0
|
Benzoylecgonine [Presence] in Unspecified specimen |
|
43230-2
|
Benzoylecgonine [Mass/volume] in Unspecified specimen |
|
77320-0
|
Benzoylecgonine [Moles/volume] in Unspecified specimen |
|
13479-1
|
Benzoylecgonine/Creatinine [Mass Ratio] in Urine |
|
93938-9
|
C Ag [Presence] on Red Blood Cells --during infancy |
|
92551-1
|
C Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92513-1
|
C Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93928-0
|
C Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93921-5
|
C Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
948-0
|
C Ag [Presence] on Red Blood Cells |
|
93946-2
|
C Ag [Presence] in Cord red blood cells |
|
33461-5
|
Candida albicans Ab [Presence] in Cerebral spinal fluid |
|
33406-0
|
Candida albicans Ab [Units/volume] in Serum by Complement fixation |
|
16537-3
|
Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID) |
|
22162-2
|
Candida albicans Ab [Presence] in Serum |
|
5074-0
|
Candida albicans Ab [Presence] in Serum by Immune diffusion (ID) |
|
22163-0
|
Candida albicans Ab [Units/volume] in Serum |
|
42859-9
|
Candida albicans Ab [Titer] in Serum |
|
68948-9
|
Candida albicans Ab [Titer] in Serum by Immunofluorescence |
|
31758-6
|
Candida albicans Ag [Presence] in Serum |
|
6337-0
|
Candida albicans Ag [Presence] in Serum by Immune diffusion (ID) |
|
31759-4
|
Candida albicans Ag [Units/volume] in Serum |
|
5075-7
|
Candida albicans Ag [Titer] in Serum by Latex agglutination |
|
7173-8
|
Candida albicans triggered histamine release [Units/volume] in Blood |
|
85781-3
|
Candida albicans DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
70022-9
|
Candida albicans DNA [Presence] in Blood by NAA with probe detection |
|
90806-1
|
Candida albicans DNA [Presence] in Serum by NAA with probe detection |
|
69562-7
|
Candida albicans DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
56151-4
|
Candida albicans IgA Ab [Units/volume] in Serum |
|
56156-3
|
Candida albicans IgA and IgG and IgM Ab panel - Serum |
|
6059-0
|
Candida albicans IgE Ab [Units/volume] in Serum |
|
61238-2
|
Candida albicans IgE Ab/IgE total in Serum |
|
7172-0
|
Candida albicans IgG Ab [Units/volume] in Serum |
|
51539-5
|
Candida albicans IgG Ab [Presence] in Serum |
|
26413-5
|
Candida albicans IgG4 Ab [Units/volume] in Serum |
|
56204-1
|
Candida albicans IgG4 Ab [Mass/volume] in Serum |
|
35530-5
|
Candida albicans IgG Ab [Mass/volume] in Serum |
|
56150-6
|
Candida albicans IgM Ab [Units/volume] in Serum |
|
13216-7
|
Candida albicans immune complex [Units/volume] in Serum or Plasma |
|
48240-6
|
Candida albicans triggered leukotriene release [Mass/volume] by Leukocytes |
|
11166-6
|
Chortoglyphus arcuatus IgE Ab [Units/volume] in Serum |
|
87620-1
|
Candida auris ITS2 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
90002-7
|
Candida auris [Presence] in Unspecified specimen by Organism specific culture |
|
80518-4
|
Clostridium baratii toxin F bont gene [Presence] in Unspecified specimen by NAA with probe detection |
|
80827-9
|
Clostridium botulinum and Clostridium baratii toxins gene panel - Unspecified specimen by NAA with probe detection |
|
33695-8
|
Clostridium botulinum [Presence] in Isolate by Organism specific culture |
|
87948-6
|
Clostridium botulinum [Presence] in Stool by Organism specific culture |
|
34664-3
|
Clostridium botulinum toxin A Ab [Presence] in Serum |
|
33709-7
|
Clostridium botulinum toxin A [Presence] in Unspecified specimen |
|
41630-5
|
Clostridium botulinum toxin A [Presence] in Unspecified specimen by Immunofluorescence |
|
33701-4
|
Clostridium botulinum toxin A [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
33712-1
|
Clostridium botulinum toxin A+B+E [Presence] in Unspecified specimen |
|
33704-8
|
Clostridium botulinum toxin A+B+E [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
38989-0
|
Clostridium botulinum toxin A+B+E+F+G [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
33713-9
|
Clostridium botulinum toxin B [Presence] in Unspecified specimen |
|
41632-1
|
Clostridium botulinum toxin B [Presence] in Unspecified specimen by Immunofluorescence |
|
33705-5
|
Clostridium botulinum toxin B [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
33710-5
|
Clostridium botulinum toxin E [Presence] in Unspecified specimen |
|
41634-7
|
Clostridium botulinum toxin E [Presence] in Unspecified specimen by Immunofluorescence |
|
33702-2
|
Clostridium botulinum toxin E [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
33711-3
|
Clostridium botulinum toxin F [Presence] in Unspecified specimen |
|
41635-4
|
Clostridium botulinum toxin F [Presence] in Unspecified specimen by Immunofluorescence |
|
33703-0
|
Clostridium botulinum toxin F [Presence] in Unspecified specimen by Mouse bioassay neutralization |
|
46705-0
|
Clostridium botulinum toxin gene [Identifier] in Unspecified specimen by NAA with probe detection |
|
20705-0
|
Clostridium botulinum toxin [Identifier] in Serum by Animal inoculation |
|
88589-7
|
Clostridium botulinum toxin [Identifier] in Serum by Mouse bioassay neutralization |
|
88578-0
|
Clostridium botulinum toxin [Identifier] in Stool by Mouse bioassay neutralization |
|
11470-2
|
Clostridium botulinum toxin [Units/volume] in Stool |
|
44796-1
|
Clostridium botulinum toxin [Identifier] in Unspecified specimen |
|
20706-8
|
Clostridium botulinum toxin [Identifier] in Unspecified specimen by Animal inoculation |
|
44274-9
|
Clostridium botulinum toxin [Identifier] in Unspecified specimen by Immunoassay |
|
33708-9
|
Clostridium botulinum toxin [Presence] in Unspecified specimen |
|
33696-6
|
Clostridium botulinum toxin [Presence] in Unspecified specimen by Mouse bioassay |
|
33694-1
|
Clostridium botulinum [Presence] in Unspecified specimen by Organism specific culture |
|
41631-3
|
Clostridium botulinum toxin A botA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
41633-9
|
Clostridium botulinum toxin B botB gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81644-7
|
Clostridium botulinum toxin C botC gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81645-4
|
Clostridium botulinum toxin D botD gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81646-2
|
Clostridium botulinum toxin E botE gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81647-0
|
Clostridium botulinum toxin F botF gene [Presence] in Unspecified specimen by NAA with probe detection |
|
81648-8
|
Clostridium botulinum toxin G botG gene [Presence] in Unspecified specimen by NAA with probe detection |
|
23020-1
|
Coxiella burnetii Ab [Presence] in Serum |
|
23017-7
|
Coxiella burnetii Ab [Presence] in Serum by Complement fixation |
|
23019-3
|
Coxiella burnetii Ab [Presence] in Serum by Immunoassay |
|
23018-5
|
Coxiella burnetii Ab [Presence] in Serum by Immunofluorescence |
|
7828-7
|
Coxiella burnetii Ab [Units/volume] in Serum |
|
32566-2
|
Coxiella burnetii Ab [Titer] in Cerebral spinal fluid |
|
22211-7
|
Coxiella burnetii Ab [Titer] in Serum |
|
5100-3
|
Coxiella burnetii Ab [Titer] in Serum by Complement fixation |
|
31783-4
|
Coxiella burnetii Ag [Presence] in Placenta |
|
23022-7
|
Coxiella burnetii Ag [Presence] in Placenta by Immunofluorescence |
|
23021-9
|
Coxiella burnetii Ag [Presence] in Tissue by Immunoassay |
|
31784-2
|
Coxiella burnetii Ag [Presence] in Unspecified specimen |
|
23023-5
|
Coxiella burnetii Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
90443-3
|
Coxiella burnetii aroE gene [Presence] in Serum, Plasma or Blood by NAA with non-probe detection |
|
90442-5
|
Coxiella burnetii aroE gene [Presence] in Tissue by NAA with non-probe detection |
|
88177-1
|
Coxiella burnetii DNA [Presence] in Blood by NAA with probe detection |
|
89649-8
|
Coxiella burnetii DNA [Presence] in Implanted device by NAA with probe detection |
|
60261-5
|
Coxiella burnetii DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
88178-9
|
Coxiella burnetii DNA [Presence] in Tissue by NAA with probe detection |
|
23024-3
|
Coxiella burnetii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
30212-5
|
Coxiella burnetii IgG Ab [Presence] in Serum |
|
56915-2
|
Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence |
|
16677-7
|
Coxiella burnetii IgG Ab [Units/volume] in Serum |
|
57681-9
|
Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen |
|
56920-2
|
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
57682-7
|
Coxiella burnetii IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen |
|
56919-4
|
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
25335-1
|
Coxiella burnetii IgG Ab [Titer] in Serum |
|
25384-9
|
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence |
|
30213-3
|
Coxiella burnetii IgM Ab [Presence] in Serum |
|
56917-8
|
Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence |
|
16678-5
|
Coxiella burnetii IgM Ab [Units/volume] in Serum |
|
57673-6
|
Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --1st specimen |
|
56918-6
|
Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
56916-0
|
Coxiella burnetii IgM Ab [Units/volume] in Serum by Immunofluorescence --2nd specimen |
|
57674-4
|
Coxiella burnetii IgM Ab [Presence] in Serum by Immunofluorescence --2nd specimen |
|
25336-9
|
Coxiella burnetii IgM Ab [Titer] in Serum |
|
25385-6
|
Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence |
|
77175-8
|
Coxiella burnetii phase 1 and 2 IgG and IgM panel - Serum |
|
31311-4
|
Coxiella burnetii phase 1 Ab [Units/volume] in Serum |
|
43050-4
|
Coxiella burnetii phase 1 Ab [Titer] in Serum |
|
29774-7
|
Coxiella burnetii phase 1 Ab [Titer] in Serum by Complement fixation |
|
27951-3
|
Coxiella burnetii phase 1 Ab [Titer] in Serum by Immunofluorescence |
|
31312-2
|
Coxiella burnetii phase 1 IgA Ab [Units/volume] in Serum |
|
49187-8
|
Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid |
|
48889-0
|
Coxiella burnetii phase 1 IgA Ab [Titer] in Body fluid by Immunofluorescence |
|
9706-3
|
Coxiella burnetii phase 1 IgA Ab [Titer] in Serum |
|
48848-6
|
Coxiella burnetii phase 1 IgA Ab [Titer] in Serum by Immunofluorescence |
|
51810-0
|
Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
32644-7
|
Coxiella burnetii phase 1 IgG Ab [Presence] in Serum |
|
48720-7
|
Coxiella burnetii phase 1 IgG Ab [Presence] in Serum by Immunofluorescence |
|
7829-5
|
Coxiella burnetii phase 1 IgG Ab [Units/volume] in Serum |
|
49186-0
|
Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid |
|
48888-2
|
Coxiella burnetii phase 1 IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
9708-9
|
Coxiella burnetii phase 1 IgG Ab [Titer] in Serum |
|
34716-1
|
Coxiella burnetii phase 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
51811-8
|
Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
42897-9
|
Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
32645-4
|
Coxiella burnetii phase 1 IgM Ab [Presence] in Serum |
|
63455-0
|
Coxiella burnetii phase 1 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7831-1
|
Coxiella burnetii phase 1 IgM Ab [Units/volume] in Serum |
|
49185-2
|
Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid |
|
48890-8
|
Coxiella burnetii phase 1 IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
9710-5
|
Coxiella burnetii phase 1 IgM Ab [Titer] in Serum |
|
47075-7
|
Coxiella burnetii phase 1 IgM Ab [Titer] in Serum by Immunofluorescence |
|
41840-0
|
Coxiella burnetii phase 1 and 2 IgG panel [Titer] - Serum |
|
41841-8
|
Coxiella burnetii phase 1 and 2 IgM panel [Titer] - Serum |
|
31313-0
|
Coxiella burnetii phase 2 Ab [Units/volume] in Serum |
|
38389-3
|
Coxiella burnetii phase 2 Ab [Titer] in Serum |
|
29772-1
|
Coxiella burnetii phase 2 Ab [Titer] in Serum by Complement fixation |
|
27945-5
|
Coxiella burnetii phase 2 Ab [Titer] in Serum by Immunofluorescence |
|
31316-3
|
Coxiella burnetii phase 2 IgA Ab [Units/volume] in Serum |
|
49184-5
|
Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid |
|
48891-6
|
Coxiella burnetii phase 2 IgA Ab [Titer] in Body fluid by Immunofluorescence |
|
9707-1
|
Coxiella burnetii phase 2 IgA Ab [Titer] in Serum |
|
48849-4
|
Coxiella burnetii phase 2 IgA Ab [Titer] in Serum by Immunofluorescence |
|
58762-6
|
Coxiella burnetii phase 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
51812-6
|
Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
31314-8
|
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum |
|
29777-0
|
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunoassay |
|
48719-9
|
Coxiella burnetii phase 2 IgG Ab [Presence] in Serum by Immunofluorescence |
|
7830-3
|
Coxiella burnetii phase 2 IgG Ab [Units/volume] in Serum |
|
58761-8
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49183-7
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid |
|
48893-2
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
9709-7
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Serum |
|
34717-9
|
Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
51813-4
|
Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
31315-5
|
Coxiella burnetii phase 2 IgM Ab [Presence] in Serum |
|
29773-9
|
Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunoassay |
|
43928-1
|
Coxiella burnetii phase 2 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7832-9
|
Coxiella burnetii phase 2 IgM Ab [Units/volume] in Serum |
|
49182-9
|
Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid |
|
48892-4
|
Coxiella burnetii phase 2 IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
9711-3
|
Coxiella burnetii phase 2 IgM Ab [Titer] in Serum |
|
44814-2
|
Coxiella burnetii phase 2 IgM Ab [Titer] in Serum by Immunofluorescence |
|
23016-9
|
Coxiella burnetii [Presence] in Placenta by Light microscopy |
|
44799-5
|
Coxiella burnetii [Presence] in Unspecified specimen by Organism specific culture |
|
44275-6
|
Coxiella burnetii [Presence] in Unspecified specimen by Light microscopy |
|
49124-1
|
Coxiella burnetii identified in Unspecified specimen by Sequencing |
|
41435-9
|
Cyclospora carcopitheci DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82206-4
|
Cyclospora cayetanensis DNA [Presence] in Stool by NAA with non-probe detection |
|
41436-7
|
Cyclospora cayetanensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10850-6
|
Cyclospora cayetanensis [Presence] in Unspecified specimen |
|
20760-5
|
Clostridium chauvoei Ag [Presence] in Tissue by Immunofluorescence |
|
56729-7
|
Cladosporium cladosporioides IgE Ab [Units/volume] in Serum |
|
51543-7
|
Cladosporium cladosporioides IgG Ab [Presence] in Serum |
|
25598-4
|
Cladosporium cladosporioides IgG Ab [Units/volume] in Serum |
|
35557-8
|
Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum |
|
16528-2
|
Campylobacter coli rRNA [Units/volume] in Serum by Probe |
|
6329-7
|
Campylobacter coli rRNA [Presence] in Unspecified specimen by Probe |
|
80684-4
|
Campylobacter coli+jejuni+lari 16S rRNA [Presence] in Stool by NAA with probe detection |
|
82196-7
|
Campylobacter coli+jejuni+upsaliensis DNA [Presence] in Stool by NAA with non-probe detection |
|
41437-5
|
Cyclospora colobi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31336-1
|
Cryptostroma corticale Ab [Presence] in Serum |
|
24499-6
|
Cryptostroma corticale Ab [Presence] in Serum by Immune diffusion (ID) |
|
6839-5
|
Cryptostroma corticale IgE Ab [Units/volume] in Serum |
|
82197-5
|
Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with non-probe detection |
|
80685-1
|
Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with probe detection |
|
31308-0
|
Clostridioides difficile Ab [Units/volume] in Serum |
|
9365-8
|
Clostridioides difficile Ab [Titer] in Serum |
|
87755-5
|
Clostridioides difficile BI-NAP1-027 strain DNA [Presence] in Stool by NAA with probe detection |
|
61367-9
|
Clostridioides difficile DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
79177-2
|
Clostridioides difficile glutamate dehydrogenase and toxins A+B [Presence] in Stool by Rapid immunoassay |
|
57901-1
|
Clostridioides difficile glutamate dehydrogenase [Presence] in Stool |
|
83087-7
|
Clostridioides difficile glutamate dehydrogenase [Presence] in Stool by Immunoassay |
|
26697-3
|
Clostridioides difficile IgA Ab [Units/volume] in Serum |
|
26702-1
|
Clostridioides difficile IgG Ab [Units/volume] in Serum |
|
26694-0
|
Clostridioides difficile IgM Ab [Units/volume] in Serum |
|
34712-0
|
Clostridioides difficile [Presence] in Stool |
|
20762-1
|
Clostridioides difficile [Presence] in Stool by Aerobe culture |
|
20761-3
|
Clostridioides difficile [Presence] in Stool by Agglutination |
|
562-9
|
Clostridioides difficile [Presence] in Stool by Organism specific culture |
|
6359-4
|
Clostridioides difficile toxin A [Units/volume] in Stool by Immunoassay |
|
13957-6
|
Clostridioides difficile toxin A [Presence] in Stool by Immunoassay |
|
6360-2
|
Clostridioides difficile toxin A [Units/volume] in Unspecified specimen by Immunoassay |
|
6361-0
|
Clostridioides difficile toxin A+B [Units/volume] in Serum by Immunoassay |
|
6363-6
|
Clostridioides difficile toxin A+B [Units/volume] in Stool by Immunoassay |
|
34713-8
|
Clostridioides difficile toxin A+B [Presence] in Stool |
|
6362-8
|
Clostridioides difficile toxin A+B [Presence] in Stool by Cytotoxin tissue culture assay |
|
34468-9
|
Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay |
|
6364-4
|
Clostridioides difficile toxin A+B [Units/volume] in Unspecified specimen by Immunoassay |
|
43055-3
|
Clostridioides difficile toxin Ab [Titer] in Serum |
|
33947-3
|
Clostridioides difficile toxin Ab [Titer] in Serum by Neutralization test |
|
6365-1
|
Clostridioides difficile toxin B [Units/volume] in Stool by Immunoassay |
|
10895-1
|
Clostridioides difficile toxin B [Presence] in Stool |
|
46131-9
|
Clostridioides difficile toxin B [Presence] in Stool by Cytotoxin tissue culture assay |
|
74822-8
|
Clostridioides difficile toxin B tcdB gene [Presence] in Stool by NAA with probe detection |
|
6366-9
|
Clostridioides difficile toxin B [Units/volume] in Unspecified specimen by Immunoassay |
|
54067-4
|
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection |
|
563-7
|
Clostridioides difficile [Presence] in Unspecified specimen by Organism specific culture |
|
5116-9
|
Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay |
|
32620-7
|
Corynebacterium diphtheriae Ab [Presence] in Serum |
|
5115-1
|
Corynebacterium diphtheriae Ab [Units/volume] in Serum |
|
32569-6
|
Corynebacterium diphtheriae Ab [Units/volume] in Serum --1st specimen |
|
31014-4
|
Corynebacterium diphtheriae Ab [Units/volume] in Serum --2nd specimen |
|
35348-2
|
Corynebacterium diphtheriae Ab [Titer] in Serum |
|
67561-1
|
Corynebacterium diphtheriae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
58787-3
|
Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay |
|
45166-6
|
Corynebacterium diphtheriae IgG Ab [Presence] in Serum |
|
13227-4
|
Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum |
|
26630-4
|
Corynebacterium diphtheriae toxin Ab [Presence] in Serum |
|
34625-4
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum |
|
47297-7
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
47429-6
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --1st specimen |
|
48655-5
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
49188-6
|
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum --2nd specimen |
|
48654-8
|
Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum by Immunoassay |
|
89642-3
|
Corynebacterium diphtheriae toxin IgG Ab [Presence] in Serum by Immunoassay |
|
49189-4
|
Corynebacterium diphtheriae toxin IgG Ab [Units/volume] in Serum |
|
88584-8
|
Corynebacterium diphtheriae [Presence] in Upper respiratory specimen by Organism specific culture |
|
16676-9
|
Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture |
|
22962-5
|
Campylobacter fetus Ab [Presence] in Genital mucus |
|
22963-3
|
Campylobacter fetus Ab [Presence] in Genital mucus by Agglutination |
|
69576-7
|
Campylobacter fetus Ab [Presence] in Serum |
|
31278-5
|
Campylobacter fetus Ab [Units/volume] in Serum |
|
25333-6
|
Campylobacter fetus Ab [Titer] in Serum |
|
25363-3
|
Campylobacter fetus Ab [Titer] in Serum by Complement fixation |
|
31755-2
|
Campylobacter fetus Ag [Presence] in Genital fluid |
|
22964-1
|
Campylobacter fetus Ag [Presence] in Genital fluid by Immunofluorescence |
|
22966-6
|
Campylobacter fetus Ag [Presence] in Tissue by Immunofluorescence |
|
31756-0
|
Campylobacter fetus Ag [Presence] in Unspecified specimen |
|
22965-8
|
Campylobacter fetus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22967-4
|
Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus |
|
22968-2
|
Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus by Agglutination |
|
22970-8
|
Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus |
|
22969-0
|
Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus by Immunoassay |
|
82181-9
|
Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
85782-1
|
Candida glabrata DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
70026-0
|
Candida glabrata DNA [Presence] in Blood by NAA with probe detection |
|
90807-9
|
Candida glabrata DNA [Presence] in Serum by NAA with probe detection |
|
69563-5
|
Candida glabrata DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
7200-9
|
Chaetomium globosum IgE Ab [Units/volume] in Serum |
|
61242-4
|
Chaetomium globosum IgE Ab/IgE total in Serum |
|
18420-0
|
Chaetomium globosum IgG Ab [Units/volume] in Serum |
|
63178-8
|
Chaetomium globosum IgG Ab [Mass/volume] in Serum |
|
64978-0
|
Cladosporium herbarum recombinant (rCla h) 8 IgE Ab [Units/volume] in Serum |
|
44460-4
|
Cladosporium herbarum Ab [Presence] in Serum by Immune diffusion (ID) |
|
16618-1
|
Cladosporium herbarum Ab [Units/volume] in Serum |
|
7231-4
|
Cladosporium herbarum triggered histamine release [Units/volume] in Blood |
|
6075-6
|
Cladosporium herbarum IgE Ab [Units/volume] in Serum |
|
61249-9
|
Cladosporium herbarum IgE Ab/IgE total in Serum |
|
51538-7
|
Cladosporium herbarum IgG Ab [Presence] in Serum |
|
7230-6
|
Cladosporium herbarum IgG Ab [Units/volume] in Serum |
|
42893-8
|
Cladosporium herbarum IgG Ab [Mass/volume] in Serum |
|
26417-6
|
Cladosporium herbarum IgG4 Ab [Units/volume] in Serum |
|
56224-9
|
Cladosporium herbarum IgG4 Ab [Mass/volume] in Serum |
|
28552-8
|
Cladosporium herbarum IgM Ab [Units/volume] in Serum |
|
48242-2
|
Cladosporium herbarum triggered leukotriene release [Mass/volume] by Leukocytes |
|
41433-4
|
Cryptosporidium hominis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22204-2
|
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid |
|
30209-1
|
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
21209-2
|
Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
16634-8
|
Coccidioides immitis Ab [Units/volume] in Cerebral spinal fluid |
|
31309-8
|
Coccidioides immitis Ab [Presence] in Body fluid |
|
31048-2
|
Coccidioides immitis Ab [Presence] in Body fluid by Complement fixation |
|
5094-8
|
Coccidioides immitis Ab [Units/volume] in Serum by Immunoassay |
|
22205-9
|
Coccidioides immitis Ab [Presence] in Serum |
|
20768-8
|
Coccidioides immitis Ab [Presence] in Serum by Complement fixation |
|
40712-2
|
Coccidioides immitis Ab [Presence] in Serum by Immunoassay |
|
5095-5
|
Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID) |
|
22206-7
|
Coccidioides immitis Ab [Units/volume] in Serum |
|
22207-5
|
Coccidioides immitis Ab [Titer] in Cerebral spinal fluid |
|
13917-0
|
Coccidioides immitis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
51452-1
|
Coccidioides immitis Ab [Titer] in Body fluid |
|
48392-5
|
Coccidioides immitis Ab [Titer] in Body fluid by Complement fixation |
|
43053-8
|
Coccidioides immitis Ab [Titer] in Pleural fluid |
|
42494-5
|
Coccidioides immitis Ab [Titer] in Pleural fluid by Complement fixation |
|
22208-3
|
Coccidioides immitis Ab [Titer] in Serum |
|
5096-3
|
Coccidioides immitis Ab [Titer] in Serum by Complement fixation |
|
26980-3
|
Coccidioides immitis Ab [Titer] in Serum by Immune diffusion (ID) |
|
6368-5
|
Coccidioides immitis Ab [Titer] in Serum by Latex agglutination |
|
38385-1
|
Coccidioides immitis Ag [Presence] in Cerebral spinal fluid |
|
31782-6
|
Coccidioides immitis Ag [Presence] in Isolate |
|
14205-9
|
Coccidioides immitis Ag [Presence] in Isolate by Immune diffusion (ID) |
|
62455-1
|
Coccidioides sp F Ab [Presence] in Serum by Immune diffusion (ID) |
|
16636-3
|
Coccidioides immitis IgA Ab [Units/volume] in Cerebral spinal fluid |
|
16635-5
|
Coccidioides immitis IgA Ab [Units/volume] in Serum by Immunoassay |
|
9705-5
|
Coccidioides immitis IgA Ab [Units/volume] in Serum |
|
16637-1
|
Coccidioides immitis IgE Ab [Units/volume] in Serum |
|
88745-5
|
Coccidioides immitis IgG and IgM panel - Cerebral spinal fluid |
|
87435-4
|
Coccidioides immitis IgG and IgM panel - Serum or Plasma |
|
30207-5
|
Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid |
|
57946-6
|
Coccidioides immitis IgG Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
16638-9
|
Coccidioides immitis IgG Ab [Units/volume] in Cerebral spinal fluid |
|
22209-1
|
Coccidioides immitis IgG Ab [Presence] in Serum |
|
13947-7
|
Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay |
|
7826-1
|
Coccidioides immitis IgG Ab [Units/volume] in Serum |
|
43380-5
|
Coccidioides immitis IgG Ab [Units/volume] in Unspecified specimen |
|
30208-3
|
Coccidioides immitis IgM Ab [Presence] in Cerebral spinal fluid |
|
16639-7
|
Coccidioides immitis IgM Ab [Units/volume] in Cerebral spinal fluid |
|
48393-3
|
Coccidioides immitis IgM Ab [Units/volume] in Body fluid |
|
22210-9
|
Coccidioides immitis IgM Ab [Presence] in Serum |
|
13948-5
|
Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay |
|
7827-9
|
Coccidioides immitis IgM Ab [Units/volume] in Serum |
|
33534-9
|
Coccidioides immitis IgM Ab [Presence] in Unspecified specimen |
|
33510-9
|
Coccidioides immitis IgM Ab [Presence] in Unspecified specimen by Immunoassay |
|
20767-0
|
Coccidioides immitis [Presence] in Isolate |
|
4994-0
|
Coccidioides immitis rRNA [Presence] in Unspecified specimen by Probe |
|
14206-7
|
Coccidioides immitis exoantigen [Identifier] in Isolate |
|
75710-4
|
Coccidioides immitis+posadasii IgM Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
26818-5
|
Campylobacter jejuni Ab [Units/volume] in Serum by Immunoassay |
|
69575-9
|
Campylobacter jejuni Ab [Presence] in Serum by Complement fixation |
|
31279-3
|
Campylobacter jejuni Ab [Units/volume] in Serum |
|
9655-2
|
Campylobacter jejuni Ab [Titer] in Serum |
|
25364-1
|
Campylobacter jejuni Ab [Titer] in Serum by Complement fixation |
|
61368-7
|
Campylobacter jejuni DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82875-6
|
Campylobacter jejuni IgA Ab [Titer] in Serum |
|
82845-9
|
Campylobacter jejuni IgA and IgG and IgM panel - Serum |
|
45325-8
|
Campylobacter jejuni IgG Ab [Titer] in Serum |
|
58789-9
|
Campylobacter jejuni IgG Ab [Titer] in Serum by Immunofluorescence |
|
45134-4
|
Campylobacter jejuni IgM Ab [Titer] in Serum |
|
58788-1
|
Campylobacter jejuni IgM Ab [Titer] in Serum by Immunofluorescence |
|
16529-0
|
Campylobacter jejuni rRNA [Units/volume] in Serum by Probe |
|
16530-8
|
Campylobacter jejuni rRNA [Presence] in Serum by Probe |
|
6333-9
|
Campylobacter jejuni rRNA [Presence] in Unspecified specimen by Probe |
|
57768-4
|
Campylobacter jejuni+Campylobacter coli Ag [Presence] in Stool |
|
85783-9
|
Candida krusei DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
70025-2
|
Candida krusei DNA [Presence] in Blood by NAA with probe detection |
|
90808-7
|
Candida krusei DNA [Presence] in Serum by NAA with probe detection |
|
72389-0
|
Candida krusei DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
16531-6
|
Campylobacter lari rRNA [Units/volume] in Serum by Probe |
|
16532-4
|
Campylobacter lari rRNA [Presence] in Serum by Probe |
|
6334-7
|
Campylobacter lari rRNA [Presence] in Unspecified specimen by Probe |
|
954-8
|
C little e Ag [Presence] on Red Blood Cells |
|
6094-7
|
Curvularia lunata IgE Ab [Units/volume] in Serum |
|
39598-8
|
Curvularia lunata IgE Ab/IgE total in Serum |
|
18409-3
|
Curvularia lunata IgG Ab [Units/volume] in Serum |
|
63162-2
|
Curvularia lunata IgG Ab [Mass/volume] in Serum |
|
72390-8
|
Candida lusitaniae DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
7842-8
|
Cryptococcus neoformans Ab [Units/volume] in Serum |
|
22237-2
|
Cryptococcus neoformans Ab [Titer] in Serum |
|
6369-3
|
Cryptococcus neoformans Ab [Titer] in Serum by Agglutination |
|
49098-7
|
Cryptococcus neoformans rRNA [Units/volume] in Unspecified specimen by NAA with probe detection |
|
4995-7
|
Cryptococcus neoformans rRNA [Presence] in Unspecified specimen by Probe |
|
38377-8
|
Cryptococcus neoformans [Presence] in Unspecified specimen by Organism specific culture |
|
20763-9
|
Clostridium novyii Ag [Presence] in Tissue by Immunofluorescence |
|
41438-3
|
Cyclospora papionis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85784-7
|
Candida parapsilosis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
70024-5
|
Candida parapsilosis DNA [Presence] in Blood by NAA with probe detection |
|
90809-5
|
Candida parapsilosis DNA [Presence] in Serum by NAA with probe detection |
|
72495-5
|
Candida parapsilosis DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
41487-0
|
Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay |
|
91677-5
|
Cryptosporidium parvum Ag [Presence] in Stool by Rapid immunoassay |
|
41434-2
|
Cryptosporidium parvum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
40958-1
|
Cryptosporidium parvum identified in Stool |
|
80681-0
|
Cryptosporidium parvum+hominis oocyst wall protein COWP gene [Presence] in Stool by NAA with probe detection |
|
92688-1
|
Cryptosporidium parvum+hominis DNA [Presence] in Stool by NAA with probe detection |
|
47583-0
|
C peptide [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose |
|
47584-8
|
C peptide [Moles/volume] in Serum or Plasma --10 minutes post dose glucose |
|
58500-0
|
C peptide [Mass/volume] in Serum or Plasma --15 minutes post dose glucose |
|
47585-5
|
C peptide [Moles/volume] in Serum or Plasma --15 minutes post dose glucose |
|
47586-3
|
C peptide [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
|
47587-1
|
C peptide [Moles/volume] in Serum or Plasma --1 minute post dose glucose |
|
55920-3
|
C peptide [Mass/volume] in 24 hour Urine |
|
27944-8
|
C peptide [Mass/time] in 24 hour Urine |
|
25872-3
|
C peptide [Moles/volume] in 24 hour Urine |
|
25358-3
|
C peptide [Moles/time] in 24 hour Urine |
|
47588-9
|
C peptide [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
|
47589-7
|
C peptide [Moles/volume] in Serum or Plasma --30 minutes post dose glucose |
|
47590-5
|
C peptide [Moles/volume] in Serum or Plasma --3 hours post dose glucose |
|
47591-3
|
C peptide [Moles/volume] in Serum or Plasma --3 minutes post dose glucose |
|
47592-1
|
C peptide [Moles/volume] in Serum or Plasma --5 minutes post dose glucose |
|
47593-9
|
C peptide [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose |
|
13037-7
|
C peptide [Mass/volume] in Serum or Plasma --fasting |
|
47594-7
|
C peptide [Moles/volume] in Serum or Plasma --pre dose glucagon |
|
47595-4
|
C peptide [Moles/volume] in Serum or Plasma --pre dose glucose |
|
1986-9
|
C peptide [Mass/volume] in Serum or Plasma |
|
35195-7
|
C peptide [Mass or Moles/volume] in Serum or Plasma |
|
14633-2
|
C peptide [Moles/volume] in Serum or Plasma |
|
1987-7
|
C peptide [Mass/volume] in Urine |
|
34253-5
|
C peptide [Moles/volume] in Urine |
|
13715-8
|
C peptide/Creatinine [Mass Ratio] in 24 hour Urine |
|
44459-6
|
C peptide/Creatinine [Mass Ratio] in Urine --2nd specimen post XXX challenge |
|
13716-6
|
C peptide/Creatinine [Mass Ratio] in Urine |
|
25091-0
|
C peptide/Creatinine [Molar ratio] in Urine |
|
87313-3
|
Clostridium perfringens iota toxin DNA [Presence] in Isolate by NAA with probe detection |
|
87304-2
|
Clostridium perfringens cpa gene [Presence] in Isolate by NAA with probe detection |
|
87397-6
|
Clostridium perfringens cpb gene [Presence] in Isolate by NAA with probe detection |
|
87305-9
|
Clostridium perfringens cpb2 gene [Presence] in Isolate by NAA with probe detection |
|
87306-7
|
Clostridium perfringens cpe gene [Presence] in Isolate by NAA with probe detection |
|
20799-3
|
Clostridium perfringens enterotoxin [Presence] in Body fluid |
|
20800-9
|
Clostridium perfringens enterotoxin [Presence] in Small intestine Fixed |
|
87307-5
|
Clostridium perfringens etx gene [Presence] in Isolate by NAA with probe detection |
|
20798-5
|
Clostridium perfringens enterotoxin [Presence] in Tissue |
|
32369-1
|
Clostridium perfringens enterotoxin [Identifier] in Unspecified specimen |
|
20764-7
|
Clostridium perfringens genotype [Identifier] in Isolate |
|
26767-4
|
Clostridium perfringens IgG Ab [Units/volume] in Serum |
|
26768-2
|
Clostridium perfringens IgM Ab [Units/volume] in Serum |
|
46706-8
|
Clostridium perfringens toxin gene [Identifier] in Unspecified specimen by NAA with probe detection |
|
77496-8
|
Clostridium perfringens [Presence] in Unspecified specimen by Organism specific culture |
|
92859-8
|
Chlamydophila pneumoniae and Mycoplasma pneumoniae DNA panel - Lower respiratory specimen by NAA with probe detection |
|
92860-6
|
Chlamydophila pneumoniae and Mycoplasma pneumoniae DNA panel - Upper respiratory specimen by NAA with probe detection |
|
33943-2
|
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
43216-1
|
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Throat by NAA with probe detection |
|
35639-4
|
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Tissue by NAA with probe detection |
|
24402-0
|
Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Unspecified specimen by Probe with amplification |
|
47052-6
|
Chlamydophila pneumoniae Ab [Units/volume] in Serum by Immunofluorescence |
|
30205-9
|
Chlamydophila pneumoniae Ab [Presence] in Serum |
|
5078-1
|
Chlamydophila pneumoniae Ab [Units/volume] in Serum |
|
44980-1
|
Chlamydophila pneumoniae Ab [Presence] in Serum --1st specimen |
|
44979-3
|
Chlamydophila pneumoniae Ab [Presence] in Serum --2nd specimen |
|
11254-0
|
Chlamydophila pneumoniae Ab [Titer] in Serum |
|
43845-7
|
Chlamydophila pneumoniae Ab [Titer] in Serum by Immunofluorescence |
|
10651-8
|
Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |
|
31778-4
|
Chlamydophila pneumoniae Ag [Presence] in Unspecified specimen |
|
29722-6
|
Chlamydophila pneumoniae Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88546-7
|
Chlamydophila pneumoniae DNA [Presence] in Aspirate by NAA with probe detection |
|
92986-9
|
Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88547-5
|
Chlamydophila pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82178-5
|
Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88718-2
|
Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92133-8
|
Chlamydophila pneumoniae DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
10652-6
|
Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |
|
92577-6
|
Chlamydophila pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
34645-2
|
Chlamydophila pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31299-1
|
Chlamydophila pneumoniae IgA Ab [Units/volume] in Cerebral spinal fluid |
|
44982-7
|
Chlamydophila pneumoniae IgA Ab [Presence] in Serum |
|
31300-7
|
Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum |
|
22169-7
|
Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid |
|
16581-1
|
Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22170-5
|
Chlamydophila pneumoniae IgA Ab [Titer] in Serum |
|
6912-0
|
Chlamydophila pneumoniae IgA Ab [Titer] in Serum by Immunofluorescence |
|
58758-4
|
Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31301-5
|
Chlamydophila pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid |
|
51806-8
|
Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
|
44981-9
|
Chlamydophila pneumoniae IgG Ab [Presence] in Serum |
|
89641-5
|
Chlamydophila pneumoniae IgG Ab [Presence] in Serum by Immunoassay |
|
31302-3
|
Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum |
|
22171-3
|
Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid |
|
16582-9
|
Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22172-1
|
Chlamydophila pneumoniae IgG Ab [Titer] in Serum |
|
6913-8
|
Chlamydophila pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence |
|
31303-1
|
Chlamydophila pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51807-6
|
Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay |
|
24004-4
|
Chlamydophila pneumoniae IgM Ab [Presence] in Serum |
|
89640-7
|
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay |
|
43844-0
|
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence |
|
31304-9
|
Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum |
|
22173-9
|
Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid |
|
16583-7
|
Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22174-7
|
Chlamydophila pneumoniae IgM Ab [Titer] in Serum |
|
6914-6
|
Chlamydophila pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence |
|
7821-2
|
Chlamydophila pneumoniae rRNA [Presence] in Serum by NAA with probe detection |
|
16585-2
|
Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by Probe |
|
16584-5
|
Chlamydophila pneumoniae rRNA [Presence] in Sputum by Probe |
|
34707-0
|
Chlamydophila pneumoniae rRNA [Presence] in Unspecified specimen by Probe |
|
21184-7
|
Chlamydophila pneumoniae [Presence] in Unspecified specimen by Organism specific culture |
|
22175-4
|
Chlamydophila psittaci Ab [Presence] in Serum |
|
22994-8
|
Chlamydophila psittaci Ab [Presence] in Serum by Agglutination |
|
20754-8
|
Chlamydophila psittaci Ab [Presence] in Serum by Complement fixation |
|
22996-3
|
Chlamydophila psittaci Ab [Presence] in Serum by Immunoassay |
|
22995-5
|
Chlamydophila psittaci Ab [Presence] in Serum by Immune diffusion (ID) |
|
7822-0
|
Chlamydophila psittaci Ab [Units/volume] in Serum |
|
22176-2
|
Chlamydophila psittaci Ab [Titer] in Serum |
|
5079-9
|
Chlamydophila psittaci Ab [Titer] in Serum by Complement fixation |
|
14198-6
|
Chlamydophila psittaci Ab [Titer] in Serum by Immunofluorescence |
|
23000-3
|
Chlamydophila psittaci Ag [Presence] in Exudate by Immune stain |
|
31779-2
|
Chlamydophila psittaci Ag [Presence] in Genital specimen |
|
6338-8
|
Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunoassay |
|
6339-6
|
Chlamydophila psittaci Ag [Presence] in Genital specimen by Immunofluorescence |
|
22999-7
|
Chlamydophila psittaci Ag [Presence] in Stool by Immune stain |
|
20753-0
|
Chlamydophila psittaci Ag [Presence] in Tissue by Immunofluorescence |
|
22998-9
|
Chlamydophila psittaci Ag [Presence] in Tissue by Immune stain |
|
31780-0
|
Chlamydophila psittaci Ag [Presence] in Unspecified specimen |
|
6340-4
|
Chlamydophila psittaci Ag [Presence] in Unspecified specimen by Immunoassay |
|
6341-2
|
Chlamydophila psittaci Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22997-1
|
Chlamydophila psittaci Ag [Presence] in Unspecified specimen by Immune stain |
|
59065-3
|
Chlamydophila psittaci [Presence] in Bronchial brush by Organism specific culture |
|
23001-1
|
Chlamydophila psittaci DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31305-6
|
Chlamydophila psittaci IgA Ab [Units/volume] in Cerebral spinal fluid |
|
44978-5
|
Chlamydophila psittaci IgA Ab [Presence] in Serum |
|
31306-4
|
Chlamydophila psittaci IgA Ab [Units/volume] in Serum |
|
22177-0
|
Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid |
|
16586-0
|
Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22178-8
|
Chlamydophila psittaci IgA Ab [Titer] in Serum |
|
6915-3
|
Chlamydophila psittaci IgA Ab [Titer] in Serum by Immunofluorescence |
|
31307-2
|
Chlamydophila psittaci IgG Ab [Units/volume] in Cerebral spinal fluid |
|
51808-4
|
Chlamydophila psittaci IgG Ab [Units/volume] in Serum by Immunoassay |
|
43868-9
|
Chlamydophila psittaci IgG Ab [Presence] in Serum |
|
5080-7
|
Chlamydophila psittaci IgG Ab [Units/volume] in Serum |
|
22179-6
|
Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid |
|
16587-8
|
Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22180-4
|
Chlamydophila psittaci IgG Ab [Titer] in Serum |
|
6916-1
|
Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence |
|
16588-6
|
Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51809-2
|
Chlamydophila psittaci IgM Ab [Units/volume] in Serum by Immunoassay |
|
44977-7
|
Chlamydophila psittaci IgM Ab [Presence] in Serum |
|
5081-5
|
Chlamydophila psittaci IgM Ab [Units/volume] in Serum |
|
43057-9
|
Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid |
|
27404-3
|
Chlamydophila psittaci IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22181-2
|
Chlamydophila psittaci IgM Ab [Titer] in Serum |
|
6917-9
|
Chlamydophila psittaci IgM Ab [Titer] in Serum by Immunofluorescence |
|
22993-0
|
Chlamydophila psittaci [Presence] in Placenta by Electron microscopy |
|
20752-2
|
Chlamydophila psittaci [Presence] in Unspecified specimen by Organism specific culture |
|
22992-2
|
Chlamydophila psittaci [Presence] in Unspecified specimen by Giemsa stain |
|
23012-8
|
Cowdria ruminantium Ab [Presence] in Serum |
|
23011-0
|
Cowdria ruminantium Ab [Presence] in Serum by Immunoassay |
|
23013-6
|
Cowdria ruminantium Ab [Presence] in Serum by Immunoblot |
|
23010-2
|
Cowdria ruminantium Ab [Presence] in Serum by Immunofluorescence |
|
23009-4
|
Cowdria ruminantium [Presence] in Brain by Giemsa stain |
|
23014-4
|
Cowdria ruminantium DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23015-1
|
Cowdria ruminantium rRNA [Presence] in Unspecified specimen by Probe |
|
20765-4
|
Clostridium septicum Ag [Presence] in Tissue by Immunofluorescence |
|
7498-9
|
Chrysonilia sitophila IgE Ab [Units/volume] in Serum |
|
20766-2
|
Clostridium sordellii Ag [Presence] in Tissue by Immunofluorescence |
|
42198-2
|
Curvularia specifera IgE Ab [Units/volume] in Serum |
|
7415-3
|
Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum |
|
7267-8
|
Cryptococcus terreus IgE Ab [Units/volume] in Serum |
|
40711-4
|
Clostridium tetani Ab [Units/volume] in Serum by Immunoassay |
|
5093-0
|
Clostridium tetani Ab [Presence] in Serum |
|
5092-2
|
Clostridium tetani Ab [Units/volume] in Serum |
|
16626-4
|
Clostridium tetani Ab [Units/volume] in Serum --1st specimen |
|
16627-2
|
Clostridium tetani Ab [Units/volume] in Serum --2nd specimen |
|
6367-7
|
Clostridium tetani IgG Ab [Units/volume] in Serum by Immunoassay |
|
33469-8
|
Clostridium tetani IgG Ab [Presence] in Serum |
|
22203-4
|
Clostridium tetani IgG Ab [Units/volume] in Serum |
|
47296-9
|
Clostridium tetani toxoid Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
41483-9
|
Clostridium tetani toxoid Ab [Units/volume] in Serum by Immunoassay |
|
26643-7
|
Clostridium tetani toxoid Ab [Presence] in Serum |
|
32775-9
|
Clostridium tetani toxoid Ab [Units/volume] in Serum |
|
19760-8
|
Clostridium tetani toxoid IgE Ab [Units/volume] in Serum |
|
58770-9
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
53935-3
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
48653-0
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
49191-0
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --1st specimen |
|
48652-2
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
49192-8
|
Clostridium tetani toxoid IgG Ab [Units/volume] in Serum --2nd specimen |
|
45130-2
|
Chlamydia trachomatis Ab [Presence] in Body fluid |
|
45007-2
|
Chlamydia trachomatis Ab [Units/volume] in Serum by Immunoassay |
|
30204-2
|
Chlamydia trachomatis Ab [Presence] in Serum |
|
45008-0
|
Chlamydia trachomatis Ab [Presence] in Serum by Complement fixation |
|
45009-8
|
Chlamydia trachomatis Ab [Presence] in Serum by Immunofluorescence |
|
7824-6
|
Chlamydia trachomatis Ab [Units/volume] in Serum |
|
44998-3
|
Chlamydia trachomatis Ab [Presence] in Serum --1st specimen |
|
44997-5
|
Chlamydia trachomatis Ab [Units/volume] in Serum --2nd specimen |
|
22187-9
|
Chlamydia trachomatis Ab [Titer] in Serum |
|
5087-2
|
Chlamydia trachomatis Ab [Titer] in Serum by Complement fixation |
|
5088-0
|
Chlamydia trachomatis Ab [Titer] in Serum by Immunofluorescence |
|
34710-4
|
Chlamydia trachomatis Ag [Presence] in Anal |
|
91861-5
|
Chlamydia trachomatis Ag [Presence] in Aspirate by Immunofluorescence |
|
31768-5
|
Chlamydia trachomatis Ag [Presence] in Blood |
|
14468-3
|
Chlamydia trachomatis Ag [Presence] in Blood by Immunoassay |
|
14507-8
|
Chlamydia trachomatis Ag [Presence] in Blood by Immunofluorescence |
|
31769-3
|
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen |
|
6350-3
|
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunoassay |
|
6351-1
|
Chlamydia trachomatis Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
31770-1
|
Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid |
|
14469-1
|
Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
14508-6
|
Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31771-9
|
Chlamydia trachomatis Ag [Presence] in Cervix |
|
14470-9
|
Chlamydia trachomatis Ag [Presence] in Cervix by Immunoassay |
|
14509-4
|
Chlamydia trachomatis Ag [Presence] in Cervix by Immunofluorescence |
|
47234-0
|
Chlamydia trachomatis Ag [Presence] in Body fluid |
|
45091-6
|
Chlamydia trachomatis Ag [Presence] in Genital specimen |
|
91860-7
|
Chlamydia trachomatis Ag [Presence] in Genital specimen by Immunofluorescence |
|
34709-6
|
Chlamydia trachomatis Ag [Presence] in Nasopharynx |
|
45092-4
|
Chlamydia trachomatis Ag [Presence] in Nasopharynx by Immunoassay |
|
31774-3
|
Chlamydia trachomatis Ag [Presence] in Stool |
|
6352-9
|
Chlamydia trachomatis Ag [Presence] in Stool by Immunofluorescence |
|
91873-0
|
Chlamydia trachomatis Ag [Presence] in Throat by Immunofluorescence |
|
6353-7
|
Chlamydia trachomatis Ag [Presence] in Tissue by Immunofluorescence |
|
31775-0
|
Chlamydia trachomatis Ag [Presence] in Urine sediment |
|
14474-1
|
Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay |
|
14513-6
|
Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence |
|
31776-8
|
Chlamydia trachomatis Ag [Presence] in Urethra |
|
14472-5
|
Chlamydia trachomatis Ag [Presence] in Urethra by Immunoassay |
|
14511-0
|
Chlamydia trachomatis Ag [Presence] in Urethra by Immunofluorescence |
|
31772-7
|
Chlamydia trachomatis Ag [Presence] in Vaginal fluid |
|
14471-7
|
Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunoassay |
|
14510-2
|
Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
31777-6
|
Chlamydia trachomatis Ag [Presence] in Unspecified specimen |
|
6354-5
|
Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunoassay |
|
6355-2
|
Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
45093-2
|
Chlamydia trachomatis [Presence] in Anal by Organism specific culture |
|
13217-5
|
Chlamydia trachomatis B Ab [Units/volume] in Serum |
|
32005-1
|
Chlamydia trachomatis B Ab [Titer] in Serum |
|
27368-0
|
Chlamydia trachomatis B Ab [Titer] in Serum by Immunofluorescence |
|
44996-7
|
Chlamydia trachomatis B IgA Ab [Presence] in Serum |
|
31294-2
|
Chlamydia trachomatis B IgA Ab [Units/volume] in Serum |
|
22194-5
|
Chlamydia trachomatis B IgA Ab [Titer] in Serum |
|
14199-4
|
Chlamydia trachomatis B IgA Ab [Titer] in Serum by Immunofluorescence |
|
44995-9
|
Chlamydia trachomatis B IgG Ab [Presence] in Serum |
|
16597-7
|
Chlamydia trachomatis B IgG Ab [Units/volume] in Serum |
|
22195-2
|
Chlamydia trachomatis B IgG Ab [Titer] in Serum |
|
14200-0
|
Chlamydia trachomatis B IgG Ab [Titer] in Serum by Immunofluorescence |
|
44994-2
|
Chlamydia trachomatis B IgM Ab [Presence] in Serum |
|
31295-9
|
Chlamydia trachomatis B IgM Ab [Units/volume] in Serum |
|
22196-0
|
Chlamydia trachomatis B IgM Ab [Titer] in Serum |
|
14201-8
|
Chlamydia trachomatis B IgM Ab [Titer] in Serum by Immunofluorescence |
|
14461-8
|
Chlamydia trachomatis [Presence] in Blood by Organism specific culture |
|
13218-3
|
Chlamydia trachomatis C Ab [Units/volume] in Serum |
|
32006-9
|
Chlamydia trachomatis C Ab [Titer] in Serum |
|
27370-6
|
Chlamydia trachomatis C Ab [Titer] in Serum by Immunofluorescence |
|
44993-4
|
Chlamydia trachomatis C IgA Ab [Presence] in Serum |
|
22197-8
|
Chlamydia trachomatis C IgA Ab [Titer] in Serum |
|
14202-6
|
Chlamydia trachomatis C IgA Ab [Titer] in Serum by Immunofluorescence |
|
44992-6
|
Chlamydia trachomatis C IgG Ab [Presence] in Serum |
|
16598-5
|
Chlamydia trachomatis C IgG Ab [Units/volume] in Serum |
|
22198-6
|
Chlamydia trachomatis C IgG Ab [Titer] in Serum |
|
14203-4
|
Chlamydia trachomatis C IgG Ab [Titer] in Serum by Immunofluorescence |
|
44991-8
|
Chlamydia trachomatis C IgM Ab [Presence] in Serum |
|
13220-9
|
Chlamydia trachomatis C IgM Ab [Units/volume] in Serum |
|
22199-4
|
Chlamydia trachomatis C IgM Ab [Titer] in Serum |
|
14204-2
|
Chlamydia trachomatis C IgM Ab [Titer] in Serum by Immunofluorescence |
|
45094-0
|
Chlamydia trachomatis [Presence] in Conjunctival specimen by Organism specific culture |
|
14462-6
|
Chlamydia trachomatis [Presence] in Cerebral spinal fluid by Organism specific culture |
|
14463-4
|
Chlamydia trachomatis [Presence] in Cervix by Organism specific culture |
|
26663-5
|
Chlamydia trachomatis D Ab [Presence] in Serum |
|
46176-4
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum |
|
43356-5
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgA Ab [Titer] in Serum by Immunofluorescence |
|
46177-2
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum |
|
43355-7
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgG Ab [Titer] in Serum by Immunofluorescence |
|
46178-0
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum |
|
43357-3
|
Chlamydia trachomatis D+E+F+G+H+I+J+K IgM Ab [Titer] in Serum by Immunofluorescence |
|
44990-0
|
Chlamydia trachomatis D+K IgA Ab [Presence] in Serum |
|
31296-7
|
Chlamydia trachomatis D+K IgA Ab [Units/volume] in Serum |
|
43060-3
|
Chlamydia trachomatis D+K IgA Ab [Titer] in Serum |
|
28557-7
|
Chlamydia trachomatis D+K IgA Ab [Titer] in Serum by Immunofluorescence |
|
44989-2
|
Chlamydia trachomatis D+K IgG Ab [Presence] in Serum |
|
31297-5
|
Chlamydia trachomatis D+K IgG Ab [Units/volume] in Serum |
|
43059-5
|
Chlamydia trachomatis D+K IgG Ab [Titer] in Serum |
|
28556-9
|
Chlamydia trachomatis D+K IgG Ab [Titer] in Serum by Immunofluorescence |
|
44988-4
|
Chlamydia trachomatis D+K IgM Ab [Presence] in Serum |
|
31298-3
|
Chlamydia trachomatis D+K IgM Ab [Units/volume] in Serum |
|
43058-7
|
Chlamydia trachomatis D+K IgM Ab [Titer] in Serum |
|
28558-5
|
Chlamydia trachomatis D+K IgM Ab [Titer] in Serum by Immunofluorescence |
|
45090-8
|
Chlamydia trachomatis DNA [Presence] in Anal by NAA with probe detection |
|
16599-3
|
Chlamydia trachomatis DNA [Presence] in Blood by NAA with probe detection |
|
21189-6
|
Chlamydia trachomatis DNA [Presence] in Cervical mucus by NAA with probe detection |
|
21187-0
|
Chlamydia trachomatis DNA [Presence] in Conjunctival specimen by NAA with probe detection |
|
21190-4
|
Chlamydia trachomatis DNA [Presence] in Cervix by NAA with probe detection |
|
6356-0
|
Chlamydia trachomatis DNA [Presence] in Genital specimen by NAA with probe detection |
|
45086-6
|
Chlamydia trachomatis DNA [Presence] in Nasopharynx by NAA with probe detection |
|
80363-5
|
Chlamydia trachomatis DNA [Presence] in Rectum by NAA with probe detection |
|
51578-3
|
Chlamydia trachomatis DNA [Presence] in Semen by NAA with probe detection |
|
88221-7
|
Chlamydia trachomatis DNA [Presence] in Throat by NAA with probe detection |
|
87949-4
|
Chlamydia trachomatis DNA [Presence] in Tissue by NAA with probe detection |
|
6357-8
|
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection |
|
21191-2
|
Chlamydia trachomatis DNA [Presence] in Urethra by NAA with probe detection |
|
45084-1
|
Chlamydia trachomatis DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
50311-0
|
Chlamydia trachomatis DNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
47212-6
|
Chlamydia trachomatis DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
49096-1
|
Chlamydia trachomatis DNA [Units/volume] in Unspecified specimen by NAA with probe detection |
|
21613-5
|
Chlamydia trachomatis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43404-3
|
Chlamydia trachomatis DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
26664-3
|
Chlamydia trachomatis E Ab [Presence] in Serum |
|
26665-0
|
Chlamydia trachomatis F Ab [Presence] in Serum |
|
13219-1
|
Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum |
|
32007-7
|
Chlamydia trachomatis G+F+K Ab [Titer] in Serum |
|
27371-4
|
Chlamydia trachomatis G+F+K Ab [Titer] in Serum by Immunofluorescence |
|
44987-6
|
Chlamydia trachomatis G+F+K IgA Ab [Presence] in Serum |
|
22200-0
|
Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum |
|
18490-3
|
Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum by Immunofluorescence |
|
22201-8
|
Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum |
|
18491-1
|
Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum by Immunofluorescence |
|
44986-8
|
Chlamydia trachomatis G+F+K IgM Ab [Presence] in Serum |
|
13221-7
|
Chlamydia trachomatis G+F+K IgM Ab [Units/volume] in Serum |
|
22202-6
|
Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum |
|
18492-9
|
Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum by Immunofluorescence |
|
45095-7
|
Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture |
|
26666-8
|
Chlamydia trachomatis H Ab [Presence] in Serum |
|
26667-6
|
Chlamydia trachomatis I Ab [Presence] in Serum |
|
33605-7
|
Chlamydia trachomatis I Ab [Titer] in Serum |
|
33575-2
|
Chlamydia trachomatis I Ab [Titer] in Serum by Immunofluorescence |
|
33604-0
|
Chlamydia trachomatis I IgM Ab [Titer] in Serum |
|
33574-5
|
Chlamydia trachomatis I IgM Ab [Titer] in Serum by Immunofluorescence |
|
45004-9
|
Chlamydia trachomatis IgA Ab [Presence] in Cerebral spinal fluid |
|
45006-4
|
Chlamydia trachomatis IgA Ab [Units/volume] in Serum by Immunoassay |
|
45005-6
|
Chlamydia trachomatis IgA Ab [Presence] in Serum |
|
31293-4
|
Chlamydia trachomatis IgA Ab [Units/volume] in Serum |
|
22188-7
|
Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid |
|
16594-4
|
Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22189-5
|
Chlamydia trachomatis IgA Ab [Titer] in Serum |
|
6918-7
|
Chlamydia trachomatis IgA Ab [Titer] in Serum by Immunofluorescence |
|
16595-1
|
Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
45002-3
|
Chlamydia trachomatis IgG Ab [Presence] in Cerebral spinal fluid |
|
22190-3
|
Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid |
|
26715-3
|
Chlamydia trachomatis IgG Ab [Units/volume] in Serum by Immunoassay |
|
43848-1
|
Chlamydia trachomatis IgG Ab [Presence] in Serum |
|
45135-1
|
Chlamydia trachomatis IgG Ab [Presence] in Serum by Immunoassay |
|
5089-8
|
Chlamydia trachomatis IgG Ab [Units/volume] in Serum |
|
43062-9
|
Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid |
|
27185-8
|
Chlamydia trachomatis IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22191-1
|
Chlamydia trachomatis IgG Ab [Titer] in Serum |
|
45003-1
|
Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunoassay |
|
6919-5
|
Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunofluorescence |
|
16596-9
|
Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
44999-1
|
Chlamydia trachomatis IgM Ab [Presence] in Cerebral spinal fluid |
|
22192-9
|
Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid |
|
45001-5
|
Chlamydia trachomatis IgM Ab [Units/volume] in Serum by Immunoassay |
|
41157-9
|
Chlamydia trachomatis IgM Ab [Presence] in Serum |
|
40710-6
|
Chlamydia trachomatis IgM Ab [Presence] in Serum by Immunoassay |
|
5090-6
|
Chlamydia trachomatis IgM Ab [Units/volume] in Serum |
|
43061-1
|
Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid |
|
27167-6
|
Chlamydia trachomatis IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22193-7
|
Chlamydia trachomatis IgM Ab [Titer] in Serum |
|
45000-7
|
Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunoassay |
|
6920-3
|
Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunofluorescence |
|
26668-4
|
Chlamydia trachomatis L1 Ab [Presence] in Serum |
|
90361-7
|
Chlamydia trachomatis L1 IgA Ab [Titer] in Serum by Immunoassay |
|
90362-5
|
Chlamydia trachomatis L1 IgG Ab [Titer] in Serum by Immunoassay |
|
90363-3
|
Chlamydia trachomatis L1 IgM Ab [Titer] in Serum by Immunoassay |
|
26626-2
|
Chlamydia trachomatis L2 Ab [Presence] in Serum |
|
47211-8
|
Chlamydia trachomatis L2 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44985-0
|
Chlamydia trachomatis L2 IgA Ab [Presence] in Serum |
|
40855-9
|
Chlamydia trachomatis L2 IgA Ab [Titer] in Serum |
|
43174-2
|
Chlamydia trachomatis L2 IgA Ab [Titer] in Serum by Immunofluorescence |
|
44984-3
|
Chlamydia trachomatis L2 IgG Ab [Presence] in Serum |
|
40854-2
|
Chlamydia trachomatis L2 IgG Ab [Titer] in Serum |
|
43173-4
|
Chlamydia trachomatis L2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
44983-5
|
Chlamydia trachomatis L2 IgM Ab [Presence] in Serum |
|
40856-7
|
Chlamydia trachomatis L2 IgM Ab [Titer] in Serum |
|
43175-9
|
Chlamydia trachomatis L2 IgM Ab [Titer] in Serum by Immunofluorescence |
|
45096-5
|
Chlamydia trachomatis [Presence] in Nasopharynx by Organism specific culture |
|
80367-6
|
Chlamydia trachomatis [Presence] in Rectum by Organism specific culture |
|
57287-5
|
Chlamydia trachomatis rRNA [Presence] in Anal by NAA with probe detection |
|
45089-0
|
Chlamydia trachomatis rRNA [Presence] in Anal by Probe |
|
38469-3
|
Chlamydia trachomatis rRNA [Presence] in Blood by Probe |
|
21188-8
|
Chlamydia trachomatis rRNA [Presence] in Conjunctival specimen by Probe |
|
50387-0
|
Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection |
|
45078-3
|
Chlamydia trachomatis rRNA [Presence] in Cervix by Probe |
|
23838-6
|
Chlamydia trachomatis rRNA [Presence] in Genital fluid by Probe |
|
16600-9
|
Chlamydia trachomatis rRNA [Presence] in Genital specimen by Probe |
|
57288-3
|
Chlamydia trachomatis rRNA [Presence] in Nasopharynx by NAA with probe detection |
|
45085-8
|
Chlamydia trachomatis rRNA [Presence] in Nasopharynx by Probe |
|
80364-3
|
Chlamydia trachomatis rRNA [Presence] in Rectum by NAA with probe detection |
|
82306-2
|
Chlamydia trachomatis rRNA [Presence] in Throat by NAA with probe detection |
|
42931-6
|
Chlamydia trachomatis rRNA [Presence] in Urine by NAA with probe detection |
|
16601-7
|
Chlamydia trachomatis rRNA [Presence] in Urine by Probe |
|
53925-4
|
Chlamydia trachomatis rRNA [Presence] in Urethra by NAA with probe detection |
|
21192-0
|
Chlamydia trachomatis rRNA [Presence] in Urethra by Probe |
|
53926-2
|
Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by NAA with probe detection |
|
45080-9
|
Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by Probe |
|
50411-8
|
Chlamydia trachomatis rRNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
43304-5
|
Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
4993-2
|
Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by Probe |
|
89648-0
|
Chlamydia trachomatis [Presence] in Throat by Organism specific culture |
|
87950-2
|
Chlamydia trachomatis [Presence] in Tissue by Organism specific culture |
|
14467-5
|
Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture |
|
14465-9
|
Chlamydia trachomatis [Presence] in Urethra by Organism specific culture |
|
14464-2
|
Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture |
|
6349-5
|
Chlamydia trachomatis [Presence] in Unspecified specimen by Organism specific culture |
|
45068-4
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection |
|
44807-6
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection |
|
44806-8
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection |
|
36903-3
|
Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
43405-0
|
Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by Probe with signal amplification |
|
36902-5
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43406-8
|
Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
70163-1
|
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Cervix by NAA with probe detection |
|
90357-5
|
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Nasopharynx by NAA with probe detection |
|
90358-3
|
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Rectum by NAA with probe detection |
|
70161-5
|
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urine by NAA with probe detection |
|
70162-3
|
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urethra by NAA with probe detection |
|
70164-9
|
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Vaginal fluid by NAA with probe detection |
|
64017-7
|
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Unspecified specimen by NAA with probe detection |
|
45072-6
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Anal by Probe |
|
80361-9
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection |
|
45067-6
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe |
|
45069-2
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Genital specimen by Probe |
|
80365-0
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Rectum by NAA with probe detection |
|
45073-4
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Tissue by Probe |
|
80360-1
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection |
|
45074-2
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe |
|
45075-9
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe |
|
80362-7
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection |
|
45070-0
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe |
|
47362-9
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
45076-7
|
Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe |
|
85785-4
|
Candida tropicalis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
70023-7
|
Candida tropicalis DNA [Presence] in Blood by NAA with probe detection |
|
90810-3
|
Candida tropicalis DNA [Presence] in Serum by NAA with probe detection |
|
72391-6
|
Candida tropicalis DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
53236-6
|
Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in DBS |
|
66951-5
|
Complement C1.functional [Units/volume] in Serum |
|
53900-7
|
C10orf2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77075-0
|
C12orf65 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77074-3
|
C12orf65 gene full mutation analysis in Blood or Tissue by Sequencing |
|
93882-9
|
N-Palmitoylsphingosine [Moles/volume] in Plasma |
|
93879-5
|
N-Palmitoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma |
|
93881-1
|
N-Stearoylsphingosine [Moles/volume] in Plasma |
|
93878-7
|
N-Stearoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma |
|
48494-9
|
Complement C1 esterase inhibitor actual/normal in Serum or Plasma |
|
51795-3
|
Complement C1 esterase inhibitor bound Ab [Mass/volume] in Serum or Plasma |
|
18210-5
|
Complement C1 esterase inhibitor bound IgG Ab [Mass/volume] in Serum or Plasma |
|
18211-3
|
Complement C1 esterase inhibitor bound IgM Ab [Mass/volume] in Serum or Plasma |
|
36906-6
|
Complement C1 esterase inhibitor [Mass/volume] in Body fluid |
|
18212-1
|
Complement C1 esterase inhibitor free IgG Ab [Mass/volume] in Serum or Plasma |
|
18213-9
|
Complement C1 esterase inhibitor free IgM Ab [Mass/volume] in Serum or Plasma |
|
34619-7
|
Complement C1 esterase inhibitor.functional [Mass/volume] in Body fluid |
|
15161-3
|
Complement C1 esterase inhibitor.functional [Presence] in Serum or Plasma |
|
4476-8
|
Complement C1 esterase inhibitor.functional [Mass/volume] in Serum or Plasma |
|
10634-4
|
Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |
|
82876-4
|
Complement C1 esterase inhibitor [Units/volume] in Serum or Plasma by Chromogenic method |
|
4477-6
|
Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma |
|
53020-4
|
Complement C1q Ab [Presence] in Serum |
|
44702-9
|
Complement C1q Ab [Units/volume] in Serum |
|
6297-6
|
Complement C1q Ag [Units/volume] in Serum |
|
13172-2
|
Complement C1q Ag [Units/volume] in Serum or Plasma by Raji cell assay |
|
4479-2
|
Complement C1q Ag [Moles/volume] in Serum or Plasma |
|
15162-1
|
Complement C1q [Mass/volume] in Body fluid |
|
4478-4
|
Complement C1q [Mass/volume] in Serum or Plasma |
|
87722-5
|
Complement C1q.functional [Units/volume] in Serum or Plasma |
|
4481-8
|
Complement C1r [Mass/volume] in Serum or Plasma |
|
4482-6
|
Complement C1r2+C1s2 [Units/volume] in Serum or Plasma |
|
4513-8
|
Complement C1r2+C1s2 [Mass/volume] in Serum or Plasma |
|
4483-4
|
Complement C1s [Mass/volume] in Serum or Plasma |
|
15163-9
|
Complement C2 [Mass/volume] in Body fluid |
|
40747-8
|
Complement C2 [Presence] in Serum or Plasma |
|
33408-6
|
Complement C2 [Units/volume] in Serum or Plasma |
|
4484-2
|
Complement C2 [Mass/volume] in Serum or Plasma |
|
93977-7
|
Complement C2.functional [Units/volume] in Serum or Plasma |
|
93880-3
|
N-Nervonoylsphingosine [Moles/volume] in Plasma |
|
93877-9
|
N-Nervonoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma |
|
79283-8
|
C29 dicarboxylate [Moles/volume] in Serum or Plasma |
|
60277-1
|
Complement C3 Ag [Presence] in Tissue by Immunofluorescence |
|
10434-9
|
Complement C3 Ag [Presence] in Tissue by Immune stain |
|
6801-5
|
Complement C3 [Mass/volume] in Body fluid |
|
4486-7
|
Complement C3 fragment [Presence] in Red Blood Cells |
|
4487-5
|
Complement C3 fragment [Mass/volume] in Red Blood Cells |
|
38387-7
|
C3 nephritic factor [Presence] in Serum or Plasma |
|
23844-4
|
C3 nephritic factor [Units/volume] in Serum or Plasma |
|
13086-4
|
C3 nephritic factor [Mass/volume] in Serum or Plasma |
|
43575-0
|
Complement C3 [Mass/volume] in Pericardial fluid |
|
43579-2
|
Complement C3 [Mass/volume] in Pleural fluid |
|
43578-4
|
Complement C3 [Mass/volume] in Peritoneal fluid |
|
38388-5
|
Complement C3 [Presence] in Serum or Plasma |
|
4485-9
|
Complement C3 [Mass/volume] in Serum or Plasma |
|
15164-7
|
Complement C3 [Mass/volume] in Synovial fluid |
|
87723-3
|
Complement C3.functional [Units/volume] in Serum or Plasma |
|
75211-3
|
Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in DBS |
|
4488-3
|
Complement C3a [Mass/volume] in Serum or Plasma |
|
14195-2
|
Complement C3b Inactive [Mass/volume] in Plasma |
|
4489-1
|
Complement C3b [Mass/volume] in Serum or Plasma |
|
4490-9
|
Complement C3b-C4b receptor [Entitic number] in Red Blood Cells |
|
6296-8
|
Complement C3b-C4b receptor [Presence] in Red Blood Cells |
|
48420-4
|
Complement C3c [Mass/volume] in Body fluid |
|
4491-7
|
Complement C3c [Mass/volume] in Serum or Plasma |
|
4492-5
|
Complement C3d [Entitic number] in Red Blood Cells |
|
6295-0
|
Complement C3d [Presence] in Red Blood Cells |
|
34401-0
|
Complement C3d [Mass/volume] in Serum or Plasma |
|
4500-5
|
Complement C4 CH50 [Mass/volume] in Cerebral spinal fluid |
|
6908-8
|
Complement C4 [Mass/volume] in Body fluid |
|
93866-2
|
C4 nephritic factor [Presence] in Serum or Plasma |
|
13085-6
|
C4 nephritic factor [Mass/volume] in Serum or Plasma |
|
43580-0
|
Complement C4 [Mass/volume] in Pericardial fluid |
|
43582-6
|
Complement C4 [Mass/volume] in Pleural fluid |
|
43581-8
|
Complement C4 [Mass/volume] in Peritoneal fluid |
|
48731-4
|
Complement C4 [Presence] in Serum or Plasma |
|
26931-6
|
Complement C4 [Units/volume] in Serum or Plasma |
|
4498-2
|
Complement C4 [Mass/volume] in Serum or Plasma |
|
76496-9
|
Complement C4 [Moles/volume] in Serum or Plasma |
|
15165-4
|
Complement C4 [Mass/volume] in Synovial fluid |
|
93978-5
|
Complement C4.functional [Units/volume] in Serum or Plasma |
|
4501-3
|
Complement C4a [Mass/volume] in Plasma |
|
4502-1
|
Complement C4b binding protein [Units/volume] in Serum or Plasma |
|
4503-9
|
Complement C4b binding protein [Mass/volume] in Serum or Plasma |
|
49461-7
|
C4d Ag [Presence] in Tissue by Immune stain |
|
4504-7
|
Complement C4d [Entitic number] in Red Blood Cells |
|
39565-7
|
Complement C4d [Mass/volume] in Plasma by Immunoassay |
|
21217-5
|
Complement C4d [Mass/volume] in Plasma |
|
6293-5
|
Complement C4d [Presence] in Red Blood Cells |
|
67709-6
|
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in DBS |
|
74629-7
|
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma |
|
81778-3
|
Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine [Molar ratio] in Urine |
|
15166-2
|
Complement C5 [Mass/volume] in Body fluid |
|
58683-4
|
Complement C5 [Presence] in Serum or Plasma |
|
4505-4
|
Complement C5 [Mass/volume] in Serum or Plasma |
|
60472-8
|
Complement C5.functional [Units/volume] in Serum or Plasma |
|
4506-2
|
Complement C5a [Mass/volume] in Plasma |
|
10435-6
|
C5B-9 Ag [Presence] in Tissue by Immune stain |
|
15167-0
|
Complement C6 [Mass/volume] in Body fluid |
|
4507-0
|
Complement C6 [Mass/volume] in Serum or Plasma |
|
60459-5
|
Complement C6.functional [Units/volume] in Serum or Plasma |
|
26996-9
|
Complement C7 [Units/volume] in Serum or Plasma |
|
4508-8
|
Complement C7 [Mass/volume] in Serum or Plasma |
|
87724-1
|
Complement C7.functional [Units/volume] in Serum or Plasma |
|
50997-6
|
Complement C8.functional [Units/volume] in Serum or Plasma |
|
4509-6
|
Complement C8 [Mass/volume] in Serum or Plasma |
|
4510-4
|
Complement C9 [Mass/volume] in Serum or Plasma |
|
87727-4
|
Complement C9.functional [Units/volume] in Serum or Plasma |
|
81847-6
|
C9orf72 gene GGGGCC repeat analysis in Amniotic fluid by Molecular genetics method |
|
81846-8
|
C9orf72 gene GGGGCC repeat analysis in Blood or Tissue by Molecular genetics method |
|
77635-1
|
C9orf72 gene GGGGCC repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
79157-4
|
Cold agglutinin [Titer] in Serum by 22 degree C incubation --1 hour post incubation |
|
79158-2
|
Cold agglutinin [Titer] in Serum by 4 deg C incubation --1 hour post incubation |
|
81310-5
|
Carbonic anhydrase 2 Ab [Presence] in Serum by Immunoassay |
|
79159-0
|
Cold agglutinin [Titer] in Serum by 4 deg C incubation --24 hour post incubation |
|
40999-5
|
Calcium hydrogen phosphate dihydrate [Mass/time] in 24 hour Urine |
|
49875-8
|
California juniper IgE Ab [Units/volume] in Serum |
|
54161-5
|
Cytoplasmic Ab pattern.PL-7+PL-12 [Presence] in Serum by Immunofluorescence |
|
54162-3
|
Cytoplasmic Ab pattern.PL-7+PL-12 [Titer] in Serum by Immunofluorescence |
|
70665-5
|
Cold agglutinin [Presence] in Serum by 18 degree C incubation |
|
70666-3
|
Cold agglutinin [Presence] in Serum by 22 degree C incubation |
|
70667-1
|
Cold agglutinin [Presence] in Serum by 28 degree C incubation |
|
32672-8
|
Cold agglutinin [Presence] in Serum or Plasma |
|
5097-1
|
Cold agglutinin [Presence] in Serum or Plasma by Agglutination |
|
14658-9
|
Cold agglutinin [Titer] in Serum or Plasma |
|
30900-5
|
Cold agglutinin [Titer] in Serum or Plasma by Adult RBC Agglutination |
|
5098-9
|
Cold agglutinin [Titer] in Serum or Plasma by Agglutination |
|
30901-3
|
Cold agglutinin [Titer] in Serum or Plasma by Cord RBC agglutination |
|
7169-6
|
Cabbage IgE Ab [Units/volume] in Serum |
|
61233-3
|
Cabbage IgE Ab/IgE total in Serum |
|
7170-4
|
Cabbage IgG Ab [Units/volume] in Serum |
|
56203-3
|
Cabbage IgG4 Ab [Mass/volume] in Serum |
|
60358-9
|
Cabbage IgG Ab [Mass/volume] in Serum |
|
49649-7
|
CACNA1A gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49650-5
|
CACNA1A gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21755-4
|
CACNA1A gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
44420-8
|
CACNA1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21641-6
|
CACNA1S gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21642-4
|
CACNA1S gene p.Arg1239Gly [Presence] in Blood or Tissue by Molecular genetics method |
|
21643-2
|
CACNA1S gene p.Arg1239His [Presence] in Blood or Tissue by Molecular genetics method |
|
21644-0
|
CACNA1S gene p.Arg528His [Presence] in Blood or Tissue by Molecular genetics method |
|
57918-5
|
CACNA1S+SCN4A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53847-0
|
CACT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
78940-4
|
Coronary artery disease risk factor panel |
|
30925-2
|
Cadmium [Mass/volume] in Urine collected for unspecified duration |
|
21130-0
|
Cadmium [Mass/volume] in 24 hour Urine |
|
5612-7
|
Cadmium [Mass/time] in 24 hour Urine |
|
34254-3
|
Cadmium [Moles/volume] in 24 hour Urine |
|
32304-8
|
Cadmium [Moles/time] in 24 hour Urine |
|
51902-5
|
Cadmium [Mass/volume] in Air |
|
5609-3
|
Cadmium [Mass/volume] in Blood |
|
15117-5
|
Cadmium [Moles/volume] in Blood |
|
9686-7
|
Cadmium [Mass/volume] in Cerebral spinal fluid |
|
51193-1
|
Cadmium [Mass/volume] in Body fluid |
|
5610-1
|
Cadmium [Mass/mass] in Hair |
|
50833-3
|
Cadmium [Moles/mass] in Hair |
|
21128-4
|
Cadmium [Mass/mass] in Nail |
|
12505-4
|
Cadmium [Mass/volume] in Red Blood Cells |
|
27117-1
|
Cadmium [Mass/mass] in Red Blood Cells |
|
50834-1
|
Cadmium [Moles/volume] in Red Blood Cells |
|
21129-2
|
Cadmium [Mass/volume] in Serum or Plasma |
|
25359-1
|
Cadmium [Moles/volume] in Serum or Plasma |
|
20737-3
|
Cadmium [Mass/mass] in Tissue |
|
5611-9
|
Cadmium [Mass/volume] in Urine |
|
25360-9
|
Cadmium [Moles/volume] in Urine |
|
34255-0
|
Cadmium [Moles/time] in Urine |
|
9466-4
|
Cadmium [Mass/volume] in Water |
|
9687-5
|
Cadmium [Mass/volume] in Unspecified specimen |
|
13828-9
|
Cadmium/Creatinine [Mass Ratio] in 24 hour Urine |
|
50835-8
|
Cadmium/Creatinine [Molar ratio] in 24 hour Urine |
|
13471-8
|
Cadmium/Creatinine [Mass Ratio] in Urine |
|
56651-3
|
Cadmium/Creatinine [Ratio] in Urine |
|
22696-9
|
Cadmium/Creatinine [Molar ratio] in Urine |
|
23686-9
|
Canine adenovirus Ag [Presence] in Tissue by Immunofluorescence |
|
31282-7
|
Canine adenovirus 1 Ab [Presence] in Serum |
|
23685-1
|
Canine adenovirus 1 Ab [Presence] in Serum by Neutralization test |
|
11017-1
|
Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain |
|
10780-5
|
Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain |
|
32814-6
|
Microscopic observation [Identifier] in Unspecified specimen by Chloracetate esterase stain |
|
22972-4
|
Caprine arthritis encephalitis virus Ab [Presence] in Milk |
|
22973-2
|
Caprine arthritis encephalitis virus Ab [Presence] in Milk by Immunoassay |
|
22164-8
|
Caprine arthritis encephalitis virus Ab [Presence] in Serum |
|
22974-0
|
Caprine arthritis encephalitis virus Ab [Presence] in Serum by Agglutination |
|
15464-1
|
Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay |
|
15465-8
|
Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23708-1
|
Caprine arthritis encephalitis virus Ag [Presence] in Unspecified specimen |
|
22976-5
|
Caprine arthritis encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22975-7
|
Caprine arthritis encephalitis virus Ag [Presence] in Unspecified specimen by Immune stain |
|
22978-1
|
Caprine arthritis encephalitis virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22977-3
|
Caprine arthritis encephalitis virus DNA [Presence] in Unspecified specimen by Polyacrylamide gel electrophoresis (PAGE) |
|
22971-6
|
Caprine arthritis encephalitis virus [Presence] in Unspecified specimen by Electron microscopy |
|
18204-8
|
Caffeine renal clearance in 24 hour Urine and Serum or Plasma |
|
29211-0
|
Caffeine [Mass/volume] in Body fluid |
|
40416-0
|
Caffeine [Presence] in Gastric fluid |
|
59811-0
|
Caffeine [Moles/volume] in Serum --peak |
|
3422-3
|
Caffeine [Mass/volume] in Serum or Plasma |
|
25361-7
|
Caffeine [Moles/volume] in Serum or Plasma |
|
74919-2
|
Caffeine [Mass/volume] in Serum or Plasma --trough |
|
59810-2
|
Caffeine [Moles/volume] in Serum --trough |
|
3423-1
|
Caffeine [Presence] in Urine |
|
3424-9
|
Caffeine [Mass/volume] in Urine |
|
43829-1
|
Caffeine [Presence] in Unspecified specimen |
|
60290-4
|
Caffeine [Moles/volume] in Unspecified specimen |
|
89001-2
|
CAGE Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
57086-1
|
Congenital adrenal hyperplasia newborn screening panel |
|
41158-7
|
Canine herpesvirus Ab [Presence] in Serum |
|
23697-6
|
Canine herpesvirus Ab [Presence] in Serum by Neutralization test |
|
23698-4
|
Canine herpesvirus Ag [Presence] in Tissue by Immunofluorescence |
|
59472-1
|
Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE) |
|
53138-4
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Arterial blood |
|
54366-0
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Cord blood |
|
53139-2
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood |
|
47598-8
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood |
|
59473-9
|
Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Venous blood by Ion-selective membrane electrode (ISE) |
|
53140-0
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Venous blood |
|
53087-3
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Nonbiological fluid |
|
50838-2
|
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Body fluid |
|
57333-7
|
Calcium.ionized [Mass/volume] adjusted to pH 7.4 in Serum or Plasma by Ion-selective membrane electrode (ISE) |
|
47596-2
|
Calcium.ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE) |
|
59470-5
|
Calcium.ionized [Mass/volume] in Arterial blood |
|
34581-9
|
Calcium.ionized [Moles/volume] in Arterial blood |
|
54367-8
|
Calcium.ionized [Moles/volume] in Cord blood |
|
83064-6
|
Calcium.ionized [Moles/volume] in Blood drawn from CRRT circuit |
|
41644-6
|
Calcium.ionized [Moles/volume] in Capillary blood |
|
38230-9
|
Calcium.ionized [Mass/volume] in Blood |
|
41646-1
|
Calcium.ionized [Moles/volume] in Mixed venous blood |
|
1994-3
|
Calcium.ionized [Moles/volume] in Blood |
|
59471-3
|
Calcium.ionized [Mass/volume] in Venous blood |
|
41645-3
|
Calcium.ionized [Moles/volume] in Venous blood |
|
46093-1
|
Calcium.ionized [Moles/volume] in Dialysis fluid |
|
53088-1
|
Calcium.ionized [Moles/volume] in Nonbiological fluid by Ion-selective membrane electrode (ISE) |
|
50837-4
|
Calcium.ionized [Moles/volume] in Body fluid |
|
13959-2
|
Calcium.ionized [Moles/volume] in Serum or Plasma by calculation |
|
17864-0
|
Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
|
12180-6
|
Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
|
17863-2
|
Calcium.ionized [Mass/volume] in Serum or Plasma |
|
42567-8
|
Calcium.ionized [Mass or Moles/volume] in Serum or Plasma |
|
1995-0
|
Calcium.ionized [Moles/volume] in Serum or Plasma |
|
7489-8
|
Cajeput tree triggered histamine release [Units/volume] in Blood |
|
6171-3
|
Cajeput tree IgE Ab [Units/volume] in Serum |
|
61284-6
|
Cajeput tree IgE Ab/IgE total in Serum |
|
56319-7
|
Cajeput tree IgG4 Ab [Mass/volume] in Serum |
|
60493-4
|
Calcidiol+Calciferol [Moles/volume] in Serum or Plasma |
|
1991-9
|
Calciferol binding proteins [Mass/volume] in Serum |
|
46413-1
|
Calcitonin [Mass/volume] in Serum or Plasma --7 minutes post 0.5 ug/kg pentagastrin IV |
|
13924-6
|
Calcitonin Ab [Presence] in Serum |
|
10468-7
|
Calcitonin Ag [Presence] in Tissue by Immune stain |
|
50179-1
|
Calcitonin Calcium and Pentagastrin challenge panel - Serum or Plasma |
|
47369-4
|
Calcitonin [Mass/volume] in Body fluid |
|
75709-6
|
Calcitonin [Mass/volume] in Lymph node fine needle aspirate |
|
1992-7
|
Calcitonin [Mass/volume] in Serum or Plasma |
|
15035-9
|
Calcitonin [Moles/volume] in Serum or Plasma |
|
32541-5
|
Calcium [Molar amount] in Urine collected for unspecified duration |
|
35675-8
|
Calcium [Mass/volume] in Urine collected for unspecified duration |
|
71790-0
|
Calcium [Moles/volume] in Urine collected for unspecified duration |
|
57335-2
|
Calcium [Mass/volume] in 12 hour Urine |
|
18186-7
|
Calcium [Mass/time] in 12 hour Urine |
|
51610-4
|
Calcium [Moles/time] in 12 hour Urine |
|
59000-0
|
Calcium [Mass/time] in 18 hour Urine |
|
53124-4
|
Calcium [Moles/time] in 1 hour Urine |
|
27172-6
|
Calcium [Mass/mass] in 24 hour Stool |
|
2001-6
|
Calcium [Moles/volume] in 24 hour Stool |
|
18488-7
|
Calcium [Mass/volume] in 24 hour Urine |
|
6874-2
|
Calcium [Mass/time] in 24 hour Urine |
|
35248-4
|
Calcium [Mass or Moles/volume] in 24 hour Urine |
|
25362-5
|
Calcium [Moles/volume] in 24 hour Urine |
|
14637-3
|
Calcium [Moles/time] in 24 hour Urine |
|
57334-5
|
Calcium [Mass/volume] in 2 hour Urine |
|
16518-3
|
Calcium [Mass/time] in 2 hour Urine |
|
12511-2
|
Calcium [Mass/volume] in 4 hour Urine |
|
27091-8
|
Calcium [Mass/time] in 4 hour Urine |
|
49764-4
|
Calcium [Mass/volume] in Amniotic fluid |
|
14415-4
|
Calcium [Moles/volume] in Amniotic fluid |
|
27182-5
|
Calcium [Presence] in Blood |
|
54365-2
|
Calcium [Moles/volume] in Cord blood |
|
42593-4
|
Calcium [Moles/volume] in Capillary blood |
|
49765-1
|
Calcium [Mass/volume] in Blood |
|
1996-8
|
Calcium [Moles/volume] in Blood |
|
42857-3
|
Calcium [Moles/volume] in Venous blood |
|
1993-5
|
Calcium renal clearance in 24 hour Urine and Serum or Plasma |
|
1997-6
|
Calcium [Moles/volume] in Cerebral spinal fluid |
|
38643-3
|
Calcium cyanamide [Mass/volume] in Air |
|
58781-6
|
Calcium [Mass/volume] in Peritoneal dialysis fluid |
|
49005-2
|
Calcium [Moles/volume] in Peritoneal dialysis fluid |
|
27373-0
|
Calcium [Mass/volume] in Dialysis fluid |
|
1998-4
|
Calcium [Moles/volume] in Dialysis fluid |
|
57919-3
|
Calcium [Mass/volume] in Nonbiological fluid |
|
54364-5
|
Calcium [Moles/volume] in Nonbiological fluid |
|
15155-5
|
Calcium [Mass/volume] in Body fluid |
|
12181-4
|
Calcium [Moles/volume] in Body fluid |
|
14419-6
|
Calcium [Moles/volume] in Gastric fluid |
|
86915-6
|
Calcium goal [Mass/volume] Serum or Plasma |
|
50836-6
|
Calcium [Moles/mass] in Hair |
|
80975-6
|
Calcium intake 24 hour Measured |
|
35264-1
|
Calcium intake 24 hour |
|
63550-8
|
Calcium magnesium phosphate/Total in Stone |
|
74909-3
|
Calcium oxalate dihydrate/Total in Stone |
|
2005-7
|
Calcium [Moles/time] in 2 hour Urine --12 hours fasting |
|
51950-4
|
Calcium [Mass/volume] in Serum or Plasma --post dialysis |
|
59148-7
|
Calcium [Moles/volume] in Serum or Plasma --post dialysis |
|
14416-2
|
Calcium [Moles/volume] in Pleural fluid |
|
14417-0
|
Calcium [Moles/volume] in Peritoneal fluid |
|
16273-5
|
Calcium [Mass/mass] in Red Blood Cells |
|
25583-6
|
Calcium [Moles/volume] in Red Blood Cells |
|
74516-6
|
Calcium [Moles/volume] in Saliva (oral fluid) |
|
17861-6
|
Calcium [Mass/volume] in Serum or Plasma |
|
35246-8
|
Calcium [Mass or Moles/volume] in Serum or Plasma |
|
2000-8
|
Calcium [Moles/volume] in Serum or Plasma |
|
69425-7
|
Calcium [Mass/volume] in Semen |
|
1999-2
|
Calcium [Moles/volume] in Semen |
|
14418-8
|
Calcium [Moles/volume] in Synovial fluid |
|
2002-4
|
Calcium [Moles/volume] in Stool |
|
14636-5
|
Calcium [Presence] in Stone |
|
47597-0
|
Calcium [Moles/volume] corrected for total protein in Blood |
|
30527-6
|
Calcium [Mass/volume] in Total parental nutrition |
|
53100-4
|
Calcium [Moles/volume] in Total parental nutrition |
|
29276-3
|
Calcium [Presence] in Urine |
|
17862-4
|
Calcium [Mass/volume] in Urine |
|
35247-6
|
Calcium [Mass or Moles/volume] in Urine |
|
2004-0
|
Calcium [Moles/volume] in Urine |
|
9467-2
|
Calcium [Mass/volume] in Water |
|
38250-7
|
Calcium [Mass/volume] in Unspecified specimen |
|
53455-2
|
Calcium [Mass/mass] in Unspecified specimen |
|
32305-5
|
Calcium [Moles/volume] in Unspecified specimen |
|
53502-1
|
Calcium [Moles/mass] in Unspecified specimen |
|
13717-4
|
Calcium/Creatinine [Mass Ratio] in 24 hour Urine |
|
50839-0
|
Calcium/Creatinine [Molar ratio] in 24 hour Urine |
|
27037-1
|
Calcium/Creatinine [Mass Ratio] in 2 hour Urine |
|
9321-1
|
Calcium/Creatinine [Mass Ratio] in Urine |
|
24518-3
|
Calcium/Creatinine [Molar ratio] in Urine |
|
6468-3
|
Microscopic observation [Identifier] in Sputum by Calcofluor white |
|
6472-5
|
Microscopic observation [Identifier] in Tissue by Calcofluor white |
|
658-5
|
Microscopic observation [Identifier] in Unspecified specimen by Calcofluor white |
|
50308-6
|
Caldesmon Ag [Presence] in Tissue by Immune stain |
|
38916-3
|
Calicivirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10649-2
|
Calicivirus [Identifier] in Stool by Electron microscopy |
|
7529-1
|
California Black Oak IgE Ab [Units/volume] in Serum |
|
7532-5
|
California Live Oak IgE Ab [Units/volume] in Serum |
|
7511-9
|
California Mugwort IgE Ab [Units/volume] in Serum |
|
7683-6
|
California Sagebrush IgE Ab [Units/volume] in Serum |
|
6274-5
|
California Walnut IgE Ab [Units/volume] in Serum |
|
33982-0
|
California Walnut Pollen IgE Ab [Units/volume] in Serum |
|
39085-6
|
California Walnut Pollen IgE Ab/IgE total in Serum |
|
80443-5
|
Calorie intake panel |
|
75302-0
|
Calorie intake 24 hour |
|
75298-0
|
Calorie intake 24 hour Estimated |
|
49462-5
|
Calponin Ag [Presence] in Tissue by Immune stain |
|
93771-4
|
Calprotectin [Mass/volume] in Synovial fluid |
|
82874-9
|
Calprotectin [Mass/volume] in Stool |
|
38445-3
|
Calprotectin [Mass/mass] in Stool |
|
82538-0
|
CALR gene exon 9 full mutation analysis in Blood or Tissue by Sequencing |
|
77174-1
|
CALR gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
47011-2
|
Calretinin Ag [Presence] in Tissue by Immune stain |
|
82736-0
|
Calcium-calmodulin-dependent protein kinase II activity actual/normal in Serum |
|
49869-1
|
Camel dander IgE Ab [Units/volume] in Serum |
|
1727-7
|
Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine |
|
34230-3
|
Adenosine monophosphate.cyclic [Moles/volume] in 24 hour Urine |
|
14584-7
|
Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine |
|
21052-6
|
Adenosine monophosphate.cyclic.nephrogenous [Moles/volume] in Urine and Serum or Plasma |
|
44428-1
|
Adenosine monophosphate.cyclic.nephrogenous/Creatinine [Molar ratio] in Urine |
|
1726-9
|
Adenosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
|
25498-7
|
Adenosine monophosphate.cyclic [Moles/volume] in Serum or Plasma |
|
50581-8
|
Adenosine monophosphate.cyclic stimulation panel - Urine |
|
6868-4
|
Adenosine monophosphate.cyclic [Mass/volume] in Urine |
|
22712-4
|
Adenosine monophosphate.cyclic [Moles/volume] in Urine |
|
25972-1
|
Adenosine monophosphate.cyclic/Creatinine [Molar ratio] in 24 hour Urine |
|
1728-5
|
Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Serum or Plasma |
|
18361-6
|
Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Urine |
|
75738-5
|
Campesterol [Mass/volume] in Serum or Plasma |
|
58464-9
|
Campesterol [Moles/volume] in Serum or Plasma |
|
9369-0
|
Camphor [Mass/volume] in Blood |
|
34620-5
|
Camphor [Mass/volume] in Body fluid |
|
71429-5
|
Campylobacter sp DNA.diarrheagenic [Presence] in Stool by NAA with probe detection |
|
26619-7
|
Campylobacter sp Ab [Presence] in Serum |
|
6330-5
|
Campylobacter sp identified in Blood by Organism specific culture |
|
49614-1
|
Campylobacter sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
20739-9
|
Campylobacter sp identified in Body fluid by Organism specific culture |
|
43068-6
|
Campylobacter sp IgA Ab [Presence] in Serum |
|
40616-5
|
Campylobacter sp IgA Ab [Presence] in Serum by Immunoassay |
|
41159-5
|
Campylobacter sp IgG Ab [Presence] in Serum |
|
40617-3
|
Campylobacter sp IgG Ab [Presence] in Serum by Immunoassay |
|
20738-1
|
Campylobacter sp identified in Isolate by Organism specific culture |
|
16534-0
|
Campylobacter sp rRNA [Presence] in Serum by Probe |
|
4992-4
|
Campylobacter sp rRNA [Presence] in Unspecified specimen by Probe |
|
6331-3
|
Campylobacter sp identified in Stool by Organism specific culture |
|
20740-7
|
Campylobacter sp identified in Tissue by Organism specific culture |
|
6332-1
|
Campylobacter sp identified in Unspecified specimen by Organism specific culture |
|
7356-9
|
Canadian blue grass IgE Ab [Units/volume] in Serum |
|
16535-7
|
Canary droppings IgE Ab [Units/volume] in Serum |
|
81784-1
|
Canary droppings IgG Ab [Mass/volume] in Serum |
|
55590-4
|
Canary feather IgE Ab [Presence] in Serum |
|
7171-2
|
Canary feather IgE Ab [Units/volume] in Serum |
|
51547-8
|
Canary feather IgG Ab [Presence] in Serum |
|
58916-8
|
Canary feather IgG Ab [Mass/volume] in Serum |
|
6058-2
|
Canary grass IgE Ab [Units/volume] in Serum |
|
50356-5
|
Canary grass IgE Ab/IgE total in Serum |
|
31280-1
|
Canary serum proteins Ab [Presence] in Serum |
|
24497-0
|
Canary serum proteins Ab [Presence] in Serum by Immune diffusion (ID) |
|
16536-5
|
Canary serum proteins Ab [Units/volume] in Serum |
|
9729-5
|
Canary serum proteins IgE Ab [Units/volume] in Serum |
|
37992-5
|
Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum by Immunoassay |
|
30538-3
|
Neutrophil cytoplasmic Ab.classic [Presence] in Serum |
|
17353-4
|
Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence |
|
8084-6
|
Neutrophil cytoplasmic Ab.classic [Units/volume] in Serum |
|
32708-0
|
Neutrophil cytoplasmic Ab.classic [Titer] in Serum |
|
14277-8
|
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence |
|
13127-6
|
Cancer Ag DM/70K [Units/volume] in Serum or Plasma |
|
50775-6
|
Cancer Ag 125 [Units/volume] in Cerebral spinal fluid |
|
59040-6
|
Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid |
|
11210-2
|
Cancer Ag 125 [Units/volume] in Body fluid |
|
68923-2
|
Cancer Ag 125 [Units/volume] in Pericardial fluid |
|
19165-0
|
Cancer Ag 125 [Units/volume] in Pleural fluid |
|
40618-1
|
Cancer Ag 125 [Units/volume] in Peritoneal fluid |
|
83082-8
|
Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay |
|
2006-5
|
Cancer Ag 125 [Presence] in Serum or Plasma |
|
10334-1
|
Cancer Ag 125 [Units/volume] in Serum or Plasma |
|
48677-9
|
Cancer Ag 125 [Presence] in Tissue by Immune stain |
|
50776-4
|
Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid |
|
29153-4
|
Cancer Ag 15-3 [Units/volume] in Body fluid |
|
50777-2
|
Cancer Ag 15-3 [Units/volume] in Pericardial fluid |
|
19186-6
|
Cancer Ag 15-3 [Units/volume] in Pleural fluid |
|
50778-0
|
Cancer Ag 15-3 [Units/volume] in Peritoneal fluid |
|
83083-6
|
Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay |
|
2007-3
|
Cancer Ag 15-3 [Presence] in Serum or Plasma |
|
6875-9
|
Cancer Ag 15-3 [Units/volume] in Serum or Plasma |
|
50779-8
|
Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid |
|
26924-1
|
Cancer Ag 19-9 [Units/volume] in Body fluid |
|
50780-6
|
Cancer Ag 19-9 [Units/volume] in Pericardial fluid |
|
19163-5
|
Cancer Ag 19-9 [Units/volume] in Pleural fluid |
|
50781-4
|
Cancer Ag 19-9 [Units/volume] in Peritoneal fluid |
|
83084-4
|
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay |
|
2009-9
|
Cancer Ag 19-9 [Presence] in Serum or Plasma |
|
24108-3
|
Cancer Ag 19-9 [Units/volume] in Serum or Plasma |
|
2011-5
|
Cancer Ag 242 [Presence] in Serum or Plasma |
|
50782-2
|
Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid |
|
19187-4
|
Cancer Ag 27-29 [Units/volume] in Pleural fluid |
|
2012-3
|
Cancer Ag 27-29 [Presence] in Serum or Plasma |
|
17842-6
|
Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
|
2013-1
|
Cancer Ag 50 [Presence] in Serum or Plasma |
|
34256-8
|
Cancer Ag 50 [Units/volume] in Serum or Plasma |
|
19190-8
|
Cancer Ag 549 [Units/volume] in Pleural fluid |
|
2014-9
|
Cancer Ag 549 [Presence] in Serum or Plasma |
|
19189-0
|
Cancer Ag 549 [Units/volume] in Serum or Plasma |
|
68925-7
|
Cancer Ag 72-4 [Units/volume] in Cerebral spinal fluid |
|
34161-0
|
Cancer Ag 72-4 [Units/volume] in Body fluid |
|
68926-5
|
Cancer Ag 72-4 [Units/volume] in Pericardial fluid |
|
19164-3
|
Cancer Ag 72-4 [Units/volume] in Pleural fluid |
|
68924-0
|
Cancer Ag 72-4 [Units/volume] in Peritoneal fluid |
|
2015-6
|
Cancer Ag 72-4 [Presence] in Serum or Plasma |
|
17843-4
|
Cancer Ag 72-4 [Units/volume] in Serum or Plasma |
|
47012-0
|
Cancer Ag 72-4 [Presence] in Tissue by Immune stain |
|
72134-0
|
Cancer event report |
|
73977-1
|
Cancer related large scale gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85904-1
|
Cancer pathology panel - Breast cancer specimen by CAP cancer protocols |
|
84907-5
|
Cancer pathology panel - Colorectal cancer specimen |
|
85905-8
|
Cancer pathology panel - Colorectal cancer specimen by CAP cancer protocols |
|
84908-3
|
Cancer pathology panel - Prostate cancer |
|
73491-3
|
Candesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73490-5
|
Candesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26636-1
|
Candida sp Ab [Presence] in Serum |
|
35270-8
|
Candida sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
43067-8
|
Candida sp Ab [Titer] in Serum |
|
40501-9
|
Candida sp Ab [Titer] in Serum by Latex agglutination |
|
16539-9
|
Candida sp Ag [Presence] in Serum |
|
35271-6
|
Candida sp Ag [Presence] in Serum by Latex agglutination |
|
31760-2
|
Candida sp Ag [Units/volume] in Serum |
|
27440-7
|
Candida sp Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
48336-2
|
Candida sp Ag [Presence] in Tissue by Immune stain |
|
9501-8
|
Candida sp Ag [Titer] in Serum |
|
10650-0
|
Candida sp DNA [Presence] in Blood by Probe with amplification |
|
62460-1
|
Candida sp DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
92699-8
|
Candida sp DNA [Presence] in Vaginal fluid by Probe |
|
54142-5
|
Candida sp DNA [Presence] in Vaginal fluid by Probe with signal amplification |
|
91081-0
|
Candida sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16538-1
|
Candida sp IgA Ab [Units/volume] in Saliva (oral fluid) |
|
27417-5
|
Candida sp IgA Ab [Units/volume] in Serum by Immunoassay |
|
34582-7
|
Candida sp IgA Ab [Presence] in Serum |
|
9498-7
|
Candida sp IgA Ab [Units/volume] in Serum |
|
34583-5
|
Candida sp IgG Ab [Presence] in Serum |
|
7174-6
|
Candida sp IgG Ab [Units/volume] in Serum |
|
40825-2
|
Candida sp IgG Ab [Titer] in Serum |
|
27391-2
|
Candida sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
34584-3
|
Candida sp IgM Ab [Presence] in Serum |
|
9500-0
|
Candida sp IgM Ab [Units/volume] in Serum |
|
88717-4
|
Candida sp identified in Isolate |
|
73962-3
|
Candida sp rRNA [Identifier] by FISH in Positive blood culture |
|
47000-5
|
Candida sp rRNA [Presence] in Vaginal fluid by Probe |
|
553-8
|
Candida sp identified in Saliva (oral fluid) by Organism specific culture |
|
92724-4
|
Candida sp and Gardnerella vaginalis and Trichomonas vaginalis DNA panel - Vaginal fluid by Probe |
|
72481-5
|
Candida sp 6 panel - Vaginal fluid by NAA with probe detection |
|
554-6
|
Candida sp identified in Stool by Organism specific culture |
|
33038-1
|
Candida sp identified in Vaginal fluid by Cyto stain |
|
555-3
|
Candida sp identified in Unspecified specimen by Organism specific culture |
|
23699-2
|
Canine parainfluenza virus 2 Ag [Presence] in Tissue by Immunofluorescence |
|
78813-3
|
Cannabicyclohexanol [Mass/volume] in Urine by Confirmatory method |
|
82964-8
|
Cannabidiol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
16243-8
|
Cannabinoids [Mass/volume] in Blood by Confirmatory method |
|
42630-4
|
Cannabinoids [Presence] in Blood |
|
42491-1
|
Cannabinoids [Presence] in Blood by Screen method |
|
50338-3
|
Cannabinoids [Mass/volume] in Dialysis fluid |
|
91041-4
|
Cannabinoids [Presence] in Body fluid by Screen method |
|
59573-6
|
Cannabinoids [Presence] in Gastric fluid |
|
33561-2
|
Cannabinoids [Mass/volume] in Gastric fluid |
|
26764-1
|
Cannabinoids [Presence] in Hair |
|
40800-5
|
Cannabinoids [Presence] in Hair by Screen method |
|
59160-2
|
Cannabinoids [Mass/mass] in Hair |
|
33282-5
|
Cannabinoids [Mass/mass] in Meconium by Confirmatory method |
|
50406-8
|
Cannabinoids [Presence] in Meconium by Confirmatory method |
|
31080-5
|
Cannabinoids [Presence] in Meconium by Screen method |
|
27024-9
|
Cannabinoids [Mass/mass] in Meconium |
|
19290-6
|
Cannabinoids positive [Identifier] in Urine by Confirmatory method |
|
40801-3
|
Cannabinoids [Presence] in Saliva (oral fluid) by Screen method |
|
16542-3
|
Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3425-6
|
Cannabinoids [Presence] in Serum or Plasma |
|
8171-1
|
Cannabinoids [Presence] in Serum or Plasma by Confirmatory method |
|
8172-9
|
Cannabinoids [Presence] in Serum or Plasma by Screen method |
|
74157-9
|
Cannabinoids [Presence] in Serum, Plasma or Blood by Screen method |
|
8170-3
|
Cannabinoids [Mass/volume] in Serum or Plasma |
|
26856-5
|
Cannabinoids [Mass/mass] in Stool |
|
73943-3
|
Cannabinoids synthetic [Presence] in Blood |
|
67126-3
|
Cannabinoids synthetic [Presence] in Urine by Confirmatory method |
|
72379-1
|
Cannabinoids synthetic [Presence] in Unspecified specimen by Screen method |
|
91048-9
|
Cannabinoids [Presence] in Tissue by Screen method |
|
20413-1
|
Cannabinoids [Mass/volume] in Urine by Confirmatory method |
|
3427-2
|
Cannabinoids [Presence] in Urine |
|
19289-8
|
Cannabinoids [Presence] in Urine by Confirmatory method |
|
18282-4
|
Cannabinoids [Presence] in Urine by Screen method |
|
70144-1
|
Cannabinoids [Presence] in Urine by Screen method >20 ng/mL |
|
70145-8
|
Cannabinoids [Presence] in Urine by Screen method >50 ng/mL |
|
70143-3
|
Cannabinoids [Mass/volume] in Urine by Screen method |
|
26760-9
|
Cannabinoids [Units/volume] in Urine |
|
42860-7
|
Cannabinoids [Mass/volume] in Urine |
|
52954-5
|
Cannabinoids [Moles/volume] in Urine |
|
16543-1
|
Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method |
|
8177-8
|
Cannabinoids [Presence] in Unknown substance |
|
8178-6
|
Cannabinoids [Presence] in Unknown substance by Confirmatory method |
|
8179-4
|
Cannabinoids [Presence] in Unknown substance by Screen method |
|
8176-0
|
Cannabinoids [Mass/volume] in Unknown substance |
|
27086-8
|
Cannabinoids [Presence] in Vitreous fluid |
|
48943-5
|
Cannabinoids [Presence] in Unspecified specimen by Confirmatory method |
|
48942-7
|
Cannabinoids [Mass/volume] in Unspecified specimen |
|
26747-6
|
Cannabinoids/Creatinine [Mass Ratio] in Urine |
|
87379-4
|
Cannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3430-6
|
Canrenone [Mass/time] in 24 hour Urine |
|
21135-9
|
Canrenone [Mass/volume] in Serum or Plasma |
|
3428-0
|
Canrenone [Presence] in Urine |
|
16544-9
|
Canrenone [Units/volume] in Urine |
|
3429-8
|
Canrenone [Mass/volume] in Urine |
|
57874-0
|
Cantaloupe triggered histamine release [Units/volume] in Blood |
|
57883-1
|
Cantaloupe IgE Ab [Units/volume] in Serum |
|
57879-9
|
Cantaloupe IgG Ab [Units/volume] in Serum |
|
57875-7
|
Cantaloupe IgG4 Ab [Mass/volume] in Serum |
|
60359-7
|
Cantaloupe IgG Ab [Mass/volume] in Serum |
|
7645-5
|
Canyon Ragweed IgE Ab [Units/volume] in Serum |
|
81623-1
|
Calcium oxalate [Energy Difference] in 24 hour Urine |
|
38251-5
|
Calcium oxalate [Mass/time] in 24 hour Urine |
|
34736-9
|
Calcium oxalate index in 24 hour Urine |
|
38520-3
|
Capillary fragility [Presence] |
|
41748-5
|
CAPN3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
45191-4
|
CAPN3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48170-5
|
Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
89483-2
|
Capreomycin [Susceptibility] by Genotype method |
|
16545-6
|
Capreomycin [Mass/volume] in Serum or Plasma |
|
22166-3
|
Caprine parapoxvirus Ab [Presence] in Serum |
|
20777-9
|
Caprine parapoxvirus Ab [Presence] in Serum by Complement fixation |
|
22167-1
|
Caprine parapoxvirus Ab [Presence] in Tissue |
|
20776-1
|
Caprine parapoxvirus Ab [Presence] in Tissue by Immunofluorescence |
|
22982-3
|
Capripox virus Ab [Presence] in Serum |
|
22983-1
|
Capripox virus Ab [Presence] in Serum by Immunoblot |
|
22984-9
|
Capripox virus Ab [Presence] in Serum by Neutralization test |
|
22990-6
|
Capripox virus Ag [Presence] in Tissue by Immunoassay |
|
22987-2
|
Capripox virus Ag [Presence] in Tissue by Immune stain |
|
31762-8
|
Capripox virus Ag [Presence] in Unspecified specimen |
|
22988-0
|
Capripox virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
22986-4
|
Capripox virus Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
22989-8
|
Capripox virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22991-4
|
Capripox virus DNA [Presence] in Unspecified specimen by RFLP |
|
22981-5
|
Capripox virus [Presence] in Tissue by Animal inoculation |
|
38644-1
|
Caprolactam [Mass/volume] in Air |
|
38645-8
|
Captan [Mass/volume] in Air |
|
73489-7
|
Captopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73488-9
|
Captopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16546-4
|
Captopril [Mass/volume] in Serum or Plasma |
|
31281-9
|
Cancer associated retinopathy Ab [Presence] in Serum |
|
25834-3
|
Cancer associated retinopathy Ab [Presence] in Serum by Immunoblot |
|
11163-3
|
Carageenan IgE Ab [Units/volume] in Serum |
|
7178-7
|
Caraway IgE Ab [Units/volume] in Serum |
|
38254-9
|
Carbonated calcium phosphate [Presence] in Stone |
|
93989-2
|
Carbohydrate challenge panel - Exhaled gas |
|
81940-9
|
Carbohydrate intake panel |
|
75288-1
|
Carbohydrate need [Mass/time] 24 hour Estimated |
|
87790-2
|
Carbadox [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87791-0
|
Carbadox [Susceptibility] |
|
87601-1
|
Carbadox [Mass/mass] in Unspecified specimen |
|
9789-9
|
Carbamate pesticides [Type] in Serum or Plasma |
|
16547-2
|
Carbamate pesticides [Type] in Urine |
|
28047-9
|
Carbamate pesticides [Mass/volume] in Urine |
|
87670-6
|
Carbamate panel - Unspecified specimen |
|
20749-8
|
Carbamates [Presence] in Feed by Screen method |
|
20745-6
|
Carbamates [Presence] in Gastric fluid by Screen method |
|
20747-2
|
Carbamates [Presence] in Ingesta by Screen method |
|
20748-0
|
Carbamates [Presence] in Tissue by Screen method |
|
20746-4
|
Carbamates [Presence] in Unspecified specimen by Screen method |
|
73050-7
|
carBAMazepine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73049-9
|
carBAMazepine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
29148-4
|
carBAMazepine.bound [Mass/volume] in Serum or Plasma |
|
41472-2
|
carBAMazepine [Mass/volume] in DBS |
|
29147-6
|
carBAMazepine 10,11-Epoxide.bound [Mass/volume] in Serum or Plasma |
|
41473-0
|
carBAMazepine 10,11-Epoxide [Mass/volume] in DBS |
|
14056-6
|
carBAMazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma |
|
47097-1
|
carBAMazepine 10,11-epoxide free [Moles/volume] in Serum or Plasma |
|
9415-1
|
carBAMazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma |
|
18270-9
|
carBAMazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma |
|
29212-8
|
carBAMazepine [Mass/volume] in Body fluid |
|
14057-4
|
carBAMazepine free [Mass/volume] in Saliva (oral fluid) |
|
3433-0
|
carBAMazepine free [Mass/volume] in Serum or Plasma |
|
32058-0
|
carBAMazepine free [Moles/volume] in Serum or Plasma |
|
74974-7
|
carBAMazepine free [Mass/volume] in Serum or Plasma --trough |
|
34545-4
|
carBAMazepine free and total panel [Mass/volume] - Serum or Plasma |
|
50337-5
|
carBAMazepine free and total and 10,11-Epoxide panel [Mass/volume] - Serum or Plasma |
|
59876-3
|
carBAMazepine [Presence] in Gastric fluid |
|
73486-3
|
carBAMazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73487-1
|
carBAMazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3431-4
|
carBAMazepine [Presence] in Serum or Plasma |
|
35599-0
|
carBAMazepine [Mass/volume] in Serum or Plasma by Screen method |
|
3432-2
|
carBAMazepine [Mass/volume] in Serum or Plasma |
|
35237-7
|
carBAMazepine [Mass or Moles/volume] in Serum or Plasma |
|
14639-9
|
carBAMazepine [Moles/volume] in Serum or Plasma |
|
74973-9
|
carBAMazepine [Mass/volume] in Serum or Plasma --trough |
|
12363-8
|
carBAMazepine [Presence] in Urine |
|
16548-0
|
carBAMazepine [Mass/volume] in Urine |
|
60291-2
|
carBAMazepine [Presence] in Unspecified specimen |
|
88462-7
|
Carbapenem [Susceptibility] |
|
74676-8
|
Carbapenemase [Type] in Isolate by Carba NP |
|
86930-5
|
Carbapenemase [Presence] in Isolate |
|
38738-1
|
Carbaryl [Mass/volume] in Air |
|
53644-1
|
Carbaryl [Presence] in Gastric fluid |
|
42861-5
|
Carbaryl [Presence] in Urine |
|
87744-9
|
Carbaryl [Mass/mass] in Unspecified specimen |
|
73485-5
|
Carbidopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73484-8
|
Carbidopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9328-6
|
Carbidopa [Mass/volume] in Serum or Plasma |
|
30517-7
|
Carbinoxamine [Mass/volume] in Serum or Plasma |
|
16549-8
|
Carbinoxamine [Presence] in Urine |
|
27282-3
|
Carbinoxamine [Mass/volume] in Urine |
|
78434-8
|
carBAMazepine free and total trough and 10,11-Epoxide panel - Serum or Plasma |
|
9689-1
|
Carbofuran [Mass/volume] in Serum or Plasma |
|
42862-3
|
Carbofuran [Presence] in Urine |
|
21139-1
|
Carbofuran [Mass/volume] in Urine |
|
87656-5
|
Carbofuran [Mass/mass] in Unspecified specimen |
|
75296-4
|
Carbohydrate intake 24 hour Estimated |
|
81953-2
|
Carbohydrate intake 24 hour Measured |
|
59015-8
|
Carbohydrates [Mass/mass] in Stool by Infrared spectroscopy |
|
55221-6
|
Carbohydrates [Presence] in Stool |
|
16550-6
|
Carbohydrates [Identifier] in Urine |
|
34466-3
|
Carbohydrates [Presence] in Unspecified specimen |
|
38577-3
|
Carbon disulfide [Mass/volume] in Air |
|
29277-1
|
Carbon disulfide [Presence] in Blood |
|
29290-4
|
Carbon disulfide [Mass/volume] in Blood |
|
23836-0
|
Carbon disulfide [Mass/volume] in Serum or Plasma |
|
18205-5
|
Carbon disulfide [Presence] in Urine |
|
23835-2
|
Carbon disulfide [Mass/volume] in Urine |
|
43166-8
|
Carbon.organic [Mass/volume] in Unspecified specimen |
|
38578-1
|
Carbon tetrachloride [Mass/volume] in Air |
|
9332-8
|
Carbon tetrachloride [Mass/volume] in Blood |
|
54936-0
|
Carbon tetrachloride [Mass/volume] in Serum or Plasma |
|
2033-9
|
Carbonate [Mass/volume] in Arterial blood |
|
2034-7
|
Carbonate [Mass/volume] in Venous blood |
|
2036-2
|
Carbonate dehydratase [Enzymatic activity/volume] in Red Blood Cells |
|
2035-4
|
Carbonate [Mass/volume] in Plasma |
|
14641-5
|
Carbonate [Presence] in Stone |
|
38652-4
|
Carbonyl sulfide [Mass/volume] in Air |
|
30024-4
|
Carbophenothion [Mass/volume] in Serum or Plasma |
|
21140-9
|
Carbophenothion [Mass/volume] in Urine |
|
9502-6
|
Carbophenothion [Mass/volume] in Unspecified specimen |
|
87745-6
|
Carbophenothion [Mass/mass] in Unspecified specimen |
|
53447-9
|
Carboxymefloquine [Mass/volume] in Serum or Plasma |
|
42492-9
|
Carboxy tetrahydrocannabinol [Presence] in Blood |
|
26995-1
|
Carboxy tetrahydrocannabinol [Mass/volume] in Blood |
|
61062-6
|
Carboxy tetrahydrocannabinol [Presence] in Gastric fluid |
|
29326-6
|
Carboxy tetrahydrocannabinol [Mass/volume] in Gastric fluid |
|
69007-3
|
Carboxy tetrahydrocannabinol [Mass/mass] in Meconium by Confirmatory method |
|
57924-3
|
Carboxy tetrahydrocannabinol [Presence] in Meconium |
|
31136-5
|
Carboxy tetrahydrocannabinol [Mass/mass] in Meconium |
|
72764-4
|
Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74678-4
|
Carboxy tetrahydrocannabinol [Presence] in Saliva (oral fluid) by Confirmatory method |
|
47386-8
|
Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method |
|
26743-5
|
Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma |
|
49746-1
|
Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method |
|
16150-5
|
Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
|
26732-8
|
Carboxy tetrahydrocannabinol [Mass/mass] in Stool |
|
20521-1
|
Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
|
3435-5
|
Carboxy tetrahydrocannabinol [Presence] in Urine |
|
19382-1
|
Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method |
|
19381-3
|
Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method |
|
3436-3
|
Carboxy tetrahydrocannabinol [Mass/volume] in Urine |
|
27213-8
|
Carboxy tetrahydrocannabinol [Mass/volume] in Vitreous fluid |
|
61063-4
|
Carboxy tetrahydrocannabinol [Presence] in Unspecified specimen |
|
48944-3
|
Carboxy tetrahydrocannabinol [Mass/volume] in Unspecified specimen |
|
19055-3
|
Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
|
75651-0
|
Tetrahydrocannabivarin [Mass/volume] in Urine |
|
60523-8
|
Carbromal [Mass/volume] in Serum or Plasma |
|
85474-5
|
Cardiac implantable loop monitor study report |
|
82657-8
|
Cardiac phase measurement panel Left ventricle SPECT |
|
82656-0
|
Cardiac summed score panel Myocardium SPECT |
|
15279-3
|
Cardamon IgE Ab [Units/volume] in Serum |
|
18745-0
|
Cardiac catheterization study |
|
82654-5
|
Nuclear cardiac imaging panel SPECT |
|
18836-7
|
Cardiac stress study Procedure |
|
76645-1
|
Cardiac stress test EKG study Type |
|
89823-9
|
Cardiac surgery Team Conference note |
|
80574-7
|
Cardiac surgery Admission history and physical note |
|
80573-9
|
Cardiac surgery Checklist |
|
89798-3
|
Cardiac surgery Conference note |
|
80575-4
|
Cardiac surgery Consult note |
|
80576-2
|
Cardiac surgery Education note |
|
80572-1
|
Cardiac surgery Flowsheet |
|
82826-9
|
Cardiac surgery Initial evaluation note |
|
80579-6
|
Cardiac surgery Surgical operation note |
|
89824-7
|
Cardiac surgery Telephone encounter Note |
|
80789-1
|
Cardiac surgery Plan of care note |
|
80578-8
|
Cardiac surgery Preoperative evaluation and management note |
|
89822-1
|
Cardiac surgery procedure note |
|
80577-0
|
Cardiac surgery Referral note |
|
80580-4
|
Cardiac surgery Transfer summary note |
|
89577-1
|
Troponin I.cardiac panel - Serum or Plasma by High sensitivity method |
|
89576-3
|
Troponin T.cardiac panel - Serum or Plasma by High sensitivity method |
|
68484-5
|
Cardiology Attending Hospital Progress note |
|
83516-5
|
Cardiology Attending Intensive care unit Admission evaluation note |
|
83517-3
|
Cardiology Attending Intensive care unit Note |
|
83518-1
|
Cardiology Attending Note |
|
83519-9
|
Cardiology Attending Outpatient Note |
|
34135-4
|
Cardiology Attending Outpatient Supervisory note |
|
83520-7
|
Cardiology Case manager Note |
|
83527-2
|
Cardiology Fellow Note |
|
83528-0
|
Cardiology Fellow Outpatient Note |
|
68483-7
|
Cardiology Medical student Hospital Admission evaluation note |
|
68486-0
|
Cardiology Medical student Hospital Consult note |
|
68485-2
|
Cardiology Medical student Hospital Progress note |
|
83530-6
|
Cardiology Nurse practitioner Note |
|
83531-4
|
Cardiology Nurse Note |
|
83532-2
|
Cardiology Nurse Outpatient Note |
|
83533-0
|
Cardiology Nurse procedure note |
|
83538-9
|
Cardiology Resident Note |
|
78497-5
|
Cardiopulmonary Admission history and physical note |
|
78448-8
|
Cardiopulmonary Checklist |
|
78498-3
|
Cardiopulmonary Consult note |
|
78499-1
|
Cardiopulmonary Education note |
|
78500-6
|
Cardiopulmonary Flowsheet |
|
82828-5
|
Cardiopulmonary Initial evaluation note |
|
78501-4
|
Cardiopulmonary Referral note |
|
78502-2
|
Cardiopulmonary Transfer summary note |
|
3180-7
|
Cardiolipin Ab [Units/volume] in Serum by Immunoassay |
|
29860-4
|
Cardiolipin Ab [Presence] in Serum |
|
46125-1
|
Cardiolipin Ab [Presence] in Serum by Immunoassay |
|
8062-2
|
Cardiolipin Ab [Units/volume] in Serum |
|
5076-5
|
Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay |
|
30470-9
|
Cardiolipin IgA Ab [Presence] in Serum |
|
43361-5
|
Cardiolipin IgA Ab [Mass/volume] in Serum |
|
8063-0
|
Cardiolipin IgA Ab [Units/volume] in Serum or Plasma |
|
20669-8
|
Cardiolipin IgA Ab [Titer] in Serum |
|
45057-7
|
Cardiolipin IgA and IgG and IgM panel - Serum |
|
3181-5
|
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay |
|
27183-3
|
Cardiolipin IgG Ab [Presence] in Serum |
|
24385-7
|
Cardiolipin IgG Ab [Presence] in Serum by Immunoassay |
|
43362-3
|
Cardiolipin IgG Ab [Mass/volume] in Serum |
|
8065-5
|
Cardiolipin IgG Ab [Units/volume] in Serum or Plasma |
|
20484-2
|
Cardiolipin IgG Ab [Titer] in Serum |
|
24319-6
|
Cardiolipin IgG and IgM panel - Serum |
|
3182-3
|
Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay |
|
24386-5
|
Cardiolipin IgM Ab [Presence] in Serum by Immunoassay |
|
43363-1
|
Cardiolipin IgM Ab [Mass/volume] in Serum |
|
8067-1
|
Cardiolipin IgM Ab [Units/volume] in Serum or Plasma |
|
20485-9
|
Cardiolipin IgM Ab [Titer] in Serum |
|
2040-4
|
Cardiolipin [Mass/volume] in Serum |
|
83521-5
|
Cardiology Clinical nurse specialist Note |
|
34099-2
|
Cardiology Consult note |
|
75425-9
|
Cardiology Diagnostic study note |
|
77408-3
|
Cardiology Discharge instructions |
|
77409-1
|
Cardiology Discharge summary |
|
77411-7
|
Cardiology Education note |
|
77437-2
|
Cardiology Flowsheet |
|
77412-5
|
Cardiology History and physical note |
|
68471-2
|
Cardiology Hospital Admission evaluation note |
|
34094-3
|
Cardiology Hospital Admission history and physical note |
|
77410-9
|
Cardiology Hospital Discharge teaching note |
|
68472-0
|
Cardiology Hospital Progress note |
|
83522-3
|
Cardiology Intensive care unit Admission evaluation note |
|
83523-1
|
Cardiology Intensive care unit Discharge summary |
|
83524-9
|
Cardiology Intensive care unit Note |
|
83525-6
|
Cardiology Intensive care unit procedure note |
|
83526-4
|
Cardiology Intensive care unit Transfer summary note |
|
77413-3
|
Cardiology Initial evaluation note |
|
34896-1
|
Cardiology Interventional procedure note |
|
34752-6
|
Cardiology Note |
|
83534-8
|
Cardiology Observation unit Note |
|
34753-4
|
Cardiology Outpatient Note |
|
34124-8
|
Cardiology Outpatient Progress note |
|
83535-5
|
Cardiology Surgical operation note |
|
83536-3
|
Cardiology Physician assistant Note |
|
83540-5
|
Cardiology Telephone encounter Note |
|
77442-2
|
Cardiology Plan of care note |
|
85938-9
|
Cardiology Postoperative evaluation and management note |
|
83537-1
|
Cardiology Preoperative evaluation and management note |
|
75426-7
|
Cardiology procedure note |
|
78710-1
|
Cardiology Progress note |
|
83529-8
|
Cardiology Patient's home Note |
|
57170-3
|
Cardiology Referral note |
|
83539-7
|
Cardiology Risk assessment and screening note |
|
86208-6
|
Cardiology Telehealth Note |
|
77414-1
|
Cardiology Transfer summary note |
|
83541-3
|
Cardiology Transplant candidate evaluation note |
|
84068-6
|
Cardiothoracic surgery Admission evaluation note |
|
78508-9
|
Cardiothoracic surgery Admission history and physical note |
|
83656-9
|
Cardiothoracic surgery Attending Admission evaluation note |
|
64073-0
|
Cardiothoracic surgery Attending Hospital Note |
|
68481-1
|
Cardiothoracic surgery Attending Hospital Progress note |
|
83657-7
|
Cardiothoracic surgery Attending Note |
|
78543-6
|
Cardiothoracic surgery Checklist |
|
34849-0
|
Cardiothoracic surgery Consult note |
|
78596-4
|
Cardiothoracic surgery Education note |
|
78626-9
|
Cardiothoracic surgery Flowsheet |
|
85850-6
|
Cardiothoracic surgery History and physical note |
|
64060-7
|
Cardiothoracic surgery Hospital Admission evaluation note |
|
64061-5
|
Cardiothoracic surgery Hospital Progress note |
|
82829-3
|
Cardiothoracic surgery Initial evaluation note |
|
64074-8
|
Cardiothoracic surgery Medical student Hospital Admission evaluation note |
|
64076-3
|
Cardiothoracic surgery Medical student Hospital Consult note |
|
64075-5
|
Cardiothoracic surgery Medical student Hospital Progress note |
|
85436-4
|
Cardiothoracic surgery Note |
|
34850-8
|
Cardiothoracic surgery Outpatient Note |
|
78679-8
|
Cardiothoracic surgery Surgical operation note |
|
85889-4
|
Cardiothoracic surgery Telephone encounter Note |
|
80749-5
|
Cardiothoracic surgery Plan of care note |
|
85853-0
|
Cardiothoracic surgery Postoperative evaluation and management note |
|
78730-9
|
Cardiothoracic surgery Preoperative evaluation and management note |
|
85854-8
|
Cardiothoracic surgery procedure note |
|
57167-9
|
Cardiothoracic surgery Referral note |
|
78681-4
|
Cardiothoracic surgery Transfer summary note |
|
85891-0
|
Cardiothoracic surgery Fellow Note |
|
85851-4
|
Cardiothoracic surgery Interdisciplinary Note |
|
85852-2
|
Cardiothoracic surgery Nurse Note |
|
85900-9
|
Cardiothoracic surgery Resident Note |
|
91983-7
|
Care management note |
|
92707-9
|
Care team information panel |
|
87704-3
|
Caregiver Patient Activation Measure - 10 [PAM] Caregiver |
|
87703-5
|
Caregiver Patient Activation Measure - 13 [PAM] Caregiver |
|
6060-8
|
Careless Weed IgE Ab [Units/volume] in Serum |
|
56205-8
|
Careless Weed IgG4 Ab [Mass/volume] in Serum |
|
78815-8
|
Carisoprodol [Mass/volume] in Blood by Confirmatory method |
|
73483-0
|
Carisoprodol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73482-2
|
Carisoprodol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72761-0
|
Carisoprodol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
3437-1
|
Carisoprodol [Mass/volume] in Serum or Plasma |
|
58427-6
|
Carisoprodol [Mass/volume] in Urine by Confirmatory method |
|
21142-5
|
Carisoprodol [Presence] in Urine |
|
58426-8
|
Carisoprodol [Presence] in Urine by Confirmatory method |
|
10979-3
|
Carisoprodol [Mass/volume] in Urine |
|
57856-7
|
Carisoprodol [Moles/volume] in Unspecified specimen |
|
58371-6
|
Carisoprodol/Creatinine [Mass Ratio] in Urine |
|
78816-6
|
Carisoprodol+Meprobamate [Presence] in Blood by Confirmatory method |
|
79140-0
|
Carisoprodol+Meprobamate [Presence] in Blood by Screen method |
|
34666-8
|
Carisoprodol+Meprobamate [Mass/volume] in Serum or Plasma |
|
75228-7
|
Carisoprodol+Meprobamate [Mass/volume] in Urine by Confirmatory method |
|
58370-8
|
Carisoprodol+Meprobamate [Presence] in Urine by Screen method |
|
74672-7
|
Carisoprodol+Meprobamate [Mass/volume] in Urine |
|
53624-3
|
Carnitine esters [Moles/volume] in DBS |
|
10876-1
|
Carnitine esters [Mass/volume] in Serum or Plasma |
|
19074-4
|
Carnitine esters [Moles/volume] in Serum or Plasma |
|
24450-9
|
Carnitine esters [Moles/mass] in Tissue |
|
26753-4
|
Carnitine esters [Units/volume] in Urine |
|
10875-3
|
Carnitine esters [Mass/volume] in Urine |
|
24449-1
|
Carnitine esters [Moles/volume] in Urine |
|
45192-2
|
Carnitine esters/Carnitine.free (C0) [Molar ratio] in DBS |
|
40869-0
|
Carnitine esters/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
14153-1
|
Carnitine esters/Creatinine [Mass Ratio] in Urine |
|
28589-0
|
Carnitine esters/Creatinine [Ratio] in Urine |
|
25141-3
|
Carnitine esters/Creatinine [Molar ratio] in Urine |
|
48430-3
|
Carnitine [Molar amount] in unspecified time Semen |
|
34257-6
|
Carnitine [Moles/volume] in 24 hour Urine |
|
24448-3
|
Carnitine [Moles/time] in 24 hour Urine |
|
2041-2
|
Carnitine acyltransferase [Enzymatic activity/volume] in Serum or Plasma |
|
34521-5
|
Carnitine acyltransferase [Enzymatic activity/mass] in Tissue |
|
16556-3
|
Carnitine [Mass/volume] in Amniotic fluid |
|
53053-5
|
Carnitine [Moles/volume] in Amniotic fluid |
|
79286-1
|
Carnitine biosynthesis intermediates panel - Cerebral spinal fluid |
|
79284-6
|
Carnitine biosynthesis intermediates panel - DBS |
|
79285-3
|
Carnitine biosynthesis intermediates panel - Serum or Plasma |
|
79287-9
|
Carnitine biosynthesis intermediates panel - Urine |
|
16555-5
|
Carnitine [Mass/volume] in Cerebral spinal fluid |
|
53071-7
|
Carnitine [Moles/volume] in Cerebral spinal fluid |
|
38480-0
|
Carnitine [Moles/volume] in DBS |
|
55200-0
|
Carnitine [Moles/volume] in Body fluid |
|
34258-4
|
Carnitine free (C0) [Moles/volume] in 24 hour Urine |
|
34259-2
|
Carnitine free (C0) [Moles/time] in 24 hour Urine |
|
53054-3
|
Carnitine free (C0) [Moles/volume] in Amniotic fluid |
|
53072-5
|
Carnitine free (C0) [Moles/volume] in Cerebral spinal fluid |
|
38481-8
|
Carnitine free (C0) [Moles/volume] in DBS |
|
74878-0
|
Carnitine free (C0) [Moles/volume] in DBS --post therapeutic diet |
|
2042-0
|
Carnitine free (C0) [Presence] in Serum or Plasma |
|
2043-8
|
Carnitine free (C0) [Mass/volume] in Serum or Plasma |
|
14286-9
|
Carnitine free (C0) [Moles/volume] in Serum or Plasma |
|
69422-4
|
Carnitine free (C0) [Moles/volume] in Semen |
|
18363-2
|
Carnitine free (C0) [Units/mass] in Tissue |
|
24452-5
|
Carnitine free (C0) [Moles/mass] in Tissue |
|
26757-5
|
Carnitine free (C0) [Units/volume] in Urine |
|
10877-9
|
Carnitine free (C0) [Mass/volume] in Urine |
|
14285-1
|
Carnitine free (C0) [Moles/volume] in Urine |
|
53233-3
|
Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
53235-8
|
Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS |
|
59206-3
|
Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in Serum or Plasma |
|
53234-1
|
Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS |
|
13718-2
|
Carnitine free (C0)/Creatinine [Mass Ratio] in Urine |
|
17867-3
|
Carnitine free (C0)/Creatinine [Ratio] in Urine |
|
22704-1
|
Carnitine free (C0)/Creatinine [Molar ratio] in Urine |
|
53262-2
|
Carnitine newborn screen panel |
|
2045-3
|
Carnitine [Presence] in Serum or Plasma |
|
2046-1
|
Carnitine [Mass/volume] in Serum or Plasma |
|
14288-5
|
Carnitine [Moles/volume] in Serum or Plasma |
|
2044-6
|
Carnitine [Mass/volume] in Semen |
|
10561-9
|
Carnitine [Moles/volume] in Semen |
|
26788-0
|
Carnitine [Units/mass] in Tissue |
|
16553-0
|
Carnitine [Mass/mass] in Tissue |
|
24451-7
|
Carnitine [Moles/mass] in Tissue |
|
2047-9
|
Carnitine [Mass/volume] in Urine |
|
14287-7
|
Carnitine [Moles/volume] in Urine |
|
44710-2
|
Carnitine/Acylcarnitine [Molar ratio] in Serum or Plasma |
|
53817-3
|
Carnosine [Presence] in Cerebral spinal fluid |
|
44304-4
|
Carnosine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56675-2
|
Carnosine/Creatinine [Ratio] in 24 hour Urine |
|
7179-5
|
Carob IgE Ab [Units/volume] in Serum |
|
2052-9
|
Carotene [Mass/volume] in Blood |
|
2053-7
|
Carotene [Mass/volume] in Serum |
|
14642-3
|
Carotene [Moles/volume] in Serum |
|
66445-8
|
Carp recombinant (rCyp c) 1 IgE Ab [Units/volume] in Serum |
|
21143-3
|
Carp IgE Ab [Units/volume] in Serum |
|
66446-6
|
Carrot recombinant (rDau c) 1 IgE Ab [Units/volume] in Serum |
|
7181-1
|
Carrot triggered histamine release [Units/volume] in Blood |
|
6061-6
|
Carrot IgE Ab [Units/volume] in Serum |
|
42900-1
|
Carrot IgE Ab/IgE total in Serum |
|
7180-3
|
Carrot IgG Ab [Units/volume] in Serum |
|
56206-6
|
Carrot IgG4 Ab [Mass/volume] in Serum |
|
60360-5
|
Carrot IgG Ab [Mass/volume] in Serum |
|
48210-9
|
Carrot triggered leukotriene release [Mass/volume] by Leukocytes |
|
51694-8
|
Carumonam [Susceptibility] |
|
73481-4
|
Carvedilol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73480-6
|
Carvedilol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
24474-9
|
Cancer associated serum Ag [Units/volume] in Serum |
|
73479-8
|
Casanthranol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73478-0
|
Casanthranol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
85222-8
|
Case manager Consult note |
|
85172-5
|
Case manager Custodial care facility Note |
|
85223-6
|
Case manager Discharge summary |
|
64065-6
|
Case manager Hospital Initial evaluation note |
|
85224-4
|
Case manager Long term care facility Note |
|
46210-1
|
Case manager Note |
|
85225-1
|
Case manager Outpatient Note |
|
85227-7
|
Case manager Telephone encounter Note |
|
85228-5
|
Case manager Plan of care note |
|
34125-5
|
Case manager Patient's home Progress note |
|
85226-9
|
Case manager Referral note |
|
78000-7
|
Case notification panel [CDC.PHIN] |
|
75218-8
|
Case report |
|
18418-4
|
Casein IgA Ab [Units/volume] in Serum |
|
6062-4
|
Casein IgE Ab [Units/volume] in Serum |
|
61241-6
|
Casein IgE Ab/IgE total in Serum |
|
51532-0
|
Casein IgG Ab [Presence] in Serum |
|
7182-9
|
Casein IgG Ab [Units/volume] in Serum |
|
26415-0
|
Casein IgG4 Ab [Units/volume] in Serum |
|
56207-4
|
Casein IgG4 Ab [Mass/volume] in Serum |
|
53829-8
|
Casein IgG Ab [Mass/volume] in Serum |
|
48204-2
|
Casein triggered leukotriene release [Mass/volume] by Leukocytes |
|
64962-4
|
Cashew nut recombinant (rAna o) 2 IgE Ab [Units/volume] in Serum |
|
82539-8
|
Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum |
|
6718-1
|
Cashew nut IgE Ab [Units/volume] in Serum |
|
38437-0
|
Cashew nut IgE Ab/IgE total in Serum |
|
7183-7
|
Cashew nut IgG Ab [Units/volume] in Serum |
|
56208-2
|
Cashew nut IgG4 Ab [Mass/volume] in Serum |
|
63109-3
|
Cashew nut IgG Ab [Mass/volume] in Serum |
|
73477-2
|
Caspofungin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73476-4
|
Caspofungin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
54185-4
|
Caspofungin [Susceptibility] by Gradient strip |
|
54175-5
|
Caspofungin [Susceptibility] by Disk diffusion (KB) |
|
54176-3
|
Caspofungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
58419-3
|
Caspofungin [Mass/volume] in Serum or Plasma |
|
90820-2
|
Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
90821-0
|
Contactin-associated protein 2 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82986-1
|
Contactin-associated protein 2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82979-6
|
Contactin-associated protein 2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
82534-9
|
CASR gene full mutation analysis in Blood or Tissue by Sequencing |
|
45190-6
|
CASR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
41854-1
|
Castor Bean DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6063-2
|
Castor Bean IgE Ab [Units/volume] in Serum |
|
56209-0
|
Castor Bean IgG4 Ab [Mass/volume] in Serum |
|
63160-6
|
Castor Bean IgG Ab [Mass/volume] in Serum |
|
58432-6
|
Casts panel - Urine sediment |
|
87827-2
|
Casts [Presence] in Urine |
|
58436-7
|
Casts [Type] in Urine sediment by Light microscopy |
|
64975-6
|
Cat recombinant (rFel d) 1 IgE Ab [Units/volume] in Serum |
|
64976-4
|
Cat recombinant (rFel d) 4 IgE Ab [Units/volume] in Serum |
|
78384-5
|
Cat dander native (nFel d) 1 IgE Ab [Units/volume] in Serum |
|
7185-2
|
Cat dander triggered histamine release [Units/volume] in Blood |
|
6833-8
|
Cat dander IgE Ab [Units/volume] in Serum |
|
38255-6
|
Cat dander IgE Ab/IgE total in Serum |
|
7184-5
|
Cat dander IgG Ab [Units/volume] in Serum |
|
56210-8
|
Cat dander IgG4 Ab [Mass/volume] in Serum |
|
63076-4
|
Cat dander IgG Ab [Mass/volume] in Serum |
|
48230-7
|
Cat dander triggered leukotriene release [Mass/volume] by Leukocytes |
|
19732-7
|
Cat serum albumin IgE Ab [Units/volume] in Serum |
|
54368-6
|
Catalase [Enzymatic activity/volume] in Plasma |
|
2054-5
|
Catalase [Enzymatic activity/volume] in Red Blood Cells |
|
49221-5
|
Catalase [Enzymatic activity/mass] in Red Blood Cells |
|
55829-6
|
Catalase [Enzymatic activity/mass] in Tissue |
|
41114-0
|
CATCH22 syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34517-3
|
CATCH22 syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38646-6
|
Catechol [Mass/volume] in Air |
|
75070-3
|
Catechol [Moles/volume] in Serum or Plasma |
|
75091-9
|
Catechol/Creatinine [Molar ratio] in Urine |
|
79391-9
|
Catecholamine metabolites panel - Cerebral spinal fluid |
|
79499-0
|
Catecholamine metabolites panel - Serum or Plasma |
|
75086-9
|
Catecholamine metabolites pattern [Interpretation] in Urine Narrative |
|
73866-6
|
Catecholamines 3 and creatinine panel [Molar ratio] - Urine |
|
34551-2
|
Catecholamines 3 panel [Mass/volume] - Plasma |
|
73865-8
|
Catecholamines 3 panel [Moles/volume] - Plasma |
|
92938-0
|
Catecholamines 3 panel - Urine |
|
73879-9
|
Catecholamine metabolites and creatinine panel - Urine |
|
32161-2
|
Catecholamines [Presence] in 24 hour Urine |
|
32000-2
|
Catecholamines [Mass/volume] in 24 hour Urine |
|
2058-6
|
Catecholamines [Mass/time] in 24 hour Urine |
|
34260-0
|
Catecholamines [Moles/volume] in 24 hour Urine |
|
15036-7
|
Catecholamines [Moles/time] in 24 hour Urine |
|
38446-1
|
Catecholamines [Mass/time] in 72 hour Urine |
|
2055-2
|
Catecholamines [Mass/volume] in Blood |
|
55830-4
|
Catecholamines [Moles/volume] in Cerebral spinal fluid |
|
55831-2
|
Catecholamines [Moles/volume] in Body fluid |
|
2056-0
|
Catecholamines [Mass/volume] in Plasma |
|
59787-2
|
Catecholamines [Moles/volume] in Plasma |
|
2057-8
|
Catecholamines [Mass/volume] in Urine |
|
34261-8
|
Catecholamines [Moles/volume] in Urine |
|
43247-6
|
Catecholamines/Creatinine [Mass Ratio] in 24 hour Urine |
|
9641-2
|
Catecholamines/Creatinine [Mass Ratio] in Urine |
|
34262-6
|
Catecholamines/Creatinine [Molar ratio] in Urine |
|
7188-6
|
Catfish triggered histamine release [Units/volume] in Blood |
|
7187-8
|
Catfish IgE Ab [Units/volume] in Serum |
|
56211-6
|
Catfish IgG4 Ab [Mass/volume] in Serum |
|
63143-2
|
Catfish IgG Ab [Mass/volume] in Serum |
|
78942-0
|
Catheterization and angiography device panel |
|
80528-3
|
Catheterization and angiography preoperative information panel |
|
80190-2
|
Catheterization and angiography procedure details panel |
|
78949-5
|
Catheterization and angiography procedures performed panel |
|
16562-1
|
Cathartic laxatives [Identifier] in Urine |
|
78958-6
|
Cathepsin A [Enzymatic activity/mass] in Leukocytes |
|
30080-6
|
Cathepsin D [Presence] in Tissue by Immune stain |
|
9794-9
|
Cathepsin D [Moles/mass] in Tissue |
|
63215-8
|
Cathepsin G Ab [Units/volume] in Serum by Immunoassay |
|
54016-1
|
Cathepsin G Ab [Presence] in Serum |
|
55832-0
|
Cathepsin K [Moles/volume] in Serum or Plasma |
|
55833-8
|
Cathepsin L [Mass/volume] in Serum or Plasma |
|
55834-6
|
Cathepsin S [Mass/volume] in Serum or Plasma |
|
3440-5
|
Cathine [Mass/time] in 24 hour Urine |
|
43933-1
|
Cathine [Mass/mass] in Meconium |
|
59724-5
|
Cathine [Mass/volume] in Serum or Plasma |
|
3438-9
|
Cathine [Presence] in Urine |
|
3439-7
|
Cathine [Mass/volume] in Urine |
|
78817-4
|
Cathinone [Mass/volume] in Urine by Confirmatory method |
|
79141-8
|
Cathinone [Presence] in Urine by Screen method |
|
7189-4
|
Cattail IgE Ab [Units/volume] in Serum |
|
7191-0
|
Cauliflower triggered histamine release [Units/volume] in Blood |
|
6835-3
|
Cauliflower IgE Ab [Units/volume] in Serum |
|
61232-5
|
Cauliflower IgE Ab/IgE total in Serum |
|
7190-2
|
Cauliflower IgG Ab [Units/volume] in Serum |
|
56212-4
|
Cauliflower IgG4 Ab [Mass/volume] in Serum |
|
60361-3
|
Cauliflower IgG Ab [Mass/volume] in Serum |
|
80356-9
|
Cause of death entity axis code [Automated] |
|
86802-6
|
Cause of death and related information Document |
|
22168-9
|
Chicken anemia virus Ab [Presence] in Serum |
|
20751-4
|
Chicken anemia virus Ab [Presence] in Serum by Immunoassay |
|
43325-0
|
Chicken anemia virus Ab [Presence] in Serum by Immunofluorescence |
|
20750-6
|
Chicken anemia virus Ab [Presence] in Serum by Neutralization test |
|
55296-8
|
CAV3 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
77195-6
|
Cardio-ankle vascular index Calculated |
|
50676-6
|
Calcium-phosphorus product panel - Serum or Plasma |
|
50675-8
|
Calcium-phosphorus product [(Mass/volume)*2] in Serum or Plasma |
|
11188-0
|
Cayenne IgE Ab [Units/volume] in Serum |
|
7590-3
|
Cayenne IgG Ab [Units/volume] in Serum |
|
63082-2
|
Cayenne IgG Ab [Mass/volume] in Serum |
|
58410-2
|
Complete blood count (hemogram) panel - Blood by Automated count |
|
57021-8
|
CBC W Auto Differential panel - Blood |
|
74412-8
|
CBC W Differential panel - Cord blood |
|
69742-5
|
CBC W Differential panel, method unspecified - Blood |
|
57782-5
|
CBC with Ordered Manual Differential panel - Blood |
|
57022-6
|
CBC W Reflex Manual Differential panel - Blood |
|
24317-0
|
Hemogram and platelets WO differential panel - Blood |
|
47288-6
|
CBC WO Differential panel - Cord blood |
|
24358-4
|
Hemogram without Platelets panel - Blood |
|
24359-2
|
Hemogram without Platelets and with Manual Differential panel - Blood |
|
50979-4
|
CBir1 Ab [Units/volume] in Serum by Immunoassay |
|
40872-4
|
CBS gene c.833T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
40873-2
|
CBS gene c.919G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
82223-9
|
Cystathionine beta synthase [Enzymatic activity/mass] in Fibroblast |
|
21646-5
|
CBS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
20566-6
|
Colony count [#/volume] in Catheter tip by Culture |
|
30121-8
|
Colony count [#/volume] in Dialysis fluid |
|
77344-0
|
Colony count [#/volume] in Implanted device by Culture |
|
20773-8
|
Colony count [#/volume] in Milk by Culture Standard Plate Count |
|
19090-0
|
Colony count [#/volume] in Urine |
|
49223-1
|
Colony count [#/volume] in Unspecified specimen by Visual count |
|
19091-8
|
Colony count [#] in Urine by Visual count |
|
38436-2
|
Colony count [#/mass] in Unspecified specimen by Visual count |
|
565-2
|
Colony count [#] in Unspecified specimen Qualitative by Visual count |
|
564-5
|
Colony count [#] in Unspecified specimen by Visual count |
|
20774-6
|
Colony count [Units/volume] in Unspecified specimen by Visual count |
|
20775-3
|
Colony count [Units/volume] in Unspecified specimen by Viability count FDA method |
|
74518-2
|
Clara cell protein 16 [Mass/volume] in Serum |
|
73805-4
|
CCHD newborn screening panel |
|
2081-8
|
Cholecystokinin [Mass/volume] in Plasma |
|
81786-6
|
Chemokine (C-C motif) ligand 17 [Mass/volume] in Serum by Immunoassay |
|
74512-5
|
Chemokine (C-C motif) ligand 18 [Mass/volume] in Serum |
|
77415-8
|
Critical care medicine Admission history and physical note |
|
64069-8
|
Critical care medicine Attending Hospital Note |
|
68473-8
|
Critical care medicine Attending Hospital Progress note |
|
78496-7
|
Critical care medicine Consult note |
|
77416-6
|
Critical care medicine Discharge instructions |
|
77417-4
|
Critical care medicine Discharge summary |
|
77418-2
|
Critical care medicine Discharge teaching note |
|
77419-0
|
Critical care medicine Education note |
|
77440-6
|
Critical care medicine Flowsheet |
|
77420-8
|
Critical care medicine History and physical note |
|
64058-1
|
Critical care medicine Hospital Admission evaluation note |
|
64059-9
|
Critical care medicine Hospital Progress note |
|
77421-6
|
Critical care medicine Initial evaluation note |
|
64070-6
|
Critical care medicine Medical student Hospital Admission evaluation note |
|
64072-2
|
Critical care medicine Medical student Hospital Consult note |
|
64071-4
|
Critical care medicine Medical student Hospital Progress note |
|
34754-2
|
Critical care medicine Note |
|
78380-3
|
Critical care medicine Surgical operation note |
|
77445-5
|
Critical care medicine Plan of care note |
|
77422-4
|
Critical care medicine procedure note |
|
57178-6
|
Critical care medicine Referral note |
|
34755-9
|
Critical care medicine Transfer summary note |
|
78204-5
|
CCND1 gene duplication [Presence] in Blood or Tissue by FISH |
|
42780-7
|
CCND1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21744-8
|
CCND1 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
32218-0
|
Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay |
|
53028-7
|
Cyclic citrullinated peptide Ab [Presence] in Serum |
|
53027-9
|
Cyclic citrullinated peptide Ab [Units/volume] in Serum |
|
82576-0
|
Cyclic citrullinated peptide IgA Ab [Units/volume] in Serum or Plasma |
|
63375-0
|
Cyclic citrullinated peptide IgA+IgG Ab [Presence] in Serum |
|
57093-7
|
Cyclic citrullinated peptide IgA+IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
63217-4
|
Cyclic citrullinated peptide IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
42898-7
|
Cyclic citrullinated peptide IgG Ab [Presence] in Serum |
|
33935-8
|
Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma |
|
70246-4
|
CCR2 gene p.Val64Ile [Presence] in Blood or Tissue by Molecular genetics method |
|
70247-2
|
CCR5 gene c.794_825del [Presence] in Blood or Tissue by Molecular genetics method |
|
21207-6
|
CCR5 gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
|
31283-5
|
Canine coronavirus Ab [Presence] in Serum |
|
23687-7
|
Canine coronavirus Ab [Presence] in Serum by Immunofluorescence |
|
23688-5
|
Canine coronavirus Ag [Presence] in Tissue by Immunofluorescence |
|
49463-3
|
CD1 Ag [Presence] in Tissue by Immune stain |
|
40551-4
|
CD10 Ag [Presence] in Tissue by Immune stain |
|
42608-0
|
CD10+CD20+ cells/100 cells in Bone marrow |
|
17100-9
|
CD103 cells/100 cells in Blood |
|
42864-9
|
CD103 cells/100 cells in Body fluid |
|
26556-1
|
CD103 cells/100 cells in Unspecified specimen |
|
42930-8
|
CD11+CD18+ cells [Presence] in Blood |
|
51184-0
|
CD117 Ag [Presence] in Blood by Immune stain |
|
51183-2
|
CD117 Ag [Presence] in Bone marrow by Immune stain |
|
40552-2
|
CD117 Ag [Presence] in Tissue by Immune stain |
|
51185-7
|
CD117 Ag [Presence] in Unspecified specimen by Immune stain |
|
51443-0
|
CD117 cells [Units/volume] in Blood |
|
42867-2
|
CD117 cells/100 cells in Body fluid |
|
42866-4
|
CD117 cells/100 cells in Bone marrow |
|
42865-6
|
CD117 cells/100 cells in Tissue |
|
77944-7
|
CD11a cells/100 cells in Unspecified specimen |
|
10445-5
|
CD11c Ag [Presence] in Tissue by Immune stain |
|
42868-0
|
CD11c+CD19+ cells/100 cells in Bone marrow |
|
29633-5
|
CD122 Ag [Presence] in Tissue by Immune stain |
|
46968-4
|
CD122 cells [#/volume] in Blood |
|
49473-2
|
CD123 Ag [Presence] in Tissue by Immune stain |
|
49464-1
|
CD13 Ag [Presence] in Tissue by Immune stain |
|
51066-9
|
CD13 blasts [Units/volume] in Bone marrow |
|
42622-1
|
CD13+CD56+ cells/100 cells in Bone marrow |
|
50309-4
|
CD138 Ag [Presence] in Tissue by Immune stain |
|
50972-9
|
CD138 cells [#/volume] in Blood |
|
42869-8
|
CD138 cells/100 cells in Blood |
|
42871-4
|
CD138 cells/100 cells in Body fluid |
|
42870-6
|
CD138 cells/100 cells in Bone marrow |
|
42872-2
|
CD138 cells/100 cells in Tissue |
|
49465-8
|
CD14 Ag [Presence] in Tissue by Immune stain |
|
90736-0
|
CD14-FLAER- cells/100 cells.CD33 in Blood |
|
51187-3
|
CD15 Ag [Presence] in Blood by Immune stain |
|
51186-5
|
CD15 Ag [Presence] in Bone marrow by Immune stain |
|
10436-4
|
CD15 Ag [Presence] in Tissue by Immune stain |
|
51188-1
|
CD15 Ag [Presence] in Unspecified specimen by Immune stain |
|
35653-5
|
CD158 cells [#/volume] in Blood |
|
38894-2
|
CD158 cells [#/volume] in Unspecified specimen |
|
73975-5
|
CD158a cells/100 cells in Unspecified specimen |
|
73976-3
|
CD158b cells/100 cells in Unspecified specimen |
|
10437-2
|
CD16 Ag [Presence] in Tissue by Immune stain |
|
20402-4
|
CD16+CD56+ cells [#/volume] in Blood |
|
26561-1
|
CD16+CD56+ cells [#/volume] in Unspecified specimen |
|
18267-5
|
CD16+CD56+ cells/100 cells in Blood |
|
18268-3
|
CD16+CD56+ cells/100 cells in Body fluid |
|
20620-1
|
CD16+CD56+ cells/100 cells in Unspecified specimen |
|
49474-0
|
CD163 Ag [Presence] in Tissue by Immune stain |
|
42874-8
|
CD18 cells/100 cells in Bone marrow |
|
42873-0
|
CD18 cells/100 cells in Tissue |
|
14964-1
|
CD19 Abnormal blood cells/Abnormal blood cells.total in Blood |
|
40553-0
|
CD19 Ag [Presence] in Tissue by Immune stain |
|
13840-4
|
CD19 blasts/100 blasts in Blood |
|
8116-6
|
CD19 cells [#/volume] in Blood |
|
43972-9
|
CD19 cells [#/volume] in Cerebral spinal fluid |
|
32524-1
|
CD19 cells [#/volume] in Bone marrow |
|
20592-2
|
CD19 cells [#/volume] in Unspecified specimen |
|
8117-4
|
CD19 cells/100 cells in Blood |
|
32755-1
|
CD19 cells/100 cells in Bronchial specimen |
|
17829-3
|
CD19 cells/100 cells in Body fluid |
|
32525-8
|
CD19 cells/100 cells in Bone marrow |
|
20593-0
|
CD19 cells/100 cells in Unspecified specimen |
|
89354-5
|
CD19+21- cells [#/volume] in Blood |
|
89353-7
|
CD19+CD27+ cells [#/volume] in Blood |
|
43273-2
|
CD19+CD27+IgD+ cells/100 cells in Blood or Tissue |
|
89351-1
|
CD19+CD27+IgD+IgM+ cells [#/volume] in Blood |
|
89349-5
|
CD19+CD27+IgD-IgM- cells [#/volume] in Blood |
|
89347-9
|
CD19+CD27+IgD-IgM+ cells [#/volume] in Blood |
|
51444-8
|
CD19+CD38+ cells [Units/volume] in Blood |
|
89343-8
|
CD19+CD38+IgM- cells [#/volume] in Blood |
|
89357-8
|
CD19+CD38+IgM+ cells [#/volume] in Blood |
|
49842-8
|
CD19+IgA+ cells/100 cells in Unspecified specimen |
|
49835-2
|
CD19+IgD+ cells/100 cells in Unspecified specimen |
|
49840-2
|
CD19+IgG+ cells/100 cells in Unspecified specimen |
|
89345-3
|
CD19+IgM+ cells [#/volume] in Blood |
|
49841-0
|
CD19+IgM+ cells/100 cells in Unspecified specimen |
|
50664-2
|
CD19+Kappa+ cells [#/volume] in Blood |
|
50665-9
|
CD19+Lambda+ cells [#/volume] in Blood |
|
47013-8
|
CD1a Ag [Presence] in Tissue by Immune stain |
|
43274-0
|
CD1c+CD22+ cells/100 cells in Unspecified specimen |
|
49466-6
|
CD2 Ag [Presence] in Tissue by Immune stain |
|
43949-7
|
CD2 cells [#/volume] in Cerebral spinal fluid |
|
43950-5
|
CD2 cells [#/volume] in Body fluid |
|
43951-3
|
CD2 cells [#/volume] in Tissue |
|
38513-8
|
CD2+CD3+ cells [#/volume] in Unspecified specimen |
|
10438-0
|
CD20 Ag [Presence] in Tissue by Immune stain |
|
45193-0
|
CD20+CD52+ cells/100 cells in Blood |
|
44071-9
|
CD20+CD52+ cells/100 cells in Cerebral spinal fluid |
|
44072-7
|
CD20+CD52+ cells/100 cells in Body fluid |
|
44070-1
|
CD20+CD52+ cells/100 cells in Bone marrow |
|
44073-5
|
CD20+CD52+ cells/100 cells in Tissue |
|
44066-9
|
CD20+FMC7+ cells [#/volume] in Cerebral spinal fluid |
|
44067-7
|
CD20+FMC7+ cells [#/volume] in Body fluid |
|
44065-1
|
CD20+FMC7+ cells [#/volume] in Bone marrow |
|
44068-5
|
CD20+FMC7+ cells [#/volume] in Tissue |
|
44069-3
|
CD20+FMC7+ cells [#/volume] in Unspecified specimen |
|
44062-8
|
CD20+FMC7+ cells/100 cells in Cerebral spinal fluid |
|
44063-6
|
CD20+FMC7+ cells/100 cells in Body fluid |
|
44061-0
|
CD20+FMC7+ cells/100 cells in Bone marrow |
|
44064-4
|
CD20+FMC7+ cells/100 cells in Tissue |
|
47014-6
|
CD21 Ag [Presence] in Tissue by Immune stain |
|
89356-0
|
CD21 cells/100 CD19 cells in Blood |
|
89355-2
|
CD21- cells/100 CD19 cells in Blood |
|
49467-4
|
CD22 Ag [Presence] in Tissue by Immune stain |
|
42875-5
|
CD22 cells/100 cells in Body fluid |
|
57398-0
|
CD22+CD19+ cells/100 cells in Body fluid |
|
10479-4
|
CD227 Ag [Presence] in Tissue by Immune stain |
|
29617-8
|
CD23 Ag [Presence] in Tissue by Immune stain |
|
50317-7
|
CD235a Ag [Presence] in Tissue by Immune stain |
|
90737-8
|
CD24-FLAER- cells/100 CD15 cells in Blood |
|
29596-4
|
CD25 Ag [Presence] in Tissue by Immune stain |
|
89431-1
|
CD25 cells/100 CD4 cells in Blood |
|
49025-0
|
CD25+CD127Low cells/CD4 cells [# Ratio] in Unspecified specimen |
|
42876-3
|
CD25+CD19+ cells/100 cells in Bone marrow |
|
89319-8
|
CD25+CD45RA+CD127Low+ cells/100 CD4 cells in Blood |
|
89320-6
|
CD25+CD45RO+CD127Low+ cells/100 CD4 cells in Blood |
|
89318-0
|
CD25-CD127+ cells/100 CD4 cells in Blood |
|
49468-2
|
CD27 Ag [Presence] in Tissue by Immune stain |
|
89358-6
|
CD27 cells/100 CD19 cells in Blood |
|
89338-8
|
CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD4+ cells in Blood |
|
89335-4
|
CD27+CD45RO+CD62L+CCR7+ cells/100 CD3+CD8+ cells in Blood |
|
89340-4
|
CD27+CD62L+ cells/100 CD3+CD4+ cells in Blood |
|
89339-6
|
CD27+CD62L+ cells/100 CD3+CD8+ cells in Blood |
|
89352-9
|
CD27+IgD+IgM+ cells/100 CD19 cells in Blood |
|
89350-3
|
CD27+IgD-IgM- cells/100 CD19 cells in Blood |
|
89348-7
|
CD27+IgD-IgM+ cells/100 CD19 cells in Blood |
|
89337-0
|
CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD4+ cells in Blood |
|
89334-7
|
CD27-CD45RO+CD62L-CCR7- cells/100 CD3+CD8+ cells in Blood |
|
42619-7
|
CD28 cells/100 cells in Bone marrow |
|
89333-9
|
CD28+HLA DR+ cells/100 CD3+CD4+ cells in Blood |
|
89332-1
|
CD28+HLA DR+ cells/100 CD3+CD8+ cells in Blood |
|
10439-8
|
CD3 Ag [Presence] in Tissue by Immune stain |
|
8122-4
|
CD3 cells [#/volume] in Blood |
|
63449-3
|
CD3 cells [#/volume] in Cerebral spinal fluid |
|
32528-2
|
CD3 cells [#/volume] in Bone marrow |
|
20598-9
|
CD3 cells [#/volume] in Unspecified specimen |
|
43275-7
|
CD3 cells/CD4 cells [# Ratio] in Unspecified specimen |
|
90304-7
|
CD3 cells/100 lymphocytes in Blood |
|
42188-3
|
CD3+CD16+CD56+ cells [#/volume] in Blood |
|
91674-2
|
CD3+CD16+CD56+ cells [#/volume] in Bone marrow |
|
91673-4
|
CD3+CD16+CD56+ cells/100 cells in Bone marrow |
|
74485-4
|
CD3 and CD20 Ag [Identifier] in Tissue by Immune stain |
|
43969-5
|
CD3+CD25+ cells [#/volume] in Tissue |
|
43967-9
|
CD3+CD25+ cells/100 cells in Cerebral spinal fluid |
|
24467-3
|
CD3+CD4+ (T4 helper) cells [#/volume] in Blood |
|
92736-8
|
CD3+CD4+ (T4 helper) cells [#/volume] in Blood by Rapid immunoassay |
|
63450-1
|
CD3+CD4+ (T4 helper) cells [#/volume] in Cerebral spinal fluid |
|
40898-9
|
CD3+CD4+ (T4 helper) cells [#/volume] in Tissue |
|
43970-3
|
CD3+CD4+ (T4 helper) cells/100 cells in Cerebral spinal fluid |
|
54218-3
|
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood |
|
89329-7
|
CD3+CD4+CD27+CD45RO+CD62L+ cells [#/volume] in Blood |
|
89331-3
|
CD3+CD4+CD27+CD62L+ cells [#/volume] in Blood |
|
89328-9
|
CD3+CD4+CD27-CD45RO+CD62L- cells [#/volume] in Blood |
|
89326-3
|
CD3+CD4+CD28+HLA DR+ cells [#/volume] in Blood |
|
85792-0
|
CD3+CD4+CD45RO+ cells [#/volume] in Blood |
|
85791-2
|
CD3+CD4+CD45RO+ cells/100 CD3 cells in Blood |
|
79187-1
|
Cells.CD3+CD4+CD8+ (Double positive) [#/volume] in Blood |
|
79186-3
|
Cells.CD3+CD4+CD8+ (Double positive)/100 cells in Blood |
|
63447-7
|
CD3+CD5- cells [#/volume] in Cerebral spinal fluid |
|
68945-5
|
CD3+CD5+ cells [#/volume] in Cerebral spinal fluid |
|
40897-1
|
CD3+CD56+ cells [#/volume] in Body fluid |
|
40895-5
|
CD3+CD56+ cells [#/volume] in Bone marrow |
|
40896-3
|
CD3+CD56+ cells [#/volume] in Tissue |
|
50640-2
|
CD3+CD57+ cells [#/volume] in Blood |
|
38233-3
|
CD3+CD62L+ cells [#/volume] in Blood |
|
14135-8
|
CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood |
|
63451-9
|
CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Cerebral spinal fluid |
|
40899-7
|
CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Tissue |
|
43971-1
|
CD3+CD8+ (T8 suppressor cells) cells/100 cells in Cerebral spinal fluid |
|
17824-4
|
CD3+CD8+ (T8 suppressor cells) cells/100 cells in Body fluid |
|
89330-5
|
CD3+CD8+CD27+CD62L+ cells [#/volume] in Blood |
|
89327-1
|
CD3+CD8+CD27-CD45RO+CD62L- cells [#/volume] in Blood |
|
89325-5
|
CD3+CD8+CD28+HLA DR+ cells [#/volume] in Blood |
|
85790-4
|
CD3+CD8+CD45RO+ cells [#/volume] in Blood |
|
85789-6
|
CD3+CD8+CD45RO+ cells/100 CD3 cells in Blood |
|
50641-0
|
CD3+CD8+CD57+ cells [#/volume] in Blood |
|
43958-8
|
CD3+HLA-DR+ cells [#/volume] in Cerebral spinal fluid |
|
43959-6
|
CD3+HLA-DR+ cells [#/volume] in Body fluid |
|
43957-0
|
CD3+HLA-DR+ cells [#/volume] in Bone marrow |
|
43960-4
|
CD3+HLA-DR+ cells [#/volume] in Tissue |
|
43961-2
|
CD3+HLA-DR+ cells [#/volume] in Unspecified specimen |
|
43968-7
|
CD3+HLA-DR+ cells/100 cells in Cerebral spinal fluid |
|
38235-8
|
CD3+TCR gamma delta+ cells [#/volume] in Blood |
|
10432-3
|
CD30 Ag [Presence] in Tissue by Immune stain |
|
47015-3
|
CD31 Ag [Presence] in Tissue by Immune stain |
|
49469-0
|
CD33 Ag [Presence] in Tissue by Immune stain |
|
10441-4
|
CD34 Ag [Presence] in Tissue by Immune stain |
|
74494-6
|
CD34 and Coagulation factor XIII Ag [Identifier] in Tissue by Immune stain |
|
49470-8
|
CD35 Ag [Presence] in Tissue by Immune stain |
|
49681-0
|
CD36 cells/100 cells in Body fluid |
|
49679-4
|
CD36 cells/100 cells in Bone marrow |
|
49680-2
|
CD36 cells/100 cells in Tissue |
|
56127-4
|
CD38 Ag [Presence] in Tissue by Immune stain |
|
26728-6
|
CD38 cells [#/volume] in Blood |
|
8126-5
|
CD38 cells/100 cells in Blood |
|
20603-7
|
CD38 cells/100 cells in Unspecified specimen |
|
50723-6
|
CD38+ Lambda+ cells [#/volume] in Blood |
|
50973-7
|
CD38+CD138+ cells [#/volume] in Blood |
|
50974-5
|
CD38+CD138+ cells/100 cells in Blood |
|
89344-6
|
CD38+IgM- cells/100 CD19 cells in Blood |
|
89341-2
|
CD38+IgM+ cells/100 CD19 cells in Blood |
|
42817-7
|
CD38+Kappa+ cells/100 cells in Blood |
|
42877-1
|
CD3-CD16+ cells [#/volume] in Body fluid |
|
42878-9
|
CD3-CD16+ cells [#/volume] in Bone marrow |
|
42879-7
|
CD3-CD16+ cells [#/volume] in Tissue |
|
56775-0
|
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Tissue |
|
73902-9
|
CD3-CD57+ cells [#/volume] in Blood by Flow cytometry (FC) |
|
40891-4
|
CD3-CD57+ cells [#/volume] in Body fluid |
|
42880-5
|
CD3-CD57+ cells [#/volume] in Bone marrow |
|
42881-3
|
CD3-CD57+ cells [#/volume] in Tissue |
|
42882-1
|
CD3-CD57+ cells/100 cells in Tissue |
|
73903-7
|
CD3-CD57+ cells/100 leukocytes in Blood by Flow cytometry (FC) |
|
73904-5
|
CD3-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC) |
|
73899-7
|
CD3- CD8- CD57+ Cells [#/volume] in Blood by Flow cytometry (FC) |
|
73900-3
|
CD3- CD8- CD57+ Cells/100 leukocytes in Blood by Flow cytometry (FC) |
|
73901-1
|
CD3- CD8- CD57+ Cells/100 lymphocytes in Blood by Flow cytometry (FC) |
|
47016-1
|
CD4 Ag [Presence] in Tissue by Immune stain |
|
53940-3
|
CD4 stimulated ATP immune response [Presence] in Blood |
|
53939-5
|
CD4 stimulated ATP immune response [Mass/volume] in Blood |
|
80223-1
|
CD4 cells/100 lymphocytes in Unspecified specimen |
|
89315-6
|
CD4+CD25+CD45RA+CD127Low+ cells [#/volume] in Blood |
|
89316-4
|
CD4+CD25+CD45RO+CD127Low+ cells [#/volume] in Blood |
|
89317-2
|
CD4+CD25-CD127+ cells [#/volume] in Blood |
|
60457-9
|
CD4+ CD26- Cells [#/volume] in Blood |
|
38237-4
|
CD4+CD28+ cells [#/volume] in Blood |
|
43944-8
|
CD4+CD45+ cells/100 cells in Bone marrow |
|
43947-1
|
CD4+CD45+ cells/100 cells in Tissue |
|
43963-8
|
CD4+CD45RA+ cells/100 cells in Cerebral spinal fluid |
|
43964-6
|
CD4+CD45RA+ cells/100 cells in Body fluid |
|
43962-0
|
CD4+CD45RA+ cells/100 cells in Bone marrow |
|
43965-3
|
CD4+CD45RA+ cells/100 cells in Tissue |
|
43966-1
|
CD4+CD45RA+ cells/100 cells in Unspecified specimen |
|
44057-8
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Cerebral spinal fluid |
|
44058-6
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Body fluid |
|
44056-0
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Bone marrow |
|
44059-4
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Tissue |
|
44060-2
|
CD4+CD45RA+CD45RB+CD45RC+ cells [#/volume] in Unspecified specimen |
|
43953-9
|
CD4+CD45RO+ cells [#/volume] in Cerebral spinal fluid |
|
43954-7
|
CD4+CD45RO+ cells [#/volume] in Body fluid |
|
43952-1
|
CD4+CD45RO+ cells [#/volume] in Bone marrow |
|
43955-4
|
CD4+CD45RO+ cells [#/volume] in Tissue |
|
43956-2
|
CD4+CD45RO+ cells [#/volume] in Unspecified specimen |
|
43946-3
|
CD4+CD45RO+ cells/100 cells in Cerebral spinal fluid |
|
43945-5
|
CD4+CD45RO+ cells/100 cells in Body fluid |
|
43948-9
|
CD4+CD45RO+ cells/100 cells in Unspecified specimen |
|
38239-0
|
CD4+CD95+ cells [#/volume] in Blood |
|
46967-6
|
CD40 cells [#/volume] in Blood |
|
42932-4
|
CD40 cells/100 cells in Unspecified specimen |
|
21016-1
|
CD41 cells [#/volume] in Blood |
|
17148-8
|
CD41 cells/100 cells in Blood |
|
20608-6
|
CD41 cells/100 cells in Unspecified specimen |
|
51445-5
|
CD41a cells [Units/volume] in Blood |
|
49475-7
|
CD41-Bf Ag [Presence] in Tissue by Immune stain |
|
29350-6
|
CD42 cells [#/volume] in Blood |
|
19122-1
|
CD42 cells/100 cells in Blood |
|
20609-4
|
CD42 cells/100 cells in Unspecified specimen |
|
77946-2
|
CD42b cells/100 cells in Unspecified specimen |
|
10443-0
|
CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |
|
40554-8
|
CD45 Ag [Presence] in Tissue by Immune stain |
|
89360-2
|
CD45RA cells/100 CD4 cells in Blood |
|
53638-3
|
CD45RB Ag [Presence] in Tissue by Immune stain |
|
29594-9
|
CD45RO Ag [Presence] in Tissue by Immune stain |
|
89336-2
|
CD45RO cells/100 CD3+CD8+ cells in Blood |
|
89362-8
|
CD45RO cells/100 CD4 cells in Blood |
|
29603-8
|
CD5 Ag [Presence] in Tissue by Immune stain |
|
56899-8
|
CD5+FMC7+ cells/100 cells in Bone marrow |
|
53639-1
|
CD52 Ag [Presence] in Tissue by Immune stain |
|
42885-4
|
CD52 cells/100 cells in Body fluid |
|
42886-2
|
CD52 cells/100 cells in Bone marrow |
|
42883-9
|
CD52 cells/100 cells in Tissue |
|
42884-7
|
CD52 cells/100 cells in Unspecified specimen |
|
43935-6
|
CD55 cells/100 cells in Body fluid |
|
43936-4
|
CD55 cells/100 cells in Tissue |
|
53832-2
|
CD55 deficient RBC/100 erythrocytes in Blood |
|
53830-6
|
CD55 deficient Granulocytes/100 cells in Blood |
|
46080-8
|
CD55 RBC/100 erythrocytes in Blood |
|
57762-7
|
CD55+CD59 cells [Presence] in Blood by Agglutination |
|
10442-2
|
CD56 Ag [Presence] in Tissue by Immune stain |
|
8133-1
|
CD56 cells/100 cells in Blood |
|
10444-8
|
CD57 Ag [Presence] in Tissue by Immune stain |
|
43938-0
|
CD59 cells/100 cells in Body fluid |
|
43937-2
|
CD59 cells/100 cells in Tissue |
|
53831-4
|
CD59 deficient Granulocytes/100 cells in Blood |
|
49550-7
|
CD59 Deficient leukocytes/100 cells in Blood |
|
21018-7
|
CD61 cells [#/volume] in Blood |
|
75023-2
|
CD63 (Activated) Basophils/100 basophils in Blood by Flow cytometry (FC) |
|
51446-3
|
CD64 cells [Units/volume] in Blood |
|
40555-5
|
CD66e Ag [Presence] in Tissue by Immune stain |
|
47017-9
|
CD68 Ag [Presence] in Tissue by Immune stain |
|
46966-8
|
CD69 cells [#/volume] in Blood |
|
50310-2
|
CD7 Ag [Presence] in Tissue by Immune stain |
|
47018-7
|
CD79a Ag [Presence] in Tissue by Immune stain |
|
51447-1
|
CD79a cells [Units/volume] in Blood |
|
42933-2
|
CD79a cells/100 cells in Unspecified specimen |
|
42888-8
|
CD79b cells/100 cells in Body fluid |
|
42889-6
|
CD79b cells/100 cells in Bone marrow |
|
42887-0
|
CD79b cells/100 cells in Tissue |
|
47019-5
|
CD8 Ag [Presence] in Tissue by Immune stain |
|
80222-3
|
CD8 cells/100 lymphocytes in Unspecified specimen |
|
77942-1
|
CD8+CD3- cells/100 cells in Unspecified specimen |
|
82743-6
|
CD8+CD45RA+ cells [#/volume] in Blood |
|
82744-4
|
CD8+CD45RA+ cells/100 CD8 cells in Blood |
|
38241-6
|
CD8+CD95+ cells [#/volume] in Blood |
|
42934-0
|
CD83 cells/100 cells in Unspecified specimen |
|
73898-9
|
CD8-CD57+ cells/100 lymphocytes in Blood by Flow cytometry (FC) |
|
77947-0
|
CD9 cells/100 cells in Unspecified specimen |
|
42628-8
|
CD9+CD41+ cells/100 cells in Blood |
|
47020-3
|
CD99 Ag [Presence] in Tissue by Immune stain |
|
93337-4
|
Chenodeoxycholate+Cholate/Bile acid.total in 48 hour Stool |
|
21652-3
|
CDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77132-9
|
CDHR1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77131-1
|
CDHR1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
48978-1
|
CDKL5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
75388-9
|
CDKN1B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
75389-7
|
CDKN1B gene full mutation analysis in Blood or Tissue by Sequencing |
|
21614-3
|
CDKN2A gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
89037-6
|
CDKN2A gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
57927-6
|
CDKN2A+CDK4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21615-0
|
CDKN2B gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
90417-7
|
Transferrin.carbohydrate deficient and Apolipoprotein C-III panel - Serum or Plasma |
|
91671-8
|
Transferrin.carbohydrate deficient.disialo/Transferrin.total standardized per IFCC-RMP for CDT in Serum or Plasma |
|
53943-7
|
Bacterial cytolethal distending toxin cdt gene [Presence] in Unspecified specimen by NAA with probe detection |
|
76613-9
|
Transferrin.carbohydrate deficient.pentasialo+hexasialo/Transferrin.total in Serum or Plasma |
|
53803-3
|
Transferrin.carbohydrate deficient panel - Serum or Plasma |
|
13999-8
|
Transferrin.carbohydrate deficient [Units/volume] in Serum or Plasma |
|
12949-4
|
Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma |
|
90420-1
|
Transferrin.carbohydrate deficient.trisialo/Transferrin.carbohydrate deficient.tetrasialo [Mass Ratio] in Serum or Plasma |
|
48495-6
|
Transferrin.carbohydrate deficient/Transferrin.total in Serum or Plasma |
|
87417-2
|
Cytolethal distending toxin B and Vinculin Ab panel - Serum by Immunoassay |
|
87418-0
|
Cytolethal distending toxin B Ab [Units/volume] in Serum by Immunoassay |
|
87419-8
|
Cytolethal distending toxin B+Vinculin Ab [Interpretation] in Serum Qualitative by Immunoassay |
|
31285-0
|
Canine distemper virus Ab [Presence] in Serum |
|
23689-3
|
Canine distemper virus Ab [Presence] in Serum by Immunofluorescence |
|
31284-3
|
Canine distemper virus Ab [Units/volume] in Serum |
|
23690-1
|
Canine distemper virus Ab [Titer] in Serum |
|
23696-8
|
Canine distemper virus Ag [Presence] in Conjunctival specimen |
|
20742-3
|
Canine distemper virus Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
23695-0
|
Canine distemper virus Ag [Presence] in Tissue by Immunofluorescence |
|
43066-0
|
Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid |
|
26903-5
|
Canine distemper virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
23692-7
|
Canine distemper virus IgG Ab [Titer] in Serum |
|
23691-9
|
Canine distemper virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
43065-2
|
Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid |
|
26890-4
|
Canine distemper virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
23694-3
|
Canine distemper virus IgM Ab [Titer] in Serum |
|
23693-5
|
Canine distemper virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
47021-1
|
CDX2 Ag [Presence] in Tissue by Immune stain |
|
93912-4
|
CE Ag [Presence] on Red Blood Cells |
|
81144-8
|
Cerium [Mass/volume] in Blood |
|
2037-0
|
Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid |
|
12515-3
|
Carcinoembryonic Ag [Mass/volume] in Body fluid |
|
40621-5
|
Carcinoembryonic Ag [Mass/volume] in Pericardial fluid |
|
19168-4
|
Carcinoembryonic Ag [Units/volume] in Pleural fluid |
|
19169-2
|
Carcinoembryonic Ag [Mass/volume] in Pleural fluid |
|
19170-0
|
Carcinoembryonic Ag [Moles/volume] in Pleural fluid |
|
40622-3
|
Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid |
|
83085-1
|
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay |
|
19166-8
|
Carcinoembryonic Ag [Units/volume] in Serum or Plasma |
|
2039-6
|
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma |
|
19167-6
|
Carcinoembryonic Ag [Moles/volume] in Serum or Plasma |
|
10560-1
|
Carcinoembryonic Ag [Units/volume] in Semen |
|
2038-8
|
Carcinoembryonic Ag [Mass/volume] in Semen |
|
10469-5
|
Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
|
75009-1
|
CEBPA gene full mutation analysis in Blood or Tissue by Molecular genetics method |
|
75032-3
|
CEBPA gene full mutation analysis in Bone marrow by Molecular genetics method |
|
64012-8
|
CEBPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7192-8
|
Cedar dust IgE Ab [Units/volume] in Serum |
|
78701-0
|
Cedar elm IgE Ab [Units/volume] in Serum |
|
26049-7
|
Cedar IgE Ab [Units/volume] in Serum |
|
42863-1
|
Cedar IgE Ab/IgE total in Serum |
|
19733-5
|
Cefaclor IgE Ab [Units/volume] in Serum |
|
34263-4
|
Cefaclor IgG Ab [Units/volume] in Serum |
|
16564-7
|
Cefaclor [Mass/volume] in Serum or Plasma |
|
73475-6
|
Cefadroxil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73474-9
|
Cefadroxil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16565-4
|
Cefadroxil [Mass/volume] in Serum or Plasma |
|
48269-5
|
Cefamandole triggered leukotriene release [Mass/volume] by Leukocytes |
|
3441-3
|
Cefamandole [Mass/volume] in Serum or Plasma |
|
73048-1
|
ceFAZolin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73047-3
|
ceFAZolin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80962-4
|
ceFAZolin free [Mass/volume] in Serum or Plasma |
|
73472-3
|
ceFAZolin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73473-1
|
ceFAZolin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
85422-4
|
ceFAZolin [Susceptibility] for UTI by Minimum inhibitory concentration (MIC) |
|
48270-3
|
ceFAZolin triggered leukotriene release [Mass/volume] by Leukocytes |
|
3443-9
|
ceFAZolin [Mass/volume] in Serum or Plasma |
|
16566-2
|
ceFAZolin [Mass/volume] in Urine |
|
25235-3
|
ceFAZolin [Mass/volume] in Unspecified specimen |
|
73046-5
|
Cefepime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73045-7
|
Cefepime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73471-5
|
Cefepime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73470-7
|
Cefepime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
50631-1
|
Cefepime [Susceptibility] by Method for Slow-growing mycobacteria |
|
38363-8
|
Cefepime [Mass/volume] in Serum or Plasma |
|
16567-0
|
Cefixime [Mass/volume] in Serum or Plasma |
|
25236-1
|
Cefixime [Mass/volume] in Unspecified specimen |
|
54174-8
|
Cefmenoxime [Susceptibility] by Disk diffusion (KB) |
|
54203-5
|
Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54908-9
|
Cefminox [Susceptibility] |
|
3444-7
|
Cefonicid [Mass/volume] in Serum or Plasma |
|
25237-9
|
Cefonicid [Mass/volume] in Unspecified specimen |
|
3445-4
|
Cefoperazone [Mass/volume] in Serum or Plasma |
|
54168-0
|
Cefoperazone+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54167-2
|
Cefoperazone+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54166-4
|
Cefoperazone+Sulbactam [Susceptibility] |
|
80961-6
|
Cefotaxime free [Mass/volume] in Serum or Plasma |
|
50632-9
|
Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria |
|
3446-2
|
Cefotaxime [Mass/volume] in Serum or Plasma |
|
25238-7
|
Cefotaxime [Mass/volume] in Unspecified specimen |
|
54193-8
|
Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54192-0
|
Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54191-2
|
Cefotaxime+Sulbactam [Susceptibility] |
|
3447-0
|
cefoTEtan [Mass/volume] in Serum or Plasma |
|
25239-5
|
cefoTEtan [Mass/volume] in Unspecified specimen |
|
87792-8
|
Cefovecin [Susceptibility] |
|
18241-0
|
cefOXitin IgE Ab [Units/volume] in Serum |
|
3448-8
|
cefOXitin [Mass/volume] in Serum or Plasma |
|
25240-3
|
cefOXitin [Mass/volume] in Unspecified specimen |
|
90849-1
|
Cefpodoxime 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25241-1
|
Cefpodoxime [Mass/volume] in Unspecified specimen |
|
131-3
|
Cefsulodin [Mass/volume] in Serum or Plasma |
|
25242-9
|
Cefsulodin [Mass/volume] in Unspecified specimen |
|
74170-2
|
Ceftaroline [Susceptibility] by Gradient strip |
|
73044-0
|
cefTAZidime induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73043-2
|
cefTAZidime induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
90850-9
|
cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
80960-8
|
cefTAZidime free [Mass/volume] in Serum or Plasma |
|
73468-1
|
cefTAZidime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73469-9
|
cefTAZidime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3449-6
|
cefTAZidime [Mass/volume] in Serum or Plasma |
|
21151-6
|
cefTAZidime [Mass/volume] in Unspecified specimen |
|
87734-0
|
cefTAZidime+Avibactam [Susceptibility] by Gradient strip |
|
73466-5
|
Ceftizoxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73467-3
|
Ceftizoxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3450-4
|
Ceftizoxime [Mass/volume] in Serum or Plasma |
|
25243-7
|
Ceftizoxime [Mass/volume] in Unspecified specimen |
|
85052-9
|
Ceftobiprole [Susceptibility] by Gradient strip |
|
87735-7
|
Ceftolozane+Tazobactam [Susceptibility] by Gradient strip |
|
73042-4
|
cefTRIAXone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73041-6
|
cefTRIAXone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80957-4
|
cefTRIAXone free [Mass/volume] in Serum or Plasma |
|
16569-6
|
cefTRIAXone IgE Ab [Mass/volume] in Serum |
|
73464-0
|
cefTRIAXone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73465-7
|
cefTRIAXone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3451-2
|
cefTRIAXone [Mass/volume] in Serum or Plasma |
|
50633-7
|
cefTRIAXone [Susceptibility] for meningitis |
|
25244-5
|
cefTRIAXone [Mass/volume] in Unspecified specimen |
|
16568-8
|
Cefuroxime IgE Ab [Units/volume] in Serum |
|
73462-4
|
Cefuroxime induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73463-2
|
Cefuroxime induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
51774-8
|
Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
48197-8
|
Cefuroxime triggered leukotriene release [Mass/volume] by Leukocytes |
|
3452-0
|
Cefuroxime Parenteral [Mass/volume] in Serum or Plasma |
|
25245-2
|
Cefuroxime Parenteral [Mass/volume] in Unspecified specimen |
|
80608-3
|
Cefuroxime [Mass/volume] in Serum or Plasma |
|
51724-3
|
Cefuroxime [Susceptibility] |
|
80617-4
|
Cefuroxime free [Mass/volume] in Serum or Plasma |
|
54932-9
|
Centers for Environmental Health abrine and ricinine panel [Mass/volume] - Urine |
|
55120-0
|
Centers for Environmental Health metabolic toxin panel [Mass/volume] - Urine |
|
55119-2
|
Centers for Environmental Health nitrogen mustard metabolite panel [Mass/volume] - Urine |
|
55118-4
|
Centers for Environmental Health trace metals panel [Mass/volume] - Urine |
|
55117-6
|
Centers for Environmental Health trace metals screen panel [Mass/volume] - Urine |
|
55116-8
|
Centers for Environmental Health volatile organic compounds panel [Mass/volume] - Serum or Plasma |
|
73040-8
|
Celecoxib induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73039-0
|
Celecoxib induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73461-6
|
Celecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73460-8
|
Celecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
28066-9
|
Celecoxib [Mass/volume] in Serum or Plasma |
|
64960-8
|
Celery recombinant (rApi g) 1 IgE Ab [Units/volume] in Serum |
|
91123-0
|
Celery recombinant (rApi g) 1 IgE Ab RAST class [Presence] in Serum |
|
7198-5
|
Celery triggered histamine release [Units/volume] in Blood |
|
6065-7
|
Celery IgE Ab [Units/volume] in Serum |
|
61218-4
|
Celery IgE Ab/IgE total in Serum |
|
7197-7
|
Celery IgG Ab [Units/volume] in Serum |
|
56213-2
|
Celery IgG4 Ab [Mass/volume] in Serum |
|
60363-9
|
Celery IgG Ab [Mass/volume] in Serum |
|
48203-4
|
Celery triggered leukotriene release [Mass/volume] by Leukocytes |
|
54230-8
|
Cell count and Diff panel with Gluc and Prot - Cerebral spinal fluid |
|
54234-0
|
Cell count and Diff panel with Gluc and Prot - Body fluid |
|
34564-5
|
Cell count and Differential panel - Cerebral spinal fluid |
|
60587-3
|
Cell count and Differential panel - Peritoneal dialysis fluid |
|
81272-7
|
Cell count and Differential panel - Dialysis fluid |
|
34557-9
|
Cell count and Differential panel - Body fluid |
|
59257-6
|
Cell count and Differential panel - Pericardial fluid |
|
34562-9
|
Cell count and Differential panel - Pleural fluid |
|
34567-8
|
Cell count and Differential panel - Peritoneal fluid |
|
34560-3
|
Cell count and Differential panel - Synovial fluid |
|
72393-2
|
Cell count and Differential panel - Vitreous fluid by Manual count |
|
34563-7
|
Cell count panel - Cerebral spinal fluid |
|
34556-1
|
Cell count panel - Body fluid |
|
69740-9
|
Cell count panel - Pericardial fluid |
|
34561-1
|
Cell count panel - Pleural fluid |
|
34558-7
|
Cell count panel - Peritoneal fluid |
|
34559-5
|
Cell count panel - Synovial fluid |
|
72394-0
|
Cell count panel - Vitreous fluid by Manual count |
|
56119-1
|
Cellular material [Mass/mass] of Stone by Estimated |
|
88053-4
|
Cells.CD4-CD8-CD45R+TCR alpha beta+ [#/volume] in Blood by Flow cytometry (FC) |
|
4469-3
|
Cellano Ag [Presence] on Red Blood Cells |
|
58469-8
|
Cells [#/volume] in Body fluid |
|
64086-2
|
Cells analyzed [#] in Chorionic villus sample by Molecular genetics method |
|
64095-3
|
Cells counted [#] in Amniotic fluid by Molecular genetics method |
|
64089-6
|
Cells counted [#] in Chorionic villus sample by Molecular genetics method |
|
64091-2
|
Cells karyotyped.total [#] in Amniotic fluid |
|
55199-4
|
Cells karyotyped.total [#] in Blood or Tissue |
|
64085-4
|
Cells karyotyped.total [#] in Chorionic villus sample |
|
58434-2
|
Cells panel - Urine sediment |
|
58438-3
|
Cells [Type] in Urine sediment by Light microscopy |
|
84915-8
|
Cells.chromosome region 11q22.3 deletion/Cells counted in Blood or Tissue by FISH |
|
84914-1
|
Cells.chromosome region 13q14 deletion/Cells counted in Blood or Tissue by FISH |
|
84916-6
|
Cells.chromosome region 17p13.1 deletion/Cells counted in Blood or Tissue by FISH |
|
84920-8
|
Cells.chromosome region 5q31 deletion/Cells counted in Blood or Tissue by FISH |
|
84912-5
|
Cells.chromosome region 5q31 deletion/Cells counted in Bone marrow by FISH |
|
84921-6
|
Cells.chromosome region 7q31 deletion/Cells counted in Blood or Tissue by FISH |
|
73974-8
|
CD158e cells/100 cells in Unspecified specimen |
|
84913-3
|
Cells.chromosome 12 trisomy/Cells counted in Blood or Tissue by FISH |
|
86239-1
|
Cells.chromosome 3 monosomy/Cells counted in Cancer specimen by FISH |
|
84922-4
|
Cells.chromosome 7 monosomy/Cells counted in Blood or Tissue by FISH |
|
88052-6
|
Cells.CD4-CD8-CD45R+TCR alpha beta+/100 CD3 cells in Blood by Flow cytometry (FC) |
|
82390-6
|
Centromere protein A Ab [Units/volume] in Serum by Line blot |
|
81714-8
|
Centromere protein A Ab [Presence] in Serum by Line blot |
|
72318-9
|
Centromere protein A IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
89207-5
|
Center for Epidemiologic Studies Depression Scale-Revised [CESD-R] |
|
89205-9
|
Center for Epidemiologic Studies Depression Scale-Revised total score [CESD-R] |
|
54150-8
|
Centriole Ab [Presence] in Serum by Immunofluorescence |
|
54151-6
|
Centriole Ab [Titer] in Serum by Immunofluorescence |
|
63530-0
|
Centromere Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63526-8
|
Centromere Ab [Presence] in Body fluid |
|
63527-6
|
Centromere Ab [Presence] in Body fluid by Immunoassay |
|
63528-4
|
Centromere Ab [Presence] in Body fluid by Immunofluorescence |
|
17830-1
|
Centromere Ab [Units/volume] in Body fluid |
|
16137-2
|
Centromere Ab [Presence] in Serum |
|
16570-4
|
Centromere Ab [Presence] in Serum by Immunofluorescence |
|
8068-9
|
Centromere Ab [Units/volume] in Serum |
|
63531-8
|
Centromere Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
42197-4
|
Centromere Ab [Titer] in Body fluid |
|
63529-2
|
Centromere Ab [Titer] in Body fluid by Immunofluorescence |
|
42196-6
|
Centromere Ab [Titer] in Serum |
|
5077-3
|
Centromere Ab [Titer] in Serum by Immunofluorescence |
|
63533-4
|
Centromere protein B Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89542-5
|
Centromere protein B Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63532-6
|
Centromere protein B Ab [Presence] in Body fluid by Immunoassay |
|
82391-4
|
Centromere protein B Ab [Units/volume] in Serum by Line blot |
|
53981-7
|
Centromere protein B Ab [Presence] in Serum |
|
56734-7
|
Centromere protein B Ab [Presence] in Serum by Immunoblot |
|
53982-5
|
Centromere protein B Ab [Units/volume] in Serum |
|
82913-5
|
Centromere protein B IgG Ab [Presence] in Serum by Line blot |
|
54001-3
|
Centromere protein F Ab [Presence] in Serum by Immunofluorescence |
|
54002-1
|
Centromere protein F Ab [Titer] in Serum by Immunofluorescence |
|
35272-4
|
Centromere IgG Ab [Presence] in Serum |
|
31290-0
|
Centromere IgG Ab [Units/volume] in Serum |
|
29966-9
|
Centromere IgG Ab [Titer] in Serum by Immunofluorescence |
|
16571-2
|
Cephadrine [Mass/volume] in Serum or Plasma |
|
21173-0
|
Cephaeline [Mass/volume] in Serum or Plasma |
|
21174-8
|
Cephaeline [Mass/volume] in Urine |
|
56695-0
|
Cephalexin IgE Ab [Units/volume] in Serum |
|
73458-2
|
Cephalexin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73459-0
|
Cephalexin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3453-8
|
Cephalexin [Mass/volume] in Serum or Plasma |
|
21175-5
|
Cephalexin [Mass/volume] in Unspecified specimen |
|
16572-0
|
Cephaloridine [Mass/volume] in Serum or Plasma |
|
7199-3
|
Cephalosporine mold IgE Ab [Units/volume] in Serum |
|
18419-2
|
Cephalosporine mold IgG Ab [Units/volume] in Serum |
|
48196-0
|
Cephalosporin C triggered leukotriene release [Mass/volume] by Leukocytes |
|
50033-0
|
Cephalosporin IgE Ab [Units/volume] in Serum |
|
3454-6
|
Cephalothin [Mass/volume] in Serum or Plasma |
|
25246-0
|
Cephalothin [Mass/volume] in Unspecified specimen |
|
10980-1
|
Cephapirin [Mass/volume] in Serum or Plasma |
|
76150-2
|
Cefquinome [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
93883-7
|
Ceramide panel - Plasma |
|
34680-9
|
Ceramide trihexoside [Presence] in Urine |
|
93770-6
|
Ceramide trihexoside [Molar ratio] in Urine |
|
87514-6
|
Cerebral monitor |
|
61017-0
|
Cerebral perfusion pressure |
|
77130-3
|
CERKL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77129-5
|
CERKL gene full mutation analysis in Blood or Tissue by Sequencing |
|
80571-3
|
Certificate |
|
87405-7
|
Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
87404-0
|
Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
53073-3
|
Ceruloplasmin [Moles/volume] in Cerebral spinal fluid |
|
46716-7
|
Ceruloplasmin [Mass/volume] in DBS |
|
29213-6
|
Ceruloplasmin [Mass/volume] in Body fluid |
|
2064-4
|
Ceruloplasmin [Mass/volume] in Serum or Plasma |
|
47600-2
|
Ceruloplasmin [Moles/volume] in Serum or Plasma |
|
65753-6
|
Cervix Pathology biopsy report |
|
79164-0
|
CES1 gene c.428G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
29982-6
|
Cesium [Mass/volume] in 24 hour Urine |
|
29983-4
|
Cesium [Mass/time] in 24 hour Urine |
|
5614-3
|
Cesium [Mass/volume] in Blood |
|
5615-0
|
Cesium [Mass/mass] in Hair |
|
5617-6
|
Cesium [Mass/volume] in Red Blood Cells |
|
5616-8
|
Cesium [Mass/volume] in Serum or Plasma |
|
5618-4
|
Cesium [Mass/volume] in Urine |
|
29984-2
|
Cesium/Creatinine [Mass Ratio] in 24 hour Urine |
|
82541-4
|
Cetuximab IgE Ab [Units/volume] in Serum |
|
43132-0
|
California encephalitis virus Ab [Units/volume] in Serum Qualitative |
|
35696-4
|
California encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
43931-5
|
California encephalitis virus Ab [Titer] in Serum |
|
88455-1
|
California encephalitis virus Ab.IgG and IgM panel - Serum by Immunofluorescence |
|
49195-1
|
California encephalitis virus IgG Ab [Units/volume] in Serum |
|
49194-4
|
California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
49138-1
|
California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
35694-9
|
California encephalitis virus IgG Ab [Titer] in Serum |
|
49140-7
|
California encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
88456-9
|
California encephalitis virus IgG+IgM Ab [Interpretation] in Serum Qualitative by Immunofluorescence |
|
49193-6
|
California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
49139-9
|
California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
35695-6
|
California encephalitis virus IgM Ab [Titer] in Serum |
|
49141-5
|
California encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
74148-8
|
Cystic fibrosis action plan |
|
85820-9
|
Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinase |
|
85819-1
|
Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude + heparinase |
|
6659-7
|
Microscopic observation [Identifier] in Tissue by Carbol-fuchsin stain |
|
659-3
|
Microscopic observation [Identifier] in Unspecified specimen by Carbol-fuchsin stain |
|
75606-4
|
Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75605-6
|
Cell-free DNA.fetal/Cell-free DNA.total in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
51779-7
|
CFH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
66753-5
|
Clot formation [Time] in Blood by Thromboelastography --after addition of heparinase |
|
42938-1
|
CFTR gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method |
|
42939-9
|
CFTR gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method |
|
38449-5
|
CFTR gene c.1078delT [Presence] in Blood or Tissue by Molecular genetics method |
|
38450-3
|
CFTR gene c.2184delA [Presence] in Blood or Tissue by Molecular genetics method |
|
38451-1
|
CFTR gene c.2789+5G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
38452-9
|
CFTR gene c.3120+1G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
34706-2
|
CFTR gene c.3199del6 [Presence] in Blood or Tissue by Molecular genetics method |
|
38453-7
|
CFTR gene c.3659delC [Presence] in Blood or Tissue by Molecular genetics method |
|
38456-0
|
CFTR gene c.3849+10kbC>T [Presence] in Blood or Tissue by Molecular genetics method |
|
70244-9
|
CFTR gene c.394delTT [Presence] in Blood or Tissue by Molecular genetics method |
|
38455-2
|
CFTR gene c.621+1G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
38447-9
|
CFTR gene c.711+1G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
69480-2
|
CFTR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
90256-9
|
CFTR gene full mutation analysis in Blood or Tissue by Sequencing |
|
53789-4
|
CFTR gene.p.IVS8 polyT 7T/9T [presence] in Blood or Tissue by Molecular genetics method |
|
43370-6
|
CFTR gene p.IVS8 PolyT [Presence] in Blood or Tissue by Molecular genetics method |
|
46989-0
|
CFTR gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
|
34718-7
|
CFTR gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
38404-0
|
CFTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21654-9
|
CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77017-2
|
CFTR gene mutation analysis [interpretation] in Blood or Tissue Qualitative by MS.MALDI |
|
54083-1
|
CFTR gene mutations found [Identifier] in DBS Nominal |
|
21656-4
|
CFTR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
38448-7
|
CFTR gene p.Ala455Glu [Presence] in Blood or Tissue by Molecular genetics method |
|
57930-0
|
CFTR gene p.Asp1152His [Presence] in Blood or Tissue by Molecular genetics method |
|
21655-6
|
CFTR gene.p.Phe508del [Presence] in Blood or Tissue by Molecular genetics method |
|
38454-5
|
CFTR gene p.Gly85Glu [Presence] in Blood or Tissue by Molecular genetics method |
|
34729-4
|
CFTR gene.p.Arg117His+5T variant [Presence] in Blood or Tissue by Molecular genetics method |
|
57931-8
|
CFTR+PRSS1+SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
10472-9
|
Chromogranin Ag [Presence] in Tissue by Immune stain |
|
10471-1
|
Chromogranin A Ag [Presence] in Tissue by Immune stain |
|
59227-9
|
Chromogranin A [Units/volume] in Cerebral spinal fluid |
|
59241-0
|
Chromogranin A [Units/volume] in Body fluid |
|
53047-7
|
Chromogranin A [Mass/volume] in Body fluid |
|
59220-4
|
Chromogranin A [Units/volume] in Pleural fluid |
|
59226-1
|
Chromogranin A [Units/volume] in Peritoneal fluid |
|
30169-7
|
Chromogranin A [Units/volume] in Serum or Plasma by Immunoassay |
|
9811-1
|
Chromogranin A [Mass/volume] in Serum or Plasma |
|
25587-7
|
Chromogranin A [Moles/volume] in Serum or Plasma |
|
2402-6
|
Guanosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
|
58053-0
|
Ch sup(a) Ag [Presence] on Red Blood Cells |
|
14076-4
|
Complement total hemolytic CH100 [Presence] in Serum or Plasma by Immune diffusion (ID) |
|
13088-0
|
Complement total hemolytic CH100 [Units/volume] in Serum or Plasma |
|
74521-6
|
Complement total hemolytic CH50 actual/normal in Serum by Immunoassay |
|
48496-4
|
Complement total hemolytic CH50 actual/normal in Serum or Plasma |
|
21218-3
|
Complement total hemolytic CH50 [Units/volume] in Cerebral spinal fluid |
|
4511-2
|
Complement total hemolytic CH50 [Units/volume] in Body fluid |
|
4532-8
|
Complement total hemolytic CH50 [Units/volume] in Serum or Plasma |
|
30131-7
|
Complement total hemolytic CH50 [Mass/volume] in Serum or Plasma |
|
48071-5
|
Complement total hemolytic CH50 [Titer] in Serum or Plasma |
|
6057-4
|
Chamomile IgE Ab [Units/volume] in Serum |
|
49967-3
|
Charcoal [Presence] in Urine sediment by Light microscopy |
|
53242-4
|
Charge ticket or encounter form |
|
86209-4
|
Community health care Case manager Note |
|
88643-2
|
Community health care Nurse Adult day care center Note |
|
85902-5
|
Community health care Nurse Note |
|
90752-7
|
Community health care Social worker Note |
|
76141-1
|
Reticulocyte corpuscular hemoglobin concentration mean [Mass/volume] in Blood |
|
93201-2
|
Coronary heart disease multigene analysis in Blood or Tissue by Molecular genetics method |
|
42240-2
|
CHD7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
76686-5
|
Reticulocyte cellular hemoglobin distribution width [Entitic mass] in Blood by calculation |
|
80566-3
|
Checklist |
|
7205-8
|
Cheese cheddar type triggered histamine release [Units/volume] in Blood |
|
6067-3
|
Cheese cheddar type IgE Ab [Units/volume] in Serum |
|
57932-6
|
Cheese cheddar type IgE Ab/IgE total in Serum |
|
7204-1
|
Cheese cheddar type IgG Ab [Units/volume] in Serum |
|
56215-7
|
Cheese cheddar type IgG4 Ab [Mass/volume] in Serum |
|
63092-1
|
Cheese cheddar type IgG Ab [Mass/volume] in Serum |
|
75224-6
|
Chediak-Higashi cells [Presence] in Blood |
|
7497-1
|
Cheese mold type triggered histamine release [Units/volume] in Blood |
|
6068-1
|
Cheese mold type IgE Ab [Units/volume] in Serum |
|
57933-4
|
Cheese mold type IgE Ab/IgE total in Serum |
|
7496-3
|
Cheese mold type IgG Ab [Units/volume] in Serum |
|
56216-5
|
Cheese mold type IgG4 Ab [Mass/volume] in Serum |
|
60364-7
|
Cheese mold type IgG Ab [Mass/volume] in Serum |
|
72518-4
|
CHEK2 gene c.470C>T and 1100delC [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
89038-4
|
CHEK2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
81191-9
|
Chemical pathology Consult note |
|
88374-4
|
Chemotherapy infusion start and stop date and time panel |
|
11486-8
|
Chemotherapy records |
|
79170-7
|
Cherry recombinant (rPru av) 1 IgE Ab [Units/volume] in Serum |
|
79169-9
|
Cherry recombinant (rPru av) 3 IgE Ab [Units/volume] in Serum |
|
79168-1
|
Cherry recombinant (rPru av) 4 IgE Ab [Units/volume] in Serum |
|
7218-1
|
Cherry triggered histamine release [Units/volume] in Blood |
|
6719-9
|
Cherry IgE Ab [Units/volume] in Serum |
|
61306-7
|
Cherry IgE Ab/IgE total in Serum |
|
7217-3
|
Cherry IgG Ab [Units/volume] in Serum |
|
56191-0
|
Cherry IgG4 Ab [Mass/volume] in Serum |
|
60365-4
|
Cherry IgG Ab [Mass/volume] in Serum |
|
6259-6
|
Chestnut IgE Ab [Units/volume] in Serum |
|
57925-0
|
Chestnut IgE Ab/IgE total in Serum |
|
56396-5
|
Chestnut IgG4 Ab [Mass/volume] in Serum |
|
63132-5
|
Chestnut IgG Ab [Mass/volume] in Serum |
|
6069-9
|
Chestnut Pollen IgE Ab [Units/volume] in Serum |
|
7221-5
|
Chewing gum IgE Ab [Units/volume] in Serum |
|
41749-3
|
CHIC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7573-9
|
Chick Pea IgE Ab [Units/volume] in Serum |
|
61244-0
|
Chick Pea IgE Ab/IgE total in Serum |
|
56217-3
|
Chick Pea IgG4 Ab [Mass/volume] in Serum |
|
63135-8
|
Chick Pea IgG Ab [Mass/volume] in Serum |
|
7223-1
|
Chicken triggered histamine release [Units/volume] in Blood |
|
65785-8
|
Chicken CSA serum albumin native (nGal d) 5 IgE Ab [Units/volume] in Serum |
|
56694-3
|
Chicken droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
19734-3
|
Chicken droppings IgE Ab [Units/volume] in Serum |
|
58911-9
|
Chicken droppings IgG Ab [Mass/volume] in Serum |
|
55591-2
|
Chicken feather IgE Ab [Presence] in Serum |
|
6070-7
|
Chicken feather IgE Ab [Units/volume] in Serum |
|
61337-2
|
Chicken feather IgE Ab/IgE total in Serum |
|
51546-0
|
Chicken feather IgG Ab [Presence] in Serum |
|
7224-9
|
Chicken feather IgG Ab [Units/volume] in Serum |
|
56437-7
|
Chicken feather IgG4 Ab [Mass/volume] in Serum |
|
81783-3
|
Chicken feather IgG Ab [Mass/volume] in Serum |
|
40879-9
|
Chicken IgE Ab [Units/volume] in Serum |
|
38465-1
|
Chicken IgE Ab/IgE total in Serum |
|
7222-3
|
Chicken IgG Ab [Units/volume] in Serum |
|
56218-1
|
Chicken IgG4 Ab [Mass/volume] in Serum |
|
35532-1
|
Chicken IgG Ab [Mass/volume] in Serum |
|
6071-5
|
Chicken meat IgE Ab [Units/volume] in Serum |
|
40843-5
|
Chicken meat IgE Ab/IgE total in Serum |
|
31291-8
|
Chicken serum Ab [Presence] in Serum |
|
24498-8
|
Chicken serum Ab [Presence] in Serum by Immune diffusion (ID) |
|
6836-1
|
Chicken serum proteins IgE Ab [Units/volume] in Serum |
|
38466-9
|
Chicken serum proteins IgG Ab [Presence] in Serum |
|
7225-6
|
Chicory IgE Ab [Units/volume] in Serum |
|
56219-9
|
Chicory IgG4 Ab [Mass/volume] in Serum |
|
63144-0
|
Chicory IgG Ab [Mass/volume] in Serum |
|
26623-9
|
Chikungunya virus Ab [Presence] in Serum |
|
74821-0
|
Chikungunya virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
43064-5
|
Chikungunya virus Ab [Titer] in Serum |
|
40505-0
|
Chikungunya virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
82297-3
|
Chikungunya virus structural proteins (E1+E2) IgG Ab [Presence] in Serum by Immunoassay |
|
83068-7
|
Chikungunya virus structural proteins (E1+E2) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
83067-9
|
Chikungunya virus structural proteins (E1+E2) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
93979-3
|
Chikungunya virus IgG Ab [Presence] in Serum |
|
88630-9
|
Chikungunya virus IgG Ab [Presence] in Serum by Immunoassay |
|
56129-0
|
Chikungunya virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
56128-2
|
Chikungunya virus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
93976-9
|
Chikungunya virus Ab.IgM and IgG panel - Serum Qualitative |
|
57934-2
|
Chikungunya virus IgM Ab [Presence] in Serum |
|
88629-1
|
Chikungunya virus IgM Ab [Presence] in Serum by Immunoassay |
|
56131-6
|
Chikungunya virus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
56130-8
|
Chikungunya virus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
81153-9
|
Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81152-1
|
Chikungunya virus non-structural protein 1 (nsP1) RNA [Presence] in Serum by NAA with probe detection |
|
86514-7
|
Chikungunya virus RNA [Presence] in Amniotic fluid by NAA with probe detection |
|
85583-3
|
Chikungunya virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
|
60260-7
|
Chikungunya virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
86515-4
|
Chikungunya virus RNA [Presence] in Urine by NAA with probe detection |
|
51664-1
|
Chikungunya virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85582-5
|
Chikungunya virus RNA+Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
|
85519-7
|
Child and adolescent psychology Consult note |
|
85520-5
|
Child and adolescent psychology Discharge summary |
|
85518-9
|
Child and adolescent psychology Initial evaluation note |
|
68696-4
|
Neurology with special qualifications in child neurology Diagnostic study note |
|
68697-2
|
Neurology with special qualifications in child neurology Discharge summary |
|
68699-8
|
Neurology with special qualifications in child neurology History and physical note |
|
68705-3
|
Neurology with special qualifications in child neurology Hospital Consult note |
|
68706-1
|
Neurology with special qualifications in child neurology Hospital Diagnostic study note |
|
68707-9
|
Neurology with special qualifications in child neurology Hospital Letter |
|
68700-4
|
Neurology with special qualifications in child neurology Note |
|
68701-2
|
Neurology with special qualifications in child neurology Preoperative evaluation and management note |
|
68702-0
|
Neurology with special qualifications in child neurology procedure note |
|
68703-8
|
Neurology with special qualifications in child neurology Progress note |
|
68704-6
|
Neurology with special qualifications in child neurology Transfer summary note |
|
68641-0
|
Child and adolescent psychiatry Diagnostic study note |
|
68642-8
|
Child and adolescent psychiatry Discharge summary |
|
77441-4
|
Child and adolescent psychiatry Flowsheet |
|
68644-4
|
Child and adolescent psychiatry History and physical note |
|
68648-5
|
Child and adolescent psychiatry Hospital Consult note |
|
68649-3
|
Child and adolescent psychiatry Hospital Letter |
|
68645-1
|
Child and adolescent psychiatry Note |
|
77446-3
|
Child and adolescent psychiatry Plan of care note |
|
68646-9
|
Child and adolescent psychiatry Progress note |
|
68647-7
|
Child and adolescent psychiatry Transfer summary note |
|
7593-7
|
Chili Pepper triggered histamine release [Units/volume] in Blood |
|
7591-1
|
Chili Pepper IgE Ab [Units/volume] in Serum |
|
7592-9
|
Chili Pepper IgG Ab [Units/volume] in Serum |
|
56220-7
|
Chili Pepper IgG4 Ab [Mass/volume] in Serum |
|
60366-2
|
Chili Pepper IgG Ab [Mass/volume] in Serum |
|
50032-2
|
China aster IgE Ab [Units/volume] in Serum |
|
30987-2
|
Chinchilla epithelium IgE Ab [Units/volume] in Serum |
|
11165-8
|
Chinchilla IgE Ab [Units/volume] in Serum |
|
7302-3
|
Chinese Elm IgE Ab [Units/volume] in Serum |
|
56221-5
|
Chinese Elm IgG4 Ab [Mass/volume] in Serum |
|
7226-4
|
Chinese Tallow Tree IgE Ab [Units/volume] in Serum |
|
84071-0
|
Chiropractic medicine Consult note |
|
28581-7
|
Chiropractic medicine Initial evaluation note |
|
84072-8
|
Chiropractic medicine Telephone encounter Note |
|
28580-9
|
Chiropractic medicine Progress note |
|
53594-8
|
Chitobioside IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
55836-1
|
Chitotriosidase [Enzymatic activity/volume] in DBS |
|
38355-4
|
Chitotriosidase [Enzymatic activity/volume] in Serum or Plasma |
|
80371-8
|
Chitotriosidase [Enzymatic activity/mass] in Serum or Plasma |
|
93740-9
|
Chives IgE Ab [Units/volume] in Serum |
|
45011-4
|
Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
38468-5
|
Chlamydia sp Ab [Presence] in Cerebral spinal fluid |
|
31292-6
|
Chlamydia sp Ab [Units/volume] in Cerebral spinal fluid |
|
16590-2
|
Chlamydia sp Ab [Units/volume] in Serum by Complement fixation |
|
5082-3
|
Chlamydia sp Ab [Units/volume] in Serum by Immunoassay |
|
16589-4
|
Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence |
|
45012-2
|
Chlamydia sp Ab [Presence] in Serum |
|
75757-5
|
Chlamydia sp Ab [Presence] in Serum by Complement fixation |
|
7823-8
|
Chlamydia sp Ab [Units/volume] in Serum |
|
23967-3
|
Chlamydia sp Ab [Titer] in Cerebral spinal fluid |
|
23990-5
|
Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
27273-2
|
Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22182-0
|
Chlamydia sp Ab [Titer] in Serum |
|
5083-1
|
Chlamydia sp Ab [Titer] in Serum by Complement fixation |
|
5084-9
|
Chlamydia sp Ab [Titer] in Serum by Immunofluorescence |
|
45105-4
|
Chlamydia sp Ag [Presence] in Anal |
|
45104-7
|
Chlamydia sp Ag [Presence] in Anal by Immunoassay |
|
45103-9
|
Chlamydia sp Ag [Presence] in Anal by Immunofluorescence |
|
31763-6
|
Chlamydia sp Ag [Presence] in Conjunctival specimen |
|
6343-8
|
Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunoassay |
|
6344-6
|
Chlamydia sp Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
45107-0
|
Chlamydia sp Ag [Presence] in Cervix |
|
45106-2
|
Chlamydia sp Ag [Presence] in Cervix by Immunoassay |
|
45108-8
|
Chlamydia sp Ag [Presence] in Cervix by Immunofluorescence |
|
31764-4
|
Chlamydia sp Ag [Presence] in Body fluid |
|
20755-5
|
Chlamydia sp Ag [Presence] in Body fluid by Immunoassay |
|
45109-6
|
Chlamydia sp Ag [Presence] in Body fluid by Immunofluorescence |
|
31765-1
|
Chlamydia sp Ag [Presence] in Genital specimen |
|
6345-3
|
Chlamydia sp Ag [Presence] in Genital specimen by Immunoassay |
|
6346-1
|
Chlamydia sp Ag [Presence] in Genital specimen by Immunofluorescence |
|
45133-6
|
Chlamydia sp Ag [Presence] in Nasopharynx |
|
45132-8
|
Chlamydia sp Ag [Presence] in Nasopharynx by Immunoassay |
|
45131-0
|
Chlamydia sp Ag [Presence] in Nasopharynx by Immunofluorescence |
|
32003-6
|
Chlamydia sp Ag [Presence] in Peritoneal fluid by Immunoassay |
|
31766-9
|
Chlamydia sp Ag [Presence] in Stool |
|
20756-3
|
Chlamydia sp Ag [Presence] in Stool by Immunoassay |
|
20757-1
|
Chlamydia sp Ag [Presence] in Tissue by Immunofluorescence |
|
16593-6
|
Chlamydia sp Ag [Presence] in Urine |
|
32004-4
|
Chlamydia sp Ag [Presence] in Urine by Immunoassay |
|
45112-0
|
Chlamydia sp Ag [Presence] in Urine by Immunofluorescence |
|
45114-6
|
Chlamydia sp Ag [Presence] in Urethra |
|
45113-8
|
Chlamydia sp Ag [Presence] in Urethra by Immunoassay |
|
45115-3
|
Chlamydia sp Ag [Presence] in Urethra by Immunofluorescence |
|
32671-0
|
Chlamydia sp Ag [Presence] in Vaginal fluid |
|
32001-0
|
Chlamydia sp Ag [Presence] in Vaginal fluid by Immunoassay |
|
31767-7
|
Chlamydia sp Ag [Presence] in Unspecified specimen |
|
6347-9
|
Chlamydia sp Ag [Presence] in Unspecified specimen by Immunoassay |
|
561-1
|
Chlamydia sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
45097-3
|
Chlamydia sp identified in Anal by Organism specific culture |
|
24005-1
|
Chlamydia sp identified in Bronchial specimen by Organism specific culture |
|
556-1
|
Chlamydia sp identified in Conjunctival specimen by Organism specific culture |
|
45098-1
|
Chlamydia sp identified in Cervix by Organism specific culture |
|
35711-1
|
Chlamydia sp DNA [Presence] in Anal by NAA with probe detection |
|
35710-3
|
Chlamydia sp DNA [Presence] in Conjunctival specimen by NAA with probe detection |
|
35713-7
|
Chlamydia sp DNA [Presence] in Cervix by NAA with probe detection |
|
32774-2
|
Chlamydia sp DNA [Presence] in Genital specimen by NAA with probe detection |
|
35412-6
|
Chlamydia sp DNA [Presence] in Nose by NAA with probe detection |
|
35722-8
|
Chlamydia sp DNA [Presence] in Serum by NAA with probe detection |
|
35724-4
|
Chlamydia sp DNA [Presence] in Throat by NAA with probe detection |
|
34708-8
|
Chlamydia sp DNA [Presence] in Urine by NAA with probe detection |
|
35727-7
|
Chlamydia sp DNA [Presence] in Urethra by NAA with probe detection |
|
35716-0
|
Chlamydia sp DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
35729-3
|
Chlamydia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
45099-9
|
Chlamydia sp identified in Body fluid by Organism specific culture |
|
557-9
|
Chlamydia sp identified in Genital specimen by Organism specific culture |
|
29677-2
|
Chlamydia sp IgA Ab [Presence] in Serum |
|
29664-0
|
Chlamydia sp IgA Ab [Presence] in Serum by Immunoassay |
|
25369-0
|
Chlamydia sp IgA Ab [Units/volume] in Serum |
|
43063-7
|
Chlamydia sp IgA Ab [Titer] in Serum |
|
34264-2
|
Chlamydia sp IgA Ab [Titer] in Serum by Immunofluorescence |
|
16591-0
|
Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
45010-6
|
Chlamydia sp IgG Ab [Presence] in Cerebral spinal fluid |
|
22183-8
|
Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid |
|
38467-7
|
Chlamydia sp IgG Ab [Presence] in Body fluid |
|
33410-2
|
Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
21185-4
|
Chlamydia sp IgG Ab [Presence] in Serum |
|
56909-5
|
Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay |
|
5085-6
|
Chlamydia sp IgG Ab [Units/volume] in Serum |
|
56910-3
|
Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57679-3
|
Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --1st specimen |
|
24238-8
|
Chlamydia sp IgG Ab [Units/volume] in Serum --1st specimen |
|
56911-1
|
Chlamydia sp IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
57680-1
|
Chlamydia sp IgG Ab [Presence] in Serum by Immunoassay --2nd specimen |
|
24239-6
|
Chlamydia sp IgG Ab [Units/volume] in Serum --2nd specimen |
|
22184-6
|
Chlamydia sp IgG Ab [Titer] in Serum |
|
10848-0
|
Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence |
|
16592-8
|
Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
22185-3
|
Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid |
|
21186-2
|
Chlamydia sp IgM Ab [Presence] in Serum |
|
5086-4
|
Chlamydia sp IgM Ab [Units/volume] in Serum |
|
22186-1
|
Chlamydia sp IgM Ab [Titer] in Serum |
|
10849-8
|
Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence |
|
45101-3
|
Chlamydia sp identified in Nasopharynx by Organism specific culture |
|
35721-0
|
Chlamydia sp rRNA [Presence] in Anal by Probe |
|
35712-9
|
Chlamydia sp rRNA [Presence] in Conjunctival specimen by Probe |
|
35714-5
|
Chlamydia sp rRNA [Presence] in Cervix by Probe |
|
35715-2
|
Chlamydia sp rRNA [Presence] in Genital specimen by Probe |
|
35718-6
|
Chlamydia sp rRNA [Presence] in Nose by Probe |
|
35736-8
|
Chlamydia sp rRNA [Presence] in Nasopharynx by Probe |
|
35723-6
|
Chlamydia sp rRNA [Presence] in Serum by Probe |
|
35725-1
|
Chlamydia sp rRNA [Presence] in Throat by Probe |
|
35726-9
|
Chlamydia sp rRNA [Presence] in Urine by Probe |
|
35728-5
|
Chlamydia sp rRNA [Presence] in Urethra by Probe |
|
35717-8
|
Chlamydia sp rRNA [Presence] in Vaginal fluid by Probe |
|
35730-1
|
Chlamydia sp rRNA [Presence] in Unspecified specimen by Probe |
|
41482-1
|
Chlamydia sp IgG and IgM panel [Titer] - Serum |
|
77166-7
|
Chlamydia sp IgG and IgM panel [Titer] - Serum by Immunofluorescence |
|
6348-7
|
Chlamydia sp identified in Sputum by Organism specific culture |
|
558-7
|
Chlamydia sp identified in Throat by Organism specific culture |
|
559-5
|
Chlamydia sp identified in Urethra by Organism specific culture |
|
45100-5
|
Chlamydia sp identified in Vaginal fluid by Organism specific culture |
|
560-3
|
Chlamydia sp identified in Unspecified specimen by Organism specific culture |
|
46179-8
|
Chlamydophila sp Ab [Presence] in Serum |
|
43847-3
|
Chlamydophila sp Ab [Presence] in Serum by Immunofluorescence |
|
12993-2
|
Hydrocarbons.chlorinated [Identifier] in Blood |
|
24422-8
|
Hydrocarbons.chlorinated [Identifier] in Unspecified specimen |
|
4071-7
|
Chloral hydrate [Mass/volume] in Blood |
|
59878-9
|
Chloral hydrate [Moles/volume] in Gastric fluid |
|
35119-7
|
Chloral hydrate [Presence] in Serum or Plasma |
|
3042-9
|
Chloral hydrate [Mass/volume] in Serum or Plasma |
|
55528-4
|
Chloral hydrate [Moles/volume] in Serum or Plasma |
|
17738-6
|
Chloral hydrate [Presence] in Urine |
|
17739-4
|
Chloral hydrate [Presence] in Urine by Confirmatory method |
|
4072-5
|
Chloral hydrate [Mass/volume] in Urine |
|
59877-1
|
Chloral hydrate [Moles/volume] in Urine |
|
60292-0
|
Chloral hydrate [Moles/volume] in Unspecified specimen |
|
44305-1
|
Chloral hydrate/Creatinine [Mass Ratio] in Urine |
|
6072-3
|
Chloramin T IgE Ab [Units/volume] in Serum |
|
48187-9
|
Chloramin T triggered leukotriene release [Mass/volume] by Leukocytes |
|
29214-4
|
Chloramphenicol [Mass/volume] in Body fluid |
|
29347-2
|
Chloramphenicol [Mass/volume] in Gastric fluid |
|
16603-3
|
Chloramphenicol [Mass/volume] in Serum or Plasma --peak |
|
3455-3
|
Chloramphenicol [Mass/volume] in Serum or Plasma |
|
15101-9
|
Chloramphenicol [Moles/volume] in Serum or Plasma |
|
16604-1
|
Chloramphenicol [Mass/volume] in Serum or Plasma --trough |
|
29346-4
|
Chloramphenicol [Mass/volume] in Urine |
|
25247-8
|
Chloramphenicol [Mass/volume] in Unspecified specimen |
|
12297-8
|
Chlorate [Presence] in Blood |
|
38579-9
|
Chlordane [Mass/volume] in Air |
|
9807-9
|
Chlordane [Mass/volume] in Serum or Plasma |
|
87746-4
|
Chlordane [Mass/mass] in Unspecified specimen |
|
12305-9
|
Chlordecone [Presence] in Blood |
|
13638-2
|
Chlordecone [Mass/volume] in Blood |
|
13639-0
|
Chlordecone [Mass/volume] in Serum or Plasma |
|
59618-9
|
chlordiazePOXIDE [Mass/volume] in Blood by Confirmatory method |
|
59617-1
|
chlordiazePOXIDE [Mass/volume] in Blood |
|
59620-5
|
chlordiazePOXIDE [Mass/volume] in Body fluid by Confirmatory method |
|
59619-7
|
chlordiazePOXIDE [Mass/volume] in Body fluid |
|
52949-5
|
chlordiazePOXIDE [Presence] in Gastric fluid |
|
29380-3
|
chlordiazePOXIDE [Mass/volume] in Gastric fluid |
|
59880-5
|
chlordiazePOXIDE [Moles/volume] in Gastric fluid |
|
26790-6
|
chlordiazePOXIDE [Mass/mass] in Hair |
|
73457-4
|
chlordiazePOXIDE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73456-6
|
chlordiazePOXIDE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59621-3
|
chlordiazePOXIDE [Mass/mass] in Meconium by Confirmatory method |
|
26938-1
|
chlordiazePOXIDE [Mass/mass] in Meconium |
|
87808-2
|
chlordiazePOXIDE [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
59622-1
|
chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3456-1
|
chlordiazePOXIDE [Presence] in Serum or Plasma |
|
35600-6
|
chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Screen method |
|
3457-9
|
chlordiazePOXIDE [Mass/volume] in Serum or Plasma |
|
32059-8
|
chlordiazePOXIDE [Moles/volume] in Serum or Plasma |
|
59623-9
|
chlordiazePOXIDE [Mass/mass] in Stool by Confirmatory method |
|
16185-1
|
chlordiazePOXIDE [Mass/volume] in Stool |
|
27418-3
|
chlordiazePOXIDE [Mass/mass] in Stool |
|
59625-4
|
chlordiazePOXIDE [Mass/mass] in Tissue by Confirmatory method |
|
59624-7
|
chlordiazePOXIDE [Mass/mass] in Tissue |
|
20522-9
|
chlordiazePOXIDE [Mass/volume] in Urine by Confirmatory method |
|
3458-7
|
chlordiazePOXIDE [Presence] in Urine |
|
19386-2
|
chlordiazePOXIDE [Presence] in Urine by Confirmatory method |
|
19385-4
|
chlordiazePOXIDE [Presence] in Urine by Screen method |
|
3459-5
|
chlordiazePOXIDE [Mass/volume] in Urine |
|
59879-7
|
chlordiazePOXIDE [Moles/volume] in Urine |
|
26900-1
|
chlordiazePOXIDE [Mass/volume] in Vitreous fluid |
|
48945-0
|
chlordiazePOXIDE [Mass/volume] in Unspecified specimen |
|
60293-8
|
chlordiazePOXIDE [Moles/volume] in Unspecified specimen |
|
66128-0
|
chlordiazePOXIDE/Creatinine [Mass Ratio] in Urine |
|
33060-5
|
chlordiazePOXIDE+Metabolites [Mass/volume] in Serum or Plasma |
|
21193-8
|
chlordiazePOXIDE+Norchlordiazepoxide [Mass/volume] in Serum or Plasma |
|
79162-4
|
chlordiazePOXIDE and Norchlordiazepoxide panel - Serum or Plasma |
|
66717-0
|
Chlorhexidine IgE Ab [Units/volume] in Serum |
|
32542-3
|
Chloride [Molar amount] in Urine collected for unspecified duration |
|
35676-6
|
Chloride [Moles/volume] in Urine collected for unspecified duration |
|
57340-2
|
Chloride [Moles/volume] in 12 hour Urine |
|
57342-8
|
Chloride [Moles/time] in 12 hour Urine |
|
58999-4
|
Chloride [Moles/time] in 18 hour Urine |
|
55837-9
|
Chloride [Moles/volume] in 24 hour Stool |
|
9742-8
|
Chloride [Moles/time] in 24 hour Stool |
|
21194-6
|
Chloride [Moles/volume] in 24 hour Urine |
|
2079-2
|
Chloride [Moles/time] in 24 hour Urine |
|
57341-0
|
Chloride [Moles/volume] in 2 hour Urine |
|
2068-5
|
Chloride [Moles/volume] in Amniotic fluid |
|
41650-3
|
Chloride [Moles/volume] in Arterial blood |
|
51590-8
|
Chloride [Moles/volume] in Capillary blood |
|
2069-3
|
Chloride [Moles/volume] in Blood |
|
41649-5
|
Chloride [Moles/volume] in Venous blood |
|
2070-1
|
Chloride [Moles/volume] in Cerebral spinal fluid |
|
39467-6
|
Chloride [Moles/volume] in Peritoneal dialysis fluid |
|
2071-9
|
Chloride [Moles/volume] in Dialysis fluid |
|
54370-2
|
Chloride [Mass/volume] in Body fluid |
|
2072-7
|
Chloride [Moles/volume] in Body fluid |
|
59178-4
|
Chloride [Moles/volume] in Gastric fluid |
|
60217-7
|
Chloride [Moles/volume] in Mother's milk |
|
54369-4
|
Chloride [Moles/volume] in Serum or Plasma --post dialysis |
|
53627-6
|
Chloride [Moles/volume] in Pleural fluid |
|
43128-8
|
Chloride panel - 24 hour Urine |
|
33366-6
|
Chloride [Moles/volume] in Peritoneal fluid |
|
2073-5
|
Chloride [Moles/volume] in Red Blood Cells |
|
2074-3
|
Chloride [Moles/volume] in Saliva (oral fluid) |
|
77138-6
|
Chloride [Moles/volume] in Serum, Plasma or Blood |
|
2075-0
|
Chloride [Moles/volume] in Serum or Plasma |
|
15158-9
|
Chloride [Moles/volume] in Stool |
|
2076-8
|
Chloride [Moles/mass] in Stool |
|
56448-4
|
Chloride [Moles/volume] in Sweat by Screen method |
|
2077-6
|
Chloride [Moles/volume] in Sweat |
|
53099-8
|
Chloride [Moles/volume] in Total parental nutrition |
|
26762-5
|
Chloride [Units/volume] in Urine |
|
2078-4
|
Chloride [Moles/volume] in Urine |
|
12898-3
|
Chloride [Moles/volume] in Vitreous fluid |
|
54494-0
|
Chloride [Mass/volume] in Water |
|
12530-2
|
Chloride [Moles/volume] in Water |
|
32307-1
|
Chloride [Moles/volume] in Unspecified specimen |
|
13721-6
|
Chloride/Creatinine [Mass Ratio] in 24 hour Urine |
|
53640-9
|
Chloride/Creatinine [Ratio] in 24 hour Urine |
|
43221-1
|
Chloride/Creatinine [Ratio] in Urine |
|
34265-9
|
Chloride/Creatinine [Molar ratio] in Urine |
|
74993-7
|
Chloride and sodium panel [Moles/volume] - Sweat |
|
87669-8
|
Chlorinated hydrocarbon panel - Unspecified specimen |
|
74674-3
|
Chlorinated solvents [Presence] in Urine |
|
38647-4
|
Chlorine [Mass/volume] in Air |
|
16606-6
|
Chlorine [Mass/volume] in Dialysis fluid |
|
43158-5
|
Chlorine.free [Mass/volume] in Water |
|
3461-1
|
Chlormerodrin [Mass/volume] in 24 hour Urine |
|
3460-3
|
Chlormerodrin [Presence] in Urine |
|
3462-9
|
Chlormerodrin [Mass/volume] in Urine |
|
12427-1
|
Chlormezanone [Mass/volume] in Serum or Plasma |
|
38654-0
|
Chloroacetate [Mass/volume] in Air |
|
53821-5
|
Chloroamphetamine [Mass/volume] in Serum |
|
38648-2
|
Chlorobenzene [Mass/volume] in Air |
|
8180-2
|
Chlorobenzene [Mass/volume] in Blood |
|
9505-9
|
Chlorobenzene [Mass/volume] in Serum or Plasma |
|
29902-4
|
Chlorobenzene [Mass/volume] in Urine |
|
38656-5
|
Chlorobenzilate [Mass/volume] in Air |
|
16605-8
|
Chlorocycline [Mass/volume] in Urine |
|
38694-6
|
Chloroethane [Mass/volume] in Air |
|
9506-7
|
Chloroethane [Mass/volume] in Blood |
|
38649-0
|
Chloroform [Mass/volume] in Air |
|
9333-6
|
Chloroform [Mass/volume] in Blood |
|
54937-8
|
Chloroform [Mass/volume] in Serum or Plasma |
|
38706-8
|
Chloromethane [Mass/volume] in Air |
|
9507-5
|
Chloromethane [Mass/volume] in Blood |
|
87610-2
|
Chlorophacinone [Mass/mass] in Unspecified specimen |
|
3463-7
|
Chloroquine [Mass/volume] in Serum or Plasma |
|
32060-6
|
Chloroquine [Moles/volume] in Serum or Plasma |
|
18386-3
|
Chlorothiazide [Presence] in Serum or Plasma |
|
3464-5
|
Chlorothiazide [Mass/volume] in Serum or Plasma |
|
9508-3
|
Chlorothiazide [Presence] in Urine |
|
9648-7
|
Chlorothiazide [Mass/volume] in Urine |
|
59883-9
|
Chlorpheniramine [Moles/volume] in Gastric fluid |
|
75759-1
|
Chlorpheniramine [Presence] in Serum or Plasma or Urine by Screen method |
|
3465-2
|
Chlorpheniramine [Presence] in Serum or Plasma |
|
3466-0
|
Chlorpheniramine [Mass/volume] in Serum or Plasma |
|
59881-3
|
Chlorpheniramine [Moles/volume] in Serum or Plasma |
|
19391-2
|
Chlorpheniramine [Mass/volume] in Urine by Confirmatory method |
|
3467-8
|
Chlorpheniramine [Presence] in Urine |
|
16209-9
|
Chlorpheniramine [Presence] in Urine by Confirmatory method |
|
19389-6
|
Chlorpheniramine [Presence] in Urine by Screen method |
|
16608-2
|
Chlorpheniramine [Units/volume] in Urine |
|
19392-0
|
Chlorpheniramine [Mass/volume] in Urine |
|
59882-1
|
Chlorpheniramine [Moles/volume] in Urine |
|
57857-5
|
Chlorpheniramine [Moles/volume] in Unspecified specimen |
|
16609-0
|
Chlorphentermine [Units/volume] in Blood |
|
3468-6
|
Chlorphentermine [Mass/volume] in Blood |
|
26716-1
|
Chlorphentermine [Mass/mass] in Meconium |
|
27171-8
|
Chlorphentermine [Mass/volume] in Milk |
|
29602-0
|
Chlorphentermine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
27307-8
|
Chlorphentermine [Mass/mass] in Stool |
|
3469-4
|
Chlorphentermine [Presence] in Urine |
|
16610-8
|
Chlorphentermine [Units/volume] in Urine |
|
3470-2
|
Chlorphentermine [Mass/volume] in Urine |
|
27253-4
|
Chlorphentermine [Mass/volume] in Vitreous fluid |
|
14644-9
|
chlorproMAZINE [Presence] in Gastric fluid |
|
29386-0
|
chlorproMAZINE [Mass/volume] in Gastric fluid |
|
59885-4
|
chlorproMAZINE [Moles/volume] in Gastric fluid |
|
73454-1
|
chlorproMAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73455-8
|
chlorproMAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13548-3
|
chlorproMAZINE [Presence] in Serum or Plasma |
|
35601-4
|
chlorproMAZINE [Mass/volume] in Serum or Plasma by Screen method |
|
3471-0
|
chlorproMAZINE [Mass/volume] in Serum or Plasma |
|
14645-6
|
chlorproMAZINE [Moles/volume] in Serum or Plasma |
|
20523-7
|
chlorproMAZINE [Mass/volume] in Urine by Confirmatory method |
|
3472-8
|
chlorproMAZINE [Presence] in Urine |
|
19396-1
|
chlorproMAZINE [Presence] in Urine by Confirmatory method |
|
19395-3
|
chlorproMAZINE [Presence] in Urine by Screen method |
|
3473-6
|
chlorproMAZINE [Mass/volume] in Urine |
|
59884-7
|
chlorproMAZINE [Moles/volume] in Urine |
|
32061-4
|
chlorproMAZINE [Presence] in Unspecified specimen |
|
60294-6
|
chlorproMAZINE [Moles/volume] in Unspecified specimen |
|
38470-1
|
Chlorpropamide [Mass/volume] in 24 hour Urine |
|
73453-3
|
Chlorpropamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73452-5
|
Chlorpropamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48329-7
|
Chlorpropamide [Presence] in Serum or Plasma |
|
3474-4
|
Chlorpropamide [Mass/volume] in Serum or Plasma |
|
32062-2
|
Chlorpropamide [Moles/volume] in Serum or Plasma |
|
12329-9
|
Chlorpropamide [Presence] in Urine |
|
12396-8
|
Chlorpropamide [Mass/volume] in Urine |
|
48324-8
|
Chlorpropamide [Presence] in Unspecified specimen |
|
47392-6
|
Chlorpropamide [Mass/volume] in Unspecified specimen |
|
3475-1
|
Chlorprothixene [Mass/volume] in Blood |
|
3476-9
|
Chlorprothixene [Mass/volume] in Serum or Plasma |
|
48353-7
|
Chlorprothixene [Moles/volume] in Serum or Plasma |
|
3477-7
|
Chlorprothixene [Mass/volume] in Urine |
|
9371-6
|
Chlorpyrifos [Mass/volume] in Blood |
|
35489-4
|
Chlorpyrifos [Mass/volume] in Serum or Plasma |
|
16611-6
|
Chlorpyrifos [Mass/volume] in Urine |
|
87747-2
|
Chlorpyrifos [Mass/mass] in Unspecified specimen |
|
87600-3
|
Chlortetracycline [Mass/mass] in Unspecified specimen |
|
3480-1
|
Chlorthalidone [Mass/time] in 24 hour Urine |
|
73451-7
|
Chlorthalidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73450-9
|
Chlorthalidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16612-4
|
Chlorthalidone [Mass/volume] in Serum or Plasma |
|
3478-5
|
Chlorthalidone [Presence] in Urine |
|
3479-3
|
Chlorthalidone [Mass/volume] in Urine |
|
12425-5
|
Chlorzoxazone [Mass/volume] in Serum or Plasma |
|
21195-3
|
Chlorzoxazone [Mass/volume] in Urine |
|
25609-9
|
Cochineal extract IgE Ab [Units/volume] in Serum |
|
61336-4
|
Cochineal extract IgE Ab/IgE total in Serum |
|
7227-2
|
Chocolate triggered histamine release [Units/volume] in Blood |
|
6073-1
|
Chocolate IgE Ab [Units/volume] in Serum |
|
57935-9
|
Chocolate IgE Ab/IgE total in Serum |
|
6720-7
|
Chocolate IgG Ab [Units/volume] in Serum |
|
56222-3
|
Chocolate IgG4 Ab [Mass/volume] in Serum |
|
35554-5
|
Chocolate IgG Ab [Mass/volume] in Serum |
|
70263-9
|
Cholesterol in pericardial fluid/Cholesterol in serum |
|
70268-8
|
Cholesterol in pleural fluid/Cholesterol in serum |
|
70261-3
|
Cholesterol in peritoneal fluid/Cholesterol in serum |
|
90364-1
|
Cholesterol.in LDL.small dense [Mass/volume] in Serum by Immunoassay |
|
2080-0
|
Cholate [Mass/volume] in Serum |
|
30518-5
|
Cholate [Moles/volume] in Serum or Plasma |
|
14438-6
|
Cholesterol [Mass/volume] in Amniotic fluid |
|
5932-9
|
Cholesterol [Presence] in Blood by Test strip |
|
77964-5
|
Cholesterol crystals [#/area] in Urine sediment by Microscopy low power field |
|
93504-9
|
Cholesterol crystals [Presence] in Stone by X-ray diffraction |
|
14439-4
|
Cholesterol [Mass/volume] in Cerebral spinal fluid |
|
59038-0
|
Cholesterol [Mass/volume] in Peritoneal dialysis fluid |
|
53082-4
|
Cholesterol [Moles/volume] in Dialysis fluid |
|
73958-1
|
Cholesterol esterase [Enzymatic activity/volume] in DBS |
|
24079-6
|
Cholesterol esterase [Enzymatic activity/mass] in Fibroblast |
|
2083-4
|
Cholesterol esterase [Enzymatic activity/volume] in Serum |
|
59248-5
|
Cholesterol esterase [Enzymatic activity/mass] in Tissue |
|
74359-1
|
Cholesterol ester transfer protein actual/normal in Serum or Plasma |
|
55839-5
|
Cholesterol ester transfer protein [Units/volume] in Serum or Plasma |
|
24080-4
|
Cholesterol esterase [Enzymatic activity/mass] in Leukocytes |
|
2084-2
|
Cholesterol esters [Mass/volume] in Serum or Plasma |
|
55840-3
|
Cholesterol esters [Moles/volume] in Serum or Plasma |
|
12183-0
|
Cholesterol [Mass/volume] in Body fluid |
|
29765-5
|
Cholesterol [Moles/volume] in Body fluid |
|
35389-6
|
Cholesterol.in chylomicrons [Presence] in Serum or Plasma |
|
34467-1
|
Cholesterol.in chylomicrons [Mass/volume] in Serum or Plasma |
|
56912-9
|
Cholesterol [Mass/volume] in Pericardial fluid |
|
78518-8
|
Cholesterol [Moles/volume] in Pericardial fluid |
|
9618-0
|
Cholesterol [Mass/volume] in Pleural fluid |
|
39468-4
|
Cholesterol [Moles/volume] in Pleural fluid |
|
9342-7
|
Cholesterol [Percentile] |
|
14441-0
|
Cholesterol [Mass/volume] in Peritoneal fluid |
|
54371-0
|
Cholesterol [Moles/volume] in Peritoneal fluid |
|
48620-9
|
Cholesterol [Mass/volume] in Serum or Plasma ultracentrifugate |
|
2093-3
|
Cholesterol [Mass/volume] in Serum or Plasma |
|
35200-5
|
Cholesterol [Mass or Moles/volume] in Serum or Plasma |
|
14647-2
|
Cholesterol [Moles/volume] in Serum or Plasma |
|
14442-8
|
Cholesterol [Mass/volume] in Semen |
|
14443-6
|
Cholesterol [Mass/volume] in Synovial fluid |
|
51591-6
|
Cholesterol [Moles/volume] in Synovial fluid |
|
14154-9
|
Cholesterol sulfate [Mass/volume] in Serum |
|
74517-4
|
Cholesterol sulfate [Moles/volume] in Serum or Plasma |
|
14444-4
|
Cholesterol [Mass/volume] in Urine |
|
32308-9
|
Cholesterol [Moles/volume] in Unspecified specimen |
|
9830-1
|
Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
|
55838-7
|
Cholesterol/Phospholipid [Molar ratio] in Serum or Plasma |
|
2082-6
|
Cholestanol [Mass/volume] in Serum or Plasma |
|
74432-6
|
Cholestanol [Moles/volume] in Serum or Plasma |
|
74433-4
|
Cholestanol/Cholesterol in Serum or Plasma |
|
72694-3
|
Cholinesterase activity panel - Serum or Plasma |
|
2097-4
|
Cholinesterase [Enzymatic activity/volume] in Amniotic fluid |
|
11154-2
|
Cholinesterase [Enzymatic activity/volume] in Blood |
|
20758-9
|
Cholinesterase [Enzymatic activity/mass] in Brain |
|
77367-1
|
Cholinesterase [Enzymatic activity/volume] in Serum or Plasma by calculation --Dibucaine |
|
89363-6
|
Cholinesterase [Enzymatic activity/volume] in Body fluid |
|
35558-6
|
Cholinesterase panel [Enzymatic activity/volume] - Blood |
|
49851-9
|
Cholinesterase [Enzymatic activity/volume] in Peritoneal fluid |
|
2099-0
|
Cholinesterase [Enzymatic activity/volume] in Red Blood Cells |
|
49231-4
|
Cholinesterase [Enzymatic activity/mass] in Red Blood Cells |
|
34711-2
|
Cholinesterase [Presence] in Serum or Plasma |
|
2098-2
|
Cholinesterase [Enzymatic activity/volume] in Serum or Plasma |
|
2101-4
|
Cholylglycine.conjugated [Mass/volume] in Serum |
|
2100-6
|
Cholylglycine [Mass/volume] in Serum |
|
18364-0
|
Chondroitin sulfate [Mass/volume] in Serum |
|
24464-0
|
Chondroitin sulfate [Presence] in Urine |
|
2102-2
|
Chondroitin sulfate [Mass/volume] in Urine |
|
2103-0
|
Choriomammotropin [Mass/volume] in Amniotic fluid |
|
2104-8
|
Choriomammotropin [Mass/volume] in Serum |
|
35292-2
|
Chromosome 11 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
|
81850-0
|
Chromosome region 11p15 methylation and deletion+duplication in Amniotic fluid by Molecular genetics method |
|
81851-8
|
Chromosome region 11p15 methylation and deletion+duplication in Blood or Tissue by Molecular genetics method |
|
57038-2
|
Chromosome 12 aneuploidy in Amniotic fluid by FISH Nominal |
|
21770-3
|
Chromosome 12 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
42635-3
|
Chromosome 12p tetrasomy [Presence] in Fixed tissue by Molecular genetics method |
|
57454-1
|
Chromosome 13 aneuploidy in Amniotic fluid by FISH Nominal |
|
57037-4
|
Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid by Molecular genetics method Nominal |
|
57317-0
|
Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid by FISH Nominal |
|
57030-9
|
Chromosome 13+18+21+X+Y aneuploidy in Blood by Molecular genetics method Nominal |
|
57318-8
|
Chromosome 13+18+21+X+Y aneuploidy in Blood or Tissue by FISH Nominal |
|
57029-1
|
Fetal chromosome 13+18+21+X+Y aneuploidy in Tissue by Molecular genetics method Nominal |
|
81749-4
|
Chromosome region 13q14 deletion in Bone marrow by FISH |
|
35123-9
|
Chromosome 14 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
|
81853-4
|
Chromosome 15 and 16 and 22 aneuploidy in Blood or Tissue by Molecular genetics method |
|
34503-3
|
Chromosome 15 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
|
82238-7
|
Chromosome region 15q11-13 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH |
|
82240-3
|
Chromosome region 16p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH |
|
82239-5
|
Chromosome region 16p13.3 deletion in Blood or Tissue by FISH |
|
82241-1
|
Chromosome region 17p11.2 deletion in Amniotic fluid or Chorionic villus sample by FISH |
|
81751-0
|
Chromosome 17p13.1 deletion and 14q32 rearrangements in Bone marrow by FISH |
|
81746-0
|
Chromosome region 17p13.1 deletion in Blood or Tissue by FISH |
|
82242-9
|
Chromosome region 17p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH |
|
82243-7
|
Chromosome region 17p13.3 deletion in Blood or Tissue by FISH |
|
57453-3
|
Chromosome 18 aneuploidy in Amniotic fluid by FISH Nominal |
|
82244-5
|
Chromosome region 1p36 deletion in Blood or Tissue by FISH |
|
81752-8
|
Chromosome region 1q21 duplication in Bone marrow by FISH |
|
84919-0
|
Chromosome 21 aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
|
21771-1
|
Chromosome 21 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
82245-2
|
Chromosome region 22q11.2 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH |
|
82246-0
|
Chromosome region 22q11.2 deletion and duplication mutation analysis in Blood or Tissue by FISH |
|
78238-3
|
Chromosome 3 copy number/nucleus in Blood or Tissue by FISH |
|
82251-0
|
Chromosome 3 and 7 and 17 aneuploidy and chromosome region 9p21 deletion in Urine by FISH |
|
81747-8
|
Chromosome region 6q22 rearrangements in Tissue by FISH |
|
92905-9
|
Chromosome 7 copy number/nucleus in Blood or Tissue by FISH |
|
21772-9
|
Chromosome 7 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
34496-0
|
Chromosome 7 uniparental disomy [Presence] in Blood or Tissue by Cytogenetics |
|
82247-8
|
Chromosome region 7q11.23 deletion in Amniotic fluid or Chorionic villus sample by FISH |
|
82248-6
|
Chromosome region 7q11.23 deletion in Blood or Tissue by FISH |
|
81852-6
|
Chromosome region 7q11.23 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
|
78237-5
|
Chromosome 8 copy number/nucleus in Blood or Tissue by FISH |
|
21773-7
|
Chromosome 8 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
36907-4
|
Chromosome 8 trisomy [Percentile] by Cytogenetics |
|
82249-4
|
Chromosome region 8q23.3-24.13 deletion in Blood or Tissue by FISH |
|
21774-5
|
Chromosome 9 trisomy [Presence] in Blood or Tissue by Cytogenetics |
|
82597-6
|
Chromosome painting analysis in Blood or Tissue by FISH |
|
75394-7
|
Chromosome uniparental disomy [Identifier] in Amniotic fluid or Chorionic villus sample by Molecular genetics method Narrative |
|
36917-3
|
Chromosome uniparental disomy [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
87436-2
|
Chromosome X and Y aneuploidy in Blood or Tissue by FISH |
|
73822-9
|
Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Nominal |
|
84918-2
|
Chromosome X aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
|
84917-4
|
Chromosome Y aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
|
81748-6
|
Chromosome region Yp11.3 deletion AndOr rearrangement in Blood or Tissue by FISH |
|
86611-1
|
Chromosome analysis in Amniotic fluid or Chorionic villus sample by Microarray |
|
94087-4
|
Chromosome analysis in Blood or Tissue by Microarray |
|
50684-0
|
Chromosome analysis.interphase [Interpretation] in Blood by FISH Narrative |
|
57802-1
|
Chromosome analysis.interphase [Interpretation] in Blood or Marrow by FISH Narrative |
|
50659-2
|
Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative |
|
62346-2
|
Chromosome analysis.interphase panel - Amniotic fluid by FISH |
|
62345-4
|
Chromosome analysis.interphase panel - Blood by FISH |
|
62354-6
|
Chromosome analysis.metaphase panel - Amniotic fluid by FISH |
|
62344-7
|
Chromosome analysis.metaphase panel - Blood by FISH |
|
64090-4
|
Chromosome analysis overall interpretation in Unspecified specimen Qualitative by Molecular genetics method |
|
62351-2
|
Chromosome analysis panel - Amniotic fluid by G-banded |
|
62355-3
|
Chromosome analysis panel by Banding |
|
62349-6
|
Chromosome analysis panel - Blood from Fetus by G-banded |
|
62348-8
|
Chromosome analysis panel - Blood by G-banded |
|
62350-4
|
Chromosome analysis panel - Chorionic villus sample by G-banded |
|
62367-8
|
Chromosome analysis panel by FISH |
|
62352-0
|
Chromosome analysis panel - Products of Conception by G-banded |
|
62353-8
|
Chromosome analysis panel - Skin by G-banded |
|
62347-0
|
Chromosome analysis.prenatal panel by FISH |
|
62386-8
|
Chromosome analysis summary panel |
|
57781-7
|
Chromosome breakage [Identifier] in Blood by Diepoxybutane Narrative |
|
34742-7
|
Chromosome breakage [Units/volume] in Blood by Diepoxybutane |
|
62377-7
|
Chromosome copy number change panel |
|
33064-7
|
Chromate [Mass/volume] in Urine |
|
68380-5
|
Chromatin Ab [Presence] in Serum or Plasma |
|
51775-5
|
Chromatin Ab [Units/volume] in Serum or Plasma |
|
32580-3
|
Chromatin IgG Ab [Units/volume] in Serum or Plasma |
|
30923-7
|
Chromium [Mass/volume] in Urine collected for unspecified duration |
|
21201-9
|
Chromium [Mass/volume] in 24 hour Urine |
|
5624-2
|
Chromium [Mass/time] in 24 hour Urine |
|
47099-7
|
Chromium [Moles/volume] in 24 hour Urine |
|
40417-8
|
Chromium [Moles/time] in 24 hour Urine |
|
51903-3
|
Chromium [Mass/volume] in Air |
|
5619-2
|
Chromium [Mass/volume] in Blood |
|
15118-3
|
Chromium [Moles/volume] in Blood |
|
57939-1
|
Chromium [Mass/volume] in Cerebral spinal fluid |
|
21199-5
|
Chromium [Mass/volume] in Body fluid |
|
47098-9
|
Chromium [Moles/volume] in Body fluid |
|
5620-0
|
Chromium [Mass/mass] in Hair |
|
50842-4
|
Chromium [Moles/mass] in Hair |
|
21200-1
|
Chromium [Mass/mass] in Nail |
|
53780-3
|
Chromium panel - Urine |
|
5621-8
|
Chromium [Mass/volume] in Red Blood Cells |
|
50841-6
|
Chromium [Moles/volume] in Red Blood Cells |
|
8181-0
|
Chromium [Mass/volume] in Saliva (oral fluid) |
|
5622-6
|
Chromium [Mass/volume] in Serum or Plasma |
|
25374-0
|
Chromium [Moles/volume] in Serum or Plasma |
|
20759-7
|
Chromium [Mass/mass] in Tissue |
|
52891-9
|
Chromium [Moles/mass] in Tissue |
|
51977-7
|
Chromium [Presence] in Urine |
|
5623-4
|
Chromium [Mass/volume] in Urine |
|
42219-6
|
Chromium [Moles/volume] in Urine |
|
9469-8
|
Chromium [Mass/volume] in Water |
|
9690-9
|
Chromium [Mass/volume] in Unspecified specimen |
|
29919-8
|
Chromium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52934-7
|
Chromium/Creatinine [Molar ratio] in 24 hour Urine |
|
13464-3
|
Chromium/Creatinine [Mass Ratio] in Urine |
|
56650-5
|
Chromium/Creatinine [Ratio] in Urine |
|
42220-4
|
Chromium/Creatinine [Molar ratio] in Urine |
|
62389-2
|
Chromosome analysis master panel |
|
48297-6
|
Chromotrope 2B triggered leukotriene release [Mass/volume] by Leukocytes |
|
92889-5
|
Chronic hepatitis differentiation between hepatitis B and C virus panel - Serum or Plasma |
|
45269-8
|
Chronic leukemia panel - Unspecified specimen by Flow cytometry (FC) |
|
73897-1
|
Chronic lyme disease panel - Blood by Flow cytometry (FC) |
|
89906-2
|
Chronic Respiratory Questionnaire Self-Administered Individualized Format [CRQ-SAI] |
|
89905-4
|
Chronic Respiratory Questionnaire Self-Administered Standardized Format [CRQ-SAS] |
|
69040-4
|
Chronic urticaria index panel - Serum or Plasma |
|
63369-3
|
Chronic urticaria index in Serum |
|
10925-6
|
Chub Mackerel IgE Ab [Units/volume] in Serum |
|
56439-3
|
Chub Mackerel IgG4 Ab [Mass/volume] in Serum |
|
63086-3
|
Chub Mackerel IgG Ab [Mass/volume] in Serum |
|
82599-2
|
Chum salmon roe IgE Ab [Units/volume] in Serum |
|
33009-2
|
Chylomicrons [Presence] in Body fluid |
|
33375-7
|
Chylomicrons [Presence] in Pleural fluid |
|
9617-2
|
Chylomicrons [Mass/volume] in Pleural fluid |
|
2121-2
|
Chylomicrons [Presence] in Serum or Plasma |
|
2120-4
|
Chylomicrons [Mass/volume] in Serum or Plasma |
|
14648-0
|
Chylomicrons [Moles/volume] in Serum or Plasma |
|
6074-9
|
Chymopapain IgE Ab [Units/volume] in Serum |
|
56451-8
|
Chymopapain IgG4 Ab [Mass/volume] in Serum |
|
2122-0
|
Chymopapain [Mass/volume] in Serum |
|
5091-4
|
Chymotrypsin Ab [Units/volume] in Serum |
|
10473-7
|
Chymotrypsin Ag [Presence] in Tissue by Immune stain |
|
2123-8
|
Chymotrypsin [Enzymatic activity/volume] in Body fluid |
|
2124-6
|
Chymotrypsin [Mass/volume] in Serum or Plasma |
|
49766-9
|
Chymotrypsin [Presence] in Stool |
|
25375-7
|
Chymotrypsin [Enzymatic activity/mass] in Stool |
|
2125-3
|
Chymotrypsin [Mass/mass] in Stool |
|
15037-5
|
Chymotrypsin [Moles/mass] in Stool |
|
44419-0
|
CIAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72856-8
|
Cidofovir [Susceptibility] by Genotype method |
|
72855-0
|
Cidofovir [Susceptibility] by Phenotype method |
|
87298-6
|
Cigarettes smoked per day by Mother--1st trimester |
|
87299-4
|
Cigarettes smoked per day by Mother--2nd trimester |
|
35477-9
|
Ciliated columnar lining cells/100 leukocytes [# Ratio] in Body fluid |
|
16650-4
|
Cilantro IgE Ab [Units/volume] in Serum |
|
73448-3
|
Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73449-1
|
Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
53790-2
|
CILD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
14649-8
|
Cimetidine [Presence] in Gastric fluid |
|
73447-5
|
Cimetidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73446-7
|
Cimetidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3481-9
|
Cimetidine [Presence] in Serum or Plasma |
|
3482-7
|
Cimetidine [Mass/volume] in Serum or Plasma |
|
3483-5
|
Cimetidine [Presence] in Urine |
|
32063-0
|
Cimetidine [Presence] in Unspecified specimen |
|
6837-9
|
Cinnamon IgE Ab [Units/volume] in Serum |
|
61245-7
|
Cinnamon IgE Ab/IgE total in Serum |
|
7229-8
|
Cinnamon IgG Ab [Units/volume] in Serum |
|
56223-1
|
Cinnamon IgG4 Ab [Mass/volume] in Serum |
|
60367-0
|
Cinnamon IgG Ab [Mass/volume] in Serum |
|
73038-2
|
Ciprofloxacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73037-4
|
Ciprofloxacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
34636-1
|
Ciprofloxacin [Mass/volume] in Cerebral spinal fluid |
|
56702-4
|
Ciprofloxacin IgE Ab [Units/volume] in Serum |
|
73445-9
|
Ciprofloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73444-2
|
Ciprofloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48272-9
|
Ciprofloxacin triggered leukotriene release [Mass/volume] by Leukocytes |
|
14031-9
|
Ciprofloxacin [Mass/volume] in Serum or Plasma --peak |
|
3484-3
|
Ciprofloxacin [Mass/volume] in Serum or Plasma |
|
14032-7
|
Ciprofloxacin [Mass/volume] in Serum or Plasma --trough |
|
25248-6
|
Ciprofloxacin [Mass/volume] in Unspecified specimen |
|
79700-1
|
cis-11,14-Eicosadienoate (cis 11,14 C20:2w6) [Moles/volume] in Serum or Plasma |
|
79696-1
|
cis-11-Eicosenoate (cis 11 C20:1w9) [Entitic substance] in Red Blood Cells |
|
79699-5
|
cis-11-Eicosenoate (cis 11 C20:1w9) [Moles/volume] in Serum or Plasma |
|
79702-7
|
cis-13-Eicosenoate (cis 13 C20:1w7) [Entitic substance] in Red Blood Cells |
|
79703-5
|
cis-13-Eicosenoate (cis 13 C20:1w7) [Moles/volume] in Serum or Plasma |
|
27069-4
|
Cisapride [Mass/volume] in Serum or Plasma |
|
3485-0
|
CISplatin [Mass/volume] in Serum or Plasma |
|
34629-6
|
CISplatin [Mass/volume] in Urine |
|
48367-7
|
cis-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma |
|
73036-6
|
Citalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73035-8
|
Citalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80560-6
|
Citalopram [Mass/volume] in DBS |
|
59887-0
|
Citalopram [Moles/volume] in Gastric fluid |
|
73443-4
|
Citalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73442-6
|
Citalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
34635-3
|
Citalopram [Mass/volume] in Serum or Plasma |
|
25589-3
|
Citalopram [Moles/volume] in Serum or Plasma |
|
59170-1
|
Citalopram [Presence] in Urine |
|
92645-1
|
Citalopram [Presence] in Urine by Confirmatory method |
|
59886-2
|
Citalopram [Moles/volume] in Urine |
|
60295-3
|
Citalopram [Moles/volume] in Unspecified specimen |
|
77765-6
|
Citalopram+Escitalopram [Mass/volume] in Urine by Confirmatory method |
|
89991-4
|
Citalopram+Escitalopram [Presence] in Urine by Screen method |
|
85090-9
|
Citalopram and norcitalopram and didesmethylcitalopram panel - Serum or Plasma |
|
41022-5
|
Citrate [Molar amount] in Urine collected for unspecified duration |
|
57337-8
|
Citrate [Mass/volume] in 12 hour Urine |
|
57339-4
|
Citrate [Mass/time] in 12 hour Urine |
|
21203-5
|
Citrate [Mass/volume] in 24 hour Urine |
|
6687-8
|
Citrate [Mass/time] in 24 hour Urine |
|
25876-4
|
Citrate [Moles/volume] in 24 hour Urine |
|
14650-6
|
Citrate [Moles/time] in 24 hour Urine |
|
57338-6
|
Citrate [Mass/volume] in 2 hour Urine |
|
2127-9
|
Citrate [Mass/volume] in Serum or Plasma |
|
15038-3
|
Citrate [Moles/volume] in Serum or Plasma |
|
2126-1
|
Citrate [Mass/volume] in Semen |
|
10567-6
|
Citrate [Moles/volume] in Semen |
|
47841-2
|
Citrate synthase [Enzymatic activity/mass] in Amniotic fluid cells |
|
49938-4
|
Citrate synthase [Enzymatic activity/mass] in Amniotic fluid |
|
53515-3
|
Citrate synthase [Enzymatic activity/mass] in Control Fibroblast |
|
47603-6
|
Citrate synthase [Enzymatic activity/mass] in Fibroblast |
|
35495-1
|
Citrate synthase [Enzymatic activity/mass] in Tissue |
|
47602-8
|
Citrate synthase [Enzymatic activity/mass] in Leukocytes |
|
27133-8
|
Citrate [Presence] in Urine |
|
2128-7
|
Citrate [Mass/volume] in Urine |
|
34266-7
|
Citrate [Moles/volume] in Urine |
|
51792-0
|
Citrate/Creatinine [Mass Ratio] in Urine collected for unspecified duration |
|
44306-9
|
Citrate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13722-4
|
Citrate/Creatinine [Mass Ratio] in Urine |
|
29527-9
|
Citrate/Creatinine [Molar ratio] in Urine |
|
88254-8
|
Citrobacter sp ompA+mrkC genes [Presence] by Probe in Positive blood culture |
|
42892-0
|
Citrulline [Moles/volume] in DBS |
|
20640-9
|
Citrulline [Moles/volume] in Serum or Plasma |
|
53506-2
|
Citrulline/Amino acids.total in Plasma |
|
49629-9
|
Citrulline [Presence] in Urine |
|
44307-7
|
Citrulline/Creatinine [Mass Ratio] in 24 hour Urine |
|
56676-0
|
Citrulline/Creatinine [Ratio] in 24 hour Urine |
|
53157-4
|
Citrulline/Phenylalanine [Molar ratio] in DBS |
|
51528-8
|
Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Presence] in Serum by Multidisk |
|
82068-8
|
Citrus Allergen Mix (Orange+Lemon+Grapefruit+Clementine) IgE Ab [Units/volume] in Serum by Multidisk |
|
50314-4
|
Cytokeratin 19 Ag [Presence] in Tissue by Immune stain |
|
68928-1
|
Cytokeratin 19 [Mass/volume] in Cerebral spinal fluid |
|
48163-0
|
Cytokeratin 19 [Mass/volume] in Body fluid |
|
68929-9
|
Cytokeratin 19 [Mass/volume] in Pericardial fluid |
|
19183-3
|
Cytokeratin 19 [Units/volume] in Pleural fluid |
|
68938-0
|
Cytokeratin 19 [Mass/volume] in Pleural fluid |
|
68927-3
|
Cytokeratin 19 [Mass/volume] in Peritoneal fluid |
|
19182-5
|
Cytokeratin 19 [Units/volume] in Serum or Plasma |
|
25390-6
|
Cytokeratin 19 [Mass/volume] in Serum or Plasma |
|
56787-5
|
Cytokeratin 19 [Units/volume] in Urine |
|
40558-9
|
Cytokeratin 20 Ag [Presence] in Tissue by Immune stain |
|
47025-2
|
Cytokeratin 5/6 Ag [Presence] in Tissue by Immune stain |
|
40559-7
|
Cytokeratin 7 Ag [Presence] in Tissue by Immune stain |
|
40560-5
|
Cytokeratin AE1/AE3 Ag [Presence] in Tissue by Immune stain |
|
2156-8
|
Creatine kinase [Enzymatic activity/volume] in Amniotic fluid |
|
51505-6
|
Creatine kinase.BB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis |
|
2152-7
|
Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
|
50756-6
|
Creatine kinase [Mass/volume] in Blood |
|
40561-3
|
Cytokeratin Cam5.2 Ag [Presence] in Tissue by Immune stain |
|
2151-9
|
Creatine kinase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
53433-9
|
Creatine kinase [Enzymatic activity/volume] in Dialysis fluid |
|
34160-2
|
Creatine kinase [Presence] in Body fluid |
|
16688-4
|
Creatine kinase [Enzymatic activity/volume] in Body fluid |
|
47026-0
|
Cytoketatin HMW Ag [Presence] in Tissue by Immune stain |
|
59149-5
|
Creatine kinase.macromolecular [Presence] in Serum or Plasma |
|
2153-5
|
Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
|
49551-5
|
Creatine kinase.MB [Mass/volume] in Blood |
|
51506-4
|
Creatine kinase.MB [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis |
|
2154-3
|
Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
|
83092-7
|
Creatine kinase.MB [Mass/volume] in Serum or Plasma by Immunoassay |
|
38482-6
|
Creatine kinase.MB [Presence] in Serum or Plasma |
|
32673-6
|
Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma |
|
13969-1
|
Creatine kinase.MB [Mass/volume] in Serum or Plasma |
|
51507-2
|
Creatine kinase.MM [Enzymatic activity/volume] in Cerebral spinal fluid by Electrophoresis |
|
2155-0
|
Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
|
24335-2
|
Creatine kinase panel - Serum or Plasma |
|
2157-6
|
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma |
|
50757-4
|
Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Blood |
|
50315-1
|
Cytokeratin 5 Ag [Presence] in Tissue by Immune stain |
|
74486-2
|
Cytokeratin 5 and p63 and Cytokeratin AE1 Ag [Identifier] in Tissue by Immune stain |
|
74491-2
|
Cytokeratin 7 and Thyroid transcription factor 1 Ag [Identifier] in Tissue by Immune stain |
|
87533-6
|
Chronic kidney disease management personal goals panel |
|
11102-1
|
Charcot-leyden crystals [type] in Unspecified specimen by Trichrome stain |
|
35304-5
|
CLA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
43691-5
|
Cladosporium sp IgE Ab [Presence] in Serum |
|
53760-5
|
Cladosporium sp IgE Ab [Units/volume] in Serum |
|
43056-1
|
Cladosporium sp IgG Ab [Presence] in Serum |
|
34267-5
|
Cladosporium sp IgG Ab [Presence] in Serum by Immune diffusion (ID) |
|
57942-5
|
Cladosporium sp IgG4 Ab [Mass/volume] in Serum |
|
7233-0
|
Clam triggered histamine release [Units/volume] in Blood |
|
6076-4
|
Clam IgE Ab [Units/volume] in Serum |
|
39090-6
|
Clam IgE Ab/IgE total in Serum |
|
7232-2
|
Clam IgG Ab [Units/volume] in Serum |
|
56225-6
|
Clam IgG4 Ab [Mass/volume] in Serum |
|
60368-8
|
Clam IgG Ab [Mass/volume] in Serum |
|
34638-7
|
Clarithromycin [Mass/volume] in Cerebral spinal fluid |
|
80559-8
|
Clarithromycin [Mass/volume] in DBS |
|
56710-7
|
Clarithromycin IgE Ab [Units/volume] in Serum |
|
73441-8
|
Clarithromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73440-0
|
Clarithromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
20375-2
|
Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
89485-7
|
Clarithromycin [Susceptibility] by Genotype method |
|
16619-9
|
Clarithromycin [Mass/volume] in Serum or Plasma |
|
25253-6
|
Clarithromycin [Mass/volume] in Unspecified specimen |
|
49736-2
|
Clarity of Cerebral spinal fluid |
|
50552-9
|
Clarity in Urine by Refractometry automated |
|
49328-8
|
Clavulanate IgE Ab [Units/volume] in Serum |
|
73439-2
|
Clavulanate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73438-4
|
Clavulanate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48599-5
|
CLCN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
60537-8
|
CLCN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
74184-3
|
Lymphocytes clefted [Presence] in Blood |
|
74750-1
|
Lymphocytes clefted [Presence] in Blood or Tissue by Light microscopy |
|
93036-2
|
Cleft and Craniofacial Outpatient Note |
|
57943-3
|
Clenbuterol [Presence] in Urine |
|
46228-3
|
Clenbuterol [Mass/volume] in Urine |
|
77548-6
|
Client accessibility panel [NMMDS] |
|
85229-3
|
Clinical nurse specialist Note |
|
81192-7
|
Clinical pathology Consult note |
|
90013-4
|
Clinical pathology Initial evaluation note |
|
90371-6
|
Clinical pathology Note |
|
90015-9
|
Clinical pathology Telephone encounter Note |
|
90010-0
|
Clinical pathology procedure note |
|
90011-8
|
Clinical pathology Progress note |
|
81196-8
|
Clinical pharmacology Consult note |
|
89826-2
|
Clinical pharmacology procedure note |
|
73034-1
|
Clindamycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73033-3
|
Clindamycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
42894-6
|
Clindamycin IgE Ab [Units/volume] in Serum |
|
73437-6
|
Clindamycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73436-8
|
Clindamycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16621-5
|
Clindamycin [Mass/volume] in Serum or Plasma --peak |
|
3486-8
|
Clindamycin [Mass/volume] in Serum or Plasma |
|
16622-3
|
Clindamycin [Mass/volume] in Serum or Plasma --trough |
|
25249-4
|
Clindamycin [Mass/volume] in Unspecified specimen |
|
68651-9
|
Clinical biochemical genetics Hospital Consult note |
|
68650-1
|
Clinical biochemical genetics Note |
|
48546-6
|
Clinical Care Classification (CCC) v2.5 panel |
|
89261-2
|
Clinical course |
|
82607-3
|
Clinical data [Date and Time Range] |
|
75842-5
|
Clinical disease activity index [CDAI] |
|
78254-0
|
Clinical genetics Consult note |
|
89993-0
|
Clinical genetics Counseling note |
|
68652-7
|
Clinical genetics Diagnostic study note |
|
68653-5
|
Clinical genetics Discharge summary |
|
78276-3
|
Clinical genetics Education note |
|
78304-3
|
Clinical genetics Flowsheet |
|
68655-0
|
Clinical genetics History and physical note |
|
68661-8
|
Clinical genetics Hospital Consult note |
|
68662-6
|
Clinical genetics Hospital Letter |
|
78311-8
|
Clinical genetics Initial evaluation note |
|
68656-8
|
Clinical genetics Note |
|
89877-5
|
Clinical genetics Outpatient Note |
|
80748-7
|
Clinical genetics Plan of care note |
|
68657-6
|
Clinical genetics Preoperative evaluation and management note |
|
68658-4
|
Clinical genetics procedure note |
|
68659-2
|
Clinical genetics Progress note |
|
78330-8
|
Clinical genetics Referral note |
|
89893-2
|
Clinical genetics Telehealth Note |
|
68660-0
|
Clinical genetics Transfer summary note |
|
80664-6
|
Clinical neurophysiology Consult note |
|
82824-4
|
Clinical neurophysiology Surgical operation note |
|
89809-8
|
Clinical neurophysiology Telephone encounter Note |
|
80670-3
|
Clinical neurophysiology procedure note |
|
80665-3
|
Clinical neurophysiology Progress note |
|
90009-2
|
Clinical pathology Team Conference note |
|
82609-9
|
Clinical practice improvement activity for population |
|
58411-0
|
Clinical research drug XXX [Mass/volume] in Plasma |
|
58439-1
|
Clinical research drug XXX [Mass/volume] in Urine |
|
90222-1
|
Clinically Useful Depression Outcome Scale [CUDOS] |
|
35506-5
|
Chronic lymphocytic leukemia gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41113-2
|
Chronic lymphocytic leukemia gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
70243-1
|
CLN3 gene exon 7+8 deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
81819-5
|
CLN5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81839-3
|
CLN8 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79408-1
|
cloBAZam and norclobazam panel - Serum or Plasma |
|
59627-0
|
cloBAZam [Mass/volume] in Blood by Confirmatory method |
|
59626-2
|
cloBAZam [Mass/volume] in Blood |
|
59629-6
|
cloBAZam [Mass/volume] in Body fluid by Confirmatory method |
|
59628-8
|
cloBAZam [Mass/volume] in Body fluid |
|
52948-7
|
cloBAZam [Presence] in Gastric fluid |
|
52964-4
|
cloBAZam [Moles/volume] in Gastric fluid |
|
59631-2
|
cloBAZam [Mass/mass] in Meconium by Confirmatory method |
|
59630-4
|
cloBAZam [Mass/mass] in Meconium |
|
59632-0
|
cloBAZam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3487-6
|
cloBAZam [Mass/volume] in Serum or Plasma |
|
14651-4
|
cloBAZam [Moles/volume] in Serum or Plasma |
|
59634-6
|
cloBAZam [Mass/mass] in Tissue by Confirmatory method |
|
59633-8
|
cloBAZam [Mass/mass] in Tissue |
|
59635-3
|
cloBAZam [Mass/volume] in Urine by Confirmatory method |
|
52959-4
|
cloBAZam [Presence] in Urine |
|
94114-6
|
cloBAZam [Presence] in Urine by Screen method |
|
12374-5
|
cloBAZam [Mass/volume] in Urine |
|
59888-8
|
cloBAZam [Moles/volume] in Urine |
|
60296-1
|
cloBAZam [Moles/volume] in Unspecified specimen |
|
55346-1
|
cloBAZam+Norclobazam [Moles/volume] in Serum or Plasma |
|
3488-4
|
Clobenzorex [Presence] in Urine |
|
3489-2
|
Clobenzorex [Mass/volume] in Urine |
|
3490-0
|
Clofibrate [Mass/volume] in Serum or Plasma |
|
77374-7
|
Clomipramine trough, Clomipramine+Norclomipramine trough and Norclomipramine panel - Serum or Plasma |
|
90975-4
|
Clomethiazole [Mass/volume] in Serum or Plasma |
|
59889-6
|
Clomipramine [Moles/volume] in Gastric fluid |
|
16624-9
|
Clomipramine [Units/volume] in Milk |
|
16625-6
|
Clomipramine [Mass/volume] in Milk |
|
13549-1
|
Clomipramine [Presence] in Serum or Plasma |
|
35602-2
|
Clomipramine [Mass/volume] in Serum or Plasma by Screen method |
|
3491-8
|
Clomipramine [Mass/volume] in Serum or Plasma |
|
14652-2
|
Clomipramine [Moles/volume] in Serum or Plasma |
|
74958-0
|
Clomipramine [Mass/volume] in Serum or Plasma --trough |
|
45144-3
|
Clomipramine [Presence] in Urine |
|
3492-6
|
Clomipramine [Mass/volume] in Urine |
|
14653-0
|
Clomipramine [Moles/volume] in Urine |
|
60297-9
|
Clomipramine [Moles/volume] in Unspecified specimen |
|
81210-7
|
Clomipramine and Norclomipramine panel - Gastric fluid |
|
43127-0
|
Clomipramine and Norclomipramine panel - Serum or Plasma |
|
81209-9
|
Clomipramine and Norclomipramine panel - Urine |
|
81212-3
|
Clomipramine and Norclomipramine panel - Unspecified specimen |
|
74945-7
|
Clomipramine+Norclomipramine [Mass/volume] in Serum or Plasma --trough |
|
91606-4
|
Clomipramine+Norclomipramine [Mass/volume] in Urine |
|
59637-9
|
clonazePAM [Mass/volume] in Blood by Confirmatory method |
|
59636-1
|
clonazePAM [Mass/volume] in Blood |
|
59639-5
|
clonazePAM [Mass/volume] in Body fluid by Confirmatory method |
|
59638-7
|
clonazePAM [Mass/volume] in Body fluid |
|
52965-1
|
clonazePAM [Presence] in Gastric fluid |
|
29399-3
|
clonazePAM [Mass/volume] in Gastric fluid |
|
73434-3
|
clonazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73435-0
|
clonazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
76349-0
|
clonazePAM [Mass/mass] in Meconium by Confirmatory method |
|
72755-2
|
clonazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
59640-3
|
clonazePAM [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13550-9
|
clonazePAM [Presence] in Serum or Plasma |
|
35603-0
|
clonazePAM [Mass/volume] in Serum or Plasma by Screen method |
|
70205-0
|
clonazePAM [Moles/volume] in Serum or Plasma by Screen method |
|
3494-2
|
clonazePAM [Mass/volume] in Serum or Plasma |
|
14655-5
|
clonazePAM [Moles/volume] in Serum or Plasma |
|
59642-9
|
clonazePAM [Mass/mass] in Tissue by Confirmatory method |
|
59641-1
|
clonazePAM [Mass/mass] in Tissue |
|
82934-1
|
clonazePAM [Mass/volume] in Serum or Plasma --trough |
|
16229-7
|
clonazePAM [Mass/volume] in Urine by Confirmatory method |
|
19245-0
|
clonazePAM [Presence] in Urine |
|
16204-0
|
clonazePAM [Presence] in Urine by Confirmatory method |
|
19399-5
|
clonazePAM [Presence] in Urine by Screen method |
|
19402-7
|
clonazePAM [Mass/volume] in Urine |
|
50843-2
|
clonazePAM [Moles/volume] in Urine |
|
61039-4
|
clonazePAM [Presence] in Unspecified specimen |
|
86225-0
|
clonazePAM/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73032-5
|
cloNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73031-7
|
cloNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73433-5
|
cloNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73432-7
|
cloNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3495-9
|
cloNIDine [Mass/volume] in Serum or Plasma |
|
52960-2
|
cloNIDine [Presence] in Urine |
|
10981-9
|
cloNIDine [Mass/volume] in Urine |
|
74373-2
|
cloNIDine [Mass/volume] in Unknown substance |
|
3496-7
|
Clopenthixol [Mass/volume] in Serum or Plasma |
|
55529-2
|
Clopenthixol [Moles/volume] in Serum or Plasma |
|
3497-5
|
Clopenthixol [Mass/volume] in Urine |
|
73030-9
|
Clopidogrel induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73029-1
|
Clopidogrel induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73430-1
|
Clopidogrel induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73431-9
|
Clopidogrel induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13551-7
|
Clorazepate [Presence] in Serum or Plasma |
|
3498-3
|
Clorazepate [Mass/volume] in Serum or Plasma |
|
32064-8
|
Clorazepate [Moles/volume] in Serum or Plasma |
|
74366-6
|
Clorazepate [Mass/volume] in Serum or Plasma --trough |
|
12314-1
|
Clorazepate [Presence] in Urine |
|
3501-4
|
Clorprenaline [Mass/time] in 24 hour Urine |
|
3499-1
|
Clorprenaline [Presence] in Urine |
|
3500-6
|
Clorprenaline [Mass/volume] in Urine |
|
72257-9
|
Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood |
|
3504-8
|
Clostebol [Mass/time] in 24 hour Urine |
|
3502-2
|
Clostebol [Presence] in Urine |
|
3503-0
|
Clostebol [Mass/volume] in Urine |
|
85818-3
|
Clot formation+Clotting time of Blood by Thromboelastography |
|
66745-1
|
Clot Lysis [Length fraction] in Blood by Thromboelastography --30 minutes post maximum clot amplitude |
|
3244-1
|
Clot Lysis [Time] in Platelet poor plasma by Coagulation assay |
|
40454-1
|
Clot Lysis [Presence] in Platelet poor plasma by Coagulation assay |
|
3245-8
|
Clot Retraction [Time] in Blood by Coagulation assay |
|
49008-6
|
Clot Retraction [Volume Fraction] in Blood |
|
54177-1
|
Clotrimazole [Susceptibility] by Disk diffusion (KB) |
|
3183-1
|
Clotting time of Blood by Lee White method |
|
52789-5
|
Clotting time of Blood by Thromboelastography |
|
81638-9
|
Clotting time of Capillary blood by Sukharev method |
|
7234-8
|
Clove IgE Ab [Units/volume] in Serum |
|
7235-5
|
Clove IgG Ab [Units/volume] in Serum |
|
56440-1
|
Clove IgG4 Ab [Mass/volume] in Serum |
|
60369-6
|
Clove IgG Ab [Mass/volume] in Serum |
|
7236-3
|
Clover IgE Ab [Units/volume] in Serum |
|
56696-8
|
Cloxacillin IgE Ab [Units/volume] in Serum |
|
16628-0
|
Cloxacillin [Mass/volume] in Serum or Plasma |
|
25250-2
|
Cloxacillin [Mass/volume] in Unspecified specimen |
|
80556-4
|
cloZAPine [Mass/volume] in DBS |
|
59890-4
|
cloZAPine [Moles/volume] in Gastric fluid |
|
29371-2
|
cloZAPine [Mass/volume] in Serum or Plasma --peak |
|
13552-5
|
cloZAPine [Presence] in Serum or Plasma |
|
6896-5
|
cloZAPine [Mass/volume] in Serum or Plasma |
|
14656-3
|
cloZAPine [Moles/volume] in Serum or Plasma |
|
29370-4
|
cloZAPine [Mass/volume] in Serum or Plasma --trough |
|
77961-1
|
cloZAPine [Mass/volume] in Urine by Confirmatory method |
|
32065-5
|
cloZAPine [Presence] in Urine |
|
50844-0
|
cloZAPine [Moles/volume] in Urine |
|
32066-3
|
cloZAPine [Presence] in Unspecified specimen |
|
60298-7
|
cloZAPine [Moles/volume] in Unspecified specimen |
|
65632-2
|
cloZAPine and Norclozapine panel - Serum or Plasma |
|
12375-2
|
cloZAPine+Norclozapine [Mass/volume] in Serum or Plasma |
|
14657-1
|
cloZAPine+Norclozapine [Moles/volume] in Serum or Plasma |
|
77749-0
|
CLRN1 gene c.144T>G [Presence] in Blood or Tissue by Molecular genetics method |
|
44241-8
|
Clue cells [#/area] in Vaginal fluid by Microscopy low power field |
|
20502-1
|
Clue cells [Presence] in Vaginal fluid by Wet preparation |
|
32764-3
|
Clue cells [Presence] in Unspecified specimen by Wet preparation |
|
50312-8
|
Clusterin Ag [Presence] in Tissue by Immune stain |
|
62343-9
|
Chromosome analysis copy number change panel by Microarray |
|
38650-8
|
Chloromethyl methyl ether [Mass/volume] in Air |
|
74144-7
|
Complex medical conditions action plan |
|
49504-4
|
CMT demyelinating gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50994-3
|
CMT demyelinating gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35464-7
|
CMT axonal gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41112-4
|
CMT axonal gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38529-4
|
CMTX2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
16713-0
|
Cytomegalovirus Ab [Units/volume] in Cerebral spinal fluid |
|
16712-2
|
Cytomegalovirus Ab [Units/volume] in Body fluid |
|
52976-8
|
Cytomegalovirus Ab [Units/volume] in Serum by Complement fixation |
|
47363-7
|
Cytomegalovirus Ab [Presence] in Serum from Donor by Hemagglutination |
|
16714-8
|
Cytomegalovirus Ab [Units/volume] in Serum by Latex agglutination |
|
15377-5
|
Cytomegalovirus Ab [Presence] in Serum by Latex agglutination |
|
47430-4
|
Cytomegalovirus Ab [Presence] in Serum or Plasma from Donor |
|
5122-7
|
Cytomegalovirus Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
|
22239-8
|
Cytomegalovirus Ab [Presence] in Serum or Plasma |
|
59838-3
|
Cytomegalovirus Ab [Presence] in Serum or Plasma by Latex agglutination |
|
7851-9
|
Cytomegalovirus Ab [Units/volume] in Serum or Plasma |
|
22240-6
|
Cytomegalovirus Ab [Titer] in Cerebral spinal fluid |
|
9514-1
|
Cytomegalovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
9513-3
|
Cytomegalovirus Ab [Titer] in Serum by Complement fixation |
|
22241-4
|
Cytomegalovirus Ab [Titer] in Serum or Plasma |
|
32170-3
|
Cytomegalovirus Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
5121-9
|
Cytomegalovirus Ab [Titer] in Serum or Plasma by Latex agglutination |
|
77388-7
|
Cytomegalovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
16718-9
|
Cytomegalovirus Ag [Presence] in Blood |
|
89583-9
|
Cytomegalovirus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
67805-2
|
Cytomegalovirus Ag [Presence] in Isolate by Immunofluorescence |
|
88566-5
|
Cytomegalovirus Ag [Presence] in Bone marrow by Immunofluorescence |
|
31795-8
|
Cytomegalovirus Ag [Presence] in Serum or Plasma |
|
6376-8
|
Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunoassay |
|
6377-6
|
Cytomegalovirus Ag [Presence] in Serum or Plasma by Immunofluorescence |
|
86517-0
|
Cytomegalovirus Ag [Presence] in Tissue by Immunofluorescence |
|
10660-9
|
Cytomegalovirus Ag [Presence] in Tissue by Immune stain |
|
31796-6
|
Cytomegalovirus Ag [Presence] in Urine |
|
16717-1
|
Cytomegalovirus Ag [Presence] in Urine by Immunoassay |
|
31797-4
|
Cytomegalovirus Ag [Presence] in Unspecified specimen |
|
6379-2
|
Cytomegalovirus Ag [Presence] in Unspecified specimen by Immunoassay |
|
6381-8
|
Cytomegalovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
42336-8
|
Cytomegalovirus Ag [#/area] in Unspecified specimen |
|
34201-4
|
Cytomegalovirus [Presence] in Amniotic fluid by Organism specific culture |
|
88624-2
|
Cytomegalovirus [Presence] in Amniotic fluid by Shell vial culture |
|
43706-1
|
Cytomegalovirus [Presence] in Anal by Shell vial culture |
|
5835-4
|
Cytomegalovirus [Presence] in Blood by Organism specific culture |
|
43703-8
|
Cytomegalovirus [Presence] in Blood by Shell vial culture |
|
32675-1
|
Cytomegalovirus [Presence] in Bronchial specimen by Organism specific culture |
|
88623-4
|
Cytomegalovirus [Presence] in Cerebral spinal fluid by Organism specific culture |
|
43702-0
|
Cytomegalovirus [Presence] in Cerebral spinal fluid by Shell vial culture |
|
49348-6
|
Cytomegalovirus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49349-4
|
Cytomegalovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
29604-6
|
Cytomegalovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
39003-9
|
Cytomegalovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
88545-9
|
Cytomegalovirus DNA [#/volume] (viral load) in DBS by NAA with probe detection |
|
49350-2
|
Cytomegalovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
88130-0
|
Cytomegalovirus DNA [#/volume] (viral load) in Ocular fluid by NAA with probe detection |
|
30247-1
|
Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49351-0
|
Cytomegalovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
54163-1
|
Cytomegalovirus DNA [#/volume] (viral load) in Urine by Probe and target amplification method detection limit = 200 copies/ml |
|
49347-8
|
Cytomegalovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
33006-8
|
Cytomegalovirus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
34719-5
|
Cytomegalovirus DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
29590-7
|
Cytomegalovirus DNA [Mass/volume] (viral load) in Blood by Probe |
|
4996-5
|
Cytomegalovirus DNA [Presence] in Blood by NAA with probe detection |
|
28008-1
|
Cytomegalovirus DNA [Presence] in Blood by Probe with signal amplification |
|
35401-9
|
Cytomegalovirus DNA [Presence] in Bronchial specimen by NAA with probe detection |
|
82189-2
|
Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
30326-3
|
Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
88535-0
|
Cytomegalovirus DNA [Presence] in DBS by NAA with probe detection |
|
88558-2
|
Cytomegalovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88567-3
|
Cytomegalovirus DNA [Presence] in Bone marrow by NAA with probe detection |
|
88131-8
|
Cytomegalovirus DNA [Presence] in Ocular fluid by NAA with probe detection |
|
72493-0
|
Cytomegalovirus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection |
|
72494-8
|
Cytomegalovirus DNA [log units/volume] (viral load) in Plasma by NAA with probe detection |
|
83065-3
|
Cytomegalovirus DNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
|
54206-8
|
Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
30246-3
|
Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
4998-1
|
Cytomegalovirus DNA [Presence] in Tissue by NAA with probe detection |
|
4997-3
|
Cytomegalovirus DNA [Presence] in Tissue by Probe |
|
4999-9
|
Cytomegalovirus DNA [Presence] in Urine by NAA with probe detection |
|
34720-3
|
Cytomegalovirus DNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
53763-9
|
Cytomegalovirus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
24041-6
|
Cytomegalovirus DNA [Units/volume] (viral load) in Unspecified specimen by Probe with signal amplification |
|
5000-5
|
Cytomegalovirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
33616-4
|
Cytomegalovirus early Ag [Presence] in Urine |
|
60541-0
|
Cytomegalovirus early Ag [Presence] in Unspecified specimen |
|
43704-6
|
Cytomegalovirus [Presence] in Body fluid by Shell vial culture |
|
40444-2
|
CMV gene mutations detected [Identifier] |
|
72605-9
|
Cytomegalovirus glycoprotein genotype in Unspecified specimen by NAA with probe detection |
|
54164-9
|
Cytomegalovirus immediate-early Ag [Presence] in Blood |
|
45286-2
|
Cytomegalovirus IgA Ab [Presence] in Body fluid |
|
52984-2
|
Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay |
|
78445-4
|
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay |
|
45326-6
|
Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma |
|
6921-1
|
Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
42495-2
|
Cytomegalovirus IgG Ab [Presence] in Cerebral spinal fluid |
|
22243-0
|
Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
50018-1
|
Cytomegalovirus IgG Ab [Presence] in Body fluid |
|
47307-4
|
Cytomegalovirus IgG Ab index [Units/volume] in Serum and CSF |
|
87726-6
|
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay |
|
5124-3
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
16715-5
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunofluorescence |
|
22244-8
|
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma |
|
13949-3
|
Cytomegalovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
7852-7
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma |
|
13225-8
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --1st specimen |
|
16716-3
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay --2nd specimen |
|
22247-1
|
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma --2nd specimen |
|
22245-5
|
Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid |
|
11008-0
|
Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22246-3
|
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma |
|
5125-0
|
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
34944-9
|
Cytomegalovirus IgG and IgM panel - Cerebral spinal fluid |
|
24315-4
|
Cytomegalovirus IgG and IgM panel - Serum or Plasma |
|
87424-8
|
Cytomegalovirus IgG and IgM panel - Serum or Plasma Qualitative |
|
44817-5
|
Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
43045-4
|
Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid |
|
42899-5
|
Cytomegalovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
13226-6
|
Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
33285-8
|
Cytomegalovirus IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
41155-3
|
Cytomegalovirus IgM Ab [Units/volume] in Body fluid |
|
87725-8
|
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma from Donor by Immunoassay |
|
5126-8
|
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
30325-5
|
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma |
|
24119-0
|
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
49539-0
|
Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
7853-5
|
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma |
|
22248-9
|
Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid |
|
21237-3
|
Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22249-7
|
Cytomegalovirus IgM Ab [Titer] in Serum or Plasma |
|
5127-6
|
Cytomegalovirus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
16719-7
|
Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation |
|
91783-1
|
Cytomegalovirus [Presence] in Lower respiratory specimen by Organism specific culture |
|
81328-7
|
Cytomegalovirus [Presence] in Lower respiratory specimen by Shell vial culture |
|
88564-0
|
Cytomegalovirus [Presence] in Bone marrow by Organism specific culture |
|
43705-3
|
Cytomegalovirus [Presence] in Bone marrow by Shell vial culture |
|
88625-9
|
Cytomegalovirus [Presence] in Ocular fluid by Organism specific culture |
|
88622-6
|
Cytomegalovirus [Presence] in Ocular fluid by Shell vial culture |
|
78001-5
|
Cytomegalovirus pp65 Ag/100000 PMN cells in Blood by Immunofluorescence |
|
72852-7
|
Cytomegalovirus resistance panel by Genotype method |
|
5836-2
|
Cytomegalovirus [Presence] in Tissue by Organism specific culture |
|
43707-9
|
Cytomegalovirus [Presence] in Tissue by Shell vial culture |
|
33631-3
|
Cytomegalovirus UL54 gene mutations detected [Identifier] |
|
33632-1
|
Cytomegalovirus UL54+UL97 gene mutations detected [Identifier] |
|
72833-7
|
Cytomegalovirus UL97 gene mutations detected [Identifier] |
|
5837-0
|
Cytomegalovirus [Presence] in Urine by Organism specific culture |
|
43700-4
|
Cytomegalovirus [Presence] in Urine by Shell vial culture |
|
5838-8
|
Cytomegalovirus [Presence] in Unspecified specimen by Organism specific culture |
|
43701-2
|
Cytomegalovirus [Presence] in Unspecified specimen by Shell vial culture |
|
94097-3
|
Cytosolic 5'-nucleotidase 1A IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
81883-1
|
CNBP gene CCTG repeat analysis in Blood or Tissue by Molecular genetics method |
|
40871-6
|
CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81827-8
|
CNGB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
31757-8
|
Canarypox virus Ag [Presence] in Serum |
|
20741-5
|
Canarypox virus Ag [Presence] in Serum by Immunofluorescence |
|
47956-8
|
CNR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
94136-9
|
Controlled substance agreement |
|
82753-5
|
County of travel [Location] |
|
92550-3
|
Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92512-3
|
Co sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
58055-5
|
Co sup(a) Ag [Presence] on Red Blood Cells |
|
92549-5
|
Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92511-5
|
Co sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
58056-3
|
Co sup(b) Ag [Presence] on Red Blood Cells |
|
35685-7
|
Carbon dioxide [Moles/volume] in Urine collected for unspecified duration |
|
34728-6
|
Carbon dioxide, total [Moles/volume] in Blood by calculation |
|
41647-9
|
Carbon dioxide, total [Moles/volume] in Arterial blood by calculation |
|
2026-3
|
Carbon dioxide, total [Moles/volume] in Arterial blood |
|
51781-3
|
Carbon dioxide, total [Moles/volume] in Capillary blood by calculation |
|
57921-9
|
Carbon dioxide, total [Moles/volume] in Arterial cord blood by calculation |
|
39466-8
|
Carbon dioxide, total [Moles/volume] in Arterial cord blood |
|
34520-7
|
Carbon dioxide, total [Moles/volume] in Cord blood |
|
57923-5
|
Carbon dioxide, total [Moles/volume] in Venous cord blood by calculation |
|
39465-0
|
Carbon dioxide, total [Moles/volume] in Venous cord blood |
|
16551-4
|
Carbon dioxide, total [Moles/volume] in Capillary blood |
|
57920-1
|
Carbon dioxide, total [Moles/volume] in Mixed venous blood by calculation |
|
19223-7
|
Carbon dioxide, total [Moles/volume] in Mixed venous blood |
|
20565-8
|
Carbon dioxide, total [Moles/volume] in Blood |
|
48391-7
|
Carbon dioxide, total [Moles/volume] in Venous blood by calculation |
|
2027-1
|
Carbon dioxide, total [Moles/volume] in Venous blood |
|
13540-0
|
Carbon dioxide, total [Moles/volume] in Cerebral spinal fluid |
|
39464-3
|
Carbon dioxide, total [Moles/volume] in Peritoneal dialysis fluid |
|
14640-7
|
Carbon dioxide, total [Moles/volume] in Dialysis fluid |
|
60809-1
|
Carbon dioxide [VFr/PPres] in Airway adaptor --during expiration |
|
76095-9
|
Carbon dioxide [VFr/PPres] in Gas delivery system.expiratory limb --during expiration |
|
60924-8
|
Carbon dioxide [VFr/PPres] in Airway adaptor --during inspiration |
|
76096-7
|
Carbon dioxide [VFr/PPres] in Gas delivery system.inspiratory limb --during inspiration |
|
60808-3
|
Carbon dioxide [VFr/PPres] in Airway adaptor --at end expiration |
|
53089-9
|
Carbon dioxide, total [Moles/volume] in Nonbiological fluid by calculation |
|
53090-7
|
Carbon dioxide, total [Moles/volume] in Nonbiological fluid |
|
11211-0
|
Carbon dioxide, total [Moles/volume] in Body fluid |
|
60789-5
|
Carbon dioxide gas delivered during case [Volume] from Gas delivery system |
|
60790-3
|
Carbon dioxide gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
74684-2
|
Carbon dioxide, total [Moles/volume] in Serum or Plasma --post dialysis |
|
76265-8
|
Carbon dioxide production (VCO2)/Body surface area in Respiratory system |
|
76266-6
|
Carbon dioxide production (VCO2)/Ideal body weight in Respiratory system |
|
57922-7
|
Carbon dioxide, total [Moles/volume] in Serum or Plasma by calculation |
|
77143-6
|
Carbon dioxide, total [Moles/volume] in Serum, Plasma or Blood |
|
2028-9
|
Carbon dioxide, total [Moles/volume] in Serum or Plasma |
|
60786-1
|
Gas delivery system inspiratory Carbon dioxide setting [VFr/PPres] |
|
14040-0
|
Carbon dioxide, total [Moles/volume] in Stool |
|
13538-4
|
Carbon dioxide, total [Moles/volume] in Urine |
|
60926-3
|
Carbon dioxide [VFr/PPres] in Airway adaptor |
|
62264-7
|
Carbon dioxide [VFr/PPres] in Gas delivery system |
|
38253-1
|
Carbon dioxide, total [Moles/volume] in Unspecified specimen |
|
80627-3
|
Coagulation factor X activated inhibitor [Mass/volume] in Platelet poor plasma |
|
70016-1
|
Staphylococcus sp.coagulase negative DNA [Presence] in Blood by NAA with probe detection |
|
63574-8
|
Staphylococcus sp.coagulase negative DNA [Presence] in Isolate by NAA with probe detection |
|
7478-1
|
Coastal Maple IgE Ab [Units/volume] in Serum |
|
61205-1
|
Coastal Maple IgE Ab/IgE total in Serum |
|
21208-4
|
Cobalt [Mass/volume] in 24 hour Urine |
|
29916-4
|
Cobalt [Mass/time] in 24 hour Urine |
|
34269-1
|
Cobalt [Moles/volume] in 24 hour Urine |
|
25379-9
|
Cobalt [Moles/time] in 24 hour Urine |
|
5625-9
|
Cobalt [Mass/volume] in Blood |
|
15119-1
|
Cobalt [Moles/volume] in Blood |
|
57944-1
|
Cobalt [Mass/volume] in Cerebral spinal fluid |
|
51194-9
|
Cobalt [Mass/volume] in Body fluid |
|
5626-7
|
Cobalt [Mass/mass] in Hair |
|
50845-7
|
Cobalt [Moles/mass] in Hair |
|
60065-0
|
Cobalt [Mass/mass] in Nail |
|
60066-8
|
Cobalt [Mass/volume] in Red Blood Cells |
|
50847-3
|
Cobalt [Moles/volume] in Red Blood Cells |
|
5627-5
|
Cobalt [Mass/volume] in Serum or Plasma |
|
25378-1
|
Cobalt [Moles/volume] in Serum or Plasma |
|
23842-8
|
Cobalt [Mass/volume] in Synovial fluid |
|
60067-6
|
Cobalt [Mass/mass] in Tissue |
|
50846-5
|
Cobalt [Moles/mass] in Tissue |
|
5628-3
|
Cobalt [Mass/volume] in Urine |
|
34268-3
|
Cobalt [Moles/volume] in Urine |
|
9691-7
|
Cobalt [Mass/volume] in Unspecified specimen |
|
29934-7
|
Cobalt/Creatinine [Mass Ratio] in 24 hour Urine |
|
52933-9
|
Cobalt/Creatinine [Molar ratio] in 24 hour Urine |
|
13468-4
|
Cobalt/Creatinine [Mass Ratio] in Urine |
|
34270-9
|
Cobalt/Creatinine [Molar ratio] in Urine |
|
82723-8
|
Cocaine+Benzoylecgonine+Cocaethylene [Presence] in Urine by Confirmatory method |
|
74670-1
|
Cocaine+Metabolites [Presence] in Saliva (oral fluid) by Confirmatory method |
|
31135-7
|
Cocaethylene [Mass/volume] in Bile fluid |
|
29324-1
|
Cocaethylene [Mass/volume] in Gastric fluid |
|
49072-2
|
Cocaethylene [Presence] in Hair |
|
16171-1
|
Cocaethylene [Mass/mass] in Hair |
|
69011-5
|
Cocaethylene [Mass/mass] in Meconium by Confirmatory method |
|
57945-8
|
Cocaethylene [Presence] in Meconium |
|
26815-1
|
Cocaethylene [Mass/mass] in Meconium |
|
59643-7
|
Cocaethylene [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13553-3
|
Cocaethylene [Presence] in Serum or Plasma |
|
27226-0
|
Cocaethylene [Mass/volume] in Serum or Plasma |
|
55530-0
|
Cocaethylene [Moles/volume] in Serum or Plasma |
|
27295-5
|
Cocaethylene [Mass/mass] in Stool |
|
16632-2
|
Cocaethylene [Mass/volume] in Urine by Confirmatory method |
|
19406-8
|
Cocaethylene [Presence] in Urine by Confirmatory method |
|
19405-0
|
Cocaethylene [Presence] in Urine by Screen method |
|
19408-4
|
Cocaethylene [Mass/volume] in Urine |
|
29325-8
|
Cocaethylene [Mass/volume] in Vitreous fluid |
|
48946-8
|
Cocaethylene [Mass/volume] in Unspecified specimen |
|
86606-1
|
Cocaethylene/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
31137-3
|
Cocaine [Mass/volume] in Bile fluid |
|
72405-4
|
Cocaine [Mass/volume] in Blood by Confirmatory method |
|
16633-0
|
Cocaine [Presence] in Blood |
|
41036-5
|
Cocaine [Presence] in Blood by Confirmatory method |
|
38384-4
|
Cocaine [Presence] in Gastric fluid |
|
29323-3
|
Cocaine [Mass/volume] in Gastric fluid |
|
41021-7
|
Cocaine [Presence] in Hair |
|
34715-3
|
Cocaine [Presence] in Hair by Screen method |
|
27114-8
|
Cocaine [Mass/mass] in Hair |
|
69009-9
|
Cocaine [Mass/mass] in Meconium by Confirmatory method |
|
40527-4
|
Cocaine [Presence] in Meconium |
|
41037-3
|
Cocaine [Presence] in Meconium by Confirmatory method |
|
26956-3
|
Cocaine [Mass/mass] in Meconium |
|
53743-1
|
Cocaine metabolites.other [Mass/volume] in Urine |
|
69008-1
|
Cocaine panel - Meconium by Confirmatory method |
|
53747-2
|
Cocaine panel - Urine |
|
72737-0
|
Cocaine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74671-9
|
Cocaine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40802-1
|
Cocaine [Presence] in Saliva (oral fluid) by Screen method |
|
74169-4
|
Cocaine [Mass/volume] in Saliva (oral fluid) by Screen method |
|
59644-5
|
Cocaine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3395-1
|
Cocaine [Presence] in Serum or Plasma |
|
8190-1
|
Cocaine [Presence] in Serum or Plasma by Confirmatory method |
|
8191-9
|
Cocaine [Presence] in Serum or Plasma by Screen method |
|
16447-5
|
Cocaine [Units/volume] in Serum or Plasma |
|
3396-9
|
Cocaine [Mass/volume] in Serum or Plasma |
|
26758-3
|
Cocaine [Mass/mass] in Stool |
|
20519-5
|
Cocaine [Mass/volume] in Urine by Confirmatory method |
|
3397-7
|
Cocaine [Presence] in Urine |
|
19360-7
|
Cocaine [Presence] in Urine by Confirmatory method |
|
19359-9
|
Cocaine [Presence] in Urine by Screen method |
|
16448-3
|
Cocaine [Units/volume] in Urine |
|
3398-5
|
Cocaine [Mass/volume] in Urine |
|
52953-7
|
Cocaine [Moles/volume] in Urine |
|
8195-0
|
Cocaine [Presence] in Unknown substance |
|
8196-8
|
Cocaine [Presence] in Unknown substance by Confirmatory method |
|
8197-6
|
Cocaine [Presence] in Unknown substance by Screen method |
|
8194-3
|
Cocaine [Mass/volume] in Unknown substance |
|
27204-7
|
Cocaine [Mass/volume] in Vitreous fluid |
|
40625-6
|
Cocaine [Presence] in Unspecified specimen |
|
48947-6
|
Cocaine [Presence] in Unspecified specimen by Confirmatory method |
|
18208-9
|
Cocaine [Mass/volume] in Unspecified specimen |
|
57898-9
|
Cocaine [Moles/volume] in Unspecified specimen |
|
86607-9
|
Cocaine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
91038-0
|
Cocaine+Benzoylecgonine [Presence] in Body fluid by Screen method |
|
91029-9
|
Cocaine+Benzoylecgonine [Presence] in Meconium by Screen method |
|
49747-9
|
Cocaine+Benzoylecgonine [Presence] in Serum or Plasma by Screen method |
|
73823-7
|
Cocaine+Benzoylecgonine [Presence] in Serum, Plasma or Blood by Screen method |
|
91049-7
|
Cocaine+Benzoylecgonine [Presence] in Tissue by Screen method |
|
47400-7
|
Cocaine+Benzoylecgonine [Presence] in Urine by Confirmatory method |
|
42241-0
|
Cocaine+Benzoylecgonine [Presence] in Urine by Screen method |
|
10655-9
|
Coccidia identified in Duodenal fluid by Acid fast stain |
|
10656-7
|
Coccidia identified in Stool by Acid fast stain |
|
24412-9
|
Coccidia identified in Small intestine Tissue by Giemsa stain |
|
49190-2
|
Coccidioides sp Ab [Presence] in Body fluid |
|
48394-1
|
Coccidioides sp Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
43224-5
|
Coccidioides sp Ab [Units/volume] in Serum by Complement fixation |
|
26625-4
|
Coccidioides sp Ab [Presence] in Serum |
|
33379-9
|
Coccidioides sp Ab [Presence] in Serum by Complement fixation |
|
33416-9
|
Coccidioides sp Ab [Presence] in Serum by Immunoassay |
|
43974-5
|
Coccidioides sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
49712-3
|
Coccidioides sp Ab [Presence] in Serum by Latex agglutination |
|
33381-5
|
Coccidioides sp Ab [Units/volume] in Serum |
|
33402-9
|
Coccidioides sp Ab [Titer] in Serum |
|
33380-7
|
Coccidioides sp Ab [Titer] in Serum by Complement fixation |
|
51788-8
|
Coccidioides sp Ab [Titer] in Serum by Immune diffusion (ID) |
|
43052-0
|
Coccidioides sp Ab [Presence] in Unspecified specimen |
|
31153-0
|
Coccidioides sp Ab [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
59049-7
|
Coccidioides sp IgG and IgM panel - Unspecified specimen |
|
93227-7
|
Coccidioides sp Ag [Mass/volume] in Urine by Immunoassay |
|
46181-4
|
Coccidioides sp IgA Ab [Presence] in Serum |
|
44811-8
|
Coccidioides sp IgA Ab [Presence] in Serum by Immunoassay |
|
93837-3
|
Coccidioides sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
46182-2
|
Coccidioides sp IgG Ab [Presence] in Serum |
|
43849-9
|
Coccidioides sp IgG Ab [Presence] in Serum by Immunoassay |
|
27009-0
|
Coccidioides sp IgG Ab [Units/volume] in Serum |
|
93836-5
|
Coccidioides sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
41156-1
|
Coccidioides sp IgG Ab [Presence] in Unspecified specimen |
|
31154-8
|
Coccidioides sp IgG Ab [Presence] in Unspecified specimen by Immunoassay |
|
93834-0
|
Coccidioides sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
46183-0
|
Coccidioides sp IgM Ab [Presence] in Serum |
|
43850-7
|
Coccidioides sp IgM Ab [Presence] in Serum by Immunoassay |
|
93835-7
|
Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
90448-2
|
Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma |
|
53367-9
|
Coccidioides sp IgM Ab [Presence] in Unspecified specimen |
|
51477-8
|
Coccidioides sp IgM Ab [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
48589-6
|
Coccidioides sp rRNA [Presence] in Isolate by NAA with probe detection |
|
48588-8
|
Coccidioides sp rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41750-1
|
COCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
31310-6
|
Cockatiel droppings Ab [Presence] in Serum |
|
23843-6
|
Cockatiel droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
16641-3
|
Cockatiel droppings Ab [Units/volume] in Serum |
|
6838-7
|
Cockatiel droppings IgE Ab [Units/volume] in Serum |
|
61348-9
|
Cockatiel droppings IgE Ab/IgE total in Serum |
|
39539-2
|
Cockatiel droppings IgG Ab [Presence] in Serum |
|
16642-1
|
Cockatiel droppings IgG Ab [Units/volume] in Serum |
|
55592-0
|
Cockatiel feather IgE Ab [Presence] in Serum |
|
11167-4
|
Cockatiel feather IgE Ab [Units/volume] in Serum |
|
61349-7
|
Cockatiel feather IgE Ab/IgE total in Serum |
|
18324-4
|
Cockatiel serum IgE Ab [Units/volume] in Serum |
|
16643-9
|
Cockatoo droppings Ab [Units/volume] in Serum |
|
7237-1
|
Cockatoo IgE Ab [Units/volume] in Serum |
|
7239-7
|
Cocklebur triggered histamine release [Units/volume] in Blood |
|
6077-2
|
Cocklebur IgE Ab [Units/volume] in Serum |
|
61326-5
|
Cocklebur IgE Ab/IgE total in Serum |
|
7238-9
|
Cocklebur IgG Ab [Units/volume] in Serum |
|
56226-4
|
Cocklebur IgG4 Ab [Mass/volume] in Serum |
|
63188-7
|
Cocklebur IgG Ab [Mass/volume] in Serum |
|
65793-2
|
Cockroach native (nBla g) 7 IgE Ab [Units/volume] in Serum |
|
7366-8
|
Cocksfoot triggered histamine release [Units/volume] in Blood |
|
6195-2
|
Cocksfoot IgE Ab [Units/volume] in Serum |
|
61256-4
|
Cocksfoot IgE Ab/IgE total in Serum |
|
7365-0
|
Cocksfoot IgG Ab [Units/volume] in Serum |
|
56339-5
|
Cocksfoot IgG4 Ab [Mass/volume] in Serum |
|
48263-8
|
Cocksfoot triggered leukotriene release [Mass/volume] by Leukocytes |
|
10942-1
|
Cockspur IgE Ab [Units/volume] in Serum |
|
6080-6
|
Cocoa IgE Ab [Units/volume] in Serum |
|
61319-0
|
Cocoa IgE Ab/IgE total in Serum |
|
7241-3
|
Coconut triggered histamine release [Units/volume] in Blood |
|
6081-4
|
Coconut IgE Ab [Units/volume] in Serum |
|
39593-9
|
Coconut IgE Ab/IgE total in Serum |
|
7240-5
|
Coconut IgG Ab [Units/volume] in Serum |
|
56227-2
|
Coconut IgG4 Ab [Mass/volume] in Serum |
|
63084-8
|
Coconut IgG Ab [Mass/volume] in Serum |
|
47516-0
|
Cocal virus Ab [Titer] in Serum |
|
45123-7
|
Cocal virus Ab [Titer] in Serum by Neutralization test |
|
45121-1
|
Cocal virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
45122-9
|
Cocal virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
38274-7
|
Columbid circovirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86799-4
|
Coded cause of death - recommended CDA R1 sections |
|
86800-0
|
Coded race and ethnicity - recommended CDA R1 sections |
|
41038-1
|
Codeine [Mass/volume] in Blood |
|
16644-7
|
Codeine Free [Presence] in Serum or Plasma by Confirmatory method |
|
46262-2
|
Codeine Free [Presence] in Serum or Plasma by Screen method |
|
12784-5
|
Codeine Free [Mass/volume] in Serum or Plasma |
|
27311-0
|
Codeine Free [Mass/mass] in Stool |
|
51739-1
|
Codeine Free [Mass/volume] in Urine |
|
14261-2
|
Codeine [Presence] in Gastric fluid |
|
29372-0
|
Codeine [Mass/volume] in Gastric fluid |
|
26720-3
|
Codeine [Mass/mass] in Hair |
|
49871-7
|
Codeine IgE Ab [Units/volume] in Serum |
|
68542-0
|
Codeine [Mass/mass] in Meconium by Confirmatory method |
|
29278-9
|
Codeine [Presence] in Meconium |
|
15364-3
|
Codeine [Mass/volume] in Meconium |
|
26865-6
|
Codeine [Mass/mass] in Meconium |
|
74675-0
|
Codeine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
57304-8
|
Codeine [Mass/volume] in Saliva (oral fluid) |
|
3505-5
|
Codeine [Presence] in Serum or Plasma |
|
86226-8
|
Codeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3506-3
|
Codeine [Mass/volume] in Serum or Plasma |
|
15102-7
|
Codeine [Moles/volume] in Serum or Plasma |
|
16250-3
|
Codeine [Mass/volume] in Urine by Confirmatory method |
|
70206-8
|
Codeine [Moles/volume] in Urine by Confirmatory method |
|
3507-1
|
Codeine [Presence] in Urine |
|
16197-6
|
Codeine [Presence] in Urine by Confirmatory method |
|
13641-6
|
Codeine [Presence] in Urine by SAMHSA confirm method |
|
19411-8
|
Codeine [Presence] in Urine by Screen method |
|
3508-9
|
Codeine [Mass/volume] in Urine |
|
40626-4
|
Codeine [Presence] in Unspecified specimen |
|
58391-4
|
Codeine/Creatinine [Mass Ratio] in Urine |
|
63473-3
|
Codfish recombinant (rGad c) 1 IgE Ab [Units/volume] in Serum |
|
7242-1
|
Codfish triggered histamine release [Units/volume] in Blood |
|
6082-2
|
Codfish IgE Ab [Units/volume] in Serum |
|
39081-5
|
Codfish IgE Ab/IgE total in Serum |
|
6721-5
|
Codfish IgG Ab [Units/volume] in Serum |
|
61268-9
|
Codfish IgG Ab/IgE total in Serum |
|
56228-0
|
Codfish IgG4 Ab [Mass/volume] in Serum |
|
49099-5
|
Codfish IgG Ab [Mass/volume] in Serum |
|
48224-0
|
Codfish triggered leukotriene release [Mass/volume] by Leukocytes |
|
7243-9
|
Coffee bean IgE Ab [Units/volume] in Serum |
|
6083-0
|
Coffee IgE Ab [Units/volume] in Serum |
|
61250-7
|
Coffee IgE Ab/IgE total in Serum |
|
6722-3
|
Coffee IgG Ab [Units/volume] in Serum |
|
56229-8
|
Coffee IgG4 Ab [Mass/volume] in Serum |
|
35533-9
|
Coffee IgG Ab [Mass/volume] in Serum |
|
45987-5
|
Cognitive patterns section |
|
86904-0
|
Carboxyhemoglobin/Hemoglobin.total in Arterial blood by Pulse oximetry |
|
32160-4
|
Carboxyhemoglobin [Presence] in Blood by Screen method |
|
31157-1
|
Carboxyhemoglobin [Mass/volume] in Blood |
|
20563-3
|
Carboxyhemoglobin/Hemoglobin.total in Blood |
|
63523-5
|
Carboxyhemoglobin/Hemoglobin.total in Arterial cord blood |
|
63524-3
|
Carboxyhemoglobin/Hemoglobin.total in Venous cord blood |
|
41648-7
|
Carboxyhemoglobin/Hemoglobin.total in Mixed venous blood |
|
78248-2
|
Colon and rectal surgery Admission history and physical note |
|
83658-5
|
Colon and rectal surgery Attending Note |
|
78505-5
|
Colon and rectal surgery Checklist |
|
78250-8
|
Colon and rectal surgery Consult note |
|
78271-4
|
Colon and rectal surgery Education note |
|
83735-1
|
Colon and rectal surgery Fellow Note |
|
78300-1
|
Colon and rectal surgery Flowsheet |
|
82827-7
|
Colon and rectal surgery Initial evaluation note |
|
84073-6
|
Colon and rectal surgery Note |
|
83542-1
|
Colon and rectal surgery Nurse practitioner Note |
|
83600-7
|
Colon and rectal surgery Nurse Note |
|
78381-1
|
Colon and rectal surgery Surgical operation note |
|
80744-6
|
Colon and rectal surgery Plan of care note |
|
78313-4
|
Colon and rectal surgery Preoperative evaluation and management note |
|
84074-4
|
Colon and rectal surgery procedure note |
|
78329-0
|
Colon and rectal surgery Referral note |
|
83753-4
|
Colon and rectal surgery Resident Note |
|
78340-7
|
Colon and rectal surgery Transfer summary note |
|
53851-2
|
COL10A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35354-0
|
COL1A1+COL1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21657-2
|
COL2A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53852-0
|
COL2A1 gene+COL11A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
41751-9
|
COL3A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43097-5
|
COL3A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53853-8
|
COL4A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41111-6
|
COL5A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38534-4
|
COL5A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49854-3
|
COL5A1 gene+COL5A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7244-7
|
Cola IgE Ab [Units/volume] in Serum |
|
7245-4
|
Cola IgG Ab [Units/volume] in Serum |
|
7246-2
|
Cola nut triggered histamine release [Units/volume] in Blood |
|
33010-0
|
Colby Cheese IgE Ab [Units/volume] in Serum |
|
60068-4
|
Colchicine [Mass/volume] in Blood |
|
73428-5
|
Colchicine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73429-3
|
Colchicine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12397-6
|
Colchicine [Mass/volume] in Serum or Plasma |
|
40706-4
|
Colchicine [Mass/volume] in Urine |
|
79160-8
|
Cold agglutinin panel - Serum |
|
20770-4
|
Coliform bacteria [#/volume] by Viability count |
|
20769-6
|
Coliform bacteria [#/volume] in Water by Viability count |
|
34890-4
|
Coliform bacteria [#/volume] in Unspecified specimen by Viability count |
|
20772-0
|
Coliform colony count [#/volume] in Milk |
|
20771-2
|
Coliform bacteria [#/mass] in Egg by Viability count |
|
86324-1
|
Coliform bacteria [#/mass] in Food by Viability count |
|
14081-4
|
Coliform bacteria [Presence] in Water |
|
39018-7
|
Coliform bacteria [#/mass] in Unspecified specimen by Viability count |
|
86221-9
|
Colistin resistance mcr-1 gene [Presence] by Molecular method |
|
16645-4
|
Colistin [Mass/volume] in Serum or Plasma |
|
29493-4
|
Colistin [Mass/volume] in Unspecified specimen |
|
16647-0
|
Collagen Ab [Units/volume] in Serum |
|
12735-7
|
Collagen Ab [Units/volume] in Urine |
|
57948-2
|
Collagen crosslinked C-telopeptide [Mass/volume] in 24 hour Urine |
|
53052-7
|
Collagen crosslinked C-telopeptide [Mass/time] in 24 hour Urine |
|
41171-0
|
Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma |
|
53092-3
|
Collagen crosslinked C-telopeptide [Moles/volume] in Serum or Plasma |
|
48586-2
|
Collagen crosslinked C-telopeptide [Mass/volume] in Urine |
|
74994-5
|
Collagen crosslinked C-telopeptide [Z-score] in Serum or Plasma |
|
48587-0
|
Collagen crosslinked C-telopeptide/Creatinine [Ratio] in Urine |
|
35334-2
|
Collagen crosslinked N-telopeptide [Moles/volume] in 24 hour Urine |
|
21215-9
|
Collagen crosslinked N-telopeptide [Moles/volume] in Serum |
|
34271-7
|
Collagen crosslinked N-telopeptide [Mass/volume] in Urine |
|
27939-8
|
Collagen crosslinked N-telopeptide [Moles/volume] in Urine |
|
44308-5
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine by Immunoassay |
|
21216-7
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine |
|
44712-8
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine by Immunoassay |
|
34272-5
|
Collagen crosslinked N-telopeptide/Creatinine [Ratio] in Urine |
|
14115-0
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine |
|
44713-6
|
Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Unspecified specimen by Immunoassay |
|
48383-4
|
Collagen.bovine type 1 Ab [Units/volume] in Serum |
|
48384-2
|
Collagen.bovine type 2 Ab [Units/volume] in Serum |
|
48385-9
|
Collagen.injectable Ab [Units/volume] in Serum |
|
48376-8
|
Collagen type 1 Ab [Units/volume] in Serum |
|
13878-4
|
Collagen type 1 IgG Ab [Units/volume] in Serum |
|
35643-6
|
Collagen type 2 Ab [Presence] in Serum by Immunoassay |
|
34605-6
|
Collagen type 2 Ab [Units/volume] in Serum |
|
13879-2
|
Collagen type 2 IgG Ab [Units/volume] in Serum |
|
10474-5
|
Collagen type 4 Ag [Presence] in Tissue by Immune stain |
|
13880-0
|
Collagen type 4 IgG Ab [Units/volume] in Serum |
|
2133-7
|
Collagenase [Enzymatic activity/volume] in Serum |
|
47842-0
|
Collection duration of Dialysis fluid |
|
34400-2
|
Colon Ab [Titer] in Serum by Immunofluorescence |
|
64096-1
|
Colonies counted [#] in Amniotic fluid by Molecular genetics method |
|
18746-8
|
Colonoscopy study |
|
94067-6
|
Color Me Healthy - children's symptom assessment app |
|
76679-0
|
Color of Cerebral spinal fluid--1st tube |
|
76680-8
|
Color of Cerebral spinal fluid--2nd tube |
|
76681-6
|
Color of Cerebral spinal fluid--3rd tube |
|
76682-4
|
Color of Cerebral spinal fluid--4th tube |
|
50553-7
|
Color of Urine by Auto |
|
68971-1
|
Color of Vitreous fluid |
|
29757-2
|
Colposcopy study |
|
93245-9
|
Columbia - suicide severity rating scale - lifetime recent [C-SSRS] |
|
93485-1
|
Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent [C-SSRS] |
|
93373-9
|
Columbia - suicide severity rating scale screener - recent [C-SSRS] |
|
6084-8
|
Colza IgE Ab [Units/volume] in Serum |
|
73568-8
|
Communication of critical results [Description] Document |
|
88640-8
|
Community health care Adult day care center Consult note |
|
88641-6
|
Community health care Adult day care center Discharge summary |
|
88642-4
|
Community health care Adult day care center Note |
|
85899-3
|
Community health care Consult note |
|
82825-1
|
Community health care Initial evaluation note |
|
80418-7
|
Community health care Medical equipment or product list |
|
85901-7
|
Community health care Note |
|
85903-3
|
Community health care Telephone encounter Note |
|
80419-5
|
Community health care Referral note |
|
80422-9
|
Community health care Report |
|
80417-9
|
Community health care Risk assessment and screening note |
|
80423-7
|
Community health care Safety issue assessment note |
|
6175-4
|
Common Millet IgE Ab [Units/volume] in Serum |
|
7494-8
|
Common Millet IgG Ab [Units/volume] in Serum |
|
56321-3
|
Common Millet IgG4 Ab [Mass/volume] in Serum |
|
63087-1
|
Common Millet IgG Ab [Mass/volume] in Serum |
|
7604-2
|
Common Pigweed IgE Ab [Units/volume] in Serum |
|
50363-1
|
Common Pigweed IgE Ab/IgE total in Serum |
|
65782-5
|
Common ragweed native (nAmb a) 1 IgE Ab [Units/volume] in Serum |
|
7652-1
|
Common Ragweed triggered histamine release [Units/volume] in Blood |
|
6085-5
|
Common Ragweed IgE Ab [Units/volume] in Serum |
|
61214-3
|
Common Ragweed IgE Ab/IgE total in Serum |
|
7646-3
|
Common Ragweed IgG Ab [Units/volume] in Serum |
|
56371-8
|
Common Ragweed IgG4 Ab [Mass/volume] in Serum |
|
63206-7
|
Common Ragweed IgG Ab [Mass/volume] in Serum |
|
48256-2
|
Common Ragweed triggered leukotriene release [Mass/volume] by Leukocytes |
|
6855-1
|
Common Reed IgE Ab [Units/volume] in Serum |
|
56230-6
|
Common Reed IgG4 Ab [Mass/volume] in Serum |
|
66714-7
|
Common wasp recombinant (rVes v) 1 IgE Ab [Units/volume] in Serum |
|
60240-9
|
Common wasp recombinant (rVes v) 5 IgE Ab [Units/volume] in Serum |
|
45991-7
|
Communication and hearing patterns section |
|
45992-5
|
Communication devices and techniques Set |
|
78923-0
|
Comorbid condition panel |
|
74519-0
|
Complement activity panel - Serum |
|
4471-9
|
Complement Activity Cell Surface Induced [Units/volume] in Serum or Plasma |
|
34544-7
|
Complement C3 and C4 panel [Mass/volume] - Serum or Plasma |
|
15168-8
|
Complement total hemolytic C50 [Units/volume] in Body fluid by Immunoassay |
|
15169-6
|
Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay |
|
15170-4
|
Complement total hemolytic C50 [Units/volume] in Synovial fluid by Immunoassay |
|
4514-6
|
Complement decay accelerating factor [Entitic number] in Red Blood Cells |
|
6292-7
|
Complement decay accelerating factor [Presence] in Red Blood Cells |
|
15178-7
|
Complement factor B [Mass/volume] in Body fluid |
|
2269-9
|
Complement factor B [Mass/volume] in Serum or Plasma |
|
4516-1
|
Complement factor Ba [Mass/volume] in Serum or Plasma |
|
4517-9
|
Complement factor Bb [Mass/volume] in Serum or Plasma |
|
4518-7
|
Complement factor D [Mass/volume] in Serum or Plasma |
|
4519-5
|
Complement factor H [Mass/volume] in Serum or Plasma |
|
4520-3
|
Complement factor I [Mass/volume] in Serum or Plasma |
|
4521-1
|
Complement factor P [Mass/volume] in Plasma |
|
58462-3
|
Complement functional activity [Units/volume] in Serum or Plasma by Immunoassay |
|
34095-0
|
Comprehensive history and physical note |
|
4524-5
|
Complement membrane attack complex (C5b-C6-C7-C8-C9n) [Mass/volume] in Plasma |
|
24322-0
|
Comprehensive metabolic 1998 panel - Serum or Plasma |
|
24323-8
|
Comprehensive metabolic 2000 panel - Serum or Plasma |
|
34547-0
|
Complement profile panel [Mass/volume] - Serum or Plasma |
|
47306-6
|
Cartilage oligomeric matrix protein [Units/volume] in Serum by Immunoassay |
|
81251-1
|
Complex genetic variant panel |
|
13946-9
|
Complement+Immunoglobulin [Presence] in Red Blood Cells |
|
4533-6
|
Complement+Immunoglobulin [Units/volume] in Red Blood Cells |
|
75285-7
|
Comparative nutrition assessment standards panel |
|
93126-1
|
Comparison with previous results |
|
57949-0
|
Complement C4c [Mass/volume] in Serum or Plasma |
|
33667-7
|
Prostate specific Ag.protein bound [Mass/volume] in Serum or Plasma |
|
60828-1
|
Compliance.static Lung |
|
60567-5
|
Comprehensive pathology report panel |
|
89556-5
|
Comprehensive Universal Behavior Health Screen [CUBS] |
|
74511-7
|
COMT gene c.1947G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
58807-9
|
Conalbumin native (nGal d) 3 IgE Ab [Units/volume] in Serum |
|
25615-6
|
Conalbumin IgE Ab [Units/volume] in Serum |
|
45973-5
|
Conditions related to mental retardation and developmental disabilities status Set |
|
77575-9
|
Condition- or population-specific panel APTA |
|
34098-4
|
Conference note |
|
75506-6
|
aPTT.lupus sensitive W excess phospholipid (LA confirm) |
|
33930-9
|
aPTT W excess hexagonal phospholipid (StaClot LA confirm) |
|
75508-2
|
aPTT.lupus sensitive W excess phospholipid actual/Normal (normalized LA confirm) |
|
47040-1
|
Consultation 2nd opinion |
|
57838-5
|
dRVVT W excess phospholipid (LA confirm) |
|
75883-9
|
dRVVT W excess hexagonal phospholipid (STA-StaClot confirm) |
|
85735-9
|
Congenital rubella case report panel |
|
75199-0
|
Congenital syphilis case investigation and report panel [CDC.CS] |
|
58351-8
|
Connective tissue growth factor [Mass/volume] in Urine |
|
58352-6
|
Connective tissue growth factor [Moles/volume] in Urine |
|
82252-8
|
Constitutive heterochromatin analysis in Blood or Tissue by Banding |
|
90353-4
|
Conscious sedation procedure note |
|
59284-0
|
Consent Document |
|
11488-4
|
Consult note |
|
18763-3
|
Consultant Initial evaluation note |
|
28569-2
|
Consultant Progress note |
|
80407-0
|
Contamination/radiation/contagion status |
|
46017-0
|
Continence appliances and programs Set |
|
46014-7
|
Continence in last 14 days section Set |
|
46015-4
|
Continence self-control categories Set |
|
48769-4
|
Continuity of Care panel |
|
93738-3
|
Cooked cauliflower IgE Ab [Units/volume] in Serum |
|
12186-3
|
Colloid oncotic pressure [Partial pressure] in Plasma |
|
30920-3
|
Copper [Mass/volume] in Urine collected for unspecified duration |
|
21219-1
|
Copper [Mass/volume] in 24 hour Urine |
|
5633-3
|
Copper [Mass/time] in 24 hour Urine |
|
25879-8
|
Copper [Moles/volume] in 24 hour Urine |
|
14666-2
|
Copper [Moles/time] in 24 hour Urine |
|
12556-7
|
Copper [Mass/volume] in Blood |
|
47100-3
|
Copper [Moles/volume] in Blood |
|
57347-7
|
Copper [Mass/volume] in Dialysis fluid |
|
93728-4
|
Copper [Moles/volume] in Dialysis fluid |
|
16648-8
|
Copper [Mass/volume] in Body fluid |
|
47101-1
|
Copper [Moles/volume] in Body fluid |
|
5629-1
|
Copper [Mass/mass] in Hair |
|
47103-7
|
Copper [Moles/mass] in Hair |
|
56126-6
|
Copper [Mass/mass] in Liver |
|
5630-9
|
Copper [Mass/volume] in Red Blood Cells |
|
27124-7
|
Copper [Mass/mass] in Red Blood Cells |
|
47102-9
|
Copper [Moles/volume] in Red Blood Cells |
|
5631-7
|
Copper [Mass/volume] in Serum or Plasma |
|
14665-4
|
Copper [Moles/volume] in Serum or Plasma |
|
10751-6
|
Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |
|
8198-4
|
Copper [Mass/mass] in Tissue |
|
52912-3
|
Copper [Moles/mass] in Tissue |
|
5632-5
|
Copper [Mass/volume] in Urine |
|
34273-3
|
Copper [Moles/volume] in Urine |
|
9470-6
|
Copper [Mass/volume] in Water |
|
20778-7
|
Copper [Mass/volume] in Unspecified specimen |
|
22744-7
|
Copper [Moles/volume] in Unspecified specimen |
|
29942-0
|
Copper/Creatinine [Mass Ratio] in 24 hour Urine |
|
52932-1
|
Copper/Creatinine [Molar ratio] in 24 hour Urine |
|
13829-7
|
Copper/Creatinine [Mass Ratio] in Urine |
|
25880-6
|
Copper/Creatinine [Molar ratio] in Urine |
|
48634-0
|
Coproporphyrin/Creatinine [Mass Ratio] in 24 hour Urine |
|
48395-8
|
Coproporphyrin/Creatinine [Molar ratio] in Urine |
|
47253-0
|
Coproporphyrin 1 [Mass/volume] in 24 hour Urine |
|
75024-0
|
Coproporphyrin 1/Porphyrins.total in Stool |
|
45305-0
|
Coproporphyrin 1 [Moles/mass] in Stool |
|
48305-7
|
Coproporphyrin 1/Creatinine [Mass Ratio] in Urine |
|
45313-4
|
Coproporphyrin 1/Creatinine [Molar ratio] in Urine |
|
47254-8
|
Coproporphyrin 3 [Mass/volume] in 24 hour Urine |
|
75025-7
|
Coproporphyrin 3/Porphyrins.total in Stool |
|
45306-8
|
Coproporphyrin 3 [Moles/mass] in Stool |
|
75000-0
|
Coproporphyrin 3/Coproporphyrin.total in 24 hour Urine |
|
75001-8
|
Coproporphyrin 3/Coproporphyrin.total in Stool |
|
45314-2
|
Coproporphyrin 3/Coproporphyrin 1 [Molar ratio] in Urine |
|
48306-5
|
Coproporphyrin 3/Creatinine [Mass Ratio] in Urine |
|
45315-9
|
Coproporphyrin 3/Creatinine [Molar ratio] in Urine |
|
16649-6
|
Coproporphyrinogen oxidase [Enzymatic activity/volume] in Red Blood Cells |
|
2138-6
|
Coproporphyrinogen oxidase [Enzymatic activity/volume] in Serum |
|
74586-9
|
Coenzyme Q cytochrome C reductase (Complex III) [Enzymatic activity/mass] in Tissue |
|
74585-1
|
Coenzyme Q cytochrome C reductase (Complex III)/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
19736-8
|
Coralbumin IgE Ab [Units/volume] in Serum |
|
51662-5
|
Core respiratory allergens panel - Serum |
|
7247-0
|
Corn triggered histamine release [Units/volume] in Blood |
|
6087-1
|
Corn IgE Ab [Units/volume] in Serum |
|
61327-3
|
Corn IgE Ab/IgE total in Serum |
|
6723-1
|
Corn IgG Ab [Units/volume] in Serum |
|
56231-4
|
Corn IgG4 Ab [Mass/volume] in Serum |
|
35534-7
|
Corn IgG Ab [Mass/volume] in Serum |
|
7703-2
|
Corn smut IgE Ab [Units/volume] in Serum |
|
56232-2
|
Corn smut IgG4 Ab [Mass/volume] in Serum |
|
7249-6
|
Cornish hen triggered histamine release [Units/volume] in Blood |
|
76640-2
|
Coronary artery catheterization Study report |
|
78895-0
|
Coronary angiography panel |
|
80192-8
|
Coronary segment additional details panel |
|
5099-7
|
Coronavirus Ab [Units/volume] in Serum |
|
55841-1
|
Corticosterone [Mass/volume] in 24 hour Urine |
|
14042-6
|
Corticosterone [Mass/time] in 24 hour Urine |
|
55843-7
|
Corticosterone [Moles/volume] in 24 hour Urine |
|
55842-9
|
Corticosterone [Moles/time] in 24 hour Urine |
|
2139-4
|
Corticosterone [Mass/volume] in Serum or Plasma |
|
25381-5
|
Corticosterone [Moles/volume] in Serum or Plasma |
|
47604-4
|
Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post 1 ug/kg CRH IV |
|
29363-9
|
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
1397-9
|
Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
|
45047-8
|
Cortisol [Moles/volume] in Serum or Plasma --12 AM specimen |
|
45048-6
|
Cortisol [Moles/volume] in Serum or Plasma --12 PM specimen |
|
47605-1
|
Cortisol [Moles/volume] in Serum or Plasma --15 minutes post 1 ug/kg CRH IV |
|
47606-9
|
Cortisol [Moles/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV |
|
26528-0
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
12567-4
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
1399-5
|
Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
12569-0
|
Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
78047-8
|
Cortisol [Moles/volume] in Serum or Plasma --24 hour post XXX challenge |
|
83089-3
|
Cortisol [Mass/volume] in 24 hour Urine by Immunoassay |
|
83091-9
|
Cortisol [Moles/volume] in 24 hour Urine by Immunoassay |
|
20622-7
|
Cortisol [Mass/volume] in 24 hour Urine |
|
14158-0
|
Cortisol [Mass/time] in 24 hour Urine |
|
50848-1
|
Cortisol [Moles/volume] in 24 hour Urine |
|
32310-5
|
Cortisol [Moles/time] in 24 hour Urine |
|
21224-1
|
Cortisol [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
47607-7
|
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV |
|
12566-6
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
1414-2
|
Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
54212-6
|
Cortisol [Moles/volume] in Serum or Plasma --3 days post dose dexamethasone |
|
21225-8
|
Cortisol [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
45049-4
|
Cortisol [Moles/volume] in Serum or Plasma --4 PM specimen |
|
45050-2
|
Cortisol [Moles/volume] in Serum or Plasma --8 AM specimen |
|
45051-0
|
Cortisol [Moles/volume] in Serum or Plasma --8 PM specimen |
|
1440-7
|
Cortisol [Mass/volume] in Serum or Plasma --9 hours post 1 mg dexamethasone PO overnight |
|
66733-7
|
Cortisol [Mass or Moles/volume] in Serum or Plasma --afternoon specimen |
|
9813-7
|
Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen |
|
66735-2
|
Cortisol [Mass or Moles/volume] in Serum or Plasma --AM peak specimen |
|
14679-5
|
Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen |
|
54235-7
|
Cortisol challenge panel - Saliva (oral fluid) |
|
33257-7
|
Cortisol [Mass/volume] in Cerebral spinal fluid |
|
53345-5
|
Cortisol [Mass/volume] in DBS |
|
53346-3
|
Cortisol [Moles/volume] in DBS |
|
14043-4
|
Cortisol Free [Mass/time] in 12 hour Urine |
|
34909-2
|
Cortisol Free [Mass/volume] in 24 hour Urine by HPLC |
|
35261-7
|
Cortisol Free [Mass or Moles/volume] in 24 hour Urine by HPLC |
|
25883-0
|
Cortisol Free [Moles/volume] in 24 hour Urine by HPLC |
|
25885-5
|
Cortisol Free [Moles/time] in 24 hour Urine by HPLC |
|
55845-2
|
Cortisol Free [Mass/volume] in 24 hour Urine by Radioimmunoassay (RIA) |
|
55844-5
|
Cortisol Free [Mass/time] in 24 hour Urine by Radioimmunoassay (RIA) |
|
25882-2
|
Cortisol Free [Moles/volume] in 24 hour Urine by Radioimmunoassay (RIA) |
|
25884-8
|
Cortisol Free [Moles/time] in 24 hour Urine by Radioimmunoassay (RIA) |
|
33346-8
|
Cortisol Free [Mass/volume] in 24 hour Urine |
|
2147-7
|
Cortisol Free [Mass/time] in 24 hour Urine |
|
75516-5
|
Cortisol Free [Moles/volume] in 24 hour Urine |
|
14676-1
|
Cortisol Free [Moles/time] in 24 hour Urine |
|
16667-8
|
Cortisol Free [Mass/time] in 48 hour Urine |
|
16668-6
|
Cortisol Free [Mass/time] in 72 hour Urine |
|
57824-5
|
Cortisol Free [Mass/volume] in Serum or Plasma --AM peak specimen |
|
57825-2
|
Cortisol Free [Mass/volume] in Serum or Plasma --PM trough specimen |
|
18365-7
|
Cortisol Free [Mass/volume] in Saliva (oral fluid) |
|
2145-1
|
Cortisol Free [Mass/volume] in Serum or Plasma |
|
15044-1
|
Cortisol Free [Moles/volume] in Serum or Plasma |
|
11040-3
|
Cortisol Free [Mass/volume] in Urine |
|
30173-9
|
Cortisol Free [Moles/volume] in Urine |
|
49029-2
|
Cortisol Free/Cortisone free [Mass Ratio] in Urine |
|
71805-6
|
Cortisol Free/Cortisone free [Molar ratio] in Urine |
|
32009-3
|
Cortisol Free/Creatinine [Mass Ratio] in 24 hour Urine |
|
30171-3
|
Cortisol Free/Creatinine [Molar ratio] in 24 hour Urine |
|
44309-3
|
Cortisol Free/Creatinine [Mass Ratio] in Urine |
|
30172-1
|
Cortisol Free/Creatinine [Molar ratio] in Urine |
|
65364-2
|
Cortisol Free/Cortisol.total in Serum or Plasma |
|
47845-3
|
Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight |
|
47846-1
|
Cortisol [Mass/volume] in Serum or Plasma --post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
47851-1
|
Cortisol [Mass/volume] in Serum or Plasma --post dose dexamethasone |
|
9812-9
|
Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen |
|
14678-7
|
Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen |
|
47609-3
|
Cortisol [Moles/volume] in Serum or Plasma --pre 1 ug/kg CRH IV |
|
1444-9
|
Cortisol [Mass/volume] in Serum or Plasma --pre 12 hour fast |
|
47608-5
|
Cortisol [Moles/volume] in Serum or Plasma --pre dose corticotropin |
|
45296-1
|
Cortisol [Moles/volume] in Serum or Plasma --pre dose dexamethasone |
|
26828-4
|
Cortisol [Units/volume] in Saliva (oral fluid) |
|
2142-8
|
Cortisol [Mass/volume] in Saliva (oral fluid) |
|
51844-9
|
Cortisol [Moles/volume] in Saliva (oral fluid) |
|
83088-5
|
Cortisol [Mass/volume] in Serum or Plasma by Immunoassay |
|
83090-1
|
Cortisol [Moles/volume] in Serum or Plasma by Immunoassay |
|
2143-6
|
Cortisol [Mass/volume] in Serum or Plasma |
|
35202-1
|
Cortisol [Mass or Moles/volume] in Serum or Plasma |
|
14675-3
|
Cortisol [Moles/volume] in Serum or Plasma |
|
28550-2
|
Cortisol [Presence] in Urine |
|
2144-4
|
Cortisol [Mass/volume] in Urine |
|
15043-3
|
Cortisol [Moles/volume] in Urine |
|
44310-1
|
Cortisol/Creatinine [Mass Ratio] in 24 hour Urine |
|
11155-9
|
Cortisol/Creatinine [Mass Ratio] in Urine |
|
87429-7
|
Cortisol AM and PM panel - Serum or Plasma |
|
43126-2
|
Cortisol.free panel - 24 hour Urine |
|
93480-2
|
Cortisol post CRH stimulation panel - Serum or Plasma |
|
30072-3
|
Cortisone [Mass/volume] in 24 hour Urine by HPLC |
|
14044-2
|
Cortisone [Mass/time] in 24 hour Urine |
|
71892-4
|
Cortisone [Moles/volume] in Saliva (oral fluid) --AM peak specimen |
|
73880-7
|
Cortisone free [Moles/volume] in 24 hour Urine |
|
71894-0
|
Cortisone free [Moles/time] in 24 hour Urine |
|
76475-3
|
Cortisone free [Moles/volume] in Serum or Plasma |
|
53777-9
|
Cortisone free [Mass/volume] in Urine |
|
73881-5
|
Cortisone free [Moles/volume] in Urine |
|
71893-2
|
Cortisone [Moles/volume] in Saliva (oral fluid) --PM trough specimen |
|
74360-9
|
Cortisone [Moles/volume] in Saliva (oral fluid) |
|
14159-8
|
Cortisone [Mass/volume] in Serum or Plasma |
|
25382-3
|
Cortisone [Moles/volume] in Serum or Plasma |
|
30511-0
|
Cortisone/Creatinine [Mass Ratio] in Urine |
|
90066-2
|
Corynebacterium sp identified in Isolate by Organism specific culture |
|
24102-6
|
Corynebacterium toxin [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
59892-0
|
Cotinine [Moles/volume] in Gastric fluid |
|
40355-0
|
Cotinine [Presence] in Hair |
|
10364-8
|
Cotinine [Mass/mass] in Hair |
|
40418-6
|
Cotinine [Presence] in Meconium |
|
74371-6
|
Cotinine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74370-8
|
Cotinine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
63044-2
|
Cotinine [Presence] in Saliva (oral fluid) by Screen method |
|
43196-5
|
Cotinine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61128-5
|
Cotinine [Presence] in Serum or Plasma |
|
59645-2
|
Cotinine [Presence] in Serum or Plasma by Screen method |
|
10365-5
|
Cotinine [Mass/volume] in Serum or Plasma |
|
59891-2
|
Cotinine [Moles/volume] in Serum or Plasma |
|
92643-6
|
Cotinine [Mass/volume] in Urine by Confirmatory method |
|
12293-7
|
Cotinine [Presence] in Urine |
|
35642-8
|
Cotinine [Presence] in Urine by Confirmatory method |
|
59646-0
|
Cotinine [Presence] in Urine by Screen method |
|
72786-7
|
Cotinine [Mass/volume] in Urine by Screen method |
|
10366-3
|
Cotinine [Mass/volume] in Urine |
|
33796-4
|
Cotinine [Moles/volume] in Urine |
|
9372-4
|
Cotinine [Mass/volume] in Unspecified specimen |
|
60299-5
|
Cotinine [Moles/volume] in Unspecified specimen |
|
44311-9
|
Cotinine/Creatinine [Mass Ratio] in Urine |
|
7206-6
|
Cottage Cheese IgE Ab [Units/volume] in Serum |
|
7207-4
|
Cottage Cheese IgG Ab [Units/volume] in Serum |
|
19737-6
|
Cotton fibers IgE Ab [Units/volume] in Serum |
|
7250-4
|
Cotton gin dust IgE Ab [Units/volume] in Serum |
|
7252-0
|
Cotton linters triggered histamine release [Units/volume] in Blood |
|
7251-2
|
Cotton linters IgE Ab [Units/volume] in Serum |
|
6089-7
|
Cottonseed IgE Ab [Units/volume] in Serum |
|
61340-6
|
Cottonseed IgE Ab/IgE total in Serum |
|
7253-8
|
Cottonseed IgG Ab [Units/volume] in Serum |
|
56452-6
|
Cottonseed IgG4 Ab [Mass/volume] in Serum |
|
63097-0
|
Cottonseed IgG Ab [Mass/volume] in Serum |
|
6090-5
|
Cottonwood IgE Ab [Units/volume] in Serum |
|
61304-2
|
Cottonwood IgE Ab/IgE total in Serum |
|
13184-7
|
Cottonwood IgG Ab [Units/volume] in Serum |
|
56233-0
|
Cottonwood IgG4 Ab [Mass/volume] in Serum |
|
63183-8
|
Cottonwood IgG Ab [Mass/volume] in Serum |
|
74113-2
|
Coumafuryl [Presence] in Unspecified specimen by Screen method |
|
30025-1
|
Coumaphos [Mass/volume] in Serum or Plasma |
|
21229-0
|
Coumaphos [Mass/volume] in Urine |
|
87748-0
|
Coumaphos [Mass/mass] in Unspecified specimen |
|
74114-0
|
Coumatetralyl [Presence] in Unspecified specimen by Screen method |
|
47042-7
|
Counseling note |
|
92841-6
|
Countermeasure report |
|
78746-5
|
Country of birth [Location] |
|
87721-7
|
County of residence [Location] |
|
25038-1
|
Courtesy consultation Unspecified body region Document |
|
87520-3
|
Coverage type |
|
6091-3
|
Cow dander IgE Ab [Units/volume] in Serum |
|
39551-7
|
Cow dander IgE Ab/IgE total in Serum |
|
56453-4
|
Cow dander IgG4 Ab [Mass/volume] in Serum |
|
7257-9
|
Cow epithelium IgE Ab [Units/volume] in Serum |
|
45195-5
|
Cow epithelium+Cow dander IgE Ab [Units/volume] in Serum |
|
30087-1
|
Cow hair+Cow dander IgE Ab [Units/volume] in Serum |
|
57035-8
|
Cow milk Ab [Presence] in Serum by Immune diffusion (ID) |
|
7259-5
|
Cow milk triggered histamine release [Units/volume] in Blood |
|
10940-5
|
Cow milk boiled IgE Ab [Units/volume] in Serum |
|
7258-7
|
Cow milk IgE Ab [Units/volume] in Serum |
|
61332-3
|
Cow milk IgE Ab/IgE total in Serum |
|
6729-8
|
Cow milk IgG Ab [Units/volume] in Serum |
|
56234-8
|
Cow milk IgG4 Ab [Mass/volume] in Serum |
|
35539-6
|
Cow milk IgG Ab [Mass/volume] in Serum |
|
48225-7
|
Cow milk triggered leukotriene release [Mass/volume] by Leukocytes |
|
7774-3
|
Cow whey IgE Ab [Units/volume] in Serum |
|
57950-8
|
Cow whey IgE Ab/IgE total in Serum |
|
56419-5
|
Cow whey IgG4 Ab [Mass/volume] in Serum |
|
59058-8
|
Cow whey IgG Ab [Mass/volume] in Serum |
|
43744-2
|
COX10 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49476-5
|
Cyclooxygenase 2 Ag [Presence] in Tissue by Immune stain |
|
52042-9
|
Continuous positive airway pressure (CPAP) attachment |
|
40994-6
|
CPEO syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
22979-9
|
Caprine herpesvirus 1 Ab [Presence] in Serum |
|
22980-7
|
Caprine herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
|
89425-3
|
CPR flowsheet |
|
89426-1
|
CPR note |
|
80737-0
|
Calculated panel reactive antibody - Serum |
|
2017-2
|
Carbamoyl phosphate synthetase (ammonia) [Enzymatic activity/mass] in Tissue |
|
2016-4
|
Carbamoyl phosphate synthetase [Enzymatic activity/volume] in Serum |
|
32233-9
|
Carbamoyl phosphate synthetase [Enzymatic activity/mass] in Tissue |
|
53854-6
|
CPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53437-0
|
Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Fibroblast |
|
53441-2
|
Carnitine palmitoyltransferase 1 [Enzymatic activity/mass] in Leukocytes |
|
74780-8
|
CPT1A gene c.1436C>T [Presence] in DBS by Molecular genetics method |
|
53434-7
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Amniotic fluid cells |
|
53436-2
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Chorionic villus sample |
|
53514-6
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Control Fibroblast |
|
53438-8
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Fibroblast |
|
49678-6
|
CPT2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40877-3
|
CPT2 gene p.Pro50His+Ser113Leu [Presence] in Blood or Tissue by Molecular genetics method |
|
40878-1
|
CPT2 gene p.Gln413FSer+Gly549Asp [Presence] in Blood or Tissue by Molecular genetics method |
|
49684-4
|
CPT2 gene p.Arg503Cys [Presence] in Blood by Molecular genetics method |
|
49686-9
|
CPT2 gene p.Arg631Cys [Presence] in Blood by Molecular genetics method |
|
53442-0
|
Carnitine palmitoyltransferase 2 [Enzymatic activity/mass] in Leukocytes |
|
53445-3
|
Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Fibroblast |
|
53446-1
|
Carnitine palmitoyltransferase 2/Citrate synthase [Enzymatic activity ratio] in Red Blood Cells |
|
23701-6
|
Canine parvovirus Ab [Presence] in Serum |
|
24411-1
|
Canine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition |
|
23700-8
|
Canine parvovirus Ab [Presence] in Serum by Immunofluorescence |
|
31286-8
|
Canine parvovirus Ab [Units/volume] in Serum |
|
31287-6
|
Canine parvovirus Ab [Presence] in Stool |
|
28607-0
|
Canine parvovirus Ab [Presence] in Stool by Hemagglutination inhibition |
|
23702-4
|
Canine parvovirus Ab [Titer] in Serum |
|
31761-0
|
Canine parvovirus Ag [Presence] in Stool |
|
23793-3
|
Canine parvovirus Ag [Presence] in Stool by Immunoassay |
|
23706-5
|
Canine parvovirus Ag [Presence] in Stool by Immunofluorescence |
|
23705-7
|
Canine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
|
23707-3
|
Canine parvovirus DNA [Presence] in Stool by Probe |
|
31288-4
|
Canine parvovirus IgG Ab [Units/volume] in Serum |
|
23703-2
|
Canine parvovirus IgG Ab [Titer] in Serum |
|
31289-2
|
Canine parvovirus IgM Ab [Units/volume] in Serum |
|
23704-0
|
Canine parvovirus IgM Ab [Titer] in Serum |
|
57951-6
|
CPVT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79288-7
|
Creatine and guanidinoacetate panel - Cerebral spinal fluid |
|
79289-5
|
Creatine and guanidinoacetate panel - Serum or Plasma |
|
79290-3
|
Creatine, guanidinoacetate and creatinine panel - Urine |
|
7261-1
|
Crab triggered histamine release [Units/volume] in Blood |
|
6092-1
|
Crab IgE Ab [Units/volume] in Serum |
|
39545-9
|
Crab IgE Ab/IgE total in Serum |
|
7260-3
|
Crab IgG Ab [Units/volume] in Serum |
|
56235-5
|
Crab IgG4 Ab [Mass/volume] in Serum |
|
60370-4
|
Crab IgG Ab [Mass/volume] in Serum |
|
48215-8
|
Crab triggered leukotriene release [Mass/volume] by Leukocytes |
|
7264-5
|
Cranberry triggered histamine release [Units/volume] in Blood |
|
7262-9
|
Cranberry IgE Ab [Units/volume] in Serum |
|
61323-2
|
Cranberry IgE Ab/IgE total in Serum |
|
7263-7
|
Cranberry IgG Ab [Units/volume] in Serum |
|
56236-3
|
Cranberry IgG4 Ab [Mass/volume] in Serum |
|
63104-4
|
Cranberry IgG Ab [Mass/volume] in Serum |
|
7265-2
|
Crawfish IgE Ab [Units/volume] in Serum |
|
61223-4
|
Crawfish IgE Ab/IgE total in Serum |
|
56237-1
|
Crawfish IgG4 Ab [Mass/volume] in Serum |
|
63137-4
|
Crawfish IgG Ab [Mass/volume] in Serum |
|
7208-2
|
Cream Cheese triggered histamine release [Units/volume] in Blood |
|
11164-1
|
Cream Cheese IgE Ab [Units/volume] in Serum |
|
48790-0
|
Creatinine [Mass/time] in unspecified time Peritoneal dialysis fluid |
|
32543-1
|
Creatinine [Molar amount] in Urine collected for unspecified duration |
|
72821-2
|
Creatinine [Mass/time] by Calculated in Urine collected for unspecified duration |
|
35674-1
|
Creatinine [Mass/volume] in Urine collected for unspecified duration |
|
55593-8
|
Creatinine [Moles/volume] in Urine collected for unspecified duration |
|
57346-9
|
Creatinine [Mass/volume] in 12 hour Urine |
|
12589-8
|
Creatinine [Mass/time] in 12 hour Urine |
|
53499-0
|
Creatinine [Moles/volume] in 12 hour Urine |
|
51592-4
|
Creatinine [Moles/time] in 12 hour Urine |
|
58998-6
|
Creatinine [Mass/time] in 18 hour Urine |
|
53120-2
|
Creatinine [Moles/time] in 1 hour Urine |
|
58446-6
|
Creatinine 24H renal clearance adjusted for body surface area panel |
|
34555-3
|
Creatinine 24H renal clearance panel |
|
57726-2
|
Creatinine [Mass/volume] in 24 hour Peritoneal dialysis fluid |
|
39471-8
|
Creatinine [Moles/volume] in 24 hour Peritoneal dialysis fluid |
|
39472-6
|
Creatinine [Moles/volume] in 24 hour Dialysis fluid |
|
40356-8
|
Creatinine [Moles/time] in 24 hour Dialysis fluid |
|
31101-9
|
Creatinine [Mass/time] in 24 hour Body fluid |
|
40357-6
|
Creatinine [Moles/time] in 24 hour Body fluid |
|
60518-8
|
Creatinine [Moles/time] in 24 hour Stool |
|
20624-3
|
Creatinine [Mass/volume] in 24 hour Urine |
|
2162-6
|
Creatinine [Mass/time] in 24 hour Urine |
|
35251-8
|
Creatinine [Mass or Moles/volume] in 24 hour Urine |
|
35262-5
|
Creatinine [Mass or Moles] in 24 hour Urine |
|
25886-3
|
Creatinine [Moles/volume] in 24 hour Urine |
|
14684-5
|
Creatinine [Moles/time] in 24 hour Urine |
|
12572-4
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
|
46086-5
|
Creatinine [Moles/volume] in Dialysis fluid --2 hour specimen |
|
57344-4
|
Creatinine [Mass/volume] in 2 hour Urine |
|
12585-6
|
Creatinine [Mass/time] in 2 hour Urine |
|
33798-0
|
Creatinine [Moles/time] in 2 hour Urine |
|
16689-2
|
Creatinine [Mass/time] in 48 hour Urine |
|
12573-2
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
|
46219-2
|
Creatinine [Moles/volume] in Dialysis fluid --4 hour specimen |
|
12586-4
|
Creatinine [Mass/time] in 4 hour Urine |
|
93733-4
|
Creatinine [Mass/time] in 5 hour Urine |
|
93735-9
|
Creatinine [Moles/volume] in 5 hour Urine |
|
93734-2
|
Creatinine [Moles/time] in 5 hour Urine |
|
12587-2
|
Creatinine [Mass/time] in 6 hour Urine |
|
16690-0
|
Creatinine [Mass/time] in 72 hour Urine |
|
39473-4
|
Creatinine [Moles/volume] in 72 hour Urine |
|
12588-0
|
Creatinine [Mass/time] in 8 hour Urine |
|
2159-2
|
Creatinine [Mass/volume] in Amniotic fluid |
|
15050-8
|
Creatinine [Moles/volume] in Amniotic fluid |
|
21232-4
|
Creatinine [Mass/volume] in Arterial blood |
|
38483-4
|
Creatinine [Mass/volume] in Blood |
|
59826-8
|
Creatinine [Moles/volume] in Blood |
|
33558-8
|
Creatinine renal clearance in Urine and Serum or Plasma collected for unspecified duration |
|
2163-4
|
Creatinine renal clearance in 12 hour Urine and Serum or Plasma |
|
2164-2
|
Creatinine renal clearance in 24 hour Urine and Serum or Plasma |
|
26752-6
|
Creatinine renal clearance in 2 hour Urine and Serum or Plasma |
|
13441-1
|
Creatinine renal clearance in 4 hour Urine and Serum or Plasma |
|
13442-9
|
Creatinine renal clearance in 6 hour Urine and Serum or Plasma |
|
13443-7
|
Creatinine renal clearance in 8 hour Urine and Serum or Plasma |
|
48788-4
|
Creatinine peritoneal dialysis clearance |
|
13451-0
|
Creatinine dialysis fluid clearance |
|
48789-2
|
Creatinine peritoneal dialysis clearance/1.73 sq M |
|
50379-7
|
Creatinine dialysis fluid clearance/1.73 sq M |
|
50380-5
|
Creatinine renal clearance/1.73 sq M.predicted among females by Cockcroft-Gault formula, BSA formula |
|
50381-3
|
Creatinine renal clearance/1.73 sq M.predicted among males by Cockcroft-Gault formula, BSA formula |
|
14398-2
|
Creatinine [Mass/volume] in Cerebral spinal fluid |
|
49004-5
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid |
|
14681-1
|
Creatinine [Moles/volume] in Peritoneal dialysis fluid |
|
5919-6
|
Creatinine [Mass/volume] in Dialysis fluid |
|
35242-7
|
Creatinine [Mass or Moles/volume] in Dialysis fluid |
|
15051-6
|
Creatinine [Moles/volume] in Dialysis fluid |
|
12190-5
|
Creatinine [Mass/volume] in Body fluid |
|
25386-4
|
Creatinine [Moles/volume] in Body fluid |
|
14402-2
|
Creatinine [Mass/volume] in Gastric fluid |
|
57345-1
|
Creatinine [Mass/volume] in Peritoneal dialysis fluid --overnight |
|
46220-0
|
Creatinine [Moles/volume] in Dialysis fluid --overnight |
|
51620-3
|
Creatinine [Moles/volume] in Serum or Plasma --post dialysis |
|
70264-7
|
Creatinine in pleural fluid/Creatinine in serum |
|
14399-0
|
Creatinine [Mass/volume] in Pleural fluid |
|
54375-1
|
Creatinine [Moles/volume] in Pleural fluid |
|
93736-7
|
Creatinine panel - 5 hour Urine |
|
72271-0
|
Creatinine [Mass/volume] in Serum or Plasma --pre contrast |
|
48630-8
|
Creatinine [Mass/volume] in Peritoneal fluid --pre dialysis |
|
51619-5
|
Creatinine [Moles/volume] in Serum or Plasma --pre dialysis |
|
70266-2
|
Creatinine in peritoneal fluid/Creatinine in serum |
|
12191-3
|
Creatinine [Mass/volume] in Peritoneal fluid |
|
39474-2
|
Creatinine [Moles/volume] in Peritoneal fluid |
|
77140-2
|
Creatinine [Moles/volume] in Serum, Plasma or Blood |
|
2160-0
|
Creatinine [Mass/volume] in Serum or Plasma |
|
35203-9
|
Creatinine [Mass or Moles/volume] in Serum or Plasma |
|
14682-9
|
Creatinine [Moles/volume] in Serum or Plasma |
|
14401-4
|
Creatinine [Mass/volume] in Synovial fluid |
|
47610-1
|
Creatinine [Moles/volume] in Stool |
|
30004-6
|
Creatinine [Mass/volume] in Urine by Test strip |
|
30002-0
|
Creatinine [Moles/volume] in Urine by Test strip |
|
2161-8
|
Creatinine [Mass/volume] in Urine |
|
35204-7
|
Creatinine [Mass or Moles/volume] in Urine |
|
14683-7
|
Creatinine [Moles/volume] in Urine |
|
12584-9
|
Creatinine [Mass/volume] in Vitreous fluid |
|
75363-2
|
Creatinine [Moles/volume] in Vitreous fluid |
|
22726-4
|
Creatinine [Moles/volume] in Unspecified specimen |
|
54374-4
|
Creatinine/Body weight [Moles/kg/time] in 24 hour Urine |
|
44716-9
|
Creatinine/Calcium [Mass Ratio] in Urine |
|
33797-2
|
Creatine [Moles/time] in 12 hour Urine |
|
49097-9
|
Creatine [Mass/volume] in 24 hour Urine |
|
2150-1
|
Creatine [Mass/time] in 24 hour Urine |
|
34274-1
|
Creatine [Moles/volume] in 24 hour Urine |
|
15047-4
|
Creatine [Moles/time] in 24 hour Urine |
|
53055-0
|
Creatine [Moles/volume] in Amniotic fluid |
|
53074-1
|
Creatine [Moles/volume] in Cerebral spinal fluid |
|
2148-5
|
Creatine [Mass/volume] in Serum or Plasma |
|
15045-8
|
Creatine [Moles/volume] in Serum or Plasma |
|
2149-3
|
Creatine [Mass/volume] in Urine |
|
15046-6
|
Creatine [Moles/volume] in Urine |
|
16687-6
|
Creatine [Mass/volume] in Vitreous fluid |
|
13484-1
|
Creatine/Creatinine [Mass Ratio] in Urine |
|
34275-8
|
Creatine/Creatinine [Molar ratio] in Urine |
|
45066-8
|
Creatinine and Glomerular filtration rate.predicted panel - Serum, Plasma or Blood |
|
65634-8
|
Creatinine 24 hour urine panel - 24 hour Urine |
|
23849-3
|
Creosol [Mass/volume] in Serum or Plasma |
|
23850-1
|
Creosol [Mass/volume] in Urine |
|
9512-5
|
Creosol [Presence] in Unspecified specimen |
|
23848-5
|
Creosol [Mass/volume] in Unspecified specimen |
|
38580-7
|
Cresols [Mass/volume] in Air |
|
16691-8
|
Cresols [Identifier] in Unspecified specimen |
|
7266-0
|
Cricket IgE Ab [Units/volume] in Serum |
|
88191-2
|
Crimean-Congo hemorrhagic fever virus IgG Ab [Presence] in Serum by Immunoassay |
|
88190-4
|
Crimean-Congo hemorrhagic fever virus IgM Ab [Presence] in Serum by Immunoassay |
|
88192-0
|
Crimean-Congo hemorrhagic fever virus RNA [Presence] in Serum by NAA with probe detection |
|
78709-3
|
Crisis intervention note |
|
29751-5
|
Critical care records |
|
3513-9
|
Cropropamide [Mass/time] in 24 hour Urine |
|
3511-3
|
Cropropamide [Presence] in Urine |
|
3512-1
|
Cropropamide [Mass/volume] in Urine |
|
3516-2
|
Crotethamide [Mass/time] in 24 hour Urine |
|
3514-7
|
Crotethamide [Presence] in Urine |
|
3515-4
|
Crotethamide [Mass/volume] in Urine |
|
87749-8
|
Crotoxyphos [Mass/mass] in Unspecified specimen |
|
71426-1
|
C reactive protein [Mass/volume] in Blood by High sensitivity method |
|
48421-2
|
C reactive protein [Mass/volume] in Capillary blood |
|
59182-6
|
C reactive protein [Mass/volume] in Cerebral spinal fluid by High sensitivity method |
|
45062-7
|
C reactive protein [Mass/volume] in Cerebral spinal fluid |
|
16503-5
|
C reactive protein [Mass/volume] in Body fluid |
|
30522-7
|
C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method |
|
76486-0
|
C reactive protein [Moles/volume] in Serum or Plasma by High sensitivity method |
|
11039-5
|
C reactive protein [Presence] in Serum or Plasma |
|
1988-5
|
C reactive protein [Mass/volume] in Serum or Plasma |
|
76485-2
|
C reactive protein [Moles/volume] in Serum or Plasma |
|
14634-0
|
C reactive protein [Titer] in Serum or Plasma |
|
69459-6
|
Care record summary panel |
|
79411-5
|
Creatine transport protein [Enzymatic activity/mass] in Fibroblast by Creatine uptake assay |
|
87636-7
|
Crufomate [Mass/mass] in Unspecified specimen |
|
81205-7
|
Cryoglobulin IgA and IgG and IgM and C3 panel - Serum |
|
15174-6
|
Cryocrit of Serum by Spun Westergren |
|
2165-9
|
Cryofibrinogen [Mass/volume] in Blood |
|
11043-7
|
Cryofibrinogen [Presence] in Plasma |
|
12197-0
|
Cryofibrinogen [Presence] in Plasma by 1 day cold incubation |
|
46265-5
|
Cryofibrinogen [Presence] in Plasma by 1 week cold incubation |
|
43401-9
|
Cryofibrinogen [Presence] in Plasma by 1 week 37 degree C incubation |
|
12198-8
|
Cryofibrinogen [Presence] in Plasma by 2 day cold incubation |
|
12199-6
|
Cryofibrinogen [Presence] in Plasma by 3 day cold incubation |
|
29744-0
|
Cryofibrinogen [Presence] in Plasma by 3 day 37 degree C incubation |
|
29743-2
|
Cryofibrinogen [Presence] in Plasma by 3 day RT incubation |
|
12196-2
|
Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation |
|
2166-7
|
Cryoglobulin [Mass/volume] in Blood |
|
55846-0
|
Cryoglobulin.IgA.monoclonal [Presence] in Serum |
|
40580-3
|
Cryoglobulin.IgA [Mass/volume] in Serum by Cold incubation |
|
40628-0
|
Cryoglobulin.IgA [Mass/volume] in Serum by 37 degree C incubation |
|
81311-3
|
Cryoglobulin.IgA [Presence] in Serum |
|
15171-2
|
Cryoglobulin.IgA [Units/volume] in Serum |
|
33650-3
|
Cryoglobulin.IgA [Mass/volume] in Serum |
|
55847-8
|
Cryoglobulin.IgG.monoclonal [Presence] in Serum |
|
40579-5
|
Cryoglobulin.IgG [Mass/volume] in Serum by Cold incubation |
|
40582-9
|
Cryoglobulin.IgG [Mass/volume] in Serum by 37 degree C incubation |
|
55848-6
|
Cryoglobulin.IgG [Presence] in Serum |
|
15172-0
|
Cryoglobulin.IgG [Units/volume] in Serum |
|
33649-5
|
Cryoglobulin.IgG [Mass/volume] in Serum |
|
55849-4
|
Cryoglobulin.IgM.monoclonal [Presence] in Serum |
|
40578-7
|
Cryoglobulin.IgM [Mass/volume] in Serum by Cold incubation |
|
40581-1
|
Cryoglobulin.IgM [Mass/volume] in Serum by 37 degree C incubation |
|
81312-1
|
Cryoglobulin.IgM [Presence] in Serum |
|
15173-8
|
Cryoglobulin.IgM [Units/volume] in Serum |
|
33651-1
|
Cryoglobulin.IgM [Mass/volume] in Serum |
|
33648-7
|
Cryoglobulin Rheumatoid Factor [Units/volume] in Serum |
|
5117-7
|
Cryoglobulin [Presence] in Serum |
|
70970-9
|
Cryoglobulin [Presence] in Serum by Hypotonic dilution |
|
48614-2
|
Cryoglobulin [Presence] in Serum by Immune diffusion (ID) |
|
78989-1
|
Cryoglobulin [Mass/volume] in Serum |
|
2167-5
|
Cryoglobulin [Presence] in Serum or Plasma |
|
2168-3
|
Cryoglobulin [Mass/volume] in Serum or Plasma |
|
48638-1
|
Cryoglobulin type [Identifier] in Serum by Immunofixation |
|
74352-6
|
Cryoglobulin and cryofibrinogen panel - Serum and Plasma |
|
81313-9
|
Cryoglobulin.complement C3 [Presence] in Serum |
|
15176-1
|
Cryoproteins identified in Serum or Plasma |
|
90338-5
|
Cryptococcus sp rRNA gene [Presence] in Blood by NAA with probe detection |
|
90337-7
|
Cryptococcus sp rRNA gene [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81649-6
|
Cryptococcus sp rRNA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
70907-1
|
Cryptococcus sp rRNA gene [Identifier] in Unspecified specimen by Sequencing |
|
7843-6
|
Cryptococcus sp Ab [Presence] in Serum |
|
6370-1
|
Cryptococcus sp Ab [Presence] in Serum by Immunofluorescence |
|
31335-3
|
Cryptococcus sp Ab [Units/volume] in Serum |
|
16123-2
|
Cryptococcus sp Ab [Titer] in Cerebral spinal fluid |
|
16124-0
|
Cryptococcus sp Ab [Titer] in Serum |
|
31788-3
|
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid |
|
29896-8
|
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
70911-3
|
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay |
|
46964-3
|
Cryptococcus sp Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
31789-1
|
Cryptococcus sp Ag [Units/volume] in Cerebral spinal fluid |
|
16692-6
|
Cryptococcus sp Ag [Presence] in Body fluid |
|
31790-9
|
Cryptococcus sp Ag [Presence] in Serum |
|
29903-2
|
Cryptococcus sp Ag [Presence] in Serum by Immunoassay |
|
70910-5
|
Cryptococcus sp Ag [Presence] in Serum by Rapid immunoassay |
|
30324-8
|
Cryptococcus sp Ag [Presence] in Serum by Latex agglutination |
|
31791-7
|
Cryptococcus sp Ag [Units/volume] in Serum |
|
70908-9
|
Cryptococcus sp Ag [Presence] in Tissue by Immunofluorescence |
|
70909-7
|
Cryptococcus sp Ag [Presence] in Tissue by Immune stain |
|
32674-4
|
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid |
|
9817-8
|
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Immunoassay |
|
9819-4
|
Cryptococcus sp Ag [Titer] in Cerebral spinal fluid by Latex agglutination |
|
40768-4
|
Cryptococcus sp Ag [Titer] in Serum |
|
9818-6
|
Cryptococcus sp Ag [Titer] in Serum by Immunoassay |
|
9820-2
|
Cryptococcus sp Ag [Titer] in Serum by Latex agglutination |
|
93766-4
|
Cryptococcus sp Ag [Titer] in Urine by Rapid immunoassay |
|
11473-6
|
Cryptococcus sp Ag [Titer] in Unspecified specimen |
|
43229-4
|
Cryptococcus sp Ag [Titer] in Unspecified specimen by Latex agglutination |
|
16693-4
|
Cryptococcus sp Ag [Presence] in Urine |
|
29533-7
|
Cryptococcus sp Ag [Presence] in Unspecified specimen |
|
43228-6
|
Cryptococcus sp Ag [Presence] in Unspecified specimen by Latex agglutination |
|
31792-5
|
Cryptococcus sp Ag [Units/volume] in Unspecified specimen |
|
38376-0
|
Cryptococcus sp identified in Unspecified specimen by Organism specific culture |
|
21233-2
|
Cryptosporidium sp Ag [Presence] in Stool |
|
6371-9
|
Cryptosporidium sp Ag [Presence] in Stool by Immunoassay |
|
39534-3
|
Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence |
|
31793-3
|
Cryptosporidium sp Ag [Units/volume] in Stool |
|
6372-7
|
Cryptosporidium sp Ag [Titer] in Stool by Immunofluorescence |
|
31794-1
|
Cryptosporidium sp Ag [Presence] in Unspecified specimen |
|
566-0
|
Cryptosporidium sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
82205-6
|
Cryptosporidium sp DNA [Presence] in Stool by NAA with non-probe detection |
|
88928-7
|
Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection |
|
88927-9
|
Cryptosporidium sp DNA [Presence] in Tissue by NAA with probe detection |
|
60545-1
|
Cryptosporidium sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
27907-5
|
Cryptosporidium sp [Identifier] in Stool by Organism specific culture |
|
20781-1
|
Cryptosporidium sp [Presence] in Stool by Acid fast stain |
|
20780-3
|
Cryptosporidium sp [Presence] in Large intestine or small intestine Tissue by Acid fast stain |
|
41488-8
|
Cryptosporidium sp [Presence] in Unspecified specimen by Acid fast stain |
|
85093-3
|
Crystal casts [Presence] in Urine sediment by Light microscopy |
|
75236-0
|
Crystals [#/area] in Body fluid by Light microscopy |
|
38459-4
|
Crystals [#/area] in Urine sediment by Microscopy high power field |
|
38397-6
|
Crystals [type] in Amniotic fluid by Light microscopy |
|
5779-4
|
Crystals [type] in Bile fluid by Light microscopy |
|
5780-2
|
Crystals [type] in Duodenal fluid by Light microscopy |
|
6825-4
|
Crystals [type] in Body fluid by Light microscopy |
|
38398-4
|
Crystals [type] in Pericardial fluid by Light microscopy |
|
6826-2
|
Crystals [type] in Pleural fluid by Light microscopy |
|
58433-4
|
Crystals panel - Urine sediment |
|
38399-2
|
Crystals [type] in Peritoneal fluid by Light microscopy |
|
5781-0
|
Crystals [type] in Synovial fluid by Light microscopy |
|
38458-6
|
Crystals [Presence] in Synovial fluid by Light microscopy |
|
47611-9
|
Crystals [type] in Tissue by Light microscopy |
|
87828-0
|
Crystals [Presence] in Urine |
|
5782-8
|
Crystals [type] in Urine sediment by Light microscopy |
|
58058-9
|
Cs sup(a) Ag [Presence] in Serum or Plasma |
|
32190-1
|
Microscopic observation [Identifier] in Cerebral spinal fluid |
|
92674-1
|
CSF3R gene exons 14 and 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
23004-5
|
Classical swine fever virus Ab [Presence] in Serum |
|
23002-9
|
Classical swine fever virus Ab [Presence] in Serum by Immunoassay |
|
23003-7
|
Classical swine fever virus Ab [Presence] in Serum by Neutralization test |
|
46180-6
|
Classical swine fever virus Ab [Titer] in Serum |
|
43326-8
|
Classical swine fever virus Ab [Titer] in Serum by Neutralization test |
|
23005-2
|
Classical swine fever virus Ag [Presence] in Tissue by Immunofluorescence |
|
23007-8
|
Classical swine fever virus Ag [Presence] in Tissue by Immune stain |
|
31781-8
|
Classical swine fever virus Ag [Presence] in Unspecified specimen |
|
23006-0
|
Classical swine fever virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
43327-6
|
Classical swine fever virus Ag [Presence] in Unspecified specimen by Immune stain |
|
58440-9
|
Classical swine fever virus E2 Ab [Units/volume] in Serum by Immunoassay |
|
44273-1
|
Classical swine fever virus RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
23008-6
|
Classical swine fever virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
34463-0
|
California serogroup RNA [Presence] in Blood by NAA with probe detection |
|
34462-2
|
California serogroup RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
55143-2
|
California serogroup RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
37986-7
|
California serogroup RNA [Presence] in Unspecified specimen by Probe |
|
41110-8
|
CSTB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34698-1
|
CSTB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
92683-2
|
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Genital specimen by NAA with probe detection |
|
92684-0
|
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Urine by NAA with probe detection |
|
85040-4
|
CT Unspecified body region 3D printed model |
|
41806-1
|
CT Abdomen |
|
35948-9
|
CT Abdominal Aorta |
|
36143-6
|
CT Abdominal Aorta W contrast IV |
|
36431-5
|
CT Abdominal Aorta WO contrast |
|
36271-5
|
CT Abdominal Aorta WO and W contrast IV |
|
36086-7
|
CT Abdomen limited |
|
36095-8
|
CT Abdomen limited W contrast IV |
|
36103-0
|
CT Abdomen limited WO contrast |
|
36102-2
|
CT Abdomen limited WO and W contrast IV |
|
79066-7
|
CT Abdomen 3D post processing WO contrast |
|
79103-8
|
CT Abdomen W contrast IV |
|
46330-7
|
CT Abdomen W reduced contrast volume IV |
|
87863-7
|
CT Abdomen WO and CT Chest and Abdomen W contrast IV |
|
87862-9
|
CT Abdomen WO and CT Abdomen and Pelvis W contrast IV |
|
87864-5
|
CT Abdomen WO and CT Chest and Abdomen and Pelvis W contrast IV |
|
36424-0
|
CT Abdomen WO contrast |
|
36267-3
|
CT Abdomen WO and W contrast IV |
|
46318-2
|
CT Abdomen WO and W reduced contrast volume IV |
|
87854-6
|
CT Abdomen and Pelvis and CT angiogram Abdominal aorta W contrast IV |
|
87853-8
|
CT Abdomen and Pelvis and CT angiogram Abdominal aorta WO and W contrast IV |
|
87865-2
|
CT Abdomen and Pelvis WO and CT Chest and Abdomen and Pelvis W contrast IV |
|
88319-9
|
CT Abdomen and Pelvis and Lower extremity - bilateral W contrast IV |
|
44115-4
|
CT Abdomen and Pelvis |
|
79065-9
|
CT Abdomen and Pelvis 3D post processing WO contrast |
|
36813-4
|
CT Abdomen and Pelvis W contrast IV |
|
36952-0
|
CT Abdomen and Pelvis WO contrast |
|
42274-1
|
CT Abdomen and Pelvis WO and W contrast IV |
|
36930-6
|
CT Adrenal gland |
|
36943-9
|
CT Adrenal gland W contrast IV |
|
36953-8
|
CT Adrenal gland WO contrast |
|
36950-4
|
CT Adrenal gland WO and W contrast IV |
|
79067-5
|
CT Airway WO contrast |
|
35940-6
|
CT Ankle |
|
36135-2
|
CT Ankle W contrast IV |
|
36425-7
|
CT Ankle WO contrast |
|
36268-1
|
CT Ankle WO and W contrast IV |
|
35941-4
|
CT Ankle - bilateral |
|
69087-5
|
CT Ankle - bilateral WO contrast |
|
35942-2
|
CT Ankle - left |
|
69102-2
|
CT Ankle - left Arthrogram |
|
36137-8
|
CT Ankle - left W contrast IV |
|
36426-5
|
CT Ankle - left WO contrast |
|
36269-9
|
CT Ankle - left WO and W contrast IV |
|
35944-8
|
CT Ankle - right |
|
69109-7
|
CT Ankle - right Arthrogram |
|
36139-4
|
CT Ankle - right W contrast IV |
|
36428-1
|
CT Ankle - right WO contrast |
|
36270-7
|
CT Ankle - right WO and W contrast IV |
|
35952-1
|
CT Appendix |
|
36145-1
|
CT Appendix W contrast IV |
|
36434-9
|
CT Appendix WO contrast |
|
79085-7
|
CT Biliary ducts WO and W contrast IV |
|
79094-9
|
CT Urinary bladder W contrast intra bladder |
|
69095-8
|
CT Urinary bladder W contrast IV |
|
44229-3
|
CT Bone |
|
35891-1
|
CT guidance for percutaneous biopsy of Bone |
|
36054-5
|
CT Brachial plexus |
|
89835-3
|
CT Brachial plexus W contrast IV |
|
89836-1
|
CT Brachial plexus WO contrast |
|
44119-6
|
CT Breast - bilateral WO contrast |
|
89833-8
|
CT Unspecified body region by reconstruction |
|
86984-2
|
CT Cervical and thoracic and lumbar spine W contrast IV |
|
86987-5
|
CT Cervical and thoracic and lumbar spine WO contrast |
|
87870-2
|
CT Cervical spine to Coccyx WO and W contrast IV |
|
87922-1
|
CT Cervical and thoracic spine W contrast IT |
|
86985-9
|
CT Cervical and thoracic spine W contrast IV |
|
83304-6
|
CT Cervical and thoracic spine WO contrast |
|
86959-4
|
CT Cervical and thoracic spine WO and W contrast IV |
|
24734-6
|
CT Cerebral cisterns W contrast IT |
|
24627-2
|
CT Chest |
|
88322-3
|
CT Chest W contrast IV and CT angiogram Pulmonary arteries for pulmonary embolus W contrast IV |
|
36089-1
|
CT Chest limited |
|
69096-6
|
CT Chest limited W contrast IV |
|
47366-0
|
CT Chest limited WO contrast |
|
79096-4
|
CT Chest 3D post processing WO contrast |
|
87279-6
|
CT Chest for screening |
|
79068-3
|
CT Chest for screening W contrast IV |
|
79086-5
|
CT Chest for screening WO contrast |
|
24628-0
|
CT Chest W contrast IV |
|
89860-1
|
CT Chest W inspiration and expiration |
|
46327-3
|
CT Chest W reduced contrast volume IV |
|
87847-0
|
CT Chest WO and CT angiogram Coronary arteries W contrast IV |
|
29252-4
|
CT Chest WO contrast |
|
30598-7
|
CT Chest WO and W contrast IV |
|
46317-4
|
CT Chest WO and W reduced contrast volume IV |
|
79097-2
|
CT Chest and Abdomen 3D post processing WO contrast |
|
42275-8
|
CT Chest and Abdomen W contrast IV |
|
42276-6
|
CT Chest and Abdomen WO contrast |
|
42277-4
|
CT Chest and Abdomen WO and W contrast IV |
|
87869-4
|
CT Chest and Abdomen and Pelvis |
|
79098-0
|
CT Chest and Abdomen and Pelvis 3D post processing WO contrast |
|
72254-6
|
CT Chest and Abdomen and Pelvis W contrast IV |
|
72253-8
|
CT Chest and Abdomen and Pelvis WO contrast |
|
72252-0
|
CT Chest and Abdomen and Pelvis WO and W contrast IV |
|
35960-4
|
CT Clavicle |
|
82685-9
|
CT Clavicle W contrast IV |
|
82687-5
|
CT Clavicle WO contrast |
|
82684-2
|
CT Clavicle WO and W contrast IV |
|
89834-6
|
CT Clavicle - bilateral WO contrast |
|
87871-0
|
CT Clavicle - left |
|
82716-2
|
CT Clavicle - left W contrast IV |
|
82682-6
|
CT Clavicle - left WO contrast |
|
87872-8
|
CT Clavicle - right |
|
82686-7
|
CT Clavicle - right W contrast IV |
|
82683-4
|
CT Clavicle - right WO contrast |
|
79069-1
|
CT Colon and Rectum for screening WO contrast IV and W air contrast PR |
|
79101-2
|
CT Colon and Rectum for screening W air contrast PR |
|
60515-4
|
CT Colon and Rectum W air contrast PR |
|
72531-7
|
CT Colon and Rectum W contrast IV and W air contrast PR |
|
79071-7
|
CT Colon and Rectum WO contrast IV and W air contrast PR |
|
82688-3
|
CT Colon and Rectum WO and W contrast IV and W air contrast PR |
|
24932-6
|
CT Cervical spine |
|
79078-2
|
CT Cervical spine by reconstruction W contrast IV |
|
79079-0
|
CT Cervical spine by reconstruction WO contrast |
|
36099-0
|
CT Cervical spine limited W contrast IV |
|
36109-7
|
CT Cervical spine limited WO contrast |
|
37496-7
|
CT Cervical spine W contrast intradisc |
|
24934-2
|
CT Cervical spine W contrast IT |
|
24933-4
|
CT Cervical spine W contrast IV |
|
30592-0
|
CT Cervical spine WO contrast |
|
36401-8
|
CT Cervical spine WO and W contrast IV |
|
83293-1
|
CT Spine Cervical and Spine Lumbar W contrast IV |
|
83305-3
|
CT Spine Cervical and Spine Lumbar WO contrast |
|
83297-2
|
CT Spine Cervical and Spine Lumbar WO and W contrast IV |
|
35962-0
|
CT Elbow |
|
36157-6
|
CT Elbow W contrast IV |
|
36443-0
|
CT Elbow WO contrast |
|
36285-5
|
CT Elbow WO and W contrast IV |
|
35965-3
|
CT Elbow - bilateral |
|
36444-8
|
CT Elbow - bilateral WO contrast |
|
35966-1
|
CT Elbow - left |
|
69103-0
|
CT Elbow - left Arthrogram |
|
36159-2
|
CT Elbow - left W contrast IV |
|
36445-5
|
CT Elbow - left WO contrast |
|
36286-3
|
CT Elbow - left WO and W contrast IV |
|
35968-7
|
CT Elbow - right |
|
69110-5
|
CT Elbow - right Arthrogram |
|
36161-8
|
CT Elbow - right W contrast IV |
|
36447-1
|
CT Elbow - right WO contrast |
|
36287-1
|
CT Elbow - right WO and W contrast IV |
|
35969-5
|
CT Esophagus |
|
24690-0
|
CT Extremity |
|
36090-9
|
CT Extremity limited |
|
24691-8
|
CT Extremity W contrast IV |
|
42278-2
|
CT Extremity WO contrast |
|
42268-3
|
CT Extremity WO and W contrast IV |
|
26224-6
|
CT Extremity - bilateral |
|
26184-2
|
CT Extremity - bilateral W contrast IV |
|
26226-1
|
CT Extremity - left |
|
26185-9
|
CT Extremity - left W contrast IV |
|
69104-8
|
CT Extremity - left WO contrast |
|
26231-1
|
CT Extremity - right |
|
26186-7
|
CT Extremity - right W contrast IV |
|
69111-3
|
CT Extremity - right WO contrast |
|
24696-7
|
CT Facial bones |
|
24697-5
|
CT Facial bones W contrast IV |
|
72249-6
|
CT Facial bones WO contrast |
|
82133-0
|
CT Face and Neck WO contrast |
|
82132-2
|
CT Face and Neck WO and W contrast IV |
|
87895-9
|
CT Finger WO contrast |
|
87888-4
|
CT Finger second - left WO contrast |
|
87892-6
|
CT Finger second - right WO contrast |
|
87893-4
|
CT Finger third - right WO contrast |
|
87887-6
|
CT Finger fourth - left W contrast IV |
|
87891-8
|
CT Finger fourth - right WO contrast |
|
87886-8
|
CT Finger fifth - left WO contrast |
|
87890-0
|
CT Finger fifth - right WO contrast |
|
89850-2
|
CT Finger - left WO contrast |
|
89849-4
|
CT Finger - right WO contrast |
|
35991-9
|
CT Foot |
|
36178-2
|
CT Foot W contrast IV |
|
36466-1
|
CT Foot WO contrast |
|
36341-6
|
CT Foot WO and W contrast IV |
|
35993-5
|
CT Foot - bilateral |
|
86973-5
|
CT Foot - bilateral W contrast IV |
|
86967-7
|
CT Foot - bilateral WO contrast |
|
35994-3
|
CT Foot - left |
|
36181-6
|
CT Foot - left W contrast IV |
|
36468-7
|
CT Foot - left WO contrast |
|
36343-2
|
CT Foot - left WO and W contrast IV |
|
35996-8
|
CT Foot - right |
|
36183-2
|
CT Foot - right W contrast IV |
|
36470-3
|
CT Foot - right WO contrast |
|
36345-7
|
CT Foot - right WO and W contrast IV |
|
37221-9
|
CT Unspecified body region for fistula |
|
35997-6
|
CT Forearm |
|
36185-7
|
CT Forearm W contrast IV |
|
36472-9
|
CT Forearm WO contrast |
|
36347-3
|
CT Forearm WO and W contrast IV |
|
35998-4
|
CT Forearm - bilateral |
|
35999-2
|
CT Forearm - left |
|
36187-3
|
CT Forearm - left W contrast IV |
|
36473-7
|
CT Forearm - left WO contrast |
|
36348-1
|
CT Forearm - left WO and W contrast IV |
|
36000-8
|
CT Forearm - right |
|
36189-9
|
CT Forearm - right W contrast IV |
|
36475-2
|
CT Forearm - right WO contrast |
|
36350-7
|
CT Forearm - right WO and W contrast IV |
|
35924-0
|
CT Guidance for drainage and placement of drainage catheter of Chest-- WO contrast |
|
35923-2
|
CT Guidance for drainage and placement of drainage catheter of Chest-- W contrast IV |
|
46291-1
|
CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- WO and W contrast IV |
|
42287-3
|
CT Guidance for drainage and placement of drainage catheter of Retroperitoneum |
|
43502-4
|
CT Guidance for drainage of abscess and placement of drainage catheter of Subphrenic space |
|
35884-6
|
CT Guidance for drainage of abscess and placement of drainage catheter of Abdomen |
|
92924-0
|
CT Guidance for aspiration of Abdomen |
|
30601-9
|
CT Guidance for biopsy of Abdomen |
|
89620-9
|
CT Guidance for biopsy of Abdomen-- W contrast IV |
|
69083-4
|
CT Guidance for biopsy of Abdomen-- WO contrast |
|
37210-2
|
CT Guidance for aspiration of cyst of Abdomen |
|
35913-3
|
CT Guidance for drainage and placement of drainage catheter of Abdomen |
|
89613-4
|
CT Guidance for drainage and placement of drainage catheter of Abdomen-- WO contrast |
|
89615-9
|
CT Guidance for drainage and placement of drainage catheter of Abdomen-- W contrast IV |
|
30602-7
|
CT Guidance for fine needle aspiration of Abdomen |
|
35930-7
|
CT Guidance for nerve block of Abdomen |
|
52790-3
|
CT Guidance for percutaneous replacement of drainage tube of Abdomen |
|
58747-7
|
CT Guidance for ablation of tissue of Unspecified body region |
|
30578-9
|
CT Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region |
|
36767-2
|
CT Guidance for biopsy of Adrenal gland |
|
44108-9
|
CT Guidance for fine needle aspiration of Adrenal gland |
|
89699-3
|
CT Guidance for injection of Ankle - left |
|
89698-5
|
CT Guidance for injection of Ankle - right |
|
35914-1
|
CT Guidance for drainage and placement of drainage catheter of Anus |
|
42280-8
|
CT Guidance for drainage of abscess and placement of drainage catheter of Appendix |
|
35915-8
|
CT Guidance for drainage and placement of drainage catheter of Appendix |
|
25042-3
|
CT Guidance for aspiration or biopsy of Unspecified body region |
|
25041-5
|
CT Guidance for aspiration or biopsy of Unspecified body region-- W contrast IV |
|
36770-6
|
CT Guidance for drainage and placement of drainage catheter of Biliary ducts and Gallbladder |
|
43567-7
|
CT Guidance for deep biopsy of Bone |
|
37211-0
|
CT Guidance for biopsy of Bone marrow |
|
89930-2
|
CT Guidance for radiofrequency ablation of Bone |
|
42265-9
|
CT Guidance for superficial biopsy of Bone |
|
35893-7
|
CT Guidance for biopsy of Breast |
|
44110-5
|
CT Guidance for needle localization of Breast |
|
44118-8
|
CT Guidance for needle localization of Breast-- WO and W contrast IV |
|
35886-1
|
CT Guidance for fluid aspiration of Breast |
|
35928-1
|
CT Guidance for localization of Breast - left |
|
35929-9
|
CT Guidance for localization of Breast - right |
|
25044-9
|
CT Guidance for biopsy of Unspecified body region |
|
42260-0
|
CT Guidance for biopsy of Unspecified body region-- W contrast IV |
|
46290-3
|
CT Guidance for biopsy of Unspecified body region-- WO contrast |
|
46289-5
|
CT Guidance for biopsy of Unspecified body region-- WO and W contrast IV |
|
92921-6
|
CT Guidance for 1 level injection of Cervical and thoracic spine |
|
46365-3
|
CT Guidance for ablation of tissue of Celiac plexus |
|
24623-1
|
CT Guidance for nerve block of Celiac plexus |
|
42281-6
|
CT Guidance for drainage of abscess and placement of drainage catheter of Chest |
|
35895-2
|
CT Guidance for biopsy of Chest |
|
35909-1
|
CT Guidance for biopsy of Chest-- W contrast IV |
|
35911-7
|
CT Guidance for biopsy of Chest-- WO contrast |
|
35910-9
|
CT Guidance for biopsy of Chest-- WO and W contrast IV |
|
35916-6
|
CT Guidance for drainage and placement of drainage catheter of Chest |
|
88317-3
|
CT Guidance for fluid aspiration of Chest |
|
37492-6
|
CT Guidance for biopsy of Chest Pleura |
|
35938-0
|
CT Guidance for placement of tube in Chest |
|
35904-2
|
CT Guidance for biopsy of Cervical spine |
|
75748-4
|
CT Guidance for fluid aspiration of Cervical spine Intervertebral disc |
|
37493-4
|
CT Guidance for injection of Cervical spine Intervertebral disc |
|
42021-6
|
CT Guidance for needle localization of Cervical spine |
|
70921-2
|
CT Guidance for nerve block of Cervical spine |
|
92925-7
|
CT Guidance for injection of Spine cervical and thoracic epidural space |
|
35887-9
|
CT Guidance for aspiration of cyst of Unspecified body region |
|
46281-2
|
CT Guidance for aspiration or injection of cyst of Unspecified body region |
|
87916-3
|
CT Guidance for injection of cyst of Unspecified body region |
|
89932-8
|
CT Guidance for deep placement of needle of Unspecified body region |
|
35922-4
|
CT Guidance for drainage and placement of drainage catheter of Unspecified body region |
|
46292-9
|
CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- W contrast IV |
|
46293-7
|
CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- WO contrast |
|
37212-8
|
CT Guidance for biopsy of Epididymis |
|
30580-5
|
CT Guidance for fine needle aspiration of Unspecified body region |
|
90307-0
|
CT Guidance for injection of Foot joint - right |
|
35917-4
|
CT Guidance for drainage and placement of drainage catheter of Gallbladder |
|
35892-9
|
CT Guidance for biopsy of Head |
|
36928-0
|
CT Guidance for stereotactic biopsy of Head |
|
24585-2
|
CT Guidance for stereotactic biopsy of Head-- W contrast IV |
|
36929-8
|
CT Guidance for stereotactic biopsy of Head-- WO contrast |
|
89955-9
|
CT Guidance for arthrocentesis of Hip - bilateral |
|
89956-7
|
CT Guidance for arthrocentesis of Hip - left |
|
89701-7
|
CT Guidance for injection of Hip - left |
|
89957-5
|
CT Guidance for arthrocentesis of Hip - right |
|
89700-9
|
CT Guidance for injection of Hip - right |
|
42136-2
|
CT Guidance for biopsy of Heart |
|
89929-4
|
CT Guidance for fluid aspiration of Intervertebral disc |
|
89628-2
|
CT Guidance for aspiration of cyst of Ileum - left |
|
89627-4
|
CT Guidance for aspiration of cyst of Ileum - right |
|
24769-2
|
CT Guidance for injection of Joint space |
|
44102-2
|
CT Guidance for procedure of Joint space |
|
30607-6
|
CT Guidance for biopsy of Kidney - bilateral |
|
89604-3
|
CT Guidance for aspiration of cyst of Kidney - bilateral |
|
30608-4
|
CT Guidance for fine needle aspiration of Kidney - bilateral |
|
44228-5
|
CT Guidance for ablation of tissue of Kidney |
|
42285-7
|
CT Guidance for drainage of abscess and placement of drainage catheter of Kidney |
|
92923-2
|
CT Guidance for aspiration of Kidney |
|
42279-0
|
CT Guidance for biopsy of Kidney |
|
89621-7
|
CT Guidance for biopsy of Kidney-- W contrast IV |
|
89614-2
|
CT Guidance for biopsy of Kidney-- WO contrast |
|
89625-8
|
CT Guidance for aspiration of cyst of Kidney |
|
89617-5
|
CT Guidance for aspiration of cyst of Kidney-- W contrast IV |
|
89618-3
|
CT Guidance for aspiration of cyst of Kidney-- WO contrast |
|
35918-2
|
CT Guidance for drainage and placement of drainage catheter of Kidney |
|
43757-4
|
CT Guidance for fine needle aspiration of Kidney |
|
36769-8
|
CT Guidance for exchange of nephrostomy tube of Kidney |
|
36772-2
|
CT Guidance for placement of nephrostomy tube in Kidney |
|
89606-8
|
CT Guidance for ablation of tissue of Kidney - left |
|
89961-7
|
CT Guidance for drainage of abscess and placement of drainage catheter of Kidney - left |
|
92918-2
|
CT Guidance for aspiration of Kidney - left |
|
88325-6
|
CT Guidance for biopsy of Kidney - left |
|
89602-7
|
CT Guidance for aspiration of cyst of Kidney - left |
|
89605-0
|
CT Guidance for ablation of tissue of Kidney - right |
|
89960-9
|
CT Guidance for drainage of abscess and placement of drainage catheter of Kidney - right |
|
92917-4
|
CT Guidance for aspiration of Kidney - right |
|
88323-1
|
CT Guidance for biopsy of Kidney - right |
|
89603-5
|
CT Guidance for aspiration of cyst of Kidney - right |
|
89706-6
|
CT Guidance for injection of Knee - bilateral |
|
82676-8
|
CT Guidance for arthrocentesis of Knee - left |
|
89708-2
|
CT Guidance for injection of Knee - left |
|
82715-4
|
CT Guidance for arthrocentesis of Knee - right |
|
89707-4
|
CT Guidance for injection of Knee - right |
|
35896-0
|
CT Guidance for biopsy of Lower extremity |
|
90317-9
|
CT Guidance for drainage and placement of drainage catheter of Lower extremity - left |
|
90318-7
|
CT Guidance for drainage and placement of drainage catheter of Lower extremity - right |
|
44101-4
|
CT Guidance for ablation of tissue of Liver |
|
42282-4
|
CT Guidance for drainage of abscess and placement of drainage catheter of Liver |
|
24812-0
|
CT Guidance for biopsy of Liver |
|
69092-5
|
CT Guidance for biopsy of Liver-- WO contrast |
|
24813-8
|
CT Guidance for core needle biopsy of Liver |
|
35919-0
|
CT Guidance for drainage and placement of drainage catheter of Liver |
|
30603-5
|
CT Guidance for fine needle aspiration of Liver |
|
24811-2
|
CT Guidance for fluid aspiration of Liver |
|
35901-8
|
CT Guidance for biopsy of Lymph node |
|
35920-8
|
CT Guidance for drainage of Lymph node |
|
44103-0
|
CT Guidance for fine needle aspiration of Lymph node |
|
35905-9
|
CT Guidance for biopsy of Lumbar spine |
|
89928-6
|
CT Guidance for fluid aspiration of Lumbar spine Intervertebral disc |
|
90335-1
|
CT Guidance for injection of Lumbar Spine Facet Joint |
|
92922-4
|
CT Guidance for intrathecal injection of Lumbar spine |
|
42020-8
|
CT Guidance for needle localization of Lumbar spine |
|
35932-3
|
CT Guidance for nerve block of Lumbar spine |
|
35934-9
|
CT Guidance for percutaneous vertebroplasty of Lumbar spine |
|
92928-1
|
CT Guidance for injection of Spine lumbar and Sacrum epidural space |
|
92920-8
|
CT Guidance for 1 level injection of Spine Lumbar and Sacrum |
|
92919-0
|
CT Guidance for 2 levels injection of Spine Lumbar and Sacrum |
|
24823-7
|
CT Guidance for biopsy of Lung |
|
30595-3
|
CT Guidance for fine needle aspiration of Lung |
|
24822-9
|
CT Guidance for fluid aspiration of Lung |
|
89962-5
|
CT Guidance for radiofrequency ablation of Lung |
|
89720-7
|
CT Guidance for drainage of abscess and placement of drainage catheter of Lung - left |
|
88324-9
|
CT Guidance for biopsy of Lung - left |
|
89629-0
|
CT Guidance for aspiration of cyst of Lung - left |
|
90319-5
|
CT Guidance for drainage and placement of drainage catheter of Lung - left |
|
89608-4
|
CT Guidance for fluid aspiration of Lung - left |
|
89719-9
|
CT Guidance for drainage of abscess and placement of drainage catheter of Lung - right |
|
88526-9
|
CT Guidance for biopsy of Lung - right |
|
89630-8
|
CT Guidance for aspiration of cyst of Lung - right |
|
90309-6
|
CT Guidance for drainage and placement of drainage catheter of Lung - right |
|
89607-6
|
CT Guidance for fluid aspiration of Lung - right |
|
36927-2
|
CT Guidance for biopsy of Maxillofacial region |
|
37213-6
|
CT Guidance for biopsy of Mediastinum |
|
44104-8
|
CT Guidance for fine needle aspiration of Mediastinum |
|
36768-0
|
CT Guidance for percutaneous biopsy of Muscle |
|
44109-7
|
CT Guidance for deep biopsy of Muscle |
|
44105-5
|
CT Guidance for fine needle aspiration of Muscle |
|
90336-9
|
CT Guidance for injection of Muscle |
|
89828-8
|
CT Guidance for superficial biopsy of Muscle |
|
24838-5
|
CT Guidance for biopsy of Neck |
|
24837-7
|
CT Guidance for fluid aspiration of Neck |
|
39026-0
|
CT Guidance for needle localization of Unspecified body region |
|
82681-8
|
CT Guidance for biopsy of Oral tissue |
|
30604-3
|
CT Guidance for biopsy of Pancreas |
|
89619-1
|
CT Guidance for biopsy of Pancreas-- W contrast IV |
|
89616-7
|
CT Guidance for aspiration of cyst of Pancreas-- WO contrast |
|
42283-2
|
CT Guidance for drainage and placement of drainage catheter of Pancreas |
|
30605-0
|
CT Guidance for fine needle aspiration of Pancreas |
|
24856-7
|
CT Guidance for fluid aspiration of Pancreas |
|
89697-7
|
CT Guidance for drainage of pseudocyst and placement of drainage catheter of Pancreas |
|
43444-9
|
CT Guidance for percutaneous drainage of abscess and placement of drainage catheter of Unspecified body region |
|
90311-2
|
CT Guidance for percutaneous replacement of drainage tube of Unspecified body region |
|
92567-7
|
CT Guidance for percutaneous drainage and placement of drainage catheter of Unspecified body region |
|
25043-1
|
CT Guidance for fluid aspiration of Unspecified body region |
|
89695-1
|
CT Guidance for drainage and placement of drainage catheter of Pelvis-- WO contrast |
|
89696-9
|
CT Guidance for drainage and placement of drainage catheter of Pelvis-- W contrast IV |
|
42286-5
|
CT Guidance for drainage of abscess and placement of drainage catheter of Pelvis |
|
24864-1
|
CT Guidance for biopsy of Pelvis |
|
69093-3
|
CT Guidance for biopsy of Pelvis-- W contrast IV |
|
69094-1
|
CT Guidance for biopsy of Pelvis-- WO contrast |
|
89958-3
|
CT Guidance for cryoablation of Pelvis |
|
35921-6
|
CT Guidance for drainage and placement of drainage catheter of Pelvis |
|
30606-8
|
CT Guidance for fine needle aspiration of Pelvis |
|
35931-5
|
CT Guidance for nerve block of Pelvis |
|
52791-1
|
CT Guidance for percutaneous replacement of drainage tube of Pelvis |
|
24863-3
|
CT Guidance for fluid aspiration of Pelvis |
|
89859-3
|
CT Guidance for transrectal drainage of abscess of Pelvis |
|
89609-2
|
CT Guidance for fluid aspiration of Pericardial space |
|
89931-0
|
CT Guidance for drainage and placement of drainage catheter of Perirectal region |
|
89854-4
|
CT Guidance for drainage of abscess and placement of drainage catheter of Perirenal space - left |
|
89855-1
|
CT Guidance for drainage of abscess and placement of drainage catheter of Perirenal space - right |
|
89624-1
|
CT Guidance for drainage of abscess and placement of drainage catheter of Peritoneal space |
|
89623-3
|
CT Guidance for drainage and placement of drainage catheter of Peritoneal space |
|
89610-0
|
CT Guidance for placement of catheter in Peritoneal space |
|
89622-5
|
CT Guidance for fluid aspiration of Peritoneal space |
|
42284-0
|
CT Guidance for drainage of abscess and placement of chest tube of Pleural space |
|
37491-8
|
CT Guidance for fluid aspiration of Pleural space |
|
75746-8
|
CT Guidance for drainage of abscess and placement of chest tube of Pleural space - bilateral |
|
90050-6
|
CT Guidance for placement of chest tube in Pleural space - bilateral |
|
92569-3
|
CT Guidance for drainage and placement of chest tube of Pleural space - bilateral |
|
75752-6
|
CT Guidance for drainage of abscess and placement of chest tube of Pleural space - left |
|
90049-8
|
CT Guidance for placement of chest tube in Pleural space - left |
|
89612-6
|
CT Guidance for fluid aspiration of Pleural space - left |
|
75818-5
|
CT Guidance for drainage of abscess and placement of chest tube of Pleural space - right |
|
90051-4
|
CT Guidance for placement of chest tube in Pleural space - right |
|
92571-9
|
CT Guidance for drainage and placement of chest tube of Pleural space - right |
|
89611-8
|
CT Guidance for fluid aspiration of Pleural space - right |
|
89858-5
|
CT Guidance for biopsy of Pleura - left |
|
89857-7
|
CT Guidance for biopsy of Pleura - right |
|
35903-4
|
CT Guidance for biopsy of Prostate |
|
44106-3
|
CT Guidance for FNA of Prostate |
|
25053-0
|
CT Guidance for radiosurgery of Unspecified body region |
|
25054-8
|
CT Guidance for radiosurgery of Unspecified body region-- W contrast IV |
|
89721-5
|
CT Guidance for drainage of abscess and placement of drainage catheter of Retroperitoneum |
|
90314-6
|
CT Guidance for drainage and placement of drainage catheter of Retroperitoneum-- W contrast IV |
|
90310-4
|
CT Guidance for drainage and placement of drainage catheter of Retroperitoneum-- WO contrast |
|
92916-6
|
CT Guidance for aspiration of Retroperitoneum |
|
44117-0
|
CT Guidance for biopsy of Retroperitoneum |
|
89830-4
|
CT Guidance for biopsy of Retroperitoneum-- W contrast IV |
|
89829-6
|
CT Guidance for biopsy of Retroperitoneum-- WO contrast |
|
44107-1
|
CT Guidance for fine needle aspiration of Retroperitoneum |
|
79072-5
|
CT Guidance for radiation treatment of Unspecified body region |
|
35937-2
|
CT Guidance for placement of radiation therapy fields in Unspecified body region |
|
30581-3
|
CT Guidance for radiation treatment of Unspecified body region-- W contrast IV |
|
30582-1
|
CT Guidance for radiation treatment of Unspecified body region-- WO contrast |
|
92926-5
|
CT Guidance for radiation treatment of Unspecified body region-- WO and W contrast IV |
|
35898-6
|
CT Guidance for biopsy of Salivary gland |
|
89702-5
|
CT Guidance for injection of Shoulder - bilateral |
|
89954-2
|
CT Guidance for arthrocentesis of Shoulder - left |
|
89703-3
|
CT Guidance for injection of Shoulder - left |
|
89953-4
|
CT Guidance for arthrocentesis of Shoulder - right |
|
89704-1
|
CT Guidance for injection of Shoulder - right |
|
24901-1
|
CT Guidance for injection of Sacroiliac Joint |
|
26319-4
|
CT Guidance for injection of Sacroiliac joint - bilateral |
|
26320-2
|
CT Guidance for injection of Sacroiliac joint - left |
|
89952-6
|
CT Guidance for arthrocentesis of Sacroiliac joint - right |
|
26321-0
|
CT Guidance for injection of Sacroiliac joint - right |
|
89959-1
|
CT Guidance for biopsy of Soft tissue |
|
90315-3
|
CT Guidance for deep biopsy of Soft tissue |
|
90316-1
|
CT Guidance for superficial biopsy of Soft tissue |
|
88316-5
|
CT Guidance for biopsy of Spinal cord |
|
24986-2
|
CT Guidance for biopsy of Spine |
|
30579-7
|
CT Guidance for injection of Spine facet joint |
|
89711-6
|
CT Guidance for 1 level injection of Spine facet joint |
|
89710-8
|
CT Guidance for 2 levels injection of Spine facet joint |
|
89709-0
|
CT Guidance for greater than 2 levels for injection of Spine facet joint |
|
42688-2
|
CT Guidance for nerve block of Spine |
|
35933-1
|
CT Guidance for percutaneous vertebroplasty of Spine |
|
30609-2
|
CT Guidance for biopsy of Spleen |
|
30610-0
|
CT Guidance for fine needle aspiration of Spleen |
|
89839-5
|
CT Guidance for biopsy of Sternum |
|
88321-5
|
CT Guidance for stereotactic localization of Unspecified body region |
|
89718-1
|
CT Guidance for stereotactic localization of Unspecified body region-- W contrast IV |
|
89856-9
|
CT Guidance for stereotactic localization of Unspecified body region-- WO contrast |
|
89717-3
|
CT Guidance for stereotactic localization of Unspecified body region-- WO and W contrast IV |
|
89831-2
|
CT Guidance for drainage and placement of drainage catheter of Subphrenic space |
|
90372-4
|
CT Guidance for injection of Tendon |
|
90373-2
|
CT Guidance for injection of Tendon or ligament |
|
35908-3
|
CT Guidance for biopsy of Thyroid gland |
|
89832-0
|
CT Guidance for deep biopsy of Tissue |
|
37214-4
|
CT Guidance for superficial biopsy of Tissue |
|
35906-7
|
CT Guidance for biopsy of Thoracic spine |
|
90334-4
|
CT Guidance for injection of Spine Thoracic Facet Joint |
|
90308-8
|
CT Guidance for needle localization of Thoracic spine |
|
70922-0
|
CT Guidance for nerve block of Thoracic spine |
|
35935-6
|
CT Guidance for percutaneous vertebroplasty of Thoracic spine |
|
35897-8
|
CT Guidance for biopsy of Upper extremity |
|
42701-3
|
CT Guidance for localization of placenta of Uterus |
|
89705-8
|
CT Guidance for injection of Wrist - left |
|
36002-4
|
CT Hand |
|
36191-5
|
CT Hand W contrast IV |
|
36477-8
|
CT Hand WO contrast |
|
36352-3
|
CT Hand WO and W contrast IV |
|
36004-0
|
CT Hand - bilateral |
|
86968-5
|
CT Hand - bilateral W contrast IV |
|
36005-7
|
CT Hand - left |
|
36193-1
|
CT Hand - left W contrast IV |
|
36478-6
|
CT Hand - left WO contrast |
|
36353-1
|
CT Hand - left WO and W contrast IV |
|
36007-3
|
CT Hand - right |
|
36195-6
|
CT Hand - right W contrast IV |
|
36480-2
|
CT Hand - right WO contrast |
|
36355-6
|
CT Hand - right WO and W contrast IV |
|
24725-4
|
CT Head |
|
88327-2
|
CT Head W contrast IV and CT angiogram Head and neck vessels W contrast IV |
|
36087-5
|
CT Head limited |
|
36104-8
|
CT Head limited WO contrast |
|
83296-4
|
CT Head W contrast IV and CT Orbit - bilateral WO and W contrast IV |
|
24727-0
|
CT Head W contrast IV |
|
46328-1
|
CT Head W reduced contrast volume IV |
|
30799-1
|
CT Head WO contrast |
|
82804-6
|
CT Head WO and W contrast IV and CT Neck W contrast IV |
|
82742-8
|
CT Head WO and W contrast IV and CT Orbit - bilateral W contrast IV |
|
82802-0
|
CT Head WO and W contrast IV and CT Sinuses W contrast IV |
|
82803-8
|
CT Head WO and W contrast IV and CT Temporal bone W contrast IV |
|
24726-2
|
CT Head WO and W contrast IV |
|
46316-6
|
CT Head WO and W reduced contrast volume IV |
|
90352-6
|
CT Head and CT Brain for perfusion and CT angiogram Head vessels WO and W contrast IV |
|
92025-6
|
CT Head and Cervical spine W contrast IV |
|
82690-9
|
CT Head and Cervical spine WO contrast |
|
93603-9
|
CT Head and Cervical spine WO and W contrast IV |
|
83307-9
|
CT Head and Mandible WO contrast |
|
87908-0
|
CT Head and Maxillofacial region W contrast IV |
|
83306-1
|
CT Head and Maxillofacial region WO contrast |
|
87911-4
|
CT Head and Maxillofacial region WO and W contrast IV |
|
86991-7
|
CT Head and Maxillofacial region and Cervical spine WO contrast |
|
82691-7
|
CT Head and Neck W contrast IV |
|
82692-5
|
CT Head and Neck WO contrast |
|
86972-7
|
CT Head and Neck WO and W contrast IV |
|
86989-1
|
CT Head and Orbit - bilateral W contrast IV |
|
86990-9
|
CT Head and Orbit - bilateral WO contrast |
|
89845-2
|
CT Head and Orbit - bilateral WO and W contrast IV |
|
87897-5
|
CT Head and Pituitary and Sella turcica W contrast IV |
|
86978-4
|
CT Head and Sinuses W contrast IV |
|
86992-5
|
CT Head and Sinuses WO contrast |
|
87910-6
|
CT Head and Sinuses WO and W contrast IV |
|
86977-6
|
CT Head and Temporal bone W contrast IV |
|
83302-0
|
CT Head and Temporal bone WO contrast |
|
89844-5
|
CT Head and Temporal bone WO and W contrast IV |
|
77448-9
|
CT Hindfoot and Midfoot |
|
77456-2
|
CT Hindfoot and Midfoot W contrast IV |
|
77458-8
|
CT Hindfoot and Midfoot WO contrast |
|
77457-0
|
CT Hindfoot and Midfoot WO and W contrast IV |
|
77466-1
|
CT Hindfoot - left and Midfoot - left W contrast IV |
|
77470-3
|
CT Hindfoot - left and Midfoot - left WO contrast |
|
77468-7
|
CT Hindfoot - left and Midfoot - left WO and W contrast IV |
|
77467-9
|
CT Hindfoot - right and Midfoot - right W contrast IV |
|
77471-1
|
CT Hindfoot - right and Midfoot - right WO contrast |
|
77469-5
|
CT Hindfoot - right and Midfoot - right WO and W contrast IV |
|
36014-9
|
CT Hip |
|
36092-5
|
CT Hip limited |
|
36200-4
|
CT Hip W contrast IV |
|
36484-4
|
CT Hip WO contrast |
|
36359-8
|
CT Hip WO and W contrast IV |
|
36016-4
|
CT Hip - bilateral |
|
36201-2
|
CT Hip - bilateral W contrast IV |
|
36485-1
|
CT Hip - bilateral WO contrast |
|
36360-6
|
CT Hip - bilateral WO and W contrast IV |
|
36018-0
|
CT Hip - left |
|
69105-5
|
CT Hip - left Arthrogram |
|
36203-8
|
CT Hip - left W contrast IV |
|
36487-7
|
CT Hip - left WO contrast |
|
36362-2
|
CT Hip - left WO and W contrast IV |
|
36021-4
|
CT Hip - right |
|
69112-1
|
CT Hip - right Arthrogram |
|
36205-3
|
CT Hip - right W contrast IV |
|
36489-3
|
CT Hip - right WO contrast |
|
36364-8
|
CT Hip - right WO and W contrast IV |
|
58744-4
|
CT Heart |
|
86956-0
|
CT Heart WO contrast IV and CT Heart for left ventricular function W contrast IV |
|
36934-8
|
CT Heart for calcium scoring |
|
36935-5
|
CT Heart for calcium scoring W contrast IV |
|
79088-1
|
CT Heart for congenital disease W contrast IV |
|
86975-0
|
CT Heart for left ventricular function W contrast IV |
|
79089-9
|
CT Heart W contrast IV |
|
89927-8
|
CT Heart and aortic root WO contrast for calcium scoring + CTA W contrast IV |
|
83289-9
|
CT for calcium scoring WO contrast and CTA W contrast IV Heart and coronary arteries |
|
79087-3
|
CT Heart and Coronary arteries for calcium scoring WO contrast |
|
35958-8
|
CT Internal auditory canal |
|
30583-9
|
CT Internal auditory canal W contrast IV |
|
46325-7
|
CT Internal auditory canal W reduced contrast volume IV |
|
30584-7
|
CT Internal auditory canal WO contrast |
|
36282-2
|
CT Internal auditory canal WO and W contrast IV |
|
46314-1
|
CT Internal auditory canal WO and W reduced contrast volume IV |
|
35957-0
|
CT Internal auditory canal - left |
|
38767-0
|
CT Internal auditory canal - right |
|
36811-8
|
CT Joint Arthrogram |
|
43767-3
|
CT Kidney - bilateral |
|
43766-5
|
CT Kidney - bilateral W contrast IV |
|
36503-1
|
CT Kidney - bilateral WO contrast |
|
36377-0
|
CT Kidney - bilateral WO and W contrast IV |
|
79074-1
|
CT Kidney and Ureter and Urinary bladder 3D post processing WO and W contrast IV |
|
87866-0
|
CT Kidney and Ureter and Urinary bladder WO and W contrast IV |
|
46322-4
|
CT Kidney W contrast IV |
|
43770-7
|
CT Kidney WO contrast |
|
43768-1
|
CT Kidney WO and W contrast IV |
|
69113-9
|
CT Kidney - right |
|
36037-0
|
CT Knee |
|
36124-6
|
CT Knee Arthrogram |
|
36222-8
|
CT Knee W contrast IV |
|
36505-6
|
CT Knee WO contrast |
|
36379-6
|
CT Knee WO and W contrast IV |
|
36040-4
|
CT Knee - bilateral |
|
87878-5
|
CT Knee - bilateral Arthrogram |
|
69088-3
|
CT Knee - bilateral W contrast IV |
|
69089-1
|
CT Knee - bilateral WO contrast |
|
36041-2
|
CT Knee - left |
|
69106-3
|
CT Knee - left Arthrogram |
|
36225-1
|
CT Knee - left W contrast IV |
|
36507-2
|
CT Knee - left WO contrast |
|
36380-4
|
CT Knee - left WO and W contrast IV |
|
36043-8
|
CT Knee - right |
|
69114-7
|
CT Knee - right Arthrogram |
|
36227-7
|
CT Knee - right W contrast IV |
|
36509-8
|
CT Knee - right WO contrast |
|
36381-2
|
CT Knee - right WO and W contrast IV |
|
36229-3
|
CT Larynx W contrast IV |
|
36511-4
|
CT Larynx WO contrast |
|
35971-1
|
CT Lower extremity |
|
37238-3
|
CT Lower Extremity Joint Arthrogram |
|
89716-5
|
CT Lower extremity joint - left Arthrogram |
|
89715-7
|
CT Lower extremity joint - right Arthrogram |
|
36106-3
|
CT Lower extremity limited WO contrast |
|
30624-1
|
CT Lower extremity W contrast IV |
|
30625-8
|
CT Lower extremity WO contrast |
|
36288-9
|
CT Lower extremity WO and W contrast IV |
|
35973-7
|
CT Lower extremity - bilateral |
|
50755-8
|
CT Lower extremity - bilateral W contrast IV |
|
36449-7
|
CT Lower extremity - bilateral WO contrast |
|
82694-1
|
CT Lower extremity - bilateral WO and W contrast IV |
|
35976-0
|
CT Lower extremity - left |
|
36164-2
|
CT Lower extremity - left W contrast IV |
|
36452-1
|
CT Lower extremity - left WO contrast |
|
36290-5
|
CT Lower extremity - left WO and W contrast IV |
|
35979-4
|
CT Lower extremity - right |
|
36166-7
|
CT Lower extremity - right W contrast IV |
|
36454-7
|
CT Lower extremity - right WO contrast |
|
36292-1
|
CT Lower extremity - right WO and W contrast IV |
|
24814-6
|
CT Liver |
|
46393-5
|
CT Liver W Xe-133 IH |
|
24815-3
|
CT Liver W contrast IV |
|
30611-8
|
CT Liver WO contrast |
|
30612-6
|
CT Liver WO and W contrast IV |
|
36074-3
|
CT Lower leg |
|
36258-2
|
CT Lower leg W contrast IV |
|
36537-9
|
CT Lower leg WO contrast |
|
36408-3
|
CT Lower leg WO and W contrast IV |
|
87879-3
|
CT Lower leg - bilateral WO contrast |
|
87882-7
|
CT Lower leg - left |
|
36260-8
|
CT Lower leg - left W contrast IV |
|
36538-7
|
CT Lower leg - left WO contrast |
|
36409-1
|
CT Lower leg - left WO and W contrast IV |
|
36262-4
|
CT Lower leg - right W contrast IV |
|
36540-3
|
CT Lower leg - right WO contrast |
|
36411-7
|
CT Lower leg - right WO and W contrast IV |
|
37232-6
|
CT Spine lumbosacral junction |
|
37288-8
|
CT Spine lumbosacral junction WO contrast |
|
24963-1
|
CT Lumbar spine |
|
87867-8
|
CT Lumbar spine by reconstruction |
|
79080-8
|
CT Lumbar spine by reconstruction W contrast IV |
|
79081-6
|
CT Lumbar spine by reconstruction WO contrast |
|
87868-6
|
CT Lumbar spine by reconstruction WO and W contrast IV |
|
36110-5
|
CT Lumbar spine limited WO contrast |
|
37509-7
|
CT Lumbar spine W contrast intradisc |
|
24965-6
|
CT Lumbar spine W contrast IT |
|
24964-9
|
CT Lumbar spine W contrast IV |
|
30620-9
|
CT Lumbar spine WO contrast |
|
44114-7
|
CT Lumbar spine WO and W contrast IT |
|
36402-6
|
CT Lumbar spine WO and W contrast IV |
|
82696-6
|
CT Spine Lumbar and Sacrum W contrast IV |
|
82697-4
|
CT Spine Lumbar and Sacrum WO contrast |
|
89827-0
|
CT Spine Lumbar and Sacrum WO and W contrast IV |
|
25039-9
|
CT Unspecified body region limited |
|
89840-3
|
CT Lumbosacral plexus WO contrast |
|
37439-7
|
CT Lung parenchyma |
|
37440-5
|
CT Lung parenchyma W contrast IV |
|
37441-3
|
CT Lung parenchyma WO contrast |
|
87873-6
|
CT Lung parenchyma WO and W contrast IV |
|
36047-9
|
CT Mandible |
|
44116-2
|
CT Mandible limited |
|
36232-7
|
CT Mandible W contrast IV |
|
36512-2
|
CT Mandible WO contrast |
|
36383-8
|
CT Mandible WO and W contrast IV |
|
87900-7
|
CT Mastoid W contrast IV |
|
46298-6
|
CT Mastoid - bilateral |
|
36049-5
|
CT Maxilla and Mandible |
|
36050-3
|
CT Maxilla |
|
41808-7
|
CT Maxillofacial region |
|
36937-1
|
CT Maxillofacial region limited |
|
36938-9
|
CT Maxillofacial region limited WO contrast |
|
30801-5
|
CT Maxillofacial region W contrast IV |
|
46326-5
|
CT Maxillofacial region W reduced contrast volume IV |
|
30802-3
|
CT Maxillofacial region WO contrast |
|
30803-1
|
CT Maxillofacial region WO and W contrast IV |
|
46315-8
|
CT Maxillofacial region WO and W reduced contrast volume IV |
|
87906-4
|
CT Maxillofacial region - right W contrast IV |
|
87874-4
|
CT Mediastinum W contrast IV |
|
89848-6
|
CT Midfoot - right WO and W contrast IV |
|
89846-0
|
CT Midfoot - left and Forefoot - left WO and W contrast IV |
|
89847-8
|
CT Midfoot - right and Forefoot - right |
|
48446-9
|
CT Nasopharynx W contrast IV |
|
48443-6
|
CT Nasopharynx WO and W contrast IV |
|
24835-1
|
CT Nasopharynx and Neck |
|
24836-9
|
CT Nasopharynx and Neck W contrast IV |
|
30585-4
|
CT Nasopharynx and Neck WO contrast |
|
36051-1
|
CT Neck |
|
88320-7
|
CT Neck W contrast IV and CT angiogram Head and neck vessels W contrast IV |
|
36235-0
|
CT Neck W contrast IV |
|
36514-8
|
CT Neck WO contrast |
|
30586-2
|
CT Neck WO and W contrast IV |
|
86986-7
|
CT Neck and Chest W contrast IV |
|
87877-7
|
CT Neck and Chest WO contrast |
|
86958-6
|
CT Neck and Chest WO and W contrast IV |
|
89283-6
|
CT Neck+Chest+Abdomen+Pelvis W contrast IV |
|
83295-6
|
CT Neck and Superior mediastinum W contrast IV |
|
83308-7
|
CT Neck and Superior mediastinum WO contrast |
|
83301-2
|
CT Neck and Superior mediastinum WO and W contrast IV |
|
41807-9
|
CT Orbit |
|
48449-3
|
CT Orbit W contrast IV |
|
46331-5
|
CT Orbit WO contrast |
|
48451-9
|
CT Orbit WO and W contrast IV |
|
46320-8
|
CT Orbit and Face W contrast IV |
|
86988-3
|
CT Orbit and Face WO contrast |
|
24848-4
|
CT Orbit - bilateral |
|
24850-0
|
CT Orbit - bilateral W contrast IV |
|
30587-0
|
CT Orbit - bilateral WO contrast |
|
24849-2
|
CT Orbit - bilateral WO and W contrast IV |
|
79093-1
|
CT Unspecified body region 3D post processing |
|
72251-2
|
CT Pulmonary arteries for pulmonary embolus |
|
24857-5
|
CT Pancreas |
|
24858-3
|
CT Pancreas W contrast IV |
|
30613-4
|
CT Pancreas WO contrast |
|
30614-2
|
CT Pancreas WO and W contrast IV |
|
87918-9
|
CT Parathyroid gland WO and W contrast IV |
|
37223-5
|
CT Parotid gland |
|
37240-9
|
CT Parotid gland W contrast IV |
|
37280-5
|
CT Parotid gland WO contrast |
|
46311-7
|
CT Parotid gland WO and W contrast IV |
|
24865-8
|
CT Pelvis |
|
86979-2
|
CT Pelvis and Hip - bilateral WO contrast |
|
87919-7
|
CT Pelvis bones |
|
87920-5
|
CT Pelvis bones W contrast IV |
|
87917-1
|
CT Pelvis bones WO contrast |
|
87914-8
|
CT Pelvis bones WO and W contrast IV |
|
87913-0
|
CT Pelvis by reconstruction |
|
79075-8
|
CT Pelvis by reconstruction W contrast IV |
|
79076-6
|
CT Pelvis by reconstruction WO contrast |
|
36098-2
|
CT Pelvis limited W contrast IV |
|
36108-9
|
CT Pelvis limited WO contrast |
|
79099-8
|
CT Pelvis 3D post processing WO contrast |
|
39046-8
|
CT Pelvis limited for pelvimetry WO contrast |
|
24866-6
|
CT Pelvis W contrast IV |
|
46329-9
|
CT Pelvis W reduced contrast volume IV |
|
30615-9
|
CT Pelvis WO contrast |
|
30616-7
|
CT Pelvis WO and W contrast IV |
|
46313-3
|
CT Pelvis WO and W reduced contrast volume IV |
|
82693-3
|
CT Pelvis and Lower extremity W contrast IV |
|
82695-8
|
CT Pelvis and Lower extremity - bilateral W contrast IV |
|
89925-2
|
CT Pelvis and Lower extremity - bilateral WO and W contrast IV |
|
24877-3
|
CT Petrous part of temporal bone |
|
24878-1
|
CT Petrous part of temporal bone W contrast IV |
|
30589-6
|
CT Petrous part of temporal bone WO contrast |
|
36835-7
|
CT Petrous part of temporal bone WO and W contrast IV |
|
36932-2
|
CT Pituitary and Sella turcica |
|
30590-4
|
CT Pituitary and Sella turcica W contrast IV |
|
30591-2
|
CT Pituitary and Sella turcica WO contrast |
|
24904-5
|
CT Pituitary and Sella turcica WO and W contrast IV |
|
91719-5
|
CT Unspecified body region Post mortem |
|
36055-2
|
CT Posterior fossa |
|
36242-6
|
CT Posterior fossa W contrast IV |
|
36517-1
|
CT Posterior fossa WO contrast |
|
36387-9
|
CT Posterior fossa WO and W contrast IV |
|
36057-8
|
CT Prostate |
|
43445-6
|
CT Pulmonary system |
|
42394-7
|
CT Pulmonary system W Xe-133 IH |
|
24566-2
|
CT Retroperitoneum |
|
42291-5
|
CT Retroperitoneum WO contrast |
|
48743-9
|
CT Retroperitoneum WO and W contrast IV |
|
82698-2
|
CT Ribs - left W contrast IV |
|
82699-0
|
CT Ribs - left WO contrast |
|
82717-0
|
CT Ribs - left WO and W contrast IV |
|
82700-6
|
CT Ribs - right W contrast IV |
|
82701-4
|
CT Ribs - right WO contrast |
|
82702-2
|
CT Ribs - right WO and W contrast IV |
|
36058-6
|
CT Sacrum |
|
36245-9
|
CT Sacrum W contrast IV |
|
36520-5
|
CT Sacrum WO contrast |
|
36390-3
|
CT Sacrum WO and W contrast IV |
|
69116-2
|
CT Sacrum and Coccyx |
|
82704-8
|
CT Sacrum and Coccyx W contrast IV |
|
86970-1
|
CT Sacrum and Coccyx WO contrast |
|
82703-0
|
CT Sacrum and Coccyx WO and W contrast IV |
|
36941-3
|
CT Salivary gland W contrast intra salivary duct |
|
86966-9
|
CT Salivary gland WO contrast |
|
86957-8
|
CT Salivary gland WO and W contrast IV |
|
82689-1
|
CT Small bowel W contrast PO and WO and W contrast IV |
|
72250-4
|
CT Small bowel W contrast PO and W contrast IV |
|
30600-1
|
CT Small bowel W positive contrast via enteroclysis tube |
|
37225-0
|
CT Sternoclavicular Joint |
|
37242-5
|
CT Sternoclavicular Joint W contrast IV |
|
37282-1
|
CT Sternoclavicular Joint WO contrast |
|
37266-4
|
CT Sternoclavicular Joint WO and W contrast IV |
|
69117-0
|
CT Scapula |
|
83292-3
|
CT Scapula W contrast |
|
69118-8
|
CT Scapula WO contrast |
|
83300-4
|
CT Scapula - bilateral WO and W contrast IV |
|
82705-5
|
CT Scapula - left WO contrast |
|
82707-1
|
CT Scapula - left WO and W contrast IV |
|
82706-3
|
CT Scapula - right WO contrast |
|
82718-8
|
CT Scapula - right WO and W contrast IV |
|
36062-8
|
CT Shoulder |
|
36128-7
|
CT Shoulder Arthrogram |
|
36250-9
|
CT Shoulder W contrast IV |
|
36524-7
|
CT Shoulder WO contrast |
|
36395-2
|
CT Shoulder WO and W contrast IV |
|
36063-6
|
CT Shoulder - bilateral |
|
87884-3
|
CT Shoulder - bilateral Arthrogram |
|
86969-3
|
CT Shoulder - bilateral W contrast IV |
|
69090-9
|
CT Shoulder - bilateral WO contrast |
|
36064-4
|
CT Shoulder - left |
|
38828-0
|
CT Shoulder - left Arthrogram |
|
36252-5
|
CT Shoulder - left W contrast IV |
|
36526-2
|
CT Shoulder - left WO contrast |
|
36396-0
|
CT Shoulder - left WO and W contrast IV |
|
36066-9
|
CT Shoulder - right |
|
36131-1
|
CT Shoulder - right Arthrogram |
|
36253-3
|
CT Shoulder - right W contrast IV |
|
36527-0
|
CT Shoulder - right WO contrast |
|
36397-8
|
CT Shoulder - right WO and W contrast IV |
|
30619-1
|
CT Sacroiliac Joint |
|
36123-8
|
CT Sacroiliac Joint Arthrogram |
|
36217-8
|
CT Sacroiliac Joint W contrast IV |
|
36501-5
|
CT Sacroiliac Joint WO contrast |
|
36375-4
|
CT Sacroiliac Joint WO and W contrast IV |
|
37237-5
|
CT Sinus tract W contrast intra sinus tract |
|
30588-8
|
CT Sinuses |
|
24913-6
|
CT Sinuses limited |
|
46304-2
|
CT Sinuses limited WO contrast |
|
36255-8
|
CT Sinuses W contrast IV |
|
36529-6
|
CT Sinuses WO contrast |
|
36398-6
|
CT Sinuses WO and W contrast IV |
|
83309-5
|
CT Sinuses and Mandible WO contrast |
|
87912-2
|
CT Sinuses and Orbit WO contrast |
|
37495-9
|
CT Skull base |
|
44112-1
|
CT Skull base WO contrast |
|
44111-3
|
CT Skull base WO and W contrast IV |
|
28566-8
|
CT Spine |
|
39322-3
|
CT Spine W contrast intradisc |
|
47985-7
|
CT Spine W contrast IT |
|
24987-0
|
CT Spine W contrast IV |
|
36530-4
|
CT Spine WO contrast |
|
48442-8
|
CT Spine WO and W contrast IT |
|
36399-4
|
CT Spine WO and W contrast IV |
|
24988-8
|
CT Spleen |
|
30622-5
|
CT Spleen W contrast IV |
|
30621-7
|
CT Spleen WO contrast |
|
24989-6
|
CT Spleen WO and W contrast IV |
|
36071-9
|
CT Sternum |
|
36257-4
|
CT Sternum W contrast IV |
|
36534-6
|
CT Sternum WO contrast |
|
36405-9
|
CT Sternum WO and W contrast IV |
|
83294-9
|
CT Thoracic and lumbar spine W contrast IV |
|
83310-3
|
CT Thoracic and lumbar spine WO contrast |
|
86974-3
|
CT Thoracic and lumbar spine WO and W contrast IV |
|
24544-9
|
CT Thoracic Aorta |
|
35945-5
|
CT Thoracic and abdominal aorta |
|
36142-8
|
CT Thoracic and abdominal aorta W contrast IV |
|
36430-7
|
CT Thoracic and abdominal aorta WO contrast |
|
87861-1
|
CT Thoracic and abdominal aorta WO and W contrast IV |
|
24545-6
|
CT Thoracic Aorta W contrast IV |
|
87860-3
|
CT Thoracic Aorta WO contrast |
|
87859-5
|
CT Thoracic Aorta WO and W contrast IV |
|
79095-6
|
CT Teeth |
|
87896-7
|
CT Teeth W contrast IV |
|
87899-1
|
CT Teeth.mandible WO contrast |
|
87898-3
|
CT Teeth.maxilla WO contrast |
|
36773-0
|
CT Temporal bone |
|
79083-2
|
CT Temporal bone by reconstruction W contrast IV |
|
79084-0
|
CT Temporal bone by reconstruction WO contrast |
|
36815-9
|
CT Temporal bone W contrast IV |
|
36866-2
|
CT Temporal bone WO contrast |
|
36837-3
|
CT Temporal bone WO and W contrast IV |
|
87902-3
|
CT Temporal bone - bilateral W contrast IV |
|
87903-1
|
CT Temporal bone - bilateral WO contrast |
|
87901-5
|
CT Temporal bone - bilateral WO and W contrast IV |
|
38835-5
|
CT Temporal bone - left W contrast IV |
|
36867-0
|
CT Temporal bone - left WO contrast |
|
89837-9
|
CT Temporal bone - left WO and W contrast IV |
|
36816-7
|
CT Temporal bone - right W contrast IV |
|
36868-8
|
CT Temporal bone - right WO contrast |
|
89838-7
|
CT Temporal bone - right WO and W contrast IV |
|
35984-4
|
CT Thigh |
|
36172-5
|
CT Thigh W contrast IV |
|
36460-4
|
CT Thigh WO contrast |
|
36338-2
|
CT Thigh WO and W contrast IV |
|
87880-1
|
CT Thigh - bilateral W contrast IV |
|
87881-9
|
CT Thigh - bilateral WO contrast |
|
35987-7
|
CT Thigh - left |
|
36174-1
|
CT Thigh - left W contrast IV |
|
36462-0
|
CT Thigh - left WO contrast |
|
36339-0
|
CT Thigh - left WO and W contrast IV |
|
35989-3
|
CT Thigh - right |
|
36176-6
|
CT Thigh - right W contrast IV |
|
36464-6
|
CT Thigh - right WO contrast |
|
36340-8
|
CT Thigh - right WO and W contrast IV |
|
83291-5
|
CT Thumb WO contrast |
|
87889-2
|
CT Thumb - left WO contrast |
|
87894-2
|
CT Thumb - right WO contrast |
|
87876-9
|
CT Thymus gland |
|
36955-3
|
CT Thyroid gland WO contrast |
|
37226-8
|
CT Temporomandibular joint |
|
87909-8
|
CT Temporomandibular joint Arthrogram |
|
37243-3
|
CT Temporomandibular joint W contrast IV |
|
37283-9
|
CT Temporomandibular joint WO contrast |
|
37267-2
|
CT Temporomandibular joint WO and W contrast IV |
|
87904-9
|
CT Temporomandibular joint - bilateral WO contrast |
|
37246-6
|
CT Temporomandibular joint - left W contrast IV |
|
37248-2
|
CT Temporomandibular joint - right W contrast IV |
|
83303-8
|
CT Toe WO contrast |
|
87921-3
|
CT Trachea WO contrast |
|
24978-9
|
CT Thoracic spine |
|
87875-1
|
CT Thoracic spine by reconstruction |
|
79082-4
|
CT Thoracic spine by reconstruction W contrast IV |
|
79091-5
|
CT Thoracic spine by reconstruction WO contrast |
|
70931-1
|
CT Thoracic spine W contrast intradisc |
|
30596-1
|
CT Thoracic spine W contrast IT |
|
24979-7
|
CT Thoracic spine W contrast IV |
|
30597-9
|
CT Thoracic spine WO contrast |
|
44113-9
|
CT Thoracic spine WO and W contrast IT |
|
36403-4
|
CT Thoracic spine WO and W contrast IV |
|
35981-0
|
CT Upper extremity |
|
89714-0
|
CT Upper extremity joint - left Arthrogram |
|
89713-2
|
CT Upper extremity joint - right Arthrogram |
|
36097-4
|
CT Upper extremity limited W contrast IV |
|
30626-6
|
CT Upper extremity W contrast IV |
|
30627-4
|
CT Upper extremity WO contrast |
|
36334-1
|
CT Upper extremity WO and W contrast IV |
|
36168-3
|
CT Upper extremity - bilateral W contrast IV |
|
36456-2
|
CT Upper extremity - bilateral WO contrast |
|
87883-5
|
CT Upper extremity - bilateral WO and W contrast IV |
|
35982-8
|
CT Upper extremity - left |
|
36169-1
|
CT Upper extremity - left W contrast IV |
|
36457-0
|
CT Upper extremity - left WO contrast |
|
36335-8
|
CT Upper extremity - left WO and W contrast IV |
|
35983-6
|
CT Upper extremity - right |
|
36170-9
|
CT Upper extremity - right W contrast IV |
|
36458-8
|
CT Upper extremity - right WO contrast |
|
36336-6
|
CT Upper extremity - right WO and W contrast IV |
|
25045-6
|
CT Unspecified body region |
|
36023-0
|
CT Upper arm |
|
36207-9
|
CT Upper arm W contrast IV |
|
36491-9
|
CT Upper arm WO contrast |
|
36366-3
|
CT Upper arm WO and W contrast IV |
|
36026-3
|
CT Upper arm - bilateral |
|
87885-0
|
CT Upper arm - bilateral WO contrast |
|
36027-1
|
CT Upper arm - left |
|
36209-5
|
CT Upper arm - left W contrast IV |
|
36492-7
|
CT Upper arm - left WO contrast |
|
36367-1
|
CT Upper arm - left WO and W contrast IV |
|
36029-7
|
CT Upper arm - right |
|
36211-1
|
CT Upper arm - right W contrast IV |
|
36494-3
|
CT Upper arm - right WO contrast |
|
36369-7
|
CT Upper arm - right WO and W contrast IV |
|
36264-0
|
CT Uterus W contrast IV |
|
53626-8
|
CT Cerebral atrophic index |
|
46305-9
|
CT Whole body |
|
46306-7
|
CT Whole body W contrast IV |
|
88326-4
|
CT Head WO contrast and CT Brain for perfusion W contrast IV and CT angiogram Head vessels W contrast IV |
|
88315-7
|
CT Head WO contrast and CT Brain for perfusion W contrast IV and CT angiogram Head and neck vessels W contrast IV |
|
37428-0
|
CT Wrist |
|
37447-0
|
CT Wrist W contrast IV |
|
37459-5
|
CT Wrist WO contrast |
|
37457-9
|
CT Wrist WO and W contrast IV |
|
37430-6
|
CT Wrist - bilateral |
|
69091-7
|
CT Wrist - bilateral W contrast IV |
|
37461-1
|
CT Wrist - bilateral WO contrast |
|
37431-4
|
CT Wrist - left |
|
69107-1
|
CT Wrist - left Arthrogram |
|
37450-4
|
CT Wrist - left W contrast IV |
|
37463-7
|
CT Wrist - left WO contrast |
|
37458-7
|
CT Wrist - left WO and W contrast IV |
|
37433-0
|
CT Wrist - right |
|
69115-4
|
CT Wrist - right Arthrogram |
|
37452-0
|
CT Wrist - right W contrast IV |
|
37465-2
|
CT Wrist - right WO contrast |
|
38802-5
|
CT Wrist - right WO and W contrast IV |
|
89852-8
|
CT Unspecified body region limited W contrast IV |
|
89853-6
|
CT Unspecified body region limited WO contrast |
|
25046-4
|
CT Unspecified body region W anesthesia |
|
25047-2
|
CT Unspecified body region W conscious sedation |
|
24753-6
|
CT Unspecified body region W contrast IV |
|
43525-5
|
CT Unspecified body region WO contrast |
|
79090-7
|
CT densitometry Lumbar spine WO contrast |
|
79092-3
|
CT densitometry Thoracic spine WO contrast |
|
24728-8
|
CT perfusion Head |
|
42377-2
|
CT perfusion Head W Xe-133 IH+WO and W contrast IV |
|
39142-5
|
CT perfusion Head W contrast IV |
|
24729-6
|
CT perfusion Head WO and W contrast IV |
|
78973-5
|
CT scanogram Lower extremity - bilateral for leg measurement WO contrast |
|
77577-5
|
Chlamydia trachomatis and Neisseria gonorrhoeae DNA panel - Urethra by NAA with probe detection |
|
72828-7
|
Chlamydia trachomatis and Neisseria gonorrhoeae DNA panel - Unspecified specimen |
|
78037-9
|
CTA Abdominal Aorta and Bilateral Runoff Vessels W contrast IV |
|
82677-6
|
CTA Abdominal Aorta W contrast IV |
|
82678-4
|
CTA Abdominal Aorta WO and W contrast IV |
|
78031-2
|
CTA Abdominal Aorta and Bilateral Runoff Vessels WO and W contrast IV |
|
77311-9
|
CTA Abdominal aorta and Bilateral vessels for endograft |
|
36828-2
|
CTA Abdominal vessels W contrast IV |
|
30805-6
|
CTA Abdominal vessels WO and W contrast IV |
|
82679-2
|
CTA Abdominal vessels and Pelvis vessels WO and W contrast IV |
|
87838-9
|
CTA Abdominal veins and Pelvis veins W contrast IV |
|
87280-4
|
CTA Abdominal veins and Pelvis veins and Lower extremity veins - bilateral W contrast IV |
|
89626-6
|
CTA Abdominal, Pelvis and Lower extremity vessels W contrast IV |
|
69908-2
|
CTA Abdominal and Pelvic vessels W contrast IV |
|
36144-4
|
CTA Aortic arch W contrast IV |
|
87837-1
|
CTA Aortic valve W contrast IV |
|
87840-5
|
CTA Coronary arteries and Pulmonary arteries W contrast IV |
|
88318-1
|
CTA Coronary arteries and Pulmonary veins W contrast IV |
|
87841-3
|
CTA Coronary arteries and Thoracic aorta W contrast IV |
|
36146-9
|
CTA Carotid artery W contrast IV |
|
83299-8
|
CT Chest and Abdomen and Pelvis WO and W contrast IV and CTA Thoracic and abdominal aorta WO and W contrast IV |
|
86981-8
|
CTA Chest vessels |
|
36266-5
|
CTA Chest vessels W contrast IV |
|
69084-2
|
CTA Chest vessels WO contrast |
|
30804-9
|
CTA Chest vessels WO and W contrast IV |
|
86982-6
|
CTA Chest and abdominal vessels W contrast IV |
|
86971-9
|
CTA Chest and abdominal vessels WO and W contrast IV |
|
86983-4
|
CTA Chest vessels and Abdominal vessels and Pelvis vessels W contrast IV |
|
83298-0
|
CTA Chest vessels and Abdominal vessels and Pelvis vessels WO and W contrast IV |
|
87856-1
|
CTA Circle of Willis and Carotid arteries W contrast IV |
|
87855-3
|
CTA Circle of Willis and Carotid arteries WO and W contrast IV |
|
75671-8
|
CTA Circle of Willis WO and W contrast IV |
|
87842-1
|
CTA Coronary arteries and Pulmonary arteries and Thoracic aorta W contrast IV |
|
87858-7
|
CTA Deep inferior epigastric artery W contrast IV |
|
87850-4
|
CTA Deep inferior epigastric artery WO and W contrast IV |
|
36814-2
|
CTA Head Arteries W contrast IV |
|
36830-8
|
CTA Head vessels W contrast IV |
|
42293-1
|
CTA Head vessels WO contrast |
|
30593-8
|
CTA Head vessels WO and W contrast IV |
|
37498-3
|
CTA Head vessels and Neck vessels W contrast IV |
|
82680-0
|
CTA Head vessels and Neck vessels WO and W contrast IV |
|
36809-2
|
CTA Hepatic artery W contrast IA |
|
87836-3
|
CTA Hepatic vessels WO and W contrast IV |
|
79073-3
|
CTA Heart and Coronary arteries W contrast IV |
|
86980-0
|
CTA Heart and Coronary arteries WO and W contrast IV |
|
87845-4
|
CTA Lower extremity vessels |
|
36831-6
|
CTA Lower extremity vessels W contrast IV |
|
30807-2
|
CTA Lower extremity vessels WO and W contrast IV |
|
82711-3
|
CTA Lower extremity vessels - bilateral |
|
86965-1
|
CTA Lower extremity vessels - bilateral W contrast IV |
|
82708-9
|
CTA Lower extremity vessels - bilateral WO and W contrast IV |
|
82712-1
|
CTA Lower extremity vessels - left |
|
86964-4
|
CTA Lower extremity vessels - left W contrast IV |
|
46308-3
|
CTA Lower extremity vessels - left WO and W contrast IV |
|
82710-5
|
CTA Lower extremity vessels - right |
|
86963-6
|
CTA Lower extremity vessels - right W contrast IV |
|
46307-5
|
CTA Lower extremity vessels - right WO and W contrast IV |
|
87281-2
|
CTA Lower extremity veins - bilateral W contrast IV |
|
36824-1
|
CTA Lower extremity veins - left W contrast IV |
|
36825-8
|
CTA Lower extremity veins - right W contrast IV |
|
87851-2
|
CTA Mesenteric vessels W contrast IV |
|
87852-0
|
CTA Mesenteric vessels WO and W contrast IV |
|
36234-3
|
CTA Neck vessels W contrast IV |
|
30594-6
|
CTA Neck vessels WO and W contrast IV |
|
79077-4
|
CTA Pulmonary arteries for pulmonary embolus W contrast IV |
|
36147-7
|
CTA Pulmonary arteries W contrast IV |
|
87849-6
|
CTA Pulmonary arteries - bilateral and Lower extremity veins - bilateral for pulmonary embolus and deep vein thrombosis |
|
87848-8
|
CTA Pulmonary arteries - bilateral and Lower extremity veins - bilateral for pulmonary embolus and deep vein thrombosis W contrast IV |
|
83290-7
|
CTA Pulmonary arteries - bilateral and Pelvis veins and Lower extremity veins - bilateral for pulmonary embolus and deep vein thrombosis W contrast IV |
|
42294-9
|
CTA Pelvis vessels W contrast IV |
|
30623-3
|
CTA Pelvis vessels WO and W contrast IV |
|
87844-7
|
CTA Pelvis veins |
|
87843-9
|
CTA Pelvis veins and Lower extremity veins - bilateral |
|
87839-7
|
CTA Pulmonary veins W contrast IV |
|
36833-2
|
CTA Renal vessels W contrast IV |
|
87846-2
|
CTA Renal vessels WO and W contrast IV |
|
77451-3
|
CTA Thoracic and Abdominal Aorta and Bilateral Vessels for endograft |
|
78038-7
|
CTA Thoracic and Abdominal Aorta and Bilateral Runoff Vessels W contrast IV |
|
78032-0
|
CTA Thoracic and Abdominal Aorta and Bilateral Runoff Vessels WO and W contrast IV |
|
82709-7
|
CTA Thoracic Aorta |
|
36141-0
|
CTA Thoracic and abdominal aorta W contrast IV |
|
87857-9
|
CTA Thoracic and abdominal aorta WO and W contrast IV |
|
69119-6
|
CTA Thoracic Aorta WO contrast |
|
42295-6
|
CTA Upper extremity vessels W contrast IV |
|
36421-6
|
CTA Upper extremity vessels WO and W contrast IV |
|
86962-8
|
CTA Upper extremity vessels - bilateral W contrast IV |
|
89841-1
|
CTA Upper extremity vessels - bilateral WO and W contrast IV |
|
82713-9
|
CTA Upper extremity vessels - left |
|
86961-0
|
CTA Upper extremity vessels - left W contrast IV |
|
46312-5
|
CTA Upper extremity vessels - left WO and W contrast IV |
|
82714-7
|
CTA Upper extremity vessels - right |
|
86960-2
|
CTA Upper extremity vessels - right W contrast IV |
|
46309-1
|
CTA Upper extremity vessels - right WO and W contrast IV |
|
89722-3
|
CTA Upper extremity veins - left W contrast IV |
|
89723-1
|
CTA Upper extremity veins - right W contrast IV |
|
36834-0
|
CTA Vessel W contrast IV |
|
89851-0
|
CTA Unspecified body region limited |
|
67568-6
|
Circulating tumor cells.breast [#/volume] in Blood |
|
68124-7
|
Circulating tumor cells.colon [#/volume] in Blood |
|
68123-9
|
Circulating tumor cells.prostate [#/volume] in Blood |
|
26653-6
|
Colorado tick fever virus Ab [Presence] in Serum |
|
42614-8
|
Colorado tick fever virus Ab [Titer] in Cerebral spinal fluid |
|
34623-9
|
Colorado tick fever virus Ab [Titer] in Serum |
|
53368-7
|
Colorado tick fever virus Ab [Presence] in Unspecified specimen |
|
50035-5
|
Colorado tick fever virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
43051-2
|
Colorado tick fever virus IgG Ab [Presence] in Serum |
|
42895-3
|
Colorado tick fever virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
13292-8
|
Colorado tick fever virus IgG Ab [Units/volume] in Serum |
|
16121-6
|
Colorado tick fever virus IgG Ab [Titer] in Serum |
|
61200-2
|
Colorado tick fever virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
35684-0
|
Colorado tick fever virus IgG and IgM panel - Serum |
|
57774-2
|
Colorado tick fever virus IgG and IgM panel [Titer] - Serum |
|
13293-6
|
Colorado tick fever virus IgM Ab [Units/volume] in Serum |
|
16122-4
|
Colorado tick fever virus IgM Ab [Titer] in Serum |
|
42896-1
|
Colorado tick fever virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
21659-8
|
CTNNB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81815-3
|
CTNS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
31337-9
|
Cytotoxic percent reactive Ab [Presence] in Serum |
|
4535-1
|
Cytotoxic percent reactive Ab [Presence] in Serum by Quick method |
|
78987-5
|
Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay |
|
81836-9
|
CTSK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
92737-6
|
7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel - Blood |
|
92739-2
|
7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel - DBS |
|
92746-7
|
7-Alpha,12-alpha dihydroxycholest-4-en-3-one and 7-Alpha hydroxy-4-cholesten-3-one panel - Serum or Plasma |
|
7269-4
|
Cucumber triggered histamine release [Units/volume] in Blood |
|
6724-9
|
Cucumber IgE Ab [Units/volume] in Serum |
|
61329-9
|
Cucumber IgE Ab/IgE total in Serum |
|
7268-6
|
Cucumber IgG Ab [Units/volume] in Serum |
|
56238-9
|
Cucumber IgG4 Ab [Mass/volume] in Serum |
|
60371-2
|
Cucumber IgG Ab [Mass/volume] in Serum |
|
54909-7
|
Culex mosquito IgE Ab [Units/volume] in Serum |
|
20430-5
|
Culture medium [Type] in Isolate |
|
7248-8
|
Cultivated Corn IgE Ab [Units/volume] in Serum |
|
6088-9
|
Cultivated Cotton IgE Ab [Units/volume] in Serum |
|
6236-4
|
Cultivated Rye IgE Ab [Units/volume] in Serum |
|
58025-8
|
Cultivated Rye IgE Ab/IgE total in Serum |
|
56381-7
|
Cultivated Rye IgG4 Ab [Mass/volume] in Serum |
|
63154-9
|
Cultivated Rye IgG Ab [Mass/volume] in Serum |
|
48258-8
|
Cultivated Rye triggered leukotriene release [Mass/volume] by Leukocytes |
|
6277-8
|
Cultivated Wheat IgE Ab [Units/volume] in Serum |
|
56418-7
|
Cultivated Wheat IgG4 Ab [Mass/volume] in Serum |
|
63155-6
|
Cultivated Wheat IgG Ab [Mass/volume] in Serum |
|
38581-5
|
Cumene [Mass/volume] in Air |
|
16694-2
|
Cumene [Presence] in Blood |
|
12430-5
|
Cumene [Mass/volume] in Serum or Plasma |
|
30507-8
|
Cumene [Mass/volume] in Urine |
|
16101-8
|
Cumin IgE Ab [Units/volume] in Serum |
|
56454-2
|
Cumin IgG4 Ab [Mass/volume] in Serum |
|
63123-4
|
Cumin IgG Ab [Mass/volume] in Serum |
|
45984-2
|
Current payment sources for nursing home stay Set |
|
7270-2
|
Curry IgE Ab [Units/volume] in Serum |
|
41849-1
|
Curry IgG Ab [Units/volume] in Serum |
|
56239-7
|
Curry IgG4 Ab [Mass/volume] in Serum |
|
63129-1
|
Curry IgG Ab [Mass/volume] in Serum |
|
7271-0
|
Curvularia sp IgE Ab [Units/volume] in Serum |
|
85177-4
|
Custodial care facility Administrative note |
|
85173-3
|
Custodial care facility Admission evaluation note |
|
85174-1
|
Custodial care facility Consult note |
|
85175-8
|
Custodial care facility Counseling note |
|
85176-6
|
Custodial care facility Discharge summary |
|
85171-7
|
Custodial care facility Education note |
|
85178-2
|
Custodial care facility Group counseling note |
|
85179-0
|
Custodial care facility History and physical note |
|
75429-1
|
Custodial care facility Note |
|
85182-4
|
Custodial care facility Plan of care note |
|
85180-8
|
Custodial care facility Risk assessment and screening note |
|
85181-6
|
Custodial care facility Transfer summary note |
|
45976-8
|
Customary routine in year prior to date of entry Set |
|
45975-0
|
Customary routine section |
|
13232-4
|
Coxsackievirus A Ab [Units/volume] in Cerebral spinal fluid |
|
16679-3
|
Coxsackievirus A Ab [Units/volume] in Serum |
|
40762-7
|
Coxsackievirus A Ab [Titer] in Serum --1st specimen |
|
40760-1
|
Coxsackievirus A Ab [Titer] in Cerebral spinal fluid --2nd specimen |
|
40761-9
|
Coxsackievirus A Ab [Titer] in Serum --2nd specimen |
|
40758-5
|
Coxsackievirus A Ab [Titer] in Cerebral spinal fluid |
|
63434-5
|
Coxsackievirus A Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
51978-5
|
Coxsackievirus A Ab [Titer] in Serum |
|
86516-2
|
Coxsackievirus A Ab [Titer] in Serum by Complement fixation |
|
41484-7
|
Coxsackievirus A Ab panel [Titer] - Serum by Complement fixation |
|
16680-1
|
Coxsackievirus A IgG Ab [Units/volume] in Serum |
|
16681-9
|
Coxsackievirus A IgM Ab [Units/volume] in Serum |
|
40759-3
|
Coxsackievirus A IgM Ab [Titer] in Serum --1st specimen |
|
13297-7
|
Coxsackievirus A1 Ab [Units/volume] in Serum |
|
13295-1
|
Coxsackievirus A10 Ab [Units/volume] in Cerebral spinal fluid |
|
31317-1
|
Coxsackievirus A10 Ab [Units/volume] in Body fluid |
|
30214-1
|
Coxsackievirus A10 Ab [Presence] in Serum |
|
11590-7
|
Coxsackievirus A10 Ab [Units/volume] in Serum |
|
24300-6
|
Coxsackievirus A10 Ab [Titer] in Serum --1st specimen |
|
24226-3
|
Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24301-4
|
Coxsackievirus A10 Ab [Titer] in Serum --2nd specimen |
|
24227-1
|
Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
22212-5
|
Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid |
|
9751-9
|
Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43049-6
|
Coxsackievirus A10 Ab [Titer] in Body fluid |
|
31051-6
|
Coxsackievirus A10 Ab [Titer] in Body fluid by Complement fixation |
|
22213-3
|
Coxsackievirus A10 Ab [Titer] in Serum |
|
9750-1
|
Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation |
|
13235-7
|
Coxsackievirus A16 Ab [Units/volume] in Cerebral spinal fluid |
|
31318-9
|
Coxsackievirus A16 Ab [Units/volume] in Body fluid |
|
30215-8
|
Coxsackievirus A16 Ab [Presence] in Serum |
|
7833-7
|
Coxsackievirus A16 Ab [Units/volume] in Serum |
|
24302-2
|
Coxsackievirus A16 Ab [Titer] in Serum --1st specimen |
|
24228-9
|
Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24303-0
|
Coxsackievirus A16 Ab [Titer] in Serum --2nd specimen |
|
24229-7
|
Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
22214-1
|
Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid |
|
9752-7
|
Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43046-2
|
Coxsackievirus A16 Ab [Titer] in Body fluid |
|
31052-4
|
Coxsackievirus A16 Ab [Titer] in Body fluid by Complement fixation |
|
22215-8
|
Coxsackievirus A16 Ab [Titer] in Serum |
|
6688-6
|
Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation |
|
59583-5
|
Coxsackievirus A16 IgG Ab [Titer] in Serum by Immunofluorescence |
|
59580-1
|
Coxsackievirus A16 IgM Ab [Titer] in Serum by Immunofluorescence |
|
13233-2
|
Coxsackievirus A2 Ab [Units/volume] in Cerebral spinal fluid |
|
30216-6
|
Coxsackievirus A2 Ab [Presence] in Serum |
|
11591-5
|
Coxsackievirus A2 Ab [Units/volume] in Serum |
|
16682-7
|
Coxsackievirus A2 Ab [Titer] in Cerebral spinal fluid |
|
22216-6
|
Coxsackievirus A2 Ab [Titer] in Serum |
|
9753-5
|
Coxsackievirus A2 Ab [Titer] in Serum by Complement fixation |
|
11599-8
|
Coxsackievirus A21 Ab [Units/volume] in Serum |
|
22217-4
|
Coxsackievirus A21 Ab [Titer] in Serum |
|
6956-7
|
Coxsackievirus A21 Ab [Titer] in Serum by Complement fixation |
|
59582-7
|
Coxsackievirus A24 IgG Ab [Titer] in Serum by Immunofluorescence |
|
59579-3
|
Coxsackievirus A24 IgM Ab [Titer] in Serum by Immunofluorescence |
|
42623-9
|
Coxsackievirus A3 Ab [Titer] in Serum |
|
13234-0
|
Coxsackievirus A4 Ab [Units/volume] in Cerebral spinal fluid |
|
30217-4
|
Coxsackievirus A4 Ab [Presence] in Serum |
|
11593-1
|
Coxsackievirus A4 Ab [Units/volume] in Serum |
|
16683-5
|
Coxsackievirus A4 Ab [Titer] in Cerebral spinal fluid |
|
22218-2
|
Coxsackievirus A4 Ab [Titer] in Serum |
|
9754-3
|
Coxsackievirus A4 Ab [Titer] in Serum by Complement fixation |
|
42603-1
|
Coxsackievirus A6 Ab [Titer] in Serum |
|
31319-7
|
Coxsackievirus A7 Ab [Units/volume] in Cerebral spinal fluid |
|
31320-5
|
Coxsackievirus A7 Ab [Units/volume] in Body fluid |
|
30218-2
|
Coxsackievirus A7 Ab [Presence] in Serum |
|
7834-5
|
Coxsackievirus A7 Ab [Units/volume] in Serum |
|
24304-8
|
Coxsackievirus A7 Ab [Titer] in Serum --1st specimen |
|
24230-5
|
Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24305-5
|
Coxsackievirus A7 Ab [Titer] in Serum --2nd specimen |
|
24231-3
|
Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
22219-0
|
Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid |
|
9756-8
|
Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43047-0
|
Coxsackievirus A7 Ab [Titer] in Body fluid |
|
31049-0
|
Coxsackievirus A7 Ab [Titer] in Body fluid by Complement fixation |
|
22220-8
|
Coxsackievirus A7 Ab [Titer] in Serum |
|
9755-0
|
Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation |
|
5101-1
|
Coxsackievirus A7 Ab [Titer] in Serum by Neutralization test |
|
59584-3
|
Coxsackievirus A7 IgG Ab [Titer] in Serum by Immunofluorescence |
|
59581-9
|
Coxsackievirus A7 IgM Ab [Titer] in Serum by Immunofluorescence |
|
27947-1
|
Coxsackievirus A7 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
|
33392-2
|
Coxsackievirus A8 Ab [Presence] in Serum |
|
33391-4
|
Coxsackievirus A8 Ab [Units/volume] in Serum |
|
31321-3
|
Coxsackievirus A9 Ab [Units/volume] in Cerebral spinal fluid |
|
31322-1
|
Coxsackievirus A9 Ab [Units/volume] in Body fluid |
|
30219-0
|
Coxsackievirus A9 Ab [Presence] in Serum |
|
7835-2
|
Coxsackievirus A9 Ab [Units/volume] in Serum |
|
24306-3
|
Coxsackievirus A9 Ab [Titer] in Serum --1st specimen |
|
24232-1
|
Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24307-1
|
Coxsackievirus A9 Ab [Titer] in Serum --2nd specimen |
|
24233-9
|
Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
22221-6
|
Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid |
|
9758-4
|
Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43048-8
|
Coxsackievirus A9 Ab [Titer] in Body fluid |
|
31050-8
|
Coxsackievirus A9 Ab [Titer] in Body fluid by Complement fixation |
|
22222-4
|
Coxsackievirus A9 Ab [Titer] in Serum |
|
9757-6
|
Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation |
|
5102-9
|
Coxsackievirus A9 Ab [Titer] in Serum by Neutralization test |
|
56621-6
|
Coxsackievirus A9 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
58792-3
|
Coxsackievirus A9 IgG Ab [Titer] in Serum by Immunofluorescence |
|
58791-5
|
Coxsackievirus A9 IgM Ab [Titer] in Serum by Immunofluorescence |
|
27969-5
|
Coxsackievirus A9 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
|
51453-9
|
Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum |
|
50691-5
|
Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab [Titer] in Serum by Complement fixation |
|
30132-5
|
Coxsackievirus Ab [Presence] in Serum --1st specimen |
|
30133-3
|
Coxsackievirus Ab [Presence] in Serum --2nd specimen |
|
45033-8
|
Cardiovascular physiologic and EKG assessment panel |
|
16684-3
|
Coxsackievirus B Ab [Units/volume] in Serum |
|
40765-0
|
Coxsackievirus B Ab [Titer] in Cerebral spinal fluid |
|
34437-4
|
Coxsackievirus B Ab [Titer] in Serum |
|
51817-5
|
Coxsackievirus B IgG Ab [Units/volume] in Serum by Immunoassay |
|
16685-0
|
Coxsackievirus B IgG Ab [Units/volume] in Serum by Neutralization test |
|
22223-2
|
Coxsackievirus B IgG Ab [Units/volume] in Serum |
|
40767-6
|
Coxsackievirus B IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen |
|
40764-3
|
Coxsackievirus B IgG Ab [Titer] in Serum --2nd specimen |
|
58780-8
|
Coxsackievirus B IgG Ab [Titer] in Serum |
|
51818-3
|
Coxsackievirus B IgM Ab [Units/volume] in Serum by Immunoassay |
|
16686-8
|
Coxsackievirus B IgM Ab [Units/volume] in Serum by Neutralization test |
|
22224-0
|
Coxsackievirus B IgM Ab [Units/volume] in Serum |
|
40766-8
|
Coxsackievirus B IgM Ab [Titer] in Cerebral spinal fluid --1st specimen |
|
40763-5
|
Coxsackievirus B IgM Ab [Titer] in Serum --1st specimen |
|
58790-7
|
Coxsackievirus B IgM Ab [Titer] in Serum by Immunofluorescence |
|
41485-4
|
Coxsackievirus B Ab panel [Titer] - Serum by Complement fixation |
|
41486-2
|
Coxsackievirus B Ab panel [Titer] - Serum by Neutralization test |
|
27908-3
|
Coxsackievirus B1 Ab [Presence] in Cerebral spinal fluid |
|
31323-9
|
Coxsackievirus B1 Ab [Units/volume] in Cerebral spinal fluid |
|
45292-0
|
Coxsackievirus B1 Ab [Presence] in Body fluid |
|
31324-7
|
Coxsackievirus B1 Ab [Units/volume] in Body fluid |
|
30220-8
|
Coxsackievirus B1 Ab [Presence] in Serum |
|
7836-0
|
Coxsackievirus B1 Ab [Units/volume] in Serum |
|
24251-1
|
Coxsackievirus B1 Ab [Titer] in Serum --1st specimen |
|
24177-8
|
Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24179-4
|
Coxsackievirus B1 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24252-9
|
Coxsackievirus B1 Ab [Titer] in Serum --2nd specimen |
|
24178-6
|
Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24180-2
|
Coxsackievirus B1 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22225-7
|
Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid |
|
9759-2
|
Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29230-0
|
Coxsackievirus B1 Ab [Titer] in Body fluid |
|
31053-2
|
Coxsackievirus B1 Ab [Titer] in Body fluid by Complement fixation |
|
22226-5
|
Coxsackievirus B1 Ab [Titer] in Serum |
|
5104-5
|
Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation |
|
5103-7
|
Coxsackievirus B1 Ab [Titer] in Serum by Neutralization test |
|
27903-4
|
Coxsackievirus B2 Ab [Presence] in Cerebral spinal fluid |
|
31325-4
|
Coxsackievirus B2 Ab [Units/volume] in Cerebral spinal fluid |
|
45291-2
|
Coxsackievirus B2 Ab [Presence] in Body fluid |
|
31326-2
|
Coxsackievirus B2 Ab [Units/volume] in Body fluid |
|
30221-6
|
Coxsackievirus B2 Ab [Presence] in Serum |
|
7837-8
|
Coxsackievirus B2 Ab [Units/volume] in Serum |
|
24255-2
|
Coxsackievirus B2 Ab [Titer] in Serum --1st specimen |
|
24181-0
|
Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24183-6
|
Coxsackievirus B2 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24256-0
|
Coxsackievirus B2 Ab [Titer] in Serum --2nd specimen |
|
24182-8
|
Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24184-4
|
Coxsackievirus B2 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22227-3
|
Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid |
|
9760-0
|
Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29231-8
|
Coxsackievirus B2 Ab [Titer] in Body fluid |
|
31054-0
|
Coxsackievirus B2 Ab [Titer] in Body fluid by Complement fixation |
|
22228-1
|
Coxsackievirus B2 Ab [Titer] in Serum |
|
5106-0
|
Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation |
|
5105-2
|
Coxsackievirus B2 Ab [Titer] in Serum by Neutralization test |
|
27917-4
|
Coxsackievirus B3 Ab [Presence] in Cerebral spinal fluid |
|
31327-0
|
Coxsackievirus B3 Ab [Units/volume] in Cerebral spinal fluid |
|
45290-4
|
Coxsackievirus B3 Ab [Presence] in Body fluid |
|
31328-8
|
Coxsackievirus B3 Ab [Units/volume] in Body fluid |
|
30222-4
|
Coxsackievirus B3 Ab [Presence] in Serum |
|
7838-6
|
Coxsackievirus B3 Ab [Units/volume] in Serum |
|
24259-4
|
Coxsackievirus B3 Ab [Titer] in Serum --1st specimen |
|
24185-1
|
Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24187-7
|
Coxsackievirus B3 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24260-2
|
Coxsackievirus B3 Ab [Titer] in Serum --2nd specimen |
|
24186-9
|
Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24188-5
|
Coxsackievirus B3 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22229-9
|
Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid |
|
9761-8
|
Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29232-6
|
Coxsackievirus B3 Ab [Titer] in Body fluid |
|
31055-7
|
Coxsackievirus B3 Ab [Titer] in Body fluid by Complement fixation |
|
22230-7
|
Coxsackievirus B3 Ab [Titer] in Serum |
|
5108-6
|
Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation |
|
5107-8
|
Coxsackievirus B3 Ab [Titer] in Serum by Neutralization test |
|
27918-2
|
Coxsackievirus B4 Ab [Presence] in Cerebral spinal fluid |
|
31329-6
|
Coxsackievirus B4 Ab [Units/volume] in Cerebral spinal fluid |
|
45289-6
|
Coxsackievirus B4 Ab [Presence] in Body fluid |
|
31330-4
|
Coxsackievirus B4 Ab [Units/volume] in Body fluid |
|
30223-2
|
Coxsackievirus B4 Ab [Presence] in Serum |
|
7839-4
|
Coxsackievirus B4 Ab [Units/volume] in Serum |
|
24263-6
|
Coxsackievirus B4 Ab [Titer] in Serum --1st specimen |
|
24189-3
|
Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24191-9
|
Coxsackievirus B4 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24264-4
|
Coxsackievirus B4 Ab [Titer] in Serum --2nd specimen |
|
24190-1
|
Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24192-7
|
Coxsackievirus B4 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22231-5
|
Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid |
|
9762-6
|
Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29233-4
|
Coxsackievirus B4 Ab [Titer] in Body fluid |
|
31056-5
|
Coxsackievirus B4 Ab [Titer] in Body fluid by Complement fixation |
|
22232-3
|
Coxsackievirus B4 Ab [Titer] in Serum |
|
5110-2
|
Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation |
|
5109-4
|
Coxsackievirus B4 Ab [Titer] in Serum by Neutralization test |
|
31331-2
|
Coxsackievirus B5 Ab [Units/volume] in Cerebral spinal fluid |
|
45288-8
|
Coxsackievirus B5 Ab [Presence] in Body fluid |
|
31332-0
|
Coxsackievirus B5 Ab [Units/volume] in Body fluid |
|
30224-0
|
Coxsackievirus B5 Ab [Presence] in Serum |
|
7840-2
|
Coxsackievirus B5 Ab [Units/volume] in Serum |
|
24267-7
|
Coxsackievirus B5 Ab [Titer] in Serum --1st specimen |
|
24193-5
|
Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24195-0
|
Coxsackievirus B5 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24268-5
|
Coxsackievirus B5 Ab [Titer] in Serum --2nd specimen |
|
24194-3
|
Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24196-8
|
Coxsackievirus B5 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22233-1
|
Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid |
|
9763-4
|
Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29234-2
|
Coxsackievirus B5 Ab [Titer] in Body fluid |
|
31057-3
|
Coxsackievirus B5 Ab [Titer] in Body fluid by Complement fixation |
|
22234-9
|
Coxsackievirus B5 Ab [Titer] in Serum |
|
5112-8
|
Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation |
|
5111-0
|
Coxsackievirus B5 Ab [Titer] in Serum by Neutralization test |
|
27960-4
|
Coxsackievirus B5 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
|
31333-8
|
Coxsackievirus B6 Ab [Units/volume] in Cerebral spinal fluid |
|
45287-0
|
Coxsackievirus B6 Ab [Presence] in Body fluid |
|
31334-6
|
Coxsackievirus B6 Ab [Units/volume] in Body fluid |
|
30225-7
|
Coxsackievirus B6 Ab [Presence] in Serum |
|
7841-0
|
Coxsackievirus B6 Ab [Units/volume] in Serum |
|
24271-9
|
Coxsackievirus B6 Ab [Titer] in Serum --1st specimen |
|
24197-6
|
Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24199-2
|
Coxsackievirus B6 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24272-7
|
Coxsackievirus B6 Ab [Titer] in Serum --2nd specimen |
|
24198-4
|
Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
24200-8
|
Coxsackievirus B6 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22235-6
|
Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid |
|
9764-2
|
Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29235-9
|
Coxsackievirus B6 Ab [Titer] in Body fluid |
|
31058-1
|
Coxsackievirus B6 Ab [Titer] in Body fluid by Complement fixation |
|
22236-4
|
Coxsackievirus B6 Ab [Titer] in Serum |
|
5114-4
|
Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation |
|
5113-6
|
Coxsackievirus B6 Ab [Titer] in Serum by Neutralization test |
|
27954-7
|
Coxsackievirus B6 RNA [Units/volume] (viral load) in Cerebral spinal fluid by Probe |
|
70013-8
|
Coxsackievirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
70012-0
|
Coxsackievirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
13509-5
|
Microscopic observation [Identifier] in Blood by Crystal violet stain |
|
48722-3
|
Microscopic observation [Identifier] in Body fluid by Crystal violet stain |
|
90822-8
|
CV2 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
63216-6
|
CV2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
52970-1
|
CV2 Ab [Units/volume] in Cerebral spinal fluid |
|
34690-8
|
CV2 Ab [Presence] in Serum or Plasma |
|
47402-3
|
CV2 Ab [Presence] in Serum or Plasma by Immunoblot |
|
72504-4
|
CV2 Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
51797-9
|
CV2 Ab [Units/volume] in Serum or Plasma |
|
56530-9
|
CV2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
51697-1
|
CV2 Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
53707-6
|
CV2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
47401-5
|
CV2 IgG Ab [Presence] in Serum by Immunoblot |
|
43103-1
|
CV2 IgG Ab [Units/volume] in Serum |
|
35385-4
|
CV2 IgG Ab [Titer] in Cerebral spinal fluid |
|
35386-2
|
CV2 IgG Ab [Titer] in Serum |
|
80696-8
|
2-Chlorovinyl arsonous acid [Mass/volume] in Urine |
|
79423-0
|
Cardiovascular disease 10Y risk [Likelihood] ACC-AHA Pooled Cohort by Goff 2013 |
|
60985-9
|
Central venous pressure (CVP) |
|
60986-7
|
Central venous pressure (CVP) Diastolic |
|
60987-5
|
Central venous pressure (CVP) Systolic |
|
22161-4
|
Cache valley virus Ab [Presence] in Serum |
|
20736-5
|
Cache valley virus Ab [Presence] in Serum by Neutralization test |
|
46175-6
|
Cache valley virus Ab [Titer] in Serum |
|
44272-3
|
Cache valley virus Ab [Titer] in Serum by Neutralization test |
|
34447-3
|
Cache valley virus RNA [Presence] in Blood by NAA with probe detection |
|
34448-1
|
Cache valley virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
55142-4
|
Cache valley virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76498-5
|
Cervical cells.overexpressing HPV E6+E7 mRNA/cervical cells by Flow cytometry (FC) |
|
960-5
|
Cw Ag [Presence] on Red Blood Cells |
|
966-2
|
Cx Ag [Presence] on Red Blood Cells |
|
74917-6
|
CXCL13 Ag [Mass/volume] in Cerebral spinal fluid |
|
49477-3
|
CXCL13 Ag [Presence] in Tissue by Immune stain |
|
49478-1
|
CXCR5 Ag [Presence] in Tissue by Immune stain |
|
13511-1
|
Cyanide ascorbate screen [Presence] in Blood |
|
43183-3
|
Cyanide [Mass/volume] in Blood by Confirmatory method |
|
46698-7
|
Cyanide [Presence] in Blood |
|
5634-1
|
Cyanide [Mass/volume] in Blood |
|
59186-7
|
Cyanide [Moles/volume] in Blood |
|
29357-1
|
Cyanide [Mass/volume] in Gastric fluid |
|
20783-7
|
Cyanide [Units/mass] in Plant Qualitative |
|
20782-9
|
Cyanide [Mass/mass] in Plant |
|
5635-8
|
Cyanide [Mass/volume] in Serum or Plasma |
|
25387-2
|
Cyanide [Moles/volume] in Serum or Plasma |
|
5636-6
|
Cyanide [Mass/mass] in Tissue |
|
59824-3
|
Cyanide [Presence] in Urine |
|
5637-4
|
Cyanide [Mass/volume] in Urine |
|
20784-5
|
Cyanide [Mass/volume] in Unspecified specimen |
|
87618-5
|
Cyanide [Mass/mass] in Unspecified specimen |
|
77321-8
|
Cyanide [Moles/volume] in Unspecified specimen |
|
10658-3
|
Cyanobacterium identified in Water by Light microscopy |
|
2182-4
|
Cytochrome B reductase [Enzymatic activity/volume] in Amniotic fluid |
|
51603-9
|
Cytochrome B5 reductase [Presence] in Red Blood Cells |
|
32703-1
|
Cytochrome B5 reductase [Enzymatic activity/mass] in Red Blood Cells |
|
2653-4
|
Cytochrome B5 reductase [Mass/volume] in Red Blood Cells |
|
2183-2
|
Cytochrome B5 reductase [Enzymatic activity/volume] in Serum |
|
48729-8
|
CYBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
90743-6
|
CYBB gene full and NCF1 gene c.75_76delGT analysis in Blood or Tissue by Molecular genetics method |
|
48734-8
|
CYBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
54382-7
|
Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid cells |
|
54384-3
|
Cytochrome C oxidase [Enzymatic activity/mass] in Amniotic fluid |
|
54383-5
|
Cytochrome C oxidase [Enzymatic activity/mass] in Fibroblast |
|
2184-0
|
Cytochrome C oxidase [Enzymatic activity/volume] in Plasma |
|
2185-7
|
Cytochrome C oxidase [Enzymatic activity/volume] in Platelets |
|
18366-5
|
Cytochrome C oxidase [Enzymatic activity/mass] in Tissue |
|
2186-5
|
Cytochrome C oxidase [Enzymatic activity/volume] in Leukocytes |
|
82877-2
|
Cytochrome C oxidase [Enzymatic activity/mass] in Leukocytes |
|
74584-4
|
Cytochrome C oxidase/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
3517-0
|
Cyclacillin [Mass/volume] in Serum or Plasma |
|
45977-6
|
Cycle of daily events Set |
|
32749-4
|
Cyclin D1 cells/100 cells in Unspecified specimen |
|
3518-8
|
Cyclizine [Mass/volume] in Serum or Plasma |
|
13554-1
|
Cyclobenzaprine [Presence] in Serum or Plasma |
|
35604-8
|
Cyclobenzaprine [Mass/volume] in Serum or Plasma by Screen method |
|
6797-5
|
Cyclobenzaprine [Mass/volume] in Serum or Plasma |
|
55531-8
|
Cyclobenzaprine [Moles/volume] in Serum or Plasma |
|
61410-7
|
Cyclobenzaprine [Mass/volume] in Urine by Confirmatory method |
|
14060-8
|
Cyclobenzaprine [Presence] in Urine |
|
61409-9
|
Cyclobenzaprine [Presence] in Urine by Confirmatory method |
|
14061-6
|
Cyclobenzaprine [Mass/volume] in Urine |
|
61408-1
|
Cyclobenzaprine/Creatinine [Mass Ratio] in Urine |
|
53448-7
|
Cycloguanil [Mass/volume] in Serum or Plasma |
|
16697-5
|
Cyclohexane [Presence] in Blood |
|
12306-7
|
Cyclohexane [Mass/volume] in Blood |
|
16698-3
|
Cyclohexanol [Mass/volume] in Blood |
|
16699-1
|
Cyclohexanol [Mass/volume] in Urine |
|
16700-7
|
Cyclohexanol/Creatinine [Mass Ratio] in Urine |
|
12995-7
|
Cyclohexanone [Mass/volume] in Blood |
|
23851-9
|
Cyclohexanone [Mass/volume] in Serum or Plasma |
|
21236-5
|
Cyclohexanone [Mass/volume] in Urine |
|
53449-5
|
Cyclophosphamide [Mass/volume] in Serum or Plasma |
|
53453-7
|
Cyclophosphamide [Mass/volume] in Urine |
|
16701-5
|
Cyclopropane [Presence] in Blood |
|
12312-5
|
Cyclopropane [Mass/volume] in Blood |
|
3519-6
|
cycloSERINE [Mass/volume] in Serum or Plasma |
|
16702-3
|
cycloSERINE [Mass/volume] in Urine |
|
25251-0
|
cycloSERINE [Mass/volume] in Unspecified specimen |
|
38403-2
|
Cyclospora sp Ag [Presence] in Stool by Immunoassay |
|
10659-1
|
Cyclospora sp identified in Stool by Acid fast stain |
|
50313-6
|
Cyclospora sp identified in Stool by Safranin stain |
|
3523-8
|
cycloSPORINE [Mass/volume] in Blood --12 hours post dose |
|
3524-6
|
cycloSPORINE [Mass/volume] in Serum --12 hours post dose |
|
77169-1
|
cycloSPORINE [Mass/volume] in Blood --1 hour post dose |
|
3525-3
|
cycloSPORINE [Mass/volume] in Blood --24 hours post dose |
|
3526-1
|
cycloSPORINE [Mass/volume] in Serum --24 hours post dose |
|
32997-9
|
cycloSPORINE [Mass/volume] in Blood --2 hours post dose |
|
77167-5
|
cycloSPORINE [Mass/volume] in Blood --3 hours post dose |
|
77168-3
|
cycloSPORINE [Mass/volume] in Blood --4 hours post dose |
|
14978-1
|
cycloSPORINE [Mass/volume] in Blood by Immunoassay |
|
78920-6
|
cycloSPORINE [Moles/volume] in Blood by Immunoassay |
|
55805-6
|
cycloSPORINE [Mass/volume] in Blood by LC/MS/MS |
|
3520-4
|
cycloSPORINE [Mass/volume] in Blood |
|
80561-4
|
cycloSPORINE [Mass/volume] in DBS |
|
17807-9
|
cycloSPORINE [Mass/volume] in Body fluid |
|
73427-7
|
cycloSPORINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73426-9
|
cycloSPORINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
45058-5
|
cycloSPORINE Monoclonal and Polyclonal panel [Mass/volume] - Blood |
|
33955-6
|
cycloSPORINE.monoclonal [Mass/volume] in Blood |
|
34426-7
|
cycloSPORINE.monoclonal [Mass/volume] in Serum or Plasma |
|
53573-2
|
cycloSPORINE [Mass/volume] in Blood --post dose |
|
53834-8
|
cycloSPORINE [Mass/volume] in Blood --peak |
|
16703-1
|
cycloSPORINE [Mass/volume] in Plasma |
|
33956-4
|
cycloSPORINE.polyclonal [Mass/volume] in Blood |
|
3521-2
|
cycloSPORINE [Mass/volume] in Serum |
|
15103-5
|
cycloSPORINE [Moles/volume] in Serum |
|
48597-9
|
cycloSPORINE [Mass/volume] in Blood by Immunoassay --trough |
|
53828-0
|
cycloSPORINE [Mass/volume] in Blood --trough |
|
3522-0
|
cycloSPORINE+Metabolites [Mass/volume] in Blood |
|
12345-5
|
Cyclothiazide [Presence] in Urine |
|
38515-3
|
Cytoplasmic Ig mu cells [#/volume] in Blood |
|
77056-0
|
CYP11B1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77055-2
|
CYP11B1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
57308-9
|
CYP11B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77058-6
|
CYP17A1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77057-8
|
CYP17A1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
75713-8
|
CYP1A2 gene c.125C>G [Presence] in Blood or Tissue by Molecular genetics method |
|
75722-9
|
CYP1A2 gene c.-163C>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75723-7
|
CYP1A2 gene c.2385G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75714-6
|
CYP1A2 gene c.-2467delT [Presence] in Blood or Tissue by Molecular genetics method |
|
75715-3
|
CYP1A2 gene c.2473G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75716-1
|
CYP1A2 gene c.2499A>T [Presence] in Blood or Tissue by Molecular genetics method |
|
75718-7
|
CYP1A2 gene c.3533G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75719-5
|
CYP1A2 gene c.-3860G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75720-3
|
CYP1A2 gene c.5090C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
75721-1
|
CYP1A2 gene c.5166G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75724-5
|
CYP1A2 gene c.558C>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75725-2
|
CYP1A2 gene c.-729C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
80687-7
|
CYP1A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72884-0
|
CYP1A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81854-2
|
CYP21A2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
48781-9
|
CYP21A2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
30005-3
|
CYP21A2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34651-0
|
CYP21A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72882-4
|
CYP2B6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
72511-9
|
CYP2B6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
66489-6
|
CYP2C19 gene targeted mutation analysis in Blood by Molecular genetics method |
|
57132-3
|
CYP2C19 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
78972-7
|
CYP2C8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
54450-2
|
CYP2C9 and VKORC1 panel - Blood or Tissue by Molecular genetics method |
|
56164-7
|
CYP2C9 gene allele 2 [Identifier] in Blood by Molecular genetics method Nominal |
|
56165-4
|
CYP2C9 gene allele 3 [Identifier] in Blood by Molecular genetics method Nominal |
|
80686-9
|
CYP2C9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46724-1
|
CYP2C9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21662-2
|
CYP2D6 gene c.2637delA [Presence] in Blood or Tissue by Molecular genetics method |
|
21661-4
|
CYP2D6 gene deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40425-1
|
CYP2D6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
47403-1
|
CYP2D6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21664-8
|
CYP2D6 gene p.Gly169Ter [Presence] in Blood or Tissue by Molecular genetics method |
|
72886-5
|
CYP2D6 gene and CYP2C19 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method |
|
72883-2
|
CYP2E1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81146-3
|
CYP3A4 and CYP3A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81642-1
|
CYP3A4 and CYP3A5 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method |
|
74003-5
|
CYP3A4 gene c.-392A>G (*1B) [Presence] in Blood or Tissue by Molecular genetics method |
|
81139-8
|
CYP3A4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74007-6
|
CYP3A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81140-6
|
CYP3A5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
72697-6
|
CYP3A5 gene c.6986A>G(*3) [Presence] in Blood or Tissue by Molecular genetics method |
|
91669-2
|
CYP3A7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
16704-9
|
Cyproheptadine [Mass/volume] in Serum or Plasma |
|
34631-2
|
Cyproheptadine [Mass/volume] in Urine |
|
16711-4
|
Cystine+Homocystine [Presence] in Urine |
|
2180-8
|
Cystine+Cysteine [Mass/volume] in Serum or Plasma |
|
10969-4
|
Cystine+Homocysteine [Presence] in Urine |
|
53066-7
|
Cystathionine [Moles/volume] in DBS |
|
53069-1
|
Cystathionine [Moles/volume] in Body fluid |
|
87430-5
|
Cystatin C and Glomerular filtration rate by Cystatin-based formula panel - Serum or Plasma |
|
54380-1
|
Cystatin C [Mass/volume] in 24 hour Urine |
|
54381-9
|
Cystatin C [Mass/time] in 24 hour Urine |
|
33863-2
|
Cystatin C [Mass/volume] in Serum or Plasma |
|
47612-7
|
Cystatin C [Mass/volume] in Urine |
|
54379-3
|
Cystatin C/Creatinine [Ratio] in Urine |
|
26843-3
|
Cystine [Presence] in 24 hour Urine |
|
32169-5
|
Cystine [Mass/volume] in 24 hour Urine |
|
2179-0
|
Cystine [Mass/time] in 24 hour Urine |
|
34278-2
|
Cystine [Moles/volume] in 24 hour Urine |
|
13966-7
|
Cystine [Moles/time] in 24 hour Urine |
|
53080-8
|
Cystine [Moles/mass] in Chorionic villus sample |
|
40870-8
|
Cystine Free [Presence] in Serum or Plasma |
|
34624-7
|
Cystine Free [Moles/volume] in Serum or Plasma |
|
43124-7
|
Cystine panel - Urine |
|
9644-6
|
Cystine [Presence] in Urine |
|
16709-8
|
Cystine [Units/volume] in Urine |
|
2178-2
|
Cystine [Mass/volume] in Urine |
|
26962-1
|
Cystine [Moles/volume] in Urine |
|
33872-3
|
Cystine [Moles/mass] in Leukocytes |
|
44312-7
|
Cystine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56677-8
|
Cystine/Creatinine [Ratio] in 24 hour Urine |
|
25894-7
|
Cystine/Creatinine [Molar ratio] in 24 hour Urine |
|
13725-7
|
Cystine/Creatinine [Mass Ratio] in Urine |
|
30065-7
|
Cystine/Creatinine [Ratio] in Urine |
|
22687-8
|
Cystine/Creatinine [Molar ratio] in Urine |
|
90785-7
|
Cystinuria panel - 24 hour Urine |
|
90784-0
|
Cystinuria panel - Urine |
|
2181-6
|
Cystinyl aminopeptidase [Enzymatic activity/volume] in Serum |
|
53450-3
|
Cytarabine [Mass/volume] in Serum or Plasma |
|
31196-9
|
Microscopic observation [Identifier] in Abdomen fine needle aspirate by Cyto stain |
|
18498-6
|
Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain |
|
50971-1
|
Cytology report of Bronchial brush Cyto stain |
|
42210-5
|
Microscopic observation [Identifier] in Bronchial specimen by Cyto stain |
|
18501-7
|
Microscopic observation [Identifier] in Buccal smear by Cyto stain |
|
42209-7
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Cyto stain |
|
10524-7
|
Microscopic observation [Identifier] in Cervix by Cyto stain |
|
19765-7
|
Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
|
19766-5
|
Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative |
|
18502-5
|
Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain |
|
49050-8
|
Microscopic observation [Identifier] in Endocervical brush by Cyto stain |
|
55604-3
|
Microscopic observation [Identifier] in Endometrium by Cyto stain |
|
43417-5
|
Microscopic observation [Identifier] in Esophageal brushing by Cyto stain |
|
11068-4
|
Microscopic observation [Identifier] in Body fluid by Cyto stain |
|
11069-2
|
Microscopic observation [Identifier] in Gastric fluid by Cyto stain |
|
31188-6
|
Microscopic observation [Identifier] in Kidney fine needle aspirate by Cyto stain |
|
31192-8
|
Microscopic observation [Identifier] in Liver fine needle aspirate by Cyto stain |
|
31187-8
|
Microscopic observation [Identifier] in Lymph node fine needle aspirate by Cyto stain |
|
31199-3
|
Microscopic observation [Identifier] in Lung fine needle aspirate by Cyto stain |
|
31189-4
|
Microscopic observation [Identifier] in Neck mass fine needle aspirate by Cyto stain |
|
18499-4
|
Microscopic observation [Identifier] in Nipple discharge by Cyto stain |
|
31193-6
|
Microscopic observation [Identifier] in Pancreas fine needle aspirate by Cyto stain |
|
31198-5
|
Microscopic observation [Identifier] in Parotid fine needle aspirate by Cyto stain |
|
55601-9
|
Microscopic observation [Identifier] in Pericardial fluid by Cyto stain |
|
31197-7
|
Microscopic observation [Identifier] in Pelvis fine needle aspirate by Cyto stain |
|
55602-7
|
Microscopic observation [Identifier] in Pleural fluid by Cyto stain |
|
31191-0
|
Microscopic observation [Identifier] in Prostate fine needle aspirate by Cyto stain |
|
55600-1
|
Microscopic observation [Identifier] in Peritoneal fluid by Cyto stain |
|
31190-2
|
Microscopic observation [Identifier] in Salivary gland fine needle aspirate by Cyto stain |
|
55603-5
|
Microscopic observation [Identifier] in Synovial fluid by Cyto stain |
|
31195-1
|
Microscopic observation [Identifier] in Soft tissue fine needle aspirate by Cyto stain |
|
10526-2
|
Microscopic observation [Identifier] in Sputum by Cyto stain |
|
31194-4
|
Microscopic observation [Identifier] in Submandibular fine needle aspirate by Cyto stain |
|
18503-3
|
Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain |
|
18497-8
|
Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain |
|
10527-0
|
Microscopic observation [Identifier] in Tissue by Cyto stain |
|
11070-0
|
Microscopic observation [Identifier] in Urine by Cyto stain |
|
10525-4
|
Microscopic observation [Identifier] in Unspecified specimen by Cyto stain |
|
55228-1
|
Cytogenetics study |
|
50789-7
|
Cytokeratin cells [#/volume] in Blood |
|
82335-1
|
Cytokines panel - Serum or Plasma |
|
40860-9
|
Cytokines [Presence] in Serum or Plasma |
|
45196-3
|
Cytokines [Presence] in Unspecified specimen |
|
59256-8
|
Cytologist who read Cyto stain of Unspecified specimen |
|
50007-4
|
Cytology report of Bronchoalveolar lavage Cyto stain |
|
47530-1
|
Cytology report of Breast ductal lavage Cyto stain |
|
47521-0
|
Cytology report of Breast fine needle aspirate Cyto stain |
|
47528-5
|
Cytology report of Cervical or vaginal smear or scraping Cyto stain |
|
47527-7
|
Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep |
|
33717-0
|
Cytology Cervical or vaginal smear or scraping study |
|
47523-6
|
Cytology report of Body fluid Cyto stain |
|
47522-8
|
Cytology report of Nipple discharge Cyto stain |
|
47520-2
|
Cytology report of Sputum Cyto stain |
|
47524-4
|
Cytology report of Thyroid fine needle aspirate Cyto stain |
|
47529-3
|
Cytology report of Tissue Other stain |
|
33718-8
|
Cytology report of Tissue fine needle aspirate Cyto stain |
|
47525-1
|
Cytology report of Urine Cyto stain |
|
47526-9
|
Cytology report of Unspecified specimen Cyto stain |
|
54239-9
|
Cytopathic effect [Presence] in Unspecified specimen |
|
55171-3
|
Cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence |
|
55170-5
|
Cytoplasmic Ab [Titer] in Serum by Immunofluorescence |
|
34404-4
|
Cytoskeleton Ab [Titer] in Serum by Immunofluorescence |
|
35478-7
|
Cytosol aminopeptidase [Enzymatic activity/time] in 24 hour Urine |
|
2187-3
|
Cytosol aminopeptidase [Enzymatic activity/volume] in Serum or Plasma |
|
2188-1
|
Cytosol aminopeptidase [Presence] in Urine |
|
2189-9
|
Cytosol aminopeptidase [Enzymatic activity/volume] in Urine |
|
93940-5
|
D Ag [Presence] on Red Blood Cells --during infancy |
|
93930-6
|
D Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
978-7
|
D Ag [Presence] on Red Blood Cells |
|
93948-8
|
D Ag [Presence] in Cord red blood cells |
|
23026-8
|
Dermatophilus congolensis Ab [Presence] in Serum |
|
23027-6
|
Dermatophilus congolensis Ab [Presence] in Serum by Immunoassay |
|
31800-6
|
Dermatophilus congolensis Ag [Presence] in Exudate |
|
23598-6
|
Dermatophilus congolensis Ag [Presence] in Exudate by Immunofluorescence |
|
23028-4
|
Dermatophilus congolensis Ag [Presence] in Tissue by Immunofluorescence |
|
23596-0
|
Dermatophilus congolensis [Presence] in Exudate by Carbol-fuchsin stain |
|
23595-2
|
Dermatophilus congolensis [Presence] in Exudate by Giemsa stain |
|
23597-8
|
Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain |
|
23025-0
|
Dermatophilus congolensis [Presence] in Skin by Giemsa stain |
|
42499-4
|
Fibrin D-dimer [Presence] in Cerebral spinal fluid |
|
91556-1
|
Fibrin D-dimer DDU [Mass/volume] in Blood by Immunoassay |
|
42727-8
|
Fibrin D-dimer DDU [Mass/volume] in Cerebral spinal fluid by Latex agglutination |
|
48058-2
|
Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay |
|
48066-5
|
Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma |
|
71427-9
|
Fibrin D-dimer FEU [Mass/volume] in Blood by Immunoassay |
|
48067-3
|
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma by Immunoassay |
|
48065-7
|
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma |
|
3246-6
|
Fibrin D-dimer [Units/volume] in Platelet poor plasma by Immunoassay |
|
15179-5
|
Fibrin D-dimer [Presence] in Platelet poor plasma |
|
29280-5
|
Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination |
|
7799-0
|
Fibrin D-dimer [Units/volume] in Platelet poor plasma |
|
38898-3
|
Fibrin D-dimer [Titer] in Platelet poor plasma |
|
65790-8
|
American house dust mite native (nDer f) 1 IgE Ab [Units/volume] in Serum |
|
78374-6
|
American house dust mite native (nDer f) 2 IgE Ab [Units/volume] in Serum |
|
7277-7
|
American house dust mite triggered histamine release [Units/volume] in Blood |
|
6095-4
|
American house dust mite IgE Ab [Units/volume] in Serum |
|
16741-1
|
American house dust mite IgG Ab [Presence] in Blood |
|
51534-6
|
American house dust mite IgG Ab [Presence] in Serum |
|
7276-9
|
American house dust mite IgG Ab [Units/volume] in Serum |
|
26419-2
|
American house dust mite IgG4 Ab [Units/volume] in Serum |
|
56241-3
|
American house dust mite IgG4 Ab [Mass/volume] in Serum |
|
63075-6
|
American house dust mite IgG Ab [Mass/volume] in Serum |
|
48235-6
|
American house dust mite triggered leukotriene release [Mass/volume] by Leukocytes |
|
70295-1
|
Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection |
|
30040-0
|
Dirofilaria immitis Ab [Units/volume] in Serum |
|
30044-2
|
Dirofilaria immitis Ab [Titer] in Serum |
|
23029-2
|
Dirofilaria immitis Ag [Presence] in Blood |
|
31801-4
|
Dirofilaria immitis Ag [Presence] in Serum |
|
23710-7
|
Dirofilaria immitis Ag [Presence] in Serum by Immunoassay |
|
93085-9
|
Dirofilaria immitis IgG Ab [Presence] in Serum by Immunoassay |
|
14036-8
|
Dermatophagoides microceras IgE Ab [Units/volume] in Serum |
|
61257-2
|
Dermatophagoides microceras IgE Ab/IgE total in Serum |
|
63456-8
|
European house dust mite native (nDer p) 1 IgE Ab [Units/volume] in Serum |
|
81792-4
|
Dermatophagoides pteronyssinus native (nDer p) 2 IgE Ab [Units/volume] in Serum |
|
63463-4
|
European house dust mite recombinant (rDer p) 10 IgE Ab [Units/volume] in Serum |
|
63457-6
|
European house dust mite recombinant (rDer p) 2 IgE Ab [Units/volume] in Serum |
|
7279-3
|
European house dust mite triggered histamine release [Units/volume] in Blood |
|
6096-2
|
European house dust mite IgE Ab [Units/volume] in Serum |
|
61258-0
|
European house dust mite IgE Ab/IgE total in Serum |
|
16742-9
|
European house dust mite IgG Ab [Presence] in Blood |
|
51533-8
|
European house dust mite IgG Ab [Presence] in Serum |
|
7278-5
|
European house dust mite IgG Ab [Units/volume] in Serum |
|
26421-8
|
European house dust mite IgG4 Ab [Units/volume] in Serum |
|
56242-1
|
European house dust mite IgG4 Ab [Mass/volume] in Serum |
|
81772-6
|
European house dust mite IgG Ab [Mass/volume] in Serum |
|
48236-4
|
European house dust mite triggered leukotriene release [Mass/volume] by Leukocytes |
|
88708-3
|
Dermatophagoides pteronyssinus recombinant (rDer p) 1 IgE Ab [Units/volume] in Serum |
|
93950-4
|
D variant Ag [Presence] on Red Blood Cells |
|
73909-4
|
D2-40 Ag [Presence] in Tissue by Immune stain |
|
79307-5
|
D-2-hydroxyglutarate [Moles/volume] in Amniotic fluid |
|
79296-0
|
D- and L-2-hydroxyglutarate panel - Amniotic fluid |
|
79294-5
|
D- and L-2-hydroxyglutarate panel - Cerebral spinal fluid |
|
79298-6
|
D- and L-2-hydroxyglutarate panel - DBS |
|
79295-2
|
D- and L-2-hydroxyglutarate panel - Serum or Plasma |
|
79297-8
|
D- and L-2-hydroxyglutarate panel - Urine |
|
79304-2
|
D-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
|
79306-7
|
D-2-hydroxyglutarate [Moles/volume] in DBS |
|
79305-9
|
D-2-hydroxyglutarate [Moles/volume] in Serum or Plasma |
|
80100-1
|
D-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine |
|
6699-3
|
Delta 5-Pregnanetriol [Mass/time] in 24 hour Urine |
|
18214-7
|
Delta 5-Pregnanetriol [Mass/volume] in Urine |
|
68980-2
|
Dabigatran [Units/volume] in Platelet poor plasma by Chromogenic method |
|
74220-5
|
Dabigatran [Mass/volume] in Platelet poor plasma by Coagulation assay |
|
74263-5
|
Dabigatran [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
72625-7
|
Dabigatran [Mass/volume] in Serum or Plasma |
|
82379-9
|
Daclatasvir [Susceptibility] by Genotype method |
|
7273-6
|
Dahlia IgE Ab [Units/volume] in Serum |
|
78708-5
|
Daily or end of shift signout note |
|
7274-4
|
Daisy IgE Ab [Units/volume] in Serum |
|
26974-6
|
Delta aminolevulinate [Mass/volume] in 24 hour Urine |
|
2200-4
|
Delta aminolevulinate [Mass/time] in 24 hour Urine |
|
25896-2
|
Delta aminolevulinate [Moles/volume] in 24 hour Urine |
|
14689-4
|
Delta aminolevulinate [Moles/time] in 24 hour Urine |
|
2198-0
|
Delta aminolevulinate [Mass/volume] in Plasma |
|
2199-8
|
Delta aminolevulinate [Mass/volume] in Serum |
|
47088-0
|
Delta aminolevulinate [Moles/volume] in Serum |
|
11215-1
|
Delta aminolevulinate [Mass/volume] in Urine |
|
12475-0
|
Delta aminolevulinate [Mass/time] in Urine |
|
34284-0
|
Delta aminolevulinate [Moles/volume] in Urine |
|
44313-5
|
Delta aminolevulinate/Creatinine [Mass Ratio] in 24 hour Urine |
|
25897-0
|
Delta aminolevulinate/Creatinine [Molar ratio] in 24 hour Urine |
|
13728-1
|
Delta aminolevulinate/Creatinine [Mass Ratio] in Urine |
|
56658-8
|
Delta aminolevulinate/Creatinine [Ratio] in Urine |
|
39782-8
|
Delta aminolevulinate/Creatinine [Molar ratio] in Urine |
|
74526-5
|
Delta aminolevulinate, porphobilinogen and creatinine panel - 24 hour Urine |
|
74527-3
|
Delta aminolevulinate, porphobilinogen and creatinine panel - Urine |
|
18215-4
|
Delta alanine [Mass/volume] in Urine |
|
80555-6
|
Diamorphine [Mass/mass] in Hair |
|
16756-9
|
Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
18387-1
|
Diamorphine [Mass/volume] in Serum or Plasma |
|
16755-1
|
Diamorphine [Mass/volume] in Urine by Confirmatory method |
|
3546-9
|
Diamorphine [Presence] in Urine |
|
16198-4
|
Diamorphine [Presence] in Urine by Confirmatory method |
|
19439-9
|
Diamorphine [Presence] in Urine by Screen method |
|
3547-7
|
Diamorphine [Mass/volume] in Urine |
|
12326-5
|
Diamorphine [Presence] in Unknown substance |
|
16754-4
|
Diamorphine [Mass/volume] in Unknown substance |
|
9814-5
|
Dextroamphetamine [Mass/volume] in Serum or Plasma |
|
20525-2
|
Dextroamphetamine [Mass/volume] in Urine by Confirmatory method |
|
19420-9
|
Dextroamphetamine [Presence] in Urine by Confirmatory method |
|
19419-1
|
Dextroamphetamine [Presence] in Urine by Screen method |
|
15366-8
|
Dextroamphetamine [Mass/volume] in Urine |
|
73688-4
|
Danazol [Presence] in Urine by Screen method |
|
6097-0
|
Dandelion IgE Ab [Units/volume] in Serum |
|
61318-2
|
Dandelion IgE Ab/IgE total in Serum |
|
56243-9
|
Dandelion IgG4 Ab [Mass/volume] in Serum |
|
60069-2
|
Dantrolene [Mass/volume] in Blood |
|
9746-9
|
Dantrolene [Mass/volume] in Serum or Plasma |
|
42665-0
|
Dantron [Mass/mass] in Stool |
|
3527-9
|
Dantron [Mass/volume] in Urine |
|
68967-9
|
Dantu Ab [Presence] in Serum or Plasma |
|
10931-4
|
Daphnia (fish feed) IgE Ab [Units/volume] in Serum |
|
20885-0
|
Microscopic observation [Identifier] in Gastric fluid by Dark field examination |
|
20884-3
|
Microscopic observation [Identifier] in Stool by Dark field examination |
|
6607-6
|
Microscopic observation [Identifier] in Tissue by Dark field examination |
|
20883-5
|
Microscopic observation [Identifier] in Urine by Dark field examination |
|
660-1
|
Microscopic observation [Identifier] in Unspecified specimen by Dark field examination |
|
75742-7
|
Dartmouth COOP Functional Assessment Charts - 2 weeks |
|
75743-5
|
Dartmouth COOP Functional Assessment Charts - 4 weeks |
|
55091-3
|
Darunavir [Susceptibility] by Genotype method |
|
49666-1
|
Darunavir [Susceptibility] by Phenotype method |
|
57954-0
|
Darunavir [Mass/volume] in Serum or Plasma |
|
49630-7
|
Darunavir+Ritonavir [Susceptibility] by Genotype method |
|
57955-7
|
Darunavir+Ritonavir [Susceptibility] by Phenotype method |
|
58956-4
|
Direct antiglobulin test.complement C3b+C4d specific reagent [Presence] on Red Blood Cells |
|
56471-6
|
Direct antiglobulin test.complement C3c specific reagent [Presence] on Red Blood Cells |
|
55774-4
|
Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells |
|
54410-6
|
Direct antiglobulin test.complement C3 specific reagent [Presence] on Red Blood Cells |
|
1004-1
|
Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
|
55775-1
|
Direct antiglobulin test.IgA specific reagent [Presence] on Red Blood Cells |
|
90907-7
|
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells --after transfusion reaction |
|
55776-9
|
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells |
|
55777-7
|
Direct antiglobulin test.IgM specific reagent [Presence] on Red Blood Cells |
|
51007-3
|
Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells --after transfusion |
|
46274-7
|
Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells --after transfusion reaction |
|
1007-4
|
Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
|
51871-2
|
Direct antiglobulin test.poly specific reagent [presence] on Cord red blood cells |
|
51006-5
|
Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells |
|
79218-4
|
Date education program completed by Patient |
|
79216-8
|
Date education program assigned to Patient |
|
79219-2
|
Date education program expires for Patient |
|
79217-6
|
Date education program started by Patient |
|
7275-1
|
Date Palm Pollen IgE Ab [Units/volume] in Serum |
|
88030-2
|
Date quit smokeless tobacco |
|
80992-1
|
Date and time of surgery |
|
80410-4
|
Date and time of transfer departure |
|
31002-9
|
Dates IgE Ab [Units/volume] in Serum |
|
56244-7
|
Dates IgG4 Ab [Mass/volume] in Serum |
|
63130-9
|
Dates IgG Ab [Mass/volume] in Serum |
|
46058-4
|
Days received the following medication Set |
|
47027-8
|
DBA44 Ag [Presence] in Tissue by Immune stain |
|
999-3
|
DBG Ag [Presence] on Red Blood Cells |
|
86463-7
|
DBT Breast - bilateral |
|
72139-9
|
DBT Breast - bilateral diagnostic |
|
91519-9
|
DBT Breast - bilateral diagnostic for implant |
|
72142-3
|
DBT Breast - bilateral screening |
|
91522-3
|
DBT Breast - bilateral screen for implant |
|
72138-1
|
DBT Breast - left diagnostic |
|
91518-1
|
DBT Breast - left diagnostic for implant |
|
72141-5
|
DBT Breast - left screening |
|
91521-5
|
DBT Breast - left screen for implant |
|
72137-3
|
DBT Breast - right diagnostic |
|
91517-3
|
DBT Breast - right diagnostic for implant |
|
72140-7
|
DBT Breast - right screening |
|
91520-7
|
DBT Breast - right screen for implant |
|
86462-9
|
DBT Breast - unilateral |
|
16766-8
|
Dichloroethane [Presence] in Blood |
|
12307-5
|
Dichloroethane [Mass/volume] in Blood |
|
16762-7
|
Dichlorobenzene [Mass/volume] in Blood |
|
84432-4
|
Dimensional Change Card Sort Test [NIH Toolbox] |
|
12996-5
|
Dichlorodifluoroethane [Mass/volume] in Blood |
|
13935-2
|
Dichlorodifluoromethane [Mass/volume] in Blood |
|
38610-2
|
Methylene chloride [Mass/volume] in Air |
|
12998-1
|
Methylene chloride [Mass/volume] in Blood |
|
56625-7
|
Methylene chloride [Moles/volume] in Blood |
|
38739-9
|
1,3-Dichloropropene [Mass/volume] in Air |
|
48969-0
|
DCX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38740-7
|
Dimethylcarbamoyl chloride [Mass/volume] in Air |
|
17695-8
|
Tetrachlorodiphenylethane [Mass/volume] in Blood |
|
40817-9
|
Tetrachlorodiphenylethane [Presence] in Serum or Plasma |
|
14257-0
|
Tetrachlorodiphenylethane [Mass/volume] in Serum or Plasma |
|
14256-2
|
Tetrachlorodiphenylethane [Mass/mass] in Tissue |
|
17696-6
|
Tetrachlorodiphenylethane [Mass/volume] in Urine |
|
38669-8
|
Dichlorodiphenyldichloroethylene [Mass/volume] in Air |
|
16764-3
|
Dichlorodiphenyldichloroethylene [Mass/volume] in Blood |
|
11093-2
|
Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma |
|
14262-0
|
Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue |
|
16763-5
|
Dichlorodiphenyldichloroethylene [Mass/volume] in Urine |
|
87640-9
|
Dichlorodiphenyldichloroethylene [Mass/mass] in Unspecified specimen |
|
9747-7
|
Dapsone [Mass/volume] in Serum or Plasma |
|
51698-9
|
Dapsone [Susceptibility] |
|
53643-3
|
Dichlorodiphenyltrichloroethane [Presence] in Gastric fluid |
|
16765-0
|
Dichlorodiphenyltrichloroethane [Mass/volume] in Milk |
|
26953-0
|
Dichlorodiphenyltrichloroethane [Presence] in Serum or Plasma |
|
11094-0
|
Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma |
|
14263-8
|
Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue |
|
87639-1
|
Dichlorodiphenyltrichloroethane [Mass/mass] in Unspecified specimen |
|
86807-5
|
Death administrative information Document |
|
64297-5
|
Death certificate |
|
74734-5
|
Death certifier details |
|
86804-2
|
Cause of death classification and related information Document |
|
74499-5
|
Death pronouncer details |
|
53459-4
|
Decadienoylcarnitine (C10:2) [Moles/volume] in Amniotic fluid |
|
53464-4
|
Decadienoylcarnitine (C10:2) [Moles/volume] in Cerebral spinal fluid |
|
53180-6
|
Decadienoylcarnitine (C10:2) [Moles/volume] in DBS |
|
74610-7
|
Decadienoylcarnitine (C10:2) [Enzymatic activity/mass] in Fibroblast |
|
53471-9
|
Decadienoylcarnitine (C10:2) [Moles/volume] in Serum or Plasma |
|
53492-5
|
Decadienoylcarnitine (C10:2) [Moles/volume] in Urine |
|
53508-8
|
Decadienoylcarnitine (C10:2)/Creatinine [Molar ratio] in Urine |
|
75116-4
|
Decanoate (C10:0) [Entitic substance] in Red Blood Cells |
|
47613-5
|
Decanoate (C10:0)/Creatinine [Molar ratio] in Urine |
|
53056-8
|
Decanoylcarnitine (C10) [Moles/volume] in Amniotic fluid |
|
53075-8
|
Decanoylcarnitine (C10) [Moles/volume] in Cerebral spinal fluid |
|
45197-1
|
Decanoylcarnitine (C10) [Moles/volume] in DBS |
|
74612-3
|
Decanoylcarnitine (C10) [Enzymatic activity/mass] in Fibroblast |
|
53102-0
|
Decanoylcarnitine (C10) [Moles/volume] in Urine |
|
53504-7
|
Decanoylcarnitine (C10)/Creatinine [Molar ratio] in Urine |
|
53208-5
|
Decatrienoylcarnitine (C10:3) [Moles/volume] in DBS |
|
74524-0
|
Decatrienoylcarnitine (C10:3) [Moles/volume] in Serum or Plasma |
|
79509-6
|
Decenedioate [Moles/volume] in Serum or Plasma |
|
78350-6
|
Decenoate (C10:1) [Entitic substance] in Red Blood Cells |
|
47614-3
|
Decenoate (C10:1)/Creatinine [Molar ratio] in Urine |
|
53057-6
|
Decenoylcarnitine (C10:1) [Moles/volume] in Amniotic fluid |
|
53076-6
|
Decenoylcarnitine (C10:1) [Moles/volume] in Cerebral spinal fluid |
|
45198-9
|
Decenoylcarnitine (C10:1) [Moles/volume] in DBS |
|
74611-5
|
Decenoylcarnitine (C10:1) [Enzymatic activity/mass] in Fibroblast |
|
53103-8
|
Decenoylcarnitine (C10:1) [Moles/volume] in Urine |
|
53108-7
|
Decenoylcarnitine (C10:1)/Creatinine [Molar ratio] in Urine |
|
16720-5
|
Dechlorane [Presence] in Blood |
|
16151-3
|
Dechlorane [Presence] in Serum or Plasma |
|
87645-8
|
Dechlorane [Mass/mass] in Unspecified specimen |
|
10926-4
|
Deer epithelium IgE Ab [Units/volume] in Serum |
|
7319-7
|
Deer Fly IgE Ab [Units/volume] in Serum |
|
56245-4
|
Deer Fly IgG4 Ab [Mass/volume] in Serum |
|
11169-0
|
Deer hair IgE Ab [Units/volume] in Serum |
|
38636-7
|
Di(2-Ethylhexyl) phthalate [Mass/volume] in Air |
|
88714-1
|
Dehydroaripiprazole [Mass/volume] in Serum or Plasma by Confirmatory method |
|
77884-5
|
Dehydroaripiprazole [Mass/volume] in Urine by Confirmatory method |
|
31013-6
|
Dehydrochlormethyltestosterone [Mass/volume] in Urine |
|
53211-9
|
Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in DBS |
|
74525-7
|
Dehydrosebacylcarnitine (C10:1-DC) [Moles/volume] in Serum or Plasma |
|
53209-3
|
Dehydrosuberylcarnitine (C8:1-DC) [Moles/volume] in DBS |
|
72728-9
|
Del(13)(q14) [Identifier] in Blood or Tissue by FISH Nominal |
|
72727-1
|
Del(13)(q14) and del(17)(p13) in Blood or Tissue |
|
72824-6
|
Del(17)(p13) [Identifier] in Blood or Tissue by FISH Nominal |
|
70289-4
|
Del(1)(p32p32)(STIL,TAL1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
42715-3
|
Del(5)(q12-35) deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93851-4
|
Delamanid [Susceptibility] |
|
29115-3
|
Delavirdine [Units/volume] in Serum or Plasma |
|
27082-7
|
Delavirdine [Mass/volume] in Serum or Plasma |
|
76021-5
|
Delta aPTT [Time] in Platelet poor plasma by Coagulation assay |
|
76020-7
|
Delta dRVVT [Time] in Platelet poor plasma by Coagulation assay |
|
60850-5
|
Delta frequency relative power on EEG |
|
11170-8
|
Dematiaceae IgE Ab [Units/volume] in Serum |
|
10982-7
|
Demeclocycline [Mass/volume] in Serum or Plasma |
|
29494-2
|
Demeclocycline [Mass/volume] in Unspecified specimen |
|
47246-4
|
HIV Antiretroviral therapy Demographic information section |
|
45970-1
|
Demographic information section |
|
74208-0
|
Demographic information + History of occupation Document |
|
13556-6
|
Demoxepam [Presence] in Serum or Plasma |
|
12377-8
|
Demoxepam [Mass/volume] in Serum or Plasma |
|
83829-2
|
Dentistry Administrative note |
|
90786-5
|
Dentistry Attending Note |
|
34756-7
|
Dentistry Consult note |
|
78259-9
|
Dentistry Diagnostic study note |
|
29761-4
|
Dentistry Discharge summary |
|
83834-2
|
Dentistry Emergency department Note |
|
78275-5
|
Dentistry Education note |
|
78301-9
|
Dentistry Flowsheet |
|
83830-0
|
Dentistry History and physical note |
|
83831-8
|
Dentistry Hospital Note |
|
34127-1
|
Dentistry Hygienist Outpatient Progress note |
|
28572-6
|
Dentistry Initial evaluation note |
|
83832-6
|
Dentistry Long term care facility Note |
|
28618-7
|
Dentistry Note |
|
83601-5
|
Dentistry Nurse Long term care facility Note |
|
34128-9
|
Dentistry Outpatient Progress note |
|
28583-3
|
Dentist Operation note |
|
83838-3
|
Dentistry Telephone encounter Note |
|
80743-8
|
Dentistry Plan of care note |
|
83833-4
|
Dentistry Postoperative evaluation and management note |
|
83828-4
|
Dentistry Preoperative evaluation and management note |
|
28577-5
|
Dentistry procedure note |
|
28617-9
|
Dentistry Progress note |
|
57134-9
|
Dentistry Referral note |
|
90787-3
|
Dentistry Resident Note |
|
83835-9
|
Dentistry Risk assessment and screening note |
|
83836-7
|
Dentistry Summary note |
|
83837-5
|
Dentistry Technician Note |
|
83839-1
|
Dentistry Transplant candidate evaluation note |
|
81154-7
|
Dengue and Chikungunya and Zika virus panel by NAA with probe detection |
|
81151-3
|
Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81150-5
|
Dengue virus 1+2+3+4 5' UTR RNA [Presence] in Serum by NAA with probe detection |
|
77958-7
|
Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Cerebral spinal fluid by NAA with probe detection |
|
88203-5
|
Dengue virus 1 and 2 and 3 and 4 RNA [Identifier] in Serum or Blood by NAA with probe detection |
|
82519-0
|
Dengue virus 1+3 and 2+4 panel - Serum by NAA with probe detection |
|
82384-9
|
Dengue virus 1+3 RNA [Presence] in Serum by NAA with probe detection |
|
82383-1
|
Dengue virus 2+4 RNA [Presence] in Serum by NAA with probe detection |
|
16740-3
|
Dengue virus Ab [Presence] in Serum |
|
40748-6
|
Dengue virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
7859-2
|
Dengue virus Ab [Units/volume] in Serum |
|
33606-5
|
Dengue virus Ab [Titer] in Serum |
|
40515-9
|
Dengue virus Ab [Titer] in Serum by Complement fixation |
|
55369-3
|
Dengue virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
33578-6
|
Dengue virus Ab [Titer] in Serum by Immunofluorescence |
|
55438-6
|
Dengue virus Ab [Titer] in Serum by Neutralization test |
|
31343-7
|
Dengue virus Ab [Presence] in Unspecified specimen |
|
50036-3
|
Dengue virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
31342-9
|
Dengue virus Ab [Units/volume] in Unspecified specimen |
|
31798-2
|
Dengue virus Ag [Presence] in Serum |
|
6384-2
|
Dengue virus Ag [Presence] in Serum by Immunofluorescence |
|
31799-0
|
Dengue virus Ag [Presence] in Unspecified specimen |
|
6385-9
|
Dengue virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
6386-7
|
Dengue virus DNA [Presence] in Serum by Probe |
|
6387-5
|
Dengue virus DNA [Presence] in Unspecified specimen by Probe |
|
23991-3
|
Dengue virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
29676-4
|
Dengue virus IgG Ab [Presence] in Serum |
|
23958-2
|
Dengue virus IgG Ab [Units/volume] in Serum |
|
29661-6
|
Dengue virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
6811-4
|
Dengue virus IgG Ab [Titer] in Serum |
|
87546-8
|
Dengue virus IgG and IgM panel - Serum Qualitative |
|
41878-0
|
Dengue virus IgG and IgM panel [Units/volume] - Serum by Immunoassay |
|
75223-8
|
Dengue virus IgG and IgM [Identifier] in Serum, Plasma or Blood by Rapid immunoassay |
|
34721-1
|
Dengue virus IgM Ab [Presence] in Cerebral spinal fluid |
|
23992-1
|
Dengue virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
25338-5
|
Dengue virus IgM Ab [Presence] in Serum |
|
25392-2
|
Dengue virus IgM Ab [Presence] in Serum by Immunoblot |
|
23968-1
|
Dengue virus IgM Ab [Units/volume] in Serum |
|
29663-2
|
Dengue virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
6812-2
|
Dengue virus IgM Ab [Titer] in Serum |
|
91064-6
|
Dengue virus NS1 Ag [Presence] in Serum or Plasma by Immunoassay |
|
75377-2
|
Dengue virus NS1 Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
85584-1
|
Dengue virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
|
22250-5
|
Dengue virus 1 Ab [Presence] in Serum |
|
7854-3
|
Dengue virus 1 Ab [Presence] in Serum by Immunoassay |
|
31338-7
|
Dengue virus 1 Ab [Units/volume] in Serum |
|
16736-1
|
Dengue virus 1 Ab [Titer] in Serum |
|
86860-4
|
Dengue virus 1 neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86865-3
|
Dengue virus 1 neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
60262-3
|
Dengue virus 1 RNA [Presence] in Serum by NAA with probe detection |
|
87440-4
|
Dengue virus 1+2+3+4 IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen Qualitative by Immunoassay |
|
88189-6
|
Dengue virus 1+2+3+4 RNA [Presence] in Blood by NAA with probe detection |
|
7855-0
|
Dengue virus 1+2+3+4 RNA [Presence] in Serum by NAA with probe detection |
|
88188-8
|
Dengue virus 1+2+3+4 RNA [Presence] in Urine by NAA with probe detection |
|
87441-2
|
Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM panel - Unspecified specimen by Immunoassay |
|
22251-3
|
Dengue virus 2 Ab [Presence] in Serum |
|
7856-8
|
Dengue virus 2 Ab [Presence] in Serum by Immunoassay |
|
31339-5
|
Dengue virus 2 Ab [Units/volume] in Serum |
|
16737-9
|
Dengue virus 2 Ab [Titer] in Serum |
|
86858-8
|
Dengue virus 2 neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86864-6
|
Dengue virus 2 neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
60420-7
|
Dengue virus 2 RNA [Presence] in Serum by NAA with probe detection |
|
22252-1
|
Dengue virus 3 Ab [Presence] in Serum |
|
7857-6
|
Dengue virus 3 Ab [Presence] in Serum by Immunoassay |
|
31340-3
|
Dengue virus 3 Ab [Units/volume] in Serum |
|
16738-7
|
Dengue virus 3 Ab [Titer] in Serum |
|
86859-6
|
Dengue virus 3 neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86863-8
|
Dengue virus 3 neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
60419-9
|
Dengue virus 3 RNA [Presence] in Serum by NAA with probe detection |
|
22253-9
|
Dengue virus 4 Ab [Presence] in Serum |
|
7858-4
|
Dengue virus 4 Ab [Presence] in Serum by Immunoassay |
|
31341-1
|
Dengue virus 4 Ab [Units/volume] in Serum |
|
16739-5
|
Dengue virus 4 Ab [Titer] in Serum |
|
86861-2
|
Dengue virus 4 neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86862-0
|
Dengue virus 4 neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
60418-1
|
Dengue virus 4 RNA [Presence] in Serum by NAA with probe detection |
|
75124-8
|
Deoxyadenosine [Moles/volume] in Cerebral spinal fluid |
|
75122-2
|
Deoxyadenosine [Moles/volume] in Serum or Plasma |
|
59199-0
|
Deoxyadenosine/Creatinine [Molar ratio] in Urine |
|
75149-5
|
Deoxyguanosine [Moles/volume] in Cerebral spinal fluid |
|
75134-7
|
Deoxyguanosine [Moles/volume] in Serum or Plasma |
|
75157-8
|
Deoxyinosine [Moles/volume] in Cerebral spinal fluid |
|
75127-1
|
Deoxyinosine [Moles/volume] in Serum or Plasma |
|
59202-2
|
Deoxyinosine/Creatinine [Molar ratio] in Urine |
|
75143-8
|
Deoxyuridine [Moles/volume] in Cerebral spinal fluid |
|
47957-6
|
Deoxyuridine [Moles/volume] in Serum or Plasma |
|
41164-5
|
Uranium depleted [Presence] in Urine |
|
41285-8
|
Uranium depleted/Creatinine [Mass Ratio] in 24 hour Urine |
|
41166-0
|
Uranium depleted/Creatinine [Mass Ratio] in Urine |
|
94016-3
|
Depression screening report |
|
89557-3
|
Depression symptoms score [CUBS] |
|
90233-8
|
Dermatan sulfate [Moles/volume] in DBS |
|
2203-8
|
Dermatan sulfate [Mass/volume] in Serum or Plasma |
|
47615-0
|
Dermatan sulfate [Presence] in Urine |
|
2204-6
|
Dermatan sulfate [Mass/volume] in Urine |
|
84076-9
|
Dermatology Administrative note |
|
83682-5
|
Dermatology Attending Note |
|
34758-3
|
Dermatology Consult note |
|
78260-7
|
Dermatology Diagnostic study note |
|
78269-8
|
Dermatology Education note |
|
78294-6
|
Dermatology Flowsheet |
|
84077-7
|
Dermatology History and physical note |
|
68551-1
|
Dermatology Hospital Consult note |
|
84078-5
|
Dermatology Hospital Note |
|
78334-0
|
Dermatology Initial evaluation note |
|
34759-1
|
Dermatology Note |
|
83543-9
|
Dermatology Nurse practitioner Note |
|
83568-6
|
Dermatology Nurse Note |
|
83569-4
|
Dermatology Nurse Outpatient Note |
|
84080-1
|
Dermatology Outpatient Note |
|
84081-9
|
Dermatology Outpatient procedure note |
|
84079-3
|
Dermatology Surgical operation note |
|
84082-7
|
Dermatology Telephone encounter Note |
|
80751-1
|
Dermatology Plan of care note |
|
85887-8
|
Dermatology Postoperative evaluation and management note |
|
68550-3
|
Dermatology Preoperative evaluation and management note |
|
78314-2
|
Dermatology procedure note |
|
78326-6
|
Dermatology Progress note |
|
57135-6
|
Dermatology Referral note |
|
83754-2
|
Dermatology Resident Note |
|
84083-5
|
Dermatology Transfer summary note |
|
41271-8
|
Dermatophagoides sp IgE Ab [Units/volume] in Serum |
|
70027-8
|
Dermatophytes chitin synthase 1 chs1 gene [Presence] in Nail by NAA with probe detection |
|
62265-4
|
Desflurane [VFr/PPres] Airway adaptor --during expiration |
|
60746-5
|
Desflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60805-9
|
Desflurane [VFr/PPres] Airway adaptor --during inspiration |
|
60747-3
|
Desflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60877-8
|
Desflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60744-0
|
Gas delivery system inspiratory Desflurane setting [VFr/PPres] |
|
60876-0
|
Desflurane [VFr/PPres] Airway adaptor |
|
60853-9
|
Desflurane [VFr/PPres] Gas delivery system |
|
80605-9
|
Desacetylrifampicin [Mass/volume] in DBS |
|
80604-2
|
Desacetylrifampicin [Mass/volume] in Serum or Plasma |
|
47404-9
|
N-desalkylflurazepam [Mass/volume] in Blood by Confirmatory method |
|
59647-8
|
N-desalkylflurazepam [Mass/volume] in Blood |
|
59649-4
|
N-desalkylflurazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59648-6
|
N-desalkylflurazepam [Mass/volume] in Body fluid |
|
61098-0
|
N-desalkylflurazepam [Presence] in Gastric fluid |
|
26841-7
|
N-desalkylflurazepam [Mass/mass] in Hair |
|
59650-2
|
N-desalkylflurazepam [Mass/mass] in Meconium by Confirmatory method |
|
26866-4
|
N-desalkylflurazepam [Mass/mass] in Meconium |
|
46980-9
|
N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13568-1
|
N-desalkylflurazepam [Presence] in Serum or Plasma |
|
35605-5
|
N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Screen method |
|
9652-9
|
N-desalkylflurazepam [Mass/volume] in Serum or Plasma |
|
14690-2
|
N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
|
59651-0
|
N-desalkylflurazepam [Mass/mass] in Stool by Confirmatory method |
|
12603-7
|
N-desalkylflurazepam [Presence] in Stool |
|
27436-5
|
N-desalkylflurazepam [Mass/mass] in Stool |
|
59653-6
|
N-desalkylflurazepam [Mass/mass] in Tissue by Confirmatory method |
|
59652-8
|
N-desalkylflurazepam [Mass/mass] in Tissue |
|
16230-5
|
N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method |
|
61040-2
|
N-desalkylflurazepam [Presence] in Urine |
|
19615-4
|
N-desalkylflurazepam [Presence] in Urine by Confirmatory method |
|
19614-7
|
N-desalkylflurazepam [Presence] in Urine by Screen method |
|
19617-0
|
N-desalkylflurazepam [Mass/volume] in Urine |
|
27194-0
|
N-desalkylflurazepam [Mass/volume] in Vitreous fluid |
|
61041-0
|
N-desalkylflurazepam [Presence] in Unspecified specimen |
|
77325-9
|
N-desalkylflurazepam [Moles/volume] in Unspecified specimen |
|
64129-0
|
N-desalkylflurazepam/Creatinine [Mass Ratio] in Urine |
|
21239-9
|
Desalkylhalazepam [Mass/volume] in Serum or Plasma |
|
79506-2
|
Desaminotyrosine [Moles/volume] in Serum or Plasma |
|
79517-9
|
Desaminotyrosine/Creatinine [Molar ratio] in Urine |
|
51195-6
|
Desbutylbupivacaine [Mass/volume] in Serum or Plasma |
|
7647-1
|
Desert Ragweed IgE Ab [Units/volume] in Serum |
|
6774-4
|
Desethylamiodarone [Mass/volume] in Serum or Plasma |
|
25393-0
|
Desethylamiodarone [Moles/volume] in Serum or Plasma |
|
59356-6
|
Desethylvardenafil [Mass/volume] in Blood |
|
59358-2
|
Desethylvardenafil [Mass/volume] in Serum or Plasma |
|
59360-8
|
Desethylvardenafil [Mass/volume] in Urine |
|
60748-1
|
Desflurane gas delivered during case [Volume] from Gas delivery system |
|
61022-0
|
Desflurane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76012-4
|
Desflurane liquid delivered during case [Volume] from Gas delivery system |
|
76013-2
|
Desflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
60741-6
|
Desflurane target [VFr/PPres] Airway adaptor --at end expiration |
|
40358-4
|
Desipramine [Presence] in Gastric fluid |
|
29409-0
|
Desipramine [Mass/volume] in Gastric fluid |
|
59893-8
|
Desipramine [Moles/volume] in Gastric fluid |
|
3532-9
|
Desipramine [Presence] in Serum or Plasma |
|
35606-3
|
Desipramine [Mass/volume] in Serum or Plasma by Screen method |
|
3531-1
|
Desipramine [Mass/volume] in Serum or Plasma |
|
14691-0
|
Desipramine [Moles/volume] in Serum or Plasma |
|
3535-2
|
Desipramine [Mass/volume] in Serum or Plasma --trough |
|
61413-1
|
Desipramine [Mass/volume] in Urine by Confirmatory method |
|
3533-7
|
Desipramine [Presence] in Urine |
|
61412-3
|
Desipramine [Presence] in Urine by Confirmatory method |
|
3534-5
|
Desipramine [Mass/volume] in Urine |
|
14692-8
|
Desipramine [Moles/volume] in Urine |
|
60300-1
|
Desipramine [Moles/volume] in Unspecified specimen |
|
61411-5
|
Desipramine/Creatinine [Mass Ratio] in Urine |
|
59299-8
|
Desloratadine [Mass/volume] in Blood |
|
59300-4
|
Desloratadine [Mass/volume] in Serum or Plasma |
|
59301-2
|
Desloratadine [Mass/volume] in Urine |
|
72457-5
|
Desmin Ab [Presence] in Serum or Plasma by Immunoblot |
|
10476-0
|
Desmin Ag [Presence] in Tissue by Immune stain |
|
57411-1
|
Desmoglein 1 Ab [Units/volume] in Serum by Immunoassay |
|
63218-2
|
Desmoglein 1 Ab [Presence] in Serum by Immunoassay |
|
43311-0
|
Desmoglein 1 Ab [Units/volume] in Serum |
|
43309-4
|
Desmoglein 1 and Desmoglein 3 Ab panel [Units/volume] - Serum |
|
57412-9
|
Desmoglein 3 Ab [Units/volume] in Serum by Immunoassay |
|
63219-0
|
Desmoglein 3 Ab [Presence] in Serum by Immunoassay |
|
43312-8
|
Desmoglein 3 Ab [Units/volume] in Serum |
|
82975-4
|
Desmosome IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
71368-5
|
Desmosome IgG Ab [Titer] in Serum by Immunofluorescence |
|
75739-3
|
Desmosterol [Mass/volume] in Serum or Plasma |
|
74905-1
|
Desmosterol [Moles/volume] in Serum or Plasma |
|
74817-8
|
Desomorphine [Mass/volume] in Urine by Confirmatory method |
|
74818-6
|
Desomorphine [Presence] in Urine by Screen method |
|
57956-5
|
Desoxymethyltestosterone [Presence] in Urine |
|
11072-6
|
Despropionylfentanyl [Mass/volume] in Serum or Plasma |
|
11073-4
|
Despropionylfentanyl [Mass/volume] in Urine |
|
45307-6
|
Deuteroporphyrin [Moles/mass] in Stool |
|
89250-5
|
Device or anatomic structure visible in wound |
|
90710-5
|
Developmental-behavioral pediatrics Consult note |
|
93957-9
|
Developmental-behavioral pediatrics Diagnostic study note |
|
68663-4
|
Developmental-behavioral pediatrics Discharge summary |
|
68665-9
|
Developmental-behavioral pediatrics History and physical note |
|
68670-9
|
Developmental-behavioral pediatrics Hospital Consult note |
|
68671-7
|
Developmental-behavioral pediatrics Hospital Letter |
|
68666-7
|
Developmental-behavioral pediatrics Note |
|
89881-7
|
Developmental-behavioral pediatrics Outpatient Note |
|
68667-5
|
Developmental-behavioral pediatrics procedure note |
|
68668-3
|
Developmental-behavioral pediatrics Progress note |
|
89896-5
|
Developmental-behavioral pediatrics Telehealth Note |
|
68669-1
|
Developmental-behavioral pediatrics Transfer summary note |
|
46067-5
|
Devices and restraints Set |
|
56712-3
|
Dexamethasone IgE Ab [Units/volume] in Serum |
|
14062-4
|
Dexamethasone [Mass/volume] in Serum or Plasma |
|
46948-6
|
Dexamethasone [Mass/volume] in Urine |
|
16751-0
|
Dezocine [Mass/volume] in Blood |
|
16750-2
|
Dezocine [Mass/volume] in Serum or Plasma |
|
14063-2
|
Dezocine [Presence] in Urine |
|
18216-2
|
Dezocine [Presence] in Urine by Confirmatory method |
|
77122-0
|
DFNB31 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77121-2
|
DFNB31 gene full mutation analysis in Blood or Tissue by Sequencing |
|
94098-1
|
Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
82998-6
|
Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Line blot |
|
75095-0
|
Docosahexaenoate (C22:6w3) [Entitic substance] in Red Blood Cells |
|
54386-8
|
Dehydroascorbate [Moles/volume] in Serum or Plasma |
|
88995-6
|
Docosahexaenoate (C22:6w3)/Fatty acids.C14-C24 in Serum or Plasma |
|
54385-0
|
Dehydroascorbate/Ascorbate in Serum or Plasma |
|
24081-2
|
Dihydroxyacetone phosphate acylcoa acyl transferase [Enzymatic activity/mass] in Fibroblast |
|
14067-3
|
Dihydrocodeine [Mass/volume] in Blood |
|
16775-9
|
Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method |
|
12785-2
|
Dihydrocodeine Free [Mass/volume] in Serum or Plasma |
|
74811-1
|
Dihydrocodeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
86227-6
|
Dihydrocodeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
42901-9
|
Dihydrocodeine [Mass/volume] in Serum or Plasma |
|
19448-0
|
Dihydrocodeine [Mass/volume] in Urine by Confirmatory method |
|
14066-5
|
Dihydrocodeine [Presence] in Urine |
|
16211-5
|
Dihydrocodeine [Presence] in Urine by Confirmatory method |
|
19446-4
|
Dihydrocodeine [Presence] in Urine by Screen method |
|
19449-8
|
Dihydrocodeine [Mass/volume] in Urine |
|
64131-6
|
Dihydrocodeine/Creatinine [Mass Ratio] in Urine |
|
27035-5
|
Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium |
|
28072-7
|
Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool |
|
46703-5
|
Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method |
|
46704-3
|
Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method |
|
49750-3
|
Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma |
|
51955-3
|
Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine |
|
46257-2
|
Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method |
|
51765-6
|
Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma |
|
51448-9
|
Dihydrocodeine+Hydrocodol [Mass/volume] in Urine |
|
55195-2
|
DHCR7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
55815-5
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in 24 hour Urine |
|
13612-7
|
Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine |
|
25895-4
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in 24 hour Urine |
|
25391-4
|
Dehydroepiandrosterone (DHEA) [Moles/time] in 24 hour Urine |
|
31020-1
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Amniotic fluid |
|
30029-3
|
Dehydroepiandrosterone (DHEA) [Units/volume] in Saliva (oral fluid) |
|
49716-4
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Saliva (oral fluid) |
|
74361-7
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in Saliva (oral fluid) |
|
2193-1
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma |
|
35206-2
|
Dehydroepiandrosterone (DHEA) [Mass or Moles/volume] in Serum or Plasma |
|
15054-0
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma |
|
2194-9
|
Dehydroepiandrosterone (DHEA) [Presence] in Urine |
|
2195-6
|
Dehydroepiandrosterone (DHEA) [Mass/volume] in Urine |
|
34279-0
|
Dehydroepiandrosterone (DHEA) [Moles/volume] in Urine |
|
29879-4
|
Dehydroepiandrosterone (DHEA)/Creatinine [Mass Ratio] in 24 hour Urine |
|
34283-2
|
Dehydroepiandrosterone (DHEA)/Creatinine [Molar ratio] in Urine |
|
82878-0
|
Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82879-8
|
Dehydroepiandrosterone (DHEA)/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
2192-3
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/time] in 24 hour Urine |
|
34281-6
|
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in 24 hour Urine |
|
15053-2
|
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/time] in 24 hour Urine |
|
2190-7
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Amniotic fluid |
|
16721-3
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Saliva (oral fluid) |
|
2191-5
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma |
|
35205-4
|
Dehydroepiandrosterone sulfate (DHEA-S) [Mass or Moles/volume] in Serum or Plasma |
|
14688-6
|
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma |
|
34280-8
|
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Urine |
|
76347-4
|
Dehydroepiandrosterone sulfate (DHEA-S)/Cortisol [Molar ratio] in Serum or Plasma |
|
34282-4
|
Dehydroepiandrosterone sulfate (DHEA-S)/Creatinine [Molar ratio] in Urine |
|
72497-1
|
Dihydropteridine reductase [Enzymatic activity/mass] in DBS |
|
79459-4
|
Dihydropteridine reductase [Enzymatic activity/mass] in Red Blood Cells |
|
2212-9
|
Dihydropteridine reductase [Enzymatic activity/volume] in Serum |
|
23034-2
|
Duck hepatitis virus 1 Ab [Presence] in Serum |
|
23033-4
|
Duck hepatitis virus 1 Ab [Presence] in Serum by Neutralization test |
|
31803-0
|
Duck hepatitis virus 1 Ag [Presence] in Unspecified specimen |
|
23035-9
|
Duck hepatitis virus 1 Ag [Presence] in Unspecified specimen by Neutralization test |
|
23036-7
|
Duck hepatitis virus 2 Ab [Presence] in Serum |
|
23037-5
|
Duck hepatitis virus 2 Ab [Presence] in Serum by Neutralization test |
|
31804-8
|
Duck hepatitis virus 2 Ag [Presence] in Unspecified specimen |
|
23038-3
|
Duck hepatitis virus 2 Ag [Presence] in Unspecified specimen by Neutralization test |
|
23039-1
|
Duck hepatitis virus 3 Ab [Presence] in Serum |
|
23040-9
|
Duck hepatitis virus 3 Ab [Presence] in Serum by Neutralization test |
|
31805-5
|
Duck hepatitis virus 3 Ag [Presence] in Unspecified specimen |
|
23041-7
|
Duck hepatitis virus 3 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
87549-2
|
1,25-Dihydroxyvitamin D and 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 panel - Serum or Plasma |
|
92548-7
|
Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92510-7
|
Di sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
984-5
|
Di sup(a) Ag [Presence] on Red Blood Cells |
|
92547-9
|
Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92509-9
|
Di sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
990-2
|
Di sup(b) Ag [Presence] on Red Blood Cells |
|
73724-7
|
Bile acid dihydroxy and trihydroxy panel - Serum or Plasma |
|
55399-0
|
Diabetes tracking panel |
|
74150-4
|
Diabetes Type I action plan |
|
74151-2
|
Diabetes Type II action plan |
|
84084-3
|
Diabetology Case manager Note |
|
34760-9
|
Diabetology Consult note |
|
34897-9
|
Diabetology Education note |
|
84085-0
|
Diabetology Group counseling note |
|
84087-6
|
Diabetology Hospital Note |
|
84086-8
|
Diabetology Initial evaluation note |
|
84088-4
|
Diabetology Medication management note |
|
34861-5
|
Diabetology Note |
|
83570-2
|
Diabetology Nurse Consult note |
|
83571-0
|
Diabetology Nurse Note |
|
83572-8
|
Diabetology Nurse Outpatient Note |
|
84089-2
|
Diabetology Outpatient Group counseling note |
|
84090-0
|
Diabetology Outpatient Initial evaluation note |
|
34110-7
|
Diabetology Outpatient Note |
|
84091-8
|
Diabetology Outpatient Risk assessment and screening note |
|
84093-4
|
Diabetology Telephone encounter Note |
|
84094-2
|
Diabetology Plan of care note |
|
57136-4
|
Diabetology Referral note |
|
84092-6
|
Diabetology Risk assessment and screening note |
|
89890-8
|
Diabetology Telehealth Note |
|
70004-7
|
Diagnostic study note |
|
18748-4
|
Diagnostic imaging study |
|
86349-8
|
Diagnostic mammogram and ultrasound panel Breast - left Document |
|
86359-7
|
Diagnostic mammogram and ultrasound panel Breast - right Document |
|
80562-2
|
Diagram |
|
87233-3
|
Dialysis Consult note |
|
87235-8
|
Dialysis Discharge summary |
|
87234-1
|
Dialysis Education note |
|
87238-2
|
Dialysis Note |
|
87237-4
|
Dialysis Plan of care note |
|
87236-6
|
Dialysis Summary note |
|
87265-5
|
Dialysis Interdisciplinary Plan of care note |
|
87267-1
|
Dialysis Physician Note |
|
87266-3
|
Dialysis Nurse Note |
|
29749-9
|
Dialysis records |
|
60438-9
|
Diamine oxidase [Units/volume] in Serum or Plasma |
|
59655-1
|
diazePAM [Mass/volume] in Blood by Confirmatory method |
|
59654-4
|
diazePAM [Mass/volume] in Blood |
|
59657-7
|
diazePAM [Mass/volume] in Body fluid by Confirmatory method |
|
59656-9
|
diazePAM [Mass/volume] in Body fluid |
|
52946-1
|
diazePAM [Presence] in Gastric fluid |
|
29384-5
|
diazePAM [Mass/volume] in Gastric fluid |
|
26837-5
|
diazePAM [Mass/mass] in Hair |
|
73423-6
|
diazePAM induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73422-8
|
diazePAM induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59658-5
|
diazePAM [Mass/mass] in Meconium by Confirmatory method |
|
26935-7
|
diazePAM [Mass/mass] in Meconium |
|
72610-9
|
diazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72611-7
|
diazePAM [Presence] in Saliva (oral fluid) |
|
26784-9
|
diazePAM [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3549-3
|
diazePAM [Presence] in Serum or Plasma |
|
35607-1
|
diazePAM [Mass/volume] in Serum or Plasma by Screen method |
|
3548-5
|
diazePAM [Mass/volume] in Serum or Plasma |
|
14697-7
|
diazePAM [Moles/volume] in Serum or Plasma |
|
59659-3
|
diazePAM [Mass/mass] in Stool by Confirmatory method |
|
12378-6
|
diazePAM [Presence] in Stool |
|
27275-7
|
diazePAM [Mass/mass] in Stool |
|
59661-9
|
diazePAM [Mass/mass] in Tissue by Confirmatory method |
|
59660-1
|
diazePAM [Mass/mass] in Tissue |
|
3552-7
|
diazePAM [Mass/volume] in Serum or Plasma --trough |
|
16227-1
|
diazePAM [Mass/volume] in Urine by Confirmatory method |
|
3550-1
|
diazePAM [Presence] in Urine |
|
18388-9
|
diazePAM [Presence] in Urine by Confirmatory method |
|
19443-1
|
diazePAM [Presence] in Urine by Screen method |
|
3551-9
|
diazePAM [Mass/volume] in Urine |
|
27192-4
|
diazePAM [Mass/volume] in Vitreous fluid |
|
61074-1
|
diazePAM [Presence] in Unspecified specimen |
|
48948-4
|
diazePAM [Mass/volume] in Unspecified specimen |
|
77323-4
|
diazePAM [Moles/volume] in Unspecified specimen |
|
64130-8
|
diazePAM/Creatinine [Mass Ratio] in Urine |
|
49044-1
|
diazePAM and Nordiazepam panel - Serum or Plasma |
|
16757-7
|
diazePAM+Nordiazepam [Mass/volume] in Serum or Plasma |
|
50849-9
|
diazePAM+Nordiazepam [Moles/volume] in Serum or Plasma |
|
21241-5
|
diazePAM+Nordiazepam [Mass/volume] in Urine |
|
5638-2
|
Diazinon [Mass/volume] in Blood |
|
35488-6
|
Diazinon [Mass/volume] in Serum or Plasma |
|
35479-5
|
Diazinon [Mass/volume] in Urine |
|
87666-4
|
Diazinon [Mass/mass] in Unspecified specimen |
|
38657-3
|
Diazomethane [Mass/volume] in Air |
|
10534-6
|
Diazoxide [Mass/volume] in Serum or Plasma |
|
3553-5
|
Dibenzepin [Mass/volume] in Blood |
|
38760-5
|
Dibenzofuran [Mass/volume] in Air |
|
72827-9
|
dic(9;20)(p11-13;q11)(wcp9+,wcp20+) [Identifier] in Blood or Tissue by FISH Nominal |
|
16758-5
|
Dicamba [Mass/volume] in Serum or Plasma |
|
16759-3
|
Dicamba [Mass/volume] in Urine |
|
2206-1
|
Dicarboxylate, C6-C8-C10 [Mass/volume] in Serum |
|
2207-9
|
Dicarboxylate, C6-C8-C10 [Mass/volume] in Urine |
|
55854-4
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Amniotic fluid |
|
55853-6
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Cerebral spinal fluid |
|
53214-3
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in DBS |
|
55855-1
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Serum or Plasma |
|
55856-9
|
Dicarboxydodecanoylcarnitine (C12-DC) [Moles/volume] in Urine |
|
53213-5
|
Dicarboxydodecenoylcarnitine (C12:1-DC) [Moles/volume] in DBS |
|
74528-1
|
Dicarboxyeicosanoylcarnitine (C20-DC) [Moles/volume] in Serum or Plasma |
|
82585-1
|
Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in DBS |
|
74529-9
|
Dicarboxyhexenoylcarnitine (C6:1-DC) [Moles/volume] in Serum or Plasma |
|
82584-4
|
Dicarboxyhexenoylcarnitine (C6:1-DC)/Creatinine [Molar ratio] in Urine |
|
69771-4
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Amniotic fluid |
|
69770-6
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Cerebral spinal fluid |
|
53219-2
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in DBS |
|
59207-1
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Serum or Plasma |
|
69773-0
|
Dicarboxyoleylcarnitine (C18:1-DC) [Moles/volume] in Urine |
|
69769-8
|
Dicarboxyoleylcarnitine (C18:1-DC)/Creatinine [Molar ratio] in Urine |
|
53217-6
|
Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in DBS |
|
74530-7
|
Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in Serum or Plasma |
|
54478-3
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Amniotic fluid |
|
54477-5
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Cerebral spinal fluid |
|
53218-4
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in DBS |
|
74598-4
|
Dicarboxypalmitoylcarnitine (C16-DC) [Enzymatic activity/mass] in Fibroblast |
|
55872-6
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Serum or Plasma |
|
54480-9
|
Dicarboxypalmitoylcarnitine (C16-DC) [Moles/volume] in Urine |
|
54459-3
|
Dicarboxypalmitoylcarnitine (C16-DC)/Creatinine [Molar ratio] in Urine |
|
54483-3
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Amniotic fluid |
|
54482-5
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Cerebral spinal fluid |
|
53220-0
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in DBS |
|
55949-2
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Serum or Plasma |
|
54485-8
|
Dicarboxystearoylcarnitine (C18-DC) [Moles/volume] in Urine |
|
54481-7
|
Dicarboxystearoylcarnitine (C18-DC)/Creatinine [Molar ratio] in Urine |
|
53216-8
|
Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in DBS |
|
74531-5
|
Dicarboxytetradecanoylcarnitine (C14-DC) [Moles/volume] in Serum or Plasma |
|
70175-5
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Amniotic fluid |
|
70174-8
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Cerebral spinal fluid |
|
53215-0
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in DBS |
|
70176-3
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Serum or Plasma |
|
70177-1
|
Dicarboxytetradecenoylcarnitine (C14:1-DC) [Moles/volume] in Urine |
|
69795-3
|
Dicarboxytetradecenoylcarnitine (C14:1-DC)/Creatinine [Molar ratio] in Urine |
|
38663-1
|
Dichlorobenzidine [Mass/volume] in Air |
|
10911-6
|
Dichlorobenzidine [Mass/volume] in Urine |
|
3557-6
|
Dichlorphenamide [Mass/time] in 24 hour Urine |
|
3555-0
|
Dichlorphenamide [Presence] in Urine |
|
3556-8
|
Dichlorphenamide [Mass/volume] in Urine |
|
38591-4
|
Dichlorvos [Mass/volume] in Air |
|
60070-0
|
Dichlorvos [Mass/volume] in Blood |
|
30026-9
|
Dichlorvos [Mass/volume] in Serum or Plasma |
|
16768-4
|
Dichlorvos [Mass/volume] in Urine |
|
87750-6
|
Dichlorvos [Mass/mass] in Unspecified specimen |
|
59662-7
|
Diclofenac [Mass/volume] in Blood |
|
56701-6
|
Diclofenac IgE Ab [Units/volume] in Serum |
|
48274-5
|
Diclofenac triggered leukotriene release [Mass/volume] by Leukocytes |
|
9515-8
|
Diclofenac [Mass/volume] in Serum or Plasma |
|
59663-5
|
Diclofenac [Mass/volume] in Urine |
|
87782-9
|
Diclofenac/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
10984-3
|
Dicloxacillin [Mass/volume] in Serum or Plasma |
|
16769-2
|
Dicloxacillin [Mass/volume] in Urine |
|
25252-8
|
Dicloxacillin [Mass/volume] in Unspecified specimen |
|
3558-4
|
Dicoumarol [Mass/volume] in Serum or Plasma |
|
16770-0
|
Dicoumarol [Mass/volume] in Urine |
|
87609-4
|
Dicoumarol [Mass/mass] in Unspecified specimen |
|
73421-0
|
Dicyclomine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73420-2
|
Dicyclomine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
16771-8
|
Dicyclomine [Mass/volume] in Serum or Plasma |
|
29116-1
|
Didanosine [Units/volume] in Serum or Plasma |
|
48307-3
|
Didanosine [Mass/volume] in Serum or Plasma |
|
74095-1
|
Didesmethylcitalopram [Mass/volume] in Serum or Plasma |
|
26042-2
|
Didesmethylcitalopram [Moles/volume] in Serum or Plasma |
|
16773-4
|
Dieldrin [Mass/volume] in Blood |
|
11095-7
|
Dieldrin [Mass/volume] in Serum or Plasma |
|
16772-6
|
Dieldrin [Mass/volume] in Urine |
|
87665-6
|
Dieldrin [Mass/mass] in Unspecified specimen |
|
38665-6
|
Diethanolamine [Mass/volume] in Air |
|
27001-7
|
Diethyl ether [Presence] in Blood |
|
13936-0
|
Diethyl ether [Mass/volume] in Blood |
|
2208-7
|
Diethyl ether [Mass/volume] in Serum or Plasma |
|
21243-1
|
Diethyl ether [Mass/volume] in Urine |
|
57860-9
|
Diethylamine [Moles/volume] in Unspecified specimen |
|
41474-8
|
Diethylcarbamazepine [Mass/volume] in DBS |
|
16774-2
|
Diethylcarbamazepine [Mass/volume] in Serum or Plasma |
|
34436-6
|
Diethylene glycol [Mass/volume] in Serum or Plasma |
|
3347-2
|
Diethylpropion [Mass/time] in 24 hour Urine |
|
90444-1
|
Diethylpropion [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
16366-7
|
Diethylpropion [Mass/volume] in Serum or Plasma |
|
55532-6
|
Diethylpropion [Moles/volume] in Serum or Plasma |
|
3345-6
|
Diethylpropion [Presence] in Urine |
|
16210-7
|
Diethylpropion [Presence] in Urine by Confirmatory method |
|
3346-4
|
Diethylpropion [Mass/volume] in Urine |
|
14064-0
|
Diethylstilbestrol [Mass/volume] in Serum or Plasma |
|
38666-4
|
Diethylsulfate [Mass/volume] in Air |
|
57957-3
|
Difenacoum [Mass/volume] in Serum or Plasma |
|
74115-7
|
Difenacoum [Presence] in Unspecified specimen by Screen method |
|
87608-6
|
Difenacoum [Mass/mass] in Unspecified specimen |
|
87607-8
|
Difethialone [Mass/mass] in Unspecified specimen |
|
82620-6
|
Diffusion capacity/Alveolar volume --post bronchodilation |
|
82619-8
|
Diffusion capacity/Alveolar volume --pre bronchodilation |
|
93784-7
|
Diffuse large B-Cell lymphoma cell of origin subclassification panel - Tissue |
|
93781-3
|
Diffuse large B-cell lymphoma.activated B-cell subtype [Likelihood] in Tissue |
|
74413-6
|
Differential panel - Cord blood |
|
81620-7
|
Differential panel - Bronchial specimen |
|
29584-0
|
Differential panel - Cerebral spinal fluid |
|
81280-0
|
Differential panel - Dialysis fluid |
|
29580-8
|
Differential panel - Body fluid |
|
47286-0
|
Differential panel - Bone marrow |
|
69741-7
|
Differential panel - Pericardial fluid |
|
29583-2
|
Differential panel - Pleural fluid |
|
29581-6
|
Differential panel - Peritoneal fluid |
|
29582-4
|
Differential panel - Synovial fluid |
|
72395-7
|
Differential panel - Vitreous fluid |
|
69738-3
|
Differential panel, method unspecified - Blood |
|
14065-7
|
Diflunisal [Mass/volume] in Serum or Plasma |
|
3561-8
|
Digitoxin>6h post dose [Mass/volume] in Serum or Plasma |
|
29215-1
|
Digitoxin [Mass/volume] in Body fluid |
|
3559-2
|
Digitoxin [Mass/volume] in Serum or Plasma |
|
15104-3
|
Digitoxin [Moles/volume] in Serum or Plasma |
|
3560-0
|
Digitoxin [Mass/volume] in Urine |
|
29216-9
|
Digoxin [Mass/volume] in Body fluid |
|
73418-6
|
Digoxin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73419-4
|
Digoxin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
83093-5
|
Digoxin [Mass/volume] in Serum or Plasma by Immunoassay |
|
83094-3
|
Digoxin [Moles/volume] in Serum or Plasma by Immunoassay |
|
10535-3
|
Digoxin [Mass/volume] in Serum or Plasma |
|
35244-3
|
Digoxin [Mass or Moles/volume] in Serum or Plasma |
|
14698-5
|
Digoxin [Moles/volume] in Serum or Plasma |
|
3563-4
|
Digoxin>12 hours post dose [Mass/volume] in Serum or Plasma |
|
48370-1
|
Dihomogammalinolenate (C20:3n-6) [Moles/volume] in Serum or Plasma |
|
2209-5
|
Dihydrofolate [Mass/volume] in Serum |
|
78694-7
|
Dihydroorotate/Creatinine [Molar ratio] in Urine |
|
78693-9
|
Dihydrothymine/Creatinine [Molar ratio] in Urine |
|
13015-3
|
Diisobutylketone [Mass/volume] in Blood |
|
21245-6
|
Diisobutylketone [Mass/volume] in Urine |
|
7280-1
|
Dill IgE Ab [Units/volume] in Serum |
|
7281-9
|
Dill IgG Ab [Units/volume] in Serum |
|
56246-2
|
Dill IgG4 Ab [Mass/volume] in Serum |
|
63127-5
|
Dill IgG Ab [Mass/volume] in Serum |
|
73416-0
|
dilTIAZem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73417-8
|
dilTIAZem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6898-1
|
dilTIAZem [Mass/volume] in Serum or Plasma |
|
55533-4
|
dilTIAZem [Moles/volume] in Serum or Plasma |
|
58417-7
|
dilTIAZem [Presence] in Urine |
|
16776-7
|
dilTIAZem [Mass/volume] in Urine |
|
12391-9
|
Dimenhydrinate [Mass/volume] in Serum or Plasma |
|
39475-9
|
Dimenhydrinate [Moles/volume] in Serum or Plasma |
|
12365-3
|
Dimenhydrinate [Presence] in Urine |
|
3566-7
|
Dimetamphetamine [Mass/time] in 24 hour Urine |
|
20526-0
|
Dimetamphetamine [Mass/volume] in Urine by Confirmatory method |
|
3564-2
|
Dimetamphetamine [Presence] in Urine |
|
19453-0
|
Dimetamphetamine [Presence] in Urine by Confirmatory method |
|
19452-2
|
Dimetamphetamine [Presence] in Urine by Screen method |
|
3565-9
|
Dimetamphetamine [Mass/volume] in Urine |
|
30027-7
|
Dimethoate [Mass/volume] in Serum or Plasma |
|
21246-4
|
Dimethoate [Mass/volume] in Urine |
|
87664-9
|
Dimethoate [Mass/mass] in Unspecified specimen |
|
38689-6
|
Dimethyl sulfate [Mass/volume] in Air |
|
38668-0
|
Dimethylaniline [Mass/volume] in Air |
|
38673-0
|
Dimethylphthalate [Mass/volume] in Air |
|
3567-5
|
Dimethyltryptamine [Mass/volume] in Serum or Plasma |
|
12292-9
|
Dimethyltryptamine [Presence] in Urine |
|
3568-3
|
Dimethyltryptamine [Mass/volume] in Urine |
|
2214-5
|
Dinitrobenzene [Mass/volume] in Urine |
|
16778-3
|
Dinitrophenol [Presence] in Serum or Plasma |
|
16779-1
|
Dinitrophenol [Mass/volume] in Urine |
|
10661-7
|
Dinoflagellate identified in Water by Light microscopy |
|
59331-9
|
Dinorsibutramine [Mass/volume] in Blood |
|
59334-3
|
Dinorsibutramine [Mass/volume] in Serum or Plasma |
|
59337-6
|
Dinorsibutramine [Mass/volume] in Urine |
|
16463-2
|
Bile acid.dihydroxy [Mass/volume] in Serum or Plasma |
|
38187-1
|
Bile acid.dihydroxy [Moles/volume] in Serum or Plasma |
|
54387-6
|
Dihydroxycholestanoate [Moles/volume] in Body fluid |
|
53479-2
|
Dihydroxycholestanoate [Moles/volume] in Serum or Plasma |
|
54388-4
|
Dihydroxycholestanoate [Moles/volume] in Urine |
|
38619-3
|
Dioxin [Mass/volume] in Air |
|
27316-9
|
Dioxin [Presence] in Serum or Plasma |
|
23854-3
|
Dioxin [Mass/volume] in Serum or Plasma |
|
87606-0
|
Diphacinone [Mass/mass] in Unspecified specimen |
|
61075-8
|
Diphenhydramine [Presence] in Gastric fluid |
|
73415-2
|
Diphenhydramine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73414-5
|
Diphenhydramine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3569-1
|
Diphenhydramine [Presence] in Serum or Plasma |
|
35608-9
|
Diphenhydramine [Mass/volume] in Serum or Plasma by Screen method |
|
3570-9
|
Diphenhydramine [Mass/volume] in Serum or Plasma |
|
39476-7
|
Diphenhydramine [Moles/volume] in Serum or Plasma |
|
92641-0
|
Diphenhydramine [Mass/volume] in Urine by Confirmatory method |
|
3571-7
|
Diphenhydramine [Presence] in Urine |
|
92647-7
|
Diphenhydramine [Presence] in Urine by Confirmatory method |
|
3572-5
|
Diphenhydramine [Mass/volume] in Urine |
|
29531-1
|
Diphenhydramine [Presence] in Unspecified specimen |
|
14699-3
|
Diphenhydramine+Dimenhydrinate [Presence] in Gastric fluid |
|
14700-9
|
Diphenhydramine+Dimenhydrinate [Presence] in Serum or Plasma |
|
14701-7
|
Diphenhydramine+Dimenhydrinate [Presence] in Urine |
|
32068-9
|
Diphenhydramine+Dimenhydrinate [Presence] in Unspecified specimen |
|
73413-7
|
Diphenoxylate and Atropine (Lomatil) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73412-9
|
Diphenoxylate and Atropine (Lomatil) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12398-4
|
Diphenoxylate [Mass/volume] in Serum or Plasma |
|
33335-1
|
Diphenylmethoxyacetate [Presence] in Urine by Screen method |
|
47853-7
|
Diphosphoglycerate phosphatase [Enzymatic activity/mass] in Red Blood Cells |
|
14483-2
|
Diphtheria identified in Bronchial specimen by Organism specific culture |
|
6596-1
|
Diphtheria identified in Isolate by Organism specific culture |
|
14481-6
|
Diphtheria identified in Nose by Organism specific culture |
|
14482-4
|
Diphtheria identified in Skin by Organism specific culture |
|
14480-8
|
Diphtheria identified in Sputum by Organism specific culture |
|
14479-0
|
Diphtheria identified in Throat by Organism specific culture |
|
567-8
|
Diphtheria identified in Unspecified specimen by Organism specific culture |
|
3575-8
|
Dipipanone [Mass/time] in 24 hour Urine |
|
3573-3
|
Dipipanone [Presence] in Urine |
|
3574-1
|
Dipipanone [Mass/volume] in Urine |
|
73411-1
|
Dipyridamole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73410-3
|
Dipyridamole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
10536-1
|
Dipyridamole [Mass/volume] in Serum or Plasma |
|
9748-5
|
Dipyridamole [Mass/volume] in Unspecified specimen |
|
48783-5
|
Dipyrone IgE Ab [Units/volume] in Serum |
|
48280-2
|
Dipyrone triggered leukotriene release [Mass/volume] by Leukocytes |
|
12339-8
|
Diquat [Presence] in Urine |
|
87416-4
|
Diagnostic imaging report - recommended DICOM PS3.20 sections |
|
2024-8
|
Carbon dioxide dissolved [Moles/volume] in Plasma |
|
2025-5
|
Carbon dioxide dissolved [Moles/volume] in Red Blood Cells |
|
85216-0
|
Disability examination note |
|
75256-8
|
Disability information and assistance needed panel [HHS.ACA Section 4302.ONC] |
|
57765-0
|
Disaccharidases panel - Small intestine Tissue |
|
7282-7
|
Discase IgE Ab [Units/volume] in Serum |
|
89242-2
|
Discharge checklist |
|
52525-3
|
Discharge date |
|
74213-0
|
Discharge instructions |
|
86531-1
|
Discharge notification note |
|
46068-3
|
Discharge potential and overall status section |
|
46069-1
|
Discharge potential Set |
|
18842-5
|
Discharge summary |
|
78039-5
|
Discharge teaching note |
|
46018-8
|
Disease or condition diagnoses section |
|
86534-5
|
Disease staging note |
|
74044-9
|
Disease of interest was cause of death in family member HL7-VMR-CDS |
|
46019-6
|
Diseases or conditions Set |
|
29217-7
|
Disopyramide [Mass/volume] in Body fluid |
|
29401-7
|
Disopyramide [Mass/volume] in Gastric fluid |
|
59898-7
|
Disopyramide [Moles/volume] in Gastric fluid |
|
13558-2
|
Disopyramide [Presence] in Serum or Plasma |
|
3576-6
|
Disopyramide [Mass/volume] in Serum or Plasma |
|
14702-5
|
Disopyramide [Moles/volume] in Serum or Plasma |
|
12366-1
|
Disopyramide [Presence] in Urine |
|
16780-9
|
Disopyramide [Mass/volume] in Urine |
|
59897-9
|
Disopyramide [Moles/volume] in Urine |
|
60301-9
|
Disopyramide [Moles/volume] in Unspecified specimen |
|
80640-6
|
Disopyramide+Nordisopyramide [Mass/volume] in Serum or Plasma |
|
43165-0
|
Dissolved solids [Mass/volume] in Water |
|
91350-9
|
Distress subscore [STarT Back] |
|
3577-4
|
Disulfiram [Mass/volume] in Serum or Plasma |
|
16781-7
|
Disulfiram [Presence] in Urine |
|
9357-5
|
Disulfiram [Mass/volume] in Urine |
|
87663-1
|
Disulfoton [Mass/mass] in Unspecified specimen |
|
32010-1
|
Diuretics [Identifier] in Serum or Plasma by Screen method |
|
12288-7
|
Diuretics [Identifier] in Urine |
|
32676-9
|
Diuretics [Mass/volume] in Urine |
|
88677-0
|
German Interdisciplinary Association of Intensive Care and Emergency Care Medicine - recommended MIND protocol set |
|
18286-5
|
Donath Landsteiner Ab [Presence] in Blood |
|
2210-3
|
Dihydrolipoamide acetyl transferase [Enzymatic activity/mass] in Tissue |
|
2211-1
|
Dihydrolipoamide dehydrogenase [Enzymatic activity/mass] in Tissue |
|
75040-6
|
D-Lactate [Moles/volume] in Cerebral spinal fluid |
|
14045-9
|
D-Lactate [Moles/volume] in Serum or Plasma |
|
74436-7
|
D-Lactate [Moles/mass] in Stool |
|
14046-7
|
D-Lactate [Moles/volume] in Urine |
|
44314-3
|
D-Lactate/Creatinine [Molar ratio] in Urine |
|
77750-8
|
DLD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93790-4
|
Delafloxacin [Susceptibility] by Gradient strip |
|
90447-4
|
Delafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
88885-9
|
Delafloxacin [Susceptibility] |
|
74626-3
|
1,1-Dimethoxyhexadecane (DMA 16:0) [Mass/mass] in Fibroblast |
|
74627-1
|
1,1-Dimethoxyhexadecane (DMA 16:0) [Moles/mass] in Red Blood Cells |
|
74624-8
|
1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Mass Ratio] in Fibroblast |
|
74625-5
|
1,1-Dimethoxyhexadecane (DMA 16:0)/palmitate (C16:0) [Molar ratio] in Red Blood Cells |
|
74618-0
|
1,1-Dimethoxyoctadecane (DMA 18:0) [Mass/mass] in Fibroblast |
|
74619-8
|
1,1-Dimethoxyoctadecane (DMA 18:0) [Moles/mass] in Red Blood Cells |
|
74616-4
|
1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Mass Ratio] in Fibroblast |
|
74617-2
|
1,1-Dimethoxyoctadecane (DMA 18:0)/Octadecanoate (C18:0) [Molar ratio] in Red Blood Cells |
|
74622-2
|
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/mass] in Fibroblast |
|
74623-0
|
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Moles/mass] in Red Blood Cells |
|
74620-6
|
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Mass Ratio] in Fibroblast |
|
74621-4
|
1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Molar ratio] in Red Blood Cells |
|
74633-9
|
Dimethylacetal (DMA) panel - Fibroblast |
|
74634-7
|
Dimethylacetal (DMA) panel - Red Blood Cells |
|
16777-5
|
Dimethylacetamide [Presence] in Urine |
|
12372-9
|
Dimethylacetamide [Mass/volume] in Urine |
|
73916-9
|
1,3-Dimethylamylamine [Mass/volume] in Urine by Confirmatory method |
|
73915-1
|
1,3-Dimethylamylamine [Presence] in Urine by Screen method |
|
38755-5
|
Dimethylbenzene [Mass/volume] in Air |
|
29296-1
|
Dimethylbenzene [Presence] in Blood |
|
13940-2
|
Dimethylbenzene [Mass/volume] in Blood |
|
5759-6
|
Dimethylbenzene [Mass/volume] in Serum or Plasma |
|
17772-5
|
Dimethylbenzene [Mass/volume] in Urine |
|
13832-1
|
Dimethylbenzene/Creatinine [Mass Ratio] in Urine |
|
75383-0
|
DMD gene deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by MLPA |
|
75385-5
|
DMD gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
50626-1
|
DMD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21247-2
|
DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
19425-8
|
Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method |
|
58925-9
|
Dextromethamphetamine [Presence] in Urine |
|
19424-1
|
Dextromethamphetamine [Presence] in Urine by Confirmatory method |
|
19423-3
|
Dextromethamphetamine [Presence] in Urine by Screen method |
|
12477-6
|
Dextromethamphetamine [Mass/volume] in Urine |
|
52947-9
|
Dextromethorphan [Presence] in Gastric fluid |
|
59896-1
|
Dextromethorphan [Moles/volume] in Gastric fluid |
|
16247-9
|
Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3538-6
|
Dextromethorphan [Presence] in Serum or Plasma |
|
27413-4
|
Dextromethorphan [Units/volume] in Serum or Plasma |
|
13623-4
|
Dextromethorphan [Mass/volume] in Serum or Plasma |
|
59894-6
|
Dextromethorphan [Moles/volume] in Serum or Plasma |
|
92642-8
|
Dextromethorphan [Mass/volume] in Urine by Confirmatory method |
|
3539-4
|
Dextromethorphan [Presence] in Urine |
|
92646-9
|
Dextromethorphan [Presence] in Urine by Confirmatory method |
|
21240-7
|
Dextromethorphan [Mass/volume] in Urine |
|
59895-3
|
Dextromethorphan [Moles/volume] in Urine |
|
40359-2
|
Dextromethorphan [Presence] in Unspecified specimen |
|
57859-1
|
Dextromethorphan [Moles/volume] in Unspecified specimen |
|
27076-9
|
Dextromethorphan+Levorphanol [Presence] in Urine |
|
38592-2
|
Dimethylformamide [Mass/volume] in Air |
|
23853-5
|
Dimethylformamide/Creatinine [Mass Ratio] in Urine |
|
38688-8
|
1,1-Dimethylhydrazine [Mass/volume] in Air |
|
2213-7
|
Dimethadione [Mass/volume] in Serum or Plasma |
|
16747-8
|
Dextromoramide [Presence] in Serum or Plasma |
|
3540-2
|
Dextromoramide [Presence] in Urine |
|
3541-0
|
Dextromoramide [Mass/volume] in Urine |
|
49837-8
|
Dimethylphosphatidyl ethanolamine/Surfactant.total in Amniotic fluid |
|
81855-9
|
DMPK gene CTG repeat analysis in Blood or Tissue by Molecular genetics method |
|
21757-0
|
DMPK gene CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
34727-8
|
DMPK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
12337-2
|
Dimethylsulfoxide [Presence] in Serum or Plasma |
|
14098-8
|
Dimethylsulfoxide [Mass/volume] in Serum or Plasma |
|
55208-3
|
DNA analysis discrete sequence variation panel |
|
59562-9
|
DNA index by Automated image cytometry |
|
34975-3
|
DNA index in Serum or Plasma by Flow cytometry (FC) |
|
30912-0
|
DNA index in Unspecified specimen by Flow cytometry (FC) |
|
53043-6
|
DNA marker analysis test coverage panel |
|
53042-8
|
DNA marker assessed panel |
|
51960-3
|
DNA marker results panel |
|
53044-4
|
DNA marker identified panel |
|
30911-2
|
DNA ploidy [Identifier] in Unspecified specimen by Flow cytometry (FC) Nominal |
|
51956-1
|
DNA region analysis test coverage panel |
|
53041-0
|
DNA region of interest panel |
|
53855-3
|
DNAI1+DNAH5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
5129-2
|
Deoxyribonuclease Ab [Units/volume] in Serum |
|
13091-4
|
Deoxyribonucleoprotein Ab [Units/volume] in Serum |
|
9308-8
|
2,4-Dinitrophenylhydrazine reacting substances [Presence] in Urine |
|
84095-9
|
Do not resuscitate |
|
92546-1
|
Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92508-1
|
Do sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
996-9
|
Do sup(a) Ag [Presence] on Red Blood Cells |
|
92545-3
|
Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92507-3
|
Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
58060-5
|
Do sup(b) Ag [Presence] on Red Blood Cells |
|
21248-0
|
Dobutamine [Mass/volume] in Serum or Plasma |
|
2201-2
|
Deoxycholate [Mass/volume] in Serum |
|
30520-1
|
Deoxycholate [Moles/volume] in Serum or Plasma |
|
2202-0
|
Deoxycholylglycine [Mass/volume] in Serum |
|
79697-9
|
Docosadienoate (C22:2w6) [Entitic substance] in Red Blood Cells |
|
79698-7
|
Docosadienoate (C22:2w6) [Moles/volume] in Serum or Plasma |
|
78348-0
|
Docosapentaenate (C22:5w6) [Entitic substance] in Red Blood Cells |
|
48371-9
|
Docosapentaenoate (C22:5 n-3) [Moles/volume] in Serum or Plasma |
|
75112-3
|
Docosatetraenoate (C22:4w6) [Entitic substance] in Red Blood Cells |
|
81765-0
|
Docosatrienoate (C22:3w9) [Entitic substance] in Red Blood Cells |
|
81764-3
|
Docosatrienoate (C22:3w9) [Moles/volume] in Serum or Plasma |
|
78345-6
|
Docosenoate (C22:1) [Entitic substance] in Red Blood Cells |
|
53109-5
|
Docosenoate (C22:1)/Creatinine [Molar ratio] in Urine |
|
81240-4
|
Document template attachment request modifier codes |
|
73409-5
|
Docusate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73408-7
|
Docusate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
53058-4
|
Dodecanoylcarnitine (C12) [Moles/volume] in Amniotic fluid |
|
53078-2
|
Dodecanoylcarnitine (C12) [Moles/volume] in Cerebral spinal fluid |
|
45199-7
|
Dodecanoylcarnitine (C12) [Moles/volume] in DBS |
|
74608-1
|
Dodecanoylcarnitine (C12) [Enzymatic activity/mass] in Fibroblast |
|
54389-2
|
Dodecanoylcarnitine (C12) [Moles/volume] in Urine |
|
53510-4
|
Dodecanoylcarnitine (C12)/Creatinine [Molar ratio] in Urine |
|
49939-2
|
Dodecenedioate/Creatinine [Molar ratio] in Urine |
|
53059-2
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in Amniotic fluid |
|
53079-0
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in Cerebral spinal fluid |
|
45200-3
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS |
|
74607-3
|
Dodecenoylcarnitine (C12:1) [Enzymatic activity/mass] in Fibroblast |
|
53104-6
|
Dodecenoylcarnitine (C12:1) [Moles/volume] in Urine |
|
53511-2
|
Dodecenoylcarnitine (C12:1)/Creatinine [Molar ratio] in Urine |
|
53542-7
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in Amniotic fluid |
|
53545-0
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in Cerebral spinal fluid |
|
53543-5
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in DBS |
|
53546-8
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in Serum or Plasma |
|
53549-2
|
Dodeicosanoylcarnitine (C22) [Moles/volume] in Urine |
|
53552-6
|
Dodeicosanoylcarnitine (C22)/Creatinine [Molar ratio] in Urine |
|
58773-3
|
Dog recombinant (rCan f) 1 IgE Ab [Units/volume] in Serum |
|
58772-5
|
Dog recombinant (rCan f) 2 IgE Ab [Units/volume] in Serum |
|
82543-0
|
Dog recombinant (rCan f) 4 IgE Ab [Units/volume] in Serum |
|
64973-1
|
Dog recombinant 5 IgE Ab [Units/volume] in Serum |
|
6098-8
|
Dog dander IgE Ab [Units/volume] in Serum |
|
61333-1
|
Dog dander IgE Ab/IgE total in Serum |
|
7284-3
|
Dog dander IgG Ab [Units/volume] in Serum |
|
56248-8
|
Dog dander IgG4 Ab [Mass/volume] in Serum |
|
63077-2
|
Dog dander IgG Ab [Mass/volume] in Serum |
|
56713-1
|
Dog dander+Dog epithelium IgE Ab [Units/volume] in Serum |
|
7286-8
|
Dog epithelium triggered histamine release [Units/volume] in Blood |
|
6099-6
|
Dog epithelium IgE Ab [Units/volume] in Serum |
|
61334-9
|
Dog epithelium IgE Ab/IgE total in Serum |
|
7285-0
|
Dog epithelium IgG Ab [Units/volume] in Serum |
|
56247-0
|
Dog epithelium IgG4 Ab [Mass/volume] in Serum |
|
48229-9
|
Dog epithelium triggered leukotriene release [Mass/volume] by Leukocytes |
|
7287-6
|
Dog Fennel IgE Ab [Units/volume] in Serum |
|
75008-3
|
Dog native (nCan f) 1 IgE Ab [Units/volume] in Serum |
|
19738-4
|
Dog serum albumin IgE Ab [Units/volume] in Serum |
|
73912-8
|
DOG1 Ag [Presence] in Tissue by Immune stain |
|
7288-4
|
Dogwood pollen IgE Ab [Units/volume] in Serum |
|
39533-5
|
Deoxyhemoglobin [Mass/volume] in Blood |
|
71854-4
|
Deoxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
|
72857-6
|
Dolutegravir [Susceptibility] by Genotype method |
|
51418-2
|
Domperidone [Moles/volume] in Body fluid |
|
51442-2
|
Domperidone [Moles/volume] in Serum or Plasma |
|
87566-6
|
Deoxynivalenol [Mass/mass] in Unspecified specimen |
|
73406-1
|
Donepezil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73407-9
|
Donepezil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
51979-3
|
Donepezil [Mass/volume] in Serum or Plasma |
|
90768-3
|
Donor blood study report |
|
92046-2
|
Donor contact information panel |
|
24534-0
|
US.doppler Abdominal vessels |
|
43572-7
|
US.doppler Abdominal vessels limited |
|
80896-4
|
US.doppler Aorta and Iliac artery - bilateral |
|
80897-2
|
US.doppler Aorta and Iliac artery - bilateral limited |
|
39523-6
|
US.doppler Artery |
|
39039-3
|
US.doppler Brachiocephalic artery |
|
69397-8
|
US.doppler Breast vessels |
|
42146-1
|
US.doppler Carotid arteries |
|
80850-1
|
US.doppler Carotid arteries limited |
|
43765-7
|
US.doppler Carotid arteries - bilateral |
|
39427-0
|
US.doppler Carotid arteries - left |
|
39437-9
|
US.doppler Carotid arteries -right |
|
80851-9
|
US.doppler Cerebral artery middle Fetal for pregnancy |
|
39042-7
|
US.doppler Extremity artery |
|
72830-3
|
US.doppler Extremity arteries - bilateral for physiologic artery study |
|
72831-1
|
US.doppler Extremity arteries - bilateral for physiologic artery study limited |
|
72832-9
|
US.doppler Extremity arteries - bilateral for physiologic artery study at rest and with exercise |
|
39031-0
|
US.doppler Extremity artery - bilateral |
|
39428-8
|
US.doppler Extremity artery - left |
|
39439-5
|
US.doppler Extremity artery - right |
|
39449-4
|
US.doppler Extremity vein |
|
39418-9
|
US.doppler Extremity vein - bilateral |
|
46301-8
|
US.doppler Extremity vein - bilateral limited |
|
39429-6
|
US.doppler Extremity vein - left |
|
39440-3
|
US.doppler Extremity vein - right |
|
69283-0
|
US.doppler Extremity veins - bilateral |
|
43771-5
|
US.doppler Extremity vessels |
|
39424-7
|
US.doppler Extremity vessels limited |
|
39495-7
|
US.doppler Extremity vessels - bilateral |
|
69398-6
|
US.doppler Extremity vessels - left |
|
39503-8
|
US.doppler Extremity vessels - right |
|
39498-1
|
US.doppler Femoral vessels - left |
|
39504-6
|
US.doppler Femoral vessels - right |
|
80864-2
|
US.doppler for pregnancy |
|
80863-4
|
US.doppler for transplanted kidney |
|
42477-0
|
US.doppler for transplanted kidney vessels |
|
46362-0
|
US.doppler Foot vessels |
|
46382-8
|
US.doppler Hand vessels |
|
80857-6
|
US.doppler Head |
|
80856-8
|
US.doppler Head limited |
|
24733-8
|
US.doppler Head vessels |
|
39044-3
|
US.doppler Head vessels limited |
|
30880-9
|
US.doppler Head vessels and Neck vessels |
|
80859-2
|
US.doppler Heart |
|
81161-2
|
US.doppler Heart for blood flow |
|
39425-4
|
US.doppler Iliac artery |
|
43776-4
|
US.doppler Iliac artery limited |
|
42147-9
|
US.doppler Iliac graft |
|
42150-3
|
US.doppler Iliac graft limited |
|
39497-3
|
US.doppler Iliac vessels |
|
39434-6
|
US.doppler Lower extremity artery |
|
38042-8
|
US.doppler Lower extremity artery limited |
|
93604-7
|
US.doppler Lower extremity arteries+veins - bilateral |
|
39421-3
|
US.doppler Lower extremity artery - bilateral |
|
39499-9
|
US.doppler Lower extremity artery - left |
|
39505-3
|
US.doppler Lower extremity artery - right |
|
30881-7
|
US.doppler Lower extremity vein |
|
39420-5
|
US.doppler Lower extremity vein - bilateral |
|
44174-1
|
US.doppler Lower extremity vessels |
|
39422-1
|
US.doppler Lower extremity vessels - bilateral |
|
39431-2
|
US.doppler Lower extremity vessels - left |
|
39430-4
|
US.doppler Lower extremity vessels - left limited |
|
39442-9
|
US.doppler Lower extremity vessels - right |
|
39441-1
|
US.doppler Lower extremity vessels - right limited |
|
42461-4
|
US.doppler Lower extremity vessel - left for graft |
|
42462-2
|
US.doppler Lower extremity vessel - right for graft |
|
39432-0
|
US.doppler Lower extremity vein - left |
|
39443-7
|
US.doppler Lower extremity vein - right |
|
69282-2
|
US.doppler Unspecified body region limited |
|
44175-8
|
US.doppler Neck vessels |
|
39502-0
|
US.doppler Ovarian vessels |
|
24870-8
|
US.doppler Pelvis vessels |
|
42152-9
|
US.doppler Pelvis vessels limited |
|
80873-3
|
US.doppler Penis limited |
|
80874-1
|
US.doppler Penis vessels |
|
69284-8
|
US.doppler Portal vein and Hepatic vein |
|
39435-3
|
US.doppler Renal artery |
|
39426-2
|
US.doppler Renal vessels |
|
39436-1
|
US.doppler Renal vessels limited |
|
39419-7
|
US.doppler Renal vessels - bilateral |
|
48742-1
|
US.doppler Scrotum and testicle |
|
44235-0
|
US.doppler Superior mesenteric vessels |
|
46388-5
|
US.doppler Thoracic and abdominal aorta |
|
39446-0
|
US.doppler Testicular vessels |
|
39447-8
|
US.doppler Upper extremity artery |
|
38143-4
|
US.doppler Upper extremity artery limited |
|
39423-9
|
US.doppler Upper extremity artery - bilateral |
|
46302-6
|
US.doppler Upper extremity artery - bilateral limited |
|
39500-4
|
US.doppler Upper extremity artery - left |
|
39506-1
|
US.doppler Upper extremity artery - right |
|
30882-5
|
US.doppler Upper extremity vein |
|
39496-5
|
US.doppler Upper extremity vein - bilateral |
|
39448-6
|
US.doppler Upper extremity vessels |
|
46385-1
|
US.doppler Upper extremity vessel for graft |
|
46303-4
|
US.doppler Upper extremity vessels limited |
|
46379-4
|
US.doppler Upper extremity vessels - bilateral |
|
44236-8
|
US.doppler Upper extremity vessel - bilateral for graft |
|
44237-6
|
US.doppler Upper extremity vessel - bilateral for graft limited |
|
39433-8
|
US.doppler Upper extremity vessels - left |
|
39444-5
|
US.doppler Upper extremity vessels - right |
|
42475-4
|
US.doppler Upper extremity vessel - left for graft |
|
42476-2
|
US.doppler Upper extremity vessel - right for graft |
|
39501-2
|
US.doppler Upper extremity vein - left |
|
39507-9
|
US.doppler Upper extremity vein - right |
|
69285-5
|
US.doppler Umbilical artery Fetal |
|
80878-2
|
US.doppler Umbilical artery Fetal for pregnancy |
|
39508-7
|
US.doppler Umbilical vessels Fetal |
|
93241-8
|
US.doppler Unspecified body region |
|
80872-5
|
US.doppler Uterus and Fallopian tubes W saline IU |
|
39525-1
|
US.doppler Vein |
|
39524-4
|
US.doppler Vein limited |
|
39445-2
|
US.doppler Vessels |
|
27212-0
|
Dopamine [Mass/volume] in 24 hour Urine |
|
2218-6
|
Dopamine [Mass/time] in 24 hour Urine |
|
25906-9
|
Dopamine [Moles/volume] in 24 hour Urine |
|
15059-9
|
Dopamine [Moles/time] in 24 hour Urine |
|
2219-4
|
Dopamine beta-hydroxylase [Enzymatic activity/volume] in Serum or Plasma |
|
74904-4
|
Dopamine [Moles/volume] in Cerebral spinal fluid |
|
2216-0
|
Dopamine [Mass/volume] in Serum or Plasma |
|
14703-3
|
Dopamine [Moles/volume] in Serum or Plasma |
|
72816-2
|
Dopamine [Mass/volume] in Urine by Confirmatory method |
|
2217-8
|
Dopamine [Mass/volume] in Urine |
|
15058-1
|
Dopamine [Moles/volume] in Urine |
|
33873-1
|
Dopamine/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
44316-8
|
Dopamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
44918-1
|
Dopamine/Creatinine [Molar ratio] in 24 hour Urine |
|
13733-1
|
Dopamine/Creatinine [Mass Ratio] in Urine |
|
24524-1
|
Dopamine/Creatinine [Molar ratio] in Urine |
|
91897-9
|
Doravirine [Susceptibility] by Genotype method |
|
72893-1
|
Doripenem [Susceptibility] by Disk diffusion (KB) |
|
56031-8
|
Doripenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
60535-2
|
Doripenem [Susceptibility] |
|
84297-1
|
Dose(s) missed since previous visit |
|
29652-5
|
Dothiepin [Mass/volume] in Serum or Plasma |
|
29653-3
|
Dothiepin [Moles/volume] in Serum or Plasma |
|
35120-5
|
Dothiepin sulfoxide [Mass/volume] in Serum or Plasma |
|
79409-9
|
Dothiepin+nordothiepin trough and dothiepin sulfoxide panel - Serum or Plasma |
|
82914-3
|
Dothiepin [Mass/volume] in Serum or Plasma --trough |
|
85089-1
|
Dothiepin and nordothiepin and dothiepin sulfoxide panel - Serum or Plasma |
|
80641-4
|
Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma |
|
79413-1
|
Dothiepin+Nordothiepin [Mass/volume] in Serum or Plasma --trough |
|
7310-6
|
Douglas Fir IgE Ab [Units/volume] in Serum |
|
56249-6
|
Douglas Fir IgG4 Ab [Mass/volume] in Serum |
|
10985-0
|
Doxapram [Mass/volume] in Serum or Plasma |
|
73404-6
|
Doxazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73405-3
|
Doxazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14704-1
|
Doxepin [Presence] in Gastric fluid |
|
29410-8
|
Doxepin [Mass/volume] in Gastric fluid |
|
47104-5
|
Doxepin [Moles/volume] in Gastric fluid |
|
3578-2
|
Doxepin [Presence] in Serum or Plasma |
|
35609-7
|
Doxepin [Mass/volume] in Serum or Plasma by Screen method |
|
3579-0
|
Doxepin [Mass/volume] in Serum or Plasma |
|
14705-8
|
Doxepin [Moles/volume] in Serum or Plasma |
|
16115-8
|
Doxepin [Mass/mass] in Tissue |
|
3584-0
|
Doxepin [Mass/volume] in Serum or Plasma --trough |
|
61416-4
|
Doxepin [Mass/volume] in Urine by Confirmatory method |
|
3580-8
|
Doxepin [Presence] in Urine |
|
61415-6
|
Doxepin [Presence] in Urine by Confirmatory method |
|
3581-6
|
Doxepin [Mass/volume] in Urine |
|
14706-6
|
Doxepin [Moles/volume] in Urine |
|
40629-8
|
Doxepin [Presence] in Unspecified specimen |
|
60302-7
|
Doxepin [Moles/volume] in Unspecified specimen |
|
61414-9
|
Doxepin/Creatinine [Mass Ratio] in Urine |
|
3583-2
|
Doxepin+Metabolites [Mass/volume] in Serum or Plasma |
|
19247-6
|
Doxepin+Metabolites [Mass/volume] in Urine |
|
81274-3
|
Doxepin and Nordoxepin panel - Gastric fluid |
|
43122-1
|
Doxepin and Nordoxepin panel - Serum or Plasma |
|
81276-8
|
Doxepin and Nordoxepin panel - Urine |
|
3582-4
|
Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma |
|
14707-4
|
Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma |
|
13624-2
|
DOXOrubicin [Mass/volume] in Serum or Plasma |
|
56706-5
|
Doxycycline IgE Ab [Units/volume] in Serum |
|
73402-0
|
Doxycycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73403-8
|
Doxycycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
10986-8
|
Doxycycline [Mass/volume] in Serum or Plasma |
|
26902-7
|
Doxycycline [Units/volume] in Unspecified specimen |
|
21250-6
|
Doxycycline [Mass/volume] in Unspecified specimen |
|
75761-7
|
Doxylamine [Presence] in Serum or Plasma or Urine by Screen method |
|
3585-7
|
Doxylamine [Presence] in Serum or Plasma |
|
16791-6
|
Doxylamine [Mass/volume] in Serum or Plasma |
|
55534-2
|
Doxylamine [Moles/volume] in Serum or Plasma |
|
3586-5
|
Doxylamine [Presence] in Urine |
|
16792-4
|
Doxylamine [Mass/volume] in Urine |
|
78347-2
|
Docosapentaenate (C22:5w3) [Entitic substance] in Red Blood Cells |
|
6937-7
|
Deoxypyridinoline [Mass/time] in 24 hour Urine |
|
25898-8
|
Deoxypyridinoline [Moles/volume] in 24 hour Urine |
|
15055-7
|
Deoxypyridinoline [Moles/time] in 24 hour Urine |
|
6936-9
|
Deoxypyridinoline [Mass/time] in 2 hour Urine |
|
13881-8
|
Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine |
|
11216-9
|
Deoxypyridinoline [Mass/volume] in Urine |
|
27424-1
|
Deoxypyridinoline [Moles/volume] in Urine |
|
35646-9
|
Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
13730-7
|
Deoxypyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
|
24456-6
|
Deoxypyridinoline/Creatinine [Molar ratio] in 24 hour Urine |
|
13731-5
|
Deoxypyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
|
25096-9
|
Deoxypyridinoline/Creatinine [Molar ratio] in 2 hour Urine |
|
13729-9
|
Deoxypyridinoline/Creatinine [Mass Ratio] in Urine |
|
25095-1
|
Deoxypyridinoline/Creatinine [Molar ratio] in Urine |
|
11044-5
|
Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells |
|
38691-2
|
1,2-Diphenylhydrazine [Mass/volume] in Air |
|
2215-2
|
Dipalmitoylphosphatidylcholine [Mass/volume] in Serum |
|
90823-6
|
Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
90824-4
|
Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82989-5
|
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82976-2
|
Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
13555-8
|
D-pseudoephedrine [Presence] in Serum or Plasma |
|
45284-7
|
DPYD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93199-8
|
DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
57958-1
|
DPYD2A gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
82739-4
|
Dopamine receptor D1 IgG Ab [Titer] in Serum by Immunoassay |
|
82738-6
|
Dopamine receptor D2 IgG Ab [Titer] in Serum by Immunoassay |
|
53245-7
|
Driver license |
|
56704-0
|
Droperidol IgE Ab [Units/volume] in Serum |
|
16144-8
|
Droperidol [Presence] in Serum or Plasma |
|
57959-9
|
Drostanolone [Presence] in Urine |
|
82664-4
|
Drug Abuse Screening Test [DAST] |
|
82666-9
|
Drug Abuse Screening Test-10 [DAST-10] |
|
13063-3
|
Drug induced platelet Ab [Units/volume] in Serum |
|
73552-2
|
Drug induced platelet Ab [Interpretation] in Serum or Plasma Narrative |
|
72909-5
|
Drug induced neutrophil Ab panel - Serum or Plasma |
|
72908-7
|
Drug induced platelet Ab panel - Serum or Plasma |
|
15401-3
|
Drugs identified in Blood by Screen method |
|
34601-5
|
Drugs identified in Body fluid |
|
12287-9
|
Drugs identified in Gastric fluid by Screen method |
|
27034-8
|
Drugs identified in Hair by Screen method |
|
32797-3
|
Drugs identified in Meconium by Screen method |
|
42326-9
|
Drugs identified in Mother's milk by Screen method |
|
24349-3
|
Drugs of abuse 5 panel - Urine |
|
65750-2
|
Drugs of abuse 5 panel - Urine by Screen method |
|
51782-1
|
Drugs of abuse 7 and Alcohol and Tricyclics panel - Urine by Screen method |
|
72479-9
|
Drugs of abuse panel - Blood by Screen method |
|
91054-7
|
Drugs of abuse panel - Body fluid |
|
91056-2
|
Drugs of abuse panel - Hair |
|
49046-6
|
Drugs of abuse panel - Meconium |
|
91055-4
|
Drugs of abuse panel - Tissue |
|
69739-1
|
Drugs of abuse panel - Urine by Screen method |
|
87428-9
|
Drugs of abuse screen W Reflex confirm panel - Urine |
|
20785-2
|
Drugs identified in Serum or Plasma by Screen method |
|
27208-8
|
Drugs identified in Stool by Screen method |
|
20786-0
|
Drugs identified in Tissue by Screen method |
|
41270-0
|
Drugs identified in Urine |
|
40464-0
|
Drugs identified in Urine by Confirmatory method |
|
12286-1
|
Drugs identified in Urine by Screen method |
|
16793-2
|
Drugs identified in Unknown substance by Screen method |
|
12289-5
|
Drugs identified in Vitreous fluid by Screen method |
|
40585-2
|
Drugs identified in Unspecified specimen by Confirmatory method |
|
20787-8
|
Drugs identified in Unspecified specimen by Screen method |
|
75511-6
|
dRVVT W excess phospholipid percent correction |
|
15360-1
|
dRVVT actual/normal [Presence] in Platelet poor plasma by Coagulation assay |
|
52756-4
|
dRVVT excess phospholipid [Presence] in Platelet poor plasma by Coagulation assay |
|
53221-8
|
dRVVT in Control Platelet poor plasma by Coagulation assay |
|
50410-0
|
dRVVT/dRVVT W excess phospholipid (screen to confirm ratio) |
|
6661-3
|
Microscopic observation [Identifier] in Tissue by Dry mount |
|
661-9
|
Microscopic observation [Identifier] in Unspecified specimen by Dry mount |
|
77149-3
|
Dry weight/Total of 24 hour Stool |
|
72281-9
|
Days in therapeutic INR range/Days INR result determined [Ratio] |
|
63410-5
|
DNA double strand Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63408-9
|
DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
63409-7
|
DNA double strand Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
48308-1
|
DNA double strand Ab [Units/volume] in Body fluid by Farr method |
|
53148-3
|
DNA double strand Ab [Presence] in Body fluid |
|
15177-9
|
DNA double strand Ab [Units/volume] in Body fluid |
|
63222-4
|
DNA double strand Ab [Units/volume] in Pleural fluid by Immunoassay |
|
63221-6
|
DNA double strand Ab [Presence] in Pleural fluid by Immunofluorescence |
|
47299-3
|
DNA double strand Ab [Units/volume] in Serum by Farr method |
|
32677-7
|
DNA double strand Ab [Units/volume] in Serum by Immunoassay |
|
54910-5
|
DNA double strand Ab [Units/volume] in Serum by Immunofluorescence |
|
31348-6
|
DNA double strand Ab [Presence] in Serum |
|
6457-6
|
DNA double strand Ab [Presence] in Serum by Immunofluorescence (IF) Crithidia luciliae |
|
12277-0
|
DNA double strand Ab [Presence] in Serum by Farr method |
|
5131-8
|
DNA double strand Ab [Presence] in Serum by Immunofluorescence |
|
81716-3
|
DNA double strand Ab [Presence] in Serum by Line blot |
|
42200-6
|
DNA double strand Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
37993-3
|
DNA double strand Ab [Mass/volume] in Serum by Radioimmunoassay (RIA) |
|
5130-0
|
DNA double strand Ab [Units/volume] in Serum |
|
63220-8
|
DNA double strand Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63223-2
|
DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence |
|
11013-0
|
DNA double strand Ab [Titer] in Serum |
|
34187-5
|
DNA double strand Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae |
|
63229-9
|
DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63228-1
|
DNA double strand IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
63535-9
|
DNA double strand IgG Ab [Units/volume] in Cerebral spinal fluid |
|
63385-9
|
DNA double strand IgG Ab [Units/volume] in Body fluid by Flow cytometry (FC) |
|
63226-5
|
DNA double strand IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
63224-0
|
DNA double strand IgG Ab [Presence] in Body fluid by Immunoassay |
|
63225-7
|
DNA double strand IgG Ab [Presence] in Body fluid by Immunofluorescence |
|
63534-2
|
DNA double strand IgG Ab [Units/volume] in Body fluid |
|
68956-2
|
DNA double strand IgG Ab [Units/volume] in Pericardial fluid by Immunoassay |
|
63386-7
|
DNA double strand IgG Ab [Units/volume] in Pleural fluid by Flow cytometry (FC) |
|
63231-5
|
DNA double strand IgG Ab [Units/volume] in Pleural fluid by Immunoassay |
|
68388-8
|
DNA double strand IgG Ab [Units/volume] in Peritoneal fluid by Immunoassay |
|
63379-2
|
DNA double strand IgG Ab [Presence] in Serum |
|
58465-6
|
DNA double strand IgG Ab [Presence] in Serum by Immunoassay |
|
33800-4
|
DNA double strand IgG Ab [Units/volume] in Serum |
|
33799-8
|
DNA double strand IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
68389-6
|
DNA double strand IgG Ab [Units/volume] in Synovial fluid by Immunoassay |
|
63230-7
|
DNA double strand IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63227-3
|
DNA double strand IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
63381-8
|
DNA double strand IgG Ab [Titer] in Serum |
|
58466-4
|
DNA double strand IgG Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae |
|
63234-9
|
DNA double strand IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63233-1
|
DNA double strand IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
63232-3
|
DNA double strand IgM Ab [Presence] in Body fluid by Immunofluorescence |
|
63235-6
|
DNA double strand IgM Ab [Units/volume] in Pleural fluid by Immunoassay |
|
63237-2
|
DNA double strand IgM Ab [Units/volume] in Serum by Immunoassay |
|
63236-4
|
DNA double strand IgM Ab [Presence] in Serum by Immunofluorescence |
|
72496-3
|
DNA double strand [Mass/volume] in Unspecified specimen |
|
13970-9
|
Delta tocopherol [Mass/volume] in Serum or Plasma |
|
91550-4
|
Duke Treadmill Score panel |
|
54425-4
|
Du Ag [Presence] on Red Blood Cells from Fetus |
|
972-0
|
Du Ag [Presence] on Red Blood Cells |
|
65319-6
|
Du sup(a) Ab [Presence] in Serum or Plasma |
|
55594-6
|
Duck feather IgE Ab [Presence] in Serum |
|
6100-2
|
Duck feather IgE Ab [Units/volume] in Serum |
|
7289-2
|
Duck feather IgG Ab [Units/volume] in Serum |
|
56250-4
|
Duck feather IgG4 Ab [Mass/volume] in Serum |
|
81785-8
|
Duck feather IgG Ab [Mass/volume] in Serum |
|
6101-0
|
Duck meat IgE Ab [Units/volume] in Serum |
|
56251-2
|
Duck meat IgG4 Ab [Mass/volume] in Serum |
|
63101-0
|
Duck meat IgG Ab [Mass/volume] in Serum |
|
13309-0
|
Duffy group Ag [Type] on Red Blood Cells |
|
90854-1
|
Duke Anxiety Depression Scale [DUKE-AD] |
|
91549-6
|
Duke Treadmill Score |
|
46227-5
|
DULoxetine [Mass/volume] in Serum or Plasma |
|
75229-5
|
DULoxetine [Presence] in Urine |
|
78823-2
|
DULoxetine [Presence] in Urine by Confirmatory method |
|
72815-4
|
DULoxetine/Creatinine [Mass Ratio] in Urine |
|
15231-4
|
Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Presence] in Serum by Multidisk |
|
30186-1
|
Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Units/volume] in Serum by Multidisk |
|
23795-8
|
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Presence] in Serum by Multidisk |
|
37987-5
|
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Units/volume] in Serum by Multidisk |
|
56291-8
|
Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgG4 Ab [Mass/volume] in Serum |
|
22254-7
|
Duck enteritis virus Ab [Presence] in Serum |
|
43328-4
|
Duck enteritis virus Ab [Presence] in Serum by Immunofluorescence |
|
20788-6
|
Duck enteritis virus Ab [Presence] in Serum by Neutralization test |
|
20852-0
|
Duck enteritis virus Ag [Presence] in Tissue by Immunofluorescence |
|
31802-2
|
Duck enteritis virus Ag [Presence] in Unspecified specimen |
|
23032-6
|
Duck enteritis virus Ag [Presence] in Unspecified specimen by Agglutination |
|
23031-8
|
Duck enteritis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
23030-0
|
Duck enteritis virus [Presence] in Tissue by Electron microscopy |
|
52797-8
|
Diagnosis ICD code [Identifier] |
|
76514-9
|
Fetal Narrative Study observation general Diagnostic imaging |
|
46383-6
|
DXA Bone [Mass/Area] Bone density |
|
83051-3
|
DXA Cervical and thoracic and lumbar spine Views for vertebral fracture |
|
80934-3
|
DXA Femur [Z-score] Bone density |
|
80954-1
|
DXA Femur - left [Mass/Area] Bone density |
|
80948-3
|
DXA Femur - left [T-score] Bone density |
|
80940-0
|
DXA Femur - left [Z-score] Bone density |
|
80953-3
|
DXA Femur - right [Mass/Area] Bone density |
|
80947-5
|
DXA Femur - right [T-score] Bone density |
|
80939-2
|
DXA Femur - right [Z-score] Bone density |
|
80956-6
|
DXA Calcaneus - left [Mass/Area] Bone density |
|
80950-9
|
DXA Calcaneus - left [T-score] Bone density |
|
80942-6
|
DXA Calcaneus - left [Z-score] Bone density |
|
80955-8
|
DXA Calcaneus - right [Mass/Area] Bone density |
|
80949-1
|
DXA Calcaneus - right [T-score] Bone density |
|
80941-8
|
DXA Calcaneus - right [Z-score] Bone density |
|
80933-5
|
DXA Hip [Z-score] Bone density |
|
80946-7
|
DXA Hip - left [T-score] Bone density |
|
80938-4
|
DXA Hip - left [Z-score] Bone density |
|
80945-9
|
DXA Hip - right [T-score] Bone density |
|
80937-6
|
DXA Hip - right [Z-score] Bone density |
|
80932-7
|
DXA Radius and Ulna [Z-score] Bone density |
|
80952-5
|
DXA Radius and Ulna - left [Mass/Area] Bone density |
|
80944-2
|
DXA Radius and Ulna - left [T-score] Bone density |
|
80936-8
|
DXA Radius and Ulna - left [Z-score] Bone density |
|
80951-7
|
DXA Radius and Ulna - right [Mass/Area] Bone density |
|
80943-4
|
DXA Radius and Ulna - right [T-score] Bone density |
|
80935-0
|
DXA Radius and Ulna - right [Z-score] Bone density |
|
83012-5
|
DXA Skeletal system.axial Views for bone density |
|
83014-1
|
DXA Skeletal system.axial Views for bone density and vertebral fracture |
|
83013-3
|
DXA Skeletal system.peripheral Views for bone density |
|
38268-9
|
DXA Skeletal system Views for bone density |
|
73566-2
|
Dextrorphan [Mass/volume] in Urine |
|
14068-1
|
Triamterene+hydroCHLOROthiazide [Mass/volume] in Serum or Plasma |
|
3587-3
|
Dyphylline [Mass/volume] in Serum or Plasma |
|
46992-4
|
DYS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
32653-8
|
DYS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
43745-9
|
DYS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
53856-1
|
DYSF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35124-7
|
Dysferlin [Presence] in Leukocytes |
|
33666-9
|
Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy |
|
93937-1
|
E Ag [Presence] on Red Blood Cells --during infancy |
|
92544-6
|
E Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92506-5
|
E Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93927-2
|
E Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93920-7
|
E Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
1021-5
|
E Ag [Presence] on Red Blood Cells |
|
93945-4
|
E Ag [Presence] in Cord red blood cells |
|
41443-3
|
Enterocytozoon bieneusi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
7874-1
|
Ehrlichia canis Ab [Presence] in Serum |
|
6400-6
|
Ehrlichia canis Ab [Presence] in Serum by Immunoassay |
|
23054-0
|
Ehrlichia canis Ab [Presence] in Serum by Immunofluorescence |
|
31361-9
|
Ehrlichia canis Ab [Units/volume] in Serum |
|
23711-5
|
Ehrlichia canis Ab [Titer] in Serum |
|
87560-9
|
Ehrlichia canis+ewingii groEL gene [Presence] in Blood by NAA with non-probe detection |
|
87559-1
|
Ehrlichia chaffeensis groEL gene [Presence] in Blood by NAA with non-probe detection |
|
45059-3
|
Ehrlichia chaffeensis IgG and IgM panel [Titer] - unspecified time Serum by Immunofluorescence |
|
32172-9
|
Ehrlichia chaffeensis Ab [Presence] in Serum |
|
13195-3
|
Ehrlichia chaffeensis Ab [Units/volume] in Serum |
|
41752-7
|
Ehrlichia chaffeensis Ab [Titer] in Serum |
|
68949-7
|
Ehrlichia chaffeensis Ab [Titer] in Serum by Immunofluorescence |
|
54035-1
|
Ehrlichia chaffeensis Ag [Presence] in Tissue by Immune stain |
|
27994-3
|
Ehrlichia chaffeensis DNA [Presence] in Blood by NAA with probe detection |
|
24042-4
|
Ehrlichia chaffeensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32678-5
|
Ehrlichia chaffeensis IgG Ab [Presence] in Cerebral spinal fluid |
|
7875-8
|
Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum by Immunoassay |
|
22283-6
|
Ehrlichia chaffeensis IgG Ab [Presence] in Serum |
|
6401-4
|
Ehrlichia chaffeensis IgG Ab [Presence] in Serum by Immunoassay |
|
22284-4
|
Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum |
|
49180-3
|
Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid |
|
48894-0
|
Ehrlichia chaffeensis IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
9783-2
|
Ehrlichia chaffeensis IgG Ab [Titer] in Serum |
|
47405-6
|
Ehrlichia chaffeensis IgG Ab [Titer] in Serum by Immunofluorescence |
|
51760-7
|
Ehrlichia chaffeensis IgG+IgM Ab [Presence] in Serum or Plasma |
|
32679-3
|
Ehrlichia chaffeensis IgM Ab [Presence] in Cerebral spinal fluid |
|
7876-6
|
Ehrlichia chaffeensis IgM Ab [Presence] in Serum |
|
6402-2
|
Ehrlichia chaffeensis IgM Ab [Presence] in Serum by Immunoassay |
|
31362-7
|
Ehrlichia chaffeensis IgM Ab [Units/volume] in Serum |
|
49179-5
|
Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid |
|
48895-7
|
Ehrlichia chaffeensis IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
9784-0
|
Ehrlichia chaffeensis IgM Ab [Titer] in Serum |
|
48850-2
|
Ehrlichia chaffeensis IgM Ab [Titer] in Serum by Immunofluorescence |
|
92985-1
|
Enterobacter cloacae complex DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85772-2
|
Enterobacter cloacae complex DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92984-4
|
Enterobacter cloacae complex DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
87317-4
|
Escherichia coli [#/volume] in Water by Viability count |
|
53945-2
|
Escherichia coli adherence pattern [Identifier] in Isolate by Hep2 substrate |
|
92983-6
|
Escherichia coli DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85773-0
|
Escherichia coli DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92982-8
|
Escherichia coli DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61398-4
|
Escherichia coli DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
53944-5
|
Escherichia coli enteroinvasive [Presence] in Isolate |
|
13318-1
|
Escherichia coli enteroinvasive identified in Stool by Organism specific culture |
|
16832-8
|
Escherichia coli enterotoxic identified in Stool by Organism specific culture |
|
20813-2
|
Escherichia coli F41 [Presence] in Isolate by Agglutination |
|
20814-0
|
Escherichia coli F41 [Presence] in Small intestine Tissue by Immunofluorescence |
|
50028-0
|
Escherichia coli IgE Ab [Units/volume] in Serum |
|
26800-3
|
Escherichia coli IgG Ab [Units/volume] in Serum |
|
26789-8
|
Escherichia coli IgM Ab [Units/volume] in Serum |
|
31824-6
|
Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid |
|
14324-8
|
Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
43431-6
|
Escherichia coli K1 Ag [Presence] in Serum |
|
43432-4
|
Escherichia coli K1 Ag [Presence] in Urine |
|
31825-3
|
Escherichia coli K1 Ag [Presence] in Unspecified specimen |
|
16833-6
|
Escherichia coli K1 Ag [Presence] in Unspecified specimen by Immunoassay |
|
16834-4
|
Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
82182-7
|
Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
87373-7
|
Escherichia coli K88 DNA [Presence] in Isolate by NAA with probe detection |
|
20816-5
|
Escherichia coli K88 [Presence] in Isolate by Agglutination |
|
20815-7
|
Escherichia coli K88 [Presence] in Small intestine Tissue by Agglutination |
|
20817-3
|
Escherichia coli K88 [Presence] in Small intestine Tissue by Immunofluorescence |
|
87374-5
|
Escherichia coli K99 DNA [Presence] in Isolate by NAA with probe detection |
|
20819-9
|
Escherichia coli K99 [Presence] in Isolate by Agglutination |
|
20821-5
|
Escherichia coli K99 [Presence] in Stool by Agglutination |
|
20818-1
|
Escherichia coli K99 [Presence] in Small intestine Tissue by Agglutination |
|
20822-3
|
Escherichia coli K99 [Presence] in Small intestine Tissue by Immunofluorescence |
|
13329-8
|
Escherichia coli labile toxin [Presence] in Unspecified specimen |
|
45162-5
|
Escherichia coli O157 Ag [Presence] in Isolate by Latex agglutination |
|
44087-5
|
Escherichia coli O157 Ag [Presence] in Unspecified specimen |
|
82204-9
|
Escherichia coli O157 DNA [Presence] in Stool by NAA with non-probe detection |
|
53955-1
|
Escherichia coli O157 identified in Isolate by Organism specific culture |
|
39019-5
|
Escherichia coli O157:H7 Ag [Presence] in Raw milk by Immunoassay |
|
32777-5
|
Escherichia coli O157:H7 Ag [Presence] in Stool |
|
44088-3
|
Escherichia coli O157:H7 DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
38990-8
|
Escherichia coli O157:H7 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
35879-6
|
Escherichia coli O157:H7 IgG Ab [Units/volume] in Serum |
|
35752-5
|
Escherichia coli O157:H7 IgG and IgM panel - Serum |
|
35878-8
|
Escherichia coli O157:H7 IgM Ab [Units/volume] in Serum |
|
44090-9
|
Escherichia coli O157:H7 [Presence] in Isolate by Organism specific culture |
|
20823-1
|
Escherichia coli O157:H7 [Presence] in Raw milk by Organism specific culture |
|
10851-4
|
Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture |
|
44089-1
|
Escherichia coli O157:H7 [Identifier] in Unspecified specimen by Organism specific culture |
|
20789-4
|
Escherichia coli serotype [Identifier] in Isolate |
|
82299-9
|
Escherichia coli shiga-like toxin 1+2 [Presence] in Stool by Immunoassay |
|
16835-1
|
Escherichia coli shiga-like toxin identified in Stool by Organism specific culture |
|
21262-1
|
Escherichia coli shiga-like toxin [Presence] in Stool by Immunoassay |
|
53946-0
|
Escherichia coli shiga-like toxin identified in Unspecified specimen |
|
28035-4
|
Escherichia coli shiga-like toxin [Units/volume] in Unspecified specimen by Immunoassay |
|
64013-6
|
Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay |
|
16836-9
|
Escherichia coli verotoxic identified in Stool by Organism specific culture |
|
16283-4
|
Escherichia coli verotoxin [Presence] in Unspecified specimen |
|
31381-7
|
Escherichia coli verotoxin 1 Ab [Units/volume] in Stool |
|
22608-4
|
Escherichia coli verotoxin 1 Ab [Titer] in Stool |
|
6575-5
|
Escherichia coli verotoxin 1 Ab [Titer] in Stool by Neutralization test |
|
6574-8
|
Escherichia coli verotoxin 1 [Presence] in Stool |
|
31382-5
|
Escherichia coli verotoxin 2 Ab [Units/volume] in Stool |
|
22609-2
|
Escherichia coli verotoxin 2 Ab [Titer] in Stool |
|
6577-1
|
Escherichia coli verotoxin 2 Ab [Titer] in Stool by Neutralization test |
|
6576-3
|
Escherichia coli verotoxin 2 [Presence] in Stool |
|
20811-6
|
Escherichia coli [Presence] in Unspecified specimen by Culture FDA method |
|
20812-4
|
Escherichia coli 987P [Presence] in Small intestine Tissue by Immunofluorescence |
|
20801-7
|
Encephalitozoon cuniculi Ab [Presence] in Serum |
|
41439-1
|
Encephalitozoon cuniculi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41442-5
|
Entamoeba dispar DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48865-0
|
Ehrlichia ewingii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61362-0
|
Enterococcus faecalis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88256-3
|
Enterococcus faecalis hsp60 gene [Presence] by Probe in Positive blood culture |
|
73963-1
|
Enterococcus faecalis and other enterococcus sp rRNA [Identifier] by FISH in Positive blood culture |
|
61397-6
|
Enterococcus faecium DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88257-1
|
Enterococcus faecium hsp60 gene [Presence] by Probe in Positive blood culture |
|
7307-2
|
Epidermophyton floccosum IgE Ab [Units/volume] in Serum |
|
63175-4
|
Epidermophyton floccosum IgG Ab [Mass/volume] in Serum |
|
43602-2
|
Echinococcus granulosus Ab [Units/volume] in Serum by Immunoassay |
|
26673-4
|
Echinococcus granulosus Ab [Presence] in Serum |
|
35416-7
|
Echinococcus granulosus Ab [Presence] in Serum by Immunoblot |
|
46184-8
|
Echinococcus granulosus Ab [Units/volume] in Serum |
|
49181-1
|
Echinococcus granulosus Ab [Titer] in Serum |
|
88921-2
|
Echinococcus granulosus Ab [Titer] in Serum by Complement fixation |
|
48359-4
|
Echinococcus granulosus Ab [Titer] in Serum by Hemagglutination |
|
23855-0
|
Echinococcus granulosus IgE Ab [Units/volume] in Serum |
|
47308-2
|
Echinococcus granulosus IgG Ab [Units/volume] in Serum by Immunoassay |
|
22264-6
|
Echinococcus granulosus IgG Ab [Presence] in Serum |
|
21252-2
|
Echinococcus granulosus IgG Ab [Presence] in Serum by Immunoblot |
|
47431-2
|
Echinococcus granulosus IgG Ab [Units/volume] in Serum |
|
41440-9
|
Encephalitozoon hellem DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
70293-6
|
Entamoeba histolytica+Entamoeba dispar+Entamoeba ecuadoriensis+Entamoeba nuttalli DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47406-4
|
Entamoeba histolytica Ab [Presence] in Cerebral spinal fluid |
|
16818-7
|
Entamoeba histolytica Ab [Units/volume] in Cerebral spinal fluid |
|
16820-3
|
Entamoeba histolytica Ab [Units/volume] in Serum by Complement fixation |
|
5151-6
|
Entamoeba histolytica Ab [Units/volume] in Serum by Hemagglutination |
|
5150-8
|
Entamoeba histolytica Ab [Units/volume] in Serum by Immunoassay |
|
9421-9
|
Entamoeba histolytica Ab [Units/volume] in Serum by Immune diffusion (ID) |
|
16819-5
|
Entamoeba histolytica Ab [Units/volume] in Serum by Immunofluorescence |
|
22285-1
|
Entamoeba histolytica Ab [Presence] in Serum |
|
90297-3
|
Entamoeba histolytica Ab [Presence] in Serum by Immunoassay |
|
16817-9
|
Entamoeba histolytica Ab [Presence] in Serum by Immune diffusion (ID) |
|
56921-0
|
Entamoeba histolytica Ab [Presence] in Serum by Immunofluorescence |
|
7880-8
|
Entamoeba histolytica Ab [Units/volume] in Serum |
|
22286-9
|
Entamoeba histolytica Ab [Titer] in Serum |
|
9420-1
|
Entamoeba histolytica Ab [Titer] in Serum by Complement fixation |
|
21259-7
|
Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination |
|
25400-3
|
Entamoeba histolytica Ab [Titer] in Serum by Immunofluorescence |
|
6397-4
|
Entamoeba histolytica Ag [Units/volume] in Serum by Immunoassay |
|
31810-5
|
Entamoeba histolytica Ag [Units/volume] in Serum |
|
6398-2
|
Entamoeba histolytica Ag [Units/volume] in Stool by Immunoassay |
|
29905-7
|
Entamoeba histolytica Ag [Presence] in Stool by Immunoassay |
|
31811-3
|
Entamoeba histolytica Ag [Units/volume] in Stool |
|
6399-0
|
Entamoeba histolytica Ag [Units/volume] in Unspecified specimen by Immunoassay |
|
31812-1
|
Entamoeba histolytica Ag [Units/volume] in Unspecified specimen |
|
91766-6
|
Entamoeba histolytica DNA [Presence] in Aspirate by NAA with probe detection |
|
82207-2
|
Entamoeba histolytica DNA [Presence] in Stool by NAA with non-probe detection |
|
92689-9
|
Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection |
|
6396-6
|
Entamoeba histolytica DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
27090-0
|
Entamoeba histolytica IgA Ab [Presence] in Saliva (oral fluid) |
|
9521-6
|
Entamoeba histolytica IgA Ab [Units/volume] in Serum by Immunoassay |
|
22287-7
|
Entamoeba histolytica IgA Ab [Units/volume] in Serum |
|
9522-4
|
Entamoeba histolytica IgG Ab [Units/volume] in Serum by Immunoassay |
|
56922-8
|
Entamoeba histolytica IgG Ab [Presence] in Serum by Immunoassay |
|
22288-5
|
Entamoeba histolytica IgG Ab [Units/volume] in Serum |
|
9523-2
|
Entamoeba histolytica IgM Ab [Units/volume] in Serum by Immunoassay |
|
22289-3
|
Entamoeba histolytica IgM Ab [Units/volume] in Serum |
|
14125-9
|
Entamoeba histolytica [Presence] in Stool by Trichrome stain |
|
80682-8
|
Entamoeba histolytica 18S rRNA [Presence] in Stool by NAA with probe detection |
|
41441-7
|
Encephalitozoon intestinalis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
66447-4
|
Euroglyphus maynei recombinant (rEur m) 2 IgE Ab [Units/volume] in Serum |
|
6114-3
|
Euroglyphus maynei IgE Ab [Units/volume] in Serum |
|
87561-7
|
Ehrlichia muris eauclairensis groEL gene [Presence] in Blood by NAA with non-probe detection |
|
6111-9
|
Epicoccum purpurascens IgE Ab [Units/volume] in Serum |
|
39599-6
|
Epicoccum purpurascens IgE Ab/IgE total in Serum |
|
18410-1
|
Epicoccum purpurascens IgG Ab [Units/volume] in Serum |
|
42904-3
|
Epicoccum purpurascens IgG Ab [Mass/volume] in Serum |
|
87367-9
|
Erysipelothrix rhusiopathiae Ab/Positive control in Serum by Immunoassay |
|
86725-9
|
Erysipelothrix rhusiopathiae Ag [Presence] in Tissue by Immune stain |
|
86726-7
|
Erysipelothrix rhusiopathiae DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86724-2
|
Erysipelothrix rhusiopathiae [Presence] in Unspecified specimen by Organism specific culture |
|
23056-5
|
Ehrlichia risticii Ab [Presence] in Serum |
|
23055-7
|
Ehrlichia risticii Ab [Presence] in Serum by Immunofluorescence |
|
46185-5
|
Ehrlichia risticii Ab [Titer] in Serum |
|
43331-8
|
Ehrlichia risticii Ab [Titer] in Serum by Immunofluorescence |
|
72505-1
|
Exserohilum rostratum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
28071-9
|
E selectin [Mass/volume] in Blood |
|
33801-2
|
E selectin [Mass/volume] in Serum or Plasma |
|
1015-7
|
E sup(w) Ag [Presence] on Red Blood Cells |
|
86728-3
|
Erysipelothrix tonsillarum DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
6676-1
|
Enterobius vermicularis [Presence] in Anal by Pinworm exam |
|
77345-7
|
Enterobius vermicularis [Presence] in Anal by Pinworm exam --2nd specimen |
|
77346-5
|
Enterobius vermicularis [Presence] in Anal by Pinworm exam --3rd specimen |
|
675-9
|
Enterobius vermicularis [Presence] in Unspecified specimen by Pinworm exam |
|
34856-5
|
Evaluation and management of anticoagulation note |
|
34859-9
|
Evaluation and management of hyperlipidemia note |
|
34860-7
|
Evaluation and management of hypertension note |
|
70005-4
|
Evaluation and management of smoking cessation note |
|
89427-9
|
Evaluation and management consent Document |
|
89553-2
|
Evaluation and management of radiation exposure note |
|
81194-3
|
Evaluation and management of workers compensation note |
|
81195-0
|
Evaluation and management of workers compensation form |
|
35121-3
|
E-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma |
|
55149-9
|
BCR-ABL1 e1a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
|
31814-7
|
Equine adenovirus Ag [Presence] in Lung |
|
20677-1
|
Equine adenovirus Ag [Presence] in Lung by Immunofluorescence |
|
44276-4
|
Equine adenovirus Ag [Titer] in Serum by Neutralization test |
|
87319-0
|
Escherichia coli enteroaggregative astA gene [Presence] in Isolate by NAA with probe detection |
|
76011-6
|
Ear temperature |
|
89082-2
|
Early visit item set [ADAPTABLE] |
|
7397-3
|
Eastern Hemlock IgE Ab [Units/volume] in Serum |
|
6282-8
|
Eastern White Pine IgE Ab [Units/volume] in Serum |
|
61299-4
|
Eastern White Pine IgE Ab/IgE total in Serum |
|
56427-8
|
Eastern White Pine IgG4 Ab [Mass/volume] in Serum |
|
7463-3
|
Easter lily IgE Ab [Units/volume] in Serum |
|
89563-1
|
Eating disorder symptoms score [CUBS] |
|
92912-5
|
Eating disorders Consult note |
|
93958-7
|
Eating disorders Diagnostic study note |
|
92911-7
|
Eating disorders Outpatient Note |
|
45978-4
|
Eating patterns Set |
|
23073-0
|
Equine arteritis virus Ab [Presence] in Serum |
|
23070-6
|
Equine arteritis virus Ab [Presence] in Serum by Immunoassay |
|
23068-0
|
Equine arteritis virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23072-2
|
Equine arteritis virus Ab [Presence] in Serum by Immunofluorescence |
|
23071-4
|
Equine arteritis virus Ab [Presence] in Serum by Neutralization test |
|
31376-7
|
Equine arteritis virus Ab [Units/volume] in Serum |
|
22299-2
|
Equine arteritis virus Ab [Titer] in Serum |
|
23069-8
|
Equine arteritis virus Ab [Titer] in Serum by Complement fixation |
|
15473-2
|
Equine arteritis virus Ab [Titer] in Serum by Neutralization test |
|
23077-1
|
Equine arteritis virus Ag [Presence] in Tissue by Immunofluorescence |
|
23078-9
|
Equine arteritis virus Ag [Presence] in Tissue by Immune stain |
|
31815-4
|
Equine arteritis virus Ag [Presence] in Unspecified specimen |
|
23074-8
|
Equine arteritis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23075-5
|
Equine arteritis virus Ag [Presence] in Unspecified specimen by Immune stain |
|
23076-3
|
Equine arteritis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
20807-4
|
Equine arteritis virus [Presence] in Blood by Organism specific culture |
|
23079-7
|
Equine arteritis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88186-2
|
Ebola and Marburg virus RNA Panel - Blood by NAA with probe detection |
|
11581-6
|
Ebola virus Ab [Units/volume] in Serum |
|
22263-8
|
Ebola virus Ab [Titer] in Serum |
|
7862-6
|
Ebola virus Ab [Titer] in Serum by Immunofluorescence |
|
71768-6
|
Ebola virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
41637-0
|
Ebola virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
71770-2
|
Ebola virus IgG Ab [Presence] in Serum by Immunoassay |
|
71767-8
|
Ebola virus IgG Ab [Titer] in Serum by Immunoassay |
|
71712-4
|
Ebola virus IgM Ab [Presence] in Serum by Immunoassay |
|
71711-6
|
Ebola virus IgM Ab [Titer] in Serum by Immunoassay |
|
86518-8
|
Ebola virus RNA [Presence] in Blood by NAA with probe detection |
|
41636-2
|
Ebola virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87554-2
|
Epstein Barr virus Ab panel - Serum Qualitative |
|
93711-0
|
Epstein Barr virus Ab panel - Serum from Donor |
|
49178-7
|
Epstein Barr virus Ab [Presence] in Serum |
|
48723-1
|
Epstein Barr virus Ab [Presence] in Serum by Immunofluorescence |
|
13238-1
|
Epstein Barr virus Ab [Units/volume] in Serum |
|
49069-8
|
Epstein Barr virus Ab [Titer] in Serum |
|
84871-3
|
Epstein Barr virus capsid p18 IgG Ab [Presence] in Serum by Rapid immunoassay |
|
49355-1
|
Epstein Barr virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49354-4
|
Epstein Barr virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
36923-1
|
Epstein Barr virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
34593-4
|
Epstein Barr virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49353-6
|
Epstein Barr virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
47982-4
|
Epstein Barr virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49356-9
|
Epstein Barr virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49352-8
|
Epstein Barr virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
32585-2
|
Epstein Barr virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
93840-7
|
Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
|
93841-5
|
Epstein Barr virus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |
|
5002-1
|
Epstein Barr virus DNA [Presence] in Blood by NAA with probe detection |
|
23858-4
|
Epstein Barr virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
59805-2
|
Epstein Barr virus DNA [Presence] in Body fluid by NAA with probe detection |
|
35397-9
|
Epstein Barr virus DNA [Presence] in Bone marrow by NAA with probe detection |
|
35398-7
|
Epstein Barr virus DNA [Presence] in Mouth by NAA with probe detection |
|
43730-1
|
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
5004-7
|
Epstein Barr virus DNA [Presence] in Tissue by NAA with probe detection |
|
5003-9
|
Epstein Barr virus DNA [Presence] in Tissue by Probe |
|
53774-6
|
Epstein Barr virus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5005-4
|
Epstein Barr virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
18427-5
|
Epstein Barr virus early Ab [Presence] in Body fluid |
|
16823-7
|
Epstein Barr virus early Ab [Units/volume] in Serum by Immunoassay |
|
7882-4
|
Epstein Barr virus early Ab [Presence] in Serum |
|
5153-2
|
Epstein Barr virus early Ab [Presence] in Serum by Immunoassay |
|
5154-0
|
Epstein Barr virus early Ab [Presence] in Serum by Immunofluorescence |
|
22293-5
|
Epstein Barr virus early Ab [Units/volume] in Serum |
|
42497-8
|
Epstein Barr virus early Ab [Titer] in Cerebral spinal fluid |
|
22294-3
|
Epstein Barr virus early Ab [Titer] in Serum |
|
14083-0
|
Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence |
|
47435-3
|
Epstein Barr virus early IgA Ab [Titer] in Serum |
|
47072-4
|
Epstein Barr virus early IgA Ab [Titer] in Serum by Immunofluorescence |
|
31371-8
|
Epstein Barr virus early IgG Ab [Units/volume] in Cerebral spinal fluid |
|
22295-0
|
Epstein Barr virus early IgG Ab [Presence] in Serum |
|
40752-8
|
Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay |
|
6814-8
|
Epstein Barr virus early IgG Ab [Presence] in Serum by Immunofluorescence |
|
24007-7
|
Epstein Barr virus early IgG Ab [Units/volume] in Serum |
|
23972-3
|
Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid |
|
23996-2
|
Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
47436-1
|
Epstein Barr virus early IgG Ab [Titer] in Body fluid |
|
47068-2
|
Epstein Barr virus early IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
23971-5
|
Epstein Barr virus early IgG Ab [Titer] in Serum |
|
23995-4
|
Epstein Barr virus early IgG Ab [Titer] in Serum by Immunofluorescence |
|
56598-6
|
Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay |
|
51454-7
|
Epstein Barr virus early diffuse Ab [Presence] in Cerebral spinal fluid |
|
47434-6
|
Epstein Barr virus early diffuse Ab [Presence] in Serum |
|
13236-5
|
Epstein Barr virus early diffuse Ab [Presence] in Serum by Immunofluorescence |
|
94102-1
|
Epstein Barr virus early diffuse IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
59183-4
|
Epstein Barr virus early diffuse IgG Ab [Presence] in Serum |
|
50969-5
|
Epstein Barr virus early diffuse IgG Ab [Units/volume] in Serum |
|
47437-9
|
Epstein Barr virus early restricted Ab [Presence] in Serum |
|
13237-3
|
Epstein Barr virus early restricted Ab [Presence] in Serum by Immunofluorescence |
|
33479-7
|
Epstein Barr virus early restricted Ab [Titer] in Serum |
|
84872-1
|
Epstein Barr virus nuclear 1 IgG Ab [Presence] in Serum by Rapid immunoassay |
|
66493-8
|
Epstein Barr virus nuclear 1 IgG Ab [Units/volume] in Serum |
|
72206-6
|
Epstein Barr virus nuclear 1 IgG and IgM [Color Ratio] in Serum or Plasma by Rapid immunoassay |
|
16824-5
|
Epstein Barr virus nuclear Ab [Presence] in Cerebral spinal fluid |
|
93712-8
|
Epstein Barr virus nuclear Ab [Presence] in Serum from Donor by Immunoassay |
|
22296-8
|
Epstein Barr virus nuclear Ab [Presence] in Serum |
|
20432-1
|
Epstein Barr virus nuclear Ab [Presence] in Serum by Immunofluorescence |
|
31372-6
|
Epstein Barr virus nuclear Ab [Units/volume] in Serum |
|
30138-2
|
Epstein Barr virus nuclear Ab [Presence] in Serum --2nd specimen |
|
42498-6
|
Epstein Barr virus nuclear Ab [Titer] in Cerebral spinal fluid |
|
22297-6
|
Epstein Barr virus nuclear Ab [Titer] in Serum |
|
21260-5
|
Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence |
|
18428-3
|
Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid |
|
31373-4
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Cerebral spinal fluid |
|
16825-2
|
Epstein Barr virus nuclear IgG Ab [Presence] in Body fluid |
|
30083-0
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
40753-6
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
7883-2
|
Epstein Barr virus nuclear IgG Ab [Presence] in Serum |
|
5156-5
|
Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
5155-7
|
Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
|
31374-2
|
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum |
|
23970-7
|
Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid |
|
23994-7
|
Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22298-4
|
Epstein Barr virus nuclear IgG Ab [Titer] in Serum |
|
12212-7
|
Epstein Barr virus nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
|
7884-0
|
Epstein Barr virus nuclear IgM Ab [Presence] in Serum |
|
6815-5
|
Epstein Barr virus nuclear IgM Ab [Presence] in Serum by Immunoassay |
|
31375-9
|
Epstein Barr virus nuclear IgM Ab [Units/volume] in Serum |
|
26705-4
|
Epstein Barr virus nuclear IgM Ab [Titer] in Serum |
|
33395-5
|
Epstein Barr virus capsid Ab [Presence] in Serum |
|
31369-2
|
Epstein Barr virus capsid IgA Ab [Units/volume] in Serum |
|
34639-5
|
Epstein Barr virus capsid IgA Ab [Titer] in Cerebral spinal fluid |
|
22290-1
|
Epstein Barr virus capsid IgA Ab [Titer] in Serum |
|
9633-9
|
Epstein Barr virus capsid IgA Ab [Titer] in Serum by Immunofluorescence |
|
81119-0
|
Epstein Barr virus capsid IgG Ab avidity [Ratio] in Serum by Immunoassay |
|
69949-6
|
Epstein Barr virus capsid IgG Ab avidity [Presence] in Serum by Immunoassay |
|
58760-0
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
16827-8
|
Epstein Barr virus capsid IgG Ab [Presence] in Cerebral spinal fluid |
|
16826-0
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid |
|
93713-6
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum from Donor by Immunoassay |
|
5157-3
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay |
|
30339-6
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum |
|
24114-1
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay |
|
40750-2
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence |
|
7885-7
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum |
|
32828-6
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
32843-5
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --1st specimen |
|
32829-4
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
30136-6
|
Epstein Barr virus capsid IgG Ab [Presence] in Serum --2nd specimen |
|
32844-3
|
Epstein Barr virus capsid IgG Ab [Units/volume] in Serum --2nd specimen |
|
22291-9
|
Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid |
|
11009-8
|
Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
47432-0
|
Epstein Barr virus capsid IgG Ab [Titer] in Body fluid |
|
47064-1
|
Epstein Barr virus capsid IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
20490-9
|
Epstein Barr virus capsid IgG Ab [Titer] in Serum |
|
5158-1
|
Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence |
|
24316-2
|
Epstein Barr virus capsid IgG and IgM panel - Serum |
|
56599-4
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31370-0
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid |
|
93714-4
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum from Donor by Immunoassay |
|
5159-9
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay |
|
30340-4
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum |
|
24115-8
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay |
|
40751-0
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunofluorescence |
|
7886-5
|
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum |
|
30137-4
|
Epstein Barr virus capsid IgM Ab [Presence] in Serum --2nd specimen |
|
22292-7
|
Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid |
|
11010-6
|
Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
47433-8
|
Epstein Barr virus capsid IgM Ab [Titer] in Body fluid |
|
47066-6
|
Epstein Barr virus capsid IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
20491-7
|
Epstein Barr virus capsid IgM Ab [Titer] in Serum |
|
5160-7
|
Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence |
|
83095-0
|
Epstein Barr virus capsid+early IgG Ab [Presence] in Serum by Immunoassay |
|
68466-2
|
Epstein-Barr virus-encoded RNA 1 [Presence] in Tissue by Probe |
|
48673-8
|
EBV-LMP Ag [Presence] in Tissue by Immune stain |
|
87402-4
|
Escherichia coli aidA-I gene [Presence] in Isolate by NAA with probe detection |
|
87318-2
|
Escherichia coli eaeA gene [Presence] in Isolate by NAA with probe detection |
|
87951-0
|
Escherichia coli eaeA gene [Presence] in Stool by NAA with probe detection |
|
63423-8
|
Escherichia coli eaeA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
87370-3
|
Escherichia coli fasA gene [Presence] in Isolate by NAA with probe detection |
|
87371-1
|
Escherichia coli fedF gene [Presence] in Isolate by NAA with probe detection |
|
87372-9
|
Escherichia coli FimF41a gene [Presence] in Isolate by NAA with probe detection |
|
88116-9
|
Escherichia coli gene panel - Unspecified specimen by NAA with probe detection |
|
80676-0
|
Escherichia coli O157 rfbE gene [Presence] in Stool by NAA with probe detection |
|
88258-9
|
Escherichia coli oppA gene [Presence] by Probe in Positive blood culture |
|
87375-2
|
Escherichia coli paa gene [Presence] in Isolate by NAA with probe detection |
|
81659-5
|
Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 genes panel - Stool by NAA with probe detection |
|
81285-9
|
Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 genes [Identifier] in Stool by NAA with probe detection |
|
87376-0
|
Escherichia coli Stx1 toxin stx1 gene [Presence] in Isolate by NAA with probe detection |
|
63427-9
|
Escherichia coli Stx1 toxin stx1 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
53947-8
|
Escherichia coli Stx1 and Stx2 toxin stx1 and stx2 and H7 flagellar fliC genes [Identifier] in Unspecified specimen by NAA with probe detection |
|
82203-1
|
Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with non-probe detection |
|
80679-4
|
Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with probe detection |
|
87377-8
|
Escherichia coli Stx2 toxin stx2 gene [Presence] in Isolate by NAA with probe detection |
|
63428-7
|
Escherichia coli Stx2 toxin stx2 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
87380-2
|
Escherichia coli Stx2e toxin stx2e gene [Presence] in Isolate by NAA with probe detection |
|
29540-2
|
E-cadherin [Presence] in Tissue by Immune stain |
|
42496-0
|
Echinococcus sp Ab [Presence] in Cerebral spinal fluid |
|
6390-9
|
Echinococcus sp Ab [Units/volume] in Serum by Complement fixation |
|
25398-9
|
Echinococcus sp Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE) |
|
5135-9
|
Echinococcus sp Ab [Units/volume] in Serum by Hemagglutination |
|
6391-7
|
Echinococcus sp Ab [Units/volume] in Serum by Immunoassay |
|
25339-3
|
Echinococcus sp Ab [Presence] in Serum |
|
40749-4
|
Echinococcus sp Ab [Presence] in Serum by Complement fixation |
|
26007-5
|
Echinococcus sp Ab [Presence] in Serum by Hemagglutination |
|
25397-1
|
Echinococcus sp Ab [Presence] in Serum by Immunoassay |
|
41416-9
|
Echinococcus sp Ab [Presence] in Serum by Immunoblot |
|
7863-4
|
Echinococcus sp Ab [Units/volume] in Serum |
|
25867-3
|
Echinococcus sp Ab [Titer] in Serum |
|
26008-3
|
Echinococcus sp Ab [Titer] in Serum by Hemagglutination |
|
31809-7
|
Echinococcus sp Ag [Presence] in Stool |
|
23053-2
|
Echinococcus sp Ag [Presence] in Stool by Immunoassay |
|
6103-6
|
Echinococcus sp IgE Ab [Units/volume] in Serum |
|
9656-0
|
Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
14082-2
|
Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoblot |
|
32171-1
|
Echinococcus sp IgG Ab [Presence] in Serum |
|
22265-3
|
Echinococcus sp IgG Ab [Units/volume] in Serum |
|
52982-6
|
Echinococcus sp IgG1 Ab [Units/volume] in Serum by Immunoassay |
|
53369-5
|
Echinococcus sp IgG1 Ab [Units/volume] in Serum |
|
52983-4
|
Echinococcus sp IgG4 Ab [Units/volume] in Serum by Immunoassay |
|
55165-5
|
Echinococcus sp IgG4 Ab [Presence] in Serum |
|
53370-3
|
Echinococcus sp IgG4 Ab [Units/volume] in Serum |
|
9657-8
|
Echinococcus sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
16794-0
|
Echinococcus sp IgM Ab [Units/volume] in Serum |
|
89246-3
|
ECOG Performance Status panel |
|
89247-1
|
ECOG Performance Status score |
|
73961-5
|
Escherichia coli and Klebsiella pneumoniae and Pseudomonas aeruginosa rRNA [Identifier] by FISH in Positive blood culture |
|
54178-9
|
Econazole [Susceptibility] by Disk diffusion (KB) |
|
57089-5
|
Eosinophil cationic protein (ECP) [Mass/volume] in Nasal fluid |
|
25638-8
|
Eosinophil cationic protein (ECP) [Mass/volume] in Serum |
|
55347-9
|
Ecarin clotting time (ECT) in Blood by Coagulation assay |
|
60242-5
|
Ecarin clotting time (ECT) in Platelet poor plasma by Coagulation assay |
|
90240-3
|
Eculizumab [Mass/volume] in Serum |
|
43120-5
|
Echovirus Ab panel - Serum |
|
16796-5
|
Echovirus Ab [Units/volume] in Serum by Complement fixation |
|
53582-3
|
Echovirus Ab [Units/volume] in Serum by Immunoassay |
|
16795-7
|
Echovirus Ab [Units/volume] in Serum |
|
30134-1
|
Echovirus Ab [Presence] in Serum --1st specimen |
|
30135-8
|
Echovirus Ab [Presence] in Serum --2nd specimen |
|
58759-2
|
Echovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
59397-0
|
Echovirus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
59401-0
|
Echovirus IgG Ab [Units/volume] in Serum by Immunoassay |
|
56622-4
|
Echovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
53371-1
|
Echovirus IgG Ab [Titer] in Serum |
|
51840-7
|
Echovirus IgG Ab [Titer] in Serum by Immunofluorescence |
|
59396-2
|
Echovirus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
53583-1
|
Echovirus IgM Ab [Units/volume] in Serum by Immunoassay |
|
56623-2
|
Echovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
53372-9
|
Echovirus IgM Ab [Titer] in Serum |
|
51841-5
|
Echovirus IgM Ab [Titer] in Serum by Immunofluorescence |
|
22282-8
|
Echovirus NOS Ab [Titer] in Serum |
|
5149-0
|
Echovirus NOS Ab [Titer] in Serum by Complement fixation |
|
5148-2
|
Echovirus NOS Ab [Titer] in Serum by Neutralization test |
|
29666-5
|
Echovirus+Coxsackievirus IgA Ab [Presence] in Serum |
|
29645-9
|
Echovirus+Coxsackievirus IgA Ab [Presence] in Serum by Immunoassay |
|
61364-6
|
Echovirus+Coxsackievirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16797-3
|
Echovirus 1 Ab [Units/volume] in Serum by Complement fixation |
|
7864-2
|
Echovirus 1 Ab [Units/volume] in Serum |
|
22266-1
|
Echovirus 1 Ab [Titer] in Serum |
|
5137-5
|
Echovirus 1 Ab [Titer] in Serum by Complement fixation |
|
5136-7
|
Echovirus 1 Ab [Titer] in Serum by Neutralization test |
|
45283-9
|
Echovirus 11 Ab [Presence] in Body fluid |
|
31350-2
|
Echovirus 11 Ab [Presence] in Serum |
|
30333-9
|
Echovirus 11 Ab [Presence] in Serum by Complement fixation |
|
7865-9
|
Echovirus 11 Ab [Units/volume] in Serum |
|
22267-9
|
Echovirus 11 Ab [Titer] in Cerebral spinal fluid |
|
9516-6
|
Echovirus 11 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43043-9
|
Echovirus 11 Ab [Titer] in Body fluid |
|
31061-5
|
Echovirus 11 Ab [Titer] in Body fluid by Complement fixation |
|
22268-7
|
Echovirus 11 Ab [Titer] in Serum |
|
6708-2
|
Echovirus 11 Ab [Titer] in Serum by Complement fixation |
|
41489-6
|
Echovirus 11 Ab [Titer] in Serum by Neutralization test |
|
27934-9
|
Echovirus 11 RNA [Presence] in Cerebral spinal fluid by Probe |
|
16798-1
|
Echovirus 14 Ab [Units/volume] in Serum |
|
22269-5
|
Echovirus 14 Ab [Titer] in Serum |
|
24008-5
|
Echovirus 14 Ab [Titer] in Serum by Complement fixation |
|
20665-6
|
Echovirus 14 Ab [Titer] in Serum by Neutralization test |
|
11594-9
|
Echovirus 16 Ab [Units/volume] in Serum |
|
22271-1
|
Echovirus 16 Ab [Titer] in Serum |
|
6813-0
|
Echovirus 16 Ab [Titer] in Serum by Complement fixation |
|
41490-4
|
Echovirus 16 Ab [Titer] in Serum by Neutralization test |
|
11595-6
|
Echovirus 18 Ab [Units/volume] in Serum |
|
22272-9
|
Echovirus 18 Ab [Titer] in Serum |
|
9517-4
|
Echovirus 18 Ab [Titer] in Serum by Complement fixation |
|
16800-5
|
Echovirus 19 Ab [Units/volume] in Serum by Complement fixation |
|
7866-7
|
Echovirus 19 Ab [Units/volume] in Serum |
|
22273-7
|
Echovirus 19 Ab [Titer] in Serum |
|
5139-1
|
Echovirus 19 Ab [Titer] in Serum by Complement fixation |
|
5138-3
|
Echovirus 19 Ab [Titer] in Serum by Neutralization test |
|
54443-7
|
Echovirus 2 Ab [Titer] in Serum |
|
16801-3
|
Echovirus 3 Ab [Units/volume] in Serum by Complement fixation |
|
7867-5
|
Echovirus 3 Ab [Units/volume] in Serum |
|
22274-5
|
Echovirus 3 Ab [Titer] in Serum |
|
5141-7
|
Echovirus 3 Ab [Titer] in Serum by Complement fixation |
|
5140-9
|
Echovirus 3 Ab [Titer] in Serum by Neutralization test |
|
31351-0
|
Echovirus 30 Ab [Units/volume] in Cerebral spinal fluid |
|
45282-1
|
Echovirus 30 Ab [Presence] in Body fluid |
|
31352-8
|
Echovirus 30 Ab [Units/volume] in Body fluid |
|
6393-3
|
Echovirus 30 Ab [Units/volume] in Serum by Neutralization test |
|
31353-6
|
Echovirus 30 Ab [Presence] in Serum |
|
30334-7
|
Echovirus 30 Ab [Presence] in Serum by Complement fixation |
|
16802-1
|
Echovirus 30 Ab [Units/volume] in Serum |
|
22275-2
|
Echovirus 30 Ab [Titer] in Cerebral spinal fluid |
|
9518-2
|
Echovirus 30 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43040-5
|
Echovirus 30 Ab [Titer] in Body fluid |
|
31062-3
|
Echovirus 30 Ab [Titer] in Body fluid by Complement fixation |
|
7868-3
|
Echovirus 30 Ab [Titer] in Serum |
|
6392-5
|
Echovirus 30 Ab [Titer] in Serum by Complement fixation |
|
41491-2
|
Echovirus 30 Ab [Titer] in Serum by Neutralization test |
|
27928-1
|
Echovirus 30 RNA [Presence] in Cerebral spinal fluid by Probe |
|
34724-5
|
Echovirus 4 Ab [Presence] in Cerebral spinal fluid |
|
31354-4
|
Echovirus 4 Ab [Units/volume] in Cerebral spinal fluid |
|
31355-1
|
Echovirus 4 Ab [Units/volume] in Body fluid |
|
16803-9
|
Echovirus 4 Ab [Units/volume] in Serum by Complement fixation |
|
31356-9
|
Echovirus 4 Ab [Presence] in Serum |
|
30335-4
|
Echovirus 4 Ab [Presence] in Serum by Complement fixation |
|
7869-1
|
Echovirus 4 Ab [Units/volume] in Serum |
|
22276-0
|
Echovirus 4 Ab [Titer] in Cerebral spinal fluid |
|
9519-0
|
Echovirus 4 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43042-1
|
Echovirus 4 Ab [Titer] in Body fluid |
|
31059-9
|
Echovirus 4 Ab [Titer] in Body fluid by Complement fixation |
|
22277-8
|
Echovirus 4 Ab [Titer] in Serum |
|
5143-3
|
Echovirus 4 Ab [Titer] in Serum by Complement fixation |
|
5142-5
|
Echovirus 4 Ab [Titer] in Serum by Neutralization test |
|
27922-4
|
Echovirus 4 RNA [Presence] in Cerebral spinal fluid |
|
6395-8
|
Echovirus 40 Ab [Units/volume] in Serum by Neutralization test |
|
16804-7
|
Echovirus 40 Ab [Units/volume] in Serum |
|
7870-9
|
Echovirus 40 Ab [Titer] in Serum |
|
6394-1
|
Echovirus 40 Ab [Titer] in Serum by Complement fixation |
|
50977-8
|
Echovirus 5 Ab [Titer] in Serum |
|
16805-4
|
Echovirus 6 Ab [Units/volume] in Serum by Complement fixation |
|
43121-3
|
Echovirus 6 Ab [Presence] in Serum |
|
7871-7
|
Echovirus 6 Ab [Units/volume] in Serum |
|
22278-6
|
Echovirus 6 Ab [Titer] in Serum |
|
5145-8
|
Echovirus 6 Ab [Titer] in Serum by Complement fixation |
|
5144-1
|
Echovirus 6 Ab [Titer] in Serum by Neutralization test |
|
16806-2
|
Echovirus 6+18+30 Ab [Units/volume] in Serum |
|
34725-2
|
Echovirus 7 Ab [Presence] in Cerebral spinal fluid |
|
18333-5
|
Echovirus 7 Ab [Units/volume] in Cerebral spinal fluid |
|
45281-3
|
Echovirus 7 Ab [Presence] in Body fluid |
|
31357-7
|
Echovirus 7 Ab [Presence] in Serum |
|
30336-2
|
Echovirus 7 Ab [Presence] in Serum by Complement fixation |
|
11601-2
|
Echovirus 7 Ab [Units/volume] in Serum |
|
23969-9
|
Echovirus 7 Ab [Titer] in Cerebral spinal fluid |
|
23993-9
|
Echovirus 7 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22279-4
|
Echovirus 7 Ab [Titer] in Serum |
|
6922-9
|
Echovirus 7 Ab [Titer] in Serum by Complement fixation |
|
41492-0
|
Echovirus 7 Ab [Titer] in Serum by Neutralization test |
|
54444-5
|
Echovirus 8 Ab [Titer] in Serum |
|
31358-5
|
Echovirus 9 Ab [Units/volume] in Cerebral spinal fluid |
|
45280-5
|
Echovirus 9 Ab [Presence] in Body fluid |
|
31359-3
|
Echovirus 9 Ab [Units/volume] in Body fluid |
|
16807-0
|
Echovirus 9 Ab [Units/volume] in Serum by Complement fixation |
|
31360-1
|
Echovirus 9 Ab [Presence] in Serum |
|
30337-0
|
Echovirus 9 Ab [Presence] in Serum by Complement fixation |
|
7872-5
|
Echovirus 9 Ab [Units/volume] in Serum |
|
22280-2
|
Echovirus 9 Ab [Titer] in Cerebral spinal fluid |
|
9520-8
|
Echovirus 9 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43041-3
|
Echovirus 9 Ab [Titer] in Body fluid |
|
31060-7
|
Echovirus 9 Ab [Titer] in Body fluid by Complement fixation |
|
22281-0
|
Echovirus 9 Ab [Titer] in Serum |
|
5147-4
|
Echovirus 9 Ab [Titer] in Serum by Complement fixation |
|
5146-6
|
Echovirus 9 Ab [Titer] in Serum by Neutralization test |
|
78249-0
|
Emergency department Admission history and physical note |
|
78447-0
|
Emergency department Checklist |
|
51846-4
|
Emergency department Consult note |
|
60280-5
|
Emergency department Discharge instructions |
|
59258-4
|
Emergency department Discharge summary |
|
78265-6
|
Emergency department Discharge teaching note |
|
78273-0
|
Emergency department Education note |
|
78303-5
|
Emergency department Flowsheet |
|
78307-6
|
Emergency department History and physical note |
|
78337-3
|
Emergency department Initial evaluation note |
|
34111-5
|
Emergency department Note |
|
88647-3
|
Emergency department Parenteral therapy note |
|
80746-1
|
Emergency department Plan of care note |
|
78316-7
|
Emergency department procedure note |
|
15507-7
|
Emergency department Progress note |
|
78341-5
|
Emergency department Transfer summary note |
|
54094-8
|
Emergency department Triage note |
|
80110-0
|
Emergency department Visit notification note |
|
74211-4
|
Emergency department+Hospital Summary of episode note |
|
38595-5
|
Ethylene dibromide [Mass/volume] in Air |
|
61076-6
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Gastric fluid |
|
80557-2
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Hair |
|
73562-1
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Meconium by Confirmatory method |
|
72385-8
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72386-6
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method |
|
41860-8
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma |
|
60071-8
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma |
|
58429-2
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method |
|
41858-2
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine |
|
58428-4
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method |
|
93495-0
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method |
|
50542-0
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine |
|
41859-0
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Unspecified specimen |
|
58390-6
|
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine |
|
72304-9
|
Edge of wound description |
|
82468-0
|
Edoxaban [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
93200-4
|
Ehlers-Danlos syndrome multigene analysis in Blood or Tissue by Molecular genetics method |
|
34895-3
|
Education note |
|
79215-0
|
Education program online access code |
|
79213-5
|
Type of education program assigned to patient |
|
79214-3
|
Education program [URI] |
|
22255-4
|
Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid |
|
20794-4
|
Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
20792-8
|
Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
22256-2
|
Eastern equine encephalitis virus Ab [Presence] in Serum |
|
23043-3
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Agglutination |
|
20793-6
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
|
20790-2
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
20791-0
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
|
23044-1
|
Eastern equine encephalitis virus Ab [Presence] in Serum by Neutralization test |
|
5134-2
|
Eastern equine encephalitis virus Ab [Units/volume] in Serum |
|
24287-5
|
Eastern equine encephalitis virus Ab [Titer] in Serum --1st specimen |
|
24213-1
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24288-3
|
Eastern equine encephalitis virus Ab [Titer] in Serum --2nd specimen |
|
24214-9
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
34723-7
|
Eastern equine encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
22257-0
|
Eastern equine encephalitis virus Ab [Titer] in Serum |
|
43329-2
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
23042-5
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
13918-8
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
|
20795-1
|
Eastern equine encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
31806-3
|
Eastern equine encephalitis virus Ag [Presence] in Brain |
|
23047-4
|
Eastern equine encephalitis virus Ag [Presence] in Brain by Complement fixation |
|
31807-1
|
Eastern equine encephalitis virus Ag [Presence] in Serum |
|
6388-3
|
Eastern equine encephalitis virus Ag [Presence] in Serum by Immunoassay |
|
6389-1
|
Eastern equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence |
|
31808-9
|
Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen |
|
23049-0
|
Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23048-2
|
Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23050-8
|
Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
29836-4
|
Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid |
|
29798-6
|
Eastern equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
13228-2
|
Eastern equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
62431-2
|
Eastern equine encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29848-9
|
Eastern equine encephalitis virus IgG Ab [Presence] in Serum |
|
52822-4
|
Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
29811-7
|
Eastern equine encephalitis virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
7860-0
|
Eastern equine encephalitis virus IgG Ab [Units/volume] in Serum |
|
22258-8
|
Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
10897-7
|
Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22259-6
|
Eastern equine encephalitis virus IgG Ab [Titer] in Serum |
|
10896-9
|
Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
29824-0
|
Eastern equine encephalitis virus IgG Ab [Presence] in Unspecified specimen |
|
29785-3
|
Eastern equine encephalitis virus IgG Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
38764-7
|
Eastern equine encephalitis virus IgG Ab [Units/volume] in Unspecified specimen |
|
69035-4
|
Eastern equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
|
69034-7
|
Eastern equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence |
|
35743-4
|
Eastern equine encephalitis virus IgG and IgM panel - Unspecified specimen |
|
43044-7
|
Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid |
|
42004-2
|
Eastern equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13229-0
|
Eastern equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
62430-4
|
Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
62429-6
|
Eastern equine encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence |
|
23046-6
|
Eastern equine encephalitis virus IgM Ab [Presence] in Serum |
|
23045-8
|
Eastern equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
7861-8
|
Eastern equine encephalitis virus IgM Ab [Units/volume] in Serum |
|
22260-4
|
Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
10899-3
|
Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22261-2
|
Eastern equine encephalitis virus IgM Ab [Titer] in Serum |
|
43330-0
|
Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunoassay |
|
10898-5
|
Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
43096-7
|
Eastern equine encephalitis virus IgM Ab [Presence] in Unspecified specimen |
|
38763-9
|
Eastern equine encephalitis virus IgM Ab [Units/volume] in Unspecified specimen |
|
34449-9
|
Eastern equine encephalitis virus RNA [Presence] in Blood by NAA with probe detection |
|
34450-7
|
Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
26825-0
|
Eastern equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe |
|
23051-6
|
Eastern equine encephalitis virus RNA [Presence] in Tissue by NAA with probe detection |
|
23052-4
|
Eastern equine encephalitis virus RNA [Presence] in Tissue by Probe |
|
50547-9
|
Eastern equine encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
37983-4
|
Eastern equine encephalitis virus RNA [Presence] in Unspecified specimen by Probe |
|
11523-8
|
EEG study report |
|
6105-1
|
Eel IgE Ab [Units/volume] in Serum |
|
56252-0
|
Eel IgG4 Ab [Mass/volume] in Serum |
|
63122-6
|
Eel IgG Ab [Mass/volume] in Serum |
|
51908-2
|
Efavirenz [Mass/volume] in Serum or Plasma --peak |
|
29117-9
|
Efavirenz [Units/volume] in Serum or Plasma |
|
33928-3
|
Efavirenz [Mass/volume] in Serum or Plasma |
|
51907-4
|
Efavirenz [Mass/volume] in Serum or Plasma --trough |
|
35588-3
|
Ethylene glycol dinitrate [Mass/volume] in Blood |
|
14049-1
|
Epidermal growth factor [Mass/volume] in Serum or Plasma |
|
39004-7
|
Epidermal growth factor receptor Ag [Presence] in Tissue |
|
32581-1
|
Epidermal growth factor receptor Ag [Presence] in Tissue by Immune stain |
|
55765-2
|
EGFR gene c.2156G>C+2155G>A+2155G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
55768-6
|
EGFR gene c.2303G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
85383-8
|
EGFR gene c.2369C>T actual/normal in Plasma cell-free DNA by Molecular genetics method |
|
55769-4
|
EGFR gene c.2369C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
55766-0
|
EGFR gene c.2573T>G [Presence] in Blood or Tissue by Molecular genetics method |
|
55767-8
|
EGFR gene c.2582T>A [Presence] in Blood or Tissue by Molecular genetics method |
|
55764-5
|
EGFR gene exon 19 deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
55770-2
|
EGFR gene exon 20 insertion [Presence] in Blood or Tissue by Molecular genetics method |
|
21665-5
|
EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
42782-3
|
Epidermal growth factor receptor.phosphorylated Ag [Presence] in Tissue by Immune stain |
|
13659-8
|
Epidermal growth factor receptor [Mass/mass] in Tissue |
|
14050-9
|
Epidermal growth factor receptor [Moles/mass] in Tissue |
|
7290-0
|
Egg white triggered histamine release [Units/volume] in Blood |
|
6106-9
|
Egg white IgE Ab [Units/volume] in Serum |
|
61338-0
|
Egg white IgE Ab/IgE total in Serum |
|
51536-1
|
Egg white IgG Ab [Presence] in Serum |
|
6725-6
|
Egg white IgG Ab [Units/volume] in Serum |
|
26423-4
|
Egg white IgG4 Ab [Units/volume] in Serum |
|
56253-8
|
Egg white IgG4 Ab [Mass/volume] in Serum |
|
35535-4
|
Egg white IgG Ab [Mass/volume] in Serum |
|
48226-5
|
Egg white triggered leukotriene release [Mass/volume] by Leukocytes |
|
7295-9
|
Egg yolk triggered histamine release [Units/volume] in Blood |
|
6107-7
|
Egg yolk IgE Ab [Units/volume] in Serum |
|
61339-8
|
Egg yolk IgE Ab/IgE total in Serum |
|
7294-2
|
Egg yolk IgG Ab [Units/volume] in Serum |
|
56254-6
|
Egg yolk IgG4 Ab [Mass/volume] in Serum |
|
35536-2
|
Egg yolk IgG Ab [Mass/volume] in Serum |
|
48207-5
|
Egg yolk triggered leukotriene release [Mass/volume] by Leukocytes |
|
7296-7
|
Eggplant IgE Ab [Units/volume] in Serum |
|
7297-5
|
Eggplant IgG Ab [Units/volume] in Serum |
|
56256-1
|
Eggplant IgG4 Ab [Mass/volume] in Serum |
|
60372-0
|
Eggplant IgG Ab [Mass/volume] in Serum |
|
34506-6
|
EGR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
34722-9
|
EGR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
20803-3
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum |
|
23060-7
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Complement fixation |
|
23059-9
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay |
|
15466-6
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
20802-5
|
Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Neutralization test |
|
23062-3
|
Epizootic hemorrhagic disease virus Ag [Presence] in Blood |
|
20804-1
|
Epizootic hemorrhagic disease virus Ag [Presence] in Blood by Immunofluorescence |
|
31813-9
|
Epizootic hemorrhagic disease virus Ag [Presence] in Lung |
|
20805-8
|
Epizootic hemorrhagic disease virus Ag [Units/mass] in Lung Qualitative by Immunofluorescence |
|
23061-5
|
Epizootic hemorrhagic disease virus Ag [Presence] in Unspecified specimen |
|
23063-1
|
Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum |
|
23064-9
|
Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum by Immune diffusion (ID) |
|
23065-6
|
Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum |
|
23066-4
|
Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum by Immune diffusion (ID) |
|
23067-2
|
Epizootic hemorrhagic disease virus RNA [Presence] in Blood by NAA with probe detection |
|
91898-7
|
Epizootic hemorrhagic disease virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
63424-6
|
Bacterial enterohemolysin ehlyA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
7879-0
|
Ehrlichia sp Ab [Presence] in Serum |
|
6405-5
|
Ehrlichia sp Ab [Presence] in Serum by Immunoassay |
|
43039-7
|
Ehrlichia sp Ab [Titer] in Serum |
|
34285-7
|
Ehrlichia sp Ab [Titer] in Serum by Complement fixation |
|
48866-8
|
Ehrlichia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
13196-1
|
Ehrlichia sp IgG Ab [Presence] in Serum |
|
32011-9
|
Ehrlichia sp IgG Ab [Titer] in Serum |
|
13197-9
|
Ehrlichia sp IgM Ab [Presence] in Serum |
|
32012-7
|
Ehrlichia sp IgM Ab [Titer] in Serum |
|
48873-4
|
Ehrlichia sp identified in Unspecified specimen by Organism specific culture |
|
48982-3
|
Ehrlichia sp [Presence] in Unspecified specimen by Light microscopy |
|
49125-8
|
Ehrlichia sp identified in Unspecified specimen by Sequencing |
|
31377-5
|
Equine herpesvirus 1 Ab [Units/volume] in Serum |
|
46186-3
|
Equine herpesvirus 1 Ab [Titer] in Cerebral spinal fluid |
|
43332-6
|
Equine herpesvirus 1 Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
22300-8
|
Equine herpesvirus 1 Ab [Titer] in Serum |
|
15467-4
|
Equine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
|
20854-6
|
Equine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
|
23081-3
|
Equine herpesvirus 1 Ag [Presence] in Tissue by Immune stain |
|
31816-2
|
Equine herpesvirus 1 Ag [Presence] in Tracheal swab |
|
20853-8
|
Equine herpesvirus 1 Ag [Presence] in Tracheal swab by Immunofluorescence |
|
31817-0
|
Equine herpesvirus 1 Ag [Presence] in Unspecified specimen |
|
23080-5
|
Equine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23082-1
|
Equine herpesvirus 1 DNA [Presence] in Nose by NAA with probe detection |
|
23084-7
|
Equine herpesvirus 1 DNA [Presence] in Tissue by NAA with probe detection |
|
23083-9
|
Equine herpesvirus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23087-0
|
Equine herpesvirus 1+4 Ab [Presence] in Serum |
|
23085-4
|
Equine herpesvirus 1+4 Ab [Presence] in Serum by Neutralization test |
|
31378-3
|
Equine herpesvirus 1+4 Ab [Units/volume] in Serum |
|
23088-8
|
Equine herpesvirus 1+4 Ab [Titer] in Serum |
|
23090-4
|
Equine herpesvirus 1+4 Ab [Titer] in Serum by Complement fixation |
|
23086-2
|
Equine herpesvirus 1+4 Ab [Titer] in Serum by Immunoassay |
|
23089-6
|
Equine herpesvirus 1+4 Ab [Titer] in Serum by Neutralization test |
|
31818-8
|
Equine herpesvirus 1+4 Ag [Presence] in Body fluid |
|
23091-2
|
Equine herpesvirus 1+4 Ag [Presence] in Body fluid by Immunofluorescence |
|
46187-1
|
Equine herpesvirus 2 Ab [Titer] in Serum |
|
43333-4
|
Equine herpesvirus 2 Ab [Titer] in Serum by Neutralization test |
|
46188-9
|
Equine herpesvirus 3 Ab [Titer] in Serum |
|
43334-2
|
Equine herpesvirus 3 Ab [Titer] in Serum by Neutralization test |
|
31819-6
|
Equine herpesvirus 4 Ag [Presence] in Unspecified specimen |
|
23092-0
|
Equine herpesvirus 4 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23093-8
|
Equine herpesvirus 4 DNA [Presence] in Nose by NAA with probe detection |
|
23094-6
|
Equine herpesvirus 4 DNA [Presence] in Tissue by NAA with probe detection |
|
23095-3
|
Equine herpesvirus 4 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22301-6
|
Equine infectious anemia virus Ab [Presence] in Serum |
|
23097-9
|
Equine infectious anemia virus Ab [Presence] in Serum by Immunoassay |
|
23096-1
|
Equine infectious anemia virus Ab [Presence] in Serum by Immunoblot |
|
15468-2
|
Equine infectious anemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31820-4
|
Equine infectious anemia virus Ag [Presence] in Unspecified specimen |
|
23099-5
|
Equine infectious anemia virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23098-7
|
Equine infectious anemia virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
79705-0
|
Eicosadienoate (C20:2w6) [Entitic substance] in Red Blood Cells |
|
79694-6
|
Eicosadienoate (C20:2w6) [Moles/volume] in Serum or Plasma |
|
53461-0
|
Eicosanoylcarnitine (C20) [Moles/volume] in Amniotic fluid |
|
53466-9
|
Eicosanoylcarnitine (C20) [Moles/volume] in Cerebral spinal fluid |
|
53462-8
|
Eicosanoylcarnitine (C20) [Moles/volume] in DBS |
|
53473-5
|
Eicosanoylcarnitine (C20) [Moles/volume] in Serum or Plasma |
|
53494-1
|
Eicosanoylcarnitine (C20) [Moles/volume] in Urine |
|
53512-0
|
Eicosanoylcarnitine (C20)/Creatinine [Molar ratio] in Urine |
|
81766-8
|
Eicosatrienoate (C20:3w3) [Entitic substance] in Serum or Plasma |
|
81767-6
|
Eicosatrienoate (C20:3w3) [Moles/volume] in Serum or Plasma |
|
23101-9
|
Equine influenza virus A1 Ab [Presence] in Serum |
|
23100-1
|
Equine influenza virus A1 Ab [Presence] in Serum by Complement fixation |
|
31379-1
|
Equine influenza virus A1 Ab [Units/volume] in Serum |
|
22302-4
|
Equine influenza virus A1 Ab [Titer] in Serum |
|
15469-0
|
Equine influenza virus A1 Ab [Titer] in Serum by Hemagglutination inhibition |
|
23102-7
|
Equine influenza virus A1 Ag [Titer] in Unspecified specimen by Hemagglutination inhibition |
|
31821-2
|
Equine influenza virus A1 Ag [Units/volume] in Unspecified specimen |
|
15470-8
|
Equine influenza virus A2 Ab [Presence] in Serum |
|
23103-5
|
Equine influenza virus A2 Ab [Presence] in Serum by Complement fixation |
|
31380-9
|
Equine influenza virus A2 Ab [Units/volume] in Serum |
|
22303-2
|
Equine influenza virus A2 Ab [Titer] in Serum |
|
15471-6
|
Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition |
|
23104-3
|
Equine influenza virus A2 Ag [Titer] in Unspecified specimen by Hemagglutination inhibition |
|
31822-0
|
Equine influenza virus A2 Ag [Units/volume] in Unspecified specimen |
|
31823-8
|
Equine influenza virus Ag [Presence] in Nose |
|
15472-4
|
Equine influenza virus Ag [Presence] in Nose by Immunoassay |
|
45149-2
|
Ej Ab [Presence] in Serum |
|
82392-2
|
Ej Ab [Presence] in Serum by Line blot |
|
48647-2
|
Ej Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA) |
|
11524-6
|
EKG study |
|
38895-9
|
ELA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
63387-5
|
Elastase Ab [Presence] in Body fluid by Immunoassay |
|
56620-8
|
Elastase Ab [Units/volume] in Serum by Immunoassay |
|
54017-9
|
Elastase Ab [Presence] in Serum |
|
85086-7
|
Elastase IgG Ab [Presence] in Serum by Immunoassay |
|
2223-6
|
Elastase.leukocyte [Enzymatic activity/volume] in Plasma |
|
33864-0
|
Elastase.leukocyte [Mass/volume] in Plasma |
|
2220-2
|
Elastase.pancreatic Free [Enzymatic activity/volume] in Serum |
|
2221-0
|
Elastase.pancreatic [Enzymatic activity/volume] in Serum |
|
14048-3
|
Elastase.pancreatic [Mass/volume] in Serum |
|
42902-7
|
Elastase.pancreatic [Presence] in Stool |
|
25907-7
|
Elastase.pancreatic [Mass/mass] in Stool |
|
2222-8
|
Elastase.pancreatic 2 [Enzymatic activity/volume] in Serum |
|
41353-4
|
Elbow - left Extension Active Range of Motion Quantitative |
|
41354-2
|
Elbow - left Extension Passive Range of Motion Quantitative |
|
41351-8
|
Elbow - left Flexion Active Range of Motion Quantitative |
|
41352-6
|
Elbow - left Flexion Passive Range of Motion Quantitative |
|
41357-5
|
Elbow - right Extension Active Range of Motion Quantitative |
|
41358-3
|
Elbow - right Extension Passive Range of Motion Quantitative |
|
41355-9
|
Elbow - right Flexion Active Range of Motion Quantitative |
|
41356-7
|
Elbow - right Flexion Passive Range of Motion Quantitative |
|
6108-5
|
Elder IgE Ab [Units/volume] in Serum |
|
7298-3
|
Elder IgG Ab [Units/volume] in Serum |
|
87444-6
|
Electrical conductivity [Fluid Conductance] of Water |
|
75921-7
|
Electrical potential Cerebral cortex Electroencephalogram (EEG) |
|
60852-1
|
Electrical potential Muscle on EMG |
|
88697-8
|
Electrolytes and Osmolality panel - Stool |
|
18749-2
|
Electromyogram study |
|
85554-4
|
Electronic Patient Centered Assessment Method panel [ePCAM] |
|
85886-0
|
Clinical cardiac electrophysiology Consult note |
|
85940-5
|
Clinical cardiac electrophysiology Postoperative evaluation and management note |
|
85939-7
|
Clinical cardiac electrophysiology Preoperative evaluation and management note |
|
18750-0
|
Electrophysiology study |
|
93971-0
|
Elevation climbed [Length/Time] 24 hour |
|
53247-3
|
Eligibility acknowledgement |
|
10927-2
|
Elk or Moose Meat IgE Ab [Units/volume] in Serum |
|
35461-3
|
ELN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48970-8
|
ELN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72526-7
|
Elvitegravir [Susceptibility] by Genotype method |
|
88986-5
|
Elvitegravir [Mass/volume] in Serum or Plasma |
|
80393-2
|
Emergency management incident name |
|
80394-0
|
Emergency management incident type |
|
20882-7
|
Microscopic observation [Identifier] in Stool by Electron microscopy negative stain |
|
8250-3
|
Microscopic observation [Identifier] in Stool by Electron microscopy |
|
20881-9
|
Microscopic observation [Identifier] in Tissue by Electron microscopy thin sectiion |
|
50668-3
|
Microscopic observation in Unspecified specimen by Electron microscopy Narrative |
|
34166-9
|
Microscopic observation [Identifier] in Unspecified specimen by Electron microscopy |
|
10478-6
|
Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
|
31364-3
|
Encephalomyocarditis virus Ab [Units/volume] in Serum |
|
29889-3
|
Encephalomyocarditis virus Ab [Titer] in Serum |
|
29886-9
|
Encephalomyocarditis virus Ab [Titer] in Serum by Neutralization test |
|
93754-0
|
Encephalomyocarditis virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87315-8
|
Encephalomyocarditis virus RNA [Presence] in Tissue by NAA with probe detection |
|
87314-1
|
Encephalomyocarditis virus [Presence] in Tissue by Organism specific culture |
|
80193-6
|
Ecgonine methyl ester [Mass/volume] in Blood by Confirmatory method |
|
80196-9
|
Ecgonine methyl ester [Presence] in Blood by Screen method |
|
80194-4
|
Ecgonine methyl ester [Mass/volume] in Body fluid by Confirmatory method |
|
30109-3
|
Ecgonine methyl ester [Mass/volume] in Gastric fluid |
|
78825-7
|
Ecgonine methyl ester [Mass/mass] in Hair |
|
30108-5
|
Ecgonine methyl ester [Mass/mass] in Meconium |
|
80195-1
|
Ecgonine methyl ester [Mass/volume] in Serum or Plasma by Confirmatory method |
|
45320-9
|
Ecgonine methyl ester [Presence] in Serum or Plasma by Confirmatory method |
|
30107-7
|
Ecgonine methyl ester [Mass/volume] in Serum or Plasma |
|
50592-5
|
Ecgonine methyl ester [Mass/volume] in Urine by Confirmatory method |
|
80144-9
|
Ecgonine methyl ester [Presence] in Urine by Screen method |
|
30110-1
|
Ecgonine methyl ester [Mass/volume] in Vitreous fluid |
|
56796-6
|
Emergency contact information panel |
|
68552-9
|
Emergency medicine Emergency department Admission evaluation note |
|
78302-7
|
Emergency medicine Emergency department Flowsheet |
|
80741-2
|
Emergency medicine Emergency department Plan of care note |
|
34878-9
|
Emergency medicine Note |
|
84096-7
|
Emergency medicine Telephone encounter Note |
|
89883-3
|
Emergency medicine Telehealth Note |
|
92840-8
|
Emergency operations standard operating procedure Document |
|
16812-0
|
Emetine [Presence] in Serum or Plasma |
|
16813-8
|
Emetine [Units/volume] in Serum or Plasma |
|
12399-2
|
Emetine [Mass/volume] in Serum or Plasma |
|
3588-1
|
Emetine [Presence] in Urine |
|
12400-8
|
Emetine [Mass/volume] in Urine |
|
85032-1
|
Emotional Support Survey - fixed length form - ages 18+ [NIH Toolbox] |
|
85029-7
|
Emotional Support Survey - fixed length form - ages 8-17 [NIH Toolbox] |
|
20527-8
|
Ethylmorphine [Mass/volume] in Urine by Confirmatory method |
|
3618-6
|
Ethylmorphine [Presence] in Urine |
|
19463-9
|
Ethylmorphine [Presence] in Urine by Confirmatory method |
|
19462-1
|
Ethylmorphine [Presence] in Urine by Screen method |
|
16851-8
|
Ethylmorphine [Units/volume] in Urine |
|
3619-4
|
Ethylmorphine [Mass/volume] in Urine |
|
52071-8
|
Employee assistance program attachment |
|
80429-4
|
Employer address |
|
89564-9
|
Employment status [CUBS] |
|
85152-7
|
Employment status of family member |
|
49669-5
|
Emtricitabine [Susceptibility] by Phenotype method |
|
63389-1
|
Extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63239-8
|
Extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
63388-3
|
Extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63238-0
|
Extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
43119-7
|
Extractable nuclear Ab panel - Serum |
|
29954-5
|
Extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
14722-3
|
Extractable nuclear Ab [Presence] in Serum |
|
63391-7
|
Extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
63390-9
|
Extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
30342-0
|
Extractable nuclear Ab [Units/volume] in Serum |
|
90228-8
|
Extractable nuclear antigen Ab.IgG panel - Serum |
|
63394-1
|
Jo-1 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
51749-0
|
Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid |
|
63267-9
|
Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89529-2
|
Jo-1 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63393-3
|
Jo-1 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63536-7
|
Jo-1 extractable nuclear Ab [Presence] in Body fluid |
|
63266-1
|
Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63265-3
|
Jo-1 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
35333-4
|
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
17032-4
|
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8076-2
|
Jo-1 extractable nuclear Ab [Presence] in Serum |
|
5234-0
|
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56731-3
|
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5235-7
|
Jo-1 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17031-6
|
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
11565-9
|
Jo-1 extractable nuclear Ab [Units/volume] in Serum |
|
14235-6
|
Jo-1 extractable nuclear Ab [Titer] in Serum |
|
44332-5
|
Jo-1 extractable nuclear IgG Ab [Presence] in Serum |
|
82918-4
|
Jo-1 extractable nuclear IgG Ab [Presence] in Serum by Line blot |
|
33571-1
|
Jo-1 extractable nuclear IgG Ab [Units/volume] in Serum |
|
63306-5
|
PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89537-5
|
PCNA extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63305-7
|
PCNA extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
8088-7
|
PCNA extractable nuclear Ab [Presence] in Serum |
|
5275-3
|
PCNA extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56733-9
|
PCNA extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5276-1
|
PCNA extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
47074-0
|
PCNA extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
53006-3
|
PCNA extractable nuclear Ab [Titer] in Serum by Immunofluorescence |
|
82841-8
|
PCNA extractable nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
|
63308-1
|
PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89536-7
|
PM-SCL extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63307-3
|
PM-SCL extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
33635-4
|
PM-SCL extractable nuclear Ab [Mass/volume] in Serum by Immune diffusion (ID) |
|
31563-0
|
PM-SCL extractable nuclear Ab [Presence] in Serum |
|
56721-4
|
PM-SCL extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
53007-1
|
PM-SCL extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
31562-2
|
PM-SCL extractable nuclear Ab [Units/volume] in Serum |
|
53008-9
|
PM-SCL extractable nuclear Ab [Titer] in Serum by Immunofluorescence |
|
49055-7
|
Ribonucleoprotein extractable nuclear 52kD Ab [Presence] in Serum |
|
68377-1
|
Ribonucleoprotein extractable nuclear 63kD Ab [Presence] in Serum or Plasma |
|
63399-0
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63319-8
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89535-9
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63398-2
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63540-9
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid |
|
63318-0
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63317-2
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
51928-0
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
17536-4
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8091-1
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum |
|
5301-7
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56723-0
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5302-5
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17535-6
|
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
29374-6
|
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum |
|
41025-8
|
Ribonucleoprotein extractable nuclear Ab [Mass/volume] in Serum |
|
9399-7
|
Ribonucleoprotein extractable nuclear Ab [Titer] in Serum |
|
29958-6
|
Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
23929-3
|
Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum |
|
31588-7
|
Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum |
|
63400-6
|
SCL-70 extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63337-0
|
SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89533-4
|
SCL-70 extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63336-2
|
SCL-70 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63542-5
|
SCL-70 extractable nuclear Ab [Presence] in Body fluid |
|
63335-4
|
SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63334-7
|
SCL-70 extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
26975-3
|
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
89502-9
|
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Line blot |
|
8092-9
|
SCL-70 extractable nuclear Ab [Presence] in Serum |
|
5348-8
|
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56693-5
|
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5349-6
|
SCL-70 extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17569-5
|
SCL-70 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
27416-7
|
SCL-70 extractable nuclear Ab [Units/volume] in Serum |
|
63338-8
|
SCL-70 extractable nuclear Ab [Titer] in Serum by Immunoassay |
|
32715-5
|
SCL-70 extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
|
47322-3
|
SCL-70 extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
21518-6
|
SCL-70 extractable nuclear IgG Ab [Presence] in Serum |
|
17570-3
|
SCL-70 extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
26023-2
|
Extractable nuclear Ab identified in Serum |
|
56148-0
|
Smith extractable nuclear Ab and Ribonucleoprotein extractable nuclear Ab panel - Serum |
|
63406-3
|
Smith extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63354-5
|
Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89531-8
|
Smith extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63405-5
|
Smith extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63546-6
|
Smith extractable nuclear Ab [Presence] in Body fluid |
|
63353-7
|
Smith extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63352-9
|
Smith extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
43182-5
|
Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
17592-7
|
Smith extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
31627-3
|
Smith extractable nuclear Ab [Presence] in Serum |
|
5355-3
|
Smith extractable nuclear Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
|
5356-1
|
Smith extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56730-5
|
Smith extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5357-9
|
Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17591-9
|
Smith extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
11090-8
|
Smith extractable nuclear Ab [Units/volume] in Serum |
|
9722-0
|
Smith extractable nuclear Ab [Titer] in Serum |
|
17590-1
|
Smith extractable nuclear Ab [Titer] in Serum by Immunoassay |
|
17589-3
|
Smith extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
|
33564-6
|
Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
33565-3
|
Smith extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
|
21523-6
|
Smith extractable nuclear IgG Ab [Presence] in Serum |
|
18323-6
|
Smith extractable nuclear IgG Ab [Units/volume] in Serum |
|
63547-4
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid |
|
14030-1
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
31628-1
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum |
|
26880-5
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
89501-1
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Line blot |
|
27048-8
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum |
|
30556-5
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Titer] in Serum by Immunofluorescence |
|
33567-9
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
33568-7
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
|
33460-7
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum |
|
21522-8
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum |
|
26703-9
|
Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Titer] in Serum by Immunoassay |
|
63548-2
|
Smith extractable nuclear B Ab [Units/volume] in Serum by Immunoassay |
|
54030-2
|
Smith extractable nuclear B Ab [Presence] in Serum |
|
88882-6
|
Smith extractable nuclear B Ab [Presence] in Serum by Line blot |
|
54031-0
|
Smith extractable nuclear D Ab [Presence] in Serum |
|
88881-8
|
Smith extractable nuclear D Ab [Presence] in Serum by Line blot |
|
82938-2
|
Smith extractable nuclear D IgG Ab [Units/volume] in Serum |
|
43100-7
|
Sjogrens syndrome-A and B extractable nuclear Ab panel - Serum |
|
87555-9
|
Sjogrens syndrome-A and B extractable nuclear IgG panel - Serum |
|
63341-2
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89532-6
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63543-3
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid |
|
63339-6
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Body fluid by Immunoassay |
|
56549-9
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum by Immunoassay |
|
53016-2
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum |
|
63342-0
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoassay |
|
63445-1
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Serum by Immunoblot |
|
53017-0
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum |
|
63340-4
|
Sjogrens syndrome-A extractable nuclear 52kD Ab [Titer] in Body fluid by Immunoassay |
|
70257-1
|
Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Units/volume] in Serum by Immunoassay |
|
82933-3
|
Sjogrens syndrome-A extractable nuclear 52kD IgG Ab [Presence] in Serum by Line blot |
|
63544-1
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid |
|
63343-8
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid by Immunoassay |
|
53018-8
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum |
|
63411-3
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoassay |
|
59014-1
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Serum by Immunoblot |
|
53019-6
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum |
|
63344-6
|
Sjogrens syndrome-A extractable nuclear 60kD Ab [Titer] in Body fluid by Immunoassay |
|
63401-4
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63402-2
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89527-6
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63348-7
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63345-3
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Flow cytometry (FC) |
|
63347-9
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63346-1
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
33569-5
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
33566-1
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoblot |
|
17584-4
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8093-7
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum |
|
5351-2
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56724-8
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5352-0
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17583-6
|
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
17792-3
|
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum |
|
32716-3
|
Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum |
|
29948-7
|
Sjogrens syndrome-A extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
|
29964-4
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
33583-6
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
|
31625-7
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum |
|
17585-1
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
33610-7
|
Sjogrens syndrome-A extractable nuclear IgG Ab [Units/volume] in Serum |
|
32041-6
|
Sjogrens syndrome-A extractable nuclear Ab+Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
|
63404-8
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63351-1
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89526-8
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63403-0
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
|
63545-8
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid |
|
63350-3
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immunoassay |
|
63349-5
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID) |
|
45142-7
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
33570-3
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoblot |
|
17587-7
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
8094-5
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum |
|
5353-8
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay |
|
56725-5
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot |
|
5354-6
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17586-9
|
Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
17791-5
|
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
|
29949-5
|
Sjogrens syndrome-B extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
|
29965-1
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoassay |
|
33598-4
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum by Immunoblot |
|
31626-5
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum |
|
17588-5
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
33613-1
|
Sjogrens syndrome-B extractable nuclear IgG Ab [Units/volume] in Serum |
|
31693-5
|
Unidentified extractable nuclear Ab [Presence] in Serum |
|
20435-4
|
Unidentified extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
73028-3
|
Enalapril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73027-5
|
Enalapril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73401-2
|
Enalapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73400-4
|
Enalapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3589-9
|
Encainide [Mass/volume] in Serum or Plasma |
|
89601-9
|
Proof of encounter certificate |
|
7304-9
|
Endive IgE Ab [Units/volume] in Serum |
|
7305-6
|
Endive IgG Ab [Units/volume] in Serum |
|
83683-3
|
Endocrinology Attending Note |
|
83736-9
|
Endocrinology Fellow Note |
|
83544-7
|
Endocrinology Nurse practitioner Note |
|
83573-6
|
Endocrinology Nurse Outpatient Note |
|
83755-9
|
Endocrinology Resident Note |
|
89799-1
|
Endocrinology Team Conference note |
|
92895-2
|
Endocrinology studies |
|
46020-4
|
Endocrine, metabolic or nutritional diseases or conditions Set |
|
34879-7
|
Endocrinology Consult note |
|
78257-3
|
Endocrinology Diagnostic study note |
|
78278-9
|
Endocrinology Education note |
|
78295-3
|
Endocrinology Flowsheet |
|
84097-5
|
Endocrinology History and physical note |
|
84098-3
|
Endocrinology Hospital Note |
|
78312-6
|
Endocrinology Initial evaluation note |
|
34898-7
|
Endocrinology Note |
|
84099-1
|
Endocrinology Outpatient Note |
|
84100-7
|
Endocrinology Telephone encounter Note |
|
80747-9
|
Endocrinology Plan of care note |
|
78321-7
|
Endocrinology procedure note |
|
78327-4
|
Endocrinology Progress note |
|
57137-2
|
Endocrinology Referral note |
|
89891-6
|
Endocrinology Telehealth Note |
|
16815-3
|
Endomysium Ab [Units/volume] in Serum by Immunofluorescence |
|
31365-0
|
Endomysium Ab [Presence] in Serum |
|
16814-6
|
Endomysium Ab [Presence] in Serum by Immunofluorescence |
|
13092-2
|
Endomysium Ab [Units/volume] in Serum |
|
14708-2
|
Endomysium Ab [Titer] in Serum |
|
25399-7
|
Endomysium Ab [Titer] in Serum by Immunofluorescence |
|
10362-2
|
Endomysium IgA Ab [Presence] in Serum |
|
46126-9
|
Endomysium IgA Ab [Presence] in Serum by Immunofluorescence |
|
31366-8
|
Endomysium IgA Ab [Units/volume] in Serum |
|
10863-9
|
Endomysium IgA Ab [Titer] in Serum |
|
27038-9
|
Endomysium IgA Ab [Titer] in Serum by Immunofluorescence |
|
39554-1
|
Endomysium IgG Ab [Presence] in Serum |
|
45136-9
|
Endomysium IgG Ab [Units/volume] in Serum |
|
49726-3
|
Endomysium IgG Ab [Titer] in Serum |
|
51699-7
|
Endomysium IgG Ab [Titer] in Serum by Immunofluorescence |
|
20796-9
|
Endophyte identified in Plant |
|
18751-8
|
Endoscopy study |
|
87661-5
|
Endosulfan I [Mass/mass] in Unspecified specimen |
|
87751-4
|
Endosulfan II [Mass/mass] in Unspecified specimen |
|
58933-3
|
Endothelial cell Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
58460-7
|
Endothelial cell Ab [Titer] in Serum or Plasma |
|
49867-5
|
Endothelin I [Mass/volume] in Serum or Plasma |
|
12737-3
|
Endothelin [Units/volume] in Serum or Plasma |
|
26769-0
|
Endothelin [Mass/volume] in Serum or Plasma |
|
74098-5
|
Endothelin [Moles/volume] in Serum or Plasma |
|
20797-7
|
Endotoxin identified in Unspecified specimen |
|
59345-9
|
Endoxifen [Mass/volume] in Blood |
|
59349-1
|
Endoxifen [Mass/volume] in Serum or Plasma |
|
23856-8
|
Endrin [Mass/volume] in Serum or Plasma |
|
87660-7
|
Endrin [Mass/mass] in Unspecified specimen |
|
74532-3
|
Energy content [Energy/mass] of 24 hour Stool.wet |
|
77151-9
|
Energy content panel - 24 hour Stool |
|
75990-2
|
Energy expended Reporting Period by Indirect calorimetry |
|
14264-6
|
Enflurane [Mass/volume] in Blood |
|
61019-6
|
Enflurane [VFr/PPres] Airway adaptor --during expiration |
|
60754-9
|
Enflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60885-1
|
Enflurane [VFr/PPres] Airway adaptor --during inspiration |
|
60855-4
|
Enflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60884-4
|
Enflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60752-3
|
Gas delivery system inspiratory Enflurane setting [VFr/PPres] |
|
62266-2
|
Enflurane [VFr/PPres] Airway adaptor |
|
60854-7
|
Enflurane [VFr/PPres] Gas delivery system |
|
60755-6
|
Enflurane gas delivered during case [Volume] from Gas delivery system |
|
61023-8
|
Enflurane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76014-0
|
Enflurane liquid delivered during case [Volume] from Gas delivery system |
|
76015-7
|
Enflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
72858-4
|
Enfuvirtide [Susceptibility] by Genotype method |
|
82719-6
|
Enfuvirtide [Susceptibility] by Phenotype method |
|
69482-8
|
ENG gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77625-2
|
ENG gene full mutation analysis in Blood or Tissue by Sequencing |
|
7766-9
|
English Walnut Pollen IgE Ab [Units/volume] in Serum |
|
7616-6
|
English plantain triggered histamine release [Units/volume] in Blood |
|
6110-1
|
English plantain IgE Ab [Units/volume] in Serum |
|
61301-8
|
English plantain IgE Ab/IgE total in Serum |
|
13189-6
|
English plantain IgG Ab [Units/volume] in Serum |
|
56257-9
|
English plantain IgG4 Ab [Mass/volume] in Serum |
|
63209-1
|
English plantain IgG Ab [Mass/volume] in Serum |
|
48253-9
|
English plantain triggered leukotriene release [Mass/volume] by Leukocytes |
|
64972-3
|
English plantain recombinant (rPla l) 1 IgE Ab [Units/volume] in Serum |
|
65766-8
|
English Walnut native (nJug r) 1 IgE Ab [Units/volume] in Serum |
|
65767-6
|
English Walnut native (nJug r) 2 IgE Ab [Units/volume] in Serum |
|
65768-4
|
English Walnut native (nJug r) 3 IgE Ab [Units/volume] in Serum |
|
81790-8
|
English walnut recombinant (rJug r) 1 IgE Ab [Units/volume] in Serum |
|
81789-0
|
English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum |
|
7765-1
|
English Walnut IgE Ab [Units/volume] in Serum |
|
61279-6
|
English Walnut IgE Ab/IgE total in Serum |
|
13179-7
|
English Walnut IgG Ab [Units/volume] in Serum |
|
77601-3
|
Enhanced note |
|
11045-2
|
Enolase [Enzymatic activity/volume] in Red Blood Cells |
|
2224-4
|
Enolase [Enzymatic activity/volume] in Serum |
|
3590-7
|
Enoxacin [Mass/volume] in Serum or Plasma |
|
16816-1
|
Enoxacin [Mass/volume] in Urine |
|
89071-5
|
Enrollment item set [ADAPTABLE] |
|
76586-7
|
ENT microorganism gene identification panel by NAA with probe detection |
|
26655-1
|
Entamoeba sp Ab [Presence] in Serum |
|
91765-8
|
Entamoeba sp DNA [Identifier] in Aspirate by Sequencing |
|
90298-1
|
Entamoeba sp DNA [Identifier] in Stool by Sequencing |
|
70294-4
|
Entamoeba sp DNA [Identifier] in Unspecified specimen by Sequencing |
|
80454-2
|
Enteral tube nutritional intake panel |
|
76632-9
|
Enterovirus sp [Presence] in Isolate by Immunofluorescence |
|
85771-4
|
Enterobacteriaceae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
88255-5
|
Enterobacter sp gyrB+metB genes [Presence] by Probe in Positive blood culture |
|
90067-0
|
Enterobacteriaceae identified in Isolate by Organism specific culture |
|
85775-5
|
Enterococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
71718-1
|
Enterococcus sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
27902-6
|
Enterococcus sp IgG Ab [Units/volume] in Serum |
|
27077-7
|
Enterococcus sp IgM Ab [Units/volume] in Serum |
|
5001-3
|
Enterococcus sp rRNA [Presence] in Unspecified specimen by Probe |
|
69039-6
|
Enterocyte Ab panel - Serum |
|
69031-3
|
Enterocyte IgA Ab [Presence] in Serum |
|
69030-5
|
Enterocyte IgG Ab [Presence] in Serum |
|
69032-1
|
Enterocyte IgM Ab [Presence] in Serum |
|
2226-9
|
Enteroglucagon [Mass/volume] in Serum |
|
2227-7
|
Enteropeptidase [Enzymatic activity/volume] in Plasma |
|
89551-6
|
Environmental health Consult note |
|
89552-4
|
Environmental health Note |
|
51411-7
|
Environmental stressors panel - Air |
|
51410-9
|
Environmental stressors panel - Water |
|
26449-9
|
Eosinophils [#/volume] in Blood |
|
711-2
|
Eosinophils [#/volume] in Blood by Automated count |
|
66141-3
|
Eosinophils [#/volume] in Blood from Fetus by Manual count |
|
74404-5
|
Eosinophils [#/volume] in Cord blood |
|
34958-9
|
Eosinophils [#/volume] in Cerebral spinal fluid |
|
34957-1
|
Eosinophils [#/volume] in Cerebral spinal fluid by Manual count |
|
35063-7
|
Eosinophils [#/volume] in Body fluid |
|
40569-6
|
Eosinophils [#/volume] in Body fluid by Manual count |
|
68398-7
|
Eosinophils [#/volume] in Pericardial fluid by Manual count |
|
68400-1
|
Eosinophils [#/volume] in Pleural fluid by Manual count |
|
68399-5
|
Eosinophils [#/volume] in Peritoneal fluid by Manual count |
|
68401-9
|
Eosinophils [#/volume] in Synovial fluid by Manual count |
|
68402-7
|
Eosinophils [#/volume] in Vitreous fluid by Manual count |
|
50340-9
|
Eosinophils [Presence] in Nose by Hansel stain |
|
29992-5
|
Eosinophils [Presence] in Nose by Wright stain |
|
50341-7
|
Eosinophils [Presence] in Sputum by Hansel stain |
|
45379-5
|
Eosinophils [Presence] in Stool by Light microscopy |
|
48049-1
|
Eosinophils [Presence] in Stool by Wright stain |
|
25156-1
|
Eosinophils [Presence] in Urine sediment by Light microscopy |
|
49839-4
|
Eosinophils [Presence] in Urine sediment by Wright stain |
|
48710-8
|
Eosinophils [Presence] in Unspecified specimen by Light microscopy |
|
30378-4
|
Eosinophils/100 leukocytes in Nose |
|
9727-9
|
Eosinophils/100 leukocytes in Nose by Manual count |
|
57391-5
|
Eosinophils/100 leukocytes in Synovial fluid by Manual count |
|
32014-3
|
Eosinophils/100 leukocytes in Urine by Manual count |
|
12210-1
|
Eosinophils/100 leukocytes in Urine sediment by Manual count |
|
68403-5
|
Eosinophils/100 leukocytes in Vitreous fluid by Manual count |
|
75097-6
|
Eicosapentaenoate (C20:5w3) [Entitic substance] in Red Blood Cells |
|
88996-4
|
Eicosapentaenoate (C20:5w3)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma |
|
88997-2
|
Eicosapentaenoate (C20:5w3)/Fatty acids.C14-C24 in Serum or Plasma |
|
90291-6
|
EpCAM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
79418-0
|
EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
24413-7
|
Eperythrozoon sp [Presence] in Blood by Giemsa stain |
|
47105-2
|
ePHEDrine [Presence] in Gastric fluid |
|
47106-0
|
ePHEDrine [Presence] in Serum or Plasma |
|
90445-8
|
ePHEDrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3591-5
|
ePHEDrine [Mass/volume] in Serum or Plasma |
|
55535-9
|
ePHEDrine [Moles/volume] in Serum or Plasma |
|
59134-7
|
ePHEDrine [Mass/volume] in Urine by Confirmatory method |
|
3592-3
|
ePHEDrine [Presence] in Urine |
|
3593-1
|
ePHEDrine [Mass/volume] in Urine |
|
14710-8
|
ePHEDrine+Pseudoephedrine [Presence] in Gastric fluid |
|
26727-8
|
ePHEDrine+Pseudoephedrine [Mass/mass] in Meconium |
|
29612-9
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3594-9
|
ePHEDrine+Pseudoephedrine [Presence] in Serum or Plasma |
|
3595-6
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Serum or Plasma |
|
26771-6
|
ePHEDrine+Pseudoephedrine [Mass/mass] in Stool |
|
58707-1
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Urine by Confirmatory method |
|
3596-4
|
ePHEDrine+Pseudoephedrine [Presence] in Urine |
|
26785-6
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Urine |
|
27412-6
|
ePHEDrine+Pseudoephedrine [Mass/volume] in Vitreous fluid |
|
32069-7
|
ePHEDrine+Pseudoephedrine [Presence] in Unspecified specimen |
|
23058-1
|
Ephemeral fever virus Ab [Presence] in Serum |
|
23057-3
|
Ephemeral fever virus Ab [Presence] in Serum by Neutralization test |
|
87926-2
|
Epithelial cells [#/volume] in Urine by Automated |
|
46133-5
|
Epithelial cells [#/area] in Urine sediment by Microscopy low power field |
|
87830-6
|
Epithelial cells [Presence] in Urine |
|
74354-2
|
Epithelial cells/100 leukocytes in Sputum |
|
2229-3
|
Epiandrosterone [Mass/volume] in Serum or Plasma |
|
38594-8
|
Epichlorohydrin [Mass/volume] in Air |
|
12999-9
|
Epichlorohydrin [Mass/volume] in Serum or Plasma |
|
24147-1
|
Epidermal Allergen Mix A (Chicken feather+Duck feather+Goose feather) IgE Ab [Units/volume] in Serum by Multidisk |
|
31005-2
|
Epidermal Allergen Mix B (Budgerigar feather+Canary feather+Parrot feather+Finch feather) IgE Ab [Presence] in Serum by Multidisk |
|
23798-2
|
Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
|
30185-3
|
Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk |
|
15213-2
|
Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Presence] in Serum by Multidisk |
|
82047-2
|
Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Units/volume] in Serum by Multidisk |
|
15215-7
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Presence] in Serum by Multidisk |
|
72279-3
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Units/volume] in Serum by Multidisk |
|
61203-6
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab/IgE total in Serum by Multidisk |
|
56259-5
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG4 Ab [Mass/volume] in Serum |
|
38361-2
|
Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgG Ab [Mass/volume] in Serum by Multidisk |
|
15216-5
|
Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
|
73713-0
|
Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk |
|
23799-0
|
Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
|
31161-3
|
Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Units/volume] in Serum by Multidisk |
|
56781-8
|
Epidermal Allergen Mix C (Canary feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
|
91010-9
|
Epidemiological investigation report Document |
|
68991-9
|
Epidemiologically important information for public health reporting panel |
|
15214-0
|
Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Presence] in Serum by Multidisk |
|
71370-1
|
Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Units/volume] in Serum by Multidisk |
|
45382-9
|
Epidermis Ab [Presence] in Serum |
|
31368-4
|
Epidermis Ab [Units/volume] in Serum |
|
8069-7
|
Epidermis Ab [Titer] in Serum |
|
5152-4
|
Epidermis Ab [Titer] in Serum by Immunofluorescence |
|
18217-0
|
Epidermis IgA Ab [Presence] in Tissue |
|
18218-8
|
Epidermis IgM Ab [Presence] in Tissue |
|
85884-5
|
Epilepsy Consult note |
|
85883-7
|
Epilepsy Note |
|
32015-0
|
EPINEPHrine [Mass/volume] in 24 hour Urine |
|
2232-7
|
EPINEPHrine [Mass/time] in 24 hour Urine |
|
25908-5
|
EPINEPHrine [Moles/volume] in 24 hour Urine |
|
14712-4
|
EPINEPHrine [Moles/time] in 24 hour Urine |
|
2230-1
|
EPINEPHrine [Mass/volume] in Plasma |
|
14711-6
|
EPINEPHrine [Moles/volume] in Plasma |
|
47140-9
|
EPINEPHrine [Moles/volume] in Urine --2nd specimen post XXX challenge |
|
1465-4
|
EPINEPHrine [Mass/volume] in Plasma --supine |
|
11046-0
|
EPINEPHrine [Mass/volume] in Urine |
|
24521-7
|
EPINEPHrine [Moles/volume] in Urine |
|
33874-9
|
EPINEPHrine/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
43248-4
|
EPINEPHrine/Creatinine [Mass Ratio] in 24 hour Urine |
|
25909-3
|
EPINEPHrine/Creatinine [Molar ratio] in 24 hour Urine |
|
13734-9
|
EPINEPHrine/Creatinine [Mass Ratio] in Urine |
|
24522-5
|
EPINEPHrine/Creatinine [Molar ratio] in Urine |
|
44837-3
|
Epinephrine+Norepinephrine [Mass/volume] in 24 hour Urine |
|
16111-7
|
Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine |
|
49552-3
|
Epinephrine+Norepinephrine [Mass/volume] in Urine |
|
13735-6
|
Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine |
|
78377-9
|
Epipregnanolone [Moles/volume] in 24 hour Urine |
|
78376-1
|
Epipregnanolone [Moles/time] in 24 hour Urine |
|
78379-5
|
Epipregnanolone [Moles/volume] in Urine |
|
81775-9
|
Epipregnanolone/Creatinine [Molar ratio] in Urine |
|
89252-1
|
Episode of Wound |
|
2233-5
|
Epitestosterone [Mass/volume] in Serum or Plasma |
|
2234-3
|
Epitestosterone [Presence] in Urine |
|
2235-0
|
Epitestosterone [Mass/volume] in Urine |
|
39080-7
|
EPM2A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
30028-5
|
O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Serum or Plasma |
|
21267-0
|
O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/volume] in Urine |
|
87752-2
|
O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate [Mass/mass] in Unspecified specimen |
|
77350-7
|
Erythropoietin (EPO) Ab [Presence] in Serum |
|
73399-8
|
Erythropoietin (EPO) induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73398-0
|
Erythropoietin (EPO) induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
15061-5
|
Erythropoietin (EPO) [Units/volume] in Serum or Plasma |
|
2237-6
|
Erythropoietin (EPO) [Mass/volume] in Serum or Plasma |
|
14714-0
|
Erythropoietin (EPO) [Moles/volume] in Serum or Plasma |
|
73397-2
|
Eptifibatide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73396-4
|
Eptifibatide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
40556-3
|
Estrogen receptor Ag [Presence] in Tissue by Immune stain |
|
14130-9
|
Estrogen receptor [Moles/mass] in Tissue |
|
14228-1
|
Cells.estrogen receptor/100 cells in Tissue by Immune stain |
|
10480-2
|
Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
|
85423-2
|
Eravacycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
42783-1
|
ERBB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
69572-6
|
ERCC1 Ag [Presence] in Tissue by Immune stain |
|
79894-2
|
Electroretinography (ERG) measurements panel |
|
87579-9
|
Ergocornine [Mass/mass] in Unspecified specimen |
|
87578-1
|
Ergocristine [Mass/mass] in Unspecified specimen |
|
87577-3
|
Ergocryptine [Mass/mass] in Unspecified specimen |
|
87576-5
|
Ergosine [Mass/mass] in Unspecified specimen |
|
15411-2
|
Ergosterol [Mass/volume] in Serum or Plasma |
|
20809-0
|
Ergot alkaloid [Mass/mass] in Feed |
|
20808-2
|
Ergot alkaloid [Mass/volume] in Unspecified specimen |
|
9773-3
|
Ergotamine [Mass/volume] in Serum or Plasma |
|
87575-7
|
Ergotamine [Mass/mass] in Unspecified specimen |
|
87574-0
|
Ergovaline [Mass/mass] in Unspecified specimen |
|
86727-5
|
Erysipelothrix sp strain 2 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
48107-7
|
Erythritol/Creatinine [Molar ratio] in Urine |
|
48139-0
|
Erythro-4,5-Dihydroxyhexanoate/Creatinine [Molar ratio] in Urine |
|
48140-8
|
Erythro-4-Deoxytetronate/Creatinine [Molar ratio] in Urine |
|
34691-6
|
Erythroamino alcohol [Mass/volume] in Serum or Plasma |
|
5161-5
|
Erythrocyte Ab [Units/volume] in Serum |
|
86285-4
|
Erythrocyte deformability [Interpretation] in Red Blood Cells Narrative |
|
48809-8
|
Erythrogram panel - Blood |
|
53610-2
|
Erythroid cells [#/volume] in Blood or Marrow |
|
11171-6
|
Erythromycin IgE Ab [Units/volume] in Serum |
|
61260-6
|
Erythromycin IgE Ab/IgE total in Serum |
|
73395-6
|
Erythromycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73394-9
|
Erythromycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3597-2
|
Erythromycin [Mass/volume] in Serum or Plasma |
|
12298-6
|
Erythromycin [Presence] in Urine |
|
16829-4
|
Erythromycin [Mass/volume] in Urine |
|
25275-9
|
Erythromycin [Mass/volume] in Unspecified specimen |
|
48300-8
|
Erythrosine triggered leukotriene release [Mass/volume] by Leukocytes |
|
85043-8
|
ESBL by cefepime to cefepime-clavulanate IC ratio [Presence] by ARD gradient strip |
|
85049-5
|
ESBL by cefotaxime to cefotaxime-clavulanate IC ratio [Presence] by ARD gradient strip |
|
85050-3
|
ESBL by cefTAZidime to cefTAZidime-clavulanate IC ratio [Presence] by ARD gradient strip |
|
11200-3
|
Escargot IgE Ab [Units/volume] in Serum |
|
39549-1
|
Escargot IgE Ab/IgE total in Serum |
|
73026-7
|
Escitalopram induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73025-9
|
Escitalopram induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
85094-1
|
Escitalopram and norescitalopram panel - Serum or Plasma |
|
73393-1
|
Escitalopram induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73392-3
|
Escitalopram induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
34405-1
|
Escitalopram [Mass/volume] in Serum or Plasma |
|
73692-6
|
Escitalopram [Mass/volume] in Urine |
|
82880-6
|
Escitalopram+norescitalopram [Mass/volume] in Serum or Plasma |
|
92937-2
|
Eslicarbazepine [Mass/volume] in Serum or Plasma |
|
73391-5
|
Esomeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73390-7
|
Esomeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60836-4
|
Esophageal temperature |
|
30341-2
|
Erythrocyte sedimentation rate |
|
43402-7
|
Erythrocyte sedimentation rate by 15 minute reading |
|
82477-1
|
Erythrocyte sedimentation rate by Photometric method |
|
4537-7
|
Erythrocyte sedimentation rate by Westergren method |
|
18184-2
|
Erythrocyte sedimentation rate by 2H Westergren method |
|
4538-5
|
Erythrocyte sedimentation rate by Wintrobe method |
|
82266-8
|
Estimated Activity metabolic rate/Measured RMR [Relative energy/Time] |
|
82269-2
|
Estimated Activity metabolic rate/Population RMR [Relative energy/Time] |
|
82274-2
|
Estimated metabolic rate/Predicted RMR [Relative energy/Time] |
|
82262-7
|
Estimated activity metabolic rate/Standard RMR [Relative energy/Time] |
|
7308-0
|
Esterase IgE Ab [Units/volume] in Serum |
|
53553-4
|
Glucose mean value [Moles/volume] in Blood Estimated from glycated hemoglobin |
|
59665-0
|
Estazolam [Mass/volume] in Blood by Confirmatory method |
|
59664-3
|
Estazolam [Mass/volume] in Blood |
|
59667-6
|
Estazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59666-8
|
Estazolam [Mass/volume] in Body fluid |
|
26914-2
|
Estazolam [Mass/mass] in Meconium |
|
59668-4
|
Estazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
14069-9
|
Estazolam [Mass/volume] in Serum or Plasma |
|
59669-2
|
Estazolam [Mass/mass] in Stool by Confirmatory method |
|
27285-6
|
Estazolam [Mass/mass] in Stool |
|
59671-8
|
Estazolam [Mass/mass] in Tissue by Confirmatory method |
|
59670-0
|
Estazolam [Mass/mass] in Tissue |
|
59672-6
|
Estazolam [Mass/volume] in Urine by Confirmatory method |
|
3598-0
|
Estazolam [Mass/volume] in Urine |
|
26683-3
|
Estazolam [Mass/volume] in Vitreous fluid |
|
48949-2
|
Estazolam [Mass/volume] in Unspecified specimen |
|
21263-9
|
Estradiol (E2) [Mass/time] in 24 hour Urine |
|
34287-3
|
Estradiol (E2) [Moles/volume] in 24 hour Urine |
|
25401-1
|
Estradiol (E2) [Moles/time] in 24 hour Urine |
|
17844-2
|
Estradiol (E2).albumin bound [Mass/volume] in Serum or Plasma |
|
31176-1
|
Estradiol (E2) [Mass/volume] in Amniotic fluid |
|
13884-2
|
Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma |
|
55857-7
|
Estradiol (E2) [Mass/volume] in Body fluid |
|
55858-5
|
Estradiol (E2) [Moles/volume] in Body fluid |
|
2240-0
|
Estradiol (E2) Free [Mass/volume] in Serum or Plasma |
|
2241-8
|
Estradiol (E2) Free [Moles/mass] in Tissue |
|
85068-5
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose dexamethasone |
|
85065-1
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose follitropin |
|
85067-7
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose gonadotropin releasing hormone |
|
85066-9
|
Estradiol (E2) [Mass/volume] in Serum or Plasma --post dose lutropin |
|
2238-4
|
Estradiol (E2) [Mass/volume] in Saliva (oral fluid) |
|
35384-7
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method |
|
72873-3
|
Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method |
|
83096-8
|
Estradiol (E2) [Mass/volume] in Serum or Plasma by Immunoassay |
|
83097-6
|
Estradiol (E2) [Moles/volume] in Serum or Plasma by Immunoassay |
|
2243-4
|
Estradiol (E2) [Mass/volume] in Serum or Plasma |
|
35207-0
|
Estradiol (E2) [Mass or Moles/volume] in Serum or Plasma |
|
14715-7
|
Estradiol (E2) [Moles/volume] in Serum or Plasma |
|
2239-2
|
Estradiol (E2) [Mass/volume] in Semen |
|
2245-9
|
Estradiol (E2) [Moles/mass] in Tissue |
|
12595-5
|
Estradiol (E2) [Mass/volume] in Urine |
|
34286-5
|
Estradiol (E2) [Moles/volume] in Urine |
|
13736-4
|
Estradiol (E2)/Creatinine [Mass Ratio] in 24 hour Urine |
|
34291-5
|
Estradiol (E2)/Creatinine [Molar ratio] in Urine |
|
43802-8
|
Estriol (E3) [Mass/volume] in 24 hour Urine |
|
2253-3
|
Estriol (E3) [Mass/time] in 24 hour Urine |
|
34292-3
|
Estriol (E3) [Moles/volume] in 24 hour Urine |
|
14718-1
|
Estriol (E3) [Moles/time] in 24 hour Urine |
|
2248-3
|
Estriol (E3) [Mass/volume] in Amniotic fluid |
|
2247-5
|
Estriol (E3).conjugated [Mass/volume] in Serum or Plasma |
|
15063-1
|
Estriol (E3).conjugated [Moles/volume] in Serum or Plasma |
|
16838-5
|
Estriol (E3) [Mass/volume] in Body fluid |
|
27225-2
|
Estriol (E3) [Mass/volume] in Saliva (oral fluid) |
|
2251-7
|
Estriol (E3) [Mass/volume] in Serum or Plasma |
|
14716-5
|
Estriol (E3) [Moles/volume] in Serum or Plasma |
|
2252-5
|
Estriol (E3) [Mass/volume] in Urine |
|
14717-3
|
Estriol (E3) [Moles/volume] in Urine |
|
13737-2
|
Estriol (E3)/Creatinine [Mass Ratio] in 24 hour Urine |
|
30510-2
|
Estriol (E3)/Creatinine [Mass Ratio] in Urine |
|
34293-1
|
Estriol (E3)/Creatinine [Molar ratio] in Urine |
|
2256-6
|
Estrogen [Mass/time] in 24 hour Urine |
|
34294-9
|
Estrogen [Moles/volume] in 24 hour Urine |
|
25402-9
|
Estrogen [Moles/time] in 24 hour Urine |
|
14051-7
|
Estrogen binding protein [Mass/volume] in Serum or Plasma |
|
53766-2
|
Estrogen fraction panel - Serum or Plasma |
|
53765-4
|
Estrogen [Mass/volume] in Serum or Plasma by calculation |
|
2254-1
|
Estrogen [Mass/volume] in Serum or Plasma |
|
70207-6
|
Estrogen [Moles/volume] in Serum or Plasma |
|
2255-8
|
Estrogen [Mass/volume] in Urine |
|
34295-6
|
Estrogen [Moles/volume] in Urine |
|
13738-0
|
Estrogen/Creatinine [Mass Ratio] in 24 hour Urine |
|
34296-4
|
Estrogen/Creatinine [Molar ratio] in Urine |
|
6776-9
|
Estrone (E1) [Mass/time] in 24 hour Urine |
|
34297-2
|
Estrone (E1) [Moles/volume] in 24 hour Urine |
|
34298-0
|
Estrone (E1) [Moles/time] in 24 hour Urine |
|
31177-9
|
Estrone (E1) [Mass/volume] in Amniotic fluid |
|
14970-8
|
Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma |
|
27998-4
|
Estrone (E1) [Mass/volume] in Saliva (oral fluid) |
|
2258-2
|
Estrone (E1) [Mass/volume] in Serum or Plasma |
|
35208-8
|
Estrone (E1) [Mass or Moles/volume] in Serum or Plasma |
|
22663-9
|
Estrone (E1) [Moles/volume] in Serum or Plasma |
|
2257-4
|
Estrone (E1) [Mass/volume] in Semen |
|
15355-1
|
Estrone sulfate [Mass/volume] in Serum or Plasma |
|
2259-0
|
Estrone (E1) [Mass/volume] in Urine |
|
25403-7
|
Estrone (E1) [Moles/volume] in Urine |
|
13739-8
|
Estrone (E1)/Creatinine [Mass Ratio] in 24 hour Urine |
|
34299-8
|
Estrone (E1)/Creatinine [Molar ratio] in Urine |
|
89042-6
|
Eszopiclone [Mass/volume] in Urine |
|
3601-2
|
Etafedrine [Mass/time] in 24 hour Urine |
|
3599-8
|
Etafedrine [Presence] in Urine |
|
3600-4
|
Etafedrine [Mass/volume] in Urine |
|
3604-6
|
Etamivan [Mass/time] in 24 hour Urine |
|
3602-0
|
Etamivan [Presence] in Urine |
|
3603-8
|
Etamivan [Mass/volume] in Urine |
|
82469-8
|
Etanercept Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
82470-6
|
Etanercept [Mass/volume] in Serum or Plasma by Immunoassay |
|
80677-8
|
Escherichia coli enterotoxigenic eltA+estB genes [Presence] in Stool by NAA with probe detection |
|
88125-0
|
Escherichia coli enterotoxigenic gene panel - Unspecified specimen by NAA with probe detection |
|
87320-8
|
Escherichia coli enterotoxigenic heat-labile toxin DNA [Presence] in Isolate by NAA with probe detection |
|
87321-6
|
Escherichia coli enterotoxigenic sta gene [Presence] in Isolate by NAA with probe detection |
|
87322-4
|
Escherichia coli enterotoxigenic stb gene [Presence] in Isolate by NAA with probe detection |
|
93705-2
|
Ethyl sulfate and Ethyl glucuronide panel - Urine |
|
74758-4
|
Ethyl sulfate+Ethyl glucuronide [Presence] in Urine by Confirmatory method |
|
93706-0
|
Ethyl sulfate+Ethyl glucuronide [Mass/volume] in Urine by Screen method |
|
16840-1
|
Ethacrynate [Mass/volume] in Serum or Plasma |
|
3605-3
|
Ethacrynate [Presence] in Urine |
|
3606-1
|
Ethacrynate [Mass/volume] in Urine |
|
89491-5
|
Ethambutol [Susceptibility] by Genotype method |
|
25404-5
|
Ethambutol [Presence] in Serum or Plasma |
|
3607-9
|
Ethambutol [Mass/volume] in Serum or Plasma |
|
13007-0
|
Ethane [Mass/volume] in Blood |
|
35664-2
|
Ethanol [Mass/volume] in Urine collected for unspecified duration |
|
56478-1
|
Ethanol [Mass/volume] in Blood by Gas chromatography |
|
5639-0
|
Ethanol [Presence] in Blood |
|
5640-8
|
Ethanol [Mass/volume] in Blood |
|
15120-9
|
Ethanol [Moles/volume] in Blood |
|
5641-6
|
Ethanol [Mass/volume] in Exhaled gas |
|
16843-5
|
Ethanol [Mass/volume] in Body fluid |
|
40530-8
|
Ethanol [Presence] in Gastric fluid |
|
61095-6
|
Ethanol [Presence] in Gastric fluid by Screen method |
|
10367-1
|
Ethanol [Mass/volume] in Gastric fluid |
|
47107-8
|
Ethanol [Moles/volume] in Gastric fluid |
|
15402-1
|
Ethanol [Presence] in Meconium |
|
74673-5
|
Ethanol [Presence] in Saliva (oral fluid) by Confirmatory method |
|
50343-3
|
Ethanol [Presence] in Saliva (oral fluid) by Screen method |
|
34882-1
|
Ethanol [Mass/volume] in Saliva (oral fluid) |
|
14336-2
|
Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography |
|
5642-4
|
Ethanol [Presence] in Serum or Plasma |
|
20470-1
|
Ethanol [Presence] in Serum or Plasma by Screen method |
|
5643-2
|
Ethanol [Mass/volume] in Serum or Plasma |
|
35240-1
|
Ethanol [Mass or Moles/volume] in Serum or Plasma |
|
14719-9
|
Ethanol [Moles/volume] in Serum or Plasma |
|
23861-8
|
Ethanol [Mass/mass] in Tissue |
|
46983-3
|
Ethanol [Mass/volume] in Urine by Confirmatory method |
|
5644-0
|
Ethanol [Presence] in Urine |
|
34180-0
|
Ethanol [Presence] in Urine by Confirmatory method |
|
42242-8
|
Ethanol [Presence] in Urine by Screen method |
|
5645-7
|
Ethanol [Mass/volume] in Urine |
|
22745-4
|
Ethanol [Moles/volume] in Urine |
|
16842-7
|
Ethanol [Mass/volume] in Unknown substance |
|
12465-1
|
Ethanol [Mass/volume] in Vitreous fluid |
|
61066-7
|
Ethanol [Presence] in Unspecified specimen by Screen method |
|
32070-5
|
Ethanol [Moles/volume] in Unspecified specimen |
|
58356-7
|
Ethanol/Creatinine [Mass Ratio] in Urine |
|
49633-1
|
Ethanolamine [Presence] in Urine |
|
56678-6
|
Ethanolamine/Creatinine [Ratio] in 24 hour Urine |
|
31090-4
|
Ethchlorvynol [Presence] in Bile fluid |
|
3608-7
|
Ethchlorvynol [Mass/volume] in Blood |
|
29373-8
|
Ethchlorvynol [Presence] in Gastric fluid |
|
3609-5
|
Ethchlorvynol [Presence] in Serum or Plasma |
|
3610-3
|
Ethchlorvynol [Mass/volume] in Serum or Plasma |
|
32071-3
|
Ethchlorvynol [Moles/volume] in Serum or Plasma |
|
3611-1
|
Ethchlorvynol [Presence] in Urine |
|
3612-9
|
Ethchlorvynol [Mass/volume] in Urine |
|
29611-1
|
Ethchlorvynol [Presence] in Unspecified specimen |
|
86451-2
|
Ethics Consult note |
|
86452-0
|
Ethics Note |
|
89800-7
|
Ethics Telephone encounter Note |
|
89801-5
|
Ethics Team Conference note |
|
16844-3
|
Ethinamate [Presence] in Serum or Plasma by Confirmatory method |
|
12401-6
|
Ethinamate [Mass/volume] in Serum or Plasma |
|
12299-4
|
Ethinamate [Presence] in Urine |
|
32651-2
|
Ethion [Mass/volume] in Serum or Plasma |
|
21266-2
|
Ethion [Mass/volume] in Urine |
|
16845-0
|
Ethionamide [Mass/volume] in Serum or Plasma |
|
57953-2
|
Ethisterone [Presence] in Urine |
|
3615-2
|
Ethoheptazine [Mass/time] in 24 hour Urine |
|
16847-6
|
Ethoheptazine [Presence] in Serum or Plasma |
|
16848-4
|
Ethoheptazine [Mass/volume] in Serum or Plasma |
|
3613-7
|
Ethoheptazine [Presence] in Urine |
|
3614-5
|
Ethoheptazine [Mass/volume] in Urine |
|
87644-1
|
Ethoprop [Mass/mass] in Unspecified specimen |
|
29218-5
|
Ethosuximide [Mass/volume] in Body fluid |
|
40769-2
|
Ethosuximide [Mass/volume] in Serum or Plasma --peak |
|
3616-0
|
Ethosuximide [Mass/volume] in Serum or Plasma |
|
14720-7
|
Ethosuximide [Moles/volume] in Serum or Plasma |
|
40770-0
|
Ethosuximide [Mass/volume] in Serum or Plasma --trough |
|
3617-8
|
Ethotoin [Mass/volume] in Serum or Plasma |
|
13937-8
|
Ethyl acetate [Mass/volume] in Blood |
|
13027-8
|
Ethyl acetate [Mass/volume] in Serum or Plasma |
|
78826-5
|
Ethyl acetate [Mass/volume] in Urine |
|
38693-8
|
Ethyl acrylate [Mass/volume] in Air |
|
8199-2
|
Ethyl benzene [Mass/volume] in Blood |
|
54938-6
|
Ethyl benzene [Mass/volume] in Serum or Plasma |
|
16849-2
|
Ethyl benzene [Mass/volume] in Urine |
|
38641-7
|
Ethyl bromide [Mass/volume] in Air |
|
89000-4
|
Ethyl glucuronide [Mass/mass] in Hair by Confirmatory method |
|
58378-1
|
Ethyl glucuronide [Mass/volume] in Urine by Confirmatory method |
|
55349-5
|
Ethyl glucuronide [Presence] in Urine |
|
58377-3
|
Ethyl glucuronide [Presence] in Urine by Confirmatory method |
|
58375-7
|
Ethyl glucuronide [Presence] in Urine by Screen method |
|
45324-1
|
Ethyl glucuronide [Mass/volume] in Urine |
|
58376-5
|
Ethyl glucuronide/Creatinine [Mass Ratio] in Urine |
|
86228-4
|
Ethyl sulfate [Presence] in Saliva (oral fluid) |
|
82508-3
|
Ethyl sulfate [Mass/volume] in Saliva (oral fluid) |
|
58425-0
|
Ethyl sulfate [Mass/volume] in Urine by Confirmatory method |
|
74683-4
|
Ethyl sulfate [Presence] in Urine by Confirmatory method |
|
58424-3
|
Ethyl sulfate [Presence] in Urine by Screen method |
|
60676-4
|
Ethyl sulfate [Mass/volume] in Urine |
|
58423-5
|
Ethyl sulfate/Creatinine [Mass Ratio] in Urine |
|
19458-9
|
Ethylamphetamine [Mass/volume] in Urine by Confirmatory method |
|
16212-3
|
Ethylamphetamine [Presence] in Urine by Confirmatory method |
|
19456-3
|
Ethylamphetamine [Presence] in Urine by Screen method |
|
19459-7
|
Ethylamphetamine [Mass/volume] in Urine |
|
12340-6
|
Ethylene [Presence] in Blood |
|
38596-3
|
Ethylene glycol [Mass/volume] in Air |
|
75646-0
|
Ethylene glycol [Presence] in Gastric fluid |
|
31082-1
|
Ethylene glycol [Mass/volume] in Gastric fluid |
|
59899-5
|
Ethylene glycol [Moles/volume] in Gastric fluid |
|
23713-1
|
Ethylene glycol [Presence] in Serum or Plasma |
|
5646-5
|
Ethylene glycol [Mass/volume] in Serum, Plasma or Blood |
|
14721-5
|
Ethylene glycol [Moles/volume] in Serum or Plasma |
|
29279-7
|
Ethylene glycol [Presence] in Urine |
|
5647-3
|
Ethylene glycol [Mass/volume] in Urine |
|
22678-7
|
Ethylene glycol [Moles/volume] in Urine |
|
87617-7
|
Ethylene glycol [Mass/mass] in Unspecified specimen |
|
22734-8
|
Ethylene glycol [Moles/volume] in Unspecified specimen |
|
38696-1
|
Ethylene oxide [Mass/volume] in Air |
|
16850-0
|
Ethylene oxide [Mass/volume] in Blood |
|
6112-7
|
Ethylene oxide IgE Ab [Units/volume] in Serum |
|
38697-9
|
Ethylene thiourea [Mass/volume] in Air |
|
38698-7
|
Ethyleneimine [Mass/volume] in Air |
|
31015-1
|
Ethylestrenol [Mass/volume] in Urine |
|
82502-6
|
Ethylmalonate [Moles/volume] in DBS |
|
79476-8
|
Ethylmalonate [Moles/volume] in Serum or Plasma |
|
30472-5
|
Ethylmalonate [Presence] in Urine |
|
2265-7
|
Ethylmalonate [Mass/volume] in Urine |
|
44354-9
|
Ethylmalonate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13741-4
|
Ethylmalonate/Creatinine [Mass Ratio] in Urine |
|
25099-3
|
Ethylmalonate/Creatinine [Molar ratio] in Urine |
|
3623-6
|
Etilefrine [Mass/time] in 24 hour Urine |
|
3621-0
|
Etilefrine [Presence] in Urine |
|
3622-8
|
Etilefrine [Mass/volume] in Urine |
|
56488-0
|
Etiocholanolone [Mass/volume] in 24 hour Urine |
|
2268-1
|
Etiocholanolone [Mass/time] in 24 hour Urine |
|
34302-0
|
Etiocholanolone [Moles/volume] in 24 hour Urine |
|
15065-6
|
Etiocholanolone [Moles/time] in 24 hour Urine |
|
13614-3
|
Etiocholanolone [Mass/volume] in Serum or Plasma |
|
80157-1
|
Etiocholanolone [Moles/volume] in Serum or Plasma |
|
2266-5
|
Etiocholanolone [Presence] in Urine |
|
2267-3
|
Etiocholanolone [Mass/volume] in Urine |
|
34301-2
|
Etiocholanolone [Moles/volume] in Urine |
|
82882-2
|
Etiocholanolone/Androsterone [Molar ratio] in 24 hour Urine |
|
82881-4
|
Etiocholanolone/Androsterone [Molar ratio] in Urine |
|
44355-6
|
Etiocholanolone/Creatinine [Mass Ratio] in 24 hour Urine |
|
30508-6
|
Etiocholanolone/Creatinine [Mass Ratio] in Urine |
|
34303-8
|
Etiocholanolone/Creatinine [Molar ratio] in Urine |
|
16852-6
|
Etodolac [Mass/volume] in Serum or Plasma |
|
52749-9
|
Etravirine [Susceptibility] by Genotype method |
|
72558-0
|
Etravirine [Susceptibility] by Phenotype method |
|
57961-5
|
Etravirine [Mass/volume] in Serum or Plasma |
|
79562-5
|
Endotracheal tube Diameter |
|
2228-5
|
Enterotoxin [Mass/volume] in Serum |
|
30916-1
|
Euploid+Aneuploid cells/100 cells in Unspecified specimen |
|
31116-7
|
Euploid+Aneuploid cells population 1/100 cells in Unspecified specimen |
|
31117-5
|
Euploid+Aneuploid cells population 2/100 cells in Unspecified specimen |
|
60238-3
|
European Ash IgE Ab [Units/volume] in Serum |
|
15342-9
|
European Hornet IgE Ab [Units/volume] in Serum |
|
61325-7
|
European Hornet IgE Ab/IgE total in Serum |
|
56999-6
|
European Hornet IgG4 Ab [Units/volume] in Serum |
|
56600-0
|
European Hornet IgG Ab [Mass/volume] in Serum |
|
48182-0
|
European Hornet triggered leukotriene release [Mass/volume] by Leukocytes |
|
58804-6
|
European paper wasp IgE Ab [Units/volume] in Serum |
|
60429-8
|
Enterovirus 71 RNA [Presence] in Isolate by NAA with probe detection |
|
62861-0
|
Enterovirus 71 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31367-6
|
Enterovirus NOS Ab [Units/volume] in Serum |
|
42903-5
|
Enterovirus NOS Ab [Titer] in Cerebral spinal fluid |
|
43038-9
|
Enterovirus NOS Ab [Titer] in Serum |
|
26022-4
|
Enterovirus NOS Ab [Titer] in Serum by Complement fixation |
|
70065-8
|
Enterovirus Ag [Presence] in Stool by Immunoassay |
|
86323-3
|
Enterovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
5839-6
|
Enterovirus identified in Cerebral spinal fluid by Organism specific culture |
|
43699-8
|
Enterovirus identified in Cerebral spinal fluid by Shell vial culture |
|
76072-8
|
Enterovirus D68 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
70010-4
|
Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
70011-2
|
Enterovirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
70008-8
|
Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
35100-7
|
Enterovirus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
70009-6
|
Enterovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
5840-4
|
Enterovirus identified in Isolate by Immunofluorescence |
|
5841-2
|
Enterovirus identified in Isolate by Neutralization test |
|
88537-6
|
Enterovirus identified in Pericardial fluid by Organism specific culture |
|
62463-5
|
Enterovirus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
62464-3
|
Enterovirus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
53256-4
|
Enterovirus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88540-0
|
Enterovirus RNA [Presence] in Aspirate by NAA with probe detection |
|
91067-9
|
Enterovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
82194-2
|
Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
29558-4
|
Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
27952-1
|
Enterovirus RNA [Presence] in Cerebral spinal fluid by Probe |
|
74424-3
|
Enterovirus RNA [Cycle Threshold #] in Stool by NAA with probe detection |
|
74423-5
|
Enterovirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87960-1
|
Enterovirus RNA [Presence] in Body fluid by NAA with probe detection |
|
60263-1
|
Enterovirus RNA [Presence] in Isolate by NAA with probe detection |
|
91066-1
|
Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
7881-6
|
Enterovirus RNA [Presence] in Nose by NAA with probe detection |
|
76074-4
|
Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
|
88538-4
|
Enterovirus RNA [Presence] in Pericardial fluid by NAA with probe detection |
|
49847-7
|
Enterovirus RNA [Presence] in Serum by NAA with probe detection |
|
91068-7
|
Enterovirus RNA [Presence] in Stool by NAA with probe detection |
|
35396-1
|
Enterovirus RNA [Presence] in Tissue by NAA with probe detection |
|
91769-0
|
Enterovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
91069-5
|
Enterovirus RNA [Presence] in Urine by NAA with probe detection |
|
93856-3
|
Enterovirus RNA [Presence] in Unspecified specimen by NAA with non-probe detection |
|
29591-5
|
Enterovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5842-0
|
Enterovirus identified in Stool by Organism specific culture |
|
60528-7
|
Enterovirus subtype in Unspecified specimen by NAA with probe detection |
|
91770-8
|
Enterovirus identified in Upper respiratory specimen by Organism specific culture |
|
5843-8
|
Enterovirus identified in Unspecified specimen by Organism specific culture |
|
43364-9
|
Enterovirus identified in Unspecified specimen by Immunofluorescence |
|
43698-0
|
Enterovirus identified in Unspecified specimen by Shell vial culture |
|
68457-1
|
Enterovirus and Parechovirus A RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
92132-0
|
Enterovirus A+B+C RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
72267-8
|
Evaluation of mental and physical incapacity certificate |
|
51848-0
|
Evaluation note |
|
51847-2
|
Evaluation + Plan note |
|
91026-5
|
Event Inter-agency communication documentation |
|
50544-6
|
Everolimus [Mass/volume] in Blood |
|
80529-1
|
Everolimus [Mass/volume] in DBS |
|
77349-9
|
Everolimus [Mass/volume] in Blood by LC/MS/MS --trough |
|
72671-1
|
Everolimus [Mass/volume] in Plasma --trough |
|
89133-3
|
Everyday Cognition - Participant Self Report Form [ECog] |
|
89090-5
|
Everyday Cognition - Study Partner Report Form [ECog.Partner] |
|
87316-6
|
Enterovirus G RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77199-8
|
Evoked potential Study report |
|
93806-8
|
EWSR1 gene rearrangements in Tissue by FISH |
|
81879-9
|
t(11;22)(q24;q12.2)(FLI1,EWSR1) and t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript in Blood or Tissue by Molecular genetics method |
|
90047-2
|
Spermatozoa.excess residual cytoplasm/100 spermatozoa in Semen |
|
18752-6
|
Exercise stress test study |
|
55409-7
|
Exercise tracking panel |
|
89574-8
|
Exercise Vital Sign (EVS) |
|
34406-9
|
Exocrine pancreas Ab [Titer] in Serum by Immunofluorescence |
|
82982-0
|
Exocrine pancreas IgA+IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
44268-1
|
Avian paramyxovirus 1.exotic RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
34485-3
|
Avian paramyxovirus 1.exotic RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76320-1
|
Expiratory airway gas flow |
|
60739-0
|
Expiration [Time] Respiratory system |
|
60792-9
|
Expiratory gas flow Respiratory system airway --on ventilator |
|
76008-2
|
Expired minute Volume during Mechanical ventilation |
|
52030-4
|
Explanation of benefits |
|
52031-2
|
Explanation of benefits to subscriber |
|
38930-4
|
EXT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53858-7
|
EXT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77598-1
|
Externally defined clinical data elements Document |
|
52763-0
|
Extrinsic coagulation system thromboelastography panel - Blood |
|
72662-0
|
Extrinsic coagulation factor activity 4 panel - Platelet poor plasma |
|
89259-6
|
Presence of wound exudate |
|
47955-0
|
EYA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48971-6
|
EYA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
29272-2
|
Eye ultrasound study |
|
75411-9
|
Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detection |
|
73389-9
|
Ezetimibe induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73388-1
|
Ezetimibe induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
74134-8
|
Ezogabine [Mass/volume] in Plasma |
|
87763-9
|
Ezogabine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
6120-0
|
Fusarium culmorum IgE Ab [Units/volume] in Serum |
|
7324-7
|
Fusarium culmorum IgG Ab [Units/volume] in Serum |
|
63443-6
|
Fasciola hepatica Ab [Presence] in Serum by Hemagglutination |
|
56923-6
|
Fasciola hepatica Ab [Presence] in Serum by Immunoassay |
|
5162-3
|
Fasciola hepatica Ab [Units/volume] in Serum |
|
43037-1
|
Fasciola hepatica Ab [Titer] in Serum |
|
87996-5
|
Fasciola hepatica Ab [Titer] in Serum by Complement fixation |
|
56924-4
|
Fasciola hepatica Ab [Titer] in Serum by Hemagglutination |
|
27342-5
|
Fasciola hepatica Ab [Titer] in Serum by Immunoassay |
|
6121-8
|
Fusarium moniliforme IgE Ab [Units/volume] in Serum |
|
39600-2
|
Fusarium moniliforme IgE Ab/IgE total in Serum |
|
7325-4
|
Fusarium moniliforme IgG Ab [Units/volume] in Serum |
|
35548-7
|
Fusarium moniliforme IgG Ab [Mass/volume] in Serum |
|
7326-2
|
Fusarium oxysporum IgE Ab [Units/volume] in Serum |
|
18421-8
|
Fusarium oxysporum IgG Ab [Units/volume] in Serum |
|
58958-0
|
Fusarium oxysporum IgG Ab [Mass/volume] in Serum |
|
63374-3
|
Fusarium roseum IgE Ab [Units/volume] in Serum |
|
7327-0
|
Fusarium solani IgE Ab [Units/volume] in Serum |
|
7328-8
|
Fusarium solani IgG Ab [Units/volume] in Serum |
|
23122-5
|
Francisella tularensis A DNA [Presence] in Tissue by NAA with probe detection |
|
23123-3
|
Francisella tularensis A rRNA [Presence] in Tissue by Probe |
|
53373-7
|
Francisella tularensis Ab [Presence] in Isolate |
|
33715-4
|
Francisella tularensis Ab [Presence] in Isolate by Slide agglutination |
|
7888-1
|
Francisella tularensis Ab [Presence] in Serum |
|
23124-1
|
Francisella tularensis Ab [Presence] in Serum by Immunoassay |
|
5166-4
|
Francisella tularensis Ab [Presence] in Serum by Latex agglutination |
|
45040-3
|
Francisella tularensis Ab [Presence] in Serum by Microagglutination |
|
31396-5
|
Francisella tularensis Ab [Units/volume] in Serum |
|
16875-7
|
Francisella tularensis Ab [Titer] in Serum |
|
23125-8
|
Francisella tularensis Ab [Titer] in Serum by Agglutination |
|
23741-2
|
Francisella tularensis Ab [Titer] in Serum by Complement fixation |
|
5167-2
|
Francisella tularensis Ab [Titer] in Serum by Latex agglutination |
|
33683-4
|
Francisella tularensis Ab [Titer] in Serum by Microagglutination |
|
33684-2
|
Francisella tularensis Ab [Titer] in Serum by Tube agglutination |
|
53374-5
|
Francisella tularensis Ab [Presence] in Unspecified specimen |
|
33714-7
|
Francisella tularensis Ab [Presence] in Unspecified specimen by Slide agglutination |
|
33678-4
|
Francisella tularensis Ag [Presence] in Isolate by Immunofluorescence |
|
31828-7
|
Francisella tularensis Ag [Presence] in Serum |
|
16879-9
|
Francisella tularensis Ag [Presence] in Serum by Immunofluorescence |
|
23127-4
|
Francisella tularensis Ag [Presence] in Tissue by Immunofluorescence |
|
23126-6
|
Francisella tularensis Ag [Presence] in Tissue by Immune stain |
|
31829-5
|
Francisella tularensis Ag [Presence] in Unspecified specimen |
|
6408-9
|
Francisella tularensis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
45041-1
|
Francisella tularensis Ag [Presence] in Unspecified specimen by Slide agglutination |
|
23128-2
|
Francisella tularensis B DNA [Presence] in Tissue by NAA with probe detection |
|
23129-0
|
Francisella tularensis B rRNA [Presence] in Tissue by Probe |
|
33680-0
|
Francisella tularensis DNA [Presence] in Isolate by NAA with probe detection |
|
23130-8
|
Francisella tularensis DNA [Presence] in Tissue by NAA with probe detection |
|
33679-2
|
Francisella tularensis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
14209-1
|
Francisella tularensis IgA Ab [Presence] in Serum |
|
16876-5
|
Francisella tularensis IgA Ab [Presence] in Serum by Latex agglutination |
|
33576-0
|
Francisella tularensis IgA Ab [Titer] in Serum |
|
7889-9
|
Francisella tularensis IgG Ab [Presence] in Serum |
|
93717-7
|
Francisella tularensis IgG Ab [Presence] in Serum by Immunoassay |
|
16877-3
|
Francisella tularensis IgG Ab [Presence] in Serum by Latex agglutination |
|
70121-9
|
Francisella tularensis IgG Ab [Units/volume] in Serum or Plasma |
|
33465-6
|
Francisella tularensis IgG Ab [Titer] in Serum |
|
7890-7
|
Francisella tularensis IgM Ab [Presence] in Serum |
|
93716-9
|
Francisella tularensis IgM Ab [Presence] in Serum by Immunoassay |
|
6407-1
|
Francisella tularensis IgM Ab [Presence] in Serum by Latex agglutination |
|
16878-1
|
Francisella tularensis IgM Ab [Units/volume] in Serum |
|
33466-4
|
Francisella tularensis IgM Ab [Titer] in Serum |
|
33682-6
|
Francisella tularensis [Presence] in Isolate by Cell wall fatty acid analysis |
|
33677-6
|
Francisella tularensis [Presence] in Isolate by Organism specific culture |
|
23131-6
|
Francisella tularensis rRNA [Presence] in Tissue by Probe |
|
46732-4
|
Francisella tularensis subtype [Identifier] in Unspecified specimen by NAA with probe detection |
|
33681-8
|
Francisella tularensis [Presence] in Unspecified specimen by Cell wall fatty acid analysis |
|
33676-8
|
Francisella tularensis [Presence] in Unspecified specimen by Organism specific culture |
|
93715-1
|
Francisella tularensis IgG and IgM panel - Serum |
|
92990-1
|
F10 gene full mutation analysis in Blood or Tissue by Sequencing |
|
81813-8
|
F11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
58937-4
|
F12 gene mutations found [Type] in Blood or Tissue by Molecular genetics method |
|
92991-9
|
F13A1 and F13B gene full mutation analysis in Blood or Tissue by Sequencing |
|
50750-9
|
F13A1 gene p.Val34Leu [Presence] in Blood or Tissue by Molecular genetics method |
|
24475-6
|
F2 gene c.20210G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
24476-4
|
F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
90782-4
|
F2-Isoprostanes [Mass/volume] in Urine |
|
90783-2
|
F2-Isoprostanes/Creatinine [Mass Ratio] in Urine |
|
91712-0
|
F5 gene c.1691G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
21667-1
|
F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93788-8
|
F5 gene HR2 haplotype [Genotype] in Blood by Molecular genetics method Nominal |
|
59047-1
|
F5 gene p.His1299Arg [Presence] in Blood or Tissue by Molecular genetics method |
|
21668-9
|
F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method |
|
21670-5
|
F7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21672-1
|
F8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82342-7
|
F8 gene intron 1 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
81762-7
|
F8 gene intron 1 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82343-5
|
F8 gene intron 1 and 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
81761-9
|
F8 gene intron 1 and 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
91680-9
|
F8 gene intron 22 inversion targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
91679-1
|
F8 gene intron 22 inversion targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
91681-7
|
F9 gene mutation analysis limited to known familial mutations in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
69483-6
|
F9 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
93811-8
|
F9 gene full mutation analysis in Blood or Tissue by Sequencing |
|
38896-7
|
F9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74918-4
|
Fatty acids [Mass/mass] in 24 hour Stool |
|
74903-6
|
Fatty acids [Mass/time] in 24 hour Stool |
|
78344-9
|
Fatty acid comprehensive (C8-C26) panel - Red Blood Cells |
|
43674-1
|
Fatty acid comprehensive (C8-C26) panel - Serum or Plasma |
|
75100-8
|
Fatty acids [Entitic substance] in Red Blood Cells |
|
43676-6
|
Fatty acid essential (C12-C22) panel - Serum or Plasma |
|
43675-8
|
Fatty acid mitochondrial (C8-C18) panel - Serum or Plasma |
|
90918-4
|
Fatty acid omega-3 and omega-6 panel - Blood |
|
88884-2
|
Fatty acid omega-3 and omega-6 panel - Serum or Plasma |
|
57084-6
|
Fatty acid oxidation newborn screen panel |
|
42669-2
|
Fatty acids [Presence] in Pleural fluid |
|
42668-4
|
Fatty acids [Presence] in Stool |
|
42667-6
|
Fatty acids [Presence] in Urine |
|
62304-1
|
Fabry disease newborn screening panel |
|
65833-6
|
Facility Address |
|
45967-7
|
Facility provider numbers Set |
|
32635-5
|
Coagulation factor II inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
40744-5
|
Factor inhibitor XXX [Presence] in Platelet poor plasma by Coagulation assay |
|
13591-3
|
Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3187-2
|
Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay |
|
88449-4
|
Coagulation factor IX activity actual/normal in Platelet poor plasma by Chromogenic method |
|
3189-8
|
Coagulation factor IX Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
30086-3
|
Coagulation factor IX inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3185-6
|
Coagulation factor IX inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3188-0
|
Coagulation factor IX activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3186-4
|
Coagulation factor IX activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3193-0
|
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3194-8
|
Coagulation factor V Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
81124-0
|
Coagulation factor V inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3191-4
|
Coagulation factor V inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3192-2
|
Coagulation factor V activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
10520-5
|
Coagulation factor VI Ag [Presence] in Tissue by Immune stain |
|
3198-9
|
Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3200-3
|
Coagulation factor VII activity actual/normal [Molar ratio] in Platelet poor plasma by Coagulation assay |
|
90225-4
|
Coagulation factor VII activity and inhibitor with Reflex panel - Platelet poor plasma by Coagulation assay |
|
49870-9
|
Coagulation factor VII Ag actual/normal in Platelet poor plasma by Immunoassay |
|
3201-1
|
Coagulation factor VII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
81123-2
|
Coagulation factor VII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3196-3
|
Coagulation factor VII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3199-7
|
Coagulation factor VII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3202-9
|
Coagulation factor VII+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3197-1
|
Coagulation factor VII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3205-2
|
Coagulation factor VIII Ab [Units/volume] in Platelet poor plasma by Immunoassay |
|
58493-8
|
Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay |
|
3209-4
|
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay |
|
49865-9
|
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Chromogenic method |
|
3213-6
|
Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3215-1
|
Coagulation factor VIII Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3214-4
|
Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by Immunoelectrophoresis |
|
10521-3
|
Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |
|
93450-5
|
Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3206-0
|
Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3207-8
|
Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method |
|
3204-5
|
Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3210-2
|
Coagulation factor VIII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3212-8
|
Coagulation factor VIII Activity.Xa activator [Units/volume] in Platelet poor plasma by Chromogenic method |
|
90919-2
|
Coagulation factor VIII.recombinant.bound/von Willebrand factor (vWf) Ag Ag in Plasma by Immunoassay |
|
3208-6
|
Coagulation factor VIII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3218-5
|
Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3220-1
|
Coagulation factor X Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
39556-6
|
Coagulation factor X inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3216-9
|
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3219-3
|
Coagulation factor X activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3222-7
|
Coagulation factor X+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3217-7
|
Coagulation factor X activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3226-8
|
Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3228-4
|
Coagulation factor XI Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
80603-4
|
Coagulation factor XI inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
3224-3
|
Coagulation factor XI inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3227-6
|
Coagulation factor XI activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
53222-6
|
Coagulation factor XI activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3232-6
|
Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3234-2
|
Coagulation factor XII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3230-0
|
Coagulation factor XII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3233-4
|
Coagulation factor XII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3231-8
|
Coagulation factor XII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3238-3
|
Coagulation factor XIII Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
10522-1
|
Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
|
3241-7
|
Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay |
|
3240-9
|
Coagulation factor XIII coagulum dissolution [Units/volume] in Platelet poor plasma by Coagulation assay |
|
57760-1
|
Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Coagulation assay |
|
50637-8
|
Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Chromogenic method |
|
3236-7
|
Coagulation factor XIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
3237-5
|
Coagulation factor XIII activated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
81712-2
|
Actin.filamentous Ab [Presence] in Serum by Line blot |
|
57410-3
|
Actin.filamentous Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
54020-3
|
Actin.filamentous Ab [Presence] in Serum or Plasma |
|
63484-0
|
Actin.filamentous Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
54021-1
|
Actin.filamentous Ab [Units/volume] in Serum or Plasma |
|
53647-4
|
Flavin adenine dinucleotide [Mass/volume] in Blood |
|
78991-7
|
Flavin adenine dinucleotide [Moles/volume] in Blood |
|
2281-4
|
Flavin adenine dinucleotide [Mass/volume] in Serum |
|
78990-9
|
Flavin adenine dinucleotide [Moles/volume] in Serum or Plasma |
|
22089-7
|
Avian adenovirus Ab [Presence] in Serum |
|
15434-4
|
Avian adenovirus Ab [Presence] in Serum by Immune diffusion (ID) |
|
47438-7
|
Fowl adenovirus Ab [Presence] in Serum |
|
43335-9
|
Fowl adenovirus Ab [Presence] in Serum by Immune diffusion (ID) |
|
43344-1
|
Avian adenovirus 127 Ab [Titer] in Serum |
|
43313-6
|
Avian adenovirus 127 Ab [Titer] in Serum by Hemagglutination inhibition |
|
22088-9
|
Avian adenovirus 2 Ab [Presence] in Serum |
|
15435-1
|
Avian adenovirus 2 Ab [Presence] in Serum by Immune diffusion (ID) |
|
20674-8
|
Avian adenovirus 2 Ag [Presence] in Tissue by Immune diffusion (ID) |
|
38928-8
|
FAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38929-6
|
FAH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75431-7
|
Fall risk assessment note |
|
6726-4
|
False oat grass IgE Ab [Units/volume] in Serum |
|
7648-9
|
False ragweed triggered histamine release [Units/volume] in Blood |
|
6115-0
|
False ragweed IgE Ab [Units/volume] in Serum |
|
61267-1
|
False ragweed IgE Ab/IgE total in Serum |
|
13187-0
|
False ragweed IgG Ab [Units/volume] in Serum |
|
56369-2
|
False ragweed IgG4 Ab [Mass/volume] in Serum |
|
63207-5
|
False ragweed IgG Ab [Mass/volume] in Serum |
|
78253-2
|
Family medicine Consult note |
|
78255-7
|
Family medicine Diagnostic study note |
|
78277-1
|
Family medicine Education note |
|
78299-5
|
Family medicine Flowsheet |
|
78338-1
|
Family medicine Initial evaluation note |
|
85437-2
|
Family medicine Note |
|
93898-5
|
Family medicine Telephone encounter Note |
|
80752-9
|
Family medicine Plan of care note |
|
78315-9
|
Family medicine procedure note |
|
78324-1
|
Family medicine Progress note |
|
78332-4
|
Family medicine Referral note |
|
72839-4
|
Famciclovir [Susceptibility] by Genotype method |
|
55146-5
|
Familial long QTS syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
86635-0
|
Family planning report Document |
|
80390-8
|
Family unification code |
|
73387-3
|
Famotidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73386-5
|
Famotidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
23862-6
|
Famotidine [Mass/volume] in Serum or Plasma |
|
87658-1
|
Famphur [Mass/mass] in Unspecified specimen |
|
75922-5
|
Fan speed Infant microenvironment.incubator |
|
43191-6
|
FANCC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
32639-7
|
FANCC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77083-4
|
FARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77082-6
|
FARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
60550-1
|
Fascin [Presence] in Tissue by Immune stain |
|
5163-1
|
Fasciola sp Ab [Units/volume] in Serum |
|
25342-7
|
Fasciola sp Ab [Titer] in Serum |
|
25406-0
|
Fasciola sp Ab [Titer] in Serum by Immunofluorescence |
|
25407-8
|
Fasciola sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
25343-5
|
Fasciola sp IgG Ab [Units/volume] in Serum |
|
34329-3
|
Fat [Mass/mass] in 24 hour Stool |
|
16142-2
|
Fat [Mass/time] in 24 hour Stool |
|
16855-9
|
Fat [Mass/time] in 48 hour Stool |
|
58934-1
|
Fat [Mass/mass] in 72 hour Stool |
|
2271-5
|
Fat [Mass/time] in 72 hour Stool |
|
32545-6
|
Fat [Moles/time] in 72 hour Stool |
|
13356-1
|
Fat [Presence] in Body fluid |
|
75297-2
|
Fat intake 24 hour Estimated |
|
81952-4
|
Fat intake 24 hour Measured |
|
81896-3
|
Fat intake panel |
|
23714-9
|
Fat [Mass/volume] in Milk |
|
75289-9
|
Fat need [Mass/time] 24 hour Estimated |
|
43118-9
|
Fat panel - Stool |
|
2270-7
|
Fat [Presence] in Stool |
|
16853-4
|
Fat [Mass] in Stool |
|
10753-2
|
Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |
|
2570-0
|
Fat [Mass/volume] in Stool |
|
63556-5
|
Fat [Mass/mass] in Stool |
|
2272-3
|
Fat [Presence] in Urine |
|
88120-1
|
Father's Bridged race [CDC] |
|
88118-5
|
Father's Tabulated ethnicity [CDC] |
|
78361-3
|
Fatty acid and triglyceride panel - 24 hour Stool |
|
74533-1
|
Fatty acid oxidation panel - Fibroblast |
|
62453-6
|
Fatty acids.ethyl esters [Moles/mass] in Hair |
|
60519-6
|
Fatty acids.ethyl esters [Moles/mass] in Meconium |
|
54930-3
|
Fava bean IgE Ab [Units/volume] in Serum |
|
69484-4
|
FBN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77114-7
|
FBN1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
40471-5
|
FBN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49735-4
|
FBN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43310-2
|
FBN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
90465-6
|
3-(4-fluorobenzoyl)propionate [Mass/volume] in Urine by Confirmatory method |
|
90466-4
|
3-(4-fluorobenzoyl)propionate [Presence] in Urine by Screen method |
|
55141-6
|
Fc epsilon RI + RII Ab [Units/volume] in Serum |
|
42177-6
|
Fc epsilon RI Ab [Presence] in Serum |
|
5164-9
|
Fc fragment Ab [Units/volume] in Serum |
|
68931-5
|
Catecholamines Free [Mass/volume] in 24 hour Urine |
|
27055-3
|
Catecholamines Free [Mass/time] in 24 hour Urine |
|
14643-1
|
Catecholamines Free [Moles/time] in 24 hour Urine |
|
42493-7
|
Catecholamines Free fractionated [Mass/volume] in Plasma |
|
11133-6
|
Catecholamines Free [Mass/volume] in Urine |
|
23717-2
|
Feline coronavirus Ab [Presence] in Serum |
|
23716-4
|
Feline coronavirus Ab [Presence] in Serum by Immunoassay |
|
31385-8
|
Feline coronavirus Ab [Units/volume] in Serum |
|
23718-0
|
Feline coronavirus Ab [Titer] in Serum |
|
31384-1
|
Feline calicivirus Ab [Units/volume] in Serum |
|
23715-6
|
Feline calicivirus Ab [Titer] in Serum |
|
86445-4
|
FDA package insert Blanket no changes certification of product listing |
|
90374-0
|
FDA package insert Clinical trials experience section |
|
77292-1
|
FDA package insert eFacility |
|
77291-3
|
FDA package insert Females and males reproductive potential |
|
88829-7
|
FDA package insert Hepatic Impairment subsection |
|
77289-7
|
FDA package insert Identification of suspect product and notification |
|
88830-5
|
FDA package insert Immunogenicity |
|
73815-3
|
FDA package insert Indexing - product concept |
|
77288-9
|
FDA package insert Indexing - warning letter alert |
|
77290-5
|
FDA package insert Lactation |
|
90375-7
|
FDA package insert Postmarketing experience section |
|
88828-9
|
FDA package insert Renal Impairment subsection |
|
77647-6
|
FDA product label Animal compounded drug label |
|
86446-2
|
FDA product label Blood establishment registration and product listing change in information |
|
85481-0
|
FDA product label Blood establishment registration and product listing |
|
81203-2
|
FDA product label Bulk ingredient - animal drug |
|
85482-8
|
FDA product label Human cell and tissue establishment registration and product listing |
|
86447-0
|
FDA product label Human cell and tissue establishment registration and product listing change in information |
|
78744-0
|
FDA product label Drug for further processing label |
|
85480-2
|
FDA product label Establishment registration exempt notification |
|
85484-4
|
FDA product label Establishment temporary inactivation notification |
|
86448-8
|
FDA product label Human salvaged drug |
|
77648-4
|
FDA product label Indexing - biologic or drug substance |
|
93723-5
|
FDA product label Indexing - drug interactions |
|
93372-1
|
FDA product label Indexing - national clinical trial number |
|
86444-7
|
FDA product label Manufacturing establishment information |
|
81204-0
|
FDA product label NDC labeler code inactivation - animal drug |
|
78745-7
|
FDA product label Recombinant deoxyribonucleic acid construct label |
|
77573-4
|
FDA product label Withdrawal of wholesale drug distributors and third-party logistics facility report |
|
89600-1
|
FDA product label FDA-initiated compliance action drug registration and listing inactivation |
|
29263-1
|
Fibrin degradation products [Presence] in Blood by Agglutination |
|
85143-6
|
Fear Survey version 2.0 - fixed length form - ages 8-17 [NIH Toolbox] |
|
91529-8
|
Fear-Affect Survey - CAT item bank - age 18+ [NIH Toolbox] |
|
85124-6
|
Fear-Over Anxious Survey version 2.0 - parent report - fixed length form - ages 3-7 [NIH Toolbox] |
|
85121-2
|
Fear-Separation Anxiety Survey version 2.0 - parent report - fixed length form - ages 3-7 [NIH Toolbox] |
|
41493-8
|
Febrile agglutinin Ab panel [Titer] - Serum |
|
57795-7
|
Fecal hydrolysis panel - Stool |
|
57962-3
|
FECH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
76470-4
|
Organization federal tax ID |
|
34588-4
|
Tick feeding duration |
|
69973-6
|
FEF 25-75% --post bronchodilation |
|
69972-8
|
FEF 25-75% --pre bronchodilation |
|
69971-0
|
FEF 25-75% Predicted |
|
31387-4
|
Feline herpesvirus Ab [Units/volume] in Serum |
|
43036-3
|
Feline herpesvirus Ab [Titer] in Serum |
|
23722-2
|
Feline herpesvirus Ab [Titer] in Serum by Neutralization test |
|
31386-6
|
Feline herpesvirus 1 Ab [Presence] in Serum |
|
27383-9
|
Feline herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
|
23719-8
|
Feline herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
|
31393-2
|
Feline herpesvirus 1 Ab [Units/volume] in Serum |
|
23738-8
|
Feline herpesvirus 1 Ab [Titer] in Serum |
|
23720-6
|
Feline herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
|
23721-4
|
Feline herpesvirus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
50611-3
|
Felbamate [Mass/volume] in Serum or Plasma by Confirmatory method |
|
6899-9
|
Felbamate [Mass/volume] in Serum or Plasma |
|
83826-8
|
Fellow Intensive care unit Admission evaluation note |
|
83827-6
|
Fellow Intensive care unit Note |
|
83825-0
|
Fellow Note |
|
23734-7
|
Feline leukemia virus Ab [Presence] in Serum |
|
23732-1
|
Feline leukemia virus Ab [Presence] in Serum by Immunoassay |
|
23733-9
|
Feline leukemia virus Ab [Presence] in Serum by Immunofluorescence |
|
31389-0
|
Feline leukemia virus Ab [Units/volume] in Serum |
|
43034-8
|
Feline leukemia virus Ab [Titer] in Serum |
|
23735-4
|
Feline leukemia virus Ab [Titer] in Serum by Neutralization test |
|
23736-2
|
Feline leukemia virus Ag [Presence] in Tissue by Immunofluorescence |
|
23731-3
|
Feline leukemia provirus [Presence] in Unspecified specimen |
|
75993-6
|
Femoral artery Blood pressure |
|
3626-9
|
Fencamfamin [Mass/time] in 24 hour Urine |
|
3624-4
|
Fencamfamin [Presence] in Urine |
|
3625-1
|
Fencamfamin [Mass/volume] in Urine |
|
35487-8
|
Fenchlorphos [Mass/volume] in Serum or Plasma |
|
21268-8
|
Fenchlorphos [Mass/volume] in Urine |
|
87637-5
|
Fenchlorphos [Mass/mass] in Unspecified specimen |
|
16857-5
|
Fenclorvos [Presence] in Blood |
|
3629-3
|
Fenetylline [Mass/time] in 24 hour Urine |
|
3627-7
|
Fenetylline [Presence] in Urine |
|
3628-5
|
Fenetylline [Mass/volume] in Urine |
|
3630-1
|
Fenfluramine [Mass/volume] in Serum or Plasma |
|
55350-3
|
Fenfluramine [Presence] in Urine |
|
3631-9
|
Fenfluramine [Mass/volume] in Urine |
|
10928-0
|
Fennel Fresh IgE Ab [Units/volume] in Serum |
|
63126-7
|
Fennel Fresh IgG Ab [Mass/volume] in Serum |
|
10929-8
|
Fennel Seed IgE Ab [Units/volume] in Serum |
|
61265-5
|
Fennel Seed IgE Ab/IgE total in Serum |
|
73024-2
|
Fenofibrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73023-4
|
Fenofibrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73385-7
|
Fenofibrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73384-0
|
Fenofibrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59901-9
|
Fenoprofen [Moles/volume] in Gastric fluid |
|
3632-7
|
Fenoprofen [Mass/volume] in Serum or Plasma |
|
55536-7
|
Fenoprofen [Moles/volume] in Serum or Plasma |
|
59900-1
|
Fenoprofen [Moles/volume] in Urine |
|
60303-5
|
Fenoprofen [Moles/volume] in Unspecified specimen |
|
3635-0
|
Fenproporex [Mass/time] in 24 hour Urine |
|
3633-5
|
Fenproporex [Presence] in Urine |
|
3634-3
|
Fenproporex [Mass/volume] in Urine |
|
26867-2
|
fentaNYL [Units/volume] in 24 hour Urine |
|
73938-3
|
fentaNYL [Mass/volume] in Blood by Confirmatory method |
|
73936-7
|
fentaNYL [Presence] in Blood by Screen method |
|
16858-3
|
fentaNYL [Mass/volume] in Body fluid |
|
61077-4
|
fentaNYL [Presence] in Gastric fluid |
|
73382-4
|
fentaNYL induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73383-2
|
fentaNYL induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72760-2
|
fentaNYL [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87815-7
|
fentaNYL [Presence] in Saliva (oral fluid) by Screen method |
|
29356-3
|
fentaNYL [Presence] in Serum or Plasma |
|
74136-3
|
fentaNYL [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3636-8
|
fentaNYL [Mass/volume] in Serum or Plasma |
|
55537-5
|
fentaNYL [Moles/volume] in Serum or Plasma |
|
58381-5
|
fentaNYL [Mass/volume] in Urine by Confirmatory method |
|
11235-9
|
fentaNYL [Presence] in Urine |
|
40839-3
|
fentaNYL [Presence] in Urine by Confirmatory method |
|
59673-4
|
fentaNYL [Presence] in Urine by Screen method |
|
3637-6
|
fentaNYL [Mass/volume] in Urine |
|
74383-1
|
fentaNYL [Mass/volume] in Unknown substance |
|
61042-8
|
fentaNYL [Presence] in Unspecified specimen |
|
58380-7
|
fentaNYL/Creatinine [Mass Ratio] in Urine |
|
81277-6
|
fentaNYL and Norfentanyl panel - Gastric fluid |
|
81275-0
|
fentaNYL and Norfentanyl panel - Serum or Plasma |
|
67822-7
|
fentaNYL and Norfentanyl panel - Urine |
|
81273-5
|
fentaNYL and Norfentanyl panel - Unspecified specimen |
|
66130-6
|
fentaNYL+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method |
|
66129-8
|
fentaNYL+Norfentanyl [Presence] in Urine by Confirmatory method |
|
58379-9
|
fentaNYL+Norfentanyl [Presence] in Urine by Screen method |
|
32652-0
|
Fenthion [Mass/volume] in Serum or Plasma |
|
21269-6
|
Fenthion [Mass/volume] in Urine |
|
87657-3
|
Fenthion [Mass/mass] in Unspecified specimen |
|
19739-2
|
Fenugreek IgE Ab [Units/volume] in Serum |
|
10573-4
|
Ferning [Type] in Cervical mucus |
|
54452-8
|
Ferning [Presence] in Cervical mucus |
|
11172-4
|
Ferret epithelium IgE Ab [Units/volume] in Serum |
|
61343-0
|
Ferret epithelium IgE Ab/IgE total in Serum |
|
24373-3
|
Ferritin [Mass/volume] in Blood |
|
53048-5
|
Ferritin [Mass/volume] in Body fluid |
|
86914-9
|
Ferritin goal [Mass/volume] Serum or Plasma |
|
48141-6
|
Ferritin [Entitic mass] in Red Blood Cells |
|
20567-4
|
Ferritin [Mass/volume] in Serum or Plasma by Immunoassay |
|
2276-4
|
Ferritin [Mass/volume] in Serum or Plasma |
|
35209-6
|
Ferritin [Mass or Moles/volume] in Serum or Plasma |
|
14723-1
|
Ferritin [Moles/volume] in Serum or Plasma |
|
2277-2
|
Ferrochelatase [Enzymatic activity/volume] in Serum |
|
89692-8
|
Heart rate 10 minutes mean Fetus |
|
75980-3
|
Fetal Chromosome 13+18+21+X+Y aneuploidy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75598-3
|
Fetal 1p36 deletion prior risk [Likelihood] based on general population risk |
|
75599-1
|
Fetal 1p36 deletion prior risk [Likelihood] based on general population risk Narrative |
|
75601-5
|
Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75602-3
|
Fetal 1p36 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75600-7
|
Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
75574-4
|
Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk |
|
75575-1
|
Fetal 22q11.2 deletion prior risk [Likelihood] based on general population risk Narrative |
|
75577-7
|
Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75578-5
|
Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75576-9
|
Fetal 22q11.2 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
75592-6
|
Fetal 5p deletion prior risk [Likelihood] based on general population risk |
|
75593-4
|
Fetal 5p deletion prior risk [Likelihood] based on general population risk Narrative |
|
75595-9
|
Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75596-7
|
Fetal 5p deletion risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75594-2
|
Fetal 5p deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
75586-8
|
Fetal Angelman syndrome prior risk [Likelihood] based on general population risk |
|
75587-6
|
Fetal Angelman syndrome prior risk [Likelihood] based on general population risk Narrative |
|
75589-2
|
Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75590-0
|
Fetal Angelman syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75588-4
|
Fetal Angelman syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
48770-2
|
Fetal Biophysical profile panel US |
|
92899-4
|
Fetal Chromosome region 11q23 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
|
75975-3
|
Fetal Chromosome 13+18+21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
92903-4
|
Fetal Chromosome region 15q11 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
|
75982-9
|
Fetal Chromosome 18 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75983-7
|
Fetal Chromosome 21 trisomy [Presence] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
92900-0
|
Fetal Chromosome region 4p16 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
|
92902-6
|
Fetal Chromosome region 8q24 deletion [Presence] based on Plasma cell-free DNA by Sequencing |
|
73821-1
|
Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
77619-5
|
Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma |
|
76664-2
|
Fetal Chromosome X and Y aneuploidy [interpretation] based on dosage of chromosome-specific cell-free DNA in Maternal plasma |
|
53668-0
|
Fetal Ear - right Maximum length US |
|
75568-6
|
Fetal Monosomy X prior risk [Likelihood] Based on maternal age Narrative |
|
75566-0
|
Fetal Monosomy X prior risk [Likelihood] Based on maternal age |
|
75569-4
|
Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75570-2
|
Fetal Monosomy X risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75567-8
|
Fetal Monosomy X risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
80109-2
|
Fetal Pregnancy risk factors for prenatal genetic testing |
|
75580-1
|
Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk |
|
75581-9
|
Fetal Prader-Willi syndrome prior risk [Likelihood] based on general population risk Narrative |
|
75583-5
|
Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75584-3
|
Fetal Prader-Willi syndrome risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75582-7
|
Fetal Prader-Willi syndrome risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
77016-4
|
Fetal RhD antigen in Plasma cell-free DNA by MS.MALDI-TOF |
|
75604-9
|
Fetal sex in Cell-free+Maternal WBC DNA by Dosage of chromosome specific circulating cell free (ccf) DNA |
|
75572-8
|
Fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75546-2
|
Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age |
|
75550-4
|
Fetal Trisomy 13 prior risk [Likelihood] Based on maternal age Narrative |
|
73824-5
|
Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
73969-8
|
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75551-2
|
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75552-0
|
Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75548-8
|
Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
75554-6
|
Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age |
|
75556-1
|
Fetal Trisomy 18 prior risk [Likelihood] Based on maternal age Narrative |
|
73825-2
|
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
73968-0
|
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75557-9
|
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75558-7
|
Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75555-3
|
Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
75560-3
|
Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age |
|
75562-9
|
Fetal Trisomy 21 prior risk [Likelihood] Based on maternal age Narrative |
|
73966-4
|
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
73970-6
|
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA |
|
75563-7
|
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75564-5
|
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Qualitative |
|
75561-1
|
Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
|
89087-1
|
Fetal Body weight Estimated |
|
75308-7
|
Fetal blood [Volume] in Blood by Flow cytometry (FC) |
|
33900-2
|
Fetal cell screen [Presence] in Blood by Rosette test |
|
50009-0
|
Fetal lung maturity panel - Amniotic fluid |
|
55729-8
|
Erythrocytes.fetal/100 erythrocytes [Ratio] in Blood by Flow cytometry (FC) |
|
75373-1
|
Erythrocytes.fetal/2000 erythrocytes in Blood by Kleihauer-Betke method |
|
88241-5
|
Fetal remains disposition method |
|
69970-2
|
FEV1/FVC --post bronchodilation |
|
73022-6
|
Fexofenadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73021-8
|
Fexofenadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60072-6
|
Fexofenadine [Mass/volume] in Blood |
|
73381-6
|
Fexofenadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73380-8
|
Fexofenadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60073-4
|
Fexofenadine [Mass/volume] in Serum or Plasma |
|
60074-2
|
Fexofenadine [Mass/volume] in Urine |
|
39152-4
|
FFD mammogram Breast Diagnostic |
|
39153-2
|
FFD mammogram Breast Screening |
|
46342-2
|
FFD mammogram Breast Views |
|
39150-8
|
FFD mammogram Breast Views Post Localization |
|
39154-0
|
FFD mammogram Breast - bilateral Diagnostic |
|
42174-3
|
FFD mammogram Breast - bilateral Screening |
|
42169-3
|
FFD mammogram Breast - left Diagnostic |
|
46355-4
|
FFD mammogram Breast - left Screening |
|
42168-5
|
FFD mammogram Breast - right Diagnostic |
|
46354-7
|
FFD mammogram Breast - right Screening |
|
92992-7
|
FGA, FGB, and FGG gene full mutation analysis in Blood or Tissue by Sequencing |
|
58988-7
|
FGB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40426-9
|
FGD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41109-0
|
FGD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
87832-2
|
Fibroblast growth factor 21.intact [Mass/volume] in Serum or Plasma |
|
47855-2
|
Fibroblast growth factor 23.C-terminal [Units/volume] in Plasma |
|
41108-2
|
FGF23 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40427-7
|
FGF23 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46699-5
|
Fibroblast growth factor 23 [Units/volume] in Plasma |
|
47854-5
|
Fibroblast growth factor 23.intact [Units/volume] in Plasma |
|
54390-0
|
Fibroblast growth factor 23.intact [Mass/volume] in Serum or Plasma |
|
42785-6
|
FGFR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
78915-6
|
FGFR1 gene rearrangements [Presence] in Blood or Tissue by FISH |
|
38412-3
|
FGFR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21674-7
|
FGFR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48972-4
|
FGFR2 gene+FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75391-3
|
FGFR3 gene targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
38413-1
|
FGFR3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21676-2
|
FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21677-0
|
FGFR3 gene p.Gly375Cys [Presence] in Blood or Tissue by Molecular genetics method |
|
21678-8
|
FGFR3 gene p.Gly380Arg [Presence] in Blood or Tissue by Molecular genetics method |
|
82137-1
|
FGFR3 gene p.Gly380Arg targeted mutation analysis in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
21679-6
|
FGFR3 gene p.Lys650Glu [Presence] in Blood or Tissue by Molecular genetics method |
|
49872-5
|
FH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81926-8
|
Fiber intake panel |
|
47407-2
|
Fibers [#/area] in Stool by Light microscopy |
|
78035-3
|
Fibers [Presence] in Body fluid |
|
38897-5
|
Fibers [Presence] in Stool by Light microscopy |
|
78036-1
|
Fibers [Presence] in Urine |
|
82393-0
|
Fibrillarin Ab [Units/volume] in Serum by Line blot |
|
49963-2
|
Fibrillarin Ab [Presence] in Serum |
|
53005-5
|
Fibrillarin Ab [Presence] in Serum by Immunofluorescence |
|
82394-8
|
Fibrillarin Ab [Presence] in Serum by Line blot |
|
51803-5
|
Fibrillarin Ab [Titer] in Serum by Immunofluorescence |
|
82915-0
|
Fibrillarin IgG Ab [Presence] in Serum by Line blot |
|
3248-2
|
Fibrin fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3249-0
|
Fibrin fragments [Identifier] in Platelet poor plasma by Immunoelectrophoresis |
|
93748-2
|
Fibrin monomer [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3250-8
|
Fibrin monomer [Units/volume] in Platelet poor plasma by Latex agglutination |
|
40702-3
|
Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination |
|
3253-2
|
Fibrin.soluble [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3254-0
|
Fibrin.soluble [Units/volume] in Serum by Coagulation assay |
|
3256-5
|
Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
42772-4
|
Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Nephelometry |
|
60278-9
|
Fibrinogen Ag [Presence] in Tissue by Immunofluorescence |
|
10523-9
|
Fibrinogen Ag [Presence] in Tissue by Immune stain |
|
31158-9
|
Fibrinogen Ag/Fibrinogen [Mass Ratio] in Platelet poor plasma |
|
3259-9
|
Fibrinogen fragments Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
27990-1
|
Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutination |
|
27991-9
|
Fibrinogen fragments [Mass/volume] in Urine by Latex agglutination |
|
56784-2
|
Fibrinogen fragments [Mass/volume] in Urine |
|
48664-7
|
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation.derived |
|
30902-1
|
Fibrinogen [Mass/volume] in Platelet poor plasma by Heat denaturation |
|
16859-1
|
Fibrinogen [Presence] in Platelet poor plasma |
|
3255-7
|
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay |
|
42568-6
|
Fibrinogen [Mass or Moles/volume] in Platelet poor plasma by Coagulation assay |
|
52764-8
|
Extrinsic coagulation system with fibrinolysis inhibition thromboelastography panel - Blood |
|
13173-0
|
Fibronectin aggregate IgA Ab [Units/volume] in Serum |
|
14095-4
|
Fibronectin aggregate IgG Ab [Units/volume] in Serum |
|
16867-4
|
Fibronectin aggregate IgG Ab [Mass/volume] in Serum |
|
20404-0
|
Fibronectin.fetal [Presence] in Vaginal fluid |
|
20403-2
|
Fibronectin.fetal [Mass/volume] in Vaginal fluid |
|
48039-2
|
Fibronectin.fetal [Presence] in Unspecified specimen |
|
2280-6
|
Fibronectin [Mass/volume] in Plasma |
|
6116-8
|
Ficus sp IgE Ab [Units/volume] in Serum |
|
11173-2
|
Fig IgE Ab [Units/volume] in Serum |
|
53862-9
|
FIG4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
44245-9
|
Fungi.filamentous [#/area] in Vaginal fluid by Wet preparation |
|
5165-6
|
Filaria Ab [Units/volume] in Serum by Hemagglutination |
|
41417-7
|
Filaria Ab [Units/volume] in Serum by Immunoassay |
|
7887-3
|
Filaria Ab [Units/volume] in Serum |
|
25344-3
|
Filaria Ab [Titer] in Serum |
|
25409-4
|
Filaria Ab [Titer] in Serum by Immunofluorescence |
|
42928-2
|
Filaria Ag [Presence] in Serum |
|
40745-2
|
Filaria identified in Blood |
|
10662-5
|
Filaria identified in Blood by Concentration |
|
10663-3
|
Filaria identified in Blood by Thick film |
|
10664-1
|
Filaria identified in Blood by Thin film |
|
88918-8
|
Filaria DNA [Presence] in Blood by NAA with probe detection |
|
88915-4
|
Filaria DNA [Presence] in Tissue by NAA with probe detection |
|
25410-2
|
Filaria IgG Ab [Units/volume] in Serum by Immunoassay |
|
13244-9
|
Filaria IgG Ab [Units/volume] in Serum |
|
49770-1
|
Filaria IgG1 Ab [Units/volume] in Serum by Immunoassay |
|
51455-4
|
Filaria IgG1 Ab [Units/volume] in Serum |
|
49767-7
|
Filaria IgG2 Ab [Units/volume] in Serum by Immunoassay |
|
51456-2
|
Filaria IgG2 Ab [Units/volume] in Serum |
|
49768-5
|
Filaria IgG3 Ab [Units/volume] in Serum by Immunoassay |
|
51457-0
|
Filaria IgG3 Ab [Units/volume] in Serum |
|
49769-3
|
Filaria IgG4 Ab [Units/volume] in Serum by Immunoassay |
|
14208-3
|
Filaria IgG4 Ab [Units/volume] in Serum |
|
13245-6
|
Filaria IgM Ab [Units/volume] in Serum |
|
76699-8
|
Filaria identified in Skin by Light microscopy |
|
31022-7
|
Filaria identified in Unspecified specimen by Concentration |
|
31395-7
|
Filovirus Ab [Units/volume] in Serum |
|
24416-0
|
Filovirus Ab [Titer] in Serum |
|
73379-0
|
Finasteride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73378-2
|
Finasteride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60075-9
|
Finasteride [Mass/volume] in Serum or Plasma |
|
16868-2
|
Finch droppings IgE Ab [Presence] in Serum |
|
39538-4
|
Finch droppings IgG Ab [Presence] in Serum |
|
55595-3
|
Finch feather IgE Ab [Presence] in Serum |
|
13833-9
|
Finch feather IgE Ab [Units/volume] in Serum |
|
60830-7
|
Finger temperature |
|
23728-9
|
Feline infectious peritonitis virus Ab [Presence] in Serum |
|
23726-3
|
Feline infectious peritonitis virus Ab [Presence] in Serum by Immunoassay |
|
23727-1
|
Feline infectious peritonitis virus Ab [Presence] in Serum by Immunofluorescence |
|
23729-7
|
Feline infectious peritonitis virus Ag [Presence] in Tissue by Immunofluorescence |
|
31826-1
|
Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue |
|
23730-5
|
Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence |
|
7084-7
|
Fire Ant IgG Ab [Units/volume] in Serum |
|
7442-7
|
Firebush IgA Ab [Units/volume] in Serum |
|
6118-4
|
Firebush IgE Ab [Units/volume] in Serum |
|
42923-3
|
Firebush IgE Ab/IgE total in Serum |
|
56299-1
|
Firebush IgG4 Ab [Mass/volume] in Serum |
|
21271-2
|
Fireweed IgE Ab [Units/volume] in Serum |
|
87226-7
|
Legal name of patient - first and last |
|
45392-8
|
First name |
|
10930-6
|
Fish Feed IgE Ab [Units/volume] in Serum |
|
7311-4
|
Fish IgE Ab [Units/volume] in Serum |
|
62369-4
|
FISH probe name panel - Laboratory device |
|
23724-8
|
Feline immunodeficiency virus Ab [Presence] in Serum |
|
23723-0
|
Feline immunodeficiency virus Ab [Presence] in Serum by Immunoassay |
|
31388-2
|
Feline immunodeficiency virus Ab [Units/volume] in Serum |
|
43035-5
|
Feline immunodeficiency virus Ab [Titer] in Serum |
|
23725-5
|
Feline immunodeficiency virus Ab [Titer] in Serum by Immunofluorescence |
|
77116-2
|
FKBP10 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77115-4
|
FKBP10 gene full mutation analysis in Blood or Tissue by Sequencing |
|
41753-5
|
FKRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53861-1
|
FKTN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38213-5
|
FLACC pain assessment panel |
|
35468-8
|
FLAER cells [Presence] in Blood |
|
77948-8
|
FLAER cells/100 cells in Unspecified specimen |
|
84433-2
|
Flanker Inhibitory Control and Attention Test [NIH Toolbox] |
|
53648-2
|
Flavin mononucleotide [Mass/volume] in Blood |
|
79393-5
|
Flavin mononucleotide [Moles/volume] in Serum or Plasma |
|
79573-2
|
Riboflavin and flavin mononucleotide and flavin adenine dinucleotide panel - Serum or Plasma |
|
71699-3
|
Flavivirus Ag [Presence] in Unspecified specimen by Immune stain |
|
86857-0
|
Flavivirus neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
51665-8
|
Flavivirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
49114-2
|
Flavivirus rRNA [Units/volume] (viral load) in Blood by NAA with probe detection |
|
6406-3
|
Flavivirus identified in Unspecified specimen by Organism specific culture |
|
7312-2
|
Flax IgE Ab [Units/volume] in Serum |
|
56261-1
|
Flax IgG4 Ab [Mass/volume] in Serum |
|
63107-7
|
Flax IgG Ab [Mass/volume] in Serum |
|
57963-1
|
FLCN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7315-5
|
Flea triggered histamine release [Units/volume] in Blood |
|
7313-0
|
Flea IgE Ab [Units/volume] in Serum |
|
7314-8
|
Flea IgG Ab [Units/volume] in Serum |
|
56262-9
|
Flea IgG4 Ab [Mass/volume] in Serum |
|
63159-8
|
Flea IgG Ab [Mass/volume] in Serum |
|
48237-2
|
Flea triggered leukotriene release [Mass/volume] by Leukocytes |
|
29339-9
|
Flecainide [Mass/volume] in Gastric fluid |
|
35111-4
|
Flecainide [Mass/volume] in Serum or Plasma --peak |
|
13559-0
|
Flecainide [Presence] in Serum or Plasma |
|
3638-4
|
Flecainide [Mass/volume] in Serum or Plasma |
|
15105-0
|
Flecainide [Moles/volume] in Serum or Plasma |
|
35110-6
|
Flecainide [Mass/volume] in Serum or Plasma --trough |
|
29338-1
|
Flecainide [Mass/volume] in Urine |
|
18753-4
|
Flexible sigmoidoscopy study |
|
35084-3
|
Fetal lung maturity in Amniotic fluid |
|
53863-7
|
FLNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87599-7
|
Florfenicol [Mass/mass] in Unspecified specimen |
|
7318-9
|
Flounder triggered histamine release [Units/volume] in Blood |
|
7316-3
|
Flounder IgE Ab [Units/volume] in Serum |
|
61345-5
|
Flounder IgE Ab/IgE total in Serum |
|
7317-1
|
Flounder IgG Ab [Units/volume] in Serum |
|
56263-7
|
Flounder IgG4 Ab [Mass/volume] in Serum |
|
60373-8
|
Flounder IgG Ab [Mass/volume] in Serum |
|
33719-6
|
Flow cytometry study |
|
80567-1
|
Flowsheet |
|
80642-2
|
Floxacillin Free [Mass/volume] in Serum or Plasma |
|
35112-2
|
Floxacillin [Mass/volume] in Serum or Plasma |
|
89487-3
|
Fluoroquinolone [Susceptibility] by Genotype method |
|
47958-4
|
FLT3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
54447-8
|
FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method |
|
79210-1
|
FLT3 gene internal tandem duplication [Presence] in Blood or Tissue by Molecular genetics method |
|
85100-6
|
FLT3 gene internal tandem duplication [Presence] in Bone marrow by Molecular genetics method |
|
92844-0
|
FLT3 gene internal tandem duplication/Normal [Ratio] in Blood or Tissue by Molecular genetics method |
|
92843-2
|
FLT3 gene p.Asp835 mutations [Presence] in Blood or Tissue by Molecular genetics method |
|
72520-0
|
FLT3 gene p.Asp835+Ile836 [Presence] in Blood or Tissue by Molecular genetics method |
|
81233-9
|
Influenza virus types A and B and subtypes panel - Respiratory specimen |
|
72366-8
|
Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay |
|
72365-0
|
Influenza virus A and B Ag [Identifier] in Nose by Immunofluorescence |
|
80381-7
|
Influenza virus A and B Ag panel - Nasopharynx by Rapid immunoassay |
|
72356-9
|
Influenza virus A and B Ag [Identifier] in Unspecified specimen by Rapid immunoassay |
|
61102-0
|
Influenza virus A and B Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
80204-1
|
Influenza virus A and B identified in Nasopharynx by Shell vial culture |
|
90455-7
|
Influenza virus types A and B panel - Cornea or Conjunctiva by NAA with probe detection |
|
90456-5
|
Influenza virus types A and B panel - Cerebral spinal fluid by NAA with probe detection |
|
88601-0
|
Influenza virus types A and B panel - Lower respiratory specimen by NAA with probe detection |
|
90457-3
|
Influenza virus types A and B panel - Tissue by NAA with probe detection |
|
92882-0
|
Influenza virus types A and B panel - Upper respiratory specimen by NAA with probe detection |
|
49537-4
|
Influenza virus A and B RNA [Identifier] in Isolate by NAA with probe detection |
|
48509-4
|
Influenza virus A and B RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
49012-8
|
Influenza virus A and B identified in Unspecified specimen by Bioassay |
|
57896-3
|
Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method |
|
44876-1
|
Influenza virus A Ab [Presence] in Cerebral spinal fluid |
|
17012-6
|
Influenza virus A Ab [Units/volume] in Cerebral spinal fluid |
|
47443-7
|
Influenza virus A Ab [Presence] in Egg yolk |
|
39295-1
|
Influenza virus A Ab [Presence] in Egg yolk by Immune diffusion (ID) |
|
44557-7
|
Influenza virus A Ab [Presence] in Body fluid |
|
53381-0
|
Influenza virus A Ab [Identifier] in Serum |
|
39536-8
|
Influenza virus A Ab [Units/volume] in Serum by Complement fixation |
|
38273-9
|
Influenza virus A Ab [Units/volume] in Serum by Immunoassay |
|
50696-4
|
Influenza virus A Ab [Identifier] in Serum by Neutralization test |
|
22096-2
|
Influenza virus A Ab [Presence] in Serum |
|
44556-9
|
Influenza virus A Ab [Presence] in Serum by Complement fixation |
|
20862-9
|
Influenza virus A Ab [Presence] in Serum by Hemagglutination inhibition |
|
22822-1
|
Influenza virus A Ab [Presence] in Serum by Immunoassay |
|
15444-3
|
Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID) |
|
7920-2
|
Influenza virus A Ab [Units/volume] in Serum |
|
47232-4
|
Influenza virus A Ab [Presence] in Serum --1st specimen |
|
24289-1
|
Influenza virus A Ab [Titer] in Serum --1st specimen |
|
24215-6
|
Influenza virus A Ab [Titer] in Serum by Complement fixation --1st specimen |
|
47233-2
|
Influenza virus A Ab [Presence] in Serum --2nd specimen |
|
24290-9
|
Influenza virus A Ab [Titer] in Serum --2nd specimen |
|
24216-4
|
Influenza virus A Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
9531-5
|
Influenza virus A Ab [Titer] in Cerebral spinal fluid |
|
22365-1
|
Influenza virus A Ab [Titer] in Serum |
|
22823-9
|
Influenza virus A Ab [Titer] in Serum by Agglutination |
|
5229-0
|
Influenza virus A Ab [Titer] in Serum by Complement fixation |
|
22824-7
|
Influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition |
|
34153-7
|
Influenza virus A Ab [Units/volume] in Unspecified specimen |
|
90323-7
|
Influenza virus A Ab/Positive control in Serum by Immunoassay |
|
50699-8
|
Influenza virus A.adamantane resistance [Presence] |
|
50698-0
|
Influenza virus A.adamantane resistance [Presence] by Phenotype method |
|
50700-4
|
Influenza virus A.adamantane resistant RNA [Presence] by NAA with probe detection |
|
77383-8
|
Influenza virus A Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
44562-7
|
Influenza virus A Ag [Presence] in Bronchial specimen |
|
44559-3
|
Influenza virus A Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
50697-2
|
Influenza virus A Ag [Identifier] in Isolate |
|
49529-1
|
Influenza virus A Ag [Presence] in Isolate by Immunofluorescence |
|
88904-8
|
Influenza virus A Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44563-5
|
Influenza virus A Ag [Presence] in Nose |
|
44564-3
|
Influenza virus A Ag [Presence] in Nose by Immunoassay |
|
44560-1
|
Influenza virus A Ag [Presence] in Nose by Immunofluorescence |
|
43874-7
|
Influenza virus A Ag [Presence] in Nasopharynx |
|
46082-4
|
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay |
|
80382-5
|
Influenza virus A Ag [Presence] in Nasopharynx by Rapid immunoassay |
|
44558-5
|
Influenza virus A Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31858-4
|
Influenza virus A Ag [Presence] in Throat |
|
5860-2
|
Influenza virus A Ag [Presence] in Throat by Immunoassay |
|
5861-0
|
Influenza virus A Ag [Presence] in Throat by Immunofluorescence |
|
86565-9
|
Influenza virus A Ag [Presence] in Tissue by Immunofluorescence |
|
44561-9
|
Influenza virus A Ag [Presence] in Trachea by Immunofluorescence |
|
31859-2
|
Influenza virus A Ag [Presence] in Unspecified specimen |
|
5862-8
|
Influenza virus A Ag [Presence] in Unspecified specimen by Immunoassay |
|
22825-4
|
Influenza virus A Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
5863-6
|
Influenza virus A Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
6639-9
|
Influenza virus A Bangkok Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7921-0
|
Influenza virus A Bangkok Ab [Units/volume] in Serum |
|
33383-1
|
Influenza virus A Bangkok Ab [Titer] in Cerebral spinal fluid |
|
38381-0
|
Influenza virus A cDNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6635-7
|
Influenza virus A England Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7922-8
|
Influenza virus A England Ab [Units/volume] in Serum |
|
81305-5
|
Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
82168-6
|
Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
60529-5
|
Influenza virus A H1 2009 pandemic Ab [Titer] in Serum |
|
86317-5
|
Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
55466-7
|
Influenza virus A H1 2009 pandemic RNA panel - Unspecified specimen by NAA with probe detection |
|
55465-9
|
Influenza virus A H1 2009 pandemic RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47444-5
|
Influenza virus A H1 Ab [Titer] in Serum |
|
39296-9
|
Influenza virus A H1 Ab [Titer] in Serum by Hemagglutination inhibition |
|
50701-2
|
Influenza virus A H1 Ag [Presence] in Isolate by Immunofluorescence |
|
85802-7
|
Influenza virus A H1 Ag [Titer] in Isolate by Hemagglutination inhibition |
|
80589-5
|
Influenza virus A H1 HA gene [Presence] in Nasopharynx by NAA with probe detection |
|
57895-5
|
Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method |
|
74038-1
|
Influenza virus A H1 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49520-0
|
Influenza virus A H1 RNA [Presence] in Isolate by NAA with probe detection |
|
82167-8
|
Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
49521-8
|
Influenza virus A H1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
60538-6
|
Influenza virus A H1+H3+B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47445-2
|
Influenza virus A H10 Ab [Titer] in Serum |
|
39297-7
|
Influenza virus A H10 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47446-0
|
Influenza virus A H11 Ab [Titer] in Serum |
|
39298-5
|
Influenza virus A H11 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47447-8
|
Influenza virus A H12 Ab [Titer] in Serum |
|
39299-3
|
Influenza virus A H12 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47448-6
|
Influenza virus A H13 Ab [Titer] in Serum |
|
39300-9
|
Influenza virus A H13 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47449-4
|
Influenza virus A H14 Ab [Titer] in Serum |
|
39301-7
|
Influenza virus A H14 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47450-2
|
Influenza virus A H15 Ab [Titer] in Serum |
|
39302-5
|
Influenza virus A H15 Ab [Titer] in Serum by Hemagglutination inhibition |
|
51460-4
|
Influenza virus A H16 Ab [Titer] in Serum |
|
49519-2
|
Influenza virus A H16 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47451-0
|
Influenza virus A H2 Ab [Titer] in Serum |
|
39303-3
|
Influenza virus A H2 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47452-8
|
Influenza virus A H3 Ab [Titer] in Serum |
|
39304-1
|
Influenza virus A H3 Ab [Titer] in Serum by Hemagglutination inhibition |
|
49522-6
|
Influenza virus A H3 Ag [Presence] in Isolate by Immunofluorescence |
|
85803-5
|
Influenza virus A H3 Ag [Titer] in Isolate by Hemagglutination inhibition |
|
74039-9
|
Influenza virus A H3 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49523-4
|
Influenza virus A H3 RNA [Presence] in Isolate by NAA with probe detection |
|
82169-4
|
Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
49524-2
|
Influenza virus A H3 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47453-6
|
Influenza virus A H4 Ab [Titer] in Serum |
|
39305-8
|
Influenza virus A H4 Ab [Titer] in Serum by Hemagglutination inhibition |
|
49525-9
|
Influenza virus A H5 Ab [Presence] in Serum |
|
47454-4
|
Influenza virus A H5 Ab [Titer] in Serum |
|
39306-6
|
Influenza virus A H5 Ab [Titer] in Serum by Hemagglutination inhibition |
|
85804-3
|
Influenza virus A H5 Ag [Titer] in Isolate by Hemagglutination inhibition |
|
81320-4
|
Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory specimen by Nucleic acid amplification using primer-probe set H5a |
|
81321-2
|
Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory specimen by Nucleic acid amplification using primer-probe set H5b |
|
44795-3
|
Influenza virus A H5 Asian RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77605-4
|
Influenza virus A H5 icA RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49526-7
|
Influenza virus A H5 RNA [Presence] in Isolate by NAA with probe detection |
|
44264-0
|
Influenza virus A H5 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
38272-1
|
Influenza virus A H5 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47455-1
|
Influenza virus A H6 Ab [Titer] in Serum |
|
39307-4
|
Influenza virus A H6 Ab [Titer] in Serum by Hemagglutination inhibition |
|
44265-7
|
Influenza virus A H6 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
38271-3
|
Influenza virus A H6 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47456-9
|
Influenza virus A H7 Ab [Titer] in Serum |
|
39308-2
|
Influenza virus A H7 Ab [Titer] in Serum by Hemagglutination inhibition |
|
85805-0
|
Influenza virus A H7 Ag [Titer] in Isolate by Hemagglutination inhibition |
|
81307-1
|
Influenza virus A H7 Eurasia RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
81428-5
|
Influenza virus A H7 Eurasia RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
49527-5
|
Influenza virus A H7 RNA [Presence] in Isolate by NAA with probe detection |
|
44266-5
|
Influenza virus A H7 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
38270-5
|
Influenza virus A H7 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47457-7
|
Influenza virus A H8 Ab [Titer] in Serum |
|
39309-0
|
Influenza virus A H8 Ab [Titer] in Serum by Hemagglutination inhibition |
|
47458-5
|
Influenza virus A H9 Ab [Titer] in Serum |
|
39310-8
|
Influenza virus A H9 Ab [Titer] in Serum by Hemagglutination inhibition |
|
60530-3
|
Influenza virus A H9 RNA [Presence] in Isolate by NAA with probe detection |
|
49528-3
|
Influenza virus A H9 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55133-3
|
Influenza virus A hemagglutinin cDNA [Identifier] in Isolate by NAA with probe detection |
|
39102-9
|
Influenza virus A hemagglutinin cDNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
39025-2
|
Influenza virus A hemagglutinin cDNA [Identifier] in Unspecified specimen by Sequencing |
|
87715-9
|
Influenza virus A HA gene [Nucleotide sequence] in Isolate by Sequencing |
|
59424-2
|
Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by NAA with probe detection |
|
49532-5
|
Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by Sequencing |
|
59423-4
|
Influenza virus A hemagglutinin type RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
72767-7
|
Influenza virus A hemagglutinin segment sequence identifier |
|
6634-0
|
Influenza virus A Hong Kong Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7923-6
|
Influenza virus A Hong Kong Ab [Units/volume] in Serum |
|
49074-8
|
Influenza virus A IgA Ab [Mass/volume] in Cerebral spinal fluid |
|
72266-0
|
Influenza virus A IgA Ab [Units/volume] in Serum by Immunoassay |
|
43851-5
|
Influenza virus A IgA Ab [Presence] in Serum |
|
49073-0
|
Influenza virus A IgG Ab [Mass/volume] in Cerebral spinal fluid |
|
47313-2
|
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay |
|
43837-4
|
Influenza virus A IgG Ab [Presence] in Serum |
|
86566-7
|
Influenza virus A IgG Ab [Presence] in Serum by Immunoassay |
|
31437-7
|
Influenza virus A IgG Ab [Units/volume] in Serum |
|
57324-6
|
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57325-3
|
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
9532-3
|
Influenza virus A IgG Ab [Titer] in Serum |
|
49075-5
|
Influenza virus A IgM Ab [Mass/volume] in Cerebral spinal fluid |
|
47312-4
|
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay |
|
43838-2
|
Influenza virus A IgM Ab [Presence] in Serum |
|
86567-5
|
Influenza virus A IgM Ab [Presence] in Serum by Immunoassay |
|
31438-5
|
Influenza virus A IgM Ab [Units/volume] in Serum |
|
57326-1
|
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57327-9
|
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
9533-1
|
Influenza virus A IgM Ab [Titer] in Serum |
|
6642-3
|
Influenza virus A Leningrad Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7924-4
|
Influenza virus A Leningrad Ab [Units/volume] in Serum |
|
87714-2
|
Influenza virus A M gene [Nucleotide sequence] in Isolate by Sequencing |
|
80588-7
|
Influenza virus A M gene [Presence] in Nasopharynx by NAA with probe detection |
|
6641-5
|
Influenza virus A Mississippi Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7925-1
|
Influenza virus A Mississippi Ab [Units/volume] in Serum |
|
50702-0
|
Influenza virus A matrix protein RNA [Presence] in Isolate by Sequencing |
|
72201-7
|
Influenza virus A matrix protein segment sequence identifier |
|
41142-1
|
Influenza virus A N1 Ab [Presence] in Serum |
|
39311-6
|
Influenza virus A N1 Ab [Presence] in Serum by Neutralization test |
|
56024-3
|
Influenza virus A N1 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
41141-3
|
Influenza virus A N2 Ab [Presence] in Serum |
|
39312-4
|
Influenza virus A N2 Ab [Presence] in Serum by Neutralization test |
|
74040-7
|
Influenza virus A N2 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
41140-5
|
Influenza virus A N3 Ab [Presence] in Serum |
|
39313-2
|
Influenza virus A N3 Ab [Presence] in Serum by Neutralization test |
|
41139-7
|
Influenza virus A N4 Ab [Presence] in Serum |
|
39314-0
|
Influenza virus A N4 Ab [Presence] in Serum by Neutralization test |
|
41138-9
|
Influenza virus A N5 Ab [Presence] in Serum |
|
39315-7
|
Influenza virus A N5 Ab [Presence] in Serum by Neutralization test |
|
41137-1
|
Influenza virus A N6 Ab [Presence] in Serum |
|
39316-5
|
Influenza virus A N6 Ab [Presence] in Serum by Neutralization test |
|
41136-3
|
Influenza virus A N7 Ab [Presence] in Serum |
|
39317-3
|
Influenza virus A N7 Ab [Presence] in Serum by Neutralization test |
|
41135-5
|
Influenza virus A N8 Ab [Presence] in Serum |
|
39318-1
|
Influenza virus A N8 Ab [Presence] in Serum by Neutralization test |
|
41134-8
|
Influenza virus A N9 Ab [Presence] in Serum |
|
39319-9
|
Influenza virus A N9 Ab [Presence] in Serum by Neutralization test |
|
39103-7
|
Influenza virus A neuraminidase cDNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
87716-7
|
Influenza virus A NA gene [Nucleotide sequence] in Isolate by Sequencing |
|
55134-1
|
Influenza virus A neuraminidase RNA [Identifier] in Isolate by NAA with probe detection |
|
61101-2
|
Influenza virus A neuraminidase RNA [Type] in Unspecified specimen by Sequencing |
|
72200-9
|
Influenza virus A neuraminidase segment sequence identifier |
|
50703-8
|
Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative by Phenotype method |
|
93762-3
|
Influenza virus A NP gene [Nucleotide sequence] in Isolate by Sequencing |
|
50704-6
|
Influenza virus A nucleoprotein RNA [Presence] in Isolate by Sequencing |
|
50705-3
|
Influenza virus A non-structural protein RNA [Presence] in Isolate by Sequencing |
|
93763-1
|
Influenza virus A NS1 gene [Nucleotide sequence] in Isolate by Sequencing |
|
93761-5
|
Influenza virus A PA gene [Nucleotide sequence] in Isolate by Sequencing |
|
50706-1
|
Influenza virus A polymerase A RNA [Presence] in Isolate by Sequencing |
|
50707-9
|
Influenza virus A polymerase B1 cDNA [Presence] in Isolate by Sequencing |
|
93760-7
|
Influenza virus A PB1 gene [Nucleotide sequence] in Isolate by Sequencing |
|
93759-9
|
Influenza virus A PB2 gene [Nucleotide sequence] in Isolate by Sequencing |
|
50708-7
|
Influenza virus A polymerase B2 RNA [Presence] in Isolate by Sequencing |
|
6640-7
|
Influenza virus A Phillipines Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7926-9
|
Influenza virus A Phillipines Ab [Units/volume] in Serum |
|
50711-1
|
Influenza virus A polymerase RNA [Identifier] in Isolate by Sequencing |
|
6636-5
|
Influenza virus A Port Chalmers Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7927-7
|
Influenza virus A Port Chalmers Ab [Units/volume] in Serum |
|
53250-7
|
Influenza virus A RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
76077-7
|
Influenza virus A RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
88193-8
|
Influenza virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
86568-3
|
Influenza virus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81308-9
|
Influenza virus A RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
49531-7
|
Influenza virus A RNA [Presence] in Isolate by NAA with probe detection |
|
92977-8
|
Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88599-6
|
Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82166-0
|
Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76078-5
|
Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection |
|
88600-2
|
Influenza virus A RNA [Presence] in Pericardial fluid by NAA with probe detection |
|
92142-9
|
Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
86569-1
|
Influenza virus A RNA [Presence] in Tissue by NAA with probe detection |
|
85477-8
|
Influenza virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
44263-2
|
Influenza virus A RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
34487-9
|
Influenza virus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88187-0
|
Influenza virus A subtype [Identifier] in Cornea or Conjunctiva by NAA with probe detection |
|
91771-6
|
Influenza virus A subtype [Identifier] in Upper respiratory specimen by NAA with probe detection |
|
22828-8
|
Influenza virus A subtype [Identifier] in Unspecified specimen by Immune diffusion (ID) |
|
22827-0
|
Influenza virus A subtype [Identifier] in Unspecified specimen by NAA with probe detection |
|
88835-4
|
Influenza virus A swine origin RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
55463-4
|
Influenza virus A swine origin RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
55464-2
|
Influenza virus A swine origin RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6638-1
|
Influenza virus A Texas Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7928-5
|
Influenza virus A Texas Ab [Units/volume] in Serum |
|
6637-3
|
Influenza virus A Victoria Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
7929-3
|
Influenza virus A Victoria Ab [Units/volume] in Serum |
|
22826-2
|
Influenza virus A identified in Unspecified specimen by Bioassay |
|
48310-7
|
Influenza virus A [Presence] in Unspecified specimen by Organism specific culture |
|
45279-7
|
Influenza virus A+B Ab [Presence] in Body fluid |
|
17013-4
|
Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence |
|
44565-0
|
Influenza virus A+B Ab [Presence] in Serum |
|
7930-1
|
Influenza virus A+B Ab [Units/volume] in Serum |
|
22366-9
|
Influenza virus A+B Ab [Titer] in Serum |
|
50693-1
|
Influenza virus A+B Ab [Titer] in Serum by Complement fixation |
|
6434-5
|
Influenza virus A+B Ab [Titer] in Serum by Immunofluorescence |
|
44566-8
|
Influenza virus A+B Ag [Presence] in Bronchial specimen |
|
44567-6
|
Influenza virus A+B Ag [Presence] in Nose |
|
72367-6
|
Influenza virus A+B Ag [Presence] in Nose by Rapid immunoassay |
|
33535-6
|
Influenza virus A+B Ag [Presence] in Nasopharynx |
|
31860-0
|
Influenza virus A+B Ag [Presence] in Throat |
|
6435-2
|
Influenza virus A+B Ag [Presence] in Throat by Immunoassay |
|
6436-0
|
Influenza virus A+B Ag [Presence] in Throat by Immunofluorescence |
|
24015-0
|
Influenza virus A+B Ag [Presence] in Unspecified specimen |
|
6437-8
|
Influenza virus A+B Ag [Presence] in Unspecified specimen by Immunoassay |
|
6438-6
|
Influenza virus A+B Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
57897-1
|
Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method |
|
62462-7
|
Influenza virus A+B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31861-8
|
Influenza virus A+B+C Ag [Presence] in Throat |
|
6439-4
|
Influenza virus A+B+C Ag [Presence] in Throat by Immunoassay |
|
6440-2
|
Influenza virus A+B+C Ag [Presence] in Throat by Immunofluorescence |
|
31862-6
|
Influenza virus A+B+C Ag [Presence] in Unspecified specimen |
|
6441-0
|
Influenza virus A+B+C Ag [Presence] in Unspecified specimen by Immunoassay |
|
6442-8
|
Influenza virus A+B+C Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
82461-5
|
Influenza virus A and B and H1 2009 pandemic RNA [Identifier] in Upper respiratory specimen by NAA with probe detection |
|
85476-0
|
Influenza virus A and B and Respiratory syncytial virus RNA panel - Upper respiratory specimen by NAA with probe detection |
|
17014-2
|
Influenza virus B Ab [Units/volume] in Cerebral spinal fluid |
|
44569-2
|
Influenza virus B Ab [Presence] in Body fluid |
|
52974-3
|
Influenza virus B Ab [Units/volume] in Serum by Complement fixation |
|
39537-6
|
Influenza virus B Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
44570-0
|
Influenza virus B Ab [Presence] in Serum |
|
44568-4
|
Influenza virus B Ab [Presence] in Serum by Complement fixation |
|
49533-3
|
Influenza virus B Ab [Presence] in Serum by Immunoassay |
|
7931-9
|
Influenza virus B Ab [Units/volume] in Serum |
|
24291-7
|
Influenza virus B Ab [Titer] in Serum --1st specimen |
|
24217-2
|
Influenza virus B Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24292-5
|
Influenza virus B Ab [Titer] in Serum --2nd specimen |
|
24218-0
|
Influenza virus B Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
9534-9
|
Influenza virus B Ab [Titer] in Cerebral spinal fluid |
|
22367-7
|
Influenza virus B Ab [Titer] in Serum |
|
5230-8
|
Influenza virus B Ab [Titer] in Serum by Complement fixation |
|
50709-5
|
Influenza virus B Ab [Titer] in Serum by Hemagglutination inhibition |
|
34154-5
|
Influenza virus B Ab [Units/volume] in Unspecified specimen |
|
77384-6
|
Influenza virus B Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
44576-7
|
Influenza virus B Ag [Presence] in Bronchial specimen |
|
44572-6
|
Influenza virus B Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
54241-5
|
Influenza virus B Ag [Presence] in Isolate |
|
49534-1
|
Influenza virus B Ag [Presence] in Isolate by Immunofluorescence |
|
88905-5
|
Influenza virus B Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44577-5
|
Influenza virus B Ag [Presence] in Nose |
|
44575-9
|
Influenza virus B Ag [Presence] in Nose by Immunoassay |
|
44573-4
|
Influenza virus B Ag [Presence] in Nose by Immunofluorescence |
|
43895-2
|
Influenza virus B Ag [Presence] in Nasopharynx |
|
46083-2
|
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay |
|
80383-3
|
Influenza virus B Ag [Presence] in Nasopharynx by Rapid immunoassay |
|
44571-8
|
Influenza virus B Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31863-4
|
Influenza virus B Ag [Presence] in Throat |
|
5864-4
|
Influenza virus B Ag [Presence] in Throat by Immunoassay |
|
5865-1
|
Influenza virus B Ag [Presence] in Throat by Immunofluorescence |
|
88194-6
|
Influenza virus B Ag [Presence] in Tissue by Immunofluorescence |
|
44574-2
|
Influenza virus B Ag [Presence] in Trachea by Immunofluorescence |
|
31864-2
|
Influenza virus B Ag [Presence] in Unspecified specimen |
|
5866-9
|
Influenza virus B Ag [Presence] in Unspecified specimen by Immunoassay |
|
5867-7
|
Influenza virus B Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
49076-3
|
Influenza virus B IgA Ab [Mass/volume] in Cerebral spinal fluid |
|
72265-2
|
Influenza virus B IgA Ab [Units/volume] in Serum by Immunoassay |
|
43852-3
|
Influenza virus B IgA Ab [Presence] in Serum |
|
49077-1
|
Influenza virus B IgG Ab [Mass/volume] in Cerebral spinal fluid |
|
47314-0
|
Influenza virus B IgG Ab [Units/volume] in Serum by Immunoassay |
|
43839-0
|
Influenza virus B IgG Ab [Presence] in Serum |
|
88903-0
|
Influenza virus B IgG Ab [Presence] in Serum by Immunoassay |
|
17015-9
|
Influenza virus B IgG Ab [Units/volume] in Serum |
|
9535-6
|
Influenza virus B IgG Ab [Titer] in Serum |
|
49078-9
|
Influenza virus B IgM Ab [Mass/volume] in Cerebral spinal fluid |
|
47315-7
|
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay |
|
43840-8
|
Influenza virus B IgM Ab [Presence] in Serum |
|
86570-9
|
Influenza virus B IgM Ab [Presence] in Serum by Immunoassay |
|
17016-7
|
Influenza virus B IgM Ab [Units/volume] in Serum |
|
57328-7
|
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57329-5
|
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
9536-4
|
Influenza virus B IgM Ab [Titer] in Serum |
|
74784-0
|
Influenza virus B lineage RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
53251-5
|
Influenza virus B RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
76079-3
|
Influenza virus B RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
88195-3
|
Influenza virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
86571-7
|
Influenza virus B RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
81309-7
|
Influenza virus B RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
90886-3
|
Influenza virus B RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49535-8
|
Influenza virus B RNA [Presence] in Isolate by NAA with probe detection |
|
49536-6
|
Influenza virus B RNA [Identifier] in Isolate by Sequencing |
|
92976-0
|
Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88592-1
|
Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82170-2
|
Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76080-1
|
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection |
|
88596-2
|
Influenza virus B RNA [Presence] in Pericardial fluid by NAA with probe detection |
|
92141-1
|
Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
86572-5
|
Influenza virus B RNA [Presence] in Tissue by NAA with probe detection |
|
85478-6
|
Influenza virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
40982-1
|
Influenza virus B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
74787-3
|
Influenza virus B Victoria and Yamagata lineage RNA panel - Unspecified specimen |
|
81327-9
|
Influenza virus B Victoria lineage RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
74785-7
|
Influenza virus B Victoria lineage RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
38382-8
|
Influenza virus B [Presence] in Unspecified specimen by Organism specific culture |
|
85801-9
|
Influenza virus B Yamagata lineage Ag [Titer] in Isolate by Hemagglutination inhibition |
|
81325-3
|
Influenza virus B Yamagata lineage RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
74786-5
|
Influenza virus B Yamagata lineage RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
73020-0
|
Fluconazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73019-2
|
Fluconazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80530-9
|
Fluconazole [Mass/volume] in DBS |
|
73376-6
|
Fluconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73377-4
|
Fluconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
10987-6
|
Fluconazole [Mass/volume] in Serum or Plasma |
|
16870-8
|
Fluconazole [Mass/volume] in Urine |
|
25255-1
|
Fluconazole [Mass/volume] in Unspecified specimen |
|
44579-1
|
Influenza virus C Ab [Presence] in Serum |
|
44578-3
|
Influenza virus C Ab [Presence] in Serum by Complement fixation |
|
7932-7
|
Influenza virus C Ab [Units/volume] in Serum |
|
22368-5
|
Influenza virus C Ab [Titer] in Serum |
|
5231-6
|
Influenza virus C Ab [Titer] in Serum by Complement fixation |
|
31865-9
|
Influenza virus C Ag [Presence] in Unspecified specimen |
|
29721-8
|
Influenza virus C Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
60267-2
|
Influenza virus C RNA [Presence] in Isolate by NAA with probe detection |
|
62860-2
|
Influenza virus C RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41754-3
|
Fludrocortisone [Mass/volume] in Serum or Plasma |
|
46949-4
|
Fludrocortisone [Mass/volume] in Urine |
|
90885-5
|
Influenza virus D RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
80444-3
|
Fluid intake panel |
|
75301-2
|
Fluid intake 24 hour Estimated |
|
81951-6
|
Fluid intake 24 hour Measured |
|
34536-3
|
Fluid intake and output panel 24 hour |
|
34537-1
|
Fluid intake and output panel 8 hour |
|
61148-3
|
Fluid management note |
|
75291-5
|
Fluid need 24 hour Estimated |
|
41755-0
|
Flunisolide [Mass/volume] in Serum or Plasma |
|
46950-2
|
Flunisolide [Mass/volume] in Urine |
|
3640-0
|
Flunitrazepam [Mass/volume] in Blood |
|
61078-2
|
Flunitrazepam [Presence] in Gastric fluid |
|
87812-4
|
Flunitrazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
50966-1
|
Flunitrazepam [Presence] in Serum, Plasma or Blood |
|
73828-6
|
Flunitrazepam [Mass/volume] in Serum, Plasma or Blood |
|
23864-2
|
Flunitrazepam [Mass/volume] in Serum or Plasma |
|
25412-8
|
Flunitrazepam [Moles/volume] in Serum or Plasma |
|
20528-6
|
Flunitrazepam [Mass/volume] in Urine by Confirmatory method |
|
41020-9
|
Flunitrazepam [Presence] in Urine |
|
19467-0
|
Flunitrazepam [Presence] in Urine by Confirmatory method |
|
19466-2
|
Flunitrazepam [Presence] in Urine by Screen method |
|
3641-8
|
Flunitrazepam [Mass/volume] in Urine |
|
61079-0
|
Flunitrazepam [Presence] in Unspecified specimen |
|
55155-6
|
Flunitrazepam and 7-Aminoflunitrazepam panel [Mass/volume] - Urine |
|
5651-5
|
Fluoride [Mass/time] in 24 hour Urine |
|
25912-7
|
Fluoride [Moles/volume] in 24 hour Urine |
|
25413-6
|
Fluoride [Moles/time] in 24 hour Urine |
|
5648-1
|
Fluoride [Mass/volume] in Blood |
|
25172-8
|
Fluoride [Moles/volume] in Blood |
|
16871-6
|
Fluoride [Units/volume] in Bone |
|
12601-1
|
Fluoride [Mass/volume] in Dialysis fluid |
|
5649-9
|
Fluoride [Mass/volume] in Serum or Plasma |
|
14726-4
|
Fluoride [Moles/volume] in Serum or Plasma |
|
5650-7
|
Fluoride [Mass/volume] in Urine |
|
34304-6
|
Fluoride [Moles/volume] in Urine |
|
9471-4
|
Fluoride [Mass/volume] in Water |
|
25913-5
|
Fluoride/Creatinine [Molar ratio] in 24 hour Urine |
|
13475-9
|
Fluoride/Creatinine [Mass Ratio] in Urine |
|
56656-2
|
Fluoride/Creatinine [Ratio] in Urine |
|
50850-7
|
Fluoride/Creatinine [Molar ratio] in Urine |
|
16872-4
|
Fluorocarbons [Identifier] in Serum or Plasma |
|
41756-8
|
Fluorometholone [Mass/volume] in Serum or Plasma |
|
46951-0
|
Fluorometholone [Mass/volume] in Urine |
|
3642-6
|
Fluorouracil [Mass/volume] in Serum or Plasma |
|
78437-1
|
FLUoxetine trough, FLUoxetine+norfluoxetine trough and Norfluoxetine panel - Serum or Plasma |
|
29219-3
|
FLUoxetine [Mass/volume] in Body fluid |
|
14727-2
|
FLUoxetine [Presence] in Gastric fluid |
|
59903-5
|
FLUoxetine [Moles/volume] in Gastric fluid |
|
73375-8
|
FLUoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73374-1
|
FLUoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3643-4
|
FLUoxetine [Presence] in Serum or Plasma |
|
35610-5
|
FLUoxetine [Mass/volume] in Serum or Plasma by Screen method |
|
3644-2
|
FLUoxetine [Mass/volume] in Serum or Plasma |
|
14728-0
|
FLUoxetine [Moles/volume] in Serum or Plasma |
|
74982-0
|
FLUoxetine [Mass/volume] in Serum or Plasma --trough |
|
20529-4
|
FLUoxetine [Mass/volume] in Urine by Confirmatory method |
|
3645-9
|
FLUoxetine [Presence] in Urine |
|
19471-2
|
FLUoxetine [Presence] in Urine by Confirmatory method |
|
19470-4
|
FLUoxetine [Presence] in Urine by Screen method |
|
12439-6
|
FLUoxetine [Mass/volume] in Urine |
|
59902-7
|
FLUoxetine [Moles/volume] in Urine |
|
32072-1
|
FLUoxetine [Presence] in Unspecified specimen |
|
60304-3
|
FLUoxetine [Moles/volume] in Unspecified specimen |
|
72813-9
|
FLUoxetine/Creatinine [Mass Ratio] in Urine |
|
43117-1
|
FLUoxetine and Norfluoxetine panel [Mass/volume] - Serum or Plasma |
|
10339-0
|
FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
|
74948-1
|
FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma --trough |
|
23865-9
|
FLUoxetine+Norfluoxetine [Presence] in Urine |
|
3648-3
|
Fluoxymesterone [Mass/time] in 24 hour Urine |
|
3646-7
|
Fluoxymesterone [Presence] in Urine |
|
3647-5
|
Fluoxymesterone [Mass/volume] in Urine |
|
34305-3
|
Flupenthixol [Mass/volume] in Serum or Plasma |
|
55538-3
|
Flupenthixol [Moles/volume] in Serum or Plasma |
|
3649-1
|
Flupenthixol [Mass/volume] in Urine |
|
75766-6
|
fluPHENAZine [Presence] in Blood or Urine by Screen method |
|
59905-0
|
fluPHENAZine [Moles/volume] in Gastric fluid |
|
38899-1
|
fluPHENAZine [Presence] in Serum or Plasma |
|
3650-9
|
fluPHENAZine [Mass/volume] in Serum or Plasma |
|
39477-5
|
fluPHENAZine [Moles/volume] in Serum or Plasma |
|
74934-1
|
fluPHENAZine [Mass/volume] in Serum or Plasma --trough |
|
14070-7
|
fluPHENAZine [Presence] in Urine |
|
3651-7
|
fluPHENAZine [Mass/volume] in Urine |
|
59904-3
|
fluPHENAZine [Moles/volume] in Urine |
|
60305-0
|
fluPHENAZine [Moles/volume] in Unspecified specimen |
|
59675-9
|
Flurazepam [Mass/volume] in Blood by Confirmatory method |
|
59674-2
|
Flurazepam [Mass/volume] in Blood |
|
59677-5
|
Flurazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59676-7
|
Flurazepam [Mass/volume] in Body fluid |
|
52963-6
|
Flurazepam [Presence] in Gastric fluid |
|
26774-0
|
Flurazepam [Mass/mass] in Hair |
|
26979-5
|
Flurazepam [Mass/mass] in Meconium |
|
87813-2
|
Flurazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
46979-1
|
Flurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3652-5
|
Flurazepam [Presence] in Serum or Plasma |
|
35611-3
|
Flurazepam [Mass/volume] in Serum or Plasma by Screen method |
|
3653-3
|
Flurazepam [Mass/volume] in Serum or Plasma |
|
14729-8
|
Flurazepam [Moles/volume] in Serum or Plasma |
|
12605-2
|
Flurazepam [Presence] in Stool |
|
27287-2
|
Flurazepam [Mass/mass] in Stool |
|
59679-1
|
Flurazepam [Mass/mass] in Tissue by Confirmatory method |
|
59678-3
|
Flurazepam [Mass/mass] in Tissue |
|
82916-8
|
Flurazepam [Mass/volume] in Serum or Plasma --trough |
|
16231-3
|
Flurazepam [Mass/volume] in Urine by Confirmatory method |
|
3654-1
|
Flurazepam [Presence] in Urine |
|
19475-3
|
Flurazepam [Presence] in Urine by Confirmatory method |
|
19474-6
|
Flurazepam [Presence] in Urine by Screen method |
|
3655-8
|
Flurazepam [Mass/volume] in Urine |
|
26901-9
|
Flurazepam [Mass/volume] in Vitreous fluid |
|
61080-8
|
Flurazepam [Presence] in Unspecified specimen |
|
48950-0
|
Flurazepam [Mass/volume] in Unspecified specimen |
|
77324-2
|
Flurazepam [Moles/volume] in Unspecified specimen |
|
73826-0
|
Flurazepam+N-desalkylflurazepam [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
14730-6
|
Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
|
12428-9
|
Flurbiprofen [Mass/volume] in Serum or Plasma |
|
55539-1
|
Flurbiprofen [Moles/volume] in Serum or Plasma |
|
79445-3
|
Fluspirilene [Mass/volume] in Serum or Plasma |
|
41757-6
|
Fluticasone propionate [Mass/volume] in Serum or Plasma |
|
46952-8
|
Fluticasone propionate [Mass/volume] in Urine |
|
18233-7
|
Influenza virus Ab [Units/volume] in Cerebral spinal fluid |
|
49518-4
|
Influenza virus Ab [Titer] in Serum |
|
54240-7
|
Influenza virus Ag [Presence] in Unspecified specimen |
|
88200-1
|
Influenza virus identified in Cornea or Conjunctiva by Organism specific culture |
|
54242-3
|
Influenza virus identified in Isolate |
|
88568-1
|
Influenza virus identified in Lower respiratory specimen by Organism specific culture |
|
50713-7
|
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype method |
|
50712-9
|
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] Qualitative |
|
54243-1
|
Influenza virus RNA [Identifier] in Unspecified specimen by Probe |
|
6601-9
|
Influenza virus identified in Sputum by Organism specific culture |
|
6602-7
|
Influenza virus identified in Sputum tracheal aspirate by Organism specific culture |
|
50710-3
|
Influenza virus susceptibility panel |
|
6603-5
|
Influenza virus identified in Throat by Organism specific culture |
|
91772-4
|
Influenza virus identified in Upper respiratory specimen by Organism specific culture |
|
54244-9
|
Influenza virus identified in Unspecified specimen |
|
6604-3
|
Influenza virus identified in Unspecified specimen by Organism specific culture |
|
49538-2
|
Influenza virus identified in Unspecified specimen by Shell vial culture |
|
73372-5
|
Fluvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73373-3
|
Fluvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59907-6
|
fluvoxaMINE [Moles/volume] in Gastric fluid |
|
13560-8
|
fluvoxaMINE [Presence] in Serum or Plasma |
|
35612-1
|
fluvoxaMINE [Mass/volume] in Serum or Plasma by Screen method |
|
10988-4
|
fluvoxaMINE [Mass/volume] in Serum or Plasma |
|
32073-9
|
fluvoxaMINE [Moles/volume] in Serum or Plasma |
|
89990-6
|
fluvoxaMINE [Mass/volume] in Urine by Confirmatory method |
|
32074-7
|
fluvoxaMINE [Presence] in Urine |
|
59906-8
|
fluvoxaMINE [Moles/volume] in Urine |
|
32075-4
|
fluvoxaMINE [Presence] in Unspecified specimen |
|
60306-8
|
fluvoxaMINE [Moles/volume] in Unspecified specimen |
|
23105-0
|
Fly larvae identified in Unspecified specimen |
|
23106-8
|
Foot and mouth disease virus Ab [Presence] in Serum |
|
23108-4
|
Foot and mouth disease virus Ab [Presence] in Serum by Immunoassay |
|
23109-2
|
Foot and mouth disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23107-6
|
Foot and mouth disease virus Ab [Presence] in Serum by Neutralization test |
|
31827-9
|
Foot and mouth disease virus Ag [Presence] in Throat |
|
23113-4
|
Foot and mouth disease virus Ag [Presence] in Throat by Complement fixation |
|
23111-8
|
Foot and mouth disease virus Ag [Presence] in Throat by Immunoassay |
|
23112-6
|
Foot and mouth disease virus Ag [Presence] in Tissue by Complement fixation |
|
23110-0
|
Foot and mouth disease virus Ag [Presence] in Tissue by Immunoassay |
|
23114-2
|
Foot and mouth disease virus RNA [Presence] in Tissue by Probe |
|
56023-5
|
Foot and mouth disease virus RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
23117-5
|
Foot and mouth disease virus serotype [Identifier] in Serum by Immunoassay |
|
23118-3
|
Foot and mouth disease virus serotype [Identifier] in Serum by Neutralization test |
|
23119-1
|
Foot and mouth disease virus serotype [Identifier] in Tissue by Complement fixation |
|
23116-7
|
Foot and mouth disease virus serotype [Identifier] in Tissue by Immunoassay |
|
23121-7
|
Foot and mouth disease virus serotype [Identifier] in Tissue by NAA with probe detection |
|
23115-9
|
Foot and mouth disease virus serotype [Identifier] in Unspecified specimen by Complement fixation |
|
23120-9
|
Foot and mouth disease virus serotype [Identifier] in Unspecified specimen by Immunoassay |
|
58748-5
|
Functional MR Brain |
|
80583-8
|
Functional MR Brain for motor function |
|
45322-5
|
FMR1 gene allele 2 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
45321-7
|
FMR1 gene allele 1 CGG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
81856-7
|
FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method |
|
21759-6
|
FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
45327-4
|
FMR1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
|
36913-2
|
FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41107-4
|
FMR1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
66875-6
|
FMR1 gene methylation/methylated+unmethylated in Blood by Molecular genetics method |
|
64081-3
|
FMRP cells/100 lymphocytes in Blood by Immune stain |
|
79574-0
|
Folate and tryptophan and metabolites pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
79572-4
|
Folate and tryptophan and metabolites panel - Cerebral spinal fluid |
|
27088-4
|
Folate [Presence] in Blood |
|
2282-2
|
Folate [Mass/volume] in Blood |
|
25415-1
|
Folate [Moles/volume] in Blood |
|
55859-3
|
Folate [Mass/volume] in Cerebral spinal fluid |
|
2283-0
|
Folate [Mass/volume] in Red Blood Cells |
|
14731-4
|
Folate [Moles/volume] in Red Blood Cells |
|
2284-8
|
Folate [Mass/volume] in Serum or Plasma |
|
35210-4
|
Folate [Mass or Moles/volume] in Serum or Plasma |
|
14732-2
|
Folate [Moles/volume] in Serum or Plasma |
|
42704-7
|
Follicle Diameter baseline US |
|
89083-0
|
Follow-up visit item set [ADAPTABLE] |
|
74217-1
|
Fondaparinux [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
74216-3
|
Fondaparinux [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
49060-7
|
Fondaparinux [Mass/volume] in Serum or Plasma |
|
31172-0
|
Fonofos [Mass/volume] in Blood |
|
35486-0
|
Fonofos [Mass/volume] in Serum or Plasma |
|
21280-3
|
Fonofos [Mass/volume] in Urine |
|
87662-3
|
Fonofos [Mass/mass] in Unspecified specimen |
|
82547-1
|
Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Presence] in Serum by Multidisk |
|
82549-7
|
Food Allergen Mix 30A (Kiwi+Papaya+Mango+Banana+Avocado) IgE Ab [Units/volume] in Serum by Multidisk |
|
71374-3
|
Food Allergen Mix 51 (Carrot+Tomato+Mustard+Potato+Garlic) IgE Ab [Units/volume] in Serum by Multidisk |
|
15220-7
|
Food Allergen Mix A (Peanut+Cow milk+Egg white+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
15223-1
|
Food Allergen Mix B (Tarragon+Lovage+Marjoram) IgE Ab [Presence] in Serum by Multidisk |
|
23794-1
|
Food Allergen Mix C (Oat+Barley+Rice+Rye+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
24149-7
|
Food Allergen Mix D (Cauliflower+Cabbage+Brussel sprouts+Broccoli) IgG Ab [Units/volume] in Serum by Multidisk |
|
15222-3
|
Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
75006-7
|
Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
|
15221-5
|
Food Allergen Mix F (Buckwheat+Soybean+Rice+Sesame seed+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
15226-4
|
Food Allergen Mix G (Beef+Chicken meat+Pork+Plaice) IgE Ab [Presence] in Serum by Multidisk |
|
15247-0
|
Food Allergen Mix H (Pineapple+Lemon+Strawberry+Avocado) IgE Ab [Presence] in Serum by Multidisk |
|
15217-3
|
Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk |
|
46708-4
|
Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk |
|
15241-3
|
Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk |
|
82052-2
|
Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk |
|
15242-1
|
Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
46711-8
|
Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
|
15243-9
|
Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Presence] in Serum by Multidisk |
|
82054-8
|
Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Units/volume] in Serum by Multidisk |
|
15244-7
|
Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Presence] in Serum by Multidisk |
|
69931-4
|
Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Units/volume] in Serum by Multidisk |
|
15245-4
|
Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
|
75005-9
|
Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk |
|
15246-2
|
Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
|
69958-7
|
Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk |
|
31006-0
|
Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Presence] in Serum by Multidisk |
|
82059-7
|
Food Allergen Mix 16 (Pineapple+Lemon+Strawberry+Pear) IgE Ab [Units/volume] in Serum by Multidisk |
|
34392-1
|
Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Presence] in Serum by Multidisk |
|
46714-2
|
Food Allergen Mix 17 (Apple+Banana+Pear+Peach) IgE Ab [Units/volume] in Serum by Multidisk |
|
15248-8
|
Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Presence] in Serum by Multidisk |
|
73711-4
|
Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Units/volume] in Serum by Multidisk |
|
15249-6
|
Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
|
73717-1
|
Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Units/volume] in Serum by Multidisk |
|
15218-1
|
Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk |
|
46712-6
|
Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Units/volume] in Serum by Multidisk |
|
15250-4
|
Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
46713-4
|
Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
|
15251-2
|
Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
|
82098-5
|
Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Units/volume] in Serum by Multidisk |
|
15252-0
|
Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Presence] in Serum by Multidisk |
|
46707-6
|
Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk |
|
31007-8
|
Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk |
|
46710-0
|
Food Allergen Mix 23 (Beef+Chicken meat+Pork+Turkey meat) IgE Ab [Units/volume] in Serum by Multidisk |
|
31008-6
|
Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Presence] in Serum by Multidisk |
|
50655-0
|
Food Allergen Mix 24 (Kiwi+Hazelnut+Banana+Shrimp) IgE Ab [Units/volume] in Serum by Multidisk |
|
31009-4
|
Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Presence] in Serum by Multidisk |
|
50657-6
|
Food Allergen Mix 25A (Onion+Garlic+Sesame seed+Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
|
82580-2
|
Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Presence] in Serum by Multidisk |
|
82582-8
|
Food Allergen Mix 25B (Garlic, Celery, Sesame seed, Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
|
34394-7
|
Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Presence] in Serum by Multidisk |
|
50651-9
|
Food Allergen Mix 26 (Peanut+Cow milk+Egg white+Mustard) IgE Ab [Units/volume] in Serum by Multidisk |
|
34395-4
|
Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
50656-8
|
Food Allergen Mix 27 (Hazelnut+Codfish+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
|
34393-9
|
Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Presence] in Serum by Multidisk |
|
50652-7
|
Food Allergen Mix 28 (Kiwi+Beef+Shrimp+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk |
|
15219-9
|
Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
52972-7
|
Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
|
50026-4
|
Food Allergen Mix 30 (Peanut+White bean+Soybean+Lentil+ Peas) IgE Ab [Units/volume] in Serum by Multidisk |
|
82577-8
|
Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Presence] in Serum by Multidisk |
|
82579-4
|
Food Allergen Mix 31 (Apple+Cherry+Plum+Peach+Pear) IgE Ab [Units/volume] in Serum by Multidisk |
|
82550-5
|
Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Presence] in Serum by Multidisk |
|
82552-1
|
Food Allergen Mix 32 (Carob+Lentil+White bean+Pea) IgE Ab [Units/volume] in Serum by Multidisk |
|
63199-4
|
Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgE Ab [Units/volume] in Serum by Multidisk |
|
56331-2
|
Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG4 Ab [Mass/volume] in Serum |
|
63151-5
|
Food Allergen Mix 46 (Cashew+Pecan or Hickory nut+Chestnut+Walnut+Pistachio) IgG Ab [Mass/volume] in Serum by Multidisk |
|
23801-4
|
Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
30187-9
|
Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
|
82553-9
|
Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
|
82555-4
|
Food Allergen Mix 6 (Buckwheat+Rice+Sesame seed+Wheat+Corn) IgE Ab [Units/volume] in Serum by Multidisk |
|
15253-8
|
Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Presence] in Serum by Multidisk |
|
47302-5
|
Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
|
31010-2
|
Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Presence] in Serum by Multidisk |
|
73712-2
|
Food Allergen Mix 70 (Tarragon+Lovage+Marjoram+Thyme) IgE Ab [Units/volume] in Serum by Multidisk |
|
15224-9
|
Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Presence] in Serum by Multidisk |
|
73714-8
|
Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Units/volume] in Serum by Multidisk |
|
15225-6
|
Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Presence] in Serum by Multidisk |
|
82074-6
|
Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Units/volume] in Serum by Multidisk |
|
15227-2
|
Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Presence] in Serum by Multidisk |
|
51828-2
|
Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Units/volume] in Serum |
|
82557-0
|
Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
82559-6
|
Food Allergen Mix 75 (Cow milk+Egg white+Cod+Wheat) IgE Ab [Units/volume] in Serum |
|
82560-4
|
Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk |
|
82562-0
|
Food Allergen Mix 76 (Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Units/volume] in Serum by Multidisk |
|
82563-8
|
Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Presence] in Serum by Multidisk |
|
82565-3
|
Food Allergen Mix 77 (Kiwi+Cashew nut+Hazel nut+Tomato+Sesame seed) IgE Ab [Units/volume] in Serum by Multidisk |
|
15254-6
|
Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Presence] in Serum by Multidisk |
|
82078-7
|
Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Units/volume] in Serum by Multidisk |
|
15255-3
|
Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Presence] in Serum by Multidisk |
|
82080-3
|
Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Units/volume] in Serum by Multidisk |
|
75004-2
|
Food Allergen Mix fp73 (Beef+Chicken+Pork+Lamb) IgE Ab [Units/volume] in Serum by Multidisk |
|
24163-8
|
Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Presence] in Serum by Multidisk |
|
69922-3
|
Food Allergen Mix fx73 (Beef+Chicken+Pork) IgE Ab [Units/volume] in Serum by Multidisk |
|
75002-6
|
Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk |
|
75003-4
|
Food Allergen Mix 7A (Peanut+Cow milk+Egg white+Soybean+Wheat+Rice) IgE Ab [Units/volume] in Serum by Multidisk |
|
49222-3
|
Food allergen panel - Serum |
|
80445-0
|
Food amounts panel |
|
75287-3
|
Food and beverage intake panel |
|
75284-0
|
Food and nutrient intake panel |
|
48294-3
|
Food colorant mix I triggered leukotriene release [Mass/volume] by Leukocytes |
|
48295-0
|
Food colorant mix II triggered leukotriene release [Mass/volume] by Leukocytes |
|
80453-4
|
Food intake panel |
|
75283-2
|
Food and nutrition history panel |
|
46051-9
|
Foot problems and care Set |
|
86954-5
|
Foreign material [Presence] in Food |
|
69438-0
|
Forensic medicine Referral note |
|
80568-9
|
Form |
|
38700-1
|
Formaldehyde [Mass/volume] in Air |
|
7322-1
|
Formaldehyde triggered histamine release [Units/volume] in Blood |
|
5652-3
|
Formaldehyde [Mass/volume] in Blood |
|
43159-3
|
Formaldehyde [Mass/volume] in Nonbiological fluid |
|
6119-2
|
Formaldehyde IgE Ab [Units/volume] in Serum |
|
13180-5
|
Formaldehyde IgG Ab [Units/volume] in Serum |
|
13190-4
|
Formaldehyde IgM Ab [Units/volume] in Serum or Plasma |
|
48189-5
|
Formaldehyde triggered leukotriene release [Mass/volume] by Leukocytes |
|
5653-1
|
Formaldehyde [Mass/volume] in Urine |
|
2291-3
|
Formate [Mass/volume] in Blood |
|
72904-6
|
Formate [Moles/volume] in Blood |
|
79538-5
|
Formate [Moles/volume] in Serum or Plasma by Confirmatory method |
|
2292-1
|
Formate [Mass/volume] in Serum or Plasma |
|
14052-5
|
Formate [Mass/volume] in Urine |
|
79449-5
|
Formate [Moles/volume] in Urine |
|
42905-0
|
Formate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13742-2
|
Formate/Creatinine [Mass Ratio] in Urine |
|
25100-9
|
Formate/Creatinine [Molar ratio] in Urine |
|
16874-0
|
Formate+Formaldehyde [Mass/volume] in Blood |
|
57964-9
|
Formebolone metabolite [Presence] in Urine |
|
53165-7
|
Formiminoglutamate [Moles/volume] in DBS |
|
24418-6
|
Formononetin [Mass/volume] in Serum or Plasma |
|
51409-1
|
Fosamprenavir+Ritonavir [Susceptibility] by Genotype method |
|
72834-5
|
Foscarnet [Susceptibility] by Phenotype method |
|
256-8
|
Foscarnet [Susceptibility] |
|
54912-1
|
Fosfomycin IgE Ab [Units/volume] in Serum |
|
73371-7
|
Fosinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73370-9
|
Fosinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
47408-0
|
Fosphenytoin [Mass/volume] in Serum or Plasma |
|
19740-0
|
Fox epithelium IgE Ab [Units/volume] in Serum |
|
14037-6
|
Fox IgE Ab [Units/volume] in Serum |
|
93807-6
|
FOXO1 gene rearrangements in Tissue by FISH |
|
49479-9
|
FOXP3 Ag [Presence] in Tissue by Immune stain |
|
11186-4
|
Foxtail Millet IgE Ab [Units/volume] in Serum |
|
33059-7
|
Fluorescence polarization [Presence] in Amniotic fluid |
|
16861-7
|
Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3264-9
|
Fibrinopeptide A Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16860-9
|
Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by Immunoassay |
|
2279-8
|
Fibrinopeptide A [Mass/volume] in Peritoneal fluid |
|
38523-7
|
Fibrinopeptide A [Mass/volume] in Urine |
|
86636-8
|
Family planning report - FPAR 2.0 set |
|
16862-5
|
Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3265-6
|
Fibrinopeptide B Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16863-3
|
Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3260-7
|
Fibrinopeptide B beta (1-14) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16864-1
|
Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3261-5
|
Fibrinopeptide B beta (1-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16865-8
|
Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3262-3
|
Fibrinopeptide B beta (15-42) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
16866-6
|
Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
3263-1
|
Fibrinopeptide B beta (43-47) Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
2278-0
|
Fibrinopeptide B [Mass/volume] in Serum |
|
31390-8
|
Feline panleukopenia virus Ab [Units/volume] in Serum |
|
23737-0
|
Feline panleukopenia virus Ab [Titer] in Serum |
|
24415-2
|
Feline panleukopenia virus Ag [Presence] in Tissue by Immunofluorescence |
|
31391-6
|
Feline panleukopenia virus IgG Ab [Units/volume] in Serum |
|
27332-6
|
Feline panleukopenia virus IgG Ab [Titer] in Serum |
|
31392-4
|
Feline panleukopenia virus IgM Ab [Units/volume] in Serum |
|
27329-2
|
Feline panleukopenia virus IgM Ab [Titer] in Serum |
|
59010-9
|
Fractional excretion of potassium [Ratio] in Urine and Serum or Plasma collected for unspecified duration |
|
49135-7
|
Fractional excretion of sodium [Ratio] in Urine and Serum or Plasma |
|
50057-9
|
Fractional excretion of phosphate [Ratio] in Urine and Serum or Plasma collected for unspecified duration |
|
56925-1
|
Fractional excretion of phosphate [Ratio] in 24 hour Urine and Serum or Plasma |
|
59009-1
|
Fractional excretion of urea [Ratio] in Urine and Serum or Plasma collected for unspecified duration |
|
80958-2
|
Fractional excretion of magnesium [Ratio] in Urine and Serum or Plasma |
|
90264-3
|
Fracture Risk Assessment [FRAX] |
|
64433-6
|
Fragile X protein (FMRP) panel - Blood |
|
88223-3
|
Francisella sp DNA [Presence] in Aspirate by NAA with probe detection |
|
91837-5
|
Francisella sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
80979-8
|
Frataxin [Mass/volume] in Blood |
|
80980-6
|
Frataxin [Mass/volume] in DBS |
|
21760-4
|
FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
81456-6
|
Functional residual capacity --pre bronchodilation |
|
77372-1
|
3-Methoxytyramine.free [Moles/volume] in Serum or Plasma |
|
87499-0
|
3-Methoxytyramine.free [Molar ratio] in Urine |
|
87498-2
|
3-Methoxytyramine.free/Creatinine [Molar ratio] in 24 hour Urine |
|
77366-3
|
Metanephrine.free and Normetanephrine.free and 3-Methoxytyramine.free panel - Serum or Plasma |
|
82290-8
|
Frequency of moderate to vigorous aerobic physical activity |
|
82293-2
|
Frequency of bone-strengthening physical activity |
|
75923-3
|
Fresh gas.air flow Gas delivery system |
|
75924-1
|
Fresh gas.nitrous oxide flow Gas delivery system |
|
75925-8
|
Fresh gas.oxygen flow Gas delivery system |
|
84932-3
|
Friendship Survey - fixed length form - ages 18+ [NIH Toolbox] |
|
84933-1
|
Friendship Survey - fixed length form - ages 8-17 [NIH Toolbox] |
|
2293-9
|
Fructokinase [Enzymatic activity/volume] in Serum |
|
33805-3
|
Fructosamine [Mass/volume] in Serum or Plasma |
|
15069-8
|
Fructosamine [Moles/volume] in Serum or Plasma |
|
53550-0
|
Fructosamine/Protein [Ratio] in Serum or Plasma |
|
48432-9
|
Fructose [Molar amount] in unspecified time Semen |
|
2297-0
|
Fructose [Mass/time] in 24 hour Urine |
|
34307-9
|
Fructose [Moles/volume] in 24 hour Urine |
|
15070-6
|
Fructose [Moles/time] in 24 hour Urine |
|
34194-1
|
Fructose [Mass/volume] in Body fluid |
|
74789-9
|
Fructose challenge (hydrogen breath test) panel - Exhaled gas |
|
74792-3
|
Fructose.PO [Mass] in Dose |
|
2296-2
|
Fructose [Mass/volume] in Serum |
|
56624-0
|
Fructose [Moles/volume] in Serum |
|
13943-6
|
Fructose [Presence] in Semen |
|
2295-4
|
Fructose [Mass/volume] in Semen |
|
10574-2
|
Fructose [Moles/volume] in Semen |
|
51593-2
|
Fructose [Presence] in Stool |
|
32240-4
|
Fructose [Presence] in Urine |
|
49772-7
|
Fructose [Mass/volume] in Urine |
|
34308-7
|
Fructose [Moles/volume] in Urine |
|
34309-5
|
Fructose/Creatinine [Molar ratio] in Urine |
|
7323-9
|
Fruit IgE Ab [Units/volume] in Serum |
|
34549-6
|
Follitropin and Lutropin panel [Units/volume] - Serum or Plasma |
|
47618-4
|
Follitropin [Units/volume] in Serum or Plasma --15 minutes post 100 ug lutenizing releasing hormone IV |
|
15068-0
|
Follitropin [Units] in 24 hour Urine |
|
34306-1
|
Follitropin [Units/volume] in 24 hour Urine by 2nd IRP |
|
27203-9
|
Follitropin [Units/volume] in 24 hour Urine |
|
2287-1
|
Follitropin [Mass/time] in 24 hour Urine |
|
14734-8
|
Follitropin [Moles/time] in 24 hour Urine |
|
47028-6
|
Follitropin Ag [Presence] in Tissue by Immune stain |
|
48570-6
|
Follitropin [Units/volume] in Serum or Plasma --on cycle day 10 |
|
48571-4
|
Follitropin [Units/volume] in Serum or Plasma --on cycle day 11 |
|
48572-2
|
Follitropin [Units/volume] in Serum or Plasma --on cycle day 21 |
|
48573-0
|
Follitropin [Units/volume] in Serum or Plasma --on cycle day 3 |
|
70255-5
|
Follitropin IgA Ab [Units/volume] in Serum by Immunoassay |
|
70254-8
|
Follitropin IgG Ab [Units/volume] in Serum by Immunoassay |
|
83098-4
|
Follitropin [Units/volume] in Serum or Plasma by Immunoassay |
|
20433-9
|
Follitropin [Units/volume] in Serum or Plasma by 2nd IRP |
|
15067-2
|
Follitropin [Units/volume] in Serum or Plasma |
|
27942-2
|
Follitropin [Mass/volume] in Serum or Plasma |
|
2286-3
|
Follitropin [Moles/volume] in Serum or Plasma |
|
2285-5
|
Follitropin [Moles/volume] in Semen |
|
25639-6
|
Follitropin [Units/volume] in Urine by 2nd IRP |
|
44356-4
|
Follitropin/Creatinine [Mass Ratio] in 24 hour Urine |
|
29155-9
|
Follitropin/Creatinine [Ratio] in 24 hour Urine |
|
13489-0
|
Follitropin/Creatinine [Mass Ratio] in Urine |
|
70041-9
|
FSHB gene c.-211G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
41105-8
|
FSHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35353-2
|
FSHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80715-6
|
FSHR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
3251-6
|
Fibrin+Fibrinogen fragments [Units/volume] in Platelet poor plasma by Latex agglutination |
|
30226-5
|
Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma |
|
3252-4
|
Fibrin+Fibrinogen fragments [Units/volume] in Serum by Latex agglutination |
|
29991-7
|
Fibrin+Fibrinogen fragments [Mass/volume] in Serum by Latex agglutination |
|
30009-5
|
Fibrin+Fibrinogen fragments [Mass/volume] in Serum |
|
48592-0
|
Fibrin+Fibrinogen fragments [Titer] in Platelet poor plasma by Latex agglutination |
|
13054-2
|
Fibrin+Fibrinogen fragments [Units/volume] in Urine |
|
31394-0
|
Feline syncytial virus Ab [Units/volume] in Serum |
|
23739-6
|
Feline syncytial virus Ab [Titer] in Serum |
|
32215-6
|
Thyroxine (T4) free index in Serum or Plasma by calculation |
|
74581-0
|
Fumarase [Enzymatic activity/mass] in Fibroblast |
|
2302-8
|
Fumarase [Enzymatic activity/volume] in Serum |
|
74580-2
|
Fumarase [Enzymatic activity/mass] in Tissue |
|
75081-0
|
Fumarate [Moles/volume] in Serum or Plasma |
|
26799-7
|
Fumarate [Presence] in Urine |
|
2303-6
|
Fumarate [Mass/volume] in Urine |
|
13743-0
|
Fumarate/Creatinine [Mass Ratio] in Urine |
|
25101-7
|
Fumarate/Creatinine [Molar ratio] in Urine |
|
2304-4
|
Fumarylacetoacetate [Mass/volume] in Serum |
|
87573-2
|
Fumonisin B1 [Mass/mass] in Unspecified specimen |
|
87572-4
|
Fumonisin B2 [Mass/mass] in Unspecified specimen |
|
87571-6
|
Fumonisin B3 [Mass/mass] in Unspecified specimen |
|
20825-6
|
Fumonisin [Mass/mass] in Feed |
|
23742-0
|
Fumonisin [Mass/volume] in Unspecified specimen |
|
77160-0
|
Functional outcome score GOSE |
|
88020-3
|
Functional capacity NYHA |
|
46010-5
|
Functional limitation in range of motion Set |
|
47420-5
|
Functional status assessment note |
|
91084-4
|
Fungal 18s rRNA gene [Presence] in Dermatologic specimen by NAA with probe detection |
|
91083-6
|
Fungal 18s rRNA gene [Presence] in Isolate by NAA with probe detection |
|
91085-1
|
Fungal 18s rRNA gene [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91082-8
|
Fungal 18s rRNA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
56146-4
|
Fungal Ab panel - Serum |
|
91088-5
|
Fungal BT2 gene [Presence] in Dermatologic specimen by NAA with probe detection |
|
91087-7
|
Fungal BT2 gene [Presence] in Isolate by NAA with probe detection |
|
91089-3
|
Fungal BT2 gene [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91086-9
|
Fungal BT2 gene [Presence] in Unspecified specimen by NAA with probe detection |
|
91092-7
|
Fungal ITS region [Presence] in Dermatologic specimen by NAA with probe detection |
|
91091-9
|
Fungal ITS region [Presence] in Isolate by NAA with probe detection |
|
91093-5
|
Fungal ITS region [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91090-1
|
Fungal ITS region [Presence] in Unspecified specimen by NAA with probe detection |
|
613-0
|
Fungal strain [Type] in Isolate by Fungus subtyping |
|
29577-4
|
Fungal susceptibility panel |
|
76692-3
|
Fungus identified [#/volume] in Mouth by Culture |
|
568-6
|
Fungus identified in Aspirate by Culture |
|
88686-1
|
Fungus identified in Bronchoalveolar lavage by Culture |
|
601-5
|
Fungus identified in Blood by Culture |
|
24009-3
|
Fungus identified in Bronchial specimen by Culture |
|
32809-6
|
Fungus identified in Bronchial specimen by Fungus stain |
|
87981-7
|
Fungus identified in Burn by Culture |
|
19101-5
|
Fungus colony count [#/volume] in Unspecified specimen by Culture |
|
10665-8
|
Fungus colony count [#/volume] in Unspecified specimen by Environmental culture |
|
88143-3
|
Fungus identified in Cornea or Conjunctiva by Culture |
|
569-4
|
Fungus identified in Cerebral spinal fluid by Culture |
|
87978-3
|
Fungus identified in Peritoneal dialysis fluid by Culture |
|
570-2
|
Fungus identified in Body fluid by Culture |
|
33039-9
|
Fungus identified in Body fluid by Fungus stain |
|
87445-3
|
Fungus [Presence] in Food by Culture |
|
41026-6
|
Fungus identified in Genital specimen by Culture |
|
571-0
|
Fungus identified in Hair by Culture |
|
87976-7
|
Fungus identified in Implanted device by Culture |
|
42804-5
|
Fungus identified in Isolate |
|
15378-3
|
Fungus identified in Isolate by Culture |
|
89656-3
|
Fungus identified in Lower respiratory specimen by Culture |
|
572-8
|
Fungus identified in Bone marrow by Culture |
|
88687-9
|
Fungus identified in Mouth by Culture |
|
573-6
|
Fungus identified in Nail by Culture |
|
76073-6
|
Fungus identified in Nose by Culture |
|
87977-5
|
Fungus identified in Pericardial fluid by Culture |
|
87979-1
|
Fungus identified in Pleural fluid by Culture |
|
574-4
|
Fungus identified in Peritoneal fluid by Culture |
|
87980-9
|
Fungus identified in Sinus by Culture |
|
575-1
|
Fungus identified in Skin by Culture |
|
576-9
|
Fungus identified in Synovial fluid by Culture |
|
577-7
|
Fungus identified in Sputum by Culture |
|
6409-7
|
Fungus identified in Sputum tracheal aspirate by Culture |
|
27414-2
|
Fungus identified in Stool by Culture |
|
578-5
|
Fungus identified in Tissue by Culture |
|
10666-6
|
Fungus identified in Tissue by Fontana-Masson stain |
|
48411-3
|
Fungus identified in Tissue by Immune stain |
|
91812-8
|
Fungus identified in Upper respiratory specimen by Culture |
|
40435-0
|
Fungus identified in Urine by Culture |
|
579-3
|
Fungus identified in Wound by Culture |
|
42805-2
|
Fungus identified in Unspecified specimen |
|
10667-4
|
Fungus identified in Unspecified specimen by Animal inoculation |
|
580-1
|
Fungus identified in Unspecified specimen by Culture |
|
10668-2
|
Fungus identified in Unspecified specimen by Environmental culture |
|
10669-0
|
Fungus identified in Unspecified specimen by Sticky tape for environmental fungus |
|
21003-9
|
Fungus identified in Unspecified specimen by Fungus stain |
|
51723-5
|
Fungus [Presence] in Unspecified specimen by Organism specific culture |
|
93470-3
|
Furanylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
57966-4
|
Furazabol metabolite [Presence] in Urine |
|
46229-1
|
Furazabol [Mass/volume] in Urine |
|
87794-4
|
Furazolidone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
69574-2
|
Furazolidone [Susceptibility] |
|
3658-2
|
Furfenorex [Mass/time] in 24 hour Urine |
|
3656-6
|
Furfenorex [Presence] in Urine |
|
3657-4
|
Furfenorex [Mass/volume] in Urine |
|
35589-1
|
Furoate/Creatinine [Mass Ratio] in Urine |
|
73018-4
|
Furosemide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73017-6
|
Furosemide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3662-4
|
Furosemide [Mass/time] in 24 hour Urine |
|
47108-6
|
Furosemide [Presence] in Gastric fluid |
|
73369-1
|
Furosemide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73368-3
|
Furosemide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3659-0
|
Furosemide [Mass/volume] in Serum or Plasma |
|
55540-9
|
Furosemide [Moles/volume] in Serum or Plasma |
|
3660-8
|
Furosemide [Presence] in Urine |
|
3661-6
|
Furosemide [Mass/volume] in Urine |
|
79492-5
|
Furoylglycine [Moles/volume] in Serum or Plasma |
|
79500-5
|
Furoylglycine/Creatinine [Molar ratio] in Urine |
|
77634-4
|
FUS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77726-8
|
Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by FVIII dosing |
|
77725-0
|
Factor VIII+von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by vWF dosing |
|
80415-3
|
Fetal Body weight growth percentile US+Estimated from Hadlock 1991 |
|
22101-0
|
Avian pox virus Ab [Presence] in Serum |
|
22837-9
|
Avian pox virus Ab [Presence] in Serum by Agglutination |
|
22841-1
|
Avian pox virus Ab [Presence] in Serum by Immunoassay |
|
15451-8
|
Avian pox virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
22838-7
|
Avian pox virus Ab [Presence] in Serum by Immunofluorescence |
|
22840-3
|
Avian pox virus Ab [Presence] in Serum by Immune stain |
|
22839-5
|
Avian pox virus Ab [Presence] in Serum by Neutralization test |
|
22842-9
|
Avian pox virus DNA [Presence] in Tissue by NAA with probe detection |
|
22843-7
|
Avian pox virus DNA [Presence] in Tissue by Probe |
|
22836-1
|
Avian pox virus [Presence] in Tissue by Electron microscopy |
|
49634-9
|
FXN gene allele 1.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49635-6
|
FXN gene allele 2.GAA repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
75392-1
|
FXN gene GAA repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
21762-0
|
FXN gene GAA repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
41106-6
|
FXN gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35298-9
|
FXN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
92543-8
|
Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92505-7
|
Fy sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1027-2
|
Fy sup(a) Ag [Presence] on Red Blood Cells |
|
92542-0
|
Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92504-0
|
Fy sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1033-0
|
Fy sup(b) Ag [Presence] on Red Blood Cells |
|
65320-4
|
Fy3 Ab [Presence] in Serum or Plasma |
|
93910-8
|
Fy3 Ag [Presence] on Red Blood Cells |
|
1041-3
|
G Ag [Presence] on Red Blood Cells |
|
7333-8
|
Geotrichum candidum IgE Ab [Units/volume] in Serum |
|
6126-7
|
Glycyphagus domesticus IgE Ab [Units/volume] in Serum |
|
56264-5
|
Glycyphagus domesticus IgG4 Ab [Mass/volume] in Serum |
|
48231-5
|
Glycyphagus domesticus triggered leukotriene release [Mass/volume] by Leukocytes |
|
63564-9
|
Giardia lamblia Ag and Cryptosporidium parvum Ag and Entamoeba histolytica/dispar Ag [Identifier] in Stool |
|
80683-6
|
Giardia lamblia 18S rRNA [Presence] in Stool by NAA with probe detection |
|
5169-8
|
Giardia lamblia Ab [Units/volume] in Serum |
|
22304-0
|
Giardia lamblia Ab [Titer] in Serum |
|
9524-0
|
Giardia lamblia Ab [Titer] in Serum by Immunofluorescence |
|
34470-5
|
Giardia lamblia Ag [Presence] in Bile fluid |
|
31831-1
|
Giardia lamblia Ag [Presence] in Stool --2nd specimen |
|
21302-5
|
Giardia lamblia Ag [Presence] in Stool by Immunoassay --2nd specimen |
|
31832-9
|
Giardia lamblia Ag [Presence] in Stool --3rd specimen |
|
21303-3
|
Giardia lamblia Ag [Presence] in Stool by Immunoassay --3rd specimen |
|
31830-3
|
Giardia lamblia Ag [Presence] in Stool |
|
6412-1
|
Giardia lamblia Ag [Presence] in Stool by Immunoassay |
|
14210-9
|
Giardia lamblia Ag [Presence] in Stool by Immunofluorescence |
|
16899-7
|
Giardia lamblia Ag [Presence] in Unspecified specimen |
|
6413-9
|
Giardia lamblia Ag [Presence] in Unspecified specimen by Immunoassay |
|
23744-6
|
Giardia lamblia Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
82208-0
|
Giardia lamblia DNA [Presence] in Stool by NAA with non-probe detection |
|
92687-3
|
Giardia lamblia DNA [Presence] in Stool by NAA with probe detection |
|
60544-4
|
Giardia lamblia DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
9658-6
|
Giardia lamblia IgA Ab [Units/volume] in Serum |
|
22305-7
|
Giardia lamblia IgA Ab [Titer] in Serum |
|
21300-9
|
Giardia lamblia IgA Ab [Titer] in Serum by Immunofluorescence |
|
41154-6
|
Giardia lamblia IgG Ab [Presence] in Serum |
|
40713-0
|
Giardia lamblia IgG Ab [Presence] in Serum by Immunoassay |
|
7891-5
|
Giardia lamblia IgG Ab [Units/volume] in Serum |
|
22306-5
|
Giardia lamblia IgG Ab [Titer] in Serum |
|
6411-3
|
Giardia lamblia IgG Ab [Titer] in Serum by Immunofluorescence |
|
41153-8
|
Giardia lamblia IgM Ab [Presence] in Serum |
|
40714-8
|
Giardia lamblia IgM Ab [Presence] in Serum by Immunoassay |
|
7892-3
|
Giardia lamblia IgM Ab [Units/volume] in Serum |
|
22307-3
|
Giardia lamblia IgM Ab [Titer] in Serum |
|
21301-7
|
Giardia lamblia IgM Ab [Titer] in Serum by Immunofluorescence |
|
10670-8
|
Giardia lamblia [Presence] in Stool by Organism specific culture |
|
91675-9
|
Giardia lamblia and Cryptosporidium parvum Ag panel - Stool by Rapid immunoassay |
|
48064-0
|
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool |
|
48063-2
|
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay |
|
48062-4
|
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Immunofluorescence |
|
49233-0
|
Giardia lamblia+Cryptosporidium parvum Ag [Presence] in Stool by Rapid, less than 30 minutes |
|
48060-8
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool |
|
48059-0
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunoassay |
|
48061-6
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Immunofluorescence |
|
49232-2
|
Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool by Rapid, less than 30 minutes |
|
16898-9
|
Giardia lamblia 65 Ag [Presence] in Stool |
|
87242-4
|
Geobacillus stearothermophilus [Presence] in Laboratory device by Culture |
|
74668-5
|
Gardnerella vaginalis DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
|
92698-0
|
Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe |
|
54143-3
|
Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification |
|
69936-3
|
Gardnerella vaginalis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
21284-5
|
Gardnerella vaginalis [Presence] in Genital specimen by Organism specific culture |
|
6410-5
|
Gardnerella vaginalis rRNA [Presence] in Genital specimen by Probe |
|
90275-9
|
Gardnerella vaginalis [Presence] in Vaginal fluid by Organism specific culture |
|
31118-3
|
G2+M phase cells/100 cells in Unspecified specimen |
|
32779-1
|
Glucose-6-Phosphatase [Enzymatic activity/volume] in Red Blood Cells |
|
2354-9
|
Glucose-6-Phosphatase [Enzymatic activity/volume] in Serum |
|
2355-6
|
Glucose-6-Phosphatase [Enzymatic activity/mass] in Tissue |
|
49862-6
|
G6PC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49502-8
|
Glucose-6-Phosphate dehydrogenase [Entitic Catalytic Activity] in Blood |
|
71593-8
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/substance] in Red Blood Cells |
|
33287-4
|
Glucose-6-Phosphate dehydrogenase [Presence] in DBS |
|
21680-4
|
G6PD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
58091-0
|
Glucose-6-Phosphate dehydrogenase newborn screen panel |
|
49925-1
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by Glock and McLean |
|
2356-4
|
Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells |
|
49926-9
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells by WHO method |
|
2357-2
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
32546-4
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells |
|
2358-0
|
Glucose-6-Phosphate dehydrogenase [Presence] in Serum |
|
2359-8
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Serum |
|
18228-7
|
Glucose-6-Phosphate dehydrogenase [Presence] in Tissue |
|
2360-6
|
Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Leukocytes |
|
74469-8
|
Glucose-6-Phosphate dehydrogenase/Pyruvate kinase [Ratio] in Blood |
|
53695-3
|
Gestational age Estimated from prior assessment |
|
53691-2
|
Gestational age Estimated from patient reported estimated date of conception |
|
76516-4
|
Gestational age--at birth |
|
27914-1
|
Gamma aminoadipate [Moles/time] in 24 hour Urine |
|
76034-8
|
GAA gene full mutation analysis in Blood or Tissue by Sequencing |
|
53864-5
|
GAA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72422-9
|
Gamma aminobutyrate [Moles/volume] in Blood from Fetus |
|
50146-0
|
Gamma aminobutyrate [Moles/volume] in DBS |
|
50147-8
|
Gamma aminobutyrate [Moles/volume] in Body fluid |
|
74439-1
|
GABA free and total panel - Cerebral spinal fluid |
|
72420-3
|
Gamma aminobutyrate.free [Moles/volume] in Cerebral spinal fluid |
|
56679-4
|
Gamma aminobutyrate/Creatinine [Ratio] in 24 hour Urine |
|
90825-1
|
GABABR Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93867-0
|
GABABR Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
84931-5
|
GABABR Ab [Presence] in Serum by Immunofluorescence |
|
90826-9
|
GABABR Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93426-5
|
GABABR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82984-6
|
GABABR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
93428-1
|
GABABR IgG Ab [Presence] in Serum or Plasma by Cell binding assay immunofluorescent assay |
|
82977-0
|
GABABR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
93425-7
|
GABABR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
93427-3
|
GABABR IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
73016-8
|
Gabapentin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73015-0
|
Gabapentin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73367-5
|
Gabapentin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73366-7
|
Gabapentin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
87496-6
|
Gabapentin [Presence] in Serum, Plasma or Blood by Screen method |
|
9738-6
|
Gabapentin [Mass/volume] in Serum, Plasma or Blood |
|
25425-0
|
Gabapentin [Moles/volume] in Serum or Plasma |
|
93121-2
|
Gabapentin [Presence] in Tissue by Screen method |
|
74964-8
|
Gabapentin [Mass/volume] in Serum or Plasma --trough |
|
72810-5
|
Gabapentin [Mass/volume] in Urine by Confirmatory method |
|
68439-9
|
Gabapentin [Presence] in Urine |
|
92648-5
|
Gabapentin [Presence] in Urine by Confirmatory method |
|
59680-9
|
Gabapentin [Mass/volume] in Urine |
|
72811-3
|
Gabapentin/Creatinine [Mass Ratio] in Urine |
|
82658-6
|
Glutamate decarboxylase Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82660-2
|
Glutamate decarboxylase Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
90829-3
|
Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
42501-7
|
Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid |
|
53708-4
|
Glutamate decarboxylase 65 Ab [Moles/volume] in Cerebral spinal fluid |
|
56540-8
|
Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay |
|
81725-4
|
Glutamate decarboxylase 65 Ab [Presence] in Serum by Line blot |
|
13926-1
|
Glutamate decarboxylase 65 Ab [Units/volume] in Serum |
|
58451-6
|
Glutamate decarboxylase 65 Ab [Mass/volume] in Serum |
|
72523-4
|
Glutamate decarboxylase 65 Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
30347-9
|
Glutamate decarboxylase 65 Ab [Moles/volume] in Serum |
|
83004-2
|
Glutamate decarboxylase 65 IgG Ab [Presence] in Serum or Plasma by Line blot |
|
8201-6
|
Gadolinium [Mass/time] in 24 hour Urine |
|
76650-1
|
Gadolinium [Mass/mass] in Hair |
|
80912-9
|
Gadolinium [Mass/volume] in Serum or Plasma |
|
80643-0
|
Gadolinium [Mass/mass] in Tissue |
|
8200-8
|
Gadolinium [Mass/volume] in Urine |
|
93854-8
|
Gadolinium/Creatinine [Mass Ratio] in Urine |
|
74632-1
|
Glycosaminoglycans [Presence] in 24 hour Urine |
|
2398-6
|
Glycosaminoglycans [Presence] in Urine |
|
2399-4
|
Glycosaminoglycans [Mass/volume] in Urine |
|
44366-3
|
Glycosaminoglycans/Creatinine [Mass Ratio] in 24 hour Urine |
|
74631-3
|
Glycosaminoglycans/Creatinine [Ratio] in 24 hour Urine |
|
32799-9
|
Glycosaminoglycans/Creatinine [Mass Ratio] in Urine |
|
46132-7
|
Glycosaminoglycans/Creatinine [Ratio] in Urine |
|
44367-1
|
Glycosaminoglycans/Creatinine [Molar ratio] in Urine |
|
23224-9
|
Mareks disease virus Ab [Presence] in Serum |
|
23225-6
|
Mareks disease virus Ab [Presence] in Serum by Immunoassay |
|
23228-0
|
Mareks disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23226-4
|
Mareks disease virus Ab [Presence] in Serum by Immunofluorescence |
|
23227-2
|
Mareks disease virus Ab [Presence] in Serum by Neutralization test |
|
31873-3
|
Mareks disease virus Ag [Presence] in Feather |
|
23230-6
|
Mareks disease virus Ag [Presence] in Feather by Immune diffusion (ID) |
|
31874-1
|
Mareks disease virus Ag [Presence] in Unspecified specimen |
|
23229-8
|
Mareks disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23231-4
|
Mareks disease virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23601-8
|
Mareks disease virus serotype [Identifier] in Tissue by Organism specific culture |
|
52045-2
|
Gait trainers attachment |
|
40842-7
|
Galactose 1 phosphate [Mass/volume] in DBS |
|
74879-8
|
Galactose 1 phosphate [Mass/volume] in DBS --post therapeutic diet |
|
2312-7
|
Galactose 1 phosphate [Mass/volume] in Red Blood Cells |
|
33360-9
|
Galactose 1 phosphate [Mass/mass] in Red Blood Cells |
|
38485-9
|
Galactose 1 phosphate [Moles/mass] in Red Blood Cells |
|
20576-5
|
Galactose 1 phosphate uridyl transferase [Presence] in Blood |
|
10970-2
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood |
|
79460-2
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/substance] in Red Blood Cells |
|
33288-2
|
Galactose 1 phosphate uridyl transferase [Presence] in DBS |
|
42906-8
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS |
|
75094-3
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in DBS --post therapeutic diet |
|
33780-8
|
Galactose 1 phosphate uridyl transferase phenotype [Type] in Blood |
|
2313-5
|
Galactose 1 phosphate uridyl transferase [Presence] in Red Blood Cells |
|
2314-3
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Red Blood Cells |
|
24082-0
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Red Blood Cells |
|
74902-8
|
Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Leukocytes |
|
49333-8
|
Galactitol [Moles/volume] in Amniotic fluid |
|
49773-5
|
Galactitol [Moles/volume] in Serum or Plasma |
|
57967-2
|
Galactitol [Presence] in Urine |
|
47857-8
|
Galactitol/Creatinine [Molar ratio] in Urine |
|
2305-1
|
Galactokinase [Enzymatic activity/volume] in Red Blood Cells |
|
81143-0
|
Galactokinase [Enzymatic activity/mass] in Red Blood Cells |
|
74437-5
|
Galactokinase [Enzymatic activity/mass] in Leukocytes |
|
88555-8
|
Galactomannan Ag [Presence] in Bronchoalveolar lavage |
|
76075-1
|
Galactomannan Ag [Units/volume] in Bronchoalveolar lavage |
|
53865-2
|
Galactomannan Ag [Units/volume] in Cerebral spinal fluid |
|
44357-2
|
Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
44099-0
|
Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay |
|
35383-9
|
Galactomannan Ag [Units/volume] in Serum or Plasma |
|
62467-6
|
Galactomannan Ag [Units/volume] in Unspecified specimen by Immunoassay |
|
35671-7
|
Galactomannan Ag [Units/volume] in Unspecified specimen |
|
80189-4
|
Galactosamine [Moles/volume] in Serum or Plasma |
|
34310-3
|
Galactose [Moles/volume] in 24 hour Urine |
|
15071-4
|
Galactose [Moles/time] in 24 hour Urine |
|
2306-9
|
Galactose [Presence] in Blood |
|
2307-7
|
Galactose [Mass/volume] in Blood |
|
2311-9
|
Galactose renal clearance in 24 hour Urine and Serum or Plasma |
|
54084-9
|
Galactose [Mass/volume] in DBS |
|
54085-6
|
Galactose [Moles/volume] in DBS |
|
75093-5
|
Galactose [Mass/volume] in DBS --post therapeutic diet |
|
49219-9
|
Galactose [Mass/volume] in Red Blood Cells |
|
2308-5
|
Galactose [Mass/volume] in Serum or Plasma |
|
25426-8
|
Galactose [Moles/volume] in Serum or Plasma |
|
51594-0
|
Galactose [Presence] in Stool |
|
2309-3
|
Galactose [Presence] in Urine |
|
2310-1
|
Galactose [Mass/volume] in Urine |
|
34311-1
|
Galactose [Moles/volume] in Urine |
|
13744-8
|
Galactose/Creatinine [Mass Ratio] in Urine |
|
25102-5
|
Galactose/Creatinine [Molar ratio] in Urine |
|
53580-7
|
Galactosylceramidase [Enzymatic activity/mass] in Amniotic fluid cells |
|
62310-8
|
Galactosylceramidase [Enzymatic activity/volume] in DBS |
|
87738-1
|
GALC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
24083-8
|
Galactosylceramidase [Enzymatic activity/mass] in Fibroblast |
|
81843-5
|
GALC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
2315-0
|
Galactosylceramidase [Enzymatic activity/mass] in Tissue |
|
24084-6
|
Galactosylceramidase [Enzymatic activity/mass] in Leukocytes |
|
50316-9
|
Galectin 3 Ag [Presence] in Tissue by Immune stain |
|
83099-2
|
Galectin 3 [Mass/volume] in Serum or Plasma by Immunoassay |
|
62419-7
|
Galectin 3 [Mass/volume] in Serum or Plasma |
|
2316-8
|
Galactosylgalactosylglucosylceramidase [Enzymatic activity/mass] in Tissue |
|
80158-9
|
Galactosylhydroxylysine/Creatinine [Molar ratio] in Urine |
|
5168-0
|
Gall canaliculi Ab [Units/volume] in Serum |
|
16881-5
|
Gallium [Mass/volume] in Blood |
|
60076-7
|
Gallium [Mass/volume] in Red Blood Cells |
|
12703-5
|
Gallium [Mass/volume] in Serum or Plasma |
|
5654-9
|
Gallium [Mass/volume] in Urine |
|
20827-2
|
Gallotannin [Mass/mass] in Gastric fluid |
|
20828-0
|
Gallotannin [Mass/mass] in Plant |
|
20826-4
|
Gallotannin [Mass/volume] in Serum or Plasma |
|
88019-5
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in DBS |
|
24095-2
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast |
|
2649-2
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue |
|
93853-0
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in Urine |
|
24096-0
|
N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes |
|
34693-2
|
GALOP Ab [Titer] in Serum or Plasma |
|
42202-2
|
GALOP IgM Ab [Titer] in Serum or Plasma |
|
42940-7
|
GALT gene allele 1 [Presence] in Blood by Molecular genetics method |
|
42941-5
|
GALT gene allele 2 [Presence] in Blood by Molecular genetics method |
|
76037-1
|
GALT gene full mutation analysis in Blood or Tissue by Sequencing |
|
42318-6
|
GALT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
70248-0
|
GALT gene p.Gln188Arg [Presence] in Blood or Tissue by Molecular genetics method |
|
7530-9
|
Gamble Oak IgE Ab [Units/volume] in Serum |
|
88376-9
|
Gamithromycin [Susceptibility] by Disk diffusion (KB) |
|
88378-5
|
Gamithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54391-8
|
Gamma globulin/Protein.total in Dialysis fluid by Electrophoresis |
|
74901-0
|
Gamma tocopherol [Entitic substance] in Red Blood Cells |
|
63370-1
|
Gamma tocopherol [Mass/volume] in Serum or Plasma |
|
59205-5
|
Gamma tocopherol [Moles/volume] in Serum or Plasma |
|
80639-8
|
Gamma-amanitin [Mass/volume] in Urine |
|
60077-5
|
Ganciclovir [Mass/volume] in Blood |
|
72854-3
|
Ganciclovir [Susceptibility] by Genotype method |
|
72861-8
|
Ganciclovir [Susceptibility] by Phenotype method |
|
59798-9
|
Ganciclovir [Mass/volume] in Plasma --peak |
|
15367-6
|
Ganciclovir [Mass/volume] in Serum or Plasma |
|
265-9
|
Ganciclovir [Susceptibility] |
|
59799-7
|
Ganciclovir [Mass/volume] in Plasma --trough |
|
60078-3
|
Ganciclovir [Mass/volume] in Urine |
|
25256-9
|
Ganciclovir [Mass/volume] in Unspecified specimen |
|
82455-7
|
Ganglioside Ab panel - Serum by Immunoassay |
|
82454-0
|
Ganglioside Ab panel - Serum by Immunoblot |
|
51701-1
|
Ganglioside IgG Ab [Presence] in Serum by Immunoblot |
|
51702-9
|
Ganglioside IgM Ab [Presence] in Serum by Immunoblot |
|
11048-6
|
Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
2384-6
|
Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Serum |
|
7331-2
|
Garlic triggered histamine release [Units/volume] in Blood |
|
6122-6
|
Garlic IgE Ab [Units/volume] in Serum |
|
61211-9
|
Garlic IgE Ab/IgE total in Serum |
|
7330-4
|
Garlic IgG Ab [Units/volume] in Serum |
|
56265-2
|
Garlic IgG4 Ab [Mass/volume] in Serum |
|
60374-6
|
Garlic IgG Ab [Mass/volume] in Serum |
|
93685-6
|
Gas and Carbon monoxide and Electrolytes panel - Arterial blood |
|
24343-6
|
Gas and Carbon monoxide panel - Blood |
|
24341-0
|
Gas and Carbon monoxide panel - Arterial blood |
|
24342-8
|
Gas and Carbon monoxide panel - Capillary blood |
|
24344-4
|
Gas and Carbon monoxide panel - Venous blood |
|
24338-6
|
Gas panel - Blood |
|
24336-0
|
Gas panel - Arterial blood |
|
24337-8
|
Gas panel - Capillary blood |
|
51974-4
|
Gas panel - Arterial cord blood |
|
51972-8
|
Gas panel - Venous cord blood |
|
51973-6
|
Gas panel - Mixed venous blood |
|
24339-4
|
Gas panel - Venous blood |
|
24340-2
|
Gas panel - Body fluid |
|
5923-8
|
Gastric acid free [Moles/volume] in Gastric fluid |
|
5922-0
|
Gastric acid [Moles/volume] in Gastric fluid |
|
5925-3
|
Gastric acid [Volume] in Gastric fluid |
|
50579-2
|
Gastric analysis panel - Gastric fluid |
|
81186-9
|
Gastric cancer pathology panel |
|
60819-0
|
Gastric mucosal pCO2 |
|
76298-9
|
Gastric pressure |
|
60817-4
|
Gastric-arterial pCO2 gap |
|
60818-2
|
Gastric-end tidal pCO2 gap |
|
10483-6
|
Gastrin Ag [Presence] in Tissue by Immune stain |
|
29395-1
|
Gastrin [Mass/volume] in Serum or Plasma --fasting |
|
26024-0
|
Gastrin [Moles/volume] in Serum or Plasma --post meal |
|
2333-3
|
Gastrin [Mass/volume] in Serum or Plasma |
|
15072-2
|
Gastrin [Moles/volume] in Serum or Plasma |
|
2332-5
|
Gastrin.14 residue fragment [Mass/volume] in Serum or Plasma |
|
2331-7
|
Gastrin.17 residue fragment [Mass/volume] in Serum or Plasma |
|
2330-9
|
Gastrin.34 residue fragment [Mass/volume] in Serum or Plasma |
|
2334-1
|
Hemoglobin.gastrointestinal [Presence] in Gastric fluid |
|
42909-2
|
Hemoglobin.gastrointestinal [Presence] in Gastric fluid --1st specimen |
|
42910-0
|
Hemoglobin.gastrointestinal [Presence] in Gastric fluid --2nd specimen |
|
42911-8
|
Hemoglobin.gastrointestinal [Presence] in Gastric fluid --3rd specimen |
|
84101-5
|
Gastroenterology Administrative note |
|
84102-3
|
Gastroenterology Admission evaluation note |
|
83684-1
|
Gastroenterology Attending Note |
|
34136-2
|
Gastroenterology Attending Outpatient Supervisory note |
|
84103-1
|
Gastroenterology Clinical nurse specialist Note |
|
34761-7
|
Gastroenterology Consult note |
|
78256-5
|
Gastroenterology Diagnostic study note |
|
78270-6
|
Gastroenterology Education note |
|
83737-7
|
Gastroenterology Fellow Note |
|
78297-9
|
Gastroenterology Flowsheet |
|
84104-9
|
Gastroenterology History and physical note |
|
84105-6
|
Gastroenterology Hospital Note |
|
78339-9
|
Gastroenterology Initial evaluation note |
|
34899-5
|
Gastroenterology Interventional procedure note |
|
84106-4
|
Gastroenterology Letter |
|
34762-5
|
Gastroenterology Note |
|
83575-1
|
Gastroenterology Nurse Note |
|
83576-9
|
Gastroenterology Nurse Outpatient Note |
|
83577-7
|
Gastroenterology Nurse procedure note |
|
84107-2
|
Gastroenterology Outpatient Note |
|
78241-7
|
Gastroenterology Surgical operation note |
|
84108-0
|
Gastroenterology Telephone encounter Note |
|
80750-3
|
Gastroenterology Plan of care note |
|
85941-3
|
Gastroenterology Postoperative evaluation and management note |
|
85942-1
|
Gastroenterology Preoperative evaluation and management note |
|
78317-5
|
Gastroenterology procedure note |
|
78323-3
|
Gastroenterology Progress note |
|
57138-0
|
Gastroenterology Referral note |
|
83756-7
|
Gastroenterology Resident Note |
|
81422-8
|
GATA1 gene exon 2 targeted mutation analysis in Blood or Tissue by Sequencing |
|
82655-2
|
Gated cardiac measurement panel Left ventricle SPECT |
|
22073-1
|
Gaucher 1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
22072-3
|
Gaucher 2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
22071-5
|
Gaucher 3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
62311-6
|
Gaucher disease newborn screening panel |
|
35686-5
|
GBA gene c.1226A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
35687-3
|
GBA gene c.1297G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
35688-1
|
GBA gene c.1448T>G and 1448T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
35689-9
|
GBA gene c.84insG [Presence] in Blood or Tissue by Molecular genetics method |
|
35690-7
|
GBA gene c.IVS2(+1)G>A and IVS2(+1)G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
35693-1
|
GBA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41104-1
|
GBA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35372-2
|
GBA gene p.Leu444Pro [Presence] in Blood or Tissue by Molecular genetics method |
|
59394-7
|
Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay |
|
68385-4
|
Glomerular basement membrane Ab [Presence] in Serum |
|
63262-0
|
Glomerular basement membrane Ab [Presence] in Serum by Immunoassay |
|
53260-6
|
Glomerular basement membrane Ab [Presence] in Serum by Immunofluorescence |
|
89514-4
|
Glomerular basement membrane Ab [Presence] in Serum by Line blot |
|
49774-3
|
Glomerular basement membrane Ab [Units/volume] in Serum |
|
51980-1
|
Glomerular basement membrane Ab [Mass/volume] in Serum |
|
53259-8
|
Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence |
|
30343-8
|
Glomerular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
|
68386-2
|
Glomerular basement membrane IgG Ab [Presence] in Serum by Immunoassay |
|
58796-4
|
Glomerular basement membrane IgG Ab [Presence] in Serum by Immunofluorescence |
|
31406-2
|
Glomerular basement membrane IgG Ab [Units/volume] in Serum |
|
58795-6
|
Glomerular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence |
|
89002-0
|
GBU4-5 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
79309-1
|
Gamma butyrobetaine [Moles/volume] in Cerebral spinal fluid |
|
79310-9
|
Gamma butyrobetaine [Moles/volume] in DBS |
|
79308-3
|
Gamma butyrobetaine [Moles/volume] in Serum or Plasma |
|
79311-7
|
Gamma butyrobetaine/Creatinine [Molar ratio] in Urine |
|
79315-8
|
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Cerebral spinal fluid |
|
79314-1
|
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in DBS |
|
79312-5
|
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Serum or Plasma |
|
79313-3
|
Gamma butyrobetaine/Trimethyllysine [Molar ratio] in Urine |
|
93334-1
|
Glycocholate [Moles/volume] in Serum or Plasma |
|
93335-8
|
Glycochenodeoxycholate [Moles/volume] in Serum or Plasma |
|
75055-4
|
Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast |
|
75401-0
|
GCDH gene full mutation analysis in Blood or Tissue by Sequencing |
|
75402-8
|
GCDH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
2375-4
|
Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Tissue |
|
75054-7
|
Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes |
|
53866-0
|
GCH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
11096-5
|
Gamma chlordane [Mass/volume] in Serum or Plasma |
|
16888-0
|
Gamma chlordane [Mass/volume] in Urine |
|
53732-4
|
GCK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
54458-5
|
Granulocyte colony stimulating factor [Mass/volume] in Serum or Plasma |
|
48656-3
|
Ganglioside GD1a Ab [Units/volume] in Serum by Immunoassay |
|
44740-9
|
Ganglioside GD1a Ab [Presence] in Serum |
|
58969-7
|
Ganglioside GD1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
57968-0
|
Ganglioside GD1a IgG Ab [Presence] in Serum |
|
82395-5
|
Ganglioside GD1a IgG Ab [Presence] in Serum by Line blot |
|
88724-0
|
Ganglioside GD1a IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
82396-3
|
Ganglioside GD1a IgG+IgM Ab [Presence] in Serum by Line blot |
|
58970-5
|
Ganglioside GD1a IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
57969-8
|
Ganglioside GD1a IgM Ab [Presence] in Serum |
|
82397-1
|
Ganglioside GD1a IgM Ab [Presence] in Serum by Line blot |
|
58971-3
|
Ganglioside GD1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
56541-6
|
Ganglioside GD1b IgG Ab [Units/volume] in Serum by Immunoassay |
|
43601-4
|
Ganglioside GD1b IgG Ab [Presence] in Serum |
|
56739-6
|
Ganglioside GD1b IgG Ab [Presence] in Serum by Immunoblot |
|
88730-7
|
Ganglioside GD1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
82398-9
|
Ganglioside GD1b IgG+IgM Ab [Presence] in Serum by Line blot |
|
56542-4
|
Ganglioside GD1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58977-0
|
Ganglioside GD1b IgM Ab [Units/volume] in Serum by Immunoassay |
|
43600-6
|
Ganglioside GD1b IgM Ab [Presence] in Serum |
|
56740-4
|
Ganglioside GD1b IgM Ab [Presence] in Serum by Immunoblot |
|
63471-7
|
Ganglioside GD2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
59034-9
|
Ganglioside GD2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
82399-7
|
Ganglioside GD2 IgG Ab [Presence] in Serum by Line blot |
|
82400-3
|
Ganglioside GD2 IgG+IgM Ab [Presence] in Serum by Line blot |
|
58980-4
|
Ganglioside GD2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
82401-1
|
Ganglioside GD2 IgM Ab [Presence] in Serum by Line blot |
|
63472-5
|
Ganglioside GD3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58979-6
|
Ganglioside GD3 IgG Ab [Units/volume] in Serum by Immunoassay |
|
82402-9
|
Ganglioside GD3 IgG Ab [Presence] in Serum by Line blot |
|
63240-6
|
Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89512-8
|
Ganglioside GD3 IgG+IgM Ab [Presence] in Serum by Line blot |
|
58978-8
|
Ganglioside GD3 IgM Ab [Units/volume] in Serum by Immunoassay |
|
82404-5
|
Ganglioside GD3 IgM Ab [Presence] in Serum by Line blot |
|
81857-5
|
GDAP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43277-3
|
GDAP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93333-3
|
Glycodeoxycholate [Moles/volume] in Serum or Plasma |
|
92665-9
|
Growth and differentiation factor 15 [Mass/volume] in Serum or Plasma by Immunoassay |
|
83034-9
|
XR Pelvis and Hip - bilateral GE 2 views for pediatrics |
|
7332-0
|
Gelatin IgE Ab [Units/volume] in Serum |
|
61269-7
|
Gelatin IgE Ab/IgE total in Serum |
|
56455-9
|
Gelatin IgG4 Ab [Mass/volume] in Serum |
|
63140-8
|
Gelatin IgG Ab [Mass/volume] in Serum |
|
11236-7
|
Gemfibrozil [Mass/volume] in Serum or Plasma |
|
75603-1
|
Genetic counselor comment on fetal 1p36 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75579-3
|
Genetic counselor comment on fetal 22q11.2 deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75597-5
|
Genetic counselor comment on fetal 5p deletion risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75591-8
|
Genetic counselor comment on fetal Angelman syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75571-0
|
Genetic counselor comment on fetal Monosomy X risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75585-0
|
Genetic counselor comment on fetal Prader-Willi syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75573-6
|
Fetal Genetic counselor comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75553-8
|
Genetic counselor comment on fetal Trisomy 13 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75559-5
|
Genetic counselor comment on fetal Trisomy 18 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
75565-2
|
Genetic counselor comment on fetal Trisomy 21 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
|
34862-3
|
General medicine Attending Hospital Admission evaluation note |
|
68475-3
|
General medicine Attending Hospital Progress note |
|
34769-0
|
General medicine Attending Note |
|
64054-0
|
General medicine Medical student Hospital Admission evaluation note |
|
64056-5
|
General medicine Medical student Hospital Consult note |
|
64055-7
|
General medicine Medical student Hospital Progress note |
|
34767-4
|
General medicine Medical student Note |
|
34768-2
|
General medicine Nurse Note |
|
93865-4
|
General medicine Team Conference note |
|
87396-8
|
GenBank accession number |
|
76691-5
|
Gender identity |
|
51966-0
|
Genetic disease DNA analysis panel |
|
48025-1
|
Gene mutations tested for [#] in Blood or Tissue by Molecular genetics method |
|
35474-6
|
Gene XXX targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41103-3
|
Gene XXX mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48016-0
|
Genechip kit panel - Blood or Tissue by Molecular genetics method |
|
46055-0
|
General activity preferences Set |
|
85022-2
|
General Life Satisfaction Survey - CAT item bank - ages 18+ [NIH Toolbox] |
|
85019-8
|
General Life Satisfaction Survey - CAT item bank - ages 8-12 [NIH Toolbox] |
|
85016-4
|
General Life Satisfaction Survey - fixed length form A - ages 18+ [NIH Toolbox] |
|
85013-1
|
General Life Satisfaction Survey - fixed length form B - ages 18+ [NIH Toolbox] |
|
85009-9
|
General Life Satisfaction Survey - parent report - fixed length form- ages 3-12 [NIH Toolbox] |
|
85133-7
|
General Life Satisfaction Survey version 2.0 - CAT item bank - ages 13-17 [NIH Toolbox] |
|
34763-3
|
General medicine Admission history and physical note |
|
34764-1
|
General medicine Consult note |
|
78262-3
|
General medicine Discharge instructions |
|
78264-9
|
General medicine Discharge summary |
|
78267-2
|
General medicine Discharge teaching note |
|
78272-2
|
General medicine Education note |
|
78298-7
|
General medicine Flowsheet |
|
78308-4
|
General medicine History and physical note |
|
64053-2
|
General medicine Hospital Admission evaluation note |
|
78335-7
|
General medicine Initial evaluation note |
|
34765-8
|
General medicine Note |
|
34101-6
|
General medicine Outpatient Consult note |
|
34766-6
|
General medicine Outpatient Note |
|
34901-9
|
General medicine Outpatient Progress note |
|
80745-3
|
General medicine Plan of care note |
|
78320-9
|
General medicine procedure note |
|
34900-1
|
General medicine Progress note |
|
57139-8
|
General medicine Referral note |
|
34770-8
|
General medicine Transfer summary note |
|
79115-2
|
General Practitioner Assessment of Cognition [GPCOG] |
|
91629-6
|
General Well-Being Schedule - 18 item [NHANES] |
|
55207-5
|
Genetic analysis discrete result panel |
|
55233-1
|
Genetic analysis master panel |
|
55232-3
|
Genetic analysis summary panel |
|
48674-6
|
Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal |
|
19102-3
|
Genetic screen in Unspecified specimen by Molecular genetics method Narrative |
|
82939-0
|
Genetic variant details in Blood or Tissue by Molecular genetics method Narrative |
|
23743-8
|
Genistein [Units/volume] in Serum or Plasma |
|
683-3
|
Genital Mycoplasma identified in Genital specimen by Organism specific culture |
|
73014-3
|
Gentamicin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73013-5
|
Gentamicin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13561-6
|
Gentamicin [Mass/volume] in Cerebral spinal fluid |
|
13562-4
|
Gentamicin [Mass/volume] in Body fluid |
|
80971-5
|
Gentamicin free [Mass/volume] in Serum or Plasma |
|
54913-9
|
Gentamicin IgE Ab [Units/volume] in Serum |
|
73365-9
|
Gentamicin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73364-2
|
Gentamicin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
50630-3
|
Gentamicin [Susceptibility] by Method for Slow-growing mycobacteria |
|
89481-6
|
Gentamicin [Susceptibility] by Genotype method |
|
59379-8
|
Gentamicin [Mass/volume] in Serum or Plasma --post dialysis |
|
39082-3
|
Gentamicin [Mass/volume] in Cerebral spinal fluid --peak |
|
3663-2
|
Gentamicin [Mass/volume] in Serum or Plasma --peak |
|
22746-2
|
Gentamicin [Moles/volume] in Serum or Plasma --peak |
|
31091-2
|
Gentamicin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
|
31093-8
|
Gentamicin [Mass/volume] in Serum or Plasma --random post extended interval dosing |
|
88111-0
|
Gentamicin [Moles/volume] in Serum or Plasma --random post extended interval dosing |
|
3664-0
|
Gentamicin [Mass/volume] in Serum or Plasma --random |
|
15106-8
|
Gentamicin [Moles/volume] in Serum or Plasma --random |
|
35668-3
|
Gentamicin [Mass/volume] in Serum or Plasma |
|
47109-4
|
Gentamicin [Moles/volume] in Serum or Plasma |
|
18929-0
|
Gentamicin.high potency [Susceptibility] |
|
31092-0
|
Gentamicin [Mass/volume] in Serum or Plasma --trough post extended interval dosing |
|
3665-7
|
Gentamicin [Mass/volume] in Serum or Plasma --trough |
|
22747-0
|
Gentamicin [Moles/volume] in Serum or Plasma --trough |
|
79515-3
|
Gentisate [Moles/volume] in Serum or Plasma |
|
47858-6
|
Gentisate/Creatinine [Molar ratio] in Urine |
|
6123-4
|
Geranium IgE Ab [Units/volume] in Serum |
|
7334-6
|
Gerbil epithelium IgE Ab [Units/volume] in Serum |
|
61341-4
|
Gerbil epithelium IgE Ab/IgE total in Serum |
|
30127-5
|
Gerbil hair IgE Ab [Units/volume] in Serum |
|
6840-3
|
Gerbil IgE Ab [Units/volume] in Serum |
|
84109-8
|
Geriatric medicine Admission evaluation note |
|
80809-7
|
Geriatric medicine Admission history and physical note |
|
84110-6
|
Geriatric medicine Annual evaluation note |
|
83702-1
|
Geriatric medicine Attending Note |
|
84111-4
|
Geriatric medicine Case manager Note |
|
34776-5
|
Geriatric medicine Consult note |
|
80810-5
|
Geriatric medicine Discharge instructions |
|
80811-3
|
Geriatric medicine Discharge summary |
|
80812-1
|
Geriatric medicine Discharge teaching note |
|
67854-0
|
Geriatric medicine Education note |
|
83738-5
|
Geriatric medicine Fellow Note |
|
80817-0
|
Geriatric medicine Flowsheet |
|
84112-2
|
Geriatric medicine Group counseling note |
|
80813-9
|
Geriatric medicine History and physical note |
|
84114-8
|
Geriatric medicine Hospital Note |
|
80814-7
|
Geriatric medicine Initial evaluation note |
|
84124-7
|
Geriatric medicine Interdisciplinary Plan of care note |
|
84115-5
|
Geriatric medicine Long term care facility Consult note |
|
84116-3
|
Geriatric medicine Long term care facility Note |
|
84117-1
|
Geriatric medicine Long term care facility Plan of care note |
|
85445-5
|
Geriatric medicine Note |
|
83545-4
|
Geriatric medicine Nurse practitioner Note |
|
83621-3
|
Geriatric medicine Nurse Consult note |
|
83622-1
|
Geriatric medicine Nurse Note |
|
83623-9
|
Geriatric medicine Nurse Outpatient Note |
|
83624-7
|
Geriatric medicine Nurse Risk assessment and screening note |
|
34902-7
|
Geriatric medicine Outpatient Education note |
|
84118-9
|
Geriatric medicine Outpatient Initial evaluation note |
|
84119-7
|
Geriatric medicine Outpatient Note |
|
84120-5
|
Geriatric medicine Pharmacist Note |
|
84123-9
|
Geriatric medicine Telephone encounter Note |
|
80818-8
|
Geriatric medicine Plan of care note |
|
82355-9
|
Geriatric medicine procedure note |
|
80815-4
|
Geriatric medicine Progress note |
|
84113-0
|
Geriatric medicine Patient's home Note |
|
57171-1
|
Geriatric medicine Referral note |
|
83757-5
|
Geriatric medicine Resident Note |
|
84121-3
|
Geriatric medicine Risk assessment and screening note |
|
68672-5
|
Geriatric medicine Skilled nursing facility Note |
|
84122-1
|
Geriatric medicine Team Note |
|
80816-2
|
Geriatric medicine Transfer summary note |
|
48542-5
|
Geriatric depression scale (GDS) panel |
|
48543-3
|
Geriatric depression scale (GDS).short version panel |
|
93737-5
|
German turnip IgE Ab [Units/volume] in Serum |
|
60079-1
|
Germanium [Mass/volume] in Blood |
|
76649-3
|
Germanium [Mass/mass] in Hair |
|
50851-5
|
Germanium [Moles/mass] in Hair |
|
60080-9
|
Germanium [Mass/volume] in Red Blood Cells |
|
60081-7
|
Germanium [Mass/volume] in Serum or Plasma |
|
5655-6
|
Germanium [Mass/volume] in Urine |
|
50582-6
|
Glucose tolerance gestational panel - Urine and Serum or Plasma |
|
58038-1
|
Gestrinone [Presence] in Urine |
|
26644-5
|
Getah virus Ab [Presence] in Serum |
|
10484-4
|
Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
|
93422-4
|
Glial fibrillary acidic protein.alpha IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93424-0
|
Glial fibrillary acidic protein.alpha IgG Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
47959-2
|
GFAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93421-6
|
Glial fibrillary acidic protein IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
93423-2
|
Glial fibrillary acidic protein IgG Ab [Titer] in Serum by Immunofluorescence |
|
77089-1
|
GFM1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77088-3
|
GFM1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
88293-6
|
Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) |
|
88294-4
|
Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) |
|
76633-7
|
Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD) in Blood |
|
33914-3
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) |
|
62238-1
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) |
|
50210-4
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin-based formula |
|
77147-7
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) |
|
50384-7
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz) |
|
69405-9
|
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood |
|
2320-0
|
Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Red Blood Cells |
|
2321-8
|
Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Serum |
|
58768-3
|
Gamma glutamyl transferase [Enzymatic activity/time] in 24 hour Urine |
|
2322-6
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Amniotic fluid |
|
53432-1
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Dialysis fluid |
|
17858-2
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid |
|
2324-2
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma |
|
2323-4
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |
|
27403-5
|
Gamma glutamyl transferase [Enzymatic activity/volume] in Urine |
|
92666-7
|
Growth hormone and glucose post cloNIDine stimulation panel - Serum or Plasma |
|
49942-6
|
Somatotropin [Units/volume] in Serum or Plasma --1 AM specimen |
|
79204-4
|
Somatotropin [Mass/volume] in Serum or Plasma --1.25 hours post dose arginine+insulin |
|
40304-8
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine |
|
79205-1
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose arginine+insulin |
|
79174-9
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
14147-3
|
Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
47887-5
|
Somatotropin [Units/volume] in Serum or Plasma --1.5 hours post dose ornithine |
|
81753-6
|
Somatotropin [Mass/volume] in Serum or Plasma --1.75 hours post dose arginine+insulin |
|
49943-4
|
Somatotropin [Units/volume] in Serum or Plasma --1:30 am specimen |
|
49944-2
|
Somatotropin [Units/volume] in Serum or Plasma --10 PM specimen |
|
49945-9
|
Somatotropin [Units/volume] in Serum or Plasma --10:30 PM specimen |
|
46412-3
|
Somatotropin [Mass/volume] in Serum or Plasma --105 minutes post dose arginine |
|
49946-7
|
Somatotropin [Units/volume] in Serum or Plasma --11 PM specimen |
|
49947-5
|
Somatotropin [Units/volume] in Serum or Plasma --11:30 PM specimen |
|
49948-3
|
Somatotropin [Units/volume] in Serum or Plasma --12 PM specimen |
|
49949-1
|
Somatotropin [Units/volume] in Serum or Plasma --12:30 PM specimen |
|
79199-6
|
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin |
|
79181-4
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
14142-4
|
Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
48122-6
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes post dose TRH |
|
82902-8
|
Somatotropin [Units/volume] in Serum or Plasma --15 minutes pre XXX challenge |
|
79203-6
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin |
|
79175-6
|
Somatotropin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
|
14146-5
|
Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
49950-9
|
Somatotropin [Units/volume] in Serum or Plasma --2 AM specimen |
|
47898-2
|
Somatotropin [Units/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin |
|
79198-8
|
Somatotropin [Mass/volume] in Serum or Plasma --2.25 hours post dose arginine+insulin |
|
48074-9
|
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin |
|
79200-2
|
Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post dose arginine+insulin |
|
79172-3
|
Somatotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
27369-8
|
Somatotropin [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
49951-7
|
Somatotropin [Units/volume] in Serum or Plasma --2:30 am specimen |
|
50685-7
|
Somatotropin [Mass/time] in 24 hour Urine |
|
40305-5
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine |
|
79197-0
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post dose arginine+insulin |
|
79173-1
|
Somatotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
|
14144-0
|
Somatotropin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
49952-5
|
Somatotropin [Units/volume] in Serum or Plasma --3 AM specimen |
|
49953-3
|
Somatotropin [Units/volume] in Serum or Plasma --3:30 AM specimen |
|
79201-0
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin |
|
79176-4
|
Somatotropin [Units/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
15347-8
|
Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
|
56500-2
|
Somatotropin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
49954-1
|
Somatotropin [Units/volume] in Serum or Plasma --4 AM specimen |
|
49955-8
|
Somatotropin [Units/volume] in Serum or Plasma --4:30 AM specimen |
|
79202-8
|
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin |
|
79180-6
|
Somatotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
56499-7
|
Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
49956-6
|
Somatotropin [Units/volume] in Serum or Plasma --5 AM specimen |
|
49957-4
|
Somatotropin [Units/volume] in Serum or Plasma --5:30 AM specimen |
|
49958-2
|
Somatotropin [Units/volume] in Serum or Plasma --6 AM specimen |
|
79179-8
|
Somatotropin [Units/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
53144-2
|
Somatotropin [Mass/volume] in Serum or Plasma --75 minutes post XXX challenge |
|
14253-9
|
Somatotropin Ab [Presence] in Serum or Plasma |
|
5359-5
|
Somatotropin Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
8096-0
|
Somatotropin Ab [Units/volume] in Serum or Plasma |
|
11014-8
|
Somatotropin Ab [Titer] in Serum or Plasma |
|
10513-0
|
Somatotropin Ag [Presence] in Tissue by Immune stain |
|
2962-9
|
Somatotropin [Mass/volume] in Amniotic fluid |
|
33858-2
|
Somatotropin [Units/volume] in Serum or Plasma |
|
2963-7
|
Somatotropin [Mass/volume] in Serum or Plasma |
|
25529-9
|
Somatotropin [Moles/volume] in Serum or Plasma |
|
33859-0
|
Somatotropin/Creatinine [Ratio] in 12 hour Urine |
|
33860-8
|
Somatotropin/Creatinine [Ratio] in 24 hour Urine |
|
44407-5
|
Somatotropin/Creatinine [Mass Ratio] in Urine |
|
90048-0
|
Somatotropin binding protein [Mass/volume] in Serum or Plasma by Immunoassay |
|
11015-5
|
Somatotropin binding protein [Moles/volume] in Serum or Plasma |
|
76474-6
|
Ghrelin [Mass/volume] in Serum or Plasma |
|
12284-6
|
Growth hormone-releasing hormone [Units/volume] in Serum or Plasma |
|
14177-0
|
Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma |
|
92695-6
|
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection |
|
92697-2
|
Gastrointestinal parasitic pathogens panel - Stool by NAA with probe detection |
|
82195-9
|
Gastrointestinal pathogens DNA and RNA panel - Stool by NAA with non-probe detection |
|
82305-4
|
Gastrointestinal pathogens panel - Stool by Culture |
|
79381-0
|
Gastrointestinal pathogens panel - Stool by NAA with probe detection |
|
92696-4
|
Gastrointestinal viral pathogens panel - Stool by NAA with probe detection |
|
54911-3
|
Giant grouper IgE Ab [Units/volume] in Serum |
|
50636-0
|
Giant Japanese spider crab IgE Ab [Units/volume] in Serum |
|
7649-7
|
Giant Ragweed triggered histamine release [Units/volume] in Blood |
|
6124-2
|
Giant Ragweed IgE Ab [Units/volume] in Serum |
|
61215-0
|
Giant Ragweed IgE Ab/IgE total in Serum |
|
24151-3
|
Giant Ragweed IgG Ab [Units/volume] in Serum |
|
56370-0
|
Giant Ragweed IgG4 Ab [Mass/volume] in Serum |
|
48255-4
|
Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes |
|
27265-8
|
Giardia sp Ag [Presence] in Stool |
|
91761-7
|
Giardia sp Ag [Presence] in Stool by Rapid immunoassay |
|
91767-4
|
Giardia sp DNA [Presence] in Duodenal fluid by NAA with probe detection |
|
91836-7
|
Giardia sp DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
90299-9
|
Giardia sp DNA [Presence] in Stool by NAA with probe detection |
|
87970-0
|
Microscopic observation [Identifier] in Amniotic fluid by Giemsa stain |
|
88684-6
|
Microscopic observation [Identifier] in Aspirate by Giemsa stain |
|
90261-9
|
Microscopic observation [Identifier] in Bile fluid by Giemsa stain |
|
51714-4
|
Microscopic observation [Identifier] in Blood by Giemsa stain |
|
87965-0
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Giemsa stain |
|
87968-4
|
Microscopic observation [Identifier] in Body fluid by Giemsa stain |
|
91850-8
|
Microscopic observation [Identifier] in Genital specimen by Giemsa stain |
|
88633-3
|
Microscopic observation [Identifier] in Lower respiratory specimen by Giemsa stain |
|
87966-8
|
Microscopic observation [Identifier] in Bone marrow by Giemsa stain |
|
88150-8
|
Microscopic observation [Identifier] in Ocular fluid by Giemsa stain |
|
90267-6
|
Microscopic observation [Identifier] in Pericardial fluid by Giemsa stain |
|
88000-5
|
Microscopic observation [Identifier] in Pleural fluid by Giemsa stain |
|
90268-4
|
Microscopic observation [Identifier] in Peritoneal fluid by Giemsa stain |
|
88235-7
|
Microscopic observation [Identifier] in Synovial fluid by Giemsa stain |
|
6662-1
|
Microscopic observation [Identifier] in Tissue by Giemsa stain |
|
662-7
|
Microscopic observation [Identifier] in Unspecified specimen by Giemsa stain |
|
6663-9
|
Microscopic observation [Identifier] in Tissue by Gimenez stain |
|
663-5
|
Microscopic observation [Identifier] in Unspecified specimen by Gimenez stain |
|
7335-3
|
Ginger IgE Ab [Units/volume] in Serum |
|
61328-1
|
Ginger IgE Ab/IgE total in Serum |
|
7336-1
|
Ginger IgG Ab [Units/volume] in Serum |
|
56267-8
|
Ginger IgG4 Ab [Mass/volume] in Serum |
|
60375-3
|
Ginger IgG Ab [Mass/volume] in Serum |
|
2326-7
|
Gastric inhibitory polypeptide [Mass/volume] in Plasma |
|
81858-3
|
GJB1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
41102-5
|
GJB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34653-6
|
GJB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82138-9
|
GJB2 gene c.35delG targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
90851-7
|
GJB2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
41101-7
|
GJB2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35300-3
|
GJB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
71358-6
|
GJB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41100-9
|
GJB6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34504-1
|
GJB6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
76036-3
|
GLA gene full mutation analysis in Blood or Tissue by Sequencing |
|
41099-3
|
GLA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34515-7
|
GLA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7337-9
|
Gladiolus IgE Ab [Units/volume] in Serum |
|
35088-4
|
Glasgow coma scale |
|
93331-7
|
Glycolithocholate [Moles/volume] in Serum or Plasma |
|
47860-2
|
Glutamate dehydrogenase [Enzymatic activity/mass] in Chorionic villus sample |
|
2367-1
|
Glutamate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
49940-0
|
Glutamate dehydrogenase [Enzymatic activity/mass] in Leukocytes |
|
92733-5
|
Glecaprevir [Susceptibility] by Genotype method |
|
79405-7
|
1,4-Alpha glucan branching enzyme [Enzymatic activity/mass] in Fibroblast |
|
1650-1
|
1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes |
|
16900-3
|
Gliadin Ab [Units/volume] in Saliva (oral fluid) |
|
53025-3
|
Gliadin Ab [Presence] in Serum |
|
7893-1
|
Gliadin Ab [Units/volume] in Serum |
|
20495-8
|
Gliadin IgA Ab [Units/volume] in Serum by Immunoassay |
|
16901-1
|
Gliadin IgA Ab [Presence] in Serum |
|
6924-5
|
Gliadin IgA Ab [Units/volume] in Serum |
|
63260-4
|
Gliadin IgA Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
20496-6
|
Gliadin IgG Ab [Units/volume] in Serum by Immunoassay |
|
16902-9
|
Gliadin IgG Ab [Presence] in Serum |
|
5170-6
|
Gliadin IgG Ab [Units/volume] in Serum |
|
63261-2
|
Gliadin IgG Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
8070-5
|
Gliadin IgM Ab [Units/volume] in Serum |
|
57776-7
|
Gliadin peptide IgA and IgG panel - Serum |
|
63453-5
|
Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay |
|
47393-4
|
Gliadin peptide IgA Ab [Presence] in Serum by Immunoassay |
|
58709-7
|
Gliadin peptide IgA Ab [Units/volume] in Serum |
|
63459-2
|
Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay |
|
47394-2
|
Gliadin peptide IgG Ab [Presence] in Serum by Immunoassay |
|
58710-5
|
Gliadin peptide IgG Ab [Units/volume] in Serum |
|
63420-4
|
Gliadin peptide+tissue transglutaminase IgA+IgG Ab [Presence] in Serum by Immunoassay |
|
90828-5
|
Glial nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
90827-7
|
Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
88726-5
|
Glial nuclear type 1 Ab [Units/volume] in Serum by Line blot |
|
84927-3
|
Glial nuclear type 1 Ab [Presence] in Serum by Immunofluorescence |
|
82444-1
|
Glial nuclear type 1 Ab [Presence] in Serum by Line blot |
|
53714-2
|
Glial nuclear type 1 Ab [Titer] in Cerebral spinal fluid |
|
53709-2
|
Glial nuclear type 1 Ab [Titer] in Serum |
|
83001-8
|
Glial nuclear type 1 IgG Ab [Presence] in Serum or Plasma by Line blot |
|
74094-4
|
Gliclazide [Mass/volume] in Serum or Plasma |
|
73363-4
|
Glimepride induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73362-6
|
Glimepride induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48325-5
|
Glimepride [Presence] in Serum or Plasma |
|
40465-7
|
Glimepride [Mass/volume] in Serum or Plasma |
|
73691-8
|
Glimepride [Mass/volume] in Urine |
|
75119-8
|
Gamma Linolenate (C18:3w6) [Entitic substance] in Red Blood Cells |
|
73360-0
|
Glipizide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73361-8
|
Glipizide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48326-3
|
Glipizide [Presence] in Serum or Plasma |
|
10539-5
|
Glipizide [Mass/volume] in Serum or Plasma |
|
47204-3
|
Glipizide [Presence] in Urine |
|
27025-6
|
Glipizide [Mass/volume] in Urine |
|
48319-8
|
Glipizide [Presence] in Unspecified specimen |
|
6944-3
|
Glipizide [Mass/volume] in Unspecified specimen |
|
74093-6
|
Gliquidone [Mass/volume] in Serum or Plasma |
|
77574-2
|
Global measure of physical function panel APTA |
|
90234-6
|
Globotriaosylsphingosine [Mass/volume] in Serum |
|
15356-9
|
Globulin [Mass/time] in 24 hour Urine |
|
14425-3
|
Globulin [Mass/volume] in Amniotic fluid |
|
14426-1
|
Globulin [Mass/volume] in Cerebral spinal fluid |
|
12217-6
|
Globulin [Mass/volume] in Body fluid |
|
13536-8
|
Globulin [Mass/volume] in Plasma |
|
14427-9
|
Globulin [Mass/volume] in Pleural fluid |
|
14428-7
|
Globulin [Mass/volume] in Peritoneal fluid |
|
10834-0
|
Globulin [Mass/volume] in Serum by calculation |
|
2336-6
|
Globulin [Mass/volume] in Serum |
|
14429-5
|
Globulin [Mass/volume] in Semen |
|
14430-3
|
Globulin [Mass/volume] in Synovial fluid |
|
18320-2
|
Globulin [Mass/volume] in Urine by calculation |
|
49047-4
|
Globulin [Mass/volume] in Urine by Electrophoresis |
|
14431-1
|
Globulin [Mass/volume] in Urine |
|
47960-0
|
GLRA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
50583-4
|
Glucose screen gestational panel - Urine and Serum or Plasma |
|
44361-4
|
Glutamate+Glutamine/Creatinine [Mass Ratio] in Urine |
|
44360-6
|
Glutamate+Glutamine/Creatinine [Molar ratio] in Urine |
|
15134-0
|
Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma |
|
15144-9
|
Glutamate+Glutamine+Threonine [Presence] in Urine |
|
10485-1
|
Glucagon Ag [Presence] in Tissue by Immune stain |
|
2337-4
|
Glucagon [Mass/volume] in Amniotic fluid |
|
2338-2
|
Glucagon [Mass/volume] in Serum or Plasma |
|
66734-5
|
Glucagon [Mass or Moles/volume] in Serum or Plasma |
|
15073-0
|
Glucagon [Moles/volume] in Serum or Plasma |
|
81322-0
|
Glucan 1,4 alpha glucosidase [Enzymatic activity/mass] in Small intestine Tissue |
|
35662-6
|
Glucose [Mass/volume] in Urine collected for unspecified duration |
|
74351-8
|
Glucose [Moles/volume] in Urine collected for unspecified duration |
|
6762-9
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO |
|
80959-0
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post meal |
|
1493-6
|
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
|
48991-4
|
Glucose [Mass/volume] in Serum or Plasma --10 PM specimen |
|
21307-4
|
Glucose [Mass/time] in 10 hour Urine |
|
92819-2
|
Glucose [Mass/volume] in Serum or Plasma --10 minutes post dose glucagon |
|
54401-5
|
Glucose [Moles/volume] in Serum or Plasma --10 minutes post dose glucagon |
|
59812-8
|
Glucose [Moles/volume] in Serum or Plasma --11 AM specimen |
|
26817-7
|
Glucose [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
|
48992-2
|
Glucose [Mass/volume] in Serum or Plasma --12 AM specimen |
|
45052-8
|
Glucose [Moles/volume] in Serum or Plasma --12 AM specimen |
|
48988-0
|
Glucose [Mass/volume] in Serum or Plasma --12 PM specimen |
|
45054-4
|
Glucose [Moles/volume] in Serum or Plasma --12 PM specimen |
|
18354-1
|
Glucose [Mass/volume] in Serum or Plasma --12 hours post 50 g lactose PO |
|
12647-4
|
Glucose [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
|
12220-0
|
Glucose [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
|
74687-5
|
Glucose [Moles/volume] in 12 hour Urine |
|
74686-7
|
Glucose [Moles/time] in 12 hour Urine |
|
74084-5
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post 50 g lactose PO |
|
79193-9
|
Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose arginine+insulin |
|
72896-4
|
Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO |
|
58997-8
|
Glucose [Mass/time] in 18 hour Urine |
|
1499-3
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV |
|
30344-6
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 1.2 g/kg lactose PO |
|
1501-6
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
|
14753-8
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
|
1503-2
|
Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO |
|
1504-0
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
|
14754-6
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
|
1505-7
|
Glucose [Mass/volume] in Urine --1 hour post 50 g glucose PO |
|
1506-5
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
|
14755-3
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
|
6747-0
|
Glucose [Presence] in Urine by Test strip --1 hour post 50 g lactose PO |
|
1507-3
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
|
6748-8
|
Glucose [Presence] in Urine by Test strip --1 hour post 75 g glucose PO |
|
1509-9
|
Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO |
|
79196-2
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose arginine+insulin |
|
12646-6
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
25665-1
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
|
20438-8
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose |
|
14756-1
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
|
26546-2
|
Glucose [Presence] in Urine by Test strip --1 hour post dose glucose |
|
25664-4
|
Glucose [Mass/volume] in Urine --1 hour post dose glucose |
|
1510-7
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
|
26778-1
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post dose lactose PO |
|
10449-7
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
|
40287-5
|
Glucose [Moles/volume] in Serum or Plasma --1 hour post meal |
|
1500-8
|
Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
45298-7
|
Glucose [Moles/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO |
|
69943-9
|
Glucose [Moles/volume] in Serum or Plasma --20 minutes post 50 g lactose PO |
|
92818-4
|
Glucose [Mass/volume] in Serum or Plasma --20 minutes post dose glucagon |
|
69941-3
|
Glucose [Moles/volume] in Serum or Plasma --20 minutes post dose lactose PO |
|
12629-2
|
Glucose [Mass/volume] in 24 hour Peritoneal dialysis fluid |
|
45297-9
|
Glucose [Moles/volume] in 24 hour Dialysis fluid |
|
40366-7
|
Glucose [Moles/time] in 24 hour Body fluid |
|
48787-6
|
Glucose [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis |
|
55860-1
|
Glucose [Mass/time] in 24 hour Stool |
|
32174-5
|
Glucose [Presence] in 24 hour Urine |
|
21305-8
|
Glucose [Mass/volume] in 24 hour Urine |
|
2351-5
|
Glucose [Mass/time] in 24 hour Urine |
|
25916-8
|
Glucose [Moles/volume] in 24 hour Urine |
|
15077-1
|
Glucose [Moles/time] in 24 hour Urine |
|
30345-3
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post 1.2 g/kg lactose PO |
|
1514-9
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
|
14757-9
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
|
1516-4
|
Glucose [Mass/volume] in Urine --2 hours post 100 g glucose PO |
|
1517-2
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
|
14758-7
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
|
6750-4
|
Glucose [Presence] in Urine by Test strip --2 hours post 50 g lactose PO |
|
1518-0
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
14995-5
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
6751-2
|
Glucose [Presence] in Urine by Test strip --2 hours post 75 g glucose PO |
|
1520-6
|
Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO |
|
12610-2
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
|
25668-5
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
|
49134-0
|
Glucose [Mass/volume] in Blood --2 hours post dose glucose |
|
20436-2
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose |
|
14759-5
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
|
26547-0
|
Glucose [Presence] in Urine by Test strip --2 hours post dose glucose |
|
25667-7
|
Glucose [Mass/volume] in Urine --2 hours post dose glucose |
|
26780-7
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose lactose PO |
|
14760-3
|
Glucose [Moles/volume] in Capillary blood --2 hours post meal |
|
6689-4
|
Glucose [Mass/volume] in Blood --2 hours post meal |
|
43278-1
|
Glucose [Mass/volume] in Milk --2 hours post meal |
|
77677-3
|
Glucose [Moles/volume] in Serum, Plasma or Blood --2 hours post meal |
|
1521-4
|
Glucose [Mass/volume] in Serum or Plasma --2 hours post meal |
|
14761-1
|
Glucose [Moles/volume] in Serum or Plasma --2 hours post meal |
|
12218-4
|
Glucose [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
|
46221-8
|
Glucose [Moles/volume] in Dialysis fluid --2 hour specimen |
|
48993-0
|
Glucose [Mass/volume] in Serum or Plasma --3 AM specimen |
|
59815-1
|
Glucose [Moles/volume] in Serum or Plasma --3 PM specimen |
|
1526-3
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
|
79194-7
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine+insulin |
|
92817-6
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucagon |
|
20439-6
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose glucose |
|
1523-0
|
Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
20437-0
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post dose glucose |
|
26781-5
|
Glucose [Mass/volume] in Serum or Plasma --3 hours post dose lactose PO |
|
45055-1
|
Glucose [Moles/volume] in Serum or Plasma --4 PM specimen |
|
69944-7
|
Glucose [Moles/volume] in Serum or Plasma --40 minutes post 50 g lactose PO |
|
69942-1
|
Glucose [Moles/volume] in Serum or Plasma --40 minutes post dose lactose PO |
|
75637-9
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post 50 g lactose PO |
|
79195-4
|
Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose arginine+insulin |
|
45299-5
|
Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose lactose PO |
|
46222-6
|
Glucose [Moles/volume] in Dialysis fluid --4 hour specimen |
|
48994-8
|
Glucose [Mass/volume] in Serum or Plasma --6 AM specimen |
|
48989-8
|
Glucose [Mass/volume] in Serum or Plasma --6 PM specimen |
|
18227-9
|
Glucose [Mass/time] in 6 hour Urine |
|
59813-6
|
Glucose [Moles/volume] in Capillary blood by Glucometer --7 AM specimen |
|
59814-4
|
Glucose [Moles/volume] in Serum or Plasma --7 AM specimen |
|
12614-4
|
Glucose [Mass/volume] in Serum or Plasma --7 hours post meal |
|
48986-4
|
Glucose [Mass/volume] in Serum or Plasma --8 AM specimen |
|
45053-6
|
Glucose [Moles/volume] in Serum or Plasma --8 AM specimen |
|
48990-6
|
Glucose [Mass/volume] in Serum or Plasma --8 PM specimen |
|
45056-9
|
Glucose [Moles/volume] in Serum or Plasma --8 PM specimen |
|
21306-6
|
Glucose [Mass/time] in 8 hour Urine |
|
6300-8
|
Glucose [Mass/volume] in Amniotic fluid |
|
2341-6
|
Glucose [Mass/volume] in Blood by Test strip manual |
|
5914-7
|
Glucose [Presence] in Blood by Test strip |
|
2340-8
|
Glucose [Mass/volume] in Blood by Automated test strip |
|
72516-8
|
Glucose [Moles/volume] in Blood by Automated test strip |
|
41651-1
|
Glucose [Mass/volume] in Arterial blood |
|
39481-7
|
Glucose [Moles/volume] in Arterial blood |
|
41653-7
|
Glucose [Mass/volume] in Capillary blood by Glucometer |
|
14743-9
|
Glucose [Moles/volume] in Capillary blood by Glucometer |
|
32016-8
|
Glucose [Mass/volume] in Capillary blood |
|
47995-6
|
Glucose [Moles/volume] in Cord blood |
|
51596-5
|
Glucose [Moles/volume] in Capillary blood |
|
2339-0
|
Glucose [Mass/volume] in Blood |
|
15074-8
|
Glucose [Moles/volume] in Blood |
|
41652-9
|
Glucose [Mass/volume] in Venous blood |
|
39480-9
|
Glucose [Moles/volume] in Venous blood |
|
81637-1
|
Glucose meter to reference method correlation [Ratio] in Serum, Plasma or Blood by calculation |
|
2342-4
|
Glucose [Mass/volume] in Cerebral spinal fluid |
|
14744-7
|
Glucose [Moles/volume] in Cerebral spinal fluid |
|
12628-4
|
Glucose [Mass/volume] in Peritoneal dialysis fluid |
|
14746-2
|
Glucose [Moles/volume] in Peritoneal dialysis fluid |
|
2343-2
|
Glucose [Mass/volume] in Dialysis fluid |
|
15075-5
|
Glucose [Moles/volume] in Dialysis fluid |
|
53084-0
|
Glucose [Moles/volume] in Nonbiological fluid |
|
2344-0
|
Glucose [Mass/volume] in Body fluid |
|
14745-4
|
Glucose [Moles/volume] in Body fluid |
|
14386-7
|
Glucose [Mass/volume] in Gastric fluid |
|
74790-7
|
Glucose challenge (hydrogen breath test) panel - Exhaled gas |
|
93791-2
|
Glucose [Mass/volume] mean in Serum or Plasma |
|
43151-0
|
Glucose meter device panel |
|
46223-4
|
Glucose [Moles/volume] in Dialysis fluid --overnight |
|
79264-8
|
Glucose [Moles/volume] in Peritoneal dialysis fluid --overnight dwell |
|
10450-5
|
Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |
|
1554-5
|
Glucose [Mass/volume] in Serum or Plasma --12 hours fasting |
|
1555-2
|
Glucose [Mass/volume] in Urine --12 hours fasting |
|
17865-7
|
Glucose [Mass/volume] in Serum or Plasma --8 hours fasting |
|
54495-7
|
Glucose [Moles/volume] in Serum or Plasma --post dialysis |
|
14770-2
|
Fasting glucose [Moles/volume] in Capillary blood by Glucometer |
|
1556-0
|
Fasting glucose [Mass/volume] in Capillary blood |
|
76629-5
|
Fasting glucose [Moles/volume] in Blood |
|
1557-8
|
Fasting glucose [Mass/volume] in Venous blood |
|
77145-1
|
Fasting glucose [Moles/volume] in Serum, Plasma or Blood |
|
1558-6
|
Fasting glucose [Mass/volume] in Serum or Plasma |
|
35184-1
|
Fasting glucose [Mass or Moles/volume] in Serum or Plasma |
|
14771-0
|
Fasting glucose [Moles/volume] in Serum or Plasma |
|
16913-6
|
Fasting glucose [Presence] in Urine |
|
6764-5
|
Fasting glucose [Presence] in Urine by Test strip |
|
92820-0
|
Glucose post glucagon stimulation panel - Serum or Plasma |
|
87422-2
|
Glucose [Mass/volume] in Blood --post meal |
|
16915-1
|
Glucose [Mass/volume] in Serum or Plasma --post meal |
|
33405-2
|
Glucose [Mass/volume] in Pericardial fluid |
|
39479-1
|
Glucose [Moles/volume] in Pericardial fluid |
|
2346-5
|
Glucose [Mass/volume] in Pleural fluid |
|
14747-0
|
Glucose [Moles/volume] in Pleural fluid |
|
70208-4
|
Glucose [Moles/volume] in Serum or Plasma --pre 100 g glucose PO |
|
1550-3
|
Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
|
14769-4
|
Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast |
|
54400-7
|
Glucose [Moles/volume] in Serum or Plasma --pre dose glucagon |
|
88365-2
|
Glucose [Mass/volume] in Blood --pre-meal |
|
53049-3
|
Glucose [Mass/volume] in Serum or Plasma --pre-meal |
|
40193-5
|
Glucose [Moles/volume] in Serum or Plasma --pre-meal |
|
2347-3
|
Glucose [Mass/volume] in Peritoneal fluid |
|
14748-8
|
Glucose [Moles/volume] in Peritoneal fluid |
|
72650-5
|
Glucose in serum - glucose in pericard fld [Molar concentration difference] |
|
72651-3
|
Glucose in serum - glucose in pleural fluid [Molar concentration difference] |
|
72649-7
|
Glucose in serum - glucose in peritoneal fluid [Molar concentration difference] |
|
72648-9
|
Glucose in serum - glucose in synovial fluid [Molar concentration difference] |
|
74774-1
|
Glucose [Mass/volume] in Serum, Plasma or Blood |
|
77135-2
|
Glucose [Moles/volume] in Serum, Plasma or Blood |
|
2345-7
|
Glucose [Mass/volume] in Serum or Plasma |
|
35211-2
|
Glucose [Mass or Moles/volume] in Serum or Plasma |
|
14749-6
|
Glucose [Moles/volume] in Serum or Plasma |
|
2348-1
|
Glucose [Mass/volume] in Synovial fluid |
|
14750-4
|
Glucose [Moles/volume] in Synovial fluid |
|
54392-6
|
Glucose [Moles/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
50206-2
|
Glucose [Mass/volume] in Serum or Plasma --1st specimen |
|
54393-4
|
Glucose [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
|
50208-8
|
Glucose [Mass/volume] in Serum or Plasma --10th specimen |
|
54394-2
|
Glucose [Moles/volume] in Serum or Plasma --11th specimen post XXX challenge |
|
54395-9
|
Glucose [Moles/volume] in Serum or Plasma --12th specimen post XXX challenge |
|
54396-7
|
Glucose [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
50212-0
|
Glucose [Mass/volume] in Serum or Plasma --2nd specimen |
|
54397-5
|
Glucose [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
50213-8
|
Glucose [Mass/volume] in Serum or Plasma --3rd specimen |
|
54398-3
|
Glucose [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
50214-6
|
Glucose [Mass/volume] in Serum or Plasma --4th specimen |
|
54496-5
|
Glucose [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
50215-3
|
Glucose [Mass/volume] in Serum or Plasma --5th specimen |
|
54497-3
|
Glucose [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
50216-1
|
Glucose [Mass/volume] in Serum or Plasma --6th specimen |
|
54498-1
|
Glucose [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
50207-0
|
Glucose [Mass/volume] in Serum or Plasma --7th specimen |
|
54499-9
|
Glucose [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
50217-9
|
Glucose [Mass/volume] in Serum or Plasma --8th specimen |
|
54399-1
|
Glucose [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
50218-7
|
Glucose [Mass/volume] in Serum or Plasma --9th specimen |
|
57797-3
|
Glucose [Mass/volume] in Stool by Post hydrolysis |
|
51595-7
|
Glucose [Presence] in Stool |
|
48036-8
|
Glucose [Mass/volume] in Stool |
|
47620-0
|
Glucose [Moles/volume] in Stool |
|
53868-6
|
Glucose tetrasaccharide/Creatinine [Molar ratio] in Urine |
|
53050-1
|
Glucose [Mass/volume] in Total parental nutrition |
|
76669-1
|
Glucose [Moles/volume] in Cerebral spinal fluid --1st tube |
|
76670-9
|
Glucose [Moles/volume] in Cerebral spinal fluid --2nd tube |
|
76671-7
|
Glucose [Moles/volume] in Cerebral spinal fluid --3rd tube |
|
76672-5
|
Glucose [Moles/volume] in Cerebral spinal fluid --4th tube |
|
2349-9
|
Glucose [Presence] in Urine |
|
25428-4
|
Glucose [Presence] in Urine by Test strip |
|
5792-7
|
Glucose [Mass/volume] in Urine by Test strip |
|
22705-8
|
Glucose [Moles/volume] in Urine by Test strip |
|
2350-7
|
Glucose [Mass/volume] in Urine |
|
35212-0
|
Glucose [Mass or Moles/volume] in Urine |
|
15076-3
|
Glucose [Moles/volume] in Urine |
|
16903-7
|
Glucose [Mass/volume] in Vitreous fluid |
|
39478-3
|
Glucose [Moles/volume] in Vitreous fluid |
|
54486-6
|
Glucose [Mass/volume] in Water |
|
54487-4
|
Glucose [Moles/volume] in Water |
|
32318-8
|
Glucose [Moles/volume] in Unspecified specimen |
|
57004-4
|
Glucose/Creatinine [Mass Ratio] in 24 hour Urine |
|
33352-6
|
Glucose/Creatinine [Mass Ratio] in Urine |
|
40488-9
|
Glucose/Creatinine [Ratio] in Urine |
|
34312-9
|
Glucose/Creatinine [Molar ratio] in Urine |
|
10577-5
|
Glucosidase [Enzymatic activity/volume] in Seminal plasma |
|
44037-0
|
Glucosylceramidase [Presence] in Blood |
|
55917-9
|
Glucosylceramidase [Enzymatic activity/volume] in DBS |
|
25829-3
|
Glucosylceramidase [Enzymatic activity/mass] in Fibroblast |
|
38477-6
|
Glucosylceramidase [Enzymatic activity/volume] in Serum or Plasma |
|
18195-8
|
Glucosylceramidase [Presence] in Tissue |
|
2361-4
|
Glucosylceramidase [Enzymatic activity/mass] in Tissue |
|
33661-0
|
Glucosylceramidase [Entitic Catalytic Activity] in Leukocytes |
|
1943-0
|
Glucosylceramidase [Enzymatic activity/volume] in Leukocytes |
|
32540-7
|
Glucosylceramidase [Enzymatic activity/mass] in Leukocytes |
|
35303-7
|
Glucosylceramidase [Enzymatic activity/mass] in Unspecified specimen |
|
53183-0
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS |
|
51414-1
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma |
|
53186-3
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
53184-8
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS |
|
53185-5
|
Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS |
|
67710-4
|
Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS |
|
30473-3
|
Glutaconate [Presence] in Urine |
|
13745-5
|
Glutaconate/Creatinine [Mass Ratio] in Urine |
|
25103-3
|
Glutaconate/Creatinine [Molar ratio] in Urine |
|
47623-4
|
Glutamate [Moles/volume] in DBS |
|
55861-9
|
Glutamate [Moles/mass] in Hair |
|
48304-0
|
Glutamate triggered leukotriene release [Mass/volume] by Leukocytes |
|
47626-7
|
Glutamate/Amino acids.total in Amniotic fluid |
|
47625-9
|
Glutamate/Amino acids.total in Cerebral spinal fluid |
|
47628-3
|
Glutamate/Amino acids.total in DBS |
|
47624-2
|
Glutamate/Amino acids.total in Hair |
|
47627-5
|
Glutamate/Amino acids.total in Serum or Plasma |
|
47629-1
|
Glutamate/Amino acids.total in Unspecified specimen |
|
44359-8
|
Glutamate/Creatinine [Mass Ratio] in 24 hour Urine |
|
56644-8
|
Glutamate/Creatinine [Ratio] in 24 hour Urine |
|
47630-9
|
Glutamine [Moles/volume] in DBS |
|
44362-2
|
Glutamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56680-2
|
Glutamine/Creatinine [Ratio] in 24 hour Urine |
|
58921-8
|
Glutamine+Histidine [Moles/volume] in Cerebral spinal fluid |
|
58930-9
|
Glutamine+Histidine [Moles/volume] in Serum or Plasma |
|
58927-5
|
Glutamine+Histidine/Creatinine [Ratio] in Urine |
|
33933-3
|
Glutaraldehyde IgE Ab [Units/volume] in Serum |
|
23866-7
|
Glutaraldehyde [Presence] in Urine |
|
54278-7
|
Glutarate [Moles/volume] in Cerebral spinal fluid |
|
82504-2
|
Glutarate [Moles/volume] in DBS |
|
35133-8
|
Glutarate [Mass/volume] in Serum or Plasma |
|
27301-1
|
Glutarate [Moles/volume] in Serum or Plasma |
|
30474-1
|
Glutarate [Presence] in Urine |
|
44363-0
|
Glutarate/Creatinine [Mass Ratio] in 24 hour Urine |
|
44364-8
|
Glutarate/Creatinine [Molar ratio] in 24 hour Urine |
|
13748-9
|
Glutarate/Creatinine [Mass Ratio] in Urine |
|
25104-1
|
Glutarate/Creatinine [Molar ratio] in Urine |
|
54281-1
|
Glutarylcarnitine (C5-DC) [Moles/volume] in Amniotic fluid |
|
54280-3
|
Glutarylcarnitine (C5-DC) [Moles/volume] in Cerebral spinal fluid |
|
45207-8
|
Glutarylcarnitine (C5-DC) [Moles/volume] in DBS |
|
54282-9
|
Glutarylcarnitine (C5-DC) [Moles/volume] in Urine |
|
75225-3
|
Glutarylcarnitine (C5-DC)/Carnitine (C0) [Molar ratio] in DBS |
|
75267-5
|
Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
88013-8
|
Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma |
|
88016-1
|
Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
88005-4
|
Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
88017-9
|
Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in DBS |
|
88026-0
|
Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3) [Molar ratio] in Serum or Plasma |
|
75216-2
|
Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) [Molar ratio] in DBS |
|
75266-7
|
Glutarylcarnitine (C5-DC)/Octanoylcarnitine+Decanoylcarnitine (C8+C10) [Molar ratio] in DBS |
|
54279-5
|
Glutarylcarnitine (C5-DC)/Creatinine [Molar ratio] in Urine |
|
91685-8
|
Glutathione [Mass/volume] in Blood |
|
65363-4
|
Glutathione [Moles/volume] in Blood |
|
45328-2
|
Glutathione peroxidase [Enzymatic activity/volume] in Blood |
|
2377-0
|
Glutathione peroxidase [Enzymatic activity/volume] in Red Blood Cells |
|
45378-7
|
Glutathione peroxidase [Enzymatic activity/mass] in Red Blood Cells |
|
2376-2
|
Glutathione peroxidase [Enzymatic activity/volume] in Serum or Plasma |
|
2383-8
|
Glutathione [Mass/volume] in Red Blood Cells |
|
16918-5
|
Glutathione [Mass/volume] in Serum or Plasma |
|
57005-1
|
Glutathione [Moles/volume] in Serum or Plasma |
|
2380-4
|
Glutathione synthase [Enzymatic activity/volume] in Red Blood Cells |
|
6125-9
|
Gluten IgE Ab [Units/volume] in Serum |
|
61270-5
|
Gluten IgE Ab/IgE total in Serum |
|
7338-7
|
Gluten IgG Ab [Units/volume] in Serum |
|
56268-6
|
Gluten IgG4 Ab [Mass/volume] in Serum |
|
63091-3
|
Gluten IgG Ab [Mass/volume] in Serum |
|
29282-1
|
Glutethimide [Presence] in Gastric fluid |
|
29291-2
|
Glutethimide [Mass/volume] in Gastric fluid |
|
47110-2
|
Glutethimide [Moles/volume] in Gastric fluid |
|
13563-2
|
Glutethimide [Presence] in Serum or Plasma |
|
35613-9
|
Glutethimide [Mass/volume] in Serum or Plasma by Screen method |
|
3666-5
|
Glutethimide [Mass/volume] in Serum or Plasma |
|
32076-2
|
Glutethimide [Moles/volume] in Serum or Plasma |
|
3667-3
|
Glutethimide [Presence] in Urine |
|
3668-1
|
Glutethimide [Mass/volume] in Urine |
|
47111-0
|
Glutethimide [Moles/volume] in Urine |
|
32077-0
|
Glutethimide [Presence] in Unspecified specimen |
|
92672-5
|
Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - DBS |
|
92673-3
|
Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - Serum or Plasma |
|
73359-2
|
Glyburide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73358-4
|
Glyburide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48327-1
|
Glyburide [Presence] in Serum or Plasma |
|
10540-3
|
Glyburide [Mass/volume] in Serum or Plasma |
|
32078-8
|
Glyburide [Moles/volume] in Serum or Plasma |
|
27175-9
|
Glyburide [Mass/volume] in Urine |
|
48320-6
|
Glyburide [Presence] in Unspecified specimen |
|
6945-0
|
Glyburide [Mass/volume] in Unspecified specimen |
|
82730-3
|
GlycA [Moles/volume] in Serum or Plasma |
|
2385-3
|
Glycerate [Mass/volume] in Serum |
|
75063-8
|
Glycerate [Moles/volume] in Serum or Plasma |
|
30475-8
|
Glycerate [Presence] in Urine |
|
2386-1
|
Glycerate [Mass/volume] in Urine |
|
13749-7
|
Glycerate/Creatinine [Mass Ratio] in Urine |
|
25105-8
|
Glycerate/Creatinine [Molar ratio] in Urine |
|
54283-7
|
Glycerol [Mass/volume] in Body fluid |
|
54284-5
|
Glycerol [Moles/volume] in Body fluid |
|
45300-1
|
Glycerol [Moles/volume] in Serum or Plasma |
|
54285-2
|
Glycerol [Moles/volume] in Urine |
|
47632-5
|
Glycerol/Creatinine [Molar ratio] in Urine |
|
73913-6
|
Glycine in CSF/Glycine in plasma |
|
47633-3
|
Glycine [Moles/volume] in DBS |
|
55862-7
|
Glycine [Moles/mass] in Hair |
|
47637-4
|
Glycine/Amino acids.total in Amniotic fluid |
|
47636-6
|
Glycine/Amino acids.total in Cerebral spinal fluid |
|
47638-2
|
Glycine/Amino acids.total in DBS |
|
47635-8
|
Glycine/Amino acids.total in Hair |
|
47634-1
|
Glycine/Amino acids.total in Serum or Plasma |
|
47639-0
|
Glycine/Amino acids.total in Unspecified specimen |
|
44365-5
|
Glycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56681-0
|
Glycine/Creatinine [Ratio] in 24 hour Urine |
|
44832-4
|
Glycogen synthase I/Glycogen synthase.total in Blood |
|
2394-5
|
Glycogen synthase [Enzymatic activity/volume] in Serum |
|
93332-5
|
Glycohyodeoxycholate [Moles/volume] in Serum or Plasma |
|
20829-8
|
Glycol [Mass/mass] in Tissue |
|
20830-6
|
Glycol [Mass/volume] in Urine |
|
73882-3
|
Glycolate [Moles/volume] in 24 hour Urine |
|
73883-1
|
Glycolate [Moles/time] in 24 hour Urine |
|
54286-0
|
Glycolate [Moles/volume] in Cerebral spinal fluid |
|
55863-5
|
Glycolate [Mass/volume] in Body fluid |
|
55864-3
|
Glycolate [Moles/volume] in Body fluid |
|
78749-9
|
Glycolate [Mass/volume] in Serum or Plasma by Gas chromatography |
|
2395-2
|
Glycolate [Mass/volume] in Serum or Plasma |
|
42502-5
|
Glycolate [Moles/volume] in Serum or Plasma |
|
20831-4
|
Glycolate [Mass/mass] in Tissue |
|
26682-5
|
Glycolate [Presence] in Urine |
|
2396-0
|
Glycolate [Mass/volume] in Urine |
|
55865-0
|
Glycolate [Moles/volume] in Urine |
|
13751-3
|
Glycolate/Creatinine [Mass Ratio] in Urine |
|
25106-6
|
Glycolate/Creatinine [Molar ratio] in Urine |
|
16920-1
|
Glycoproteins [Presence] in Serum or Plasma |
|
2397-8
|
Glycoproteins [Presence] in Urine |
|
30476-6
|
Glyoxylate [Presence] in Urine |
|
13752-1
|
Glyoxylate/Creatinine [Mass Ratio] in Urine |
|
25107-4
|
Glyoxylate/Creatinine [Molar ratio] in Urine |
|
44737-5
|
Asialoganglioside GM1 Ab [Units/volume] in Serum by Immunoassay |
|
43861-4
|
Asialoganglioside GM1 Ab [Presence] in Serum |
|
44736-7
|
Asialoganglioside GM1 Ab [Presence] in Serum by Immunoassay |
|
58968-9
|
Asialoganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
44708-6
|
Asialoganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
44738-3
|
Asialoganglioside GM1 IgG Ab [Presence] in Serum |
|
63212-5
|
Asialoganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay |
|
46969-2
|
Asialoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay |
|
88723-2
|
Asialoganglioside GM1 IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
59027-3
|
Asialoganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
44709-4
|
Asialoganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
63384-2
|
Asialoganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay |
|
43179-1
|
Asialoganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay |
|
49636-4
|
Ganglioside GM1 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
48660-5
|
Ganglioside GM1 Ab [Units/volume] in Serum by Immunoassay |
|
42203-0
|
Ganglioside GM1 Ab [Titer] in Serum |
|
44749-0
|
Ganglioside GM1 IgA Ab [Presence] in Serum |
|
58972-1
|
Ganglioside GM1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63242-2
|
Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89541-7
|
Ganglioside GM1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63241-4
|
Ganglioside GM1 IgG Ab [Presence] in Body fluid by Immunoassay |
|
51729-2
|
Ganglioside GM1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
45169-0
|
Ganglioside GM1 IgG Ab [Presence] in Serum |
|
63243-0
|
Ganglioside GM1 IgG Ab [Presence] in Serum by Immunoassay |
|
89521-9
|
Ganglioside GM1 IgG Ab [Presence] in Serum by Line blot |
|
31499-7
|
Ganglioside GM1 IgG Ab [Units/volume] in Serum |
|
43240-1
|
Ganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay |
|
63244-8
|
Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89519-3
|
Ganglioside GM1 IgG+IgM Ab [Presence] in Serum by Line blot |
|
59028-1
|
Ganglioside GM1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63246-3
|
Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89540-9
|
Ganglioside GM1 IgM Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63245-5
|
Ganglioside GM1 IgM Ab [Presence] in Body fluid by Immunoassay |
|
51703-7
|
Ganglioside GM1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
44750-8
|
Ganglioside GM1 IgM Ab [Presence] in Serum |
|
63247-1
|
Ganglioside GM1 IgM Ab [Presence] in Serum by Immunoassay |
|
89518-5
|
Ganglioside GM1 IgM Ab [Presence] in Serum by Line blot |
|
31502-8
|
Ganglioside GM1 IgM Ab [Units/volume] in Serum |
|
43241-9
|
Ganglioside GM1 IgM Ab [Titer] in Serum by Immunoassay |
|
45164-1
|
Asialoganglioside GM2 Ab [Presence] in Serum |
|
48657-1
|
Ganglioside GM2 Ab [Units/volume] in Serum by Immunoassay |
|
58973-9
|
Ganglioside GM2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
56543-2
|
Ganglioside GM2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
63248-9
|
Ganglioside GM2 IgG Ab [Presence] in Serum by Immunoassay |
|
89525-0
|
Ganglioside GM2 IgG Ab [Presence] in Serum by Line blot |
|
88731-5
|
Ganglioside GM2 IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
63249-7
|
Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89517-7
|
Ganglioside GM2 IgG+IgM Ab [Presence] in Serum by Line blot |
|
58974-7
|
Ganglioside GM2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
56544-0
|
Ganglioside GM2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
63250-5
|
Ganglioside GM2 IgM Ab [Presence] in Serum by Immunoassay |
|
89524-3
|
Ganglioside GM2 IgM Ab [Presence] in Serum by Line blot |
|
63466-7
|
Ganglioside GM3 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
59033-1
|
Ganglioside GM3 IgG Ab [Units/volume] in Serum by Immunoassay |
|
63251-3
|
Ganglioside GM3 IgG Ab [Presence] in Serum by Immunoassay |
|
89522-7
|
Ganglioside GM3 IgG Ab [Presence] in Serum by Line blot |
|
63252-1
|
Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89511-0
|
Ganglioside GM3 IgG+IgM Ab [Presence] in Serum by Line blot |
|
63467-5
|
Ganglioside GM3 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58967-1
|
Ganglioside GM3 IgM Ab [Units/volume] in Serum by Immunoassay |
|
63253-9
|
Ganglioside GM3 IgM Ab [Presence] in Serum by Immunoassay |
|
89510-2
|
Ganglioside GM3 IgM Ab [Presence] in Serum by Line blot |
|
63470-9
|
Ganglioside GM4 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58966-3
|
Ganglioside GM4 IgG Ab [Units/volume] in Serum by Immunoassay |
|
82407-8
|
Ganglioside GM4 IgG Ab [Presence] in Serum by Line blot |
|
82408-6
|
Ganglioside GM4 IgG+IgM Ab [Presence] in Serum by Line blot |
|
58965-5
|
Ganglioside GM4 IgM Ab [Units/volume] in Serum by Immunoassay |
|
82409-4
|
Ganglioside GM4 IgM Ab [Presence] in Serum by Line blot |
|
14162-2
|
Gamma melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
|
93407-5
|
Gram negative blood culture panel by NAA with probe detection in Positive blood culture |
|
88260-5
|
Gram negative blood culture panel by Probe in Positive blood culture |
|
93698-9
|
Gram negative bacterial resistance panel by Molecular genetics method |
|
41758-4
|
GNAS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7339-5
|
Gnat whole body IgE Ab [Units/volume] in Serum |
|
41418-5
|
Gnathostoma sp Ab [Presence] in Serum by Immunoblot |
|
44803-5
|
GNE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77060-2
|
GNMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77059-4
|
GNMT gene full mutation analysis in Blood or Tissue by Sequencing |
|
13660-6
|
Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma |
|
2581-7
|
Gonadotropin releasing hormone [Moles/volume] in Serum or Plasma |
|
6127-5
|
Goat epithelium IgE Ab [Units/volume] in Serum |
|
7340-3
|
Goat milk IgE Ab [Units/volume] in Serum |
|
61335-6
|
Goat milk IgE Ab/IgE total in Serum |
|
7341-1
|
Goat milk IgG Ab [Units/volume] in Serum |
|
56269-4
|
Goat milk IgG4 Ab [Mass/volume] in Serum |
|
63133-3
|
Goat milk IgG Ab [Mass/volume] in Serum |
|
50148-6
|
Gamma hydroxybutyrate [Moles/volume] in Amniotic fluid |
|
28038-8
|
Gamma hydroxybutyrate [Mass/volume] in Blood |
|
72433-6
|
Gamma hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
|
50965-3
|
Gamma hydroxybutyrate cutoff [Mass/volume] in Serum or Plasma |
|
79142-6
|
Gamma hydroxybutyrate [Mass/volume] in Body fluid |
|
68441-5
|
Gamma hydroxybutyrate [Moles/volume] in Gastric fluid |
|
78829-9
|
Gamma hydroxybutyrate [Mass/mass] in Hair |
|
43194-0
|
Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma by Confirmatory method |
|
46085-7
|
Gamma hydroxybutyrate [Presence] in Serum or Plasma |
|
59681-7
|
Gamma hydroxybutyrate [Presence] in Serum or Plasma by Screen method |
|
73827-8
|
Gamma hydroxybutyrate [Mass/volume] in Serum, Plasma or Blood |
|
28041-2
|
Gamma hydroxybutyrate [Mass/volume] in Serum or Plasma |
|
59209-7
|
Gamma hydroxybutyrate [Moles/volume] in Serum or Plasma |
|
43198-1
|
Gamma hydroxybutyrate [Mass/volume] in Urine by Confirmatory method |
|
29868-7
|
Gamma hydroxybutyrate [Presence] in Urine |
|
57746-0
|
Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method |
|
43197-3
|
Gamma hydroxybutyrate [Presence] in Urine by Screen method |
|
28044-6
|
Gamma hydroxybutyrate [Mass/volume] in Urine |
|
68440-7
|
Gamma hydroxybutyrate [Moles/volume] in Urine |
|
81629-8
|
Gamma hydroxybutyrate [Presence] in Unspecified specimen by Confirmatory method |
|
77733-4
|
Gamma hydroxybutyrate [Presence] in Unspecified specimen by Screen method |
|
68970-3
|
Gamma hydroxybutyrate [Moles/volume] in Unspecified specimen |
|
44358-0
|
Gamma hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
|
47542-6
|
Gamma hydroxybutyrate/Creatinine [Molar ratio] in Urine |
|
30918-7
|
Gold [Mass/volume] in Urine collected for unspecified duration |
|
29987-5
|
Gold [Mass/volume] in 24 hour Urine |
|
5661-4
|
Gold [Mass/time] in 24 hour Urine |
|
50852-3
|
Gold [Moles/volume] in 24 hour Urine |
|
47112-8
|
Gold [Moles/time] in 24 hour Urine |
|
5656-4
|
Gold [Mass/volume] in Blood |
|
5657-2
|
Gold [Mass/volume] in Cerebral spinal fluid |
|
21312-4
|
Gold [Mass/volume] in Body fluid |
|
5658-0
|
Gold [Mass/mass] in Hair |
|
60082-5
|
Gold [Mass/volume] in Red Blood Cells |
|
5659-8
|
Gold [Mass/volume] in Serum or Plasma |
|
14772-8
|
Gold [Moles/volume] in Serum or Plasma |
|
5660-6
|
Gold [Mass/volume] in Urine |
|
32079-6
|
Gold [Moles/volume] in Urine |
|
29988-3
|
Gold/Creatinine [Mass Ratio] in 24 hour Urine |
|
47113-6
|
Gold/Creatinine [Molar ratio] in 24 hour Urine |
|
7343-7
|
Goldenrod triggered histamine release [Units/volume] in Blood |
|
6128-3
|
Goldenrod IgE Ab [Units/volume] in Serum |
|
61316-6
|
Goldenrod IgE Ab/IgE total in Serum |
|
7342-9
|
Goldenrod IgG Ab [Units/volume] in Serum |
|
56271-0
|
Goldenrod IgG4 Ab [Mass/volume] in Serum |
|
63200-0
|
Goldenrod IgG Ab [Mass/volume] in Serum |
|
54007-0
|
Golgi apparatus Ab [Presence] in Serum by Immunofluorescence |
|
54008-8
|
Golgi apparatus Ab [Titer] in Serum by Immunofluorescence |
|
87407-3
|
Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
87406-5
|
Golimumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
55596-1
|
Goose feather IgE Ab [Presence] in Serum |
|
6129-1
|
Goose feather IgE Ab [Units/volume] in Serum |
|
39605-1
|
Goose feather IgE Ab/IgE total in Serum |
|
7344-5
|
Goose feather IgG Ab [Units/volume] in Serum |
|
56272-8
|
Goose feather IgG4 Ab [Mass/volume] in Serum |
|
78366-2
|
Goose feather IgG Ab [Mass/volume] in Serum |
|
6130-9
|
Goose meat IgE Ab [Units/volume] in Serum |
|
64971-5
|
Goosefoot recombinant (rChe a) 1 IgE Ab [Units/volume] in Serum |
|
7450-0
|
Goosefoot triggered histamine release [Units/volume] in Blood |
|
6156-4
|
Goosefoot IgE Ab [Units/volume] in Serum |
|
61243-2
|
Goosefoot IgE Ab/IgE total in Serum |
|
24154-7
|
Goosefoot IgG Ab [Units/volume] in Serum |
|
56303-1
|
Goosefoot IgG4 Ab [Mass/volume] in Serum |
|
63186-1
|
Goosefoot IgG Ab [Mass/volume] in Serum |
|
42183-4
|
Gossypol negative isomer [Mass/volume] in Unspecified specimen |
|
42184-2
|
Gossypol posiitve isomer [Mass/volume] in Unspecified specimen |
|
42182-6
|
Gossypol bound [Mass/volume] in Unspecified specimen |
|
20832-2
|
Gossypol [Mass/mass] in Feed |
|
23746-1
|
Gossypol Free [Mass/volume] in Unspecified specimen |
|
23745-3
|
Gossypol [Mass/volume] in Unspecified specimen |
|
87616-9
|
Gossypol [Mass/mass] in Unspecified specimen |
|
20488-3
|
Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid |
|
14323-0
|
Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
41508-3
|
Streptococcus agalactiae Ag [Presence] in Body fluid |
|
31967-3
|
Streptococcus agalactiae Ag [Presence] in Throat |
|
6551-6
|
Streptococcus agalactiae Ag [Presence] in Throat by Immunofluorescence |
|
24020-0
|
Streptococcus agalactiae Ag [Presence] in Urine |
|
40784-1
|
Streptococcus agalactiae Ag [Presence] in Vaginal fluid |
|
11266-4
|
Streptococcus agalactiae Ag [Presence] in Unspecified specimen |
|
20459-4
|
Streptococcus agalactiae Ag [Presence] in Unspecified specimen by Latex agglutination |
|
52968-5
|
Streptococcus agalactiae [Presence] in Anal by Organism specific culture |
|
581-9
|
Streptococcus agalactiae [Presence] in Cervix by Organism specific culture |
|
92951-3
|
Streptococcus agalactiae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85767-2
|
Streptococcus agalactiae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
82186-8
|
Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
91847-4
|
Streptococcus agalactiae DNA [Presence] in Genital specimen by NAA with probe detection |
|
92950-5
|
Streptococcus agalactiae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
90272-6
|
Streptococcus agalactiae DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
91875-5
|
Streptococcus agalactiae DNA [Presence] in Vag+Rectum by NAA with probe detection |
|
48683-7
|
Streptococcus agalactiae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
583-5
|
Streptococcus agalactiae [Presence] in Genital lochia by Organism specific culture |
|
582-7
|
Streptococcus agalactiae [Presence] in Genital specimen by Organism specific culture |
|
5034-4
|
Streptococcus agalactiae rRNA [Presence] in Unspecified specimen by Probe |
|
585-0
|
Streptococcus agalactiae [Presence] in Throat by Organism specific culture |
|
584-3
|
Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture |
|
72607-5
|
Streptococcus agalactiae [Presence] in Vag+Rectum by Organism specific culture |
|
586-8
|
Streptococcus agalactiae [Presence] in Unspecified specimen by Organism specific culture |
|
88262-1
|
Gram positive blood culture panel by Probe in Positive blood culture |
|
90070-4
|
Gram positive catalase producing cocci identified in Isolate by Organism specific culture |
|
90071-2
|
Gram positive non-catalase producing cocci identified in Isolate by Organism specific culture |
|
10336-6
|
Gonadotropin peptide [Mass/volume] in Urine |
|
13481-7
|
Gonadotropin peptide/Creatinine [Mass Ratio] in Urine |
|
41098-5
|
GPC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34499-4
|
GPC3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
11047-8
|
Glucose phosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
|
44050-3
|
Glucose phosphate isomerase [Enzymatic activity/mass] in Red Blood Cells |
|
2353-1
|
Glucose phosphate isomerase [Enzymatic activity/volume] in Serum |
|
81336-0
|
Patient Goals, preferences, and priorities under certain health conditions |
|
81338-6
|
Patient Goals, preferences, and priorities for care experience |
|
81337-8
|
Patient Goals, preferences, and priorities upon death |
|
48975-7
|
GPR143 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77124-6
|
GPR98 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77123-8
|
GPR98 gene full mutation analysis in Blood or Tissue by Sequencing |
|
46189-7
|
Goose parvovirus Ab [Presence] in Serum |
|
43336-7
|
Goose parvovirus Ab [Presence] in Serum by Immunofluorescence |
|
43337-5
|
Goose parvovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
58975-4
|
Ganglioside GQ1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
57660-3
|
Ganglioside GQ1b IgG Ab [Units/volume] in Serum by Immunoassay |
|
63254-7
|
Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoassay |
|
56741-2
|
Ganglioside GQ1b IgG Ab [Presence] in Serum by Immunoblot |
|
88729-9
|
Ganglioside GQ1b IgG+IgM Ab [Units/volume] in Serum by Immunoassay |
|
82410-2
|
Ganglioside GQ1b IgG+IgM Ab [Presence] in Serum by Line blot |
|
58976-2
|
Ganglioside GQ1b IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
56545-7
|
Ganglioside GQ1b IgM Ab [Units/volume] in Serum by Immunoassay |
|
63255-4
|
Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoassay |
|
56742-0
|
Ganglioside GQ1b IgM Ab [Presence] in Serum by Immunoblot |
|
29281-3
|
Glutathione reductase [Presence] in Red Blood Cells |
|
2378-8
|
Glutathione reductase [Enzymatic activity/volume] in Red Blood Cells |
|
50382-1
|
Glutathione reductase [Enzymatic activity/mass] in Red Blood Cells |
|
45329-0
|
Glutathione reductase [Enzymatic activity/volume] in Serum |
|
73851-8
|
18-Beta glycyrrhetinate [Mass/volume] in 24 hour Urine |
|
73850-0
|
18-Beta glycyrrhetinate [Mass/volume] in Urine |
|
7346-0
|
Grain dust IgE Ab [Units/volume] in Serum |
|
7345-2
|
Grain IgE Ab [Units/volume] in Serum |
|
7347-8
|
Grain mill dust IgE Ab [Units/volume] in Serum |
|
11174-0
|
Grain weevel IgE Ab [Units/volume] in Serum |
|
90068-8
|
Gram negative bacilli identified in Isolate by Organism specific culture |
|
90069-6
|
Gram positive bacilli identified in Isolate by Organism specific culture |
|
87971-8
|
Microscopic observation [Identifier] in Amniotic fluid by Gram stain |
|
72408-8
|
Microscopic observation [Identifier] in Anal by Gram stain |
|
14358-6
|
Microscopic observation [Identifier] in Aspirate by Gram stain |
|
90262-7
|
Microscopic observation [Identifier] in Bile fluid by Gram stain |
|
87969-2
|
Microscopic observation [Identifier] in Blood by Gram stain |
|
21021-1
|
Microscopic observation [Identifier] in Bronchial specimen by Gram stain |
|
87974-2
|
Microscopic observation [Identifier] in Burn by Gram stain |
|
90282-5
|
Microscopic observation [Identifier] in Catheter tip by Gram stain |
|
87999-9
|
Microscopic observation [Identifier] in Contact lens by Gram stain |
|
88170-6
|
Microscopic observation [Identifier] in Cornea or Conjunctiva by Gram stain |
|
14357-8
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain |
|
6464-2
|
Microscopic observation [Identifier] in Cervix by Gram stain |
|
88001-3
|
Microscopic observation [Identifier] in Peritoneal dialysis fluid by Gram stain |
|
21022-9
|
Microscopic observation [Identifier] in Dialysis fluid by Gram stain |
|
14365-1
|
Microscopic observation [Identifier] in Ear by Gram stain |
|
14364-4
|
Microscopic observation [Identifier] in Eye by Gram stain |
|
27112-2
|
Microscopic observation [Identifier] in Body fluid by Gram stain |
|
48712-4
|
Microscopic observation [Identifier] in Genital specimen by Gram stain |
|
6467-5
|
Microscopic observation [Identifier] in Genital fluid by Gram stain |
|
10856-3
|
Microscopic observation [Identifier] in Genital mucus by Gram stain |
|
89659-7
|
Microscopic observation [Identifier] in Implanted device by Gram stain |
|
87975-9
|
Microscopic observation [Identifier] in Isolate by Gram stain |
|
88632-5
|
Microscopic observation [Identifier] in Lower respiratory specimen by Gram stain |
|
87967-6
|
Microscopic observation [Identifier] in Bone marrow by Gram stain |
|
90263-5
|
Microscopic observation [Identifier] in Milk by Gram stain |
|
32026-7
|
Microscopic observation [Identifier] in Nose by Gram stain |
|
88149-0
|
Microscopic observation [Identifier] in Nasopharynx by Gram stain |
|
88158-1
|
Microscopic observation [Identifier] in Ocular fluid by Gram stain |
|
88147-4
|
Microscopic observation [Identifier] in Pericardial fluid by Gram stain |
|
88146-6
|
Microscopic observation [Identifier] in Placenta by Gram stain |
|
14360-2
|
Microscopic observation [Identifier] in Pleural fluid by Gram stain |
|
14359-4
|
Microscopic observation [Identifier] in Peritoneal fluid by Gram stain |
|
643-7
|
Microscopic observation [Identifier] in Pus by Gram stain |
|
88634-1
|
Microscopic observation [Identifier] in Saliva (oral fluid) by Gram stain |
|
87972-6
|
Microscopic observation [Identifier] in Sinus by Gram stain |
|
90296-5
|
Microscopic observation [Identifier] in Skin by Gram stain |
|
87973-4
|
Microscopic observation [Identifier] in Semen by Gram stain |
|
14363-6
|
Microscopic observation [Identifier] in Synovial fluid by Gram stain |
|
648-6
|
Microscopic observation [Identifier] in Sputum by Gram stain |
|
649-4
|
Microscopic observation [Identifier] in Stool by Gram stain |
|
14362-8
|
Microscopic observation [Identifier] in Throat by Gram stain |
|
6664-7
|
Microscopic observation [Identifier] in Tissue by Gram stain |
|
91808-6
|
Microscopic observation [Identifier] in Upper respiratory specimen by Gram stain |
|
653-6
|
Microscopic observation [Identifier] in Urine by Gram stain |
|
6474-1
|
Microscopic observation [Identifier] in Urethra by Gram stain |
|
14361-0
|
Microscopic observation [Identifier] in Vaginal fluid by Gram stain |
|
88635-8
|
Microscopic observation [Identifier] in Vomitus by Gram stain |
|
10357-2
|
Microscopic observation [Identifier] in Wound by Gram stain |
|
664-3
|
Microscopic observation [Identifier] in Unspecified specimen by Gram stain |
|
7360-1
|
Gramma grass (Bouteloua gracilis) IgE Ab [Units/volume] in Serum |
|
46134-3
|
Granular casts [#/area] in Urine sediment by Microscopy high power field |
|
74140-5
|
Granulocytes [#/volume] in Peritoneal dialysis fluid |
|
74142-1
|
Granulocytes [#/volume] in Body fluid |
|
74141-3
|
Granulocytes/100 leukocytes in Peritoneal dialysis fluid |
|
74143-9
|
Granulocytes/100 leukocytes in Body fluid |
|
50318-5
|
Granzyme B Ag [Presence] in Tissue by Immune stain |
|
6841-1
|
Grape IgE Ab [Units/volume] in Serum |
|
43587-5
|
Grape IgE Ab/IgE total in Serum |
|
7348-6
|
Grape IgG Ab [Units/volume] in Serum |
|
56273-6
|
Grape IgG4 Ab [Mass/volume] in Serum |
|
60376-1
|
Grape IgG Ab [Mass/volume] in Serum |
|
7349-4
|
Grape raisin triggered histamine release [Units/volume] in Blood |
|
7351-0
|
Grapefruit triggered histamine release [Units/volume] in Blood |
|
6131-7
|
Grapefruit IgE Ab [Units/volume] in Serum |
|
61247-3
|
Grapefruit IgE Ab/IgE total in Serum |
|
7350-2
|
Grapefruit IgG Ab [Units/volume] in Serum |
|
56274-4
|
Grapefruit IgG4 Ab [Mass/volume] in Serum |
|
60377-9
|
Grapefruit IgG Ab [Mass/volume] in Serum |
|
31003-7
|
Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
|
82101-7
|
Grass Allergen Mix 6 (Brome+Bermuda grass+Velvet grass+Perennial rye grass+Bahia grass+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
24515-9
|
Grass Allergen Mix A (Sweet vernal grass+Bermuda grass+Perennial rye grass+Timothy+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
24132-3
|
Grass Allergen Mix B (Sweet vernal grass+Perennial rye grass+Common reed+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
|
15230-6
|
Grass Allergen Mix C (Brome+Bermuda grass+Velvet grass+Bahia grass+Timothy+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
|
23802-2
|
Grass Allergen Mix D (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
|
48266-1
|
Grass Allergen Mix E (Cocksfoot+Meadow Fescue+Velvet grass+Perennial rye grass+Timothy+Kentucky blue grass ) triggered leukotriene release [Mass/volume] by Leukocytes |
|
23803-0
|
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Presence] in Serum by Multidisk |
|
30189-5
|
Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
51523-9
|
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
|
30188-7
|
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
61204-4
|
Grass Allergen Mix 2 (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass+Bahia grass) IgE Ab/IgE total in Serum by Multidisk |
|
15229-8
|
Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
|
50654-3
|
Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
15228-0
|
Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Presence] in Serum by Multidisk |
|
69960-3
|
Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Units/volume] in Serum by Multidisk |
|
82566-1
|
Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Presence] in Serum by Multidisk |
|
82568-7
|
Grass Allergen Mix 5 (Sweet Vernal grass+Bermuda grass+Cocksfoot+Timothy+Common Reed) IgE Ab [Units/volume] in Serum by Multidisk |
|
82612-3
|
Grass Allergen Mix 7 (Bermuda grass+Meadow fescue+Rye grass+Timothy grass+Cultivated rye) IgE Ab [Units/volume] in Serum by Multidisk |
|
7380-9
|
Grayfish IgE Ab [Units/volume] in Serum |
|
82523-2
|
Grazoprevir [Susceptibility] by Genotype method |
|
7381-7
|
Greasewood IgE Ab [Units/volume] in Serum |
|
21078-1
|
Green Ash IgE Ab [Units/volume] in Serum |
|
7128-2
|
Green Bean triggered histamine release [Units/volume] in Blood |
|
6831-2
|
Green Bean IgE Ab [Units/volume] in Serum |
|
57912-8
|
Green Bean IgE Ab/IgE total in Serum |
|
7127-4
|
Green Bean IgG Ab [Units/volume] in Serum |
|
56275-1
|
Green Bean IgG4 Ab [Mass/volume] in Serum |
|
60353-0
|
Green Bean IgG Ab [Mass/volume] in Serum |
|
6132-5
|
Green Coffee Bean IgE Ab [Units/volume] in Serum |
|
6133-3
|
Green Nimitti IgE Ab [Units/volume] in Serum |
|
6852-8
|
Green Pepper IgE Ab [Units/volume] in Serum |
|
7594-5
|
Green Pepper IgG Ab [Units/volume] in Serum |
|
56278-5
|
Green Pepper IgG4 Ab [Mass/volume] in Serum |
|
60393-6
|
Green Pepper IgG Ab [Mass/volume] in Serum |
|
15284-3
|
Grey Alder IgE Ab [Units/volume] in Serum |
|
61212-7
|
Grey Alder IgE Ab/IgE total in Serum |
|
81837-7
|
GRHPR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
83145-3
|
Grip Strength Test [NIH Toolbox] |
|
54202-7
|
Griseofulvin [Susceptibility] by Disk diffusion (KB) |
|
54201-9
|
Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
12402-4
|
Griseofulvin [Mass/volume] in Serum or Plasma |
|
54200-1
|
Griseofulvin [Susceptibility] |
|
81859-1
|
GRN gene full mutation analysis in Blood or Tissue by Sequencing |
|
7110-0
|
Groundsel Tree IgE Ab [Units/volume] in Serum |
|
47043-5
|
Group counseling note |
|
2327-5
|
Gastrin releasing polypeptide [Mass/volume] in Cerebral spinal fluid |
|
2328-3
|
Gastrin releasing polypeptide [Moles/volume] in Cerebral spinal fluid |
|
2329-1
|
Gastrin releasing polypeptide [Mass/volume] in Serum or Plasma |
|
48112-7
|
Glutathione.reduced [Units/mass] in Red Blood Cells |
|
2382-0
|
Glutathione.reduced [Mass/volume] in Red Blood Cells |
|
48111-9
|
Glutathione.reduced [Moles/mass] in Red Blood Cells |
|
53642-5
|
Glutathione.reduced/glutathione.oxidized [Molar ratio] in Blood |
|
2381-2
|
Glutathione.oxidized [Mass/volume] in Red Blood Cells |
|
47631-7
|
Glutathione.oxidized [Moles/mass] in Red Blood Cells |
|
2379-6
|
Glutathione S-transferase [Enzymatic activity/volume] in Red Blood Cells |
|
59585-0
|
GSTP1 gene+APC gene methylation [Presence] in Tissue by Molecular genetics method |
|
70108-6
|
Glutathione S-transferase T1 Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
63468-3
|
Ganglioside GT1a IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58964-8
|
Ganglioside GT1a IgG Ab [Units/volume] in Serum by Immunoassay |
|
82411-0
|
Ganglioside GT1a IgG Ab [Presence] in Serum by Line blot |
|
63256-2
|
Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89509-4
|
Ganglioside GT1a IgG+IgM Ab [Presence] in Serum by Line blot |
|
58963-0
|
Ganglioside GT1a IgM Ab [Units/volume] in Serum by Immunoassay |
|
82413-6
|
Ganglioside GT1a IgM Ab [Presence] in Serum by Line blot |
|
58459-9
|
Ganglioside GT1b Ab [Presence] in Serum by Immunofluorescence |
|
63469-1
|
Ganglioside GT1b IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
58962-2
|
Ganglioside GT1b IgG Ab [Units/volume] in Serum by Immunoassay |
|
63257-0
|
Ganglioside GT1b IgG Ab [Presence] in Serum by Immunoassay |
|
89523-5
|
Ganglioside GT1b IgG Ab [Presence] in Serum by Line blot |
|
63258-8
|
Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
89516-9
|
Ganglioside GT1b IgG+IgM Ab [Presence] in Serum by Line blot |
|
58961-4
|
Ganglioside GT1b IgM Ab [Units/volume] in Serum by Immunoassay |
|
63259-6
|
Ganglioside GT1b IgM Ab [Presence] in Serum by Immunoassay |
|
89515-1
|
Ganglioside GT1b IgM Ab [Presence] in Serum by Line blot |
|
72171-2
|
Glucose tolerance 2 hours panel - Serum or Plasma |
|
50586-7
|
Glucose tolerance 3 hours panel - Serum or Plasma |
|
50587-5
|
Glucose tolerance 4 hours panel - Serum or Plasma |
|
50588-3
|
Glucose tolerance 5 hours panel - Serum or Plasma |
|
50589-1
|
Glucose tolerance 6 hours panel - Serum or Plasma |
|
81324-6
|
Glucose tolerance 2 hours gestational panel - Serum or Plasma |
|
24353-5
|
Glucose tolerance 2 hours gestational panel - Urine and Serum or Plasma |
|
50608-9
|
Glucose tolerance 3 hours gestational panel - Serum or Plasma |
|
93794-6
|
Glucose tolerance and insulin sensitivity 2 hour panel - Serum or Plasma |
|
16923-5
|
guaiFENesin [Mass/volume] in Serum or Plasma |
|
87787-8
|
guaiFENesin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
54288-6
|
Guanidinoacetate [Moles/volume] in Amniotic fluid |
|
54287-8
|
Guanidinoacetate [Moles/volume] in Cerebral spinal fluid |
|
93488-5
|
Guanidinoacetate [Moles/volume] in DBS |
|
33244-5
|
Guanidinoacetate [Moles/volume] in Serum or Plasma |
|
34155-2
|
Guanidinoacetate/Creatinine [Molar ratio] in Urine |
|
2400-0
|
Guanine deaminase [Enzymatic activity/volume] in Blood |
|
2401-8
|
Guanine deaminase [Enzymatic activity/volume] in Serum |
|
78695-4
|
Guanine/Creatinine [Molar ratio] in Urine |
|
78691-3
|
Guanosine/Creatinine [Molar ratio] in Urine |
|
10933-0
|
Guar gum IgE Ab [Units/volume] in Serum |
|
87294-5
|
Guardian or legally authorized representative signature for Social Security Number request |
|
10934-8
|
Guava IgE Ab [Units/volume] in Serum |
|
93330-9
|
Glycoursodeoxycholate [Moles/volume] in Serum or Plasma |
|
88940-2
|
Guidance for repair of aneurysm of Abdominal Aorta |
|
87056-8
|
Guidance for biopsy of Abdomen |
|
87057-6
|
Guidance for placement of fiducial marker in Abdomen |
|
87078-2
|
Guidance for percutaneous drainage and placement of drainage catheter of Abdomen |
|
88943-6
|
Guidance for venous sampling of Adrenal vein |
|
87132-7
|
Guidance for injection of Ankle |
|
87193-9
|
Guidance for initial day infusion of thrombolytic of Artery-- W thrombolytic via catheter |
|
87020-4
|
Guidance for embolization of Artery |
|
88942-8
|
Guidance for repair of endoleak of Artery |
|
86999-0
|
Guidance for additional percutaneous mechanical thrombectomy of Artery |
|
87169-9
|
Guidance for initial mechanical thrombectomy of Artery |
|
87184-8
|
Guidance for percutaneous transluminal angioplasty of arterial anastomosis of Artery |
|
87164-0
|
Guidance for secondary mechanical thrombectomy of Artery |
|
87200-2
|
Guidance for placement of stent in Artery |
|
87001-4
|
Guidance for additional placement of stent of Artery |
|
87201-0
|
Guidance for treatment of AV fistula |
|
88930-3
|
Guidance for dilation of stricture and placement of stent of Biliary ducts-- W contrast IV |
|
87059-2
|
Guidance for biopsy of Biliary ducts |
|
87060-0
|
Guidance for removal of calculus from Biliary ducts |
|
87061-8
|
Guidance for injection of contrast of Biliary ducts |
|
88937-8
|
Guidance for placement of stent in Biliary ducts |
|
87051-9
|
Guidance for dilation of stricture of Biliary ducts |
|
87310-9
|
Guidance for transhepatic exchange of catheter of Biliary ducts |
|
87309-1
|
Guidance for transhepatic placement of catheter of Biliary ducts |
|
87308-3
|
Guidance for transhepatic removal of catheter of Biliary ducts |
|
87044-4
|
Guidance for check of tube of Biliary ducts |
|
87013-9
|
Guidance for percutaneous biopsy of Bone |
|
87010-5
|
Guidance for aspiration of cyst of Bone |
|
87018-8
|
Guidance for deep biopsy of Bone |
|
87014-7
|
Guidance for biopsy of Bone marrow |
|
87008-9
|
Guidance for fluid aspiration of Bone marrow |
|
87176-4
|
Guidance for radiofrequency ablation of Bone |
|
87145-9
|
Guidance for embolization of Brachial artery |
|
87101-2
|
Guidance for percutaneous transluminal angioplasty of Brachiocephalic artery |
|
87062-6
|
Guidance for nerve block of Celiac plexus |
|
87034-5
|
Guidance for exchange of catheter portion only of CV catheter with port of Chest |
|
87149-1
|
Guidance for exchange of chest tube of Chest |
|
87104-6
|
Guidance for injection of CV catheter of Chest |
|
87105-3
|
Guidance for reposition of CV catheter in Chest |
|
87035-2
|
Guidance for exchange of CV catheter with port of Chest |
|
87106-1
|
Guidance for placement of CV catheter with port in Chest |
|
87107-9
|
Guidance for removal of CV catheter with port from Chest |
|
87108-7
|
Guidance for repair of CV catheter with port of Chest |
|
87205-1
|
Guidance for exchange of non-tunneled CV catheter of Chest |
|
87115-2
|
Guidance for repair of non-tunneled CV catheter without port of Chest |
|
87027-9
|
Guidance for biopsy of Chest Pleura |
|
87177-2
|
Guidance for radiofrequency ablation of Chest Pleura |
|
87121-0
|
Guidance for placement of tunneled catheter in Chest Pleura |
|
88243-1
|
Guidance for removal of tunneled catheter from Chest Pleura |
|
87109-5
|
Guidance for placement of Swan-Ganz catheter in Chest |
|
87111-1
|
Guidance for thoracentesis of Chest |
|
87110-3
|
Guidance for thoracentesis and insertion of tube of Chest |
|
87112-9
|
Guidance for exchange of tunneled CV catheter without port of Chest |
|
87113-7
|
Guidance for placement of tunneled CV catheter without port in Chest |
|
87114-5
|
Guidance for removal of tunneled CV catheter without port from Chest |
|
87031-1
|
Guidance for check of peritoneovenous shunt of Chest and Abdomen |
|
87097-2
|
Guidance for placement of peritoneovenous shunt in Chest and Abdomen |
|
87098-0
|
Guidance for removal of peritoneovenous shunt from Chest and Abdomen |
|
87099-8
|
Guidance for revision of peritoneovenous shunt of Chest and Abdomen |
|
87154-1
|
Guidance for diagnostic puncture of Cervical spine |
|
87153-3
|
Guidance for therapeutic puncture and drainage of Cervical spine |
|
87186-3
|
Guidance for mechanical thrombectomy of central venous catheter lumen obstruction |
|
92682-4
|
Guidance for dilation of existing nephrostomy tract and placement of nephrostomy tube at new site of Kidney |
|
87161-6
|
Guidance for injection of Spine epidural space |
|
87130-1
|
Guidance for laser ablation of Extremity vein |
|
87138-4
|
Guidance for additional laser ablation of Extremity vein |
|
87131-9
|
Guidance for greater than 20 stab phlebectomy of Extremity vein |
|
87180-6
|
Guidance for dilation of Fallopian tube |
|
87133-5
|
Guidance for percutaneous transluminal angioplasty of Femoral artery and Popliteal artery |
|
87134-3
|
Guidance for placement of stent in Femoral artery and Popliteal artery |
|
87046-9
|
Guidance for cholangioscopy of Gallbladder |
|
87045-1
|
Guidance for cholangioscopy and removal of calculus of Gallbladder |
|
87047-7
|
Guidance for cholecystostomy of Gallbladder |
|
88935-2
|
Guidance for chemoembolization of Hepatic artery-- W chemotherapy IA+W embolic agent IA |
|
88939-4
|
Guidance for radioembolization for tumor of Hepatic artery-- W Yttrium-90 IA |
|
88242-3
|
Guidance for infusion of non-thrombolytic of Head Arteries |
|
88936-0
|
Guidance for injection of Hepatic artery-- W Tc-99m MAA IA |
|
88931-1
|
Guidance for embolization for tumor of Hepatic artery-- W embolic agent IA |
|
87135-0
|
Guidance for injection of Hip |
|
87117-8
|
Guidance for pericardiocentesis of Heart |
|
87165-7
|
Guidance for placement of endograft in Iliac artery |
|
87150-9
|
Guidance for percutaneous transluminal angioplasty of Iliac artery |
|
87038-6
|
Guidance for additional transluminal angioplasty of Iliac artery |
|
87151-7
|
Guidance for placement of stent in Iliac artery |
|
87037-8
|
Guidance for additional placement of stent of Iliac artery |
|
87004-8
|
Guidance for arthrocentesis of Intermediate joint |
|
87092-3
|
Guidance for placement of venous filter in Inferior vena cava |
|
87093-1
|
Guidance for removal of venous filter from Inferior vena cava |
|
87094-9
|
Guidance for reposition of venous filter in Inferior vena cava |
|
87007-1
|
Guidance for arthrocentesis of Joint |
|
87188-9
|
Guidance for exchange of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87041-0
|
Guidance for percutaneous biopsy of Kidney |
|
87049-3
|
Guidance for cryoablation of Kidney |
|
87040-2
|
Guidance for aspiration of cyst of Kidney |
|
92681-6
|
Guidance for dilation of existing nephrostomy tract of Kidney |
|
87054-3
|
Guidance for exchange of nephrostomy tube of Kidney |
|
87066-7
|
Guidance for percutaneous placement of nephrostomy tube of Kidney |
|
87058-4
|
Guidance for radiofrequency ablation of Kidney |
|
87067-5
|
Guidance for transjugular biopsy of Kidney |
|
87068-3
|
Guidance for transjugular biopsy and venography of Kidney |
|
87136-8
|
Guidance for arthrocentesis of Knee |
|
87137-6
|
Guidance for injection of Knee |
|
87042-8
|
Guidance for percutaneous biopsy of Liver |
|
87050-1
|
Guidance for cryoablation of Liver |
|
87069-1
|
Guidance for hemodynamic evaluation of Liver |
|
87070-9
|
Guidance for microwave ablation of Liver |
|
87071-7
|
Guidance for radiofrequency ablation of Liver |
|
87072-5
|
Guidance for placement of TIPS of Liver |
|
87073-3
|
Guidance for revision of TIPS of Liver |
|
87074-1
|
Guidance for transhepatic revision of tube of Liver |
|
87075-8
|
Guidance for transjugular biopsy of Liver |
|
87076-6
|
Guidance for transjugular biopsy and hemodynamic evaluation of Liver |
|
87077-4
|
Guidance for transjugular biopsy and venography of Liver |
|
87015-4
|
Guidance for biopsy of Lymph node |
|
87012-1
|
Guidance for fluid aspiration of Lymph node |
|
87129-3
|
Guidance for percutaneous transluminal angioplasty of Lower leg |
|
87139-2
|
Guidance for additional transluminal angioplasty of Lower leg |
|
87140-0
|
Guidance for additional placement of stent of Lower leg vessel |
|
87089-9
|
Guidance for kyphoplasty of Lumbar spine |
|
87036-0
|
Guidance for additional level kyphoplasty of Lumbar spine |
|
87090-7
|
Guidance for myelography of Lumbar spine |
|
87088-1
|
Guidance for puncture of Lumbar spine |
|
87091-5
|
Guidance for vertebroplasty of Lumbar spine |
|
87039-4
|
Guidance for additional vertebroplasty of Lumbar spine |
|
87028-7
|
Guidance for biopsy of Lung |
|
87032-9
|
Guidance for cryoablation of Lung |
|
87118-6
|
Guidance for placement of fiducial marker in Lung |
|
87119-4
|
Guidance for microwave ablation of Lung |
|
87120-2
|
Guidance for radiofrequency ablation of Lung |
|
87170-7
|
Guidance for ligation of Lymphatic vessel |
|
87005-5
|
Guidance for arthrocentesis of Major joint |
|
87029-5
|
Guidance for biopsy of Mediastinum |
|
87174-9
|
Guidance for biopsy of Muscle |
|
87183-0
|
Guidance for greater than 2 injections of trigger point of Muscle |
|
86994-1
|
Guidance for 1 or 2 injections of trigger point of Muscle |
|
87030-3
|
Guidance for biopsy of Neck or Chest Soft tissue |
|
87203-6
|
Guidance for transurethral exchange of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87189-7
|
Guidance for transurethral removal of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87187-1
|
Guidance for nerve block of Nerve root |
|
87185-5
|
Guidance for sympathectomy of Nerve |
|
87055-0
|
Guidance for biopsy of Pancreas |
|
87190-5
|
Guidance for percutaneous placement of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87191-3
|
Guidance for removal of nephroureteral stent of Kidney and Ureter and Urinary bladder |
|
87175-6
|
Guidance for deep drainage and placement of drainage catheter of Pelvis |
|
87081-6
|
Guidance for placement of catheter in Peritoneum |
|
87082-4
|
Guidance for removal of catheter from Peritoneum |
|
87083-2
|
Guidance for reposition of catheter in Peritoneum |
|
87084-0
|
Guidance for removal of foreign body from Peritoneum |
|
87079-0
|
Guidance for paracentesis and insertion of tube of Peritoneum |
|
87080-8
|
Guidance for paracentesis of Peritoneum |
|
87085-7
|
Guidance for placement of port in Peritoneum |
|
87086-5
|
Guidance for removal of port from Peritoneum |
|
87116-0
|
Guidance for placement of chest tube in Pleural space |
|
87033-7
|
Guidance for drainage and placement of chest tube of Pleural space |
|
87206-9
|
Guidance for nerve block of Peripheral nerve |
|
88933-7
|
Guidance for embolization of Portal vein-- W embolic agent IV |
|
87173-1
|
Guidance for biopsy of Prostate |
|
87087-3
|
Guidance for percutaneous transluminal angioplasty of Renal artery |
|
87146-7
|
Guidance for injection of Shoulder |
|
87006-3
|
Guidance for arthrocentesis of Small joint |
|
87016-2
|
Guidance for biopsy of Soft tissue |
|
88932-9
|
Guidance for embolization for tumor of Spinal artery-- W embolic agent IA |
|
87160-8
|
Guidance for injection of Spine facet joint |
|
88934-5
|
Guidance for embolization of Splenic artery-- W embolic agent IA |
|
87052-7
|
Guidance for exchange of G-tube of Stomach |
|
87128-5
|
Guidance for placement of venous filter in Superior vena cava |
|
87126-9
|
Guidance for removal of venous filter from Superior vena cava |
|
87127-7
|
Guidance for reposition of venous filter in Superior vena cava |
|
87100-4
|
Guidance for percutaneous transluminal angioplasty of Thoracic and abdominal aorta |
|
88941-0
|
Guidance for repair of aneurysm of Thoracic Aorta |
|
87158-2
|
Guidance for injection of Tendon |
|
86997-4
|
Guidance for additional day infusion of thrombolytic of Vessel-- W thrombolytic via catheter |
|
87024-6
|
Guidance for additional day infusion of thrombolytic of Chest-- W thrombolytic via chest tube |
|
87102-0
|
Guidance for initial day infusion of thrombolytic of Chest-- W thrombolytic via chest tube |
|
87103-8
|
Guidance for infusion of thrombolytic of Chest-- W thrombolytic via CVC |
|
87155-8
|
Guidance for fine needle aspiration of Thyroid gland |
|
87156-6
|
Guidance for percutaneous biopsy.core needle of Thyroid gland |
|
87159-0
|
Guidance for injection of Temporomandibular joint |
|
87125-1
|
Guidance for nerve block of Thoracic spine intercostal nerve |
|
87122-8
|
Guidance for kyphoplasty of Thoracic spine |
|
87025-3
|
Guidance for additional level kyphoplasty of Thoracic spine |
|
87123-6
|
Guidance for myelography of Thoracic spine |
|
87124-4
|
Guidance for vertebroplasty of Thoracic spine |
|
87026-1
|
Guidance for additional vertebroplasty of Thoracic spine |
|
87142-6
|
Guidance for exchange of CV catheter with port of Upper extremity |
|
87141-8
|
Guidance for placement of CV catheter with port in Upper extremity |
|
87143-4
|
Guidance for exchange of peripherally inserted central catheter of Upper extremity |
|
87144-2
|
Guidance for placement of peripherally-inserted central venous catheter in Upper extremity |
|
87048-5
|
Guidance for conversion of G-tube to GJ-tube of Gastrointestinal tract upper |
|
87064-2
|
Guidance for placement of GJ-tube in Gastrointestinal tract upper |
|
87063-4
|
Guidance for removal of GJ-tube from Gastrointestinal tract upper |
|
87065-9
|
Guidance for placement of G-tube in Gastrointestinal tract upper |
|
87053-5
|
Guidance for exchange of J-tube of Gastrointestinal tract upper |
|
87017-0
|
Guidance for check of drainage catheter for abscess |
|
87023-8
|
Guidance for exchange of drainage catheter for abscess |
|
87198-8
|
Guidance for placement of drainage catheter for abscess |
|
86995-8
|
Guidance for abscess |
|
87171-5
|
Guidance for placement of clip |
|
87172-3
|
Guidance for placement of clip-- preoperative |
|
87199-6
|
Guidance for substance removal of central venous catheter pericatheter obstruction |
|
87009-7
|
Guidance for aspiration of cyst |
|
87019-6
|
Guidance for drainage and placement of drainage catheter |
|
87179-8
|
Guidance for fine needle aspiration |
|
87011-3
|
Guidance for aspiration of ganglion cyst |
|
88349-6
|
Guidance-- during surgery |
|
25072-0
|
Guidance for placement of infusion port |
|
87162-4
|
Guidance for placement of needle |
|
87157-4
|
Guidance for injection of platelet rich plasma |
|
87192-1
|
Guidance for thrombectomy |
|
87167-3
|
Guidance for transcatheter biopsy |
|
87168-1
|
Guidance for transcatheter placement of stent |
|
87182-2
|
Guidance for placement of wire |
|
87002-2
|
Guidance for additional placement of wire |
|
87043-6
|
Guidance for biopsy of Ureter |
|
88938-6
|
Guidance for placement of stent in Ureter |
|
87152-5
|
Guidance for exchange of ureterostomy through ileal conduit of Ureter |
|
87181-4
|
Guidance for embolization of Uterine artery |
|
87021-2
|
Guidance for embolization of Vein |
|
87163-2
|
Guidance for placement of endovascular device in Vein |
|
87000-6
|
Guidance for additional placement of endovascular device of Vein |
|
25027-4
|
Guidance for placement of large bore CV catheter in Vein |
|
86998-2
|
Guidance for additional percutaneous mechanical thrombectomy of Vein |
|
87194-7
|
Guidance for initial mechanical thrombectomy of Vein |
|
87166-5
|
Guidance for percutaneous transluminal angioplasty of Vein |
|
88929-5
|
Guidance for additional transluminal angioplasty of Vein |
|
87312-5
|
Guidance for percutaneous transluminal angioplasty for dialysis of Vein |
|
87195-4
|
Guidance for initial day infusion of thrombolytic of Vein-- W thrombolytic via catheter |
|
87202-8
|
Guidance for venous sampling of Vein |
|
26307-9
|
Guidance for placement of large bore CV catheter in Vein - bilateral |
|
26308-7
|
Guidance for placement of large bore CV catheter in Vein - left |
|
26309-5
|
Guidance for placement of large bore CV catheter in Vein - right |
|
86996-6
|
Guidance for additional augmentation of Spine vertebra |
|
86993-3
|
Guidance for 1 level kyphoplasty of Spine vertebra |
|
87003-0
|
Guidance for additional vertebroplasty of Spine vertebra |
|
87197-0
|
Guidance for retrieval of foreign body of Vessel |
|
87196-2
|
Guidance for infusion of non-thrombolytic of Vessel |
|
87178-0
|
Guidance for final day of infusion of thrombolytic of Vessel-- W thrombolytic via catheter |
|
87311-7
|
Guidance for embolization for tumor, ischemia or infarction of Vessel |
|
87022-0
|
Guidance for embolization of Vessels |
|
87095-6
|
Guidance for percutaneous transluminal angioplasty of Visceral artery |
|
87096-4
|
Guidance for placement of stent in Visceral artery |
|
87147-5
|
Guidance for injection of Wrist |
|
6134-1
|
Guinea pig epithelium IgE Ab [Units/volume] in Serum |
|
39603-6
|
Guinea pig epithelium IgE Ab/IgE total in Serum |
|
56279-3
|
Guinea pig epithelium IgG4 Ab [Mass/volume] in Serum |
|
7382-5
|
Gum arabic IgE Ab [Units/volume] in Serum |
|
56166-2
|
Gum arabic IgG4 Ab [Mass/volume] in Serum |
|
63145-7
|
Gum arabic IgG Ab [Mass/volume] in Serum |
|
6113-5
|
Gum-Tree IgE Ab [Units/volume] in Serum |
|
61261-4
|
Gum-Tree IgE Ab/IgE total in Serum |
|
56258-7
|
Gum-Tree IgG4 Ab [Mass/volume] in Serum |
|
89455-0
|
Gynecology Attending Note |
|
89453-5
|
Gynecology Nurse practitioner Note |
|
89451-9
|
Gynecology Nurse Note |
|
89463-4
|
Gynecology Nurse Outpatient Note |
|
80396-5
|
Gynecologic oncology Consult note |
|
85444-8
|
Gynecologic oncology Note |
|
93896-9
|
Gynecologic oncology Telephone encounter Note |
|
89803-1
|
Gynecologic oncology procedure note |
|
89802-3
|
Gynecologic oncology Progress note |
|
93895-1
|
Gynecologic oncology Team Conference note |
|
89441-0
|
Gynecology Resident Note |
|
89473-3
|
Gynecology Administrative note |
|
89215-8
|
Gynecology Admission history and physical note |
|
89445-1
|
Gynecology Checklist |
|
89216-6
|
Gynecology Consult note |
|
89499-8
|
Gynecology Diagnostic study note |
|
89217-4
|
Gynecology Discharge instructions |
|
89218-2
|
Gynecology Discharge summary |
|
89219-0
|
Gynecology Discharge teaching note |
|
89220-8
|
Gynecology Education note |
|
89237-2
|
Gynecology Flowsheet |
|
89221-6
|
Gynecology History and physical note |
|
89447-7
|
Gynecology Hospital Consult note |
|
89449-3
|
Gynecology Hospital Letter |
|
89459-2
|
Gynecology Hospital Note |
|
89222-4
|
Gynecology Initial evaluation note |
|
85937-1
|
Gynecology Note |
|
89461-8
|
Gynecology Outpatient Note |
|
89472-5
|
Gynecology Surgical operation note |
|
89465-9
|
Gynecology Telephone encounter Note |
|
89239-8
|
Gynecology Plan of care note |
|
89467-5
|
Gynecology Postoperative evaluation and management note |
|
89469-1
|
Gynecology Preoperative evaluation and management note |
|
89223-2
|
Gynecology procedure note |
|
89224-0
|
Gynecology Progress note |
|
89225-7
|
Gynecology Referral note |
|
89471-7
|
Gynecology Summary note |
|
89897-3
|
Gynecology Telehealth Note |
|
89226-5
|
Gynecology Transfer summary note |
|
53867-8
|
GYS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
91682-5
|
Histoplasma capsulatum Ab [Identifier] in Cerebral spinal fluid by Immune diffusion (ID) |
|
22345-3
|
Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid |
|
21330-6
|
Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
|
40827-8
|
Histoplasma capsulatum Ab [Presence] in Body fluid |
|
43019-9
|
Histoplasma capsulatum Ab [Presence] in Pleural fluid |
|
42509-0
|
Histoplasma capsulatum Ab [Presence] in Pleural fluid by Immune diffusion (ID) |
|
6426-1
|
Histoplasma capsulatum Ab [Units/volume] in Serum by Immunoassay |
|
22346-1
|
Histoplasma capsulatum Ab [Presence] in Serum |
|
16970-6
|
Histoplasma capsulatum Ab [Presence] in Serum by Complement fixation |
|
44869-6
|
Histoplasma capsulatum Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
|
44522-1
|
Histoplasma capsulatum Ab [Presence] in Serum by Immunoassay |
|
5218-3
|
Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID) |
|
6427-9
|
Histoplasma capsulatum Ab [Presence] in Serum by Latex agglutination |
|
7916-0
|
Histoplasma capsulatum Ab [Units/volume] in Serum |
|
90232-0
|
Histoplasma capsulatum Ab [Identifier] in Serum or Plasma by Immune diffusion (ID) |
|
22347-9
|
Histoplasma capsulatum Ab [Titer] in Serum |
|
5219-1
|
Histoplasma capsulatum Ab [Titer] in Serum by Complement fixation |
|
27266-6
|
Histoplasma capsulatum Ab [Titer] in Serum by Immune diffusion (ID) |
|
53930-4
|
Histoplasma capsulatum Ag [Units/volume] in Bronchoalveolar lavage by Immunoassay |
|
53931-2
|
Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
51754-0
|
Histoplasma capsulatum Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay |
|
40776-7
|
Histoplasma capsulatum Ag [Presence] in Cerebral spinal fluid |
|
34158-6
|
Histoplasma capsulatum Ag [Units/volume] in Cerebral spinal fluid |
|
57766-8
|
Histoplasma capsulatum Ag [Mass/volume] in Body fluid |
|
6428-7
|
Histoplasma capsulatum Ag [Units/volume] in Serum by Immunoassay |
|
51753-2
|
Histoplasma capsulatum Ag [Mass/volume] in Serum by Immunoassay |
|
19108-0
|
Histoplasma capsulatum Ag [Presence] in Serum |
|
44525-4
|
Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay |
|
19107-2
|
Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
31855-0
|
Histoplasma capsulatum Ag [Units/volume] in Serum |
|
48338-8
|
Histoplasma capsulatum Ag [Presence] in Tissue by Immune stain |
|
13971-7
|
Histoplasma capsulatum Ag [Units/volume] in Urine by Immunoassay |
|
35734-3
|
Histoplasma capsulatum Ag [Presence] in Urine |
|
44524-7
|
Histoplasma capsulatum Ag [Presence] in Urine by Immunoassay |
|
44870-4
|
Histoplasma capsulatum Ag [Presence] in Urine by Radioimmunoassay (RIA) |
|
31856-8
|
Histoplasma capsulatum Ag [Units/volume] in Urine |
|
48952-6
|
Histoplasma capsulatum Ag [Mass/volume] in Urine |
|
42916-7
|
Histoplasma capsulatum Ag [Units/volume] in Unspecified specimen by Immunoassay |
|
19109-8
|
Histoplasma capsulatum Ag [Presence] in Unspecified specimen |
|
34171-9
|
Histoplasma capsulatum Ag [Units/volume] in Unspecified specimen |
|
51771-4
|
Histoplasma capsulatum DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
88926-1
|
Histoplasma capsulatum DNA [Presence] in Tissue by NAA with probe detection |
|
5015-3
|
Histoplasma capsulatum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23135-7
|
Histoplasma farciminosum Ab [Presence] in Serum |
|
23134-0
|
Histoplasma farciminosum Ab [Presence] in Serum by Hemagglutination |
|
23133-2
|
Histoplasma farciminosum Ab [Presence] in Serum by Immunoassay |
|
23132-4
|
Histoplasma farciminosum Ab [Presence] in Serum by Immunofluorescence |
|
44526-2
|
Histoplasma capsulatum H Ab [Presence] in Cerebral spinal fluid |
|
44527-0
|
Histoplasma capsulatum H Ab [Presence] in Serum |
|
35732-7
|
Histoplasma capsulatum H Ab [Presence] in Serum by Immune diffusion (ID) |
|
91683-3
|
Histoplasma capsulatum H and M and Blastomyces dermatitidis Ab panel - Cerebral spinal fluid |
|
9528-1
|
Histoplasma capsulatum IgA Ab [Units/volume] in Serum by Immunoassay |
|
22348-7
|
Histoplasma capsulatum IgA Ab [Presence] in Serum |
|
16971-4
|
Histoplasma capsulatum IgA Ab [Presence] in Serum by Immune diffusion (ID) |
|
22349-5
|
Histoplasma capsulatum IgA Ab [Units/volume] in Serum |
|
22350-3
|
Histoplasma capsulatum IgE Ab [Presence] in Serum |
|
16972-2
|
Histoplasma capsulatum IgE Ab [Presence] in Serum by Immune diffusion (ID) |
|
93839-9
|
Histoplasma capsulatum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
46191-3
|
Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid |
|
44523-9
|
Histoplasma capsulatum IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
31200-9
|
Histoplasma capsulatum IgG Ab [Presence] in Serum |
|
39588-9
|
Histoplasma capsulatum IgG Ab [Presence] in Serum by Immunoassay |
|
22351-1
|
Histoplasma capsulatum IgG Ab [Units/volume] in Serum |
|
9529-9
|
Histoplasma capsulatum IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
40774-2
|
Histoplasma capsulatum IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen |
|
40778-3
|
Histoplasma capsulatum IgG Ab [Titer] in Serum --2nd specimen |
|
93838-1
|
Histoplasma capsulatum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
22352-9
|
Histoplasma capsulatum IgM Ab [Presence] in Serum |
|
16973-0
|
Histoplasma capsulatum IgM Ab [Presence] in Serum by Immune diffusion (ID) |
|
22353-7
|
Histoplasma capsulatum IgM Ab [Units/volume] in Serum |
|
9530-7
|
Histoplasma capsulatum IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
40773-4
|
Histoplasma capsulatum IgM Ab [Titer] in Cerebral spinal fluid --1st specimen |
|
40775-9
|
Histoplasma capsulatum IgM Ab [Titer] in Serum --1st specimen |
|
49904-6
|
Histoplasma capsulatum M Ab [Presence] in Cerebral spinal fluid |
|
44528-8
|
Histoplasma capsulatum M Ab [Presence] in Serum |
|
35733-5
|
Histoplasma capsulatum M Ab [Presence] in Serum by Immune diffusion (ID) |
|
12456-0
|
Histoplasma capsulatum mycelial phase Ab [Presence] in Cerebral spinal fluid |
|
31425-2
|
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Cerebral spinal fluid |
|
31426-0
|
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Body fluid |
|
20497-4
|
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum by Complement fixation |
|
6816-3
|
Histoplasma capsulatum mycelial phase Ab [Presence] in Serum |
|
30360-2
|
Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Complement fixation |
|
44529-6
|
Histoplasma capsulatum mycelial phase Ab [Presence] in Serum by Immune diffusion (ID) |
|
22354-5
|
Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum |
|
43018-1
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid |
|
27220-3
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43017-3
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid |
|
31071-4
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Body fluid by Complement fixation |
|
20417-2
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum |
|
20573-2
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation |
|
51789-6
|
Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Immune diffusion (ID) |
|
5016-1
|
Histoplasma capsulatum rRNA [Presence] in Unspecified specimen by Probe |
|
14214-1
|
Histoplasma capsulatum exoantigen [Identifier] in Isolate |
|
12455-2
|
Histoplasma capsulatum yeast phase Ab [Presence] in Cerebral spinal fluid |
|
31427-8
|
Histoplasma capsulatum yeast phase Ab [Units/volume] in Cerebral spinal fluid |
|
31428-6
|
Histoplasma capsulatum yeast phase Ab [Units/volume] in Body fluid |
|
20498-2
|
Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum by Complement fixation |
|
6817-1
|
Histoplasma capsulatum yeast phase Ab [Presence] in Serum |
|
35435-7
|
Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Complement fixation |
|
44530-4
|
Histoplasma capsulatum yeast phase Ab [Presence] in Serum by Immune diffusion (ID) |
|
22355-2
|
Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum |
|
43016-5
|
Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid |
|
27209-6
|
Histoplasma capsulatum yeast phase Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
43015-7
|
Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid |
|
31070-6
|
Histoplasma capsulatum yeast phase Ab [Titer] in Body fluid by Complement fixation |
|
20418-0
|
Histoplasma capsulatum yeast phase Ab [Titer] in Serum |
|
20574-0
|
Histoplasma capsulatum yeast phase Ab [Titer] in Serum by Complement fixation |
|
91684-1
|
Histoplasma capsulatum H and M Ab panel - Cerebral spinal fluid |
|
90227-0
|
Histoplasma capsulatum H and M Ab panel - Serum |
|
70055-9
|
Hantavirus dobrova IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
70054-2
|
Hantavirus dobrova IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
76076-9
|
Haemophilus ducreyi DNA [Presence] in Genital specimen by NAA with probe detection |
|
29559-2
|
Haemophilus ducreyi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91789-8
|
Haemophilus ducreyi [Presence] in Genital specimen by Organism specific culture |
|
11255-7
|
Haemophilus ducreyi [Presence] in Unspecified specimen by Organism specific culture |
|
24421-0
|
Haemobartonella felis [Presence] in Blood by Light microscopy |
|
85678-1
|
Haemophilus influenzae acs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85683-1
|
Haemophilus influenzae bcs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85679-9
|
Haemophilus influenzae bex gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85682-3
|
Haemophilus influenzae ccs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85681-5
|
Haemophilus influenzae dcs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85680-7
|
Haemophilus influenzae ecs gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85627-8
|
Haemophilus influenzae hpd gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
7393-2
|
Helminthosporium interseminatum IgE Ab [Units/volume] in Serum |
|
63170-5
|
Helminthosporium interseminatum IgG Ab [Mass/volume] in Serum |
|
50860-6
|
Hydrogen ion [Moles/volume] in Arterial cord blood |
|
50858-0
|
Hydrogen ion [Moles/volume] in Mixed venous cord blood |
|
50862-2
|
Hydrogen ion [Moles/volume] in Cord blood |
|
50859-8
|
Hydrogen ion [Moles/volume] in Venous cord blood |
|
50861-4
|
Hydrogen ion [Moles/volume] in Capillary blood |
|
53143-4
|
Hydrogen ion [Moles/volume] in Mixed venous blood |
|
50863-0
|
Hydrogen ion [Moles/volume] in Blood |
|
50864-8
|
Hydrogen ion [Moles/volume] in Venous blood |
|
50865-5
|
Hydrogen ion [Moles/volume] in Serum or Plasma |
|
7394-0
|
Helminthosporium maydis IgE Ab [Units/volume] in Serum |
|
34884-7
|
Haemophilus paragallinarum Ab [Units/volume] in Serum by Immunoassay |
|
41152-0
|
Haemophilus paragallinarum Ab [Units/volume] in Serum |
|
20833-0
|
Haemophilus paragallinarum serotype [Identifier] in Isolate |
|
87364-6
|
Haemophilus parasuis Ab/Positive control in Serum by Immunoassay |
|
86729-1
|
Haemophilus parasuis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
90322-9
|
Haemophilus parasuis serotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
88509-5
|
Helicobacter pylori 23S rRNA clarithromycin resistance mutation [Identifier] by Molecular method |
|
5174-8
|
Helicobacter pylori Ab [Units/volume] in Serum by Immunoassay |
|
16929-2
|
Helicobacter pylori Ab [Units/volume] in Serum by Immunofluorescence |
|
22310-7
|
Helicobacter pylori Ab [Presence] in Serum |
|
6419-6
|
Helicobacter pylori Ab [Presence] in Serum by Immunofluorescence |
|
7900-4
|
Helicobacter pylori Ab [Units/volume] in Serum |
|
16533-2
|
Helicobacter pylori Ab [Titer] in Serum |
|
5175-5
|
Helicobacter pylori Ab [Titer] in Serum by Latex agglutination |
|
31843-6
|
Helicobacter pylori Ag [Presence] in Stool |
|
17780-8
|
Helicobacter pylori Ag [Presence] in Stool by Immunoassay |
|
80373-4
|
Helicobacter pylori Ag [Presence] in Stool by Rapid immunoassay |
|
50320-1
|
Helicobacter pylori Ag [Presence] in Tissue by Immune stain |
|
91061-2
|
Helicobacter pylori DNA [Presence] in Stool by NAA with probe detection |
|
91060-4
|
Helicobacter pylori DNA [Presence] in Tissue by NAA with probe detection |
|
49101-9
|
Helicobacter pylori DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44015-6
|
Helicobacter pylori [Presence] in Gastric fluid by Organism specific culture |
|
6420-4
|
Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay |
|
16125-7
|
Helicobacter pylori IgA Ab [Presence] in Serum |
|
7901-2
|
Helicobacter pylori IgA Ab [Units/volume] in Serum |
|
40820-3
|
Helicobacter pylori IgA Ab [Titer] in Serum |
|
26984-5
|
Helicobacter pylori IgG Ab [Units/volume] in Saliva (oral fluid) |
|
5176-3
|
Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay |
|
16126-5
|
Helicobacter pylori IgG Ab [Presence] in Serum |
|
7902-0
|
Helicobacter pylori IgG Ab [Units/volume] in Serum |
|
17859-0
|
Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
5177-1
|
Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay |
|
16127-3
|
Helicobacter pylori IgM Ab [Presence] in Serum |
|
46987-4
|
Helicobacter pylori IgM Ab [Presence] in Serum by Immunoassay |
|
7903-8
|
Helicobacter pylori IgM Ab [Units/volume] in Serum |
|
40821-1
|
Helicobacter pylori IgM Ab [Titer] in Serum |
|
87952-8
|
Helicobacter pylori [Presence] in Stool by Organism specific culture |
|
87953-6
|
Helicobacter pylori [Presence] in Tissue by Organism specific culture |
|
587-6
|
Helicobacter pylori [Presence] in Unspecified specimen by Organism specific culture |
|
70056-7
|
Hantavirus saaremaa IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
70057-5
|
Hantavirus saaremaa IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
11175-7
|
Helminthosporium sativum IgE Ab [Units/volume] in Serum |
|
70060-9
|
Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
31407-0
|
Haemophilus somnus Ab [Units/volume] in Serum |
|
24420-2
|
Haemophilus somnus Ab [Titer] in Serum |
|
34117-2
|
History and physical note |
|
6665-4
|
Microscopic observation [Identifier] in Tissue by Hematoxylin and eosin stain |
|
665-0
|
Microscopic observation [Identifier] in Unspecified specimen by Hematoxylin and eosin stain |
|
49100-1
|
H2a-H2b DNA IgG Ab [Presence] in Serum |
|
14231-5
|
H2a-H2b DNA IgG Ab [Units/volume] in Serum |
|
82414-4
|
Ha Ab [Units/volume] in Serum by Line blot |
|
82415-1
|
Ha Ab [Presence] in Serum by Line blot |
|
34145-3
|
Human antichimeric Ab [Mass/volume] in Serum |
|
7383-3
|
Hackberry tree IgE Ab [Units/volume] in Serum |
|
7384-1
|
Haddock IgE Ab [Units/volume] in Serum |
|
7385-8
|
Haddock IgG Ab [Units/volume] in Serum |
|
56280-1
|
Haddock IgG4 Ab [Mass/volume] in Serum |
|
60378-7
|
Haddock IgG Ab [Mass/volume] in Serum |
|
34501-7
|
HADHA gene c.1528G>C [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
41097-7
|
HADHA gene c.1528G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
21685-3
|
HADHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
92852-3
|
Adenovirus and Bocavirus DNA panel - Lower respiratory specimen by NAA with probe detection |
|
92853-1
|
Adenovirus and Bocavirus DNA panel - Upper respiratory specimen by NAA with probe detection |
|
94040-3
|
Adenovirus A+B+C+D+E DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
88716-6
|
Adenovirus A+B+C+D+E+F DNA [Presence] in Nasopharynx by NAA with probe detection |
|
43617-0
|
Adenovirus Ab [Presence] in Cerebral spinal fluid |
|
13192-0
|
Adenovirus Ab [Units/volume] in Cerebral spinal fluid |
|
31217-3
|
Adenovirus Ab [Units/volume] in Body fluid |
|
44289-7
|
Adenovirus Ab [Units/volume] in Serum by Complement fixation |
|
43616-2
|
Adenovirus Ab [Presence] in Serum |
|
43618-8
|
Adenovirus Ab [Presence] in Serum by Complement fixation |
|
7805-5
|
Adenovirus Ab [Units/volume] in Serum |
|
24249-5
|
Adenovirus Ab [Titer] in Serum --1st specimen |
|
24175-2
|
Adenovirus Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24250-3
|
Adenovirus Ab [Titer] in Serum --2nd specimen |
|
24176-0
|
Adenovirus Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
34576-9
|
Adenovirus Ab [Titer] in Cerebral spinal fluid |
|
23950-9
|
Adenovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29416-5
|
Adenovirus Ab [Titer] in Body fluid |
|
29314-2
|
Adenovirus Ab [Titer] in Body fluid by Complement fixation |
|
22080-6
|
Adenovirus Ab [Titer] in Serum |
|
5041-9
|
Adenovirus Ab [Titer] in Serum by Complement fixation |
|
13913-9
|
Adenovirus Ab [Titer] in Serum by Immunofluorescence |
|
43714-5
|
Adenovirus Ab [Presence] in Unspecified specimen |
|
77382-0
|
Adenovirus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
43611-3
|
Adenovirus Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
31710-7
|
Adenovirus Ag [Presence] in Conjunctival specimen |
|
5823-0
|
Adenovirus Ag [Presence] in Conjunctival specimen by Immunoassay |
|
5824-8
|
Adenovirus Ag [Presence] in Conjunctival specimen by Immunofluorescence |
|
87959-3
|
Adenovirus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
43615-4
|
Adenovirus Ag [Presence] in Genital specimen |
|
88603-6
|
Adenovirus Ag [Presence] in Lower respiratory specimen by Immunoassay |
|
91841-7
|
Adenovirus Ag [Presence] in Lower respiratory specimen by Rapid immunoassay |
|
88897-4
|
Adenovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
43614-7
|
Adenovirus Ag [Presence] in Nose |
|
43612-1
|
Adenovirus Ag [Presence] in Nose by Immunofluorescence |
|
35705-3
|
Adenovirus Ag [Presence] in Nasopharynx |
|
88602-8
|
Adenovirus Ag [Presence] in Nasopharynx by Immunoassay |
|
43610-5
|
Adenovirus Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31711-5
|
Adenovirus Ag [Presence] in Stool |
|
5825-5
|
Adenovirus Ag [Presence] in Stool by Immunoassay |
|
78529-5
|
Adenovirus Ag [Presence] in Stool by Rapid immunoassay |
|
5826-3
|
Adenovirus Ag [Presence] in Stool by Immunofluorescence |
|
31712-3
|
Adenovirus Ag [Presence] in Throat |
|
5827-1
|
Adenovirus Ag [Presence] in Throat by Immunoassay |
|
5828-9
|
Adenovirus Ag [Presence] in Throat by Immunofluorescence |
|
5829-7
|
Adenovirus Ag [Presence] in Tissue by Immunoassay |
|
5830-5
|
Adenovirus Ag [Presence] in Tissue by Immunofluorescence |
|
43613-9
|
Adenovirus Ag [Presence] in Trachea by Immunofluorescence |
|
91822-7
|
Adenovirus Ag [Presence] in Upper respiratory specimen by Immunoassay |
|
91821-9
|
Adenovirus Ag [Presence] in Upper respiratory specimen by Rapid immunoassay |
|
31713-1
|
Adenovirus Ag [Presence] in Urine |
|
5831-3
|
Adenovirus Ag [Presence] in Urine by Immunoassay |
|
5832-1
|
Adenovirus Ag [Presence] in Urine by Immunofluorescence |
|
31714-9
|
Adenovirus Ag [Presence] in Unspecified specimen |
|
5833-9
|
Adenovirus Ag [Presence] in Unspecified specimen by Immunoassay |
|
5834-7
|
Adenovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88899-0
|
Adenovirus [Presence] in Cornea or Conjunctiva by Organism specific culture |
|
49336-1
|
Adenovirus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49341-1
|
Adenovirus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
92854-9
|
Adenovirus DNA [#/volume] (viral load) in Cornea or Conjunctiva by NAA with probe detection |
|
49338-7
|
Adenovirus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
66721-2
|
Adenovirus DNA [#/volume] (viral load) in Body fluid by NAA with probe detection |
|
66727-9
|
Adenovirus DNA [#/volume] (viral load) in Genital specimen by NAA with probe detection |
|
49337-9
|
Adenovirus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49334-6
|
Adenovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
66729-5
|
Adenovirus DNA [#/volume] (viral load) in Skin by NAA with probe detection |
|
49339-5
|
Adenovirus DNA [#/volume] (viral load) in Stool by NAA with probe detection |
|
49335-3
|
Adenovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
48609-2
|
Adenovirus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49340-3
|
Adenovirus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88541-8
|
Adenovirus DNA [Presence] in Aspirate by NAA with probe detection |
|
62480-9
|
Adenovirus DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
66725-3
|
Adenovirus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
|
86511-3
|
Adenovirus DNA [Presence] in Blood by NAA with probe detection |
|
88533-5
|
Adenovirus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
66730-3
|
Adenovirus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
38375-2
|
Adenovirus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
66720-4
|
Adenovirus DNA [Log #/volume] (viral load) in Body fluid by NAA with probe detection |
|
66726-1
|
Adenovirus DNA [Log #/volume] (viral load) in Genital specimen by NAA with probe detection |
|
60259-9
|
Adenovirus DNA [Presence] in Isolate by NAA with probe detection |
|
92987-7
|
Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
90463-1
|
Adenovirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82160-3
|
Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76070-2
|
Adenovirus DNA [Presence] in Nasopharynx by NAA with probe detection |
|
66723-8
|
Adenovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
21055-9
|
Adenovirus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
66728-7
|
Adenovirus DNA [Log #/volume] (viral load) in Skin by NAA with probe detection |
|
66731-1
|
Adenovirus DNA [Log #/volume] (viral load) in Sputum or Bronchial by NAA with probe detection |
|
66724-6
|
Adenovirus DNA [Log #/volume] (viral load) in Stool by NAA with probe detection |
|
88539-2
|
Adenovirus DNA [Presence] in Stool by NAA with probe detection |
|
66722-0
|
Adenovirus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection |
|
86510-5
|
Adenovirus DNA [Presence] in Tissue by NAA with probe detection |
|
91820-1
|
Adenovirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
66719-6
|
Adenovirus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
|
86512-1
|
Adenovirus DNA [Presence] in Urine by NAA with probe detection |
|
40976-3
|
Adenovirus DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
64038-3
|
Adenovirus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
39528-5
|
Adenovirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
40975-5
|
Adenovirus DNA [Identifier] in Unspecified specimen by RFLP |
|
69920-7
|
Adenovirus IgA Ab [Presence] in Serum by Immunoassay |
|
51822-5
|
Adenovirus IgG Ab [Units/volume] in Serum by Immunoassay |
|
41162-9
|
Adenovirus IgG Ab [Presence] in Serum |
|
40977-1
|
Adenovirus IgG Ab [Presence] in Serum by Immunoassay |
|
13914-7
|
Adenovirus IgG Ab [Units/volume] in Serum |
|
21053-4
|
Adenovirus IgG Ab [Titer] in Serum |
|
55160-6
|
Adenovirus IgG and IgM panel - Serum |
|
51823-3
|
Adenovirus IgM Ab [Units/volume] in Serum by Immunoassay |
|
21054-2
|
Adenovirus IgM Ab [Presence] in Serum |
|
86513-9
|
Adenovirus IgM Ab [Presence] in Serum by Immunoassay |
|
5042-7
|
Adenovirus IgM Ab [Units/volume] in Serum |
|
13915-4
|
Adenovirus IgM Ab [Titer] in Serum |
|
88898-2
|
Adenovirus [Presence] in Lower respiratory specimen by Organism specific culture |
|
6307-3
|
Adenovirus rRNA [Presence] in Tissue by Probe |
|
6308-1
|
Adenovirus rRNA [Presence] in Unspecified specimen by Probe |
|
88901-4
|
Adenovirus [Presence] in Stool by Organism specific culture |
|
88900-6
|
Adenovirus [Presence] in Upper respiratory specimen by Organism specific culture |
|
88902-2
|
Adenovirus [Presence] in Urine by Organism specific culture |
|
55095-4
|
Adenovirus [Presence] in Unspecified specimen by Organism specific culture |
|
40831-0
|
Adenovirus+Rotavirus Ag [Presence] in Stool |
|
32134-9
|
Adenovirus+Rotavirus [Identifier] in Stool |
|
90072-0
|
Haemophilus and Neisseria species identified in Isolate by Organism specific culture |
|
16926-8
|
Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid |
|
6610-0
|
Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
16925-0
|
Haemophilus influenzae A Ag [Presence] in Urine |
|
31833-7
|
Haemophilus influenzae A Ag [Presence] in Unspecified specimen |
|
6414-7
|
Haemophilus influenzae A Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
29906-5
|
Haemophilus influenzae A DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5178-9
|
Haemophilus influenzae Ab [Units/volume] in Serum by Immunoassay |
|
7894-9
|
Haemophilus influenzae Ab [Units/volume] in Serum |
|
25432-6
|
Haemophilus influenzae Ab [Mass/volume] in Serum |
|
32139-8
|
Haemophilus influenzae Ag [Presence] in Cerebral spinal fluid |
|
40771-8
|
Haemophilus influenzae Ag [Presence] in Urine |
|
13246-4
|
Haemophilus influenzae B Ab [Units/volume] in Serum |
|
22755-3
|
Haemophilus influenzae B Ab [Mass/volume] in Serum |
|
24010-1
|
Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid |
|
6611-8
|
Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
14321-4
|
Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
20486-7
|
Haemophilus influenzae B Ag [Units/volume] in Cerebral spinal fluid |
|
41495-3
|
Haemophilus influenzae B Ag [Presence] in Body fluid |
|
43429-0
|
Haemophilus influenzae B Ag [Presence] in Serum |
|
15379-1
|
Haemophilus influenzae B Ag [Presence] in Urine |
|
31834-5
|
Haemophilus influenzae B Ag [Presence] in Unspecified specimen |
|
6599-5
|
Haemophilus influenzae B Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
21320-7
|
Haemophilus influenzae B Ag [Presence] in Unspecified specimen by Latex agglutination |
|
53607-8
|
Haemophilus influenzae B DNA [Presence] in Blood by NAA with probe detection |
|
29907-3
|
Haemophilus influenzae B DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
11257-3
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay |
|
16927-6
|
Haemophilus influenzae B IgG Ab [Units/volume] in Serum |
|
11256-5
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum |
|
47310-8
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47439-5
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --1st specimen |
|
47311-6
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
31018-5
|
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum --2nd specimen |
|
31835-2
|
Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid |
|
6612-6
|
Haemophilus influenzae C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31836-0
|
Haemophilus influenzae C Ag [Presence] in Unspecified specimen |
|
8271-9
|
Haemophilus influenzae C Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
31837-8
|
Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid |
|
6613-4
|
Haemophilus influenzae D Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31838-6
|
Haemophilus influenzae D Ag [Presence] in Unspecified specimen |
|
6416-2
|
Haemophilus influenzae D Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
92981-0
|
Haemophilus influenzae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85778-9
|
Haemophilus influenzae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
82183-5
|
Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
92127-0
|
Haemophilus influenzae DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
92980-2
|
Haemophilus influenzae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61366-1
|
Haemophilus influenzae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31839-4
|
Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid |
|
6614-2
|
Haemophilus influenzae E Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31840-2
|
Haemophilus influenzae E Ag [Presence] in Unspecified specimen |
|
6417-0
|
Haemophilus influenzae E Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
31841-0
|
Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid |
|
6615-9
|
Haemophilus influenzae F Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31842-8
|
Haemophilus influenzae F Ag [Presence] in Unspecified specimen |
|
6418-8
|
Haemophilus influenzae F Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
16924-3
|
Haemophilus influenzae IgG Ab [Units/volume] in Serum |
|
5006-2
|
Haemophilus influenzae rRNA [Presence] in Unspecified specimen by Probe |
|
58473-0
|
Haemophilus influenzae serotype DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
6600-1
|
Haemophilus sp identified in Unspecified specimen by Organism specific culture |
|
58353-4
|
Human antihuman Ab [Mass/volume] in Plasma |
|
58354-2
|
Human antihuman Ab [Moles/volume] in Plasma |
|
51896-9
|
Healthcare Associated Infection report - recommended CDA R2 sections |
|
86535-2
|
Healthcare associated infection report - recommended CDA R3 set |
|
19741-8
|
Hake IgE Ab [Units/volume] in Serum |
|
12335-6
|
Halothane [Presence] in Blood |
|
27202-1
|
Halothane [Mass/volume] in Blood |
|
61020-4
|
Halothane [VFr/PPres] Airway adaptor --during expiration |
|
60761-4
|
Halothane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
61021-2
|
Halothane [VFr/PPres] Airway adaptor --during inspiration |
|
60857-0
|
Halothane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60889-3
|
Halothane [VFr/PPres] Airway adaptor --at end expiration |
|
2425-7
|
Histidine ammonia lyase [Enzymatic activity/volume] in Serum |
|
60759-8
|
Gas delivery system inspiratory Halothane setting [VFr/PPres] |
|
62267-0
|
Halothane [VFr/PPres] Airway adaptor |
|
60856-2
|
Halothane [VFr/PPres] Gas delivery system |
|
12379-4
|
Halazepam [Mass/volume] in Serum or Plasma |
|
7387-4
|
Halibut triggered histamine release [Units/volume] in Blood |
|
6842-9
|
Halibut IgE Ab [Units/volume] in Serum |
|
39595-4
|
Halibut IgE Ab/IgE total in Serum |
|
7386-6
|
Halibut IgG Ab [Units/volume] in Serum |
|
56281-9
|
Halibut IgG4 Ab [Mass/volume] in Serum |
|
60379-5
|
Halibut IgG Ab [Mass/volume] in Serum |
|
12295-2
|
Hallucinogens [Identifier] in Urine |
|
87550-0
|
Haloperidol and reduced haloperidol panel - Serum or Plasma |
|
60762-2
|
Halothane gas delivered during case [Volume] from Gas delivery system |
|
61024-6
|
Halothane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76016-5
|
Halothane liquid delivered during case [Volume] from Gas delivery system |
|
76017-3
|
Halothane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
13003-9
|
Halogenated organic molecules [Identifier] in Blood |
|
12446-1
|
Halogenated organic molecules [Identifier] in Urine |
|
75760-9
|
Haloperidol [Presence] in Blood or Urine by Screen method |
|
73356-8
|
Haloperidol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73357-6
|
Haloperidol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26847-4
|
Haloperidol [Presence] in Serum or Plasma |
|
3669-9
|
Haloperidol [Mass/volume] in Serum or Plasma |
|
14774-4
|
Haloperidol [Moles/volume] in Serum or Plasma |
|
74965-5
|
Haloperidol [Mass/volume] in Serum or Plasma --trough |
|
20530-2
|
Haloperidol [Mass/volume] in Urine by Confirmatory method |
|
3670-7
|
Haloperidol [Presence] in Urine |
|
19479-5
|
Haloperidol [Presence] in Urine by Confirmatory method |
|
19478-7
|
Haloperidol [Presence] in Urine by Screen method |
|
3671-5
|
Haloperidol [Mass/volume] in Urine |
|
7388-2
|
Ham triggered histamine release [Units/volume] in Blood |
|
84125-4
|
Surgery of the hand Admission evaluation note |
|
84126-2
|
Surgery of the hand Consult note |
|
84127-0
|
Surgery of the hand Hospital Note |
|
84128-8
|
Surgery of the hand Note |
|
84129-6
|
Surgery of the hand Outpatient Note |
|
42503-3
|
Hantavirus Ab [Presence] in Serum |
|
5046-8
|
Hantavirus Ab [Units/volume] in Serum |
|
60264-9
|
Hantavirus Ab [Titer] in Serum |
|
65762-7
|
Hantavirus Ag [Presence] in Tissue by Immune stain |
|
26620-5
|
Hantavirus IgG Ab [Presence] in Serum |
|
35392-0
|
Hantavirus IgG Ab [Units/volume] in Serum |
|
32131-5
|
Hantavirus IgM Ab [Presence] in Serum |
|
35393-8
|
Hantavirus IgM Ab [Units/volume] in Serum |
|
86520-4
|
Hantavirus RNA [Presence] in Blood by NAA with probe detection |
|
86536-0
|
Hantavirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91130-5
|
Hantavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
7899-8
|
Hantavirus RNA [Presence] in Serum by NAA with probe detection |
|
86537-8
|
Hantavirus RNA [Presence] in Tissue by NAA with probe detection |
|
86538-6
|
Hantavirus RNA [Presence] in Urine by NAA with probe detection |
|
83011-7
|
Haplotype definition panel |
|
29220-1
|
Haptoglobin [Mass/volume] in Body fluid |
|
4543-5
|
Haptoglobin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
46127-7
|
Haptoglobin [Mass/volume] in Serum or Plasma by Nephelometry |
|
40717-1
|
Haptoglobin [Presence] in Serum or Plasma |
|
4542-7
|
Haptoglobin [Mass/volume] in Serum or Plasma |
|
70209-2
|
Haptoglobin [Moles/volume] in Serum or Plasma |
|
87443-8
|
Hardness [Mass/volume] of Water by Calculation |
|
77105-5
|
HARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77104-8
|
HARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
48227-3
|
Human serum albumin triggered leukotriene release [Mass/volume] by Leukocytes |
|
31718-0
|
Astrovirus Ag [Presence] in Stool |
|
7810-5
|
Astrovirus Ag [Presence] in Stool by Immunoassay |
|
7811-3
|
Astrovirus RNA [Presence] in Serum by NAA with probe detection |
|
92691-5
|
Astrovirus RNA [Presence] in Stool by NAA with probe detection |
|
69938-9
|
Astrovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10646-8
|
Astrovirus [Identifier] in Stool by Electron microscopy |
|
7809-7
|
Astrovirus [Presence] in Stool by Electron microscopy |
|
51661-7
|
Hepatitis A virus Ab [Presence] in Body fluid |
|
53775-3
|
Hepatitis A virus Ab panel - Serum |
|
20575-7
|
Hepatitis A virus Ab [Presence] in Serum |
|
13951-9
|
Hepatitis A virus Ab [Presence] in Serum by Immunoassay |
|
5184-7
|
Hepatitis A virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22312-3
|
Hepatitis A virus Ab [Units/volume] in Serum |
|
5183-9
|
Hepatitis A virus Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
89373-5
|
Hepatitis A virus genotype in Unspecified specimen by NAA with probe detection |
|
5179-7
|
Hepatitis A virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
32018-4
|
Hepatitis A virus IgG Ab [Presence] in Serum |
|
40724-7
|
Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay |
|
5180-5
|
Hepatitis A virus IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22313-1
|
Hepatitis A virus IgG Ab [Units/volume] in Serum |
|
51913-2
|
Hepatitis A virus IgG+IgM Ab [Presence] in Serum |
|
78444-7
|
Hepatitis A virus IgG+IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
51660-9
|
Hepatitis A virus IgM Ab [Presence] in Body fluid |
|
5181-3
|
Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
22314-9
|
Hepatitis A virus IgM Ab [Presence] in Serum |
|
5182-1
|
Hepatitis A virus IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22315-6
|
Hepatitis A virus IgM Ab [Units/volume] in Serum |
|
13950-1
|
Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
75542-1
|
Hepatitis A virus RNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection |
|
7904-6
|
Hepatitis A virus RNA [Presence] in Serum by NAA with probe detection |
|
91070-3
|
Hepatitis A virus RNA [Presence] in Stool by NAA with probe detection |
|
75860-7
|
Hepatitis A virus RNA and Parvovirus B19 DNA panel - Plasma from Donor by NAA with probe detection |
|
75540-5
|
Hepatitis A virus RNA+Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection |
|
92890-3
|
Hepatitis A and B and C virus immunity AndOr previous exposure panel - Serum or Plasma |
|
79125-1
|
Hawkinsin [Moles/volume] in Serum or Plasma |
|
7389-0
|
Hay IgE Ab [Units/volume] in Serum |
|
65765-0
|
Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum |
|
69421-6
|
Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum |
|
64968-1
|
Hazelnut recombinant (rCor a) 1.0101 IgE Ab [Units/volume] in Serum |
|
64964-0
|
Hazelnut recombinant (rCor a) 1.0401 IgE Ab [Units/volume] in Serum |
|
81788-2
|
Hazelnut recombinant (rCor a) 14 IgE Ab [Units/volume] in Serum |
|
58753-5
|
Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum |
|
7392-4
|
Hazelnut triggered histamine release [Units/volume] in Blood |
|
6136-6
|
Hazelnut IgE Ab [Units/volume] in Serum |
|
39543-4
|
Hazelnut IgE Ab/IgE total in Serum |
|
7391-6
|
Hazelnut IgG Ab [Units/volume] in Serum |
|
56283-5
|
Hazelnut IgG4 Ab [Mass/volume] in Serum |
|
63080-6
|
Hazelnut IgG Ab [Mass/volume] in Serum |
|
48216-6
|
Hazelnut triggered leukotriene release [Mass/volume] by Leukocytes |
|
6137-4
|
Hazelnut Pollen IgE Ab [Units/volume] in Serum |
|
56282-7
|
Hazelnut Pollen IgG4 Ab [Mass/volume] in Serum |
|
48248-9
|
Hazelnut Pollen triggered leukotriene release [Mass/volume] by Leukocytes |
|
43150-2
|
Hemoglobin A1c measurement device panel |
|
64116-7
|
Hemoglobin observations newborn screening panel |
|
87730-8
|
HBA1 and HBA2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
21687-9
|
HBA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
66502-6
|
HBA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85091-7
|
HBA2 gene alpha 3.7kb triplication [Presence] in Blood by Molecular genetics method |
|
60540-2
|
HBA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
90925-9
|
HBB gene full mutation analysis in Amniotic fluid or Chorionic villus sample by Sequencing |
|
77627-8
|
HBB gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
79401-6
|
HBB gene full mutation analysis [Identifier] in Blood or Tissue by Sequencing |
|
21689-5
|
HBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50996-8
|
HBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21690-3
|
HBB gene p.Glu6Val [Presence] in Blood or Tissue by Molecular genetics method |
|
50319-3
|
HBME-1 Ag [Presence] in Tissue by Immune stain |
|
92135-3
|
Human bocavirus 1+2+3 DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91832-6
|
Human bocavirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
91811-0
|
Human bocavirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence |
|
48056-6
|
Human bocavirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88593-9
|
Human bocavirus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
86559-2
|
Human bocavirus DNA [Presence] in Tissue by NAA with probe detection |
|
88613-5
|
Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
62424-7
|
Human bocavirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
49175-3
|
Human bocavirus IgG Ab [Presence] in Unspecified specimen |
|
48057-4
|
Human bocavirus IgG Ab [Presence] in Unspecified specimen by Immunoassay |
|
49877-4
|
Hepatitis B virus codon 173 [Identifier] by Genotype method |
|
49878-2
|
Hepatitis B virus codon 180 [Identifier] by Genotype method |
|
49879-0
|
Hepatitis B virus codon 181 [Identifier] by Genotype method |
|
49880-8
|
Hepatitis B virus codon 204 [Identifier] by Genotype method |
|
49881-6
|
Hepatitis B virus codon 236 [Identifier] by Genotype method |
|
49882-4
|
Hepatitis B virus codon 80 [Identifier] by Genotype method |
|
61161-6
|
Hepatitis B virus codon A181T [Presence] by Genotype method |
|
61160-8
|
Hepatitis B virus codon A181V [Presence] by Genotype method |
|
61163-2
|
Hepatitis B virus codon A194T [Presence] by Genotype method |
|
54210-0
|
Hepatitis B virus basal core promoter mutation [Identifier] in Serum by NAA with probe detection |
|
92898-6
|
Hepatitis B virus core Ab and surface and little e Ab and Ag panel - Serum or Plasma |
|
77190-7
|
Hepatitis B virus core and surface Ab and surface Ag panel - Serum |
|
39005-4
|
Hepatitis B virus core Ab [Presence] in Body fluid |
|
21005-4
|
Hepatitis B virus core Ab [Units/volume] in Serum from Donor by Immunoassay |
|
47440-3
|
Hepatitis B virus core Ab [Presence] in Serum from Donor |
|
47358-7
|
Hepatitis B virus core Ab [Presence] in Serum from Donor by Immunoassay |
|
22317-2
|
Hepatitis B virus core Ab [Units/volume] in Serum from Donor |
|
5187-0
|
Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay |
|
16933-4
|
Hepatitis B virus core Ab [Presence] in Serum |
|
5188-8
|
Hepatitis B virus core Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22316-4
|
Hepatitis B virus core Ab [Units/volume] in Serum |
|
13952-7
|
Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay |
|
10673-2
|
Hepatitis B virus core Ag [Presence] in Tissue by Immune stain |
|
13919-6
|
Hepatitis B virus core IgG Ab [Units/volume] in Serum by Immunoassay |
|
32685-0
|
Hepatitis B virus core IgG Ab [Presence] in Serum |
|
40725-4
|
Hepatitis B virus core IgG Ab [Presence] in Serum by Immunoassay |
|
22318-0
|
Hepatitis B virus core IgG Ab [Units/volume] in Serum |
|
51914-0
|
Hepatitis B virus core IgG+IgM Ab [Presence] in Serum |
|
83100-8
|
Hepatitis B virus core IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
51658-3
|
Hepatitis B virus core IgM Ab [Presence] in Body fluid |
|
31204-1
|
Hepatitis B virus core IgM Ab [Presence] in Serum |
|
5186-2
|
Hepatitis B virus core IgM Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22319-8
|
Hepatitis B virus core IgM Ab [Units/volume] in Serum |
|
5185-4
|
Hepatitis B virus core IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
24113-3
|
Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
49363-5
|
Hepatitis B virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49364-3
|
Hepatitis B virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
20442-0
|
Hepatitis B virus DNA [#/volume] (viral load) in Serum by Probe with signal amplification |
|
47216-7
|
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 200 copies/ml |
|
48650-6
|
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 copies/mL |
|
29615-2
|
Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49365-0
|
Hepatitis B virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49362-7
|
Hepatitis B virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5007-0
|
Hepatitis B virus DNA [Presence] in Blood by NAA with probe detection |
|
49357-7
|
Hepatitis B virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49601-8
|
Hepatitis B virus DNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49367-6
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49358-5
|
Hepatitis B virus DNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49602-6
|
Hepatitis B virus DNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49359-3
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection |
|
40459-0
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Serum by Probe with signal amplification |
|
29900-8
|
Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe with signal amplification |
|
23869-1
|
Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe |
|
11258-1
|
Hepatitis B virus DNA [Units/volume] in Serum |
|
32686-8
|
Hepatitis B virus DNA [Mass/volume] in Serum |
|
42595-9
|
Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
48398-2
|
Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
45161-7
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
29610-3
|
Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
49368-4
|
Hepatitis B virus DNA [Units/volume] (viral load) in Tissue by NAA with probe detection |
|
49606-7
|
Hepatitis B virus DNA [log units/volume] (viral load) in Tissue by NAA with probe detection |
|
49361-9
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Tissue by NAA with probe detection |
|
5008-8
|
Hepatitis B virus DNA [Presence] in Tissue by NAA with probe detection |
|
49360-1
|
Hepatitis B virus DNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49600-0
|
Hepatitis B virus DNA [log units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49366-8
|
Hepatitis B virus DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5009-6
|
Hepatitis B virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16934-2
|
Hepatitis B virus polymerase DNA [Presence] in Blood by NAA with probe detection |
|
39006-2
|
Hepatitis B virus e Ab [Presence] in Body fluid |
|
5189-6
|
Hepatitis B virus e Ab [Units/volume] in Serum by Immunoassay |
|
22320-6
|
Hepatitis B virus e Ab [Presence] in Serum |
|
5190-4
|
Hepatitis B virus e Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22321-4
|
Hepatitis B virus e Ab [Units/volume] in Serum |
|
13953-5
|
Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay |
|
77176-6
|
Hepatitis B virus little e Ag and Ab panel - Serum |
|
5191-2
|
Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay |
|
31844-4
|
Hepatitis B virus e Ag [Presence] in Serum |
|
5192-0
|
Hepatitis B virus e Ag [Presence] in Serum by Radioimmunoassay (RIA) |
|
31845-1
|
Hepatitis B virus e Ag [Units/volume] in Serum |
|
13954-3
|
Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay |
|
75408-5
|
Hepatitis B virus e Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
32178-6
|
Hepatitis B virus e Ag [Titer] in Serum |
|
39007-0
|
Hepatitis B virus e Ag [Presence] in Unspecified specimen |
|
41151-2
|
Hepatitis B virus e IgG Ab [Presence] in Serum |
|
33463-1
|
Hepatitis B virus e IgG Ab [Presence] in Serum by Immunoassay |
|
32366-7
|
Hepatitis B virus genotype [Identifier] in Serum or Plasma by NAA with probe detection |
|
61169-9
|
Hepatitis B virus codon I233V [Presence] by Genotype method |
|
61154-1
|
Hepatitis B virus codon L180M [Presence] by Genotype method |
|
61173-1
|
Hepatitis B virus codon L80I [Presence] by Genotype method |
|
61155-8
|
Hepatitis B virus codon L80V [Presence] by Genotype method |
|
61158-2
|
Hepatitis B virus codon M204I [Presence] by Genotype method |
|
61159-0
|
Hepatitis B virus codon M204S [Presence] by Genotype method |
|
61157-4
|
Hepatitis B virus codon M204V [Presence] by Genotype method |
|
61171-5
|
Hepatitis B virus codon M250I [Presence] by Genotype method |
|
61172-3
|
Hepatitis B virus codon M250L [Presence] by Genotype method |
|
61170-7
|
Hepatitis B virus codon M250V [Presence] by Genotype method |
|
61162-4
|
Hepatitis B virus codon N236T [Presence] by Genotype method |
|
33633-9
|
Hepatitis B virus precore TAG [Presence] in Serum by NAA with probe detection |
|
49883-2
|
Hepatitis B virus resistance panel by Genotype method |
|
6421-2
|
Hepatitis B virus rRNA [Presence] in Unspecified specimen by Probe |
|
42322-8
|
Hepatitis B virus S+pol gene [Identifier] in Serum or Plasma by NAA with probe detection |
|
61167-3
|
Hepatitis B virus codon S202C [Presence] by Genotype method |
|
61166-5
|
Hepatitis B virus codon S202G [Presence] by Genotype method |
|
61168-1
|
Hepatitis B virus codon S202I [Presence] by Genotype method |
|
33629-7
|
Hepatitis B virus sequencing [Identifier] in Serum by NAA with probe detection |
|
42504-1
|
Hepatitis B virus surface Ab [Presence] in Cerebral spinal fluid |
|
21006-2
|
Hepatitis B virus surface Ab [Units/volume] in Serum from Donor by Immunoassay |
|
22323-0
|
Hepatitis B virus surface Ab [Units/volume] in Serum from Donor |
|
22322-2
|
Hepatitis B virus surface Ab [Presence] in Serum |
|
10900-9
|
Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay |
|
39535-0
|
Hepatitis B virus surface Ab [Presence] in Serum by Radioimmunoassay (RIA) |
|
5194-6
|
Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
16935-9
|
Hepatitis B virus surface Ab [Units/volume] in Serum |
|
5193-8
|
Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
75409-3
|
Hepatitis B virus surface Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
32019-2
|
Hepatitis B virus surface Ab [Titer] in Serum |
|
50967-9
|
Hepatitis B virus surface Ag [Presence] in Blood from Donor by Neutralization test |
|
42505-8
|
Hepatitis B virus surface Ag [Presence] in Cerebral spinal fluid |
|
51659-1
|
Hepatitis B virus surface Ag [Presence] in Body fluid |
|
47364-5
|
Hepatitis B virus surface Ag [Presence] in Serum from Donor by Immunoassay |
|
5195-3
|
Hepatitis B virus surface Ag [Presence] in Serum |
|
5197-9
|
Hepatitis B virus surface Ag [Presence] in Serum by Radioimmunoassay (RIA) |
|
58452-4
|
Hepatitis B virus surface Ag [Units/volume] in Serum |
|
70154-0
|
Hepatitis B virus surface Ag in Serum or Plasma by Confirmatory method |
|
63557-3
|
Hepatitis B virus surface Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
65633-0
|
Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Confirmatory method |
|
5196-1
|
Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay |
|
7905-3
|
Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test |
|
75410-1
|
Hepatitis B virus surface Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
10674-0
|
Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain |
|
10675-7
|
Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain |
|
49177-9
|
Hepatitis B virus surface IgG Ab [Presence] in Serum |
|
48070-7
|
Hepatitis B virus surface IgG Ab [Presence] in Serum by Immunoassay |
|
61165-7
|
Hepatitis B virus codon T184I [Presence] by Genotype method |
|
61164-0
|
Hepatitis B virus codon T184S [Presence] by Genotype method |
|
61156-6
|
Hepatitis B virus codon V173L [Presence] by Genotype method |
|
43279-9
|
Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection |
|
50627-9
|
HC gene rearrangements in Blood or Tissue by Molecular genetics method Narrative |
|
21747-1
|
HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
34600-7
|
HC gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
|
60575-8
|
HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method |
|
80416-1
|
Head circumference/Abdominal circumference US+Estimated from Campbell 1977 |
|
38598-9
|
Hexachlorobenzene [Mass/volume] in Air |
|
9474-8
|
Hexachlorobenzene [Mass/volume] in Serum or Plasma |
|
87653-2
|
Hexachlorobenzene [Mass/mass] in Unspecified specimen |
|
38599-7
|
Hexachlorobutadiene [Mass/volume] in Air |
|
28077-6
|
Hexachlorobutadiene [Presence] in Serum or Plasma |
|
38600-3
|
Hexachloroethane [Mass/volume] in Air |
|
16966-4
|
Hexachloroethane [Mass/volume] in Blood |
|
10470-3
|
Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
|
55870-0
|
Choriogonadotropin [Units/volume] in Cord blood |
|
12184-8
|
Choriogonadotropin [Presence] in Body fluid |
|
42891-2
|
Choriogonadotropin [Units/volume] in Body fluid |
|
80385-8
|
Choriogonadotropin (pregnancy test) [Presence] in Serum by Rapid immunoassay |
|
2118-8
|
Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma |
|
2106-3
|
Choriogonadotropin (pregnancy test) [Presence] in Urine |
|
80384-1
|
Choriogonadotropin (pregnancy test) [Presence] in Urine by Rapid immunoassay |
|
83086-9
|
Choriogonadotropin [Units/volume] in Serum or Plasma by Immunoassay |
|
19080-1
|
Choriogonadotropin [Units/volume] in Serum or Plasma |
|
34670-0
|
Choriogonadotropin [Mass/volume] in Serum or Plasma |
|
2119-6
|
Choriogonadotropin [Moles/volume] in Serum or Plasma |
|
10565-0
|
Choriogonadotropin [Units/volume] in Semen |
|
2105-5
|
Choriogonadotropin [Moles/volume] in Semen |
|
25372-4
|
Choriogonadotropin [Units/volume] in Urine |
|
2107-1
|
Choriogonadotropin [Moles/volume] in Urine |
|
53959-3
|
Choriogonadotropin.tumor marker [Units/volume] in Serum or Plasma |
|
53957-7
|
Choriogonadotropin.tumor marker [Mass/volume] in Serum or Plasma |
|
53958-5
|
Choriogonadotropin.tumor marker [Moles/volume] in Serum or Plasma |
|
60492-6
|
Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81860-9
|
Hypertrophic cardiomyopathy gene targeted mutation analysis in Blood or Tissue by Sequencing |
|
80613-3
|
Bicarbonate [Moles/volume] in Urine collected for unspecified duration |
|
47580-6
|
Bicarbonate [Moles/volume] in 24 hour Urine |
|
47579-8
|
Bicarbonate [Moles/time] in 24 hour Urine |
|
16462-4
|
Bicarbonate [Moles/volume] in Amniotic fluid |
|
1960-4
|
Bicarbonate [Moles/volume] in Arterial blood |
|
28640-1
|
Bicarbonate [Moles/volume] in Arterial cord blood |
|
14151-5
|
Bicarbonate [Moles/volume] in Cord blood |
|
28641-9
|
Bicarbonate [Moles/volume] in Venous cord blood |
|
1961-2
|
Bicarbonate [Moles/volume] in Capillary blood |
|
19229-4
|
Bicarbonate [Moles/volume] in Mixed venous blood |
|
1959-6
|
Bicarbonate [Moles/volume] in Blood |
|
14627-4
|
Bicarbonate [Moles/volume] in Venous blood |
|
16460-8
|
Bicarbonate [Moles/volume] in Cerebral spinal fluid |
|
12514-6
|
Bicarbonate [Moles/volume] in Dialysis fluid |
|
53086-5
|
Bicarbonate [Moles/volume] in Nonbiological fluid |
|
16459-0
|
Bicarbonate [Moles/volume] in Body fluid |
|
86920-6
|
Bicarbonate goal [Moles/volume] Blood |
|
54359-5
|
Bicarbonate [Moles/volume] in Plasma --post dialysis |
|
48631-6
|
Bicarbonate [Moles/volume] in Serum --post dialysis |
|
1962-0
|
Bicarbonate [Moles/volume] in Plasma |
|
54361-1
|
Bicarbonate [Moles/volume] in Pleural fluid |
|
54360-3
|
Bicarbonate [Moles/volume] in Peritoneal fluid |
|
16461-6
|
Bicarbonate [Moles/volume] in Red Blood Cells |
|
1963-8
|
Bicarbonate [Moles/volume] in Serum or Plasma |
|
69964-5
|
Bicarbonate [Moles/volume] standard in Plasma |
|
1964-6
|
Bicarbonate [Moles/volume] in Urine |
|
12513-8
|
Bicarbonate [Moles/volume] in Water |
|
22735-5
|
Bicarbonate [Moles/volume] in Unspecified specimen |
|
41004-3
|
Human coronavirus 229E Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41013-4
|
Human coronavirus 229E IgG Ab [Presence] in Serum |
|
41002-7
|
Human coronavirus 229E IgG Ab [Presence] in Serum by Immunoassay |
|
88607-7
|
Human coronavirus 229E RNA [Presence] in Aspirate by NAA with probe detection |
|
88609-3
|
Human coronavirus 229E RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88608-5
|
Human coronavirus 229E RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82163-7
|
Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88610-1
|
Human coronavirus 229E RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41003-5
|
Human coronavirus 229E RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88891-7
|
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88719-0
|
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92146-0
|
Human coronavirus 229E+NL63 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
77008-1
|
Human coronavirus 229E+OC43 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
41453-2
|
Human coronavirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88611-9
|
Human coronavirus HKU1 RNA [Presence] in Aspirate by NAA with probe detection |
|
88612-7
|
Human coronavirus HKU1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88594-7
|
Human coronavirus HKU1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82161-1
|
Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88604-4
|
Human coronavirus HKU1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
62423-9
|
Human coronavirus HKU1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
92147-8
|
Human coronavirus HKU1+OC43 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
41014-2
|
Human coronavirus NL63 IgG Ab [Presence] in Serum |
|
41006-8
|
Human coronavirus NL63 IgG Ab [Presence] in Serum by Immunoassay |
|
88615-0
|
Human coronavirus NL63 RNA [Presence] in Aspirate by NAA with probe detection |
|
88617-6
|
Human coronavirus NL63 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88616-8
|
Human coronavirus NL63 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82162-9
|
Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88618-4
|
Human coronavirus NL63 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41005-0
|
Human coronavirus NL63 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41007-6
|
Human coronavirus OC43 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41015-9
|
Human coronavirus OC43 IgG Ab [Presence] in Serum |
|
41008-4
|
Human coronavirus OC43 IgG Ab [Presence] in Serum by Immunoassay |
|
88619-2
|
Human coronavirus OC43 RNA [Presence] in Aspirate by NAA with probe detection |
|
88621-8
|
Human coronavirus OC43 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88605-1
|
Human coronavirus OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82164-5
|
Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88626-7
|
Human coronavirus OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41009-2
|
Human coronavirus OC43 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
63430-3
|
Human coronavirus RNA panel - Unspecified specimen by NAA with probe detection |
|
88614-3
|
Human coronavirus RNA [Presence] in Aspirate by NAA with probe detection |
|
88628-3
|
Human coronavirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
92979-4
|
Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88620-0
|
Human coronavirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
60265-6
|
Human coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
88627-5
|
Human coronavirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41000-1
|
Human coronavirus RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
41001-9
|
Human coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41454-0
|
Human coronavirus identified in Unspecified specimen |
|
2408-3
|
Hexachlorophene [Mass/volume] in Blood |
|
86558-4
|
Healthcare personnel influenza vaccination summary report Document |
|
20570-8
|
Hematocrit [Volume Fraction] of Blood |
|
4544-3
|
Hematocrit [Volume Fraction] of Blood by Automated count |
|
31100-1
|
Hematocrit [Volume Fraction] of Blood by Impedance |
|
4545-0
|
Hematocrit [Volume Fraction] of Blood by Centrifugation |
|
32354-3
|
Hematocrit [Volume Fraction] of Arterial blood |
|
42908-4
|
Hematocrit [Volume Fraction] of Capillary blood |
|
11151-8
|
Hematocrit [Volume Fraction] of Cord blood |
|
41655-2
|
Hematocrit [Volume Fraction] of Mixed venous blood |
|
41654-5
|
Hematocrit [Volume Fraction] of Venous blood |
|
30398-2
|
Hematocrit [Volume Fraction] of Cerebral spinal fluid |
|
13508-7
|
Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation |
|
47640-8
|
Hematocrit [Volume Fraction] of Dialysis fluid |
|
11153-4
|
Hematocrit [Volume Fraction] of Body fluid |
|
55781-9
|
Hematocrit [Volume Fraction] of Bone marrow |
|
70169-8
|
Hematocrit [Volume Fraction] of Pleural fluid |
|
70168-0
|
Hematocrit [Volume Fraction] of Synovial fluid |
|
43416-7
|
Hematocrit [Volume Fraction] of Stem cell product |
|
17809-5
|
Hematocrit [Volume Fraction] of Urine |
|
71833-8
|
Hematocrit [Pure volume fraction] of Blood by Automated count |
|
71832-0
|
Hematocrit [Pure volume fraction] of Arterial blood |
|
71831-2
|
Hematocrit [Pure volume fraction] of Capillary blood |
|
71830-4
|
Hematocrit [Pure volume fraction] of Mixed venous blood |
|
71829-6
|
Hematocrit [Pure volume fraction] of Venous blood |
|
71828-8
|
Hematocrit [Pure volume fraction] of Body fluid |
|
42506-6
|
Hepatitis C virus Ab [Presence] in Cerebral spinal fluid |
|
51657-5
|
Hepatitis C virus Ab [Presence] in Body fluid |
|
75886-2
|
HCV antibody screening - Meaningful Use set |
|
75887-0
|
HCV antibody RIBA tests - Meaningful Use set by Immunoblot |
|
48159-8
|
Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay |
|
47441-1
|
Hepatitis C virus Ab [Presence] in Serum from Donor |
|
47365-2
|
Hepatitis C virus Ab [Presence] in Serum from Donor by Immunoassay |
|
5198-7
|
Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay |
|
16128-1
|
Hepatitis C virus Ab [Presence] in Serum |
|
5199-5
|
Hepatitis C virus Ab [Presence] in Serum by Immunoblot |
|
22327-1
|
Hepatitis C virus Ab [Units/volume] in Serum |
|
13955-0
|
Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay |
|
72376-7
|
Hepatitis C virus Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
56926-9
|
Hepatitis C virus c1 Ab [Presence] in Serum by Immunoblot |
|
44831-6
|
Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum |
|
56927-7
|
Hepatitis C virus c2 Ab [Presence] in Serum by Immunoblot |
|
81116-6
|
Hepatitis C virus core Ab+Ag [Presence] in Serum |
|
49846-9
|
Hepatitis C virus core Ag [Presence] in Blood or Marrow from Donor |
|
54914-7
|
Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay |
|
79189-7
|
Hepatitis C virus core Ag [Presence] in Serum or Plasma by Immunoassay |
|
56928-5
|
Hepatitis C virus E2 Ab [Presence] in Serum by Immunoblot |
|
48796-7
|
Hepatitis C virus FibroSURE panel - Serum or Plasma |
|
82381-5
|
Hepatitis C virus genotype 1 NS5b gene mutations detected [Identifier] |
|
82380-7
|
Hepatitis C virus genotype 1 NS5a gene mutations detected [Identifier] |
|
82513-3
|
Hepatitis C virus genotype 3 [Presence] in Serum or Plasma by NAA with probe detection |
|
48574-8
|
Hepatitis C virus genotype [Identifier] in Blood by NAA with probe detection |
|
32286-7
|
Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection |
|
92731-9
|
Hepatitis C virus genotype in Serum or Plasma by Sequencing |
|
49607-5
|
Hepatitis C virus genotype [Identifier] in Tissue by NAA with probe detection |
|
48575-5
|
Hepatitis C virus genotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
82525-7
|
Hepatitis C virus genotype and drug resistance panel |
|
57006-9
|
Hepatitis C virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
16129-9
|
Hepatitis C virus IgG Ab [Presence] in Serum |
|
33462-3
|
Hepatitis C virus IgG Ab [Presence] in Serum by Immunoblot |
|
16936-7
|
Hepatitis C virus IgG Ab [Units/volume] in Serum |
|
40726-2
|
Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
89359-4
|
Hepatitis C virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
51824-1
|
Hepatitis C virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
53376-0
|
Hepatitis C virus IgM Ab [Units/volume] in Serum |
|
56929-3
|
Hepatitis C virus NS3 Ab [Presence] in Serum by Immunoblot |
|
73654-6
|
Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method |
|
56930-1
|
Hepatitis C virus NS4 Ab [Presence] in Serum by Immunoblot |
|
73655-3
|
Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method |
|
72862-6
|
Hepatitis C virus resistance panel by Genotype method |
|
49369-2
|
Hepatitis C virus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49370-0
|
Hepatitis C virus RNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
20416-4
|
Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
20571-6
|
Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
|
49371-8
|
Hepatitis C virus RNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49380-9
|
Hepatitis C virus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5010-4
|
Hepatitis C virus RNA [Presence] in Blood by NAA with probe detection |
|
49377-5
|
Hepatitis C virus RNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49603-4
|
Hepatitis C virus RNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49373-4
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
51655-9
|
Hepatitis C virus RNA [Presence] in Body fluid by NAA with probe detection |
|
49378-3
|
Hepatitis C virus RNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49604-2
|
Hepatitis C virus RNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49374-2
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection |
|
75888-8
|
HCV RNA screening tests - Meaningful Use set |
|
50023-1
|
Hepatitis C virus RNA panel (viral load) in Serum or Plasma by NAA with probe detection |
|
34703-9
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 IU/mL |
|
34704-7
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL |
|
49758-6
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 5 iU/mL |
|
11011-4
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
38180-6
|
Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
47252-2
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
10676-5
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
|
29609-5
|
Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
|
42617-1
|
Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
|
42003-4
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with signal amplification |
|
11259-9
|
Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
49379-1
|
Hepatitis C virus RNA [Units/volume] (viral load) in Tissue by NAA with probe detection |
|
49608-3
|
Hepatitis C virus RNA [log units/volume] (viral load) in Tissue by NAA with probe detection |
|
49375-9
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Tissue by NAA with probe detection |
|
5011-2
|
Hepatitis C virus RNA [Presence] in Tissue by NAA with probe detection |
|
49376-7
|
Hepatitis C virus RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49605-9
|
Hepatitis C virus RNA [log units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49372-6
|
Hepatitis C virus RNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5012-0
|
Hepatitis C virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48576-3
|
Hepatitis C virus RNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
22328-9
|
Hepatitis C virus superoxide dismutase Ab [Presence] in Serum |
|
11077-5
|
Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot |
|
55878-3
|
Homocysteine [Moles/volume] in 24 hour Urine |
|
32690-0
|
Homocysteine [Moles/time] in 24 hour Urine |
|
72501-0
|
Homocyst(e)ine [Moles/volume] in Serum or Plasma --6 hours post dose methionine |
|
72502-8
|
Homocyst(e)ine [Molar concentration difference] in Serum or Plasma --6 hours post dose methionine - post CFst |
|
54300-9
|
Homocysteine [Moles/volume] in Amniotic fluid |
|
44375-4
|
Homocysteine [Presence] in Blood |
|
49727-1
|
Homocysteine [Moles/volume] in Cerebral spinal fluid |
|
44376-2
|
Homocysteine [Presence] in DBS |
|
54301-7
|
Homocysteine [Moles/volume] in DBS |
|
55877-5
|
Homocysteine [Moles/volume] in Body fluid |
|
72500-2
|
Homocyst(e)ine [Moles/volume] in Serum or Plasma --fasting |
|
44374-7
|
Homocysteine [Presence] in Serum or Plasma |
|
2428-1
|
Homocysteine [Mass/volume] in Serum or Plasma |
|
13965-9
|
Homocysteine [Moles/volume] in Serum or Plasma |
|
44373-9
|
Homocysteine [Presence] in Urine |
|
12470-1
|
Homocysteine [Mass/volume] in Urine |
|
32020-0
|
Homocysteine [Moles/volume] in Urine |
|
48115-0
|
Homocysteine.free/Creatinine [Molar ratio] in Urine |
|
44377-0
|
Homocysteine/Creatinine [Molar ratio] in 24 hour Urine |
|
13758-8
|
Homocysteine/Creatinine [Mass Ratio] in Urine |
|
26582-7
|
Homocysteine/Creatinine [Molar ratio] in Urine |
|
93329-1
|
Hyodeoxycholate [Moles/volume] in Serum or Plasma |
|
2573-4
|
Lipoprotein.alpha [Mass/volume] in Serum or Plasma |
|
49748-7
|
Lipoprotein.alpha [Moles/volume] in Serum or Plasma |
|
50409-2
|
Cholesterol in HDL 2+3 [Mass/volume] in Serum or Plasma |
|
57936-7
|
Cholesterol in HDL 2a [Mass/volume] in Serum or Plasma |
|
56132-4
|
Cholesterol in HDL 2a [Moles/volume] in Serum or Plasma |
|
56133-2
|
Cholesterol in HDL 2b [Moles/volume] in Serum or Plasma |
|
57937-5
|
Cholesterol in HDL 3a [Mass/volume] in Serum or Plasma |
|
54470-0
|
Cholesterol in HDL 3b/Cholesterol in total HDL in Serum or Plasma by Electrophoresis |
|
53135-0
|
Cholesterol in HDL [Moles/volume] in Dialysis fluid |
|
54372-8
|
Cholesterol in HDL [Mass/volume] in Body fluid |
|
50840-8
|
Cholesterol in HDL [Moles/volume] in Body fluid |
|
2095-8
|
Cholesterol in HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma |
|
49130-8
|
Cholesterol in HDL [Mass/volume] in Serum or Plasma by Electrophoresis |
|
27340-9
|
Cholesterol in HDL [Presence] in Serum or Plasma |
|
2085-9
|
Cholesterol in HDL [Mass/volume] in Serum or Plasma |
|
35197-3
|
Cholesterol in HDL [Mass or Moles/volume] in Serum or Plasma |
|
14646-4
|
Cholesterol in HDL [Moles/volume] in Serum or Plasma |
|
51654-2
|
Hepatitis D virus Ab [Presence] in Body fluid |
|
5200-1
|
Hepatitis D virus Ab [Units/volume] in Serum by Immunoassay |
|
13248-0
|
Hepatitis D virus Ab [Presence] in Serum |
|
40727-0
|
Hepatitis D virus Ab [Presence] in Serum by Immunoassay |
|
5201-9
|
Hepatitis D virus Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
22330-5
|
Hepatitis D virus Ab [Units/volume] in Serum |
|
44755-7
|
Hepatitis D virus Ag [Units/volume] in Serum by Immunoassay |
|
33464-9
|
Hepatitis D virus Ag [Presence] in Serum |
|
44754-0
|
Hepatitis D virus Ag [Presence] in Serum by Immunoassay |
|
43281-5
|
Hepatitis D virus Ag [Mass/volume] in Serum |
|
43280-7
|
Hepatitis D virus Ag [Mass/volume] in Urine |
|
72606-7
|
Hepatitis D virus genotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
49775-0
|
Hepatitis D virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
35283-1
|
Hepatitis D virus IgG Ab [Presence] in Serum |
|
35273-2
|
Hepatitis D virus IgG Ab [Presence] in Serum by Immunoassay |
|
51458-8
|
Hepatitis D virus IgG Ab [Units/volume] in Serum |
|
44826-6
|
Hepatitis D virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
34597-5
|
Hepatitis D virus IgM Ab [Presence] in Serum |
|
44938-9
|
Hepatitis D virus IgM Ab [Presence] in Serum by Immunoassay |
|
9525-7
|
Hepatitis D virus IgM Ab [Units/volume] in Serum |
|
80426-0
|
Hepatitis D virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
85512-2
|
Hepatitis D virus RNA [Units/volume] (viral load) in Serum by NAA with probe detection |
|
85513-0
|
Hepatitis D virus RNA [log units/volume] (viral load) in Serum by NAA with probe detection |
|
7906-1
|
Hepatitis D virus RNA [Presence] in Serum by NAA with probe detection |
|
46423-0
|
Hemoglobin distribution width [Mass/volume] in Blood |
|
76139-5
|
Reticulocyte hemoglobin distribution width [Mass/volume] in Blood by calculation |
|
65323-8
|
He Ab [Presence] in Serum or Plasma |
|
76119-7
|
Helium gas delivered during case [Volume] from Gas delivery system |
|
76122-1
|
Helium gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
55180-4
|
Human epididymis protein 4 [Moles/volume] in Serum or Plasma |
|
83329-3
|
Health and well-being panel [PCAM] |
|
75310-3
|
Health concerns Document |
|
46030-3
|
Health conditions section |
|
64290-0
|
Health insurance card |
|
64291-8
|
Health insurance-related form |
|
83336-8
|
Health literacy and communication panel [PCAM] |
|
81335-2
|
Patient Healthcare agent |
|
89015-2
|
Hearing threshold measurement panel Ear |
|
74146-2
|
Heart disease action plan |
|
90771-7
|
Heart failure Consult note |
|
90770-9
|
Heart failure Initial evaluation note |
|
90773-3
|
Heart failure Telephone encounter Note |
|
90769-1
|
Heart failure Plan of care note |
|
90772-5
|
Heart failure Progress note |
|
90774-1
|
Heart failure Team Conference note |
|
55405-5
|
Heart failure tracking panel |
|
46021-2
|
Heart or circulation diseases or conditions Set |
|
76476-1
|
Heart rate by Transthoracic impedance |
|
43149-4
|
Heart rate device panel |
|
89278-6
|
Heart rate --during anesthesia |
|
89271-1
|
Heart rate --during apnea |
|
76477-9
|
Heart rate by Noninvasive |
|
89282-8
|
Heart rate --post bronchodilation |
|
89273-7
|
Heart rate --W exercise |
|
89291-9
|
Heart rate --W pain |
|
76282-3
|
Heart rate.beat-to-beat by EKG |
|
79102-0
|
Heart transplant acute cellular rejection risk [Score] in Mononuclear cells Calculated by AlloMap |
|
75927-4
|
Heater power Infant microenvironment |
|
75926-6
|
Heater type Infant microenvironment |
|
29588-1
|
Heavy metals panel - Blood |
|
34667-6
|
Heavy metals panel - Hair |
|
51992-6
|
Heavy metals panel - Serum or Plasma |
|
29589-9
|
Heavy metals panel - Urine |
|
32591-0
|
Heavy metals [Presence] in 24 hour Urine |
|
31148-0
|
Heavy metals [Identifier] in Tissue |
|
40772-6
|
Heavy metals [Presence] in Urine |
|
5662-2
|
Heavy metals [Presence] in Urine by Reinsch |
|
23747-9
|
Heavy metals [Presence] in Unspecified specimen |
|
67767-4
|
HEDIS 2012 panel |
|
72199-3
|
HEDIS 2013 panel |
|
74254-4
|
HEDIS 2014-2018 Value Set - Rh |
|
74255-1
|
HEDIS 2014-2018 Value Set - Rubella Antibody |
|
74262-7
|
HEDIS 2014-2018 Value Set - Toxoplasma Antibody |
|
74256-9
|
HEDIS 2014-2019 Value Set - Serum Creatinine |
|
75867-2
|
HEDIS 2015-2018 Value Set - Cholesterol Tests Other Than LDL |
|
75863-1
|
HEDIS 2015-2018 Value Set - Digoxin Level |
|
75864-9
|
HEDIS 2015-2018 Value Set - Glucose Tests |
|
75865-6
|
HEDIS 2015-2018 Value Set - PSA Test Exclusion |
|
75866-4
|
HEDIS 2015-2018 Value Set - PSA Tests |
|
75862-3
|
HEDIS 2015-2020 Value Set - HbA1C Tests |
|
75861-5
|
HEDIS 2015-2020 Value Set - LDL-C Tests |
|
79540-1
|
HEDIS 2016-2018 Value Set - PHQ-9 Total Score |
|
79539-3
|
HEDIS 2016-2018 Value Set - Urine Protein Tests |
|
79543-5
|
HEDIS 2016-2019 Value Set - ABO and Rh |
|
79541-9
|
HEDIS 2016-2020 Value Set - Lead Tests |
|
82957-2
|
HEDIS 2017, 2018 Value Set - Chlamydia Tests |
|
82958-0
|
HEDIS 2017, 2018 Value Set - Cytomegalovirus Antibody |
|
82960-6
|
HEDIS 2017, 2018 Value Set - Group A Strep Tests |
|
82963-0
|
HEDIS 2017, 2018 Value Set - HPV Vaccine Administered |
|
82961-4
|
HEDIS 2017, 2018 Value Set - Pregnancy Test Exclusion |
|
82962-2
|
HEDIS 2017, 2018 Value Set - Serum Potassium |
|
82956-4
|
HEDIS 2017-2020 Value Set - FIT-DNA |
|
82959-8
|
HEDIS 2017-2020 Value Set - FOBT |
|
87624-3
|
HEDIS 2018 Alcohol Screening |
|
87623-5
|
HEDIS 2018 Value Set - Depression Screen |
|
87625-0
|
HEDIS 2018 Value Sets |
|
90777-4
|
HEDIS 2019 Value Set - Cytomegalovirus Antibody |
|
90765-9
|
HEDIS 2019 Value Set - Rh |
|
90776-6
|
HEDIS 2019 Value Set - Rubella Antibody |
|
90764-2
|
HEDIS 2019 Value Set - Toxoplasma Antibody |
|
90766-7
|
HEDIS 2019 Value Sets |
|
90763-4
|
HEDIS 2019-2020 Value Set - Chlamydia Tests |
|
90997-8
|
HEDIS 2019-2020 Value Set - Group A Strep Tests |
|
54567-3
|
Height and weight |
|
46039-4
|
Height and weight Set |
|
43142-9
|
Height measurement device panel |
|
60813-3
|
Helium [VFr/PPres] Airway adaptor --during expiration |
|
76097-5
|
Helium [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60934-7
|
Helium [VFr/PPres] Airway adaptor --during inspiration |
|
76098-3
|
Helium [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60812-5
|
Helium [VFr/PPres] Airway adaptor --at end expiration |
|
60932-1
|
Helium [VFr/PPres] Airway adaptor |
|
76110-6
|
Helium [VFr/PPres] Gas delivery system |
|
7395-7
|
Helminthosporium sp IgE Ab [Units/volume] in Serum |
|
7396-5
|
Helminthosporium sp IgG Ab [Units/volume] in Serum |
|
42907-6
|
Helminthosporium sp IgG Ab [Mass/volume] in Serum |
|
59466-3
|
Hematologist review of results |
|
78251-6
|
Hematology Consult note |
|
85442-2
|
Hematology Discharge summary |
|
78274-8
|
Hematology Education note |
|
78291-2
|
Hematology Flowsheet |
|
78310-0
|
Hematology Initial evaluation note |
|
85443-0
|
Hematology Note |
|
89804-9
|
Hematology Telephone encounter Note |
|
80740-4
|
Hematology Plan of care note |
|
78319-1
|
Hematology procedure note |
|
78328-2
|
Hematology Progress note |
|
93894-4
|
Hematology Team Conference note |
|
89031-9
|
Hematology Telehealth Consult note |
|
50045-4
|
Hemicystine [Moles/volume] in Amniotic fluid |
|
50177-5
|
Hemicystine [Moles/volume] in Cerebral spinal fluid |
|
50047-0
|
Hemicystine [Moles/volume] in DBS |
|
50046-2
|
Hemicystine [Moles/volume] in Serum or Plasma |
|
50050-4
|
Hemicystine/Amino acids.total in Amniotic fluid |
|
50052-0
|
Hemicystine/Amino acids.total in DBS |
|
50049-6
|
Hemicystine/Amino acids.total in Hair |
|
50051-2
|
Hemicystine/Amino acids.total in Serum or Plasma |
|
50053-8
|
Hemicystine/Amino acids.total in Unspecified specimen |
|
50048-8
|
Hemicystine [Moles/volume] in Unspecified specimen |
|
50054-6
|
Hemicystine/Creatinine [Molar ratio] in Urine |
|
14563-1
|
Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen |
|
57905-2
|
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --1st specimen |
|
42913-4
|
Hemoglobin.gastrointestinal [Presence] in Unspecified specimen --1st specimen |
|
42912-6
|
Hemoglobin.gastrointestinal [Presence] in Unspecified specimen --2nd specimen |
|
50017-3
|
Hemoglobin.gastrointestinal [Presence] in Sputum or Gastric fluid |
|
58453-2
|
Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay |
|
2335-8
|
Hemoglobin.gastrointestinal [Presence] in Stool |
|
29771-3
|
Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay |
|
80372-6
|
Hemoglobin.gastrointestinal [Presence] in Stool by Rapid immunoassay |
|
27396-1
|
Hemoglobin.gastrointestinal [Mass/mass] in Stool |
|
48047-5
|
Hemoglobin.gastrointestinal [Presence] in Vomitus |
|
92540-4
|
Hemoglobin S inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92502-4
|
Hemoglobin S inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
4640-9
|
Hemolysin cold [Mass/volume] in Plasma |
|
4641-7
|
Hemolysin warm [Mass/volume] in Plasma |
|
83685-8
|
Hematology+Medical oncology Attending Consult note |
|
83686-6
|
Hematology+Medical oncology Attending Note |
|
84138-7
|
Hematology+Medical oncology Conference note |
|
34779-9
|
Hematology+Medical oncology Consult note |
|
85588-2
|
Hematology+Medical oncology Diagnostic study note |
|
84139-5
|
Hematology+Medical oncology Discharge summary |
|
86215-1
|
Hematology+Medical oncology Disease staging note |
|
84140-3
|
Hematology+Medical oncology Education note |
|
83739-3
|
Hematology+Medical oncology Fellow Note |
|
84141-1
|
Hematology+Medical oncology Group counseling note |
|
84142-9
|
Hematology+Medical oncology Hospital Consult note |
|
68555-2
|
Hematology+Medical oncology Hospital Letter |
|
84143-7
|
Hematology+Medical oncology Hospital Note |
|
68553-7
|
Hematology+Medical oncology Initial evaluation note |
|
84144-5
|
Hematology+Medical oncology Medication management note |
|
34780-7
|
Hematology+Medical oncology Note |
|
83546-2
|
Hematology+Medical oncology Nurse practitioner Note |
|
83578-5
|
Hematology+Medical oncology Nurse Consult note |
|
83579-3
|
Hematology+Medical oncology Nurse Note |
|
83580-1
|
Hematology+Medical oncology Nurse Outpatient Note |
|
84145-2
|
Hematology+Medical oncology Outpatient Consult note |
|
84146-0
|
Hematology+Medical oncology Outpatient Note |
|
78242-5
|
Hematology+Medical oncology Surgical operation note |
|
88648-1
|
Hematology+Medical oncology Parenteral therapy note |
|
84137-9
|
Hematology+Medical oncology Pharmacist Note |
|
84150-2
|
Hematology+Medical oncology Telephone encounter Note |
|
84151-0
|
Hematology+Medical oncology Plan of care note |
|
84147-8
|
Hematology+Medical oncology procedure note |
|
68554-5
|
Hematology+Medical oncology Progress note |
|
57172-9
|
Hematology+Medical oncology Referral note |
|
83758-3
|
Hematology+Medical oncology Resident Note |
|
84148-6
|
Hematology+Medical oncology Risk assessment and screening note |
|
84149-4
|
Hematology+Medical oncology Team Note |
|
89884-1
|
Hematology+Medical oncology Telehealth Note |
|
40633-0
|
Hemopexin [Presence] in Serum |
|
2403-4
|
Hemopexin [Mass/volume] in Serum |
|
2404-2
|
Hemopexin [Mass/volume] in Urine |
|
4643-3
|
Hemosiderin [Mass/volume] in Serum |
|
40722-1
|
Hemosiderin [Presence] in Sputum |
|
4644-1
|
Hemosiderin [Presence] in Urine |
|
4645-8
|
Hemosiderin [Mass/volume] in Urine |
|
33923-4
|
Hemosiderin [Presence] in Unspecified specimen |
|
7399-9
|
Hemp fiber IgE Ab [Units/volume] in Serum |
|
7398-1
|
Hemp IgE Ab [Units/volume] in Serum |
|
81281-8
|
Heparin dose response panel - Blood |
|
24324-6
|
Hepatic function 1996 panel - Serum or Plasma |
|
24325-3
|
Hepatic function 2000 panel - Serum or Plasma |
|
90235-3
|
Heparan sulfate [Moles/volume] in DBS |
|
18229-5
|
Heparan sulfate [Presence] in Serum or Plasma |
|
93725-0
|
Heparan sulfate [Mass/volume] in Serum or Plasma |
|
2405-9
|
Heparan sulfate [Presence] in Urine |
|
2406-7
|
Heparan sulfate [Mass/volume] in Urine |
|
24085-3
|
Heparan-N-sulfatase [Enzymatic activity/mass] in Fibroblast |
|
24086-1
|
Heparan-N-sulfatase [Enzymatic activity/mass] in Leukocytes |
|
55253-9
|
Heparin 10000 U/mL given [Volume] |
|
55254-7
|
Heparin 5000 U/mL given [Volume] |
|
40723-9
|
Heparin Ab [Presence] in Platelet poor plasma by Platelet aggregation |
|
31159-7
|
Heparin anti Xa [Units/volume] in Nonbiological fluid |
|
3268-0
|
Heparin cofactor II Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
47285-2
|
Heparin cofactor II Ag [Units/volume] in Platelet poor plasma |
|
48388-3
|
Heparin IgE Ab [Units/volume] in Serum |
|
52777-0
|
Intrinsic coagulation system with heparin inhibition thromboelastography panel - Blood |
|
3269-8
|
Heparin neutralization [Presence] in Platelet poor plasma |
|
42679-1
|
Heparin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
13055-9
|
Heparin [Units/volume] in Platelet poor plasma |
|
28652-6
|
Heparinoid [Units/volume] in Platelet poor plasma by Chromogenic method |
|
24313-9
|
Hepatitis 1996 panel - Serum |
|
42191-7
|
Hepatitis A and B and C 7a panel - Serum |
|
83581-9
|
Hepatology Nurse Note |
|
50321-9
|
Hepatocyte Ag [Presence] in Tissue by Immune stain |
|
84152-8
|
Hepatology Consult note |
|
84153-6
|
Hepatology Counseling note |
|
84154-4
|
Hepatology Education note |
|
87268-9
|
Hepatology Immunization note |
|
84155-1
|
Hepatology Initial evaluation note |
|
84156-9
|
Hepatology Note |
|
84157-7
|
Hepatology Outpatient Note |
|
84159-3
|
Hepatology Telephone encounter Note |
|
84158-5
|
Hepatology procedure note |
|
84160-1
|
Hepatology Transplant candidate evaluation note |
|
71386-7
|
Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma |
|
92744-2
|
Hepatosplenomegaly due to lysosomal storage disorders screening panel - Blood |
|
92745-9
|
Hepatosplenomegaly due to lysosomal storage disorders screening panel - DBS |
|
92743-4
|
Hepatosplenomegaly due to lysosomal storage disorders screening panel - Serum or Plasma |
|
40367-5
|
Heptacarboxylate [Moles/time] in 24 hour Urine |
|
14776-9
|
Heptacarboxylate [Moles/volume] in Plasma |
|
14777-7
|
Heptacarboxylate [Moles/volume] in Stool |
|
45308-4
|
Heptacarboxylate [Moles/mass] in Stool |
|
14778-5
|
Heptacarboxylate [Moles/volume] in Urine |
|
49225-6
|
Heptacarboxylate/Creatinine [Molar ratio] in 24 hour Urine |
|
38175-6
|
Heptacarboxylate/Creatinine [Molar ratio] in Urine |
|
38597-1
|
Heptachlor [Mass/volume] in Air |
|
87655-7
|
Heptachlor epoxide [Mass/mass] in Unspecified specimen |
|
9472-2
|
Heptachlor [Mass/volume] in Serum or Plasma |
|
16939-1
|
Heptachlor [Mass/volume] in Urine |
|
87654-0
|
Heptachlor [Mass/mass] in Unspecified specimen |
|
9473-0
|
Heptachlorepoxide [Mass/volume] in Serum or Plasma |
|
16940-9
|
Heptachlorepoxide [Mass/volume] in Urine |
|
48632-4
|
Heptacarboxylporphyrin [Mass/time] in 24 hour Stool |
|
41997-8
|
Heptacarboxylporphyrin [Mass/volume] in 24 hour Urine |
|
45209-4
|
Heptacarboxylporphyrin [Moles/volume] in DBS |
|
49900-4
|
Heptacarboxylporphyrin I [Mass/time] in 24 hour Stool |
|
93505-6
|
Heptacarboxylporphyrin I [Moles/time] in 24 hour Urine |
|
49918-6
|
Heptacarboxylporphyrin II [Mass/time] in unspecified time Stool |
|
76773-1
|
Heptacarboxylporphyrin [Moles/volume] in Serum or Plasma |
|
50853-1
|
Heptacarboxylporphyrin [Moles/mass] in Stool |
|
50628-7
|
Heptacarboxylporphyrin/Creatinine [Molar ratio] in Urine |
|
49901-2
|
Heptacarboxylporphyrin III [Mass/time] in 24 hour Stool |
|
93506-4
|
Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine |
|
74088-6
|
Heptacarboxylporphyrin III [Moles/mass] in Stool |
|
74091-0
|
Heptacarboxylporphyrin III/Creatinine [Molar ratio] in Urine |
|
48113-5
|
Heptadecenoate/Creatinine [Molar ratio] in Urine |
|
3674-9
|
Heptaminol [Mass/time] in 24 hour Urine |
|
3672-3
|
Heptaminol [Presence] in Urine |
|
3673-1
|
Heptaminol [Mass/volume] in Urine |
|
17360-9
|
Heptane [Mass/volume] in Blood |
|
54292-8
|
Heptanoylcarnitine (C7) [Moles/volume] in Amniotic fluid |
|
54291-0
|
Heptanoylcarnitine (C7) [Moles/volume] in Cerebral spinal fluid |
|
53204-4
|
Heptanoylcarnitine (C7) [Moles/volume] in DBS |
|
55871-8
|
Heptanoylcarnitine (C7) [Moles/volume] in Serum or Plasma |
|
54293-6
|
Heptanoylcarnitine (C7) [Moles/volume] in Urine |
|
54290-2
|
Heptanoylcarnitine (C7)/Creatinine [Molar ratio] in Urine |
|
18474-7
|
HER2 Ag [Presence] in Tissue by Immune stain |
|
85319-2
|
HER2 [Presence] in Breast cancer specimen by Immune stain |
|
49683-6
|
HER2 gene copy number/Chromosome 17 copy number in Tissue by FISH |
|
74885-5
|
HER2 panel - Tissue by FISH |
|
42914-2
|
HER2 [Mass/volume] in Serum by Immunoassay |
|
51981-9
|
HER2 [Presence] in Serum by Immunoassay |
|
32996-1
|
HER2 [Mass/volume] in Serum |
|
72382-5
|
HER2 [Units/volume] in Tissue by Immunoassay |
|
31150-6
|
HER2 [Presence] in Tissue by FISH |
|
72383-3
|
HER2 [Presence] in Tissue by Immunoassay |
|
42786-4
|
HER3 Ag [Presence] in Tissue by Immune stain |
|
42787-2
|
HER4 Ag [Presence] in Tissue by Immune stain |
|
20837-1
|
Herbicide [Identifier] in Feed |
|
20842-1
|
Herbicide [Presence] in Feed by Screen method |
|
20838-9
|
Herbicide [Presence] in Gastric fluid by Screen method |
|
20835-5
|
Herbicide [Identifier] in Ingesta |
|
20840-5
|
Herbicide [Presence] in Ingesta by Screen method |
|
20836-3
|
Herbicide [Identifier] in Tissue |
|
20841-3
|
Herbicide [Presence] in Tissue by Screen method |
|
16941-7
|
Herbicide [Identifier] in Unspecified specimen |
|
20839-7
|
Herbicide [Presence] in Unspecified specimen by Screen method |
|
45174-0
|
Herpes gestationis Ab panel - Serum |
|
57031-7
|
Herpesviruses 6 DNA panel - Unspecified specimen by NAA with probe detection |
|
6139-0
|
Herring IgE Ab [Units/volume] in Serum |
|
7401-3
|
Herring IgG Ab [Units/volume] in Serum |
|
56284-3
|
Herring IgG4 Ab [Mass/volume] in Serum |
|
63111-9
|
Herring IgG Ab [Mass/volume] in Serum |
|
22344-6
|
Heterophile Ab after absorption [Titer] in Serum |
|
5216-7
|
Heterophile Ab after absorption [Titer] in Serum by Latex agglutination |
|
7914-5
|
Heterophile Ab after beef cell absorption [Titer] in Serum |
|
69420-8
|
Heterophile Ab [Presence] in Blood by Immunoassay |
|
7915-2
|
Heterophile Ab after guinea pig cell absorption [Titer] in Serum |
|
31418-7
|
Heterophile Ab [Presence] in Serum |
|
5213-4
|
Heterophile Ab [Presence] in Serum by Latex agglutination |
|
12221-8
|
Heterophile Ab [Presence] in Serum by Sheep Cell Agglutination |
|
11610-3
|
Heterophile Ab [Units/volume] in Serum |
|
6425-3
|
Heterophile Ab [Presence] in Serum or Plasma by Immunoassay |
|
31419-5
|
Heterophile Ab [Presence] in Synovial fluid |
|
16962-3
|
Heterophile Ab [Presence] in Synovial fluid by Latex agglutination |
|
43020-7
|
Heterophile Ab [Titer] in Serum |
|
6424-6
|
Heterophile Ab [Titer] in Serum by Agglutination |
|
5215-9
|
Heterophile Ab [Titer] in Serum by Latex agglutination |
|
28632-8
|
Heterophoria study |
|
74858-2
|
Hepatitis E virus genotypes 1+2+3+4 RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
|
51653-4
|
Hepatitis E virus Ab [Presence] in Body fluid |
|
49776-8
|
Hepatitis E virus Ab [Units/volume] in Serum by Immunoassay |
|
13294-4
|
Hepatitis E virus Ab [Presence] in Serum |
|
58936-6
|
Hepatitis E virus Ab [Presence] in Serum by Immunoassay |
|
51459-6
|
Hepatitis E virus Ab [Units/volume] in Serum |
|
60430-6
|
Hepatitis E virus genotype [Identifier] in Blood by NAA with probe detection |
|
14211-7
|
Hepatitis E virus IgG Ab [Presence] in Serum |
|
49693-5
|
Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay |
|
56513-5
|
Hepatitis E virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
35680-8
|
Hepatitis E virus IgG and IgM panel - Serum |
|
14212-5
|
Hepatitis E virus IgM Ab [Presence] in Serum |
|
51798-7
|
Hepatitis E virus IgM Ab [Units/volume] in Serum |
|
83128-9
|
Hepatitis E virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
69577-5
|
Hepatitis E virus RNA [Presence] in Blood by NAA with probe detection |
|
69961-1
|
Hepatitis E virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
78750-7
|
Hepatitis E virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
90460-7
|
Hepatitis E virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
91071-1
|
Hepatitis E virus RNA [Presence] in Stool by NAA with probe detection |
|
81689-2
|
Hendra virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87543-5
|
Beta-N-acetylhexosaminidase.A and beta-N-acetylhexosaminidase with reflex to HEXA gene panel [Enzymatic activity/mass] - Leukocytes |
|
38701-9
|
Hexachlorocyclopentadiene [Mass/volume] in Air |
|
35381-3
|
HEXA gene c.IVS12+1G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
35473-8
|
HEXA gene 7.6kb deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
35472-0
|
HEXA gene c.1277insTATC [Presence] in Blood or Tissue by Molecular genetics method |
|
35380-5
|
HEXA gene c.IVS7+1G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
76033-0
|
HEXA gene full mutation analysis in Blood or Tissue by Sequencing |
|
32632-2
|
HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
51773-0
|
HEXA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35382-1
|
HEXA gene p.Gly269Ser [Presence] in Blood or Tissue by Molecular genetics method |
|
40368-3
|
Hexacarboxylate [Moles/time] in 24 hour Urine |
|
14779-3
|
Hexacarboxylate [Moles/volume] in Plasma |
|
14780-1
|
Hexacarboxylate [Moles/volume] in Stool |
|
45309-2
|
Hexacarboxylate [Moles/mass] in Stool |
|
14781-9
|
Hexacarboxylate [Moles/volume] in Urine |
|
45316-7
|
Hexacarboxylate/Creatinine [Molar ratio] in Urine |
|
43115-5
|
Hexacarboxylporphyrin [Presence] in 24 hour Urine |
|
41998-6
|
Hexacarboxylporphyrin [Mass/volume] in 24 hour Urine |
|
93507-2
|
Hexacarboxylporphyrin I [Moles/time] in 24 hour Urine |
|
74988-7
|
Hexacarboxylporphyrin [Moles/volume] in Red Blood Cells |
|
59790-6
|
Hexacarboxylporphyrin [Moles/volume] in Serum or Plasma |
|
50855-6
|
Hexacarboxylporphyrin [Moles/mass] in Stool |
|
48621-7
|
Hexacarboxylporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
|
93508-0
|
Hexacarboxylporphyrin III [Moles/time] in 24 hour Urine |
|
74087-8
|
Hexacarboxylporphyrin III [Moles/mass] in Stool |
|
74090-2
|
Hexacarboxylporphyrin III/Creatinine [Molar ratio] in Urine |
|
78353-0
|
Hexadecadienoate (C16:2) [Entitic substance] in Red Blood Cells |
|
50332-6
|
Hexadecanedioate/Creatinine [Mass Ratio] in Urine |
|
48114-3
|
Hexadecanedioate/Creatinine [Molar ratio] in Urine |
|
78346-4
|
Hexadecenoate (C16:1w9) [Entitic substance] in Red Blood Cells |
|
47642-4
|
Hexadecenoate (C16:1w9)/Creatinine [Molar ratio] in Urine |
|
38601-1
|
Hexane [Mass/volume] in Air |
|
9475-5
|
Hexane [Mass/volume] in Blood |
|
75372-3
|
Hexane [Mass/volume] in Serum or Plasma by Screen method |
|
85087-5
|
Hexanoate (C6:0) [Moles/volume] in Serum or Plasma |
|
54297-7
|
Hexanoylcarnitine (C6) [Moles/volume] in Amniotic fluid |
|
54296-9
|
Hexanoylcarnitine (C6) [Moles/volume] in Cerebral spinal fluid |
|
45211-0
|
Hexanoylcarnitine (C6) [Moles/volume] in DBS |
|
74594-3
|
Hexanoylcarnitine (C6) [Enzymatic activity/mass] in Fibroblast |
|
54298-5
|
Hexanoylcarnitine (C6) [Moles/volume] in Urine |
|
54295-1
|
Hexanoylcarnitine (C6)/Creatinine [Molar ratio] in Urine |
|
79473-5
|
Hexanoylglycine [Moles/volume] in Serum or Plasma |
|
30477-4
|
Hexanoylglycine [Presence] in Urine |
|
9476-3
|
Hexanoylglycine [Moles/volume] in Urine |
|
44368-9
|
Hexanoylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
49902-0
|
Hexanoylglycine/Creatinine [Molar ratio] in 24 hour Urine |
|
13753-9
|
Hexanoylglycine/Creatinine [Mass Ratio] in Urine |
|
24438-4
|
Hexanoylglycine/Creatinine [Molar ratio] in Urine |
|
76029-8
|
HEXB gene full mutation analysis in Blood or Tissue by Sequencing |
|
53203-6
|
Hexenoylcarnitine (C6:1) [Moles/volume] in DBS |
|
74540-6
|
Hexenoylcarnitine (C6:1) [Moles/volume] in Serum or Plasma |
|
12493-3
|
Hexobarbital [Mass/volume] in Serum or Plasma |
|
27165-0
|
Hexobarbital [Mass/volume] in Urine |
|
44369-7
|
Hexokinase [Presence] in Plasma |
|
2409-1
|
Hexokinase [Enzymatic activity/volume] in Plasma |
|
2410-9
|
Hexokinase [Enzymatic activity/volume] in Red Blood Cells |
|
49216-5
|
Hexokinase [Enzymatic activity/mass] in Red Blood Cells |
|
16967-2
|
Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells |
|
16968-0
|
Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells |
|
87545-0
|
Beta-N-acetylhexosaminidase.A and beta-N-acetylhexosaminidase panel - Serum or Plasma |
|
87544-3
|
Beta-N-acetylhexosaminidase.A and beta-N-acetylhexosaminidase panel [Enzymatic activity/mass] - Leukocytes |
|
80425-2
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in DBS |
|
25831-9
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Fibroblast |
|
1956-2
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Serum or Plasma |
|
18196-6
|
Beta-N-acetylhexosaminidase.A [Presence] in Tissue |
|
16457-4
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes |
|
50759-0
|
Beta-N-acetylhexosaminidase.A [Enzymatic activity/mass] in Leukocytes |
|
33657-8
|
Beta-N-acetylhexosaminidase.A [Moles/volume] in Leukocytes |
|
24072-1
|
Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Fibroblast |
|
1957-0
|
Beta-N-acetylhexosaminidase.B [Enzymatic activity/volume] in Serum or Plasma |
|
24073-9
|
Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Leukocytes |
|
33656-0
|
Beta-N-acetylhexosaminidase.B [Moles/volume] in Leukocytes |
|
1958-8
|
Beta-N-acetylhexosaminidase.I [Enzymatic activity/volume] in Serum |
|
90717-0
|
Heart failure+Transplant cardiology Consult note |
|
93959-5
|
Heart failure+Transplant cardiology Diagnostic study note |
|
68622-0
|
Heart failure+Transplant cardiology History and physical note |
|
68624-6
|
Heart failure+Transplant cardiology Hospital Letter |
|
93956-1
|
Heart failure+Transplant cardiology Letter |
|
68621-2
|
Heart failure+Transplant cardiology Note |
|
68623-8
|
Heart failure+Transplant cardiology Preoperative evaluation and management note |
|
48578-9
|
HFE gene c.187G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
34519-9
|
HFE gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21694-5
|
HFE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21695-2
|
HFE gene.p.Cys282Tyr [Presence] in Blood or Tissue by Molecular genetics method |
|
21696-0
|
HFE gene p.His63Asp [Presence] in Blood or Tissue by Molecular genetics method |
|
38380-2
|
HFE gene.p.Ser65Cys [Presence] in Blood or Tissue by Molecular genetics method |
|
63392-5
|
Herpes gestationis Ab [Titer] in Serum by Immunofluorescence |
|
45179-9
|
Herpes gestationis IgG Ab complement fixing [Presence] in Serum by Immunofluorescence |
|
45177-3
|
Herpes gestationis IgG Ab non-complement fixing [Presence] in Serum by Immunofluorescence |
|
45208-6
|
Hemoglobin A [Presence] in Blood by Electrophoresis |
|
41995-2
|
Hemoglobin A1c [Mass/volume] in Blood |
|
86910-7
|
Hemoglobin A1c/Hemoglobin.total goal Blood |
|
4548-4
|
Hemoglobin A1c/Hemoglobin.total in Blood |
|
17855-8
|
Hemoglobin A1c/Hemoglobin.total in Blood by calculation |
|
4549-2
|
Hemoglobin A1c/Hemoglobin.total in Blood by Electrophoresis |
|
17856-6
|
Hemoglobin A1c/Hemoglobin.total in Blood by HPLC |
|
62388-4
|
Hemoglobin A1c/Hemoglobin.total in Blood by JDS/JSCC protocol |
|
71875-9
|
Hemoglobin A1c/Hemoglobin.total [Pure mass fraction] in Blood |
|
59261-8
|
Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol |
|
4550-0
|
Hemoglobin A2 [Moles/volume] in Blood by Chromatography column |
|
28559-3
|
Hemoglobin A2 [Presence] in Blood |
|
10486-9
|
Hemoglobin Ag [Presence] in Tissue by Immune stain |
|
54289-4
|
Hemoglobin [Mass/volume] in Blood from Blood product unit |
|
61180-6
|
Hemoglobin [Mass/volume] in Blood from Fetus |
|
55782-7
|
Hemoglobin [Mass/volume] in Blood by Oximetry |
|
717-9
|
Hemoglobin [Presence] in Blood |
|
14775-1
|
Hemoglobin [Mass/volume] in Arterial blood by Oximetry |
|
30313-1
|
Hemoglobin [Mass/volume] in Arterial blood |
|
75928-2
|
Hemoglobin [Moles/volume] in Arterial blood |
|
30352-9
|
Hemoglobin [Mass/volume] in Capillary blood |
|
30354-5
|
Hemoglobin [Mass/volume] in Arterial cord blood |
|
40719-7
|
Hemoglobin [Mass/volume] in Cord blood |
|
30353-7
|
Hemoglobin [Mass/volume] in Venous cord blood |
|
718-7
|
Hemoglobin [Mass/volume] in Blood |
|
76768-1
|
Hemoglobin [Mass/volume] in Mixed venous blood by Oximetry |
|
30351-1
|
Hemoglobin [Mass/volume] in Mixed venous blood |
|
59260-0
|
Hemoglobin [Moles/volume] in Blood |
|
76769-9
|
Hemoglobin [Mass/volume] in Venous blood by Oximetry |
|
30350-3
|
Hemoglobin [Mass/volume] in Venous blood |
|
93846-4
|
Hemoglobin [Moles/volume] in Venous blood |
|
40720-5
|
Hemoglobin C [Presence] in Blood |
|
40545-6
|
Hemoglobin C [Presence] in Blood by Electrophoresis |
|
54209-2
|
Hemoglobin C - Harlem/Hemoglobin.total in Blood |
|
48035-0
|
Hemoglobin [Presence] in Cerebral spinal fluid |
|
719-5
|
Hemoglobin [Mass/volume] in Cerebral spinal fluid |
|
40546-4
|
Hemoglobin E [Presence] in Blood by Electrophoresis |
|
44922-3
|
Hemoglobin E/Hemoglobin.total in Blood by HPLC |
|
71866-8
|
Hemoglobin E/Hemoglobin.total [Pure mass fraction] in Blood by HPLC |
|
73895-5
|
Hemoglobin [Entitic substance] in Reticulocytes by Automated count |
|
28067-7
|
Hemoglobin F [Presence] in Amniotic fluid |
|
40549-8
|
Hemoglobin F [Mass/volume] in Blood by Electrophoresis |
|
4579-9
|
Hemoglobin F [Presence] in Blood |
|
4632-6
|
Hemoglobin F [Presence] in Blood by Alkali denaturation |
|
32140-6
|
Hemoglobin F [Presence] in Blood by Kleihauer-Betke method |
|
53857-9
|
Hemoglobin F [Mass/volume] in Blood |
|
18277-4
|
Hemoglobin F [Presence] in Gastric fluid by Apt-Downey method |
|
18278-2
|
Hemoglobin F [Presence] in Meconium by Apt-Downey method |
|
4631-8
|
Hemoglobin F [Presence] in Stool by Apt-Downey method |
|
28006-5
|
Hemoglobin F [Presence] in Vomitus |
|
30074-9
|
Hemoglobin F [Presence] in Unspecified specimen |
|
40721-3
|
Hemoglobin F [Presence] in Unspecified specimen by Apt-Downey method |
|
33517-4
|
Hemoglobin [Presence] in Body fluid |
|
33509-1
|
Hemoglobin [Mass/volume] in Body fluid |
|
13514-5
|
Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative |
|
87433-9
|
Free hemoglobin and oxyhemoglobin panel - Plasma |
|
49000-3
|
Free Hemoglobin [Presence] in Cerebral spinal fluid |
|
89364-4
|
Free Hemoglobin [Mass/volume] in Body fluid |
|
48711-6
|
Free Hemoglobin [Mass/volume] in Plasma --after transfusion reaction |
|
720-3
|
Free Hemoglobin [Presence] in Plasma |
|
721-1
|
Free Hemoglobin [Mass/volume] in Plasma |
|
25433-4
|
Free Hemoglobin [Moles/volume] in Plasma |
|
4635-9
|
Free Hemoglobin [Mass/volume] in Serum |
|
33411-0
|
Free Hemoglobin [Presence] in Urine |
|
4636-7
|
Free Hemoglobin [Mass/volume] in Urine |
|
86912-3
|
Hemoglobin goal [Mass/volume] Blood |
|
40550-6
|
Hemoglobin H [Mass/volume] in Blood by Electrophoresis |
|
40547-2
|
Hemoglobin H [Presence] in Blood |
|
17871-5
|
Hemoglobin H [Presence] in Blood by Heat denaturation |
|
80656-2
|
Hemoglobin Hope/Hemoglobin.total in Blood |
|
48343-8
|
Hemoglobin.other/Hemoglobin.total in Blood |
|
69950-4
|
Hemoglobin [Mass/volume] in Pericardial fluid |
|
35183-3
|
Hemoglobin [Mass or Moles/volume] in Plasma |
|
722-9
|
Hemoglobin [Mass/volume] in Pleural fluid |
|
43113-0
|
Hemoglobin electrophoresis panel in Blood |
|
48725-6
|
Hemoglobin [Mass/volume] in Blood --pre therapeutic phlebotomy |
|
723-7
|
Hemoglobin [Mass/volume] in Peritoneal fluid |
|
34663-5
|
Hemoglobin S [Presence] in Amniotic fluid |
|
4621-9
|
Hemoglobin S [Presence] in Blood |
|
6864-3
|
Hemoglobin S [Presence] in Blood by Solubility test |
|
4625-0
|
Hemoglobin S/Hemoglobin.total in Blood |
|
44923-1
|
Hemoglobin S/Hemoglobin.total in Blood by HPLC |
|
724-5
|
Hemoglobin [Mass/volume] in Synovial fluid |
|
34743-5
|
Stable Hemoglobin [Presence] in Blood by Isopropanol stability |
|
4639-1
|
Unstable Hemoglobin [Presence] in Red Blood Cells |
|
41619-8
|
Unstable Hemoglobin [Presence] in Red Blood Cells by Isopropanol stability |
|
725-2
|
Hemoglobin [Presence] in Urine |
|
726-0
|
Hemoglobin [Mass/volume] in Urine |
|
34618-9
|
Hemoglobin [Presence] in Unspecified specimen |
|
24360-0
|
Hemoglobin and Hematocrit panel - Blood |
|
43801-0
|
Choriogonadotropin.intact [Units/volume] in Amniotic fluid |
|
48625-8
|
Choriogonadotropin.intact [Presence] in Body fluid |
|
2116-2
|
Choriogonadotropin.intact [Presence] in Serum or Plasma |
|
30243-0
|
Choriogonadotropin.intact [Units/volume] in Serum or Plasma |
|
2117-0
|
Choriogonadotropin.intact [Moles/volume] in Serum or Plasma |
|
16617-3
|
Choriogonadotropin.intact [Moles/volume] in Semen |
|
45194-8
|
Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma |
|
93769-8
|
Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma |
|
81826-0
|
HGD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79394-3
|
Hepatocyte growth factor [Mass/volume] in Serum or Plasma |
|
77173-3
|
Hepatocyte growth factor receptor Ag [Presence] in Tissue by Immune stain |
|
49777-6
|
Hepatitis G virus Ab [Units/volume] in Serum |
|
55166-3
|
Hepatitis G virus E2 Ab [Presence] in Serum |
|
16937-5
|
Hepatitis G virus RNA [Presence] in Serum by NAA with probe detection |
|
19742-6
|
Hexahydrophthalic anhydride (HHPA) IgE Ab [Units/volume] in Serum |
|
62481-7
|
Herpes virus 6A DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
62483-3
|
Herpes virus 6A DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
62485-8
|
Herpes virus 6A DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
62482-5
|
Herpes virus 6B DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
62484-1
|
Herpes virus 6B DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
62486-6
|
Herpes virus 6B DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20445-3
|
Herpes virus identified in Unspecified specimen by Organism specific culture |
|
43695-6
|
Herpes virus identified in Unspecified specimen by Shell vial culture |
|
51704-5
|
Herpes virus 6 Ab [Units/volume] in Serum by Immunoassay |
|
44519-7
|
Herpes virus 6 Ab [Presence] in Serum |
|
53378-6
|
Herpes virus 6 Ab [Units/volume] in Serum |
|
49387-4
|
Herpes virus 6 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49391-6
|
Herpes virus 6 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49388-2
|
Herpes virus 6 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49389-0
|
Herpes virus 6 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49392-4
|
Herpes virus 6 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49390-8
|
Herpes virus 6 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49393-2
|
Herpes virus 6 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
38349-7
|
Herpes virus 6 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
33941-6
|
Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection |
|
82192-6
|
Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
33942-4
|
Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
86543-6
|
Herpes virus 6 DNA [Presence] in Bone marrow by NAA with probe detection |
|
38351-3
|
Herpes virus 6 DNA panel - Unspecified specimen by NAA with probe detection |
|
43244-3
|
Herpes virus 6 DNA [Presence] in Serum by NAA with probe detection |
|
47410-6
|
Herpes virus 6 DNA [Identifier] in Serum or Plasma by NAA with probe detection |
|
33940-8
|
Herpes virus 6 DNA [Presence] in Tissue by NAA with probe detection |
|
38348-9
|
Herpes virus 6 DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
38350-5
|
Herpes virus 6 DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
29495-9
|
Herpes virus 6 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44520-5
|
Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid |
|
31414-6
|
Herpes virus 6 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
41148-8
|
Herpes virus 6 IgG Ab [Presence] in Serum |
|
40730-4
|
Herpes virus 6 IgG Ab [Presence] in Serum by Immunoassay |
|
44521-3
|
Herpes virus 6 IgG Ab [Presence] in Serum by Immunofluorescence |
|
5211-8
|
Herpes virus 6 IgG Ab [Units/volume] in Serum |
|
43024-9
|
Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid |
|
27168-4
|
Herpes virus 6 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
41496-1
|
Herpes virus 6 IgG Ab [Titer] in Serum |
|
34179-2
|
Herpes virus 6 IgG Ab [Titer] in Serum by Immunoassay |
|
25416-9
|
Herpes virus 6 IgG Ab [Titer] in Serum by Immunofluorescence |
|
34946-4
|
Herpes virus 6 IgG and IgM panel - Cerebral spinal fluid |
|
34945-6
|
Herpes virus 6 IgG and IgM panel - Serum |
|
13250-6
|
Herpes virus 6 IgG+IgM Ab [Units/volume] in Serum |
|
42915-9
|
Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid |
|
31415-3
|
Herpes virus 6 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
41147-0
|
Herpes virus 6 IgM Ab [Presence] in Serum |
|
40731-2
|
Herpes virus 6 IgM Ab [Presence] in Serum by Immunoassay |
|
5212-6
|
Herpes virus 6 IgM Ab [Units/volume] in Serum |
|
43025-6
|
Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid |
|
27159-3
|
Herpes virus 6 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
32182-8
|
Herpes virus 6 IgM Ab [Titer] in Serum |
|
25417-7
|
Herpes virus 6 IgM Ab [Titer] in Serum by Immunofluorescence |
|
49395-7
|
Herpes virus 7 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49398-1
|
Herpes virus 7 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49400-5
|
Herpes virus 7 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49396-5
|
Herpes virus 7 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49397-3
|
Herpes virus 7 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49401-3
|
Herpes virus 7 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49394-0
|
Herpes virus 7 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49399-9
|
Herpes virus 7 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
86544-4
|
Herpes virus 7 DNA [Presence] in Blood by NAA with probe detection |
|
44423-2
|
Herpes virus 7 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31416-1
|
Herpes virus 7 IgG Ab [Units/volume] in Serum |
|
43023-1
|
Herpes virus 7 IgG Ab [Titer] in Serum |
|
26972-0
|
Herpes virus 7 IgG Ab [Titer] in Serum by Immunofluorescence |
|
34947-2
|
Herpes virus 7 IgG and IgM panel - Serum |
|
41842-6
|
Herpes virus 7 IgG and IgM panel [Titer] - Serum by Immunofluorescence |
|
31417-9
|
Herpes virus 7 IgM Ab [Units/volume] in Serum |
|
43022-3
|
Herpes virus 7 IgM Ab [Titer] in Serum |
|
27177-5
|
Herpes virus 7 IgM Ab [Titer] in Serum by Immunofluorescence |
|
39083-1
|
Herpes virus 8 Ab [Presence] in Serum |
|
49409-6
|
Herpes virus 8 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49406-2
|
Herpes virus 8 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49407-0
|
Herpes virus 8 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49408-8
|
Herpes virus 8 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49404-7
|
Herpes virus 8 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49402-1
|
Herpes virus 8 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49405-4
|
Herpes virus 8 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49403-9
|
Herpes virus 8 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
86545-1
|
Herpes virus 8 DNA [Presence] in Blood by NAA with probe detection |
|
49102-7
|
Herpes virus 8 DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
32364-2
|
Herpes virus 8 DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
86546-9
|
Herpes virus 8 DNA [Presence] in Tissue by NAA with probe detection |
|
51826-6
|
Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunoassay |
|
42508-2
|
Herpes virus 8 IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
41146-2
|
Herpes virus 8 IgG Ab [Presence] in Serum |
|
40834-4
|
Herpes virus 8 IgG Ab [Presence] in Serum by Immunofluorescence |
|
43021-5
|
Herpes virus 8 IgG Ab [Units/volume] in Serum |
|
68950-5
|
Herpes virus 8 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
47442-9
|
Herpes virus 8 IgG Ab [Titer] in Serum |
|
47050-0
|
Herpes virus 8 IgG Ab [Titer] in Serum by Immunofluorescence |
|
49176-1
|
Herpes virus 8 IgM Ab [Titer] in Serum |
|
48358-6
|
Herpes virus 8 IgM Ab [Titer] in Serum by Immunofluorescence |
|
49480-7
|
Herpes virus 8 latent nuclear Ag [Presence] in Tissue by Immune stain |
|
82216-3
|
3-Hydroxyisobutyrate dehydrogenase [Enzymatic activity/mass] in Fibroblast |
|
82217-1
|
3-Hydroxyisobutyryl-CoA hydrolase [Enzymatic activity/mass] in Fibroblast |
|
87300-0
|
Highest level of education Father |
|
76505-7
|
Highest pressure ulcer stage NPUAP |
|
82316-1
|
Hip dysfunction and osteoarthritis outcome score for joint replacement [HOOSJR] |
|
41323-7
|
Hip - left Abduction Active Range of Motion Quantitative |
|
41324-5
|
Hip - left Abduction Passive Range of Motion Quantitative |
|
41325-2
|
Hip - left Adduction Active Range of Motion Quantitative |
|
41326-0
|
Hip - left Adduction Passive Range of Motion Quantitative |
|
41321-1
|
Hip - left Extension Active Range of Motion Quantitative |
|
41322-9
|
Hip - left Extension Passive Range of Motion Quantitative |
|
41329-4
|
Hip - left External rotation Active Range of Motion Quantitative |
|
41330-2
|
Hip - left External rotation Passive Range of Motion Quantitative |
|
41319-5
|
Hip - left Flexion Active Range of Motion Quantitative |
|
41320-3
|
Hip - left Flexion Passive Range of Motion Quantitative |
|
41327-8
|
Hip - left Internal rotation Active Range of Motion Quantitative |
|
41328-6
|
Hip - left Internal rotation Passive Range of Motion Quantitative |
|
2413-3
|
Hippuran renal clearance in 24 hour Urine and Serum or Plasma |
|
2414-1
|
Hippurate [Mass/time] in 24 hour Urine |
|
75069-5
|
Hippurate [Moles/volume] in Serum or Plasma |
|
26833-4
|
Hippurate [Presence] in Urine |
|
6709-0
|
Hippurate [Mass/volume] in Urine |
|
44370-5
|
Hippurate/Creatinine [Mass Ratio] in 24 hour Urine |
|
56649-7
|
Hippurate/Creatinine [Ratio] in 24 hour Urine |
|
49903-8
|
Hippurate/Creatinine [Molar ratio] in 24 hour Urine |
|
13754-7
|
Hippurate/Creatinine [Mass Ratio] in Urine |
|
29528-7
|
Hippurate/Creatinine [Molar ratio] in Urine |
|
41335-1
|
Hip - right Abduction Active Range of Motion Quantitative |
|
41336-9
|
Hip - right Abduction Passive Range of Motion Quantitative |
|
41337-7
|
Hip - right Adduction Active Range of Motion Quantitative |
|
41338-5
|
Hip - right Adduction Passive Range of Motion Quantitative |
|
41333-6
|
Hip - right Extension Active Range of Motion Quantitative |
|
41334-4
|
Hip - right Extension Passive Range of Motion Quantitative |
|
41341-9
|
Hip - right External rotation Active Range of Motion Quantitative |
|
41342-7
|
Hip - right External rotation Passive Range of Motion Quantitative |
|
41331-0
|
Hip - right Flexion Active Range of Motion Quantitative |
|
41332-8
|
Hip - right Flexion Passive Range of Motion Quantitative |
|
41339-3
|
Hip - right Internal rotation Active Range of Motion Quantitative |
|
41340-1
|
Hip - right Internal rotation Passive Range of Motion Quantitative |
|
50746-7
|
Hirudin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
55353-7
|
Hirudin [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
9410-2
|
Histamine [Mass/time] in 24 hour Urine |
|
34317-8
|
Histamine [Moles/volume] in 24 hour Urine |
|
25439-1
|
Histamine [Moles/time] in 24 hour Urine |
|
50857-2
|
Histamine [Moles/volume] in 3 hour Urine |
|
2415-8
|
Histamine [Mass/volume] in Blood |
|
46436-2
|
Histamine [Moles/volume] in Blood |
|
7408-8
|
Histamine extract triggered histamine release [Units/volume] in Blood |
|
2416-6
|
Histamine [Mass/volume] in Serum or Plasma |
|
35260-9
|
Histamine [Mass or Moles/volume] in Serum or Plasma |
|
34316-0
|
Histamine [Moles/volume] in Serum or Plasma |
|
2417-4
|
Histamine [Mass/volume] in Urine |
|
33290-8
|
Histamine [Moles/volume] in Urine |
|
13756-2
|
Histamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
25925-9
|
Histamine/Creatinine [Molar ratio] in 24 hour Urine |
|
13755-4
|
Histamine/Creatinine [Mass Ratio] in Urine |
|
43577-6
|
Histamine/Creatinine [Ratio] in Urine |
|
44371-3
|
Histamine/Creatinine [Molar ratio] in Urine |
|
47643-2
|
Histidine [Moles/volume] in DBS |
|
55874-2
|
Histidine [Moles/mass] in Hair |
|
47646-5
|
Histidine/Amino acids.total in Amniotic fluid |
|
47645-7
|
Histidine/Amino acids.total in Cerebral spinal fluid |
|
47648-1
|
Histidine/Amino acids.total in DBS |
|
47644-0
|
Histidine/Amino acids.total in Hair |
|
47647-3
|
Histidine/Amino acids.total in Serum or Plasma |
|
47649-9
|
Histidine/Amino acids.total in Unspecified specimen |
|
44372-1
|
Histidine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56683-6
|
Histidine/Creatinine [Ratio] in 24 hour Urine |
|
63264-6
|
Histone Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89530-0
|
Histone Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63263-8
|
Histone Ab [Presence] in Body fluid by Immunoassay |
|
43231-0
|
Histone Ab [Units/volume] in Serum by Immunoassay |
|
8071-3
|
Histone Ab [Presence] in Serum |
|
58765-9
|
Histone Ab [Presence] in Serum by Immunoassay |
|
56717-2
|
Histone Ab [Presence] in Serum by Immunoblot |
|
5217-5
|
Histone Ab [Presence] in Serum by Immunofluorescence |
|
30359-4
|
Histone Ab [Units/volume] in Serum |
|
16969-8
|
Histone H2a+H2b Ab [Units/volume] in Serum by Immunofluorescence |
|
31424-5
|
Histone H2a+H2b Ab [Presence] in Serum |
|
18231-1
|
Histone H2a+H2b Ab [Presence] in Serum by Immunofluorescence |
|
18230-3
|
Histone H2a+H2b Ab [Units/volume] in Serum |
|
29996-6
|
Histone IgG Ab [Units/volume] in Serum by Immunoassay |
|
35284-9
|
Histone IgG Ab [Presence] in Serum |
|
35274-0
|
Histone IgG Ab [Presence] in Serum by Immunoassay |
|
31423-7
|
Histone IgG Ab [Units/volume] in Serum |
|
35089-2
|
History and physical panel |
|
33345-0
|
Histrelin [Mass/volume] in Urine |
|
69918-1
|
Thrombin time.high dose in Platelet poor plasma by Coagulation assay |
|
69668-2
|
HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay |
|
80203-3
|
HIV 1 and 2 Ab [Identifier] in Serum, Plasma or Blood by Rapid immunoassay |
|
77685-6
|
HIV 1 and 2 IgG Ab [Identifier] in Serum or Plasma by Immunoblot |
|
85037-0
|
HIV 1 and 2 Ab and HIV 1 p24 Ag panel - Serum or Plasma by Immunoassay |
|
89365-1
|
HIV 1 and 2 Ab panel - Serum, Plasma or Blood by Rapid immunoassay |
|
75622-1
|
HIV 1 and 2 tests - Meaningful Use set |
|
74854-1
|
HIV 1 proviral DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
78007-2
|
HIV 1 proviral DNA [Logarithmic entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection |
|
78009-8
|
HIV 1 proviral DNA [Entitic number] (viral load) in Blood mononuclear cells by NAA with probe detection |
|
44871-2
|
HIV 1 proviral DNA [Presence] in Blood by NAA with probe detection |
|
9837-6
|
HIV 1 proviral DNA [Presence] in Blood by Probe with amplification |
|
88212-6
|
HIV 1 proviral DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
48023-6
|
HIV 1 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
77368-9
|
HIV 1 proviral DNA [Presence] in Semen by NAA with probe detection |
|
78008-0
|
HIV 1 proviral DNA [Entitic number] (viral load) in Mononuclear cells from unspecified specimen by NAA with probe detection |
|
74855-8
|
HIV 1 proviral DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
74853-3
|
HIV 1 proviral DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80695-0
|
HIV 1 proviral DNA genotype in Mononuclear cells from whole blood |
|
83326-9
|
HIV 1 RNA genotype and phenotype in Isolate |
|
83325-1
|
HIV 1 RNA genotype in Isolate |
|
88542-6
|
HIV 1 RNA integrase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
|
90903-6
|
HIV 1 RNA integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
83327-7
|
HIV 1 RNA phenotype in Isolate |
|
50624-6
|
HIV 1 RNA panel (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
88543-4
|
HIV 1 RNA protease gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
|
90904-4
|
HIV 1 RNA protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
80689-3
|
HIV 1 RNA reverse transcriptase and protease and integrase gene mutations detected [Identifier] in Plasma by Sequencing |
|
90901-0
|
HIV 1 RNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
81122-4
|
HIV 1 RNA reverse transcriptase and protease gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
88544-2
|
HIV 1 RNA reverse transcriptase gene mutations detected [Identifier] in Cerebral spinal fluid by Sequencing |
|
90902-8
|
HIV 1 RNA reverse transcriptase gene [Nucleotide sequence] in Serum, Plasma or Blood by Sequencing |
|
79380-2
|
HIV 1 RNA+proviral DNA [Presence] in Blood by NAA with probe detection |
|
79379-4
|
HIV 1 RNA+proviral DNA [Presence] in Plasma by NAA with probe detection |
|
87962-7
|
HIV 1 subtype identified in Cerebral spinal fluid by NAA with probe detection |
|
73658-7
|
HIV 1 subtype in Unspecified specimen by NAA with probe detection |
|
83101-6
|
HIV 1+2 Ab and HIV1 p24 Ag panel - Serum or Plasma by Immunoassay |
|
58900-2
|
HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
56888-1
|
HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay |
|
75666-8
|
HIV 1+2 Ab and HIV1 p24 Ag [Identifier] in Serum, Plasma or Blood by Rapid immunoassay |
|
38998-1
|
HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma from Blood product unit by NAA with probe detection |
|
53825-6
|
HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
59052-1
|
HIV 1+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
57975-5
|
HIV 1+O+2 Ab [Presence] in Body fluid |
|
48345-3
|
HIV 1+O+2 Ab [Presence] in Serum or Plasma |
|
48346-1
|
HIV 1+O+2 Ab [Units/volume] in Serum or Plasma |
|
47029-4
|
HIV 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
7919-4
|
HIV 2 Ab [Presence] in Serum |
|
5225-8
|
HIV 2 Ab [Presence] in Serum by Immunoblot |
|
22358-6
|
HIV 2 Ab [Units/volume] in Serum |
|
5224-1
|
HIV 2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
30361-0
|
HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay |
|
81641-3
|
HIV 2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
33807-9
|
HIV 2 IgG Ab [Presence] in Serum |
|
33806-1
|
HIV 2 IgG Ab [Presence] in Serum by Immunoblot |
|
25841-8
|
HIV 2 proviral DNA [Presence] in Blood by NAA with probe detection |
|
34699-9
|
HIV 2 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
25842-6
|
HIV 2 proviral DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86547-7
|
HIV 2 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
86548-5
|
HIV 2 RNA [#/volume] (viral load) in Plasma by NAA with probe detection |
|
86549-3
|
HIV 2 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
81246-1
|
HIV 2 RNA panel - Serum or Plasma by NAA with probe detection |
|
69354-9
|
HIV 2 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
81652-0
|
HIV 2 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
69353-1
|
HIV 2 RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
73659-5
|
HIV 2 subtype in Unspecified specimen by NAA with probe detection |
|
6429-5
|
HIV identified in Blood by Organism specific culture |
|
47249-8
|
HIV Antiretroviral therapy HIV care and family status section |
|
48558-1
|
HIV genotype [Susceptibility] |
|
49573-9
|
HIV genotype [Susceptibility] in Isolate by Genotype method Narrative |
|
72560-6
|
HIV integrase inhibitor susceptibility panel by Genotype method |
|
72559-8
|
HIV integrase inhibitor susceptibility panel by Phenotype method |
|
45176-5
|
HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier] |
|
45175-7
|
HIV nucleoside reverse transcriptase gene mutations detected [Identifier] |
|
45182-3
|
HIV phenotype [Susceptibility] |
|
33630-5
|
HIV protease gene mutations detected [Identifier] |
|
9836-8
|
HIV proviral DNA [Presence] in Blood by Probe with amplification |
|
86664-0
|
HIV Referral note |
|
30554-0
|
HIV reverse transcriptase gene mutations detected [Identifier] |
|
34700-5
|
HIV reverse transcriptase+protease gene mutations tested for |
|
47245-6
|
HIV treatment form Document |
|
6430-3
|
HIV identified in Semen by Organism specific culture |
|
74264-3
|
HIV Summary registry report |
|
49660-4
|
HIV susceptibility panel by Genotype method |
|
49665-3
|
HIV susceptibility panel by Phenotype method |
|
6431-1
|
HIV identified in Unspecified specimen by Organism specific culture |
|
41145-4
|
HIV 1 Ab [Presence] in Capillary blood |
|
33866-5
|
HIV 1 Ab [Presence] in Capillary blood by Immunoassay |
|
16974-8
|
HIV 1 Ab [Presence] in Cerebral spinal fluid |
|
42627-0
|
HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
29327-4
|
HIV 1 Ab [Presence] in Body fluid |
|
34591-8
|
HIV 1 Ab [Presence] in Body fluid by Immunoassay |
|
34592-6
|
HIV 1 Ab [Presence] in Body fluid by Immunoblot |
|
35438-1
|
HIV 1 Ab [Units/volume] in Saliva (oral fluid) by Immunoassay |
|
41144-7
|
HIV 1 Ab [Presence] in Saliva (oral fluid) |
|
35437-3
|
HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoassay |
|
35439-9
|
HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoblot |
|
41143-9
|
HIV 1 Ab [Units/volume] in Saliva (oral fluid) |
|
21007-0
|
HIV 1 Ab [Presence] in Serum from Donor |
|
43599-0
|
HIV 1 Ab [Units/volume] in Serum by Immunofluorescence |
|
7917-8
|
HIV 1 Ab [Presence] in Serum |
|
14092-1
|
HIV 1 Ab [Presence] in Serum by Immunofluorescence |
|
22356-0
|
HIV 1 Ab [Units/volume] in Serum |
|
5220-9
|
HIV 1 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
29893-5
|
HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay |
|
5221-7
|
HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot |
|
68961-2
|
HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
86233-4
|
HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunoblot |
|
85686-4
|
HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunofluorescence |
|
32571-2
|
HIV 1 Ab [Presence] in Urine by Immunoblot |
|
53379-4
|
HIV 1 Ab [Presence] in Unspecified specimen |
|
89374-3
|
HIV 1 Ab [Presence] in Unspecified specimen by Immunoassay |
|
49905-3
|
HIV 1 Ab [Presence] in Unspecified specimen by Rapid immunoassay |
|
16977-1
|
HIV 1 Ag [Presence] in Cerebral spinal fluid |
|
44531-2
|
HIV 1 Ag [Presence] in Serum from Donor |
|
24012-7
|
HIV 1 Ag [Presence] in Serum |
|
16976-3
|
HIV 1 Ag [Units/volume] in Serum |
|
5222-5
|
HIV 1 Ag [Presence] in Serum or Plasma by Immunoassay |
|
44532-0
|
HIV 1 gp120 Ab [Presence] in Serum |
|
43013-2
|
HIV 1 gp120+gp160 Ab [Presence] in Serum |
|
43012-4
|
HIV 1 gp41 Ab [Presence] in Serum |
|
31430-2
|
HIV 1 IgG Ab [Presence] in Cerebral spinal fluid |
|
28004-0
|
HIV 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
16975-5
|
HIV 1 IgG Ab [Presence] in Serum |
|
40732-0
|
HIV 1 IgG Ab [Presence] in Serum by Immunoblot |
|
61199-6
|
HIV 1 integrase gene mutations detected [Identifier] |
|
43011-6
|
HIV 1 p24 Ab [Presence] in Serum |
|
49718-0
|
HIV 1 p24 Ag [Presence] in Cerebral spinal fluid |
|
9665-1
|
HIV 1 p24 Ag [Units/volume] in Serum |
|
44872-0
|
HIV 1 p24 Ag [Presence] in Serum or Plasma from Donor by Immunoassay |
|
53601-1
|
HIV 1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay |
|
42339-2
|
HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay |
|
90900-2
|
HIV 1 proviral DNA integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing |
|
80691-9
|
HIV 1 proviral DNA integrase gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing |
|
90899-6
|
HIV 1 proviral DNA reverse transcriptase and protease gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing |
|
80692-7
|
HIV 1 proviral DNA reverse transcriptase and protease gene mutations detected [Identifier] in Blood mononuclear cells by Sequencing |
|
90898-8
|
HIV 1 proviral DNA reverse transcriptase and protease and integrase gene [Nucleotide sequence] in Blood mononuclear cells by Sequencing |
|
80690-1
|
HIV 1 proviral DNA tropism [Identifier] in Blood mononuclear cells |
|
41498-7
|
HIV 1 RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
70241-5
|
HIV 1 RNA [#/volume] (viral load) in Plasma by Probe and target amplification method detection limit = 20 copies/mL |
|
59419-2
|
HIV 1 RNA [#/volume] (viral load) in Plasma by Probe with signal amplification |
|
21333-0
|
HIV 1 RNA [#/volume] in Serum |
|
48551-6
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 400 copies/mL |
|
48511-0
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 copies/mL |
|
20447-9
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
21008-8
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe |
|
41513-3
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 400 copies/mL |
|
41515-8
|
HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 75 copies/mL |
|
25836-8
|
HIV 1 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5017-9
|
HIV 1 RNA [Presence] in Blood by NAA with probe detection |
|
41497-9
|
HIV 1 RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
42917-5
|
HIV 1 RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
23876-6
|
HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe with signal amplification |
|
29539-4
|
HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe with signal amplification |
|
47359-5
|
HIV 1 RNA [Presence] in Serum or Plasma from Donor by Probe with amplification |
|
51780-5
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 0.5 log copies/mL |
|
48510-2
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 1.7 log copies/mL |
|
48552-4
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 2.6 log copies/mL |
|
62469-2
|
HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
29541-0
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
41516-6
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 1.9 log copies/mL |
|
41514-1
|
HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with amplification detection limit = 2.6 log copies/mL |
|
10351-5
|
HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
|
25835-0
|
HIV 1 RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
77369-7
|
HIV 1 RNA [Presence] in Semen by NAA with probe detection |
|
87963-5
|
HIV 1 RNA tropism [Identifier] in Cerebral spinal fluid |
|
50790-5
|
HIV 1 RNA tropism [Identifier] |
|
80688-5
|
HIV 1 RNA tropism [Identifier] in Plasma |
|
57182-8
|
HIV 1 RNA tropism [Identifier] in Plasma Narrative |
|
49890-7
|
HIV 1 RNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
5018-7
|
HIV 1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
53923-9
|
HIV 1 tropism [Identifier] in Blood Narrative |
|
32602-5
|
HIV 1+2 Ab [Presence] in Cerebral spinal fluid |
|
44533-8
|
HIV 1+2 Ab [Presence] in Serum from Donor |
|
7918-6
|
HIV 1+2 Ab [Presence] in Serum |
|
22357-8
|
HIV 1+2 Ab [Units/volume] in Serum |
|
5223-3
|
HIV 1+2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
31201-7
|
HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay |
|
80387-4
|
HIV 1+2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
43010-8
|
HIV 1+2 Ab [Presence] in Unspecified specimen |
|
42600-7
|
HIV 1+2 Ab [Presence] in Unspecified specimen by Immunoassay |
|
49580-4
|
HIV 1+2 Ab [Presence] in Unspecified specimen by Rapid immunoassay |
|
73906-0
|
HIV 1+2 IgG Ab [Presence] in Blood by Rapid immunoassay |
|
54086-4
|
HIV 1+2 IgG Ab [Presence] in DBS |
|
43009-0
|
HIV 1+2 IgG Ab [Presence] in Serum |
|
40733-8
|
HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
73905-2
|
HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Rapid immunoassay |
|
43008-2
|
HIV 1+2 IgM Ab [Units/volume] in Serum |
|
41290-8
|
HIV 1+2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
85361-4
|
HIV 1+2 RNA [Presence] in Blood by NAA with probe detection |
|
85368-9
|
HIV 1+2 RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
74856-6
|
HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
|
88453-6
|
HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection |
|
48549-0
|
HIV-Signs and Symptoms Checklist (SSC) panel |
|
31420-3
|
Highlands J virus Ab [Units/volume] in Cerebral spinal fluid |
|
31421-1
|
Highlands J virus Ab [Units/volume] in Serum |
|
29835-6
|
Highlands J virus Ab [Titer] in Cerebral spinal fluid |
|
29797-8
|
Highlands J virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
29847-1
|
Highlands J virus Ab [Titer] in Serum |
|
29810-9
|
Highlands J virus Ab [Titer] in Serum by Neutralization test |
|
29823-2
|
Highlands J virus Ab [Titer] in Unspecified specimen |
|
29784-6
|
Highlands J virus Ab [Titer] in Unspecified specimen by Neutralization test |
|
31422-9
|
Highlands J virus Ab [Units/volume] in Unspecified specimen |
|
45153-4
|
HLA Ab in Serum |
|
46993-2
|
HLA Ab panel - Serum |
|
35471-2
|
HLA Ab [Presence] |
|
50968-7
|
HLA Ab [Type] in Serum |
|
44534-6
|
HLA Ab [Presence] in Serum |
|
41618-0
|
HLA Ab [Presence] in Serum by Flow cytometry (FC) |
|
48501-1
|
HLA Ab [Presence] in Serum by Immunoassay |
|
40734-6
|
HLA Ab [Units/volume] in Serum |
|
77639-3
|
HLA class I and II IgG panel - Serum or Plasma by Immunoassay |
|
77637-7
|
HLA-A and B and C (class I) IgG panel [Identifier] - Serum or Plasma by Immunoassay |
|
77638-5
|
HLA-DP and DQ and DR (class II) IgG panel [Identifier] - Serum or Plasma by Immunoassay |
|
45023-9
|
HLA typing for celiac disease panel - Blood or Tissue |
|
45024-7
|
HLA typing for narcolepsy panel - Blood |
|
59586-8
|
HLA IgG Ab [Presence] in Serum by Immunofluorescence |
|
78013-0
|
HLA-A and B and DRB and DQB1 panel [Type] - Blood or Tissue by Low resolution |
|
57290-9
|
HLA-A [Type] by High resolution |
|
77641-9
|
HLA-A IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
38548-4
|
HLA-A locus [Type] |
|
45025-4
|
HLA-A SBT [Type] by High resolution |
|
79712-6
|
HLA-A*31:01 [Presence] in Blood or Tissue |
|
51937-1
|
HLA-A+B+Bw+DR [Type] |
|
51938-9
|
HLA-A+B+Bw+DR [Type] in Donor |
|
46994-0
|
HLA-A+B+C (class I) Ab in Serum |
|
49555-6
|
HLA-A+B+C (class I) Ag [Presence] in Tissue by Immune stain |
|
72328-8
|
HLA-A+B+C (class I) IgG Ab [Presence] in Serum by Flow cytometry (FC) |
|
72322-1
|
HLA-A+B+C (class I) IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
45027-0
|
HLA-A2 panel - Blood |
|
45026-2
|
HLA-A2 SBT [Type] by High resolution |
|
57291-7
|
HLA-B [Type] by High resolution |
|
77642-7
|
HLA-B IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
38546-8
|
HLA-B locus [Type] |
|
53937-9
|
HLA-B w4+w6 [Type] in Leukocytes |
|
46236-6
|
HLA-B*51 [Type] in Leukocytes |
|
50956-2
|
HLA-B*57:01 [Presence] |
|
42358-2
|
HLA-B*57:01 [Presence] in Unspecified specimen |
|
79711-8
|
HLA-B*58:01 [Presence] in Blood or Tissue |
|
4821-5
|
HLA-B27 [Presence] |
|
26028-1
|
HLA-B27 [Presence] by Flow cytometry (FC) |
|
26043-0
|
HLA-B27 [Presence] by NAA with probe detection |
|
44726-8
|
HLA-B51 [Presence] |
|
77636-9
|
HLA-C [Type] by High resolution typing |
|
77643-5
|
HLA-C IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
45031-2
|
HLA-C SBT [Type] by High resolution |
|
57297-4
|
HLA-Cw [Type] by High resolution |
|
77644-3
|
HLA-DP IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
50019-9
|
HLA-DP+DQ+DR (class II) [Type] |
|
46995-7
|
HLA-DP+DQ+DR (class II) Ab in Serum |
|
72323-9
|
HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Flow cytometry (FC) |
|
72321-3
|
HLA-DP+DQ+DR (class II) IgG Ab [Presence] in Serum by Immunoassay |
|
59018-2
|
HLA-DPA1 [Type] by High resolution |
|
59017-4
|
HLA-DPB1 [Type] by High resolution |
|
77645-0
|
HLA-DQ IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
59019-0
|
HLA-DQA1 [Type] by High resolution |
|
53737-3
|
HLA-DQA1*01:02 [Presence] |
|
57090-3
|
HLA-DQA1*05:01 [Presence] |
|
53938-7
|
HLA-DQB1 [Type] |
|
57299-0
|
HLA-DQB1 [Type] by High resolution |
|
43291-4
|
HLA-DQB1 [Presence] |
|
45029-6
|
HLA-DQB1 SBT [Type] by High resolution |
|
57091-1
|
HLA-DQB1*02:01 [Presence] |
|
63558-1
|
HLA-DQB1*06:02 [Presence] |
|
53738-1
|
HLA-DQB1*2 [Presence] |
|
53739-9
|
HLA-DQB1*9 [Presence] |
|
93351-5
|
HLA-DR Ag [Entitic number] on Monocyte by Flow cytometry (FC) |
|
42323-6
|
HLA-DR Ag [Type] in Tissue |
|
77646-8
|
HLA-DR IgG Ab [Identifier] in Serum or Plasma by Immunoassay |
|
57298-2
|
HLA-DRB1 [Type] |
|
57293-3
|
HLA-DRB1 [Type] by High resolution |
|
43290-6
|
HLA-DRB1 [Presence] |
|
45030-4
|
HLA-DRB1 SBT [Type] by High resolution |
|
53758-9
|
HLA-DRB1 SBT [Type] in Unspecified specimen by High resolution |
|
59029-9
|
HLA-DRB1*15:01 [Presence] |
|
53740-7
|
HLA-DRB1*17 [Presence] |
|
53741-5
|
HLA-DRB1*7 [Presence] |
|
59022-4
|
HLA-DRB3 [Type] |
|
57294-1
|
HLA-DRB3 [Type] by High resolution |
|
43379-7
|
HLA-DRB3 [Presence] |
|
59021-6
|
HLA-DRB4 [Type] |
|
57295-8
|
HLA-DRB4 [Type] by High resolution |
|
59020-8
|
HLA-DRB5 [Type] |
|
57296-6
|
HLA-DRB5 [Type] by High resolution |
|
43729-3
|
Lipoprotein.alpha.subparticle.large [Moles/volume] in Serum or Plasma |
|
10487-7
|
HMB-45 Ag [Presence] in Tissue by Immune stain |
|
38702-7
|
Hexamethylene diisocyanate [Mass/volume] in Air |
|
2444-8
|
Hydroxymethylglutaryl CoA lyase [Enzymatic activity/volume] in Serum |
|
82388-0
|
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Units/volume] in Serum by Line blot |
|
82389-8
|
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab [Presence] in Serum by Line blot |
|
93493-5
|
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Units/volume] in Serum by Immunoassay |
|
82990-3
|
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Presence] in Serum or Plasma by Line blot |
|
38703-5
|
Hexamethylphosphoramide [Mass/volume] in Air |
|
79523-7
|
3-(3-Hydroxyphenyl)propanoate [Moles/volume] in Serum or Plasma |
|
79482-6
|
3-(3-Hydroxyphenyl)propanoate/Creatinine [Molar ratio] in Urine |
|
92880-4
|
Human metapneumovirus and Respiratory syncytial virus RNA panel - Lower respiratory specimen by NAA with probe detection |
|
92881-2
|
Human metapneumovirus and Respiratory syncytial virus RNA panel - Upper respiratory specimen by NAA with probe detection |
|
67820-1
|
Human metapneumovirus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80587-9
|
Human metapneumovirus A+B L+N genes [Presence] in Nasopharynx by NAA with probe detection |
|
91831-8
|
Human metapneumovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
88222-5
|
Human metapneumovirus Ag [Presence] in Nasopharynx by Immunofluorescence |
|
91810-2
|
Human metapneumovirus Ag [Presence] in Upper respiratory specimen by Immunofluorescence |
|
60425-6
|
Human metapneumovirus Ag [Presence] in Unspecified specimen |
|
40979-7
|
Human metapneumovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
67821-9
|
Human metapneumovirus B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41011-8
|
Human metapneumovirus IgG Ab [Presence] in Serum |
|
40980-5
|
Human metapneumovirus IgG Ab [Presence] in Serum by Immunoassay |
|
53249-9
|
Human metapneumovirus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88534-3
|
Human metapneumovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60266-4
|
Human metapneumovirus RNA [Presence] in Isolate by NAA with probe detection |
|
92978-6
|
Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
89651-4
|
Human metapneumovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82165-2
|
Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
92134-6
|
Human metapneumovirus RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91809-4
|
Human metapneumovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
40978-9
|
Human metapneumovirus RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
38917-1
|
Human metapneumovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91778-1
|
Human metapneumovirus identified in Upper respiratory specimen by Organism specific culture |
|
6135-8
|
Hamster epithelium IgE Ab [Units/volume] in Serum |
|
39602-8
|
Hamster epithelium IgE Ab/IgE total in Serum |
|
56270-2
|
Hamster epithelium IgG4 Ab [Mass/volume] in Serum |
|
52754-9
|
Kininogen HMW activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3277-1
|
Kininogen HMW [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3276-3
|
Kininogen HMW [Units/volume] in Platelet poor plasma by Coagulation assay |
|
72921-0
|
HNA 1 genotype in Blood |
|
72920-2
|
HNA 1c genotype [Presence] in Blood |
|
72919-4
|
HNA 3 genotype in Blood |
|
72918-6
|
HNA 4 genotype in Blood |
|
72917-8
|
HNA 5 genotype in Blood |
|
72906-1
|
HNA Ab panel - Serum or Plasma |
|
72907-9
|
HNA genotype panel - Serum or Plasma |
|
75397-0
|
HNF1A gene full mutation analysis in Blood or Tissue by Sequencing |
|
75398-8
|
HNF1B gene full mutation analysis in Blood or Tissue by Sequencing |
|
75399-6
|
HNF4A gene full mutation analysis in Blood or Tissue by Sequencing |
|
80663-8
|
4-Hydroxy 3-Nitrophenylacetate (HNPAA) [Mass/volume] in Urine |
|
35379-7
|
HNPCC genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93842-3
|
HOGA1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
58982-0
|
Holm oak IgE Ab [Units/volume] in Serum |
|
72160-5
|
Holo-transcobalamin II [Moles/volume] in Serum |
|
18754-2
|
Holter monitor study |
|
47214-2
|
Homeostasis model assessment |
|
44962-9
|
Homans sign of Lower extremity - left |
|
93666-6
|
Home accessibility modification panel |
|
55419-6
|
Home drug screening panel - Urine |
|
52035-3
|
Home health claims |
|
52036-1
|
Home health prior authorization |
|
75638-7
|
Homocarnosine [Moles/volume] in Cerebral spinal fluid |
|
54299-3
|
Homocitrulline [Moles/volume] in Amniotic fluid |
|
55875-9
|
Homocitrulline [Moles/volume] in Cerebral spinal fluid |
|
53158-2
|
Homocitrulline [Moles/volume] in DBS |
|
55876-7
|
Homocitrulline [Moles/volume] in Serum or Plasma |
|
74483-9
|
Homocitrulline [Moles/volume] in Urine |
|
33937-4
|
Homocystine Free [Moles/volume] in Serum or Plasma |
|
33936-6
|
Homocystine Free [Moles/volume] in Urine |
|
79704-3
|
Homo-gamma Linolenate (C20:3w6) [Entitic substance] in Red Blood Cells |
|
51800-1
|
Homogentisate [Mass/volume] in 24 hour Urine |
|
51705-2
|
Homogentisate [Mass/time] in 24 hour Urine |
|
2432-3
|
Homogentisate [Presence] in Urine |
|
2433-1
|
Homogentisate [Mass/volume] in Urine |
|
75085-1
|
Homogentisate/Creatinine [Molar ratio] in 24 hour Urine |
|
47650-7
|
Homogentisate/Creatinine [Molar ratio] in Urine |
|
44906-6
|
Homovanillate panel - 24 hour Urine |
|
65791-6
|
Honey bee native (nApi m) 4 IgE Ab [Units/volume] in Serum |
|
82613-1
|
Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum |
|
6844-5
|
Honey bee IgE Ab [Units/volume] in Serum |
|
40997-9
|
Honey bee IgE Ab/IgE total in Serum |
|
6727-2
|
Honey bee IgG Ab [Units/volume] in Serum |
|
26407-7
|
Honey bee IgG4 Ab [Units/volume] in Serum |
|
56286-8
|
Honey bee IgG4 Ab [Mass/volume] in Serum |
|
49739-6
|
Honey bee IgG Ab [Mass/volume] in Serum |
|
48185-3
|
Honey bee triggered leukotriene release [Mass/volume] by Leukocytes |
|
7412-0
|
Honey IgE Ab [Units/volume] in Serum |
|
7411-2
|
Honey IgG Ab [Units/volume] in Serum |
|
56285-0
|
Honey IgG4 Ab [Mass/volume] in Serum |
|
63119-2
|
Honey IgG Ab [Mass/volume] in Serum |
|
7413-8
|
Honeysuckle IgE Ab [Units/volume] in Serum |
|
6141-6
|
Hop IgE Ab [Units/volume] in Serum |
|
61275-4
|
Hop IgE Ab/IgE total in Serum |
|
7414-6
|
Hop IgG Ab [Units/volume] in Serum |
|
56288-4
|
Hop IgG4 Ab [Mass/volume] in Serum |
|
63138-2
|
Hop IgG Ab [Mass/volume] in Serum |
|
7416-1
|
Horn beam IgE Ab [Units/volume] in Serum |
|
6142-4
|
Hornet venom IgE Ab [Units/volume] in Serum |
|
50982-8
|
Horowitz index in Blood |
|
50984-4
|
Horowitz index in Arterial blood |
|
50983-6
|
Horowitz index in Capillary blood |
|
50985-1
|
Horowitz index in Mixed venous blood |
|
50986-9
|
Horowitz index in Venous blood |
|
50987-7
|
Horowitz index adjusted to patients actual temperature in Blood |
|
50989-3
|
Horowitz index adjusted to patients actual temperature in Arterial blood |
|
50988-5
|
Horowitz index adjusted to patients actual temperature in Capillary blood |
|
50990-1
|
Horowitz index adjusted to patients actual temperature in Mixed venous blood |
|
50991-9
|
Horowitz index adjusted to patients actual temperature in Venous blood |
|
64974-9
|
Horse recombinant (rEqu c) 1 IgE Ab [Units/volume] in Serum |
|
15281-9
|
Horse Bot Fly IgE Ab [Units/volume] in Serum |
|
58467-2
|
Horse Bot Fly IgG4 Ab [Mass/volume] in Serum |
|
30983-1
|
Horse Chestnut IgE Ab [Presence] in Serum |
|
7220-7
|
Horse Chestnut IgE Ab [Units/volume] in Serum |
|
7418-7
|
Horse dander triggered histamine release [Units/volume] in Blood |
|
6143-2
|
Horse dander IgE Ab [Units/volume] in Serum |
|
39550-9
|
Horse dander IgE Ab/IgE total in Serum |
|
56456-7
|
Horse dander IgG4 Ab [Mass/volume] in Serum |
|
7419-5
|
Horse epithelium IgE Ab [Units/volume] in Serum |
|
6144-0
|
Horse Fly IgE Ab [Units/volume] in Serum |
|
7320-5
|
Horse Fly IgG Ab [Units/volume] in Serum |
|
56467-4
|
Horse Fly IgG4 Ab [Mass/volume] in Serum |
|
30088-9
|
Horse hair+Horse dander IgE Ab [Units/volume] in Serum |
|
19743-4
|
Horse meat IgE Ab [Units/volume] in Serum |
|
65788-2
|
Horse serum albumin native (nEqu c) 3 IgE Ab [Units/volume] in Serum |
|
10935-5
|
Horse serum proteins IgE Ab [Units/volume] in Serum |
|
65792-4
|
Horseradish native (nArm r) HRP IgE Ab [Units/volume] in Serum |
|
7420-3
|
Horseradish IgE Ab [Units/volume] in Serum |
|
41847-5
|
Horseradish IgG Ab [Units/volume] in Serum |
|
56289-2
|
Horseradish IgG4 Ab [Mass/volume] in Serum |
|
63147-3
|
Horseradish IgG Ab [Mass/volume] in Serum |
|
79429-7
|
Hospital Admission notification note |
|
67852-4
|
Hospital Admission evaluation note |
|
47039-3
|
Hospital Admission history and physical note |
|
47041-9
|
Hospital Consultation 2nd opinion |
|
34104-0
|
Hospital Consult note |
|
8653-8
|
Hospital Discharge instructions |
|
79430-5
|
Hospital Discharge notification note |
|
34105-7
|
Hospital Discharge summary |
|
64142-3
|
Hospital Evaluation and management of smoking cessation note |
|
34114-9
|
Hospital Group counseling note |
|
11492-6
|
Provider-unspecifed, History and physical note |
|
47044-3
|
Hospital Initial evaluation note |
|
68609-7
|
Hospital Letter |
|
85471-1
|
Hospital Medication management note |
|
34112-3
|
Hospital Note |
|
68610-5
|
Hospital Postoperative evaluation and management note |
|
34130-5
|
Hospital Progress note |
|
85184-0
|
Hospital Transfer summary note |
|
18841-7
|
Hospital consultations Document |
|
6018-6
|
House dust Allergopharma IgE Ab [Units/volume] in Serum |
|
7421-1
|
House dust AP IgE Ab [Units/volume] in Serum |
|
7422-9
|
House dust AP IgG Ab [Units/volume] in Serum |
|
7423-7
|
House dust triggered histamine release [Units/volume] in Blood |
|
6040-0
|
House dust Bencard IgE Ab [Units/volume] in Serum |
|
9828-5
|
House dust Greer IgE Ab [Units/volume] in Serum |
|
61274-7
|
House dust Greer IgE Ab/IgE total in Serum |
|
7424-5
|
House dust Greer IgG Ab [Units/volume] in Serum |
|
56290-0
|
House dust Greer IgG4 Ab [Mass/volume] in Serum |
|
63157-2
|
House dust Greer IgG Ab [Mass/volume] in Serum |
|
9444-1
|
House dust Hausstaub IgE Ab [Units/volume] in Serum |
|
7425-2
|
House dust Hollister Stier IgE Ab [Units/volume] in Serum |
|
7426-0
|
House dust Hollister Stier IgG Ab [Units/volume] in Serum |
|
63158-0
|
House dust Hollister Stier IgG Ab [Mass/volume] in Serum |
|
6145-7
|
House dust IgE Ab [Units/volume] in Serum |
|
92280-7
|
PhenX - house rules about tobacco use protocol 711101 |
|
7321-3
|
Housefly triggered histamine release [Units/volume] in Blood |
|
49715-6
|
Housefly IgE Ab [Units/volume] in Serum |
|
88037-7
|
How often have you had five or more drinks in one day during the past year [Reported] |
|
55744-7
|
howRU |
|
22070-7
|
HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35577-6
|
Hypersensitivity pneumonitis panel - Serum |
|
53950-2
|
HPA 1a/1a+Gp IIb/IIIa [Presence] in Blood |
|
57096-0
|
HPA 1a/1a+HPA 3a/3a [Presence] in Blood |
|
53949-4
|
HPA 1a/1a+HPA 3b/3b [Presence] in Blood |
|
53952-8
|
HPA 1b/1b+Gp IIb/IIa [Presence] in Blood |
|
53951-0
|
HPA 1b/1b+HPA 3a/3a [Presence] in Blood |
|
53953-6
|
HPA 5a/5a+Gp Ia/IIa [Presence] in Blood |
|
53954-4
|
HPA 5a/5b+Gp Ia/IIa [Presence] in Blood |
|
50604-8
|
HPA panel [Type] in Blood |
|
50599-0
|
HPA-1 [Type] in Blood |
|
50598-2
|
HPA-15 [Type] in Blood |
|
50596-6
|
HPA-1a [Type] in Blood |
|
50597-4
|
HPA-2 [Type] in Blood |
|
50600-6
|
HPA-3 [Type] in Blood |
|
50601-4
|
HPA-4 [Type] in Blood |
|
50602-2
|
HPA-5 [Type] in Blood |
|
50603-0
|
HPA-6 [Type] in Blood |
|
77062-8
|
HPD gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77061-0
|
HPD gene full mutation analysis in Blood or Tissue by Sequencing |
|
49562-2
|
Holoprosencephaly gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
70014-6
|
Parainfluenza virus 1+2+3+4 IgA Ab [Presence] in Serum by Immunoassay |
|
93747-4
|
Parainfluenza virus 1+2+3+4 IgG Ab [Presence] in Serum by Immunoassay |
|
70017-9
|
Parainfluenza virus 1+2+3+4 IgM Ab [Presence] in Serum by Immunoassay |
|
92883-8
|
Parainfluenza virus 1+2+3+4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88890-9
|
Parainfluenza virus 1+2+3+4 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
92884-6
|
Parainfluenza virus 1+2+3+4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
31555-6
|
Parainfluenza virus Ab [Units/volume] in Serum |
|
42982-9
|
Parainfluenza virus Ab [Titer] in Serum |
|
49713-1
|
Parainfluenza virus Ab [Titer] in Serum by Complement fixation |
|
26855-7
|
Parainfluenza virus Ab [Titer] in Serum by Immunofluorescence |
|
43366-4
|
Parainfluenza virus Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
31929-3
|
Parainfluenza virus Ag [Presence] in Unspecified specimen |
|
13327-2
|
Parainfluenza virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
21442-9
|
Parainfluenza virus identified in Nose by Organism specific culture |
|
41505-9
|
Parainfluenza virus Ag panel - Unspecified specimen by Immunofluorescence |
|
88529-3
|
Parainfluenza virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
92963-8
|
Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88562-4
|
Parainfluenza virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91798-9
|
Parainfluenza virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
61365-3
|
Parainfluenza virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
40436-8
|
Parainfluenza virus identified in Unspecified specimen by Organism specific culture |
|
31548-1
|
Parainfluenza virus 1 Ab [Units/volume] in Body fluid |
|
7978-0
|
Parainfluenza virus 1 Ab [Units/volume] in Serum |
|
24293-3
|
Parainfluenza virus 1 Ab [Titer] in Serum --1st specimen |
|
24219-8
|
Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
42984-5
|
Parainfluenza virus 1 Ab [Titer] in Serum --2nd specimen |
|
25297-3
|
Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
46199-6
|
Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid |
|
43203-9
|
Parainfluenza virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29417-3
|
Parainfluenza virus 1 Ab [Titer] in Body fluid |
|
29366-2
|
Parainfluenza virus 1 Ab [Titer] in Body fluid by Complement fixation |
|
22437-8
|
Parainfluenza virus 1 Ab [Titer] in Serum |
|
5268-8
|
Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation |
|
77385-3
|
Parainfluenza virus 1 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
67808-6
|
Parainfluenza virus 1 Ag [Presence] in Isolate by Immunofluorescence |
|
88906-3
|
Parainfluenza virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
38396-8
|
Parainfluenza virus 1 Ag [Presence] in Nose by Immunofluorescence |
|
38395-0
|
Parainfluenza virus 1 Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31923-6
|
Parainfluenza virus 1 Ag [Presence] in Throat |
|
5868-5
|
Parainfluenza virus 1 Ag [Presence] in Throat by Immunofluorescence |
|
31924-4
|
Parainfluenza virus 1 Ag [Presence] in Unspecified specimen |
|
5869-3
|
Parainfluenza virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
15389-0
|
Parainfluenza virus 1 IgG Ab [Presence] in Serum |
|
40983-9
|
Parainfluenza virus 1 IgG Ab [Presence] in Serum by Immunoassay |
|
38182-2
|
Parainfluenza virus 1 IgG Ab [Units/volume] in Serum |
|
15390-8
|
Parainfluenza virus 1 IgM Ab [Presence] in Serum |
|
31549-9
|
Parainfluenza virus 1 IgM Ab [Units/volume] in Serum |
|
15391-6
|
Parainfluenza virus 1 IgM Ab [Titer] in Serum |
|
53252-3
|
Parainfluenza virus 1 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88208-4
|
Parainfluenza virus 1 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60269-8
|
Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection |
|
88563-2
|
Parainfluenza virus 1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82171-0
|
Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76084-3
|
Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92140-3
|
Parainfluenza virus 1 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91802-9
|
Parainfluenza virus 1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29908-1
|
Parainfluenza virus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55097-0
|
Parainfluenza virus 1 [Presence] in Unspecified specimen by Organism specific culture |
|
38400-8
|
Parainfluenza virus 1+2+3 Ab [Presence] in Serum |
|
51466-1
|
Parainfluenza virus 1+2+3 Ab [Titer] in Serum |
|
50692-3
|
Parainfluenza virus 1+2+3 Ab [Titer] in Serum by Complement fixation |
|
17414-4
|
Parainfluenza virus 1+2+3 Ag [Presence] in Unspecified specimen |
|
60254-0
|
Parainfluenza virus 1+2+3 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43204-7
|
Parainfluenza virus 2 Ab [Units/volume] in Cerebral spinal fluid |
|
31550-7
|
Parainfluenza virus 2 Ab [Units/volume] in Body fluid |
|
7979-8
|
Parainfluenza virus 2 Ab [Units/volume] in Serum |
|
24294-1
|
Parainfluenza virus 2 Ab [Titer] in Serum --1st specimen |
|
24220-6
|
Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24295-8
|
Parainfluenza virus 2 Ab [Titer] in Serum --2nd specimen |
|
24221-4
|
Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
29359-7
|
Parainfluenza virus 2 Ab [Titer] in Body fluid |
|
29367-0
|
Parainfluenza virus 2 Ab [Titer] in Body fluid by Complement fixation |
|
22438-6
|
Parainfluenza virus 2 Ab [Titer] in Serum |
|
5269-6
|
Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation |
|
77386-1
|
Parainfluenza virus 2 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
67809-4
|
Parainfluenza virus 2 Ag [Presence] in Isolate by Immunofluorescence |
|
88907-1
|
Parainfluenza virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
77391-1
|
Parainfluenza virus 2 Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31925-1
|
Parainfluenza virus 2 Ag [Presence] in Throat |
|
5870-1
|
Parainfluenza virus 2 Ag [Presence] in Throat by Immunofluorescence |
|
31926-9
|
Parainfluenza virus 2 Ag [Presence] in Unspecified specimen |
|
5871-9
|
Parainfluenza virus 2 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
41405-2
|
Parainfluenza virus 2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
15392-4
|
Parainfluenza virus 2 IgG Ab [Presence] in Serum |
|
40984-7
|
Parainfluenza virus 2 IgG Ab [Presence] in Serum by Immunoassay |
|
38183-0
|
Parainfluenza virus 2 IgG Ab [Units/volume] in Serum |
|
29667-3
|
Parainfluenza virus 2 IgM Ab [Presence] in Serum |
|
29646-7
|
Parainfluenza virus 2 IgM Ab [Presence] in Serum by Immunoassay |
|
31551-5
|
Parainfluenza virus 2 IgM Ab [Units/volume] in Serum |
|
15393-2
|
Parainfluenza virus 2 IgM Ab [Titer] in Serum |
|
53253-1
|
Parainfluenza virus 2 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88209-2
|
Parainfluenza virus 2 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60417-3
|
Parainfluenza virus 2 RNA [Presence] in Isolate by NAA with probe detection |
|
88559-0
|
Parainfluenza virus 2 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82172-8
|
Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76085-0
|
Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92139-5
|
Parainfluenza virus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91801-1
|
Parainfluenza virus 2 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29909-9
|
Parainfluenza virus 2 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55098-8
|
Parainfluenza virus 2 [Presence] in Unspecified specimen by Organism specific culture |
|
46200-2
|
Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid |
|
43205-4
|
Parainfluenza virus 3 Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
31552-3
|
Parainfluenza virus 3 Ab [Units/volume] in Body fluid |
|
7980-6
|
Parainfluenza virus 3 Ab [Units/volume] in Serum |
|
24296-6
|
Parainfluenza virus 3 Ab [Titer] in Serum --1st specimen |
|
24222-2
|
Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --1st specimen |
|
24297-4
|
Parainfluenza virus 3 Ab [Titer] in Serum --2nd specimen |
|
24223-0
|
Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
29414-0
|
Parainfluenza virus 3 Ab [Titer] in Body fluid |
|
29368-8
|
Parainfluenza virus 3 Ab [Titer] in Body fluid by Complement fixation |
|
22439-4
|
Parainfluenza virus 3 Ab [Titer] in Serum |
|
5270-4
|
Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation |
|
15493-0
|
Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
|
77387-9
|
Parainfluenza virus 3 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
67810-2
|
Parainfluenza virus 3 Ag [Presence] in Isolate by Immunofluorescence |
|
88908-9
|
Parainfluenza virus 3 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
77392-9
|
Parainfluenza virus 3 Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31927-7
|
Parainfluenza virus 3 Ag [Presence] in Throat |
|
5872-7
|
Parainfluenza virus 3 Ag [Presence] in Throat by Immunofluorescence |
|
31928-5
|
Parainfluenza virus 3 Ag [Presence] in Unspecified specimen |
|
5873-5
|
Parainfluenza virus 3 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
15394-0
|
Parainfluenza virus 3 IgG Ab [Presence] in Serum |
|
40985-4
|
Parainfluenza virus 3 IgG Ab [Presence] in Serum by Immunoassay |
|
31553-1
|
Parainfluenza virus 3 IgG Ab [Units/volume] in Serum |
|
11262-3
|
Parainfluenza virus 3 IgG Ab [Titer] in Serum |
|
15395-7
|
Parainfluenza virus 3 IgM Ab [Presence] in Serum |
|
31554-9
|
Parainfluenza virus 3 IgM Ab [Units/volume] in Serum |
|
11263-1
|
Parainfluenza virus 3 IgM Ab [Titer] in Serum |
|
53254-9
|
Parainfluenza virus 3 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
88210-0
|
Parainfluenza virus 3 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60416-5
|
Parainfluenza virus 3 RNA [Presence] in Isolate by NAA with probe detection |
|
88560-8
|
Parainfluenza virus 3 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82173-6
|
Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76086-8
|
Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92138-7
|
Parainfluenza virus 3 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91800-3
|
Parainfluenza virus 3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29910-7
|
Parainfluenza virus 3 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55099-6
|
Parainfluenza virus 3 [Presence] in Unspecified specimen by Organism specific culture |
|
67811-0
|
Parainfluenza virus 4 Ag [Presence] in Isolate by Immunofluorescence |
|
60424-9
|
Parainfluenza virus 4 Ag [Presence] in Unspecified specimen |
|
40986-2
|
Parainfluenza virus 4 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
42983-7
|
Parainfluenza virus 4 IgG Ab [Presence] in Serum |
|
41990-3
|
Parainfluenza virus 4 IgG Ab [Presence] in Serum by Immunoassay |
|
88530-1
|
Parainfluenza virus 4 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60415-7
|
Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection |
|
88561-6
|
Parainfluenza virus 4 RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82174-4
|
Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76087-6
|
Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92137-9
|
Parainfluenza virus 4 RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91799-7
|
Parainfluenza virus 4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
41010-0
|
Parainfluenza virus 4 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
67818-5
|
Parainfluenza virus 4a RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17415-1
|
Parainfluenza virus A Ab [Units/volume] in Serum |
|
47861-0
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Amniotic fluid cells |
|
79461-0
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/substance] in Red Blood Cells |
|
47652-3
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Placenta |
|
2454-7
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
|
2455-4
|
Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Tissue |
|
53870-2
|
HPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82456-5
|
Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection |
|
7975-6
|
Human papilloma virus Ab [Presence] in Genital specimen |
|
6510-2
|
Human papilloma virus Ab [Presence] in Genital specimen by Immunoassay |
|
6511-0
|
Human papilloma virus Ab [Presence] in Genital specimen by Immunoblot |
|
22434-5
|
Human papilloma virus Ab [Presence] in Tissue |
|
6512-8
|
Human papilloma virus Ab [Presence] in Tissue by Immunoassay |
|
6513-6
|
Human papilloma virus Ab [Presence] in Tissue by Immunoblot |
|
14499-8
|
Human papilloma virus Ag [Presence] in Cervix |
|
12222-6
|
Human papilloma virus Ag [Presence] in Genital specimen |
|
14501-1
|
Human papilloma virus Ag [Presence] in Penis |
|
10705-2
|
Human papilloma virus Ag [Presence] in Tissue by Immune stain |
|
14502-9
|
Human papilloma virus Ag [Presence] in Urethra |
|
14500-3
|
Human papilloma virus Ag [Presence] in Vaginal fluid |
|
11083-3
|
Human papilloma virus identified in Cervix |
|
44550-2
|
Human papilloma virus DNA [Presence] in Cervix by Probe |
|
38372-9
|
Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification |
|
91852-4
|
Human papilloma virus DNA [Presence] in Genital specimen by NAA with probe detection |
|
86564-2
|
Human papilloma virus DNA [Presence] in Tissue by NAA with probe detection |
|
44551-0
|
Human papilloma virus DNA [Presence] in Tissue by Probe |
|
44545-2
|
Human papilloma virus DNA [Presence] in Urethra by Probe |
|
44548-6
|
Human papilloma virus DNA [Presence] in Urethra by Probe with signal amplification |
|
44546-0
|
Human papilloma virus DNA [Presence] in Vaginal fluid by Probe |
|
44549-4
|
Human papilloma virus DNA [Presence] in Vaginal fluid by Probe with signal amplification |
|
49891-5
|
Human papilloma virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16280-0
|
Human papilloma virus DNA [Presence] in Unspecified specimen by Probe with amplification |
|
44547-8
|
Human papilloma virus DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
74763-4
|
Human papilloma virus E6+E7 mRNA [Presence] in Anal by NAA with probe detection |
|
69358-0
|
HPV E6+E7 mRNA cells/cells [Presence] in Cervix by Flow cytometry (FC) |
|
69002-4
|
Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection |
|
91851-6
|
Human papilloma virus genotype [Identifier] in Genital specimen by NAA with probe detection |
|
48560-7
|
Human papilloma virus genotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
73959-9
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA [Presence] in Tissue by Probe |
|
73732-0
|
Human papilloma virus 26+31+33+35+39+45+51+52+53+56+58+59+66+68+73+82 DNA [Presence] in Genital specimen by NAA with probe detection |
|
42770-8
|
Human papilloma virus high and Low risk DNA panel - Cervix |
|
77394-5
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal by NAA with probe detection |
|
75696-5
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Anorectal specimen by Probe and signal amplification method |
|
71431-1
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection |
|
91853-2
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Genital specimen by NAA with probe detection |
|
86563-4
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Tissue by NAA with probe detection |
|
77375-4
|
Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
56140-7
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Anal by Probe with signal amplification |
|
30167-1
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification |
|
91855-7
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by NAA with probe detection |
|
86561-8
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Tissue by NAA with probe detection |
|
49896-4
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32047-3
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+68+70 DNA [Presence] in Tissue by Probe |
|
43210-4
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by NAA with probe detection |
|
43209-6
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA [Presence] in Anal by Probe with signal amplification |
|
82675-0
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection |
|
59420-0
|
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification |
|
21440-3
|
Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe |
|
13321-5
|
Human papilloma virus IgG Ab [Presence] in Serum |
|
13322-3
|
Human papilloma virus IgM Ab [Presence] in Serum |
|
43211-2
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe |
|
50642-8
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Anal by Probe with signal amplification |
|
21441-1
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe |
|
42481-2
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe with signal amplification |
|
55298-4
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Urethra by Probe with signal amplification |
|
55299-2
|
Human papilloma virus 6+11+42+43+44 DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
6514-4
|
Human papilloma virus rRNA [Presence] in Genital specimen by NAA with probe detection |
|
6515-1
|
Human papilloma virus rRNA [Presence] in Tissue by NAA with probe detection |
|
6516-9
|
Human papilloma virus rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
11481-9
|
Human papilloma virus identified in Unspecified specimen |
|
17398-9
|
Human papilloma virus 11 Ag [Presence] in Unspecified specimen |
|
74779-0
|
Human papilloma virus 11 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
74778-2
|
Human papilloma virus 11 DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
61394-3
|
Human papilloma virus 11 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17399-7
|
Human papilloma virus 16 Ag [Presence] in Unspecified specimen |
|
70061-7
|
Human papilloma virus 16 and 18 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77396-0
|
Human papilloma virus 16 DNA [Presence] in Anorectal by NAA with probe detection |
|
75664-3
|
Human papilloma virus 16 DNA [Presence] in Anorectal specimen by Probe and signal amplification method |
|
77399-4
|
Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection |
|
59263-4
|
Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification |
|
91856-5
|
Human papilloma virus 16 DNA [Presence] in Genital specimen by NAA with probe detection |
|
86560-0
|
Human papilloma virus 16 DNA [Presence] in Tissue by NAA with probe detection |
|
61372-9
|
Human papilloma virus 16 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82457-3
|
Human papilloma virus 16 and 18+45 E6+E7 mRNA panel - Cervix by NAA with probe detection |
|
14503-7
|
Human papilloma virus 16+18 Ag [Presence] in Cervix |
|
12223-4
|
Human papilloma virus 16+18 Ag [Presence] in Genital specimen |
|
14505-2
|
Human papilloma virus 16+18 Ag [Presence] in Penis |
|
14506-0
|
Human papilloma virus 16+18 Ag [Presence] in Urethra |
|
14504-5
|
Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid |
|
17400-3
|
Human papilloma virus 16+18 Ag [Presence] in Unspecified specimen |
|
18478-8
|
Human papilloma virus 16+18 DNA [Presence] in Tissue by Probe |
|
93777-1
|
Human papilloma virus 16+18 E6+E7 mRNA [Presence] in Tissue by Probe |
|
82354-2
|
Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection |
|
77376-2
|
Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Anorectal |
|
71432-9
|
Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Cervix |
|
77378-8
|
Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Unspecified specimen |
|
17401-1
|
Human papilloma virus 18 Ag [Presence] in Unspecified specimen |
|
77395-2
|
Human papilloma virus 18 DNA [Presence] in Anorectal by NAA with probe detection |
|
75695-7
|
Human papilloma virus 18 DNA [Presence] in Anorectal specimen by Probe and signal amplification method |
|
77400-0
|
Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection |
|
59264-2
|
Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification |
|
91854-0
|
Human papilloma virus 18 DNA [Presence] in Genital specimen by NAA with probe detection |
|
86562-6
|
Human papilloma virus 18 DNA [Presence] in Tissue by NAA with probe detection |
|
61373-7
|
Human papilloma virus 18 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
75694-0
|
Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection |
|
61374-5
|
Human papilloma virus 26 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17402-9
|
Human papilloma virus 31 Ag [Presence] in Unspecified specimen |
|
61375-2
|
Human papilloma virus 31 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44543-7
|
Human papilloma virus 31+33 Ag [Presence] in Unspecified specimen |
|
81439-2
|
Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe |
|
43170-0
|
Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe with signal amplification |
|
17403-7
|
Human papilloma virus 31+33+35 Ag [Presence] in Unspecified specimen |
|
18479-6
|
Human papilloma virus 31+35+51 DNA [Presence] in Tissue by Probe |
|
17404-5
|
Human papilloma virus 33 Ag [Presence] in Unspecified specimen |
|
61376-0
|
Human papilloma virus 33 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44544-5
|
Human papilloma virus 35 Ag [Presence] in Unspecified specimen |
|
61377-8
|
Human papilloma virus 35 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61378-6
|
Human papilloma virus 39 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17405-2
|
Human papilloma virus 42 Ag [Presence] in Unspecified specimen |
|
61395-0
|
Human papilloma virus 42 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17406-0
|
Human papilloma virus 43 Ag [Presence] in Unspecified specimen |
|
17407-8
|
Human papilloma virus 44 Ag [Presence] in Unspecified specimen |
|
61379-4
|
Human papilloma virus 44 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17408-6
|
Human papilloma virus 45 Ag [Presence] in Unspecified specimen |
|
61380-2
|
Human papilloma virus 45 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17409-4
|
Human papilloma virus 5 Ag [Presence] in Unspecified specimen |
|
17410-2
|
Human papilloma virus 51 Ag [Presence] in Unspecified specimen |
|
61381-0
|
Human papilloma virus 51 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61382-8
|
Human papilloma virus 52 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61383-6
|
Human papilloma virus 53 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61396-8
|
Human papilloma virus 56 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61384-4
|
Human papilloma virus 58 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61385-1
|
Human papilloma virus 59 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17411-0
|
Human papilloma virus 6 Ag [Presence] in Unspecified specimen |
|
74777-4
|
Human papilloma virus 6 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
74776-6
|
Human papilloma virus 6 DNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
61393-5
|
Human papilloma virus 6 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17412-8
|
Human papilloma virus 6+11 Ag [Presence] in Unspecified specimen |
|
18480-4
|
Human papilloma virus 6+11 DNA [Presence] in Tissue by Probe |
|
93778-9
|
Human papilloma virus 6+11 E6+E7 mRNA [Presence] in Tissue by Probe |
|
61386-9
|
Human papilloma virus 66 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61387-7
|
Human papilloma virus 67 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61388-5
|
Human papilloma virus 68 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61389-3
|
Human papilloma virus 69 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61390-1
|
Human papilloma virus 70 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61391-9
|
Human papilloma virus 73 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
61392-7
|
Human papilloma virus 82 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
21698-6
|
HRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53871-0
|
HRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53623-5
|
HRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
|
88861-0
|
Hematopoietic stem cell transplantation risk panel EBMT |
|
88856-0
|
Hematopoietic stem cell transplantation risk score EBMT |
|
81814-6
|
HSD17B4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
68934-9
|
Heat shock protein 60 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
92847-3
|
Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Blood by NAA with probe detection |
|
92849-9
|
Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Cerebral spinal fluid by NAA with probe detection |
|
92862-2
|
Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Serum or Plasma by NAA with probe detection |
|
92861-4
|
Herpes simplex virus 1 and 2 and Varicella zoster virus DNA panel - Skin by NAA with probe detection |
|
81621-5
|
Herpes simplex virus 1 and 2 IgG panel - Serum or Plasma |
|
90229-6
|
Herpes simplex virus 1 and 2 Ab.IgG and IgM panel - Serum or Plasma |
|
80354-4
|
Herpes simplex virus 1 and 2 DNA panel - Anogenital specimen by Probe and target amplification method |
|
92869-7
|
Herpes simplex virus 1 and 2 DNA panel - Bronchoalveolar lavage by NAA with probe detection |
|
93440-6
|
Herpes simplex virus 1 and 2 DNA panel - Blood by NAA with non-probe detection |
|
92867-1
|
Herpes simplex virus 1 and 2 DNA panel - Blood by NAA with probe detection |
|
92865-5
|
Herpes simplex virus 1 and 2 DNA panel - Cerebral spinal fluid by NAA with probe detection |
|
92864-8
|
Herpes simplex virus 1 and 2 DNA panel - Lower respiratory specimen by NAA with probe detection |
|
92866-3
|
Herpes simplex virus 1 and 2 DNA panel - Serum or Plasma by NAA with probe detection |
|
92863-0
|
Herpes simplex virus 1 and 2 DNA panel - Skin by NAA with probe detection |
|
92868-9
|
Herpes simplex virus 1 and 2 DNA panel - Upper respiratory specimen by NAA with probe detection |
|
87431-3
|
Herpes simplex virus 1 and 2 DNA panel - Unspecified specimen Qualitative by NAA with probe detection |
|
44506-4
|
Herpes simplex virus Ab [Presence] in Cerebral spinal fluid |
|
31413-8
|
Herpes simplex virus Ab [Units/volume] in Cerebral spinal fluid |
|
46190-5
|
Herpes simplex virus Ab [Presence] in Body fluid |
|
44504-9
|
Herpes simplex virus Ab [Presence] in Body fluid by Immunofluorescence |
|
43112-2
|
Herpes simplex virus Ab panel - Serum |
|
52977-6
|
Herpes simplex virus Ab [Units/volume] in Serum by Complement fixation |
|
5202-7
|
Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay |
|
5203-5
|
Herpes simplex virus Ab [Units/volume] in Serum by Latex agglutination |
|
22339-6
|
Herpes simplex virus Ab [Presence] in Serum |
|
16942-5
|
Herpes simplex virus Ab [Presence] in Serum by Immunoblot |
|
7907-9
|
Herpes simplex virus Ab [Units/volume] in Serum |
|
22340-4
|
Herpes simplex virus Ab [Titer] in Cerebral spinal fluid |
|
9454-0
|
Herpes simplex virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22341-2
|
Herpes simplex virus Ab [Titer] in Serum |
|
5204-3
|
Herpes simplex virus Ab [Titer] in Serum by Complement fixation |
|
44513-0
|
Herpes simplex virus Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
88681-2
|
Herpes simplex virus Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence |
|
47229-0
|
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid |
|
44514-8
|
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
88680-4
|
Herpes simplex virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
44508-0
|
Herpes simplex virus Ag [Presence] in Cervix |
|
44515-5
|
Herpes simplex virus Ag [Presence] in Cervix by Immunoassay |
|
44516-3
|
Herpes simplex virus Ag [Presence] in Cervix by Immunofluorescence |
|
44511-4
|
Herpes simplex virus Ag [Presence] in Eye |
|
31852-7
|
Herpes simplex virus Ag [Presence] in Genital specimen |
|
5850-3
|
Herpes simplex virus Ag [Presence] in Genital specimen by Immunoassay |
|
5851-1
|
Herpes simplex virus Ag [Presence] in Genital specimen by Immunofluorescence |
|
91833-4
|
Herpes simplex virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44512-2
|
Herpes simplex virus Ag [Presence] in Nose |
|
44509-8
|
Herpes simplex virus Ag [Presence] in Penis |
|
31853-5
|
Herpes simplex virus Ag [Presence] in Serum |
|
29957-8
|
Herpes simplex virus Ag [Presence] in Serum by Immunoblot |
|
31854-3
|
Herpes simplex virus Ag [Presence] in Skin |
|
5852-9
|
Herpes simplex virus Ag [Presence] in Skin by Immunoassay |
|
5853-7
|
Herpes simplex virus Ag [Presence] in Skin by Immunofluorescence |
|
44510-6
|
Herpes simplex virus Ag [Presence] in Vaginal fluid |
|
16945-8
|
Herpes simplex virus Ag [Presence] in Unspecified specimen |
|
5854-5
|
Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
5855-2
|
Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
35417-5
|
Herpes simplex virus identified in Anal by Organism specific culture |
|
91773-2
|
Herpes simplex virus identified in Aspirate by Organism specific culture |
|
35418-3
|
Herpes simplex virus identified in Bronchial specimen by Organism specific culture |
|
88127-6
|
Herpes simplex virus identified in Cornea or Conjunctiva by Organism specific culture |
|
35419-1
|
Herpes simplex virus identified in Cerebral spinal fluid by Organism specific culture |
|
10680-7
|
Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy |
|
43696-4
|
Herpes simplex virus identified in Cerebral spinal fluid by Shell vial culture |
|
35420-9
|
Herpes simplex virus identified in Cervix by Organism specific culture |
|
44517-1
|
Herpes simplex virus DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
90450-8
|
Herpes simplex virus DNA [Presence] in Aspirate by NAA with probe detection |
|
34451-5
|
Herpes simplex virus DNA [Presence] in Blood by NAA with probe detection |
|
88138-3
|
Herpes simplex virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
5013-8
|
Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91857-3
|
Herpes simplex virus DNA [Presence] in Genital specimen by NAA with probe detection |
|
89584-7
|
Herpes simplex virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
44518-9
|
Herpes simplex virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
86542-8
|
Herpes simplex virus DNA [Presence] in Tissue by NAA with probe detection |
|
72838-6
|
Herpes simplex virus DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
5014-6
|
Herpes simplex virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
35421-7
|
Herpes simplex virus identified in Ear by Organism specific culture |
|
32689-2
|
Herpes simplex virus identified in Eye by Organism specific culture |
|
35422-5
|
Herpes simplex virus identified in Body fluid by Organism specific culture |
|
5856-0
|
Herpes simplex virus identified in Genital specimen by Organism specific culture |
|
47230-8
|
Herpes simplex virus glycoprotein G IgG Ab [Presence] in Serum |
|
9659-4
|
Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
44505-6
|
Herpes simplex virus IgG Ab [Presence] in Cerebral spinal fluid |
|
16943-3
|
Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
53533-6
|
Herpes simplex virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
52981-8
|
Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
19106-4
|
Herpes simplex virus IgG Ab [Presence] in Serum |
|
40728-8
|
Herpes simplex virus IgG Ab [Presence] in Serum by Immunoassay |
|
9422-7
|
Herpes simplex virus IgG Ab [Units/volume] in Serum |
|
53377-8
|
Herpes simplex virus IgG Ab [Titer] in Serum |
|
51915-7
|
Herpes simplex virus IgG Ab [Titer] in Serum by Immunoassay |
|
53538-5
|
Herpes simplex virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
53560-9
|
Herpes simplex virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
25435-9
|
Herpes simplex virus IgM Ab [Presence] in Serum |
|
40729-6
|
Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay |
|
44507-2
|
Herpes simplex virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
16944-1
|
Herpes simplex virus IgM Ab [Units/volume] in Serum |
|
22343-8
|
Herpes simplex virus IgM Ab [Titer] in Serum |
|
10350-7
|
Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |
|
14213-3
|
Herpes simplex virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
5857-8
|
Herpes simplex virus identified in Isolate by Immunofluorescence |
|
88606-9
|
Herpes simplex virus identified in Lower respiratory specimen by Organism specific culture |
|
35451-4
|
Herpes simplex virus identified in Nasopharynx by Organism specific culture |
|
35424-1
|
Herpes simplex virus identified in Penis by Organism specific culture |
|
35425-8
|
Herpes simplex virus identified in Placenta by Organism specific culture |
|
35426-6
|
Herpes simplex virus identified in Pleural fluid by Organism specific culture |
|
35427-4
|
Herpes simplex virus identified in Peritoneal fluid by Organism specific culture |
|
5858-6
|
Herpes simplex virus identified in Skin by Organism specific culture |
|
35428-2
|
Herpes simplex virus identified in Synovial fluid by Organism specific culture |
|
35429-0
|
Herpes simplex virus identified in Stool by Organism specific culture |
|
35430-8
|
Herpes simplex virus identified in Throat by Organism specific culture |
|
35431-6
|
Herpes simplex virus identified in Tissue by Organism specific culture |
|
10681-5
|
Herpes simplex virus identified in Tissue by Electron microscopy |
|
35432-4
|
Herpes simplex virus identified in Urine by Organism specific culture |
|
35433-2
|
Herpes simplex virus identified in Urethra by Organism specific culture |
|
35423-3
|
Herpes simplex virus identified in Vaginal fluid by Organism specific culture |
|
35434-0
|
Herpes simplex virus identified in Wound by Organism specific culture |
|
5859-4
|
Herpes simplex virus identified in Unspecified specimen by Organism specific culture |
|
43697-2
|
Herpes simplex virus identified in Unspecified specimen by Shell vial culture |
|
33027-4
|
Herpes simplex virus+Varicella zoster virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
62454-4
|
Herpes simplex virus and Varicella zoster virus identified in Unspecified specimen by Organism specific culture |
|
41033-2
|
Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
22331-3
|
Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid |
|
16947-4
|
Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
31410-4
|
Herpes simplex virus 1 Ab [Units/volume] in Cerebral spinal fluid |
|
44469-5
|
Herpes simplex virus 1 Ab [Presence] in Body fluid |
|
29237-5
|
Herpes simplex virus 1 Ab [Units/volume] in Body fluid |
|
5205-0
|
Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunoassay |
|
13324-9
|
Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunofluorescence |
|
43111-4
|
Herpes simplex virus 1 Ab [Presence] in Serum |
|
7908-7
|
Herpes simplex virus 1 Ab [Units/volume] in Serum |
|
32180-2
|
Herpes simplex virus 1 Ab [Units/volume] in Synovial fluid |
|
43032-2
|
Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid |
|
25838-4
|
Herpes simplex virus 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
43031-4
|
Herpes simplex virus 1 Ab [Titer] in Serum |
|
25837-6
|
Herpes simplex virus 1 Ab [Titer] in Serum by Immunofluorescence |
|
44470-3
|
Herpes simplex virus 1 Ag [Presence] in Anal |
|
88678-8
|
Herpes simplex virus 1 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence |
|
89586-2
|
Herpes simplex virus 1 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
44471-1
|
Herpes simplex virus 1 Ag [Presence] in Cervix |
|
44472-9
|
Herpes simplex virus 1 Ag [Presence] in Eye |
|
31846-9
|
Herpes simplex virus 1 Ag [Presence] in Genital specimen |
|
5844-6
|
Herpes simplex virus 1 Ag [Presence] in Genital specimen by Immunofluorescence |
|
91835-9
|
Herpes simplex virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44473-7
|
Herpes simplex virus 1 Ag [Presence] in Penis |
|
31847-7
|
Herpes simplex virus 1 Ag [Presence] in Skin |
|
5845-3
|
Herpes simplex virus 1 Ag [Presence] in Skin by Immunofluorescence |
|
44474-5
|
Herpes simplex virus 1 Ag [Presence] in Throat |
|
44475-2
|
Herpes simplex virus 1 Ag [Presence] in Tissue |
|
88201-9
|
Herpes simplex virus 1 Ag [Presence] in Tissue by Immunofluorescence |
|
10677-3
|
Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain |
|
44476-0
|
Herpes simplex virus 1 Ag [Presence] in Urethra |
|
44477-8
|
Herpes simplex virus 1 Ag [Presence] in Vaginal fluid |
|
31848-5
|
Herpes simplex virus 1 Ag [Presence] in Unspecified specimen |
|
5846-1
|
Herpes simplex virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
44468-7
|
Herpes simplex virus 1 [Presence] in Anal by Organism specific culture |
|
44467-9
|
Herpes simplex virus 1 [Presence] in Cervix by Organism specific culture |
|
62472-6
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
62473-4
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49985-5
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49987-1
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49986-3
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection |
|
62470-0
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
50660-0
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
62471-8
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
50661-8
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
60461-1
|
Herpes simplex virus 1 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
44478-6
|
Herpes simplex virus 1 DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
92872-1
|
Herpes simplex virus 1 DNA [Presence] in Anogenital by NAA with probe detection |
|
90451-6
|
Herpes simplex virus 1 DNA [Presence] in Aspirate by NAA with probe detection |
|
93439-8
|
Herpes simplex virus 1 DNA [Presence] in Blood by NAA with non-probe detection |
|
92870-5
|
Herpes simplex virus 1 DNA [Presence] in Blood by NAA with probe detection |
|
88128-4
|
Herpes simplex virus 1 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
82190-0
|
Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
16952-4
|
Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91859-9
|
Herpes simplex virus 1 DNA [Presence] in Genital specimen by NAA with probe detection |
|
89585-4
|
Herpes simplex virus 1 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
16953-2
|
Herpes simplex virus 1 DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
92871-3
|
Herpes simplex virus 1 DNA [Presence] in Skin by NAA with probe detection |
|
86539-4
|
Herpes simplex virus 1 DNA [Presence] in Tissue by NAA with probe detection |
|
90452-4
|
Herpes simplex virus 1 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
16130-7
|
Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44465-3
|
Herpes simplex virus 1 [Presence] in Genital specimen by Organism specific culture |
|
48399-0
|
Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid |
|
42337-6
|
Herpes simplex virus 1 glycoprotein G IgG Ab [Units/volume] in Serum |
|
58786-5
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
42507-4
|
Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid |
|
28001-6
|
Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
16948-2
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
31066-4
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Body fluid |
|
5206-8
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
17850-9
|
Herpes simplex virus 1 IgG Ab [Presence] in Serum |
|
33291-6
|
Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoblot |
|
7909-5
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum |
|
51916-5
|
Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
16949-0
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --1st specimen |
|
16950-8
|
Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --2nd specimen |
|
22333-9
|
Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid |
|
14086-3
|
Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
73559-7
|
Herpes simplex virus 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
58784-0
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
69921-5
|
Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
88457-7
|
Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
13251-4
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
31068-0
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Body fluid |
|
5207-6
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Serum by Immunoassay |
|
32687-6
|
Herpes simplex virus 1 IgM Ab [Presence] in Serum |
|
40466-5
|
Herpes simplex virus 1 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7910-3
|
Herpes simplex virus 1 IgM Ab [Units/volume] in Serum |
|
22334-7
|
Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid |
|
14087-1
|
Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
21326-4
|
Herpes simplex virus 1 IgM Ab [Titer] in Serum |
|
50758-2
|
Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence |
|
14084-8
|
Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence |
|
44464-6
|
Herpes simplex virus 1 [Presence] in Skin by Organism specific culture |
|
44466-1
|
Herpes simplex virus 1 [Presence] in Throat by Organism specific culture |
|
44463-8
|
Herpes simplex virus 1 [Presence] in Vaginal fluid by Organism specific culture |
|
16291-7
|
Herpes simplex virus 1 [Presence] in Unspecified specimen by Organism specific culture |
|
44479-4
|
Herpes simplex virus 1+2 Ab [Presence] in Cerebral spinal fluid |
|
35875-4
|
Herpes simplex virus 1+2 Ab [Units/volume] in Cerebral spinal fluid |
|
44480-2
|
Herpes simplex virus 1+2 Ab [Presence] in Serum |
|
43033-0
|
Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid |
|
33292-4
|
Herpes simplex virus 1+2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
48400-6
|
Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immunofluorescence |
|
10678-1
|
Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain |
|
49385-8
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49386-6
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
34655-1
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49384-1
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
47409-8
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49382-5
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49383-3
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49381-7
|
Herpes simplex virus 1+2 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
58414-4
|
Herpes simplex virus 1+2 DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
32141-4
|
Herpes simplex virus 1+2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
44868-8
|
Herpes simplex virus 1+2 DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
20444-6
|
Herpes simplex virus 1+2 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44481-0
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid |
|
33293-2
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
13249-8
|
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
44482-8
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Body fluid |
|
27948-9
|
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
36921-5
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Serum |
|
90461-5
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoassay |
|
49848-5
|
Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoblot |
|
31411-2
|
Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum |
|
34613-0
|
Herpes simplex virus 1+2 IgG Ab [Titer] in Serum |
|
41150-4
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid |
|
33294-0
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63432-9
|
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
44483-6
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Body fluid |
|
41399-7
|
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
41149-6
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Serum |
|
90464-9
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunoassay |
|
30355-2
|
Herpes simplex virus 1+2 IgM Ab [Presence] in Serum by Immunofluorescence |
|
43030-6
|
Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum |
|
39571-5
|
Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid |
|
49731-3
|
Herpes simplex virus 1+2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
34152-9
|
Herpes simplex virus 1+2 IgM Ab [Titer] in Serum |
|
41034-0
|
Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
44493-5
|
Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid |
|
44492-7
|
Herpes simplex virus 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
27087-6
|
Herpes simplex virus 2 Ab [Units/volume] in Cerebral spinal fluid |
|
44491-9
|
Herpes simplex virus 2 Ab [Presence] in Body fluid |
|
29236-7
|
Herpes simplex virus 2 Ab [Units/volume] in Body fluid |
|
5208-4
|
Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunoassay |
|
13323-1
|
Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunofluorescence |
|
16954-0
|
Herpes simplex virus 2 Ab [Presence] in Serum |
|
48784-3
|
Herpes simplex virus 2 Ab [Presence] in Serum by Immunoassay |
|
7911-1
|
Herpes simplex virus 2 Ab [Units/volume] in Serum |
|
32181-0
|
Herpes simplex virus 2 Ab [Units/volume] in Synovial fluid |
|
43029-8
|
Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid |
|
25840-0
|
Herpes simplex virus 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
43028-0
|
Herpes simplex virus 2 Ab [Titer] in Serum |
|
25839-2
|
Herpes simplex virus 2 Ab [Titer] in Serum by Immunofluorescence |
|
44498-4
|
Herpes simplex virus 2 Ag [Presence] in Anal |
|
88679-6
|
Herpes simplex virus 2 Ag [Presence] in Cornea or Conjunctiva by Immunofluorescence |
|
89588-8
|
Herpes simplex virus 2 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
44500-7
|
Herpes simplex virus 2 Ag [Presence] in Cervix |
|
44495-0
|
Herpes simplex virus 2 Ag [Presence] in Eye |
|
31849-3
|
Herpes simplex virus 2 Ag [Presence] in Genital specimen |
|
5847-9
|
Herpes simplex virus 2 Ag [Presence] in Genital specimen by Immunofluorescence |
|
91834-2
|
Herpes simplex virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
44496-8
|
Herpes simplex virus 2 Ag [Presence] in Penis |
|
31850-1
|
Herpes simplex virus 2 Ag [Presence] in Skin |
|
5848-7
|
Herpes simplex virus 2 Ag [Presence] in Skin by Immunofluorescence |
|
44501-5
|
Herpes simplex virus 2 Ag [Presence] in Throat |
|
44502-3
|
Herpes simplex virus 2 Ag [Presence] in Tissue |
|
86540-2
|
Herpes simplex virus 2 Ag [Presence] in Tissue by Immunofluorescence |
|
10679-9
|
Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain |
|
44499-2
|
Herpes simplex virus 2 Ag [Presence] in Urethra |
|
44497-6
|
Herpes simplex virus 2 Ag [Presence] in Vaginal fluid |
|
31851-9
|
Herpes simplex virus 2 Ag [Presence] in Unspecified specimen |
|
5849-5
|
Herpes simplex virus 2 Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
44490-1
|
Herpes simplex virus 2 [Presence] in Anal by Organism specific culture |
|
44489-3
|
Herpes simplex virus 2 [Presence] in Cervix by Organism specific culture |
|
62476-7
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
62477-5
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49988-9
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49990-5
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49989-7
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Body fluid by NAA with probe detection |
|
62474-2
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
50662-6
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
62475-9
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
50663-4
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
60462-9
|
Herpes simplex virus 2 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
44503-1
|
Herpes simplex virus 2 DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
92875-4
|
Herpes simplex virus 2 DNA [Presence] in Anogenital by NAA with probe detection |
|
90453-2
|
Herpes simplex virus 2 DNA [Presence] in Aspirate by NAA with probe detection |
|
93438-0
|
Herpes simplex virus 2 DNA [Presence] in Blood by NAA with non-probe detection |
|
92873-9
|
Herpes simplex virus 2 DNA [Presence] in Blood by NAA with probe detection |
|
88133-4
|
Herpes simplex virus 2 DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
82191-8
|
Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
16960-7
|
Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91858-1
|
Herpes simplex virus 2 DNA [Presence] in Genital specimen by NAA with probe detection |
|
89587-0
|
Herpes simplex virus 2 DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
16959-9
|
Herpes simplex virus 2 DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
92874-7
|
Herpes simplex virus 2 DNA [Presence] in Skin by NAA with probe detection |
|
86541-0
|
Herpes simplex virus 2 DNA [Presence] in Tissue by NAA with probe detection |
|
90454-0
|
Herpes simplex virus 2 DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
16131-5
|
Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44487-7
|
Herpes simplex virus 2 [Presence] in Genital specimen by Organism specific culture |
|
48401-4
|
Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Cerebral spinal fluid |
|
42338-4
|
Herpes simplex virus 2 glycoprotein G IgG Ab [Units/volume] in Serum |
|
58785-7
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
27315-1
|
Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid |
|
16956-5
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid |
|
31067-2
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Body fluid |
|
5209-2
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay |
|
17851-7
|
Herpes simplex virus 2 IgG Ab [Presence] in Serum |
|
16955-7
|
Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot |
|
7912-9
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum |
|
43180-9
|
Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
16957-3
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen |
|
57321-2
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
16958-1
|
Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --2nd specimen |
|
22337-0
|
Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid |
|
14089-7
|
Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
24014-3
|
Herpes simplex virus 2 IgG Ab [Titer] in Serum |
|
58783-2
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
43026-4
|
Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid |
|
42606-4
|
Herpes simplex virus 2 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
13252-2
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
31412-0
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Body fluid |
|
5210-0
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
32688-4
|
Herpes simplex virus 2 IgM Ab [Presence] in Serum |
|
44494-3
|
Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunoassay |
|
45210-2
|
Herpes simplex virus 2 IgM Ab [Presence] in Serum by Immunofluorescence |
|
7913-7
|
Herpes simplex virus 2 IgM Ab [Units/volume] in Serum |
|
22338-8
|
Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid |
|
14090-5
|
Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
43027-2
|
Herpes simplex virus 2 IgM Ab [Titer] in Body fluid |
|
31069-8
|
Herpes simplex virus 2 IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
21327-2
|
Herpes simplex virus 2 IgM Ab [Titer] in Serum |
|
26927-4
|
Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence |
|
14085-5
|
Herpes simplex virus 2 [Presence] in Isolate by Immunofluorescence |
|
44486-9
|
Herpes simplex virus 2 [Presence] in Skin by Organism specific culture |
|
44488-5
|
Herpes simplex virus 2 [Presence] in Throat by Organism specific culture |
|
44485-1
|
Herpes simplex virus 2 [Presence] in Vaginal fluid by Organism specific culture |
|
44484-4
|
Herpes simplex virus 2 [Presence] in Unspecified specimen by Organism specific culture |
|
53849-6
|
HTC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
73012-7
|
hydroCHLOROthiazide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73011-9
|
hydroCHLOROthiazide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
44384-6
|
hydroCHLOROthiazide [Presence] in 24 hour Urine |
|
3678-0
|
hydroCHLOROthiazide [Mass/time] in 24 hour Urine |
|
73353-5
|
hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73352-7
|
hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
44552-8
|
hydroCHLOROthiazide [Presence] in Serum or Plasma |
|
3675-6
|
hydroCHLOROthiazide [Mass/volume] in Serum or Plasma |
|
55541-7
|
hydroCHLOROthiazide [Moles/volume] in Serum or Plasma |
|
3676-4
|
hydroCHLOROthiazide [Presence] in Urine |
|
3677-2
|
hydroCHLOROthiazide [Mass/volume] in Urine |
|
73351-9
|
hydroCHLOROthiazide+Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73350-1
|
hydroCHLOROthiazide+Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
40822-9
|
HTLV I Ab [Presence] in Cerebral spinal fluid |
|
44535-3
|
HTLV I Ab [Presence] in Serum from Donor |
|
67815-1
|
HTLV I Ab [Units/volume] in Serum by Immunoassay |
|
22359-4
|
HTLV I Ab [Presence] in Serum |
|
11260-7
|
HTLV I Ab [Presence] in Serum by Immunoassay |
|
6432-9
|
HTLV I Ab [Presence] in Serum by Immunoblot |
|
11609-5
|
HTLV I Ab [Units/volume] in Serum |
|
44537-9
|
HTLV I DNA [Presence] in Blood by NAA with probe detection |
|
44536-1
|
HTLV I DNA [Presence] in Blood by Probe |
|
32021-8
|
HTLV I DNA [Presence] in Serum by NAA with probe detection |
|
16981-3
|
HTLV I DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
14215-8
|
HTLV I g46 Ab [Presence] in Serum |
|
44810-0
|
HTLV I gp21e Ab [Presence] in Serum |
|
22360-2
|
HTLV I IgG Ab [Presence] in Serum |
|
6433-7
|
HTLV I IgG Ab [Presence] in Serum by Immunoassay |
|
42340-0
|
HTLV I p42 Ab [Presence] in Serum by Immunoblot |
|
14224-0
|
HTLV I rgp21 Ab [Presence] in Serum |
|
48160-6
|
HTLV I rgp21 Ab [Presence] in Serum by Immunoblot |
|
63460-0
|
HTLV I+II Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
22361-0
|
HTLV I+II Ab [Presence] in Cerebral spinal fluid |
|
21345-4
|
HTLV I+II Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
13247-2
|
HTLV I+II Ab [Units/volume] in Cerebral spinal fluid |
|
55162-2
|
HTLV I+II Ab panel - Serum Qualitative |
|
44538-7
|
HTLV I+II Ab [Presence] in Serum from Donor |
|
5226-6
|
HTLV I+II Ab [Units/volume] in Serum by Immunoassay |
|
22362-8
|
HTLV I+II Ab [Presence] in Serum |
|
29901-6
|
HTLV I+II Ab [Presence] in Serum by Immunoassay |
|
16982-1
|
HTLV I+II Ab [Presence] in Serum by Immunoblot |
|
22363-6
|
HTLV I+II Ab [Units/volume] in Serum |
|
43007-4
|
HTLV I+II Ab [Titer] in Serum |
|
34318-6
|
HTLV I+II Ab [Titer] in Serum by Complement fixation |
|
30159-8
|
HTLV I+II DNA [Presence] in Blood by NAA with probe detection |
|
43296-3
|
HTLV I+II gp46 Ab [Presence] in Serum |
|
93745-8
|
HTLV I+II IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
|
93744-1
|
HTLV I and II IgG panel - Cerebral spinal fluid |
|
31431-0
|
HTLV I+II IgG Ab [Presence] in Serum |
|
21348-8
|
HTLV I+II IgG Ab [Presence] in Serum by Immunoassay |
|
40735-3
|
HTLV I+II IgG Ab [Presence] in Serum by Immunoblot |
|
43299-7
|
HTLV I+II p19 Ab [Presence] in Serum |
|
43300-3
|
HTLV I+II p24 Ab [Presence] in Serum |
|
43294-8
|
HTLV I+II p26 Ab [Presence] in Serum |
|
43293-0
|
HTLV I+II p28 Ab [Presence] in Serum |
|
43297-1
|
HTLV I+II p32 Ab [Presence] in Serum |
|
43301-1
|
HTLV I+II p36 Ab [Presence] in Serum |
|
43295-5
|
HTLV I+II p53 Ab [Presence] in Serum |
|
77742-5
|
HTLV I and II panel - Serum or Plasma by Immunoblot |
|
43298-9
|
HTLV I+II rgp21 Ab [Presence] in Serum |
|
14027-7
|
HTLV I+II rgp21 Ab [Presence] in Serum or Plasma by Immunoblot |
|
86550-1
|
HTLV I+II RNA [Presence] in Blood by NAA with probe detection |
|
44874-6
|
HTLV I+II RNA [Presence] in Serum by NAA with probe detection |
|
5019-5
|
HTLV I+II RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
40823-7
|
HTLV II Ab [Presence] in Cerebral spinal fluid |
|
26656-9
|
HTLV II Ab [Presence] in Serum |
|
44539-5
|
HTLV II Ab [Presence] in Serum by Immunoassay |
|
44542-9
|
HTLV II DNA [Presence] in Blood by NAA with probe detection |
|
44541-1
|
HTLV II DNA [Presence] in Blood by Probe |
|
16980-5
|
HTLV II DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
14225-7
|
HTLV II g46 Ab [Presence] in Serum |
|
46192-1
|
HTLV II IgG Ab [Presence] in Serum |
|
44540-3
|
HTLV II IgG Ab [Presence] in Serum by Immunoassay |
|
13289-4
|
Hantavirus hantaan Ab [Units/volume] in Serum |
|
7895-6
|
Hantavirus hantaan IgG Ab [Units/volume] in Serum |
|
70052-6
|
Hantavirus hantaan IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
7896-4
|
Hantavirus hantaan IgM Ab [Units/volume] in Serum |
|
70053-4
|
Hantavirus hantaan IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
75731-0
|
HTR2A gene c.102T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
75729-4
|
HTR2A gene c.1354C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
75726-0
|
HTR2A gene c.-1438G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75728-6
|
HTR2A gene c.74C>A [Presence] in Blood or Tissue by Molecular genetics method |
|
75727-8
|
HTR2A gene c.IVS2+54538A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
46726-6
|
HTR2A gene+HTR2C gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
75732-8
|
HTR2C gene c.-759C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
75730-2
|
HTR2C gene c.796G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
49637-2
|
HTT gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49638-0
|
HTT gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
75393-9
|
HTT gene CAG repeats [Presence] in Amniotic fluid or Chorionic villus sample by Molecular genetics method |
|
21763-8
|
HTT gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
53782-9
|
HTT gene CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
42321-0
|
HTT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50621-2
|
HTT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53783-7
|
HTT gene mutation panel - Blood or Tissue by Molecular genetics method |
|
11089-0
|
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid |
|
17341-9
|
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
81728-8
|
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Line blot |
|
14240-6
|
Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid |
|
19137-9
|
Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot |
|
33600-8
|
Neuronal nuclear Ab [Units/volume] in Serum by Immunofluorescence |
|
11088-2
|
Neuronal nuclear Ab [Presence] in Serum |
|
35278-1
|
Neuronal nuclear Ab [Presence] in Serum by Immunoblot |
|
49738-8
|
Neuronal nuclear Ab [Presence] in Serum by Immunofluorescence |
|
31535-8
|
Neuronal nuclear Ab [Units/volume] in Serum |
|
16139-8
|
Neuronal nuclear Ab [Titer] in Cerebral spinal fluid |
|
15398-1
|
Neuronal nuclear Ab [Titer] in Serum |
|
59390-5
|
Neuronal nuclear Ab [Titer] in Serum by Immunofluorescence |
|
33590-1
|
Neuronal nuclear IgG Ab [Units/volume] in Cerebral spinal fluid |
|
33591-9
|
Neuronal nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) |
|
15399-9
|
Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
48405-5
|
Neuronal nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
|
31536-6
|
Neuronal nuclear IgG Ab [Units/volume] in Serum |
|
44770-6
|
Neuronal nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
|
44769-8
|
Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
44768-0
|
Neuronal nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31537-4
|
Neuronal nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid |
|
33615-6
|
Neuronal nuclear type 1 Ab [Presence] in Serum |
|
41769-1
|
Neuronal nuclear type 1 Ab [Presence] in Serum by Immunoblot |
|
12854-6
|
Neuronal nuclear type 1 Ab [Units/volume] in Serum |
|
53711-8
|
Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid |
|
24403-8
|
Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunoblot |
|
24400-4
|
Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
13997-2
|
Neuronal nuclear type 1 Ab [Titer] in Serum |
|
54921-2
|
Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
17343-5
|
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid |
|
63291-9
|
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
56959-0
|
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
89538-3
|
Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid by Line blot |
|
31538-2
|
Neuronal nuclear type 2 Ab [Units/volume] in Cerebral spinal fluid |
|
17344-3
|
Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence |
|
31539-0
|
Neuronal nuclear type 2 Ab [Presence] in Serum |
|
33008-4
|
Neuronal nuclear type 2 Ab [Presence] in Serum by Immunoblot |
|
43187-4
|
Neuronal nuclear type 2 Ab [Presence] in Serum by Immunofluorescence |
|
17342-7
|
Neuronal nuclear type 2 Ab [Units/volume] in Serum |
|
53712-6
|
Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid |
|
24404-6
|
Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunoblot |
|
24401-2
|
Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
13998-0
|
Neuronal nuclear type 2 Ab [Titer] in Serum |
|
43188-2
|
Neuronal nuclear type 2 Ab [Titer] in Serum by Immunofluorescence |
|
69954-6
|
Neuronal nuclear type 2 IgG Ab [Presence] in Serum by Immunoassay |
|
90838-4
|
Neuronal nuclear type 3 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
90836-8
|
Neuronal nuclear type 3 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
43102-3
|
Neuronal nuclear type 3 Ab [Presence] in Serum |
|
35144-5
|
Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid |
|
90837-6
|
Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
33924-2
|
Neuronal nuclear type 3 Ab [Titer] in Serum |
|
82417-7
|
Human upstream binding factor Ab [Units/volume] in Serum by Line blot |
|
54003-9
|
Human upstream binding factor Ab [Presence] in Serum by Immunofluorescence |
|
82418-5
|
Human upstream binding factor Ab [Presence] in Serum by Line blot |
|
54004-7
|
Human upstream binding factor Ab [Titer] in Serum by Immunofluorescence |
|
69956-1
|
Human upstream binding factor IgG Ab [Presence] in Serum by Immunoassay |
|
89003-8
|
HuD Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
62373-6
|
Human reference assembly release, UCSC version [Identifier] |
|
50006-6
|
Human antimouse Ab [Presence] in Serum |
|
13164-9
|
Human antimouse Ab [Units/volume] in Serum |
|
14975-7
|
Human antimouse Ab [Mass/volume] in Serum |
|
42205-5
|
Human antimouse IgG Ab [Mass/volume] in Serum |
|
81326-1
|
Human RNase P RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection |
|
76499-3
|
Humiliation, Afraid, Rape, and Kick questionnaire [HARK] |
|
88121-9
|
Hunger Vital Sign [HVS] |
|
59587-6
|
Homovanillate [Mass/volume] in Urine collected for unspecified duration |
|
53595-5
|
Homovanillate [Mass/volume] in 24 hour Urine |
|
2436-4
|
Homovanillate [Mass/time] in 24 hour Urine |
|
25930-9
|
Homovanillate [Moles/volume] in 24 hour Urine |
|
14783-5
|
Homovanillate [Moles/time] in 24 hour Urine |
|
2434-9
|
Homovanillate [Mass/volume] in Cerebral spinal fluid |
|
40846-8
|
Homovanillate [Moles/volume] in Cerebral spinal fluid |
|
2435-6
|
Homovanillate [Mass/volume] in Serum |
|
55880-9
|
Homovanillate [Moles/volume] in Serum |
|
27267-4
|
Homovanillate [Presence] in Urine |
|
11144-3
|
Homovanillate [Mass/volume] in Urine |
|
12715-9
|
Homovanillate [Mass/time] in Urine |
|
14782-7
|
Homovanillate [Moles/volume] in Urine |
|
13760-4
|
Homovanillate/Creatinine [Mass Ratio] in 24 hour Urine |
|
25931-7
|
Homovanillate/Creatinine [Molar ratio] in 24 hour Urine |
|
11146-8
|
Homovanillate/Creatinine [Mass Ratio] in Urine |
|
22708-2
|
Homovanillate/Creatinine [Molar ratio] in Urine |
|
86188-0
|
History of Occupation industry |
|
74164-5
|
History of Usual occupation and industry Narrative |
|
87729-0
|
History of Occupational hazard |
|
80286-8
|
History of Surgical procedures of cardiovascular system |
|
80274-4
|
History of Surgical procedures of gastrointestinal system |
|
80336-1
|
History of Surgical procedures of genitourinary system |
|
80329-6
|
History of Surgical procedures of musculoskeletal system |
|
21843-8
|
History of Usual occupation |
|
88038-5
|
Hy Ab [Presence] in Serum or Plasma |
|
92541-2
|
Hy Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92503-2
|
Hy Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
35302-9
|
HYAL1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
46135-0
|
Hyaline casts [#/area] in Urine sediment by Microscopy high power field |
|
29240-9
|
Hyaluronate [Mass/volume] in Body fluid |
|
44383-8
|
Hyaluronate [Presence] in Pleural fluid |
|
51706-0
|
Hyaluronate [Mass/volume] in Pleural fluid |
|
56601-8
|
Hyaluronate [Mass/volume] in Peritoneal fluid |
|
12736-5
|
Hyaluronate [Mass/volume] in Serum or Plasma |
|
79167-3
|
Honey bee recombinant (rApi m) 2 IgE Ab [Units/volume] in Serum |
|
32622-3
|
Hyaluronidase Ab [Presence] in Serum |
|
31435-1
|
Hyaluronidase Ab [Units/volume] in Serum |
|
10903-3
|
Hyaluronidase Ab [Titer] in Serum |
|
59252-7
|
Homocysteine cysteine disulfide [Moles/volume] in Cerebral spinal fluid |
|
32615-7
|
Homocysteine cysteine disulfide [Moles/volume] in Serum or Plasma |
|
59253-5
|
Homocysteine cysteine disulfide [Moles/volume] in Urine |
|
32616-5
|
Homocysteine cysteine disulfide/Creatinine [Ratio] in Urine |
|
79496-6
|
Hydantoin-5-propionate [Moles/volume] in Serum or Plasma |
|
79481-8
|
Hydantoin-5-propionate/Creatinine [Molar ratio] in Urine |
|
18306-1
|
Hydatid cyst identified in Aspirate by Iron hematoxylin stain |
|
10683-1
|
Hydatid cyst identified in Aspirate by Immune stain |
|
10684-9
|
Hydatid cyst identified in Liver by Wet preparation |
|
10685-6
|
Hydatid cyst identified in Lung tissue by Wet preparation |
|
11474-4
|
Hydatid cyst identified in Unspecified specimen by Wet preparation |
|
73355-0
|
hydrALAZINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73354-3
|
hydrALAZINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12336-4
|
hydrALAZINE [Presence] in Serum or Plasma |
|
11237-5
|
hydrALAZINE [Mass/volume] in Serum or Plasma |
|
16983-9
|
hydrALAZINE [Presence] in Urine |
|
34632-0
|
hydrALAZINE [Mass/volume] in Urine |
|
27160-1
|
Hydrastine [Presence] in Serum or Plasma |
|
16984-7
|
Hydrastine [Presence] in Urine |
|
38602-9
|
Hydrazine [Mass/volume] in Air |
|
35582-6
|
Hydrazine [Mass/volume] in Blood |
|
35583-4
|
Hydrazine/Creatinine [Mass Ratio] in Urine |
|
35576-8
|
Hydrocarbon and Oxygenated Volatiles panel - Serum or Plasma |
|
74760-0
|
HYDROcodone and metabolites panel - Urine by Confirmatory method |
|
73939-1
|
HYDROcodone Free [Mass/volume] in Blood |
|
46261-4
|
HYDROcodone Free [Presence] in Serum or Plasma |
|
12786-0
|
HYDROcodone Free [Mass/volume] in Serum or Plasma |
|
27312-8
|
HYDROcodone Free [Mass/mass] in Stool |
|
51738-3
|
HYDROcodone Free [Mass/volume] in Urine |
|
27357-3
|
HYDROcodone Free [Mass/volume] in Vitreous fluid |
|
40634-8
|
HYDROcodone [Presence] in Gastric fluid |
|
26719-5
|
HYDROcodone [Mass/mass] in Hair |
|
73349-3
|
HYDROcodone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73348-5
|
HYDROcodone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
68544-6
|
HYDROcodone [Mass/mass] in Meconium by Confirmatory method |
|
57981-3
|
HYDROcodone [Presence] in Meconium |
|
26863-1
|
HYDROcodone [Mass/mass] in Meconium |
|
72753-7
|
HYDROcodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74644-6
|
HYDROcodone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3679-8
|
HYDROcodone [Presence] in Serum or Plasma |
|
86229-2
|
HYDROcodone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3680-6
|
HYDROcodone [Mass/volume] in Serum or Plasma |
|
16252-9
|
HYDROcodone [Mass/volume] in Urine by Confirmatory method |
|
12308-3
|
HYDROcodone [Presence] in Urine |
|
19483-7
|
HYDROcodone [Presence] in Urine by Confirmatory method |
|
19482-9
|
HYDROcodone [Presence] in Urine by Screen method |
|
3681-4
|
HYDROcodone [Mass/volume] in Urine |
|
32080-4
|
HYDROcodone [Presence] in Unspecified specimen |
|
57861-7
|
HYDROcodone [Moles/volume] in Unspecified specimen |
|
58393-0
|
HYDROcodone/Creatinine [Mass Ratio] in Urine |
|
73347-7
|
HYDROcodone+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73346-9
|
HYDROcodone+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73345-1
|
HYDROcodone+Chlorpheniramine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73344-4
|
HYDROcodone+Chlorpheniramine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9411-0
|
Hydrocorticosterone [Mass/time] in 24 hour Urine |
|
18232-9
|
Hydrocorticosterone [Presence] in Urine |
|
73342-8
|
Hydrocortisone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73343-6
|
Hydrocortisone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
57862-5
|
Hydrocortisone [Moles/volume] in Unspecified specimen |
|
44385-3
|
Hydroflumethiazide [Presence] in 24 hour Urine |
|
42918-3
|
Hydroflumethiazide [Mass/volume] in Serum or Plasma |
|
40469-9
|
Hydroflumethiazide [Presence] in Urine |
|
9649-5
|
Hydroflumethiazide [Mass/volume] in Urine |
|
38743-1
|
Hydrogen chloride [Mass/volume] in Air |
|
38744-9
|
Hydrogen fluoride [Mass/volume] in Air |
|
38603-7
|
Hydrogen sulfide [Mass/volume] in Air |
|
29283-9
|
Hydrogen sulfide [Presence] in Blood |
|
29292-0
|
Hydrogen sulfide [Mass/volume] in Blood |
|
73940-9
|
HYDROmorphone Free [Mass/volume] in Blood |
|
46260-6
|
HYDROmorphone Free [Presence] in Serum or Plasma by Screen method |
|
12787-8
|
HYDROmorphone Free [Mass/volume] in Serum or Plasma |
|
27314-4
|
HYDROmorphone Free [Mass/mass] in Stool |
|
46971-8
|
HYDROmorphone Free [Mass/volume] in Urine by Confirmatory method |
|
51737-5
|
HYDROmorphone Free [Mass/volume] in Urine |
|
27196-5
|
HYDROmorphone Free [Mass/volume] in Vitreous fluid |
|
40369-1
|
HYDROmorphone [Presence] in Gastric fluid |
|
26718-7
|
HYDROmorphone [Mass/mass] in Hair |
|
73341-0
|
HYDROmorphone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73340-2
|
HYDROmorphone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
68541-2
|
HYDROmorphone [Mass/mass] in Meconium by Confirmatory method |
|
57982-1
|
HYDROmorphone [Presence] in Meconium |
|
26862-3
|
HYDROmorphone [Mass/mass] in Meconium |
|
72733-9
|
HYDROmorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74645-3
|
HYDROmorphone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3682-2
|
HYDROmorphone [Presence] in Serum or Plasma |
|
86230-0
|
HYDROmorphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3683-0
|
HYDROmorphone [Mass/volume] in Serum or Plasma |
|
16998-7
|
HYDROmorphone [Mass/volume] in Urine by Confirmatory method |
|
9834-3
|
HYDROmorphone [Presence] in Urine |
|
18473-9
|
HYDROmorphone [Presence] in Urine by Confirmatory method |
|
19486-0
|
HYDROmorphone [Presence] in Urine by Screen method |
|
9835-0
|
HYDROmorphone [Mass/volume] in Urine |
|
74380-7
|
HYDROmorphone [Mass/volume] in Unknown substance |
|
32081-2
|
HYDROmorphone [Presence] in Unspecified specimen |
|
57863-3
|
HYDROmorphone [Moles/volume] in Unspecified specimen |
|
58394-8
|
HYDROmorphone/Creatinine [Mass Ratio] in Urine |
|
38604-5
|
Hydroquinone [Mass/volume] in Air |
|
16999-5
|
Hydroquinone [Mass/volume] in Urine |
|
81622-3
|
Hydroxyapatite [Energy Difference] in 24 hour Urine |
|
59909-2
|
hydrOXYzine [Moles/volume] in Gastric fluid |
|
73339-4
|
hydrOXYzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73338-6
|
hydrOXYzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3686-3
|
hydrOXYzine [Mass/volume] in Serum or Plasma |
|
55544-1
|
hydrOXYzine [Moles/volume] in Serum or Plasma |
|
12324-0
|
hydrOXYzine [Presence] in Urine |
|
11240-9
|
hydrOXYzine [Mass/volume] in Urine |
|
59908-4
|
hydrOXYzine [Moles/volume] in Urine |
|
60307-6
|
hydrOXYzine [Moles/volume] in Unspecified specimen |
|
78959-4
|
Hyocholate [Moles/volume] in Serum or Plasma |
|
60087-4
|
Hyoscyamine [Mass/volume] in Blood |
|
11241-7
|
Hyoscyamine [Mass/volume] in Serum or Plasma |
|
60088-2
|
Hyoscyamine [Mass/volume] in Urine |
|
30914-6
|
Hyperdiploid cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
|
53710-0
|
Hyperoxaluria panel - Urine |
|
44387-9
|
Hypnotics [Presence] in Gastric fluid by Screen method |
|
33040-7
|
Hypnotics [Presence] in Serum or Plasma by Screen method |
|
33041-5
|
Hypnotics [Presence] in Urine by Screen method |
|
68318-5
|
Hypoglycemics panel - Serum or Plasma |
|
75123-0
|
Hypoxanthine [Moles/volume] in Cerebral spinal fluid |
|
2452-1
|
Hypoxanthine [Mass/volume] in Body fluid |
|
2453-9
|
Hypoxanthine [Mass/volume] in Serum |
|
75135-4
|
Hypoxanthine [Moles/volume] in Serum or Plasma |
|
17004-3
|
Hypoxanthine [Mass/volume] in Urine |
|
38366-1
|
Hypoxanthine/Creatinine [Molar ratio] in Urine |
|
52028-8
|
Hysterectomy consent Document |
|
10400-0
|
I Ag [Presence] on Red Blood Cells |
|
44330-9
|
Isospora belli [Presence] in Stool |
|
26704-7
|
Isospora belli [Presence] in Stool by Immunofluorescence |
|
10853-0
|
Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified |
|
42324-4
|
I group phenotype [Identifier] in Blood |
|
14164-8
|
Immunosuppressive acidic protein [Mass/volume] in Serum or Plasma |
|
1003-3
|
Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
|
50012-4
|
Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method |
|
50959-6
|
Indirect antiglobulin test.unspecified reagent [Presence] in Serum or Plasma |
|
56886-5
|
Indirect antiglobulin test.unspecified reagent [Titer] in Serum or Plasma |
|
59059-6
|
Inflammatory bowel disease Ab 7 panel - Serum |
|
42760-9
|
Inflammatory bowel disease Ab panel - Serum |
|
74149-6
|
Inflammatory bowel disease action plan |
|
53598-9
|
Irritable bowel disease prognostic panel - Serum or Plasma by Immunoassay |
|
22364-4
|
Infectious bursal disease virus Ab [Presence] in Serum |
|
15475-7
|
Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay |
|
15474-0
|
Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31436-9
|
Infectious bursal disease virus Ab [Units/volume] in Serum |
|
23139-9
|
Infectious bursal disease virus Ab [Titer] in Serum |
|
23140-7
|
Infectious bursal disease virus Ab [Titer] in Serum by Immune diffusion (ID) |
|
23141-5
|
Infectious bursal disease virus Ab [Titer] in Serum by Neutralization test |
|
23143-1
|
Infectious bursal disease virus Ag [Presence] in Bursa of Fabricius by Immune diffusion (ID) |
|
31857-6
|
Infectious bursal disease virus Ag [Presence] in Unspecified specimen |
|
23142-3
|
Infectious bursal disease virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
73010-1
|
Ibuprofen induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73009-3
|
Ibuprofen induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59911-8
|
Ibuprofen [Moles/volume] in Gastric fluid |
|
49868-3
|
Ibuprofen IgE Ab [Units/volume] in Serum |
|
73336-0
|
Ibuprofen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73337-8
|
Ibuprofen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48275-2
|
Ibuprofen triggered leukotriene release [Mass/volume] by Leukocytes |
|
13564-0
|
Ibuprofen [Presence] in Serum or Plasma |
|
35614-7
|
Ibuprofen [Mass/volume] in Serum or Plasma by Screen method |
|
3687-1
|
Ibuprofen [Mass/volume] in Serum or Plasma |
|
32082-0
|
Ibuprofen [Moles/volume] in Serum or Plasma |
|
14071-5
|
Ibuprofen [Presence] in Urine |
|
73997-9
|
Ibuprofen [Mass/volume] in Urine |
|
59910-0
|
Ibuprofen [Moles/volume] in Urine |
|
60308-4
|
Ibuprofen [Moles/volume] in Unspecified specimen |
|
31236-3
|
Infectious bronchitis virus Ab [Units/volume] in Serum |
|
22801-5
|
Infectious bronchitis virus Ab [Titer] in Serum |
|
22802-3
|
Infectious bronchitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
22803-1
|
Infectious bronchitis virus Ab [Titer] in Serum by Immunoassay |
|
22804-9
|
Infectious bronchitis virus Ab [Titer] in Serum by Neutralization test |
|
22806-4
|
Infectious bronchitis virus Ag [Presence] in Tissue by Immune stain |
|
31719-8
|
Infectious bronchitis virus Ag [Presence] in Unspecified specimen |
|
22807-2
|
Infectious bronchitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
22805-6
|
Infectious bronchitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
31237-1
|
Infectious bronchitis virus Ark-99 Ab [Units/volume] in Serum |
|
22092-1
|
Infectious bronchitis virus Ark-99 Ab [Titer] in Serum |
|
15439-3
|
Infectious bronchitis virus Ark-99 Ab [Titer] in Serum by Hemagglutination inhibition |
|
31238-9
|
Infectious bronchitis virus Conn-42 Ab [Units/volume] in Serum |
|
22093-9
|
Infectious bronchitis virus Conn-42 Ab [Titer] in Serum |
|
15441-9
|
Infectious bronchitis virus Conn-42 Ab [Titer] in Serum by Hemagglutination inhibition |
|
20861-1
|
Infectious bronchitis virus genotype [Identifier] in Isolate by NAA with probe detection |
|
20858-7
|
Infectious bronchitis virus genotype [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) |
|
46193-9
|
Infectious bronchitis virus JMK Ab [Titer] in Serum |
|
43338-3
|
Infectious bronchitis virus JMK Ab [Titer] in Serum by Hemagglutination inhibition |
|
31239-7
|
Infectious bronchitis virus Mass-41 Ab [Units/volume] in Serum |
|
22094-7
|
Infectious bronchitis virus Mass-41 Ab [Titer] in Serum |
|
15440-1
|
Infectious bronchitis virus Mass-41 Ab [Titer] in Serum by Hemagglutination inhibition |
|
22810-6
|
Infectious bronchitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22809-8
|
Infectious bronchitis virus RNA [Presence] in Unspecified specimen by Probe |
|
20859-5
|
Infectious bronchitis virus serotype [Identifier] in Isolate by Neutralization test |
|
20860-3
|
Infectious bronchitis virus [Presence] in Tissue by Organism specific culture |
|
22808-0
|
Infectious bronchitis virus [Presence] in Unspecified specimen by Electron microscopy |
|
43303-7
|
Immune Complex C3d [Units/volume] in Serum or Plasma |
|
47217-5
|
Immune Complex C3d [Mass/volume] in Serum or Plasma |
|
38457-8
|
Immune complex.C3d+IgG [Units/volume] in Serum or Plasma |
|
84173-4
|
Interventional cardiology Consult note |
|
23879-0
|
Immune complex [Units/volume] in Body fluid by C1q binding assay |
|
23882-4
|
Immune complex [Units/volume] in Body fluid by Conglutinin assay |
|
23881-6
|
Immune complex [Mass/volume] in Body fluid by Polyethylene glycol (PEG) assay |
|
23880-8
|
Immune complex [Units/volume] in Body fluid by Raji cell assay |
|
18269-1
|
Immune complex [Units/volume] in Body fluid |
|
33953-1
|
Immune complex IgA [Mass/volume] in Serum or Plasma |
|
33960-6
|
Immune complex IgE [Units/volume] in Serum or Plasma |
|
48997-1
|
Immune complex.IgG [Mass/volume] in Body fluid by C1q binding assay |
|
42639-5
|
Immune complex.IgG [Units/volume] in Serum or Plasma by C1q binding assay |
|
48419-6
|
Immune complex.IgG [Mass/volume] in Serum or Plasma by C1q binding assay |
|
33954-9
|
Immune complex.IgG [Mass/volume] in Serum or Plasma |
|
42601-5
|
Immune complex.IgG [Units/volume] in Synovial fluid by C1q binding assay |
|
33952-3
|
Immune complex.IgM [Mass/volume] in Serum or Plasma |
|
84174-2
|
Interventional cardiology Note |
|
84175-9
|
Interventional cardiology Surgical operation note |
|
84176-7
|
Interventional cardiology Postoperative evaluation and management note |
|
84177-5
|
Interventional cardiology Preoperative evaluation and management note |
|
27831-7
|
Immune complex [Units/volume] in Serum or Plasma by C1q binding assay |
|
14275-2
|
Immune complex [Units/volume] in Serum or Plasma by C3b binding assay |
|
45158-3
|
Immune complex [Units/volume] in Serum or Plasma by C3d binding assay |
|
13170-6
|
Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay |
|
52971-9
|
Immune complex [Mass/volume] in Serum or Plasma by Immunoassay |
|
13171-4
|
Immune complex [Units/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
|
13631-7
|
Immune complex [Mass/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
|
44393-7
|
Immune complex [Presence] in Serum or Plasma |
|
44391-1
|
Immune complex [Presence] in Serum or Plasma by C1q binding assay |
|
44392-9
|
Immune complex [Presence] in Serum or Plasma by Raji cell assay |
|
10864-7
|
Immune complex [Units/volume] in Serum or Plasma by Raji cell assay |
|
5228-2
|
Immune complex [Units/volume] in Serum or Plasma |
|
49778-4
|
Immune complex [Mass/volume] in Serum or Plasma |
|
93455-4
|
IC-26 [Mass/volume] in Urine by Confirmatory method |
|
4522-9
|
Complement iC3 [Mass/volume] in Plasma |
|
4523-7
|
Complement iC3b receptors [Entitic number] in Leukocytes |
|
6291-9
|
Complement iC3b receptors [Presence] in Leukocytes |
|
60956-0
|
Intracranial pressure (ICP) |
|
60957-8
|
Intracranial pressure (ICP) Diastolic |
|
60958-6
|
Intracranial pressure (ICP) Mean |
|
60959-4
|
Intracranial pressure (ICP) Systolic |
|
17021-7
|
Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence |
|
10865-4
|
Intercellular substance Ab [Presence] in Serum |
|
17020-9
|
Intercellular substance Ab [Presence] in Serum by Immunofluorescence |
|
31441-9
|
Intercellular substance Ab [Units/volume] in Serum |
|
9424-3
|
Intercellular substance Ab [Titer] in Serum |
|
51708-6
|
Intercellular substance Ab [Titer] in Serum by Immunofluorescence |
|
42936-5
|
Intercellular substance IgA Ab [Presence] in Serum by Immunofluorescence |
|
93233-5
|
Intercellular substance IgG Ab [Presence] in Serum by Immunofluorescence |
|
84075-1
|
Intensive care unit Admission evaluation note |
|
34100-8
|
Intensive care unit Consult note |
|
75432-5
|
Intensive care unit Note |
|
34126-3
|
Intensive care unit Progress note |
|
76698-0
|
Identifier assigning authority |
|
45982-6
|
Identification and background information section |
|
45964-4
|
Identification information section |
|
54096-3
|
Identity testing [Identifier] in Index case from Comparison case by Molecular genetics method Narrative |
|
35865-5
|
Lipoprotein.intermediate density [Presence] in Serum or Plasma |
|
56134-0
|
Cholesterol in IDL 1 [Moles/volume] in Serum or Plasma |
|
56135-7
|
Cholesterol in IDL 2 [Moles/volume] in Serum or Plasma |
|
76030-6
|
IDS gene full mutation analysis in Blood or Tissue by Sequencing |
|
76028-0
|
IDUA gene full mutation analysis in Blood or Tissue by Sequencing |
|
79462-8
|
Iduronate-2-Sulfatase [Enzymatic activity/volume] in DBS |
|
24088-7
|
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Fibroblast |
|
24087-9
|
Iduronate-2-Sulfatase [Enzymatic activity/volume] in Serum or Plasma |
|
2456-2
|
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Tissue |
|
24089-5
|
Iduronate-2-Sulfatase [Enzymatic activity/mass] in Leukocytes |
|
75885-4
|
IEEE 11073 Rosetta panel |
|
34672-6
|
Immunoelectrophoresis panel - 24 hour Urine |
|
29586-5
|
Immunoelectrophoresis panel - Serum |
|
29585-7
|
Immunoelectrophoresis panel - Urine |
|
56539-0
|
Intrinsic factor Ab [Units/volume] in Serum by Immunoassay |
|
30530-0
|
Intrinsic factor Ab [Presence] in Serum |
|
24383-2
|
Intrinsic factor Ab [Presence] in Serum by Immunoassay |
|
89508-6
|
Intrinsic factor Ab [Presence] in Serum by Line blot |
|
5233-2
|
Intrinsic factor Ab [Presence] in Serum by Radioimmunoassay (RIA) |
|
11564-2
|
Intrinsic factor Ab [Units/volume] in Serum |
|
31444-3
|
Intrinsic factor blocking Ab [Presence] in Serum |
|
9537-2
|
Intrinsic factor blocking Ab [Presence] in Serum by Radioimmunoassay (RIA) |
|
31443-5
|
Intrinsic factor blocking Ab [Units/volume] in Serum |
|
2489-3
|
Intrinsic factor blocking Ab [Titer] in Serum |
|
26892-0
|
Intrinsic factor blocking IgG Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
31445-0
|
Intrinsic factor blocking IgG Ab [Units/volume] in Serum |
|
60221-9
|
Intrinsic factor IgG Ab [Units/volume] in Serum |
|
2488-5
|
Intrinsic factor [Mass/volume] in Serum |
|
35347-4
|
Microscopic observation [Identifier] in Unspecified specimen by Immunofluorescence |
|
88473-4
|
If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this [SAQ] |
|
77052-9
|
IFITM5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77051-1
|
IFITM5 gene full mutation analysis in Blood or Tissue by Sequencing |
|
4649-0
|
Interferon [Units/volume] in Serum |
|
49329-6
|
Interferon alpha Ab [Presence] in Serum or Plasma by Immunoassay |
|
44320-0
|
Interferon alpha [Presence] in Serum or Plasma |
|
12731-6
|
Interferon alpha [Units/volume] in Serum or Plasma |
|
33820-2
|
Interferon alpha [Mass/volume] in Serum or Plasma |
|
29647-5
|
Interferon beta Ab [Presence] in Serum or Plasma |
|
34607-2
|
Interferon beta Ab [Units/volume] in Serum or Plasma |
|
35139-5
|
Interferon beta Ab [Titer] in Serum or Plasma |
|
27871-3
|
Interferon beta IgG Ab [Units/volume] in Serum or Plasma |
|
12730-8
|
Interferon beta [Units/volume] in Serum or Plasma |
|
61113-7
|
Immunoglobulin gene rearrangements in Blood or Tissue by Molecular genetics method Narrative |
|
87552-6
|
IgA, IgA1 and IgA2 panel - Serum or Plasma |
|
44388-7
|
IgA [Presence] in 24 hour Urine by Immunofixation |
|
26871-4
|
IgA [Mass/volume] in 24 hour Urine |
|
58763-4
|
IgA [Mass/time] in 24 hour Urine |
|
44584-1
|
IgA Ab [Presence] in Serum or Plasma |
|
44583-3
|
IgA Ab [Presence] in Serum or Plasma by Hemagglutination inhibition |
|
49907-9
|
IgA Ag [Presence] in Tissue by Immunofluorescence |
|
10488-5
|
IgA Ag [Presence] in Tissue by Immune stain |
|
24431-9
|
IgA.canine [Mass/volume] in Serum by Immune diffusion (ID) |
|
2457-0
|
IgA [Mass/volume] in Cerebral spinal fluid |
|
15181-1
|
IgA [Mass/volume] in Body fluid |
|
10489-3
|
IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
|
44585-8
|
IgA IgG Ab [Presence] in Serum or Plasma |
|
13312-4
|
IgA IgG Ab [Units/volume] in Serum or Plasma |
|
44586-6
|
IgA IgM Ab [Presence] in Serum or Plasma |
|
74864-0
|
IgA.kappa [Mass/volume] in Serum or Plasma |
|
74869-9
|
IgA.kappa/IgA.lambda [Mass Ratio] in Serum or Plasma |
|
74865-7
|
IgA.lambda [Mass/volume] in Serum or Plasma |
|
54900-6
|
IgA [Mass/volume] in Peritoneal fluid |
|
6938-5
|
IgA [Mass/volume] in Saliva (oral fluid) |
|
55902-1
|
IgA [Mass/volume] in Serum by Electrophoresis |
|
44389-5
|
IgA [Presence] in Serum |
|
2458-8
|
IgA [Mass/volume] in Serum or Plasma |
|
76487-8
|
IgA [Moles/volume] in Serum or Plasma |
|
44582-5
|
IgA [Presence] in Skin by Immunofluorescence |
|
6779-3
|
IgA [Mass/volume] in Urine by Immunoassay |
|
56121-7
|
IgA [Mass/volume] in Urine |
|
48665-4
|
IgA.intrathecally synthesized [Mass/volume] in Serum and CSF |
|
17005-0
|
IgA subclass 1 [Mass/volume] in Cerebral spinal fluid |
|
6886-6
|
IgA subclass 1 [Mass/volume] in Serum |
|
17006-8
|
IgA subclass 2 [Mass/volume] in Cerebral spinal fluid |
|
6939-3
|
IgA subclass 2 [Mass/volume] in Serum |
|
29863-8
|
IgD Ag [Presence] in Tissue by Immune stain |
|
42511-6
|
IgD [Mass/volume] in Cerebral spinal fluid |
|
44592-4
|
IgD [Presence] in Serum |
|
56688-5
|
IgD [Units/volume] in Serum |
|
2460-4
|
IgD [Mass/volume] in Serum |
|
42510-8
|
IgD [Mass/volume] in Urine |
|
10490-1
|
IgE Ag [Presence] in Tissue by Immune stain |
|
14001-2
|
IgE [Units/volume] in Cord blood |
|
42513-2
|
IgE [Units/volume] in Cerebral spinal fluid |
|
57092-9
|
IgE [Units/volume] in Nasal fluid |
|
44594-0
|
IgE [Presence] in Serum |
|
2462-0
|
IgE [Mass/volume] in Serum |
|
83102-4
|
IgE [Units/volume] in Serum or Plasma by Immunoassay |
|
76488-6
|
IgE [Mass/volume] in Serum or Plasma by Immunoassay |
|
19113-0
|
IgE [Units/volume] in Serum or Plasma |
|
14292-7
|
IgE [Moles/volume] in Serum |
|
93732-6
|
IgE [Units/volume] in Tear |
|
42512-4
|
IgE [Units/volume] in Urine |
|
45167-4
|
IgE [Mass/volume] in Unspecified specimen |
|
12722-5
|
Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma |
|
69945-4
|
Insulin-like growth factor binding protein 1 [Presence] in Vaginal fluid |
|
12723-3
|
Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma |
|
38491-7
|
Insulin-like growth factor binding protein 3.acid labile [Mass/volume] in Serum or Plasma |
|
2483-6
|
Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma |
|
33808-7
|
Insulin-like growth factor binding protein 3 [Moles/volume] in Serum or Plasma |
|
48628-2
|
Insulin-like growth factor binding protein 3 [Presence] in Urine |
|
25528-1
|
Insulin-like growth factor [Moles/volume] in Serum or Plasma |
|
13896-6
|
Insulin-like growth factor-I [Units/volume] in Blood |
|
32023-4
|
Insulin-like growth factor-I [Mass/volume] in Blood |
|
49850-1
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --baseline |
|
38492-5
|
Insulin-like growth factor-I [Units/volume] in Serum or Plasma |
|
2484-4
|
Insulin-like growth factor-I [Mass/volume] in Serum or Plasma |
|
35213-8
|
Insulin-like growth factor-I [Mass or Moles/volume] in Serum or Plasma |
|
29775-4
|
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma |
|
2485-1
|
Insulin-like growth factor-II [Mass/volume] in Serum or Plasma |
|
42788-0
|
Insulin-like growth factor-I receptor Ag [Presence] in Tissue by Immune stain |
|
44595-7
|
IgG [Presence] in 24 hour Urine by Immunofixation |
|
47083-1
|
IgG [Mass/volume] in 24 hour Urine |
|
44596-5
|
IgG Ag [Presence] in Skin by Immunofluorescence |
|
10491-9
|
IgG Ag [Presence] in Tissue by Immune stain |
|
56122-5
|
IgG [Mass/volume] in Cord blood |
|
20855-3
|
IgG.bovine [Mass/volume] in Serum by Immune diffusion (ID) |
|
24432-7
|
IgG.canine [Mass/volume] in Serum by Immune diffusion (ID) |
|
2464-6
|
IgG [Mass/volume] in Cerebral spinal fluid |
|
76489-4
|
IgG [Moles/volume] in Cerebral spinal fluid |
|
20857-9
|
IgG.equine [Mass/volume] in Colostrum by Immune diffusion (ID) |
|
20856-1
|
IgG.equine [Mass/volume] in Body fluid from Fetus by Immune diffusion (ID) |
|
24433-5
|
IgG.equine [Mass/volume] in Serum |
|
55975-7
|
IgG [Mass/volume] in Body fluid by Immune diffusion (ID) |
|
15183-7
|
IgG [Mass/volume] in Body fluid |
|
10492-7
|
IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
|
74862-4
|
IgG.kappa [Mass/volume] in Serum or Plasma |
|
74868-1
|
IgG.kappa/IgG.lambda [Mass Ratio] in Serum or Plasma |
|
74863-2
|
IgG.lambda [Mass/volume] in Serum or Plasma |
|
54901-4
|
IgG [Mass/volume] in Peritoneal fluid |
|
55922-9
|
IgG [Mass/volume] in Serum by Electrophoresis |
|
55974-0
|
IgG [Mass/volume] in Serum by Immune diffusion (ID) |
|
17007-6
|
IgG [Presence] in Serum |
|
38488-3
|
IgG [Units/volume] in Serum |
|
2465-3
|
IgG [Mass/volume] in Serum or Plasma |
|
77177-4
|
IgG [Moles/volume] in Serum or Plasma |
|
47290-2
|
IgG subclass panel [Mass/volume] - Serum |
|
14116-8
|
IgG synthesis rate [Mass/time] in Serum and CSF by calculation |
|
13456-9
|
IgG synthesis rate [Units/volume] in Serum and CSF |
|
6781-9
|
IgG [Mass/volume] in Urine by Immunoassay |
|
33415-1
|
IgG [Mass/volume] in Urine |
|
76490-2
|
IgG [Moles/volume] in Urine |
|
48666-2
|
IgG.intrathecally synthesized [Mass/volume] in Serum and CSF |
|
78961-0
|
IgG clearance/Albumin clearance [Ratio] in Urine and Serum or Plasma |
|
6782-7
|
IgG/Albumin [Mass Ratio] in Serum |
|
33948-1
|
IgG/Creatinine [Mass Ratio] in Urine |
|
78962-8
|
IgG clearance/Transferrin clearance [Ratio] in Urine and Serum or Plasma |
|
47289-4
|
IgG and IgG subclass panel [Mass/volume] - Serum |
|
88184-7
|
IgG+IgM.porcine [Presence] in Pleural fluid from Fetus by Immune diffusion (ID) |
|
88185-4
|
IgG+IgM.porcine [Presence] in Serum from Fetus by Immune diffusion (ID) |
|
2466-1
|
IgG subclass 1 [Mass/volume] in Serum |
|
2467-9
|
IgG subclass 2 [Mass/volume] in Serum |
|
2468-7
|
IgG subclass 3 [Mass/volume] in Serum |
|
49471-6
|
IgG subclass 4 Ag [Presence] in Tissue by Immune stain |
|
2469-5
|
IgG subclass 4 [Mass/volume] in Serum |
|
78221-9
|
IGH gene rearrangements [Presence] in Blood or Tissue by FISH |
|
26958-9
|
IgM [Mass/volume] in 24 hour Urine |
|
58764-2
|
IgM [Mass/time] in 24 hour Urine |
|
47231-6
|
IgM Ab [Presence] in Serum or Plasma |
|
13313-2
|
IgM IgM Ab [Units/volume] in Serum or Plasma |
|
44875-3
|
IgM Ag [Presence] in Skin by Immunofluorescence |
|
10493-5
|
IgM Ag [Presence] in Tissue by Immune stain |
|
14002-0
|
IgM [Units/volume] in Cord blood |
|
50992-7
|
IgM [Mass/volume] in Cord blood |
|
24434-3
|
IgM.canine [Mass/volume] in Serum by Immune diffusion (ID) |
|
89346-1
|
IgM cells/100 CD19 cells in Blood |
|
2471-1
|
IgM [Mass/volume] in Cerebral spinal fluid |
|
15185-2
|
IgM [Mass/volume] in Body fluid |
|
10494-3
|
IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
|
74866-5
|
IgM.kappa [Mass/volume] in Serum or Plasma |
|
74870-7
|
IgM.kappa/IgM.lambda [Mass Ratio] in Serum or Plasma |
|
74867-3
|
IgM.lambda [Mass/volume] in Serum or Plasma |
|
54902-2
|
IgM [Mass/volume] in Peritoneal fluid |
|
55925-2
|
IgM [Mass/volume] in Serum by Electrophoresis |
|
17009-2
|
IgM [Presence] in Serum |
|
2472-9
|
IgM [Mass/volume] in Serum or Plasma |
|
76491-0
|
IgM [Moles/volume] in Serum or Plasma |
|
6784-3
|
IgM [Mass/volume] in Urine by Immunoassay |
|
56123-3
|
IgM [Mass/volume] in Urine |
|
48667-0
|
IgM.intrathecally synthesized [Mass/volume] in Serum and CSF |
|
60485-0
|
Interferon gamma [Mass/volume] in Body fluid |
|
74279-1
|
Gamma interferon negative control spot count [#] in Blood |
|
12729-0
|
Interferon gamma [Units/volume] in Serum or Plasma |
|
27415-9
|
Interferon gamma [Mass/volume] in Serum or Plasma |
|
48670-4
|
IgVH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
32811-2
|
Microscopic observation [Identifier] in Bronchial specimen by Iron hematoxylin stain |
|
14841-1
|
Microscopic observation [Identifier] in Unspecified specimen by Iron hematoxylin stain |
|
57753-6
|
IKBKG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
4650-8
|
Interleukin 1 [Units/volume] in Serum or Plasma |
|
34407-7
|
Interleukin 1 [Mass/volume] in Serum or Plasma |
|
17022-5
|
Interleukin 1+2 [Units/volume] in Serum or Plasma |
|
49909-5
|
Interleukin 10 [Mass/volume] in Cerebral spinal fluid |
|
49733-9
|
Interleukin 10 [Mass/volume] in Body fluid |
|
26848-2
|
Interleukin 10 [Mass/volume] in Serum or Plasma |
|
47317-3
|
Interleukin 12 [Mass/volume] in Body fluid by Immunoassay |
|
12732-4
|
Interleukin 12 [Units/volume] in Serum or Plasma |
|
41760-0
|
Interleukin 12 [Mass/volume] in Serum or Plasma |
|
70089-8
|
Interleukin 13 [Mass/volume] in Cerebral spinal fluid |
|
70090-6
|
Interleukin 13 [Mass/volume] in Body fluid |
|
33822-8
|
Interleukin 13 [Mass/volume] in Serum or Plasma |
|
82334-4
|
Interleukin 17A [Mass/volume] in Serum or Plasma |
|
33823-6
|
Interleukin 18 [Mass/volume] in Serum or Plasma |
|
70075-7
|
Interleukin 1 alpha [Mass/volume] in Cerebral spinal fluid |
|
70076-5
|
Interleukin 1 alpha [Mass/volume] in Body fluid |
|
33821-0
|
Interleukin 1 alpha [Mass/volume] in Serum or Plasma |
|
49717-2
|
Interleukin 1 beta [Mass/volume] in Body fluid |
|
13629-1
|
Interleukin 1 beta [Mass/volume] in Serum or Plasma |
|
70078-1
|
Interleukin 2 [Mass/volume] in Body fluid |
|
4651-6
|
Interleukin 2 [Units/volume] in Serum or Plasma |
|
33939-0
|
Interleukin 2 [Mass/volume] in Serum or Plasma |
|
60279-7
|
IL28B gene associated variant rs12979860 [Presence] in Blood or Tissue by Molecular genetics method |
|
43171-8
|
Interleukin 2 receptor [Units/volume] in Serum or Plasma |
|
24458-2
|
Interleukin 2 receptor [Mass/volume] in Serum or Plasma |
|
23884-0
|
Interleukin 2 receptor [Presence] in Tissue by Immunocytochemical assay |
|
38352-1
|
Interleukin 2 receptor [Units/volume] in Unspecified specimen |
|
55926-0
|
Interleukin 1 receptor alpha chain [Mass/volume] in Serum or Plasma |
|
70080-7
|
Interleukin 3 [Mass/volume] in Cerebral spinal fluid |
|
70081-5
|
Interleukin 3 [Mass/volume] in Body fluid |
|
4652-4
|
Interleukin 3 [Units/volume] in Serum or Plasma |
|
70079-9
|
Interleukin 3 [Mass/volume] in Serum or Plasma |
|
70083-1
|
Interleukin 4 [Mass/volume] in Cerebral spinal fluid |
|
70082-3
|
Interleukin 4 [Mass/volume] in Body fluid |
|
4653-2
|
Interleukin 4 [Units/volume] in Serum or Plasma |
|
27161-9
|
Interleukin 4 [Mass/volume] in Serum or Plasma |
|
70084-9
|
Interleukin 5 [Mass/volume] in Cerebral spinal fluid |
|
70085-6
|
Interleukin 5 [Mass/volume] in Body fluid |
|
44321-8
|
Interleukin 5 [Presence] in Serum or Plasma |
|
4654-0
|
Interleukin 5 [Units/volume] in Serum or Plasma |
|
33938-2
|
Interleukin 5 [Mass/volume] in Serum or Plasma |
|
49919-4
|
Interleukin 6 [Mass/volume] in Cerebral spinal fluid |
|
49732-1
|
Interleukin 6 [Mass/volume] in Body fluid |
|
44322-6
|
Interleukin 6 [Presence] in Serum or Plasma |
|
4655-7
|
Interleukin 6 [Units/volume] in Serum or Plasma |
|
26881-3
|
Interleukin 6 [Mass/volume] in Serum or Plasma |
|
70087-2
|
Interleukin 7 [Mass/volume] in Cerebral spinal fluid |
|
70088-0
|
Interleukin 7 [Mass/volume] in Body fluid |
|
4656-5
|
Interleukin 7 [Units/volume] in Serum or Plasma |
|
70086-4
|
Interleukin 7 [Mass/volume] in Serum or Plasma |
|
49714-9
|
Interleukin 8 [Mass/volume] in Body fluid |
|
33211-4
|
Interleukin 8 [Mass/volume] in Serum or Plasma |
|
45214-4
|
Isoleucine+Leucine [Moles/volume] in DBS |
|
15131-6
|
Isoleucine+Leucine [Presence] in Serum or Plasma |
|
72899-8
|
Isoleucine+Leucine [Moles/volume] in Serum or Plasma |
|
15138-1
|
Isoleucine+Leucine [Presence] in Urine |
|
59289-9
|
Iloperidone [Mass/volume] in Blood |
|
59290-7
|
Iloperidone [Mass/volume] in Serum or Plasma |
|
22095-4
|
Avian infectious laryngotracheitis virus Ab [Presence] in Serum |
|
15442-7
|
Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immunoassay |
|
15443-5
|
Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31240-5
|
Avian infectious laryngotracheitis virus Ab [Units/volume] in Serum |
|
22815-5
|
Avian infectious laryngotracheitis virus Ab [Titer] in Serum |
|
22813-0
|
Avian infectious laryngotracheitis virus Ab [Titer] in Serum by Immunofluorescence |
|
22814-8
|
Avian infectious laryngotracheitis virus Ab [Titer] in Serum by Neutralization test |
|
31720-6
|
Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue |
|
20844-7
|
Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue by Immunofluorescence |
|
31721-4
|
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea |
|
22818-9
|
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunoassay |
|
22817-1
|
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immune diffusion (ID) |
|
20843-9
|
Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunofluorescence |
|
31722-2
|
Avian infectious laryngotracheitis virus Ag [Presence] in Unspecified specimen |
|
22819-7
|
Avian infectious laryngotracheitis virus Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
22816-3
|
Avian infectious laryngotracheitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
22811-4
|
Avian infectious laryngotracheitis virus [Presence] in Unspecified specimen by Electron microscopy |
|
75239-4
|
Albumin.ischemia modified [Units/volume] in Serum |
|
57844-3
|
Imatinib mesylate [Mass/volume] in Serum or Plasma |
|
93232-7
|
Imipenem+Relebactam [Susceptibility] by Gradient strip |
|
85424-0
|
Imipenem+Relebactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
73334-5
|
Imipenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73335-2
|
Imipenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17010-0
|
Imipenem [Mass/volume] in Serum or Plasma |
|
27331-8
|
Imipenem [Units/volume] in Unspecified specimen |
|
25257-7
|
Imipenem [Mass/volume] in Unspecified specimen |
|
54172-2
|
Imipenem+EDTA [Susceptibility] by Disk diffusion (KB) |
|
54171-4
|
Imipenem+EDTA [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54170-6
|
Imipenem+EDTA [Susceptibility] |
|
40370-9
|
Imipramine [Presence] in Gastric fluid |
|
29408-2
|
Imipramine [Mass/volume] in Gastric fluid |
|
59913-4
|
Imipramine [Moles/volume] in Gastric fluid |
|
3689-7
|
Imipramine [Presence] in Serum or Plasma |
|
3690-5
|
Imipramine [Mass/volume] in Serum or Plasma |
|
15107-6
|
Imipramine [Moles/volume] in Serum or Plasma |
|
3693-9
|
Imipramine [Mass/volume] in Serum or Plasma --trough |
|
61419-8
|
Imipramine [Mass/volume] in Urine by Confirmatory method |
|
3691-3
|
Imipramine [Presence] in Urine |
|
61418-0
|
Imipramine [Presence] in Urine by Confirmatory method |
|
3692-1
|
Imipramine [Mass/volume] in Urine |
|
59912-6
|
Imipramine [Moles/volume] in Urine |
|
44390-3
|
Imipramine [Presence] in Unspecified specimen |
|
6946-8
|
Imipramine [Mass/volume] in Unspecified specimen |
|
60309-2
|
Imipramine [Moles/volume] in Unspecified specimen |
|
61417-2
|
Imipramine/Creatinine [Mass Ratio] in Urine |
|
14791-8
|
Imipramine+Desipramine [Presence] in Gastric fluid |
|
43123-9
|
Imipramine and Desipramine panel - Serum or Plasma |
|
14792-6
|
Imipramine+Desipramine [Presence] in Serum or Plasma |
|
9627-1
|
Imipramine+Desipramine [Mass/volume] in Serum or Plasma |
|
14794-2
|
Imipramine+Desipramine [Moles/volume] in Serum or Plasma |
|
78362-1
|
Imipramine+Desipramine [Mass/volume] in Serum or Plasma --trough |
|
14793-4
|
Imipramine+Desipramine [Presence] in Urine |
|
32083-8
|
Imipramine+Desipramine [Presence] in Unspecified specimen |
|
77333-3
|
Imipramine+Desipramine [Moles/volume] in Unspecified specimen |
|
78365-4
|
Imipramine trough, Imipramine+desimipramine trough and Desipramine panell - Serum or Plasma |
|
51584-1
|
Immature granulocytes [#/volume] in Blood |
|
74773-3
|
Immunoglobulin light chains and heavy chains panel - Serum or Plasma |
|
76142-9
|
Immature lymphocytes [Presence] in Blood by Manual count |
|
74138-9
|
Immature monocytes [Presence] in Blood |
|
54225-8
|
Immune response panel - Unspecified specimen by Flow cytometry (FC) |
|
55229-9
|
Immune stain study |
|
87273-9
|
Immunization note |
|
82593-5
|
Immunization summary report |
|
49120-9
|
Immunodeficiency follow-up panel - Unspecified specimen by Flow cytometry (FC) |
|
45268-0
|
Immunodeficiency panel - Blood by Flow cytometry (FC) |
|
57778-3
|
Immunoglobulin light chains.free panel - Serum |
|
43110-6
|
Immunoglobulin light chains panel - 24 hour Urine |
|
81632-2
|
Immunoglobulin light chains panel - Serum by Nephelometry |
|
44793-8
|
Immunoglobulin light chains panel [Mass/volume] - Serum |
|
44792-0
|
Immunoglobulin light chains panel - Urine |
|
34550-4
|
Immunoglobulin panel [Mass/volume] - Serum |
|
92915-8
|
Immunology Consult note |
|
93960-3
|
Immunology Diagnostic study note |
|
92914-1
|
Immunology Outpatient Note |
|
92913-3
|
Immunology Telehealth Note |
|
55230-7
|
Immunophenotyping study |
|
52047-8
|
Immunosuppressive drug attachment |
|
73333-7
|
Imipenem+Cilastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73332-9
|
Imipenem+Cilastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80644-8
|
Isopropyl methylphosphonate [Mass/volume] in Blood |
|
54098-9
|
Isopropyl methylphosphonate [Mass/volume] in Urine |
|
58062-1
|
In sup (b) Ag [Presence] on Red Blood Cells |
|
638-7
|
Microscopic observation [Identifier] in Cerebral spinal fluid by India ink prep |
|
6666-2
|
Microscopic observation [Identifier] in Tissue by India ink prep |
|
666-8
|
Microscopic observation [Identifier] in Unspecified specimen by India ink prep |
|
43598-2
|
Indicans [Presence] in 24 hour Urine |
|
6887-4
|
Indicans [Mass/time] in 24 hour Urine |
|
47089-8
|
Indicans [Moles/time] in 24 hour Urine |
|
2474-5
|
Indicans [Presence] in Urine |
|
26699-9
|
Indicans [Units/volume] in Urine |
|
2475-2
|
Indicans [Mass/volume] in Urine |
|
47090-6
|
Indicans/Creatinine [Molar ratio] in 24 hour Urine |
|
50866-3
|
Indicans/Creatinine [Molar ratio] in Urine |
|
45990-9
|
Indicators of delirium - periodic disorded thinking or awareness Set |
|
45997-4
|
Indicators of depression, anxiety, sad mood Set |
|
46031-1
|
Indicators of fluid status Set |
|
48302-4
|
Indigo carmine triggered leukotriene release [Mass/volume] by Leukocytes |
|
29118-7
|
Indinavir [Units/volume] in Serum or Plasma |
|
31033-4
|
Indinavir [Mass/volume] in Serum or Plasma |
|
51918-1
|
Indinavir [Mass/volume] in Serum or Plasma --trough |
|
49619-0
|
Indinavir+Ritonavir [Susceptibility] by Genotype method |
|
57984-7
|
Indinavir+Ritonavir [Susceptibility] by Phenotype method |
|
5665-5
|
Indium [Mass/volume] in Blood |
|
60089-0
|
Indium [Mass/volume] in Red Blood Cells |
|
60090-8
|
Indium [Mass/volume] in Serum or Plasma |
|
5666-3
|
Indium [Mass/volume] in Urine |
|
9429-2
|
Indium [Mass/volume] in Unspecified specimen |
|
74282-5
|
Individual counseling note |
|
51975-1
|
Individual allele results panel |
|
48015-2
|
Individual allele panel |
|
2476-0
|
Indolamine [Mass/volume] in Serum |
|
2477-8
|
Indole [Mass/volume] in Serum |
|
75067-9
|
Indole-3-Acetate [Moles/volume] in Serum or Plasma |
|
48142-4
|
Indole-3-Acetate/Creatinine [Molar ratio] in Urine |
|
59915-9
|
Indomethacin [Moles/volume] in Gastric fluid |
|
48276-0
|
Indomethacin triggered leukotriene release [Mass/volume] by Leukocytes |
|
3694-7
|
Indomethacin [Mass/volume] in Serum or Plasma |
|
55545-8
|
Indomethacin [Moles/volume] in Serum or Plasma |
|
59914-2
|
Indomethacin [Moles/volume] in Urine |
|
60310-0
|
Indomethacin [Moles/volume] in Unspecified specimen |
|
85657-5
|
Occupation industry CDC Census code |
|
76305-2
|
Infusion dose.programmed [Mass] Infusion pump |
|
80446-8
|
Infant formula intake panel |
|
76324-3
|
Infusion pump Alert type |
|
76317-7
|
Infusion pump Volume.start |
|
76307-8
|
Infusion time.programmed Infusion pump |
|
76310-2
|
Infusion volume.programmed Procedure Infusion pump |
|
31442-7
|
Interferon.beta 1 Ab [Units/volume] in Serum or Plasma |
|
31021-9
|
Interferon.beta 1 Ab [Titer] in Serum or Plasma by Neutralization test |
|
60551-9
|
Interferon.beta 1a Ab [Titer] in Serum or Plasma |
|
60552-7
|
Interferon.beta 1b Ab [Titer] in Serum or Plasma |
|
83740-1
|
Infectious disease Fellow Note |
|
83626-2
|
Infectious disease Nurse Note |
|
83627-0
|
Infectious disease Nurse Outpatient Note |
|
83759-1
|
Infectious disease Resident Note |
|
72519-2
|
Infections present AndOr treated during this pregnancy for live birth [US Standard Certificate of Live Birth] |
|
46028-7
|
Infections Set |
|
88357-9
|
Infectious disease Alert |
|
83783-1
|
Infectious disease Attending Note |
|
34781-5
|
Infectious disease Consult note |
|
84166-8
|
Infectious disease Counseling note |
|
78258-1
|
Infectious disease Diagnostic study note |
|
78281-3
|
Infectious disease Education note |
|
78293-8
|
Infectious disease Flowsheet |
|
84167-6
|
Infectious disease Group counseling note |
|
84168-4
|
Infectious disease Hospital Note |
|
78333-2
|
Infectious disease Initial evaluation note |
|
34782-3
|
Infectious disease Note |
|
84169-2
|
Infectious disease Outpatient Note |
|
84171-8
|
Infectious disease Telephone encounter Note |
|
80739-6
|
Infectious disease Plan of care note |
|
78318-3
|
Infectious disease procedure note |
|
78325-8
|
Infectious disease Progress note |
|
57141-4
|
Infectious disease Referral note |
|
84170-0
|
Infectious disease Risk assessment and screening note |
|
89892-4
|
Infectious disease Telehealth Note |
|
85264-0
|
Infectious disease Transplant candidate evaluation note |
|
76295-5
|
Inflation phase duration [Time] Ventilator |
|
90780-8
|
inFLIXimab Ab [Units/volume] in Serum by Immunoassay |
|
86897-6
|
inFLIXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
72623-2
|
inFLIXimab Ab [Mass/volume] in Serum or Plasma |
|
86896-8
|
inFLIXimab [Mass/volume] in Serum or Plasma by Immunoassay |
|
39803-2
|
inFLIXimab [Mass/volume] in Serum or Plasma |
|
46077-4
|
Influenza vaccine Set |
|
65806-2
|
Inhalation challenge test report Document --W methacholine inhaled |
|
90881-4
|
Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Presence] in Serum by Multidisk |
|
71375-0
|
Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
71376-8
|
Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum by Multidisk |
|
82114-0
|
Inhalant Allergen Mix 7 (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) IgE Ab [Units/volume] in Serum |
|
37989-1
|
Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Presence] in Serum by Multidisk |
|
71373-5
|
Inhalant Allergen Mix 8 (Mugwort+Common silver birch+Cat dander+C herbarum+Dermatophagoides pteronyssinus+Dog dander+Timothy grass+Rye) IgE Ab [Units/volume] in Serum by Multidisk |
|
87426-3
|
Inhibin A and B panel - Serum or Plasma |
|
27014-0
|
Inhibin A [Presence] in Serum or Plasma |
|
23883-2
|
Inhibin A [Mass/volume] in Serum or Plasma |
|
42514-0
|
Inhibin Ag [Presence] in Tissue by Immune stain |
|
56940-0
|
Inhibin B [Mass/volume] in Serum or Plasma by Immunoassay |
|
39532-7
|
Inhibin B [Presence] in Serum or Plasma |
|
30521-9
|
Inhibin B [Units/volume] in Serum or Plasma |
|
34319-4
|
Inhibin B [Mass/volume] in Serum or Plasma |
|
27174-2
|
Inhibin [Units/volume] in Serum or Plasma |
|
2478-6
|
Inhibin [Mass/volume] in Serum or Plasma |
|
28636-9
|
Initial evaluation note |
|
55731-4
|
Inject Rh immune globulin [Mass] |
|
60837-2
|
Injectate temperature |
|
74209-8
|
Injury event summary Document |
|
74496-1
|
Injury location ICD code |
|
88126-8
|
Injury severity |
|
43694-9
|
Inner Ear 68kD Ab [Presence] in Body fluid |
|
47316-5
|
Inner Ear 68kD Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
34585-0
|
Inner Ear 68kD Ab [Presence] in Serum or Plasma |
|
43597-4
|
Inner Ear 68kD Ab [Presence] in Serum or Plasma by Immunoblot |
|
51707-8
|
Inner Ear 68kD Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
41992-9
|
Arsenic.inorganic [Mass/volume] in 24 hour Urine |
|
53838-9
|
Arsenic.inorganic [Mass/time] in 24 hour Urine |
|
50815-0
|
Arsenic.inorganic [Moles/time] in 24 hour Urine |
|
12481-8
|
Arsenic.inorganic [Mass/volume] in Urine |
|
50814-3
|
Arsenic.inorganic [Moles/volume] in Urine |
|
44300-2
|
Arsenic.inorganic/Creatinine [Mass Ratio] in 24 hour Urine |
|
52940-4
|
Arsenic.inorganic/Creatinine [Molar ratio] in 24 hour Urine |
|
13825-5
|
Arsenic.inorganic/Creatinine [Mass Ratio] in Urine |
|
52939-6
|
Arsenic.inorganic/Creatinine [Molar ratio] in Urine |
|
44324-2
|
Iodine.inorganic [Presence] in Serum or Plasma |
|
17024-1
|
Iodine.inorganic [Mass/volume] in Serum or Plasma |
|
2976-9
|
Sulfate.inorganic [Mass/volume] in Serum or Plasma |
|
75154-5
|
Inosine [Moles/volume] in Cerebral spinal fluid |
|
2479-4
|
Inosine [Mass/volume] in Serum |
|
75150-3
|
Inosine [Moles/volume] in Serum or Plasma |
|
2480-2
|
Inositol Free [Mass/volume] in Serum |
|
76135-3
|
Inositol Free/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
|
74890-5
|
Inositol Free/Creatinine [Molar ratio] in Urine |
|
93128-7
|
Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0 [CMS Assessment] |
|
83265-9
|
Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.4 [CMS Assessment] |
|
87414-9
|
Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.5 [CMS Assessment] |
|
88329-8
|
Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 2.0 [CMS Assessment] |
|
89963-3
|
Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 3.0 [CMS Assessment] |
|
34714-6
|
INR in Blood by Coagulation assay |
|
6301-6
|
INR in Platelet poor plasma by Coagulation assay |
|
61189-7
|
INR in Platelet poor plasma from Fetus by Coagulation assay |
|
75387-1
|
INS gene full mutation analysis in Blood or Tissue by Sequencing |
|
10644-3
|
Arthropod identified in Unspecified specimen |
|
14787-6
|
Arthropod identified in Unspecified specimen by Permanent mount |
|
81449-1
|
Inspiratory gas flow.max Respiratory system airway --post bronchodilation |
|
81448-3
|
Inspiratory gas flow.max Respiratory system airway --pre bronchodilation |
|
60740-8
|
Inspiration [Time] Respiratory system |
|
75932-4
|
Inspiratory time percent |
|
76334-2
|
Inspiratory time setting Ventilator |
|
75931-6
|
Inspiration/Expiration time Ratio |
|
76009-0
|
Inspired minute Volume during Mechanical ventilation |
|
69730-0
|
Instructions |
|
84956-2
|
Instrumental Support Survey - fixed length form - ages 18+ [NIH Toolbox] |
|
47658-0
|
Insulin [Units/volume] in Serum or Plasma --1.5 hours post dose glucose |
|
47653-1
|
Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucagon |
|
47654-9
|
Insulin [Units/volume] in Serum or Plasma --10 minutes post dose glucose |
|
47655-6
|
Insulin [Units/volume] in Serum or Plasma --15 minutes post dose glucagon |
|
72902-0
|
Insulin [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
|
27379-7
|
Insulin [Units/volume] in Serum or Plasma --1 hour post XXX challenge |
|
47657-2
|
Insulin [Units/volume] in Serum or Plasma --1 hour post dose glucose |
|
47656-4
|
Insulin [Units/volume] in Serum or Plasma --1 minute post dose glucose |
|
47660-6
|
Insulin [Units/volume] in Serum or Plasma --2.5 hours post dose glucose |
|
47661-4
|
Insulin [Units/volume] in Serum or Plasma --20 minutes post dose glucose |
|
47659-8
|
Insulin [Units/volume] in Serum or Plasma --2 hours post dose glucose |
|
47663-0
|
Insulin [Units/volume] in Serum or Plasma --30 minutes post dose glucose |
|
47662-2
|
Insulin [Units/volume] in Serum or Plasma --3 hours post dose glucose |
|
47664-8
|
Insulin [Units/volume] in Serum or Plasma --3 minutes post dose glucose |
|
47665-5
|
Insulin [Units/volume] in Serum or Plasma --5 minutes post dose glucose |
|
47666-3
|
Insulin [Units/volume] in Serum or Plasma --5 minutes pre dose glucose |
|
47667-1
|
Insulin [Units/volume] in Serum or Plasma --6 minutes post dose glucagon |
|
56546-5
|
Insulin Ab [Units/volume] in Serum by Immunoassay |
|
2481-0
|
Insulin Ab [Presence] in Serum |
|
5232-4
|
Insulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
8072-1
|
Insulin Ab [Units/volume] in Serum |
|
2482-8
|
Insulin Ab [Mass/volume] in Serum |
|
60463-7
|
Insulin Ab [Moles/volume] in Serum |
|
11087-4
|
Insulin Ab [Titer] in Serum |
|
10495-0
|
Insulin Ag [Presence] in Tissue by Immune stain |
|
44319-2
|
Insulin.bound [Presence] in Serum or Plasma |
|
34156-0
|
Insulin.bound [Units/volume] in Serum or Plasma |
|
44397-8
|
Insulin bovine Ab [Presence] in Serum |
|
8073-9
|
Insulin bovine Ab [Units/volume] in Serum |
|
38489-1
|
Insulin bovine Ab [Titer] in Serum |
|
6147-3
|
Insulin bovine IgE Ab [Units/volume] in Serum |
|
56197-7
|
Insulin bovine IgG4 Ab [Mass/volume] in Serum |
|
43148-6
|
Insulin delivery device panel |
|
29238-3
|
Insulin [Units/volume] in Body fluid |
|
50867-1
|
Insulin [Moles/volume] in Body fluid |
|
6901-3
|
Insulin Free [Units/volume] in Serum or Plasma |
|
43942-2
|
Insulin Free [Mass/volume] in Serum or Plasma |
|
25447-4
|
Insulin Free [Moles/volume] in Serum or Plasma |
|
44462-0
|
Insulin Free+Bound [Presence] in Serum or Plasma |
|
44317-6
|
Insulin human Ab [Presence] in Serum |
|
8074-7
|
Insulin human Ab [Units/volume] in Serum |
|
6148-1
|
Insulin human IgE Ab [Units/volume] in Serum |
|
56292-6
|
Insulin human IgG4 Ab [Mass/volume] in Serum |
|
56533-3
|
Insulin IgG Ab [Units/volume] in Serum |
|
89324-8
|
Insulin intact [Units/volume] in Serum by LC/MS/MS |
|
93793-8
|
Insulin [Units/volume] mean in Serum or Plasma |
|
30363-6
|
Insulin [Units/volume] in Serum or Plasma --12 hours fasting |
|
1573-5
|
Insulin [Mass/volume] in Serum or Plasma --12 hours fasting |
|
27873-9
|
Insulin [Units/volume] in Serum or Plasma --fasting |
|
59179-2
|
Insulin [Moles/volume] in Serum or Plasma --fasting |
|
47862-8
|
Insulin [Units/volume] in Serum or Plasma --post meal |
|
93727-6
|
Insulin [Moles/volume] in Serum or Plasma --post meal |
|
44318-4
|
Insulin porcine Ab [Presence] in Serum |
|
8075-4
|
Insulin porcine Ab [Units/volume] in Serum |
|
38490-9
|
Insulin porcine Ab [Titer] in Serum |
|
6149-9
|
Insulin porcine IgE Ab [Units/volume] in Serum |
|
61276-2
|
Insulin porcine IgE Ab/IgE total in Serum |
|
56363-5
|
Insulin porcine IgG4 Ab [Mass/volume] in Serum |
|
42919-1
|
Insulin [Mass/volume] in Serum or Plasma --pre 100 g glucose PO |
|
47669-7
|
Insulin [Units/volume] in Serum or Plasma --pre dose glucagon |
|
47668-9
|
Insulin [Units/volume] in Serum or Plasma --pre dose glucose |
|
47670-5
|
Insulin [Units/volume] in Serum or Plasma --pre-meal |
|
13633-3
|
Insulin receptor Ab [Presence] in Serum |
|
31439-3
|
Insulin receptor Ab [Units/volume] in Serum |
|
13632-5
|
Insulin receptor Ab [Titer] in Serum |
|
92845-7
|
Insulin resistance score in Serum by Calculated.CardioIQ |
|
44396-0
|
Insulin [Presence] in Serum or Plasma |
|
20448-7
|
Insulin [Units/volume] in Serum or Plasma |
|
3695-4
|
Insulin [Mass/volume] in Serum or Plasma |
|
14796-7
|
Insulin [Moles/volume] in Serum or Plasma |
|
18234-5
|
Insulin [Presence] in Unknown substance |
|
50673-3
|
Insulin XXX challenge panel - Serum |
|
48615-9
|
Insulin.free and Insulin.total panel [Units/volume] - Serum or Plasma |
|
49085-4
|
First and Second trimester integrated maternal screen panel |
|
91986-0
|
Integrative medicine Consult note |
|
93961-1
|
Integrative medicine Diagnostic study note |
|
91985-2
|
Integrative medicine Outpatient Note |
|
2487-7
|
Inter alpha trypsin inhibitor [Mass/volume] in Serum |
|
31440-1
|
Intercalated disk Ab [Units/volume] in Serum |
|
14096-2
|
Intercalated disk Ab [Titer] in Serum by Immunofluorescence |
|
75433-3
|
Interdisciplinary Education note |
|
84172-6
|
Interdisciplinary Hospital Plan of care note |
|
84186-6
|
Interdisciplinary Long term care facility Note |
|
84187-4
|
Interdisciplinary Long term care facility Plan of care note |
|
34794-8
|
Interdisciplinary Note |
|
84361-5
|
Interdisciplinary Outpatient Note |
|
81200-8
|
Interdisciplinary Plan of care note |
|
84163-5
|
Interdisciplinary Patient's home Note |
|
84164-3
|
Interdisciplinary Patient's home Plan of care note |
|
83951-4
|
Interdisciplinary Risk assessment and screening note |
|
7533-3
|
Interior Live Oak IgE Ab [Units/volume] in Serum |
|
85250-9
|
Internal medicine Admission evaluation note |
|
85233-5
|
Internal medicine Attending Admission evaluation note |
|
85218-6
|
Internal medicine Attending Hospital Note |
|
85235-0
|
Internal medicine Attending Intensive care unit Note |
|
75472-1
|
Internal medicine Attending Note |
|
85238-4
|
Internal medicine Consult note |
|
85183-2
|
Internal medicine Custodial care facility Note |
|
85243-4
|
Internal medicine Discharge summary |
|
85244-2
|
Internal medicine Education note |
|
85245-9
|
Internal medicine History and physical note |
|
75434-1
|
Internal medicine Hospital Note |
|
85239-2
|
Internal medicine Intensive care unit Admission evaluation note |
|
85240-0
|
Internal medicine Intensive care unit Discharge summary |
|
85241-8
|
Internal medicine Intensive care unit Note |
|
85242-6
|
Internal medicine Intensive care unit procedure note |
|
85219-4
|
Internal medicine Intensive care unit Transfer summary note |
|
85254-1
|
Internal medicine Interdisciplinary Plan of care note |
|
85266-5
|
Internal medicine Interdisciplinary Note |
|
85246-7
|
Internal medicine Intern Admission evaluation note |
|
85247-5
|
Internal medicine Long term care facility Note |
|
85234-3
|
Internal medicine Attending Intensive care unit Admission evaluation note |
|
75435-8
|
Internal medicine Note |
|
85248-3
|
Internal medicine Nurse practitioner Note |
|
85249-1
|
Internal medicine Nurse Note |
|
75436-6
|
Internal medicine Outpatient Note |
|
88649-9
|
Internal medicine Parenteral therapy note |
|
85265-7
|
Internal medicine Pharmacist Medication management note |
|
85252-5
|
Internal medicine Telephone encounter Note |
|
85236-8
|
Internal medicine procedure note |
|
85251-7
|
Internal medicine Resident Admission evaluation note |
|
75478-8
|
Internal medicine Resident Note |
|
85253-3
|
Internal medicine Transfer summary note |
|
88379-3
|
International Physical Activity Questionnaire self-administered long form [IPAQ] |
|
77582-5
|
International Physical Activity Questionnaire Self-Administered Short Form [IPAQ] |
|
88434-6
|
International Physical Activity Questionnaire telephone long form [IPAQ] |
|
88412-2
|
International Physical Activity Questionnaire telephone short form [IPAQ] |
|
80976-4
|
International Prostate Symptom Score [IPSS] |
|
49275-1
|
Immunofixation for Serum or Plasma Narrative |
|
13440-3
|
Immunofixation for Urine |
|
74188-4
|
interRAI Acute Care (AC) Hospital Document |
|
74197-5
|
interRAI Contact Assessment (CA) Document |
|
74194-2
|
interRAI Community Health Assessment (CHA) Document |
|
74191-8
|
interRAI Community Health Assessment - Assisted Living Supplement (CHA-AL) Document |
|
74190-0
|
interRAI Community Health Assessment - Deafblind Supplement (CHA-Db) Document |
|
74193-4
|
interRAI Community Health Assessment - Functional Supplement (CHA-FS) Document |
|
74192-6
|
interRAI Community Health Assessment - Mental Health Supplement (CHA-MH) Document |
|
74187-6
|
interRAI Emergency Screener for Psychiatry (ESP) Document |
|
74196-7
|
interRAI Home Care (HC) Document |
|
74195-9
|
interRAI Long Term Care Facility (LTCF) Document |
|
74189-2
|
interRAI Palliative Care (PC) Document |
|
34121-4
|
Interventional procedure note |
|
77600-5
|
Interval note |
|
46065-9
|
Intervention programs for mood, behavior and cognitive loss Set |
|
69955-3
|
Intestinal goblet cell Ab [Presence] in Serum by Immunoassay |
|
58461-5
|
Intestinal goblet cell Ab [Titer] in Serum |
|
46214-3
|
Intracardiac ablation study |
|
60738-2
|
Intraluminal [Pressure] Esophagus |
|
76280-7
|
Intramucosal gastric pH |
|
82721-2
|
Intravenous lipid emulsion [Mass/volume] in Serum by Nephelometry |
|
52762-2
|
Intrinsic coagulation system thromboelastography panel - Blood |
|
72661-2
|
Intrinsic coagulation factor activity 4 panel - Platelet poor plasma by Coagulation assay |
|
2491-9
|
Inulin renal clearance in 24 hour Urine and Serum or Plasma |
|
72159-7
|
Inulin renal clearance/1.73 sq M in 4 hour Urine and Serum or Plasma |
|
2490-1
|
Inulin [Mass/volume] in Serum or Plasma |
|
77034-7
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript in Blood or Tissue by FISH |
|
70291-0
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75010-9
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
72210-8
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
70156-5
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [Log Number Ratio] in Blood or Tissue |
|
72209-0
|
inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
79206-9
|
inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Blood or Tissue by FISH |
|
88744-8
|
inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Tissue by Molecular genetics method |
|
77041-2
|
inv(3)(q21;q26.2)+t(3;3)(q21;q26.2)(PSMD2,MECOM) fusion transcript in Blood or Tissue by FISH |
|
45980-0
|
Involvement patterns Set |
|
59697-3
|
Iodide [Mass/volume] in Serum or Plasma |
|
51001-6
|
Iodide [Mass/volume] in Urine |
|
44790-4
|
Iodide [Mass/volume] in Unspecified specimen |
|
53872-8
|
Iodine [Mass/volume] in Urine collected for unspecified duration |
|
26842-5
|
Iodine [Mass/volume] in 24 hour Urine |
|
2492-7
|
Iodine [Mass/time] in 24 hour Urine |
|
25936-6
|
Iodine [Moles/volume] in 24 hour Urine |
|
25449-0
|
Iodine [Moles/time] in 24 hour Urine |
|
11220-1
|
Iodine Free [Mass/time] in 24 hour Urine |
|
18367-3
|
Iodine Free [Mass/volume] in Serum or Plasma |
|
2493-5
|
Iodine Free [Mass/volume] in Urine |
|
76657-6
|
Iodine [Mass/mass] in Hair |
|
50868-9
|
Iodine [Moles/mass] in Hair |
|
20865-2
|
Iodine [Mass/mass] in Liver |
|
20864-5
|
Iodine [Mass/volume] in Milk |
|
44323-4
|
Iodine [Presence] in Serum or Plasma |
|
2494-3
|
Iodine [Mass/volume] in Serum or Plasma |
|
25448-2
|
Iodine [Moles/volume] in Serum or Plasma |
|
2495-0
|
Iodine [Mass/volume] in Urine |
|
34320-2
|
Iodine [Moles/volume] in Urine |
|
34321-0
|
Iodine/Creatinine [Molar ratio] in Urine |
|
7428-6
|
Iodinebush IgE Ab [Units/volume] in Serum |
|
2496-8
|
Iodohippuran renal clearance in 24 hour Urine and Serum or Plasma |
|
50055-3
|
Iohexol renal clearance in Urine and Serum or Plasma |
|
93974-4
|
Iohexol [Mass/volume] in Serum or Plasma |
|
93973-6
|
Iohexol [Mass/volume] in Urine |
|
90993-7
|
Iothalamate clearance panel - Urine and Serum or Plasma |
|
90994-5
|
Iothalamate renal clearance |
|
90995-2
|
Iothalamate renal clearance/Body surface area |
|
93980-1
|
Iothalamate [Mass/volume] in Serum or Plasma |
|
93855-5
|
Iothalamate [Mass/volume] in Urine |
|
73331-1
|
Ipratropium induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73330-3
|
Ipratropium induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72555-6
|
Interventional radiology Consult note |
|
89805-6
|
Interventional radiology Initial evaluation note |
|
84178-3
|
Interventional radiology Note |
|
83582-7
|
Interventional radiology Nurse Note |
|
89806-4
|
Interventional radiology Telephone encounter Note |
|
75238-6
|
Interventional radiology procedure note |
|
72556-4
|
Interventional radiology Progress note |
|
83760-9
|
Interventional radiology Resident Note |
|
73329-5
|
Irbesartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73328-7
|
Irbesartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73327-9
|
Irbesartan+hydroCHLOROthiazide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73326-1
|
Irbesartan+hydroCHLOROthiazide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
53873-6
|
IRF6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
88872-7
|
IRF-PAI v3.0 - Medications - admission [CMS Assessment] |
|
93417-4
|
IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM) [CMS Assessment] |
|
54915-4
|
Iroko IgE Ab [Units/volume] in Serum |
|
30919-5
|
Iron [Mass/volume] in Urine collected for unspecified duration |
|
30030-1
|
Iron [Mass/volume] in 24 hour Urine |
|
2499-2
|
Iron [Mass/time] in 24 hour Urine |
|
35256-7
|
Iron [Mass or Moles/volume] in 24 hour Urine |
|
25937-4
|
Iron [Moles/volume] in 24 hour Urine |
|
14799-1
|
Iron [Moles/time] in 24 hour Urine |
|
34615-5
|
Iron.microscopic observation [Identifier] in Blood by Potassium ferrocyanide stain |
|
10758-1
|
Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain |
|
2503-1
|
Iron.chelated [Mass/volume] in Urine |
|
57988-8
|
Iron [Mass/volume] in Cerebral spinal fluid |
|
44327-5
|
Iron [Presence] in Body fluid |
|
44867-0
|
Iron.microscopic observation [Presence] in Body fluid by Other stain |
|
51197-2
|
Iron [Mass/volume] in Body fluid |
|
29764-8
|
Iron [Moles/volume] in Body fluid |
|
44325-9
|
Iron [Presence] in Hair |
|
2497-6
|
Iron [Mass/mass] in Hair |
|
50869-7
|
Iron [Moles/mass] in Hair |
|
57028-3
|
Iron [Mass/mass] in Liver |
|
13513-7
|
Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain |
|
75689-0
|
Iron panel - Serum or Plasma |
|
86913-1
|
Iron saturation goal Serum or Plasma |
|
2502-3
|
Iron saturation [Mass Fraction] in Serum or Plasma |
|
14801-5
|
Iron saturation [Molar fraction] in Serum or Plasma |
|
44326-7
|
Iron [Presence] in Serum or Plasma |
|
2498-4
|
Iron [Mass/volume] in Serum or Plasma |
|
35214-6
|
Iron [Mass or Moles/volume] in Serum or Plasma |
|
14798-3
|
Iron [Moles/volume] in Serum or Plasma |
|
50198-1
|
Iron [Mass/volume] in Serum or Plasma --1st specimen |
|
50199-9
|
Iron [Mass/volume] in Serum or Plasma --2nd specimen |
|
50200-5
|
Iron [Mass/volume] in Serum or Plasma --3rd specimen |
|
50201-3
|
Iron [Mass/volume] in Serum or Plasma --4th specimen |
|
50202-1
|
Iron [Mass/volume] in Serum or Plasma --5th specimen |
|
50203-9
|
Iron [Mass/volume] in Serum or Plasma --6th specimen |
|
50204-7
|
Iron [Mass/volume] in Serum or Plasma --7th specimen |
|
50205-4
|
Iron [Mass/volume] in Serum or Plasma --8th specimen |
|
10759-9
|
Iron.microscopic observation [Identifier] in Sputum by Gomori stain |
|
34612-2
|
Iron [Mass/volume] in Stool |
|
10760-7
|
Iron.microscopic observation [Identifier] in Tissue by Gomori stain |
|
10761-5
|
Iron.microscopic observation [Identifier] in Tissue by Other stain |
|
15357-7
|
Iron [Mass/mass] in Tissue |
|
38414-9
|
Iron [Moles/mass] in Tissue |
|
2504-9
|
Iron [Mass/volume] in Urine |
|
33824-4
|
Iron [Moles/volume] in Urine |
|
53501-3
|
Iron [Moles/volume] in Water |
|
53456-0
|
Iron [Mass/mass] in Unspecified specimen |
|
53503-9
|
Iron [Moles/mass] in Unspecified specimen |
|
57014-3
|
Iron/Creatinine [Mass Ratio] in 24 hour Urine |
|
53149-1
|
Iron/Creatinine [Molar ratio] in 24 hour Urine |
|
27411-8
|
Iron/Creatinine [Mass Ratio] in Urine |
|
34322-8
|
Iron/Creatinine [Molar ratio] in Urine |
|
60517-0
|
Iron/Transferrin [Ratio] in Serum or Plasma |
|
50190-8
|
Iron and Iron binding capacity panel - Serum or Plasma |
|
88887-5
|
Isavuconazole [Susceptibility] |
|
64093-8
|
ISCN band level [#] in Amniotic fluid Qualitative by Molecular genetics method |
|
64087-0
|
ISCN band level [#] in Chorionic villus sample Qualitative by Molecular genetics method |
|
56718-0
|
Islet cell 512 Ab [Units/volume] in Serum by Immunoassay |
|
31209-0
|
Islet cell 512 Ab [Units/volume] in Serum |
|
81155-4
|
Islet cell 512 Ab [Moles/volume] in Serum |
|
32636-3
|
Islet cell 512 Ab [Titer] in Serum |
|
70253-0
|
Islet cell 512 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
70252-2
|
Islet cell 512 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
12992-4
|
Isobutane [Mass/volume] in Blood |
|
9431-8
|
Isobutanol [Mass/volume] in Blood |
|
9692-5
|
Isobutanol [Mass/volume] in Unspecified specimen |
|
14265-3
|
Isobutyl acetate [Mass/volume] in Blood |
|
9432-6
|
Isobutyl acetate [Mass/volume] in Unspecified specimen |
|
9430-0
|
Isobutylcarbinol [Mass/volume] in Blood |
|
45213-6
|
Isobutyrylcarnitine (C4) [Moles/volume] in DBS |
|
54304-1
|
Isobutyrylglycine [Moles/volume] in Urine |
|
12551-8
|
Isocarboxazid [Mass/volume] in Serum or Plasma |
|
44328-3
|
Isocitrate [Presence] in 24 hour Urine |
|
2506-4
|
Isocitrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
75090-1
|
Isocitrate [Moles/volume] in Serum or Plasma |
|
27269-0
|
Isocitrate [Presence] in Urine |
|
49910-3
|
Isocitrate/Creatinine [Molar ratio] in 24 hour Urine |
|
13764-6
|
Isocitrate/Creatinine [Mass Ratio] in Urine |
|
25111-6
|
Isocitrate/Creatinine [Molar ratio] in Urine |
|
74085-2
|
Isocoproporphyrin [Moles/mass] in Stool |
|
7429-4
|
Isocyanate HDI IgE Ab [Units/volume] in Serum |
|
61277-0
|
Isocyanate HDI IgE Ab/IgE total in Serum |
|
61141-8
|
Isocyanate HDI IgG Ab [Mass/volume] in Serum |
|
17026-6
|
Isocyanate IgE Ab [Units/volume] in Serum |
|
17027-4
|
Isocyanate IgG Ab [Units/volume] in Serum |
|
17028-2
|
Isocyanate IgM Ab [Units/volume] in Serum |
|
38745-6
|
Isocyanate MDI [Mass/volume] in Air |
|
7430-2
|
Isocyanate MDI IgE Ab [Units/volume] in Serum |
|
61140-0
|
Isocyanate MDI IgG Ab [Mass/volume] in Serum |
|
7431-0
|
Isocyanate TDI IgE Ab [Units/volume] in Serum |
|
61278-8
|
Isocyanate TDI IgE Ab/IgE total in Serum |
|
61139-2
|
Isocyanate TDI IgG Ab [Mass/volume] in Serum |
|
60766-3
|
Gas delivery system inspiratory Isoflurane setting [VFr/PPres] |
|
87652-4
|
Isofenphos [Mass/mass] in Unspecified specimen |
|
9433-4
|
Isoflurane [Mass/volume] in Blood |
|
62269-6
|
Isoflurane [VFr/PPres] Airway adaptor --during expiration |
|
60768-9
|
Isoflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
62270-4
|
Isoflurane [VFr/PPres] Airway adaptor --during inspiration |
|
60859-6
|
Isoflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60895-0
|
Isoflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60769-7
|
Isoflurane gas delivered during case [Volume] from Gas delivery system |
|
61025-3
|
Isoflurane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76130-4
|
Isoflurane liquid delivered during case [Volume] from Gas delivery system |
|
76131-2
|
Isoflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
62268-8
|
Isoflurane [VFr/PPres] Airway adaptor |
|
60858-8
|
Isoflurane [VFr/PPres] Gas delivery system |
|
47671-3
|
Isoleucine [Moles/volume] in DBS |
|
55929-4
|
Isoleucine [Moles/mass] in Hair |
|
74881-4
|
Isoleucine [Moles/volume] in DBS --post therapeutic diet |
|
47674-7
|
Isoleucine/Amino acids.total in Amniotic fluid |
|
47673-9
|
Isoleucine/Amino acids.total in Cerebral spinal fluid |
|
47676-2
|
Isoleucine/Amino acids.total in DBS |
|
47672-1
|
Isoleucine/Amino acids.total in Hair |
|
47675-4
|
Isoleucine/Amino acids.total in Serum or Plasma |
|
47677-0
|
Isoleucine/Amino acids.total in Unspecified specimen |
|
44329-1
|
Isoleucine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56689-3
|
Isoleucine/Creatinine [Ratio] in 24 hour Urine |
|
29640-0
|
Isomaltase [Enzymatic activity/mass] in Tissue |
|
74954-9
|
Isomaltase [Enzymatic activity/mass] in Small intestine Tissue |
|
89488-1
|
Isoniazid [Susceptibility] by Genotype method |
|
26756-7
|
Isoniazid [Units/volume] in Serum or Plasma |
|
3697-0
|
Isoniazid [Mass/volume] in Serum or Plasma |
|
25451-6
|
Isoniazid [Moles/volume] in Serum or Plasma |
|
40371-7
|
Isoniazid [Presence] in Urine |
|
38762-1
|
Iso-octane [Mass/volume] in Air |
|
38704-3
|
Isophorone [Mass/volume] in Air |
|
39530-1
|
Isopropanol [Presence] in Blood |
|
5667-1
|
Isopropanol [Mass/volume] in Blood |
|
50870-5
|
Isopropanol [Moles/volume] in Body fluid |
|
40372-5
|
Isopropanol [Presence] in Gastric fluid |
|
23888-1
|
Isopropanol [Mass/volume] in Gastric fluid |
|
59916-7
|
Isopropanol [Moles/volume] in Gastric fluid |
|
15403-9
|
Isopropanol [Presence] in Meconium |
|
5668-9
|
Isopropanol [Presence] in Serum or Plasma |
|
20471-9
|
Isopropanol [Presence] in Serum or Plasma by Screen method |
|
5669-7
|
Isopropanol [Mass/volume] in Serum or Plasma |
|
14802-3
|
Isopropanol [Moles/volume] in Serum or Plasma |
|
9435-9
|
Isopropanol [Mass/mass] in Tissue |
|
5670-5
|
Isopropanol [Presence] in Urine |
|
9434-2
|
Isopropanol [Mass/volume] in Urine |
|
32085-3
|
Isopropanol [Moles/volume] in Urine |
|
32084-6
|
Isopropanol [Moles/volume] in Unspecified specimen |
|
17030-8
|
Isopropyl ether [Presence] in Blood |
|
12371-1
|
Isopropyl ether [Mass/volume] in Blood |
|
49920-2
|
Isopropyl ether [Presence] in Serum or Plasma |
|
73325-3
|
Isosorbide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73324-6
|
Isosorbide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
78006-4
|
Isotopic Glomerular filtration rate/1.73 sq M [Volume Rate/Area] in Urine and Serum or Plasma |
|
87378-6
|
Isotopic Tubular extraction rate/1.73 sq M [Volume Rate/Area] in Serum or Blood |
|
73323-8
|
ISOtretinoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73322-0
|
ISOtretinoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6947-6
|
ISOtretinoin [Mass/volume] in Serum or Plasma |
|
54306-6
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Amniotic fluid |
|
54305-8
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Cerebral spinal fluid |
|
45216-9
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in DBS |
|
54307-4
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5) [Moles/volume] in Urine |
|
53238-2
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in DBS |
|
88007-0
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
53239-0
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
53240-8
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) [Molar ratio] in DBS |
|
54931-1
|
Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Creatinine [Molar ratio] in Urine |
|
42920-9
|
Isovalerylcarnitine (C5) [Moles/volume] in DBS |
|
54308-2
|
Isovalerylglycine [Moles/volume] in Cerebral spinal fluid |
|
55930-2
|
Isovalerylglycine [Moles/volume] in Plasma |
|
44331-7
|
Isovalerylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
49911-1
|
Isovalerylglycine/Creatinine [Molar ratio] in 24 hour Urine |
|
79316-6
|
Isoxanthopterin [Moles/volume] in Serum or Plasma |
|
6150-7
|
Ispaghula laxative IgE Ab [Units/volume] in Serum |
|
88076-5
|
Injury severity score NACA |
|
43207-0
|
Invasive trophoblast Ag [Presence] in Serum or Plasma |
|
40583-7
|
Invasive trophoblast Ag [Mass/volume] in Serum or Plasma |
|
15340-3
|
Italian Cedar IgE Ab [Units/volume] in Serum |
|
6151-5
|
Italian Cypress IgE Ab [Units/volume] in Serum |
|
61254-9
|
Italian Cypress IgE Ab/IgE total in Serum |
|
56293-4
|
Italian Cypress IgG4 Ab [Mass/volume] in Serum |
|
94093-2
|
Itemized bill |
|
48026-9
|
ITGA2B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
58987-9
|
ITGB3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
91137-0
|
ITPA gene g.9330C>A [Type] in Serum or Plasma by Molecular genetics method |
|
80424-5
|
Inosine triphosphate pyrophosphatase [Enzymatic activity/substance] in Red Blood Cells |
|
80531-7
|
Itraconazole [Mass/volume] in DBS |
|
54179-7
|
Itraconazole [Susceptibility] by Disk diffusion (KB) |
|
32184-4
|
Itraconazole [Mass/volume] in Serum or Plasma --peak |
|
10989-2
|
Itraconazole [Mass/volume] in Serum or Plasma |
|
32185-1
|
Itraconazole [Mass/volume] in Serum or Plasma --trough |
|
25258-5
|
Itraconazole [Mass/volume] in Unspecified specimen |
|
27081-9
|
Itraconazole+Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
|
88346-2
|
Intravascular blood pressure with exercise and post exercise panel |
|
94121-1
|
Inferior vena cava Blood pressure by US |
|
81844-3
|
IVD gene full mutation analysis in Blood or Tissue by Sequencing |
|
82518-2
|
IVD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
19744-2
|
Jackfruit IgE Ab [Units/volume] in Serum |
|
82253-6
|
JAG1 gene deletion in Blood or Tissue by FISH |
|
47962-6
|
JAG1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
55300-8
|
JAK2 gene exon 12 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80186-0
|
JAK2 gene exon 12 targeted mutation analysis in Bone marrow by Molecular genetics method |
|
63421-2
|
JAK2 gene exon 12 mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
55301-6
|
JAK2 gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80187-8
|
JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80188-6
|
JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method |
|
48726-4
|
JAK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43399-5
|
JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method |
|
72333-8
|
JAK2 gene p.Val617Phe [Presence] in Bone marrow by Molecular genetics method |
|
53761-3
|
JAK2 gene.p.Val617Phe mutant/Normal in Blood or Tissue by Molecular genetics method |
|
85039-6
|
JAK2 gene.p.Val617Phe mutant/Normal in Bone marrow by Molecular genetics method |
|
47963-4
|
JAK3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
11189-8
|
Jalepeno Pepper IgE Ab [Units/volume] in Serum |
|
65777-5
|
Japanese Cedar native (nCry j) 1 IgE Ab [Units/volume] in Serum |
|
14035-0
|
Japanese Cedar IgE Ab [Units/volume] in Serum |
|
61251-5
|
Japanese Cedar IgE Ab/IgE total in Serum |
|
48245-5
|
Japanese Cedar triggered leukotriene release [Mass/volume] by Leukocytes |
|
40788-2
|
Japanese cypress IgE Ab [Units/volume] in Serum |
|
40789-0
|
Japanese hop IgE Ab [Units/volume] in Serum |
|
70173-0
|
JC virus Ab [Presence] in Serum or Plasma by Immunoassay |
|
49416-1
|
JC virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49414-6
|
JC virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49410-4
|
JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49415-3
|
JC virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49413-8
|
JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49417-9
|
JC virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49411-2
|
JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49412-0
|
JC virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
49547-3
|
JC virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
|
86573-3
|
JC virus DNA [Presence] in Blood by NAA with probe detection |
|
49545-7
|
JC virus DNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
33295-7
|
JC virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
32363-4
|
JC virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
34586-8
|
JC virus DNA [Presence] in Tissue by NAA with probe detection |
|
35661-8
|
JC virus DNA [Presence] in Urine by NAA with probe detection |
|
42921-7
|
JC virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
26642-9
|
Jamestown canyon virus Ab [Presence] in Serum |
|
74823-6
|
Jamestown canyon virus Ab [Presence] in Serum by Immunoassay |
|
31446-8
|
Jamestown canyon virus Ab [Units/volume] in Serum |
|
43006-6
|
Jamestown canyon virus Ab [Titer] in Serum |
|
40507-6
|
Jamestown canyon virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
40506-8
|
Jamestown canyon virus Ab [Titer] in Serum by Immunofluorescence |
|
29562-6
|
Jamestown canyon virus Ab [Titer] in Serum by Neutralization test |
|
41133-0
|
Jamestown canyon virus Ab [Presence] in Unspecified specimen |
|
30175-4
|
Jamestown canyon virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
29801-8
|
Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
29839-8
|
Jamestown canyon virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
29814-1
|
Jamestown canyon virus IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
29851-3
|
Jamestown canyon virus IgG Ab [Units/volume] in Serum |
|
43005-8
|
Jamestown canyon virus IgG Ab [Titer] in Serum |
|
29561-8
|
Jamestown canyon virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
43004-1
|
Jamestown canyon virus IgG Ab [Titer] in Unspecified specimen |
|
30174-7
|
Jamestown canyon virus IgG Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
29788-7
|
Jamestown canyon virus IgG Ab [Units/volume] in Unspecified specimen by Immunofluorescence |
|
29827-3
|
Jamestown canyon virus IgG Ab [Units/volume] in Unspecified specimen |
|
29799-4
|
Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
29838-0
|
Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid |
|
29800-0
|
Jamestown canyon virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
29837-2
|
Jamestown canyon virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
29812-5
|
Jamestown canyon virus IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
29850-5
|
Jamestown canyon virus IgM Ab [Presence] in Serum |
|
29813-3
|
Jamestown canyon virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
29849-7
|
Jamestown canyon virus IgM Ab [Units/volume] in Serum |
|
62946-9
|
Jamestown canyon virus IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
43003-3
|
Jamestown canyon virus IgM Ab [Titer] in Serum |
|
40508-4
|
Jamestown canyon virus IgM Ab [Titer] in Serum by Neutralization test |
|
29786-1
|
Jamestown canyon virus IgM Ab [Units/volume] in Unspecified specimen by Immunofluorescence |
|
29826-5
|
Jamestown canyon virus IgM Ab [Presence] in Unspecified specimen |
|
29787-9
|
Jamestown canyon virus IgM Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
29825-7
|
Jamestown canyon virus IgM Ab [Units/volume] in Unspecified specimen |
|
34452-3
|
Jamestown canyon virus RNA [Presence] in Blood by NAA with probe detection |
|
34453-1
|
Jamestown canyon virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
42515-7
|
Jamestown canyon virus RNA [Presence] in Urine by NAA with probe detection |
|
53874-4
|
Jamestown canyon virus RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
7531-7
|
Jerusalem oak IgE Ab [Units/volume] in Serum |
|
22369-3
|
Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid |
|
7933-5
|
Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
7935-0
|
Japanese encephalitis virus Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
22370-1
|
Japanese encephalitis virus Ab [Presence] in Serum |
|
23146-4
|
Japanese encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
7934-3
|
Japanese encephalitis virus Ab [Presence] in Serum by Immunoassay |
|
11608-7
|
Japanese encephalitis virus Ab [Units/volume] in Serum |
|
49912-9
|
Japanese encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
23147-2
|
Japanese encephalitis virus Ab [Titer] in Serum |
|
23145-6
|
Japanese encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
23144-9
|
Japanese encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
31866-7
|
Japanese encephalitis virus Ag [Presence] in Unspecified specimen |
|
23149-8
|
Japanese encephalitis virus Ag [Presence] in Unspecified specimen by Hemagglutination inhibition |
|
23148-0
|
Japanese encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
63563-1
|
Japanese encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
63562-3
|
Japanese encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
60532-9
|
Japanese encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
60531-1
|
Japanese encephalitis virus IgM Ab [Titer] in Serum |
|
7936-8
|
Japanese encephalitis virus RNA [Presence] in Serum by NAA with probe detection |
|
51666-6
|
Japanese encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80205-8
|
Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
80206-6
|
Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
92539-6
|
Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92501-6
|
Jk sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1072-8
|
Jk sup(a) Ag [Presence] on Red Blood Cells |
|
92538-8
|
Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92500-8
|
Jk sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1078-5
|
Jk sup(b) Ag [Presence] on Red Blood Cells |
|
65324-6
|
Jk3 Ab [Presence] in Serum or Plasma |
|
93909-0
|
Jk3 Ag [Presence] on Red Blood Cells |
|
92537-0
|
Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92499-3
|
Jo sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
7361-9
|
Johnson grass triggered histamine release [Units/volume] in Blood |
|
6152-3
|
Johnson grass IgE Ab [Units/volume] in Serum |
|
39091-4
|
Johnson grass IgE Ab/IgE total in Serum |
|
24138-0
|
Johnson grass IgG Ab [Units/volume] in Serum |
|
56294-2
|
Johnson grass IgG4 Ab [Mass/volume] in Serum |
|
63153-1
|
Johnson grass IgG Ab [Mass/volume] in Serum |
|
7705-7
|
Johnson grass smut IgE Ab [Units/volume] in Serum |
|
7706-5
|
Johnson grass smut IgG Ab [Units/volume] in Serum |
|
63179-6
|
Johnson grass smut IgG Ab [Mass/volume] in Serum |
|
58064-7
|
Jr sup(a) Ag [Presence] on Red Blood Cells |
|
92536-2
|
Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92498-5
|
Js sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1084-3
|
Js sup(a) Ag [Presence] on Red Blood Cells |
|
55597-9
|
Js sup(b) Ab [Titer] in Serum or Plasma |
|
92535-4
|
Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92497-7
|
Js sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1090-0
|
Js sup(b) Ag [Presence] on Red Blood Cells |
|
25703-0
|
Jujube IgE Ab [Units/volume] in Serum |
|
54920-4
|
Jumper ant IgE Ab [Units/volume] in Serum |
|
7433-6
|
Juniper triggered histamine release [Units/volume] in Blood |
|
7432-8
|
Juniper IgE Ab [Units/volume] in Serum |
|
22371-9
|
Junin virus Ab [Presence] in Serum |
|
7937-6
|
Junin virus Ab [Presence] in Serum by Immunoassay |
|
11607-9
|
Junin virus Ab [Units/volume] in Serum |
|
86801-8
|
Jurisdiction death information - recommended CDA R1 sections |
|
86806-7
|
Jurisdiction death registration Document |
|
7436-9
|
Jute IgE Ab [Units/volume] in Serum |
|
73920-1
|
JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood |
|
72459-1
|
JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method |
|
73949-0
|
JWH-018 (synthetic cannabinoid) [Presence] in Blood |
|
72808-9
|
JWH-018 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72809-7
|
JWH-018 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73923-5
|
JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72782-6
|
JWH-018 pentanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72461-7
|
JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
72783-4
|
JWH-018 pentanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
72780-0
|
JWH-018 pentanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72781-8
|
JWH-018 pentanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73914-4
|
JWH-018 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method |
|
73921-9
|
JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72460-9
|
JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73926-8
|
JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72464-1
|
JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73953-2
|
JWH-073 (synthetic cannabinoid) [Presence] in Blood |
|
73927-6
|
JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72778-4
|
JWH-073 butanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72465-8
|
JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
72779-2
|
JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
72875-8
|
JWH-073 butanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72874-1
|
JWH-073 butanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
72806-3
|
JWH-073 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72807-1
|
JWH-073 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73918-5
|
JWH-073 (synthetic cannabinoid) [Presence] in Urine by Confirmatory method |
|
77771-4
|
JWH-081 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
73956-5
|
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72474-0
|
JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73948-2
|
JWH-122 (synthetic cannabinoid) [Presence] in Blood |
|
73924-3
|
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78843-0
|
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72462-5
|
JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
78845-5
|
JWH-200 6-Hydroxyindole (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
73946-6
|
JWH-200 (synthetic cannabinoid) [Presence] in Blood |
|
78848-9
|
JWH-210 5-Hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72805-5
|
JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73917-7
|
JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73929-2
|
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72802-2
|
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72467-4
|
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
72803-0
|
JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
|
73928-4
|
JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72466-6
|
JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73950-8
|
JWH-250 (synthetic cannabinoid) [Presence] in Blood |
|
73954-0
|
JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72473-2
|
JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73947-4
|
JWH-398 (synthetic cannabinoid) [Presence] in Blood |
|
92975-2
|
Klebsiella aerogenes DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
92974-5
|
Klebsiella aerogenes DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
93934-8
|
K Ag [Presence] on Red Blood Cells --during infancy |
|
92534-7
|
K Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92496-9
|
K Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93924-9
|
K Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93917-3
|
K Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
1096-7
|
K Ag [Presence] on Red Blood Cells |
|
93942-1
|
K Ag [Presence] in Cord red blood cells |
|
32158-8
|
Klebsiella granulomatis [Presence] in Genital specimen by Light microscopy |
|
6595-3
|
Klebsiella granulomatis [Presence] in Isolate by Organism specific culture |
|
91059-6
|
Kingella kingae DNA [Presence] in Blood by NAA with probe detection |
|
91058-8
|
Kingella kingae DNA [Presence] in Synovial fluid by NAA with probe detection |
|
65809-6
|
Kingella kingae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48291-9
|
Potassium metabisulfite triggered leukotriene release [Mass/volume] by Leukocytes |
|
92973-7
|
Klebsiella oxytoca DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85774-8
|
Klebsiella oxytoca DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
70019-5
|
Klebsiella oxytoca DNA [Presence] in Blood by NAA with probe detection |
|
92972-9
|
Klebsiella oxytoca DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
88263-9
|
Klebsiella oxytoca ompA gene [Presence] by Probe in Positive blood culture |
|
92971-1
|
Klebsiella pneumoniae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85761-5
|
Klebsiella pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92970-3
|
Klebsiella pneumoniae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61399-2
|
Klebsiella pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88264-7
|
Klebsiella pneumoniae yggE gene [Presence] by Probe in Positive blood culture |
|
61361-2
|
Klebsiella aerogenes DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
4657-3
|
Kallikrein [Enzymatic activity/volume] in Plasma |
|
4658-1
|
Kallikrein Tissue type [Units/volume] in Plasma |
|
24153-9
|
Kamut flour IgG Ab [Units/volume] in Serum |
|
89482-4
|
Kanamycin [Susceptibility] by Genotype method |
|
3698-8
|
Kanamycin [Mass/volume] in Serum or Plasma --peak |
|
3699-6
|
Kanamycin [Mass/volume] in Serum or Plasma --random |
|
47395-9
|
Kanamycin [Mass/volume] in Serum or Plasma |
|
3700-2
|
Kanamycin [Mass/volume] in Serum or Plasma --trough |
|
23889-9
|
Kanamycin [Mass/volume] in Unspecified specimen |
|
86923-0
|
Kansas City Cardiomyopathy Questionnaire - 12 item [KCCQ-12] |
|
7438-5
|
Kapok triggered histamine release [Units/volume] in Blood |
|
7437-7
|
Kapok IgE Ab [Units/volume] in Serum |
|
10497-6
|
Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
|
44394-5
|
Kappa light chains [Presence] in 24 hour Urine |
|
88304-1
|
Kappa light chains [Presence] in 24 hour Urine by Immunofixation |
|
15188-6
|
Kappa light chains [Mass/volume] in 24 hour Urine |
|
25682-6
|
Kappa light chains [Mass/time] in 24 hour Urine |
|
10496-8
|
Kappa light chains Ag [Presence] in Tissue by Immune stain |
|
48771-0
|
Kappa light chains [Mass/volume] in Cerebral spinal fluid |
|
88301-7
|
Kappa light chains.free [Presence] in 24 hour Urine by Immunofixation |
|
43940-6
|
Kappa light chains.free [Mass/volume] in 24 hour Urine |
|
38177-2
|
Kappa light chains.free [Mass/time] in 24 hour Urine |
|
48774-4
|
Kappa light chains.free [Mass/volume] in Cerebral spinal fluid |
|
80515-0
|
Kappa light chains.free [Mass/volume] in Serum by Nephelometry |
|
36916-5
|
Kappa light chains.free [Mass/volume] in Serum |
|
12777-9
|
Kappa light chains.free [Units/volume] in Urine |
|
38176-4
|
Kappa light chains.free [Mass/volume] in Urine |
|
49553-1
|
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in 24 hour Urine |
|
48378-4
|
Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum |
|
21748-9
|
Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
6785-0
|
Kappa light chains [Presence] in Serum by Electrophoresis |
|
6787-6
|
Kappa light chains [Presence] in Serum by Immunoassay |
|
25681-8
|
Kappa light chains [Presence] in Serum by Immunoelectrophoresis |
|
11050-2
|
Kappa light chains [Mass/volume] in Serum or Plasma |
|
27365-6
|
Kappa light chains [Mass/volume] in Urine |
|
7439-3
|
Karaya gum IgE Ab [Units/volume] in Serum |
|
56295-9
|
Karaya gum IgG4 Ab [Mass/volume] in Serum |
|
63146-5
|
Karaya gum IgG Ab [Mass/volume] in Serum |
|
77111-3
|
KARS gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77110-5
|
KARS gene full mutation analysis in Blood or Tissue by Sequencing |
|
33773-3
|
Karyotype [Identifier] in Amniotic fluid Nominal |
|
64094-6
|
Karyotype [Identifier] in Amniotic fluid Narrative |
|
29770-5
|
Karyotype [Identifier] in Blood or Tissue Nominal |
|
50619-6
|
Karyotype [Identifier] in Blood or Tissue Narrative |
|
48818-9
|
Karyotype [Identifier] in Blood or Tissue by High resolution Nominal |
|
48820-5
|
Karyotype [Identifier] in Cord blood Nominal |
|
33774-1
|
Karyotype [Identifier] in Chorionic villus sample Nominal |
|
64088-8
|
Karyotype [Identifier] in Chorionic villus sample Narrative |
|
33893-9
|
Karyotype [Identifier] in Bone marrow Nominal |
|
81861-7
|
Karyotype in Bone marrow |
|
81862-5
|
Karyotype in Blood or Tissue --post mitogen stimulation |
|
77164-2
|
Karyotype [Identifier] in Products of Conception Nominal |
|
48819-7
|
Karyotype [Identifier] in Tissue from Fetus Nominal |
|
38471-9
|
Karyotype [Identifier] in Urine Nominal |
|
35129-6
|
Karyotype [Identifier] in Unspecified specimen Nominal |
|
53726-6
|
KCNC3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81863-3
|
KCNH2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
75400-2
|
KCNJ11 gene full mutation analysis in Blood or Tissue by Sequencing |
|
81864-1
|
KCNQ1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
43746-7
|
KCNQ1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
44608-8
|
KCNQ1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
48580-5
|
KCNQ1OT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49707-3
|
KCNQ2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48054-1
|
Kaolin activated time [Units/volume] in Blood |
|
13053-4
|
Kaolin activated time [Units/volume] in Platelet poor plasma |
|
34656-9
|
KEL gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
|
41096-9
|
KEL gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
13310-8
|
Kell group Ag [Type] on Red Blood Cells |
|
33004-3
|
Kelp or Seaweed IgE Ab [Units/volume] in Serum |
|
7358-5
|
Kentucky blue grass triggered histamine release [Units/volume] in Blood |
|
6153-1
|
Kentucky blue grass IgE Ab [Units/volume] in Serum |
|
61303-4
|
Kentucky blue grass IgE Ab/IgE total in Serum |
|
24148-9
|
Kentucky blue grass IgG Ab [Units/volume] in Serum |
|
56296-7
|
Kentucky blue grass IgG4 Ab [Mass/volume] in Serum |
|
49719-8
|
Kentucky blue grass IgG Ab [Mass/volume] in Serum |
|
48259-6
|
Kentucky blue grass triggered leukotriene release [Mass/volume] by Leukocytes |
|
2511-4
|
Keratan sulfate [Mass/volume] in Blood |
|
90236-1
|
Keratan sulfate [Moles/volume] in DBS |
|
93724-3
|
Keratan sulfate [Mass/volume] in Serum or Plasma |
|
24463-2
|
Keratan sulfate [Presence] in Urine |
|
2512-2
|
Keratan sulfate [Mass/volume] in Urine |
|
92806-9
|
Keratan sulfate/Creatinine [Ratio] in Urine |
|
63268-7
|
Keratin Ab [Presence] in Serum by Immunofluorescence |
|
34409-3
|
Keratin Ab [Titer] in Serum by Immunofluorescence |
|
10498-4
|
Keratin Ag [Presence] in Tissue by Immune stain |
|
61081-6
|
Ketamine [Presence] in Gastric fluid |
|
42922-5
|
Ketamine [Presence] in Serum or Plasma |
|
3701-0
|
Ketamine [Mass/volume] in Serum or Plasma |
|
20537-7
|
Ketamine [Mass/volume] in Urine by Confirmatory method |
|
12327-3
|
Ketamine [Presence] in Urine |
|
17033-2
|
Ketamine [Presence] in Urine by Confirmatory method |
|
19499-3
|
Ketamine [Mass/volume] in Urine by Screen method |
|
11052-8
|
Ketamine [Mass/volume] in Urine |
|
61043-6
|
Ketamine [Presence] in Unspecified specimen |
|
72801-4
|
Ketamine/Creatinine [Mass Ratio] in Urine |
|
3702-8
|
Ketobemidone [Presence] in Urine |
|
3703-6
|
Ketobemidone [Mass/volume] in Urine |
|
60091-6
|
Ketoconazole [Mass/volume] in Blood |
|
10990-0
|
Ketoconazole [Mass/volume] in Serum or Plasma |
|
60092-4
|
Ketoconazole [Mass/volume] in Urine |
|
25259-3
|
Ketoconazole [Mass/volume] in Unspecified specimen |
|
18235-2
|
Ketone solvents [Identifier] in Blood |
|
33043-1
|
Ketones [Presence] in 24 hour Urine |
|
68955-4
|
Ketones [Presence] in Blood by Tablet |
|
53061-8
|
Ketones [Moles/volume] in Blood |
|
12448-7
|
Ketones [Mass/volume] in Urine by Test strip --fasting |
|
2513-0
|
Ketones [Presence] in Serum or Plasma |
|
32547-2
|
Ketones [Moles/volume] in Serum or Plasma by Test strip |
|
33058-9
|
Ketones [Mass/volume] in Serum or Plasma |
|
38493-3
|
Ketones [Titer] in Serum or Plasma |
|
33903-6
|
Ketones [Presence] in Urine |
|
2514-8
|
Ketones [Presence] in Urine by Test strip |
|
5797-6
|
Ketones [Mass/volume] in Urine by Test strip |
|
22702-5
|
Ketones [Moles/volume] in Urine by Test strip |
|
49779-2
|
Ketones [Mass/volume] in Urine |
|
40641-3
|
Ketones [Presence] in Vitreous fluid |
|
32323-8
|
Ketones [Moles/volume] in Unspecified specimen |
|
60093-2
|
Ketoprofen [Mass/volume] in Blood |
|
59918-3
|
Ketoprofen [Moles/volume] in Gastric fluid |
|
17034-0
|
Ketoprofen [Mass/volume] in Serum or Plasma |
|
55546-6
|
Ketoprofen [Moles/volume] in Serum or Plasma |
|
60094-0
|
Ketoprofen [Mass/volume] in Urine |
|
59917-5
|
Ketoprofen [Moles/volume] in Urine |
|
60311-8
|
Ketoprofen [Moles/volume] in Unspecified specimen |
|
87783-7
|
Ketoprofen/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73321-2
|
Ketorolac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73320-4
|
Ketorolac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17035-7
|
Ketorolac [Mass/volume] in Serum or Plasma |
|
54160-7
|
Ki Ab [Presence] in Serum |
|
33055-5
|
Ki-67 nuclear Ag [Presence] in Tissue by Immune stain |
|
29593-1
|
Cells.Ki-67 nuclear Ag/100 cells in Tissue by Immune stain |
|
53898-3
|
KIAA0196 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85626-0
|
Kidney failure 2-year and 5-year risk panel by KFRE |
|
85624-5
|
Kidney failure 2-year risk [Likelihood] by KFRE |
|
85625-2
|
Kidney failure 5-year risk [Likelihood] by KFRE |
|
65757-7
|
Kidney Pathology biopsy report |
|
92932-3
|
KIF6 gene.c.2155T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
34783-1
|
Kinesiotherapy Consult note |
|
84179-1
|
Kinesiotherapy Discharge summary |
|
84180-9
|
Kinesiotherapy Education note |
|
84182-5
|
Kinesiotherapy Initial evaluation note |
|
84183-3
|
Kinesiotherapy Long term care facility Plan of care note |
|
34784-9
|
Kinesiotherapy Note |
|
84184-1
|
Kinesiotherapy Outpatient Note |
|
84185-8
|
Kinesiotherapy Plan of care note |
|
84181-7
|
Kinesiotherapy Patient's home Note |
|
57142-2
|
Kinesiotherapy Referral note |
|
14842-9
|
Microscopic observation [Identifier] in Unspecified specimen by Kinyoun iron hematoxylin stain |
|
64418-7
|
KIR genotyping panel - Blood or Tissue |
|
88519-4
|
KIT gene c.2447A>T [Presence] in Blood or Tissue by Molecular genetics method |
|
77171-7
|
KIT gene exon 11 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
87732-4
|
KIT gene exon 13 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87731-6
|
KIT gene exon 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87733-2
|
KIT gene exon 8 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77172-5
|
KIT gene exon 9 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
55201-8
|
KIT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
65795-7
|
Kiwi native (nAct d) 1 IgE Ab [Units/volume] in Serum |
|
65796-5
|
Kiwi native (nAct d) 2 IgE Ab [Units/volume] in Serum |
|
65764-3
|
Kiwi native (nAct d) 5 IgE Ab [Units/volume] in Serum |
|
64959-0
|
Kiwi recombinant (rAct d) 8 IgE Ab [Units/volume] in Serum |
|
7441-9
|
Kiwifruit triggered histamine release [Units/volume] in Blood |
|
6154-9
|
Kiwifruit IgE Ab [Units/volume] in Serum |
|
45186-4
|
Kiwifruit IgE Ab/IgE total in Serum |
|
7440-1
|
Kiwifruit IgG Ab [Units/volume] in Serum |
|
56298-3
|
Kiwifruit IgG4 Ab [Mass/volume] in Serum |
|
63093-9
|
Kiwifruit IgG Ab [Mass/volume] in Serum |
|
93369-7
|
Krebs von den Lungen-6 [Units/volume] in Serum or Plasma by Immunoassay |
|
73979-7
|
Keyhole limpet hemocyanin Ab panel - Serum or Plasma |
|
73745-2
|
Keyhole limpet hemocyanin IgA Ab [Mass/volume] in Serum |
|
73746-0
|
Keyhole limpet hemocyanin IgG Ab [Mass/volume] in Serum |
|
73747-8
|
Keyhole limpet hemocyanin IgM Ab [Mass/volume] in Serum |
|
21700-0
|
Kallmann syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
58069-6
|
Kn sup (b) Ag [Presence] on Red Blood Cells |
|
58066-2
|
Kn sup(a) Ag [Presence] on Red Blood Cells |
|
82324-5
|
Knee injury and osteoarthritis outcome score for joint replacement [KOOSJR] |
|
41345-0
|
Knee - left Extension Active Range of Motion Quantitative |
|
41346-8
|
Knee - left Extension Passive Range of Motion Quantitative |
|
41343-5
|
Knee - left Flexion Active Range of Motion Quantitative |
|
41344-3
|
Knee - left Flexion Passive Range of Motion Quantitative |
|
41349-2
|
Knee - right Extension Active Range of Motion Quantitative |
|
41350-0
|
Knee - right Extension Passive Range of Motion Quantitative |
|
41347-6
|
Knee - right Flexion Active Range of Motion Quantitative |
|
41348-4
|
Knee - right Flexion Passive Range of Motion Quantitative |
|
7362-7
|
Koehlers grass IgE Ab [Units/volume] in Serum |
|
73694-2
|
Microscopic observation [Identifier] in Blood by KOH preparation |
|
639-5
|
Microscopic observation [Identifier] in Cerebral spinal fluid by KOH preparation |
|
14355-2
|
Microscopic observation [Identifier] in Cervix by KOH preparation |
|
68383-9
|
Microscopic observation [Identifier] in Body fluid by KOH preparation |
|
10688-0
|
Microscopic observation [Identifier] in Hair by KOH preparation |
|
88685-3
|
Microscopic observation [Identifier] in Lower respiratory specimen by KOH preparation |
|
10689-8
|
Microscopic observation [Identifier] in Nail by KOH preparation |
|
644-5
|
Microscopic observation [Identifier] in Skin by KOH preparation |
|
17281-7
|
Microscopic observation [Identifier] in Sputum by KOH preparation |
|
6667-0
|
Microscopic observation [Identifier] in Tissue by KOH preparation |
|
68958-8
|
Microscopic observation [Identifier] in Urine by KOH preparation |
|
14356-0
|
Microscopic observation [Identifier] in Vaginal fluid by KOH preparation |
|
667-6
|
Microscopic observation [Identifier] in Unspecified specimen by KOH preparation |
|
92533-9
|
Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92495-1
|
Kp sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1102-3
|
Kp sup(a) Ag [Presence] on Red Blood Cells |
|
92532-1
|
Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92494-4
|
Kp sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1108-0
|
Kp sup(b) Ag [Presence] on Red Blood Cells |
|
89245-5
|
Karnofsky Performance Status [Interpretation] |
|
89244-8
|
Karnofsky Performance Status panel |
|
89243-0
|
Karnofsky Performance Status score |
|
62307-4
|
Krabbe disease newborn screening panel |
|
81420-2
|
KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82535-6
|
KRAS gene full mutation analysis in Blood or Tissue by Sequencing |
|
21702-6
|
KRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75974-6
|
KRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53620-1
|
KRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
|
83059-6
|
KRAS gene [VCF] in Cancer specimen by Sequencing |
|
82421-9
|
Ks Ab [Units/volume] in Serum by Line blot |
|
82422-7
|
Ks Ab [Presence] in Serum by Line blot |
|
63269-5
|
Ku Ab [Presence] in Body fluid by Immunoassay |
|
18484-6
|
Ku Ab [Presence] in Serum |
|
69556-9
|
Ku Ab [Presence] in Serum by Immunoblot |
|
65325-3
|
Ku Ab [Presence] in Serum or Plasma |
|
82919-2
|
Ku IgG Ab [Presence] in Serum by Line blot |
|
53489-1
|
Kynurenate [Moles/time] in 24 hour Urine |
|
53469-3
|
Kynurenate [Moles/volume] in Serum or Plasma |
|
2515-5
|
Kynurenate [Mass/volume] in Urine |
|
53101-2
|
Kynurenate [Moles/volume] in Urine |
|
53107-9
|
Kynurenate/Creatinine [Molar ratio] in Urine |
|
53491-7
|
Kynurenin [Moles/time] in 24 hour Urine |
|
74942-4
|
Kynurenin [Moles/volume] in Cerebral spinal fluid |
|
53470-1
|
Kynurenin [Moles/volume] in Serum or Plasma |
|
53490-9
|
Kynurenin [Moles/volume] in Urine |
|
53507-0
|
Kynurenin/Creatinine [Molar ratio] in Urine |
|
20866-0
|
Lactobacillus acidophilus colony count [#/volume] in Milk by Organism specific culture |
|
81098-6
|
Leptospira borgpetersenii sv Arborea Ab [Titer] in Serum by Agglutination |
|
86730-9
|
Leptospira borgpetersenii sv Hardjo-bovis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
23167-0
|
Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum |
|
23168-8
|
Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum by Agglutination |
|
42996-9
|
Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum |
|
40643-9
|
Leptospira borgpetersenii sv Ballum Ab [Titer] in Serum by Agglutination |
|
23193-6
|
Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum |
|
23194-4
|
Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum by Agglutination |
|
31476-5
|
Leptospira borgpetersenii sv Sejroe Ab [Units/volume] in Serum |
|
25866-5
|
Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum |
|
40644-7
|
Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Agglutination |
|
25940-8
|
Leptospira borgpetersenii sv Sejroe Ab [Titer] in Serum by Complement fixation |
|
23208-2
|
Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum |
|
23209-0
|
Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum by Agglutination |
|
42995-1
|
Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum |
|
40645-4
|
Leptospira borgpetersenii sv Tarrasovi Ab [Titer] in Serum by Agglutination |
|
26633-8
|
Legionella bozemaniae Ab [Presence] in Serum |
|
26637-9
|
Leishmania brasilensis Ab [Presence] in Serum |
|
43000-9
|
Leishmania brasilensis Ab [Titer] in Serum |
|
41419-3
|
Leishmania brasilensis Ab [Titer] in Serum by Immunofluorescence |
|
35404-3
|
Leishmania brasilensis IgG Ab [Presence] in Serum |
|
13258-9
|
Leishmania brasilensis IgG Ab [Units/volume] in Serum |
|
15380-9
|
Leishmania brasilensis IgG Ab [Titer] in Serum |
|
44821-7
|
Leishmania brasilensis IgG Ab [Titer] in Serum by Immunofluorescence |
|
35405-0
|
Leishmania brasilensis IgM Ab [Presence] in Serum |
|
13259-7
|
Leishmania brasilensis IgM Ab [Units/volume] in Serum |
|
15381-7
|
Leishmania brasilensis IgM Ab [Titer] in Serum |
|
44820-9
|
Leishmania brasilensis IgM Ab [Titer] in Serum by Immunofluorescence |
|
43266-6
|
Leishmania chagasi K39 Ab [Presence] in Serum |
|
64981-4
|
Lepidoglyphus destructor recombinant (rLep d) 2 IgE Ab [Units/volume] in Serum |
|
6160-6
|
Lepidoglyphus destructor IgE Ab [Units/volume] in Serum |
|
57993-8
|
Lepidoglyphus destructor IgE Ab/IgE total in Serum |
|
56300-7
|
Lepidoglyphus destructor IgG4 Ab [Mass/volume] in Serum |
|
48233-1
|
Lepidoglyphus destructor triggered leukotriene release [Mass/volume] by Leukocytes |
|
26638-7
|
Leishmania donovani Ab [Presence] in Serum |
|
31475-7
|
Leishmania donovani Ab [Units/volume] in Serum |
|
25633-9
|
Leishmania donovani Ab [Titer] in Serum |
|
25708-9
|
Leishmania donovani Ab [Titer] in Serum by Immunofluorescence |
|
23150-6
|
Leishmania donovani Ag [Presence] in Tissue by Immune stain |
|
35402-7
|
Leishmania donovani IgG Ab [Presence] in Serum |
|
13256-3
|
Leishmania donovani IgG Ab [Units/volume] in Serum |
|
15382-5
|
Leishmania donovani IgG Ab [Titer] in Serum |
|
44824-1
|
Leishmania donovani IgG Ab [Titer] in Serum by Immunofluorescence |
|
35403-5
|
Leishmania donovani IgM Ab [Presence] in Serum |
|
13257-1
|
Leishmania donovani IgM Ab [Units/volume] in Serum |
|
15383-3
|
Leishmania donovani IgM Ab [Titer] in Serum |
|
44819-1
|
Leishmania donovani IgM Ab [Titer] in Serum by Immunofluorescence |
|
26632-0
|
Legionella dumoffii Ab [Presence] in Serum |
|
26634-6
|
Legionella gormanii Ab [Presence] in Serum |
|
80208-2
|
Leishmania infantum+donovani IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
80207-4
|
Leishmania infantum+donovani IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
7960-8
|
Leptospira interrogans Ab [Units/volume] in Serum by Hemagglutination |
|
23187-8
|
Leptospira interrogans Ab [Presence] in Serum |
|
23188-6
|
Leptospira interrogans Ab [Presence] in Serum by Agglutination |
|
23186-0
|
Leptospira interrogans Ab [Presence] in Serum by Immunoassay |
|
11606-1
|
Leptospira interrogans Ab [Units/volume] in Serum |
|
56952-5
|
Leptospira interrogans Ab [Titer] in Serum by Agglutination |
|
6605-0
|
Leptospira interrogans Ag [Presence] in Tissue by Immunofluorescence |
|
31871-7
|
Leptospira interrogans Ag [Presence] in Unspecified specimen |
|
6452-7
|
Leptospira interrogans Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23164-7
|
Leptospira interrogans sv Australis Ab [Presence] in Serum |
|
23163-9
|
Leptospira interrogans sv Australis Ab [Presence] in Serum by Agglutination |
|
59370-7
|
Leptospira interrogans sv Australis Ab [Titer] in Serum by Agglutination |
|
23166-2
|
Leptospira interrogans sv Autumnalis Ab [Presence] in Serum |
|
23165-4
|
Leptospira interrogans sv Autumnalis Ab [Presence] in Serum by Agglutination |
|
59371-5
|
Leptospira interrogans sv Autumnalis Ab [Titer] in Serum by Agglutination |
|
59372-3
|
Leptospira interrogans sv Ballum Ab [Titer] in Serum by Agglutination |
|
23170-4
|
Leptospira interrogans sv Bataviae Ab [Presence] in Serum |
|
23169-6
|
Leptospira interrogans sv Bataviae Ab [Presence] in Serum by Agglutination |
|
59368-1
|
Leptospira interrogans sv Bataviae Ab [Titer] in Serum by Agglutination |
|
23172-0
|
Leptospira interrogans sv Bratislava Ab [Presence] in Serum |
|
23171-2
|
Leptospira interrogans sv Bratislava Ab [Presence] in Serum by Agglutination |
|
31477-3
|
Leptospira interrogans sv Bratislava Ab [Units/volume] in Serum |
|
22400-6
|
Leptospira interrogans sv Bratislava Ab [Titer] in Serum |
|
15476-5
|
Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination |
|
29695-4
|
Leptospira interrogans sv Bulgarica Ab [Presence] in Serum |
|
29725-9
|
Leptospira interrogans sv Bulgarica Ab [Presence] in Serum by Agglutination |
|
81099-4
|
Leptospira interrogans sv Bulgarica Ab [Titer] in Serum by Agglutination |
|
23173-8
|
Leptospira interrogans sv Canicola Ab [Presence] in Serum |
|
23174-6
|
Leptospira interrogans sv Canicola Ab [Presence] in Serum by Agglutination |
|
31478-1
|
Leptospira interrogans sv Canicola Ab [Units/volume] in Serum |
|
22401-4
|
Leptospira interrogans sv Canicola Ab [Titer] in Serum |
|
15477-3
|
Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination |
|
25709-7
|
Leptospira interrogans sv Canicola Ab [Titer] in Serum by Complement fixation |
|
29694-7
|
Leptospira interrogans sv Celledoni Ab [Presence] in Serum |
|
29724-2
|
Leptospira interrogans sv Celledoni Ab [Presence] in Serum by Agglutination |
|
81100-0
|
Leptospira interrogans sv Celledoni Ab [Titer] in Serum by Agglutination |
|
23175-3
|
Leptospira interrogans sv Copenhageni Ab [Presence] in Serum |
|
23176-1
|
Leptospira interrogans sv Copenhageni Ab [Presence] in Serum by Agglutination |
|
81101-8
|
Leptospira interrogans sv Copenhageni Ab [Titer] in Serum by Agglutination |
|
29696-2
|
Leptospira interrogans sv Cynopteri Ab [Presence] in Serum |
|
29726-7
|
Leptospira interrogans sv Cynopteri Ab [Presence] in Serum by Agglutination |
|
81102-6
|
Leptospira interrogans sv Cynopteri Ab [Titer] in Serum by Agglutination |
|
29697-0
|
Leptospira interrogans sv Djasiman Ab [Presence] in Serum |
|
29727-5
|
Leptospira interrogans sv Djasiman Ab [Presence] in Serum by Agglutination |
|
23177-9
|
Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum |
|
23178-7
|
Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum by Agglutination |
|
31479-9
|
Leptospira interrogans sv Grippotyphosa Ab [Units/volume] in Serum |
|
22402-2
|
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum |
|
15478-1
|
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination |
|
25710-5
|
Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Complement fixation |
|
23181-1
|
Leptospira interrogans sv Hardjo Ab [Presence] in Serum |
|
23180-3
|
Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Agglutination |
|
23179-5
|
Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Immunoassay |
|
31480-7
|
Leptospira interrogans sv Hardjo Ab [Units/volume] in Serum |
|
22403-0
|
Leptospira interrogans sv Hardjo Ab [Titer] in Serum |
|
15479-9
|
Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination |
|
23183-7
|
Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum |
|
23182-9
|
Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum by Agglutination |
|
59369-9
|
Leptospira interrogans sv Hebdomadis Ab [Titer] in Serum by Agglutination |
|
23185-2
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum |
|
23184-5
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum by Agglutination |
|
31481-5
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Units/volume] in Serum |
|
22404-8
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum |
|
15480-7
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination |
|
25711-3
|
Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Complement fixation |
|
46196-2
|
Leptospira interrogans IgG Ab [Titer] in Serum |
|
45330-8
|
Leptospira interrogans IgG Ab [Titer] in Serum by Immunofluorescence |
|
56953-3
|
Leptospira interrogans IgM Ab [Presence] in Serum by Immunoassay |
|
29698-8
|
Leptospira interrogans sv Javanica Ab [Presence] in Serum |
|
29728-3
|
Leptospira interrogans sv Javanica Ab [Presence] in Serum by Agglutination |
|
59422-6
|
Leptospira interrogans sv Javanica Ab [Titer] in Serum by Agglutination |
|
29739-0
|
Leptospira interrogans sv Kremastos Ab [Presence] in Serum |
|
29733-3
|
Leptospira interrogans sv Kremastos Ab [Presence] in Serum by Agglutination |
|
81103-4
|
Leptospira interrogans sv Kremastos Ab [Titer] in Serum by Agglutination |
|
59363-2
|
Leptospira interrogans sv Manhao Ab [Titer] in Serum by Agglutination |
|
29741-6
|
Leptospira interrogans sv Medanensis Ab [Presence] in Serum |
|
29735-8
|
Leptospira interrogans sv Medanensis Ab [Presence] in Serum by Agglutination |
|
81104-2
|
Leptospira interrogans sv Medanensis Ab [Titer] in Serum by Agglutination |
|
59365-7
|
Leptospira interrogans sv Mini Ab [Titer] in Serum by Agglutination |
|
23189-4
|
Leptospira interrogans sv Mitis Ab [Presence] in Serum |
|
23190-2
|
Leptospira interrogans sv Mitis Ab [Presence] in Serum by Agglutination |
|
29699-6
|
Leptospira interrogans sv Panama Ab [Presence] in Serum |
|
29729-1
|
Leptospira interrogans sv Panama Ab [Presence] in Serum by Agglutination |
|
81105-9
|
Leptospira interrogans sv Panama Ab [Titer] in Serum by Agglutination |
|
23191-0
|
Leptospira interrogans sv Pomona Ab [Presence] in Serum |
|
23192-8
|
Leptospira interrogans sv Pomona Ab [Presence] in Serum by Agglutination |
|
31482-3
|
Leptospira interrogans sv Pomona Ab [Units/volume] in Serum |
|
22405-5
|
Leptospira interrogans sv Pomona Ab [Titer] in Serum |
|
15481-5
|
Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination |
|
25712-1
|
Leptospira interrogans sv Pomona Ab [Titer] in Serum by Complement fixation |
|
59364-0
|
Leptospira interrogans sv Pyrogenes Ab [Titer] in Serum by Agglutination |
|
29738-2
|
Leptospira interrogans sv Robinsoni Ab [Presence] in Serum |
|
29732-5
|
Leptospira interrogans sv Robinsoni Ab [Presence] in Serum by Agglutination |
|
81106-7
|
Leptospira interrogans sv Robinsoni Ab [Titer] in Serum by Agglutination |
|
59366-5
|
Leptospira interrogans sv Sejroe Ab [Titer] in Serum by Agglutination |
|
29700-2
|
Leptospira interrogans sv Shermani Ab [Presence] in Serum |
|
29730-9
|
Leptospira interrogans sv Shermani Ab [Presence] in Serum by Agglutination |
|
81107-5
|
Leptospira interrogans sv Shermani Ab [Titer] in Serum by Agglutination |
|
29740-8
|
Leptospira interrogans sv Szwajizak Ab [Presence] in Serum |
|
29734-1
|
Leptospira interrogans sv Szwajizak Ab [Presence] in Serum by Agglutination |
|
81108-3
|
Leptospira interrogans sv Szwajizak Ab [Titer] in Serum by Agglutination |
|
59367-3
|
Leptospira interrogans sv Tarassovi Ab [Titer] in Serum by Agglutination |
|
29701-0
|
Leptospira interrogans sv Zanoni Ab [Presence] in Serum |
|
29731-7
|
Leptospira interrogans sv Zanoni Ab [Presence] in Serum by Agglutination |
|
81109-1
|
Leptospira interrogans sv Zanoni Ab [Titer] in Serum by Agglutination |
|
87369-5
|
Lawsonia intracellularis VNTR pattern [Type] in Unspecified specimen by Molecular genetics method |
|
53584-9
|
Loa loa DNA [Presence] in Blood by NAA with probe detection |
|
81690-0
|
Legionella longbeachae 1 and 2 DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
26674-2
|
Legionella longbeachae 1 Ab [Presence] in Serum |
|
17053-0
|
Legionella longbeachae 1 IgG Ab [Presence] in Serum |
|
17054-8
|
Legionella longbeachae 1 IgM Ab [Presence] in Serum |
|
13255-5
|
Legionella longbeachae 1+2 Ab [Presence] in Serum |
|
32694-2
|
Legionella longbeachae 1+2 Ab [Titer] in Serum |
|
26675-9
|
Legionella longbeachae 2 Ab [Presence] in Serum |
|
17055-5
|
Legionella longbeachae 2 IgG Ab [Presence] in Serum |
|
17056-3
|
Legionella longbeachae 2 IgM Ab [Presence] in Serum |
|
48718-1
|
Leishmania mexicana IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
35406-8
|
Leishmania mexicana IgG Ab [Presence] in Serum |
|
13260-5
|
Leishmania mexicana IgG Ab [Units/volume] in Serum |
|
15384-1
|
Leishmania mexicana IgG Ab [Titer] in Serum |
|
48314-9
|
Leishmania mexicana IgG Ab [Titer] in Serum by Immunofluorescence |
|
48717-3
|
Leishmania mexicana IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
35407-6
|
Leishmania mexicana IgM Ab [Presence] in Serum |
|
13261-3
|
Leishmania mexicana IgM Ab [Units/volume] in Serum |
|
15385-8
|
Leishmania mexicana IgM Ab [Titer] in Serum |
|
48315-6
|
Leishmania mexicana IgM Ab [Titer] in Serum by Immunofluorescence |
|
26635-3
|
Legionella micdadei Ab [Presence] in Serum |
|
67563-7
|
Legionella micdadei DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5240-7
|
Listeria monocytogenes Ab [Units/volume] in Serum |
|
22406-3
|
Listeria monocytogenes Ab [Titer] in Serum |
|
6456-8
|
Listeria monocytogenes Ab [Titer] in Serum by Complement fixation |
|
85763-1
|
Listeria monocytogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
89596-1
|
Listeria monocytogenes DNA [Presence] in Blood by NAA with probe detection |
|
82184-3
|
Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
61369-5
|
Listeria monocytogenes DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
51820-9
|
Listeria monocytogenes IgG Ab [Units/volume] in Serum by Immunoassay |
|
26698-1
|
Listeria monocytogenes IgG Ab [Units/volume] in Serum |
|
68944-8
|
Listeria monocytogenes IgG Ab [Titer] in Serum by Agglutination |
|
5021-1
|
Listeria monocytogenes rRNA [Presence] in Unspecified specimen by Probe |
|
41167-8
|
Listeria monocytogenes H Ab [Titer] in Serum |
|
41029-0
|
Listeria monocytogenes H1 Ab [Titer] in Serum |
|
41028-2
|
Listeria monocytogenes O1 Ab [Titer] in Serum |
|
41030-8
|
Listeria monocytogenes O4b Ab [Titer] in Serum |
|
45138-5
|
Listeria monocytogenes O4b IgG Ab [Titer] in Serum |
|
45139-3
|
Listeria monocytogenes O4b IgM Ab [Titer] in Serum |
|
43853-1
|
Legionella pneumophila 1+3+4+5+6+8 IgM Ab [Presence] in Serum |
|
47459-3
|
Legionella pneumophila 10 IgG Ab [Titer] in Serum |
|
47082-3
|
Legionella pneumophila 10 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47460-1
|
Legionella pneumophila 10 IgM Ab [Titer] in Serum |
|
47054-2
|
Legionella pneumophila 10 IgM Ab [Titer] in Serum by Immunofluorescence |
|
47461-9
|
Legionella pneumophila 11 IgG Ab [Titer] in Serum |
|
47055-9
|
Legionella pneumophila 11 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47462-7
|
Legionella pneumophila 11 IgM Ab [Titer] in Serum |
|
47056-7
|
Legionella pneumophila 11 IgM Ab [Titer] in Serum by Immunofluorescence |
|
47463-5
|
Legionella pneumophila 12 IgG Ab [Titer] in Serum |
|
47057-5
|
Legionella pneumophila 12 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47464-3
|
Legionella pneumophila 12 IgM Ab [Titer] in Serum |
|
47058-3
|
Legionella pneumophila 12 IgM Ab [Titer] in Serum by Immunofluorescence |
|
47465-0
|
Legionella pneumophila 13 IgG Ab [Titer] in Serum |
|
47059-1
|
Legionella pneumophila 13 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47466-8
|
Legionella pneumophila 13 IgM Ab [Titer] in Serum |
|
47060-9
|
Legionella pneumophila 13 IgM Ab [Titer] in Serum by Immunofluorescence |
|
47467-6
|
Legionella pneumophila 14 IgG Ab [Titer] in Serum |
|
47061-7
|
Legionella pneumophila 14 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47468-4
|
Legionella pneumophila 14 IgM Ab [Titer] in Serum |
|
47062-5
|
Legionella pneumophila 14 IgM Ab [Titer] in Serum by Immunofluorescence |
|
53742-3
|
Legionella pneumophila 2+3+4+5+6+8 Ab [Presence] in Serum |
|
46195-4
|
Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum |
|
43192-4
|
Legionella pneumophila 2+3+4+5+6+8 Ab [Titer] in Serum by Immunofluorescence |
|
54205-0
|
Legionella pneumophila 7+8+9+10+11+12+13+14 Ab [Titer] in Serum |
|
30046-7
|
Legionella pneumophila Ab [Units/volume] in Serum by Immunoassay |
|
7947-5
|
Legionella pneumophila Ab [Presence] in Serum |
|
5236-5
|
Legionella pneumophila Ab [Presence] in Serum by Immunofluorescence |
|
31471-6
|
Legionella pneumophila Ab [Units/volume] in Serum |
|
24277-6
|
Legionella pneumophila Ab [Titer] in Serum --1st specimen |
|
24203-2
|
Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24278-4
|
Legionella pneumophila Ab [Titer] in Serum --2nd specimen |
|
24204-0
|
Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22396-6
|
Legionella pneumophila Ab [Titer] in Serum |
|
5237-3
|
Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence |
|
89594-6
|
Legionella pneumophila Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
31869-1
|
Legionella pneumophila Ag [Presence] in Sputum |
|
6445-1
|
Legionella pneumophila Ag [Presence] in Sputum by Immunofluorescence |
|
6446-9
|
Legionella pneumophila Ag [Presence] in Sputum by Latex agglutination |
|
89595-3
|
Legionella pneumophila Ag [Presence] in Tissue by Immunofluorescence |
|
31870-9
|
Legionella pneumophila Ag [Presence] in Urine |
|
6447-7
|
Legionella pneumophila Ag [Presence] in Urine by Immunoassay |
|
17059-7
|
Legionella pneumophila Ag [Presence] in Urine by Immunofluorescence |
|
17058-9
|
Legionella pneumophila Ag [Presence] in Urine by Latex agglutination |
|
6448-5
|
Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA) |
|
17057-1
|
Legionella pneumophila Ag [Presence] in Unspecified specimen |
|
588-4
|
Legionella pneumophila Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
6449-3
|
Legionella pneumophila Ag [Presence] in Unspecified specimen by Latex agglutination |
|
13254-8
|
Legionella pneumophila atypical Ab [Presence] in Serum |
|
31473-2
|
Legionella pneumophila atypical Ab [Units/volume] in Serum |
|
32695-9
|
Legionella pneumophila atypical Ab [Titer] in Serum |
|
27966-1
|
Legionella pneumophila atypical Ab [Titer] in Serum by Immunofluorescence |
|
18237-8
|
Legionella pneumophila atypical IgM Ab [Presence] in Serum |
|
92969-5
|
Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88590-5
|
Legionella pneumophila DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
92145-2
|
Legionella pneumophila DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
88577-2
|
Legionella pneumophila DNA [Presence] in Tissue by NAA with probe detection |
|
21363-7
|
Legionella pneumophila DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82920-0
|
Legionella pneumophila IgA Ab [Units/volume] in Serum by Immunoassay |
|
29955-2
|
Legionella pneumophila IgG Ab [Units/volume] in Serum by Immunoassay |
|
49913-7
|
Legionella pneumophila IgG Ab [Presence] in Serum |
|
56514-3
|
Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence |
|
30085-5
|
Legionella pneumophila IgG Ab [Units/volume] in Serum |
|
57675-1
|
Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --1st specimen |
|
57008-5
|
Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
57676-9
|
Legionella pneumophila IgG Ab [Presence] in Serum by Immunofluorescence --2nd specimen |
|
56950-9
|
Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22397-4
|
Legionella pneumophila IgG Ab [Titer] in Serum |
|
21362-9
|
Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence |
|
51814-2
|
Legionella pneumophila IgM Ab [Units/volume] in Serum by Immunoassay |
|
31472-4
|
Legionella pneumophila IgM Ab [Units/volume] in Serum |
|
22398-2
|
Legionella pneumophila IgM Ab [Titer] in Serum |
|
16133-1
|
Legionella pneumophila IgM Ab [Titer] in Serum by Immunofluorescence |
|
32696-7
|
Legionella pneumophila 1+2+3+4+5+6 Ab [Titer] in Serum |
|
53770-4
|
Legionella pneumophila 1+2+3+4+5+6 IgG Ab [Titer] in Serum |
|
49914-5
|
Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Presence] in Serum |
|
53784-5
|
Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Titer] in Serum |
|
40840-1
|
Legionella pneumophila 1 Ab [Presence] in Serum |
|
31454-2
|
Legionella pneumophila 1 Ab [Units/volume] in Serum |
|
17060-5
|
Legionella pneumophila 1 Ab [Titer] in Serum |
|
7948-3
|
Legionella pneumophila 1 Ab [Titer] in Serum by Immunofluorescence |
|
31868-3
|
Legionella pneumophila 1 Ag [Presence] in Urine |
|
41499-5
|
Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay |
|
77684-9
|
Legionella pneumophila 1 Ag [Presence] in Urine by Rapid immunoassay |
|
9543-0
|
Legionella pneumophila 1 Ag [Presence] in Urine by Radioimmunoassay (RIA) |
|
58799-8
|
Legionella pneumophila 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
35394-6
|
Legionella pneumophila 1 IgG Ab [Presence] in Serum |
|
31455-9
|
Legionella pneumophila 1 IgG Ab [Units/volume] in Serum |
|
22381-8
|
Legionella pneumophila 1 IgG Ab [Titer] in Serum |
|
9541-4
|
Legionella pneumophila 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
31456-7
|
Legionella pneumophila 1 IgM Ab [Units/volume] in Cerebral spinal fluid |
|
35395-3
|
Legionella pneumophila 1 IgM Ab [Presence] in Serum |
|
17061-3
|
Legionella pneumophila 1 IgM Ab [Units/volume] in Serum |
|
43002-5
|
Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid |
|
31075-5
|
Legionella pneumophila 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22382-6
|
Legionella pneumophila 1 IgM Ab [Titer] in Serum |
|
9542-2
|
Legionella pneumophila 1 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31457-5
|
Legionella pneumophila 2 Ab [Units/volume] in Serum |
|
17062-1
|
Legionella pneumophila 2 Ab [Titer] in Serum |
|
7949-1
|
Legionella pneumophila 2 Ab [Titer] in Serum by Immunofluorescence |
|
31458-3
|
Legionella pneumophila 2 IgG Ab [Units/volume] in Serum |
|
22383-4
|
Legionella pneumophila 2 IgG Ab [Titer] in Serum |
|
9544-8
|
Legionella pneumophila 2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
58798-0
|
Legionella pneumophila 2 IgM Ab [Units/volume] in Serum by Immunoassay |
|
17063-9
|
Legionella pneumophila 2 IgM Ab [Units/volume] in Serum |
|
22384-2
|
Legionella pneumophila 2 IgM Ab [Titer] in Serum |
|
9545-5
|
Legionella pneumophila 2 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31459-1
|
Legionella pneumophila 3 Ab [Units/volume] in Serum |
|
17064-7
|
Legionella pneumophila 3 Ab [Titer] in Serum |
|
7950-9
|
Legionella pneumophila 3 Ab [Titer] in Serum by Immunofluorescence |
|
31460-9
|
Legionella pneumophila 3 IgG Ab [Units/volume] in Serum |
|
22385-9
|
Legionella pneumophila 3 IgG Ab [Titer] in Serum |
|
9546-3
|
Legionella pneumophila 3 IgG Ab [Titer] in Serum by Immunofluorescence |
|
17065-4
|
Legionella pneumophila 3 IgM Ab [Units/volume] in Serum |
|
22386-7
|
Legionella pneumophila 3 IgM Ab [Titer] in Serum |
|
9547-1
|
Legionella pneumophila 3 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31461-7
|
Legionella pneumophila 4 Ab [Units/volume] in Serum |
|
17066-2
|
Legionella pneumophila 4 Ab [Titer] in Serum |
|
7951-7
|
Legionella pneumophila 4 Ab [Titer] in Serum by Immunofluorescence |
|
31462-5
|
Legionella pneumophila 4 IgG Ab [Units/volume] in Serum |
|
22387-5
|
Legionella pneumophila 4 IgG Ab [Titer] in Serum |
|
9548-9
|
Legionella pneumophila 4 IgG Ab [Titer] in Serum by Immunofluorescence |
|
17067-0
|
Legionella pneumophila 4 IgM Ab [Units/volume] in Serum |
|
22388-3
|
Legionella pneumophila 4 IgM Ab [Titer] in Serum |
|
9549-7
|
Legionella pneumophila 4 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31463-3
|
Legionella pneumophila 5 Ab [Units/volume] in Serum |
|
17068-8
|
Legionella pneumophila 5 Ab [Titer] in Serum |
|
7952-5
|
Legionella pneumophila 5 Ab [Titer] in Serum by Immunofluorescence |
|
31464-1
|
Legionella pneumophila 5 IgG Ab [Units/volume] in Serum |
|
22389-1
|
Legionella pneumophila 5 IgG Ab [Titer] in Serum |
|
9550-5
|
Legionella pneumophila 5 IgG Ab [Titer] in Serum by Immunofluorescence |
|
17069-6
|
Legionella pneumophila 5 IgM Ab [Units/volume] in Serum |
|
22390-9
|
Legionella pneumophila 5 IgM Ab [Titer] in Serum |
|
9551-3
|
Legionella pneumophila 5 IgM Ab [Titer] in Serum by Immunofluorescence |
|
31465-8
|
Legionella pneumophila 6 Ab [Units/volume] in Serum |
|
17070-4
|
Legionella pneumophila 6 Ab [Titer] in Serum |
|
7953-3
|
Legionella pneumophila 6 Ab [Titer] in Serum by Immunofluorescence |
|
31466-6
|
Legionella pneumophila 6 IgG Ab [Units/volume] in Serum |
|
22391-7
|
Legionella pneumophila 6 IgG Ab [Titer] in Serum |
|
9552-1
|
Legionella pneumophila 6 IgG Ab [Titer] in Serum by Immunofluorescence |
|
31467-4
|
Legionella pneumophila 6 IgM Ab [Units/volume] in Serum |
|
22392-5
|
Legionella pneumophila 6 IgM Ab [Titer] in Serum |
|
9553-9
|
Legionella pneumophila 6 IgM Ab [Titer] in Serum by Immunofluorescence |
|
17071-2
|
Legionella pneumophila 7 Ab [Presence] in Serum |
|
31468-2
|
Legionella pneumophila 7 Ab [Units/volume] in Serum |
|
22393-3
|
Legionella pneumophila 7 Ab [Titer] in Serum |
|
7954-1
|
Legionella pneumophila 7 Ab [Titer] in Serum by Immunofluorescence |
|
47469-2
|
Legionella pneumophila 7 IgG Ab [Titer] in Serum |
|
47076-5
|
Legionella pneumophila 7 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47470-0
|
Legionella pneumophila 7 IgM Ab [Titer] in Serum |
|
47077-3
|
Legionella pneumophila 7 IgM Ab [Titer] in Serum by Immunofluorescence |
|
17072-0
|
Legionella pneumophila 8 Ab [Presence] in Serum |
|
31469-0
|
Legionella pneumophila 8 Ab [Units/volume] in Serum |
|
22394-1
|
Legionella pneumophila 8 Ab [Titer] in Serum |
|
7955-8
|
Legionella pneumophila 8 Ab [Titer] in Serum by Immunofluorescence |
|
47471-8
|
Legionella pneumophila 8 IgG Ab [Titer] in Serum |
|
47078-1
|
Legionella pneumophila 8 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47472-6
|
Legionella pneumophila 8 IgM Ab [Titer] in Serum |
|
47079-9
|
Legionella pneumophila 8 IgM Ab [Titer] in Serum by Immunofluorescence |
|
17073-8
|
Legionella pneumophila 9 Ab [Presence] in Serum |
|
31470-8
|
Legionella pneumophila 9 Ab [Units/volume] in Serum |
|
22395-8
|
Legionella pneumophila 9 Ab [Titer] in Serum |
|
7956-6
|
Legionella pneumophila 9 Ab [Titer] in Serum by Immunofluorescence |
|
47473-4
|
Legionella pneumophila 9 IgG Ab [Titer] in Serum |
|
47080-7
|
Legionella pneumophila 9 IgG Ab [Titer] in Serum by Immunofluorescence |
|
47474-2
|
Legionella pneumophila 9 IgM Ab [Titer] in Serum |
|
47081-5
|
Legionella pneumophila 9 IgM Ab [Titer] in Serum by Immunofluorescence |
|
73671-0
|
Legionella pneumophila serogroup [Type] in Isolate by Agglutination |
|
26639-5
|
Leishmania tropica Ab [Presence] in Serum |
|
42998-5
|
Leishmania tropica Ab [Titer] in Serum |
|
41420-1
|
Leishmania tropica Ab [Titer] in Serum by Immunofluorescence |
|
48715-7
|
Leishmania tropica IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
35408-4
|
Leishmania tropica IgG Ab [Presence] in Serum |
|
13262-1
|
Leishmania tropica IgG Ab [Units/volume] in Serum |
|
15386-6
|
Leishmania tropica IgG Ab [Titer] in Serum |
|
48316-4
|
Leishmania tropica IgG Ab [Titer] in Serum by Immunofluorescence |
|
48714-0
|
Leishmania tropica IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
35409-2
|
Leishmania tropica IgM Ab [Presence] in Serum |
|
13263-9
|
Leishmania tropica IgM Ab [Units/volume] in Serum |
|
15387-4
|
Leishmania tropica IgM Ab [Titer] in Serum |
|
48317-2
|
Leishmania tropica IgM Ab [Titer] in Serum by Immunofluorescence |
|
81110-9
|
Leptospira weilii serovar Topaz Ab [Titer] in Serum by Agglutination |
|
57056-4
|
Labor and delivery admission history and physical note |
|
57057-2
|
Labor and delivery summary note |
|
41095-1
|
L1CAM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40477-2
|
L1CAM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79319-0
|
L-2-hydroxyglutarate [Moles/volume] in Amniotic fluid |
|
79317-4
|
L-2-hydroxyglutarate [Moles/volume] in Cerebral spinal fluid |
|
79318-2
|
L-2-hydroxyglutarate [Moles/volume] in Serum or Plasma |
|
80099-5
|
L-2-hydroxyglutarate/Creatinine [Molar ratio] in Urine |
|
75515-7
|
Lupus anticoagulant aPTT and dRVVT screening panel W Reflex |
|
75881-3
|
Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex |
|
17259-3
|
Methadone.long acting metabolite [Mass/volume] in Serum or Plasma |
|
33527-3
|
Methadone.long acting metabolite [Mass/volume] in Urine |
|
43308-6
|
Lupus anticoagulant neutralization buffer [Time] in Platelet poor plasma by Coagulation assay |
|
50376-3
|
Lupus anticoagulant neutralization dilute phospholipid actual/normal in Platelet poor plasma by Coagulation assay |
|
53748-0
|
Lupus anticoagulant neutralization dilute phospholipid [Time] in Platelet poor plasma |
|
15191-0
|
Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma |
|
3283-9
|
Lupus anticoagulant neutralization high phospholipid [Time] in Platelet poor plasma by Coagulation assay |
|
3284-7
|
Lupus anticoagulant neutralization platelet [Time] in Platelet poor plasma by Coagulation assay |
|
40647-0
|
Lupus anticoagulant neutralization platelet [Presence] in Platelet poor plasma by Coagulation assay |
|
60988-3
|
Left atrial pressure |
|
75933-2
|
Left atrial pressure Diastolic |
|
60989-1
|
Left atrial pressure Systolic |
|
3019-7
|
Thyrotropin.long acting [Presence] in Serum or Plasma |
|
30151-5
|
Thyrotropin.long acting [Units/volume] in Serum or Plasma |
|
90946-5
|
Date of laboratory phone call to provider to communicate test result |
|
3707-7
|
Labetalol [Mass/time] in 24 hour Urine |
|
17040-7
|
Labetalol [Presence] in Serum or Plasma |
|
3704-4
|
Labetalol [Mass/volume] in Serum or Plasma |
|
55547-4
|
Labetalol [Moles/volume] in Serum or Plasma |
|
3705-1
|
Labetalol [Presence] in Urine |
|
3706-9
|
Labetalol [Mass/volume] in Urine |
|
15508-5
|
Labor and delivery records |
|
11502-2
|
Laboratory report |
|
59296-4
|
Lacosamide [Mass/volume] in Blood |
|
59297-2
|
Lacosamide [Mass/volume] in Serum or Plasma |
|
59298-0
|
Lacosamide [Mass/volume] in Urine |
|
7446-8
|
Lactalbumin triggered histamine release [Units/volume] in Blood |
|
57991-2
|
Lactalbumin IgE Ab/IgE total in Serum |
|
7444-3
|
Lactalbumin IgG Ab [Units/volume] in Serum |
|
81315-4
|
Lactase [Enzymatic activity/mass] in Small intestine Tissue |
|
2526-2
|
Lactate [Mass/time] in 24 hour Urine |
|
34323-6
|
Lactate [Moles/volume] in 24 hour Urine |
|
15078-9
|
Lactate [Moles/time] in 24 hour Urine |
|
30242-2
|
Lactate [Mass/volume] in Arterial blood |
|
2518-9
|
Lactate [Moles/volume] in Arterial blood |
|
75366-5
|
Lactate [Moles/volume] in Capillary blood from Fetus by Test strip |
|
51829-0
|
Lactate [Mass/volume] in Capillary blood |
|
55932-8
|
Lactate [Moles/volume] in Cord blood |
|
19239-3
|
Lactate [Moles/volume] in Capillary blood |
|
59032-3
|
Lactate [Mass/volume] in Blood |
|
19240-1
|
Lactate [Moles/volume] in Mixed venous blood |
|
32693-4
|
Lactate [Moles/volume] in Blood |
|
30241-4
|
Lactate [Mass/volume] in Venous blood |
|
2519-7
|
Lactate [Moles/volume] in Venous blood |
|
27941-4
|
Lactate [Mass/volume] in Cerebral spinal fluid |
|
2520-5
|
Lactate [Moles/volume] in Cerebral spinal fluid |
|
55931-0
|
Lactate [Moles/volume] in Dialysis fluid |
|
29246-6
|
Lactate [Mass/volume] in Body fluid |
|
14165-5
|
Lactate [Moles/volume] in Body fluid |
|
2521-3
|
Lactate [Presence] in Gastric fluid |
|
27976-0
|
Lactate [Mass/volume] in Blood --fasting |
|
32132-3
|
Lactate [Moles/volume] in Arterial plasma |
|
32133-1
|
Lactate [Moles/volume] in Plasma venous |
|
2522-1
|
Lactate [Moles/volume] in Pleural fluid |
|
2523-9
|
Lactate [Moles/volume] in Peritoneal fluid |
|
14118-4
|
Lactate [Mass/volume] in Serum or Plasma |
|
35245-0
|
Lactate [Mass or Moles/volume] in Serum or Plasma |
|
2524-7
|
Lactate [Moles/volume] in Serum or Plasma |
|
2525-4
|
Lactate [Moles/volume] in Synovial fluid |
|
74896-2
|
Lactate [Moles/mass] in Stool |
|
29875-2
|
Lactate [Presence] in Urine |
|
34324-4
|
Lactate [Moles/volume] in Urine |
|
44333-3
|
Lactate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13767-9
|
Lactate/Creatinine [Mass Ratio] in Urine |
|
25112-4
|
Lactate/Creatinine [Molar ratio] in Urine |
|
59048-9
|
Lactate/Pyruvate [Mass Ratio] in Blood |
|
90073-8
|
Lactobacillales identified in Isolate by Organism specific culture |
|
74669-3
|
Lactobacillus sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
|
27900-0
|
Lactobacillus sp IgG Ab [Units/volume] in Serum |
|
27901-8
|
Lactobacillus sp IgM Ab [Units/volume] in Serum |
|
59003-4
|
Lactoferrin Ab [Units/volume] in Serum by Immunoassay |
|
54018-7
|
Lactoferrin Ab [Presence] in Serum |
|
26029-9
|
Lactoferrin bovine IgE Ab [Units/volume] in Serum |
|
2551-0
|
Lactoferrin [Mass/volume] in Serum |
|
63376-8
|
Lactoferrin [Presence] in Stool |
|
40703-1
|
Lactoferrin [Presence] in Stool by Immunoassay |
|
6443-6
|
Lactoferrin [Presence] in Stool by Latex agglutination |
|
42924-1
|
Lactoferrin [Mass/volume] in Stool |
|
6444-4
|
Lactoferrin [Presence] in Unspecified specimen by Latex agglutination |
|
25455-7
|
Lactoglobulin IgA Ab [Units/volume] in Serum |
|
17042-3
|
Lactoglobulin IgE Ab [Units/volume] in Serum |
|
7447-6
|
Lactoglobulin IgG Ab [Units/volume] in Serum |
|
26427-5
|
Lactoglobulin IgG4 Ab [Units/volume] in Serum |
|
51700-3
|
Microscopic observation [Identifier] in Unspecified specimen by Lactophenol blue |
|
78515-4
|
Lactose [Moles/volume] in Serum or Plasma --15 minutes post dose lactose PO |
|
2554-4
|
Lactose [Mass/time] in 24 hour Urine |
|
50584-2
|
Lactose challenge (hydrogen breath test) panel - Exhaled gas |
|
56879-0
|
Lactose IgE Ab [Units/volume] in Serum |
|
74349-2
|
Lactose [Moles/volume] in Serum or Plasma --fasting |
|
1585-9
|
Lactose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
|
2552-8
|
Lactose [Mass/volume] in Serum or Plasma |
|
51598-1
|
Lactose [Presence] in Stool |
|
69555-1
|
Lactose tolerance panel [Mass/volume] in Serum or Plasma |
|
69554-4
|
Lactose tolerance panel [Moles/volume] in Serum or Plasma |
|
2553-6
|
Lactose [Presence] in Urine |
|
17043-1
|
Lactose [Mass/volume] in Urine |
|
74438-3
|
Lactose/Creatinine [Molar ratio] in Urine |
|
74788-1
|
Lactulose challenge (hydrogen breath test) panel - Exhaled gas |
|
76136-1
|
Lactulose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO |
|
74900-2
|
Lactulose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
|
74899-6
|
Lactulose/Mannitol [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
|
79521-1
|
Lactyl lactate [Moles/volume] in Serum or Plasma |
|
79487-5
|
Lactyl lactate/Creatinine [Molar ratio] in Urine |
|
31448-4
|
La Crosse virus Ab [Units/volume] in Cerebral spinal fluid |
|
44748-2
|
La Crosse virus Ab [Units/volume] in Serum by Immunoassay |
|
44746-6
|
La Crosse virus Ab [Units/volume] in Serum by Immunofluorescence |
|
44747-4
|
La Crosse virus Ab [Presence] in Serum |
|
40736-1
|
La Crosse virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
44745-8
|
La Crosse virus Ab [Presence] in Serum by Immunoassay |
|
44744-1
|
La Crosse virus Ab [Presence] in Serum by Immunofluorescence |
|
5073-2
|
La Crosse virus Ab [Units/volume] in Serum |
|
24283-4
|
La Crosse virus Ab [Titer] in Serum --1st specimen |
|
24209-9
|
La Crosse virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24284-2
|
La Crosse virus Ab [Titer] in Serum --2nd specimen |
|
24210-7
|
La Crosse virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
17037-3
|
La Crosse virus Ab [Titer] in Cerebral spinal fluid |
|
9538-0
|
La Crosse virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
35709-5
|
La Crosse virus Ab [Titer] in Body fluid |
|
17036-5
|
La Crosse virus Ab [Titer] in Serum |
|
35697-2
|
La Crosse virus Ab [Titer] in Serum by Complement fixation |
|
29563-4
|
La Crosse virus Ab [Titer] in Serum by Neutralization test |
|
31449-2
|
La Crosse virus Ab [Presence] in Unspecified specimen |
|
30176-2
|
La Crosse virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
29840-6
|
La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid |
|
29802-6
|
La Crosse virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31450-0
|
La Crosse virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
62433-8
|
La Crosse virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
48716-5
|
La Crosse virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
29852-1
|
La Crosse virus IgG Ab [Presence] in Serum |
|
52823-2
|
La Crosse virus IgG Ab [Presence] in Serum by Immunoassay |
|
29815-8
|
La Crosse virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
7940-0
|
La Crosse virus IgG Ab [Units/volume] in Serum |
|
22373-5
|
La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid |
|
9539-8
|
La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
17038-1
|
La Crosse virus IgG Ab [Titer] in Serum |
|
10904-1
|
La Crosse virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
29828-1
|
La Crosse virus IgG Ab [Presence] in Unspecified specimen |
|
29789-5
|
La Crosse virus IgG Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
29841-4
|
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid |
|
52825-7
|
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
29803-4
|
La Crosse virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31451-8
|
La Crosse virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
62432-0
|
La Crosse virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
29853-9
|
La Crosse virus IgM Ab [Presence] in Serum |
|
52824-0
|
La Crosse virus IgM Ab [Presence] in Serum by Immunoassay |
|
29816-6
|
La Crosse virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
7941-8
|
La Crosse virus IgM Ab [Units/volume] in Serum |
|
22375-0
|
La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid |
|
9540-6
|
La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
17039-9
|
La Crosse virus IgM Ab [Titer] in Serum |
|
44822-5
|
La Crosse virus IgM Ab [Titer] in Serum by Immunoassay |
|
10905-8
|
La Crosse virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
29829-9
|
La Crosse virus IgM Ab [Presence] in Unspecified specimen |
|
29790-3
|
La Crosse virus IgM Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
34454-9
|
La Crosse virus RNA [Presence] in Blood by NAA with probe detection |
|
34455-6
|
La Crosse virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
69767-2
|
La Crosse virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76614-7
|
Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-oleate substrate |
|
76615-4
|
Lysosomal acid lipase [Enzymatic activity/mass] in Fibroblast by 4-MU-palmitate substrate |
|
76621-2
|
Lysosomal acid lipase panel - Fibroblast |
|
33643-8
|
Limulus amebocyte lysate test [Units/volume] in Nonbiological fluid |
|
82883-0
|
Lysosomal acid lipase [Enzymatic activity/mass] in Leukocytes by 4-MU-palmitate substrate |
|
41094-4
|
LAMA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38535-1
|
LAMA2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82517-4
|
LAMA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7449-2
|
Lamb triggered histamine release [Units/volume] in Blood |
|
6155-6
|
Lamb IgE Ab [Units/volume] in Serum |
|
39552-5
|
Lamb IgE Ab/IgE total in Serum |
|
7448-4
|
Lamb IgG Ab [Units/volume] in Serum |
|
56457-5
|
Lamb IgG4 Ab [Mass/volume] in Serum |
|
60380-3
|
Lamb IgG Ab [Mass/volume] in Serum |
|
81831-0
|
LAMB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
10500-7
|
Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
|
44395-2
|
Lambda light chains [Presence] in 24 hour Urine |
|
88303-3
|
Lambda light chains [Presence] in 24 hour Urine by Immunofixation |
|
15187-8
|
Lambda light chains [Mass/volume] in 24 hour Urine |
|
25684-2
|
Lambda light chains [Mass/time] in 24 hour Urine |
|
10499-2
|
Lambda light chains Ag [Presence] in Tissue by Immune stain |
|
48772-8
|
Lambda light chains [Mass/volume] in Cerebral spinal fluid |
|
88302-5
|
Lambda light chains.free [Presence] in 24 hour Urine by Immunofixation |
|
53574-0
|
Lambda light chains.free [Mass/volume] in 24 hour Urine |
|
38169-9
|
Lambda light chains.free [Mass/time] in 24 hour Urine |
|
48775-1
|
Lambda light chains.free [Mass/volume] in Cerebral spinal fluid |
|
80516-8
|
Lambda light chains.free [Mass/volume] in Serum by Nephelometry |
|
33944-0
|
Lambda light chains.free [Mass/volume] in Serum or Plasma |
|
56481-5
|
Lambda light chains.free [Presence] in Urine by Immunofixation |
|
12778-7
|
Lambda light chains.free [Units/volume] in Urine |
|
38178-0
|
Lambda light chains.free [Mass/volume] in Urine |
|
21749-7
|
Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
6789-2
|
Lambda light chains [Presence] in Serum by Electrophoresis |
|
6791-8
|
Lambda light chains [Presence] in Serum by Immunoassay |
|
25683-4
|
Lambda light chains [Presence] in Serum by Immunoelectrophoresis |
|
11051-0
|
Lambda light chains [Mass/volume] in Serum or Plasma |
|
27394-6
|
Lambda light chains [Mass/volume] in Urine |
|
82516-6
|
LAMC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
19114-8
|
Lamellar bodies [#/volume] in Amniotic fluid |
|
17044-9
|
Lamellar bodies [Presence] in Amniotic fluid |
|
54027-8
|
Lamin Ab [Presence] in Serum by Immunofluorescence |
|
54028-6
|
Lamin Ab [Titer] in Serum by Immunofluorescence |
|
53596-3
|
Laminaribioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
29119-5
|
lamiVUDine [Units/volume] in Serum or Plasma |
|
49226-4
|
lamiVUDine [Mass/volume] in Serum or Plasma |
|
49620-8
|
lamiVUDine or Emtricitabine [Susceptibility] by Genotype method |
|
59920-9
|
lamoTRIgine [Moles/volume] in Gastric fluid |
|
51982-7
|
lamoTRIgine [Presence] in Serum or Plasma |
|
41761-8
|
lamoTRIgine [Mass/volume] in Serum or Plasma by Screen method |
|
6948-4
|
lamoTRIgine [Mass/volume] in Serum or Plasma |
|
25458-1
|
lamoTRIgine [Moles/volume] in Serum or Plasma |
|
74944-0
|
lamoTRIgine [Mass/volume] in Serum or Plasma --trough |
|
59919-1
|
lamoTRIgine [Moles/volume] in Urine |
|
60312-6
|
lamoTRIgine [Moles/volume] in Unspecified specimen |
|
87772-0
|
lamoTRIgine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
65326-1
|
LAN Ab [Presence] in Serum or Plasma |
|
68964-6
|
LAN Ag [Presence] on Red Blood Cells |
|
45972-7
|
Language Set |
|
74898-8
|
Lanosterol [Moles/volume] in Serum or Plasma |
|
73008-5
|
Lansoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73007-7
|
Lansoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73319-6
|
Lansoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73318-8
|
Lansoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55804-9
|
Leukocyte phosphatase [Presence] in Leukocytes |
|
15112-6
|
Leukocyte phosphatase [Units/volume] in Leukocytes |
|
4659-9
|
Leukocyte phosphatase [Enzymatic activity/volume] in Leukocytes |
|
26845-8
|
Sialate.lipid bound [Mass/volume] in Serum or Plasma |
|
26031-5
|
Sialate.lipid bound [Moles/volume] in Serum or Plasma |
|
88012-0
|
Sialate.lipid bound/Creatinine [Molar ratio] in Urine |
|
87598-9
|
Lasalocid [Mass/mass] in Unspecified specimen |
|
45394-4
|
Last name |
|
31867-5
|
Lassa virus Ag [Presence] in Serum |
|
7946-7
|
Lassa virus Ag [Presence] in Serum by Immunoassay |
|
22377-6
|
Lassa virus IgG Ab [Presence] in Serum |
|
7942-6
|
Lassa virus IgG Ab [Presence] in Serum by Immunoassay |
|
31452-6
|
Lassa virus IgG Ab [Units/volume] in Serum |
|
22378-4
|
Lassa virus IgG Ab [Titer] in Serum |
|
71710-8
|
Lassa virus IgG Ab [Titer] in Serum by Immunoassay |
|
7943-4
|
Lassa virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
22379-2
|
Lassa virus IgM Ab [Presence] in Serum |
|
7944-2
|
Lassa virus IgM Ab [Presence] in Serum by Immunoassay |
|
31453-4
|
Lassa virus IgM Ab [Units/volume] in Serum |
|
22380-0
|
Lassa virus IgM Ab [Titer] in Serum |
|
71709-0
|
Lassa virus IgM Ab [Titer] in Serum by Immunoassay |
|
7945-9
|
Lassa virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
50646-9
|
Latex recombinant (rHev b) 1 IgE Ab [Units/volume] in Serum |
|
82601-6
|
Latex recombinant (rHev b) 10 IgE Ab [Units/volume] in Serum |
|
50647-7
|
Latex recombinant (rHev b) 11 IgE Ab [Units/volume] in Serum |
|
82603-2
|
Latex recombinant (rHev b) 2 IgE Ab [Units/volume] in Serum |
|
56595-2
|
Latex recombinant (rHev b) 3 IgE Ab [Units/volume] in Serum |
|
56596-0
|
Latex recombinant (rHev b) 5 IgE Ab [Units/volume] in Serum |
|
66448-2
|
Latex recombinant (rHev b) 6 IgE Ab [Units/volume] in Serum |
|
50648-5
|
Latex recombinant (rHev b) 6.01 IgE Ab [Units/volume] in Serum |
|
50649-3
|
Latex recombinant (rHev b) 6.02 IgE Ab [Units/volume] in Serum |
|
56597-8
|
Latex recombinant (rHev b) 8 IgE Ab [Units/volume] in Serum |
|
59395-4
|
Latex recombinant (rHev b) 9 IgE Ab [Units/volume] in Serum |
|
75740-1
|
Lathosterol [Mass/volume] in Serum or Plasma |
|
77373-9
|
Lathosterol [Moles/volume] in Serum or Plasma |
|
75099-2
|
Laurate (C12:0) [Entitic substance] in Red Blood Cells |
|
78349-8
|
Lauroleate (C12:1) [Entitic substance] in Red Blood Cells |
|
48429-5
|
Lavender IgE Ab [Units/volume] in Serum |
|
21361-1
|
Laxatives present [Identifier] in Stool by Screen method |
|
17051-4
|
Laxatives [Identifier] in Urine |
|
88054-2
|
Lipopolysaccharide binding protein [Mass/volume] in Serum or Plasma by Immunoassay |
|
60491-8
|
LCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
10446-3
|
Leukocyte common Ag [Presence] in Tissue by Immune stain |
|
77134-5
|
LCA5 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77133-7
|
LCA5 gene full mutation analysis in Blood or Tissue by Sequencing |
|
74362-5
|
Lecithin cholesterol acyltransferase actual/normal in Serum or Plasma |
|
2555-1
|
Lecithin cholesterol acyltransferase [Enzymatic activity/volume] in Serum or Plasma |
|
85649-2
|
LCDS v4.00 - Signs and Symptoms of Delirium (from CAM) [CMS Assessment] |
|
31491-4
|
Lymphocytic choriomeningitis virus Ab [Units/volume] in Cerebral spinal fluid |
|
11605-3
|
Lymphocytic choriomeningitis virus Ab [Units/volume] in Serum |
|
17228-8
|
Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid |
|
9564-6
|
Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22408-9
|
Lymphocytic choriomeningitis virus Ab [Titer] in Serum |
|
5241-5
|
Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Complement fixation |
|
6458-4
|
Lymphocytic choriomeningitis virus Ab [Titer] in Serum by Immunofluorescence |
|
45219-3
|
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Cerebral spinal fluid |
|
31492-2
|
Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
45278-9
|
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Body fluid |
|
45218-5
|
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum |
|
88206-8
|
Lymphocytic choriomeningitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
31493-0
|
Lymphocytic choriomeningitis virus IgG Ab [Units/volume] in Serum |
|
22409-7
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
9766-7
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22410-5
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum |
|
40500-1
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunoassay |
|
9765-9
|
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
93787-0
|
Lymphocytic choriomeningitis virus IgG+IgM Ab [Presence] in Cerebral spinal fluid |
|
35650-1
|
Lymphocytic choriomeningitis virus IgG and IgM panel - Cerebral spinal fluid |
|
35666-7
|
Lymphocytic choriomeningitis virus IgG and IgM panel - Serum |
|
41843-4
|
Lymphocytic choriomeningitis virus IgG and IgM panel [Titer] - Cerebral spinal fluid by Immunofluorescence |
|
45221-9
|
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Cerebral spinal fluid |
|
31494-8
|
Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
45277-1
|
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Body fluid |
|
45220-1
|
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum |
|
88205-0
|
Lymphocytic choriomeningitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
31495-5
|
Lymphocytic choriomeningitis virus IgM Ab [Units/volume] in Serum |
|
17229-6
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
9768-3
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22411-3
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum |
|
40499-6
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunoassay |
|
9767-5
|
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
88207-6
|
Lymphocytic choriomeningitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
51667-4
|
Lymphocytic choriomeningitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
58938-2
|
LCT gene mutations found [Type] in Blood or Tissue by Molecular genetics method |
|
58924-2
|
LCT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
47678-8
|
Lactate dehydrogenase [Enzymatic activity/volume] in 24 hour Urine |
|
47863-6
|
Lactate dehydrogenase [Enzymatic activity/time] in 24 hour Urine |
|
2527-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Amniotic fluid |
|
60024-7
|
Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction |
|
60023-9
|
Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Pyruvate to lactate reaction |
|
2528-8
|
Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
81430-1
|
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal dialysis fluid by Lactate to pyruvate reaction |
|
5921-2
|
Lactate dehydrogenase [Enzymatic activity/volume] in Dialysis fluid |
|
14803-1
|
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
|
60017-1
|
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction |
|
2529-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid |
|
14403-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid |
|
60019-7
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Lactate to pyruvate reaction |
|
60018-9
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Pyruvate to lactate reaction |
|
33367-4
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid |
|
60022-1
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction |
|
60021-3
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Pyruvate to lactate reaction |
|
2530-4
|
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid |
|
42929-0
|
Lactate dehydrogenase panel - Serum or Plasma |
|
68387-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Lactate to pyruvate reaction |
|
60020-5
|
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Pyruvate to lactate reaction |
|
2531-2
|
Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid |
|
11053-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
14804-9
|
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction |
|
14805-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction |
|
2532-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
|
57664-5
|
Lactate dehydrogenase [Enzymatic activity/volume] in Semen |
|
68453-0
|
Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Lactate to pyruvate reaction |
|
68452-2
|
Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Pyruvate to lactate reaction |
|
2533-8
|
Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid |
|
17041-5
|
Lactate dehydrogenase [Presence] in Urine |
|
2534-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Urine |
|
32324-6
|
Lactate dehydrogenase [Enzymatic activity/volume] in Unspecified specimen |
|
75639-5
|
Lactate dehydrogenase in body fluid/Lactate dehydrogenase in serum |
|
53561-7
|
Lactate dehydrogenase/Creatinine [Ratio] in Urine |
|
43727-7
|
Lipoprotein.beta.subparticle.small [Moles/volume] in Serum or Plasma |
|
68935-6
|
LDL.oxidized Ab [Units/volume] in Serum by Immunoassay |
|
48143-2
|
LDL.oxidized Ab [Units/volume] in Serum |
|
54238-1
|
LDL.oxidized [Units/volume] in Serum or Plasma |
|
43392-0
|
LDL 1 [Mass/volume] in Serum or Plasma |
|
56136-5
|
LDL 1 [Moles/volume] in Serum or Plasma |
|
46984-1
|
LDL 2 [Mass/volume] in Serum or Plasma |
|
56137-3
|
LDL 2 [Moles/volume] in Serum or Plasma |
|
46985-8
|
LDL 3 [Mass/volume] in Serum or Plasma |
|
56138-1
|
LDL 3 [Moles/volume] in Serum or Plasma |
|
43393-8
|
LDL 4 [Mass/volume] in Serum or Plasma |
|
56139-9
|
LDL 4 [Moles/volume] in Serum or Plasma |
|
57938-3
|
LDL 5 [Mass/volume] in Serum or Plasma |
|
49026-8
|
LDL 6 [Mass/volume] in Serum or Plasma |
|
49027-6
|
LDL 7 [Mass/volume] in Serum or Plasma |
|
53133-5
|
Cholesterol in LDL [Moles/volume] in Body fluid |
|
86911-5
|
Cholesterol in LDL goal [Mass/volume] Serum or Plasma |
|
39469-2
|
Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation |
|
18262-6
|
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay |
|
69419-0
|
Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay |
|
49132-4
|
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Electrophoresis |
|
2089-1
|
Cholesterol in LDL [Mass/volume] in Serum or Plasma |
|
35198-1
|
Cholesterol in LDL [Mass or Moles/volume] in Serum or Plasma |
|
22748-8
|
Cholesterol in LDL [Moles/volume] in Serum or Plasma |
|
43394-6
|
Cholesterol in LDL acylated [Mass/volume] in Serum or Plasma |
|
69486-9
|
LDLR gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
69485-1
|
LDLR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
90258-5
|
LDLR gene full mutation analysis in Blood or Tissue by Sequencing |
|
56159-7
|
LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53077-4
|
Levodopa [Moles/volume] in Cerebral spinal fluid |
|
35131-2
|
L-dopa decarboxylase [Enzymatic activity/volume] in Plasma |
|
73309-7
|
Levodopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73308-9
|
Levodopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
51983-5
|
Levodopa [Presence] in Serum or Plasma |
|
9385-6
|
Levodopa [Mass/volume] in Serum or Plasma |
|
34328-5
|
Levodopa [Moles/volume] in Serum or Plasma |
|
53477-6
|
Levodopa/Tyrosine [Molar ratio] in Serum or Plasma |
|
30084-8
|
Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay |
|
31490-6
|
Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum |
|
18239-4
|
Lupus erythematosus factor [Mass/volume] in Blood by Latex agglutination |
|
17092-8
|
Lupus erythematosus factor [Presence] in Serum by Latex agglutination |
|
1115-5
|
Le sup(a) Ag [Presence] on Red Blood Cells |
|
1121-3
|
Le sup(b) Ag [Presence] on Red Blood Cells |
|
30931-0
|
Lead [Mass/volume] in Urine collected for unspecified duration |
|
14333-9
|
Lead [Presence] in 24 hour Urine |
|
20625-0
|
Lead [Mass/volume] in 24 hour Urine |
|
5677-0
|
Lead [Mass/time] in 24 hour Urine |
|
34325-1
|
Lead [Moles/volume] in 24 hour Urine |
|
14809-8
|
Lead [Moles/time] in 24 hour Urine |
|
31083-9
|
Lead [Mass/time] in 8 hour Urine |
|
17052-2
|
Lead [Presence] in Blood |
|
10368-9
|
Lead [Mass/volume] in Capillary blood |
|
5671-3
|
Lead [Mass/volume] in Blood |
|
14807-2
|
Lead [Moles/volume] in Blood |
|
77307-7
|
Lead [Mass/volume] in Venous blood |
|
20867-8
|
Lead [Mass/mass] in Bone |
|
79266-3
|
Lead [Mass/mass] in Dentin |
|
5933-7
|
Lead [Mass/volume] in Dialysis fluid |
|
9436-7
|
Lead [Mass/volume] in Body fluid |
|
5673-9
|
Lead [Mass/mass] in Hair |
|
50871-3
|
Lead [Moles/mass] in Hair |
|
27232-8
|
Lead [Mass/volume] in Milk |
|
8202-4
|
Lead [Mass/mass] in Nail |
|
55393-3
|
Lead [Moles/mass] in Nail |
|
5674-7
|
Lead [Mass/volume] in Red Blood Cells |
|
27129-6
|
Lead [Mass/mass] in Red Blood Cells |
|
32325-3
|
Lead [Moles/volume] in Red Blood Cells |
|
10912-4
|
Lead [Mass/volume] in Serum or Plasma |
|
25459-9
|
Lead [Moles/volume] in Serum or Plasma |
|
40451-7
|
Lead [Presence] in Stool |
|
18236-0
|
Lead [Presence] in Tissue |
|
12770-4
|
Lead [Mass/mass] in Tissue |
|
52890-1
|
Lead [Moles/mass] in Tissue |
|
5675-4
|
Lead [Presence] in Urine |
|
5676-2
|
Lead [Mass/volume] in Urine |
|
14808-0
|
Lead [Moles/volume] in Urine |
|
9477-1
|
Lead [Mass/volume] in Water |
|
23749-5
|
Lead [Mass/volume] in Unspecified specimen |
|
23890-7
|
Lead [Mass/mass] in Unspecified specimen |
|
29943-8
|
Lead/Creatinine [Mass Ratio] in 24 hour Urine |
|
52931-3
|
Lead/Creatinine [Molar ratio] in 24 hour Urine |
|
13466-8
|
Lead/Creatinine [Mass Ratio] in Urine |
|
34327-7
|
Lead/Creatinine [Molar ratio] in Urine |
|
91557-9
|
Lean body weight |
|
88334-8
|
Lean body weight Calculated |
|
27233-6
|
Lecithin [Units/volume] in Amniotic fluid |
|
49577-0
|
Lecithin/Surfactant.total in Amniotic fluid |
|
2556-9
|
Lecithin phosphorus [Mass/volume] in Amniotic fluid |
|
2783-9
|
Lecithin [Mass/volume] in Plasma |
|
72339-5
|
Lecithin [Presence] in Prostatic fluid by Light microscopy |
|
2557-7
|
Lecithin/Sphingomyelin [Mass Ratio] in Amniotic fluid |
|
14976-5
|
Lecithin/Sphingomyelin [Ratio] in Amniotic fluid |
|
56746-1
|
Leeks IgE Ab [Units/volume] in Serum |
|
85425-7
|
Lefamulin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
38901-5
|
Leflunomide [Mass/volume] in Serum or Plasma |
|
64299-1
|
Legal document |
|
78506-3
|
Legal letter |
|
54503-8
|
Legal name of patient |
|
38392-7
|
Legionella sp Ab [Presence] in Serum |
|
7957-4
|
Legionella sp Ab [Units/volume] in Serum |
|
30143-2
|
Legionella sp Ab [Presence] in Serum --1st specimen |
|
30144-0
|
Legionella sp Ab [Presence] in Serum --2nd specimen |
|
51920-7
|
Legionella sp Ab [Titer] in Serum --2nd specimen |
|
43001-7
|
Legionella sp Ab [Titer] in Cerebral spinal fluid |
|
42516-5
|
Legionella sp Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22399-0
|
Legionella sp Ab [Titer] in Serum |
|
6450-1
|
Legionella sp Ab [Titer] in Serum by Immunofluorescence |
|
73833-6
|
Legionella sp Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
38460-2
|
Legionella sp Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
38461-0
|
Legionella sp Ag [Presence] in Pleural fluid by Immunofluorescence |
|
38462-8
|
Legionella sp Ag [Presence] in Sputum by Immunofluorescence |
|
32781-7
|
Legionella sp Ag [Presence] in Urine |
|
38463-6
|
Legionella sp Ag [Presence] in Urine by Immunofluorescence |
|
26621-3
|
Legionella sp Ag [Presence] in Unspecified specimen |
|
39541-8
|
Legionella sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
589-2
|
Legionella sp identified in Bronchial specimen by Organism specific culture |
|
88588-9
|
Legionella sp DNA [Identifier] in Lower respiratory specimen by NAA with probe detection |
|
88587-1
|
Legionella sp DNA [Identifier] in Tissue by NAA with probe detection |
|
49616-6
|
Legionella sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
49915-2
|
Legionella sp IgG Ab [Presence] in Serum |
|
81118-2
|
Legionella sp IgM Ab [Presence] in Serum |
|
31474-0
|
Legionella sp IgM Ab [Units/volume] in Serum |
|
39559-0
|
Legionella sp IgM Ab [Titer] in Serum |
|
28612-0
|
Legionella sp IgM Ab [Titer] in Serum by Immunofluorescence |
|
71377-6
|
Legionella sp [Identifier] in Isolate by Agglutination |
|
13253-0
|
Legionella non-pneumophila Ab [Presence] in Serum |
|
46194-7
|
Legionella non-pneumophila Ab [Titer] in Serum |
|
43193-2
|
Legionella non-pneumophila Ab [Titer] in Serum by Immunofluorescence |
|
38393-5
|
Legionella sp identified in Pleural fluid by Organism specific culture |
|
26627-0
|
Legionella polyvalent A Ab [Presence] in Serum |
|
26628-8
|
Legionella polyvalent B Ab [Presence] in Serum |
|
26629-6
|
Legionella polyvalent C Ab [Presence] in Serum |
|
5020-3
|
Legionella sp rRNA [Presence] in Unspecified specimen by Probe |
|
590-0
|
Legionella sp identified in Sputum by Organism specific culture |
|
38394-3
|
Legionella sp identified in Urine by Organism specific culture |
|
593-4
|
Legionella sp identified in Unspecified specimen by Organism specific culture |
|
42999-3
|
Leishmania sp Ab [Presence] in Cerebral spinal fluid |
|
42517-3
|
Leishmania sp Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
51711-0
|
Leishmania sp Ab [Presence] in Body fluid |
|
7958-2
|
Leishmania sp Ab [Presence] in Serum |
|
23157-1
|
Leishmania sp Ab [Presence] in Serum by Agglutination |
|
6623-3
|
Leishmania sp Ab [Presence] in Serum by Complement fixation |
|
6622-5
|
Leishmania sp Ab [Presence] in Serum by Hemagglutination |
|
23153-0
|
Leishmania sp Ab [Presence] in Serum by Immunoassay |
|
23155-5
|
Leishmania sp Ab [Presence] in Serum by Immunoelectrophoresis |
|
6621-7
|
Leishmania sp Ab [Presence] in Serum by Immunofluorescence |
|
5238-1
|
Leishmania sp Ab [Units/volume] in Serum |
|
23152-2
|
Leishmania sp Ab [Titer] in Serum |
|
23154-8
|
Leishmania sp Ab [Titer] in Serum by Hemagglutination |
|
23156-3
|
Leishmania sp Ab [Titer] in Serum by Immunofluorescence |
|
49780-0
|
Leishmania sp DNA [Presence] in Blood by NAA with probe detection |
|
88917-0
|
Leishmania sp DNA [Identifier] in Bone marrow by NAA with probe detection |
|
88916-2
|
Leishmania sp DNA [Identifier] in Tissue by NAA with probe detection |
|
23159-7
|
Leishmania sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
40853-4
|
Leishmania sp IgG Ab [Units/volume] in Cerebral spinal fluid |
|
56951-7
|
Leishmania sp IgG Ab [Presence] in Serum by Immunofluorescence |
|
40852-6
|
Leishmania sp IgG Ab [Units/volume] in Serum |
|
34608-0
|
Leishmania sp IgG Ab [Titer] in Serum |
|
52985-9
|
Leishmania sp IgG Ab [Titer] in Serum by Immunofluorescence |
|
39577-2
|
Leishmania sp IgM Ab [Titer] in Serum |
|
88682-0
|
Leishmania sp IgM Ab [Titer] in Serum by Immunofluorescence |
|
23158-9
|
Leishmania sp rRNA [Identifier] in Unspecified specimen by Probe |
|
43109-8
|
Leishmania sp IgG and IgM panel - Serum |
|
53625-0
|
Leishmania sp identified in Tissue |
|
10687-2
|
Leishmania sp identified in Tissue by Organism specific culture |
|
23161-3
|
Leishmania sp identified in Tissue by Electrophoresis |
|
10686-4
|
Leishmania sp identified in Tissue by Giemsa stain |
|
23160-5
|
Leishmania sp identified in Tissue by Immunofluorescence |
|
23162-1
|
Leishmania sp identified in Tissue by Polyacrylamide gel electrophoresis (PAGE) |
|
51710-2
|
Leishmania sp identified in Unspecified specimen by Organism specific culture |
|
51709-4
|
Leishmania sp identified in Unspecified specimen by Giemsa stain |
|
7456-7
|
Lemon triggered histamine release [Units/volume] in Blood |
|
6159-8
|
Lemon IgE Ab [Units/volume] in Serum |
|
61246-5
|
Lemon IgE Ab/IgE total in Serum |
|
7455-9
|
Lemon IgG Ab [Units/volume] in Serum |
|
56304-9
|
Lemon IgG4 Ab [Mass/volume] in Serum |
|
60381-1
|
Lemon IgG Ab [Mass/volume] in Serum |
|
6239-8
|
Lenscale IgE Ab [Units/volume] in Serum |
|
61224-2
|
Lenscale IgE Ab/IgE total in Serum |
|
56305-6
|
Lenscale IgG4 Ab [Mass/volume] in Serum |
|
7458-3
|
Lentils IgE Ab [Units/volume] in Serum |
|
7459-1
|
Lentils IgG Ab [Units/volume] in Serum |
|
56306-4
|
Lentils IgG4 Ab [Mass/volume] in Serum |
|
63118-4
|
Lentils IgG Ab [Mass/volume] in Serum |
|
73317-0
|
Lepirudin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73316-2
|
Lepirudin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
21365-2
|
Leptin [Mass/volume] in Serum or Plasma |
|
23196-9
|
Leptospira sp Ab [Presence] in Serum |
|
23197-7
|
Leptospira sp Ab [Presence] in Serum by Agglutination |
|
23195-1
|
Leptospira sp Ab [Presence] in Serum by Immunoassay |
|
31483-1
|
Leptospira sp Ab [Units/volume] in Serum |
|
32604-1
|
Leptospira sp Ab [Titer] in Serum --1st specimen |
|
32605-8
|
Leptospira sp Ab [Titer] in Serum --2nd specimen |
|
42994-4
|
Leptospira sp Ab [Titer] in Cerebral spinal fluid |
|
42518-1
|
Leptospira sp Ab [Titer] in Cerebral spinal fluid by Agglutination |
|
7959-0
|
Leptospira sp Ab [Titer] in Serum |
|
23198-5
|
Leptospira sp Ab [Titer] in Serum by Agglutination |
|
5239-9
|
Leptospira sp Ab [Titer] in Serum by Latex agglutination |
|
23203-3
|
Leptospira sp Ag [Presence] in Tissue by Immunofluorescence |
|
23204-1
|
Leptospira sp Ag [Presence] in Tissue by Immune stain |
|
31872-5
|
Leptospira sp Ag [Presence] in Urine |
|
23750-3
|
Leptospira sp Ag [Presence] in Urine by Immunofluorescence |
|
6453-5
|
Leptospira sp identified in Blood by Organism specific culture |
|
6454-3
|
Leptospira sp identified in Cerebral spinal fluid by Organism specific culture |
|
52989-1
|
Leptospira sp DNA [Presence] in Blood by NAA with probe detection |
|
52988-3
|
Leptospira sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
86731-7
|
Leptospira sp DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
23205-8
|
Leptospira sp DNA [Presence] in Body fluid by NAA with probe detection |
|
23206-6
|
Leptospira sp DNA [Presence] in Tissue by NAA with probe detection |
|
52990-9
|
Leptospira sp DNA [Presence] in Urine by NAA with probe detection |
|
35491-0
|
Leptospira sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
27093-4
|
Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31484-9
|
Leptospira sp IgG Ab [Units/volume] in Cerebral spinal fluid |
|
51815-9
|
Leptospira sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
23200-9
|
Leptospira sp IgG Ab [Presence] in Serum |
|
23199-3
|
Leptospira sp IgG Ab [Presence] in Serum by Immunoassay |
|
31485-6
|
Leptospira sp IgG Ab [Units/volume] in Serum |
|
13264-7
|
Leptospira sp IgG Ab [Titer] in Serum |
|
27384-7
|
Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31486-4
|
Leptospira sp IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51819-1
|
Leptospira sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
23202-5
|
Leptospira sp IgM Ab [Presence] in Serum |
|
23201-7
|
Leptospira sp IgM Ab [Presence] in Serum by Immunoassay |
|
31487-2
|
Leptospira sp IgM Ab [Units/volume] in Serum |
|
13265-4
|
Leptospira sp IgM Ab [Titer] in Serum |
|
71378-4
|
Leptospira sp [Identifier] in Isolate by Agglutination |
|
86732-5
|
Leptospira sp identified [Type] in Isolate by Sequencing |
|
23600-0
|
Leptospira sp identified in Milk by Organism specific culture |
|
23207-4
|
Leptospira subtype [Identifier] in Unspecified specimen |
|
23599-4
|
Leptospira sp identified in Tissue by Organism specific culture |
|
20869-4
|
Leptospira sp [Presence] in Tissue by Organism specific culture |
|
20868-6
|
Leptospira sp [Presence] in Tissue by Immunofluorescence |
|
6455-0
|
Leptospira sp identified in Urine by Organism specific culture |
|
594-2
|
Leptospira sp identified in Unspecified specimen by Organism specific culture |
|
51852-2
|
Letter |
|
7461-7
|
Lettuce triggered histamine release [Units/volume] in Blood |
|
6161-4
|
Lettuce IgE Ab [Units/volume] in Serum |
|
61280-4
|
Lettuce IgE Ab/IgE total in Serum |
|
7460-9
|
Lettuce IgG Ab [Units/volume] in Serum |
|
56307-2
|
Lettuce IgG4 Ab [Mass/volume] in Serum |
|
51919-9
|
Lettuce IgG Ab [Mass/volume] in Serum |
|
57996-1
|
Leucine+Isoleucine [Mass/volume] in DBS |
|
32783-3
|
Leucine+Isoleucine+Valine [Identifier] in Serum or Plasma |
|
47679-6
|
Leucine [Moles/volume] in DBS |
|
55933-6
|
Leucine [Moles/mass] in Hair |
|
74882-2
|
Leucine [Moles/volume] in DBS --post therapeutic diet |
|
47682-0
|
Leucine/Amino acids.total in Amniotic fluid |
|
47681-2
|
Leucine/Amino acids.total in Cerebral spinal fluid |
|
47684-6
|
Leucine/Amino acids.total in DBS |
|
47680-4
|
Leucine/Amino acids.total in Hair |
|
47683-8
|
Leucine/Amino acids.total in Serum or Plasma |
|
47685-3
|
Leucine/Amino acids.total in Unspecified specimen |
|
49834-5
|
Leucine [Presence] in Urine |
|
57994-6
|
Leucine/Alanine [Mass Ratio] in DBS |
|
44334-1
|
Leucine/Creatinine [Mass Ratio] in 24 hour Urine |
|
75268-3
|
Leucine/Phenylalanine [Molar ratio] in DBS |
|
12726-6
|
Leucine-enkephalin [Units/volume] in Serum or Plasma |
|
72104-3
|
Acute and chronic leukemia fusion transcript per control transcript panel - Blood or Tissue by Molecular genetics method |
|
74347-6
|
Leukocyte aggregates [Presence] in Blood by Light microscopy |
|
59262-6
|
Leukocyte esterase [Presence] in Cerebral spinal fluid by Test strip |
|
77563-5
|
Leukocyte esterase [Presence] in Body fluid by Automated test strip |
|
60026-2
|
Leukocyte esterase [Presence] in Urine by Automated test strip |
|
27297-1
|
Leukocyte esterase [Units/volume] in Urine |
|
2563-5
|
Leukocyte esterase [Enzymatic activity/volume] in Leukocytes |
|
48808-0
|
Leukogram panel - Blood |
|
73315-4
|
Leuprolide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73314-7
|
Leuprolide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73313-9
|
Levalbuterol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73312-1
|
Levalbuterol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59291-5
|
Levamisole [Mass/volume] in Blood |
|
59292-3
|
Levamisole [Mass/volume] in Body fluid |
|
59293-1
|
Levamisole [Mass/volume] in Serum or Plasma |
|
59294-9
|
Levamisole [Mass/mass] in Tissue |
|
59295-6
|
Levamisole [Mass/volume] in Urine |
|
80391-6
|
Level of care [Type] |
|
73006-9
|
levETIRAcetam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73005-1
|
levETIRAcetam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73311-3
|
levETIRAcetam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73310-5
|
levETIRAcetam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
30471-7
|
levETIRAcetam [Mass/volume] in Serum or Plasma |
|
48347-9
|
levETIRAcetam [Moles/volume] in Serum or Plasma |
|
42249-3
|
levETIRAcetam [Presence] in Urine by Screen method |
|
38159-0
|
levETIRAcetam [Mass/volume] in Urine |
|
87765-4
|
levETIRAcetam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73004-4
|
levoFLOXacin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73003-6
|
levoFLOXacin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48173-9
|
levoFLOXacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
73307-1
|
levoFLOXacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73306-3
|
levoFLOXacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
53716-7
|
levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
30532-6
|
levoFLOXacin [Mass/volume] in Serum or Plasma --peak |
|
21368-6
|
levoFLOXacin [Mass/volume] in Serum or Plasma |
|
30533-4
|
levoFLOXacin [Mass/volume] in Serum or Plasma --trough |
|
3713-5
|
Levorphanol [Mass/time] in 24 hour Urine |
|
3710-1
|
Levorphanol [Mass/volume] in Serum or Plasma |
|
20540-1
|
Levorphanol [Mass/volume] in Urine by Confirmatory method |
|
3711-9
|
Levorphanol [Presence] in Urine |
|
16213-1
|
Levorphanol [Presence] in Urine by Confirmatory method |
|
19516-4
|
Levorphanol [Presence] in Urine by Screen method |
|
3712-7
|
Levorphanol [Mass/volume] in Urine |
|
90795-6
|
Levothyroxine absorption panel - Serum or Plasma |
|
79484-2
|
Levulinate [Moles/volume] in Serum or Plasma |
|
79504-7
|
Levulinate/Creatinine [Molar ratio] in Urine |
|
93785-4
|
Large B-cell lymphoma classification panel - Tissue |
|
90830-1
|
Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
90831-9
|
Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
82985-3
|
Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82978-8
|
Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
15080-5
|
Lutropin [Units] in 24 hour Urine |
|
34333-5
|
Lutropin [Units/volume] in 24 hour Urine by 1st IRP |
|
29156-7
|
Lutropin [Units/volume] in 24 hour Urine |
|
6692-8
|
Lutropin [Moles/time] in 24 hour Urine |
|
10502-3
|
Lutropin Ag [Presence] in Tissue by Immune stain |
|
48581-3
|
Lutropin [Units/volume] in Serum or Plasma --on cycle day 11 |
|
48583-9
|
Lutropin [Units/volume] in Serum or Plasma --on cycle day 21 |
|
48582-1
|
Lutropin [Units/volume] in Serum or Plasma --on cycle day 3 |
|
47688-7
|
Lutropin [Units/volume] in Serum or Plasma --pre 100 ug lutenizing releasing hormone IV |
|
83103-2
|
Lutropin [Units/volume] in Serum or Plasma by Immunoassay |
|
20419-8
|
Lutropin [Units/volume] in Serum or Plasma by 1st IRP |
|
10501-5
|
Lutropin [Units/volume] in Serum or Plasma |
|
2579-1
|
Lutropin [Moles/volume] in Serum or Plasma |
|
2578-3
|
Lutropin [Moles/volume] in Semen |
|
25716-2
|
Lutropin [Units/volume] in Urine by 1st IRP |
|
15079-7
|
Lutropin [Units/volume] in Urine |
|
2580-9
|
Lutropin [Moles/volume] in Urine |
|
29157-5
|
Lutropin/Creatinine [Ratio] in 24 hour Urine |
|
13490-8
|
Lutropin/Creatinine [Mass Ratio] in Urine |
|
34334-3
|
Lutropin/Creatinine [Ratio] in Urine |
|
35358-1
|
LHON syndrome gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41093-6
|
LHON syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7462-5
|
Licorice IgE Ab [Units/volume] in Serum |
|
2516-3
|
L-iditol dehydrogenase [Enzymatic activity/volume] in Amniotic fluid |
|
2517-1
|
L-iditol dehydrogenase [Enzymatic activity/volume] in Serum |
|
3717-6
|
Lidocaine [Mass/volume] in Serum or Plasma -->45 minutes post bolus dose |
|
17076-1
|
Lidocaine [Mass/volume] in Body fluid |
|
41850-9
|
Lidocaine IgE Ab [Units/volume] in Serum |
|
73305-5
|
Lidocaine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73304-8
|
Lidocaine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48194-5
|
Lidocaine triggered leukotriene release [Mass/volume] by Leukocytes |
|
3715-0
|
Lidocaine [Presence] in Serum or Plasma |
|
35615-4
|
Lidocaine [Mass/volume] in Serum or Plasma by Screen method |
|
3714-3
|
Lidocaine [Mass/volume] in Serum or Plasma |
|
14812-2
|
Lidocaine [Moles/volume] in Serum or Plasma |
|
3716-8
|
Lidocaine [Presence] in Urine |
|
17075-3
|
Lidocaine [Mass/volume] in Urine |
|
32086-1
|
Lidocaine [Presence] in Unspecified specimen |
|
87759-7
|
Lifetime risk for developing genetic disease assessed Lifetime |
|
89559-9
|
Lifetime suicide risk score [CUBS] |
|
6162-2
|
Lilac IgE Ab [Units/volume] in Serum |
|
7131-6
|
Lima Bean IgE Ab [Units/volume] in Serum |
|
7132-4
|
Lima Bean IgG Ab [Units/volume] in Serum |
|
56308-0
|
Lima Bean IgG4 Ab [Mass/volume] in Serum |
|
63106-9
|
Lima Bean IgG Ab [Mass/volume] in Serum |
|
7464-1
|
Lime IgE Ab [Units/volume] in Serum |
|
57941-7
|
Lime IgE Ab/IgE total in Serum |
|
7465-8
|
Lime IgG Ab [Units/volume] in Serum |
|
56309-8
|
Lime IgG4 Ab [Mass/volume] in Serum |
|
60382-9
|
Lime IgG Ab [Mass/volume] in Serum |
|
6163-0
|
Lime Tree (Citrus aurantifolia tree) IgE Ab [Units/volume] in Serum |
|
87597-1
|
Lincomycin [Mass/mass] in Unspecified specimen |
|
38605-2
|
Lindane [Mass/volume] in Air |
|
16965-6
|
Lindane [Mass/volume] in Blood |
|
11097-3
|
Lindane [Mass/volume] in Serum or Plasma |
|
13643-2
|
Lindane [Mass/volume] in Urine |
|
87649-0
|
Lindane [Mass/mass] in Unspecified specimen |
|
11179-9
|
Linden IgE Ab [Units/volume] in Serum |
|
7466-6
|
Linen IgE Ab [Units/volume] in Serum |
|
80609-1
|
Linezolid [Mass/volume] in DBS |
|
73302-2
|
Linezolid induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73303-0
|
Linezolid induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
34202-2
|
Linezolid [Mass/volume] in Serum or Plasma |
|
75117-2
|
Linoleate (C18:2w6) [Entitic substance] in Red Blood Cells |
|
47686-1
|
Linoleate (C18:2w6)/Creatinine [Molar ratio] in Urine |
|
54312-4
|
Linoleoylcarnitine (C18:2) [Moles/volume] in Amniotic fluid |
|
54311-6
|
Linoleoylcarnitine (C18:2) [Moles/volume] in Cerebral spinal fluid |
|
45217-7
|
Linoleoylcarnitine (C18:2) [Moles/volume] in DBS |
|
54313-2
|
Linoleoylcarnitine (C18:2) [Moles/volume] in Urine |
|
54310-8
|
Linoleoylcarnitine (C18:2)/Creatinine [Molar ratio] in Urine |
|
25992-9
|
Lipase [Enzymatic activity/volume] in 24 hour Urine |
|
25543-0
|
Lipase [Enzymatic activity/time] in 24 hour Urine |
|
3039-5
|
Lipase [Enzymatic activity/volume] in Amniotic fluid |
|
88712-5
|
Lipase [Enzymatic activity/volume] in Peritoneal dialysis fluid |
|
55934-4
|
Lipase [Enzymatic activity/volume] in Dialysis fluid |
|
15212-4
|
Lipase [Enzymatic activity/volume] in Body fluid |
|
47418-9
|
Lipase [Enzymatic activity/volume] in Pleural fluid |
|
32722-1
|
Lipase [Enzymatic activity/volume] in Peritoneal fluid |
|
3040-3
|
Lipase [Enzymatic activity/volume] in Serum or Plasma |
|
10888-6
|
Lipase [Enzymatic activity/volume] in Urine |
|
24331-1
|
Lipid 1996 panel - Serum or Plasma |
|
57698-3
|
Lipid panel with direct LDL - Serum or Plasma |
|
12912-2
|
Lipids [Mass/volume] in Body fluid |
|
2569-2
|
Lipids [Mass/volume] in Serum |
|
7467-4
|
Lipolase IgE Ab [Units/volume] in Serum |
|
59062-0
|
Lipoprofile panel - Serum or Plasma |
|
91136-2
|
Lipoprotein metabolism panel - Serum or Plasma |
|
92722-8
|
Lipoprotein subparticle profile panel - Serum |
|
73002-8
|
Lisinopril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73001-0
|
Lisinopril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73301-4
|
Lisinopril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73300-6
|
Lisinopril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
84434-0
|
List Sorting Working Memory Test [NIH Toolbox] |
|
31488-0
|
Listeria sp Ab [Units/volume] in Cerebral spinal fluid |
|
23210-8
|
Listeria sp Ab [Presence] in Serum |
|
23211-6
|
Listeria sp Ab [Presence] in Serum by Agglutination |
|
26907-6
|
Listeria sp Ab [Titer] in Cerebral spinal fluid |
|
51461-2
|
Listeria sp Ab [Titer] in Serum |
|
49711-5
|
Listeria sp Ab [Titer] in Serum by Complement fixation |
|
20871-0
|
Listeria sp [Presence] in Cheese by Organism specific culture |
|
90100-9
|
Listeria sp identified in Isolate by Organism specific culture |
|
20870-2
|
Listeria sp [Presence] in Milk by Organism specific culture |
|
88265-4
|
Listeria sp tuf gene [Presence] by Probe in Positive blood culture |
|
6609-2
|
Listeria sp identified in Unspecified specimen by Organism specific culture |
|
38902-3
|
LITAF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38919-7
|
LITAF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
25714-7
|
Litchi IgE Ab [Units/volume] in Serum |
|
34330-1
|
Lithium [Moles/volume] in 24 hour Urine |
|
18477-0
|
Lithium [Moles/time] in 24 hour Urine |
|
25461-5
|
Lithium [Moles/volume] in Blood |
|
3722-6
|
Lithium renal clearance in 24 hour Urine and Serum or Plasma |
|
17086-0
|
Lithium [Mass/volume] in Body fluid |
|
80970-7
|
Lithium free [Moles/volume] in Serum or Plasma |
|
56032-6
|
Lithium [Moles/volume] in Gastric fluid |
|
3718-4
|
Lithium [Mass/mass] in Hair |
|
50872-1
|
Lithium [Moles/mass] in Hair |
|
9815-2
|
Lithium [Mass/volume] in Red Blood Cells |
|
25462-3
|
Lithium [Moles/volume] in Red Blood Cells |
|
9358-3
|
Lithium [Mass/volume] in Saliva (oral fluid) |
|
43176-7
|
Lithium [Moles/volume] in Saliva (oral fluid) |
|
3720-0
|
Lithium [Presence] in Serum or Plasma |
|
3719-2
|
Lithium [Mass/volume] in Serum or Plasma |
|
14334-7
|
Lithium [Moles/volume] in Serum or Plasma |
|
18238-6
|
Lithium [Mass/mass] in Tissue |
|
3723-4
|
Lithium [Mass/volume] in Serum or Plasma --trough |
|
74806-1
|
Lithium [Moles/volume] in Serum or Plasma --trough |
|
3721-8
|
Lithium [Mass/volume] in Urine |
|
25463-1
|
Lithium [Moles/volume] in Urine |
|
34331-9
|
Lithium/Creatinine [Molar ratio] in Urine |
|
2577-5
|
Lithocholate [Mass/volume] in Serum |
|
74897-0
|
Lithocholate [Moles/volume] in Serum or Plasma |
|
93936-3
|
little c Ag [Presence] on Red Blood Cells --during infancy |
|
92529-7
|
little c Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92491-0
|
little c Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93926-4
|
little c Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93919-9
|
little c Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
1159-3
|
little c Ag [Presence] on Red Blood Cells |
|
93944-7
|
little c Ag [Presence] in Cord red blood cells |
|
65331-1
|
little cE Ab [Presence] in Serum or Plasma |
|
93911-6
|
little cE Ag [Presence] on Red Blood Cells |
|
93935-5
|
little e Ag [Presence] on Red Blood Cells --during infancy |
|
92528-9
|
little e Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92490-2
|
little e Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93925-6
|
little e Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant |
|
93918-1
|
little e Ag [Presence] on Red Blood Cells --after transfusion reaction |
|
1165-0
|
little e Ag [Presence] on Red Blood Cells |
|
93943-9
|
little e Ag [Presence] in Cord red blood cells |
|
1171-8
|
little f Ag [Presence] on Red Blood Cells |
|
10408-3
|
little i Ag [Presence] on Red Blood Cells |
|
92527-1
|
little k Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92489-4
|
little k Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1195-7
|
little k Ag [Presence] on Red Blood Cells |
|
88041-9
|
little p phenotype [Presence] on Red Blood Cells from Blood product unit |
|
88042-7
|
little p phenotype [Presence] on Red Blood Cells from Donor |
|
88039-3
|
little p phenotype [Presence] on Red Blood Cells |
|
92526-3
|
little s Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92488-6
|
little s Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1213-8
|
little s Ag [Presence] on Red Blood Cells |
|
7144-9
|
Liver beef triggered histamine release [Units/volume] in Blood |
|
7469-0
|
Liver calf IgE Ab [Units/volume] in Serum |
|
90293-2
|
Liver cancer antibodies and AFP panel - Serum or Plasma by Immunoassay |
|
13175-5
|
Liver cytosol Ab [Presence] in Serum |
|
57748-6
|
Liver cytosol Ab [Presence] in Serum by Immunoassay |
|
56719-8
|
Liver cytosol Ab [Presence] in Serum by Immunoblot |
|
34621-3
|
Liver cytosol Ab [Units/volume] in Serum |
|
63395-8
|
Liver cytosol Ab [Titer] in Serum by Immunofluorescence |
|
82921-8
|
Liver cytosol IgG Ab [Presence] in Serum by Line blot |
|
85092-5
|
Autoimmune liver diseases IgG panel - Serum or Plasma by Line blot |
|
78699-6
|
Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter |
|
78698-8
|
Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore |
|
78894-3
|
Liver fibrosis score in Serum or Plasma Calculated by HepaScore |
|
88055-9
|
Liver fibrosis score in Serum or Plasma by Calculated by ELF |
|
77616-1
|
Liver fibrosis score in Serum or Plasma Calculated by FibroMeter |
|
88447-8
|
Liver fibrosis interpretation in Serum Qualitative |
|
7468-2
|
Liver IgE Ab [Units/volume] in Serum |
|
65752-8
|
Liver Pathology biopsy report |
|
48548-2
|
Living with HIV (LIV-HIV) panel |
|
14272-9
|
Liver kidney microsomal Ab [Presence] in Serum |
|
56760-2
|
Liver kidney microsomal Ab [Presence] in Serum by Immunoblot |
|
53030-3
|
Liver kidney microsomal Ab [Presence] in Serum by Immunofluorescence |
|
11566-7
|
Liver kidney microsomal Ab [Units/volume] in Serum |
|
9838-4
|
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence |
|
82842-6
|
Liver kidney microsomal IgG Ab [Presence] in Serum by Immunofluorescence |
|
50629-5
|
Liver kidney microsomal IgG Ab [Titer] in Serum |
|
46982-5
|
Liver kidney microsomal IgG Ab [Titer] in Serum by Immunofluorescence |
|
63272-9
|
Liver kidney microsomal 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63270-3
|
Liver kidney microsomal 1 Ab [Presence] in Body fluid by Immunofluorescence |
|
30535-9
|
Liver kidney microsomal 1 Ab [Presence] in Serum |
|
59072-9
|
Liver kidney microsomal 1 Ab [Presence] in Serum by Immunoblot |
|
58907-7
|
Liver kidney microsomal 1 Ab [Presence] in Serum by Immunofluorescence |
|
32220-6
|
Liver kidney microsomal 1 Ab [Units/volume] in Serum |
|
63273-7
|
Liver kidney microsomal 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63271-1
|
Liver kidney microsomal 1 Ab [Titer] in Body fluid by Immunofluorescence |
|
57434-3
|
Liver kidney microsomal 1 Ab [Titer] in Serum by Immunofluorescence |
|
47318-1
|
Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
43234-4
|
Liver kidney microsomal 1 IgG Ab [Presence] in Serum |
|
69952-0
|
Liver kidney microsomal 1 IgG Ab [Presence] in Serum by Immunoassay |
|
43202-1
|
Liver kidney microsomal 1 IgG Ab [Units/volume] in Serum |
|
63274-5
|
Liver kidney microsomal 2 Ab [Presence] in Serum by Immunofluorescence |
|
63275-2
|
Liver kidney microsomal 2 Ab [Titer] in Serum by Immunofluorescence |
|
7470-8
|
Llama fur IgE Ab [Units/volume] in Serum |
|
19512-3
|
Levomethamphetamine [Mass/volume] in Urine by Confirmatory method |
|
19511-5
|
Levomethamphetamine [Presence] in Urine by Confirmatory method |
|
19510-7
|
Levomethamphetamine [Presence] in Urine by Screen method |
|
12478-4
|
Levomethamphetamine [Mass/volume] in Urine |
|
35297-1
|
LMNA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49705-7
|
LMNA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
45274-8
|
Low molecular weight heparin induced platelet Ab [Presence] in Serum |
|
3272-2
|
LMW Heparin [Mass/time] in 24 hour Urine |
|
3271-4
|
LMW Heparin [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3270-6
|
LMW Heparin [Units/volume] in Platelet poor plasma by Coagulation assay |
|
32684-3
|
LMW Heparin [Units/volume] in Platelet poor plasma |
|
3279-7
|
Kininogen LMW [Mass/volume] in Platelet poor plasma by Immunoassay |
|
3280-5
|
Kininogen LMW [Mass/volume] in Serum by Immunoassay |
|
53875-1
|
LMX1B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
66112-4
|
Lymph node Pathology biopsy report |
|
7608-3
|
Loblolly Pine IgE Ab [Units/volume] in Serum |
|
6165-5
|
Lobster IgE Ab [Units/volume] in Serum |
|
39546-7
|
Lobster IgE Ab/IgE total in Serum |
|
7471-6
|
Lobster IgG Ab [Units/volume] in Serum |
|
56310-6
|
Lobster IgG4 Ab [Mass/volume] in Serum |
|
60383-7
|
Lobster IgG Ab [Mass/volume] in Serum |
|
7472-4
|
Locust tree IgE Ab [Units/volume] in Serum |
|
56311-4
|
Locust tree IgG4 Ab [Mass/volume] in Serum |
|
21461-9
|
Lodgepole Pine+Pondersosa Pine IgE Ab [Units/volume] in Serum |
|
6672-0
|
Microscopic observation [Identifier] in Tissue by Methylene blue stain.Loeffler |
|
671-8
|
Microscopic observation [Identifier] in Unspecified specimen by Methylene blue stain.Loeffler |
|
65781-7
|
London Plane native (nPla a) 2 IgE Ab [Units/volume] in Serum |
|
64969-9
|
London Plane recombinant (rPla a) 1 IgE Ab [Units/volume] in Serum |
|
64970-7
|
London Plane recombinant (rPla a) 3 IgE Ab [Units/volume] in Serum |
|
15285-0
|
London Plane IgE Ab [Units/volume] in Serum |
|
61302-6
|
London Plane IgE Ab/IgE total in Serum |
|
84957-0
|
Loneliness Survey - fixed length form - ages 18+ [NIH Toolbox] |
|
84958-8
|
Loneliness Survey - fixed length form - ages 8-17 [NIH Toolbox] |
|
10955-3
|
Long Leaf Pine IgE Ab [Units/volume] in Serum |
|
85645-0
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 3.00 [CMS Assessment] |
|
87509-6
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 4.00 [CMS Assessment] |
|
93222-8
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00 [CMS Assessment] |
|
85671-6
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 3.00 [CMS Assessment] |
|
87506-2
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 4.00 [CMS Assessment] |
|
93219-4
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00 [CMS Assessment] |
|
85662-5
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 3.00 [CMS Assessment] |
|
87507-0
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 4.00 [CMS Assessment] |
|
93221-0
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00 [CMS Assessment] |
|
85668-2
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 3.00 [CMS Assessment] |
|
87508-8
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 4.00 [CMS Assessment] |
|
93220-2
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00 [CMS Assessment] |
|
85654-2
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 3.00 [CMS Assessment] |
|
87505-4
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 4.00 [CMS Assessment] |
|
93223-6
|
Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00 [CMS Assessment] |
|
60095-7
|
Loperamide [Mass/volume] in Blood |
|
73299-0
|
Loperamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73298-2
|
Loperamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17087-8
|
Loperamide [Mass/volume] in Serum or Plasma |
|
60096-5
|
Loperamide [Mass/volume] in Urine |
|
31179-5
|
Lopinavir [Mass/volume] in Serum or Plasma |
|
51921-5
|
Lopinavir [Mass/volume] in Serum or Plasma --trough |
|
57997-9
|
Lopinavir+Ritonavir [Susceptibility] by Phenotype method |
|
73000-2
|
Loratadine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72999-6
|
Loratadine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60097-3
|
Loratadine [Mass/volume] in Blood |
|
73297-4
|
Loratadine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73296-6
|
Loratadine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
27070-2
|
Loratadine [Mass/volume] in Serum or Plasma |
|
60098-1
|
Loratadine [Mass/volume] in Urine |
|
59700-5
|
LORazepam [Mass/volume] in Blood by Confirmatory method |
|
59699-9
|
LORazepam [Mass/volume] in Blood |
|
59702-1
|
LORazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59701-3
|
LORazepam [Mass/volume] in Body fluid |
|
52945-3
|
LORazepam [Presence] in Gastric fluid |
|
29344-9
|
LORazepam [Mass/volume] in Gastric fluid |
|
47114-4
|
LORazepam [Moles/volume] in Gastric fluid |
|
94109-6
|
LORazepam glucuronide [Presence] in Urine by Screen method |
|
26838-3
|
LORazepam [Mass/mass] in Hair |
|
73295-8
|
LORazepam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73294-1
|
LORazepam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26934-0
|
LORazepam [Mass/mass] in Meconium |
|
72754-5
|
LORazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72380-9
|
LORazepam [Mass/volume] in Saliva (oral fluid) |
|
59703-9
|
LORazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13565-7
|
LORazepam [Presence] in Serum or Plasma |
|
35616-2
|
LORazepam [Mass/volume] in Serum or Plasma by Screen method |
|
3724-2
|
LORazepam [Mass/volume] in Serum or Plasma |
|
14817-1
|
LORazepam [Moles/volume] in Serum or Plasma |
|
12380-2
|
LORazepam [Presence] in Stool |
|
27237-7
|
LORazepam [Mass/mass] in Stool |
|
59704-7
|
LORazepam [Mass/mass] in Tissue |
|
74980-4
|
LORazepam [Mass/volume] in Serum or Plasma --trough |
|
17088-6
|
LORazepam [Mass/volume] in Urine by Confirmatory method |
|
18187-5
|
LORazepam [Presence] in Urine |
|
16205-7
|
LORazepam [Presence] in Urine by Confirmatory method |
|
19520-6
|
LORazepam [Presence] in Urine by Screen method |
|
3725-9
|
LORazepam [Mass/volume] in Urine |
|
47115-1
|
LORazepam [Moles/volume] in Urine |
|
26851-6
|
LORazepam [Mass/volume] in Vitreous fluid |
|
61044-4
|
LORazepam [Presence] in Unspecified specimen |
|
48955-9
|
LORazepam [Mass/volume] in Unspecified specimen |
|
77326-7
|
LORazepam [Moles/volume] in Unspecified specimen |
|
58366-6
|
LORazepam/Creatinine [Mass Ratio] in Urine |
|
17089-4
|
Lorcainide [Mass/volume] in Serum or Plasma |
|
34332-7
|
Lormetazepam [Mass/volume] in Serum or Plasma |
|
20541-9
|
Lormetazepam [Mass/volume] in Urine by Confirmatory method |
|
19525-5
|
Lormetazepam [Presence] in Urine by Confirmatory method |
|
19524-8
|
Lormetazepam [Presence] in Urine by Screen method |
|
3726-7
|
Lormetazepam [Mass/volume] in Urine |
|
72998-8
|
Losartan induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72997-0
|
Losartan induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73292-5
|
Losartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73293-3
|
Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
46107-9
|
Loss of interest Set |
|
15278-5
|
Lovage IgE Ab [Units/volume] in Serum |
|
73291-7
|
Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73290-9
|
Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60099-9
|
Loxapine [Mass/volume] in Blood |
|
3727-5
|
Loxapine [Presence] in Serum or Plasma |
|
3728-3
|
Loxapine [Mass/volume] in Serum or Plasma |
|
32087-9
|
Loxapine [Moles/volume] in Serum or Plasma |
|
89972-4
|
Loxapine [Mass/volume] in Urine by Confirmatory method |
|
3729-1
|
Loxapine [Presence] in Urine |
|
60100-5
|
Loxapine [Mass/volume] in Urine |
|
6691-0
|
Loxapine+8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
|
17090-2
|
Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma |
|
92930-7
|
LPA gene.c.3947+467T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
92931-5
|
LPA gene.c.5673A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
35387-0
|
Cholesterol. in Lipoprotein (a) [Presence] in Serum or Plasma |
|
35388-8
|
Cholesterol. in Lipoprotein (a) [Mass/volume] in Serum or Plasma |
|
10835-7
|
Lipoprotein a [Mass/volume] in Serum or Plasma |
|
43583-4
|
Lipoprotein a [Moles/volume] in Serum or Plasma |
|
35361-5
|
Triglyceride in Lipoprotein a [Presence] in Serum or Plasma |
|
35360-7
|
Triglyceride in Lipoprotein a [Mass/volume] in Serum or Plasma |
|
2572-6
|
Lipoprotein lipase [Enzymatic activity/volume] in Serum or Plasma |
|
84188-2
|
Licensed practical nurse Long term care facility Note |
|
75437-4
|
Licensed practical nurse Note |
|
84189-0
|
Licensed practical nurse Outpatient Note |
|
39804-0
|
Lipoprotein associated phospholipase A2 [Mass/volume] in Serum or Plasma |
|
45360-5
|
Lymphocyte proliferation stimulated by 0.125 ug pokeweed mitogen in Blood |
|
45361-3
|
Lymphocyte proliferation stimulated by 0.25 ug pokeweed mitogen in Blood |
|
45369-6
|
Lymphocyte proliferation stimulated by 0.5 ug phytohemagglutinin in Blood |
|
38277-0
|
Lymphocyte proliferation stimulated by 0.5 ug/mL Candida albicans [Units/volume] in Blood |
|
45362-1
|
Lymphocyte proliferation stimulated by 0.50 ug pokeweed mitogen in Blood |
|
49676-0
|
Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --5 days post incubation |
|
49677-8
|
Lymphocyte proliferation stimulated by 1 umol beryllium [Ratio] in Blood --7 day post incubation |
|
45363-9
|
Lymphocyte proliferation stimulated by 1.0 ug phytohemagglutinin in Blood |
|
45364-7
|
Lymphocyte proliferation stimulated by 1.0 ug pokeweed mitogen [Units/volume] in Blood |
|
38278-8
|
Lymphocyte proliferation stimulated by 1.0 ug/mL Candida albicans [Units/volume] in Blood |
|
45365-4
|
Lymphocyte proliferation stimulated by 10 ug concanavalin A in Blood |
|
49674-5
|
Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Blood --5 days post incubation |
|
49917-8
|
Lymphocyte proliferation stimulated by 10 umol beryllium [Ratio] in Leukocytes --6 days post incubation |
|
49675-2
|
Lymphocyte proliferation stimulated by 10 umol beryllium [Units/volume] in Blood --7 day post incubation |
|
48661-3
|
Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --5 days post incubation |
|
49673-7
|
Lymphocyte proliferation stimulated by 100 umol beryllium [Ratio] in Blood --7 day post incubation |
|
38284-6
|
Lymphocyte proliferation stimulated by 19.3 ug/mL tetanus toxoid [Units/volume] in Blood |
|
45366-2
|
Lymphocyte proliferation stimulated by 2.0 ug phytohemagglutinin in Blood |
|
38281-2
|
Lymphocyte proliferation stimulated by 2.41 ug/mL tetanus toxoid [Units/volume] in Blood |
|
38279-6
|
Lymphocyte proliferation stimulated by 2.5 ug/mL Candida albicans [Units/volume] in Blood |
|
45367-0
|
Lymphocyte proliferation stimulated by 20 ug concanavalin A in Blood |
|
38282-0
|
Lymphocyte proliferation stimulated by 4.83 ug/mL tetanus toxoid [Units/volume] in Blood |
|
45368-8
|
Lymphocyte proliferation stimulated by 5 ug concanavalin A in Blood |
|
38280-4
|
Lymphocyte proliferation stimulated by 5.0 ug/mL Candida albicans [Units/volume] in Blood |
|
38283-8
|
Lymphocyte proliferation stimulated by 9.67 ug/mL tetanus toxoid [Units/volume] in Blood |
|
33931-7
|
Lymphocyte proliferation stimulated by Borrelia burgdorferi [Ratio] in Blood |
|
49885-7
|
Lymphocyte proliferation.beryllium stimulation panel - Blood |
|
33639-6
|
Lymphocyte proliferation stimulated by Candida albicans [Units/volume] in Blood |
|
49921-0
|
Lymphocyte proliferation stimulated by concanavalin A in Blood |
|
69015-6
|
Lymphocyte proliferation.Candida albicans.maximum/CD3 in Blood by Flow cytometry (FC) |
|
57741-1
|
Lymphocyte proliferation stimulated by OKT3 in Blood |
|
49682-8
|
Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood --3 days post incubation |
|
33638-8
|
Lymphocyte proliferation stimulated by phytohemagglutinin [Mass/volume] in Blood |
|
49922-8
|
Lymphocyte proliferation stimulated by phytohemagglutinin in Blood |
|
48662-1
|
Lymphocyte proliferation stimulated by phytohemagglutinin [Ratio] in Blood |
|
49923-6
|
Lymphocyte proliferation stimulated by pokeweed mitogen in Blood |
|
49884-0
|
Lymphocyte proliferation stimulated by tetanus toxoid [Ratio] in Blood --7 day post incubation |
|
33640-4
|
Lymphocyte proliferation stimulated by tetanus toxoid [Units/volume] in Blood |
|
33641-2
|
Lymphocyte proliferation stimulated by tuberculin [Units/volume] in Blood |
|
42178-4
|
Lipoprotein.X [Presence] in Serum or Plasma |
|
53876-9
|
LRRK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82139-7
|
LRRK2 gene Arg1441Gly and Gly2019Ser targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
61094-9
|
Lysergate diethylamide [Presence] in Gastric fluid |
|
73726-2
|
Lysergate diethylamide [Presence] in Hair |
|
73730-4
|
Lysergate diethylamide [Presence] in Meconium |
|
62300-9
|
Lysosomal storage disorders newborn screening panel |
|
3730-9
|
Lysergate diethylamide [Presence] in Serum or Plasma |
|
5678-8
|
Lysergate diethylamide [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
3731-7
|
Lysergate diethylamide [Mass/volume] in Serum or Plasma |
|
20542-7
|
Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method |
|
3732-5
|
Lysergate diethylamide [Presence] in Urine |
|
16214-9
|
Lysergate diethylamide [Presence] in Urine by Confirmatory method |
|
19528-9
|
Lysergate diethylamide [Presence] in Urine by Screen method |
|
33350-0
|
Lysergate diethylamide [Mass/volume] in Urine by Screen method |
|
5679-6
|
Lysergate diethylamide [Mass/volume] in Urine |
|
61065-9
|
Lysergate diethylamide [Presence] in Unspecified specimen |
|
23216-5
|
Lumpy skin disease virus Ab [Presence] in Serum |
|
23214-0
|
Lumpy skin disease virus Ab [Presence] in Serum by Immunoblot |
|
23215-7
|
Lumpy skin disease virus Ab [Presence] in Serum by Neutralization test |
|
31489-8
|
Lumpy skin disease virus Ab [Units/volume] in Serum |
|
23217-3
|
Lumpy skin disease virus Ab [Titer] in Serum |
|
23213-2
|
Lumpy skin disease virus Ab [Titer] in Serum by Immunofluorescence |
|
23218-1
|
Lumpy skin disease virus Ag [Presence] in Tissue by Immunoassay |
|
23220-7
|
Lumpy skin disease virus Ag [Presence] in Unspecified specimen |
|
23219-9
|
Lumpy skin disease virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23222-3
|
Lumpy skin disease virus Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
23221-5
|
Lumpy skin disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23223-1
|
Lumpy skin disease virus DNA [Presence] in Unspecified specimen by RFLP |
|
23212-4
|
Lumpy skin disease virus [Presence] in Tissue by Electron microscopy |
|
44775-5
|
Liver transplant anastomosis site Portal vein from Graft |
|
63425-3
|
Bacterial heat-labile enterotoxin LT gene [Presence] in Unspecified specimen by NAA with probe detection |
|
85189-9
|
Long term care facility Admission evaluation note |
|
85190-7
|
Long term care facility Annual evaluation note |
|
85191-5
|
Long term care facility Conference note |
|
51854-8
|
Long term care facility Consult note |
|
85192-3
|
Long term care facility Discharge summary |
|
85193-1
|
Long term care facility Education note |
|
85194-9
|
Long term care facility Fall risk assessment note |
|
85195-6
|
Long term care facility Group counseling note |
|
85196-4
|
Long term care facility History and physical note |
|
85185-7
|
Long term care facility Initial evaluation note |
|
75438-2
|
Long term care facility Note |
|
85186-5
|
Long term care facility Plan of care note |
|
85199-8
|
Long term care facility Referral note |
|
85188-1
|
Long term care facility Respite note |
|
85880-3
|
Long term care facility Restraint note |
|
85197-2
|
Long term care facility Risk assessment and screening note |
|
85187-3
|
Long term care facility Transfer summary note |
|
7451-8
|
Latex ALK triggered histamine release [Units/volume] in Blood |
|
7452-6
|
Latex Bencard triggered histamine release [Units/volume] in Blood |
|
17047-2
|
Latex Bencard IgE Ab [Units/volume] in Serum |
|
17049-8
|
Latex glove extract ammoniated IgE Ab [Units/volume] in Blood |
|
6845-2
|
Latex glove extract ammoniated IgE Ab [Units/volume] in Serum |
|
17050-6
|
Latex glove extract buffered IgE Ab [Units/volume] in Blood |
|
6846-0
|
Latex glove extract buffered IgE Ab [Units/volume] in Serum |
|
17048-0
|
Latex glove extract IgE Ab [Units/volume] in Blood |
|
6728-0
|
Latex glove extract IgE Ab [Units/volume] in Serum |
|
7453-4
|
Latex Greer triggered histamine release [Units/volume] in Blood |
|
17045-6
|
Latex IgE Ab [Units/volume] in Blood |
|
6158-0
|
Latex IgE Ab [Units/volume] in Serum |
|
48402-2
|
Latex IgE Ab/IgE total in Serum |
|
17046-4
|
Latex IgG Ab [Units/volume] in Serum |
|
56441-9
|
Latex IgG4 Ab [Mass/volume] in Serum |
|
63161-4
|
Latex IgG Ab [Mass/volume] in Serum |
|
48188-7
|
Latex triggered leukotriene release [Mass/volume] by Leukocytes |
|
7454-2
|
Latex Stallerg triggered histamine release [Units/volume] in Blood |
|
65327-9
|
Lu 14 Ab [Presence] in Serum or Plasma |
|
93907-4
|
Lu 20 Ag [Presence] on Red Blood Cells |
|
92531-3
|
Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92493-6
|
Lu sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1138-7
|
Lu sup(a) Ag [Presence] on Red Blood Cells |
|
92530-5
|
Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92492-8
|
Lu sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1147-8
|
Lu sup(b) Ag [Presence] on Red Blood Cells |
|
17091-0
|
Lumpfish roe IgE Ab [Units/volume] in Serum |
|
88863-6
|
Lung cancer antibody panel - Serum or Plasma by Immunoassay |
|
66107-4
|
Lung Pathology biopsy report |
|
11180-7
|
Lupin IgE Ab [Units/volume] in Serum |
|
50650-1
|
Lupin seed IgE Ab [Units/volume] in Serum |
|
93437-2
|
Lurasidone [Mass/volume] in Serum or Plasma |
|
78884-4
|
Lurasidone [Mass/volume] in Urine by Confirmatory method |
|
75919-1
|
Left ventricular Cardiac index |
|
75988-6
|
Left ventricular End diastolic volume |
|
60974-3
|
Left ventricular Ejection Time |
|
75989-4
|
Left ventricular End systolic volume |
|
81393-1
|
Left ventricular Myocardial performance index (Tei) by US.doppler |
|
81095-2
|
Left ventricular Myocardial mass/Body surface area [Mass/Area] by US.2D+Calculated by Devereux method |
|
81390-7
|
Left ventricular Cardiac output by US 3D |
|
76519-8
|
Left ventricular Cardiac output by Continuous |
|
60973-5
|
Left ventricular Pre ejection Time |
|
76297-1
|
Left ventricular Stroke volume index |
|
78950-3
|
Left ventricle Segmental wall motion panel by Angiogram |
|
81391-5
|
Left ventricular outflow tract Ejection time by US.doppler |
|
1219-5
|
LW Ag [Presence] on Red Blood Cells |
|
65328-7
|
LW sup(a) Ab [Presence] in Serum or Plasma |
|
92525-5
|
LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92487-8
|
LW sup(a) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
92524-8
|
LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92486-0
|
LW sup(b) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
27075-1
|
Lycopene [Moles/volume] in Plasma |
|
11181-5
|
Lycopodium spp IgE Ab [Units/volume] in Serum |
|
68406-8
|
Abnormal lymphocytes/100 leukocytes in Vitreous fluid by Manual count |
|
90416-9
|
Lymphocyte subset and B-cell phenotyping panel - Blood |
|
80721-4
|
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood |
|
80718-0
|
Lymphocyte TCR gamma delta and alpha beta subsets panel - Blood |
|
52048-6
|
Lymphedema pump attachment |
|
33642-0
|
Lymphocyte Ab [Units/volume] in Serum by Flow cytometry (FC) |
|
69042-0
|
Lymphocyte proliferation antigen panel - Blood by Flow cytometry (FC) |
|
69018-0
|
Lymphocyte proliferation mitogen panel - Blood by Flow cytometry (FC) |
|
59063-8
|
Lymphocyte proliferation panel - Blood |
|
66140-5
|
Lymphocytes [#/volume] in Blood from Fetus by Manual count |
|
68404-3
|
Lymphocytes [#/volume] in Pericardial fluid by Manual count |
|
68405-0
|
Lymphocytes [#/volume] in Pleural fluid by Manual count |
|
51627-8
|
Lymphocytes [#/volume] in Peritoneal fluid by Manual count |
|
68407-6
|
Lymphocytes [#/volume] in Vitreous fluid by Manual count |
|
76409-2
|
Lymphocytes [#] in Body fluid by Manual count |
|
72364-3
|
Lymphocytes/100 leukocytes in Vitreous fluid by Manual count |
|
54227-4
|
Lymphoma - acute screen panel - Unspecified specimen by Flow cytometry (FC) |
|
54228-2
|
Lymphoma - CLL screen panel - Unspecified specimen by Flow cytometry (FC) |
|
54229-0
|
Lymphoma - T-cell screen panel - Unspecified specimen by Flow cytometry (FC) |
|
54226-6
|
Lymphoma panel - Unspecified specimen by Flow cytometry (FC) |
|
48273-7
|
Lysine acetylsalicylate triggered leukotriene release [Mass/volume] by Leukocytes |
|
47689-5
|
Lysine [Moles/volume] in DBS |
|
55935-1
|
Lysine [Moles/mass] in Hair |
|
47692-9
|
Lysine/Amino acids.total in Amniotic fluid |
|
47691-1
|
Lysine/Amino acids.total in Cerebral spinal fluid |
|
47694-5
|
Lysine/Amino acids.total in DBS |
|
47690-3
|
Lysine/Amino acids.total in Hair |
|
47693-7
|
Lysine/Amino acids.total in Serum or Plasma |
|
47695-2
|
Lysine/Amino acids.total in Unspecified specimen |
|
44335-8
|
Lysine/Creatinine [Mass Ratio] in 24 hour Urine |
|
82740-2
|
Lysoganglioside GM1 IgG Ab [Titer] in Serum by Immunoassay |
|
2588-2
|
Lysolecithin acyltransferase [Enzymatic activity/volume] in Red Blood Cells |
|
75736-9
|
Lysophosphatidylcholine(16:0) [Moles/volume] in Plasma |
|
75737-7
|
Lysophosphatidylcholine(18:0) [Moles/volume] in Plasma |
|
79320-8
|
Lysophosphatidylcholine(26:0) [Moles/volume] in Cerebral spinal fluid |
|
79567-4
|
Lysophosphatidylcholine(26:0) [Moles/volume] in DBS by LC/MS/MS |
|
79321-6
|
Lysophosphatidylcholine(26:0) [Moles/volume] in DBS |
|
79322-4
|
Lysophosphatidylcholine(26:0) [Moles/volume] in Serum or Plasma |
|
17231-2
|
Lysosomal enzymes [Identifier] in Plasma |
|
48311-5
|
Lysosomal enzymes screen [Identifier] in Blood |
|
14294-3
|
Lysosomal enzymes screen [Identifier] in Plasma and Urine |
|
54009-6
|
Lysosome Ab [Presence] in Serum by Immunofluorescence |
|
54010-4
|
Lysosome Ab [Titer] in Serum by Immunofluorescence |
|
56038-3
|
Lysozyme [Units] in 24 hour Urine |
|
34335-0
|
Lysozyme [Mass/volume] in 24 hour Urine |
|
2590-8
|
Lysozyme [Mass/time] in 24 hour Urine |
|
75640-3
|
Lysozyme [Moles/volume] in 24 hour Urine |
|
54019-5
|
Lysozyme Ab [Presence] in Serum |
|
10503-1
|
Lysozyme Ag [Presence] in Tissue by Immune stain |
|
55936-9
|
Lysozyme [Mass/volume] in Cerebral spinal fluid |
|
29956-0
|
Lysozyme [Mass/volume] in Body fluid |
|
11182-3
|
Lysozyme IgE Ab [Units/volume] in Serum |
|
54917-0
|
Lysozyme [Mass/volume] in Pleural fluid |
|
4665-6
|
Lysozyme [Enzymatic activity/volume] in Serum or Plasma |
|
2589-0
|
Lysozyme [Mass/volume] in Serum or Plasma |
|
6289-3
|
Lysozyme [Moles/volume] in Serum or Plasma |
|
27186-6
|
Lysozyme [Presence] in Stool |
|
17232-0
|
Lysozyme [Enzymatic activity/volume] in Tear |
|
56039-1
|
Lysozyme [Units/volume] in Urine |
|
10971-0
|
Lysozyme [Mass/volume] in Urine |
|
34336-8
|
Lysozyme/Creatinine [Ratio] in Urine |
|
34554-6
|
Electrolytes 1998 and Venous pH panel - Serum or Plasma + Blood venous |
|
24326-1
|
Electrolytes 1998 panel - Serum or Plasma |
|
75667-6
|
Electrolytes 3 panel - 24 hour Urine |
|
75641-1
|
Electrolytes 3 panel - Cerebral spinal fluid |
|
24327-9
|
Electrolytes 3 panel - Body fluid |
|
24328-7
|
Electrolytes 3 panel - Stool |
|
24329-5
|
Electrolytes 3 panel - Urine |
|
55231-5
|
Electrolytes panel - Blood |
|
77735-9
|
Mycobacterium abscessus complex clarithromycin resistance erm(41) truncated gene [Presence] by Molecular method |
|
77734-2
|
Mycobacterium abscessus complex clarithromycin resistance erm(41) full length gene [Presence] by Molecular method |
|
77736-7
|
Mycobacterium abscessus complex clarithromycin resistance erm(41) gene [Interpretation] by Molecular method |
|
77737-5
|
Mycobacterium abscessus complex clarithromycin resistance erm(41) gene panel by Molecular genetics method |
|
92523-0
|
M Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92485-2
|
M Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1231-0
|
M Ag [Presence] on Red Blood Cells |
|
23251-2
|
Mycoplasma agalactiae Ab [Presence] in Serum |
|
23249-6
|
Mycoplasma agalactiae Ab [Presence] in Serum by Complement fixation |
|
23250-4
|
Mycoplasma agalactiae Ab [Presence] in Serum by Immunoassay |
|
23248-8
|
Mycoplasma agalactiae Ab [Presence] in Serum by Neutralization test |
|
23252-0
|
Mycoplasma agalactiae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23253-8
|
Mycoplasma arginini Ab [Presence] in Serum |
|
23254-6
|
Mycoplasma arginini Ab [Presence] in Serum by Complement fixation |
|
82387-2
|
Mycobacterium avium tuberculin stimulated gamma interferon [Units/volume] in Blood |
|
23234-8
|
Mycobacterium avium ss avium Ab [Presence] in Blood |
|
23235-5
|
Mycobacterium avium ss avium Ab [Presence] in Blood by Agglutination |
|
23236-3
|
Mycobacterium avium ss avium rRNA [Presence] in Tissue by Probe |
|
5023-7
|
Mycobacterium avium ss avium rRNA [Presence] in Unspecified specimen by Probe |
|
23238-9
|
Mycobacterium avium ss avium serotype [Identifier] in Unspecified specimen |
|
23237-1
|
Mycobacterium avium ss avium identified in Unspecified specimen by Bioassay |
|
71719-9
|
Mycobacterium avium complex DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20463-6
|
Mycobacterium avium complex rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5022-9
|
Mycobacterium avium complex rRNA [Presence] in Unspecified specimen by Probe |
|
70671-3
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Milk by Immunoassay |
|
35268-2
|
Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum by Immunoassay |
|
22421-2
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum |
|
20894-2
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Complement fixation |
|
15483-1
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay |
|
15482-3
|
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID) |
|
41130-6
|
Mycobacterium avium ss paratuberculosis Ab [Units/volume] in Serum |
|
23246-2
|
Mycobacterium avium ss paratuberculosis DNA [Presence] in Stool by NAA with probe detection |
|
23245-4
|
Mycobacterium avium ss paratuberculosis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20893-4
|
Mycobacterium avium ss paratuberculosis [Presence] in Stool by Organism specific culture |
|
23243-9
|
Mycobacterium avium ss paratuberculosis [Presence] in Stool by Acid fast stain.Ziehl-Neelsen |
|
20892-6
|
Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Organism specific culture |
|
23244-7
|
Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Acid fast stain.Ziehl-Neelsen |
|
24427-7
|
Mycobacterium avium ss paratuberculosis [Presence] in Unspecified specimen by Organism specific culture |
|
85581-7
|
Mycobacterium avium and Mycobacterium intracellulare DNA [Identifier] in Sputum or Bronchial by NAA with probe detection |
|
23239-7
|
Mycobacterium bovis Ab [Presence] in Serum |
|
23240-5
|
Mycobacterium bovis Ab [Presence] in Serum by Immunoassay |
|
23242-1
|
Mycobacterium bovis Ag [Presence] in Blood |
|
23241-3
|
Mycobacterium bovis Ag [Presence] in Tissue by Immune stain |
|
53703-5
|
Mycobacterium bovis tuberculin stimulated gamma interferon panel - Blood |
|
82511-7
|
Mycobacterium bovis tuberculin stimulated gamma interferon [Units/volume] in Blood |
|
23259-5
|
Mycoplasma capricolum ss capricolum Ab [Presence] in Serum |
|
23258-7
|
Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Complement fixation |
|
23257-9
|
Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Immunoassay |
|
31508-5
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood |
|
23264-5
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood by Agglutination |
|
31510-1
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum |
|
23260-3
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Agglutination |
|
23266-0
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Complement fixation |
|
23263-7
|
Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Immunoassay |
|
31509-3
|
Mycoplasma capricolum ss capripneumonia Ab [Units/volume] in Serum |
|
23262-9
|
Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum |
|
23265-2
|
Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum by Complement fixation |
|
23270-2
|
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Tissue |
|
23269-4
|
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Unspecified specimen |
|
23268-6
|
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23267-8
|
Mycoplasma capricolum ss capripneumonia Ag [Presence] in Unspecified specimen by Neutralization test |
|
23272-8
|
Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23271-0
|
Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Unspecified specimen by Probe |
|
92966-1
|
Moraxella catarrhalis DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
92144-5
|
Moraxella catarrhalis DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
92965-3
|
Moraxella catarrhalis DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
17299-9
|
Mycoplasma fermentans Ab [Presence] in Serum |
|
34150-3
|
Mycoplasma fermentans DNA [Presence] in Blood by NAA with probe detection |
|
10949-6
|
Malassezia furfur IgE Ab [Units/volume] in Serum |
|
22422-0
|
Mycoplasma gallisepticum Ab [Presence] in Serum |
|
15484-9
|
Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination |
|
23273-6
|
Mycoplasma gallisepticum Ab [Presence] in Serum by Hemagglutination |
|
15485-6
|
Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay |
|
31511-9
|
Mycoplasma gallisepticum Ab [Units/volume] in Serum |
|
23275-1
|
Mycoplasma gallisepticum Ab [Titer] in Serum |
|
23274-4
|
Mycoplasma gallisepticum Ab [Titer] in Serum by Hemagglutination |
|
20895-9
|
Mycoplasma gallisepticum Ag [Presence] in Tissue by Immune stain |
|
31901-2
|
Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen |
|
23276-9
|
Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23277-7
|
Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen by Immune stain |
|
23278-5
|
Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen by Neutralization test |
|
23279-3
|
Mycoplasma gallisepticum DNA [Presence] in Nose or Trachea by NAA with probe detection |
|
15486-4
|
Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by Probe |
|
88229-0
|
Mycoplasma genitalium DNA [Presence] in Anorectal by NAA with probe detection |
|
89597-9
|
Mycoplasma genitalium DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88227-4
|
Mycoplasma genitalium DNA [Presence] in Cervix by NAA with probe detection |
|
91849-0
|
Mycoplasma genitalium DNA [Presence] in Genital specimen by NAA with probe detection |
|
91828-4
|
Mycoplasma genitalium DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88230-8
|
Mycoplasma genitalium DNA [Presence] in Throat by NAA with probe detection |
|
88226-6
|
Mycoplasma genitalium DNA [Presence] in Urine by NAA with probe detection |
|
91874-8
|
Mycoplasma genitalium DNA [Presence] in Urethra by NAA with probe detection |
|
88228-2
|
Mycoplasma genitalium DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
69935-5
|
Mycoplasma genitalium DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
45116-1
|
Mycobacterium gordonae rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5024-5
|
Mycobacterium gordonae rRNA [Presence] in Unspecified specimen by Probe |
|
17301-3
|
Mycoplasma hominis Ab [Presence] in Serum |
|
31512-7
|
Mycoplasma hominis Ab [Units/volume] in Serum |
|
22423-8
|
Mycoplasma hominis Ab [Titer] in Serum |
|
17300-5
|
Mycoplasma hominis Ab [Titer] in Serum by Complement fixation |
|
42621-3
|
Mycoplasma hominis DNA [Presence] in Blood by NAA with probe detection |
|
89598-7
|
Mycoplasma hominis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
91848-2
|
Mycoplasma hominis DNA [Presence] in Genital specimen by NAA with probe detection |
|
91827-6
|
Mycoplasma hominis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
68546-1
|
Mycoplasma hominis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
15388-2
|
Mycoplasma hominis [Presence] in Unspecified specimen by Organism specific culture |
|
80219-9
|
Mycoplasma hyopneumoniae Ab sample/Positive control in Serum by Immunoassay |
|
31513-5
|
Mycoplasma hyopneumoniae Ab [Presence] in Serum |
|
24428-5
|
Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunoassay |
|
23753-7
|
Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunofluorescence |
|
80217-3
|
Mycoplasma hyopneumoniae Ag [Presence] in Fixed tissue by Immune stain |
|
80244-7
|
Mycoplasma hyopneumoniae DNA (Cycle Threshold #) in Unspecified specimen by Probe and target amplification method |
|
90324-5
|
Mycoplasma hyopneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85527-0
|
Mycoplasma hyopneumoniae P146 gene sequence and phylogenetic analysis in Unspecified specimen Document |
|
93756-5
|
Mycoplasma hyorhinis IgG Ab/Positive control in Serum by Immunoassay |
|
5025-2
|
Mycobacterium intracellulare rRNA [Presence] in Unspecified specimen by Probe |
|
45117-9
|
Mycobacterium kansasii rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5026-0
|
Mycobacterium kansasii rRNA [Presence] in Unspecified specimen by Probe |
|
91805-2
|
Mycobacterium leprae DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
72868-3
|
Mycobacterium leprae folP1 gene dapsone resistance mutation [Presence] by Molecular method |
|
72869-1
|
Mycobacterium leprae gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method |
|
72863-4
|
Mycobacterium leprae gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method |
|
72870-9
|
Mycobacterium leprae rpoB gene rifAMPin resistance mutation [Presence] by Molecular method |
|
22424-6
|
Mycoplasma meleagridis Ab [Presence] in Serum |
|
15488-0
|
Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination |
|
23280-1
|
Mycoplasma meleagridis Ab [Presence] in Serum by Hemagglutination |
|
15487-2
|
Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay |
|
23282-7
|
Mycoplasma mycoides ss capri Ab [Presence] in Serum |
|
23281-9
|
Mycoplasma mycoides ss capri Ab [Presence] in Serum by Complement fixation |
|
31514-3
|
Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum |
|
23283-5
|
Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Complement fixation |
|
23284-3
|
Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Immunoassay |
|
23285-0
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum |
|
23289-2
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Agglutination |
|
23288-4
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Complement fixation |
|
23287-6
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoassay |
|
23286-8
|
Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoblot |
|
23292-6
|
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Tissue by Immune stain |
|
31902-0
|
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Unspecified specimen |
|
23290-0
|
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
|
23291-8
|
Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23293-4
|
Mycoplasma mycoides ss mycoides small colony DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47965-9
|
Mycoplasma penetrans DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
63173-9
|
Mycogone perniciosa IgG Ab [Mass/volume] in Serum |
|
7506-9
|
Mucor plumbeus IgE Ab [Units/volume] in Serum |
|
63172-1
|
Mucor plumbeus IgG Ab [Mass/volume] in Serum |
|
17303-9
|
Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid |
|
39012-0
|
Mycoplasma pneumoniae Ab [Presence] in Body fluid |
|
52987-5
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum by Complement fixation |
|
5252-2
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
|
17302-1
|
Mycoplasma pneumoniae Ab [Presence] in Serum |
|
5253-0
|
Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay |
|
7969-9
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum |
|
13268-8
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum --1st specimen |
|
24310-5
|
Mycoplasma pneumoniae Ab [Titer] in Serum --1st specimen |
|
24236-2
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --1st specimen |
|
13269-6
|
Mycoplasma pneumoniae Ab [Units/volume] in Serum --2nd specimen |
|
24311-3
|
Mycoplasma pneumoniae Ab [Titer] in Serum --2nd specimen |
|
24237-0
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
42993-6
|
Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid |
|
28548-6
|
Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
27318-5
|
Mycoplasma pneumoniae Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22425-3
|
Mycoplasma pneumoniae Ab [Titer] in Serum |
|
91896-1
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Agglutination |
|
5254-8
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation |
|
31202-5
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Immunofluorescence |
|
60533-7
|
Mycoplasma pneumoniae Ab [Titer] in Serum by Latex agglutination |
|
53255-6
|
Mycoplasma pneumoniae DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
49104-3
|
Mycoplasma pneumoniae DNA [Units/volume] in Blood by NAA with probe detection |
|
92964-6
|
Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88579-8
|
Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82177-7
|
Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88720-8
|
Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with probe detection |
|
92126-2
|
Mycoplasma pneumoniae DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91804-5
|
Mycoplasma pneumoniae DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
29257-3
|
Mycoplasma pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31515-0
|
Mycoplasma pneumoniae IgA Ab [Presence] in Serum |
|
26684-1
|
Mycoplasma pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
|
13270-4
|
Mycoplasma pneumoniae IgA Ab [Units/volume] in Serum |
|
18243-6
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid |
|
5255-5
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
|
46198-8
|
Mycoplasma pneumoniae IgG Ab [Presence] in Serum |
|
45224-3
|
Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay |
|
7970-7
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum |
|
56958-2
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57677-7
|
Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --1st specimen |
|
24234-7
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --1st specimen |
|
57009-3
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
57678-5
|
Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay --2nd specimen |
|
24235-4
|
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen |
|
42992-8
|
Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid |
|
26947-2
|
Mycoplasma pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
42526-4
|
Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid |
|
42989-4
|
Mycoplasma pneumoniae IgG Ab [Titer] in Pleural fluid by Immunofluorescence |
|
22426-1
|
Mycoplasma pneumoniae IgG Ab [Titer] in Serum |
|
6481-6
|
Mycoplasma pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence |
|
58733-7
|
Mycoplasma pneumoniae IgG and IgM panel - Serum |
|
17304-7
|
Mycoplasma pneumoniae IgG+IgM Ab [Units/volume] in Serum |
|
58782-4
|
Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31516-8
|
Mycoplasma pneumoniae IgM Ab [Units/volume] in Cerebral spinal fluid |
|
5256-3
|
Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay |
|
21406-4
|
Mycoplasma pneumoniae IgM Ab [Presence] in Serum |
|
5257-1
|
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay |
|
58708-9
|
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunofluorescence |
|
8078-8
|
Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum |
|
42991-0
|
Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid |
|
26946-4
|
Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
42990-2
|
Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid |
|
42525-6
|
Mycoplasma pneumoniae IgM Ab [Titer] in Pleural fluid by Immunofluorescence |
|
22427-9
|
Mycoplasma pneumoniae IgM Ab [Titer] in Serum |
|
5258-9
|
Mycoplasma pneumoniae IgM Ab [Titer] in Serum by Immunofluorescence |
|
6482-4
|
Mycoplasma pneumoniae rRNA [Presence] in Sputum by Probe |
|
6483-2
|
Mycoplasma pneumoniae rRNA [Presence] in Unspecified specimen by Probe |
|
19054-6
|
Mycoplasma pneumoniae [Presence] in Unspecified specimen by Organism specific culture |
|
74637-0
|
Protein.monoclonal band 2 [Mass/time] in 24 hour Urine by Electrophoresis |
|
42484-6
|
Protein.monoclonal/Protein.total in 24 hour Urine by Electrophoresis |
|
42482-0
|
Protein.monoclonal [Mass/time] in 24 hour Urine by Electrophoresis |
|
74636-2
|
Protein.monoclonal band 3 [Mass/time] in 24 hour Urine by Electrophoresis |
|
75517-3
|
Protein.monoclonal band 4 [Mass/time] in 24 hour Urine by Electrophoresis |
|
42483-8
|
Protein.monoclonal/Protein.total in Urine by Electrophoresis |
|
48627-4
|
Protein.monoclonal [Units/volume] in Urine |
|
23296-7
|
Mycoplasma putrefaciens Ab [Presence] in Serum |
|
23295-9
|
Mycoplasma putrefaciens Ab [Presence] in Serum by Complement fixation |
|
23294-2
|
Mycoplasma putrefaciens Ab [Presence] in Serum by Immunoassay |
|
7508-5
|
Mucor racemosus triggered histamine release [Units/volume] in Blood |
|
6182-0
|
Mucor racemosus IgE Ab [Units/volume] in Serum |
|
7507-7
|
Mucor racemosus IgG Ab [Units/volume] in Serum |
|
56324-7
|
Mucor racemosus IgG4 Ab [Mass/volume] in Serum |
|
35549-5
|
Mucor racemosus IgG Ab [Mass/volume] in Serum |
|
22429-5
|
Mycoplasma synoviae Ab [Presence] in Serum |
|
15490-6
|
Mycoplasma synoviae Ab [Presence] in Serum by Agglutination |
|
23302-3
|
Mycoplasma synoviae Ab [Presence] in Serum by Hemagglutination |
|
15489-8
|
Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay |
|
31518-4
|
Mycoplasma synoviae Ab [Units/volume] in Serum |
|
42988-6
|
Mycoplasma synoviae Ab [Titer] in Serum |
|
23755-2
|
Mycoplasma synoviae Ab [Titer] in Serum by Hemagglutination |
|
15491-4
|
Mycoplasma synoviae rRNA [Presence] in Serum by Probe |
|
55224-0
|
Mycobacterium tuberculosis A60 Ab [Presence] in Serum by Immunoassay |
|
55223-2
|
Mycobacterium tuberculosis A60 IgM Ab [Presence] in Serum by Immunoassay |
|
88874-3
|
Mycobacterium tuberculosis complex DNA [Presence] in Isolate or Specimen by Molecular genetics method |
|
85362-2
|
Mycobacterium tuberculosis complex DNA [Presence] in Sputum or Bronchial by NAA with probe detection |
|
38379-4
|
Mycobacterium tuberculosis complex DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
42717-9
|
Mycobacterium tuberculosis complex genotype [Identifier] in Isolate |
|
83066-1
|
Mycobacterium tuberculosis complex immunogenic protein MPB64 [Presence] in Isolate by Immunoassay |
|
48174-7
|
Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17296-5
|
Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by Probe |
|
53257-2
|
Mycobacterium tuberculosis DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
91763-3
|
Mycobacterium tuberculosis DNA [Presence] in Aspirate by NAA with probe detection |
|
78357-1
|
Mycobacterium tuberculosis DNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
90283-3
|
Mycobacterium tuberculosis DNA [Presence] in Bile fluid by NAA with probe detection |
|
16278-4
|
Mycobacterium tuberculosis DNA [Presence] in Blood by NAA with probe detection |
|
14557-3
|
Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by NAA with probe detection |
|
88165-6
|
Mycobacterium tuberculosis DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
14561-5
|
Mycobacterium tuberculosis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
58931-7
|
Mycobacterium tuberculosis DNA [Presence] in Body fluid by NAA with probe detection |
|
14558-1
|
Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by NAA with probe detection |
|
89635-7
|
Mycobacterium tuberculosis DNA [Presence] in Implanted device by NAA with probe detection |
|
91829-2
|
Mycobacterium tuberculosis DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88166-4
|
Mycobacterium tuberculosis DNA [Presence] in Ocular fluid by NAA with probe detection |
|
14559-9
|
Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by NAA with probe detection |
|
14562-3
|
Mycobacterium tuberculosis DNA [Presence] in Semen by NAA with probe detection |
|
14556-5
|
Mycobacterium tuberculosis DNA [Presence] in Sputum by NAA with probe detection |
|
14560-7
|
Mycobacterium tuberculosis DNA [Presence] in Urine by NAA with probe detection |
|
13956-8
|
Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
35352-4
|
Mycobacterium tuberculosis genotype [Identifier] in Isolate |
|
71773-6
|
Mycobacterium tuberculosis stimulated gamma interferon [Interpretation] in Blood Qualitative |
|
46217-6
|
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] in Blood |
|
88517-8
|
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] corrected for background in Blood |
|
71775-1
|
Mycobacterium tuberculosis stimulated gamma interferon panel - Blood |
|
74277-5
|
Mycobacterium tuberculosis stimulated gamma interferon CFP10 Ag spot count [#] in Blood |
|
74278-3
|
Mycobacterium tuberculosis stimulated gamma interferon ESAT-6 Ag spot count [#] in Blood |
|
74281-7
|
Mycobacterium tuberculosis stimulated gamma interferon and spot count panel - Blood |
|
54146-6
|
Mycobacterium tuberculosis IgG Ab [Units/volume] in Serum by Immunoassay |
|
5027-8
|
Mycobacterium tuberculosis rRNA [Presence] in Unspecified specimen by Probe |
|
45323-3
|
Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood |
|
39017-9
|
Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon in Blood |
|
88518-6
|
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood |
|
82889-7
|
Meta methylhippurate+Ortho methylhippurate+Para methylhippurate [Moles/volume] in Urine |
|
82890-5
|
Meta methylhippurate+Ortho methylhippurate+Para methylhippurate/Creatinine [Molar ratio] in Urine |
|
54939-4
|
Meta methylhippurate+Para methylhippurate [Mass/volume] in Serum or Plasma |
|
12541-9
|
Meta methylhippurate+Para methylhippurate [Mass/volume] in Urine |
|
1249-2
|
M1 Ag [Presence] on Red Blood Cells |
|
81727-0
|
Mitochondria M2-3E Ab [Presence] in Serum by Line blot |
|
72320-5
|
Mitochondria M2-3E IgG Ab [Presence] in Serum by Immunoassay |
|
10447-1
|
M-5 Ag [Presence] in Tissue by Immune stain |
|
76027-2
|
Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Fibroblast |
|
78963-6
|
Mannose-6-phosphate isomerase [Enzymatic activity/mass] in Leukocytes |
|
90833-5
|
Ma+Ta Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
57452-5
|
Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
90832-7
|
Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
54918-8
|
Ma+Ta Ab [Units/volume] in Serum by Immunoassay |
|
35458-9
|
Ma+Ta Ab [Presence] in Serum |
|
56720-6
|
Ma+Ta Ab [Presence] in Serum by Immunoblot |
|
82423-5
|
Ma+Ta Ab [Presence] in Serum by Line blot |
|
56529-1
|
Ma+Ta Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
51712-8
|
Ma+Ta Ab [Titer] in Serum by Immunofluorescence |
|
82983-8
|
Ma+Ta IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
69559-3
|
Ma1 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
69558-5
|
Ma1 Ab [Presence] in Serum by Immunoblot |
|
87487-5
|
MAB-CHMINACA butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
11183-1
|
Macadamia IgE Ab [Units/volume] in Serum |
|
61283-8
|
Macadamia IgE Ab/IgE total in Serum |
|
6669-6
|
Microscopic observation [Identifier] in Tissue by Macchiavello stain |
|
669-2
|
Microscopic observation [Identifier] in Unspecified specimen by Macchiavello stain |
|
15280-1
|
Mace IgE Ab [Units/volume] in Serum |
|
7475-7
|
Mackerel triggered histamine release [Units/volume] in Blood |
|
7474-0
|
Mackerel IgE Ab [Units/volume] in Serum |
|
55204-2
|
Macroamylase [Presence] in Pleural fluid |
|
15358-5
|
Macroamylase [Presence] in Serum or Plasma |
|
2591-6
|
Macroamylase [Enzymatic activity/volume] in Serum or Plasma |
|
2592-4
|
Macroglobulin [Mass/volume] in Serum or Plasma |
|
81895-5
|
Macronutrient intake panel |
|
68408-4
|
Macrophages [#/volume] in Pericardial fluid by Manual count |
|
68410-0
|
Macrophages [#/volume] in Pleural fluid by Manual count |
|
68409-2
|
Macrophages [#/volume] in Peritoneal fluid by Manual count |
|
68411-8
|
Macrophages [#/volume] in Synovial fluid by Manual count |
|
68413-4
|
Macrophages [#/volume] in Vitreous fluid by Manual count |
|
68412-6
|
Macrophages/100 leukocytes in Vitreous fluid by Manual count |
|
72680-2
|
Macroprolactin [Presence] in Serum or Plasma |
|
74953-1
|
Macroprolactin [Units/volume] in Serum or Plasma |
|
38926-2
|
Macroprolactin [Mass/volume] in Serum or Plasma |
|
51441-4
|
Macroprolactin/Prolactin [Mass] in Serum or Plasma |
|
48389-1
|
Macroprolactin/Prolactin [Moles] in Serum or Plasma |
|
87928-8
|
Macroscopic observation [Interpretation] in Stool Narrative |
|
14072-3
|
Monoacetyldapsone [Mass/volume] in Serum or Plasma |
|
13461-9
|
Monoacetyldapsone/Dapsone [Mass Ratio] in Serum or Plasma |
|
63290-1
|
Myelin associated glycoprotein Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31519-2
|
Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid |
|
12897-5
|
Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
63289-3
|
Myelin associated glycoprotein Ab [Units/volume] in Body fluid by Immunoassay |
|
63288-5
|
Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoassay |
|
63396-6
|
Myelin associated glycoprotein Ab [Presence] in Body fluid by Immunoblot |
|
17308-8
|
Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunoblot |
|
45170-8
|
Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunofluorescence |
|
31521-8
|
Myelin associated glycoprotein Ab [Presence] in Serum |
|
26775-7
|
Myelin associated glycoprotein Ab [Presence] in Serum by Immunoassay |
|
13119-3
|
Myelin associated glycoprotein Ab [Presence] in Serum by Immunoblot |
|
17310-4
|
Myelin associated glycoprotein Ab [Presence] in Serum by Immunofluorescence |
|
31520-0
|
Myelin associated glycoprotein Ab [Units/volume] in Serum |
|
33394-8
|
Myelin associated glycoprotein Ab [Titer] in Serum |
|
17311-2
|
Myelin associated glycoprotein IgA Ab [Units/volume] in Serum |
|
17313-8
|
Myelin associated glycoprotein IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
17312-0
|
Myelin associated glycoprotein IgG Ab [Units/volume] in Serum |
|
33602-4
|
Myelin associated glycoprotein IgG Ab [Titer] in Serum |
|
90835-0
|
Myelin associated glycoprotein IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
27030-6
|
Myelin associated glycoprotein IgM Ab [Units/volume] in Cerebral spinal fluid |
|
17314-6
|
Myelin associated glycoprotein IgM Ab [Units/volume] in Serum by Immunoassay |
|
31522-6
|
Myelin associated glycoprotein IgM Ab [Presence] in Serum |
|
31023-5
|
Myelin associated glycoprotein IgM Ab [Presence] in Serum by Immunoblot |
|
21411-4
|
Myelin associated glycoprotein IgM Ab [Units/volume] in Serum |
|
91001-8
|
Myelin associated glycoprotein IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
21410-6
|
Myelin associated glycoprotein IgM Ab [Titer] in Serum |
|
39087-2
|
Myelin associated glycoprotein IgM Ab [Titer] in Serum by Immunoassay |
|
42211-3
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside Ab [Titer] in Serum |
|
23907-9
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Units/volume] in Serum |
|
90848-3
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
13664-8
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum |
|
43190-8
|
Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum by Immunoassay |
|
89004-6
|
MAGE A4 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
30922-9
|
Magnesium [Mass/volume] in Urine collected for unspecified duration |
|
57367-5
|
Magnesium [Mass/volume] in 12 hour Urine |
|
57368-3
|
Magnesium [Mass/time] in 12 hour Urine |
|
74696-6
|
Magnesium [Moles/volume] in 12 hour Urine |
|
58995-2
|
Magnesium [Mass/time] in 18 hour Urine |
|
23891-5
|
Magnesium [Moles/volume] in 24 hour Stool |
|
27255-9
|
Magnesium [Moles/mass] in 24 hour Stool |
|
23892-3
|
Magnesium [Moles/time] in 24 hour Stool |
|
32024-2
|
Magnesium [Mass/volume] in 24 hour Urine |
|
24447-5
|
Magnesium [Mass/time] in 24 hour Urine |
|
35252-6
|
Magnesium [Mass or Moles/volume] in 24 hour Urine |
|
25954-9
|
Magnesium [Moles/volume] in 24 hour Urine |
|
2599-9
|
Magnesium [Moles/time] in 24 hour Urine |
|
18368-1
|
Magnesium [Moles/time] in 2 hour Urine |
|
18369-9
|
Magnesium [Moles/time] in 4 hour Urine |
|
27210-4
|
Magnesium [Presence] in Blood |
|
21377-7
|
Magnesium [Mass/volume] in Blood |
|
2593-2
|
Magnesium [Moles/volume] in Blood |
|
29364-7
|
Magnesium [Mass/volume] in Cerebral spinal fluid |
|
2594-0
|
Magnesium [Moles/volume] in Cerebral spinal fluid |
|
49007-8
|
Magnesium [Moles/volume] in Peritoneal dialysis fluid |
|
42616-3
|
Magnesium [Mass/volume] in Dialysis fluid |
|
2595-7
|
Magnesium [Moles/volume] in Dialysis fluid |
|
57998-7
|
Magnesium [Mass/volume] in Nonbiological fluid |
|
29365-4
|
Magnesium [Mass/volume] in Body fluid |
|
2596-5
|
Magnesium [Moles/volume] in Body fluid |
|
16172-9
|
Magnesium [Mass/mass] in Hair |
|
17237-9
|
Magnesium [Moles/mass] in Hair |
|
20872-8
|
Magnesium [Mass/volume] in Ocular fluid |
|
55937-7
|
Magnesium [Moles/volume] in Serum or Plasma --post dialysis |
|
26746-8
|
Magnesium [Mass/volume] in Red Blood Cells |
|
27122-1
|
Magnesium [Mass/mass] in Red Blood Cells |
|
2597-3
|
Magnesium [Moles/volume] in Red Blood Cells |
|
19123-9
|
Magnesium [Mass/volume] in Serum or Plasma |
|
35249-2
|
Magnesium [Mass or Moles/volume] in Serum or Plasma |
|
2601-3
|
Magnesium [Moles/volume] in Serum or Plasma |
|
54919-6
|
Magnesium [Mass/volume] in Semen |
|
29911-5
|
Magnesium [Mass/volume] in Stool |
|
10880-3
|
Magnesium [Mass/mass] in Stool |
|
29912-3
|
Magnesium [Mass/time] in Stool |
|
17236-1
|
Magnesium [Moles/volume] in Stool |
|
26708-8
|
Magnesium [Moles/mass] in Stool |
|
52911-5
|
Magnesium [Moles/mass] in Tissue |
|
30536-7
|
Magnesium [Mass/volume] in Total parental nutrition |
|
55938-5
|
Magnesium [Moles/volume] in Total parental nutrition |
|
19124-7
|
Magnesium [Mass/volume] in Urine |
|
35250-0
|
Magnesium [Mass or Moles/volume] in Urine |
|
2598-1
|
Magnesium [Moles/volume] in Urine |
|
9478-9
|
Magnesium [Mass/volume] in Water |
|
17235-3
|
Magnesium [Moles/volume] in Leukocytes |
|
32329-5
|
Magnesium [Moles/volume] in Unspecified specimen |
|
44336-6
|
Magnesium/Creatinine [Mass Ratio] in 24 hour Urine |
|
50873-9
|
Magnesium/Creatinine [Molar ratio] in 24 hour Urine |
|
13474-2
|
Magnesium/Creatinine [Mass Ratio] in Urine |
|
33950-7
|
Magnesium/Creatinine [Molar ratio] in Urine |
|
50185-8
|
Magnolia IgE Ab [Units/volume] in Serum |
|
82570-3
|
Mahi mahi IgE Ab [Units/volume] in Serum |
|
50029-8
|
Mahogany wood dust IgE Ab [Units/volume] in Serum |
|
33962-2
|
Melanoma inhibitory activity protein [Mass/volume] in Serum or Plasma |
|
53799-3
|
Major crossmatch [Interpretation] by Electronic |
|
1251-8
|
Major crossmatch [Interpretation] by Immediate spin |
|
13010-4
|
Methyl amyl ketone [Mass/volume] in Blood |
|
31184-5
|
Methyl amyl ketone [Mass/volume] in Urine |
|
33699-0
|
Microscopic observation [Identifier] in Unspecified specimen by Malachite green stain |
|
23893-1
|
Malaoxon [Mass/volume] in Blood |
|
11098-1
|
Malaoxon [Mass/volume] in Serum or Plasma |
|
32700-7
|
Microscopic observation [Identifier] in Blood by Malaria smear |
|
6670-4
|
Microscopic observation [Identifier] in Tissue by Malaria smear |
|
33271-8
|
Microscopic observation [Identifier] in Blood by Malaria thin smear |
|
51857-1
|
Malassezia sp IgE Ab [Units/volume] in Serum |
|
2602-1
|
Malate dehydrogenase [Enzymatic activity/volume] in Serum |
|
75068-7
|
Malate [Moles/volume] in Serum or Plasma |
|
13770-3
|
Malate/Creatinine [Mass Ratio] in Urine |
|
25113-2
|
Malate/Creatinine [Molar ratio] in Urine |
|
5680-4
|
Malathion [Mass/volume] in Serum or Plasma |
|
21378-5
|
Malathion [Mass/volume] in Urine |
|
87648-2
|
Malathion [Mass/mass] in Unspecified specimen |
|
38606-0
|
Maleic anhydride [Mass/volume] in Air |
|
19746-7
|
Maleic anhydride IgE Ab [Units/volume] in Serum |
|
44890-2
|
Malignant cells [#/volume] in Cerebral spinal fluid |
|
44883-7
|
Malignant cells [#/volume] in Cerebral spinal fluid by Manual count |
|
44891-0
|
Malignant cells [#/volume] in Pericardial fluid |
|
44886-0
|
Malignant cells [#/volume] in Pericardial fluid by Manual count |
|
44889-4
|
Malignant cells [#/volume] in Pleural fluid |
|
44884-5
|
Malignant cells [#/volume] in Pleural fluid by Manual count |
|
44882-9
|
Malignant cells [#/volume] in Peritoneal fluid |
|
44887-8
|
Malignant cells [#/volume] in Peritoneal fluid by Manual count |
|
44888-6
|
Malignant cells [#/volume] in Synovial fluid |
|
44885-2
|
Malignant cells [#/volume] in Synovial fluid by Manual count |
|
81284-2
|
Malignant cells/100 cells in Bronchoalveolar lavage by Manual count |
|
44892-8
|
Malignant cells/100 cells in Cerebral spinal fluid |
|
44894-4
|
Malignant cells/100 cells in Cerebral spinal fluid by Manual count |
|
44901-7
|
Malignant cells/100 cells in Liver by Manual count |
|
44903-3
|
Malignant cells/100 cells in Bone marrow |
|
44900-9
|
Malignant cells/100 cells in Bone marrow by Manual count |
|
44904-1
|
Malignant cells/100 cells in Pericardial fluid |
|
44897-7
|
Malignant cells/100 cells in Pericardial fluid by Manual count |
|
44902-5
|
Malignant cells/100 cells in Pleural fluid |
|
44895-1
|
Malignant cells/100 cells in Pleural fluid by Manual count |
|
44905-8
|
Malignant cells/100 cells in Peritoneal fluid |
|
44898-5
|
Malignant cells/100 cells in Peritoneal fluid by Manual count |
|
44893-6
|
Malignant cells/100 cells in Synovial fluid |
|
44896-9
|
Malignant cells/100 cells in Synovial fluid by Manual count |
|
44899-3
|
Malignant cells/100 cells in Urine by Manual count |
|
32025-9
|
Malignin Ab [Presence] in Serum |
|
17238-7
|
Malignin Ab [Units/volume] in Serum |
|
90873-1
|
Malocclusion severity assessment |
|
2603-9
|
Malonate [Mass/volume] in Serum |
|
75061-2
|
Malonate [Moles/volume] in Serum or Plasma |
|
30478-2
|
Malonate [Presence] in Urine |
|
45168-2
|
Malonate [Mass/volume] in Urine |
|
51843-1
|
Malonate/Creatinine [Mass Ratio] in Urine |
|
47696-0
|
Malonate/Creatinine [Molar ratio] in Urine |
|
72258-7
|
Malondialdehyde [Entitic substance] in Platelets |
|
47865-1
|
Malondialdehyde [Moles/volume] in Plasma |
|
55939-3
|
Malondialdehyde [Moles/mass] in Red Blood Cells |
|
50550-3
|
Malondialdehyde.free [Moles/volume] in Plasma |
|
67708-8
|
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS |
|
74630-5
|
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Serum or Plasma |
|
75213-9
|
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
|
81779-1
|
Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine [Molar ratio] in Urine |
|
54461-9
|
Malonylcarnitine (C3-DC) [Moles/volume] in Amniotic fluid |
|
54460-1
|
Malonylcarnitine (C3-DC) [Moles/volume] in Cerebral spinal fluid |
|
54462-7
|
Malonylcarnitine (C3-DC) [Moles/volume] in DBS |
|
55940-1
|
Malonylcarnitine (C3-DC) [Moles/volume] in Serum or Plasma |
|
54463-5
|
Malonylcarnitine (C3-DC) [Moles/volume] in Urine |
|
75212-1
|
Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
|
54314-0
|
Malonylcarnitine (C3-DC)/Creatinine [Molar ratio] in Urine |
|
6166-3
|
Malt IgE Ab [Units/volume] in Serum |
|
7476-5
|
Malt IgG Ab [Units/volume] in Serum |
|
56312-2
|
Malt IgG4 Ab [Mass/volume] in Serum |
|
51922-3
|
Malt IgG Ab [Mass/volume] in Serum |
|
66950-7
|
MALT1 18q21 gene rearrangements in Blood or Tissue by FISH |
|
91122-2
|
Maltose binding protein IgE Ab [Units/volume] in Serum |
|
91121-4
|
Maltose binding protein IgE Ab RAST class [Presence] in Serum |
|
57848-4
|
Maltose [Presence] in Urine |
|
74895-4
|
Maltose/Creatinine [Molar ratio] in Urine |
|
73944-1
|
MAM-2201 (synthetic cannabinoid) [Presence] in Blood |
|
73919-3
|
MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72470-8
|
MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
74034-0
|
MAML2 11q21 gene rearrangements in Tissue by FISH |
|
49472-4
|
Mammaglobin Ag [Presence] in Tissue by Immune stain |
|
81825-2
|
MAN2B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7731-3
|
Mandarin IgE Ab [Units/volume] in Serum |
|
7732-1
|
Mandarin IgG Ab [Units/volume] in Serum |
|
56400-5
|
Mandarin IgG4 Ab [Mass/volume] in Serum |
|
60408-2
|
Mandarin IgG Ab [Mass/volume] in Serum |
|
80564-8
|
Mandatory reporting form |
|
75072-9
|
Mandelate [Moles/volume] in Serum or Plasma |
|
27929-9
|
Mandelate [Presence] in Urine |
|
13000-5
|
Mandelate [Mass/volume] in Urine |
|
13001-3
|
Mandelate/Creatinine [Mass Ratio] in Urine |
|
47697-8
|
Mandelate/Creatinine [Molar ratio] in Urine |
|
30932-8
|
Manganese [Mass/volume] in Urine collected for unspecified duration |
|
21382-7
|
Manganese [Mass/volume] in 24 hour Urine |
|
8203-2
|
Manganese [Mass/time] in 24 hour Urine |
|
42222-0
|
Manganese [Moles/time] in 24 hour Urine |
|
5681-2
|
Manganese [Mass/volume] in Blood |
|
25466-4
|
Manganese [Moles/volume] in Blood |
|
57999-5
|
Manganese [Mass/volume] in Cerebral spinal fluid |
|
20875-1
|
Manganese [Mass/mass] in Feed |
|
51198-0
|
Manganese [Mass/volume] in Body fluid |
|
47116-9
|
Manganese [Moles/volume] in Gastric fluid |
|
17244-5
|
Manganese [Mass/mass] in Hair |
|
50874-7
|
Manganese [Moles/mass] in Hair |
|
58736-0
|
Manganese panel - Urine |
|
5682-0
|
Manganese [Mass/volume] in Red Blood Cells |
|
50875-4
|
Manganese [Moles/volume] in Red Blood Cells |
|
5683-8
|
Manganese [Mass/volume] in Serum or Plasma |
|
25467-2
|
Manganese [Moles/volume] in Serum or Plasma |
|
20874-4
|
Manganese [Mass/mass] in Tissue |
|
5684-6
|
Manganese [Mass/volume] in Urine |
|
42221-2
|
Manganese [Moles/volume] in Urine |
|
29935-4
|
Manganese/Creatinine [Mass Ratio] in 24 hour Urine |
|
52930-5
|
Manganese/Creatinine [Molar ratio] in 24 hour Urine |
|
27367-2
|
Manganese/Creatinine [Mass Ratio] in Urine |
|
42223-8
|
Manganese/Creatinine [Molar ratio] in Urine |
|
6167-1
|
Mango IgE Ab [Units/volume] in Serum |
|
24155-4
|
Mango IgG Ab [Units/volume] in Serum |
|
56313-0
|
Mango IgG4 Ab [Mass/volume] in Serum |
|
63096-2
|
Mango IgG Ab [Mass/volume] in Serum |
|
7477-3
|
Mango Pollen IgE Ab [Units/volume] in Serum |
|
2604-7
|
Mannitol renal clearance in 24 hour Urine and Serum or Plasma |
|
74894-7
|
Mannitol [Moles/time] in 5 hour Urine --post XXX g sugar solution PO |
|
33838-4
|
Mannitol [Moles/volume] in Serum or Plasma |
|
55941-9
|
Mannitol [Mass/volume] in Urine |
|
47698-6
|
Mannitol/Creatinine [Molar ratio] in Urine |
|
53597-1
|
Mannobioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
48144-0
|
Mannose [Presence] in Urine |
|
74893-9
|
Mannose/Creatinine [Molar ratio] in Urine |
|
30152-3
|
Mannose-binding protein [Mass/volume] in Serum |
|
51393-7
|
Manometry Study observation Narrative |
|
24318-8
|
Manual Differential panel - Blood |
|
50957-0
|
Manual differential performed [Presence] in Blood |
|
52049-4
|
Manual wheelchair attachment |
|
82884-8
|
MAOA gene upstream VNTR repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
60495-9
|
MAP2K1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
60496-7
|
MAP2K2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
42789-8
|
Mitogen-Activated protein kinase 14 Ag [Presence] in Tissue by Immune stain |
|
42791-4
|
Mitogen-Activated protein kinase 3 Ag [Presence] in Tissue by Immune stain |
|
42792-2
|
Mitogen-Activated protein kinase 8 Ag [Presence] in Tissue by Immune stain |
|
42793-0
|
Mitogen-Activated protein kinase 9 Ag [Presence] in Tissue by Immune stain |
|
6168-9
|
Maple IgE Ab [Units/volume] in Serum |
|
7482-3
|
Maple sugar IgE Ab [Units/volume] in Serum |
|
58000-1
|
Maple sugar IgE Ab/IgE total in Serum |
|
7483-1
|
Maple syrup IgE Ab [Units/volume] in Serum |
|
24156-2
|
Maple syrup IgG Ab [Units/volume] in Serum |
|
56314-8
|
Maple syrup IgG4 Ab [Mass/volume] in Serum |
|
63148-1
|
Maple syrup IgG Ab [Mass/volume] in Serum |
|
85088-3
|
Maprotiline and normaprotiline panel - Serum or Plasma |
|
40379-0
|
Maprotiline [Presence] in Gastric fluid |
|
29405-8
|
Maprotiline [Mass/volume] in Gastric fluid |
|
47117-7
|
Maprotiline [Moles/volume] in Gastric fluid |
|
3734-1
|
Maprotiline [Presence] in Serum or Plasma |
|
3735-8
|
Maprotiline [Mass/volume] in Serum or Plasma |
|
14825-4
|
Maprotiline [Moles/volume] in Serum or Plasma |
|
74962-2
|
Maprotiline [Mass/volume] in Serum or Plasma --trough |
|
3737-4
|
Maprotiline [Presence] in Urine |
|
3738-2
|
Maprotiline [Mass/volume] in Urine |
|
47118-5
|
Maprotiline [Moles/volume] in Urine |
|
60313-4
|
Maprotiline [Moles/volume] in Unspecified specimen |
|
80645-5
|
Maprotiline+normaprotiline [Mass/volume] in Serum or Plasma |
|
40478-0
|
MAPT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41092-8
|
MAPT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
80565-5
|
Medication administration record |
|
82254-4
|
Marker and derivative chromosome analysis in Amniotic fluid or Chorionic villus sample Document by Cytogenetics |
|
82255-1
|
Marker and derivative chromosome analysis in Blood or Tissue Document by Cytogenetics |
|
33721-2
|
Bone marrow Pathology biopsy report |
|
66119-9
|
Bone marrow Pathology biopsy report Narrative |
|
88987-3
|
Maraviroc [Mass/volume] in Serum or Plasma |
|
10936-3
|
Mare milk IgE Ab [Units/volume] in Serum |
|
72853-5
|
Maribavir [Susceptibility] by Genotype method |
|
10937-1
|
Marjoram IgE Ab [Units/volume] in Serum |
|
74834-3
|
MARS2 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
6232-3
|
Marsh Elder IgE Ab [Units/volume] in Serum |
|
39084-9
|
Marsh Elder IgE Ab/IgE total in Serum |
|
24141-4
|
Marsh Elder IgG Ab [Units/volume] in Serum |
|
56316-3
|
Marsh Elder IgG4 Ab [Mass/volume] in Serum |
|
63190-3
|
Marsh Elder IgG Ab [Mass/volume] in Serum |
|
17509-1
|
Marsh Ragweed IgE Ab [Units/volume] in Serum |
|
71708-2
|
Marburg virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
71769-4
|
Marburg virus IgG Ab [Presence] in Serum by Immunoassay |
|
71707-4
|
Marburg virus IgG Ab [Titer] in Serum by Immunoassay |
|
71771-0
|
Marburg virus IgM Ab [Presence] in Serum by Immunoassay |
|
71706-6
|
Marburg virus IgM Ab [Titer] in Serum by Immunoassay |
|
86574-1
|
Marburg virus RNA [Presence] in Blood by NAA with probe detection |
|
41638-8
|
Marburg virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
81247-9
|
Master HL7 genetic variant reporting panel |
|
79397-6
|
Mastic tree (Pistacia lentiscus) IgE Ab [Units/volume] in Serum |
|
49087-0
|
Maternal screen clinical predictors panel |
|
50580-0
|
Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel - Serum or Plasma |
|
2625-2
|
Methionine adenosyltransferase [Enzymatic activity/volume] in Serum |
|
35457-1
|
Maternal cell contamination [Identifier] in Amniotic fluid Nominal |
|
40704-9
|
Maternal cell contamination [Identifier] in Blood Nominal |
|
59266-7
|
Maternal cell contamination [Identifier] in Unspecified specimen Nominal |
|
80673-7
|
Maternal and fetal medicine Consult note |
|
85439-8
|
Maternal and fetal medicine Note |
|
89808-0
|
Maternal and fetal medicine Telephone encounter Note |
|
89807-2
|
Maternal and fetal medicine Telephone encounter Progress note |
|
89951-8
|
Maternal and fetal medicine procedure note |
|
93897-7
|
Maternal and fetal medicine Progress note |
|
92016-5
|
Maternal pregnancy risk factors Document |
|
79192-1
|
Maternal pregnancy information Narrative |
|
92017-3
|
Maternal pregnancy summary Document |
|
7486-4
|
Mattress dust IgE Ab [Units/volume] in Serum |
|
81447-5
|
Maximum expiratory pressure Respiratory system --post bronchodilation |
|
81446-7
|
Maximum expiratory pressure Respiratory system --pre bronchodilation |
|
76092-6
|
Maximum gradient during systole [Pressure] Aortic valve |
|
81445-9
|
Maximum inspiratory pressure Respiratory system --post bronchodilation |
|
81444-2
|
Maximum inspiratory pressure Respiratory system --pre bronchodilation |
|
11185-6
|
Maxatase IgE Ab [Units/volume] in Serum |
|
7488-0
|
Mayfly triggered histamine release [Units/volume] in Blood |
|
7487-2
|
Mayfly IgE Ab [Units/volume] in Serum |
|
12341-4
|
Mazindol [Presence] in Serum or Plasma |
|
85053-7
|
MBL by imipenem to imipenem-EDTA IC ratio [Presence] by ARD gradient strip |
|
85047-9
|
MBL by meropenem to meropenem-EDTA IC ratio [Presence] by ARD gradient strip |
|
76068-6
|
MBL2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
47319-9
|
Myelin basic protein Ab [Units/volume] in Serum by Immunoassay |
|
27360-7
|
Myelin basic protein Ab [Units/volume] in Serum |
|
17315-3
|
Myelin basic protein Ab [Mass/volume] in Serum |
|
8082-0
|
Myelin basic protein Ab [Titer] in Serum |
|
5259-7
|
Myelin basic protein Ab [Titer] in Serum by Immunofluorescence |
|
10504-9
|
Myelin basic protein Ag [Presence] in Tissue by Immune stain |
|
26940-7
|
Myelin basic protein [Units/volume] in Cerebral spinal fluid |
|
2638-5
|
Myelin basic protein [Mass/volume] in Cerebral spinal fluid |
|
14237-2
|
Myelin basic protein IgA Ab [Units/volume] in Serum |
|
14238-0
|
Myelin basic protein IgG Ab [Units/volume] in Serum |
|
14239-8
|
Myelin basic protein IgM Ab [Units/volume] in Serum |
|
56661-2
|
Myelin basic protein [Mass/volume] in Serum |
|
44703-7
|
MC4R gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
19188-2
|
Mucin-like carcinoma associated Ag [Units/volume] in Pleural fluid |
|
12776-1
|
Mucin-like carcinoma associated Ag [Units/volume] in Serum or Plasma |
|
74892-1
|
Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Fibroblast |
|
74891-3
|
Medium-chain Acyl CoA dehydrogenase [Enzymatic activity/mass] in Leukocytes |
|
65329-5
|
McC sup(c) Ab [Presence] in Serum or Plasma |
|
2631-0
|
Methylmalonyl CoA mutase [Enzymatic activity/volume] in Serum |
|
72872-5
|
MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34658-5
|
MCOLN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
46965-0
|
MCOLN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48330-5
|
MCOLN1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
4525-2
|
Complement membrane C3b-C4b cofactor protein [Entitic number] in Leukocytes |
|
6290-1
|
Complement membrane C3b-C4b cofactor protein [Presence] in Leukocytes |
|
78852-1
|
M-chlorophenylpiperazine [Mass/volume] in Blood |
|
78853-9
|
M-chlorophenylpiperazine [Mass/volume] in Body fluid |
|
78851-3
|
M-chlorophenylpiperazine [Mass/mass] in Hair |
|
35467-0
|
M-chlorophenylpiperazine [Presence] in Serum or Plasma |
|
78854-7
|
M-chlorophenylpiperazine [Mass/volume] in Serum or Plasma |
|
92640-2
|
M-chlorophenylpiperazine [Mass/volume] in Urine by Confirmatory method |
|
75230-3
|
M-chlorophenylpiperazine [Presence] in Urine |
|
78855-4
|
M-chlorophenylpiperazine [Mass/volume] in Urine |
|
38671-4
|
M-cresol [Mass/volume] in Air |
|
93413-3
|
Mechanical circulatory support Consultation note |
|
47282-9
|
MCV [Entitic volume] in Cord blood |
|
74147-0
|
Muscular Dystrophy action plan |
|
83804-5
|
Physician Administrative note |
|
83805-2
|
Physician Admission evaluation note |
|
83803-7
|
Physician Custodial care facility Note |
|
83802-9
|
Physician Discharge instructions |
|
11490-0
|
Physician Discharge summary |
|
28568-4
|
Physician Emergency department Note |
|
28626-0
|
Physician History and physical note |
|
34106-5
|
Physician Hospital Discharge summary |
|
83800-3
|
Physician Hospital Note |
|
68474-6
|
Physician Hospital Restraint note |
|
18736-9
|
Physician Initial evaluation note |
|
75475-4
|
Physician Letter |
|
83793-0
|
Physician Long term care facility Note |
|
86210-2
|
Physician Medical clearance note |
|
75476-2
|
Physician Note |
|
34116-4
|
Physician Nursing facility History and physical note |
|
83798-9
|
Physician Outpatient Note |
|
28573-4
|
Physician, Operation note |
|
83795-5
|
Physician Telephone encounter Note |
|
11505-5
|
Physician procedure note |
|
83801-1
|
Physician Patient's home Note |
|
83797-1
|
Physician Referral note |
|
85873-8
|
Physician Restraint note |
|
83796-3
|
Physician Summary of death note |
|
28616-1
|
Physician Transfer note |
|
83799-7
|
Physician Transplant candidate evaluation note |
|
83794-8
|
Physician Urgent care center Note |
|
18359-0
|
Methylenedioxyamphetamine [Mass/volume] in Blood |
|
40531-6
|
Methylenedioxyamphetamine [Presence] in Gastric fluid |
|
80534-1
|
Methylenedioxyamphetamine [Mass/mass] in Hair |
|
69023-0
|
Methylenedioxyamphetamine [Mass/mass] in Meconium by Confirmatory method |
|
27244-3
|
Methylenedioxyamphetamine [Mass/mass] in Meconium |
|
26742-7
|
Methylenedioxyamphetamine [Mass/volume] in Milk |
|
72736-2
|
Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74648-7
|
Methylenedioxyamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
29598-0
|
Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61045-1
|
Methylenedioxyamphetamine [Presence] in Serum or Plasma |
|
74647-9
|
Methylenedioxyamphetamine [Mass/volume] in Serum, Plasma or Blood |
|
59837-5
|
Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma |
|
55551-6
|
Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma |
|
26792-2
|
Methylenedioxyamphetamine [Mass/mass] in Stool |
|
20545-0
|
Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method |
|
42253-5
|
Methylenedioxyamphetamine [Presence] in Urine |
|
19566-9
|
Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method |
|
19565-1
|
Methylenedioxyamphetamine [Presence] in Urine by Screen method |
|
18355-8
|
Methylenedioxyamphetamine [Mass/volume] in Urine |
|
27189-0
|
Methylenedioxyamphetamine [Mass/volume] in Vitreous fluid |
|
61046-9
|
Methylenedioxyamphetamine [Presence] in Unspecified specimen |
|
64138-1
|
Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine |
|
88725-7
|
MDA5 Ab [Units/volume] in Serum by Line blot |
|
82424-3
|
MDA5 Ab [Presence] in Serum by Line blot |
|
82994-5
|
MDA5 IgG Ab [Presence] in Serum by Line blot |
|
48974-0
|
MDCR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
80536-6
|
Methylenedioxyethylamphetamine [Mass/volume] in Blood |
|
61082-4
|
Methylenedioxyethylamphetamine [Presence] in Gastric fluid |
|
80535-8
|
Methylenedioxyethylamphetamine [Mass/mass] in Hair |
|
69024-8
|
Methylenedioxyethylamphetamine [Mass/mass] in Meconium by Confirmatory method |
|
27080-1
|
Methylenedioxyethylamphetamine [Mass/mass] in Meconium |
|
27074-4
|
Methylenedioxyethylamphetamine [Mass/volume] in Milk |
|
74649-5
|
Methylenedioxyethylamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74650-3
|
Methylenedioxyethylamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
29599-8
|
Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61047-7
|
Methylenedioxyethylamphetamine [Presence] in Serum or Plasma |
|
82965-5
|
Methylenedioxyethylamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
33016-7
|
Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma |
|
27079-3
|
Methylenedioxyethylamphetamine [Mass/mass] in Stool |
|
45143-5
|
Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method |
|
61048-5
|
Methylenedioxyethylamphetamine [Presence] in Urine |
|
59844-1
|
Methylenedioxyethylamphetamine [Presence] in Urine by Screen method |
|
27085-0
|
Methylenedioxyethylamphetamine [Mass/volume] in Urine |
|
27299-7
|
Methylenedioxyethylamphetamine [Mass/volume] in Vitreous fluid |
|
61049-3
|
Methylenedioxyethylamphetamine [Presence] in Unspecified specimen |
|
64127-4
|
Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine |
|
48268-7
|
Minor determinant mixture triggered leukotriene release [Mass/volume] by Leukocytes |
|
93808-4
|
MDM2 gene amplification in Tissue by FISH |
|
93809-2
|
MDM2 gene copy number/Chromosome 12 copy number in Tissue by FISH |
|
18357-4
|
Methylenedioxymethamphetamine [Mass/volume] in Blood |
|
61083-2
|
Methylenedioxymethamphetamine [Presence] in Gastric fluid |
|
80537-4
|
Methylenedioxymethamphetamine [Mass/mass] in Hair |
|
69025-5
|
Methylenedioxymethamphetamine [Mass/mass] in Meconium by Confirmatory method |
|
74651-1
|
Methylenedioxymethamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74653-7
|
Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
87810-8
|
Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Screen method |
|
29619-4
|
Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
40493-9
|
Methylenedioxymethamphetamine [Presence] in Serum or Plasma |
|
74652-9
|
Methylenedioxymethamphetamine [Mass/volume] in Serum, Plasma or Blood |
|
18356-6
|
Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma |
|
26793-0
|
Methylenedioxymethamphetamine [Mass/mass] in Stool |
|
18358-2
|
Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method |
|
14267-9
|
Methylenedioxymethamphetamine [Presence] in Urine |
|
19569-3
|
Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method |
|
19568-5
|
Methylenedioxymethamphetamine [Presence] in Urine by Screen method |
|
19570-1
|
Methylenedioxymethamphetamine [Mass/volume] in Urine |
|
27188-2
|
Methylenedioxymethamphetamine [Mass/volume] in Vitreous fluid |
|
40481-4
|
Methylenedioxymethamphetamine [Presence] in Unspecified specimen |
|
44424-0
|
Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine |
|
75648-6
|
Methylenedioxymethamphetamine+Methylenedioxyamphetamine [Presence] in Blood |
|
73971-4
|
Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative |
|
90747-7
|
MDMB-FUBINACA-M1 [Mass/volume] in Urine by Confirmatory method |
|
72797-4
|
Methylenedioxypyrovalerone [Mass/volume] in Urine by Confirmatory method |
|
73687-6
|
Methylenedioxypyrovalerone [Presence] in Urine by Screen method |
|
72798-2
|
Methylenedioxypyrovalerone/Creatinine [Mass Ratio] in Urine |
|
78702-8
|
Multiple drug resistant gram negative organism [Identifier] in Unspecified specimen by Culture |
|
40684-3
|
Acinetobacter sp multidrug resistant identified in Unspecified specimen by Organism specific culture |
|
42775-7
|
Multiple drug resistant organism identified in Sputum |
|
42773-2
|
Multiple drug resistant organism identified in Urine |
|
42774-0
|
Multiple drug resistant organism identified in Wound |
|
45969-3
|
MDS background information at admission form - version 2.0 |
|
45963-6
|
MDS basic assessment tracking form - version 2.0 |
|
45981-8
|
MDS full assessment form - version 2.0 |
|
46102-0
|
MDS quarterly assessment form - version 2.0 |
|
46103-8
|
MDS quarterly assessment form - version 2.0 - optional version for RUG-III |
|
46104-6
|
MDS quarterly assessment form - version 2.0 - optional version for RUG-III 1997 update |
|
86870-3
|
MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed OMRA (NO/SO) item set [CMS Assessment] |
|
86874-5
|
MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed OMRA start of therapy (NS/SS) item set [CMS Assessment] |
|
86875-2
|
MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed tracking (NT/ST) item set [CMS Assessment] |
|
86522-0
|
MDS v3.0 - RAI v1.14.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
|
86872-9
|
MDS v3.0 - RAI v1.14.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment] |
|
86871-1
|
MDS v3.0 - RAI v1.14.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment] |
|
86873-7
|
MDS v3.0 - RAI v1.14.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment] |
|
86877-8
|
MDS v3.0 - RAI v1.14.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment] |
|
86856-2
|
MDS v3.0 - RAI v1.14.1 - Nursing home PPS (NP) and Nursing home quarterly (NQ) item set [CMS Assessment] |
|
86876-0
|
MDS v3.0 - RAI v1.14.1 - Swing bed PPS (SP) item set [CMS Assessment] |
|
88305-8
|
MDS v3.0 - RAI v1.15.1 - Medications - NOD, NP, SOD, SP [CMS Assessment] |
|
88306-6
|
MDS v3.0 - RAI v1.15.1 - Medications - NSD, ND, SSD, SD [CMS Assessment] |
|
88279-5
|
MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed OMRA (NO and SO) item set [CMS Assessment] |
|
88280-3
|
MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed OMRA start of therapy (NS and SS) item set [CMS Assessment] |
|
88281-1
|
MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment] |
|
88282-9
|
MDS v3.0 - RAI v1.15.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
|
88283-7
|
MDS v3.0 - RAI v1.15.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment] |
|
88284-5
|
MDS v3.0 - RAI v1.15.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment] |
|
88285-2
|
MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment] |
|
88286-0
|
MDS v3.0 - RAI v1.15.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment] |
|
88287-8
|
MDS v3.0 - RAI v1.15.1 - Nursing home PPS (NP) item set [CMS Assessment] |
|
88292-8
|
MDS v3.0 - RAI v1.15.1 - Nursing home quarterly (NQ) item set [CMS Assessment] |
|
88288-6
|
MDS v3.0 - RAI v1.15.1 - Swing bed PPS (SP) item set [CMS Assessment] |
|
88951-9
|
MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed OMRA (NO and SO) item set [CMS Assessment] |
|
88952-7
|
MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed OMRA start of therapy (NS and SS) item set [CMS Assessment] |
|
88953-5
|
MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment] |
|
88954-3
|
MDS v3.0 - RAI v1.16.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
|
88945-1
|
MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment] |
|
88946-9
|
MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment] |
|
88947-7
|
MDS v3.0 - RAI v1.16.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment] |
|
88948-5
|
MDS v3.0 - RAI v1.16.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment] |
|
88949-3
|
MDS v3.0 - RAI v1.16.1 - Nursing home PPS (NP) item set [CMS Assessment] |
|
88955-0
|
MDS v3.0 - RAI v1.16.1 - Nursing home quarterly (NQ) item set [CMS Assessment] |
|
88950-1
|
MDS v3.0 - RAI v1.16.1 - Swing bed PPS (SP) item set [CMS Assessment] |
|
90480-5
|
MDS v3.0 - RAI v1.17.1 - Interim Payment Assessment (IPA) item set [CMS Assessment] |
|
90479-7
|
MDS v3.0 - RAI v1.17.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment] |
|
90473-0
|
MDS v3.0 - RAI v1.17.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
|
90477-1
|
MDS v3.0 - RAI v1.17.1 - Nursing home discharge (ND) item set [CMS Assessment] |
|
90478-9
|
MDS v3.0 - RAI v1.17.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment] |
|
90474-8
|
MDS v3.0 - RAI v1.17.1 - Nursing home PPS (NP) item set [CMS Assessment] |
|
90475-5
|
MDS v3.0 - RAI v1.17.1 - Nursing home quarterly (NQ) item set [CMS Assessment] |
|
90481-3
|
MDS v3.0 - RAI v1.17.1 - Optional State Assessment (OSA) item set [CMS Assessment] |
|
86585-7
|
MDS v3.0 - RAI v1.17.1 - Signs and symptoms of delirium (from CAM) [CMS Assessment] |
|
91552-0
|
MDS v3.0 - RAI v1.17.1 - Swing bed discharge (SD) item set [CMS Assessment] |
|
90476-3
|
MDS v3.0 - RAI v1.17.1 - Swing bed PPS (SP) item set [CMS Assessment] |
|
88880-0
|
Monocyte distribution width [Entitic volume] in Blood by Automated |
|
38608-6
|
Methyl bromide [Mass/volume] in Air |
|
9790-7
|
Methyl bromide [Mass/volume] in Serum or Plasma |
|
17270-0
|
Methylacrylate [Mass/volume] in Serum or Plasma |
|
75106-5
|
Mead acid (C20:3w9) [Entitic substance] in Red Blood Cells |
|
7359-3
|
Meadow Fescue triggered histamine release [Units/volume] in Blood |
|
6169-7
|
Meadow Fescue IgE Ab [Units/volume] in Serum |
|
61264-8
|
Meadow Fescue IgE Ab/IgE total in Serum |
|
7364-3
|
Meadow Fescue IgG Ab [Units/volume] in Serum |
|
56317-1
|
Meadow Fescue IgG4 Ab [Mass/volume] in Serum |
|
49720-6
|
Meadow Fescue IgG Ab [Mass/volume] in Serum |
|
48262-0
|
Meadow Fescue triggered leukotriene release [Mass/volume] by Leukocytes |
|
6170-5
|
Meadow Foxtail IgE Ab [Units/volume] in Serum |
|
56318-9
|
Meadow Foxtail IgG4 Ab [Mass/volume] in Serum |
|
80447-6
|
Meal andor snack pattern panel |
|
19747-5
|
Mealworm IgE Ab [Units/volume] in Serum |
|
60843-0
|
Mean dominant power frequency on EEG |
|
89199-4
|
Mean score [ECog.Partner] |
|
89198-6
|
Mean score [ECog] |
|
94052-8
|
Mean score [PCPCM] |
|
91147-9
|
Mean score [PEG] |
|
85146-9
|
Meaning and Purpose Survey - CAT item bank - age 18+ [NIH Toolbox] |
|
82265-0
|
Measured Activity metabolic rate/Measured RMR [Relative energy/Time] |
|
82270-0
|
Measured Activity metabolic rate/Population RMR [Relative energy/Time] |
|
82276-7
|
Measured Activity metabolic rate/Predicted RMR [Relative energy/Time] |
|
82261-9
|
Measured activity metabolic rate/Standard RMR [Relative energy/Time] |
|
74045-6
|
Measure description Narrative |
|
82278-3
|
Measured RMR |
|
75240-2
|
Meat fibers [#/area] in Stool by Microscopy low power field |
|
28069-3
|
Meat fibers [#/area] in Stool by Light microscopy |
|
2605-4
|
Meat fibers [Presence] in Stool by Light microscopy |
|
85786-2
|
Methicillin resistance mecA gene [Presence] by NAA with non-probe detection in Positive blood culture |
|
88251-4
|
Methicillin resistance mecA gene [Presence] by Probe in Positive blood culture |
|
48813-0
|
Methicillin resistance mecA gene [Presence] by Molecular method |
|
77666-6
|
Methicillin resistance mecA mRNA [Presence] by FISH in Positive blood culture |
|
92968-7
|
Methicillin resistance mecA+mecC genes [Presence] in Isolate or Specimen by Molecular genetics method |
|
86620-2
|
Methicillin resistance mecA+mecC genes [Presence] in Nose by NAA with probe detection |
|
12532-8
|
Meclizine [Presence] in Serum or Plasma |
|
13904-8
|
Meclizine [Mass/volume] in Serum or Plasma |
|
13905-5
|
Meclofenamate [Mass/volume] in Serum or Plasma |
|
35137-9
|
MECP2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
87232-5
|
Medication administration.brief |
|
87231-7
|
Medication administration.extended Document |
|
88363-7
|
Medical equipment or product note |
|
82215-5
|
Medical equipment or product list |
|
10938-9
|
Mediterranean flour moth IgE Ab [Units/volume] in Serum |
|
85230-1
|
Medical genetics Nurse procedure note |
|
70006-2
|
Medication management note |
|
81193-5
|
Medical microbiology - pathology Consult note |
|
80820-4
|
Medication reconciliation form |
|
94118-7
|
Medical records in response to authorization denial |
|
84190-8
|
Medical toxicology Consult note |
|
84191-6
|
Medical toxicology Note |
|
77604-7
|
Medication treatment plan.brief Document |
|
77603-9
|
Medication treatment plan.extended Document |
|
60486-8
|
MED12 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
3739-0
|
Medazepam [Mass/volume] in Blood |
|
3740-8
|
Medazepam [Mass/volume] in Urine |
|
60844-8
|
Median power frequency on EEG |
|
45400-9
|
Medicaid number |
|
64285-0
|
Medical history screening form |
|
91642-9
|
Medical Outcomes Study Social Support Survey panel [MOS Social Support Survey] |
|
11503-0
|
Medical records |
|
80389-0
|
Special medical equipment AndOr resuscitation needs |
|
45397-7
|
Medicare or comparable number |
|
46057-6
|
Medications section |
|
18486-1
|
Methylenediamine [Presence] in Urine |
|
19562-8
|
Methylenediamine [Presence] in Urine by Confirmatory method |
|
19561-0
|
Methylenediamine [Presence] in Urine by Screen method |
|
10914-0
|
Methylenediamine [Mass/volume] in Urine |
|
3805-9
|
MethylePHEDrine [Mass/time] in 24 hour Urine |
|
58348-4
|
MethylePHEDrine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
59706-2
|
MethylePHEDrine [Mass/volume] in Serum or Plasma |
|
20547-6
|
MethylePHEDrine [Mass/volume] in Urine by Confirmatory method |
|
3803-4
|
MethylePHEDrine [Presence] in Urine |
|
16216-4
|
MethylePHEDrine [Presence] in Urine by Confirmatory method |
|
19573-5
|
MethylePHEDrine [Presence] in Urine by Screen method |
|
17273-4
|
MethylePHEDrine [Units/volume] in Urine |
|
3804-2
|
MethylePHEDrine [Mass/volume] in Urine |
|
17274-2
|
Methylergonovine [Mass/volume] in Serum or Plasma |
|
80408-8
|
Meets CDC field triage criteria |
|
59923-3
|
Mefenamate [Moles/volume] in Gastric fluid |
|
48278-6
|
Mefenamate triggered leukotriene release [Mass/volume] by Leukocytes |
|
17246-0
|
Mefenamate [Mass/volume] in Serum or Plasma |
|
59921-7
|
Mefenamate [Moles/volume] in Serum or Plasma |
|
59922-5
|
Mefenamate [Moles/volume] in Urine |
|
60314-2
|
Mefenamate [Moles/volume] in Unspecified specimen |
|
3743-2
|
Mefenorex [Mass/time] in 24 hour Urine |
|
3741-6
|
Mefenorex [Presence] in Urine |
|
3742-4
|
Mefenorex [Mass/volume] in Urine |
|
17275-9
|
Methylfentanyl [Mass/volume] in Serum or Plasma |
|
29149-2
|
Mefloquine [Mass/volume] in Serum or Plasma |
|
29150-0
|
Mefloquine [Mass/volume] in Urine |
|
36925-6
|
MEFV gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41091-0
|
MEFV gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
69567-6
|
Megasphaera sp type 1 DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
74762-6
|
Megasphaera sp DNA [Log #/volume] in Vaginal fluid by NAA with probe detection |
|
41762-6
|
Megestrol acetate [Mass/volume] in Serum or Plasma |
|
46953-6
|
Megestrol acetate [Mass/volume] in Urine |
|
53187-1
|
Methylglutarylcarnitine (C6-DC) [Moles/volume] in DBS |
|
59180-0
|
Monoethylglycinexylidide [Presence] in Urine |
|
34344-2
|
N-methylhistamine [Moles/volume] in 24 hour Urine |
|
26053-9
|
N-methylhistamine [Moles/time] in 24 hour Urine |
|
12714-2
|
N-methylhistamine [Mass/volume] in Urine |
|
34345-9
|
N-methylhistamine [Moles/volume] in Urine |
|
44340-8
|
N-methylhistamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
80152-2
|
N-methylhistamine/Creatinine [Molar ratio] in 24 hour Urine |
|
13781-0
|
N-methylhistamine/Creatinine [Mass Ratio] in Urine |
|
34346-7
|
N-methylhistamine/Creatinine [Molar ratio] in Urine |
|
12543-5
|
Methyl formamide [Mass/volume] in Urine |
|
56660-4
|
Methyl formamide/Creatinine [Ratio] in Urine |
|
13011-2
|
Methyl ethyl ketone [Mass/volume] in Blood |
|
69800-1
|
Methyl ethyl ketone [Mass/volume] in Body fluid |
|
50879-6
|
Methyl ethyl ketone [Moles/volume] in Body fluid |
|
46255-6
|
Methyl ethyl ketone [Mass/volume] in Serum or Plasma |
|
50880-4
|
Methyl ethyl ketone [Moles/volume] in Serum or Plasma |
|
13009-6
|
Methyl ethyl ketone [Mass/volume] in Urine |
|
56639-8
|
Methyl ethyl ketone [Moles/volume] in Urine |
|
59189-1
|
Methyl ethyl ketone/Creatinine [Molar ratio] in Urine |
|
47031-0
|
Melan-A Ag [Presence] in Tissue by Immune stain |
|
74489-6
|
Melan-A and Ki67 Ag [Identifier] in Tissue by Immune stain |
|
17248-6
|
Melanin [Units/volume] in Serum or Plasma |
|
2606-2
|
Melanin [Presence] in Urine |
|
17247-8
|
Melanin [Units/volume] in Urine |
|
2607-0
|
Melanin [Mass/volume] in Urine |
|
35132-0
|
MELAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41090-2
|
MELAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
18183-4
|
Melatonin [Mass/time] in 24 hour Urine |
|
11056-9
|
Melatonin [Flow] in 24 hour Urine |
|
49725-5
|
Melatonin [Mass/volume] in Cerebral spinal fluid |
|
27060-3
|
Melatonin [Presence] in Saliva (oral fluid) |
|
78992-5
|
Melatonin [Mass/volume] in Saliva (oral fluid) |
|
12721-7
|
Melatonin [Units/volume] in Serum or Plasma |
|
11055-1
|
Melatonin [Mass/volume] in Serum or Plasma |
|
57885-6
|
Honeydew melon triggered histamine release [Units/volume] in Blood |
|
57884-9
|
Honeydew melon IgE Ab [Units/volume] in Serum |
|
57952-4
|
Honeydew melon IgE Ab/IgE total in Serum |
|
57880-7
|
Honeydew melon IgG Ab [Units/volume] in Serum |
|
57876-5
|
Honeydew melon IgG4 Ab [Mass/volume] in Serum |
|
63095-4
|
Honeydew melon IgG Ab [Mass/volume] in Serum |
|
88988-1
|
Melperone [Mass/volume] in Serum or Plasma |
|
54318-1
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Amniotic fluid |
|
54317-3
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Cerebral spinal fluid |
|
45222-7
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in DBS |
|
54319-9
|
Methylmalonylcarnitine (C4-DC) [Moles/volume] in Urine |
|
53181-4
|
Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS |
|
54316-5
|
Methylmalonylcarnitine (C4-DC)/Creatinine [Molar ratio] in Urine |
|
51415-8
|
Methylmalonylcarnitine+Succinylcarnitine (C4-DC) [Moles/volume] in Serum or Plasma |
|
59302-0
|
Memantine [Mass/volume] in Blood |
|
59303-8
|
Memantine [Mass/volume] in Body fluid |
|
59304-6
|
Memantine [Mass/volume] in Serum or Plasma |
|
59305-3
|
Memantine [Mass/mass] in Tissue |
|
59306-1
|
Memantine [Mass/volume] in Urine |
|
52037-9
|
Member ID card copy |
|
45989-1
|
Memory recall/ability Set |
|
45988-3
|
Memory Set |
|
75386-3
|
MEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
35288-0
|
MEN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41089-4
|
MEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
3129-4
|
Menadione [Mass/volume] in Serum or Plasma |
|
82180-1
|
Meningitis+Encephalitis pathogens DNA and RNA panel - Cerebral spinal fluid by NAA with non-probe detection |
|
44791-2
|
Menorrhagia coagulation panel - Platelet poor plasma |
|
75440-8
|
Mental health Administrative note |
|
84192-4
|
Mental health Admission evaluation note |
|
78246-6
|
Mental health Admission history and physical note |
|
84194-0
|
Mental health Agreement |
|
88358-7
|
Mental health Alert |
|
78504-8
|
Mental health Checklist |
|
84193-2
|
Mental health Conference note |
|
34785-6
|
Mental health Consult note |
|
34864-9
|
Mental health Counseling note |
|
78707-7
|
Mental health Crisis intervention note |
|
84196-5
|
Mental health Custodial care facility Note |
|
75441-6
|
Mental health Diagnostic study note |
|
78261-5
|
Mental health Discharge instructions |
|
78263-1
|
Mental health Discharge summary |
|
78266-4
|
Mental health Discharge teaching note |
|
84198-1
|
Mental health Emergency department Note |
|
78279-7
|
Mental health Education note |
|
78296-1
|
Mental health Flowsheet |
|
78305-0
|
Mental health Form |
|
34787-2
|
Mental health Group counseling note |
|
78306-8
|
Mental health History and physical note |
|
84200-5
|
Mental health Hospital Admission evaluation note |
|
84201-3
|
Mental health Hospital Group counseling note |
|
84202-1
|
Mental health Hospital Note |
|
84203-9
|
Mental health Hospital Plan of care note |
|
84195-7
|
Mental health Intensive care unit Note |
|
78309-2
|
Mental health Individual counseling note |
|
78466-0
|
Mental health Initial evaluation note |
|
84205-4
|
Mental health Long term care facility Note |
|
80420-3
|
Mental health Mandatory reporting form |
|
75442-4
|
Mental health Medication management note |
|
34786-4
|
Mental health Note |
|
84206-2
|
Mental health Observation unit Note |
|
84207-0
|
Mental health Outpatient Group counseling note |
|
84208-8
|
Mental health Outpatient Initial evaluation note |
|
75443-2
|
Mental health Outpatient Note |
|
84210-4
|
Mental health Outpatient Plan of care note |
|
84209-6
|
Mental health Outpatient Risk assessment and screening note |
|
84211-2
|
Mental health Outreach note |
|
75444-0
|
Mental health Telephone encounter Note |
|
80742-0
|
Mental health Plan of care note |
|
87239-0
|
Mental health Postoperative evaluation and management note |
|
87240-8
|
Mental health Preoperative evaluation and management note |
|
78472-8
|
Mental health procedure note |
|
34904-3
|
Mental health Progress note |
|
84199-9
|
Mental health Patient's home Note |
|
57143-0
|
Mental health Referral note |
|
78485-0
|
Mental health Restraint note |
|
78486-8
|
Mental health Risk assessment and screening note |
|
84215-3
|
Mental health Telehealth Note |
|
78488-4
|
Mental health Transfer summary note |
|
84218-7
|
Mental health Triage note |
|
84216-1
|
Mental health Transplant candidate evaluation note |
|
46611-0
|
Mental residual functional capacity (RFC) assessment form |
|
45974-3
|
Mental retardation and developmental disabilities with organic condition Set |
|
17249-4
|
Menthol [Mass/volume] in Blood |
|
81278-4
|
Meperidine and Normeperidine panel - Gastric fluid |
|
68314-4
|
Meperidine and Normeperidine panel - Serum or Plasma |
|
58953-1
|
Meperidine and Normeperidine panel - Urine |
|
81279-2
|
Meperidine and Normeperidine panel - Unspecified specimen |
|
3748-1
|
Meperidine [Mass/time] in 24 hour Urine |
|
14826-2
|
Meperidine [Presence] in Gastric fluid |
|
29400-9
|
Meperidine [Mass/volume] in Gastric fluid |
|
73729-6
|
Meperidine [Presence] in Hair |
|
75647-8
|
Meperidine [Presence] in Meconium |
|
72749-5
|
Meperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74108-2
|
Meperidine [Presence] in Saliva (oral fluid) by Screen method |
|
3744-0
|
Meperidine [Presence] in Serum or Plasma |
|
35617-0
|
Meperidine [Mass/volume] in Serum or Plasma by Screen method |
|
87497-4
|
Meperidine [Presence] in Serum, Plasma or Blood by Screen method |
|
73934-2
|
Meperidine [Mass/volume] in Serum, Plasma or Blood |
|
3745-7
|
Meperidine [Mass/volume] in Serum or Plasma |
|
59924-1
|
Meperidine [Moles/volume] in Serum or Plasma |
|
16253-7
|
Meperidine [Mass/volume] in Urine by Confirmatory method |
|
3746-5
|
Meperidine [Presence] in Urine |
|
16207-3
|
Meperidine [Presence] in Urine by Confirmatory method |
|
19532-1
|
Meperidine [Presence] in Urine by Screen method |
|
3747-3
|
Meperidine [Mass/volume] in Urine |
|
74378-1
|
Meperidine [Mass/volume] in Unknown substance |
|
32088-7
|
Meperidine [Presence] in Unspecified specimen |
|
57864-1
|
Meperidine [Moles/volume] in Unspecified specimen |
|
58386-4
|
Meperidine/Creatinine [Mass Ratio] in Urine |
|
51984-3
|
Meperidine+Normeperidine [Presence] in Serum or Plasma by Screen method |
|
72384-1
|
Meperidine+Normeperidine [Presence] in Urine by Confirmatory method |
|
58385-6
|
Meperidine+Normeperidine [Presence] in Urine by Screen method |
|
72795-8
|
Mephedrone [Mass/volume] in Urine by Confirmatory method |
|
67838-3
|
Mephedrone [Presence] in Urine by Confirmatory method |
|
72796-6
|
Mephedrone/Creatinine [Mass Ratio] in Urine |
|
72994-7
|
Methylphenidate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72993-9
|
Methylphenidate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3810-9
|
Methylphenidate [Mass/time] in 24 hour Urine |
|
61084-0
|
Methylphenidate [Presence] in Gastric fluid |
|
80538-2
|
Methylphenidate [Mass/mass] in Hair |
|
73278-4
|
Methylphenidate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73279-2
|
Methylphenidate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
87806-6
|
Methylphenidate [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87805-8
|
Methylphenidate [Presence] in Saliva (oral fluid) by Screen method |
|
3806-7
|
Methylphenidate [Presence] in Serum or Plasma |
|
3807-5
|
Methylphenidate [Mass/volume] in Serum or Plasma |
|
55552-4
|
Methylphenidate [Moles/volume] in Serum or Plasma |
|
20548-4
|
Methylphenidate [Mass/volume] in Urine by Confirmatory method |
|
3808-3
|
Methylphenidate [Presence] in Urine |
|
19578-4
|
Methylphenidate [Presence] in Urine by Confirmatory method |
|
19577-6
|
Methylphenidate [Presence] in Urine by Screen method |
|
3809-1
|
Methylphenidate [Mass/volume] in Urine |
|
61050-1
|
Methylphenidate [Presence] in Unspecified specimen |
|
72792-5
|
Methylphenidate/Creatinine [Mass Ratio] in Urine |
|
12403-2
|
Mephentermine [Mass/volume] in Blood |
|
26857-3
|
Mephentermine [Mass/mass] in Meconium |
|
26992-8
|
Mephentermine [Mass/volume] in Milk |
|
29597-2
|
Mephentermine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
26772-4
|
Mephentermine [Mass/mass] in Stool |
|
12291-1
|
Mephentermine [Presence] in Urine |
|
26786-4
|
Mephentermine [Mass/volume] in Urine |
|
27300-3
|
Mephentermine [Mass/volume] in Vitreous fluid |
|
3749-9
|
Mephenytoin [Mass/volume] in Serum or Plasma |
|
25468-0
|
Mephenytoin [Moles/volume] in Serum or Plasma |
|
34662-7
|
Mephenytoin+Normephenytoin [Mass/volume] in Serum or Plasma |
|
26906-8
|
Mephobarbital [Mass/mass] in Hair |
|
27003-3
|
Mephobarbital [Mass/mass] in Meconium |
|
27050-4
|
Mephobarbital [Mass/volume] in Milk |
|
16215-6
|
Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3750-7
|
Mephobarbital [Mass/volume] in Serum or Plasma |
|
32089-5
|
Mephobarbital [Moles/volume] in Serum or Plasma |
|
27241-9
|
Mephobarbital [Mass/mass] in Stool |
|
17250-2
|
Mephobarbital [Mass/volume] in Urine by Confirmatory method |
|
12315-8
|
Mephobarbital [Presence] in Urine |
|
19537-0
|
Mephobarbital [Presence] in Urine by Confirmatory method |
|
19536-2
|
Mephobarbital [Presence] in Urine by Screen method |
|
19539-6
|
Mephobarbital [Mass/volume] in Urine |
|
56877-4
|
Mepivacaine IgE Ab [Units/volume] in Serum |
|
17251-0
|
Mepivacaine [Presence] in Serum or Plasma |
|
10541-1
|
Mepivacaine [Mass/volume] in Serum or Plasma |
|
32090-3
|
Mepivacaine [Presence] in Urine |
|
73277-6
|
Methylprednisolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73276-8
|
Methylprednisolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14186-1
|
Methylprednisolone [Mass/volume] in Serum or Plasma |
|
46954-4
|
Methylprednisolone [Mass/volume] in Urine |
|
78856-2
|
Meprobamate [Mass/volume] in Blood by Confirmatory method |
|
40380-8
|
Meprobamate [Presence] in Gastric fluid |
|
29381-1
|
Meprobamate [Mass/volume] in Gastric fluid |
|
47119-3
|
Meprobamate [Moles/volume] in Gastric fluid |
|
72748-7
|
Meprobamate [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87811-6
|
Meprobamate [Presence] in Saliva (oral fluid) by Screen method |
|
3752-3
|
Meprobamate [Presence] in Serum or Plasma |
|
3753-1
|
Meprobamate [Mass/volume] in Serum or Plasma |
|
25469-8
|
Meprobamate [Moles/volume] in Serum or Plasma |
|
58374-0
|
Meprobamate [Mass/volume] in Urine by Confirmatory method |
|
3754-9
|
Meprobamate [Presence] in Urine |
|
58373-2
|
Meprobamate [Presence] in Urine by Confirmatory method |
|
3755-6
|
Meprobamate [Mass/volume] in Urine |
|
47120-1
|
Meprobamate [Moles/volume] in Urine |
|
32092-9
|
Meprobamate [Presence] in Unspecified specimen |
|
32091-1
|
Meprobamate [Moles/volume] in Unspecified specimen |
|
58372-4
|
Meprobamate/Creatinine [Mass Ratio] in Urine |
|
65330-3
|
MER Ab [Presence] in Serum or Plasma |
|
43639-4
|
Mercaptopurine [Presence] in Blood |
|
17252-8
|
Mercaptopurine [Presence] in Serum or Plasma |
|
11242-5
|
Mercaptopurine [Mass/volume] in Serum or Plasma |
|
30921-1
|
Mercury [Mass/volume] in Urine collected for unspecified duration |
|
13961-8
|
Mercury [Presence] in 24 hour Urine |
|
21383-5
|
Mercury [Mass/volume] in 24 hour Urine |
|
6693-6
|
Mercury [Mass/time] in 24 hour Urine |
|
34337-6
|
Mercury [Moles/volume] in 24 hour Urine |
|
25471-4
|
Mercury [Moles/time] in 24 hour Urine |
|
5685-3
|
Mercury [Mass/volume] in Blood |
|
25170-2
|
Mercury [Moles/volume] in Blood |
|
9693-3
|
Mercury [Mass/volume] in Cerebral spinal fluid |
|
12775-3
|
Mercury [Mass/volume] in Dentin |
|
17255-1
|
Mercury [Mass/volume] in Dialysis fluid |
|
20876-9
|
Mercury [Mass/mass] in Feed |
|
29221-9
|
Mercury [Mass/volume] in Body fluid |
|
17254-4
|
Mercury [Mass/volume] in Food |
|
39583-0
|
Mercury [Presence] in Hair |
|
5686-1
|
Mercury [Mass/mass] in Hair |
|
50876-2
|
Mercury [Moles/mass] in Hair |
|
17253-6
|
Mercury [Mass/volume] in Milk |
|
39584-8
|
Mercury [Presence] in Nail |
|
8204-0
|
Mercury [Mass/mass] in Nail |
|
79143-4
|
Mercury [Moles/mass] in Nail |
|
12774-6
|
Mercury [Mass/volume] in Red Blood Cells |
|
27130-4
|
Mercury [Mass/mass] in Red Blood Cells |
|
50878-8
|
Mercury [Moles/volume] in Red Blood Cells |
|
25470-6
|
Mercury [Moles/volume] in Saliva (oral fluid) |
|
5687-9
|
Mercury [Mass/volume] in Serum or Plasma |
|
32330-3
|
Mercury [Moles/volume] in Serum or Plasma |
|
8205-7
|
Mercury [Mass/mass] in Tissue |
|
50877-0
|
Mercury [Moles/mass] in Tissue |
|
19056-1
|
Mercury [Presence] in Urine |
|
5688-7
|
Mercury [Presence] in Urine by Visual.Reinsch |
|
5689-5
|
Mercury [Mass/volume] in Urine |
|
34338-4
|
Mercury [Moles/volume] in Urine |
|
9479-7
|
Mercury [Mass/volume] in Water |
|
23896-4
|
Mercury [Mass/mass] in Unspecified specimen |
|
47121-9
|
Mercury [Moles/mass] in Unspecified specimen |
|
26688-2
|
Mercury/Creatinine [Mass Ratio] in 24 hour Urine |
|
52929-7
|
Mercury/Creatinine [Molar ratio] in 24 hour Urine |
|
13465-0
|
Mercury/Creatinine [Mass Ratio] in Urine |
|
56653-9
|
Mercury/Creatinine [Ratio] in Urine |
|
22680-3
|
Mercury/Creatinine [Molar ratio] in Urine |
|
90980-4
|
Meropenem+Vaborbactam [Susceptibility] by Gradient strip |
|
85427-3
|
Meropenem+Vaborbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
88892-5
|
Meropenem+Vaborbactam [Susceptibility] |
|
73289-1
|
Meropenem induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73288-3
|
Meropenem induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
85426-5
|
Meropenem [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
|
41406-0
|
Meropenem [Mass/volume] in Serum or Plasma |
|
34649-4
|
MERRF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41088-6
|
MERRF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
3758-0
|
Mersalyl [Mass/time] in 24 hour Urine |
|
3756-4
|
Mersalyl [Presence] in Urine |
|
3757-2
|
Mersalyl [Mass/volume] in Urine |
|
74473-0
|
Middle East respiratory syndrome coronavirus (MERS-CoV) N2 gene RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
74472-2
|
Middle East respiratory syndrome coronavirus (MERS-CoV) N3 gene RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88199-5
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Aspirate by NAA with probe detection |
|
86578-2
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Blood by NAA with probe detection |
|
88198-7
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
92967-9
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
91830-0
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88889-1
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88197-9
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with probe detection |
|
74408-6
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA panel - Unspecified specimen |
|
88196-1
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Stool by NAA with probe detection |
|
91807-8
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
86579-0
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Urine by NAA with probe detection |
|
74475-5
|
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Interpretation] in Unspecified specimen Qualitative by NAA with probe detection |
|
74474-8
|
Middle East respiratory syndrome coronavirus (MERS-CoV) upE gene RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
16145-5
|
Mescaline [Mass/volume] in Serum or Plasma |
|
20543-5
|
Mescaline [Mass/volume] in Urine by Confirmatory method |
|
12296-0
|
Mescaline [Presence] in Urine |
|
19543-8
|
Mescaline [Presence] in Urine by Confirmatory method |
|
19542-0
|
Mescaline [Presence] in Urine by Screen method |
|
9726-1
|
Mescaline [Mass/volume] in Urine |
|
13002-1
|
Mesityl oxide [Mass/volume] in Blood |
|
31168-8
|
Mesityl oxide [Mass/volume] in Urine |
|
45310-0
|
Mesoporphyrin [Moles/mass] in Stool |
|
75767-4
|
Mesoridazine [Presence] in Blood or Urine by Screen method |
|
59926-6
|
Mesoridazine [Moles/volume] in Gastric fluid |
|
13566-5
|
Mesoridazine [Presence] in Serum or Plasma |
|
3760-6
|
Mesoridazine [Mass/volume] in Serum or Plasma |
|
25472-2
|
Mesoridazine [Moles/volume] in Serum or Plasma |
|
20544-3
|
Mesoridazine [Mass/volume] in Urine by Confirmatory method |
|
12367-9
|
Mesoridazine [Presence] in Urine |
|
19547-9
|
Mesoridazine [Presence] in Urine by Confirmatory method |
|
19546-1
|
Mesoridazine [Presence] in Urine by Screen method |
|
17256-9
|
Mesoridazine [Mass/volume] in Urine |
|
59925-8
|
Mesoridazine [Moles/volume] in Urine |
|
60315-9
|
Mesoridazine [Moles/volume] in Unspecified specimen |
|
74125-6
|
Mesothelin Ag [Presence] in Tissue by Immune stain |
|
68414-2
|
Mesothelial cells [#/volume] in Pericardial fluid by Manual count |
|
68416-7
|
Mesothelial cells [#/volume] in Pleural fluid by Manual count |
|
68415-9
|
Mesothelial cells [#/volume] in Peritoneal fluid by Manual count |
|
68417-5
|
Mesothelial cells [#/volume] in Synovial fluid by Manual count |
|
68419-1
|
Mesothelial cells [#/volume] in Vitreous fluid by Manual count |
|
74852-5
|
Mesothelial cells/100 cells in Lymph node by Manual count |
|
68418-3
|
Mesothelial cells/100 leukocytes in Vitreous fluid by Manual count |
|
6173-9
|
Mesquite IgE Ab [Units/volume] in Serum |
|
61305-9
|
Mesquite IgE Ab/IgE total in Serum |
|
13182-1
|
Mesquite IgG Ab [Units/volume] in Serum |
|
56320-5
|
Mesquite IgG4 Ab [Mass/volume] in Serum |
|
63185-3
|
Mesquite IgG Ab [Mass/volume] in Serum |
|
58002-7
|
Mestanolone metabolite [Presence] in Urine |
|
3763-0
|
Mesterolone [Mass/time] in 24 hour Urine |
|
3761-4
|
Mesterolone [Presence] in Urine |
|
3762-2
|
Mesterolone [Mass/volume] in Urine |
|
69828-2
|
Methylsuccinate [Moles/volume] in Amniotic fluid |
|
82503-4
|
Methylsuccinate [Moles/volume] in DBS |
|
69829-0
|
Methylsuccinate [Moles/volume] in Serum or Plasma |
|
30479-0
|
Methylsuccinate [Presence] in Urine |
|
13777-8
|
Methylsuccinate/Creatinine [Mass Ratio] in Urine |
|
25117-3
|
Methylsuccinate/Creatinine [Molar ratio] in Urine |
|
82259-3
|
Metabolic equivalent of task and Resting metabolic rate panel |
|
2634-4
|
Methyltestosterone [Mass/time] in 24 hour Urine |
|
90926-7
|
MET gene amplification in Blood or Tissue by FISH |
|
92906-7
|
MET gene copy number/nucleus in Blood or Tissue by FISH |
|
49856-8
|
Methyltestosterone [Presence] in Serum or Plasma |
|
2632-8
|
Methyltestosterone [Presence] in Urine |
|
2633-6
|
Methyltestosterone [Mass/volume] in Urine |
|
15130-8
|
Methionine+Tryptophan [Presence] in Serum or Plasma |
|
15145-6
|
Methionine+Tryptophan [Presence] in Urine |
|
41966-3
|
Name of Metabolism measurement device |
|
54232-4
|
Metabolic panel.large animal - Serum or Plasma |
|
54233-2
|
Metabolic panel.small animal - Serum or Plasma |
|
74873-1
|
Metabolic disorder being monitored [Identifier] in DBS |
|
74874-9
|
Metabolic disorder therapy monitoring panel - DBS |
|
88843-8
|
Metabolic panel.dialysis patient - Serum or Plasma |
|
69429-9
|
Metabolic rate --resting |
|
43147-8
|
Metabolism measurement device panel |
|
23751-1
|
Metaldehyde [Mass/volume] in Unspecified specimen |
|
66137-1
|
Metamyelocytes [#/volume] in Blood from Fetus by Manual count |
|
3766-3
|
Metandienone [Mass/time] in 24 hour Urine |
|
17258-5
|
Metandienone [Mass/volume] in Serum or Plasma |
|
3764-8
|
Metandienone [Presence] in Urine |
|
3765-5
|
Metandienone [Mass/volume] in Urine |
|
21019-5
|
Metanephrine [Mass/volume] in 24 hour Urine |
|
19049-6
|
Metanephrine [Mass/time] in 24 hour Urine |
|
25955-6
|
Metanephrine [Moles/volume] in 24 hour Urine |
|
11140-1
|
Metanephrine [Moles/time] in 24 hour Urine |
|
32634-8
|
Metanephrine Free [Mass/time] in 24 hour Urine |
|
38494-1
|
Metanephrine Free [Mass/volume] in Serum or Plasma |
|
49700-8
|
Metanephrine Free [Moles/volume] in Serum or Plasma |
|
44337-4
|
Metanephrine Free/Creatinine [Mass Ratio] in Urine |
|
29141-9
|
Metanephrine [Mass/volume] in Serum or Plasma |
|
25473-0
|
Metanephrine [Moles/volume] in Serum or Plasma |
|
11139-3
|
Metanephrine [Mass/volume] in Urine |
|
34339-2
|
Metanephrine [Moles/volume] in Urine |
|
47699-4
|
Metanephrine/Creatinine [Molar ratio] in 24 hour Urine |
|
57772-6
|
Metanephrine.free and Normetanephrine.free panel [Moles/volume] - Serum or Plasma |
|
43108-0
|
Metanephrine and Normetanephrine panel [Mass/volume] - Serum or Plasma |
|
51993-4
|
Metanephrine and Normetanephrine panel - Urine |
|
19050-4
|
Metanephrines [Mass/volume] in 24 hour Urine |
|
2609-6
|
Metanephrines [Mass/time] in 24 hour Urine |
|
71791-8
|
Metanephrines [Moles/volume] in 24 hour Urine |
|
14833-8
|
Metanephrines [Moles/time] in 24 hour Urine |
|
29142-7
|
Metanephrines [Mass/volume] in Serum or Plasma |
|
25474-8
|
Metanephrines [Moles/volume] in Serum or Plasma |
|
2608-8
|
Metanephrines [Mass/volume] in Urine |
|
14832-0
|
Metanephrines [Moles/volume] in Urine |
|
32655-3
|
Metanephrines/Creatinine [Mass Ratio] in 24 hour Urine |
|
27978-6
|
Metanephrines/Creatinine [Molar ratio] in 24 hour Urine |
|
13771-1
|
Metanephrines/Creatinine [Mass Ratio] in Urine |
|
86931-3
|
Metanephrine, Normetanephrine and Creatinine panel - 24 hour Urine |
|
68317-7
|
Metanephrine, Normetanephrine and Creatinine panel - Urine |
|
6949-2
|
Metaproterenol [Mass/volume] in Serum or Plasma |
|
3767-1
|
Metaraminol [Mass/volume] in Urine |
|
31175-3
|
Metasystox [Mass/volume] in Blood |
|
35485-2
|
Metasystox [Mass/volume] in Serum or Plasma |
|
21385-0
|
Metasystox [Mass/volume] in Urine |
|
59307-9
|
Metaxalone [Mass/volume] in Blood |
|
59308-7
|
Metaxalone [Mass/volume] in Serum or Plasma |
|
59309-5
|
Metaxalone [Mass/volume] in Urine |
|
87775-3
|
Metaxalone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
3770-5
|
Metenolone [Mass/time] in 24 hour Urine |
|
3768-9
|
Metenolone [Presence] in Urine |
|
3769-7
|
Metenolone [Mass/volume] in Urine |
|
72996-2
|
metFORMIN induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72995-4
|
metFORMIN induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73287-5
|
metFORMIN induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73286-7
|
metFORMIN induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35698-0
|
metFORMIN [Mass/volume] in Serum or Plasma |
|
55548-2
|
metFORMIN [Moles/volume] in Serum or Plasma |
|
3775-4
|
Methadone [Mass/time] in 24 hour Urine |
|
31084-7
|
Methadone [Mass/volume] in Bile fluid |
|
72400-5
|
Methadone [Presence] in Blood by Screen method |
|
80532-5
|
Methadone [Mass/volume] in Blood |
|
29285-4
|
Methadone [Presence] in Gastric fluid |
|
29294-6
|
Methadone [Mass/volume] in Gastric fluid |
|
73727-0
|
Methadone [Presence] in Hair |
|
11243-3
|
Methadone [Mass/mass] in Hair |
|
43595-8
|
Methadone [Presence] in Meconium |
|
11025-4
|
Methadone [Mass/volume] in Meconium |
|
29159-1
|
Methadone [Mass/mass] in Meconium |
|
27052-0
|
Methadone [Mass/volume] in Milk |
|
72476-5
|
Methadone panel - Saliva (oral fluid) by Confirmatory method |
|
73661-1
|
Methadone panel - Saliva (oral fluid) by Screen method |
|
72388-2
|
Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72387-4
|
Methadone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
72626-5
|
Methadone [Presence] in Saliva (oral fluid) by Screen method |
|
72734-7
|
Methadone [Mass/volume] in Saliva (oral fluid) by Screen method |
|
3771-3
|
Methadone [Presence] in Serum or Plasma |
|
47411-4
|
Methadone [Presence] in Serum or Plasma by Confirmatory method |
|
59705-4
|
Methadone [Presence] in Serum or Plasma by Screen method |
|
35618-8
|
Methadone [Mass/volume] in Serum or Plasma by Screen method |
|
3772-1
|
Methadone [Mass/volume] in Serum or Plasma |
|
15108-4
|
Methadone [Moles/volume] in Serum or Plasma |
|
12356-2
|
Methadone [Presence] in Stool |
|
27283-1
|
Methadone [Mass/mass] in Stool |
|
16246-1
|
Methadone [Mass/volume] in Urine by Confirmatory method |
|
3773-9
|
Methadone [Presence] in Urine |
|
16199-2
|
Methadone [Presence] in Urine by Confirmatory method |
|
19550-3
|
Methadone [Presence] in Urine by Screen method |
|
70148-2
|
Methadone [Presence] in Urine by Screen method >150 ng/mL |
|
70149-0
|
Methadone [Presence] in Urine by Screen method >300 ng/mL |
|
70147-4
|
Methadone [Mass/volume] in Urine by Screen method |
|
3774-7
|
Methadone [Mass/volume] in Urine |
|
52958-6
|
Methadone [Moles/volume] in Urine |
|
27207-0
|
Methadone [Mass/volume] in Vitreous fluid |
|
48956-7
|
Methadone [Mass/volume] in Unspecified specimen by Confirmatory method |
|
32093-7
|
Methadone [Presence] in Unspecified specimen |
|
29532-9
|
Methadone [Units/volume] in Unspecified specimen |
|
48957-5
|
Methadone [Mass/volume] in Unspecified specimen |
|
77328-3
|
Methadone [Moles/volume] in Unspecified specimen |
|
41466-4
|
Methadone/Creatinine [Mass Ratio] in Urine |
|
91039-8
|
Methadone+Metabolite [Presence] in Body fluid by Screen method |
|
91046-3
|
Methadone+Metabolite [Presence] in Hair by Screen method |
|
91030-7
|
Methadone+Metabolite [Presence] in Meconium by Screen method |
|
72475-7
|
Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method |
|
91033-1
|
Methadone+Metabolite [Presence] in Serum, Plasma or Blood by Screen method |
|
48403-0
|
Methadone+Metabolite [Mass/volume] in Serum or Plasma |
|
91050-5
|
Methadone+Metabolite [Presence] in Tissue by Screen method |
|
42251-9
|
Methadone+Metabolite [Presence] in Urine by Screen method |
|
3776-2
|
Methamphetamine [Mass/volume] in Blood |
|
14834-6
|
Methamphetamine [Presence] in Gastric fluid |
|
40652-0
|
Methamphetamine [Presence] in Hair |
|
40803-9
|
Methamphetamine [Presence] in Hair by Screen method |
|
80533-3
|
Methamphetamine [Mass/mass] in Hair |
|
69022-2
|
Methamphetamine [Mass/mass] in Meconium by Confirmatory method |
|
29286-2
|
Methamphetamine [Presence] in Meconium |
|
15405-4
|
Methamphetamine [Mass/volume] in Meconium |
|
27289-8
|
Methamphetamine [Mass/mass] in Meconium |
|
27116-3
|
Methamphetamine [Mass/volume] in Milk |
|
72735-4
|
Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74646-1
|
Methamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40804-7
|
Methamphetamine [Presence] in Saliva (oral fluid) by Screen method |
|
17260-1
|
Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3777-0
|
Methamphetamine [Presence] in Serum or Plasma |
|
82966-3
|
Methamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3778-8
|
Methamphetamine [Mass/volume] in Serum or Plasma |
|
26734-4
|
Methamphetamine [Mass/mass] in Stool |
|
16235-4
|
Methamphetamine [Mass/volume] in Urine by Confirmatory method |
|
3779-6
|
Methamphetamine [Presence] in Urine |
|
19555-2
|
Methamphetamine [Presence] in Urine by Confirmatory method |
|
21386-8
|
Methamphetamine [Presence] in Urine by SAMHSA confirm method |
|
19554-5
|
Methamphetamine [Presence] in Urine by Screen method |
|
3780-4
|
Methamphetamine [Mass/volume] in Urine |
|
55587-0
|
Methamphetamine [Moles/volume] in Urine |
|
27277-3
|
Methamphetamine [Mass/volume] in Vitreous fluid |
|
40381-6
|
Methamphetamine [Presence] in Unspecified specimen |
|
58358-3
|
Methamphetamine/Creatinine [Mass Ratio] in Urine |
|
91042-2
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Body fluid by Screen method |
|
91045-5
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Hair by Screen method |
|
91031-5
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Meconium by Screen method |
|
91034-9
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Serum, Plasma or Blood by Screen method |
|
91051-3
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Tissue by Screen method |
|
91037-2
|
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Urine by Screen method |
|
14166-3
|
Methane [Mass/volume] in Blood |
|
2610-4
|
Methane [Mass/volume] in Exhaled gas |
|
38705-0
|
Methanol [Mass/volume] in Air |
|
5690-3
|
Methanol [Presence] in Blood |
|
9334-4
|
Methanol [Mass/volume] in Blood |
|
5691-1
|
Methanol [Presence] in Exhaled gas |
|
40532-4
|
Methanol [Presence] in Gastric fluid |
|
23899-8
|
Methanol [Mass/volume] in Gastric fluid |
|
59927-4
|
Methanol [Moles/volume] in Gastric fluid |
|
15407-0
|
Methanol [Presence] in Meconium |
|
5692-9
|
Methanol [Presence] in Serum or Plasma |
|
20579-9
|
Methanol [Presence] in Serum or Plasma by Screen method |
|
5693-7
|
Methanol [Mass/volume] in Serum or Plasma |
|
14835-3
|
Methanol [Moles/volume] in Serum or Plasma |
|
23900-4
|
Methanol [Mass/mass] in Tissue |
|
5694-5
|
Methanol [Presence] in Urine |
|
34181-8
|
Methanol [Presence] in Urine by Confirmatory method |
|
5695-2
|
Methanol [Mass/volume] in Urine |
|
32095-2
|
Methanol [Moles/volume] in Urine |
|
29375-3
|
Methanol [Mass/volume] in Unknown substance |
|
32094-5
|
Methanol [Moles/volume] in Unspecified specimen |
|
46230-9
|
Methanolone [Mass/volume] in Urine |
|
75762-5
|
Methapyrilene [Presence] in Serum or Plasma or Urine by Screen method |
|
3781-2
|
Methapyrilene [Presence] in Serum or Plasma |
|
3782-0
|
Methapyrilene [Mass/volume] in Serum or Plasma |
|
3783-8
|
Methapyrilene [Presence] in Urine |
|
17261-9
|
Methapyrilene [Mass/volume] in Urine |
|
31085-4
|
Methaqualone [Mass/volume] in Bile fluid |
|
50005-8
|
Methaqualone [Presence] in Body fluid by Screen method |
|
40382-4
|
Methaqualone [Presence] in Gastric fluid |
|
29388-6
|
Methaqualone [Mass/volume] in Gastric fluid |
|
59929-0
|
Methaqualone [Moles/volume] in Gastric fluid |
|
13646-5
|
Methaqualone [Mass/mass] in Hair |
|
11026-2
|
Methaqualone [Mass/volume] in Meconium |
|
27262-5
|
Methaqualone [Mass/mass] in Meconium |
|
34182-6
|
Methaqualone metabolite [Presence] in Serum or Plasma by Confirmatory method |
|
3784-6
|
Methaqualone [Presence] in Serum or Plasma |
|
35619-6
|
Methaqualone [Mass/volume] in Serum or Plasma by Screen method |
|
3785-3
|
Methaqualone [Mass/volume] in Serum or Plasma |
|
25475-5
|
Methaqualone [Moles/volume] in Serum or Plasma |
|
12353-9
|
Methaqualone [Presence] in Stool |
|
16244-6
|
Methaqualone [Mass/volume] in Urine by Confirmatory method |
|
3786-1
|
Methaqualone [Presence] in Urine |
|
18389-7
|
Methaqualone [Presence] in Urine by Confirmatory method |
|
19558-6
|
Methaqualone [Presence] in Urine by Screen method |
|
3787-9
|
Methaqualone [Mass/volume] in Urine |
|
59928-2
|
Methaqualone [Moles/volume] in Urine |
|
27347-4
|
Methaqualone [Mass/volume] in Vitreous fluid |
|
32096-0
|
Methaqualone [Presence] in Unspecified specimen |
|
60316-7
|
Methaqualone [Moles/volume] in Unspecified specimen |
|
42252-7
|
Methaqualone+Metabolite [Presence] in Urine by Screen method |
|
10542-9
|
Metharbital [Mass/volume] in Serum or Plasma |
|
12498-2
|
Metharbital [Presence] in Stool |
|
58004-3
|
Methasterone [Presence] in Urine |
|
10841-5
|
methazolAMIDE [Mass/volume] in Serum or Plasma |
|
78858-8
|
Methcathinone [Mass/volume] in Urine by Confirmatory method |
|
79144-2
|
Methcathinone [Presence] in Urine by Screen method |
|
87762-1
|
Methcathinone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
45145-0
|
Methdilazine [Presence] in Serum or Plasma |
|
12801-7
|
Methdilazine [Mass/volume] in Serum or Plasma |
|
79246-5
|
Methedrone [Mass/volume] in Urine by Confirmatory method |
|
17263-5
|
Methemalbumin [Presence] in Serum or Plasma |
|
2612-0
|
Methemalbumin [Mass/volume] in Serum or Plasma |
|
2613-8
|
Methemoglobin [Presence] in Blood |
|
15082-1
|
Methemoglobin [Mass/volume] in Blood |
|
56040-9
|
Methemoglobin [Moles/volume] in Blood |
|
72262-9
|
Methemoglobin [Moles/volume] in Cerebral spinal fluid |
|
2614-6
|
Methemoglobin/Hemoglobin.total in Blood |
|
41607-3
|
Methemoglobin/Hemoglobin.total in Mixed venous blood |
|
2619-5
|
Methemoglobin [Presence] in Red Blood Cells |
|
3788-7
|
Methicillin [Mass/volume] in Serum or Plasma |
|
29492-6
|
Methicillin [Mass/volume] in Unspecified specimen |
|
34185-9
|
methIMAzole [Mass/time] in 24 hour Urine |
|
14185-3
|
methIMAzole [Mass/volume] in Serum or Plasma |
|
2620-3
|
Methionine [Presence] in Blood |
|
63380-0
|
Methionine [Presence] in DBS |
|
47700-0
|
Methionine [Moles/volume] in DBS |
|
55943-5
|
Methionine [Moles/mass] in Hair |
|
47703-4
|
Methionine/Amino acids.total in Amniotic fluid |
|
47702-6
|
Methionine/Amino acids.total in Cerebral spinal fluid |
|
47705-9
|
Methionine/Amino acids.total in DBS |
|
47701-8
|
Methionine/Amino acids.total in Hair |
|
47704-2
|
Methionine/Amino acids.total in Serum or Plasma |
|
47706-7
|
Methionine/Amino acids.total in Unspecified specimen |
|
44338-2
|
Methionine/Creatinine [Mass Ratio] in 24 hour Urine |
|
53156-6
|
Methionine/Phenylalanine [Molar ratio] in DBS |
|
73285-9
|
Methocarbamol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73284-2
|
Methocarbamol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3789-5
|
Methocarbamol [Presence] in Serum or Plasma |
|
17265-0
|
Methocarbamol [Units/volume] in Serum or Plasma |
|
3790-3
|
Methocarbamol [Mass/volume] in Serum or Plasma |
|
55549-0
|
Methocarbamol [Moles/volume] in Serum or Plasma |
|
3791-1
|
Methocarbamol [Presence] in Urine |
|
12491-7
|
Methohexital [Presence] in Serum or Plasma |
|
27042-1
|
Methohexital [Mass/volume] in Serum or Plasma |
|
27187-4
|
Methohexital [Mass/volume] in Urine |
|
87650-8
|
Methomyl [Mass/mass] in Unspecified specimen |
|
80969-9
|
Methotrexate free [Mass/volume] in Serum or Plasma |
|
59931-6
|
Methotrimeprazine [Moles/volume] in Gastric fluid |
|
59172-7
|
Methotrimeprazine metabolite [Presence] in Urine |
|
40424-4
|
Methotrimeprazine [Presence] in Serum or Plasma |
|
63482-4
|
Methotrimeprazine [Mass/volume] in Serum or Plasma |
|
48351-1
|
Methotrimeprazine [Moles/volume] in Serum or Plasma |
|
20538-5
|
Methotrimeprazine [Mass/volume] in Urine by Confirmatory method |
|
40422-8
|
Methotrimeprazine [Presence] in Urine |
|
19503-2
|
Methotrimeprazine [Presence] in Urine by Confirmatory method |
|
19502-4
|
Methotrimeprazine [Presence] in Urine by Screen method |
|
3708-5
|
Methotrimeprazine [Mass/volume] in Urine |
|
59930-8
|
Methotrimeprazine [Moles/volume] in Urine |
|
40423-6
|
Methotrimeprazine [Presence] in Unspecified specimen |
|
60317-5
|
Methotrimeprazine [Moles/volume] in Unspecified specimen |
|
55252-1
|
Methoxsalen 0.02 mg/mL given [Volume] |
|
13625-9
|
Methoxsalen [Mass/volume] in Serum or Plasma |
|
2626-0
|
Methoxyacetate [Mass/volume] in Serum or Plasma |
|
44860-5
|
Methoxyacetate/Creatinine [Mass Ratio] in Urine |
|
38607-8
|
Methoxychlor [Mass/volume] in Air |
|
11099-9
|
Methoxychlor [Mass/volume] in Serum or Plasma |
|
17267-6
|
Methoxychlor [Mass/volume] in Urine |
|
87647-4
|
Methoxychlor [Mass/mass] in Unspecified specimen |
|
14266-1
|
Methoxyflurane [Mass/volume] in Blood |
|
3800-0
|
Methoxyphenamine [Mass/time] in 24 hour Urine |
|
3798-6
|
Methoxyphenamine [Presence] in Urine |
|
3799-4
|
Methoxyphenamine [Mass/volume] in Urine |
|
3801-8
|
Methsuximide [Mass/volume] in Serum or Plasma |
|
14837-9
|
Methsuximide [Moles/volume] in Serum or Plasma |
|
10543-7
|
Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
|
55550-8
|
Methsuximide+Normethsuximide [Moles/volume] in Serum or Plasma |
|
18469-7
|
Methyclothiazide [Mass/volume] in Serum or Plasma |
|
12346-3
|
Methyclothiazide [Presence] in Urine |
|
9650-3
|
Methyclothiazide [Mass/volume] in Urine |
|
38708-4
|
Methyl hydrazine [Mass/volume] in Air |
|
38709-2
|
Methyl iodide [Mass/volume] in Air |
|
38747-2
|
Methyl isocyanate [Mass/volume] in Air |
|
53650-8
|
Methyl parathion [Mass/volume] in Gastric fluid |
|
35484-5
|
Methyl parathion [Mass/volume] in Serum or Plasma |
|
18371-5
|
Methyl parathion [Mass/volume] in Urine |
|
87646-6
|
Methyl parathion [Mass/mass] in Unspecified specimen |
|
58003-5
|
Methylandrostenediol [Presence] in Urine |
|
73281-8
|
Methyldopa induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73280-0
|
Methyldopa induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3802-6
|
Methyldopa [Mass/volume] in Serum or Plasma |
|
21387-6
|
Methylhippurate [Mass/volume] in Urine |
|
9437-5
|
Methylhippurate [Mass/time] in Urine |
|
13774-5
|
Methylhippurate/Creatinine [Mass Ratio] in Urine |
|
85097-4
|
Meta methylhippurate and ortho methylhippurate and para methylhippurate and creatinine panel - Urine |
|
29342-3
|
Methylmalonate [Mass/time] in 24 hour Urine |
|
42520-7
|
Methylmalonate [Moles/volume] in 24 hour Urine |
|
47091-4
|
Methylmalonate [Moles/time] in 24 hour Urine |
|
34627-0
|
Methylmalonate [Moles/volume] in Amniotic fluid |
|
32259-4
|
Methylmalonate [Mass/volume] in Cerebral spinal fluid |
|
54315-7
|
Methylmalonate [Moles/volume] in Cerebral spinal fluid |
|
82385-6
|
Methylmalonate [Moles/volume] in DBS |
|
2629-4
|
Methylmalonate [Mass/volume] in Serum or Plasma |
|
13964-2
|
Methylmalonate [Moles/volume] in Serum or Plasma |
|
29877-8
|
Methylmalonate [Presence] in Urine |
|
2630-2
|
Methylmalonate [Mass/volume] in Urine |
|
32287-5
|
Methylmalonate [Moles/volume] in Urine |
|
13775-2
|
Methylmalonate/Creatinine [Mass Ratio] in 24 hour Urine |
|
25115-7
|
Methylmalonate/Creatinine [Molar ratio] in 24 hour Urine |
|
13776-0
|
Methylmalonate/Creatinine [Mass Ratio] in Urine |
|
56664-6
|
Methylmalonate/Creatinine [Ratio] in Urine |
|
25116-5
|
Methylmalonate/Creatinine [Molar ratio] in Urine |
|
44719-3
|
Methylmalonate/Homocysteine [Mass Ratio] in Serum or Plasma |
|
44720-1
|
Methylmalonate/Homocystine [Molar ratio] in Serum or Plasma |
|
47707-5
|
Methylmalonate/Urea [Molar ratio] in Amniotic fluid |
|
47708-3
|
Methylmalonate/Urea [Molar ratio] in Serum or Plasma |
|
47709-1
|
Methylmalonate/Urea [Molar ratio] in Urine |
|
38545-0
|
Methylmercury [Mass/mass] in Tissue |
|
33934-1
|
Methylmethacrylate IgE Ab [Presence] in Serum |
|
58005-0
|
Methylnortestosterone [Presence] in Urine |
|
72793-3
|
Methylone [Mass/volume] in Urine by Confirmatory method |
|
73686-8
|
Methylone [Presence] in Urine by Screen method |
|
72794-1
|
Methylone/Creatinine [Mass Ratio] in Urine |
|
40862-5
|
Methylparaben IgE Ab [Units/volume] in Serum |
|
18242-8
|
Methyprylon [Mass/time] in 24 hour Urine |
|
40383-2
|
Methyprylon [Presence] in Gastric fluid |
|
47122-7
|
Methyprylon [Moles/volume] in Gastric fluid |
|
3811-7
|
Methyprylon [Presence] in Serum or Plasma |
|
3812-5
|
Methyprylon [Mass/volume] in Serum or Plasma |
|
25478-9
|
Methyprylon [Moles/volume] in Serum or Plasma |
|
20549-2
|
Methyprylon [Mass/volume] in Urine by Confirmatory method |
|
3813-3
|
Methyprylon [Presence] in Urine |
|
16217-2
|
Methyprylon [Presence] in Urine by Confirmatory method |
|
19581-8
|
Methyprylon [Presence] in Urine by Screen method |
|
3814-1
|
Methyprylon [Mass/volume] in Urine |
|
32097-8
|
Methyprylon [Presence] in Unspecified specimen |
|
72992-1
|
Metoclopramide induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72991-3
|
Metoclopramide induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73275-0
|
Metoclopramide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73274-3
|
Metoclopramide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9774-1
|
Metoclopramide [Mass/volume] in Serum or Plasma |
|
18471-3
|
Metoclopramide [Mass/volume] in Urine |
|
17277-5
|
metOLazone [Mass/volume] in Serum or Plasma |
|
12347-1
|
metOLazone [Presence] in Urine |
|
9651-1
|
metOLazone [Mass/volume] in Urine |
|
72990-5
|
Metoprolol induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72989-7
|
Metoprolol induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3818-2
|
Metoprolol [Mass/time] in 24 hour Urine |
|
73273-5
|
Metoprolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73272-7
|
Metoprolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35620-4
|
Metoprolol [Presence] in Serum or Plasma by Screen method |
|
3815-8
|
Metoprolol [Mass/volume] in Serum or Plasma |
|
55553-2
|
Metoprolol [Moles/volume] in Serum or Plasma |
|
74916-8
|
Metoprolol [Mass/volume] in Serum or Plasma --trough |
|
3816-6
|
Metoprolol [Presence] in Urine |
|
3817-4
|
Metoprolol [Mass/volume] in Urine |
|
56708-1
|
metroNIDAZOLE IgE Ab [Units/volume] in Serum |
|
73271-9
|
metroNIDAZOLE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73270-1
|
metroNIDAZOLE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
10991-8
|
metroNIDAZOLE [Mass/volume] in Serum or Plasma |
|
92929-9
|
Measles, Mumps and Rubella virus IgG panel [Units/volume] - Serum or Plasma |
|
17553-9
|
Measles virus Ab [Units/volume] in Cerebral spinal fluid |
|
5242-3
|
Measles virus Ab [Units/volume] in Serum by Immunoassay |
|
46197-0
|
Measles virus Ab [Presence] in Serum |
|
43976-0
|
Measles virus Ab [Presence] in Serum by Immunoassay |
|
7961-6
|
Measles virus Ab [Units/volume] in Serum |
|
17555-4
|
Measles virus Ab [Units/volume] in Serum --1st specimen |
|
17556-2
|
Measles virus Ab [Units/volume] in Serum --2nd specimen |
|
22498-0
|
Measles virus Ab [Titer] in Cerebral spinal fluid |
|
9565-3
|
Measles virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22499-8
|
Measles virus Ab [Titer] in Serum |
|
5243-1
|
Measles virus Ab [Titer] in Serum by Complement fixation |
|
41501-8
|
Measles virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
77310-1
|
Measles virus IgG associated observations panel - Serum |
|
31875-8
|
Measles virus Ag [Presence] in Cerebral spinal fluid |
|
14534-2
|
Measles virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31876-6
|
Measles virus Ag [Presence] in Cervix |
|
14540-9
|
Measles virus Ag [Presence] in Cervix by Immunofluorescence |
|
31877-4
|
Measles virus Ag [Presence] in Eye |
|
14537-5
|
Measles virus Ag [Presence] in Eye by Immunofluorescence |
|
67806-0
|
Measles virus Ag [Presence] in Isolate by Immunofluorescence |
|
31879-0
|
Measles virus Ag [Presence] in Nose |
|
14538-3
|
Measles virus Ag [Presence] in Nose by Immunofluorescence |
|
31880-8
|
Measles virus Ag [Presence] in Penis |
|
14543-3
|
Measles virus Ag [Presence] in Penis by Immunofluorescence |
|
31881-6
|
Measles virus Ag [Presence] in Serum or Plasma |
|
13328-0
|
Measles virus Ag [Presence] in Serum or Plasma by Immunofluorescence |
|
31882-4
|
Measles virus Ag [Presence] in Skin |
|
14536-7
|
Measles virus Ag [Presence] in Skin by Immunofluorescence |
|
31883-2
|
Measles virus Ag [Presence] in Sputum |
|
14539-1
|
Measles virus Ag [Presence] in Sputum by Immunofluorescence |
|
31884-0
|
Measles virus Ag [Presence] in Throat |
|
14535-9
|
Measles virus Ag [Presence] in Throat by Immunofluorescence |
|
31885-7
|
Measles virus Ag [Presence] in Urine sediment |
|
14542-5
|
Measles virus Ag [Presence] in Urine sediment by Immunofluorescence |
|
31886-5
|
Measles virus Ag [Presence] in Urethra |
|
14544-1
|
Measles virus Ag [Presence] in Urethra by Immunofluorescence |
|
31878-2
|
Measles virus Ag [Presence] in Vaginal fluid |
|
14541-7
|
Measles virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
31887-3
|
Measles virus Ag [Presence] in Unspecified specimen |
|
12232-5
|
Measles virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
60422-3
|
Measles virus genotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
17554-7
|
Measles virus IgA Ab [Units/volume] in Serum |
|
9566-1
|
Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
41132-2
|
Measles virus IgG Ab [Presence] in Cerebral spinal fluid |
|
40648-8
|
Measles virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
22500-3
|
Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
74418-5
|
Measles virus IgG Ab [Units/volume] in Body fluid by Immunoassay |
|
53536-9
|
Measles virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29242-5
|
Measles virus IgG Ab [Units/volume] in Body fluid |
|
5244-9
|
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
20479-2
|
Measles virus IgG Ab [Presence] in Serum |
|
35275-7
|
Measles virus IgG Ab [Presence] in Serum by Immunoassay |
|
7962-4
|
Measles virus IgG Ab [Units/volume] in Serum |
|
14304-0
|
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
22503-7
|
Measles virus IgG Ab [Units/volume] in Serum --1st specimen |
|
14305-7
|
Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
22504-5
|
Measles virus IgG Ab [Units/volume] in Serum --2nd specimen |
|
22501-1
|
Measles virus IgG Ab [Titer] in Cerebral spinal fluid |
|
21500-4
|
Measles virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22502-9
|
Measles virus IgG Ab [Titer] in Serum |
|
21501-2
|
Measles virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
34949-8
|
Measles virus IgG and IgM panel - Cerebral spinal fluid |
|
90254-4
|
Measles virus IgG and IgM panel [Titer] - Cerebral spinal fluid |
|
90253-6
|
Measles virus IgG and IgM Ql panel - Serum |
|
34948-0
|
Measles virus IgG and IgM Qn panel - Serum |
|
40649-6
|
Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
74417-7
|
Measles virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13283-7
|
Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
74416-9
|
Measles virus IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
53537-7
|
Measles virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
25421-9
|
Measles virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
21503-8
|
Measles virus IgM Ab [Presence] in Serum |
|
35276-5
|
Measles virus IgM Ab [Presence] in Serum by Immunoassay |
|
7963-2
|
Measles virus IgM Ab [Units/volume] in Serum |
|
22505-2
|
Measles virus IgM Ab [Titer] in Cerebral spinal fluid |
|
21502-0
|
Measles virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22506-0
|
Measles virus IgM Ab [Titer] in Serum |
|
5245-6
|
Measles virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
91780-7
|
Measles virus [Presence] in Lower respiratory specimen by Organism specific culture |
|
85798-7
|
Measles virus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85806-8
|
Measles virus RNA and N gene panel - Unspecified specimen by NAA with probe detection |
|
86575-8
|
Measles virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91132-1
|
Measles virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
7964-0
|
Measles virus RNA [Presence] in Nose by NAA with probe detection |
|
86576-6
|
Measles virus RNA [Presence] in Serum by NAA with probe detection |
|
91077-8
|
Measles virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
86577-4
|
Measles virus RNA [Presence] in Urine by NAA with probe detection |
|
48508-6
|
Measles virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91786-4
|
Measles virus [Presence] in Upper respiratory specimen by Organism specific culture |
|
76626-1
|
Measles virus [Presence] in Unspecified specimen by Organism specific culture |
|
88876-8
|
Measles virus genotype A vaccine strain N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
88875-0
|
Measles virus genotype A vaccine strain N gene [Presence] in Unspecified specimen by NAA with probe detection |
|
13778-6
|
Mevalonate/Creatinine [Mass Ratio] in Urine |
|
25118-1
|
Mevalonate/Creatinine [Molar ratio] in Urine |
|
48145-7
|
Mevalonolactone/Creatinine [Molar ratio] in Urine |
|
31173-8
|
Mevinphos [Mass/volume] in Blood |
|
35483-7
|
Mevinphos [Mass/volume] in Serum or Plasma |
|
21388-4
|
Mevinphos [Mass/volume] in Urine |
|
87630-0
|
Mevinphos [Mass/mass] in Unspecified specimen |
|
87631-8
|
Mexacarbate [Mass/mass] in Unspecified specimen |
|
7491-4
|
Mexican Firebush IgE Ab [Units/volume] in Serum |
|
6847-8
|
Mexican tea IgE Ab [Units/volume] in Serum |
|
29222-7
|
Mexiletine [Mass/volume] in Body fluid |
|
29336-5
|
Mexiletine [Mass/volume] in Gastric fluid |
|
59933-2
|
Mexiletine [Moles/volume] in Gastric fluid |
|
40780-9
|
Mexiletine [Mass/volume] in Serum or Plasma --peak |
|
13567-3
|
Mexiletine [Presence] in Serum or Plasma |
|
3819-0
|
Mexiletine [Mass/volume] in Serum or Plasma |
|
32098-6
|
Mexiletine [Moles/volume] in Serum or Plasma |
|
40779-1
|
Mexiletine [Mass/volume] in Serum or Plasma --trough |
|
29335-7
|
Mexiletine [Mass/volume] in Urine |
|
59932-4
|
Mexiletine [Moles/volume] in Urine |
|
60318-3
|
Mexiletine [Moles/volume] in Unspecified specimen |
|
3820-8
|
Mezlocillin [Mass/volume] in Serum or Plasma |
|
54196-1
|
Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54195-3
|
Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54194-6
|
Mezlocillin+Sulbactam [Susceptibility] |
|
6668-8
|
Microscopic observation [Identifier] in Tissue by M'Fadyean stain |
|
668-4
|
Microscopic observation [Identifier] in Unspecified specimen by M'Fadyean stain |
|
38920-5
|
MFN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38904-9
|
MFN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
1225-2
|
Mg Ag [Presence] on Red Blood Cells |
|
36319-2
|
MG Breast 4 Views |
|
36962-9
|
MG Breast Axillary |
|
69268-1
|
MG Breast duct Single view W contrast intra duct |
|
39054-2
|
MG Breast duct Views W contrast intra duct |
|
39148-2
|
MG Breast duct Views W contrast intra multiple ducts |
|
46352-1
|
MG Breast duct Views during surgery W contrast intra duct |
|
38095-6
|
MG Breast duct - bilateral Views W contrast intra duct |
|
39146-6
|
MG Breast duct - bilateral Views W contrast intra multiple ducts |
|
49510-1
|
MG Breast duct - left Single view W contrast intra duct |
|
38096-4
|
MG Breast duct - left Views W contrast intra duct |
|
39145-8
|
MG Breast duct - left Views W contrast intra multiple ducts |
|
49509-3
|
MG Breast duct - right Single view W contrast intra duct |
|
38825-6
|
MG Breast duct - right Views W contrast intra duct |
|
39147-4
|
MG Breast duct - right Views W contrast intra multiple ducts |
|
24605-8
|
MG Breast Diagnostic |
|
86367-0
|
MG Breast Diagnostic for clinical call back |
|
86370-4
|
MG Breast Diagnostic for technical call back |
|
24606-6
|
MG Breast Screening |
|
24597-7
|
MG Breast specimen Views |
|
38079-0
|
MG Breast specimen - bilateral Views |
|
38080-8
|
MG Breast specimen - left Views |
|
38821-5
|
MG Breast specimen - right Views |
|
37028-8
|
MG Breast Tangential |
|
37037-9
|
MG Breast True lateral |
|
36625-2
|
MG Breast Views |
|
24604-1
|
MG Breast Diagnostic Limited Views |
|
38070-9
|
MG Breast Views for implant |
|
37539-4
|
MG Breast Grid Views |
|
24610-8
|
MG Breast Limited Views |
|
37542-8
|
MG Breast Magnification Views |
|
69251-7
|
MG Breast Views Post Wire Placement |
|
37551-9
|
MG Breast Spot Views |
|
42680-9
|
MG Breast XCCL |
|
46335-6
|
MG Breast - bilateral Single view |
|
26346-7
|
MG Breast - bilateral Diagnostic |
|
48475-8
|
MG Breast - bilateral Diagnostic for implant |
|
37554-3
|
MG Breast - bilateral Magnification and Spot |
|
37006-4
|
MG Breast - bilateral MLO |
|
86416-5
|
MG Breast - bilateral Guidance for needle localization and Breast specimen Views |
|
26175-0
|
MG Breast - bilateral Screening |
|
48492-3
|
MG Breast - bilateral Screening for implant |
|
37029-6
|
MG Breast - bilateral Tangential |
|
37038-7
|
MG Breast - bilateral True lateral |
|
36626-0
|
MG Breast - bilateral Views |
|
38090-7
|
MG Breast - bilateral Air gap Views |
|
26349-1
|
MG Breast - bilateral Diagnostic Limited Views |
|
38071-7
|
MG Breast - bilateral Views for implant |
|
26287-3
|
MG Breast - bilateral Limited Views |
|
37543-6
|
MG Breast - bilateral Magnification Views |
|
42415-0
|
MG Breast - bilateral Views Post Wire Placement |
|
37016-3
|
MG Breast - bilateral Rolled Views |
|
37552-7
|
MG Breast - bilateral Spot Views |
|
46351-3
|
MG Breast - bilateral Displacement Views for Implant |
|
37052-8
|
MG Breast - bilateral XCCL |
|
46336-4
|
MG Breast - left Single view |
|
36642-7
|
MG Breast - left 2 Views |
|
26347-5
|
MG Breast - left Diagnostic |
|
86368-8
|
MG Breast - left Diagnostic for clinical call back |
|
69150-1
|
MG Breast - left Diagnostic for implant |
|
37005-6
|
MG Breast - left Magnification |
|
38854-6
|
MG Breast - left Magnification and Spot |
|
86348-0
|
MG Breast - left Guidance for needle localization and Breast specimen Views |
|
26176-8
|
MG Breast - left Screening |
|
37030-4
|
MG Breast - left Tangential |
|
38855-3
|
MG Breast - left True lateral |
|
36627-8
|
MG Breast - left Views |
|
38091-5
|
MG Breast - left Air gap Views |
|
26350-9
|
MG Breast - left Diagnostic Limited Views |
|
38072-5
|
MG Breast - left Views for implant |
|
26289-9
|
MG Breast - left Limited Views |
|
42416-8
|
MG Breast - left Views Post Wire Placement |
|
37017-1
|
MG Breast - left Rolled Views |
|
37553-5
|
MG Breast - left Spot Views compression |
|
37053-6
|
MG Breast - left XCCL |
|
46337-2
|
MG Breast - right Single view |
|
37768-9
|
MG Breast - right 2 Views |
|
26348-3
|
MG Breast - right Diagnostic |
|
86369-6
|
MG Breast - right Diagnostic for clinical call back |
|
69259-0
|
MG Breast - right Diagnostic for implant |
|
37773-9
|
MG Breast - right Magnification |
|
37769-7
|
MG Breast - right Magnification and Spot |
|
86360-5
|
MG Breast - right Guidance for needle localization and Breast specimen Views |
|
26177-6
|
MG Breast - right Screening |
|
37770-5
|
MG Breast - right Tangential |
|
37771-3
|
MG Breast - right True lateral |
|
37774-7
|
MG Breast - right Views |
|
26351-7
|
MG Breast - right Diagnostic Limited Views |
|
38820-7
|
MG Breast - right Views for implant |
|
26291-5
|
MG Breast - right Limited Views |
|
37775-4
|
MG Breast - right Rolled Views |
|
38807-4
|
MG Breast - right Spot Views |
|
37772-1
|
MG Breast - right XCCL |
|
46338-0
|
MG Breast - unilateral Single view |
|
86350-6
|
MG Breast - unilateral Single view for clip placement |
|
46350-5
|
MG Breast - unilateral Diagnostic |
|
46356-2
|
MG Breast - unilateral Screening |
|
46339-8
|
MG Breast - unilateral Views |
|
46380-2
|
MG Breast - unilateral Views for implant |
|
53706-8
|
Myasthenia grav eval adult rflx panel - Serum |
|
53705-0
|
Myasthenia gravis evaluation pediatric panel - Serum |
|
24602-5
|
MG Guidance for biopsy of Breast |
|
24594-4
|
MG Guidance for aspiration of cyst of Breast |
|
46387-7
|
MG Guidance for fine needle aspiration of Breast |
|
48735-5
|
MG Guidance for localization of Breast |
|
24595-1
|
MG Guidance for needle localization of mass of Breast |
|
24609-0
|
MG Guidance for percutaneous biopsy.core needle of Breast |
|
24598-5
|
MG Guidance for fluid aspiration of Breast |
|
48740-5
|
MG Guidance for sentinel lymph node injection of Breast |
|
26337-6
|
MG Guidance for biopsy of Breast - bilateral |
|
26343-4
|
MG Guidance for aspiration of cyst of Breast - bilateral |
|
69068-5
|
MG Guidance for needle localization of Breast - bilateral |
|
26315-2
|
MG Guidance for needle localization of mass of Breast - bilateral |
|
26334-3
|
MG Guidance for percutaneous biopsy.core needle of Breast - bilateral |
|
26338-4
|
MG Guidance for biopsy of Breast - left |
|
86353-0
|
MG Guidance for placement of clip in Breast - left |
|
26344-2
|
MG Guidance for aspiration of cyst of Breast - left |
|
86351-4
|
MG Guidance for additional aspiration of cyst of Breast - left |
|
46284-6
|
MG Guidance for fine needle aspiration of Breast - left |
|
42296-4
|
MG Guidance for localization of Breast - left |
|
86357-1
|
MG Guidance for needle localization of Breast - left |
|
86355-5
|
MG Guidance for additional needle localization of Breast - left |
|
26316-0
|
MG Guidance for needle localization of mass of Breast - left |
|
26335-0
|
MG Guidance for percutaneous biopsy.core needle of Breast - left |
|
48736-3
|
MG Guidance for sentinel lymph node injection of Breast - left |
|
86365-4
|
MG Guidance for vacuum biopsy of Breast - left |
|
86363-9
|
MG Guidance for additional vacuum biopsy of Breast - left |
|
26339-2
|
MG Guidance for biopsy of Breast - right |
|
86354-8
|
MG Guidance for placement of clip in Breast - right |
|
26345-9
|
MG Guidance for aspiration of cyst of Breast - right |
|
86352-2
|
MG Guidance for additional aspiration of cyst of Breast - right |
|
46283-8
|
MG Guidance for fine needle aspiration of Breast - right |
|
42297-2
|
MG Guidance for localization of Breast - right |
|
86358-9
|
MG Guidance for needle localization of Breast - right |
|
86356-3
|
MG Guidance for additional needle localization of Breast - right |
|
26317-8
|
MG Guidance for needle localization of mass of Breast - right |
|
26336-8
|
MG Guidance for percutaneous biopsy.core needle of Breast - right |
|
48739-7
|
MG Guidance for sentinel lymph node injection of Breast - right |
|
86366-2
|
MG Guidance for vacuum biopsy of Breast - right |
|
86364-7
|
MG Guidance for additional vacuum biopsy of Breast - right |
|
73573-8
|
Magnesium Ionized [Moles/volume] adjusted to pH 7.4 in Blood by Ion-selective membrane electrode (ISE) |
|
73572-0
|
Magnesium Ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE) |
|
32698-3
|
Magnesium Ionized [Mass/volume] in Serum or Plasma |
|
2600-5
|
Magnesium Ionized [Moles/volume] in Serum or Plasma |
|
24603-3
|
MG stereo Guidance for biopsy of Breast |
|
46296-0
|
MG stereo Guidance for percutaneous biopsy.core needle of Breast |
|
26292-3
|
MG stereo Guidance for biopsy of Breast - bilateral |
|
26293-1
|
MG stereo Guidance for biopsy of Breast - left |
|
86361-3
|
MG stereo Guidance for additional biopsy of Breast - left |
|
46295-2
|
MG stereo Guidance for percutaneous biopsy.core needle of Breast - left |
|
26294-9
|
MG stereo Guidance for biopsy of Breast - right |
|
86362-1
|
MG stereo Guidance for additional biopsy of Breast - right |
|
42433-3
|
MG stereo Guidance for percutaneous biopsy.core needle of Breast - right |
|
93500-7
|
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93498-4
|
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
93501-5
|
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
93499-2
|
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
60252-4
|
MGMT gene methylation [Presence] in Tissue by Molecular genetics method |
|
83704-7
|
Mental health Attending Note |
|
75427-5
|
Mental health Case manager Note |
|
84197-3
|
Mental health Custodial care facility Plan of care note |
|
84204-7
|
Mental health Interdisciplinary Note |
|
84217-9
|
Mental health Interdisciplinary Plan of care note |
|
83784-9
|
Mental health Physician Note |
|
83547-0
|
Mental health Nurse practitioner Note |
|
83628-8
|
Mental health Nurse Admission evaluation note |
|
83629-6
|
Mental health Nurse Custodial care facility Note |
|
83630-4
|
Mental health Nurse Group counseling note |
|
83631-2
|
Mental health Nurse Hospital Note |
|
83632-0
|
Mental health Nurse Long term care facility Note |
|
83633-8
|
Mental health Nurse Medication management note |
|
75459-8
|
Mental health Nurse Note |
|
83634-6
|
Mental health Nurse Outpatient Note |
|
83635-3
|
Mental health Nurse Plan of care note |
|
85879-5
|
Mental health Nurse Restraint note |
|
83636-1
|
Mental health Nurse Triage note |
|
83747-6
|
Mental health Physician assistant Note |
|
83761-7
|
Mental health Resident Note |
|
94015-5
|
Mental health screening report |
|
90754-3
|
Mental health Social worker Note |
|
84212-0
|
Mental health Team Conference note |
|
84213-8
|
Mental health Team Consult note |
|
84214-6
|
Mental health Team Note |
|
1234-4
|
Mi sup(a) Ag [Presence] on Red Blood Cells |
|
63276-0
|
Mi-2 Ab [Presence] in Body fluid by Immunoassay |
|
56637-2
|
Mi-2 Ab [Units/volume] in Serum by Immunoassay |
|
18485-3
|
Mi-2 Ab [Presence] in Serum |
|
56743-8
|
Mi-2 Ab [Presence] in Serum by Immunoblot |
|
88732-3
|
Mi-2 alpha Ab [Units/volume] in Serum by Line blot |
|
82997-8
|
Mi-2 alpha IgG Ab [Presence] in Serum by Line blot |
|
88733-1
|
Mi-2 beta Ab [Units/volume] in Serum by Line blot |
|
82996-0
|
Mi-2 beta IgG Ab [Presence] in Serum by Line blot |
|
70051-8
|
Multiple inhalant allergen IgE Ab [Presence] in Serum by Immunoassay |
|
7492-2
|
Multiple inhalant allergen IgE Ab [Units/volume] in Serum |
|
13012-0
|
Methyl isoamyl ketone [Mass/volume] in Blood |
|
31166-2
|
Methyl isoamyl ketone [Mass/volume] in Urine |
|
2635-1
|
Mianserin [Mass/volume] in Serum or Plasma |
|
25721-2
|
Mianserin [Moles/volume] in Serum or Plasma |
|
79412-3
|
Mianserin trough and Normianserin panel - Serum or Plasma |
|
72669-5
|
Mianserin [Mass/volume] in Serum or Plasma --trough |
|
2636-9
|
Mianserin [Mass/volume] in Urine |
|
34341-8
|
Mianserin+Normianserin [Mass/volume] in Serum or Plasma |
|
38611-0
|
Methyl isobutyl ketone [Mass/volume] in Air |
|
13013-8
|
Methyl isobutyl ketone [Mass/volume] in Blood |
|
17269-2
|
Methyl isobutyl ketone [Mass/volume] in Urine |
|
58006-8
|
Mibolerone [Presence] in Urine |
|
74409-4
|
MICA IgG panel - Serum |
|
74346-8
|
MICA*001 IgG Ab [Presence] in Serum |
|
74345-0
|
MICA*002 IgG Ab [Presence] in Serum |
|
74344-3
|
MICA*004 IgG Ab [Presence] in Serum |
|
74343-5
|
MICA*005 IgG Ab [Presence] in Serum |
|
74342-7
|
MICA*006 IgG Ab [Presence] in Serum |
|
74341-9
|
MICA*007 IgG Ab [Presence] in Serum |
|
74340-1
|
MICA*008 IgG Ab [Presence] in Serum |
|
74339-3
|
MICA*009 IgG Ab [Presence] in Serum |
|
74338-5
|
MICA*011 IgG Ab [Presence] in Serum |
|
74337-7
|
MICA*012 IgG Ab [Presence] in Serum |
|
74336-9
|
MICA*015 IgG Ab [Presence] in Serum |
|
74335-1
|
MICA*016 IgG Ab [Presence] in Serum |
|
74334-4
|
MICA*017 IgG Ab [Presence] in Serum |
|
74333-6
|
MICA*018 IgG Ab [Presence] in Serum |
|
74332-8
|
MICA*019 IgG Ab [Presence] in Serum |
|
74331-0
|
MICA*024 IgG Ab [Presence] in Serum |
|
74330-2
|
MICA*028 IgG Ab [Presence] in Serum |
|
74329-4
|
MICA*029 IgG Ab [Presence] in Serum |
|
74328-6
|
MICA*030 IgG Ab [Presence] in Serum |
|
74327-8
|
MICA*033 IgG Ab [Presence] in Serum |
|
74326-0
|
MICA*036 IgG Ab [Presence] in Serum |
|
74325-2
|
MICA*037 IgG Ab [Presence] in Serum |
|
74324-5
|
MICA*041 IgG Ab [Presence] in Serum |
|
74323-7
|
MICA*042 IgG Ab [Presence] in Serum |
|
74322-9
|
MICA*043 IgG Ab [Presence] in Serum |
|
74321-1
|
MICA*046 IgG Ab [Presence] in Serum |
|
74320-3
|
MICA*050 IgG Ab [Presence] in Serum |
|
74319-5
|
MICA*051 IgG Ab [Presence] in Serum |
|
85048-7
|
Micafungin [Susceptibility] by Gradient strip |
|
58418-5
|
Micafungin [Mass/volume] in Serum or Plasma |
|
54180-5
|
Miconazole [Susceptibility] by Disk diffusion (KB) |
|
17278-3
|
Miconazole [Mass/volume] in Serum or Plasma |
|
33270-0
|
Microscopic observation [Identifier] in Buffy Coat by Light microscopy |
|
88850-3
|
Microbiology CNAMTS panel - Blood |
|
88844-6
|
Microbiology CNAMTS panel - Bronchial specimen |
|
88864-4
|
Microbiology CNAMTS panel - Cornea or Conjunctiva |
|
88842-0
|
Microbiology CNAMTS panel - Cerebral spinal fluid |
|
88839-6
|
Microbiology CNAMTS panel - Pus |
|
88838-8
|
Microbiology CNAMTS panel - Semen |
|
88841-2
|
Microbiology CNAMTS panel - Synovial fluid |
|
88837-0
|
Microbiology CNAMTS panel - Sputum |
|
88847-9
|
Microbiology CNAMTS panel - Stool |
|
88836-2
|
Microbiology CNAMTS panel - Throat |
|
88848-7
|
Microbiology CNAMTS panel - Urine |
|
88840-4
|
Microbiology CNAMTS panel - Urethra |
|
88849-5
|
Microbiology CNAMTS panel - Vaginal fluid |
|
88845-3
|
Microbiology CNAMTS panel - Unspecified specimen |
|
92254-2
|
Microorganism identification and resistance pattern determination panel by Molecular genetics method |
|
92252-6
|
Microorganism molecular resistance panel by Molecular genetics method |
|
72375-9
|
Microscopic method - Urine |
|
49023-5
|
Microalbumin [Mass/time] in Urine collected for unspecified duration |
|
57369-1
|
Microalbumin [Mass/volume] in 12 hour Urine |
|
43607-1
|
Microalbumin [Mass/time] in 12 hour Urine |
|
47558-2
|
Microalbumin/Protein.total in 24 hour Urine |
|
53530-2
|
Microalbumin [Mass/volume] in 24 hour Urine by Detection limit <= 1.0 mg/L |
|
53532-8
|
Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 1.0 mg/L |
|
90000-1
|
Albumin [Mass/time] in 24 hour Urine by Detection limit <= 3.0 mg/L |
|
30003-8
|
Microalbumin [Mass/volume] in 24 hour Urine |
|
14956-7
|
Microalbumin [Mass/time] in 24 hour Urine |
|
43605-5
|
Microalbumin [Mass/volume] in 4 hour Urine |
|
43606-3
|
Microalbumin [Mass/time] in 4 hour Urine |
|
56553-1
|
Microalbumin [Mass/time] in 8 hour Urine |
|
53529-4
|
Microalbumin [Mass/volume] in Body fluid by Detection limit <= 1.0 mg/L |
|
58431-8
|
Microalbumin panel - 24 hour Urine |
|
58448-2
|
Microalbumin ug/min [Mass/time] in 24 hour Urine |
|
53531-0
|
Microalbumin [Mass/volume] in Urine by Detection limit <= 1.0 mg/L |
|
89999-7
|
Albumin [Mass/volume] in Urine by Detection limit <= 3.0 mg/L |
|
77158-4
|
Albumin [Moles/volume] in Urine by Detection limit <= 3.0 mg/L |
|
11218-5
|
Microalbumin [Mass/volume] in Urine by Test strip |
|
14957-5
|
Microalbumin [Mass/volume] in Urine |
|
44292-1
|
Microalbumin/Creatinine [Mass Ratio] in 12 hour Urine |
|
14958-3
|
Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine |
|
77254-1
|
Microalbumin/Creatinine [Ratio] in 24 hour Urine by Detection limit <= 1.0 mg/L |
|
59159-4
|
Microalbumin/Creatinine [Ratio] in 24 hour Urine |
|
58447-4
|
Microalbumin/Creatinine panel in 24H Urine |
|
34535-5
|
Microalbumin/Creatinine panel in random Urine |
|
14959-1
|
Microalbumin/Creatinine [Mass Ratio] in Urine |
|
77253-3
|
Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 1.0 mg/L |
|
89998-9
|
Albumin/Creatinine [Ratio] in Urine by Detection limit <= 3.0 mg/L |
|
30001-2
|
Microalbumin/Creatinine [Ratio] in Urine by Test strip |
|
30000-4
|
Microalbumin/Creatinine [Ratio] in Urine |
|
74761-8
|
Microcytes/100 erythrocytes in Blood |
|
49028-4
|
Microdeletion syndromes [Identifier] in Blood or Tissue by FISH Nominal |
|
50020-7
|
Microdeletion syndromes in Blood or Tissue by FISH |
|
49063-1
|
Microdeletion syndromes in Unspecified specimen by FISH Nominal |
|
81941-7
|
Micronutrient intake panel |
|
90426-8
|
Microorganism preliminary growth [Presence] in Blood by Aerobic culture with antimicrobial neutralizer |
|
90427-6
|
Microorganism preliminary growth [Presence] in Blood by Anaerobic culture with antimicrobial neutralizer |
|
90428-4
|
Microorganism preliminary growth [Presence] in Body fluid by Aerobic culture with antimicrobial neutralizer |
|
90431-8
|
Microorganism preliminary growth [Presence] in Body fluid by Anaerobic culture with antimicrobial neutralizer |
|
90435-9
|
Microorganism preliminary growth [Presence] in Blood by Aerobe culture |
|
90437-5
|
Microorganism preliminary growth [Presence] in Blood by Anaerobe culture |
|
90423-5
|
Microorganism preliminary growth detection panel - Blood by Culture |
|
90424-3
|
Microorganism preliminary growth detection panel - Body fluid by Culture |
|
90425-0
|
Microorganism preliminary growth detection panel - Platelets from Blood product unit by Culture |
|
90429-2
|
Microorganism preliminary growth [Presence] in Body fluid by Aerobe culture |
|
90430-0
|
Microorganism preliminary growth [Presence] in Body fluid by Anaerobe culture |
|
90436-7
|
Microorganism preliminary growth [Presence] in Body fluid by Organism specific culture |
|
90434-2
|
Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Aerobe culture |
|
90432-6
|
Microorganism preliminary growth [Presence] in Platelets from Blood product unit by Anaerobe culture |
|
43161-9
|
Microorganism [#/volume] in Unspecified specimen by Viability count |
|
49034-2
|
Microorganism identified in Cervical or vaginal smear or scraping by Cyto stain |
|
76346-6
|
Microorganism identified in Isolate by MS.MALDI-TOF |
|
92253-4
|
Microorganism identified in Isolate or Specimen by Molecular genetics method |
|
11475-1
|
Microorganism identified in Unspecified specimen by Culture |
|
41852-5
|
Microorganism or agent identified in Unspecified specimen |
|
58437-5
|
Microorganisms seen [Type] in Urine sediment by Light microscopy |
|
58435-9
|
Microorganisms panel - Urine sediment |
|
88345-4
|
Microscopic exam panel - Ear by Light microscopy |
|
57764-3
|
Microscopic exam [Interpretation] of Bone marrow by Cytology |
|
88160-7
|
Microsporidia DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88925-3
|
Microsporidia DNA [Presence] in Stool by NAA with probe detection |
|
88924-6
|
Microsporidia DNA [Presence] in Tissue by NAA with probe detection |
|
10690-6
|
Microsporidia identified in Duodenal fluid by Trichrome stain modified |
|
32701-5
|
Microsporidia identified in Stool by Trichrome stain modified |
|
32819-5
|
Microsporidia identified in Stool by Trichrome stain |
|
10857-1
|
Microsporidia identified in Unspecified specimen by Light microscopy |
|
59708-8
|
Midazolam [Mass/volume] in Blood by Confirmatory method |
|
59707-0
|
Midazolam [Mass/volume] in Blood |
|
59710-4
|
Midazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59709-6
|
Midazolam [Mass/volume] in Body fluid |
|
26802-9
|
Midazolam [Mass/mass] in Hair |
|
73269-3
|
Midazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73268-5
|
Midazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
27302-9
|
Midazolam [Mass/mass] in Meconium |
|
87814-0
|
Midazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
59711-2
|
Midazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3821-6
|
Midazolam [Mass/volume] in Serum or Plasma |
|
15109-2
|
Midazolam [Moles/volume] in Serum or Plasma |
|
12440-4
|
Midazolam [Presence] in Stool |
|
27288-0
|
Midazolam [Mass/mass] in Stool |
|
59713-8
|
Midazolam [Mass/mass] in Tissue by Confirmatory method |
|
59712-0
|
Midazolam [Mass/mass] in Tissue |
|
16233-9
|
Midazolam [Mass/volume] in Urine by Confirmatory method |
|
19586-7
|
Midazolam [Presence] in Urine by Confirmatory method |
|
19585-9
|
Midazolam [Presence] in Urine by Screen method |
|
19588-3
|
Midazolam [Mass/volume] in Urine |
|
74381-5
|
Midazolam [Mass/volume] in Unknown substance |
|
26899-5
|
Midazolam [Mass/volume] in Vitreous fluid |
|
48958-3
|
Midazolam [Mass/volume] in Unspecified specimen |
|
86231-8
|
Midazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
54154-0
|
Midbody Ab [Presence] in Serum by Immunofluorescence |
|
54155-7
|
Midbody Ab [Titer] in Serum by Immunofluorescence |
|
45393-6
|
Middle initial |
|
6253-9
|
Midge stinging IgE Ab [Units/volume] in Serum |
|
27019-9
|
IgA.monoclonal [Presence] in Serum |
|
55901-3
|
IgA.monoclonal [Presence] in Serum by Immunoelectrophoresis |
|
2459-6
|
IgA.monoclonal [Mass/volume] in Serum |
|
55903-9
|
IgD.monoclonal [Presence] in Serum by Immunoelectrophoresis |
|
2461-2
|
IgD.monoclonal [Mass/volume] in Serum |
|
55904-7
|
IgE.monoclonal [Presence] in Serum by Immunoelectrophoresis |
|
2463-8
|
IgE.monoclonal [Mass/volume] in Serum |
|
27018-1
|
IgG.monoclonal [Presence] in Serum |
|
55921-1
|
IgG.monoclonal [Presence] in Serum by Immunoelectrophoresis |
|
26814-4
|
IgG.monoclonal [Mass/volume] in Serum |
|
27020-7
|
IgM.monoclonal [Presence] in Serum |
|
2473-7
|
IgM.monoclonal [Mass/volume] in Serum |
|
7493-0
|
Milk evaporated IgE Ab [Units/volume] in Serum |
|
6174-7
|
Milk IgE Ab [Units/volume] in Serum |
|
10941-3
|
Milk powder IgE Ab [Units/volume] in Serum |
|
59310-3
|
Milnacipran [Mass/volume] in Blood |
|
59311-1
|
Milnacipran [Mass/volume] in Serum or Plasma |
|
59312-9
|
Milnacipran [Mass/volume] in Urine |
|
87788-6
|
Milnacipran/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73266-9
|
Milrinone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73267-7
|
Milrinone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6176-2
|
Mimosa IgE Ab [Units/volume] in Serum |
|
81943-3
|
Mineral AndOr trace element intake panel |
|
86521-2
|
Minimum Data Set (MDS) - version 3.0 - Resident Assessment and Care Screening (RAI) version 1.14.1 [CMS Assessment] |
|
88278-7
|
Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.15.1 [CMS Assessment] |
|
88956-8
|
Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.16.1 [CMS Assessment] |
|
89724-9
|
Minimum Data Set (MDS) for Public Health Emergency Operations Centers (EOC) [CDC Emergency Operations Centers] |
|
46076-6
|
Minimum Data Set (MDS) supplemental items section - version 2.0 |
|
45962-8
|
Minimum data set for nursing home resident assessment and care screen |
|
10943-9
|
Mink epithelium IgE Ab [Units/volume] in Serum |
|
71939-3
|
Minnesota Living with Heart Failure Questionnaire [MLHFQ] |
|
34606-4
|
Minocycline [Mass/volume] in Cerebral spinal fluid |
|
73265-1
|
Minocycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73264-4
|
Minocycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3822-4
|
Minocycline [Mass/volume] in Serum or Plasma |
|
49757-8
|
Minocycline [Mass/volume] in Unspecified specimen |
|
73263-6
|
Minoxidil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73262-8
|
Minoxidil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17282-5
|
Minoxidil [Mass/volume] in Serum or Plasma |
|
11190-6
|
Mint IgE Ab [Units/volume] in Serum |
|
78435-5
|
Mirtazapine trough and Normirtazapine panel - Serum or Plasma |
|
73261-0
|
Mirtazapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73260-2
|
Mirtazapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
47980-8
|
Mirtazapine [Presence] in Serum or Plasma |
|
17283-3
|
Mirtazapine [Mass/volume] in Serum or Plasma |
|
55554-0
|
Mirtazapine [Moles/volume] in Serum or Plasma |
|
72668-7
|
Mirtazapine [Mass/volume] in Serum or Plasma --trough |
|
74812-9
|
Mirtazapine [Presence] in Urine |
|
78859-6
|
Mirtazapine [Presence] in Urine by Confirmatory method |
|
49690-1
|
Mirtazapine [Mass/volume] in Urine |
|
62848-7
|
Mirtazapine+Normirtazapine [Mass/volume] in Serum or Plasma |
|
83104-0
|
Mullerian inhibiting substance [Mass/volume] in Serum or Plasma by Immunoassay |
|
83105-7
|
Mullerian inhibiting substance [Moles/volume] in Serum or Plasma by Immunoassay |
|
38476-8
|
Mullerian inhibiting substance [Mass/volume] in Serum or Plasma |
|
48377-6
|
Mullerian inhibiting substance [Moles/volume] in Serum or Plasma |
|
79420-6
|
Miscellaneous allergen IgE Ab [Units/volume] in Serum |
|
50622-0
|
Miscellaneous allergen IgG Ab [Identifier] in Serum |
|
90861-6
|
Missing teeth [#] |
|
7495-5
|
Mite dust IgE Ab [Units/volume] in Serum |
|
23752-9
|
Mite identified in Skin |
|
23232-2
|
Mite identified in Skin by Flotation |
|
23233-0
|
Mite identified in Skin by Parasite sedimentation |
|
76618-8
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-glutamate substrate |
|
76620-4
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-leucine substrate |
|
76616-2
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 1-14C-pyruvate substrate |
|
76619-6
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2,3-14C-succinate substrate |
|
76617-0
|
Mitochondrial respiratory chain enzymes [Enzymatic activity/mass] in Fibroblast by 2-14C-pyruvate substrate |
|
35502-4
|
Mitochondrial myopathy enzyme panel [Enzymatic activity/mass] - Tissue |
|
76623-8
|
Mitochondrial respiratory chain enzyme analysis panel - Fibroblast |
|
63279-4
|
Mitochondria Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63277-8
|
Mitochondria Ab [Presence] in Body fluid by Immunofluorescence |
|
17285-8
|
Mitochondria Ab [Units/volume] in Serum by Immunofluorescence |
|
14236-4
|
Mitochondria Ab [Presence] in Serum |
|
17284-1
|
Mitochondria Ab [Presence] in Serum by Immunofluorescence |
|
8077-0
|
Mitochondria Ab [Units/volume] in Serum |
|
42522-3
|
Mitochondria Ab [Titer] in Cerebral spinal fluid |
|
63280-2
|
Mitochondria Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63278-6
|
Mitochondria Ab [Titer] in Body fluid by Immunofluorescence |
|
20483-4
|
Mitochondria Ab [Titer] in Serum |
|
5247-2
|
Mitochondria Ab [Titer] in Serum by Immunofluorescence |
|
82840-0
|
Mitochondria IgG Ab [Presence] in Serum by Immunofluorescence |
|
63282-8
|
Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89539-1
|
Mitochondria M2 Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63281-0
|
Mitochondria M2 Ab [Presence] in Body fluid by Immunoassay |
|
51715-1
|
Mitochondria M2 Ab [Units/volume] in Serum by Immunoassay |
|
26054-7
|
Mitochondria M2 Ab [Presence] in Serum |
|
63283-6
|
Mitochondria M2 Ab [Presence] in Serum by Immunoassay |
|
56735-4
|
Mitochondria M2 Ab [Presence] in Serum by Immunoblot |
|
49781-8
|
Mitochondria M2 Ab [Units/volume] in Serum |
|
51794-6
|
Mitochondria M2 Ab [Titer] in Serum by Immunofluorescence |
|
82928-3
|
Mitochondria M2 IgG Ab [Presence] in Serum by Line blot |
|
14251-3
|
Mitochondria M2 IgG Ab [Units/volume] in Serum |
|
56632-3
|
Mitochondria M2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
34411-9
|
Mitochondria M4 Ab [Presence] in Serum |
|
53000-6
|
Mitochondria M4 Ab [Units/volume] in Serum |
|
63284-4
|
Mitochondria M5 Ab [Presence] in Serum by Immunofluorescence |
|
63285-1
|
Mitochondria M5 Ab [Titer] in Serum by Immunofluorescence |
|
34412-7
|
Mitochondria M9 Ab [Presence] in Serum |
|
53001-4
|
Mitochondria M9 Ab [Units/volume] in Serum |
|
74280-9
|
Mitogen stimulated gamma interferon positive control spot count [#] in Blood |
|
13626-7
|
Mitotane [Mass/volume] in Serum or Plasma |
|
53004-8
|
Mitotic spindle apparatus Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
34677-5
|
Mitotic spindle apparatus Ab [Titer] in Serum or Plasma |
|
53003-0
|
Mitotic spindle apparatus Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
72730-5
|
Mitragynine/Creatinine [Mass Ratio] in Urine |
|
75649-4
|
Mitragynine+7-Hydroxymitragynine [Presence] in Urine by Confirmatory method |
|
48283-6
|
Mivacurium triggered leukotriene release [Mass/volume] by Leukocytes |
|
75510-8
|
aPTT.lupus sensitive with 1:1 PNP (LA mix) |
|
91104-0
|
aPTT.factor sensitive with 1:1 Pooled Normal Plasma in Platelet poor plasma by Coagulation assay |
|
75509-0
|
aPTT.lupus sensitive with 1:1 PNP actual/Normal (normalized LA mix) |
|
75513-2
|
dRVVT with 1:1 PNP (LA mix) |
|
75512-4
|
dRVVT with 1:1 PNP actual/normal (normalized LA mix) |
|
82425-0
|
Mj Ab [Units/volume] in Serum by Line blot |
|
82426-8
|
Mj Ab [Presence] in Serum by Line blot |
|
82993-7
|
Mj IgG Ab [Presence] in Serum by Line blot |
|
49647-1
|
MJD gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49648-9
|
MJD gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21764-6
|
MJD gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
81841-9
|
MLC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80154-8
|
Monolysocardiolipin/Cardiolipin [Molar ratio] in DBS |
|
50322-7
|
MLH-1 Ag [Presence] in Tissue by Immune stain |
|
92676-6
|
MLH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
79416-4
|
MLH1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
58416-9
|
MLH1 gene methylation [Presence] in Tissue by Molecular genetics method |
|
38536-9
|
MLH1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41086-0
|
MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
79570-8
|
MLH1+MSH2+MSH6+PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
35454-8
|
MLL gene rearrangements in Blood or Tissue by Molecular genetics method |
|
78226-8
|
MLL gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
|
78219-3
|
MLL gene rearrangements [Presence] in Blood or Tissue by FISH |
|
35753-3
|
Mitochondrial myopathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41087-8
|
Mitochondrial myopathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35351-6
|
Myotonic dystrophy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41080-3
|
Myotonic dystrophy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82885-5
|
Meta methylhippurate [Moles/volume] in Urine |
|
82886-3
|
Meta methylhippurate/Creatinine [Molar ratio] in Urine |
|
75630-4
|
Interstitial collagenase [Mass/volume] in Serum or Plasma |
|
74102-5
|
Matrix metallopeptidase 2 [Mass/volume] in Serum |
|
75631-2
|
Stromelysin-1 [Mass/volume] in Serum or Plasma |
|
90294-0
|
MMP-9 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
58001-9
|
Matrix metallopeptidase 9 [Mass/volume] in Blood |
|
60243-3
|
Matrix metallopeptidase 9 [Mass/volume] in Serum |
|
81694-2
|
Mismatch repair endonuclease PMS2 [Presence] in Cancer specimen by Immune stain |
|
81691-8
|
DNA mismatch repair protein Mlh1 [Presence] in Cancer specimen by Immune stain |
|
81692-6
|
DNA mismatch repair protein Msh2 [Presence] in Cancer specimen by Immune stain |
|
81693-4
|
DNA mismatch repair protein Msh6 [Presence] in Cancer specimen by Immune stain |
|
13014-6
|
Methyl butyl ketone [Mass/volume] in Blood |
|
31165-4
|
Methyl butyl ketone [Mass/volume] in Urine |
|
13311-6
|
MNS group Ag [Type] on Red Blood Cells |
|
6475-8
|
Mobiluncus sp rRNA [Presence] in Unspecified specimen by Probe |
|
74941-6
|
Moclobemide [Mass/volume] in Serum or Plasma |
|
34413-5
|
Moclobemide [Moles/volume] in Serum or Plasma |
|
74940-8
|
Moclobemide [Mass/volume] in Serum or Plasma --trough |
|
51985-0
|
Modafinil [Mass/volume] in Serum or Plasma |
|
45993-3
|
Modes of expression Set |
|
46011-3
|
Modes of locomotion Set |
|
46012-1
|
Modes of transfer Set |
|
91543-9
|
Myelin oligodendrocyte glycoprotein Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
91545-4
|
Myelin oligodendrocyte glycoprotein Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
84873-9
|
Myelin oligodendrocyte glycoprotein IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
90248-6
|
Myelin oligodendrocyte glycoprotein IgG1 Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
15233-0
|
Mold Allergen Mix A (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
|
23800-6
|
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
|
41742-8
|
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk |
|
61201-0
|
Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab/IgE total in Serum by Multidisk |
|
15234-8
|
Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
|
30183-8
|
Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Units/volume] in Serum by Multidisk |
|
31004-5
|
Mold Allergen Mix 3 (Staphylococcus aureus enterotoxin A+Staphylococcus aureus enterotoxin B) IgE Ab [Presence] in Serum by Multidisk |
|
51529-6
|
Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Presence] in Serum by Multidisk |
|
82085-2
|
Mold Allergen Mix 4 (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) IgE Ab [Units/volume] in Serum by Multidisk |
|
51861-3
|
Mold Allergen Mix 6 (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) IgG Ab [Presence] in Serum by Multidisk |
|
51862-1
|
Mold Allergen Mix 7 (Saccharopolyspora rectivirgula+Thermoactinomyces vulgaris) IgG Ab [Presence] in Serum by Multidisk |
|
89984-9
|
Molindone [Presence] in Serum or Plasma by Screen method |
|
10340-8
|
Molindone [Mass/volume] in Serum or Plasma |
|
89970-8
|
Molindone [Presence] in Urine by Screen method |
|
42523-1
|
Molindone [Mass/volume] in Urine |
|
87778-7
|
Molindone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
29974-3
|
Molybdenum [Mass/volume] in 24 hour Urine |
|
29975-0
|
Molybdenum [Mass/time] in 24 hour Urine |
|
50884-6
|
Molybdenum [Moles/time] in 24 hour Urine |
|
5696-0
|
Molybdenum [Mass/volume] in Blood |
|
55555-7
|
Molybdenum [Moles/volume] in Blood |
|
20888-4
|
Molybdenum [Mass/mass] in Feed |
|
51199-8
|
Molybdenum [Mass/volume] in Body fluid |
|
5697-8
|
Molybdenum [Mass/mass] in Hair |
|
50881-2
|
Molybdenum [Moles/mass] in Hair |
|
60101-3
|
Molybdenum [Mass/mass] in Nail |
|
27343-3
|
Molybdenum [Mass/mass] in Red Blood Cells |
|
50883-8
|
Molybdenum [Moles/volume] in Red Blood Cells |
|
5698-6
|
Molybdenum [Mass/volume] in Serum or Plasma |
|
25481-3
|
Molybdenum [Moles/volume] in Serum or Plasma |
|
20887-6
|
Molybdenum [Mass/mass] in Tissue |
|
5699-4
|
Molybdenum [Mass/volume] in Urine |
|
50882-0
|
Molybdenum [Moles/volume] in Urine |
|
20886-8
|
Molybdenum [Mass/volume] in Unspecified specimen |
|
29976-8
|
Molybdenum/Creatinine [Mass Ratio] in 24 hour Urine |
|
52927-1
|
Molybdenum/Creatinine [Molar ratio] in 24 hour Urine |
|
73583-7
|
Molybdenum/Creatinine [Mass Ratio] in Urine |
|
52928-9
|
Molybdenum/Creatinine [Molar ratio] in Urine |
|
20890-0
|
Monensin [Mass/mass] in Feed |
|
20889-2
|
Monensin [Mass/mass] in Gastric fluid |
|
7499-7
|
Monkey epithelium IgE Ab [Units/volume] in Serum |
|
93357-2
|
Monotypic plasma cell identification and risk stratification panel - Bone marrow by Molecular genetics method |
|
12919-7
|
Monoamine oxidase [Enzymatic activity/volume] in Blood |
|
12918-9
|
Monoamine oxidase [Enzymatic activity/volume] in Platelet rich plasma |
|
43162-7
|
Monochloramine [Mass/volume] in Water |
|
54945-1
|
Monochloroacetate [Mass/volume] in Urine |
|
13348-8
|
Monoclonal band observed [Identifier] in Serum or Plasma |
|
74666-9
|
Monoclonal band observed [Identifier] in Urine by Immunofixation |
|
90992-9
|
Monoclonal gammopathy panel - Serum or Plasma |
|
80646-3
|
Monocyclohexyl methylphosphonate [Mass/volume] in Blood |
|
54100-3
|
Monocyclohexyl methylphosphonate [Mass/volume] in Urine |
|
66143-9
|
Monocytes [#/volume] in Blood from Fetus by Manual count |
|
68420-9
|
Monocytes [#/volume] in Pericardial fluid by Manual count |
|
68422-5
|
Monocytes [#/volume] in Pleural fluid by Manual count |
|
68421-7
|
Monocytes [#/volume] in Peritoneal fluid by Manual count |
|
68424-1
|
Monocytes [#/volume] in Vitreous fluid by Manual count |
|
74400-3
|
Monocytes/100 leukocytes in Cord blood |
|
68423-3
|
Monocytes/100 leukocytes in Vitreous fluid by Manual count |
|
80647-1
|
Monoethyl methylphosphonate [Mass/volume] in Blood |
|
54102-9
|
Monoethyl methylphosphonate [Mass/volume] in Urine |
|
54944-4
|
Monofluoroacetate [Mass/volume] in Urine |
|
74139-7
|
Mononuclear cells [#/volume] in Peritoneal dialysis fluid |
|
75656-9
|
Mononuclear cells [#] in Pericardial fluid by Manual count |
|
75657-7
|
Mononuclear cells [#] in Pleural fluid by Manual count |
|
49782-6
|
Mononuclear cells/100 leukocytes in Pericardial fluid |
|
76408-4
|
Monocytes+Macrophages [#] in Body fluid by Manual count |
|
49119-1
|
Monosaccharides.sulfated [Presence] in Urine |
|
72988-9
|
Montelukast induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72987-1
|
Montelukast induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73259-4
|
Montelukast induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73258-6
|
Montelukast induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
50635-2
|
Monterey cypress IgE Ab [Units/volume] in Serum |
|
45996-6
|
Mood and behavior patterns section |
|
91688-2
|
Mood and Feelings Questionnaire [MFQ] Adult self-report long form |
|
91689-0
|
Mood and Feelings Questionnaire [MFQ] Adult self-report short form |
|
85102-2
|
Mood Disorder Questionnaire [MDQ] |
|
3825-7
|
Morazone [Mass/time] in 24 hour Urine |
|
3823-2
|
Morazone [Presence] in Urine |
|
3824-0
|
Morazone [Mass/volume] in Urine |
|
9775-8
|
Moricizine [Mass/volume] in Serum or Plasma |
|
3832-3
|
Morphine [Mass/time] in 24 hour Urine |
|
27053-8
|
Morphine [Mass/volume] in Cerebral spinal fluid |
|
31086-2
|
Morphine Free [Mass/volume] in Bile fluid |
|
73972-2
|
Morphine Free [Mass/volume] in Blood |
|
27054-6
|
Morphine Free [Mass/volume] in Cerebral spinal fluid |
|
29337-3
|
Morphine Free [Mass/volume] in Gastric fluid |
|
46259-8
|
Morphine Free [Presence] in Serum or Plasma by Screen method |
|
11244-1
|
Morphine Free [Mass/volume] in Serum or Plasma |
|
26696-5
|
Morphine Free [Mass/mass] in Stool |
|
20550-0
|
Morphine Free [Mass/volume] in Urine by Confirmatory method |
|
3828-1
|
Morphine Free [Presence] in Urine |
|
19602-2
|
Morphine Free [Presence] in Urine by Confirmatory method |
|
19601-4
|
Morphine Free [Presence] in Urine by Screen method |
|
3829-9
|
Morphine Free [Mass/volume] in Urine |
|
27206-2
|
Morphine Free [Mass/volume] in Vitreous fluid |
|
9438-3
|
Morphine [Presence] in Gastric fluid |
|
40384-0
|
Morphine [Presence] in Hair |
|
80539-0
|
Morphine [Mass/mass] in Hair |
|
73257-8
|
Morphine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73256-0
|
Morphine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
69027-1
|
Morphine [Mass/mass] in Meconium by Confirmatory method |
|
29287-0
|
Morphine [Presence] in Meconium |
|
15370-0
|
Morphine [Mass/volume] in Meconium |
|
26860-7
|
Morphine [Mass/mass] in Meconium |
|
72752-9
|
Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74654-5
|
Morphine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3826-5
|
Morphine [Presence] in Serum or Plasma |
|
17290-8
|
Morphine [Presence] in Serum or Plasma by Confirmatory method |
|
74131-4
|
Morphine [Mass/volume] in Serum, Plasma or Blood |
|
3827-3
|
Morphine [Mass/volume] in Serum or Plasma |
|
15110-0
|
Morphine [Moles/volume] in Serum or Plasma |
|
16251-1
|
Morphine [Mass/volume] in Urine by Confirmatory method |
|
70210-0
|
Morphine [Moles/volume] in Urine by Confirmatory method |
|
3830-7
|
Morphine [Presence] in Urine |
|
16196-8
|
Morphine [Presence] in Urine by Confirmatory method |
|
13648-1
|
Morphine [Presence] in Urine by SAMHSA confirm method |
|
19597-4
|
Morphine [Presence] in Urine by Screen method |
|
3831-5
|
Morphine [Mass/volume] in Urine |
|
74379-9
|
Morphine [Mass/volume] in Unknown substance |
|
32100-0
|
Morphine [Presence] in Unspecified specimen |
|
77332-5
|
Morphine [Moles/volume] in Unspecified specimen |
|
58392-2
|
Morphine/Creatinine [Mass Ratio] in Urine |
|
48364-4
|
Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma |
|
48363-6
|
Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma |
|
82465-6
|
Mosquito identified [Type] in Environmental specimen |
|
82464-9
|
Mosquito count [#] in Environmental specimen |
|
7503-6
|
Moth triggered histamine release [Units/volume] in Blood |
|
7502-8
|
Moth IgE Ab [Units/volume] in Serum |
|
87301-8
|
Mother was married at any time during pregnancy |
|
87303-4
|
Mother WIC food recipient |
|
88119-3
|
Mother's Bridged race [CDC] |
|
77739-1
|
Mother's Hepatitis B virus surface Ag status |
|
88117-7
|
Mother's Tabulated ethnicity [CDC] |
|
13130-0
|
Motilin [Units/volume] in Serum or Plasma |
|
13891-7
|
Motilin [Mass/volume] in Serum or Plasma |
|
4463-6
|
Spermatozoa motility and count panel |
|
52050-2
|
Motorized wheelchair attachment |
|
6179-6
|
Mouse epithelium IgE Ab [Units/volume] in Serum |
|
19751-7
|
Mouse epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum |
|
7504-4
|
Mouse hair IgE Ab [Units/volume] in Serum |
|
65789-0
|
Mouse lipocain native (nMus m) 1 IgE Ab [Units/volume] in Serum |
|
7505-1
|
Mouse multi IgE Ab [Units/volume] in Serum |
|
6180-4
|
Mouse serum proteins IgE Ab [Units/volume] in Serum |
|
6181-2
|
Mouse urine proteins IgE Ab [Units/volume] in Serum |
|
61342-2
|
Mouse urine proteins IgE Ab/IgE total in Serum |
|
3833-1
|
Moxalactam [Mass/volume] in Serum or Plasma |
|
80540-8
|
Moxifloxacin [Mass/volume] in DBS |
|
73254-5
|
Moxifloxacin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73255-2
|
Moxifloxacin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
43751-7
|
Moxifloxacin [Mass/volume] in Serum or Plasma |
|
7211-6
|
Mozzarella Cheese triggered histamine release [Units/volume] in Blood |
|
7209-0
|
Mozzarella Cheese IgE Ab [Units/volume] in Serum |
|
7210-8
|
Mozzarella Cheese IgG Ab [Units/volume] in Serum |
|
23255-3
|
Mycoplasma bovis Ab [Presence] in Serum |
|
23256-1
|
Mycoplasma bovis Ab [Presence] in Serum by Complement fixation |
|
11057-7
|
Monophosphoglyceromutase [Enzymatic activity/volume] in Red Blood Cells |
|
81817-9
|
MPI gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
13008-8
|
Methyl propyl ketone [Mass/volume] in Blood |
|
31167-0
|
Methyl propyl ketone [Mass/volume] in Urine |
|
75033-1
|
MPL gene mutations tested for in Bone marrow by Molecular genetics method Nominal |
|
56141-5
|
MPL gene p.Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method |
|
58009-2
|
MPL gene p.Trp515 [Presence] in Blood or Tissue by Molecular genetics method |
|
56142-3
|
MPL gene p.Trp515Leu+Trp515Lys [Presence] in Blood or Tissue by Molecular genetics method |
|
62947-7
|
MPL gene p.Trp515Leu+Trp515Lys+Ser505Asn [Presence] in Blood or Tissue by Molecular genetics method |
|
57777-5
|
Myeloperoxidase Ab and Proteinase 3 panel - Serum |
|
90230-4
|
Myeloperoxidase Ab.IgG and Proteinase 3 Ab.IgG Panel - Serum |
|
79563-3
|
Mucopolysaccharidosis type I newborn screening panel |
|
93726-8
|
Dermatan sulfate and heparan sulfate and keratan sulfate panel - Serum or Plasma |
|
10823-3
|
Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale |
|
34654-4
|
MPZ gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41085-2
|
MPZ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85041-2
|
MR Unspecified body region 3D printed model |
|
24556-3
|
MR Abdomen |
|
35949-7
|
MR Abdominal Aorta |
|
36273-1
|
MR Abdominal Aorta WO and W contrast IV |
|
36134-5
|
MR Abdomen W contrast IV |
|
30668-8
|
MR Abdomen WO contrast |
|
24557-1
|
MR Abdomen WO and W contrast IV |
|
72247-0
|
MR Abdomen and Pelvis W contrast PO and WO contrast IV |
|
72246-2
|
MR Abdomen and Pelvis W contrast PO and WO and W contrast IV |
|
36496-8
|
MR Acromioclavicular Joint WO contrast |
|
36931-4
|
MR Adrenal gland |
|
44124-6
|
MR Adrenal gland W contrast IV |
|
36954-6
|
MR Adrenal gland WO contrast |
|
36951-2
|
MR Adrenal gland WO and W contrast IV |
|
24538-1
|
MR Ankle |
|
36115-4
|
MR Ankle Arthrogram |
|
36136-0
|
MR Ankle W contrast IV |
|
30680-3
|
MR Ankle WO contrast |
|
24539-9
|
MR Ankle WO and W contrast IV |
|
37222-7
|
MR Ankle and Foot |
|
26208-9
|
MR Ankle - bilateral |
|
69163-4
|
MR Ankle - bilateral W contrast IV |
|
69164-2
|
MR Ankle - bilateral WO contrast |
|
26187-5
|
MR Ankle - bilateral WO and W contrast IV |
|
26209-7
|
MR Ankle - left |
|
43555-2
|
MR Ankle - left dynamic W contrast IV |
|
36116-2
|
MR Ankle - left Arthrogram |
|
36138-6
|
MR Ankle - left W contrast IV |
|
36427-3
|
MR Ankle - left WO contrast |
|
26188-3
|
MR Ankle - left WO and W contrast IV |
|
26210-5
|
MR Ankle - right |
|
43449-8
|
MR Ankle - right dynamic W contrast IV |
|
36117-0
|
MR Ankle - right Arthrogram |
|
36140-2
|
MR Ankle - right W contrast IV |
|
36429-9
|
MR Ankle - right WO contrast |
|
26189-1
|
MR Ankle - right WO and W contrast IV |
|
43508-1
|
MR Axilla - left |
|
43504-0
|
MR Axilla - left W contrast IV |
|
43509-9
|
MR Axilla - left WO and W contrast IV |
|
43510-7
|
MR Axilla - right |
|
43505-7
|
MR Axilla - right W contrast IV |
|
43511-5
|
MR Axilla - right WO and W contrast IV |
|
37220-1
|
MR Biliary ducts and Pancreatic duct |
|
44125-3
|
MR Biliary ducts and Pancreatic duct W contrast IV |
|
44123-8
|
MR Biliary ducts and Pancreatic duct WO contrast |
|
36944-7
|
MR Biliary ducts and Pancreatic duct WO and W contrast IV |
|
37219-3
|
MR Biliary ducts |
|
42693-2
|
MR Urinary bladder and Urethra cine |
|
39141-7
|
MR Bone marrow |
|
80513-5
|
MR Bone marrow W contrast IV |
|
80512-7
|
MR Bone marrow WO contrast |
|
80514-3
|
MR Bone marrow WO and W contrast IV |
|
24582-9
|
MR Brachial plexus |
|
36239-2
|
MR Brachial plexus W contrast IV |
|
30654-8
|
MR Brachial plexus WO contrast |
|
24583-7
|
MR Brachial plexus WO and W contrast IV |
|
26211-3
|
MR Brachial plexus - bilateral |
|
26190-9
|
MR Brachial plexus - bilateral WO and W contrast IV |
|
26212-1
|
MR Brachial plexus - left |
|
36240-0
|
MR Brachial plexus - left W contrast IV |
|
38833-0
|
MR Brachial plexus - left WO contrast |
|
26191-7
|
MR Brachial plexus - left WO and W contrast IV |
|
26213-9
|
MR Brachial plexus - right |
|
36241-8
|
MR Brachial plexus - right W contrast IV |
|
36516-3
|
MR Brachial plexus - right WO contrast |
|
26192-5
|
MR Brachial plexus - right WO and W contrast IV |
|
24590-2
|
MR Brain |
|
42386-3
|
MR Brain cine for CSF flow |
|
80507-7
|
MR Brain for high grade tumor WO and W contrast IV |
|
80506-9
|
MR Brain for low grade tumor WO and W contrast IV |
|
80510-1
|
MR Brain for metastasis WO and W contrast IV |
|
80505-1
|
MR Brain for new diagnosis tumor WO and W contrast IV |
|
80511-9
|
MR Brain for postoperative |
|
36096-6
|
MR Brain limited W contrast IV |
|
36105-5
|
MR Brain limited WO contrast |
|
37217-7
|
MR Brain stem and Cranial nerves |
|
24586-0
|
MR Brain W anesthesia |
|
24589-4
|
MR Brain W contrast IV |
|
30657-1
|
MR Brain WO contrast |
|
24587-8
|
MR Brain WO and W contrast IV |
|
24588-6
|
MR Brain WO and W contrast IV and W anesthesia |
|
37218-5
|
MR Brain.temporal |
|
48444-4
|
MR Brain.temporal W contrast IV |
|
48453-5
|
MR Brain.temporal WO contrast |
|
48694-4
|
MR Brain.temporal WO and W contrast IV |
|
82128-0
|
MR Brain and Face WO contrast |
|
82129-8
|
MR Brain and Face WO and W contrast IV |
|
43772-3
|
MR Brain and Internal auditory canal |
|
37239-1
|
MR Brain and Internal auditory canal W contrast IV |
|
37278-9
|
MR Brain and Internal auditory canal WO contrast |
|
43769-9
|
MR Brain and Internal auditory canal WO and W contrast IV |
|
37215-1
|
MR Brain and Larynx W contrast IV |
|
37279-7
|
MR Brain and Larynx WO contrast |
|
91591-8
|
MR Brain and Orbit - bilateral W contrast IV |
|
91593-4
|
MR Brain and Orbit - bilateral WO contrast |
|
91592-6
|
MR Brain and Orbit - bilateral WO and W contrast IV |
|
42385-5
|
MR Brain and Pituitary and Sella turcica |
|
42391-3
|
MR Brain and Pituitary and Sella turcica W contrast IV |
|
42393-9
|
MR Brain and Pituitary and Sella turcica WO contrast |
|
42392-1
|
MR Brain and Pituitary and Sella turcica WO and W contrast IV |
|
30794-2
|
MR Breast |
|
37437-1
|
MR Breast dynamic W contrast IV |
|
69190-7
|
MR Breast for implant W contrast IV |
|
69191-5
|
MR Breast for implant WO contrast |
|
69189-9
|
MR Breast for implant WO and W contrast IV |
|
36149-3
|
MR Breast W contrast IV |
|
36436-4
|
MR Breast WO contrast |
|
36276-4
|
MR Breast WO and W contrast IV |
|
30795-9
|
MR Breast - bilateral |
|
36114-7
|
MR Breast - bilateral dynamic W contrast IV |
|
69165-9
|
MR Breast - bilateral for implant |
|
69167-5
|
MR Breast - bilateral for implant W contrast IV |
|
69168-3
|
MR Breast - bilateral for implant WO contrast |
|
69166-7
|
MR Breast - bilateral for implant WO and W contrast IV |
|
36150-1
|
MR Breast - bilateral W contrast IV |
|
36437-2
|
MR Breast - bilateral WO contrast |
|
36277-2
|
MR Breast - bilateral WO and W contrast IV |
|
35954-7
|
MR Breast - left |
|
38057-6
|
MR Breast - left for implant |
|
38064-2
|
MR Breast - left for implant WO contrast |
|
38870-2
|
MR Breast - left for implant WO and W contrast IV |
|
36151-9
|
MR Breast - left W contrast IV |
|
36438-0
|
MR Breast - left WO contrast |
|
36278-0
|
MR Breast - left WO and W contrast IV |
|
35955-4
|
MR Breast - right |
|
38058-4
|
MR Breast - right for implant |
|
38817-3
|
MR Breast - right for implant WO contrast |
|
38062-6
|
MR Breast - right for implant WO and W contrast IV |
|
36152-7
|
MR Breast - right W contrast IV |
|
36439-8
|
MR Breast - right WO contrast |
|
36279-8
|
MR Breast - right WO and W contrast IV |
|
46299-4
|
MR Breast - unilateral |
|
46323-2
|
MR Breast - unilateral W contrast IV |
|
46333-1
|
MR Breast - unilateral WO contrast |
|
43528-9
|
MR Breast - unilateral WO and W contrast IV |
|
38061-8
|
MR Spine Cervical and Spine Thoracic and Spine Lumbar and Sacrum W contrast IV |
|
42698-1
|
MR Cervical and thoracic and lumbar spine |
|
91561-1
|
MR Cervical and thoracic and lumbar spine W contrast IV |
|
30854-4
|
MR Cervical and thoracic and lumbar spine WO contrast |
|
30855-1
|
MR Cervical and thoracic and lumbar spine WO and W contrast IV |
|
43457-1
|
MR Cervical and thoracic spine |
|
89284-4
|
MR Cervical and thoracic spine W contrast IV |
|
43456-3
|
MR Cervical and thoracic spine WO and W contrast IV |
|
30655-5
|
MR Cerebral cisterns |
|
24629-8
|
MR Chest |
|
36156-8
|
MR Chest W contrast IV |
|
36442-2
|
MR Chest WO contrast |
|
36283-0
|
MR Chest WO and W contrast IV |
|
94089-0
|
MR Chest WO and W contrast IV and MRA Chest W contrast IV |
|
36942-1
|
MR Chest and Abdomen W contrast IV |
|
36284-8
|
MR Chest and Abdomen WO and W contrast IV |
|
91523-1
|
MR Chest and Abdomen and Pelvis W contrast IV |
|
91525-6
|
MR Chest and Abdomen and Pelvis WO contrast |
|
91524-9
|
MR Chest and Abdomen and Pelvis WO and W contrast IV |
|
42387-1
|
MR Unspecified body region cine for CSF flow |
|
35961-2
|
MR Clavicle |
|
42694-0
|
MR Clavicle W contrast IV |
|
42302-0
|
MR Clavicle WO contrast |
|
42299-8
|
MR Clavicle WO and W contrast IV |
|
48457-6
|
MR Clavicle - left W contrast IV |
|
48459-2
|
MR Clavicle - left WO contrast |
|
48455-0
|
MR Clavicle - left WO and W contrast IV |
|
48456-8
|
MR Clavicle - right W contrast IV |
|
48458-4
|
MR Clavicle - right WO contrast |
|
48454-3
|
MR Clavicle - right WO and W contrast IV |
|
24935-9
|
MR Cervical spine |
|
24936-7
|
MR Cervical spine W anesthesia |
|
48447-7
|
MR Cervical spine W contrast IT |
|
24938-3
|
MR Cervical spine W contrast IV |
|
42270-9
|
MR Cervical spine W flexion and W extension |
|
30667-0
|
MR Cervical spine WO contrast |
|
48450-1
|
MR Cervical spine WO and W contrast IT |
|
24937-5
|
MR Cervical spine WO and W contrast IV |
|
24674-4
|
MR Elbow |
|
46319-0
|
MR Elbow Arthrogram |
|
36158-4
|
MR Elbow W contrast IV |
|
30796-7
|
MR Elbow WO contrast |
|
24675-1
|
MR Elbow WO and W contrast IV |
|
26220-4
|
MR Elbow - bilateral |
|
69170-9
|
MR Elbow - bilateral W contrast IV |
|
69171-7
|
MR Elbow - bilateral WO contrast |
|
26193-3
|
MR Elbow - bilateral WO and W contrast IV |
|
26221-2
|
MR Elbow - left |
|
43450-6
|
MR Elbow - left dynamic W contrast IV |
|
36118-8
|
MR Elbow - left Arthrogram |
|
36160-0
|
MR Elbow - left W contrast IV |
|
36446-3
|
MR Elbow - left WO contrast |
|
26194-1
|
MR Elbow - left WO and W contrast IV |
|
26222-0
|
MR Elbow - right |
|
43451-4
|
MR Elbow - right dynamic W contrast IV |
|
36119-6
|
MR Elbow - right Arthrogram |
|
36162-6
|
MR Elbow - right W contrast IV |
|
36448-9
|
MR Elbow - right WO contrast |
|
26195-8
|
MR Elbow - right WO and W contrast IV |
|
42390-5
|
MR Endovaginal |
|
69193-1
|
MR Extremity |
|
35953-9
|
MR Face |
|
36148-5
|
MR Face W contrast IV |
|
36435-6
|
MR Face WO contrast |
|
24694-2
|
MR Face WO and W contrast IV |
|
82130-6
|
MR Face and Neck WO contrast |
|
82131-4
|
MR Face and Neck WO and W contrast IV |
|
69172-5
|
MR Femur - bilateral W contrast IV |
|
69173-3
|
MR Femur - bilateral WO contrast |
|
35990-1
|
MR Fetal |
|
24705-6
|
MR Finger |
|
69195-6
|
MR Finger W contrast IV |
|
69196-4
|
MR Finger WO contrast |
|
69194-9
|
MR Finger WO and W contrast IV |
|
26238-6
|
MR Finger - bilateral |
|
26239-4
|
MR Finger - left |
|
69205-3
|
MR Finger - left W contrast IV |
|
69206-1
|
MR Finger - left WO contrast |
|
69204-6
|
MR Finger - left WO and W contrast IV |
|
26240-2
|
MR Finger - right |
|
69215-2
|
MR Finger - right W contrast IV |
|
69216-0
|
MR Finger - right WO contrast |
|
69214-5
|
MR Finger - right WO and W contrast IV |
|
24707-2
|
MR Foot |
|
36179-0
|
MR Foot W contrast IV |
|
30681-1
|
MR Foot WO contrast |
|
30682-9
|
MR Foot WO and W contrast IV |
|
26241-0
|
MR Foot - bilateral |
|
36180-8
|
MR Foot - bilateral W contrast IV |
|
36467-9
|
MR Foot - bilateral WO contrast |
|
36342-4
|
MR Foot - bilateral WO and W contrast IV |
|
26242-8
|
MR Foot - left |
|
36182-4
|
MR Foot - left W contrast IV |
|
36469-5
|
MR Foot - left WO contrast |
|
36344-0
|
MR Foot - left WO and W contrast IV |
|
26243-6
|
MR Foot - right |
|
36184-0
|
MR Foot - right W contrast IV |
|
36471-1
|
MR Foot - right WO contrast |
|
36346-5
|
MR Foot - right WO and W contrast IV |
|
24710-6
|
MR Forearm |
|
36186-5
|
MR Forearm W contrast IV |
|
30683-7
|
MR Forearm WO contrast |
|
30684-5
|
MR Forearm WO and W contrast IV |
|
26244-4
|
MR Forearm - bilateral |
|
69175-8
|
MR Forearm - bilateral W contrast IV |
|
69176-6
|
MR Forearm - bilateral WO contrast |
|
69174-1
|
MR Forearm - bilateral WO and W contrast IV |
|
26245-1
|
MR Forearm - left |
|
36188-1
|
MR Forearm - left W contrast IV |
|
36474-5
|
MR Forearm - left WO contrast |
|
36349-9
|
MR Forearm - left WO and W contrast IV |
|
26246-9
|
MR Forearm - right |
|
36190-7
|
MR Forearm - right W contrast IV |
|
36476-0
|
MR Forearm - right WO contrast |
|
36351-5
|
MR Forearm - right WO and W contrast IV |
|
36936-3
|
MR Guidance for stereotactic biopsy of Brain |
|
30656-3
|
MR Guidance for stereotactic localization of Brain-- W contrast IV |
|
30800-7
|
MR Guidance for stereotactic localization of Brain-- WO contrast |
|
44122-0
|
MR Guidance for stereotactic localization of Brain-- WO and W contrast IV |
|
69192-3
|
MR Guidance for aspiration of cyst of Breast |
|
69169-1
|
MR Guidance for biopsy of Breast - bilateral |
|
69203-8
|
MR Guidance for biopsy of Breast - left |
|
80498-9
|
MR Guidance for needle localization of Breast - left |
|
69213-7
|
MR Guidance for biopsy of Breast - right |
|
80497-1
|
MR Guidance for needle localization of Breast - right |
|
80504-4
|
MR Guidance for biopsy of Unspecified body region |
|
69200-4
|
MR Guidance for biopsy of Chest Pleura |
|
80509-3
|
MR Guidance for placement of clip in Unspecified body region |
|
69197-2
|
MR Guidance for biopsy of Liver |
|
69198-0
|
MR Guidance for biopsy of Muscle |
|
39028-6
|
MR Guidance for needle localization of Unspecified body region |
|
69199-8
|
MR Guidance for biopsy of Pancreas |
|
82123-1
|
MR Guidance for radiation treatment of Unspecified body region |
|
30664-7
|
MR Guidance for radiation treatment of Unspecified body region-- W contrast IV |
|
30665-4
|
MR Guidance for radiation treatment of Unspecified body region-- WO contrast |
|
69201-2
|
MR Guidance for biopsy of Salivary gland |
|
69202-0
|
MR Guidance for biopsy of Thyroid gland |
|
24720-5
|
MR Hand |
|
36192-3
|
MR Hand W contrast IV |
|
30685-2
|
MR Hand WO contrast |
|
30686-0
|
MR Hand WO and W contrast IV |
|
26247-7
|
MR Hand - bilateral |
|
69178-2
|
MR Hand - bilateral W contrast IV |
|
69179-0
|
MR Hand - bilateral WO contrast |
|
69177-4
|
MR Hand - bilateral WO and W contrast IV |
|
26248-5
|
MR Hand - left |
|
36194-9
|
MR Hand - left W contrast IV |
|
36479-4
|
MR Hand - left WO contrast |
|
36354-9
|
MR Hand - left WO and W contrast IV |
|
26249-3
|
MR Hand - right |
|
36196-4
|
MR Hand - right W contrast IV |
|
36481-0
|
MR Hand - right WO contrast |
|
36356-4
|
MR Hand - right WO and W contrast IV |
|
36013-1
|
MR Hip |
|
36120-4
|
MR Hip Arthrogram |
|
36199-8
|
MR Hip W contrast IV |
|
30687-8
|
MR Hip WO contrast |
|
30688-6
|
MR Hip WO and W contrast IV |
|
36017-2
|
MR Hip - bilateral |
|
36202-0
|
MR Hip - bilateral W contrast IV |
|
36486-9
|
MR Hip - bilateral WO contrast |
|
36361-4
|
MR Hip - bilateral WO and W contrast IV |
|
36020-6
|
MR Hip - left |
|
36121-2
|
MR Hip - left Arthrogram |
|
36204-6
|
MR Hip - left W contrast IV |
|
36488-5
|
MR Hip - left WO contrast |
|
69207-9
|
MR Hip - left Arthrogram WO and W contrast |
|
36363-0
|
MR Hip - left WO and W contrast IV |
|
36022-2
|
MR Hip - right |
|
36122-0
|
MR Hip - right Arthrogram |
|
36206-1
|
MR Hip - right W contrast IV |
|
36490-1
|
MR Hip - right WO contrast |
|
69217-8
|
MR Hip - right Arthrogram WO and W contrast |
|
36365-5
|
MR Hip - right WO and W contrast IV |
|
24748-6
|
MR Heart |
|
39140-9
|
MR Heart cine for blood flow velocity mapping |
|
44126-1
|
MR Heart cine for blood flow velocity mapping W contrast IV |
|
37434-8
|
MR Heart cine for function |
|
44127-9
|
MR Heart limited cine for function |
|
36091-7
|
MR Heart limited |
|
36197-2
|
MR Heart W contrast IV |
|
58750-1
|
MR Heart W stress |
|
80500-2
|
MR Heart W stress and WO contrast |
|
58749-3
|
MR Heart W stress and WO and W contrast IV |
|
36482-8
|
MR Heart WO contrast |
|
36357-2
|
MR Heart WO and W contrast IV |
|
35956-2
|
MR Internal auditory canal |
|
36088-3
|
MR Internal auditory canal limited |
|
36155-0
|
MR Internal auditory canal W contrast IV |
|
30658-9
|
MR Internal auditory canal WO contrast |
|
30659-7
|
MR Internal auditory canal WO and W contrast IV |
|
24735-3
|
MR Internal auditory canal and Posterior fossa |
|
24740-3
|
MR Internal auditory canal and Posterior fossa WO and W contrast IV |
|
36083-4
|
MR Inferior vena cava |
|
36545-2
|
MR Inferior vena cava WO contrast |
|
36418-2
|
MR Inferior vena cava WO and W contrast IV |
|
28576-7
|
MR Joint |
|
36812-6
|
MR Joint Arthrogram |
|
36871-2
|
MR Joint WO contrast |
|
36034-7
|
MR Kidney - bilateral |
|
36219-4
|
MR Kidney - bilateral W contrast IV |
|
36504-9
|
MR Kidney - bilateral WO contrast |
|
36378-8
|
MR Kidney - bilateral WO and W contrast IV |
|
36033-9
|
MR Kidney |
|
36113-9
|
MR Kidney W contrast IV |
|
43773-1
|
MR Kidney WO contrast |
|
43775-6
|
MR Kidney WO and W contrast IV |
|
36035-4
|
MR Kidney - left |
|
36220-2
|
MR Kidney - left W contrast IV |
|
36036-2
|
MR Kidney - right |
|
36221-0
|
MR Kidney - right W contrast IV |
|
24802-1
|
MR Knee |
|
36125-3
|
MR Knee Arthrogram |
|
36223-6
|
MR Knee W contrast IV |
|
30691-0
|
MR Knee WO contrast |
|
24803-9
|
MR Knee WO and W contrast IV |
|
26256-8
|
MR Knee - bilateral |
|
36224-4
|
MR Knee - bilateral W contrast IV |
|
36506-4
|
MR Knee - bilateral WO contrast |
|
26199-0
|
MR Knee - bilateral WO and W contrast IV |
|
26257-6
|
MR Knee - left |
|
43452-2
|
MR Knee - left dynamic W contrast IV |
|
36126-1
|
MR Knee - left Arthrogram |
|
36226-9
|
MR Knee - left W contrast IV |
|
36508-0
|
MR Knee - left WO contrast |
|
26200-6
|
MR Knee - left WO and W contrast IV |
|
26258-4
|
MR Knee - right |
|
43453-0
|
MR Knee - right dynamic W contrast IV |
|
36127-9
|
MR Knee - right Arthrogram |
|
36228-5
|
MR Knee - right W contrast IV |
|
36510-6
|
MR Knee - right WO contrast |
|
26201-4
|
MR Knee - right WO and W contrast IV |
|
36045-3
|
MR Larynx |
|
36230-1
|
MR Larynx W contrast IV |
|
48445-1
|
MR Larynx WO contrast |
|
36382-0
|
MR Larynx WO and W contrast IV |
|
30692-8
|
MR Lower extremity |
|
24687-6
|
MR Lower Extremity Joint |
|
36093-3
|
MR Lower Extremity Joint limited |
|
69210-3
|
MR Lower Extremity Joint Arthrogram |
|
36213-7
|
MR Lower Extremity Joint W contrast IV |
|
36497-6
|
MR Lower Extremity Joint WO contrast |
|
36371-3
|
MR Lower Extremity Joint WO and W contrast IV |
|
26227-9
|
MR Lower extremity joint - bilateral |
|
26228-7
|
MR Lower extremity joint - left |
|
36107-1
|
MR Lower extremity joint - left limited WO contrast |
|
36214-5
|
MR Lower extremity joint - left W contrast IV |
|
36498-4
|
MR Lower extremity joint - left WO contrast |
|
36372-1
|
MR Lower extremity joint - left WO and W contrast IV |
|
26229-5
|
MR Lower extremity joint - right |
|
38769-6
|
MR Lower extremity joint - right limited WO contrast |
|
36215-2
|
MR Lower extremity joint - right W contrast IV |
|
36499-2
|
MR Lower extremity joint - right WO contrast |
|
36373-9
|
MR Lower extremity joint - right WO and W contrast IV |
|
39293-6
|
MR Lower extremity W contrast IV |
|
39292-8
|
MR Lower extremity WO contrast |
|
39291-0
|
MR Lower extremity WO and W contrast IV |
|
35975-2
|
MR Lower extremity - bilateral |
|
36163-4
|
MR Lower extremity - bilateral W contrast IV |
|
36451-3
|
MR Lower extremity - bilateral WO contrast |
|
36289-7
|
MR Lower extremity - bilateral WO and W contrast IV |
|
35978-6
|
MR Lower extremity - left |
|
36165-9
|
MR Lower extremity - left W contrast IV |
|
36453-9
|
MR Lower extremity - left WO contrast |
|
36291-3
|
MR Lower extremity - left WO and W contrast IV |
|
35980-2
|
MR Lower extremity - right |
|
36167-5
|
MR Lower extremity - right W contrast IV |
|
36455-4
|
MR Lower extremity - right WO contrast |
|
36333-3
|
MR Lower extremity - right WO and W contrast IV |
|
36046-1
|
MR Liver |
|
36231-9
|
MR Liver W contrast IV |
|
30669-6
|
MR Liver WO contrast |
|
30670-4
|
MR Liver WO and W contrast IV |
|
43448-0
|
MR Liver WO and W ferumoxides IV |
|
24821-1
|
MR Lower leg |
|
36259-0
|
MR Lower leg W contrast IV |
|
30869-2
|
MR Lower leg WO contrast |
|
30870-0
|
MR Lower leg WO and W contrast IV |
|
42696-5
|
MR Lower leg - bilateral |
|
42695-7
|
MR Lower leg - bilateral W contrast IV |
|
69185-7
|
MR Lower leg - bilateral WO contrast |
|
42697-3
|
MR Lower leg - bilateral WO and W contrast IV |
|
36075-0
|
MR Lower leg - left |
|
36261-6
|
MR Lower leg - left W contrast IV |
|
36539-5
|
MR Lower leg - left WO contrast |
|
36410-9
|
MR Lower leg - left WO and W contrast IV |
|
36076-8
|
MR Lower leg - right |
|
36263-2
|
MR Lower leg - right W contrast IV |
|
36541-1
|
MR Lower leg - right WO contrast |
|
36412-5
|
MR Lower leg - right WO and W contrast IV |
|
24968-0
|
MR Lumbar spine |
|
36100-6
|
MR Lumbar spine limited W contrast IV |
|
36111-3
|
MR Lumbar spine limited WO contrast |
|
24977-1
|
MR Lumbar spine W anesthesia |
|
48436-0
|
MR Lumbar spine W contrast IT |
|
30678-7
|
MR Lumbar spine W contrast IV |
|
30679-5
|
MR Lumbar spine WO contrast |
|
48452-7
|
MR Lumbar spine WO and W contrast IT |
|
24967-2
|
MR Lumbar spine WO and W contrast IV |
|
91715-3
|
MR Spine Lumbar and Sacrum W contrast IV |
|
91717-9
|
MR Spine Lumbar and Sacrum WO contrast |
|
91716-1
|
MR Spine Lumbar and Sacrum WO and W contrast IV |
|
48460-0
|
MR Unspecified body region limited |
|
30866-8
|
MR Lumbosacral plexus |
|
37234-2
|
MR Mediastinum |
|
80495-5
|
MR Mediastinum WO contrast |
|
37272-2
|
MR Mediastinum WO and W contrast IV |
|
69211-1
|
MR Nasal bones |
|
30860-1
|
MR Nasopharynx |
|
36233-5
|
MR Nasopharynx W contrast IV |
|
36513-0
|
MR Nasopharynx WO contrast |
|
36384-6
|
MR Nasopharynx WO and W contrast IV |
|
24839-3
|
MR Neck |
|
48461-8
|
MR Neck limited |
|
24841-9
|
MR Neck W contrast IV |
|
30660-5
|
MR Neck WO contrast |
|
24840-1
|
MR Neck WO and W contrast IV |
|
30857-7
|
MR Nerves cranial |
|
36777-1
|
MR Orbit |
|
36820-9
|
MR Orbit W contrast IV |
|
36872-0
|
MR Orbit WO contrast |
|
36842-3
|
MR Orbit WO and W contrast IV |
|
42303-8
|
MR Orbit and Face |
|
39038-5
|
MR Orbit and Face W contrast IV |
|
36956-1
|
MR Orbit and Face WO contrast |
|
39029-4
|
MR Orbit and Face WO and W contrast IV |
|
43530-5
|
MR Orbit and Face and Neck |
|
46321-6
|
MR Orbit and Face and Neck W contrast IV |
|
46332-3
|
MR Orbit and Face and Neck WO contrast |
|
46310-9
|
MR Orbit and Face and Neck WO and W contrast IV |
|
24852-6
|
MR Orbit - bilateral W contrast IV |
|
30661-3
|
MR Orbit - bilateral WO contrast |
|
24851-8
|
MR Orbit - bilateral WO and W contrast IV |
|
38836-3
|
MR Orbit - left |
|
36821-7
|
MR Orbit - left W contrast IV |
|
36873-8
|
MR Orbit - left WO contrast |
|
36843-1
|
MR Orbit - left WO and W contrast IV |
|
36778-9
|
MR Orbit - right |
|
36822-5
|
MR Orbit - right W contrast IV |
|
36874-6
|
MR Orbit - right WO contrast |
|
36844-9
|
MR Orbit - right WO and W contrast IV |
|
43455-5
|
MR Oropharynx |
|
36779-7
|
MR Ovary |
|
36823-3
|
MR Ovary W contrast IV |
|
36875-3
|
MR Ovary WO contrast |
|
36845-6
|
MR Ovary WO and W contrast IV |
|
43506-5
|
MR Ovary - bilateral |
|
80496-3
|
MR Unspecified body region 3D post processing |
|
36052-9
|
MR Pancreas |
|
36236-8
|
MR Pancreas W contrast IV |
|
36515-5
|
MR Pancreas WO contrast |
|
36385-3
|
MR Pancreas WO and W contrast IV |
|
36053-7
|
MR Parathyroid gland |
|
37224-3
|
MR Parotid gland |
|
37241-7
|
MR Parotid gland W contrast IV |
|
37281-3
|
MR Parotid gland WO contrast |
|
37265-6
|
MR Parotid gland WO and W contrast IV |
|
24867-4
|
MR Pelvis |
|
24872-4
|
MR Pelvis and Hip |
|
30671-2
|
MR Pelvis and Hip WO contrast |
|
30672-0
|
MR Pelvis and Hip WO and W contrast IV |
|
26259-2
|
MR Pelvis and Hip - bilateral |
|
26260-0
|
MR Pelvis and Hip - left |
|
26261-8
|
MR Pelvis and Hip - right |
|
72245-4
|
MR Pelvis Defecography W contrast PR |
|
42389-7
|
MR Pelvis Endorectal |
|
80585-3
|
MR Pelvis Endorectal W contrast IV |
|
72244-7
|
MR Pelvis Endorectal WO and W contrast IV |
|
69212-9
|
MR Pelvis limited |
|
36237-6
|
MR Pelvis W contrast IV |
|
30673-8
|
MR Pelvis WO contrast |
|
30674-6
|
MR Pelvis WO and W contrast IV |
|
24880-7
|
MR Pituitary and Sella turcica |
|
36238-4
|
MR Pituitary and Sella turcica W contrast IV |
|
30666-2
|
MR Pituitary and Sella turcica WO contrast |
|
24879-9
|
MR Pituitary and Sella turcica WO and W contrast IV |
|
91718-7
|
MR Unspecified body region Post mortem |
|
36056-0
|
MR Posterior fossa |
|
36243-4
|
MR Posterior fossa W contrast IV |
|
36518-9
|
MR Posterior fossa WO contrast |
|
36388-7
|
MR Posterior fossa WO and W contrast IV |
|
30675-3
|
MR Prostate |
|
42388-9
|
MR Prostate Endorectal |
|
36244-2
|
MR Prostate W contrast IV |
|
36519-7
|
MR Prostate WO contrast |
|
36389-5
|
MR Prostate WO and W contrast IV |
|
43454-8
|
MR Pulmonary system |
|
36059-4
|
MR Sacrum |
|
91594-2
|
MR Sacrum and Sacroiliac joint W contrast IV |
|
91596-7
|
MR Sacrum and Sacroiliac joint WO contrast |
|
91595-9
|
MR Sacrum and Sacroiliac joint WO and W contrast IV |
|
36246-7
|
MR Sacrum W contrast IV |
|
36521-3
|
MR Sacrum WO contrast |
|
36391-1
|
MR Sacrum WO and W contrast IV |
|
36060-2
|
MR Sacrum and Coccyx |
|
36247-5
|
MR Sacrum and Coccyx W contrast IV |
|
36522-1
|
MR Sacrum and Coccyx WO contrast |
|
36392-9
|
MR Sacrum and Coccyx WO and W contrast IV |
|
36933-0
|
MR Salivary gland |
|
80501-0
|
MR Small bowel W contrast PO and WO contrast IV |
|
80503-6
|
MR Small bowel W contrast PO and WO and W contrast IV |
|
36061-0
|
MR Scapula |
|
36248-3
|
MR Scapula - left W contrast IV |
|
36523-9
|
MR Scapula - left WO contrast |
|
36393-7
|
MR Scapula - left WO and W contrast IV |
|
36249-1
|
MR Scapula - right W contrast IV |
|
38770-4
|
MR Scapula - right WO contrast |
|
36394-5
|
MR Scapula - right WO and W contrast IV |
|
36073-5
|
MR Scrotum and testicle |
|
69221-0
|
MR Scrotum and testicle W contrast IV |
|
36535-3
|
MR Scrotum and testicle WO contrast |
|
36406-7
|
MR Scrotum and testicle WO and W contrast IV |
|
24905-2
|
MR Shoulder |
|
36129-5
|
MR Shoulder Arthrogram |
|
36251-7
|
MR Shoulder W contrast IV |
|
30693-6
|
MR Shoulder WO contrast |
|
24906-0
|
MR Shoulder WO and W contrast IV |
|
26266-7
|
MR Shoulder - bilateral |
|
69184-0
|
MR Shoulder - bilateral W contrast IV |
|
36525-4
|
MR Shoulder - bilateral WO contrast |
|
26202-2
|
MR Shoulder - bilateral WO and W contrast IV |
|
26268-3
|
MR Shoulder - left |
|
36130-3
|
MR Shoulder - left Arthrogram |
|
38830-6
|
MR Shoulder - left W contrast IV |
|
38834-8
|
MR Shoulder - left WO contrast |
|
69208-7
|
MR Shoulder - left Arthrogram WO and W contrast |
|
26203-0
|
MR Shoulder - left WO and W contrast IV |
|
26270-9
|
MR Shoulder - right |
|
36132-9
|
MR Shoulder - right Arthrogram |
|
36254-1
|
MR Shoulder - right W contrast IV |
|
36528-8
|
MR Shoulder - right WO contrast |
|
69218-6
|
MR Shoulder - right Arthrogram WO and W contrast |
|
26204-8
|
MR Shoulder - right WO and W contrast IV |
|
36031-3
|
MR Sacroiliac Joint |
|
36218-6
|
MR Sacroiliac Joint W contrast IV |
|
36502-3
|
MR Sacroiliac Joint WO contrast |
|
36376-2
|
MR Sacroiliac Joint WO and W contrast IV |
|
24914-4
|
MR Sinuses |
|
24915-1
|
MR Sinuses W contrast IV |
|
30662-1
|
MR Sinuses WO contrast |
|
30663-9
|
MR Sinuses WO and W contrast IV |
|
48440-2
|
MR Skull base W contrast IV |
|
48687-8
|
MR Skull base WO contrast |
|
69220-2
|
MR Skull base WO and W contrast IV |
|
37253-2
|
MR Soft tissue W contrast IV |
|
37293-8
|
MR Soft tissue WO contrast |
|
36067-7
|
MR Spine |
|
18756-7
|
MR Spine study |
|
36256-6
|
MR Spine W contrast IV |
|
36531-2
|
MR Spine WO contrast |
|
36400-0
|
MR Spine WO and W contrast IV |
|
36070-1
|
MR Spleen |
|
36533-8
|
MR Spleen WO contrast |
|
36404-2
|
MR Spleen WO and W contrast IV |
|
36072-7
|
MR Sternum |
|
36546-0
|
MR Superior vena cava WO contrast |
|
36419-0
|
MR Superior vena cava WO and W contrast IV |
|
94088-2
|
MR Thoracic and lumbar spine WO and W contrast |
|
35950-5
|
MR Thoracic Aorta |
|
35947-1
|
MR Thoracic and abdominal aorta |
|
24702-3
|
MR Thigh |
|
36173-3
|
MR Thigh W contrast IV |
|
36461-2
|
MR Thigh WO contrast |
|
24703-1
|
MR Thigh WO and W contrast IV |
|
26235-2
|
MR Thigh - bilateral |
|
26196-6
|
MR Thigh - bilateral WO and W contrast IV |
|
26236-0
|
MR Thigh - left |
|
36175-8
|
MR Thigh - left W contrast IV |
|
36463-8
|
MR Thigh - left WO contrast |
|
26197-4
|
MR Thigh - left WO and W contrast IV |
|
26237-8
|
MR Thigh - right |
|
36177-4
|
MR Thigh - right W contrast IV |
|
36465-3
|
MR Thigh - right WO contrast |
|
26198-2
|
MR Thigh - right WO and W contrast IV |
|
43507-3
|
MR Thymus gland |
|
42300-4
|
MR Thyroid gland |
|
36536-1
|
MR Thyroid gland WO contrast |
|
36407-5
|
MR Thyroid gland WO and W contrast IV |
|
24999-5
|
MR Temporomandibular joint |
|
37435-5
|
MR Temporomandibular joint cine |
|
37244-1
|
MR Temporomandibular joint W contrast IV |
|
37284-7
|
MR Temporomandibular joint WO contrast |
|
37268-0
|
MR Temporomandibular joint WO and W contrast IV |
|
37228-4
|
MR Temporomandibular joint - bilateral |
|
37245-8
|
MR Temporomandibular joint - bilateral W contrast IV |
|
37285-4
|
MR Temporomandibular joint - bilateral WO contrast |
|
37269-8
|
MR Temporomandibular joint - bilateral WO and W contrast IV |
|
37230-0
|
MR Temporomandibular joint - left |
|
37247-4
|
MR Temporomandibular joint - left W contrast IV |
|
37286-2
|
MR Temporomandibular joint - left WO contrast |
|
37270-6
|
MR Temporomandibular joint - left WO and W contrast IV |
|
37231-8
|
MR Temporomandibular joint - right |
|
37249-0
|
MR Temporomandibular joint - right W contrast IV |
|
37287-0
|
MR Temporomandibular joint - right WO contrast |
|
37271-4
|
MR Temporomandibular joint - right WO and W contrast IV |
|
36780-5
|
MR Toe |
|
91597-5
|
MR Toe WO and W contrast IV |
|
72243-9
|
MR Toes - left W contrast IV |
|
72242-1
|
MR Toes - left WO contrast |
|
72241-3
|
MR Toes - left WO and W contrast IV |
|
72240-5
|
MR Toes - right W contrast IV |
|
72239-7
|
MR Toes - right WO contrast |
|
72238-9
|
MR Toes - right WO and W contrast IV |
|
24980-5
|
MR Thoracic spine |
|
36101-4
|
MR Thoracic spine limited W contrast IV |
|
36112-1
|
MR Thoracic spine limited WO contrast |
|
48439-4
|
MR Thoracic spine W contrast IT |
|
24982-1
|
MR Thoracic spine W contrast IV |
|
36532-0
|
MR Thoracic spine WO contrast |
|
48441-0
|
MR Thoracic spine WO and W contrast IT |
|
24981-3
|
MR Thoracic spine WO and W contrast IV |
|
24688-4
|
MR Upper extremity |
|
30875-9
|
MR Upper extremity.joint |
|
36094-1
|
MR Upper extremity.joint limited |
|
80508-5
|
MR Upper extremity.joint Arthrogram |
|
36216-0
|
MR Upper extremity.joint W contrast IV |
|
36500-7
|
MR Upper extremity.joint WO contrast |
|
36374-7
|
MR Upper extremity.joint WO and W contrast IV |
|
36817-5
|
MR Upper extremity joint - bilateral W contrast IV |
|
36774-8
|
MR Upper extremity joint - left |
|
36818-3
|
MR Upper extremity joint - left W contrast IV |
|
36869-6
|
MR Upper extremity joint - left WO contrast |
|
36840-7
|
MR Upper extremity joint - left WO and W contrast IV |
|
36775-5
|
MR Upper extremity joint - right |
|
36819-1
|
MR Upper extremity joint - right W contrast IV |
|
36870-4
|
MR Upper extremity joint - right WO contrast |
|
36841-5
|
MR Upper extremity joint - right WO and W contrast IV |
|
39037-7
|
MR Upper extremity W contrast IV |
|
39033-6
|
MR Upper extremity WO contrast |
|
39034-4
|
MR Upper extremity WO and W contrast IV |
|
26232-9
|
MR Upper extremity - bilateral |
|
69187-3
|
MR Upper extremity - bilateral W contrast IV |
|
69188-1
|
MR Upper extremity - bilateral WO contrast |
|
69186-5
|
MR Upper extremity - bilateral WO and W contrast IV |
|
26233-7
|
MR Upper extremity - left |
|
38829-8
|
MR Upper extremity - left W contrast IV |
|
38832-2
|
MR Upper extremity - left WO contrast |
|
38831-4
|
MR Upper extremity - left WO and W contrast IV |
|
26234-5
|
MR Upper extremity - right |
|
36171-7
|
MR Upper extremity - right W contrast IV |
|
36459-6
|
MR Upper extremity - right WO contrast |
|
36337-4
|
MR Upper extremity - right WO and W contrast IV |
|
25056-3
|
MR Unspecified body region |
|
36025-5
|
MR Upper arm |
|
36208-7
|
MR Upper arm W contrast IV |
|
30689-4
|
MR Upper arm WO contrast |
|
30690-2
|
MR Upper arm WO and W contrast IV |
|
69180-8
|
MR Upper arm - bilateral |
|
69182-4
|
MR Upper arm - bilateral W contrast IV |
|
69183-2
|
MR Upper arm - bilateral WO contrast |
|
69181-6
|
MR Upper arm - bilateral WO and W contrast IV |
|
36028-9
|
MR Upper arm - left |
|
36210-3
|
MR Upper arm - left W contrast IV |
|
36493-5
|
MR Upper arm - left WO contrast |
|
36368-9
|
MR Upper arm - left WO and W contrast IV |
|
36030-5
|
MR Upper arm - right |
|
36212-9
|
MR Upper arm - right W contrast IV |
|
36495-0
|
MR Upper arm - right WO contrast |
|
36370-5
|
MR Upper arm - right WO and W contrast IV |
|
80584-6
|
MR Urethra Endovaginal WO contrast |
|
42301-2
|
MR Uterus |
|
36265-7
|
MR Uterus W contrast IV |
|
36542-9
|
MR Uterus WO contrast |
|
36413-3
|
MR Uterus WO and W contrast IV |
|
69222-8
|
MR Vena cava |
|
46358-8
|
MR Whole body |
|
80499-7
|
MR Whole body WO and W contrast IV |
|
25033-2
|
MR Wrist |
|
37444-7
|
MR Wrist Arthrogram |
|
37448-8
|
MR Wrist W contrast IV |
|
37460-3
|
MR Wrist WO contrast |
|
25035-7
|
MR Wrist WO and W contrast IV |
|
36008-1
|
MR Wrist and Hand |
|
69209-5
|
MR Wrist - left and Hand - left |
|
69219-4
|
MR Wrist - right and Hand - right |
|
26277-4
|
MR Wrist - bilateral |
|
37449-6
|
MR Wrist - bilateral W contrast IV |
|
37462-9
|
MR Wrist - bilateral WO contrast |
|
26205-5
|
MR Wrist - bilateral WO and W contrast IV |
|
26279-0
|
MR Wrist - left |
|
37445-4
|
MR Wrist - left Arthrogram |
|
37451-2
|
MR Wrist - left W contrast IV |
|
37464-5
|
MR Wrist - left WO contrast |
|
26206-3
|
MR Wrist - left WO and W contrast IV |
|
26281-6
|
MR Wrist - right |
|
37446-2
|
MR Wrist - right Arthrogram |
|
37453-8
|
MR Wrist - right W contrast IV |
|
37466-0
|
MR Wrist - right WO contrast |
|
26207-1
|
MR Wrist - right WO and W contrast IV |
|
25057-1
|
MR Unspecified body region W conscious sedation |
|
49507-7
|
MR Unspecified body region W contrast IV |
|
69223-6
|
MR Unspecified body region WO contrast |
|
42298-0
|
MR Unspecified body region WO and W contrast IV |
|
80502-8
|
MRA Abdominal Aorta and Bilateral Runoff Vessels WO and W contrast IV |
|
36432-3
|
MRA Abdominal Aorta WO contrast |
|
36272-3
|
MRA Abdominal Aorta WO and W contrast IV |
|
36791-2
|
MRA Abdominal vessels |
|
24533-2
|
MRA Abdominal vessels W contrast IV |
|
36878-7
|
MRA Abdominal vessels WO contrast |
|
36855-5
|
MRA Abdominal vessels WO and W contrast IV |
|
36781-3
|
MRA Abdominal veins |
|
36846-4
|
MRA Abdominal veins WO and W contrast IV |
|
30864-3
|
MRA Abdominal veins and IVC |
|
30861-9
|
MRA Aortic arch and Neck vessels |
|
36792-0
|
MRA Adrenal vessels |
|
36879-5
|
MRA Ankle vessels WO contrast |
|
35951-3
|
MRA Aortic arch |
|
44130-3
|
MRA Aortic arch WO contrast |
|
46360-4
|
MRA Aortic arch WO and W contrast IV |
|
30859-3
|
MRA Carotid vessels and Neck vessels |
|
30865-0
|
MRA Celiac vessels and Superior mesenteric Vessels |
|
30862-7
|
MRA Chest vessels |
|
24659-5
|
MRA Chest vessels W contrast IV |
|
36547-8
|
MRA Chest vessels WO contrast |
|
36420-8
|
MRA Chest vessels WO and W contrast IV |
|
36848-0
|
MRA Chest veins WO and W contrast IV |
|
37235-9
|
MRA Circle of Willis |
|
37254-0
|
MRA Circle of Willis W contrast IV |
|
69161-8
|
MRA Circle of Willis WO and W contrast IV |
|
37501-4
|
MRA Cervical spine vessels W contrast IV |
|
37511-3
|
MRA Cervical spine vessels WO contrast |
|
37506-3
|
MRA Cervical spine vessels WO and W contrast IV |
|
30876-7
|
MRA Extremity veins |
|
36794-6
|
MRA Extremity vessels |
|
30871-8
|
MRA Femoral vessels |
|
30873-4
|
MRA Forearm vessels |
|
30872-6
|
MRA Foot vessels |
|
30856-9
|
MRA Head vessels |
|
36808-4
|
MRA Head vessels limited |
|
24593-6
|
MRA Head vessels W contrast IV |
|
36881-1
|
MRA Head vessels WO contrast |
|
36857-1
|
MRA Head vessels WO and W contrast IV |
|
30858-5
|
MRA Head veins |
|
36826-6
|
MRA Head veins W contrast IV |
|
36876-1
|
MRA Head veins WO contrast |
|
36847-2
|
MRA Head veins WO and W contrast IV |
|
42304-6
|
MRA Head vessels and Neck vessels |
|
36009-9
|
MRA Heart |
|
36082-6
|
MRA Inferior vena cava |
|
36790-4
|
MRA Inferior vena cava + tributaries |
|
36799-5
|
MRA Knee vessels |
|
36800-1
|
MRA Knee vessels - left |
|
38837-1
|
MRA Knee vessels - left WO and W contrast IV |
|
36801-9
|
MRA Knee vessels - right |
|
36862-1
|
MRA Knee vessels - right WO and W contrast IV |
|
30874-2
|
MRA Lower extremity vessels |
|
46324-0
|
MRA Lower extremity vessels W contrast IV |
|
44129-5
|
MRA Lower extremity vessels WO contrast |
|
44128-7
|
MRA Lower extremity vessels WO and W contrast IV |
|
35974-5
|
MRA Lower extremity vessels - bilateral |
|
44135-2
|
MRA Lower extremity vessels - bilateral W contrast IV |
|
36450-5
|
MRA Lower extremity vessels - bilateral WO contrast |
|
36795-3
|
MRA Lower extremity vessels - left |
|
36882-9
|
MRA Lower extremity vessels - left WO contrast |
|
36858-9
|
MRA Lower extremity vessels - left WO and W contrast IV |
|
36796-1
|
MRA Lower extremity vessels - right |
|
38773-8
|
MRA Lower extremity vessels - right WO contrast |
|
36859-7
|
MRA Lower extremity vessels - right WO and W contrast IV |
|
36079-2
|
MRA Lower extremity veins |
|
36416-6
|
MRA Lower extremity veins WO and W contrast IV |
|
36784-7
|
MRA Lower extremity veins - left |
|
36849-8
|
MRA Lower extremity veins - left WO and W contrast IV |
|
36785-4
|
MRA Lower extremity veins - right |
|
36850-6
|
MRA Lower extremity veins - right WO and W contrast IV |
|
24820-3
|
MRA Lower leg vessels W contrast IV |
|
43512-3
|
MRA Lower leg vessels - bilateral W contrast IV |
|
43513-1
|
MRA Lower leg vessels - left |
|
43556-0
|
MRA Lower leg vessels - right |
|
37502-2
|
MRA Lumbar spine vessels W contrast IV |
|
37994-1
|
MRA Lumbar spine vessels WO contrast |
|
37507-1
|
MRA Lumbar spine vessels WO and W contrast IV |
|
36085-9
|
MRA Neck vessels |
|
24844-3
|
MRA Neck vessels W contrast IV |
|
36549-4
|
MRA Neck vessels WO contrast |
|
36423-2
|
MRA Neck vessels WO and W contrast IV |
|
36788-8
|
MRA Neck veins |
|
36827-4
|
MRA Neck veins W contrast IV |
|
36877-9
|
MRA Neck veins WO contrast |
|
36853-0
|
MRA Neck veins WO and W contrast IV |
|
36802-7
|
MRA Orbit vessels |
|
36832-4
|
MRA Orbit vessels W contrast IV |
|
43458-9
|
MRA Orbit vessels WO and W contrast IV |
|
69162-6
|
MRA Pulmonary artery - bilateral W contrast IA |
|
30867-6
|
MRA Pelvis vessels |
|
24873-2
|
MRA Pelvis vessels W contrast IV |
|
36883-7
|
MRA Pelvis vessels WO contrast |
|
36863-9
|
MRA Pelvis vessels WO and W contrast IV |
|
36789-6
|
MRA Pelvis veins |
|
36854-8
|
MRA Pelvis veins WO and W contrast IV |
|
36077-6
|
MRA Portal vein |
|
36543-7
|
MRA Portal vein WO contrast |
|
36414-1
|
MRA Portal vein WO and W contrast IV |
|
36803-5
|
MRA Pulmonary vessels |
|
36275-6
|
MRA Renal artery WO and W contrast IV |
|
36078-4
|
MRA Renal vein |
|
36544-5
|
MRA Renal vein WO contrast |
|
36415-8
|
MRA Renal vein WO and W contrast IV |
|
30868-4
|
MRA Renal vessels |
|
30887-4
|
MRA Renal vessels W contrast IV |
|
44133-7
|
MRA Renal vessels WO contrast |
|
44134-5
|
MRA Renal vessels WO and W contrast IV |
|
36804-3
|
MRA Renal vessels - bilateral |
|
36805-0
|
MRA Shoulder vessels |
|
36806-8
|
MRA Shoulder vessels - left |
|
36864-7
|
MRA Shoulder vessels - left WO and W contrast IV |
|
36807-6
|
MRA Shoulder vessels - right |
|
36865-4
|
MRA Shoulder vessels - right WO and W contrast IV |
|
46359-6
|
MRA Superior mesenteric vessels |
|
44230-1
|
MRA Superior mesenteric vessels WO contrast |
|
44231-9
|
MRA Superior mesenteric vessels WO and W contrast IV |
|
37277-1
|
MRA Spinal veins WO and W contrast IV |
|
37497-5
|
MRA Spine vessels |
|
37500-6
|
MRA Spine vessels W contrast IV |
|
37510-5
|
MRA Spine vessels WO contrast |
|
37505-5
|
MRA Spine vessels WO and W contrast IV |
|
36782-1
|
MRA Subclavian artery |
|
24660-3
|
MRA Thoracic Aorta |
|
35946-3
|
MRA Thoracic and abdominal aorta |
|
44132-9
|
MRA Thoracic and abdominal aorta WO contrast |
|
44131-1
|
MRA Thoracic and abdominal aorta WO and W contrast IV |
|
36433-1
|
MRA Thoracic Aorta WO contrast |
|
36274-9
|
MRA Thoracic Aorta WO and W contrast IV |
|
25003-5
|
MRA Thigh vessels W contrast IV |
|
43514-9
|
MRA Thigh vessels - left WO contrast |
|
43515-6
|
MRA Thigh vessels - right WO contrast |
|
24584-5
|
MRA Thoracic inlet vessels W contrast IV |
|
26181-8
|
MRA Thoracic inlet vessels - bilateral W contrast IV |
|
26182-6
|
MRA Thoracic inlet vessels - left W contrast IV |
|
26183-4
|
MRA Thoracic inlet vessels - right W contrast IV |
|
30888-2
|
MRA Tibioperoneal vessels |
|
49565-5
|
MRA Thoracic spine vessels |
|
37503-0
|
MRA Thoracic spine vessels W contrast IV |
|
37512-1
|
MRA Thoracic spine vessels WO contrast |
|
37508-9
|
MRA Thoracic spine vessels WO and W contrast IV |
|
36084-2
|
MRA Upper extremity vessels |
|
24549-8
|
MRA Upper extremity vessels W contrast IV |
|
36548-6
|
MRA Upper extremity vessels WO contrast |
|
36422-4
|
MRA Upper extremity vessels WO and W contrast IV |
|
36797-9
|
MRA Upper extremity vessels - left |
|
36860-5
|
MRA Upper extremity vessels - left WO and W contrast IV |
|
36798-7
|
MRA Upper extremity vessels - right |
|
36861-3
|
MRA Upper extremity vessels - right WO and W contrast IV |
|
36080-0
|
MRA Upper extremity veins |
|
36417-4
|
MRA Upper extremity veins WO and W contrast IV |
|
36786-2
|
MRA Upper extremity veins - left |
|
36851-4
|
MRA Upper extremity veins - left WO and W contrast IV |
|
36787-0
|
MRA Upper extremity veins - right |
|
36852-2
|
MRA Upper extremity veins - right WO and W contrast IV |
|
36783-9
|
MRA Veins |
|
36081-8
|
MRA Vena cava |
|
43516-4
|
MRA Wrist vessels - left WO contrast |
|
43517-2
|
MRA Wrist vessels - right WO contrast |
|
25058-9
|
MRA Unspecified body region W contrast IV |
|
86621-0
|
Methicillin resistance mecC gene [Presence] by Molecular method |
|
72248-8
|
MRCP Abdomen WO and W contrast IV |
|
58740-2
|
MRCP Abdomen WO contrast |
|
77101-4
|
MRPL18A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77100-6
|
MRPL18A gene full mutation analysis in Blood or Tissue by Sequencing |
|
77077-6
|
MRPL40 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77076-8
|
MRPL40 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77099-0
|
MRPL44 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77098-2
|
MRPL44 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77095-8
|
MRPS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77094-1
|
MRPS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77097-4
|
MRPS22 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77096-6
|
MRPS22 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77093-3
|
MRRF gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77092-5
|
MRRF gene full mutation analysis in Blood or Tissue by Sequencing |
|
75859-9
|
Modified rankin scale |
|
37442-1
|
MR spectroscopy Brain |
|
37443-9
|
MR spectroscopy Unspecified body region |
|
90001-9
|
Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Nose by NAA with probe detection |
|
35492-8
|
Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
53572-4
|
Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture |
|
52969-3
|
Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture |
|
76081-9
|
Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture |
|
77682-3
|
Staphylococcus aureus methicillin resistance SCCmec+orfX junction [Presence] in Nose by NAA with probe detection |
|
13317-3
|
Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture |
|
74145-4
|
Multiple sclerosis action plan |
|
34115-6
|
Medical student Hospital History and physical note |
|
76082-7
|
Microscopic observation [Identifier] in Bronchoalveolar lavage by Methenamine silver nitrate stain |
|
89658-9
|
Microscopic observation [Identifier] in Lower respiratory specimen by Methenamine silver nitrate stain |
|
6671-2
|
Microscopic observation [Identifier] in Tissue by Methenamine silver nitrate stain |
|
670-0
|
Microscopic observation [Identifier] in Unspecified specimen by Methenamine silver nitrate stain |
|
75439-0
|
Medical student Note |
|
55121-8
|
Multiple sclerosis panel - Serum and CSF |
|
17289-0
|
Monosodium glutamate (MSG) IgE Ab [Units/volume] in Serum |
|
48191-1
|
Monosodium glutamate (MSG) triggered leukotriene release [Mass/volume] by Leukocytes |
|
50323-5
|
MSH-2 Ag [Presence] in Tissue by Immune stain |
|
89039-2
|
MSH2 gene deletion+duplication and full mutation analysis and EPCAM gene exons 8 and 9 deletion and duplication mutation analysis in Blood or Tissue by Molecular genetics method |
|
92675-8
|
MSH2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
79415-6
|
MSH2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
38550-0
|
MSH2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41084-5
|
MSH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
32630-6
|
MSH2 gene+MLH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
76063-7
|
MSH2 gene+MLH1 gene+MSH6 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
58010-0
|
MSH2 gene+MLH1 gene+MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50324-3
|
MSH-6 Ag [Presence] in Tissue by Immune stain |
|
79414-9
|
MSH6 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
38906-4
|
MSH6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38921-3
|
MSH6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81711-4
|
Microsatellite instability marker panel - Cancer specimen |
|
43368-0
|
Microsatellite instability [Identifier] in Tissue by Molecular genetics method Nominal |
|
62862-8
|
Microsatellite instability [Presence] in Tissue by Immune stain |
|
25957-2
|
Methionine sulfoxide [Moles/volume] in 24 hour Urine |
|
25477-1
|
Methionine sulfoxide [Moles/time] in 24 hour Urine |
|
34340-0
|
Methionine sulfoxide [Moles/volume] in Urine |
|
25958-0
|
Methionine sulfoxide/Creatinine [Molar ratio] in 24 hour Urine |
|
75755-9
|
Methicillin susceptible Staphylococcus aureus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
7194-4
|
Mountain Juniper triggered histamine release [Units/volume] in Blood |
|
6178-8
|
Mountain Juniper IgE Ab [Units/volume] in Serum |
|
38464-4
|
Mountain Juniper IgE Ab/IgE total in Serum |
|
7193-6
|
Mountain Juniper IgG Ab [Units/volume] in Serum |
|
56323-9
|
Mountain Juniper IgG4 Ab [Mass/volume] in Serum |
|
63181-2
|
Mountain Juniper IgG Ab [Mass/volume] in Serum |
|
61116-0
|
Mitochondria rRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
61111-1
|
Mitochondria tRNA targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
93456-2
|
MT-45 [Mass/volume] in Urine by Confirmatory method |
|
21704-2
|
MT-ATP6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38405-7
|
MT-ATP6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
40341-0
|
MT-ATP6 gene m.8993T>G [Presence] in Blood or Tissue by Molecular genetics method |
|
89371-9
|
MTB complex DNA and rpoB RIF resistance mutation panel [Presence] |
|
94053-6
|
Mycobacterium tuberculosis complex resistance panel by Molecular genetics method |
|
92827-5
|
Mycobacterium tuberculosis complex species identified in Unspecified specimen by Sequencing |
|
72866-7
|
Mycobacterium tuberculosis ethA gene ethionamide resistance mutation [Presence] by Molecular method |
|
72865-9
|
Mycobacterium tuberculosis ethB gene ethionamide resistance mutation [Presence] by Molecular method |
|
72276-9
|
Mycobacterium tuberculosis gyrA gene fluoroquinolone resistance mutation [Presence] by Molecular method |
|
72867-5
|
Mycobacterium tuberculosis gyrB gene fluoroquinolone resistance mutation [Presence] by Molecular method |
|
63072-3
|
Mycobacterium tuberculosis inhA gene isoniazid low level resistance mutation [Presence] by Molecular method |
|
48175-4
|
Mycobacterium tuberculosis katG + inhA gene isoniazid resistance mutation [Presence] by Molecular method |
|
89876-7
|
MTB complex rifAMPin and isoniazid resistance panel by Molecular genetics method |
|
33634-7
|
Mycobacterium tuberculosis rifAMPin resistance gene [Identifier] in Sputum by NAA with probe detection |
|
89372-7
|
Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation [Presence] by Molecular method |
|
72864-2
|
Mycobacterium tuberculosis rpsL+rrs genes aminoglycoside resistance mutation [Presence] by Molecular method |
|
38609-4
|
Methyl tert-butyl ether [Mass/volume] in Air |
|
18336-8
|
Methyl tert-butyl ether [Mass/volume] in Blood |
|
40346-9
|
MT-CO1 gene m.7445A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
2627-8
|
Methylenetetrahydrofolate dehydrogenase NAD [Enzymatic activity/volume] in Serum |
|
2628-6
|
Methylenetetrahydrofolate dehydrogenase NADP [Enzymatic activity/volume] in Serum |
|
35470-4
|
Mitochondria Genes deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
61108-7
|
Mitochondria DNA complex I targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
61114-5
|
Mitochondria DNA complex III targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
61115-2
|
Mitochondria DNA complex IV targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
34675-9
|
Mitochondria Genes targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
40995-3
|
Mitochondria Genes mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
61109-5
|
Mitochondria DNA complex V targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77079-2
|
MTFMT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77078-4
|
MTFMT gene full mutation analysis in Blood or Tissue by Sequencing |
|
28060-2
|
MTHFR gene c.1298A>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
28005-7
|
MTHFR gene c.677C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
74998-6
|
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Fibroblast |
|
21709-1
|
MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38415-6
|
MTHFR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
74984-6
|
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Lymphoblasts |
|
43723-6
|
5,10-Methylenetetrahydrofolate reductase [Presence] in Serum |
|
1691-5
|
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/volume] in Serum |
|
74999-4
|
5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/mass] in Leukocytes |
|
19748-3
|
Methyltetrahydrophthalic anhydride (MTHPA) IgE Ab [Units/volume] in Serum |
|
35122-1
|
MTM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41083-7
|
MTM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40354-3
|
MT-ND1 gene m.3460G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
48027-7
|
MT-ND4 gene c.G15257A [Presence] in Blood or Tissue by Molecular genetics method |
|
21705-9
|
MT-ND4 gene m.11696G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
40351-9
|
MT-ND4 gene m.11778G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
21707-5
|
MT-ND4 gene p.Thr109Ala [Presence] in Blood or Tissue by Molecular genetics method |
|
40352-7
|
MT-ND5 gene m.13513G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
74692-5
|
MT-ND6 gene m.14459G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
40353-5
|
MT-ND6 gene m.14484T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
79575-7
|
Metanephrine, Normetanephrine, 3-Methoxytyramine and Creatinine panel - 24 hour Urine |
|
72670-3
|
Metanephrine, Normetanephrine, 3-Methoxytyramine and Creatinine panel - Urine |
|
77054-5
|
MTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77053-7
|
MTR gene full mutation analysis in Blood or Tissue by Sequencing |
|
34678-3
|
MT-RNR1 gene m.1555A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
34490-3
|
MT-TK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41082-9
|
MT-TK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40343-6
|
MT-TK gene m.8296A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
21713-3
|
MT-TK gene m.8344A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
40345-1
|
MT-TK gene m.8356T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
40349-3
|
MT-TK gene m.8363G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
21714-1
|
MT-TL1 gene m.3243A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
40348-5
|
MT-TL1 gene m.3252T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
40347-7
|
MT-TL1 gene m.3256C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
40342-8
|
MT-TL1 gene m.3271T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
40350-1
|
MT-TL1 gene m.3291T>C [Presence] in Blood or Tissue by Molecular genetics method |
|
51599-9
|
Methotrexate [Moles/volume] in Serum or Plasma --12 hours post dose |
|
3794-5
|
Methotrexate [Mass/volume] in Serum or Plasma --1-2 weeks post dose |
|
3795-2
|
Methotrexate [Mass/volume] in Serum or Plasma --24 hours post dose |
|
51600-5
|
Methotrexate [Moles/volume] in Serum or Plasma --24 hours post dose |
|
3796-0
|
Methotrexate [Mass/volume] in Serum or Plasma --48 hours post dose |
|
51611-2
|
Methotrexate [Moles/volume] in Serum or Plasma --48 hours post dose |
|
51601-3
|
Methotrexate [Moles/volume] in Serum or Plasma --4 hours post dose |
|
3797-8
|
Methotrexate [Mass/volume] in Serum or Plasma --72 hours post dose |
|
51602-1
|
Methotrexate [Moles/volume] in Serum or Plasma --72 hours post dose |
|
3792-9
|
Methotrexate [Mass/volume] in Cerebral spinal fluid |
|
34628-8
|
Methotrexate [Moles/volume] in Cerebral spinal fluid |
|
34599-1
|
Methotrexate [Mass/volume] in Body fluid |
|
73283-4
|
Methotrexate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73282-6
|
Methotrexate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3793-7
|
Methotrexate [Mass/volume] in Serum or Plasma |
|
14836-1
|
Methotrexate [Moles/volume] in Serum or Plasma |
|
17266-8
|
Methotrexate [Mass/volume] in Urine |
|
81627-2
|
Methotrexate diglutamate [Moles/volume] in Red Blood Cells |
|
81626-4
|
Methotrexate triglutamate [Moles/volume] in Red Blood Cells |
|
81625-6
|
Methotrexate tetraglutamate [Moles/volume] in Red Blood Cells |
|
81624-9
|
Methotrexate pentaglutamate [Moles/volume] in Red Blood Cells |
|
81630-6
|
Methotrexate polyglutamates 1-5 and total panel - Red Blood Cells |
|
76351-6
|
Methotrexate polyglutamates [Moles/volume] in Red Blood Cells |
|
74126-4
|
Mucin-4 (MUC-4) Ag [Presence] in Tissue by Immune stain |
|
6909-6
|
Mucin clot [Appearance] in Synovial fluid Qualitative |
|
2637-7
|
Mucoprotein [Mass/volume] in Serum |
|
5248-0
|
Mucor sp Ab [Units/volume] in Serum |
|
7509-3
|
Mucor sp IgG Ab [Units/volume] in Serum |
|
42524-9
|
Mucus [Presence] in Stool by Light microscopy |
|
63458-4
|
Mugwort native (nArt v) 1 IgE Ab [Units/volume] in Serum |
|
65783-3
|
Mugwort native (nArt v) 3 IgE Ab [Units/volume] in Serum |
|
7510-1
|
Mugwort triggered histamine release [Units/volume] in Blood |
|
6183-8
|
Mugwort IgE Ab [Units/volume] in Serum |
|
39604-4
|
Mugwort IgE Ab/IgE total in Serum |
|
13188-8
|
Mugwort IgG Ab [Units/volume] in Serum |
|
56325-4
|
Mugwort IgG4 Ab [Mass/volume] in Serum |
|
63208-3
|
Mugwort IgG Ab [Mass/volume] in Serum |
|
48254-7
|
Mugwort triggered leukotriene release [Mass/volume] by Leukocytes |
|
88080-7
|
Multiple birth set identifier |
|
93022-2
|
Multiple myeloma minimal residual disease panel - Bone marrow by Flow cytometry (FC) |
|
84403-5
|
Multi-specialty program Case manager Note |
|
78252-4
|
Multi-specialty program Consult note |
|
68673-3
|
Multi-specialty program Diagnostic study note |
|
68674-1
|
Multi-specialty program Discharge summary |
|
78268-0
|
Multi-specialty program Education note |
|
78454-6
|
Multi-specialty program Flowsheet |
|
83866-4
|
Multi-specialty program Group counseling note |
|
68676-6
|
Multi-specialty program History and physical note |
|
68681-6
|
Multi-specialty program Hospital Consult note |
|
68682-4
|
Multi-specialty program Hospital Letter |
|
78336-5
|
Multi-specialty program Initial evaluation note |
|
68677-4
|
Multi-specialty program Note |
|
84333-4
|
Multi-specialty program Nurse Note |
|
84404-3
|
Multi-specialty program Telephone encounter Note |
|
80754-5
|
Multi-specialty program Plan of care note |
|
68678-2
|
Multi-specialty program Preoperative evaluation and management note |
|
68679-0
|
Multi-specialty program Progress note |
|
75445-7
|
Multi-specialty program Patient's home Note |
|
78331-6
|
Multi-specialty program Referral note |
|
90753-5
|
Multi-specialty program Social worker Note |
|
85888-6
|
Multi-specialty program Telehealth Note |
|
84069-4
|
Multi-specialty program Telehealth Summary note |
|
68680-8
|
Multi-specialty program Transfer summary note |
|
84070-2
|
Multi-specialty program Telehealth Plan of care note |
|
50325-0
|
MUM-1 Ag [Presence] in Tissue by Immune stain |
|
88458-5
|
Mumps virus Ab.IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
|
77398-6
|
Mumps virus IgG and IgM index panel - Serum |
|
7133-2
|
Mung Bean IgE Ab [Units/volume] in Serum |
|
7134-0
|
Mung Bean IgG Ab [Units/volume] in Serum |
|
48553-2
|
Muscle sarcolemma Ab [Units/volume] in Pleural fluid |
|
32702-3
|
Muscle sarcolemma Ab [Presence] in Serum |
|
5251-4
|
Muscle sarcolemma Ab [Units/volume] in Serum |
|
49626-5
|
Muscle sarcolemma Ab [Titer] in Pleural fluid by Immunofluorescence |
|
49627-3
|
Muscle sarcolemma Ab [Titer] in Serum by Immunofluorescence |
|
40562-1
|
Actin muscle specific Ag [Presence] in Tissue by Immune stain |
|
85364-8
|
Muscarinic acetylcholine receptor M3 Ab [Presence] in Serum |
|
65751-0
|
Muscle Pathology biopsy report |
|
46022-0
|
Musculoskeletal diseases or conditions Set |
|
7516-8
|
Mushroom triggered histamine release [Units/volume] in Blood |
|
20891-8
|
Mushroom identified |
|
6848-6
|
Mushroom IgE Ab [Units/volume] in Serum |
|
61209-3
|
Mushroom IgE Ab/IgE total in Serum |
|
7515-0
|
Mushroom IgG Ab [Units/volume] in Serum |
|
56326-2
|
Mushroom IgG4 Ab [Mass/volume] in Serum |
|
35540-4
|
Mushroom IgG Ab [Mass/volume] in Serum |
|
17294-0
|
Mushroom toxins [Identifier] in Urine |
|
57436-8
|
Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay |
|
38362-0
|
Muscle specific receptor tyrosine kinase Ab [Presence] in Serum |
|
51716-9
|
Muscle specific receptor tyrosine kinase Ab [Moles/volume] in Serum |
|
51763-1
|
Muscle specific receptor tyrosine kinase Ab [Titer] in Serum or Plasma |
|
63537-5
|
Muscle specific receptor tyrosine kinase IgG Ab [Mass/volume] in Serum by Immunoassay |
|
6185-3
|
Mustard IgE Ab [Units/volume] in Serum |
|
50350-8
|
Mustard IgE Ab/IgE total in Serum |
|
7521-8
|
Mustard IgG Ab [Units/volume] in Serum |
|
56328-8
|
Mustard IgG4 Ab [Mass/volume] in Serum |
|
60384-5
|
Mustard IgG Ab [Mass/volume] in Serum |
|
54022-9
|
Mutated citrullinated vimentin Ab [Units/volume] in Serum |
|
41081-1
|
MUTYH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40959-9
|
MUTYH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
17292-4
|
Mumps virus Ab [Units/volume] in Cerebral spinal fluid |
|
47412-2
|
Mumps virus Ab [Units/volume] in Serum by Immunoassay |
|
31503-6
|
Mumps virus Ab [Presence] in Serum |
|
26942-3
|
Mumps virus Ab [Presence] in Serum by Immunoassay |
|
7965-7
|
Mumps virus Ab [Units/volume] in Serum |
|
30146-5
|
Mumps virus Ab [Presence] in Serum --2nd specimen |
|
22413-9
|
Mumps virus Ab [Titer] in Cerebral spinal fluid |
|
9567-9
|
Mumps virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22414-7
|
Mumps virus Ab [Titer] in Serum |
|
5249-8
|
Mumps virus Ab [Titer] in Serum by Complement fixation |
|
5250-6
|
Mumps virus Ab [Titer] in Serum by Immunofluorescence |
|
31888-1
|
Mumps virus Ag [Presence] in Cerebral spinal fluid |
|
14545-8
|
Mumps virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31889-9
|
Mumps virus Ag [Presence] in Cervix |
|
14551-6
|
Mumps virus Ag [Presence] in Cervix by Immunofluorescence |
|
31890-7
|
Mumps virus Ag [Presence] in Eye |
|
14548-2
|
Mumps virus Ag [Presence] in Eye by Immunofluorescence |
|
67807-8
|
Mumps virus Ag [Presence] in Isolate by Immunofluorescence |
|
31892-3
|
Mumps virus Ag [Presence] in Nose |
|
14549-0
|
Mumps virus Ag [Presence] in Nose by Immunofluorescence |
|
31893-1
|
Mumps virus Ag [Presence] in Penis |
|
14554-0
|
Mumps virus Ag [Presence] in Penis by Immunofluorescence |
|
31894-9
|
Mumps virus Ag [Presence] in Serum |
|
6480-8
|
Mumps virus Ag [Presence] in Serum by Immunofluorescence |
|
31895-6
|
Mumps virus Ag [Presence] in Skin |
|
14547-4
|
Mumps virus Ag [Presence] in Skin by Immunofluorescence |
|
31896-4
|
Mumps virus Ag [Presence] in Sputum |
|
14550-8
|
Mumps virus Ag [Presence] in Sputum by Immunofluorescence |
|
31897-2
|
Mumps virus Ag [Presence] in Throat |
|
14546-6
|
Mumps virus Ag [Presence] in Throat by Immunofluorescence |
|
31898-0
|
Mumps virus Ag [Presence] in Urine sediment |
|
14553-2
|
Mumps virus Ag [Presence] in Urine sediment by Immunofluorescence |
|
31899-8
|
Mumps virus Ag [Presence] in Urethra |
|
14555-7
|
Mumps virus Ag [Presence] in Urethra by Immunofluorescence |
|
31891-5
|
Mumps virus Ag [Presence] in Vaginal fluid |
|
14552-4
|
Mumps virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
31900-4
|
Mumps virus Ag [Presence] in Unspecified specimen |
|
12237-4
|
Mumps virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
85807-6
|
Mumps virus genotype in Unspecified specimen |
|
39011-2
|
Mumps virus IgG Ab [Presence] in Cerebral spinal fluid |
|
40737-9
|
Mumps virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13266-2
|
Mumps virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
74422-7
|
Mumps virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29241-7
|
Mumps virus IgG Ab [Units/volume] in Body fluid |
|
25418-5
|
Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
22415-4
|
Mumps virus IgG Ab [Presence] in Serum |
|
6476-6
|
Mumps virus IgG Ab [Presence] in Serum by Immunoassay |
|
7966-5
|
Mumps virus IgG Ab [Units/volume] in Serum |
|
24240-4
|
Mumps virus IgG Ab [Units/volume] in Serum --1st specimen |
|
24241-2
|
Mumps virus IgG Ab [Units/volume] in Serum --2nd specimen |
|
22416-2
|
Mumps virus IgG Ab [Titer] in Cerebral spinal fluid |
|
21401-5
|
Mumps virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22417-0
|
Mumps virus IgG Ab [Titer] in Serum |
|
6477-4
|
Mumps virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
88454-4
|
Mumps virus IgG+IgM Ab [Interpretation] in Cerebral spinal fluid Qualitative by Immunofluorescence |
|
77250-9
|
Mumps virus IgG and IgM panel - Serum |
|
17293-2
|
Mumps virus IgG+IgM Ab [Units/volume] in Serum |
|
41131-4
|
Mumps virus IgM Ab [Presence] in Cerebral spinal fluid |
|
40738-7
|
Mumps virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13267-0
|
Mumps virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
74421-9
|
Mumps virus IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
69766-4
|
Mumps virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
25419-3
|
Mumps virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
22418-8
|
Mumps virus IgM Ab [Presence] in Serum |
|
6478-2
|
Mumps virus IgM Ab [Presence] in Serum by Immunoassay |
|
7967-3
|
Mumps virus IgM Ab [Units/volume] in Serum |
|
22419-6
|
Mumps virus IgM Ab [Titer] in Cerebral spinal fluid |
|
21402-3
|
Mumps virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22420-4
|
Mumps virus IgM Ab [Titer] in Serum |
|
6479-0
|
Mumps virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
93749-0
|
Mumps virus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
93750-8
|
Mumps virus RNA and N gene panel - Unspecified specimen |
|
85808-4
|
Mumps virus RNA and SH gene panel - Unspecified specimen by NAA with probe detection |
|
7968-1
|
Mumps virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
53603-7
|
Mumps virus RNA [Presence] in Serum by NAA with probe detection |
|
91806-0
|
Mumps virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
86580-8
|
Mumps virus RNA [Presence] in Urine by NAA with probe detection |
|
47532-7
|
Mumps virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31504-4
|
Mumps virus soluble Ab [Units/volume] in Cerebral spinal fluid |
|
31505-1
|
Mumps virus soluble Ab [Units/volume] in Serum |
|
31132-4
|
Mumps virus soluble Ab [Titer] in Cerebral spinal fluid |
|
31130-8
|
Mumps virus soluble Ab [Titer] in Serum |
|
91787-2
|
Mumps virus [Presence] in Upper respiratory specimen by Organism specific culture |
|
31506-9
|
Mumps virus particle-bound Ab [Units/volume] in Cerebral spinal fluid |
|
31507-7
|
Mumps virus particle-bound Ab [Units/volume] in Serum |
|
31133-2
|
Mumps virus particle-bound Ab [Titer] in Cerebral spinal fluid |
|
31131-6
|
Mumps virus particle-bound Ab [Titer] in Serum |
|
13921-2
|
Mumps virus [Presence] in Unspecified specimen by Organism specific culture |
|
81398-0
|
Mitral valve Maximum E-wave velocity/Flow propagation velocity.E wave by US.M-mode+doppler.A4C |
|
81397-2
|
Mitral valve lateral annulus Tissue velocity.A-wave.max by US.tissue doppler |
|
81396-4
|
Mitral valve medial annulus Tissue velocity.A-wave.max by US.tissue doppler |
|
81394-9
|
Mitral valve Regurgitant volume by US.doppler+Calculated by volumetric method |
|
81395-6
|
Mitral valve Regurgitant fraction by US.doppler+Calculated by volumetric method |
|
81121-6
|
Murray Valley encephalitis virus Ab [Presence] in Serum |
|
81115-8
|
Murray Valley encephalitis virus Ab [Titer] in Serum |
|
81111-7
|
Murray Valley encephalitis virus IgG Ab [Presence] in Serum |
|
81112-5
|
Murray Valley encephalitis virus IgG Ab [Titer] in Serum |
|
81113-3
|
Murray Valley encephalitis virus IgM Ab [Presence] in Serum |
|
81114-1
|
Murray Valley encephalitis virus IgM Ab [Titer] in Serum |
|
81651-2
|
Murray Valley encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47964-2
|
MVK gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21715-8
|
MXI1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
78245-8
|
MYB gene deletion [Presence] in Blood or Tissue by FISH |
|
81865-8
|
MYBPC3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
42794-8
|
MYC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21750-5
|
MYC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
78215-1
|
MYC gene rearrangements [Presence] in Blood or Tissue by FISH |
|
93796-1
|
MYCN gene amplification in Tissue by FISH |
|
90433-4
|
Mycobacterium preliminary growth [Presence] in Sputum by Organism specific culture |
|
90438-3
|
Mycobacterium preliminary growth [Presence] in Tissue by Organism specific culture |
|
614-8
|
Mycobacterial strain [Type] in Isolate by Mycobacterial subtyping |
|
29579-0
|
Mycobacterial susceptibility panel by Method for Slow-growing mycobacteria |
|
89486-5
|
Mycobacterial susceptibility panel Qualitative by Genotype method |
|
532-2
|
Mycobacterium sp identified in Aspirate by Organism specific culture |
|
76687-3
|
Mycobacterium sp identified in Bronchoalveolar lavage by Organism specific culture |
|
90284-1
|
Mycobacterium sp identified in Bile fluid by Organism specific culture |
|
533-0
|
Mycobacterium sp identified in Blood by Organism specific culture |
|
64412-0
|
Mycobacterium sp [Presence] in Blood by Organism specific culture |
|
9823-6
|
Mycobacterium sp identified in Bronchial specimen by Organism specific culture |
|
88167-2
|
Mycobacterium sp identified in Cornea or Conjunctiva by Organism specific culture |
|
534-8
|
Mycobacterium sp identified in Cerebral spinal fluid by Organism specific culture |
|
30045-9
|
Mycobacterium sp identified in Dialysis fluid by Organism specific culture |
|
21405-6
|
Mycobacterium sp DNA [Presence] in Bronchial specimen by NAA with probe detection |
|
14972-4
|
Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
14973-2
|
Mycobacterium sp DNA [Presence] in Sputum by NAA with probe detection |
|
23247-0
|
Mycobacterium sp DNA [Presence] in Tissue by NAA with probe detection |
|
30523-5
|
Mycobacterium sp DNA [Presence] in Urine by NAA with probe detection |
|
14974-0
|
Mycobacterium sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
535-5
|
Mycobacterium sp identified in Body fluid by Organism specific culture |
|
9824-4
|
Mycobacterium sp identified in Gastric fluid by Organism specific culture |
|
89637-3
|
Mycobacterium sp identified in Implanted device by Organism specific culture |
|
9825-1
|
Mycobacterium sp identified in Isolate |
|
88183-9
|
Mycobacterium sp identified in Isolate by Sequencing |
|
89636-5
|
Mycobacterium sp identified in Lower respiratory specimen by Organism specific culture |
|
536-3
|
Mycobacterium sp identified in Bone marrow by Organism specific culture |
|
88168-0
|
Mycobacterium sp identified in Ocular fluid by Organism specific culture |
|
53909-8
|
Mycobacterium sp identified in Pleural fluid by Organism specific culture |
|
537-1
|
Mycobacterium sp identified in Peritoneal fluid by Organism specific culture |
|
88266-2
|
Mycobacterium sp rRNA [Identifier] by Probe in Positive blood culture |
|
42716-1
|
Mycobacterium sp rRNA [Identifier] in Isolate by NAA with probe detection |
|
43854-9
|
Mycobacterium sp rRNA [Presence] in Unspecified specimen by Probe |
|
538-9
|
Mycobacterium sp identified in Synovial fluid by Organism specific culture |
|
539-7
|
Mycobacterium sp identified in Sputum by Organism specific culture |
|
540-5
|
Mycobacterium sp identified in Tissue by Organism specific culture |
|
541-3
|
Mycobacterium sp identified in Urine by Organism specific culture |
|
542-1
|
Mycobacterium sp identified in Wound by Organism specific culture |
|
40699-1
|
Mycobacterium sp identified in Unspecified specimen |
|
543-9
|
Mycobacterium sp identified in Unspecified specimen by Organism specific culture |
|
50941-4
|
Mycobacterium sp [Presence] in Unspecified specimen by Organism specific culture |
|
90306-2
|
Mycobacterium sp identified in Unspecified specimen by Sequencing |
|
7522-6
|
Mycogone sp IgE Ab [Units/volume] in Serum |
|
87432-1
|
Mycophenolate and mycophenolate glucuronide panel - Serum or Plasma |
|
72986-3
|
Mycophenolate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72985-5
|
Mycophenolate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80697-6
|
Mycophenolate acyl-glucuronide [Mass/volume] in Serum or Plasma |
|
73253-7
|
Mycophenolate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73252-9
|
Mycophenolate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73680-1
|
Mycophenolate [Mass/volume] in Serum or Plasma --peak |
|
55806-4
|
Mycophenolate [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
23905-3
|
Mycophenolate [Mass/volume] in Serum or Plasma |
|
70211-8
|
Mycophenolate [Moles/volume] in Serum or Plasma |
|
72667-9
|
Mycophenolate [Mass/volume] in Serum or Plasma --trough |
|
55807-2
|
Mycophenolate glucuronide [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
23906-1
|
Mycophenolate glucuronide [Mass/volume] in Serum or Plasma |
|
59836-7
|
Mycoplasma sp+Ureaplasma urealyticum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
14484-0
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Cervix by Organism specific culture |
|
14486-5
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Penis by Organism specific culture |
|
43107-2
|
Mycoplasma sp and Ureaplasma sp panel - Unspecified specimen by Organism specific culture |
|
20902-3
|
Mycoplasma sp+Ureaplasma sp [Presence] in Tissue by Organism specific culture |
|
14487-3
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Urethra by Organism specific culture |
|
14485-7
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Vaginal fluid by Organism specific culture |
|
687-4
|
Mycoplasma sp and Ureaplasma sp [Identifier] in Unspecified specimen by Organism specific culture |
|
55167-1
|
Mycoplasma sp Ab [Presence] in Cerebral spinal fluid |
|
22428-7
|
Mycoplasma sp Ab [Presence] in Serum |
|
23297-5
|
Mycoplasma sp Ab [Presence] in Serum by Complement fixation |
|
20900-7
|
Mycoplasma sp Ab [Presence] in Serum by Immunoassay |
|
31517-6
|
Mycoplasma sp Ab [Units/volume] in Serum |
|
23754-5
|
Mycoplasma sp Ab [Titer] in Serum |
|
20901-5
|
Mycoplasma sp Ag [Presence] in Isolate by Immune stain |
|
34883-9
|
Mycoplasma sp Ag [Presence] in Tissue by Immune stain |
|
23299-1
|
Mycoplasma sp Ag [Presence] in Unspecified specimen |
|
23298-3
|
Mycoplasma sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
46111-1
|
Mycoplasma sp DNA [Presence] in Body fluid by NAA with probe detection |
|
23301-5
|
Mycoplasma sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20899-1
|
Mycoplasma sp [Presence] in Exudate by Organism specific culture |
|
20898-3
|
Mycoplasma sp [Presence] in Milk by Organism specific culture |
|
23300-7
|
Mycoplasma sp rRNA [Presence] in Unspecified specimen by Probe |
|
20897-5
|
Mycoplasma sp serotype [Identifier] in Isolate |
|
90325-2
|
Mycoplasma suis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
20896-7
|
Mycoplasma sp [Presence] in Tissue by Culture NPIP (National Poultry Improvement Plan) |
|
49110-0
|
Mycoplasma sp identified in Urine by Organism specific culture |
|
40698-3
|
Mycoplasma sp identified in Unspecified specimen |
|
6486-5
|
Mycoplasma sp identified in Unspecified specimen by Organism specific culture |
|
34702-1
|
Mycoplasma sp [Presence] in Unspecified specimen by Hoechst stain |
|
20903-1
|
Mycotoxin identified in Feed |
|
82140-5
|
MYD88 gene p.Leu265Pro targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
63287-7
|
Myelin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63286-9
|
Myelin Ab [Presence] in Body fluid by Immunofluorescence |
|
72524-2
|
Myelin Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
90834-3
|
Myelin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
56629-9
|
Myelin Ab [Titer] in Serum by Immunofluorescence |
|
17305-4
|
Myelin IgA Ab [Presence] in Serum |
|
8079-6
|
Myelin IgA Ab [Units/volume] in Serum |
|
21407-2
|
Myelin IgA Ab [Titer] in Serum |
|
17306-2
|
Myelin IgG Ab [Presence] in Serum |
|
58011-8
|
Myelin IgG Ab [Presence] in Serum by Immunofluorescence |
|
8080-4
|
Myelin IgG Ab [Units/volume] in Serum |
|
21408-0
|
Myelin IgG Ab [Titer] in Serum |
|
17307-0
|
Myelin IgM Ab [Presence] in Serum |
|
8081-2
|
Myelin IgM Ab [Units/volume] in Serum |
|
21409-8
|
Myelin IgM Ab [Titer] in Serum |
|
66136-3
|
Myelocytes [#/volume] in Blood from Fetus by Manual count |
|
63397-4
|
Myeloperoxidase Ab [Presence] in Body fluid by Immunoassay |
|
63538-3
|
Myeloperoxidase Ab [Units/volume] in Body fluid |
|
46266-3
|
Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay |
|
17316-1
|
Myeloperoxidase Ab [Presence] in Serum |
|
29643-4
|
Myeloperoxidase Ab [Presence] in Serum by Immunoassay |
|
89507-8
|
Myeloperoxidase Ab [Presence] in Serum by Line blot |
|
6969-0
|
Myeloperoxidase Ab [Units/volume] in Serum |
|
51801-9
|
Myeloperoxidase Ab [Titer] in Serum by Immunofluorescence |
|
34959-7
|
Microscopic observation [Identifier] in Blood by Myeloperoxidase stain |
|
57435-0
|
Myeloperoxidase cells [Presence] in Body fluid |
|
42890-4
|
Myeloperoxidase cells/100 cells in Body fluid |
|
81771-8
|
Myeloperoxidase IgG Ab [Presence] in Serum by Immunoblot |
|
48404-8
|
Myeloperoxidase IgG Ab [Units/volume] in Serum |
|
81787-4
|
Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
72515-0
|
Myeloperoxidase IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
13510-3
|
Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain |
|
66853-3
|
Myeloperoxidase [Moles/volume] in Plasma |
|
48146-5
|
Myeloperoxidase [Units/volume] in Serum |
|
32817-9
|
Microscopic observation [Identifier] in Unspecified specimen by Myeloperoxidase stain |
|
81866-6
|
MYH7 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
49506-9
|
MYOC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
61009-7
|
Myocardial temperature |
|
30537-5
|
Myocardium Ab [Presence] in Serum |
|
42181-8
|
Myocardium Ab [Presence] in Serum by Immunofluorescence |
|
8083-8
|
Myocardium Ab [Units/volume] in Serum |
|
48554-0
|
Myocardium Ab [Titer] in Pleural fluid by Immunofluorescence |
|
5260-5
|
Myocardium Ab [Titer] in Serum by Immunofluorescence |
|
35277-3
|
Myocardium IgG Ab [Presence] in Serum |
|
56633-1
|
Myocardium IgG Ab [Titer] in Serum by Immunofluorescence |
|
47032-8
|
MyoD1 Ag [Presence] in Tissue by Immune stain |
|
47033-6
|
Myogenin Ag [Presence] in Tissue by Immune stain |
|
68960-4
|
Myoglobin [Presence] in 24 hour Urine |
|
32197-6
|
Myoglobin [Mass/volume] in 24 hour Urine |
|
2642-7
|
Myoglobin [Mass/time] in 24 hour Urine |
|
10505-6
|
Myoglobin Ag [Presence] in Tissue by Immune stain |
|
53833-0
|
Myoglobin [Mass/volume] in Blood |
|
85096-6
|
Myoglobin casts [Presence] in Urine sediment by Light microscopy |
|
83106-5
|
Myoglobin [Mass/volume] in Serum or Plasma by Immunoassay |
|
32331-1
|
Myoglobin [Presence] in Serum or Plasma |
|
2639-3
|
Myoglobin [Mass/volume] in Serum or Plasma |
|
56887-3
|
Myoglobin [Moles/volume] in Serum or Plasma |
|
2640-1
|
Myoglobin [Presence] in Urine |
|
2641-9
|
Myoglobin [Mass/volume] in Urine |
|
11147-6
|
Myoglobin/Creatinine [Mass Ratio] in Urine |
|
72458-3
|
Myosin Ab [Presence] in Serum or Plasma by Immunoblot |
|
75103-2
|
Myristate (C14:0) [Entitic substance] in Red Blood Cells |
|
47783-6
|
Myristate (C14:0)/Creatinine [Molar ratio] in Urine |
|
54341-3
|
Myristoleate (C14:1)/Creatinine [Molar ratio] in Urine |
|
23304-9
|
Myxoma virus Ab [Presence] in Serum |
|
23307-2
|
Myxoma virus Ab [Presence] in Serum by Complement fixation |
|
23303-1
|
Myxoma virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23309-8
|
Myxoma virus Ab [Presence] in Serum by Immunofluorescence |
|
23308-0
|
Myxoma virus Ab [Presence] in Serum by Neutralization test |
|
31523-4
|
Myxoma virus Ab [Units/volume] in Serum |
|
23305-6
|
Myxoma virus Ab [Titer] in Serum |
|
23306-4
|
Myxoma virus Ab [Titer] in Serum by Immunofluorescence |
|
23310-6
|
Myxoma virus Ag [Presence] in Skin by Immune diffusion (ID) |
|
31903-8
|
Myxoma virus Ag [Presence] in Unspecified specimen |
|
23311-4
|
Myxoma virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
92522-2
|
N Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92484-5
|
N Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1261-7
|
N Ag [Presence] on Red Blood Cells |
|
23756-0
|
Neospora caninum Ab [Units/volume] in Serum by Immunoassay |
|
22432-9
|
Neospora caninum Ab [Presence] in Serum |
|
15492-2
|
Neospora caninum Ab [Presence] in Serum by Immunoassay |
|
20904-9
|
Neospora caninum Ab [Presence] in Serum by Immunofluorescence |
|
31529-1
|
Neospora caninum Ab [Units/volume] in Serum |
|
23758-6
|
Neospora caninum Ab [Titer] in Serum |
|
23757-8
|
Neospora caninum Ab [Titer] in Serum by Immunofluorescence |
|
23760-2
|
Neospora caninum Ag [Presence] in Fixed tissue by Immune stain |
|
23759-4
|
Neospora caninum Ag [Presence] in Tissue by Immune stain |
|
7971-5
|
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid |
|
6625-8
|
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
6624-1
|
Naegleria fowleri Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
41444-1
|
Naegleria fowleri DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
87758-9
|
Naegleria fowleri DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
31525-9
|
Neisseria gonorrhoeae Ab [Units/volume] in Cerebral spinal fluid |
|
32704-9
|
Neisseria gonorrhoeae Ab [Presence] in Serum |
|
5261-3
|
Neisseria gonorrhoeae Ab [Units/volume] in Serum |
|
42987-8
|
Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid |
|
27021-5
|
Neisseria gonorrhoeae Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
22430-3
|
Neisseria gonorrhoeae Ab [Titer] in Serum |
|
9568-7
|
Neisseria gonorrhoeae Ab [Titer] in Serum by Complement fixation |
|
31905-3
|
Neisseria gonorrhoeae Ag [Presence] in Genital specimen |
|
6487-3
|
Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunoassay |
|
6488-1
|
Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunofluorescence |
|
6489-9
|
Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Latex agglutination |
|
6490-7
|
Neisseria gonorrhoeae Ag [Presence] in Urethra |
|
31906-1
|
Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen |
|
29311-8
|
Neisseria gonorrhoeae Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
14127-5
|
Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture |
|
91781-5
|
Neisseria gonorrhoeae [Presence] in Aspirate by Organism specific culture |
|
30099-6
|
Neisseria gonorrhoeae [Presence] in Conjunctival specimen by Organism specific culture |
|
688-2
|
Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture |
|
88224-1
|
Neisseria gonorrhoeae DNA [Presence] in Anorectal by NAA with probe detection |
|
21414-8
|
Neisseria gonorrhoeae DNA [Presence] in Cervical mucus by NAA with probe detection |
|
35735-0
|
Neisseria gonorrhoeae DNA [Presence] in Conjunctival specimen by NAA with probe detection |
|
47387-6
|
Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection |
|
57180-2
|
Neisseria gonorrhoeae DNA [Presence] in Nasopharynx by NAA with probe detection |
|
88225-8
|
Neisseria gonorrhoeae DNA [Presence] in Throat by NAA with probe detection |
|
21416-3
|
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection |
|
21415-5
|
Neisseria gonorrhoeae DNA [Presence] in Urethra by NAA with probe detection |
|
32705-6
|
Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by NAA with probe detection |
|
50326-8
|
Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
24111-7
|
Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43403-5
|
Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe with signal amplification |
|
690-8
|
Neisseria gonorrhoeae [Presence] in Endometrium by Organism specific culture |
|
692-4
|
Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture |
|
691-6
|
Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture |
|
53762-1
|
Neisseria gonorrhoeae IgG Ab [Titer] in Serum |
|
80368-4
|
Neisseria gonorrhoeae [Presence] in Rectum by Organism specific culture |
|
57458-2
|
Neisseria gonorrhoeae rRNA [Presence] in Anal by NAA with probe detection |
|
33904-4
|
Neisseria gonorrhoeae rRNA [Presence] in Conjunctival specimen by Probe |
|
50388-8
|
Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection |
|
32198-4
|
Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe |
|
57289-1
|
Neisseria gonorrhoeae rRNA [Presence] in Nasopharynx by NAA with probe detection |
|
80366-8
|
Neisseria gonorrhoeae rRNA [Presence] in Rectum by NAA with probe detection |
|
60255-7
|
Neisseria gonorrhoeae rRNA [Presence] in Throat by NAA with probe detection |
|
60256-5
|
Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection |
|
53927-0
|
Neisseria gonorrhoeae rRNA [Presence] in Urethra by NAA with probe detection |
|
32199-2
|
Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe |
|
53879-3
|
Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection |
|
50412-6
|
Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen from Donor by NAA with probe detection |
|
43305-2
|
Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5028-6
|
Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe |
|
694-0
|
Neisseria gonorrhoeae [Presence] in Semen by Organism specific culture |
|
695-7
|
Neisseria gonorrhoeae [Presence] in Synovial fluid by Organism specific culture |
|
696-5
|
Neisseria gonorrhoeae [Presence] in Throat by Organism specific culture |
|
697-3
|
Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture |
|
693-2
|
Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture |
|
698-1
|
Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture |
|
17322-9
|
Neisseria meningitidis Ab [Presence] in Serum |
|
17324-5
|
Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination |
|
6508-6
|
Neisseria meningitidis Ag [Presence] in Cerebral spinal fluid |
|
31911-1
|
Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid |
|
65763-5
|
Neisseria meningitidis Ag [Presence] in Tissue by Immune stain |
|
17323-7
|
Neisseria meningitidis Ag [Presence] in Urine |
|
31912-9
|
Neisseria meningitidis Ag [Presence] in Unspecified specimen |
|
6492-3
|
Neisseria meningitidis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
86581-6
|
Neisseria meningitidis [Presence] in Cerebral spinal fluid by Organism specific culture |
|
85779-7
|
Neisseria meningitidis DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
53606-0
|
Neisseria meningitidis DNA [Presence] in Blood by NAA with probe detection |
|
82185-0
|
Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
91803-7
|
Neisseria meningitidis DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
71788-4
|
Neisseria meningitidis DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
49671-1
|
Neisseria meningitidis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
44093-3
|
Neisseria meningitidis [Identifier] in Isolate by Organism specific culture |
|
17331-0
|
Neisseria meningitidis polyvalent Ab [Units/volume] in Serum |
|
17332-8
|
Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid |
|
6509-4
|
Neisseria meningitidis rRNA [Presence] in Cerebral spinal fluid by Probe |
|
5029-4
|
Neisseria meningitidis rRNA [Presence] in Unspecified specimen by Probe |
|
70172-2
|
Neisseria meningitidis serogroup [Identifier] in Unspecified specimen |
|
73702-3
|
Neisseria meningitidis serosubtype [Type] in Isolate by Immunoassay |
|
13271-2
|
Neisseria meningitidis serogroup A Ab [Units/volume] in Serum |
|
31907-9
|
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid |
|
6493-1
|
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
17326-0
|
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6494-9
|
Neisseria meningitidis serogroup A Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
31908-7
|
Neisseria meningitidis serogroup A Ag [Presence] in Unspecified specimen |
|
6495-6
|
Neisseria meningitidis serogroup A Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
30094-7
|
Neisseria meningitidis serogroup A Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74539-8
|
Neisseria meningitidis serogroup A DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
28546-0
|
Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
31526-7
|
Neisseria meningitidis serogroup A IgG Ab [Units/volume] in Serum |
|
42986-0
|
Neisseria meningitidis serogroup A IgG Ab [Mass/volume] in Serum |
|
86234-2
|
Neisseria meningitidis serogroup A sacB gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
59421-8
|
Neisseria meningitidis serogroups A+B+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
41845-9
|
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Agglutination |
|
41844-2
|
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Serum by Agglutination |
|
41846-7
|
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Urine by Agglutination |
|
78514-7
|
Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
31909-5
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid |
|
19133-8
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
33396-3
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum |
|
33397-1
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Serum by Latex agglutination |
|
32706-4
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine |
|
33398-9
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Urine by Latex agglutination |
|
31910-3
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Unspecified specimen |
|
19259-1
|
Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Unspecified specimen by Latex agglutination |
|
42341-8
|
Neisseria meningitidis serogroups A+w135 Ag [Presence] in Body fluid |
|
20487-5
|
Neisseria meningitidis serogroups A+Y Ag [Presence] in Cerebral spinal fluid |
|
17321-1
|
Neisseria meningitidis serogroups A+Y Ag [Presence] in Urine |
|
32848-4
|
Neisseria meningitidis serogroups A+Y Ag [Presence] in Unspecified specimen |
|
32851-8
|
Neisseria meningitidis serogroups A+Y Ag [Presence] in Unspecified specimen by Latex agglutination |
|
50607-1
|
Neisseria meningitidis serogroups Ag panel - Unspecified specimen by Latex agglutination |
|
17327-8
|
Neisseria meningitidis serogroup B Ab [Units/volume] in Serum |
|
24017-6
|
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid |
|
6496-4
|
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
6497-2
|
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6498-0
|
Neisseria meningitidis serogroup B Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
41503-4
|
Neisseria meningitidis serogroup B Ag [Presence] in Body fluid |
|
43430-8
|
Neisseria meningitidis serogroup B Ag [Presence] in Serum |
|
24018-4
|
Neisseria meningitidis serogroup B Ag [Presence] in Urine |
|
17328-6
|
Neisseria meningitidis serogroup B Ag [Presence] in Urine by Latex agglutination |
|
31913-7
|
Neisseria meningitidis serogroup B Ag [Presence] in Unspecified specimen |
|
30095-4
|
Neisseria meningitidis serogroup B Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74538-0
|
Neisseria meningitidis serogroup B DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86235-9
|
Neisseria meningitidis serogroup B synD gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
31914-5
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid |
|
19134-6
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
33399-7
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum |
|
33400-3
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Serum by Latex agglutination |
|
32707-2
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine |
|
33401-1
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Urine by Latex agglutination |
|
31915-2
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Unspecified specimen |
|
19260-9
|
Neisseria meningitidis serogroup B+Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
13272-0
|
Neisseria meningitidis serogroup C Ab [Units/volume] in Serum |
|
31916-0
|
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid |
|
6499-8
|
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
17329-4
|
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6500-3
|
Neisseria meningitidis serogroup C Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
31917-8
|
Neisseria meningitidis serogroup C Ag [Presence] in Unspecified specimen |
|
6501-1
|
Neisseria meningitidis serogroup C Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
30096-2
|
Neisseria meningitidis serogroup C Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74537-2
|
Neisseria meningitidis serogroup C DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
28547-8
|
Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum by Immunoassay |
|
31527-5
|
Neisseria meningitidis serogroup C IgG Ab [Units/volume] in Serum |
|
42985-2
|
Neisseria meningitidis serogroup C IgG Ab [Mass/volume] in Serum |
|
86236-7
|
Neisseria meningitidis serogroup C synE gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
19022-3
|
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Cerebral spinal fluid |
|
17325-2
|
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Urine |
|
32841-9
|
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Unspecified specimen |
|
32800-5
|
Neisseria meningitidis serogroups C+w135 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
85797-9
|
Neisseria meningitidis serogroup DNA panel - Unspecified specimen by NAA with probe detection |
|
39610-1
|
Neisseria meningitidis serogroup w135 Ab [Mass/volume] in Serum |
|
31918-6
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid |
|
6506-0
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6507-8
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
31919-4
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma |
|
17333-6
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Serum or Plasma by Latex agglutination |
|
31920-2
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Unspecified specimen |
|
30097-0
|
Neisseria meningitidis serogroup w135 Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74536-4
|
Neisseria meningitidis serogroup w135 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
60465-2
|
Neisseria meningitidis serogroup w135 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86237-5
|
Neisseria meningitidis serogroup w135 synG gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
74535-6
|
Neisseria meningitidis serogroup X DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
86238-3
|
Neisseria meningitidis serogroup X xcbB gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
39618-4
|
Neisseria meningitidis serogroup Y Ab [Mass/volume] in Serum |
|
22431-1
|
Neisseria meningitidis serogroup Y Ab [Titer] in Unspecified specimen |
|
6502-9
|
Neisseria meningitidis serogroup Y Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
7972-3
|
Neisseria meningitidis serogroup Y Ab [Presence] in Unspecified specimen |
|
31528-3
|
Neisseria meningitidis serogroup Y Ab [Units/volume] in Unspecified specimen |
|
17330-2
|
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid |
|
6503-7
|
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
6504-5
|
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
6505-2
|
Neisseria meningitidis serogroup Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
31921-0
|
Neisseria meningitidis serogroup Y Ag [Presence] in Unspecified specimen |
|
30098-8
|
Neisseria meningitidis serogroup Y Ag [Presence] in Unspecified specimen by Latex agglutination |
|
74534-9
|
Neisseria meningitidis serogroup Y DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
60466-0
|
Neisseria meningitidis serogroup Y IgG Ab [Mass/volume] in Serum by Immunoassay |
|
87958-5
|
Neisseria meningitidis [Presence] in Throat by Organism specific culture |
|
91788-0
|
Neisseria meningitidis [Presence] in Upper respiratory specimen by Organism specific culture |
|
16134-9
|
Neisseria meningitidis [Presence] in Unspecified specimen by Organism specific culture |
|
85628-6
|
Neisseria meningitidis sodC gene [Presence] in Unspecified specimen by NAA with probe detection |
|
7525-9
|
Nigrospora oryzae IgE Ab [Units/volume] in Serum |
|
6187-9
|
Neurospora sitophila IgE Ab [Units/volume] in Serum |
|
63171-3
|
Neurospora sitophila IgG Ab [Mass/volume] in Serum |
|
7526-7
|
Nigrospora sphaerica IgE Ab [Units/volume] in Serum |
|
90781-6
|
N,N'-dimethylarginine [Mass/volume] in Serum or Plasma |
|
80981-4
|
N,N-dimethylarginine [Mass/volume] in Serum or Plasma |
|
74363-3
|
N,N-dimethylarginine [Moles/volume] in Serum or Plasma |
|
50888-7
|
Nitrogen [Moles/time] in 24 hour Body fluid |
|
77358-0
|
Nitrogen [Mass/mass] in 24 hour Stool |
|
16141-4
|
Nitrogen [Mass/time] in 24 hour Stool |
|
77357-2
|
Nitrogen [Moles/mass] in 24 hour Stool |
|
53142-6
|
Nitrogen [Moles/time] in 24 hour Stool |
|
2660-9
|
Nitrogen [Mass/time] in 24 hour Urine |
|
50889-5
|
Nitrogen [Moles/volume] in 24 hour Urine |
|
40388-1
|
Nitrogen [Moles/time] in 24 hour Urine |
|
69424-0
|
Nitrogen [Mass/time] in 72 hour Stool |
|
53554-2
|
Nitrogen [Mass/volume] in Air |
|
18247-7
|
Nitrogen [Mass/volume] in Dialysis fluid |
|
76103-1
|
Nitrogen [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60921-4
|
Nitrogen [VFr/PPres] Airway adaptor --during inspiration |
|
76104-9
|
Nitrogen [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60920-6
|
Nitrogen [VFr/PPres] Airway adaptor --at end expiration |
|
2658-3
|
Nitrogen [Mass/volume] in Exhaled gas |
|
18246-9
|
Nitrogen [Mass/volume] in Stool |
|
47712-5
|
Nitrogen [Presence] in Sweat |
|
54352-0
|
Nitrogen [Mass/volume] in Urine |
|
2665-8
|
Nitrogen [Mass/time] in Urine |
|
79403-2
|
Nitrogen [Moles/volume] in Urine |
|
60919-8
|
Nitrogen [VFr/PPres] Airway adaptor |
|
76112-2
|
Nitrogen [VFr/PPres] Gas delivery system |
|
59714-6
|
Nitrous oxide [Mass/volume] in Blood |
|
60939-6
|
Nitrous oxide [VFr/PPres] Airway adaptor --during expiration |
|
60861-2
|
Nitrous oxide [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
62272-0
|
Nitrous oxide [VFr/PPres] Airway adaptor --during inspiration |
|
60862-0
|
Nitrous oxide [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60901-6
|
Nitrous oxide [VFr/PPres] Airway adaptor --at end expiration |
|
60775-4
|
Nitrous oxide gas delivered during case [Volume] from Gas delivery system |
|
61026-1
|
Nitrous oxide gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
59715-3
|
Nitrous oxide [Mass/volume] in Serum or Plasma |
|
60773-9
|
Gas delivery system inspiratory Nitrous oxide setting [VFr/PPres] |
|
62271-2
|
Nitrous oxide [VFr/PPres] Airway adaptor |
|
60860-4
|
Nitrous oxide [VFr/PPres] Gas delivery system |
|
49143-1
|
North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel |
|
49083-9
|
North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel |
|
59852-4
|
North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
|
78964-4
|
N-acetylaspartylglutamate [Moles/volume] in Cerebral spinal fluid |
|
12405-7
|
Nabumetone [Mass/volume] in Serum or Plasma |
|
74135-5
|
N-acetyl ezogabine [Mass/volume] in Plasma |
|
42233-7
|
Acetylcholine receptor ganglionic neuronal Ab [Moles/volume] in Serum |
|
34149-5
|
N-acetyl-L-aspartate [Moles/volume] in Amniotic fluid |
|
74922-6
|
N-acetyl-L-aspartate [Moles/volume] in Cerebral spinal fluid |
|
33212-2
|
N-acetyl-L-aspartate [Mass/volume] in Body fluid |
|
75080-2
|
N-acetyl-L-aspartate [Moles/volume] in Serum or Plasma |
|
33299-9
|
N-acetyl-L-aspartate [Presence] in Urine |
|
13779-4
|
N-acetyl-L-aspartate/Creatinine [Mass Ratio] in Urine |
|
76023-1
|
N-acetyl-L-aspartate/Creatinine [Molar ratio] in Urine |
|
2368-9
|
Glutamate dehydrogenase.NAD [Enzymatic activity/volume] in Serum or Plasma |
|
35497-7
|
NADH cytochrome C reductase [Enzymatic activity/mass] in Tissue |
|
74590-1
|
NADH cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
2651-8
|
NADH dehydrogenase [Enzymatic activity/volume] in Plasma |
|
2652-6
|
NADH dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
|
35496-9
|
NADH dehydrogenase [Enzymatic activity/mass] in Tissue |
|
79395-0
|
NADH:ubiquinone reductase [Enzymatic activity/mass] in Fibroblast |
|
79396-8
|
NADH:ubiquinone reductase [Enzymatic activity/mass] in Tissue |
|
3838-0
|
Nadolol [Mass/time] in 24 hour Urine |
|
12406-5
|
Nadolol [Mass/volume] in Serum or Plasma |
|
55556-5
|
Nadolol [Moles/volume] in Serum or Plasma |
|
3836-4
|
Nadolol [Presence] in Urine |
|
3837-2
|
Nadolol [Mass/volume] in Urine |
|
2369-7
|
Glutamate dehydrogenase.NADP [Enzymatic activity/volume] in Serum or Plasma |
|
10694-8
|
Naegleria sp identified in Tissue by Organism specific culture |
|
10695-5
|
Naegleria sp identified in Tissue by Wet preparation |
|
73251-1
|
Nafcillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73250-3
|
Nafcillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41704-8
|
Nafcillin [Susceptibility] by Gradient strip |
|
10993-4
|
Nafcillin [Mass/volume] in Serum or Plasma |
|
25232-0
|
Nafcillin [Mass/volume] in Unspecified specimen |
|
24097-8
|
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast |
|
2650-0
|
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/volume] in Serum |
|
34164-4
|
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Tissue |
|
24098-6
|
N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes |
|
53877-7
|
NAGS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
72283-5
|
Nail assessment panel |
|
3841-4
|
Nalbuphine [Mass/time] in 24 hour Urine |
|
17318-7
|
Nalbuphine [Mass/volume] in Serum or Plasma |
|
20551-8
|
Nalbuphine [Mass/volume] in Urine by Confirmatory method |
|
3839-8
|
Nalbuphine [Presence] in Urine |
|
16218-0
|
Nalbuphine [Presence] in Urine by Confirmatory method |
|
19605-5
|
Nalbuphine [Presence] in Urine by Screen method |
|
3840-6
|
Nalbuphine [Mass/volume] in Urine |
|
9777-4
|
Nalbuphine [Mass/volume] in Unspecified specimen |
|
17319-5
|
Nalidixate [Mass/volume] in Serum or Plasma |
|
25261-9
|
Nalidixate [Mass/volume] in Unspecified specimen |
|
3842-2
|
Nalorphine [Mass/volume] in Urine |
|
78862-0
|
Naloxol [Mass/volume] in Urine by Confirmatory method |
|
87807-4
|
Naloxone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
28061-0
|
Naloxone [Mass/volume] in Serum or Plasma |
|
77207-9
|
Naloxone [Mass/volume] in Urine by Confirmatory method |
|
92649-3
|
Naloxone [Presence] in Urine by Confirmatory method |
|
42618-9
|
Naloxone [Presence] in Urine by Screen method |
|
79377-8
|
Naltrexol [Mass/volume] in Urine by Confirmatory method |
|
87823-1
|
Naltrexone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87822-3
|
Naltrexone [Presence] in Saliva (oral fluid) by Screen method |
|
10994-2
|
Naltrexone [Mass/volume] in Serum or Plasma |
|
19610-5
|
Naltrexone [Mass/volume] in Urine by Confirmatory method |
|
12309-1
|
Naltrexone [Presence] in Urine |
|
18334-3
|
Naltrexone [Presence] in Urine by Confirmatory method |
|
19609-7
|
Naltrexone [Presence] in Urine by Screen method |
|
19611-3
|
Naltrexone [Mass/volume] in Urine |
|
72789-1
|
Naltrexone/Creatinine [Mass Ratio] in Urine |
|
87292-9
|
Name not yet chosen |
|
45965-1
|
Name Set |
|
45395-1
|
Name suffix |
|
3845-5
|
Nandrolone [Mass/time] in 24 hour Urine |
|
3843-0
|
Nandrolone [Presence] in Urine |
|
3844-8
|
Nandrolone [Mass/volume] in Urine |
|
60042-9
|
N-acetylprocainamide [Mass/volume] in Blood |
|
17806-1
|
N-acetylprocainamide [Mass/volume] in Body fluid |
|
3834-9
|
N-acetylprocainamide [Mass/volume] in Serum or Plasma |
|
14846-0
|
N-acetylprocainamide [Moles/volume] in Serum or Plasma |
|
17317-9
|
N-acetylprocainamide [Mass/volume] in Urine |
|
29369-6
|
N-acetylprocainamide/Procainamide [Mass Ratio] in Serum or Plasma |
|
38612-8
|
Naphthalene [Mass/volume] in Air |
|
12435-4
|
Naphthalene [Mass/volume] in Serum or Plasma |
|
12436-2
|
Naphthol [Mass/volume] in Serum or Plasma |
|
79232-5
|
Naphyrone [Mass/volume] in Urine by Confirmatory method |
|
59935-7
|
Naproxen [Moles/volume] in Gastric fluid |
|
56700-8
|
Naproxen IgE Ab [Units/volume] in Serum |
|
73249-5
|
Naproxen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73248-7
|
Naproxen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3846-3
|
Naproxen [Mass/volume] in Serum or Plasma |
|
50885-3
|
Naproxen [Moles/volume] in Serum or Plasma |
|
33300-5
|
Naproxen [Presence] in Urine by Screen method |
|
59934-0
|
Naproxen [Moles/volume] in Urine |
|
60319-1
|
Naproxen [Moles/volume] in Unspecified specimen |
|
87784-5
|
Naproxen/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
87570-8
|
Narasin [Mass/mass] in Unspecified specimen |
|
50027-2
|
Narcissus IgE Ab [Units/volume] in Serum |
|
38553-4
|
Narcolepsy associated Ag [Presence] in Serum or Plasma |
|
31088-8
|
Narcotics and opioids [Identifier] in Bile fluid |
|
29376-1
|
Narcotics and opioids [Identifier] in Blood |
|
29377-9
|
Narcotics and opioids [Identifier] in Gastric fluid |
|
12554-2
|
Narcotics and opioids [Identifier] in Urine |
|
77103-0
|
NARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77102-2
|
NARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
76010-8
|
Nasal temperature |
|
93691-4
|
Nonalcoholic steatohepatitis and fibrosis panel - Serum or Plasma |
|
60838-0
|
Nasopharyngeal temperature |
|
69581-7
|
National (USA) PFGE cluster code or CDC cluster [Identifier] in Isolate |
|
79514-6
|
N-acetyltyrosine [Moles/volume] in Serum or Plasma |
|
29632-7
|
N-acetyltyrosine [Presence] in Urine |
|
13780-2
|
N-acetyltyrosine/Creatinine [Mass Ratio] in Urine |
|
25119-9
|
N-acetyltyrosine/Creatinine [Molar ratio] in Urine |
|
90259-3
|
NAT2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
58012-6
|
Natalizumab Ab [Presence] in Serum |
|
49598-6
|
Natalizumab Ab [Presence] in Serum by Immunoassay |
|
49487-2
|
Nateglinide [Presence] in Serum or Plasma |
|
49702-4
|
Nateglinide [Mass/volume] in Serum or Plasma |
|
73690-0
|
Nateglinide [Mass/volume] in Urine |
|
53759-7
|
Natural killer cell panel - Blood by Flow cytometry (FC) |
|
93903-3
|
Healthcare navigator Discharge summary |
|
93901-7
|
Healthcare navigator Telephone encounter Note |
|
93902-5
|
Healthcare navigator Plan of care note |
|
93900-9
|
Healthcare navigator Progress note |
|
74128-0
|
Neuroblastoma 84 Ag [Presence] in Tissue by Immune stain |
|
77182-4
|
Niobium [Mass/volume] in Blood |
|
77181-6
|
Niobium [Moles/volume] in Blood |
|
21716-6
|
NB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
54111-0
|
Newborn hearing screening panel |
|
54108-6
|
Newborn hearing screen of Ear - left |
|
54109-4
|
Newborn hearing screen of Ear - right |
|
54078-1
|
Cystic fibrosis newborn screening panel |
|
54076-5
|
Endocrine newborn screening panel |
|
54075-7
|
Endocrine newborn screening panel (SI units) |
|
54079-9
|
Galactosemia newborn screening panel |
|
54080-7
|
Galactosemia newborn screening panel (SI units) |
|
54081-5
|
Hemoglobinopathies newborn screening panel |
|
54082-3
|
Infectious diseases newborn screening panel |
|
54090-6
|
Thyroid newborn screening panel |
|
54077-3
|
Thyroid newborn screening panel (SI units) |
|
54089-8
|
Newborn screening panel American Health Information Community (AHIC) |
|
77179-0
|
Niobium [Mass/mass] in Tissue |
|
77220-2
|
Niobium [Moles/mass] in Tissue |
|
77180-8
|
Niobium [Mass/volume] in Urine |
|
77183-2
|
Niobium [Moles/volume] in Urine |
|
77184-0
|
Niobium/Creatinine [Molar ratio] in Urine |
|
82515-8
|
NBN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
74001-9
|
NBOMe [Presence] in Urine by Screen method |
|
57717-1
|
Newborn screen card data panel |
|
73741-1
|
Newborn hearing screen panel of Ear - left |
|
73744-5
|
Newborn hearing screen panel of Ear - right |
|
57128-1
|
Newborn Screening Report summary panel |
|
73738-7
|
Newborn screening test results panel - Point of Care |
|
57794-0
|
Newborn screening test results panel - DBS |
|
32631-4
|
Nitroblue Tetrazolium Test (NBT) [Presence] in Blood |
|
50609-7
|
Nitroblue Tetrazolium Test (NBT) [Units/volume] in Blood |
|
48732-2
|
NCF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48728-0
|
NCF1+NCF2+CYBB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48733-0
|
NCF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
47966-7
|
NCF2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38712-6
|
N-nitrosodimethylamine [Mass/volume] in Air |
|
2094-1
|
Cholesterol.non-esterified [Mass/volume] in Serum or Plasma |
|
54373-6
|
Cholesterol.non-esterified [Moles/volume] in Serum or Plasma |
|
44704-5
|
NEB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82226-2
|
Neck Disability Index [NDI] |
|
88448-6
|
Necroinflammatory activity interpretation in Serum Qualitative |
|
7523-4
|
Nectarine IgE Ab [Units/volume] in Serum |
|
7524-2
|
Nectarine IgG Ab [Units/volume] in Serum |
|
56329-6
|
Nectarine IgG4 Ab [Mass/volume] in Serum |
|
63102-8
|
Nectarine IgG Ab [Mass/volume] in Serum |
|
1769-9
|
Fatty acids.nonesterified [Mass/volume] in Serum or Plasma |
|
15066-4
|
Fatty acids.nonesterified [Moles/volume] in Serum or Plasma |
|
12544-3
|
Nefazodone [Mass/volume] in Serum or Plasma |
|
25484-7
|
Nefazodone [Moles/volume] in Serum or Plasma |
|
75231-1
|
Nefazodone [Presence] in Urine |
|
17320-3
|
Nefazodone [Mass/volume] in Urine |
|
41079-5
|
NEFL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34740-1
|
NEFL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
6673-8
|
Microscopic observation [Identifier] in Tissue by Neisser stain |
|
672-6
|
Microscopic observation [Identifier] in Unspecified specimen by Neisser stain |
|
43386-2
|
Neisseria sp identified in Anal by Organism specific culture |
|
43385-4
|
Neisseria sp identified in Cervix by Organism specific culture |
|
80369-2
|
Neisseria sp identified in Rectum by Organism specific culture |
|
43383-9
|
Neisseria sp identified in Throat by Organism specific culture |
|
43384-7
|
Neisseria sp identified in Urethra by Organism specific culture |
|
43387-0
|
Neisseria sp identified in Unspecified specimen by Organism specific culture |
|
35113-0
|
Nelfinavir M8 [Mass/volume] in Serum or Plasma |
|
51923-1
|
Nelfinavir [Mass/volume] in Serum or Plasma --peak |
|
29120-3
|
Nelfinavir [Units/volume] in Serum or Plasma |
|
32647-0
|
Nelfinavir [Mass/volume] in Serum or Plasma |
|
3620-2
|
N-ethylnicotinamide [Mass/volume] in Urine |
|
78386-0
|
Neonatal perinatal medicine Admission history and physical note |
|
78405-8
|
Neonatal perinatal medicine Consult note |
|
78410-8
|
Neonatal perinatal medicine Discharge instructions |
|
78418-1
|
Neonatal perinatal medicine Discharge summary |
|
78422-3
|
Neonatal perinatal medicine Discharge teaching note |
|
78429-8
|
Neonatal perinatal medicine Education note |
|
78455-3
|
Neonatal perinatal medicine Flowsheet |
|
68683-2
|
Neonatal perinatal medicine History and physical note |
|
68685-7
|
Neonatal perinatal medicine Hospital Consult note |
|
68686-5
|
Neonatal perinatal medicine Hospital Letter |
|
78467-8
|
Neonatal perinatal medicine Initial evaluation note |
|
68684-0
|
Neonatal perinatal medicine Letter |
|
85438-0
|
Neonatal perinatal medicine Note |
|
89880-9
|
Neonatal perinatal medicine Outpatient Note |
|
80760-2
|
Neonatal perinatal medicine Plan of care note |
|
78473-6
|
Neonatal perinatal medicine procedure note |
|
78479-3
|
Neonatal perinatal medicine Progress note |
|
78483-5
|
Neonatal perinatal medicine Referral note |
|
89894-0
|
Neonatal perinatal medicine Telehealth Note |
|
78489-2
|
Neonatal perinatal medicine Transfer summary note |
|
58903-6
|
Neomycin IgE Ab [Units/volume] in Serum |
|
10995-9
|
Neomycin [Mass/volume] in Serum or Plasma |
|
25262-7
|
Neomycin [Mass/volume] in Unspecified specimen |
|
50189-0
|
Neonatal bilirubin panel [Mass/volume] - Serum or Plasma |
|
29750-7
|
Neonatal intensive care records |
|
73790-8
|
Neonatal skin risk assessment scale panel [NSRAS] |
|
55945-0
|
Neopterin [Moles/volume] in 24 hour Urine |
|
55944-3
|
Neopterin [Moles/time] in 24 hour Urine |
|
34146-1
|
Neopterin [Moles/volume] in Cerebral spinal fluid |
|
34908-4
|
Neopterin [Mass/volume] in Serum or Plasma |
|
35259-1
|
Neopterin [Mass or Moles/volume] in Serum or Plasma |
|
3847-1
|
Neopterin [Mass/volume] in Urine |
|
55946-8
|
Neopterin [Moles/volume] in Urine |
|
17334-4
|
Neopterin/Creatinine [Mass Ratio] in Urine |
|
47711-7
|
Neopterin/Creatinine [Molar ratio] in Urine |
|
48874-2
|
Neorickettsia sp [Presence] in Unspecified specimen by Organism specific culture |
|
17335-1
|
Neostigmine [Mass/volume] in Serum or Plasma |
|
78387-8
|
Nephrology Admission history and physical note |
|
83687-4
|
Nephrology Attending Note |
|
34795-5
|
Nephrology Consult note |
|
93962-9
|
Nephrology Diagnostic study note |
|
78411-6
|
Nephrology Discharge instructions |
|
78419-9
|
Nephrology Discharge summary |
|
78423-1
|
Nephrology Discharge teaching note |
|
78430-6
|
Nephrology Education note |
|
83741-9
|
Nephrology Fellow Note |
|
78456-1
|
Nephrology Flowsheet |
|
78463-7
|
Nephrology History and physical note |
|
84220-3
|
Nephrology Hospital Note |
|
84221-1
|
Nephrology Hospital Transfer summary note |
|
78468-6
|
Nephrology Initial evaluation note |
|
34796-3
|
Nephrology Note |
|
83548-8
|
Nephrology Nurse practitioner Note |
|
83583-5
|
Nephrology Nurse Note |
|
83584-3
|
Nephrology Nurse Outpatient Note |
|
84222-9
|
Nephrology Outpatient Note |
|
84224-5
|
Nephrology Telephone encounter Note |
|
80755-2
|
Nephrology Plan of care note |
|
78474-4
|
Nephrology procedure note |
|
78480-1
|
Nephrology Progress note |
|
84219-5
|
Nephrology Patient's home Note |
|
57144-8
|
Nephrology Referral note |
|
83762-5
|
Nephrology Resident Note |
|
84223-7
|
Nephrology Team Note |
|
89032-7
|
Nephrology Telehealth Consult note |
|
89898-1
|
Nephrology Telehealth Note |
|
78490-0
|
Nephrology Transfer summary note |
|
29755-6
|
Nerve conduction study |
|
75098-4
|
Nervonate (C24:1) [Entitic substance] in Red Blood Cells |
|
54942-8
|
N-ethyldiethanolamine [Mass/volume] in Urine |
|
3848-9
|
Netilmicin [Mass/volume] in Serum or Plasma --peak |
|
59567-8
|
Netilmicin [Moles/volume] in Serum or Plasma --peak |
|
3849-7
|
Netilmicin [Mass/volume] in Serum or Plasma --random |
|
47385-0
|
Netilmicin [Mass/volume] in Serum or Plasma |
|
59566-0
|
Netilmicin [Moles/volume] in Serum or Plasma |
|
3850-5
|
Netilmicin [Mass/volume] in Serum or Plasma --trough |
|
59565-2
|
Netilmicin [Moles/volume] in Serum or Plasma --trough |
|
25263-5
|
Netilmicin [Mass/volume] in Unspecified specimen |
|
6186-1
|
Nettle IgE Ab [Units/volume] in Serum |
|
58033-2
|
Nettle IgE Ab/IgE total in Serum |
|
13185-4
|
Nettle IgG Ab [Units/volume] in Serum |
|
56330-4
|
Nettle IgG4 Ab [Mass/volume] in Serum |
|
63191-1
|
Nettle IgG Ab [Mass/volume] in Serum |
|
50327-6
|
Neu-N Ag [Presence] in Tissue by Immune stain |
|
83585-0
|
Neurology Nurse Note |
|
83586-8
|
Neurology Nurse Outpatient Note |
|
83659-3
|
Neurological surgery Attending Admission evaluation note |
|
83660-1
|
Neurological surgery Attending Note |
|
83661-9
|
Neurological surgery Attending Preoperative evaluation and management note |
|
83549-6
|
Neurological surgery Nurse practitioner Note |
|
83602-3
|
Neurological surgery Nurse Note |
|
83764-1
|
Neurological surgery Resident Note |
|
89810-6
|
Neurological surgery Team Conference note |
|
84235-1
|
Neurological surgery Admission evaluation note |
|
78388-6
|
Neurological surgery Admission history and physical note |
|
78449-6
|
Neurological surgery Checklist |
|
34798-9
|
Neurological surgery Consult note |
|
68687-3
|
Neurological surgery Diagnostic study note |
|
68688-1
|
Neurological surgery Discharge summary |
|
78431-4
|
Neurological surgery Education note |
|
78457-9
|
Neurological surgery Flowsheet |
|
68690-7
|
Neurological surgery History and physical note |
|
68694-9
|
Neurological surgery Hospital Consult note |
|
68695-6
|
Neurological surgery Hospital Letter |
|
84236-9
|
Neurological surgery Hospital Note |
|
82830-1
|
Neurological surgery Initial evaluation note |
|
34799-7
|
Neurological surgery Note |
|
84237-7
|
Neurological surgery Outpatient Note |
|
78487-6
|
Neurological surgery Surgical operation note |
|
84239-3
|
Neurological surgery Telephone encounter Note |
|
80756-0
|
Neurological surgery Plan of care note |
|
84238-5
|
Neurological surgery Postoperative evaluation and management note |
|
68691-5
|
Neurological surgery Preoperative evaluation and management note |
|
68692-3
|
Neurological surgery procedure note |
|
68693-1
|
Neurological surgery Progress note |
|
57146-3
|
Neurological surgery Referral note |
|
78492-6
|
Neurological surgery Transfer summary note |
|
47034-4
|
Neurofilament Ag [Presence] in Tissue by Immune stain |
|
21417-1
|
Neurokinin A [Units/volume] in Serum or Plasma |
|
49728-9
|
Neurokinin A [Mass/volume] in Serum or Plasma |
|
46023-8
|
Neurological diseases or conditions Set |
|
84225-2
|
Neurology Administrative note |
|
84226-0
|
Neurology Admission evaluation note |
|
78389-4
|
Neurology Admission history and physical note |
|
83688-2
|
Neurology Attending Admission evaluation note |
|
83689-0
|
Neurology Attending Note |
|
34797-1
|
Neurology Consult note |
|
68556-0
|
Neurology Diagnostic study note |
|
78412-4
|
Neurology Discharge instructions |
|
78420-7
|
Neurology Discharge summary |
|
78424-9
|
Neurology Discharge teaching note |
|
78432-2
|
Neurology Education note |
|
78458-7
|
Neurology Flowsheet |
|
78464-5
|
Neurology History and physical note |
|
84227-8
|
Neurology Hospital Note |
|
84228-6
|
Neurology Hospital Transfer summary note |
|
78469-4
|
Neurology Initial evaluation note |
|
34905-0
|
Neurology Note |
|
84229-4
|
Neurology Outpatient Note |
|
84234-4
|
Neurology Telephone encounter Note |
|
80761-0
|
Neurology Plan of care note |
|
78475-1
|
Neurology procedure note |
|
75221-2
|
Neurology Progress note |
|
57145-5
|
Neurology Referral note |
|
83763-3
|
Neurology Resident Note |
|
76641-0
|
Neurology Study report |
|
84230-2
|
Neurology Team Note |
|
84231-0
|
Neurology Telehealth Consult note |
|
84233-6
|
Neurology Telehealth Initial evaluation note |
|
84232-8
|
Neurology Telehealth Note |
|
78491-8
|
Neurology Transfer summary note |
|
17339-3
|
Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
31531-7
|
Neuronal Ab [Presence] in Cerebral spinal fluid |
|
17337-7
|
Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31530-9
|
Neuronal Ab [Units/volume] in Cerebral spinal fluid |
|
32853-4
|
Neuronal Ab [Units/volume] in Serum by Immunoassay |
|
17338-5
|
Neuronal Ab [Units/volume] in Serum by Immunofluorescence |
|
31533-3
|
Neuronal Ab [Presence] in Serum |
|
17336-9
|
Neuronal Ab [Presence] in Serum by Immunofluorescence |
|
31532-5
|
Neuronal Ab [Units/volume] in Serum |
|
31534-1
|
Neuronal IgG Ab [Presence] in Body fluid |
|
17340-1
|
Neuronal IgG Ab [Presence] in Body fluid by Immunoassay |
|
33418-5
|
Neuronal IgG Ab [Presence] in Serum |
|
28560-1
|
Neuronal thread protein [Mass/volume] in Cerebral spinal fluid |
|
49866-7
|
Neuropeptide Y [Mass/volume] in Serum |
|
2654-2
|
Neurophysin [Mass/volume] in Serum or Plasma |
|
85890-2
|
Neuropsychology Consult note |
|
85878-7
|
Neuropsychology Discharge summary |
|
85877-9
|
Neuropsychology Initial evaluation note |
|
85876-1
|
Neuropsychology Note |
|
2655-9
|
Neurotensin [Mass/volume] in Plasma |
|
34971-2
|
Neutrophil associated Ab [Presence] in Blood |
|
24382-4
|
Neutrophil associated Ab [Identifier] in Serum |
|
93354-9
|
Neutrophil CD64 and Monocyte HLA DR panel - Blood by Flow cytometry (FC) |
|
85376-2
|
Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Blood by Flow cytometry (FC) |
|
85377-0
|
Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total in Control Blood by Flow cytometry (FC) |
|
85373-9
|
Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Blood by Flow cytometry (FC) |
|
85372-1
|
Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total in Control Blood by Flow cytometry (FC) |
|
85370-5
|
Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Blood by Flow cytometry (FC) |
|
85371-3
|
Neutrophil.fMLP stimulated.DHR mean fluorescence intensity in Control Blood by Flow cytometry (FC) |
|
85374-7
|
Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Blood by Flow cytometry (FC) |
|
85375-4
|
Neutrophil.PMA stimulated.DHR mean fluorescence instensity in Control Blood by Flow cytometry (FC) |
|
42666-8
|
Fat.neutral [#/area] in Pleural fluid by Microscopy high power field |
|
42674-2
|
Fat.neutral [#/area] in Urine by Microscopy high power field |
|
12598-9
|
Fat.neutral [Presence] in Stool |
|
59025-7
|
Neutrophil Ab [Units/volume] in Serum by Flow cytometry (FC) |
|
45150-0
|
Neutrophil Ab [Units/volume] in Serum by Immunoassay |
|
17347-6
|
Neutrophil Ab [Units/volume] in Serum by Immunofluorescence |
|
21418-9
|
Neutrophil Ab [Presence] in Serum |
|
41617-2
|
Neutrophil Ab [Presence] in Serum by Flow cytometry (FC) |
|
39587-1
|
Neutrophil Ab [Presence] in Serum by Immunoassay |
|
17346-8
|
Neutrophil Ab [Presence] in Serum by Immunofluorescence |
|
5171-4
|
Neutrophil Ab [Units/volume] in Serum |
|
17348-4
|
Neutrophil IgA Ab [Units/volume] in Serum |
|
17349-2
|
Neutrophil IgG Ab [Units/volume] in Serum |
|
73077-0
|
Neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17350-0
|
Neutrophil IgM Ab [Units/volume] in Serum |
|
73076-2
|
Neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
85365-5
|
Neutrophil membrane Ab [Presence] in Serum by Immunofluorescence |
|
85367-1
|
Neutrophil membrane IgG Ab [Presence] in Serum by Immunofluorescence |
|
85366-3
|
Neutrophil membrane IgM Ab [Presence] in Serum by Immunofluorescence |
|
43292-2
|
Neutrophil oxidative burst/unstimulated in Blood |
|
30903-9
|
Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC) |
|
72905-3
|
Neutrophil Ab and HLA Ab screen panel - Serum or Plasma |
|
66139-7
|
Neutrophils [#/volume] in Blood from Fetus by Manual count |
|
85369-7
|
Neutrophils [#/volume] in Control Blood by Flow cytometry (FC) |
|
68425-8
|
Neutrophils [#/volume] in Pericardial fluid by Manual count |
|
72347-8
|
Neutrophils [#/volume] in Prostatic fluid by Manual count |
|
68427-4
|
Neutrophils [#/volume] in Vitreous fluid by Manual count |
|
48048-3
|
Neutrophils [Presence] in Nose by Wright stain |
|
48050-9
|
Neutrophils [Presence] in Stool by Wright stain |
|
68426-6
|
Neutrophils/100 leukocytes in Vitreous fluid by Manual count |
|
66138-9
|
Band form neutrophils [#/volume] in Blood from Fetus by Manual count |
|
51925-6
|
Nevirapine [Mass/volume] in Serum or Plasma --peak |
|
29121-1
|
Nevirapine [Units/volume] in Serum or Plasma |
|
32646-2
|
Nevirapine [Mass/volume] in Serum or Plasma |
|
48299-2
|
New coccine triggered leukotriene release [Mass/volume] by Leukocytes |
|
92015-7
|
Newborn administrative information |
|
45331-6
|
NF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
21717-4
|
NF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
45332-4
|
NF2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
78969-3
|
Neurofilament heavy chain Ab [Mass/volume] in Cerebral spinal fluid |
|
78965-1
|
Neurofilament medium chain Ab [Mass/volume] in Cerebral spinal fluid |
|
74103-3
|
Neutrophil gelatinase-associated lipocalin [Mass/volume] in Serum or Plasma by Rapid immunoassay |
|
74099-3
|
Neutrophil gelatinase-associated lipocalin [Mass/volume] in Urine by Rapid immunoassay |
|
75619-7
|
National Health Care Surveys report |
|
2656-7
|
Niacin [Mass/time] in 24 hour Urine |
|
10836-5
|
Niacin [Mass/volume] in Blood |
|
79402-4
|
Niacin [Moles/volume] in Blood |
|
18244-4
|
Niacin [Mass/volume] in Serum or Plasma |
|
34342-6
|
Niacin [Moles/volume] in Serum or Plasma |
|
73247-9
|
Niacin+Lovastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73246-1
|
Niacin+Lovastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
51986-8
|
niCARdipine [Presence] in Serum or Plasma |
|
30933-6
|
Nickel [Mass/volume] in Urine collected for unspecified duration |
|
5703-4
|
Nickel [Mass/time] in 24 hour Stool |
|
29936-2
|
Nickel [Mass/volume] in 24 hour Urine |
|
5705-9
|
Nickel [Mass/time] in 24 hour Urine |
|
25961-4
|
Nickel [Moles/volume] in 24 hour Urine |
|
25487-0
|
Nickel [Moles/time] in 24 hour Urine |
|
5700-0
|
Nickel [Mass/volume] in Blood |
|
25169-4
|
Nickel [Moles/volume] in Blood |
|
51200-4
|
Nickel [Mass/volume] in Body fluid |
|
5701-8
|
Nickel [Mass/mass] in Hair |
|
47123-5
|
Nickel [Moles/mass] in Hair |
|
12780-3
|
Nickel [Mass/volume] in Red Blood Cells |
|
50887-9
|
Nickel [Moles/volume] in Red Blood Cells |
|
8207-3
|
Nickel [Mass/volume] in Saliva (oral fluid) |
|
5702-6
|
Nickel [Mass/volume] in Serum or Plasma |
|
25486-2
|
Nickel [Moles/volume] in Serum or Plasma |
|
50886-1
|
Nickel [Moles/mass] in Tissue |
|
5704-2
|
Nickel [Presence] in Urine |
|
14099-6
|
Nickel [Mass/volume] in Urine |
|
12779-5
|
Nickel [Mass/time] in Urine |
|
34343-4
|
Nickel [Moles/volume] in Urine |
|
13649-9
|
Nickel [Mass/volume] in Water |
|
18245-1
|
Nickel [Mass/volume] in Unspecified specimen |
|
42001-8
|
Nickel/Creatinine [Mass Ratio] in 24 hour Urine |
|
25962-2
|
Nickel/Creatinine [Molar ratio] in 24 hour Urine |
|
13472-6
|
Nickel/Creatinine [Mass Ratio] in Urine |
|
56654-7
|
Nickel/Creatinine [Ratio] in Urine |
|
52926-3
|
Nickel/Creatinine [Molar ratio] in Urine |
|
52462-9
|
Nickname |
|
27339-1
|
Nicotinamide [Presence] in Blood |
|
56961-6
|
Nicotinamide [Mass/volume] in Serum or Plasma |
|
25488-8
|
Nicotinamide [Moles/volume] in Serum or Plasma |
|
17362-5
|
Nicotinamide [Presence] in Urine |
|
3852-1
|
Nicotinamide [Mass/volume] in Urine |
|
90226-2
|
Nicotine and Cotinine panel - Serum or Plasma |
|
40387-3
|
Nicotine [Presence] in Gastric fluid |
|
59937-3
|
Nicotine [Moles/volume] in Gastric fluid |
|
40386-5
|
Nicotine [Presence] in Hair |
|
80541-6
|
Nicotine [Mass/mass] in Hair |
|
40385-7
|
Nicotine [Presence] in Meconium |
|
55558-1
|
Nicotine [Moles/volume] in Serum or Plasma by Screen method |
|
3853-9
|
Nicotine [Mass/volume] in Serum or Plasma |
|
55557-3
|
Nicotine [Moles/volume] in Serum or Plasma |
|
12294-5
|
Nicotine [Presence] in Urine |
|
43195-7
|
Nicotine [Presence] in Urine by Confirmatory method |
|
3854-7
|
Nicotine [Mass/volume] in Urine |
|
59936-5
|
Nicotine [Moles/volume] in Urine |
|
43830-9
|
Nicotine [Presence] in Unspecified specimen |
|
87596-3
|
Nicotine [Mass/mass] in Unspecified specimen |
|
60320-9
|
Nicotine [Moles/volume] in Unspecified specimen |
|
43218-7
|
Nicotine+Cotinine [Presence] in Urine |
|
28555-1
|
Nicotine+Cotinine [Presence] in Urine by Confirmatory method |
|
43125-4
|
Nicotine and Metabolites panel [Mass/volume] - Urine |
|
72306-4
|
Nicotinurate [Mass/volume] in Serum or Plasma |
|
43594-1
|
Nidus [Mass] in Stone |
|
62315-7
|
Niemann Pick disease A/B newborn screening panel |
|
73245-3
|
NIFEdipine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73244-6
|
NIFEdipine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9386-4
|
NIFEdipine [Mass/volume] in Serum or Plasma |
|
10637-7
|
Microscopic observation [Identifier] in Tissue by Night blue stain |
|
3857-0
|
Nikethamide [Mass/time] in 24 hour Urine |
|
3855-4
|
Nikethamide [Presence] in Urine |
|
3856-2
|
Nikethamide [Mass/volume] in Urine |
|
92901-8
|
Noninvasive prenatal fetal aneuploidy and microdeletion panel - Plasma cell-free DNA by Sequencing |
|
75547-0
|
Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
|
38907-2
|
NIPA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81884-9
|
NIPA1 and REEP1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
40428-5
|
NIPBL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41078-7
|
NIPBL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
12538-5
|
Nitrate [Mass/volume] in Blood |
|
32030-9
|
Nitrate [Presence] in Urine |
|
21420-5
|
Nitrate [Mass/volume] in Urine |
|
74100-9
|
Nitrate+Nitrite [Moles/volume] in Serum or Plasma |
|
23762-8
|
Nitrate+Nitrite [Mass/volume] in Unspecified specimen |
|
76493-6
|
Nitrazepam [Moles/volume] in Gastric fluid |
|
17363-3
|
Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3858-8
|
Nitrazepam [Mass/volume] in Serum or Plasma |
|
14849-4
|
Nitrazepam [Moles/volume] in Serum or Plasma |
|
72666-1
|
Nitrazepam [Mass/volume] in Serum or Plasma --trough |
|
20552-6
|
Nitrazepam [Mass/volume] in Urine by Confirmatory method |
|
19621-2
|
Nitrazepam [Presence] in Urine by Confirmatory method |
|
19620-4
|
Nitrazepam [Presence] in Urine by Screen method |
|
3859-6
|
Nitrazepam [Mass/volume] in Urine |
|
14850-2
|
Nitrazepam [Moles/volume] in Urine |
|
55947-6
|
Nitrite [Mass/volume] in Dialysis fluid |
|
55948-4
|
Nitrite [Moles/volume] in Serum or Plasma |
|
32710-6
|
Nitrite [Presence] in Urine |
|
38710-0
|
Nitrobenzene [Mass/volume] in Air |
|
73243-8
|
Nitrofurantoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73242-0
|
Nitrofurantoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3860-4
|
Nitrofurantoin [Mass/volume] in Serum or Plasma |
|
87793-6
|
Nitrofurazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
2661-7
|
Nitrogen.nonprotein [Presence] in Blood |
|
2662-5
|
Nitrogen.nonprotein [Mass/volume] in Blood |
|
2663-3
|
Nitrogen.nonprotein [Mass/volume] in Serum or Plasma |
|
53091-5
|
Nitrogen.nonprotein [Moles/volume] in Serum or Plasma |
|
77365-5
|
Nitrogen panel - 24 hour Stool |
|
73241-2
|
Nitroglycerin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73240-4
|
Nitroglycerin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12404-0
|
Nitroglycerin [Mass/volume] in Serum or Plasma |
|
13016-1
|
Nitrophenol [Units/volume] in Blood |
|
17364-1
|
Nitrophenol [Presence] in Urine |
|
17365-8
|
Nitroprusside [Mass/volume] in Serum or Plasma |
|
32548-0
|
Nitroprusside reacting substances [Presence] in Urine |
|
13892-5
|
Nitrosonaphthol [Presence] in Urine |
|
54181-3
|
Nitroxoline [Susceptibility] by Disk diffusion (KB) |
|
87569-0
|
Nivalenol [Mass/mass] in Unspecified specimen |
|
73239-6
|
Nizatidine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73238-8
|
Nizatidine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17366-6
|
Nizatidine [Mass/volume] in Serum or Plasma |
|
73810-4
|
CD3-CD16+CD56+HLA-DR+ (activated Natural Killer) cells/100 cells.CD3-CD16+CD56+ (Natural killer) cells in Blood by Flow cytometry (FC) |
|
34439-0
|
Natural killer cell function [Units/volume] in Blood |
|
90242-9
|
Natural killer cell cytotoxicity.IL-stimulated 0.9:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90243-7
|
Natural killer cell cytotoxicity.IL-stimulated 1.88:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90244-5
|
Natural killer cell cytotoxicity.IL-stimulated 15:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90245-2
|
Natural killer cell cytotoxicity.IL-stimulated 3.75:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90241-1
|
Natural killer cell cytotoxicity.IL-2 stimulated 30:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
90249-4
|
Natural killer cell cytotoxicity.IL-stimulated 7.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells |
|
82720-4
|
Natural killer cell cytotoxicity panel - Blood mononuclear cells |
|
47035-1
|
NKI/C3 Ag [Presence] in Tissue by Immune stain |
|
39738-0
|
NM Abdomen Views W In-111 Satumomab IV |
|
44149-3
|
NM Abdomen and Pelvis Views for shunt patency W Tc-99m MAA inj |
|
44140-2
|
NM Abdomen and Pelvis Views for tumor |
|
81545-6
|
NM Abdomen and Pelvis Views for shunt patency |
|
39857-8
|
NM Adrenal gland Views W I-131 MIBG IV |
|
39624-2
|
NM Adrenal gland Views W I-131 NP59 IV |
|
42158-6
|
NM Adrenal gland Views |
|
39625-9
|
NM Artery Views W Tc-99m DTPA IA |
|
24571-2
|
NM Biliary ducts and Gallbladder Views for patency of biliary structures and ejection fraction W sincalide and W radionuclide IV |
|
24572-0
|
NM Biliary ducts and Gallbladder Views for patency of biliary structures W Tc-99m IV |
|
25018-3
|
NM Urinary bladder Views |
|
39880-0
|
NM Bone 2 Phase Views |
|
39901-4
|
NM Bone 3 Phase Views multiple areas |
|
39902-2
|
NM Bone 3 Phase Views single area |
|
39883-4
|
NM Bone 3 Phase Views |
|
39884-2
|
NM Bone Blood pool |
|
39819-8
|
NM Bone Delayed Views |
|
39822-2
|
NM Bone marrow Limited Views |
|
39824-8
|
NM Bone marrow Views |
|
44146-9
|
NM Bone marrow Views W Tc-99m SC IV |
|
39907-1
|
NM Bone marrow Multiple area Views |
|
41836-8
|
NM Bone Limited Views W In-111 tagged WBC IV |
|
39627-5
|
NM Bone Limited Views |
|
25032-4
|
NM Bone Views W In-111 tagged WBC IV |
|
25031-6
|
NM Bone Views |
|
39820-6
|
NM Bone Views W Sm-153 IV |
|
42700-5
|
NM Bone Views W Tc-99m tagged WBC IV |
|
39812-3
|
NM Bone Views W Tc-99m HMPAO IV |
|
44142-8
|
NM Bone Views W Tc-99m medronate IV |
|
39858-6
|
NM Bone Views for blood flow |
|
39904-8
|
NM Bone Multiple area Views |
|
81597-7
|
NM Bones Views for metastasis W Ra-223 IV |
|
81573-8
|
NM Brain Brain death protocol Views |
|
24591-0
|
NM Brain Brain death protocol Views W Tc-99m HMPAO IV |
|
39859-4
|
NM Brain Delayed Views |
|
81575-3
|
NM Brain GE 4 Views for blood flow |
|
81574-6
|
NM Brain GE 4 Views |
|
81576-1
|
NM Brain LT 4 Views for blood flow |
|
43459-7
|
NM Brain Views during electroconvulsive shock treatment |
|
39634-1
|
NM Brain Limited Views |
|
24730-4
|
NM Brain Views |
|
44150-1
|
NM Brain Views W Tc-99m bicisate IV |
|
39642-4
|
NM Brain Views W Tc-99m glucoheptonate IV |
|
39630-9
|
NM Brain Views W Tc-99m HMPAO IV |
|
39635-8
|
NM Brain Views W Tl-201 IV |
|
39636-6
|
NM Brain Views for blood flow |
|
44148-5
|
NM Brain Views for blood flow W Tc-99m bicisate IV |
|
43642-8
|
NM Brain Views for blood flow W Tc-99m DTPA IV |
|
43643-6
|
NM Brain Views for blood flow W Tc-99m glucoheptonate IV |
|
43550-3
|
NM Brain Views for blood flow and function |
|
43644-4
|
NM Brain Limited Views for blood flow |
|
39643-2
|
NM Brain veins Views |
|
64051-6
|
NM Breast lymphatic vessels - left Views W radionuclide intra lymphatic |
|
64052-4
|
NM Breast lymphatic vessels - right Views W radionuclide intra lymphatic |
|
39645-7
|
NM Breast Limited Views |
|
39646-5
|
NM Breast Views |
|
51389-5
|
NM Breast Views W Tl-201 IV |
|
39874-3
|
NM Cerebral cisterns Delayed Views W radionuclide IT |
|
24663-7
|
NM Cerebral cisterns Views W radionuclide IT |
|
39672-1
|
NM Esophagus Views for motility W radionuclide PO |
|
39673-9
|
NM Esophagus Views for reflux W radionuclide PO |
|
24683-5
|
NM Esophagus+Stomach Views W Tc-99m SC PO |
|
81590-2
|
NM Extremity veins - bilateral Views for thrombosis |
|
81591-0
|
NM Extremity veins - unilateral Views for thrombosis |
|
39895-8
|
NM Gallbladder Views for ejection fraction W Tc-99m DISIDA IV |
|
41770-9
|
NM Gallbladder Views W cholecystokinin and W radionuclide IV |
|
39674-7
|
NM Gallbladder Views W Tc-99m DISIDA IV |
|
39689-5
|
NM Gastrointestinal tract Views W Tc-99m SC IV |
|
81544-9
|
NM Gastrointestinal tract Views for gastrointestinal bleeding |
|
24714-8
|
NM Gastrointestinal tract Views for gastrointestinal bleeding W Tc-99m tagged RBC IV |
|
39761-2
|
NM Guidance limited for localization of tumor-- W Tc-99m Sestamibi IV |
|
39620-0
|
NM Guidance for abscess localization limited of Unspecified body region |
|
39758-8
|
NM Guidance for localization of tumor of Breast |
|
39760-4
|
NM Guidance limited for localization of tumor |
|
39953-5
|
NM Guidance for localization of tumor multiple areas of Unspecified body region |
|
81599-3
|
NM Guidance for multiple days for localization of tumor of Whole body |
|
39623-4
|
NM Guidance for abscess localization of Whole body |
|
39763-8
|
NM Guidance for localization of tumor of Whole body |
|
24876-5
|
NM Head to Pelvis Views for shunt patency W Tc-99m DTPA IT |
|
39849-5
|
NM Head to Pelvis Views for shunt patency W radionuclide IT |
|
39848-7
|
NM Head to Pelvis Views for shunt patency W In-111 IT |
|
81611-6
|
NM Head to Pelvis Views for shunt patency |
|
81543-1
|
NM Head Views for CSF leak with rhinorrhea or otorrhea W radionuclide IT |
|
42166-9
|
NM Heart 2 Views at rest and W Tl-201 IV |
|
39861-0
|
NM Heart Blood pool |
|
39860-2
|
NM Heart Blood pool W stress and W radionuclide IV |
|
81612-4
|
NM Heart Blood pool and Ejection fraction and First pass |
|
39863-6
|
NM Heart First pass at rest and W stress and W radionuclide IV |
|
39867-7
|
NM Heart First pass at rest and W radionuclide IV |
|
39866-9
|
NM Heart First pass at rest and W Tc-99m Sestamibi IV |
|
39864-4
|
NM Heart First pass |
|
39869-3
|
NM Heart First pass W stress and W radionuclide IV |
|
39868-5
|
NM Heart First pass W stress and W Tc-99m Sestamibi IV |
|
81563-9
|
NM Heart First pass and Blood pool |
|
39887-5
|
NM Heart First pass and Ejection fraction at rest and W radionuclide IV |
|
39889-1
|
NM Heart First pass and Ejection fraction |
|
39885-9
|
NM Heart First pass and Ventricular volume |
|
39886-7
|
NM Heart First pass and Wall motion at rest and W radionuclide IV |
|
39890-9
|
NM Heart First pass and Wall motion |
|
39888-3
|
NM Heart First pass and Wall motion W stress and W radionuclide IV |
|
39910-5
|
NM Heart First pass and Wall motion and Ejection fraction |
|
39908-9
|
NM Heart First pass and Wall motion and Ventricular volume W stress and W radionuclide IV |
|
39912-1
|
NM Heart First pass and Wall motion and Ventricular volume and Ejection fraction |
|
39909-7
|
NM Heart First pass and Wall motion and Ventricular volume and Ejection fraction W stress and W radionuclide IV |
|
81566-2
|
NM Heart Gated and Blood pool and Ejection fraction and Wall motion W multiple states of exercise |
|
81567-0
|
NM Heart Gated and Blood pool and Ejection fraction and Wall motion W single state of exercise |
|
39924-6
|
NM Heart Gated at rest and W stress and W radionuclide IV |
|
39921-2
|
NM Heart Gated at rest and W radionuclide IV |
|
39920-4
|
NM Heart Gated at rest and W Tc-99m Sestamibi IV |
|
39922-0
|
NM Heart Gated at rest and W Tc-99m pertechnetate IV |
|
39915-4
|
NM Heart Gated |
|
39928-7
|
NM Heart Gated W stress and W radionuclide IV |
|
39927-9
|
NM Heart Gated W stress and W Tc-99m pertechnetate IV |
|
39914-7
|
NM Heart Gated W Tc-99m Sestamibi IV |
|
39923-8
|
NM Heart Gated and Ejection fraction at rest and W radionuclide IV |
|
39917-0
|
NM Heart Gated and Ejection fraction |
|
39919-6
|
NM Heart Gated and First pass |
|
42306-1
|
NM Heart Gated and Wall motion |
|
39929-5
|
NM Heart Gated and Wall motion W stress and W radionuclide IV |
|
39925-3
|
NM Heart Gated and Wall motion and Ejection fraction at rest and W radionuclide IV |
|
39931-1
|
NM Heart Gated and Wall motion and Ejection fraction |
|
43660-0
|
NM Heart Perfusion qualitative at rest and W radionuclide IV |
|
43661-8
|
NM Heart Perfusion quantitative at rest and W radionuclide IV |
|
43658-4
|
NM Heart Perfusion quantitative |
|
39726-5
|
NM Heart Perfusion at rest and W stress and W radionuclide IV |
|
39727-3
|
NM Heart Perfusion at rest and W stress and W Tc-99m Sestamibi IV |
|
39719-0
|
NM Heart Perfusion at rest and W adenosine and W radionuclide IV |
|
43777-2
|
NM Heart Perfusion at rest and W adenosine and W Tl-201 IV |
|
39722-4
|
NM Heart Perfusion at rest and W dipyridamole and W radionuclide IV |
|
39720-8
|
NM Heart Perfusion at rest and W dipyridamole and W Tc-99m Sestamibi IV |
|
39728-1
|
NM Heart Perfusion at rest and W radionuclide IV |
|
39699-4
|
NM Heart Perfusion at rest and W Tc-99m Sestamibi IV |
|
39701-8
|
NM Heart Perfusion W adenosine and W radionuclide IV |
|
39731-5
|
NM Heart Perfusion W adenosine and W Tc-99m Sestamibi IV |
|
39735-6
|
NM Heart Perfusion W adenosine and W Tl-201 IV |
|
39703-4
|
NM Heart Perfusion W dobutamine IV |
|
39702-6
|
NM Heart Perfusion W dobutamine and W Tc-99m Sestamibi IV |
|
39733-1
|
NM Heart Perfusion W dobutamine and W Tl-201 IV |
|
39709-1
|
NM Heart Perfusion W dipyridamole and W Tc-99m IV |
|
39705-9
|
NM Heart Perfusion W dipyridamole and W Tc-99m Sestamibi IV |
|
39708-3
|
NM Heart Perfusion W dipyridamole IV |
|
39707-5
|
NM Heart Perfusion W dipyridamole and W Tl-201 IV |
|
81571-2
|
NM Heart Perfusion W multiple states of exercise |
|
39716-6
|
NM Heart Perfusion |
|
81570-4
|
NM Heart Perfusion W single state of exercise |
|
39730-7
|
NM Heart Perfusion W stress and W radionuclide IV |
|
39732-3
|
NM Heart Perfusion W stress and W Tc-99m Sestamibi IV |
|
39715-8
|
NM Heart Perfusion W stress and W Tl-201 IV |
|
39704-2
|
NM Heart Perfusion W Tc-99m Sestamibi IV |
|
39714-1
|
NM Heart Perfusion W Tl-201 IV |
|
39713-3
|
NM Heart Perfusion W Tl-201 IV and W Tc-99m Tetrofosmin IV |
|
39893-3
|
NM Heart Views for blood flow and shunt detection |
|
39663-0
|
NM Heart Views at rest and W stress and W radionuclide IV |
|
42309-5
|
NM Heart Views at rest and W stress and W Tl-201 IV |
|
39661-4
|
NM Heart Views at rest and W dobutamine and W radionuclide IV |
|
39660-6
|
NM Heart Views at rest and W dipyridamole and W radionuclide IV |
|
24750-2
|
NM Heart Views at rest and W Tl-201 IV |
|
39651-5
|
NM Heart Views W adenosine and W Tl-201 IV |
|
42161-0
|
NM Heart Views W dobutamine IV |
|
39652-3
|
NM Heart Views W dobutamine and W Tl-201 IV |
|
39650-7
|
NM Heart Views |
|
39666-3
|
NM Heart Views W stress and W 201 Th IV |
|
39667-1
|
NM Heart Views W stress and W radionuclide IV |
|
69231-9
|
NM Heart Views W stress and W Tc-99m IV |
|
69232-7
|
NM Heart Views W stress and W Tc-99m Sestamibi IV |
|
44143-6
|
NM Heart Views W Tc-99m tagged RBC IV |
|
39871-9
|
NM Heart Views for blood flow |
|
39870-1
|
NM Heart Views for blood flow W Tc-99m pertechnetate IV |
|
39665-5
|
NM Heart Views for shunt detection |
|
39664-8
|
NM Heart Views for shunt detection W Tc-99m MAA IV |
|
39653-1
|
NM Heart Views for infarct |
|
39657-2
|
NM Heart Views for infarct W Tc-99m PYP IV |
|
39892-5
|
NM Heart Views for infarct and first pass |
|
39891-7
|
NM Heart Views for infarct and first pass W Tc-99m PYP IV |
|
43645-1
|
NM Heart Qualitative Views for infarct |
|
43646-9
|
NM Heart Qualitative and Quantitative Views for infarct |
|
43647-7
|
NM Heart Quantitative Views for infarct |
|
39873-5
|
NM Heart Wall motion |
|
39932-9
|
NM Heart Wall motion and Ejection fraction |
|
39936-0
|
NM Joint Limited Views |
|
24770-0
|
NM Joint Views W In-111 intrajoint |
|
39939-4
|
NM Joint Views |
|
39937-8
|
NM Joint Multiple area Views W radionuclide XXX |
|
39850-3
|
NM Kidney - bilateral Views W I-131 IV |
|
81607-4
|
NM Kidney cortex Views |
|
81604-1
|
NM Kidney Views for glomerular filtration rate |
|
43461-3
|
NM Kidney Views W furosemide IV |
|
24776-7
|
NM Kidney Views |
|
24773-4
|
NM Kidney Views W radionuclide transplant scan |
|
41771-7
|
NM Kidney Views W Tc-99m DMSA IV |
|
39745-5
|
NM Kidney Views W Tc-99m DTPA IV |
|
44234-3
|
NM Kidney Views W Tc-99m glucoheptonate IV |
|
39746-3
|
NM Kidney Views W Tc-99m Mertiatide IV |
|
44233-5
|
NM Kidney Views WO and W Tc-99m DTPA IV |
|
44232-7
|
NM Kidney Views WO and W Tc-99m Mertiatide IV |
|
42261-8
|
NM Kidney Views for blood flow |
|
30877-5
|
NM Kidney+Renal vessels Views |
|
43667-5
|
NM Kidney+Renal vessels Views W Tc-99m DTPA IV |
|
43666-7
|
NM Kidney+Renal vessels Views for blood flow W Tc-99m glucoheptonate IV |
|
24804-7
|
NM Knee Views |
|
26088-5
|
NM Knee - bilateral Views |
|
26089-3
|
NM Knee - left Views |
|
26090-1
|
NM Knee - right Views |
|
39670-5
|
NM Lacrimal duct Views W radionuclide intra lacrimal duct |
|
42709-6
|
NM Liver Blood pool |
|
44144-4
|
NM Liver Views W Xe-133 IH |
|
39693-7
|
NM Liver Views |
|
81609-0
|
NM Liver Views W SIR-spheres intraarterial hepatic injection |
|
39690-3
|
NM Liver Views W Tc-99m tagged RBC IV |
|
69230-1
|
NM Liver Views W Tc-99m SC IV |
|
81610-8
|
NM Liver Views W Theraspheres intraarterial hepatic injection |
|
42262-6
|
NM Liver Views for blood flow |
|
43654-3
|
NM Liver Views for blood flow W Tc-99m tagged RBC IV |
|
43789-7
|
NM Liver and Biliary ducts and Gallbladder Views for patency W Tc-99m IV |
|
43650-1
|
NM Liver and Biliary ducts and Gallbladder Views W cholecystokinin and W radionuclide IV |
|
43557-8
|
NM Liver and Biliary ducts and Gallbladder Views |
|
43651-9
|
NM Liver and Biliary ducts and Gallbladder Views W sincalide and W radionuclide IV |
|
81606-6
|
NM Liver and Biliary ducts and Gallbladder Views W cholecystokinetic IV |
|
39877-6
|
NM Liver and Spleen Views |
|
44141-0
|
NM Liver and Spleen Views W Tc-99m MAA IV |
|
81206-5
|
NM Liver and Spleen Views W Tc-99m SC IV |
|
43653-5
|
NM Liver and Spleen Views for blood flow |
|
81595-1
|
NM Lymph node Views for lymphedema |
|
81593-6
|
NM Lymph node Views |
|
81594-4
|
NM Lymph node - bilateral Views |
|
81542-3
|
NM Lumbar spine Views for CSF leak post lumbar puncture W radionuclide IT |
|
39940-2
|
NM Lung Clearance W Tc-99m DTPA aerosol IH |
|
43656-8
|
NM Lung Perfusion quantitative |
|
39697-8
|
NM Lung Perfusion |
|
43657-6
|
NM Lung Quantitative Views |
|
46361-2
|
NM Lung Ventilation W Xe-133 IH |
|
39837-0
|
NM Lung Ventilation |
|
39834-7
|
NM Lung Ventilation W Tc-99m DTPA aerosol IH |
|
39947-7
|
NM Lung Ventilation and Equilibrium |
|
39944-4
|
NM Lung Ventilation and Equilibrium and Washout |
|
39695-2
|
NM Lung Limited Views |
|
24824-5
|
NM Lung Portable Views |
|
39696-0
|
NM Lung Views W depreotide IV |
|
81596-9
|
NM Lung Quantitative Views Ventilation and Perfusion |
|
39942-8
|
NM Lung Ventilation and Perfusion |
|
39946-9
|
NM Lung Ventilation and Perfusion and Differential |
|
88944-4
|
NM Lung and Liver Views for AV shunt W Tc-99m MAA+W intraarterial hepatic injection |
|
39897-4
|
NM Lung and Liver Views |
|
39865-1
|
NM Left ventricle First pass |
|
24826-0
|
NM Lymphatic vessels Views W radionuclide intra lymphatic |
|
39737-2
|
NM Neck Views |
|
39739-8
|
NM Pancreas Views |
|
39741-4
|
NM Parathyroid gland Delayed Views |
|
39742-2
|
NM Parathyroid gland Views |
|
44145-1
|
NM Parathyroid gland Views W Tc-99m Sestamibi IV |
|
24751-0
|
NM Parathyroid gland Views W TI-201 subtraction Tc-99m IV |
|
69233-5
|
NM Parotid gland Views W Tc-99m pertechnetate IV |
|
39847-9
|
NM Parotid gland Views for blood flow |
|
39744-8
|
NM Prostate Views W Tc-99m capromab pendatide IV |
|
39950-1
|
NM Prostate Multiple area Views W Tc-99m capromab pendatide IV |
|
39619-2
|
NM Pulmonary system Views |
|
24888-0
|
NM Pulmonary system Ventilation and Perfusion W Xe-133 IH and W Tc-99m MAA IV |
|
30697-7
|
NM Pulmonary system Ventilation and Perfusion |
|
39671-3
|
NM Rectum Views W radionuclide PO |
|
43669-1
|
NM Renal vessels Views |
|
43664-2
|
NM Renal vessels Views for blood flow W Tc-99m DTPA IV |
|
43663-4
|
NM Renal vessels Views for blood flow W Tc-99m glucoheptonate IV |
|
43665-9
|
NM Renal vessels Views for blood flow W Tc-99m Mertiatide IV |
|
39747-1
|
NM Salivary gland Views |
|
39899-0
|
NM Salivary gland Views for blood flow |
|
81572-0
|
NM Salivary gland Views for function |
|
39629-1
|
NM Small bowel Views for Meckel's diverticulum |
|
30696-9
|
NM Scrotum and testicle Views |
|
39753-9
|
NM Scrotum and testicle Views W Tc-99m DTPA IV |
|
25001-9
|
NM Scrotum and testicle Views W Tc-99m pertechnetate IV |
|
42308-7
|
NM Scrotum and testicle Views for blood flow |
|
39952-7
|
NM Scrotum and testicle Views for blood flow and function |
|
26091-9
|
NM Scrotum and Testicle - bilateral Views W Tc-99m pertechnetate IV |
|
26092-7
|
NM Scrotum and Testicle - left Views W Tc-99m pertechnetate IV |
|
26093-5
|
NM Scrotum and Testicle - right Views W Tc-99m pertechnetate IV |
|
43562-8
|
NM Skeletal system.axial Views for bone density |
|
43563-6
|
NM Skeletal system.peripheral Views for bone density |
|
24831-0
|
NM Small bowel Views for Meckel's diverticulum W Tc-99m M04 IV |
|
39751-3
|
NM Spleen Views |
|
42263-4
|
NM Spleen Views for blood flow |
|
39752-1
|
NM Spleen Views W radionuclide tagged heat damaged RBC IV |
|
39769-5
|
NM Stomach Views for gastric emptying W radionuclide PO |
|
39768-7
|
NM Stomach Views for gastric emptying W Tc-99m SC PO |
|
39767-9
|
NM Stomach Views for gastric emptying liquid phase W radionuclide PO |
|
81602-5
|
NM Stomach Views for gastric emptying solid phase W radionuclide PO |
|
24997-9
|
NM Stomach Views for gastric emptying solid phase W Tc-99m SC PO |
|
30694-4
|
NM Thyroid gland and uptake single view |
|
43671-7
|
NM Thyroid gland Spot |
|
81582-9
|
NM Thyroid gland Uptake |
|
81581-1
|
NM Thyroid gland Views for dosimetry W radionuclide PO |
|
81580-3
|
NM Thyroid gland Views for therapy W I-131 PO |
|
39754-7
|
NM Thyroid gland Limited Views W I-131 IV |
|
25007-6
|
NM Thyroid gland Views W I-131 IV |
|
30695-1
|
NM Thyroid gland Views |
|
39757-0
|
NM Thyroid gland Views W Tc-99m IV |
|
39756-2
|
NM Thyroid gland Views W Tc-99m Sestamibi IV |
|
42271-7
|
NM Thyroid gland Views and Views uptake W I-123 IV |
|
60527-9
|
NM Thyroid gland Views and Views uptake W I-123 PO |
|
25008-4
|
NM Thyroid gland Views and Views uptake W I-131 IV |
|
69236-8
|
NM Thyroid gland Views and Views uptake W I-131 PO |
|
43672-5
|
NM Thyroid gland Views and Views uptake |
|
39856-0
|
NM Thyroid gland Views for blood flow |
|
44147-7
|
NM Thyroid gland Views and Views uptake W Tc-99m pertechnetate IV |
|
81605-8
|
NM Ureter and Urinary bladder Views |
|
39765-3
|
NM Vein Views W Tc-99m DTPA IV |
|
39766-1
|
NM Vein Views W Tc-99m HDP IV |
|
39764-6
|
NM Vein Views W Tc-99m SC IV |
|
39954-3
|
NM Vein Views for thrombosis |
|
39626-7
|
NM Vein - bilateral Views |
|
43501-6
|
NM Vessel Views |
|
43500-8
|
NM Vessel Views for blood flow |
|
39685-3
|
NM Unspecified body region Views for abscess W Ga-67 IV |
|
42776-5
|
NM Unspecified body region Views for AV shunt |
|
39677-0
|
NM Unspecified body region Views for infection W Ga-67 IV |
|
81592-8
|
NM Views for transplanted kidney |
|
39694-5
|
NM Views for transplanted liver |
|
39679-6
|
NM Unspecified body region Views for tumor W Ga-67 IV |
|
39750-5
|
NM Unspecified body region Views for tumor W Tc-99m Sestamibi IV |
|
39687-9
|
NM Unspecified body region Limited Views W Ga-67 IV |
|
49571-3
|
NM Unspecified body region Limited Views W I-131 MIBG IV |
|
39843-8
|
NM Unspecified body region Limited Views W In-111 Satumomab IV |
|
39688-7
|
NM Unspecified body region Views W Ga-67 IV |
|
39841-2
|
NM Unspecified body region Views W I-131 MIBG IV |
|
39846-1
|
NM Unspecified body region Views W In-111 Satumomab IV |
|
49118-3
|
NM Unspecified body region Views |
|
81585-2
|
NM Unspecified body region Views W tagged WBC IV |
|
81608-2
|
NM Views for blood flow and kidney function W ACE inhibitor PO |
|
81603-3
|
NM Views for blood flow and kidney function W diuretic IV |
|
81546-4
|
NM Views for blood flow and kidney function |
|
43648-5
|
NM Unspecified body region Views for endocrine tumor multiple areas W I-131 MIBG IV |
|
43649-3
|
NM Unspecified body region Views for endocrine tumor multiple areas W In-111 pentetreotide IV |
|
39933-7
|
NM Unspecified body region Views for infection multiple areas W Ga-67 IV |
|
39831-3
|
NM Unspecified body region Limited Views for tumor W Ga-67 IV |
|
39934-5
|
NM Unspecified body region Views for tumor multiple areas W Ga-67 IV |
|
81587-8
|
NM Unspecified body region Limited Views for infection or inflammation |
|
81600-9
|
NM Unspecified body region Limited Views for infection or inflammation W Tc-99m tagged WBC IV |
|
39951-9
|
NM Unspecified body region Views for tumor multiple areas W Tc-99m Sestamibi IV |
|
39935-2
|
NM Unspecified body region Multiple area Views W Ga-67 IV |
|
39949-3
|
NM Unspecified body region Multiple area Views W In-111 Satumomab IV |
|
39882-6
|
NM Whole body Bone 3 Phase Views |
|
39826-3
|
NM Whole body Bone marrow Views |
|
39818-0
|
NM Whole body Bone Views |
|
39686-1
|
NM Whole body Views for lymphoma W Ga-67 IV |
|
42170-1
|
NM Whole body Views for lymphoma |
|
42305-3
|
NM Whole body Views for tumor W Tl-201 IV |
|
39827-1
|
NM Whole body Views for endocrine tumor W I-131 MIBG IV |
|
81598-5
|
NM Whole body Views for thyroid tumor metastasis post therapy |
|
82136-3
|
NM Whole body Views for tumor W I-123 MIBG IV |
|
39875-0
|
NM Whole body Delayed Views W Ga-67 IV |
|
39840-4
|
NM Whole body Delayed Views W I-131 MIBG IV |
|
39842-0
|
NM Whole body Delayed Views W In-111 Satumomab IV |
|
39829-7
|
NM Whole body Views for tumor W Ga-67 IV |
|
42171-9
|
NM Whole body Views for tumor |
|
39683-8
|
NM Whole body Views W Ga-67 IV |
|
39698-6
|
NM Whole body Views W I-131 MIBG IV |
|
39845-3
|
NM Whole body Views W In-111 Satumomab IV |
|
42711-2
|
NM Whole body Views W In-111 tagged WBC IV |
|
42708-8
|
NM Whole body Views W In-111 tiuxetan IV |
|
42175-0
|
NM Whole body Views |
|
81583-7
|
NM Whole body Views W Sm-153 IV |
|
81584-5
|
NM Whole body Views W tagged WBC IV |
|
39669-7
|
NM Whole body Views W Tc-99m Arcitumomab IV |
|
81586-0
|
NM Whole body Views W Y-90 ibritumomab tiuxetan IV |
|
39828-9
|
NM Whole body Views for endocrine tumor W In-111 pentetreotide IV |
|
39830-5
|
NM Whole body Views for infection W Ga-67 IV |
|
81589-4
|
NM Whole body Views for infection or inflammation |
|
81588-6
|
NM Whole body Views for thyroid tumor |
|
39749-7
|
NM Whole body Views for tumor W Tc-99m Sestamibi IV |
|
81601-7
|
NM Unspecified body region Limited Views for thyroid tumor metastasis |
|
12542-7
|
N-methylacetamide [Mass/volume] in Urine |
|
27163-5
|
N-methylacetamide/Creatinine [Mass Ratio] in Urine |
|
82988-7
|
NMDAR IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
82981-2
|
NMDAR IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
80220-7
|
NMDAR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
80221-5
|
NMDAR IgG Ab [Titer] in Serum by Immunofluorescence |
|
90839-2
|
NMDAR subunit 1 Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93870-4
|
NMDAR subunit 1 Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
84928-1
|
NMDAR subunit 1 Ab [Presence] in Serum by Immunofluorescence |
|
90840-0
|
NMDAR subunit 1 Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93502-3
|
NMDAR subunit 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
93503-1
|
NMDAR subunit 1 IgG Ab [Presence] in Serum by Cell binding assay immunofluorescent assay |
|
35580-0
|
N-methyl valine [Mass/volume] in Blood |
|
54943-6
|
N-methyldiethanolamine [Mass/volume] in Urine |
|
14167-1
|
N-methylimidazoleacetate [Mass/time] in 24 hour Urine |
|
80648-9
|
N-monodesmethyl bedaquiline [Mass/volume] in Serum or Plasma |
|
38713-4
|
N-nitrosomorpholine [Mass/volume] in Air |
|
3851-3
|
Nicomorphine [Mass/volume] in Urine |
|
50666-7
|
Nuclear matrix protein 22 [Presence] in Urine |
|
31134-0
|
Nuclear matrix protein 22 [Units/volume] in Urine |
|
72747-9
|
N-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
92904-2
|
N-nortramadol [Mass/volume] in Urine by Confirmatory method |
|
87760-5
|
N-nortramadol/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
76117-1
|
Nitric oxide [VFr/PPres] Airway adaptor --during expiration |
|
76099-1
|
Nitric oxide [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
76120-5
|
Nitric oxide [VFr/PPres] Airway adaptor --during inspiration |
|
76100-7
|
Nitric oxide [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
76115-5
|
Nitric oxide [VFr/PPres] Airway adaptor --at end expiration |
|
74369-0
|
Nitric oxide [Moles/volume] in Exhaled gas |
|
76123-9
|
Nitric oxide gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76093-4
|
Nitric oxide [VFr/PPres] Airway adaptor |
|
76111-4
|
Nitric oxide [VFr/PPres] Gas delivery system |
|
75935-7
|
Nitrogen dioxide [VFr/PPres] Airway adaptor --during expiration |
|
76101-5
|
Nitrogen dioxide [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
75936-5
|
Nitrogen dioxide [VFr/PPres] Airway adaptor --during inspiration |
|
76102-3
|
Nitrogen dioxide [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
75937-3
|
Nitrogen dioxide [VFr/PPres] Airway adaptor --at end expiration |
|
75934-0
|
Nitrogen dioxide [VFr/PPres] Airway adaptor |
|
76113-0
|
Nitrogen dioxide [VFr/PPres] Gas delivery system |
|
5263-9
|
Nocardia sp Ab [Units/volume] in Serum |
|
91764-1
|
Nocardia sp identified in Aspirate by Organism specific culture |
|
9569-5
|
Nocardia sp IgG Ab [Units/volume] in Serum |
|
89639-9
|
Nocardia sp identified in Implanted device by Organism specific culture |
|
55096-2
|
Nocardia sp identified in Isolate |
|
14226-5
|
Nocardia sp identified in Isolate by Organism specific culture |
|
89638-1
|
Nocardia sp identified in Lower respiratory specimen by Organism specific culture |
|
43365-6
|
Nocardia sp identified in Unspecified specimen by Organism specific culture |
|
40429-3
|
NOD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41115-7
|
NOD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
52066-8
|
Notice of Discharge Medicare Appeal Rights (NODMAR) form |
|
17367-4
|
Nomifensine [Mass/volume] in Serum or Plasma |
|
10983-5
|
Norparamethadione [Mass/volume] in Serum or Plasma |
|
27402-7
|
Norparamethadione [Mass/volume] in Urine |
|
53207-7
|
Nonanoylcarnitine (C9) [Moles/volume] in DBS |
|
74523-2
|
Nonanoylcarnitine (C9) [Moles/volume] in Serum or Plasma |
|
81777-5
|
Nonanoylcarnitine (C9)/Creatinine [Molar ratio] in Urine |
|
52072-6
|
Non-emergency transportation attachment |
|
90075-3
|
Non-Enterobacteriaceae identified in Isolate by Organism specific culture |
|
32151-3
|
Microscopic observation [Identifier] in Vaginal fluid by Non-gynecological cytology method |
|
32785-8
|
Microscopic observation [Identifier] in Unspecified specimen by Non-gynecological cytology method |
|
33716-2
|
Non-gynecological cytology method study |
|
77197-2
|
Noninvasive arteriosclerosis studies panel |
|
77198-0
|
Noninvasive arteriosclerosis study report |
|
77354-9
|
Noninvasive colorectal cancer DNA and occult blood screening [Presence] in Stool |
|
77018-0
|
Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing |
|
77019-8
|
Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing |
|
53246-5
|
Non-medical services attachment |
|
93795-3
|
NOP56 gene GGCCTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
12709-2
|
Norastemizole [Mass/volume] in Serum or Plasma |
|
78866-1
|
Norbuprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
82370-8
|
Norbuprenorphine [Presence] in Gastric fluid by Screen method |
|
75379-8
|
Norbuprenorphine [Mass/mass] in Meconium by Confirmatory method |
|
72746-1
|
Norbuprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
53880-1
|
Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
66131-4
|
Norbuprenorphine [Presence] in Serum or Plasma by Confirmatory method |
|
82374-0
|
Norbuprenorphine [Presence] in Serum or Plasma by Screen method |
|
75370-7
|
Norbuprenorphine [Mass/volume] in Serum, Plasma or Blood |
|
53881-9
|
Norbuprenorphine [Mass/volume] in Serum or Plasma |
|
49751-1
|
Norbuprenorphine [Mass/volume] in Urine by Confirmatory method |
|
58362-5
|
Norbuprenorphine [Presence] in Urine by Confirmatory method |
|
82371-6
|
Norbuprenorphine [Presence] in Urine by Screen method |
|
49753-7
|
Norbuprenorphine [Mass/volume] in Urine |
|
82375-7
|
Norbuprenorphine [Presence] in Unspecified specimen by Screen method |
|
58361-7
|
Norbuprenorphine/Creatinine [Mass Ratio] in Urine |
|
93462-0
|
Norcarfentanil [Mass/volume] in Urine by Confirmatory method |
|
72406-2
|
Norchlordiazepoxide [Mass/volume] in Blood by Confirmatory method |
|
13569-9
|
Norchlordiazepoxide [Presence] in Serum or Plasma |
|
9776-6
|
Norchlordiazepoxide [Mass/volume] in Serum or Plasma |
|
33301-3
|
Norchlordiazepoxide [Presence] in Urine by Screen method |
|
27036-3
|
Norchlordiazepoxide [Mass/volume] in Urine |
|
80542-4
|
Norcitalopram [Mass/volume] in DBS |
|
35106-4
|
Norcitalopram [Mass/volume] in Serum or Plasma |
|
26040-6
|
Norcitalopram [Moles/volume] in Serum or Plasma |
|
75232-9
|
Norcitalopram [Presence] in Urine |
|
73584-5
|
Norcitalopram [Mass/volume] in Urine |
|
59939-9
|
Norclobazam [Moles/volume] in Gastric fluid |
|
35107-2
|
Norclobazam [Mass/volume] in Serum or Plasma |
|
14693-6
|
Norclobazam [Moles/volume] in Serum or Plasma |
|
94113-8
|
Norclobazam [Presence] in Urine by Screen method |
|
59938-1
|
Norclobazam [Moles/volume] in Urine |
|
60321-7
|
Norclobazam [Moles/volume] in Unspecified specimen |
|
59941-5
|
Norclomipramine [Moles/volume] in Gastric fluid |
|
13570-7
|
Norclomipramine [Presence] in Serum or Plasma |
|
35621-2
|
Norclomipramine [Mass/volume] in Serum or Plasma by Screen method |
|
3536-0
|
Norclomipramine [Mass/volume] in Serum or Plasma |
|
14694-4
|
Norclomipramine [Moles/volume] in Serum or Plasma |
|
58013-4
|
Norclomipramine [Presence] in Urine |
|
18470-5
|
Norclomipramine [Mass/volume] in Urine |
|
59940-7
|
Norclomipramine [Moles/volume] in Urine |
|
60322-5
|
Norclomipramine [Moles/volume] in Unspecified specimen |
|
58041-5
|
Norclostebol [Presence] in Urine |
|
80543-2
|
Norclozapine [Mass/volume] in DBS |
|
13571-5
|
Norclozapine [Presence] in Serum or Plasma |
|
10992-6
|
Norclozapine [Mass/volume] in Serum or Plasma |
|
14851-0
|
Norclozapine [Moles/volume] in Serum or Plasma |
|
89975-7
|
Norclozapine [Mass/volume] in Urine by Confirmatory method |
|
59171-9
|
Norclozapine [Presence] in Urine |
|
50890-3
|
Norclozapine [Moles/volume] in Urine |
|
73728-8
|
Norcocaine [Presence] in Meconium |
|
49830-3
|
Norcodeine [Mass/volume] in Serum or Plasma |
|
49829-5
|
Norcodeine [Mass/volume] in Urine |
|
86608-7
|
Norcodeine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
77740-9
|
Norcotinine [Mass/volume] in Urine |
|
59717-9
|
Nordiazepam [Mass/volume] in Blood by Confirmatory method |
|
59716-1
|
Nordiazepam [Mass/volume] in Blood |
|
59719-5
|
Nordiazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59718-7
|
Nordiazepam [Mass/volume] in Body fluid |
|
61085-7
|
Nordiazepam [Presence] in Gastric fluid |
|
29385-2
|
Nordiazepam [Mass/volume] in Gastric fluid |
|
26840-9
|
Nordiazepam [Mass/mass] in Hair |
|
59720-3
|
Nordiazepam [Mass/mass] in Meconium by Confirmatory method |
|
26891-2
|
Nordiazepam [Mass/mass] in Meconium |
|
72739-6
|
Nordiazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72615-8
|
Nordiazepam [Presence] in Saliva (oral fluid) |
|
72377-5
|
Nordiazepam [Mass/volume] in Saliva (oral fluid) |
|
59721-1
|
Nordiazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13572-3
|
Nordiazepam [Presence] in Serum or Plasma |
|
35622-0
|
Nordiazepam [Mass/volume] in Serum or Plasma by Screen method |
|
70212-6
|
Nordiazepam [Moles/volume] in Serum or Plasma by Screen method |
|
3537-8
|
Nordiazepam [Mass/volume] in Serum or Plasma |
|
26021-6
|
Nordiazepam [Moles/volume] in Serum or Plasma |
|
59722-9
|
Nordiazepam [Mass/mass] in Stool by Confirmatory method |
|
18248-5
|
Nordiazepam [Mass/volume] in Stool |
|
27239-3
|
Nordiazepam [Mass/mass] in Stool |
|
59723-7
|
Nordiazepam [Mass/mass] in Tissue |
|
74975-4
|
Nordiazepam [Mass/volume] in Serum or Plasma --trough |
|
16228-9
|
Nordiazepam [Mass/volume] in Urine by Confirmatory method |
|
70213-4
|
Nordiazepam [Moles/volume] in Urine by Confirmatory method |
|
3861-2
|
Nordiazepam [Presence] in Urine |
|
16202-4
|
Nordiazepam [Presence] in Urine by Confirmatory method |
|
19624-6
|
Nordiazepam [Presence] in Urine by Screen method |
|
15372-6
|
Nordiazepam [Mass/volume] in Urine |
|
26816-9
|
Nordiazepam [Mass/volume] in Vitreous fluid |
|
61051-9
|
Nordiazepam [Presence] in Unspecified specimen |
|
48959-1
|
Nordiazepam [Mass/volume] in Unspecified specimen |
|
77447-1
|
Nordiazepam [Moles/volume] in Unspecified specimen |
|
58367-4
|
Nordiazepam/Creatinine [Mass Ratio] in Urine |
|
35114-8
|
Nordothiepin [Mass/volume] in Serum or Plasma |
|
29411-6
|
Nordoxepin [Mass/volume] in Gastric fluid |
|
59943-1
|
Nordoxepin [Moles/volume] in Gastric fluid |
|
13573-1
|
Nordoxepin [Presence] in Serum or Plasma |
|
35623-8
|
Nordoxepin [Mass/volume] in Serum or Plasma by Screen method |
|
3862-0
|
Nordoxepin [Mass/volume] in Serum or Plasma |
|
14695-1
|
Nordoxepin [Moles/volume] in Serum or Plasma |
|
58014-2
|
Nordoxepin [Presence] in Urine |
|
12386-9
|
Nordoxepin [Mass/volume] in Urine |
|
59942-3
|
Nordoxepin [Moles/volume] in Urine |
|
60323-3
|
Nordoxepin [Moles/volume] in Unspecified specimen |
|
27221-1
|
Norepinephrine [Mass/volume] in 24 hour Urine |
|
2668-2
|
Norepinephrine [Mass/time] in 24 hour Urine |
|
25963-0
|
Norepinephrine [Moles/volume] in 24 hour Urine |
|
14854-4
|
Norepinephrine [Moles/time] in 24 hour Urine |
|
2666-6
|
Norepinephrine [Mass/volume] in Plasma |
|
14852-8
|
Norepinephrine [Moles/volume] in Plasma |
|
2667-4
|
Norepinephrine [Mass/volume] in Urine |
|
14853-6
|
Norepinephrine [Moles/volume] in Urine |
|
32549-8
|
Norepinephrine/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
44341-6
|
Norepinephrine/Creatinine [Mass Ratio] in 24 hour Urine |
|
27977-8
|
Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine |
|
13782-8
|
Norepinephrine/Creatinine [Mass Ratio] in Urine |
|
24523-3
|
Norepinephrine/Creatinine [Molar ratio] in Urine |
|
85099-0
|
Norescitalopram [Mass/volume] in Serum or Plasma |
|
3865-3
|
Norethandrolone [Mass/time] in 24 hour Urine |
|
3863-8
|
Norethandrolone [Presence] in Urine |
|
3864-6
|
Norethandrolone [Mass/volume] in Urine |
|
13907-1
|
Norethindrone [Mass/volume] in Serum or Plasma |
|
49756-0
|
Norethindrone [Mass/volume] in Urine |
|
3866-1
|
Norfenefrine [Mass/volume] in Urine |
|
12431-3
|
Norfenfluramine [Mass/volume] in Serum or Plasma |
|
73937-5
|
Norfentanyl [Mass/volume] in Blood by Confirmatory method |
|
78867-9
|
Norfentanyl cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method |
|
61086-5
|
Norfentanyl [Presence] in Gastric fluid |
|
72745-3
|
Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
61052-7
|
Norfentanyl [Presence] in Serum or Plasma |
|
74137-1
|
Norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
11074-2
|
Norfentanyl [Mass/volume] in Serum or Plasma |
|
58383-1
|
Norfentanyl [Mass/volume] in Urine by Confirmatory method |
|
43199-9
|
Norfentanyl [Presence] in Urine |
|
43200-5
|
Norfentanyl [Presence] in Urine by Confirmatory method |
|
11075-9
|
Norfentanyl [Mass/volume] in Urine |
|
61053-5
|
Norfentanyl [Presence] in Unspecified specimen |
|
58382-3
|
Norfentanyl/Creatinine [Mass Ratio] in Urine |
|
3867-9
|
Norfloxacin [Mass/volume] in Serum or Plasma |
|
17375-7
|
Norflunitrazepam [Mass/volume] in Blood |
|
32650-4
|
Norflunitrazepam [Mass/volume] in Serum or Plasma |
|
26039-8
|
Norflunitrazepam [Moles/volume] in Serum or Plasma |
|
27083-5
|
Norflunitrazepam [Mass/volume] in Urine |
|
13574-9
|
Norfluoxetine [Presence] in Serum or Plasma |
|
35624-6
|
Norfluoxetine [Mass/volume] in Serum or Plasma by Screen method |
|
3868-7
|
Norfluoxetine [Mass/volume] in Serum or Plasma |
|
14855-1
|
Norfluoxetine [Moles/volume] in Serum or Plasma |
|
20553-4
|
Norfluoxetine [Mass/volume] in Urine by Confirmatory method |
|
19629-5
|
Norfluoxetine [Presence] in Urine by Confirmatory method |
|
19628-7
|
Norfluoxetine [Presence] in Urine by Screen method |
|
12445-3
|
Norfluoxetine [Mass/volume] in Urine |
|
72812-1
|
Norfluoxetine/Creatinine [Mass Ratio] in Urine |
|
90469-8
|
Norfluvoxamine [Mass/volume] in Urine by Confirmatory method |
|
90470-6
|
Norfluvoxamine [Presence] in Urine by Screen method |
|
72744-6
|
Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
78363-9
|
Norhydrocodone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
61422-2
|
Norhydrocodone [Mass/volume] in Urine by Confirmatory method |
|
61421-4
|
Norhydrocodone [Presence] in Urine by Confirmatory method |
|
61420-6
|
Norhydrocodone/Creatinine [Mass Ratio] in Urine |
|
21421-3
|
Norketamine [Mass/volume] in Serum or Plasma |
|
72799-0
|
Norketamine [Mass/volume] in Urine by Confirmatory method |
|
18322-8
|
Norketamine [Mass/volume] in Urine |
|
72800-6
|
Norketamine/Creatinine [Mass Ratio] in Urine |
|
75914-2
|
aPTT W hexagonal phospholipid/Normal (StaClot LA confirm) |
|
75913-4
|
dRVVT W excess hexagonal phospholipid/Normal (StaClot LA confirm) |
|
66736-0
|
Normalized silica clotting time of Platelet poor plasma |
|
13575-6
|
Normaprotiline [Presence] in Serum or Plasma |
|
35108-0
|
Normaprotiline [Mass/volume] in Serum or Plasma |
|
57858-3
|
Normaprotiline [Moles/volume] in Unspecified specimen |
|
61087-3
|
Normeperidine [Presence] in Gastric fluid |
|
72743-8
|
Normeperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
10544-5
|
Normeperidine [Presence] in Serum or Plasma |
|
35625-3
|
Normeperidine [Mass/volume] in Serum or Plasma by Screen method |
|
73933-4
|
Normeperidine [Mass/volume] in Serum, Plasma or Blood |
|
10996-7
|
Normeperidine [Mass/volume] in Serum or Plasma |
|
59944-9
|
Normeperidine [Moles/volume] in Serum or Plasma |
|
58389-8
|
Normeperidine [Mass/volume] in Urine by Confirmatory method |
|
27920-8
|
Normeperidine [Presence] in Urine |
|
58388-0
|
Normeperidine [Presence] in Urine by Confirmatory method |
|
3869-5
|
Normeperidine [Mass/volume] in Urine |
|
61054-3
|
Normeperidine [Presence] in Unspecified specimen |
|
58387-2
|
Normeperidine/Creatinine [Mass Ratio] in Urine |
|
10545-2
|
Normephenytoin [Mass/volume] in Serum or Plasma |
|
26041-4
|
Normephenytoin [Moles/volume] in Serum or Plasma |
|
57462-4
|
Normetanephrine Free [Mass/volume] in Serum or Plasma |
|
40851-8
|
Normetanephrine Free [Moles/volume] in Serum or Plasma |
|
21422-1
|
Normetanephrine [Mass/volume] in 24 hour Urine |
|
2671-6
|
Normetanephrine [Mass/time] in 24 hour Urine |
|
25964-8
|
Normetanephrine [Moles/volume] in 24 hour Urine |
|
15083-9
|
Normetanephrine [Moles/time] in 24 hour Urine |
|
2669-0
|
Normetanephrine [Mass/volume] in Serum or Plasma |
|
25489-6
|
Normetanephrine [Moles/volume] in Serum or Plasma |
|
2670-8
|
Normetanephrine [Mass/volume] in Urine |
|
34347-5
|
Normetanephrine [Moles/volume] in Urine |
|
44342-4
|
Normetanephrine/Creatinine [Mass Ratio] in 24 hour Urine |
|
13783-6
|
Normetanephrine/Creatinine [Mass Ratio] in Urine |
|
34348-3
|
Normetanephrine/Creatinine [Molar ratio] in Urine |
|
10546-0
|
Normethsuximide [Mass/volume] in Serum or Plasma |
|
39483-3
|
Normethsuximide [Moles/volume] in Serum or Plasma |
|
34414-3
|
Normianserin [Mass/volume] in Serum or Plasma |
|
74389-8
|
Normirtazapine [Mass/volume] in Blood |
|
74388-0
|
Normirtazapine [Mass/volume] in Body fluid |
|
74385-6
|
Normirtazapine [Mass/mass] in Hair |
|
34415-0
|
Normirtazapine [Mass/volume] in Serum or Plasma |
|
74387-2
|
Normirtazapine [Mass/volume] in Urine |
|
74386-4
|
Normirtazapine [Mass/mass] in Unspecified specimen |
|
51579-1
|
Normoblasts/100 cells in Bone marrow by Manual count |
|
49831-1
|
Normorphine [Mass/volume] in Urine |
|
33917-6
|
Nornicotine [Mass/volume] in Urine |
|
57727-0
|
Norolanzapine [Mass/volume] in Serum or Plasma |
|
74083-7
|
Norolanzapine [Moles/volume] in Serum or Plasma |
|
89968-2
|
Norolanzapine [Mass/volume] in Urine by Confirmatory method |
|
89969-0
|
Norolanzapine [Presence] in Urine by Screen method |
|
49117-5
|
Norovirus Ag [Presence] in Stool |
|
80375-9
|
Norovirus Ag [Presence] in Stool by Rapid immunoassay |
|
76628-7
|
Norovirus genogroup I and II RNA [Identifier] in Stool by NAA with probe detection |
|
90449-0
|
Norovirus genogroup I and II RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
40863-3
|
Norovirus Genogroup I Ag [Presence] in Stool |
|
54905-5
|
Norovirus Genogroup I RNA [Presence] in Stool by NAA with probe detection |
|
90288-2
|
Norovirus Genogroup I RNA [Presence] in Vomitus by NAA with probe detection |
|
82211-4
|
Norovirus genogroup I+II RNA [Presence] in Stool by NAA with non-probe detection |
|
92692-3
|
Norovirus genogroup I+II RNA [Presence] in Stool by NAA with probe detection |
|
54906-3
|
Norovirus Genogroup II RNA [Presence] in Stool by NAA with probe detection |
|
90289-0
|
Norovirus Genogroup II RNA [Presence] in Vomitus by NAA with probe detection |
|
60427-2
|
Norovirus RNA [Presence] in Isolate by NAA with probe detection |
|
7974-9
|
Norovirus RNA [Presence] in Stool by NAA with probe detection |
|
90287-4
|
Norovirus RNA [Presence] in Vomitus by NAA with probe detection |
|
56748-7
|
Norovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41035-7
|
Norovirus RNA [Presence] in Unspecified specimen by Probe |
|
10696-3
|
Norovirus [Identifier] in Stool by Electron microscopy |
|
7973-1
|
Norovirus [Presence] in Stool by Electron microscopy |
|
72742-0
|
Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
61425-5
|
Noroxycodone [Mass/volume] in Urine by Confirmatory method |
|
61424-8
|
Noroxycodone [Presence] in Urine by Confirmatory method |
|
61423-0
|
Noroxycodone/Creatinine [Mass Ratio] in Urine |
|
90894-7
|
Noroxymorphone [Mass/volume] in Urine by Confirmatory method |
|
86609-5
|
Noroxymorphone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
29387-8
|
Norpropoxyphene [Mass/volume] in Gastric fluid |
|
27211-2
|
Norpropoxyphene [Mass/mass] in Hair |
|
27029-8
|
Norpropoxyphene [Mass/mass] in Meconium |
|
72620-8
|
Norpropoxyphene [Presence] in Saliva (oral fluid) |
|
72619-0
|
Norpropoxyphene [Mass/volume] in Saliva (oral fluid) |
|
3870-3
|
Norpropoxyphene [Presence] in Serum or Plasma |
|
35626-1
|
Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method |
|
10341-6
|
Norpropoxyphene [Mass/volume] in Serum or Plasma |
|
55559-9
|
Norpropoxyphene [Moles/volume] in Serum or Plasma |
|
27041-3
|
Norpropoxyphene [Mass/mass] in Stool |
|
17377-3
|
Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
|
3871-1
|
Norpropoxyphene [Presence] in Urine |
|
17376-5
|
Norpropoxyphene [Presence] in Urine by Confirmatory method |
|
19632-9
|
Norpropoxyphene [Presence] in Urine by Screen method |
|
19635-2
|
Norpropoxyphene [Mass/volume] in Urine |
|
48960-9
|
Norpropoxyphene [Mass/volume] in Unspecified specimen |
|
77334-1
|
Norpropoxyphene [Moles/volume] in Unspecified specimen |
|
58399-7
|
Norpropoxyphene/Creatinine [Mass Ratio] in Urine |
|
88715-8
|
Norquetiapine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
89966-6
|
Norquetiapine [Mass/volume] in Urine by Confirmatory method |
|
89967-4
|
Norquetiapine [Presence] in Urine by Screen method |
|
13557-4
|
Norsertraline [Presence] in Serum or Plasma |
|
6897-3
|
Norsertraline [Mass/volume] in Serum or Plasma |
|
75233-7
|
Norsertraline [Presence] in Urine |
|
74655-2
|
Norsertraline [Mass/volume] in Urine |
|
59330-1
|
Norsibutramine [Mass/volume] in Blood |
|
59333-5
|
Norsibutramine [Mass/volume] in Serum or Plasma |
|
59336-8
|
Norsibutramine [Mass/volume] in Urine |
|
43239-3
|
Norsildenafil [Mass/volume] in Serum or Plasma |
|
86232-6
|
Norsufentanil [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
59348-3
|
Nortamoxifen [Mass/volume] in Blood |
|
59351-7
|
Nortamoxifen [Mass/volume] in Serum or Plasma |
|
81754-4
|
Nortapentadol [Mass/volume] in Urine by Confirmatory method |
|
65808-8
|
Nortapentadol [Mass/volume] in Urine |
|
75243-6
|
Norton scale panel |
|
75249-3
|
Norton scale total score |
|
72741-2
|
Nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
18340-0
|
Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method |
|
18339-2
|
Nortramadol [Presence] in Serum or Plasma by Confirmatory method |
|
12438-8
|
Nortramadol [Mass/volume] in Serum or Plasma |
|
18338-4
|
Nortramadol [Mass/volume] in Urine |
|
49691-9
|
Nortrimipramine [Presence] in Serum or Plasma |
|
16746-0
|
Nortrimipramine [Mass/volume] in Serum or Plasma |
|
25394-8
|
Nortrimipramine [Moles/volume] in Serum or Plasma |
|
58015-9
|
Nortrimipramine [Presence] in Urine |
|
12444-6
|
Nortrimipramine [Mass/volume] in Urine |
|
77331-7
|
Nortrimipramine [Moles/volume] in Unspecified specimen |
|
3876-0
|
Nortriptyline [Mass/volume] in Serum or Plasma --trough >12 hours post dose |
|
80544-0
|
Nortriptyline [Mass/volume] in DBS |
|
40389-9
|
Nortriptyline [Presence] in Gastric fluid |
|
29407-4
|
Nortriptyline [Mass/volume] in Gastric fluid |
|
59945-6
|
Nortriptyline [Moles/volume] in Gastric fluid |
|
3873-7
|
Nortriptyline [Presence] in Serum or Plasma |
|
35627-9
|
Nortriptyline [Mass/volume] in Serum or Plasma by Screen method |
|
3872-9
|
Nortriptyline [Mass/volume] in Serum or Plasma |
|
14856-9
|
Nortriptyline [Moles/volume] in Serum or Plasma |
|
74924-2
|
Nortriptyline [Mass/volume] in Serum or Plasma --trough |
|
61428-9
|
Nortriptyline [Mass/volume] in Urine by Confirmatory method |
|
3874-5
|
Nortriptyline [Presence] in Urine |
|
61427-1
|
Nortriptyline [Presence] in Urine by Confirmatory method |
|
93496-8
|
Nortriptyline [Presence] in Urine by Screen method |
|
3875-2
|
Nortriptyline [Mass/volume] in Urine |
|
45301-9
|
Nortriptyline [Moles/volume] in Urine |
|
60324-1
|
Nortriptyline [Moles/volume] in Unspecified specimen |
|
61426-3
|
Nortriptyline/Creatinine [Mass Ratio] in Urine |
|
79161-6
|
Nortriptyline and E-10-hydroxynortriptyline and Z-10-hydroxynortriptyline panel - Serum or Plasma |
|
35628-7
|
Norverapamil [Presence] in Serum or Plasma by Screen method |
|
6903-9
|
Norverapamil [Mass/volume] in Serum or Plasma |
|
93451-3
|
Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method |
|
81867-4
|
NOTCH3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
41077-9
|
NOTCH3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34492-9
|
NOTCH3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
34109-9
|
Note |
|
53244-0
|
Notice of privacy practices receipt |
|
17378-1
|
Novobiocin [Mass/volume] in Serum or Plasma |
|
49864-2
|
Novocaine IgE Ab [Units/volume] in Serum |
|
76031-4
|
NPC1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
41076-1
|
NPDC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34505-8
|
NPDC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
60487-6
|
NPHP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41075-3
|
NPHS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34512-4
|
NPHS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41074-6
|
NPHS1 gene mutations found [Identifier] in Body fluid by Molecular genetics method Nominal |
|
34513-2
|
NPHS1 gene targeted mutation analysis in Body fluid by Molecular genetics method |
|
60488-4
|
NPHS2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72311-4
|
NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72335-3
|
NPM1 gene c.956dupTCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
54448-6
|
NPM1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75034-9
|
NPM1 gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
|
72310-6
|
NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72334-6
|
NPM1 gene c.960insCATG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
72309-8
|
NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72336-1
|
NPM1 gene c.960insCCTG transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
73967-2
|
Noninvasive prenatal fetal aneuploidy test panel - Plasma cell-free DNA |
|
41073-8
|
NR0B1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34739-3
|
NR0B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21719-0
|
NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53621-9
|
NRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
|
83060-4
|
NRAS gene [VCF] in Cancer specimen by Sequencing |
|
771-6
|
Nucleated erythrocytes [#/volume] in Blood by Automated count |
|
49229-8
|
Nucleated erythrocytes/100 leukocytes [Ratio] in Body fluid |
|
70170-6
|
Nucleated erythrocytes/100 cells in Pleural fluid |
|
70171-4
|
Nucleated erythrocytes/100 cells in Peritoneal fluid |
|
80198-5
|
Nonsteroidal antiinflammatory drugs [Presence] in Blood by Screen method |
|
80199-3
|
Nonsteroidal antiinflammatory drugs [Presence] in Body fluid by Screen method |
|
80200-9
|
Nonsteroidal antiinflammatory drugs [Presence] in Urine by Screen method |
|
35645-1
|
NSD1 gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
47967-5
|
NSD1 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
23316-3
|
Nairobi sheep disease virus Ab [Presence] in Serum |
|
23314-8
|
Nairobi sheep disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
23315-5
|
Nairobi sheep disease virus Ab [Presence] in Serum by Immunofluorescence |
|
31524-2
|
Nairobi sheep disease virus Ab [Units/volume] in Serum |
|
23313-0
|
Nairobi sheep disease virus Ab [Titer] in Serum |
|
31904-6
|
Nairobi sheep disease virus Ag [Presence] in Unspecified specimen |
|
23318-9
|
Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23320-5
|
Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23319-7
|
Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
10477-8
|
Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
|
47053-4
|
Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid by Immunoassay |
|
44802-7
|
Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid |
|
48164-8
|
Enolase.neuron specific [Mass/volume] in Body fluid |
|
68952-1
|
Enolase.neuron specific [Mass/volume] in Pericardial fluid |
|
19194-0
|
Enolase.neuron specific [Units/volume] in Pleural fluid |
|
68939-8
|
Enolase.neuron specific [Mass/volume] in Pleural fluid |
|
69560-1
|
Enolase.neuron specific [Mass/volume] in Peritoneal fluid |
|
57371-7
|
Enolase.neuron specific [Mass/volume] in Serum or Plasma by Immunoassay |
|
48138-2
|
Enolase.neuron specific [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
19193-2
|
Enolase.neuron specific [Units/volume] in Serum or Plasma |
|
2225-1
|
Enolase.neuron specific [Enzymatic activity/volume] in Serum or Plasma |
|
15060-7
|
Enolase.neuron specific [Mass/volume] in Serum or Plasma |
|
77362-2
|
N-tau methylimidazoleacetate/Creatinine [Molar ratio] in 24 hour Urine |
|
77363-0
|
N-tau methylimidazoleacetate/Creatinine [Molar ratio] in Urine |
|
85098-2
|
Nitisinone [Moles/volume] in DBS by LC/MS/MS |
|
87825-6
|
National Trauma Data Standard - version 2018 set |
|
71425-3
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Blood by Immunoassay |
|
77622-9
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Peritoneal dialysis fluid by Immunoassay |
|
77621-1
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay |
|
83107-3
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma by Immunoassay |
|
83108-1
|
Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma by Immunoassay |
|
33762-6
|
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma |
|
33763-4
|
Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma |
|
93813-4
|
NTRK1, NTRK2 and NTRK3 gene rearrangements in Tissue by Molecular genetics method |
|
50774-9
|
Nucleated cells [#/volume] in Blood |
|
74813-7
|
Nucleated cells [#/volume] in Dialysis fluid by Manual count |
|
82586-9
|
Nucleated cells [#/volume] in Bone marrow by Automated count |
|
51926-4
|
Nucleated cells [#/volume] in Peritoneal fluid by Manual count |
|
90342-7
|
Nuclear medicine Attending Note |
|
90345-0
|
Nuclear medicine Nurse Note |
|
90348-4
|
Nuclear medicine Resident Note |
|
90341-9
|
Nuclear medicine Administrative note |
|
90343-5
|
Nuclear medicine Consult note |
|
85895-1
|
Nuclear medicine Diagnostic study note |
|
90344-3
|
Nuclear medicine Note |
|
90349-2
|
Nuclear medicine Telephone encounter Note |
|
90346-8
|
Nuclear medicine Postoperative evaluation and management note |
|
90347-6
|
Nuclear medicine Preoperative evaluation and management note |
|
90350-0
|
Nuclear medicine procedure note |
|
82931-7
|
Nuclear pore protein gp210 IgG Ab [Presence] in Serum by Line blot |
|
42331-9
|
Nuclear IgG Ab [Units/volume] in Serum by Flow cytometry (FC) |
|
70256-3
|
Nuclear IgG Ab [Ratio] in Serum by Immunoassay |
|
31545-7
|
Nuclear IgG Ab [Presence] in Serum |
|
29950-3
|
Nuclear IgG Ab [Presence] in Serum by Immunoassay |
|
21424-7
|
Nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
|
56634-9
|
Nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
|
54025-2
|
Nuclear pore protein gp210 Ab [Presence] in Serum |
|
56716-4
|
Nuclear pore protein gp210 Ab [Presence] in Serum by Immunoblot |
|
63299-2
|
Nucleosome Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89528-4
|
Nucleosome Ab [Presence] in Cerebral spinal fluid by Line blot |
|
63298-4
|
Nucleosome Ab [Presence] in Body fluid by Immunoassay |
|
34416-8
|
Nucleosome Ab [Units/volume] in Serum by Immunoassay |
|
53015-4
|
Nucleosome Ab [Presence] in Serum |
|
63300-8
|
Nucleosome Ab [Presence] in Serum by Immunoassay |
|
89506-0
|
Nucleosome Ab [Presence] in Serum by Line blot |
|
53014-7
|
Nucleosome Ab [Units/volume] in Serum |
|
82844-2
|
Number affected by condition Population |
|
1766-5
|
Aldosterone receptors [#] in Leukocytes |
|
51872-0
|
Transfuse platelet concentrate units [#] |
|
54152-4
|
Nuclear mitotic apparatus Ab [Presence] in Serum by Immunofluorescence |
|
54153-2
|
Nuclear mitotic apparatus Ab [Titer] in Serum by Immunofluorescence |
|
93084-2
|
NuMoM2b Difficulties in Pregnancy form [NuMoM2b] |
|
84240-1
|
Nurse Administrative note |
|
34744-3
|
Nurse Admission evaluation note |
|
78390-2
|
Nurse Admission history and physical note |
|
88637-4
|
Nurse Agreement |
|
88359-5
|
Nurse Alert |
|
84241-9
|
Nurse Consult note |
|
78407-4
|
Nurse Counseling note |
|
84242-7
|
Nurse Crisis intervention note |
|
84246-8
|
Nurse Custodial care facility Note |
|
78409-0
|
Nurse Daily or end of shift signout note |
|
85896-9
|
Nurse Diagnostic study note |
|
84245-0
|
Nurse Diagram |
|
78413-2
|
Nurse Discharge instructions |
|
34745-0
|
Nurse Discharge summary |
|
78425-6
|
Nurse Discharge teaching note |
|
84247-6
|
Nurse Evaluation and management of anticoagulation note |
|
83953-0
|
Nurse Evaluation and management of smoking cessation note |
|
84248-4
|
Nurse Emergency department Discharge summary |
|
57053-1
|
Nurse Emergency department Note |
|
84249-2
|
Nurse Emergency department Triage note |
|
57054-9
|
Nurse Emergency department Triage+care note |
|
75446-5
|
Nurse Education note |
|
75447-3
|
Nurse Fall risk assessment note |
|
75448-1
|
Nurse Flowsheet |
|
90359-1
|
Nurse Fluid management note |
|
84250-0
|
Nurse Group counseling note |
|
84253-4
|
Nurse Hospital Admission evaluation note |
|
84254-2
|
Nurse Hospital Discharge summary |
|
68477-9
|
Nurse Hospital Education note |
|
75449-9
|
Nurse Hospital Note |
|
68476-1
|
Nurse Hospital Restraint note |
|
68482-9
|
Nurse Hospital Transfer summary note |
|
84243-5
|
Nurse Intensive care unit Flowsheet |
|
75450-7
|
Nurse Intensive care unit Note |
|
84244-3
|
Nurse Intensive care unit Plan of care note |
|
87269-7
|
Nurse Immunization note |
|
29753-1
|
Nurse Initial evaluation note |
|
84255-9
|
Nurse Long term care facility Admission evaluation note |
|
88638-2
|
Nurse Long term care facility Agreement |
|
84256-7
|
Nurse Long term care facility Annual evaluation note |
|
84257-5
|
Nurse Long term care facility Discharge summary |
|
84258-3
|
Nurse Long term care facility Initial evaluation note |
|
75451-5
|
Nurse Long term care facility Note |
|
84259-1
|
Nurse Long term care facility Referral note |
|
84260-9
|
Nurse Long term care facility Risk assessment and screening note |
|
88348-8
|
Nurse Long term care facility Transfer summary note |
|
75452-3
|
Nurse Medication management note |
|
34746-8
|
Nurse Note |
|
84261-7
|
Nurse Observation unit Admission evaluation note |
|
84262-5
|
Nurse Observation unit Discharge summary |
|
84263-3
|
Nurse Observation unit Note |
|
84265-8
|
Nurse Outpatient Evaluation and management of anticoagulation note |
|
87270-5
|
Nurse Outpatient Immunization note |
|
84266-6
|
Nurse Outpatient Initial evaluation note |
|
84267-4
|
Nurse Outpatient Medication management note |
|
75453-1
|
Nurse Outpatient Note |
|
84268-2
|
Nurse Outpatient Surgical operation note |
|
84269-0
|
Nurse Outpatient Triage note |
|
84264-1
|
Nurse Surgical operation note |
|
88650-7
|
Nurse Parenteral therapy note |
|
34139-6
|
Nurse Telephone encounter Note |
|
75457-2
|
Nurse Telephone encounter Triage note |
|
64295-9
|
Nurse Plan of care note |
|
84270-8
|
Nurse Postoperative evaluation and management note |
|
83550-4
|
Nurse practitioner Admission evaluation note |
|
78391-0
|
Nurse practitioner Admission history and physical note |
|
78406-6
|
Nurse practitioner Consult note |
|
78408-2
|
Nurse practitioner Counseling note |
|
78414-0
|
Nurse practitioner Discharge instructions |
|
83551-2
|
Nurse practitioner Discharge summary |
|
78426-4
|
Nurse practitioner Discharge teaching note |
|
89554-0
|
Nurse practitioner Evaluation and management of radiation exposure note |
|
78450-4
|
Nurse practitioner Education note |
|
78459-5
|
Nurse practitioner Flowsheet |
|
83552-0
|
Nurse practitioner History and physical note |
|
83554-6
|
Nurse practitioner Hospital Note |
|
28621-1
|
Nurse practitioner Initial evaluation note |
|
83555-3
|
Nurse practitioner Long term care facility Note |
|
75454-9
|
Nurse practitioner Note |
|
83556-1
|
Nurse practitioner Outpatient Note |
|
83557-9
|
Nurse practitioner Telephone encounter Note |
|
80757-8
|
Nurse practitioner Plan of care note |
|
78476-9
|
Nurse practitioner procedure note |
|
28575-9
|
Nurse practitioner Progress note |
|
83553-8
|
Nurse practitioner Patient's home Note |
|
78484-3
|
Nurse practitioner Referral note |
|
34747-6
|
Nurse Preoperative evaluation and management note |
|
75455-6
|
Nurse procedure note |
|
28623-7
|
Nurse Progress note |
|
84252-6
|
Nurse Patient's home Initial evaluation note |
|
84251-8
|
Nurse Patient's home Note |
|
85875-3
|
Nurse Recovery room Discharge summary |
|
85874-6
|
Nurse Recovery room Note |
|
84271-6
|
Nurse Referral note |
|
84272-4
|
Nurse Respite note |
|
85848-0
|
Nurse Restraint note |
|
75456-4
|
Nurse Risk assessment and screening note |
|
61143-4
|
Nurse Summary note |
|
82811-1
|
Nurse summary note - recommended sections |
|
84273-2
|
Nurse Summary of death note |
|
84274-0
|
Nurse Telehealth Note |
|
28651-8
|
Nurse Transfer note |
|
75458-0
|
Nurse Triage note |
|
84275-7
|
Nurse Urgent care center Note |
|
84276-5
|
Nurse Urgent care center Triage note |
|
11543-6
|
Nursery records |
|
34096-8
|
Nursing facility Comprehensive history and physical note |
|
34097-6
|
Nursing facility Conference note |
|
67856-5
|
Nursing facility History and physical note |
|
34119-8
|
Nursing facility Initial evaluation note |
|
34113-1
|
Nursing facility Note |
|
80346-0
|
Nursing physiologic assessment panel |
|
46066-7
|
Nursing rehabilitation and restorative care Set |
|
30164-8
|
Nut Allergen Mix (Cashew+Pecan or Hickory nut+English walnut) IgE Ab [Presence] in Serum by Multidisk |
|
63486-5
|
Nut allergen panel - Serum |
|
6188-7
|
Nutmeg IgE Ab [Units/volume] in Serum |
|
7527-5
|
Nutmeg IgG Ab [Units/volume] in Serum |
|
56332-0
|
Nutmeg IgG4 Ab [Mass/volume] in Serum |
|
60385-2
|
Nutmeg IgG Ab [Mass/volume] in Serum |
|
75282-4
|
Nutrition assessment panel |
|
75306-1
|
Nutrition status etiology Narrative |
|
75304-6
|
Nutrition status observation panel |
|
75307-9
|
Nutrition status signs and symptoms Narrative |
|
75305-3
|
Nutrition status |
|
84277-3
|
Nutrition and dietetics Administrative note |
|
34800-3
|
Nutrition and dietetics Consult note |
|
78716-8
|
Nutrition and dietetics Counseling note |
|
78415-7
|
Nutrition and dietetics Discharge instructions |
|
84278-1
|
Nutrition and dietetics Discharge summary |
|
78427-2
|
Nutrition and dietetics Discharge teaching note |
|
78451-2
|
Nutrition and dietetics Education note |
|
78460-3
|
Nutrition and dietetics Flowsheet |
|
84279-9
|
Nutrition and dietetics Group counseling note |
|
84284-9
|
Nutrition and dietetics Hospital Note |
|
78470-2
|
Nutrition and dietetics Initial evaluation note |
|
84295-5
|
Nutrition and dietetics Interdisciplinary Plan of care note |
|
84285-6
|
Nutrition and dietetics Long term care facility Initial evaluation note |
|
84286-4
|
Nutrition and dietetics Long term care facility Note |
|
84287-2
|
Nutrition and dietetics Long term care facility Referral note |
|
34801-1
|
Nutrition and dietetics Note |
|
83637-9
|
Nutrition and dietetics Nurse Note |
|
84288-0
|
Nutrition and dietetics Outpatient Initial evaluation note |
|
84289-8
|
Nutrition and dietetics Outpatient Note |
|
84290-6
|
Nutrition and dietetics Outpatient Risk assessment and screening note |
|
84294-8
|
Nutrition and dietetics Telephone encounter Note |
|
80791-7
|
Nutrition and dietetics Plan of care note |
|
78494-2
|
Nutrition and dietetics procedure note |
|
78481-9
|
Nutrition and dietetics Progress note |
|
84283-1
|
Nutrition and dietetics Patient's home Risk assessment and screening note |
|
84280-7
|
Nutrition and dietetics Patient's home Consult note |
|
84281-5
|
Nutrition and dietetics Patient's home Initial evaluation note |
|
84282-3
|
Nutrition and dietetics Patient's home Note |
|
57173-7
|
Nutrition and dietetics Referral note |
|
84291-4
|
Nutrition and dietetics Risk assessment and screening note |
|
84292-2
|
Nutrition and dietetics Team Consult note |
|
84293-0
|
Nutrition and dietetics Team Note |
|
81674-4
|
Nutrition and fluid intake assessment panel |
|
75286-5
|
Nutrition related anthropometric measurements panel |
|
46042-8
|
Nutritional approaches Set |
|
46041-0
|
Nutritional problems Set |
|
88701-8
|
Norovirus genogroups I and II RNA panel - Stool by NAA with probe detection |
|
89005-3
|
NY-ESO-1 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
93124-6
|
New York Heart Association Functional Classification panel |
|
29754-9
|
Nystagmogram study |
|
73237-0
|
Nystatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73236-2
|
Nystatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14994-8
|
O group [Presence] on Red Blood Cells |
|
8006-9
|
Orientia tsutsugamushi Ab [Units/volume] in Serum |
|
22485-7
|
Orientia tsutsugamushi Ab [Titer] in Serum |
|
5323-1
|
Orientia tsutsugamushi Ab [Titer] in Serum by Complement fixation |
|
60268-0
|
Orientia tsutsugamushi DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
48867-6
|
Orientia tsutsugamushi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
29687-1
|
Orientia tsutsugamushi Gilliam Ab [Presence] in Serum |
|
29714-3
|
Orientia tsutsugamushi Gilliam Ab [Presence] in Serum by Immunofluorescence |
|
31607-5
|
Orientia tsutsugamushi Gilliam Ab [Units/volume] in Serum |
|
29686-3
|
Orientia tsutsugamushi Gilliam Ab [Titer] in Serum |
|
29713-5
|
Orientia tsutsugamushi Gilliam Ab [Titer] in Serum by Immunofluorescence |
|
49174-6
|
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid |
|
48897-3
|
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49173-8
|
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum |
|
48852-8
|
Orientia tsutsugamushi Gilliam IgG Ab [Titer] in Serum by Immunofluorescence |
|
49172-0
|
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid |
|
48896-5
|
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49171-2
|
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum |
|
48851-0
|
Orientia tsutsugamushi Gilliam IgM Ab [Titer] in Serum by Immunofluorescence |
|
31606-7
|
Orientia tsutsugamushi IgG Ab [Units/volume] in Serum |
|
21498-1
|
Orientia tsutsugamushi IgG Ab [Titer] in Serum |
|
33897-0
|
Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma |
|
33896-2
|
Orientia tsutsugamushi IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
29689-7
|
Orientia tsutsugamushi Karp Ab [Presence] in Serum |
|
29716-8
|
Orientia tsutsugamushi Karp Ab [Presence] in Serum by Immunofluorescence |
|
31608-3
|
Orientia tsutsugamushi Karp Ab [Units/volume] in Serum |
|
29688-9
|
Orientia tsutsugamushi Karp Ab [Titer] in Serum |
|
29715-0
|
Orientia tsutsugamushi Karp Ab [Titer] in Serum by Immunofluorescence |
|
49170-4
|
Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid |
|
48898-1
|
Orientia tsutsugamushi Karp IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49169-6
|
Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum |
|
48853-6
|
Orientia tsutsugamushi Karp IgG Ab [Titer] in Serum by Immunofluorescence |
|
49168-8
|
Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid |
|
48899-9
|
Orientia tsutsugamushi Karp IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49167-0
|
Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum |
|
48854-4
|
Orientia tsutsugamushi Karp IgM Ab [Titer] in Serum by Immunofluorescence |
|
29691-3
|
Orientia tsutsugamushi Kato Ab [Presence] in Serum |
|
29718-4
|
Orientia tsutsugamushi Kato Ab [Presence] in Serum by Immunofluorescence |
|
31609-1
|
Orientia tsutsugamushi Kato Ab [Units/volume] in Serum |
|
29690-5
|
Orientia tsutsugamushi Kato Ab [Titer] in Serum |
|
29717-6
|
Orientia tsutsugamushi Kato Ab [Titer] in Serum by Immunofluorescence |
|
49166-2
|
Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid |
|
48900-5
|
Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49165-4
|
Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum |
|
48855-1
|
Orientia tsutsugamushi Kato IgG Ab [Titer] in Serum by Immunofluorescence |
|
49164-7
|
Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid |
|
48901-3
|
Orientia tsutsugamushi Kato IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49163-9
|
Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum |
|
48856-9
|
Orientia tsutsugamushi Kato IgM Ab [Titer] in Serum by Immunofluorescence |
|
29693-9
|
Orientia tsutsugamushi Litchfield Ab [Presence] in Serum |
|
29720-0
|
Orientia tsutsugamushi Litchfield Ab [Presence] in Serum by Immunofluorescence |
|
31610-9
|
Orientia tsutsugamushi Litchfield Ab [Units/volume] in Serum |
|
29692-1
|
Orientia tsutsugamushi Litchfield Ab [Titer] in Serum |
|
29719-2
|
Orientia tsutsugamushi Litchfield Ab [Titer] in Serum by Immunofluorescence |
|
48875-9
|
Orientia tsutsugamushi [Presence] in Unspecified specimen by Organism specific culture |
|
49126-6
|
Orientia tsutsugamushi identified in Unspecified specimen by Sequencing |
|
87641-7
|
o,p'- Dichlorodiphenyltrichloroethane [Mass/mass] in Unspecified specimen |
|
87643-3
|
o,p'- DDD [Mass/mass] in Unspecified specimen |
|
87642-5
|
o,p'- DDE [Mass/mass] in Unspecified specimen |
|
50625-3
|
Ova and parasites identified in Blood or Tissue by Wright stain |
|
10855-5
|
Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy |
|
91826-8
|
Ova and parasites identified in Lower respiratory specimen by Light microscopy |
|
18494-5
|
Ova and parasites identified in Stool by Concentration--2nd specimen |
|
13319-9
|
Ova and parasites identified in Stool by Light microscopy--2nd specimen |
|
18496-0
|
Ova and parasites identified in Stool by Trichrome stain--2nd specimen |
|
52795-2
|
Ova and parasites identified in Unspecified specimen by Light microscopy--2nd specimen |
|
18493-7
|
Ova and parasites identified in Stool by Concentration--3rd specimen |
|
13320-7
|
Ova and parasites identified in Stool by Light microscopy--3rd specimen |
|
18495-2
|
Ova and parasites identified in Stool by Trichrome stain--3rd specimen |
|
52794-5
|
Ova and parasites identified in Unspecified specimen by Light microscopy--3rd specimen |
|
91768-2
|
Ova and parasites identified in Sputum by Light microscopy |
|
20926-2
|
Ova and parasites identified in Stool by Baerman concentration |
|
10701-1
|
Ova and parasites identified in Stool by Concentration |
|
18307-9
|
Ova and parasites identified in Stool by Iron hematoxylin stain |
|
10702-9
|
Ova and parasites identified in Stool by Immune stain |
|
10703-7
|
Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain |
|
20925-4
|
Ova and parasites identified in Stool by McMaster concentration |
|
10704-5
|
Ova and parasites identified in Stool by Light microscopy |
|
20924-7
|
Ova and parasites identified in Stool by Parasite sedimentation |
|
43227-8
|
Ova and parasites identified in Stool by Trichrome stain |
|
6674-6
|
Ova and parasites identified in Tissue by Light microscopy |
|
26885-4
|
Ova and parasites identified in Unspecified specimen by Concentration |
|
673-4
|
Ova and parasites identified in Unspecified specimen by Light microscopy |
|
53809-0
|
Oxygen.alveolar - arterial [Partial pressure difference] adjusted to patient's actual temperature Respiratory system |
|
59404-4
|
Oxygen capacity [Moles/volume] in Arterial blood |
|
60842-2
|
Oxygen consumption (VO2) |
|
55962-5
|
Oxygen content in Cord blood |
|
10226-9
|
Oxygen content in Intravascular space |
|
10245-9
|
Oxygen content in Main pulmonary artery |
|
10244-2
|
Oxygen content in Left pulmonary artery |
|
10246-7
|
Oxygen content in Right pulmonary artery |
|
10247-5
|
Oxygen content in Pulmonary wedge |
|
60867-9
|
Oxygen [VFr/PPres] Airway adaptor --during expiration |
|
76105-6
|
Oxygen [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
62274-6
|
Oxygen [VFr/PPres] Airway adaptor --during inspiration |
|
76106-4
|
Oxygen [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60943-8
|
Oxygen [VFr/PPres] Airway adaptor --at end expiration |
|
75991-0
|
Oxygen extraction ratio |
|
75998-5
|
Oxygen gas delivered during case [Volume] from Gas delivery system |
|
75999-3
|
Oxygen gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
60799-4
|
Gas delivery system inspiratory Oxygen setting [VFr/PPres] |
|
75939-9
|
Oxygen gas setting Infant microenvironment.incubator |
|
55415-4
|
Oxygen therapy tracking panel |
|
60866-1
|
Oxygen [VFr/PPres] Airway adaptor |
|
61018-8
|
Oxygen [VFr/PPres] Gas delivery system |
|
75938-1
|
Oxygen/Gas total Infant microenvironment.incubator |
|
57085-3
|
Organic acid newborn screen panel |
|
50030-6
|
Oak wood dust IgE Ab [Units/volume] in Serum |
|
38737-3
|
O-anisidine [Mass/volume] in Air |
|
50040-5
|
Advanced oxidation protein products [Moles/volume] in Serum or Plasma |
|
7539-0
|
Oat triggered histamine release [Units/volume] in Blood |
|
6190-3
|
Oat IgE Ab [Units/volume] in Serum |
|
61226-7
|
Oat IgE Ab/IgE total in Serum |
|
7538-2
|
Oat IgG Ab [Units/volume] in Serum |
|
56333-8
|
Oat IgG4 Ab [Mass/volume] in Serum |
|
51901-7
|
Oat IgG Ab [Mass/volume] in Serum |
|
48220-8
|
Oat triggered leukotriene release [Mass/volume] by Leukocytes |
|
6093-9
|
Oat pollen IgE Ab [Units/volume] in Serum |
|
56334-6
|
Oat pollen IgG4 Ab [Mass/volume] in Serum |
|
7707-3
|
Oat smut IgE Ab [Units/volume] in Serum |
|
56459-1
|
Oat smut IgG4 Ab [Mass/volume] in Serum |
|
7117-5
|
Oat+Barley IgE Ab [Units/volume] in Serum |
|
89442-8
|
Obstetrics Administrative note |
|
89443-6
|
Obstetrics Admission history and physical note |
|
89454-3
|
Obstetrics Attending Note |
|
89444-4
|
Obstetrics Checklist |
|
89227-3
|
Obstetrics Consult note |
|
89236-4
|
Obstetrics Diagnostic study note |
|
89228-1
|
Obstetrics Discharge instructions |
|
89214-1
|
Obstetrics Discharge summary |
|
89229-9
|
Obstetrics Discharge teaching note |
|
89230-7
|
Obstetrics Education note |
|
93086-7
|
Obstetrics Emergency procedure note |
|
89238-0
|
Obstetrics Flowsheet |
|
89213-3
|
Obstetrics History and physical note |
|
89446-9
|
Obstetrics Hospital Consult note |
|
89448-5
|
Obstetrics Hospital Letter |
|
89458-4
|
Obstetrics Hospital Note |
|
89231-5
|
Obstetrics Initial evaluation note |
|
82356-7
|
Obstetrics Midwife Consult note |
|
89241-4
|
Obstetrics Note |
|
89452-7
|
Obstetrics Nurse practitioner Note |
|
89450-1
|
Obstetrics Nurse Note |
|
89462-6
|
Obstetrics Nurse Outpatient Note |
|
89460-0
|
Obstetrics Outpatient Note |
|
89457-6
|
Obstetrics Surgical operation note |
|
89464-2
|
Obstetrics Telephone encounter Note |
|
89240-6
|
Obstetrics Plan of care note |
|
50191-6
|
Occult blood panel - Gastric fluid |
|
50196-5
|
Occult blood panel - Stool |
|
57803-9
|
Occult blood panel - Stool by Immunoassay |
|
89466-7
|
Obstetrics Postoperative evaluation and management note |
|
89468-3
|
Obstetrics Preoperative evaluation and management note |
|
89232-3
|
Obstetrics procedure note |
|
89233-1
|
Obstetrics Progress note |
|
89234-9
|
Obstetrics Referral note |
|
89456-8
|
Obstetrics Resident Note |
|
89470-9
|
Obstetrics Summary note |
|
89235-6
|
Obstetrics Transfer summary note |
|
35096-7
|
OB ultrasound panel |
|
90354-2
|
Obesity medicine Consult note |
|
90355-9
|
Obesity medicine Group counseling note |
|
90356-7
|
Obesity medicine Initial evaluation note |
|
75430-9
|
Obesity medicine Note |
|
85472-9
|
Obesity medicine Telephone encounter Note |
|
84305-2
|
Obstetrics and Gynecology Administrative note |
|
78718-4
|
Obstetrics and Gynecology Admission history and physical note |
|
83690-8
|
Obstetrics and gynecology Attending Note |
|
78717-6
|
Obstetrics and Gynecology Checklist |
|
34777-3
|
Obstetrics and Gynecology Consult note |
|
68557-8
|
Obstetrics and Gynecology Diagnostic study note |
|
78720-0
|
Obstetrics and Gynecology Discharge instructions |
|
68558-6
|
Obstetrics and Gynecology Discharge summary |
|
78721-8
|
Obstetrics and Gynecology Discharge teaching note |
|
78722-6
|
Obstetrics and Gynecology Education note |
|
78711-9
|
Obstetrics and Gynecology Flowsheet |
|
68560-2
|
Obstetrics and Gynecology History and physical note |
|
68566-9
|
Obstetrics and Gynecology Hospital Consult note |
|
68567-7
|
Obstetrics and Gynecology Hospital Letter |
|
84304-5
|
Obstetrics and Gynecology Hospital Note |
|
78723-4
|
Obstetrics and Gynecology Initial evaluation note |
|
34778-1
|
Obstetrics and Gynecology Note |
|
83558-7
|
Obstetrics and gynecology Nurse practitioner Note |
|
83587-6
|
Obstetrics and gynecology Nurse Note |
|
83588-4
|
Obstetrics and gynecology Nurse Outpatient Note |
|
84384-7
|
Obstetrics and Gynecology Outpatient Note |
|
78719-2
|
Obstetrics and Gynecology Surgical operation note |
|
84386-2
|
Obstetrics and Gynecology Telephone encounter Note |
|
80787-5
|
Obstetrics and Gynecology Plan of care note |
|
84385-4
|
Obstetrics and Gynecology Postoperative evaluation and management note |
|
68562-8
|
Obstetrics and Gynecology Preoperative evaluation and management note |
|
68563-6
|
Obstetrics and Gynecology procedure note |
|
68564-4
|
Obstetrics and Gynecology Progress note |
|
57179-4
|
Obstetrics and Gynecology Referral note |
|
83765-8
|
Obstetrics and gynecology Resident Note |
|
77962-9
|
Obstetrics and Gynecology Summary note |
|
68565-1
|
Obstetrics and Gynecology Transfer summary note |
|
79898-3
|
Objective refraction measurements panel |
|
88021-1
|
Objective assessment of cardiovascular disease NYHA |
|
84387-0
|
Observation unit Admission evaluation note |
|
85200-4
|
Observation unit Discharge summary |
|
85201-2
|
Observation unit History and physical note |
|
82610-7
|
Observation unit Note |
|
24364-2
|
Obstetric 1996 panel - Serum and Blood |
|
20907-2
|
Organochlorine pesticides [Identifier] in Blood |
|
20912-2
|
Organochlorine pesticides [Presence] in Blood by Screen method |
|
20909-8
|
Organochlorine pesticides [Identifier] in Gastric fluid |
|
20914-8
|
Organochlorine pesticides [Presence] in Gastric fluid by Screen method |
|
20910-6
|
Organochlorine pesticides [Identifier] in Milk |
|
20915-5
|
Organochlorine pesticides [Presence] in Milk by Screen method |
|
9791-5
|
Organochlorine pesticides [Type] in Serum or Plasma |
|
20911-4
|
Organochlorine pesticides [Identifier] in Tissue |
|
20916-3
|
Organochlorine pesticides [Presence] in Tissue by Screen method |
|
17388-0
|
Organochlorine pesticides [Type] in Urine |
|
20908-0
|
Organochlorine pesticides [Identifier] in Unspecified specimen |
|
20913-0
|
Organochlorine pesticides [Presence] in Unspecified specimen by Screen method |
|
43747-5
|
OCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
15235-5
|
Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
|
73715-5
|
Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk |
|
15236-3
|
Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Presence] in Serum by Multidisk |
|
82088-6
|
Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Units/volume] in Serum by Multidisk |
|
15237-1
|
Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Presence] in Serum by Multidisk |
|
82090-2
|
Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Units/volume] in Serum by Multidisk |
|
15238-9
|
Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk |
|
82092-8
|
Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Units/volume] in Serum by Multidisk |
|
15239-7
|
Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
|
73718-9
|
Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk |
|
15240-5
|
Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
|
73716-3
|
Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Units/volume] in Serum by Multidisk |
|
85659-1
|
Occupation CDC Census code |
|
84388-8
|
Occupational medicine Admission evaluation note |
|
34803-7
|
Occupational medicine Consult note |
|
87271-3
|
Occupational medicine Immunization note |
|
34802-9
|
Occupational medicine Note |
|
84389-6
|
Occupational medicine Nurse Note |
|
84390-4
|
Occupational medicine Outpatient Note |
|
84392-0
|
Occupational medicine Telephone encounter Note |
|
84391-2
|
Occupational medicine procedure note |
|
57147-1
|
Occupational medicine Referral note |
|
74163-7
|
Usual occupation duration |
|
85078-4
|
Occupation industry [Type] |
|
85658-3
|
Occupation [Type] |
|
74166-0
|
Occupational summary note |
|
93463-8
|
Ocfentanil [Mass/volume] in Urine by Confirmatory method |
|
53883-5
|
OCRL1 mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
2682-3
|
Ornithine carbamoyltransferase [Enzymatic activity/volume] in Amniotic fluid |
|
2683-1
|
Ornithine carbamoyltransferase [Enzymatic activity/volume] in Serum |
|
87674-8
|
Optical coherence tomography study report |
|
32617-3
|
Ornithine carbamoyltransferase [Enzymatic activity/mass] in Tissue |
|
53641-7
|
OCT2 Ag [Presence] in Tissue by Immune stain |
|
75118-0
|
Octadecanoate (C18:0) [Entitic substance] in Red Blood Cells |
|
47779-4
|
Octadecanoate (C18:0)/Creatinine [Molar ratio] in Urine |
|
79706-8
|
Octadecatetraenoate (C18:4w3) [Entitic substance] in Red Blood Cells |
|
79695-3
|
Octadecatetraenoate (C18:4w3) [Moles/volume] in Serum or Plasma |
|
75120-6
|
Octanoate (C8:0) [Entitic substance] in Red Blood Cells |
|
54322-3
|
Octanoylcarnitine (C8) [Moles/volume] in Amniotic fluid |
|
54321-5
|
Octanoylcarnitine (C8) [Moles/volume] in Cerebral spinal fluid |
|
53175-6
|
Octanoylcarnitine (C8) [Moles/volume] in DBS |
|
74592-7
|
Octanoylcarnitine (C8) [Enzymatic activity/mass] in Fibroblast |
|
55950-0
|
Octanoylcarnitine (C8) [Moles/volume] in Urine |
|
88014-6
|
Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in DBS |
|
88006-2
|
Octanoylcarnitine (C8)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
53177-2
|
Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS |
|
59208-9
|
Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Serum or Plasma |
|
53176-4
|
Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
59200-6
|
Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
54320-7
|
Octanoylcarnitine (C8)/Creatinine [Molar ratio] in Urine |
|
79516-1
|
Octenedioate (C8:1) [Moles/volume] in Serum or Plasma |
|
55953-4
|
Octenoylcarnitine (C8:1) [Moles/volume] in Amniotic fluid |
|
55952-6
|
Octenoylcarnitine (C8:1) [Moles/volume] in Cerebral spinal fluid |
|
53174-9
|
Octenoylcarnitine (C8:1) [Moles/volume] in DBS |
|
55954-2
|
Octenoylcarnitine (C8:1) [Moles/volume] in Urine |
|
55951-8
|
Octenoylcarnitine (C8:1)/Creatinine [Molar ratio] in Urine |
|
2672-4
|
Octopamine [Moles/volume] in Urine |
|
10944-7
|
Octopus IgE Ab [Units/volume] in Serum |
|
58016-7
|
Octreotide [Mass/volume] in Serum or Plasma |
|
88569-9
|
Ocular pathogens panel - Cornea or Conjunctiva Qualitative by NAA with probe detection |
|
14335-4
|
Optical density of Amniotic fluid by Spectrophotometry |
|
10997-5
|
O-desmethylencainide [Mass/volume] in Serum or Plasma |
|
60102-1
|
Norvenlafaxine [Mass/volume] in Blood |
|
60103-9
|
Norvenlafaxine [Mass/volume] in Body fluid |
|
9628-9
|
Norvenlafaxine [Mass/volume] in Serum or Plasma |
|
48362-8
|
Norvenlafaxine [Moles/volume] in Serum or Plasma |
|
60104-7
|
Norvenlafaxine [Mass/mass] in Tissue |
|
72772-7
|
Norvenlafaxine [Mass/volume] in Urine by Confirmatory method |
|
75234-5
|
Norvenlafaxine [Presence] in Urine |
|
53882-7
|
Norvenlafaxine [Mass/volume] in Urine |
|
72773-5
|
Norvenlafaxine/Creatinine [Mass Ratio] in Urine |
|
3877-8
|
Ofloxacin [Mass/volume] in Serum or Plasma |
|
25264-3
|
Ofloxacin [Mass/volume] in Unspecified specimen |
|
16186-9
|
Hydroxyalprazolam [Mass/volume] in Stool |
|
20500-5
|
Hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
|
19490-2
|
Hydroxyalprazolam [Presence] in Urine by Confirmatory method |
|
19489-4
|
Hydroxyalprazolam [Presence] in Urine by Screen method |
|
11238-3
|
Hydroxyalprazolam [Mass/volume] in Urine |
|
90467-2
|
Hydroxyaripiprazole [Mass/volume] in Urine by Confirmatory method |
|
90468-0
|
Hydroxyaripiprazole [Presence] in Urine by Screen method |
|
60083-3
|
Hydroxybupropion [Mass/volume] in Blood |
|
60084-1
|
Hydroxybupropion [Mass/volume] in Body fluid |
|
9418-5
|
Hydroxybupropion [Mass/volume] in Serum or Plasma |
|
55542-5
|
Hydroxybupropion [Moles/volume] in Serum or Plasma |
|
60085-8
|
Hydroxybupropion [Mass/mass] in Tissue |
|
78831-5
|
Hydroxybupropion [Presence] in Urine by Confirmatory method |
|
89992-2
|
Hydroxybupropion [Presence] in Urine by Screen method |
|
60086-6
|
Hydroxybupropion [Mass/volume] in Urine |
|
2439-8
|
Hydroxycalcidiol [Mass/volume] in Serum |
|
3684-8
|
Hydroxychloroquine [Mass/volume] in Serum or Plasma |
|
55543-3
|
Hydroxychloroquine [Moles/volume] in Serum or Plasma |
|
74986-1
|
Hydroxychloroquine [Mass/volume] in Serum or Plasma --trough |
|
49906-1
|
Hydroxydecanedioate/Creatinine [Molar ratio] in 24 hour Urine |
|
59683-3
|
Hydroxyethylflurazepam [Mass/volume] in Blood by Confirmatory method |
|
59682-5
|
Hydroxyethylflurazepam [Mass/volume] in Blood |
|
59685-8
|
Hydroxyethylflurazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59684-1
|
Hydroxyethylflurazepam [Mass/volume] in Body fluid |
|
26836-7
|
Hydroxyethylflurazepam [Mass/mass] in Hair |
|
59686-6
|
Hydroxyethylflurazepam [Mass/mass] in Meconium by Confirmatory method |
|
26936-5
|
Hydroxyethylflurazepam [Mass/mass] in Meconium |
|
16245-3
|
Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
32648-8
|
Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma |
|
59687-4
|
Hydroxyethylflurazepam [Mass/mass] in Stool by Confirmatory method |
|
12604-5
|
Hydroxyethylflurazepam [Presence] in Stool |
|
27247-6
|
Hydroxyethylflurazepam [Mass/mass] in Stool |
|
59689-0
|
Hydroxyethylflurazepam [Mass/mass] in Tissue by Confirmatory method |
|
59688-2
|
Hydroxyethylflurazepam [Mass/mass] in Tissue |
|
20532-8
|
Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method |
|
19494-4
|
Hydroxyethylflurazepam [Presence] in Urine by Confirmatory method |
|
19493-6
|
Hydroxyethylflurazepam [Presence] in Urine by Screen method |
|
12602-9
|
Hydroxyethylflurazepam [Mass/volume] in Urine |
|
48953-4
|
Hydroxyethylflurazepam [Mass/volume] in Unspecified specimen |
|
44553-6
|
Hydroxyitraconazole [Presence] in Serum or Plasma |
|
18337-6
|
Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
|
78833-1
|
Hydroxylurasidone [Mass/volume] in Urine by Confirmatory method |
|
54303-3
|
Hydroxylysine [Moles/volume] in DBS |
|
56034-2
|
Hydroxylysine [Moles/volume] in Body fluid |
|
49849-3
|
Hydroxylysine.free/Creatinine [Molar ratio] in 24 hour Urine |
|
55891-6
|
Hydroxylysine [Moles/mass] in Hair |
|
56684-4
|
Hydroxylysine/Creatinine [Ratio] in 24 hour Urine |
|
3685-5
|
Hydroxymethoxyphenamine [Mass/volume] in Urine |
|
42538-9
|
Hydroxyperhexiline [Mass/volume] in Serum or Plasma |
|
42539-7
|
Hydroxyperhexiline/Perhexiline [Mass Ratio] in Serum or Plasma |
|
26810-2
|
Hydroxyproline [Presence] in 24 hour Urine |
|
59392-1
|
Hydroxyproline [Mass/volume] in 24 hour Urine |
|
2447-1
|
Hydroxyproline [Mass/time] in 24 hour Urine |
|
25934-1
|
Hydroxyproline [Moles/volume] in 24 hour Urine |
|
14785-0
|
Hydroxyproline [Moles/time] in 24 hour Urine |
|
12720-9
|
Hydroxyproline [Mass/volume] in 2 hour Urine |
|
13401-5
|
Hydroxyproline [Mass/volume] in Amniotic fluid |
|
27181-7
|
Hydroxyproline [Moles/volume] in Amniotic fluid |
|
13374-4
|
Hydroxyproline [Mass/volume] in Cerebral spinal fluid |
|
26596-7
|
Hydroxyproline [Moles/volume] in Cerebral spinal fluid |
|
47651-5
|
Hydroxyproline [Moles/volume] in DBS |
|
32249-5
|
Hydroxyproline [Moles/volume] in Body fluid |
|
30139-0
|
Hydroxyproline Free [Presence] in 24 hour Urine |
|
2450-5
|
Hydroxyproline Free [Mass/time] in 24 hour Urine |
|
32022-6
|
Hydroxyproline Free [Moles/volume] in 24 hour Urine |
|
14784-3
|
Hydroxyproline Free [Moles/time] in 24 hour Urine |
|
2448-9
|
Hydroxyproline Free [Mass/volume] in Serum or Plasma |
|
56685-1
|
Hydroxyproline Free [Moles/volume] in Serum or Plasma |
|
2449-7
|
Hydroxyproline Free [Mass/volume] in Urine |
|
32183-6
|
Hydroxyproline Free [Moles/volume] in Urine |
|
56686-9
|
Hydroxyproline Free/Creatinine [Ratio] in 24 hour Urine |
|
74880-6
|
Hydroxyproline [Moles/volume] in DBS --post therapeutic diet |
|
2445-5
|
Hydroxyproline [Presence] in Serum or Plasma |
|
2446-3
|
Hydroxyproline [Mass/volume] in Serum or Plasma |
|
20647-4
|
Hydroxyproline [Moles/volume] in Serum or Plasma |
|
17001-9
|
Hydroxyproline [Presence] in Urine |
|
2451-3
|
Hydroxyproline [Mass/volume] in Urine |
|
26740-1
|
Hydroxyproline [Moles/volume] in Urine |
|
32250-3
|
Hydroxyproline [Moles/volume] in Vitreous fluid |
|
44386-1
|
Hydroxyproline/Creatinine [Mass Ratio] in 24 hour Urine |
|
13996-4
|
Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine |
|
59383-0
|
Hydroxyproline/Creatinine [Mass Ratio] in 2 hour Urine |
|
13763-8
|
Hydroxyproline/Creatinine [Mass Ratio] in Urine |
|
28601-3
|
Hydroxyproline/Creatinine [Ratio] in Urine |
|
25110-8
|
Hydroxyproline/Creatinine [Molar ratio] in Urine |
|
59691-6
|
Hydroxytriazolam [Mass/volume] in Blood by Confirmatory method |
|
59690-8
|
Hydroxytriazolam [Mass/volume] in Blood |
|
59693-2
|
Hydroxytriazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59692-4
|
Hydroxytriazolam [Mass/volume] in Body fluid |
|
26877-1
|
Hydroxytriazolam [Mass/mass] in Hair |
|
59694-0
|
Hydroxytriazolam [Mass/mass] in Meconium by Confirmatory method |
|
26912-6
|
Hydroxytriazolam [Mass/mass] in Meconium |
|
17002-7
|
Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
32649-6
|
Hydroxytriazolam [Mass/volume] in Serum or Plasma |
|
12383-6
|
Hydroxytriazolam [Presence] in Stool |
|
26976-1
|
Hydroxytriazolam [Mass/mass] in Stool |
|
59696-5
|
Hydroxytriazolam [Mass/mass] in Tissue by Confirmatory method |
|
59695-7
|
Hydroxytriazolam [Mass/mass] in Tissue |
|
20501-3
|
Hydroxytriazolam [Mass/volume] in Urine by Confirmatory method |
|
20533-6
|
Hydroxytriazolam [Presence] in Urine by Confirmatory method |
|
19497-7
|
Hydroxytriazolam [Presence] in Urine by Screen method |
|
12432-1
|
Hydroxytriazolam [Mass/volume] in Urine |
|
48954-2
|
Hydroxytriazolam [Mass/volume] in Unspecified specimen |
|
7543-2
|
Oidiodendrum spp IgE Ab [Units/volume] in Serum |
|
27943-0
|
Interferon omega [Mass/volume] in Serum or Plasma |
|
40790-8
|
Oil palm IgE Ab [Units/volume] in Serum |
|
82430-0
|
OJ Ab [Units/volume] in Serum by Line blot |
|
45152-6
|
OJ Ab [Presence] in Serum |
|
69557-7
|
OJ Ab [Presence] in Serum by Immunoblot |
|
48649-8
|
OJ Ab [Presence] in Serum by Radioimmunoprecipitation assay (RIPA) |
|
83137-0
|
OJ IgG Ab [Presence] in Serum by Line blot |
|
55225-7
|
Okoume IgE Ab [Units/volume] in Serum |
|
7544-0
|
Okra IgE Ab [Units/volume] in Serum |
|
56335-3
|
Okra IgG4 Ab [Mass/volume] in Serum |
|
63149-9
|
Okra IgG Ab [Mass/volume] in Serum |
|
35476-1
|
OKT3 blocking Ab [Titer] in Serum or Plasma by Flow cytometry (FC) |
|
14187-9
|
OKT3 [Mass/volume] in Serum or Plasma |
|
72984-8
|
OLANZapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72983-0
|
OLANZapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60105-4
|
OLANZapine [Mass/volume] in Blood |
|
60106-2
|
OLANZapine [Mass/volume] in Body fluid |
|
59946-4
|
OLANZapine [Moles/volume] in Gastric fluid |
|
73235-4
|
OLANZapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73234-7
|
OLANZapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
75021-6
|
OLANZapine panel - Serum or Plasma |
|
89983-1
|
OLANZapine [Presence] in Serum or Plasma by Screen method |
|
12389-3
|
OLANZapine [Mass/volume] in Serum or Plasma |
|
39484-1
|
OLANZapine [Moles/volume] in Serum or Plasma |
|
60107-0
|
OLANZapine [Mass/mass] in Tissue |
|
77888-6
|
OLANZapine [Mass/volume] in Urine by Confirmatory method |
|
40390-7
|
OLANZapine [Presence] in Urine |
|
50891-1
|
OLANZapine [Moles/volume] in Urine |
|
60325-8
|
OLANZapine [Moles/volume] in Unspecified specimen |
|
20906-4
|
Oleandrin [Mass/volume] in Ingesta |
|
20905-6
|
Oleandrin [Mass/volume] in Urine |
|
75102-4
|
Oleate (C18:1w9) [Entitic substance] in Red Blood Cells |
|
47713-3
|
Oleate (C18:1w9)/Creatinine [Molar ratio] in Urine |
|
55957-5
|
Oleoylcarnitine (C18:1) [Moles/volume] in Amniotic fluid |
|
55956-7
|
Oleoylcarnitine (C18:1) [Moles/volume] in Cerebral spinal fluid |
|
53202-8
|
Oleoylcarnitine (C18:1) [Moles/volume] in DBS |
|
55958-3
|
Oleoylcarnitine (C18:1) [Moles/volume] in Urine |
|
55955-9
|
Oleoylcarnitine (C18:1)/Creatinine [Molar ratio] in Urine |
|
35568-5
|
Oligoclonal bands [#] in Cerebral spinal fluid by Electrophoresis |
|
32358-4
|
Oligoclonal bands [Presence] in Cerebral spinal fluid |
|
56764-4
|
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing |
|
35569-3
|
Oligoclonal bands [#] in Serum or Plasma |
|
56974-9
|
Oligoclonal bands [Interpretation] in Serum or Plasma by Isoelectric focusing |
|
48422-0
|
Oligoclonal bands [Presence] in Serum or Plasma |
|
38525-2
|
Oligoclonal bands [Mass/volume] in Urine by Electrophoresis |
|
48668-8
|
Protein fractions.oligoclonal bands.intrathecal [Presence] in Serum and CSF |
|
82506-7
|
Oligosaccharides pattern [Interpretation] in Fibroblast by Screen method Narrative |
|
82507-5
|
Oligosaccharides pattern [Interpretation] in Leukocytes by Screen method Narrative |
|
12239-0
|
Oligosaccharides [Presence] in Urine |
|
48147-3
|
Oligosaccharides/Creatinine [Molar ratio] in Urine |
|
58754-3
|
Olive pollen native (nOle e) 1 IgE Ab [Units/volume] in Serum |
|
66450-8
|
Olive native (nOle e) 2 IgE Ab [Units/volume] in Serum |
|
65779-1
|
Olive pollen native (nOle e) 7 IgE Ab [Units/volume] in Serum |
|
56727-1
|
Olive recombinant (rOle e) 2 IgE Ab [Units/volume] in Serum |
|
65780-9
|
Olive pollen recombinant (rOle e) 9 IgE Ab [Units/volume] in Serum |
|
21428-8
|
Olive IgE Ab [Units/volume] in Serum |
|
7546-5
|
Olive IgG Ab [Units/volume] in Serum |
|
56276-9
|
Olive IgG4 Ab [Mass/volume] in Serum |
|
78697-0
|
Olive IgG Ab [Mass/volume] in Serum |
|
6192-9
|
Olive Pollen IgE Ab [Units/volume] in Serum |
|
58017-5
|
Olive Pollen IgE Ab/IgE total in Serum |
|
56336-1
|
Olive Pollen IgG4 Ab [Mass/volume] in Serum |
|
48246-3
|
Olive Pollen triggered leukotriene release [Mass/volume] by Leukocytes |
|
48547-4
|
Omaha System 2005 panel |
|
88999-8
|
Omega-3 (EPA+DHA) index risk in Serum or Plasma |
|
88998-0
|
Omega-3 (EPA+DHA) index in Serum or Plasma |
|
72982-2
|
Omeprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72981-4
|
Omeprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73233-9
|
Omeprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73232-1
|
Omeprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14188-7
|
Omeprazole [Mass/volume] in Serum or Plasma |
|
82887-1
|
Ortho methylhippurate [Moles/volume] in Urine |
|
82888-9
|
Ortho methylhippurate/Creatinine [Molar ratio] in Urine |
|
42722-9
|
OmpC Ab [Presence] in Serum |
|
42724-5
|
OmpC Ab [Presence] in Serum by Immunoassay |
|
42723-7
|
OmpC Ab [Units/volume] in Serum |
|
66482-1
|
OmpC IgA Ab [Units/volume] in Serum by Immunoassay |
|
45148-4
|
OmpC IgA Ab [Presence] in Serum |
|
58706-3
|
OmpC IgA Ab [Presence] in Serum by Immunoassay |
|
2688-0
|
Orotidine-5'-Phosphate decarboxylase [Enzymatic activity/volume] in Serum |
|
84382-1
|
Oral and Maxillofacial Surgery Admission evaluation note |
|
78511-3
|
Oral and Maxillofacial Surgery Admission history and physical note |
|
83662-7
|
Oral and maxillofacial surgery Attending Note |
|
78540-2
|
Oral and Maxillofacial Surgery Checklist |
|
34812-8
|
Oral and Maxillofacial Surgery Consult note |
|
78594-9
|
Oral and Maxillofacial Surgery Education note |
|
78616-0
|
Oral and Maxillofacial Surgery Flowsheet |
|
82834-3
|
Oral and Maxillofacial Surgery Initial evaluation note |
|
34813-6
|
Oral and Maxillofacial Surgery Note |
|
84381-3
|
Oral and Maxillofacial Surgery Outpatient Note |
|
78678-0
|
Oral and Maxillofacial Surgery Surgical operation note |
|
80769-3
|
Oral and Maxillofacial Surgery Plan of care note |
|
84380-5
|
Oral and Maxillofacial Surgery Postoperative evaluation and management note |
|
78715-0
|
Oral and Maxillofacial Surgery Preoperative evaluation and management note |
|
84379-7
|
Oral and Maxillofacial Surgery procedure note |
|
57174-5
|
Oral and Maxillofacial Surgery Referral note |
|
83767-4
|
Oral and maxillofacial surgery Resident Note |
|
78684-8
|
Oral and Maxillofacial Surgery Transfer summary note |
|
5264-7
|
Onchocerca sp Ab [Units/volume] in Serum |
|
49771-9
|
Onchocerca sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
87992-4
|
Onchocerca sp IgG Ab [Presence] in Serum by Immunoassay |
|
49784-2
|
Onchocerca sp IgG Ab [Units/volume] in Serum |
|
49785-9
|
Onchocerca sp IgG2 Ab [Units/volume] in Serum by Immunoassay |
|
88573-1
|
Onchocerca sp IgG2 Ab [Presence] in Serum by Immunoassay |
|
51462-0
|
Onchocerca sp IgG2 Ab [Units/volume] in Serum |
|
49786-7
|
Onchocerca sp IgG3 Ab [Units/volume] in Serum by Immunoassay |
|
88574-9
|
Onchocerca sp IgG3 Ab [Presence] in Serum by Immunoassay |
|
51463-8
|
Onchocerca sp IgG3 Ab [Units/volume] in Serum |
|
49783-4
|
Onchocerca sp IgG4 Ab [Units/volume] in Serum by Immunoassay |
|
88575-6
|
Onchocerca sp IgG4 Ab [Presence] in Serum by Immunoassay |
|
51464-6
|
Onchocerca sp IgG4 Ab [Units/volume] in Serum |
|
10699-7
|
Onchocerca sp identified in Tissue by Wet preparation |
|
78392-8
|
Oncology Admission history and physical note |
|
81634-8
|
Oncology Recommended cancer surveillance |
|
74156-1
|
Oncology Plan of care and summary note |
|
34805-2
|
Oncology Consult note |
|
78417-3
|
Oncology Discharge instructions |
|
78421-5
|
Oncology Discharge summary |
|
78428-0
|
Oncology Discharge teaching note |
|
78453-8
|
Oncology Education note |
|
78462-9
|
Oncology Flowsheet |
|
78706-9
|
Oncology Form |
|
78465-2
|
Oncology History and physical note |
|
78471-0
|
Oncology Initial evaluation note |
|
34806-0
|
Oncology Note |
|
80759-4
|
Oncology Plan of care note |
|
78478-5
|
Oncology procedure note |
|
78482-7
|
Oncology Progress note |
|
81633-0
|
Oncology Recommended follow-up tests or procedures |
|
57149-7
|
Oncology Referral note |
|
78493-4
|
Oncology Transfer summary note |
|
73231-3
|
Ondansetron induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73230-5
|
Ondansetron induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
30168-9
|
Oneseed Juniper IgE Ab [Units/volume] in Serum |
|
7549-9
|
Onion triggered histamine release [Units/volume] in Blood |
|
6193-7
|
Onion IgE Ab [Units/volume] in Serum |
|
61210-1
|
Onion IgE Ab/IgE total in Serum |
|
7548-1
|
Onion IgG Ab [Units/volume] in Serum |
|
56337-9
|
Onion IgG4 Ab [Mass/volume] in Serum |
|
35541-2
|
Onion IgG Ab [Mass/volume] in Serum |
|
73973-0
|
O-nortramadol [Mass/volume] in Blood |
|
90750-1
|
O-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
82974-7
|
O-nortramadol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
92639-4
|
O-nortramadol [Mass/volume] in Urine by Confirmatory method |
|
91984-5
|
Outpatient Care management note |
|
24611-6
|
Outpatient Consultation 2nd opinion |
|
51845-6
|
Outpatient Consult note |
|
85202-0
|
Outpatient Evaluation and management of smoking cessation note |
|
67855-7
|
Outpatient Education note |
|
34120-6
|
Outpatient Initial evaluation note |
|
89430-3
|
Outpatient Medical history screening form |
|
54097-1
|
Organophosphonate nerve agent metabolite panel [Mass/volume] - Urine |
|
34108-1
|
Outpatient Note |
|
34137-0
|
Outpatient Surgical operation note |
|
9792-3
|
Organophosphate pesticides [Identifier] in Blood |
|
20917-1
|
Organophosphate pesticides [Presence] in Blood by Screen method |
|
20922-1
|
Organophosphate pesticides [Identifier] in Gastric fluid |
|
20919-7
|
Organophosphate pesticides [Presence] in Gastric fluid by Screen method |
|
20923-9
|
Organophosphate pesticides [Identifier] in Tissue |
|
20920-5
|
Organophosphate pesticides [Presence] in Tissue by Screen method |
|
18472-1
|
Organophosphate pesticides [Identifier] in Urine |
|
28042-0
|
Organophosphate pesticides [Mass/volume] in Urine by Screen method |
|
20921-3
|
Organophosphate pesticides [Identifier] in Unspecified specimen |
|
20918-9
|
Organophosphate pesticides [Presence] in Unspecified specimen by Screen method |
|
34131-3
|
Outpatient Progress note |
|
67865-6
|
Outpatient Supervisory note |
|
48601-9
|
OPA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81816-1
|
OPA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
23338-7
|
Ovine pulmonary adenomatosis retrovirus RNA [Presence] in Lung tissue by NAA with probe detection |
|
78870-3
|
OPC3373 (Metabolite of Ariprazole) [Mass/volume] in Urine by Confirmatory method |
|
61358-8
|
Surgical operation consent Document |
|
11504-8
|
Surgical operation note |
|
89429-5
|
Surgical operation order |
|
83691-6
|
Ophthalmology Attending Note |
|
83692-4
|
Ophthalmology Attending Surgical operation note |
|
83693-2
|
Ophthalmology Attending Preoperative evaluation and management note |
|
83742-7
|
Ophthalmology Fellow Note |
|
83589-2
|
Ophthalmology Nurse Note |
|
83574-4
|
Ophthalmology Nurse Outpatient Note |
|
83766-6
|
Ophthalmology Resident Note |
|
84409-2
|
Ophthalmology Technician Note |
|
84405-0
|
Ophthalmology Admission evaluation note |
|
78713-5
|
Ophthalmology Admission history and physical note |
|
84055-3
|
Ophthalmology Annual evaluation note |
|
78712-7
|
Ophthalmology Checklist |
|
34807-8
|
Ophthalmology Consult note |
|
78573-3
|
Ophthalmology Diagnostic study note |
|
84406-8
|
Ophthalmology Diagram |
|
68572-7
|
Ophthalmology Discharge summary |
|
78608-7
|
Ophthalmology Education note |
|
78638-4
|
Ophthalmology Flowsheet |
|
68573-5
|
Ophthalmology History and physical note |
|
68575-0
|
Ophthalmology Hospital Consult note |
|
68576-8
|
Ophthalmology Hospital Letter |
|
84407-6
|
Ophthalmology Hospital Note |
|
78647-5
|
Ophthalmology Initial evaluation note |
|
34808-6
|
Ophthalmology Note |
|
75462-2
|
Ophthalmology Outpatient Note |
|
34867-2
|
Ophthalmology Outpatient Postoperative evaluation and management note |
|
84408-4
|
Ophthalmology Outpatient procedure note |
|
78714-3
|
Ophthalmology Surgical operation note |
|
84410-0
|
Ophthalmology Telephone encounter Note |
|
80779-2
|
Ophthalmology Plan of care note |
|
67861-5
|
Ophthalmology Postoperative evaluation and management note |
|
34809-4
|
Ophthalmology Preoperative evaluation and management note |
|
78657-4
|
Ophthalmology procedure note |
|
68574-3
|
Ophthalmology Progress note |
|
84056-1
|
Ophthalmology Patient's home Note |
|
57150-5
|
Ophthalmology Referral note |
|
84412-6
|
Ophthalmology Risk assessment and screening note |
|
78513-9
|
Ophthalmology Summary of encounters note |
|
78512-1
|
Ophthalmology Summary note |
|
85882-9
|
Ophthalmology Teleimaging Consult note |
|
85881-1
|
Ophthalmology Teleimaging Note |
|
68887-9
|
Ophthalmology Transfer summary note |
|
51691-4
|
Opiates [Presence] in Blood by Screen method |
|
50620-4
|
Opiates cutoff [Mass/mass] in Meconium for Confirmatory method |
|
91043-0
|
Opiates [Presence] in Body fluid by Screen method |
|
8210-7
|
Opiates [Presence] in Gastric fluid |
|
8211-5
|
Opiates [Presence] in Gastric fluid by Confirmatory method |
|
8212-3
|
Opiates [Presence] in Gastric fluid by Screen method |
|
8209-9
|
Opiates [Mass/volume] in Gastric fluid |
|
40528-2
|
Opiates [Presence] in Hair |
|
40805-4
|
Opiates [Presence] in Hair by Screen method |
|
10369-7
|
Opiates [Mass/mass] in Hair |
|
8214-9
|
Opiates [Presence] in Meconium |
|
8215-6
|
Opiates [Presence] in Meconium by Confirmatory method |
|
8216-4
|
Opiates [Presence] in Meconium by Screen method |
|
26744-3
|
Opiates [Mass/mass] in Meconium by Screen method |
|
8213-1
|
Opiates [Mass/volume] in Meconium |
|
29158-3
|
Opiates [Mass/mass] in Meconium |
|
27321-9
|
Opiates [Mass/volume] in Milk |
|
69026-3
|
Opiates panel - Meconium by Confirmatory method |
|
19298-9
|
Opiates positive [Identifier] in Urine by Confirmatory method |
|
74656-0
|
Opiates [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40806-2
|
Opiates [Presence] in Saliva (oral fluid) by Screen method |
|
74167-8
|
Opiates [Mass/volume] in Saliva (oral fluid) by Screen method |
|
3878-6
|
Opiates [Presence] in Serum or Plasma |
|
8218-0
|
Opiates [Presence] in Serum or Plasma by Confirmatory method |
|
8219-8
|
Opiates [Presence] in Serum or Plasma by Screen method |
|
8217-2
|
Opiates [Mass/volume] in Serum or Plasma |
|
12354-7
|
Opiates [Presence] in Stool |
|
27064-5
|
Opiates [Mass/mass] in Stool |
|
91052-1
|
Opiates [Presence] in Tissue by Screen method |
|
5706-7
|
Opiates [Identifier] in Urine |
|
17384-9
|
Opiates [Mass/volume] in Urine by Confirmatory method |
|
3879-4
|
Opiates [Presence] in Urine |
|
18390-5
|
Opiates [Presence] in Urine by Confirmatory method |
|
8221-4
|
Opiates [Presence] in Urine by SAMHSA confirm method |
|
8222-2
|
Opiates [Presence] in Urine by SAMHSA screen method |
|
19295-5
|
Opiates [Presence] in Urine by Screen method |
|
21431-2
|
Opiates [Presence] in Urine by Screen method >2000 ng/mL |
|
70151-6
|
Opiates [Presence] in Urine by Screen method >300 ng/mL |
|
70150-8
|
Opiates [Mass/volume] in Urine by Screen method |
|
8220-6
|
Opiates [Mass/volume] in Urine |
|
52952-9
|
Opiates [Moles/volume] in Urine |
|
8224-8
|
Opiates [Presence] in Unknown substance |
|
8225-5
|
Opiates [Presence] in Unknown substance by Confirmatory method |
|
8226-3
|
Opiates [Presence] in Unknown substance by Screen method |
|
8223-0
|
Opiates [Mass/volume] in Unknown substance |
|
27136-1
|
Opiates [Presence] in Vitreous fluid |
|
34177-6
|
Opiates [Presence] in Unspecified specimen |
|
48961-7
|
Opiates [Mass/volume] in Unspecified specimen |
|
41465-6
|
Opiates/Creatinine [Mass Ratio] in Urine |
|
89424-6
|
Long-term opioid therapy for pain consent Document |
|
90976-2
|
Opipramol [Mass/volume] in Serum or Plasma |
|
23328-8
|
Ovine progressive pneumonia virus Ab [Presence] in Milk |
|
23333-8
|
Ovine progressive pneumonia virus Ab [Presence] in Milk by Immunoassay |
|
23329-6
|
Ovine progressive pneumonia virus Ab [Presence] in Serum |
|
23330-4
|
Ovine progressive pneumonia virus Ab [Presence] in Serum by Immunoassay |
|
23332-0
|
Ovine progressive pneumonia virus Ab [Presence] in Serum by Immune diffusion (ID) |
|
31922-8
|
Ovine progressive pneumonia virus Ag [Presence] in Unspecified specimen |
|
23334-6
|
Ovine progressive pneumonia virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23335-3
|
Ovine progressive pneumonia virus Ag [Presence] in Unspecified specimen by Immune stain |
|
23337-9
|
Ovine progressive pneumonia virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23336-1
|
Ovine progressive pneumonia virus DNA [Presence] in Unspecified specimen by Polyacrylamide gel electrophoresis (PAGE) |
|
2687-2
|
Orotate phosphoribosyltransferase [Enzymatic activity/volume] in Serum |
|
34810-2
|
Optometry Consult note |
|
78574-1
|
Optometry Diagnostic study note |
|
78605-3
|
Optometry Education note |
|
78617-8
|
Optometry Flowsheet |
|
78648-3
|
Optometry Initial evaluation note |
|
34811-0
|
Optometry Note |
|
84411-8
|
Optometry Outpatient Note |
|
84383-9
|
Optometry Telephone encounter Note |
|
80773-5
|
Optometry Plan of care note |
|
78661-6
|
Optometry procedure note |
|
78667-3
|
Optometry Progress note |
|
57151-3
|
Optometry Referral note |
|
90788-1
|
Optometry Resident Note |
|
84431-6
|
Optometry Technician Note |
|
46037-8
|
Oral and nutritional status section |
|
39137-5
|
Oral assessment panel |
|
79335-6
|
Hypoglycemics.oral [Presence] in Blood by Screen method |
|
79337-2
|
Hypoglycemics.oral [Presence] in Body fluid by Screen method |
|
79334-9
|
Hypoglycemics.oral [Presence] in Hair by Screen method |
|
79336-4
|
Hypoglycemics.oral [Presence] in Serum or Plasma by Screen method |
|
12330-7
|
Hypoglycemics.oral [Identifier] in Urine |
|
79338-0
|
Hypoglycemics.oral [Presence] in Urine by Screen method |
|
46044-4
|
Oral or dental status section |
|
46038-6
|
Oral problems Set |
|
84435-7
|
Oral Reading Recognition Test [NIH Toolbox] |
|
46045-1
|
Oral status and disease prevention Set |
|
7550-7
|
Orange triggered histamine release [Units/volume] in Blood |
|
6194-5
|
Orange IgE Ab [Units/volume] in Serum |
|
61248-1
|
Orange IgE Ab/IgE total in Serum |
|
6730-6
|
Orange IgG Ab [Units/volume] in Serum |
|
56338-7
|
Orange IgG4 Ab [Mass/volume] in Serum |
|
51904-1
|
Orange IgG Ab [Mass/volume] in Serum |
|
48209-1
|
Orange triggered leukotriene release [Mass/volume] by Leukocytes |
|
11196-3
|
Orange roughy IgE Ab [Units/volume] in Serum |
|
7551-5
|
Orange Tree IgE Ab [Units/volume] in Serum |
|
46101-2
|
Ordered therapies Set |
|
77597-3
|
Orders placed Document |
|
7554-9
|
Oregano triggered histamine release [Units/volume] in Blood |
|
7552-3
|
Oregano IgE Ab [Units/volume] in Serum |
|
61290-3
|
Oregano IgE Ab/IgE total in Serum |
|
7553-1
|
Oregano IgG Ab [Units/volume] in Serum |
|
56340-3
|
Oregano IgG4 Ab [Mass/volume] in Serum |
|
60387-8
|
Oregano IgG Ab [Mass/volume] in Serum |
|
6832-0
|
Oregon Ash IgE Ab [Units/volume] in Serum |
|
91670-0
|
Orexin-A [Mass/volume] in Cerebral spinal fluid |
|
64300-7
|
Organ donation consent Document |
|
17386-4
|
Organic acids [Units/volume] in Blood |
|
35866-3
|
Organic acids panel - Serum or Plasma |
|
48797-5
|
Organic acids panel - Urine |
|
10837-3
|
Organic acids [Presence] in Serum or Plasma |
|
17387-2
|
Organic acids [Units/volume] in Serum or Plasma |
|
38172-3
|
Organic acids [Moles/volume] in Serum or Plasma |
|
55818-9
|
Organic acids [Moles/mass] in Stool |
|
2676-5
|
Organic acids [Presence] in Urine |
|
17385-6
|
Organic acids [Units/volume] in Urine |
|
10972-8
|
Organic acids [Mass/volume] in Urine |
|
44343-2
|
Organic acids/Creatinine [Mass Ratio] in Urine |
|
14295-0
|
Organic acids/Creatinine [Molar ratio] in Urine |
|
699-9
|
Organism count [#/volume] in Unspecified specimen by Microscopic count |
|
90055-5
|
Organization information panel |
|
76469-6
|
Organization name |
|
76468-8
|
Organization NPI |
|
2677-3
|
Organochloride [Mass/volume] in Blood |
|
88032-8
|
Organophosphate panel - Unspecified specimen |
|
25611-5
|
Oriental Cockroach IgE Ab [Units/volume] in Serum |
|
87795-1
|
Ormetoprim+Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87801-7
|
Ormetoprim+Sulfadimethoxine [Susceptibility] |
|
47714-1
|
Ornithine [Moles/volume] in DBS |
|
74883-0
|
Ornithine [Moles/volume] in DBS --post therapeutic diet |
|
55959-1
|
Ornithine/Amino acids.total in Serum or Plasma |
|
75215-4
|
Ornithine/Citrulline [Molar ratio] in DBS |
|
44344-0
|
Ornithine/Creatinine [Mass Ratio] in 24 hour Urine |
|
81427-7
|
Microscopic observation [Identifier] in Venous blood by Oil red O stain |
|
32812-0
|
Microscopic observation [Identifier] in Bronchial specimen by Oil red O stain |
|
81425-1
|
Microscopic observation [Identifier] in Bone marrow by Oil red O stain |
|
59568-6
|
Orotate [Moles/time] in 24 hour Urine |
|
75126-3
|
Orotate [Moles/volume] in Cerebral spinal fluid |
|
69772-2
|
Orotate [Moles/volume] in Serum or Plasma |
|
30480-8
|
Orotate [Presence] in Urine |
|
26872-2
|
Orotate [Units/volume] in Urine |
|
2686-4
|
Orotate [Mass/volume] in Urine |
|
13963-4
|
Orotate [Moles/volume] in Urine |
|
44345-7
|
Orotate/Creatinine [Molar ratio] in 24 hour Urine |
|
13787-7
|
Orotate/Creatinine [Mass Ratio] in Urine |
|
32262-8
|
Orotate/Creatinine [Ratio] in Urine |
|
17869-9
|
Orotate/Creatinine [Molar ratio] in Urine |
|
75148-7
|
Orotidine [Moles/volume] in Cerebral spinal fluid |
|
75125-5
|
Orotidine [Moles/volume] in Serum or Plasma |
|
12240-8
|
Orotidine [Moles/volume] in Urine |
|
17870-7
|
Orotidine/Creatinine [Molar ratio] in Urine |
|
75763-3
|
Orphenadrine [Presence] in Serum or Plasma or Urine by Screen method |
|
3880-2
|
Orphenadrine [Mass/volume] in Serum or Plasma |
|
55560-7
|
Orphenadrine [Moles/volume] in Serum or Plasma |
|
29288-8
|
Orphenadrine [Presence] in Urine |
|
17390-6
|
Orphenadrine [Mass/volume] in Urine |
|
7555-6
|
Orris root IgE Ab [Units/volume] in Serum |
|
91393-9
|
Opioid risk tool panel |
|
83663-5
|
Orthopaedic surgery Attending Note |
|
83664-3
|
Orthopaedic surgery Attending Preoperative evaluation and management note |
|
83559-5
|
Orthopaedic surgery Nurse practitioner Note |
|
83603-1
|
Orthopaedic surgery Nurse Note |
|
83604-9
|
Orthopaedic surgery Nurse Outpatient Note |
|
83748-4
|
Orthopaedic surgery Physician assistant Note |
|
83768-2
|
Orthopaedic surgery Resident Note |
|
93893-6
|
Orthopaedic surgery Team Conference note |
|
38670-6
|
Orthocresol [Mass/volume] in Air |
|
17391-4
|
Orthocresol [Mass/volume] in Blood |
|
13026-0
|
Orthocresol [Mass/volume] in Urine |
|
13477-5
|
Orthocresol/Creatinine [Mass Ratio] in Urine |
|
90874-9
|
Orthodontic evaluation summary Document |
|
90875-6
|
Orthodontic service attachment |
|
90868-1
|
Orthognathic surgery consideration summary Narrative |
|
84378-9
|
Orthopaedic surgery Admission evaluation note |
|
78509-7
|
Orthopaedic surgery Admission history and physical note |
|
78541-0
|
Orthopaedic surgery Checklist |
|
34814-4
|
Orthopaedic surgery Consult note |
|
68577-6
|
Orthopaedic surgery Diagnostic study note |
|
68578-4
|
Orthopaedic surgery Discharge summary |
|
78593-1
|
Orthopaedic surgery Education note |
|
78631-9
|
Orthopaedic surgery Flowsheet |
|
68580-0
|
Orthopaedic surgery History and physical note |
|
68585-9
|
Orthopaedic surgery Hospital Letter |
|
84377-1
|
Orthopaedic surgery Hospital Note |
|
82833-5
|
Orthopaedic surgery Initial evaluation note |
|
34815-1
|
Orthopaedic surgery Note |
|
84376-3
|
Orthopaedic surgery Outpatient Note |
|
84375-5
|
Orthopaedic surgery Outpatient procedure note |
|
34868-0
|
Orthopaedic surgery Surgical operation note |
|
84373-0
|
Orthopaedic surgery Telephone encounter Note |
|
80766-9
|
Orthopaedic surgery Plan of care note |
|
85943-9
|
Orthopaedic surgery Postoperative evaluation and management note |
|
68581-8
|
Orthopaedic surgery Preoperative evaluation and management note |
|
84374-8
|
Orthopaedic surgery procedure note |
|
68582-6
|
Orthopaedic surgery Progress note |
|
57175-2
|
Orthopaedic surgery Referral note |
|
89899-9
|
Orthopaedic surgery Telehealth Note |
|
68583-4
|
Orthopaedic surgery Transfer summary note |
|
41853-3
|
Orthopoxvirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
10700-3
|
Orthopoxvirus [Identifier] in Skin by Electron microscopy |
|
34553-8
|
Orthostatic blood pressure panel |
|
75465-5
|
Orthotics prosthetics Consult note |
|
84372-2
|
Orthotics prosthetics Education note |
|
75466-3
|
Orthotics prosthetics Note |
|
84370-6
|
Orthotics prosthetics Outpatient Note |
|
84369-8
|
Orthotics prosthetics Telephone encounter Note |
|
84371-4
|
Orthotics prosthetics Patient's home Note |
|
60440-5
|
Oseltamivir [Susceptibility] by Genotype method |
|
60441-3
|
Oseltamivir+Zanamivir [Susceptibility] by Genotype method |
|
26748-4
|
Osmium [Mass/volume] in Blood |
|
17392-2
|
Osmium [Mass/volume] in Urine |
|
73571-2
|
Osmol gap of Stool |
|
57372-5
|
Osmolality of 12 hour Urine |
|
2694-8
|
Osmolality of 24 hour Urine |
|
2689-8
|
Osmolality of Amniotic fluid |
|
55960-9
|
Osmolality of Dialysis fluid |
|
15200-9
|
Osmolality of Body fluid |
|
17794-9
|
Osmolality of Hyperal solution |
|
2690-6
|
Osmolality of Pleural fluid |
|
2691-4
|
Osmolality of Peritoneal fluid |
|
2692-2
|
Osmolality of Serum or Plasma |
|
57731-2
|
Osmolality of Urine--2nd specimen |
|
57732-0
|
Osmolality of Urine--3rd specimen |
|
2693-0
|
Osmolality of Stool |
|
49001-1
|
Osmolality of Sweat |
|
2695-5
|
Osmolality of Urine |
|
48148-1
|
Osmolality of Urine by calculation |
|
48149-9
|
Osmolality.urine/Osmolality.serum |
|
2696-3
|
Osmolality of Unspecified specimen |
|
21435-3
|
Osteocalcin.bovine [Mass/volume] in Serum or Plasma |
|
2697-1
|
Osteocalcin [Mass/volume] in Serum or Plasma |
|
35218-7
|
Osteocalcin [Mass or Moles/volume] in Serum or Plasma |
|
15084-7
|
Osteocalcin [Moles/volume] in Serum or Plasma |
|
74995-2
|
Osteocalcin [Z-score] in Serum or Plasma |
|
52052-8
|
Osteogenesis stimulator attachment |
|
2698-9
|
Osteonectin [Mass/volume] in Plasma |
|
34855-7
|
Occupational therapy Consult note |
|
78416-5
|
Occupational therapy Discharge instructions |
|
84393-8
|
Occupational therapy Discharge summary |
|
78383-7
|
Occupational therapy Discharge teaching note |
|
78452-0
|
Occupational therapy Education note |
|
78461-1
|
Occupational therapy Flowsheet |
|
68570-1
|
Occupational therapy Hospital Consult note |
|
68571-9
|
Occupational therapy Hospital Letter |
|
84397-9
|
Occupational therapy Hospital Note |
|
18734-4
|
Occupational therapy Initial evaluation note |
|
84430-8
|
Occupational therapy Interdisciplinary Note |
|
84398-7
|
Occupational therapy Long term care facility Consult note |
|
84399-5
|
Occupational therapy Long term care facility Note |
|
28578-3
|
Occupational therapy Note |
|
84400-1
|
Occupational therapy Outpatient Note |
|
84402-7
|
Occupational therapy Telephone encounter Note |
|
80758-6
|
Occupational therapy Plan of care note |
|
78477-7
|
Occupational therapy procedure note |
|
11507-1
|
Occupational therapy Progress note |
|
84394-6
|
Occupational therapy Patient's home Consult note |
|
84395-3
|
Occupational therapy Patient's home Initial evaluation note |
|
84396-1
|
Occupational therapy Patient's home Note |
|
57148-9
|
Occupational therapy Referral note |
|
84401-9
|
Occupational therapy Risk assessment and screening note |
|
68569-3
|
Occupational therapy Transfer summary note |
|
87568-2
|
Ochratoxin A [Mass/mass] in Unspecified specimen |
|
43233-6
|
OTC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21721-6
|
OTC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
44433-1
|
Other Antibiotic [Mass/volume] in Serum or Plasma --peak |
|
23816-2
|
Other Antibiotic [Mass/volume] in Serum or Plasma |
|
44434-9
|
Other Antibiotic [Mass/volume] in Serum or Plasma --trough |
|
34617-1
|
Other Antibiotic [Mass/volume] in Unspecified specimen |
|
75271-7
|
Other cells/100 cells in Lymph node by Manual count |
|
88866-9
|
Other Chemical [Mass/mass] in Unspecified specimen |
|
46029-5
|
Other current or more detailed diagnoses and ICD9 codes Set |
|
46027-9
|
Other diseases or conditions Set |
|
46032-9
|
Other indicators Set |
|
45042-9
|
XXX microorganism Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
62202-7
|
XXX microorganism DNA [Identifier] in Isolate by NAA with probe detection |
|
62201-9
|
XXX microorganism DNA [Identifier] in Serum or Plasma by NAA with probe detection |
|
40972-2
|
XXX microorganism DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
40971-4
|
XXX microorganism DNA [Presence] in Urine by NAA with probe detection |
|
38347-1
|
XXX microorganism DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
35691-5
|
XXX microorganism DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
40440-0
|
XXX microorganism serotype [Identifier] in Isolate by Agglutination |
|
46049-3
|
Other skin problems or lesions present Set |
|
18326-9
|
Microscopic observation [Identifier] in Cervix by Other stain |
|
18327-7
|
Microscopic observation [Identifier] in Duodenal fluid by Other stain |
|
18328-5
|
Microscopic observation [Identifier] in Body fluid by Other stain |
|
6471-7
|
Microscopic observation [Identifier] in Tissue by Other stain |
|
11546-9
|
Microscopic observation [Identifier] in Unspecified specimen by Other stain |
|
53884-3
|
OTOF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
84368-0
|
Otolaryngology Admission evaluation note |
|
80733-9
|
Otolaryngology Admission history and physical note |
|
83694-0
|
Otolaryngology Attending Admission evaluation note |
|
83695-7
|
Otolaryngology Attending Note |
|
83696-5
|
Otolaryngology Attending Preoperative evaluation and management note |
|
80732-1
|
Otolaryngology Checklist |
|
34816-9
|
Otolaryngology Consult note |
|
78575-8
|
Otolaryngology Diagnostic study note |
|
84367-2
|
Otolaryngology Discharge summary |
|
78612-9
|
Otolaryngology Education note |
|
78618-6
|
Otolaryngology Flowsheet |
|
84366-4
|
Otolaryngology History and physical note |
|
84365-6
|
Otolaryngology Hospital Note |
|
78649-1
|
Otolaryngology Initial evaluation note |
|
34817-7
|
Otolaryngology Note |
|
83590-0
|
Otolaryngology Nurse Note |
|
83591-8
|
Otolaryngology Nurse Outpatient Note |
|
84364-9
|
Otolaryngology Outpatient Note |
|
34818-5
|
Otolaryngology Surgical operation note |
|
84362-3
|
Otolaryngology Telephone encounter Note |
|
80778-4
|
Otolaryngology Plan of care note |
|
84363-1
|
Otolaryngology Postoperative evaluation and management note |
|
80734-7
|
Otolaryngology Preoperative evaluation and management note |
|
78655-8
|
Otolaryngology procedure note |
|
78669-9
|
Otolaryngology Progress note |
|
57176-0
|
Otolaryngology Referral note |
|
83769-0
|
Otolaryngology Resident Note |
|
89902-1
|
Otolaryngology Telehealth Note |
|
80735-4
|
Otolaryngology Transfer summary note |
|
3881-0
|
Ouabain [Mass/volume] in Serum or Plasma |
|
46462-8
|
Outcome and assessment information set (OASIS) form - version B1 |
|
86261-5
|
Outcome and assessment information set (OASIS) form - version C2 - Discharged from agency - death at home [CMS Assessment] |
|
86264-9
|
Outcome and assessment information set (OASIS) form - version C2 - Discharged from agency [CMS Assessment] |
|
86244-1
|
Outcome and assessment information set (OASIS) form - version C2 - Follow-up - recertification or other follow-up [CMS Assessment] |
|
86189-8
|
Outcome and assessment information set (OASIS) form - version C2 - Resumption of care [CMS Assessment] |
|
85907-4
|
Outcome and assessment information set (OASIS) form - version C2 - Start of care [CMS Assessment] |
|
86259-9
|
Outcome and assessment information set (OASIS) form - version C2 - Transfer To inpatient facility - patient discharged or not discharged [CMS Assessment] |
|
86905-7
|
Outcome and assessment information set (OASIS) form - version C2 [CMS Assessment] |
|
88369-4
|
Outcome and assessment information set (OASIS) form - version D - Follow-up - recertification or other follow-up [CMS Assessment] |
|
88372-8
|
Outcome and assessment information set (OASIS) form - version D [CMS Assessment] |
|
88370-2
|
Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency - death at home [CMS Assessment] |
|
88371-0
|
Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency [CMS Assessment] |
|
88368-6
|
Outcome and assessment information set (OASIS) form - version D, D1 - Resumption of care [CMS Assessment] |
|
88373-6
|
Outcome and assessment information set (OASIS) form - version D, D1 - Start of care [CMS Assessment] |
|
88367-8
|
Outcome and assessment information set (OASIS) form - version D, D1 - Transfer to inpatient facility - patient discharged or not discharged [CMS Assessment] |
|
93058-6
|
Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up [CMS Assessment] |
|
93055-2
|
Outcome and assessment information set (OASIS) form - version D1 [CMS Assessment] |
|
88644-0
|
Outpatient hospital Consult note |
|
88645-7
|
Outpatient hospital Discharge summary |
|
88646-5
|
Outpatient hospital Note |
|
81677-7
|
Output assessment panel |
|
81667-8
|
Output count panel |
|
85213-7
|
Outreach note |
|
62488-2
|
Ova1 test [Presence] in Serum |
|
72499-7
|
Oval fat bodies (globules) [#/area] in Stool by Microscopy low power field |
|
7556-4
|
Ovalbumin IgE Ab [Units/volume] in Serum |
|
17393-0
|
Ovary Ab [Presence] in Serum |
|
21436-1
|
Ovary Ab [Presence] in Serum by Immunofluorescence |
|
13120-1
|
Ovary Ab [Units/volume] in Serum |
|
33246-0
|
Ovary Ab [Titer] in Serum |
|
25725-3
|
Ovary Ab [Titer] in Serum by Immunofluorescence |
|
56962-4
|
Ovary IgG Ab [Presence] in Serum by Immunofluorescence |
|
31546-5
|
Ovary IgG Ab [Units/volume] in Serum |
|
26729-4
|
Ovary IgG Ab [Titer] in Serum by Immunofluorescence |
|
66116-5
|
Ovary Pathology biopsy report |
|
23321-3
|
Ovine herpesvirus 2 Ab [Presence] in Serum |
|
23322-1
|
Ovine herpesvirus 2 Ab [Presence] in Serum by Complement fixation |
|
23325-4
|
Ovine herpesvirus 2 Ab [Presence] in Serum by Immunoassay |
|
23324-7
|
Ovine herpesvirus 2 Ab [Presence] in Serum by Immunofluorescence |
|
23326-2
|
Ovine herpesvirus 2 Ab [Presence] in Serum by Immune stain |
|
23327-0
|
Ovine herpesvirus 2 DNA [Presence] in Tissue by NAA with probe detection |
|
7557-2
|
Ovomucoid IgE Ab [Units/volume] in Serum |
|
58018-3
|
Oxabolone [Presence] in Urine |
|
73229-7
|
Oxacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73228-9
|
Oxacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3882-8
|
Oxacillin [Mass/volume] in Serum or Plasma |
|
25265-0
|
Oxacillin [Mass/volume] in Unspecified specimen |
|
57373-3
|
Oxalate [Mass/volume] in 12 hour Urine |
|
57375-8
|
Oxalate [Mass/time] in 12 hour Urine |
|
27222-9
|
Oxalate [Mass/volume] in 24 hour Urine |
|
2701-1
|
Oxalate [Mass/time] in 24 hour Urine |
|
34349-1
|
Oxalate [Moles/volume] in 24 hour Urine |
|
14862-7
|
Oxalate [Moles/time] in 24 hour Urine |
|
57374-1
|
Oxalate [Mass/volume] in 2 hour Urine |
|
2702-9
|
Oxalate renal clearance in 24 hour Urine and Serum or Plasma |
|
47715-8
|
Oxalate [Moles/volume] in Dialysis fluid |
|
20928-8
|
Oxalate [Mass/mass] in Plant |
|
2699-7
|
Oxalate [Mass/volume] in Serum or Plasma |
|
15085-4
|
Oxalate [Moles/volume] in Serum or Plasma |
|
20927-0
|
Oxalate [Mass/mass] in Tissue |
|
26796-3
|
Oxalate [Presence] in Urine |
|
2700-3
|
Oxalate [Mass/volume] in Urine |
|
15086-2
|
Oxalate [Moles/volume] in Urine |
|
55961-7
|
Oxalate [Moles/volume] in Water |
|
13788-5
|
Oxalate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13483-3
|
Oxalate/Creatinine [Mass Ratio] in Urine |
|
34350-9
|
Oxalate/Creatinine [Molar ratio] in Urine |
|
73227-1
|
Oxaliplatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73226-3
|
Oxaliplatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3885-1
|
Oxandrolone [Mass/time] in 24 hour Urine |
|
3883-6
|
Oxandrolone [Presence] in Urine |
|
3884-4
|
Oxandrolone [Mass/volume] in Urine |
|
87785-2
|
Oxaprozin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
59726-0
|
Oxazepam [Mass/volume] in Blood by Confirmatory method |
|
59725-2
|
Oxazepam [Mass/volume] in Blood |
|
59728-6
|
Oxazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59727-8
|
Oxazepam [Mass/volume] in Body fluid |
|
61088-1
|
Oxazepam [Presence] in Gastric fluid |
|
94107-0
|
Oxazepam glucuronide [Presence] in Urine by Screen method |
|
26839-1
|
Oxazepam [Mass/mass] in Hair |
|
59729-4
|
Oxazepam [Mass/mass] in Meconium by Confirmatory method |
|
26933-2
|
Oxazepam [Mass/mass] in Meconium |
|
72613-3
|
Oxazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72614-1
|
Oxazepam [Presence] in Saliva (oral fluid) |
|
72378-3
|
Oxazepam [Mass/volume] in Saliva (oral fluid) |
|
59730-2
|
Oxazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
12362-0
|
Oxazepam [Presence] in Serum or Plasma |
|
35629-5
|
Oxazepam [Mass/volume] in Serum or Plasma by Screen method |
|
3886-9
|
Oxazepam [Mass/volume] in Serum or Plasma |
|
29655-8
|
Oxazepam [Moles/volume] in Serum or Plasma |
|
59731-0
|
Oxazepam [Mass/mass] in Stool by Confirmatory method |
|
12381-0
|
Oxazepam [Presence] in Stool |
|
27238-5
|
Oxazepam [Mass/mass] in Stool |
|
59732-8
|
Oxazepam [Mass/mass] in Tissue |
|
82935-8
|
Oxazepam [Mass/volume] in Serum or Plasma --trough |
|
16201-6
|
Oxazepam [Mass/volume] in Urine by Confirmatory method |
|
70214-2
|
Oxazepam [Moles/volume] in Urine by Confirmatory method |
|
12361-2
|
Oxazepam [Presence] in Urine |
|
19639-4
|
Oxazepam [Presence] in Urine by Confirmatory method |
|
19638-6
|
Oxazepam [Presence] in Urine by Screen method |
|
3887-7
|
Oxazepam [Mass/volume] in Urine |
|
26850-8
|
Oxazepam [Mass/volume] in Vitreous fluid |
|
61055-0
|
Oxazepam [Presence] in Unspecified specimen |
|
48962-5
|
Oxazepam [Mass/volume] in Unspecified specimen |
|
77336-6
|
Oxazepam [Moles/volume] in Unspecified specimen |
|
58368-2
|
Oxazepam/Creatinine [Mass Ratio] in Urine |
|
79165-7
|
OXcarbazepine trough and 10-hydroxycarbazepine panel - Serum or Plasma |
|
59948-0
|
OXcarbazepine [Moles/volume] in Gastric fluid |
|
73224-8
|
OXcarbazepine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73225-5
|
OXcarbazepine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35331-8
|
OXcarbazepine [Mass/volume] in Serum or Plasma |
|
25726-1
|
OXcarbazepine [Moles/volume] in Serum or Plasma |
|
72659-6
|
OXcarbazepine [Mass/volume] in Serum or Plasma --trough |
|
88110-2
|
OXcarbazepine [Moles/volume] in Serum or Plasma --trough |
|
59947-2
|
OXcarbazepine [Moles/volume] in Urine |
|
60326-6
|
OXcarbazepine [Moles/volume] in Unspecified specimen |
|
55588-8
|
OXcarbazepine + 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma |
|
3888-5
|
Oxedrine [Mass/volume] in Urine |
|
6196-0
|
Ox-eye daisy IgE Ab [Units/volume] in Serum |
|
56341-1
|
Ox-eye daisy IgG4 Ab [Mass/volume] in Serum |
|
60112-0
|
Oxipurinol [Mass/volume] in Blood |
|
13908-9
|
Oxipurinol [Mass/volume] in Serum or Plasma |
|
25492-0
|
Oxipurinol [Moles/volume] in Serum or Plasma |
|
75132-1
|
Oxipurinol/Creatinine [Molar ratio] in Urine |
|
3892-7
|
Oxprenolol [Mass/time] in 24 hour Urine |
|
3889-3
|
Oxprenolol [Mass/volume] in Serum or Plasma |
|
55561-5
|
Oxprenolol [Moles/volume] in Serum or Plasma |
|
3890-1
|
Oxprenolol [Presence] in Urine |
|
3891-9
|
Oxprenolol [Mass/volume] in Urine |
|
12408-1
|
Oxybutynin [Mass/volume] in Serum or Plasma |
|
12994-0
|
Oxychlordane [Mass/volume] in Blood |
|
60108-8
|
Oxychlordane [Mass/volume] in Body fluid |
|
21437-9
|
Oxychlordane [Mass/volume] in Serum or Plasma |
|
60109-6
|
Oxychlordane [Mass/mass] in Tissue |
|
17394-8
|
Oxychlordane [Mass/volume] in Urine |
|
72402-1
|
oxyCODONE [Presence] in Blood by Screen method |
|
46256-4
|
oxyCODONE Free [Presence] in Serum or Plasma by Screen method |
|
12789-4
|
oxyCODONE Free [Mass/volume] in Serum or Plasma |
|
27293-0
|
oxyCODONE Free [Mass/mass] in Stool |
|
46973-4
|
oxyCODONE Free [Mass/volume] in Urine by Confirmatory method |
|
51954-6
|
oxyCODONE Free [Mass/volume] in Urine |
|
14863-5
|
oxyCODONE [Presence] in Gastric fluid |
|
73753-6
|
oxyCODONE [Presence] in Hair |
|
26722-9
|
oxyCODONE [Mass/mass] in Hair |
|
73222-2
|
oxyCODONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73223-0
|
oxyCODONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
68543-8
|
oxyCODONE [Mass/mass] in Meconium by Confirmatory method |
|
73996-1
|
oxyCODONE [Presence] in Meconium by Screen method |
|
26869-8
|
oxyCODONE [Mass/mass] in Meconium |
|
72750-3
|
oxyCODONE [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74657-8
|
oxyCODONE [Presence] in Saliva (oral fluid) by Confirmatory method |
|
69356-4
|
oxyCODONE [Presence] in Saliva (oral fluid) by Screen method |
|
72751-1
|
oxyCODONE [Mass/volume] in Saliva (oral fluid) by Screen method |
|
13576-4
|
oxyCODONE [Presence] in Serum or Plasma |
|
77730-0
|
oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
50021-5
|
oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Screen method |
|
3893-5
|
oxyCODONE [Mass/volume] in Serum or Plasma |
|
16249-5
|
oxyCODONE [Mass/volume] in Urine by Confirmatory method |
|
70215-9
|
oxyCODONE [Moles/volume] in Urine by Confirmatory method |
|
10998-3
|
oxyCODONE [Presence] in Urine |
|
19643-6
|
oxyCODONE [Presence] in Urine by Confirmatory method |
|
19642-8
|
oxyCODONE [Presence] in Urine by Screen method |
|
11246-6
|
oxyCODONE [Mass/volume] in Urine |
|
32101-8
|
oxyCODONE [Presence] in Unspecified specimen |
|
57865-8
|
oxyCODONE [Moles/volume] in Unspecified specimen |
|
58395-5
|
oxyCODONE/Creatinine [Mass Ratio] in Urine |
|
73221-4
|
oxyCODONE+Acetylsalicylate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73220-6
|
oxyCODONE+Acetylsalicylate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
91044-8
|
oxyCODONE+oxyMORphone [Presence] in Body fluid by Screen method |
|
91032-3
|
oxyCODONE+oxyMORphone [Presence] in Meconium by Screen method |
|
74658-6
|
oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
71430-3
|
oxyCODONE+oxyMORphone [Presence] in Saliva (oral fluid) by Screen method |
|
77731-8
|
oxyCODONE+oxyMORphone [Interpretation] in Serum, Plasma or Blood Qualitative by Confirmatory method |
|
77732-6
|
oxyCODONE+oxyMORphone [Presence] in Serum, Plasma or Blood by Screen method |
|
91053-9
|
oxyCODONE+oxyMORphone [Presence] in Tissue by Screen method |
|
61197-0
|
oxyCODONE+oxyMORphone [Presence] in Urine by Confirmatory method |
|
58430-0
|
oxyCODONE+oxyMORphone [Presence] in Urine by Screen method |
|
72263-7
|
Oxyhemoglobin [Moles/volume] in Cerebral spinal fluid |
|
71839-5
|
Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood |
|
87437-0
|
Oxyhemoglobin [Mass/volume] in Plasma |
|
3896-8
|
Oxymesterone [Mass/time] in 24 hour Urine |
|
3894-3
|
Oxymesterone [Presence] in Urine |
|
3895-0
|
Oxymesterone [Mass/volume] in Urine |
|
3899-2
|
Oxymetholone [Mass/time] in 24 hour Urine |
|
3897-6
|
Oxymetholone [Presence] in Urine |
|
3898-4
|
Oxymetholone [Mass/volume] in Urine |
|
46974-2
|
oxyMORphone Free [Mass/volume] in Serum or Plasma by Confirmatory method |
|
46258-0
|
oxyMORphone Free [Presence] in Serum or Plasma by Screen method |
|
46975-9
|
oxyMORphone Free [Mass/volume] in Urine by Confirmatory method |
|
51736-7
|
oxyMORphone Free [Mass/volume] in Urine |
|
69028-9
|
oxyMORphone [Mass/mass] in Meconium by Confirmatory method |
|
72766-9
|
oxyMORphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74659-4
|
oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method |
|
12342-2
|
oxyMORphone [Presence] in Serum or Plasma |
|
77729-2
|
oxyMORphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
60467-8
|
oxyMORphone [Mass/volume] in Serum or Plasma |
|
17395-5
|
oxyMORphone [Mass/volume] in Urine by Confirmatory method |
|
11247-4
|
oxyMORphone [Presence] in Urine |
|
18325-1
|
oxyMORphone [Presence] in Urine by Confirmatory method |
|
19646-9
|
oxyMORphone [Presence] in Urine by Screen method |
|
19648-5
|
oxyMORphone [Mass/volume] in Urine |
|
58396-3
|
oxyMORphone/Creatinine [Mass Ratio] in Urine |
|
60110-4
|
Oxyphenbutazone [Mass/volume] in Blood |
|
3900-8
|
Oxyphenbutazone [Mass/volume] in Serum or Plasma |
|
55562-3
|
Oxyphenbutazone [Moles/volume] in Serum or Plasma |
|
60111-2
|
Oxyphenbutazone [Mass/volume] in Urine |
|
10891-0
|
Oxyphenisatin [Mass/mass] in Stool |
|
27031-4
|
Oxyphenisatin [Mass/volume] in Urine |
|
92738-4
|
Cholestane-3-beta, 5-alpha, 6-beta triol and Lyso-sphingomyelin panel - Blood |
|
92741-8
|
Cholestane-3-beta, 5-alpha, 6-beta triol and Lyso-sphingomyelin panel - DBS |
|
92740-0
|
Oxysterols panel - Serum or Plasma |
|
17396-3
|
Oxytetracycline [Mass/volume] in Serum or Plasma |
|
25266-8
|
Oxytetracycline [Mass/volume] in Unspecified specimen |
|
87595-5
|
Oxytetracycline [Mass/mass] in Unspecified specimen |
|
74364-1
|
Oxytocin [Mass/volume] in Saliva (oral fluid) |
|
75035-6
|
Oxytocin [Moles/volume] in Saliva (oral fluid) |
|
35415-9
|
Oxytocin [Units/volume] in Serum or Plasma |
|
2718-5
|
Oxytocin [Mass/volume] in Serum or Plasma |
|
17397-1
|
Oxytriphylline [Mass/volume] in Serum or Plasma |
|
7560-6
|
Oyster triggered histamine release [Units/volume] in Blood |
|
7558-0
|
Oyster IgE Ab [Units/volume] in Serum |
|
61292-9
|
Oyster IgE Ab/IgE total in Serum |
|
7559-8
|
Oyster IgG Ab [Units/volume] in Serum |
|
56342-9
|
Oyster IgG4 Ab [Mass/volume] in Serum |
|
60388-6
|
Oyster IgG Ab [Mass/volume] in Serum |
|
7517-6
|
Oyster Mushroom IgE Ab [Units/volume] in Serum |
|
63480-8
|
Pseudomonas aeruginosa.multidrug resistant isolate [Presence] in Unspecified specimen by Organism specific culture |
|
17502-6
|
Pseudomonas aeruginosa Ab [Units/volume] in Serum |
|
68976-0
|
Pseudomonas aeruginosa alkaline protease Ab [Titer] in Serum by Immunoassay |
|
92960-4
|
Pseudomonas aeruginosa DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85780-5
|
Pseudomonas aeruginosa DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92959-6
|
Pseudomonas aeruginosa DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61401-6
|
Pseudomonas aeruginosa DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
68977-8
|
Pseudomonas aeruginosa elastase Ab [Titer] in Serum by Immunoassay |
|
68978-6
|
Pseudomonas aeruginosa exotoxin A Ab [Titer] in Serum by Immunoassay |
|
88268-8
|
Pseudomonas aeruginosa sodA gene [Presence] by Probe in Positive blood culture |
|
6216-6
|
Phoma betae IgE Ab [Units/volume] in Serum |
|
50362-3
|
Phoma betae IgE Ab/IgE total in Serum |
|
30032-7
|
Phoma betae IgG Ab [Units/volume] in Serum |
|
35551-1
|
Phoma betae IgG Ab [Mass/volume] in Serum |
|
42970-4
|
Pseudallescheria boydii IgG Ab [Presence] in Serum |
|
34232-9
|
Pseudallescheria boydii IgG Ab [Presence] in Serum by Immune diffusion (ID) |
|
26640-3
|
Paracoccidioides brasiliensis Ab [Presence] in Serum |
|
7976-4
|
Paracoccidioides brasiliensis Ab [Units/volume] in Serum |
|
22435-2
|
Paracoccidioides brasiliensis Ab [Titer] in Serum |
|
5266-2
|
Paracoccidioides brasiliensis Ab [Titer] in Serum by Complement fixation |
|
6211-7
|
Penicillium brevicompactum IgE Ab [Units/volume] in Serum |
|
63164-8
|
Penicillium brevicompactum IgG Ab [Mass/volume] in Serum |
|
56967-3
|
Plasmodium falciparum Ab [Presence] in Serum by Immunoassay |
|
5278-7
|
Plasmodium falciparum Ab [Units/volume] in Serum |
|
22441-0
|
Plasmodium falciparum Ab [Titer] in Serum |
|
21465-0
|
Plasmodium falciparum Ab [Titer] in Serum by Immunofluorescence |
|
10709-4
|
Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence |
|
76772-3
|
Plasmodium falciparum Ag [Presence] in Blood by Rapid immunoassay |
|
41447-4
|
Plasmodium falciparum DNA [Presence] in Blood by NAA with probe detection |
|
56515-0
|
Plasmodium falciparum IgG Ab [Presence] in Serum by Immunofluorescence |
|
51467-9
|
Plasmodium falciparum IgG Ab [Titer] in Serum |
|
49743-8
|
Plasmodium falciparum IgG Ab [Titer] in Serum by Immunofluorescence |
|
57683-5
|
Plasmodium falciparum IgM Ab [Presence] in Serum by Immunoassay |
|
53382-8
|
Plasmodium falciparum IgM Ab [Titer] in Serum |
|
51842-3
|
Plasmodium falciparum IgM Ab [Titer] in Serum by Immunofluorescence |
|
11187-2
|
Penicillium frequentans IgE Ab [Units/volume] in Serum |
|
39580-6
|
Phoma herbarum Ab [Mass/volume] in Serum |
|
13240-7
|
Phoma herbarum IgE Ab [Units/volume] in Serum |
|
17445-8
|
Phoma herbarum IgG Ab [Units/volume] in Serum |
|
26952-2
|
Phoma herbarum IgG Ab [Mass/volume] in Serum |
|
88691-1
|
Pneumocystis jiroveci Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
31932-7
|
Pneumocystis jiroveci Ag [Presence] in Blood |
|
14514-4
|
Pneumocystis jiroveci Ag [Presence] in Blood by Immunofluorescence |
|
31933-5
|
Pneumocystis jiroveci Ag [Presence] in Bronchial specimen |
|
14522-7
|
Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
31934-3
|
Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid |
|
14515-1
|
Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31935-0
|
Pneumocystis jiroveci Ag [Presence] in Eye |
|
14519-3
|
Pneumocystis jiroveci Ag [Presence] in Eye by Immunofluorescence |
|
91824-3
|
Pneumocystis jiroveci Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
31936-8
|
Pneumocystis jiroveci Ag [Presence] in Nose |
|
14520-1
|
Pneumocystis jiroveci Ag [Presence] in Nose by Immunofluorescence |
|
31937-6
|
Pneumocystis jiroveci Ag [Presence] in Serum |
|
6518-5
|
Pneumocystis jiroveci Ag [Presence] in Serum by Immunofluorescence |
|
31938-4
|
Pneumocystis jiroveci Ag [Presence] in Semen |
|
14516-9
|
Pneumocystis jiroveci Ag [Presence] in Semen by Immunofluorescence |
|
31939-2
|
Pneumocystis jiroveci Ag [Presence] in Sputum |
|
6519-3
|
Pneumocystis jiroveci Ag [Presence] in Sputum by Immunofluorescence |
|
31940-0
|
Pneumocystis jiroveci Ag [Presence] in Stool |
|
14517-7
|
Pneumocystis jiroveci Ag [Presence] in Stool by Immunofluorescence |
|
31941-8
|
Pneumocystis jiroveci Ag [Presence] in Throat |
|
14518-5
|
Pneumocystis jiroveci Ag [Presence] in Throat by Immunofluorescence |
|
31942-6
|
Pneumocystis jiroveci Ag [Presence] in Urine |
|
14521-9
|
Pneumocystis jiroveci Ag [Presence] in Urine by Immunofluorescence |
|
31943-4
|
Pneumocystis jiroveci Ag [Presence] in Unspecified specimen |
|
700-5
|
Pneumocystis jiroveci Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
49438-5
|
Pneumocystis jiroveci DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection |
|
49436-9
|
Pneumocystis jiroveci DNA [#/volume] in Blood by NAA with probe detection |
|
49439-3
|
Pneumocystis jiroveci DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection |
|
88688-7
|
Pneumocystis jiroveci DNA [#/volume] in Lower respiratory specimen by NAA with probe detection |
|
49442-7
|
Pneumocystis jiroveci DNA [#/volume] in Bone marrow by NAA with probe detection |
|
49440-1
|
Pneumocystis jiroveci DNA [#/volume] in Serum or Plasma by NAA with probe detection |
|
49437-7
|
Pneumocystis jiroveci DNA [#/volume] in Tissue by NAA with probe detection |
|
49441-9
|
Pneumocystis jiroveci DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
89996-3
|
Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
88690-3
|
Pneumocystis jiroveci DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
6521-9
|
Pneumocystis jiroveci DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88689-5
|
Pneumocystis jiroveci [Presence] in Lower respiratory specimen by Calcofluor white |
|
48055-8
|
Pneumocystis jiroveci [Presence] in Unspecified specimen by Calcofluor white |
|
70568-1
|
Plasmodium knowlesi DNA [Presence] in Blood by NAA with probe detection |
|
6305-7
|
Plasmodium malariae Ab [Units/volume] in Serum |
|
22442-8
|
Plasmodium malariae Ab [Titer] in Serum |
|
21466-8
|
Plasmodium malariae Ab [Titer] in Serum by Immunofluorescence |
|
41448-2
|
Plasmodium malariae DNA [Presence] in Blood by NAA with probe detection |
|
9670-1
|
Plasmodium malariae IgG Ab [Units/volume] in Serum |
|
43593-3
|
Plasmodium malariae IgG Ab [Titer] in Serum |
|
49741-2
|
Plasmodium malariae IgG Ab [Titer] in Serum by Immunofluorescence |
|
9671-9
|
Plasmodium malariae IgM Ab [Units/volume] in Serum |
|
61400-8
|
Proteus mirabilis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22440-2
|
Pasteurella multocida Ab [Presence] in Serum |
|
15494-8
|
Pasteurella multocida Ab [Presence] in Serum by Immunoassay |
|
31559-8
|
Pasteurella multocida Ab [Units/volume] in Serum |
|
23342-9
|
Pasteurella multocida Ab [Titer] in Serum |
|
23341-1
|
Pasteurella multocida Ab [Titer] in Serum by Immunoassay |
|
23343-7
|
Pasteurella multocida Ag [Titer] in Unspecified specimen by Agglutination |
|
31930-1
|
Pasteurella multocida Ag [Units/volume] in Unspecified specimen |
|
23344-5
|
Pasteurella multocida rRNA [Presence] in Unspecified specimen by Probe |
|
23763-6
|
Pasteurella multocida serotype [Identifier] in Isolate |
|
20935-3
|
Pasteurella multocida serotype [Identifier] in Isolate by Immune diffusion (ID) |
|
23345-2
|
Pasteurella multocida serotype [Identifier] in Unspecified specimen by Agglutination |
|
23346-0
|
Pasteurella multocida serotype [Identifier] in Unspecified specimen by Immunoelectrophoresis |
|
23347-8
|
Pasteurella multocida serotype [Identifier] in Unspecified specimen by Immunofluorescence |
|
23349-4
|
Pasteurella multocida toxin [Presence] in Unspecified specimen by Immunoassay |
|
29887-7
|
Pasteurella multocida type [Identifier] in Isolate |
|
63483-2
|
Penicillium notatum Ab [Presence] in Serum by Immune diffusion (ID) |
|
39579-8
|
Penicillium notatum Ab [Mass/volume] in Serum |
|
7585-3
|
Penicillium notatum triggered histamine release [Units/volume] in Blood |
|
6212-5
|
Penicillium notatum IgE Ab [Units/volume] in Serum |
|
7584-6
|
Penicillium notatum IgG Ab [Units/volume] in Serum |
|
26957-1
|
Penicillium notatum IgG Ab [Mass/volume] in Serum |
|
56355-1
|
Penicillium notatum IgG4 Ab [Mass/volume] in Serum |
|
48243-0
|
Penicillium notatum triggered leukotriene release [Mass/volume] by Leukocytes |
|
6560-7
|
Plasmodium ovale Ab [Units/volume] in Serum |
|
22443-6
|
Plasmodium ovale Ab [Titer] in Serum |
|
21467-6
|
Plasmodium ovale Ab [Titer] in Serum by Immunofluorescence |
|
41449-0
|
Plasmodium ovale DNA [Presence] in Blood by NAA with probe detection |
|
51468-7
|
Plasmodium ovale IgG Ab [Titer] in Serum |
|
49744-6
|
Plasmodium ovale IgG Ab [Titer] in Serum by Immunofluorescence |
|
5277-9
|
Penicillium roqueforti Ab [Units/volume] in Serum |
|
17426-8
|
Penicillium roqueforti IgE Ab [Units/volume] in Serum |
|
82198-3
|
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection |
|
70296-9
|
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with probe detection |
|
88044-3
|
P sup(k) Ab [Presence] in Serum or Plasma from Blood product unit |
|
88045-0
|
P sup(k) Ab [Presence] in Serum or Plasma from Donor |
|
88043-5
|
P sup(k) Ab [Presence] in Serum or Plasma |
|
88047-6
|
P sup(k) Ag [Presence] on Red Blood Cells from Blood product unit |
|
88048-4
|
P sup(k) Ag [Presence] on Red Blood Cells from Donor |
|
88046-8
|
P sup(k) Ag [Presence] on Red Blood Cells |
|
50680-8
|
Paecilomyces variottii IgE Ab [Units/volume] in Serum |
|
5280-3
|
Plasmodium vivax Ab [Units/volume] in Serum |
|
22444-4
|
Plasmodium vivax Ab [Titer] in Serum |
|
21468-4
|
Plasmodium vivax Ab [Titer] in Serum by Immunofluorescence |
|
10711-0
|
Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence |
|
31931-9
|
Plasmodium vivax Ag [Units/volume] in Blood |
|
41450-8
|
Plasmodium vivax DNA [Presence] in Blood by NAA with probe detection |
|
51469-5
|
Plasmodium vivax IgG Ab [Titer] in Serum |
|
49742-0
|
Plasmodium vivax IgG Ab [Titer] in Serum by Immunofluorescence |
|
87638-3
|
p,p'- Dichlorodiphenyldichloroethane [Mass/mass] in Unspecified specimen |
|
1291-4
|
P1 Ag [Presence] on Red Blood Cells |
|
49556-4
|
p16INK4a Ag [Presence] in Tissue by Immune stain |
|
88050-0
|
P2 phenotype [Presence] on Red Blood Cells from Blood product unit |
|
88051-8
|
P2 phenotype [Presence] on Red Blood Cells from Donor |
|
88049-2
|
P2 phenotype [Presence] on Red Blood Cells |
|
74118-1
|
P27 Ag [Presence] in Tissue by Immune stain |
|
74119-9
|
P504S Ag [Presence] in Tissue by Immune stain |
|
74487-0
|
P504S and p63 and Cytokeratin 903 Ag [Identifier] in Tissue by Immune stain |
|
89006-1
|
p53 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
31149-8
|
P53 protein Ag/100 cells in Tissue by Immune stain |
|
14229-9
|
P53 protein Ag [Presence] in Tissue by Immune stain |
|
48678-7
|
P57 Ag [Presence] in Tissue by Immune stain |
|
2902-5
|
Pyrimidine-5'-Nucleotidase [Presence] in Blood |
|
2903-3
|
Pyrimidine-5'-Nucleotidase [Enzymatic activity/volume] in Blood |
|
44055-2
|
Pyrimidine-5'-Nucleotidase [Enzymatic activity/mass] in Blood |
|
74488-8
|
p63 and Smooth muscle myosin heavy chain and Cytokeratin 8 Ag [Identifier] in Tissue by Immune stain |
|
78525-3
|
Platelet aggregation arachidonate induced in Platelet rich plasma --1.6 mmol/L |
|
49011-0
|
Platelet aggregation arachidonate induced [Units/volume] in Platelet rich plasma |
|
24374-1
|
Platelet associated Ab [Presence] in Blood |
|
45141-9
|
Platelet associated Ab [Presence] in Blood by Flow cytometry (FC) |
|
83809-4
|
Physician assistant Admission evaluation note |
|
79188-9
|
Platelet aggregation ADP induced in Platelet rich plasma --10 umol/L |
|
78519-6
|
Platelet aggregation ADP induced in Platelet rich plasma --2 umol/L |
|
78520-4
|
Platelet aggregation ADP induced in Platelet rich plasma --2.5 umol/L |
|
78521-2
|
Platelet aggregation ADP induced in Platelet rich plasma --4 umol/L |
|
78522-0
|
Platelet aggregation ADP induced in Platelet rich plasma --5 umol/L |
|
49010-2
|
Platelet aggregation ADP induced [Units/volume] in Platelet rich plasma |
|
78688-9
|
Platelet aggregation adenosine diphosphate+prostaglandin E1 induced [Units/volume] in Blood |
|
76284-9
|
Pulmonary artery Blood pressure |
|
78526-1
|
Platelet aggregation collagen induced in Platelet rich plasma --1.25 ug/ml |
|
78527-9
|
Platelet aggregation collagen induced in Platelet rich plasma --5 ug/mL |
|
78685-5
|
Platelet aggregation collagen induced [Units/volume] in Blood |
|
83807-8
|
Physician assistant Custodial care facility Note |
|
83810-2
|
Physician assistant Discharge summary |
|
93408-3
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --10 umol/L |
|
78523-8
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --100 umol/L |
|
93409-1
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --5 umol/L |
|
78524-6
|
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --6 umol/L |
|
83812-8
|
Physician assistant History and physical note |
|
83814-4
|
Physician assistant Hospital Note |
|
29496-7
|
Platelet associated IgA Ab [Presence] in Blood by Flow cytometry (FC) |
|
13064-1
|
Platelet associated IgA Ab [Units/volume] in Blood |
|
14012-9
|
Platelet associated IgG Ab [Units/volume] in Blood by Flow cytometry (FC) |
|
29497-5
|
Platelet associated IgG Ab [Presence] in Blood by Flow cytometry (FC) |
|
8089-5
|
Platelet associated IgG Ab [Units/volume] in Blood |
|
47008-8
|
Platelet associated IgG Ab [Presence] in Serum by Immunoassay |
|
14013-7
|
Platelet associated IgM Ab [Units/volume] in Blood by Flow cytometry (FC) |
|
29498-3
|
Platelet associated IgM Ab [Presence] in Blood by Flow cytometry (FC) |
|
8090-3
|
Platelet associated IgM Ab [Units/volume] in Blood |
|
83811-0
|
Physician assistant Long term care facility Note |
|
83806-0
|
Physician assistant Note |
|
83808-6
|
Physician assistant Outpatient Note |
|
83813-6
|
Physician assistant Patient's home Note |
|
78528-7
|
Platelet aggregation ristocetin induced in Platelet rich plasma --1.25 mg/ml |
|
93702-9
|
Platelet aggregation ristocetin induced in Platelet rich plasma --15 ug/mL |
|
93410-9
|
Platelet aggregation ristocetin induced in Platelet rich plasma --5 ug/mL |
|
79130-1
|
Platelet aggregation ristocetin induced in Platelet rich plasma --500 ug/mL |
|
87403-2
|
Platelet aggregation ristocetin induced in Platelet rich plasma --750 ug/mL |
|
78686-3
|
Platelet aggregation ristocetin induced [Units/volume] in Blood --High dose |
|
81125-7
|
Platelet aggregation.ristocetin inhibitor [Presence] in Platelet poor plasma |
|
78739-0
|
Platelet aggregation ristocetin induced [Units/volume] in Blood --Low dose |
|
78687-1
|
Platelet aggregation thrombin receptor activating peptide-6 induced [Units/volume] in Blood |
|
34186-7
|
Para aminobenzoate [Mass/time] in 24 hour Urine |
|
40391-5
|
Para aminobenzoate free [Mass/volume] in Serum or Plasma |
|
18249-3
|
Para aminobenzoate [Mass/volume] in Serum or Plasma |
|
38406-5
|
PABPN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35355-7
|
PABPN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
76000-9
|
Paced heart rate by EKG |
|
14038-4
|
Pacific Squid IgE Ab [Units/volume] in Serum |
|
60114-6
|
PACLitaxel [Mass/volume] in Serum or Plasma |
|
10509-8
|
Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
|
10553-6
|
Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |
|
43718-6
|
Prostatic acid phosphatase [Presence] in Serum |
|
1714-5
|
Prostatic acid phosphatase [Enzymatic activity/volume] in Serum |
|
20420-6
|
Prostatic acid phosphatase [Mass/volume] in Serum |
|
1713-7
|
Prostatic acid phosphatase [Enzymatic activity/volume] in Semen |
|
16317-0
|
Prostatic acid phosphatase [Presence] in Vaginal fluid |
|
1712-9
|
Prostatic acid phosphatase [Enzymatic activity/volume] in Vaginal fluid |
|
46201-0
|
Porcine adenovirus Ab [Presence] in Serum |
|
43339-1
|
Porcine adenovirus Ab [Presence] in Serum by Immunofluorescence |
|
87381-0
|
Porcine adenovirus Ab [Titer] in Serum by Immunoassay |
|
23765-1
|
Porcine adenovirus Ag [Presence] in Tissue by Immunofluorescence |
|
6197-8
|
Paecilomyces sp IgE Ab [Units/volume] in Serum |
|
63163-0
|
Paecilomyces sp IgG Ab [Mass/volume] in Serum |
|
2723-5
|
Para aminohippurate renal clearance in 24 hour Urine and Serum or Plasma |
|
49014-4
|
PAH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
70245-6
|
PAH gene.p.Arg408Trp [Presence] in Blood or Tissue by Molecular genetics method |
|
2724-3
|
Para aminohippurate [Mass/volume] in Urine |
|
5980-8
|
Plasminogen activator inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5975-8
|
Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
22758-7
|
Plasminogen activator inhibitor 1 Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5974-1
|
Plasminogen activator inhibitor 1 [Units/volume] in Platelet poor plasma by Chromogenic method |
|
5976-6
|
Plasminogen activator inhibitor 1 [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
17467-2
|
Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
5977-4
|
Plasminogen activator inhibitor 2 Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5978-2
|
Plasminogen activator inhibitor 2 [Units/volume] in Platelet poor plasma by Chromogenic method |
|
38212-7
|
Pain assessment panel |
|
83647-8
|
Pain medicine Nurse Note |
|
83648-6
|
Pain medicine Nurse Outpatient Note |
|
83653-6
|
Pain medicine Team Consult note |
|
83654-4
|
Pain medicine Team Note |
|
88639-0
|
Pain medicine Controlled substance agreement |
|
78567-5
|
Pain medicine Consult note |
|
68708-7
|
Pain medicine Diagnostic study note |
|
68709-5
|
Pain medicine Discharge summary |
|
83643-7
|
Pain medicine Emergency department Note |
|
78610-3
|
Pain medicine Education note |
|
78621-0
|
Pain medicine Flowsheet |
|
89433-7
|
Pain medicine Group counseling note |
|
68711-1
|
Pain medicine History and physical note |
|
68716-0
|
Pain medicine Hospital Consult note |
|
68717-8
|
Pain medicine Hospital Letter |
|
83644-5
|
Pain medicine Hospital Note |
|
78651-7
|
Pain medicine Initial evaluation note |
|
83645-2
|
Pain medicine Long term care facility Note |
|
83646-0
|
Pain medicine Medication management note |
|
34858-1
|
Pain medicine Note |
|
83649-4
|
Pain medicine Outpatient Initial evaluation note |
|
83650-2
|
Pain medicine Outpatient Note |
|
83651-0
|
Pain medicine Outpatient procedure note |
|
83655-1
|
Pain medicine Telephone encounter Note |
|
80764-4
|
Pain medicine Plan of care note |
|
68713-7
|
Pain medicine Preoperative evaluation and management note |
|
68714-5
|
Pain medicine procedure note |
|
78668-1
|
Pain medicine Progress note |
|
78672-3
|
Pain medicine Referral note |
|
83652-8
|
Pain medicine Risk assessment and screening note |
|
90714-7
|
Pain medicine Telehealth Consult note |
|
89885-8
|
Pain medicine Telehealth Note |
|
68715-2
|
Pain medicine Transfer summary note |
|
46034-5
|
Pain site Set |
|
46033-7
|
Pain symptoms Set |
|
14168-9
|
Palatinase [Enzymatic activity/mass] in Tissue |
|
81314-7
|
Palatinase [Enzymatic activity/mass] in Small intestine Tissue |
|
81845-0
|
PALB2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
60117-9
|
Palladium [Mass/volume] in Blood |
|
51201-2
|
Palladium [Mass/volume] in Body fluid |
|
76648-5
|
Palladium [Mass/mass] in Hair |
|
50892-9
|
Palladium [Moles/mass] in Hair |
|
60118-7
|
Palladium [Mass/volume] in Red Blood Cells |
|
60119-5
|
Palladium [Mass/volume] in Serum or Plasma |
|
60120-3
|
Palladium [Mass/volume] in Urine |
|
78538-6
|
Palliative care Admission history and physical note |
|
78568-3
|
Palliative care Consult note |
|
84360-7
|
Palliative care Counseling note |
|
78579-0
|
Palliative care Discharge instructions |
|
78585-7
|
Palliative care Discharge summary |
|
78587-3
|
Palliative care Discharge teaching note |
|
78599-8
|
Palliative care Education note |
|
78636-8
|
Palliative care Flowsheet |
|
84359-9
|
Palliative care Group counseling note |
|
78643-4
|
Palliative care History and physical note |
|
78650-9
|
Palliative care Initial evaluation note |
|
84356-5
|
Palliative care Long term care facility Note |
|
85435-6
|
Palliative care Note |
|
84355-7
|
Palliative care Outpatient Note |
|
84350-8
|
Palliative care Telephone encounter Note |
|
80780-0
|
Palliative care Plan of care note |
|
82357-5
|
Palliative care procedure note |
|
78663-2
|
Palliative care Progress note |
|
84358-1
|
Palliative care Patient's home Consult note |
|
84357-3
|
Palliative care Patient's home Note |
|
78676-4
|
Palliative care Referral note |
|
84353-2
|
Palliative care Risk assessment and screening note |
|
90755-0
|
Palliative care Social worker Long term care facility Note |
|
90756-8
|
Palliative care Social worker Note |
|
90715-4
|
Palliative care Telehealth Consult note |
|
89886-6
|
Palliative care Telehealth Note |
|
78682-2
|
Palliative care Transfer summary note |
|
83705-4
|
Palliative care Attending Note |
|
83785-6
|
Palliative care Physician Note |
|
83641-1
|
Palliative care Nurse Note |
|
84354-0
|
Palliative care Pharmacist Note |
|
83770-8
|
Palliative care Resident Note |
|
84352-4
|
Palliative care Team Consult note |
|
84351-6
|
Palliative care Team Note |
|
75115-6
|
Palmitate (C16:0) [Entitic substance] in Red Blood Cells |
|
47641-6
|
Palmitate (C16:0)/Creatinine [Molar ratio] in Urine |
|
55873-4
|
Palmitate (C16:0)/Laurate (C12:0) [Molar ratio] in Serum or Plasma |
|
75111-5
|
Palmitoleate (C16:1w7) [Entitic substance] in Red Blood Cells |
|
55965-8
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in Amniotic fluid |
|
55964-1
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in Cerebral spinal fluid |
|
53198-8
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in DBS |
|
74600-8
|
Palmitoleylcarnitine (C16:1) [Enzymatic activity/mass] in Fibroblast |
|
55966-6
|
Palmitoleylcarnitine (C16:1) [Moles/volume] in Urine |
|
55963-3
|
Palmitoleylcarnitine (C16:1)/Creatinine [Molar ratio] in Urine |
|
59243-6
|
Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
59204-8
|
Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
54325-6
|
Palmitoylcarnitine (C16) [Moles/volume] in Amniotic fluid |
|
41040-7
|
Palmitoylcarnitine (C16) [Moles/volume] in Blood |
|
54324-9
|
Palmitoylcarnitine (C16) [Moles/volume] in Cerebral spinal fluid |
|
53199-6
|
Palmitoylcarnitine (C16) [Moles/volume] in DBS |
|
74601-6
|
Palmitoylcarnitine (C16) [Enzymatic activity/mass] in Fibroblast |
|
55967-4
|
Palmitoylcarnitine (C16) [Moles/volume] in Urine |
|
88024-5
|
Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in DBS |
|
88008-8
|
Palmitoylcarnitine (C16)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
88015-3
|
Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
88009-6
|
Palmitoylcarnitine (C16)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
25828-5
|
Palo verde IgE Ab [Units/volume] in Serum |
|
12334-9
|
Para aminophenol [Mass/volume] in Urine |
|
27022-3
|
Para aminophenol/Creatinine [Mass Ratio] in Urine |
|
56659-6
|
Para aminophenol/Creatinine [Ratio] in Urine |
|
38718-3
|
Phthalic anhydride [Mass/volume] in Air |
|
54158-1
|
Pancytokeratin Ab [Presence] in Serum by Immunofluorescence |
|
54159-9
|
Pancytokeratin Ab [Titer] in Serum by Immunofluorescence |
|
48679-5
|
Pancytokeratin Ag [Presence] in Tissue by Immune stain |
|
7601-8
|
Phthalic anhydride IgE Ab [Units/volume] in Serum |
|
61297-8
|
Phthalic anhydride IgE Ab/IgE total in Serum |
|
18423-4
|
Phthalic anhydride IgG Ab [Units/volume] in Serum |
|
35550-3
|
Phthalic anhydride IgG Ab [Mass/volume] in Serum |
|
18424-2
|
Phthalic anhydride IgM Ab [Units/volume] in Serum |
|
48190-3
|
Phthalic anhydride triggered leukotriene release [Mass/volume] by Leukocytes |
|
45171-6
|
Pancreatic islet cell Ab [Units/volume] in Serum by Immunofluorescence |
|
31547-3
|
Pancreatic islet cell Ab [Presence] in Serum |
|
5265-4
|
Pancreatic islet cell Ab [Presence] in Serum by Immunofluorescence |
|
8086-1
|
Pancreatic islet cell Ab [Units/volume] in Serum |
|
34652-8
|
Pancreatic islet cell Ab [Moles/volume] in Serum |
|
13927-9
|
Pancreatic islet cell Ab [Titer] in Serum |
|
45225-0
|
Pancreatic islet cell complement fixing Ab [Titer] in Serum by Immunofluorescence |
|
33563-8
|
Pancreatic islet cell IgG Ab [Units/volume] in Serum |
|
56687-7
|
Pancreatic islet cell IgG Ab [Titer] in Serum by Immunofluorescence |
|
2721-9
|
Pancreatic polypeptide [Mass/volume] in Serum or Plasma |
|
55226-5
|
Pancreatic polypeptide [Moles/volume] in Serum or Plasma |
|
53029-5
|
Neutrophil cytoplasmic Ab.perinuclear.atypical [Presence] in Serum by Immunofluorescence |
|
49503-6
|
Neutrophil cytoplasmic Ab.perinuclear.atypical [Titer] in Serum by Immunofluorescence |
|
72522-6
|
p-ANCA formalin resistant IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
72521-8
|
p-ANCA formalin sensitive IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
37991-7
|
Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum by Immunoassay |
|
30539-1
|
Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum |
|
17357-5
|
Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence |
|
8085-3
|
Neutrophil cytoplasmic Ab.perinuclear [Units/volume] in Serum |
|
32787-4
|
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum |
|
14278-6
|
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence |
|
66115-7
|
Pancreas Pathology biopsy report |
|
49013-6
|
Pancreastatin [Mass/volume] in Serum or Plasma |
|
60121-1
|
Pancuronium [Mass/volume] in Blood |
|
48284-4
|
Pancuronium triggered leukotriene release [Mass/volume] by Leukocytes |
|
60122-9
|
Pancuronium [Mass/volume] in Serum or Plasma |
|
60123-7
|
Pancuronium [Mass/mass] in Tissue |
|
60124-5
|
Pancuronium [Mass/volume] in Urine |
|
82741-0
|
Pediatric autoimmune neuropsychiatric disorder associated with streptococcus (PANDAS) panel - Serum |
|
41072-0
|
PANK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34508-2
|
PANK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72980-6
|
Pantoprazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72979-8
|
Pantoprazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73219-8
|
Pantoprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73218-0
|
Pantoprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
27351-6
|
Pantothenate [Presence] in Serum, Plasma or Blood |
|
2722-7
|
Pantothenate [Mass/volume] in Serum, Plasma or Blood |
|
75066-1
|
Pantothenate [Moles/volume] in Serum or Plasma |
|
75060-4
|
Pantothenate/Creatinine [Molar ratio] in Urine |
|
69999-1
|
Positive airway pressure panel |
|
5969-1
|
Plasmin-plasmin inhibitor complex [Mass/volume] in Platelet poor plasma by Immunoassay |
|
10945-4
|
Papain IgE Ab [Units/volume] in Serum |
|
50352-4
|
Papain IgE Ab/IgE total in Serum |
|
60125-2
|
Papaverine [Mass/volume] in Blood |
|
73216-4
|
Papaverine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73217-2
|
Papaverine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12550-0
|
Papaverine [Mass/volume] in Serum or Plasma |
|
60126-0
|
Papaverine [Mass/volume] in Urine |
|
6850-2
|
Papaya (Carica papaya) IgE Ab [Units/volume] in Serum |
|
56343-7
|
Papaya (Carica papaya) IgG4 Ab [Mass/volume] in Serum |
|
63131-7
|
Papaya (Carica papaya) IgG Ab [Mass/volume] in Serum |
|
7562-2
|
Paper IgE Ab [Units/volume] in Serum |
|
16104-2
|
Paper Mulberry IgE Ab [Units/volume] in Serum |
|
63436-0
|
Paper wasp recombinant (rPol d) 5 IgE Ab [Units/volume] in Serum |
|
6198-6
|
Paper wasp IgE Ab [Units/volume] in Serum |
|
41204-9
|
Paper wasp IgE Ab/IgE total in Serum |
|
41235-3
|
Paper wasp IgE Ab [Mass/volume] in Serum |
|
6731-4
|
Paper wasp IgG Ab [Units/volume] in Serum |
|
56969-9
|
Paper wasp IgG4 Ab [Units/volume] in Serum |
|
56344-5
|
Paper wasp IgG4 Ab [Mass/volume] in Serum |
|
41219-7
|
Paper wasp IgG Ab [Mass/volume] in Serum |
|
48183-8
|
Paper wasp triggered leukotriene release [Mass/volume] by Leukocytes |
|
76348-2
|
Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma |
|
32046-5
|
Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma |
|
48407-1
|
Pregnancy associated plasma protein A [Mass/volume] in Serum or Plasma |
|
7563-0
|
Paprika IgE Ab [Units/volume] in Serum |
|
61239-0
|
Paprika IgE Ab/IgE total in Serum |
|
41848-3
|
Paprika IgG Ab [Units/volume] in Serum |
|
56345-2
|
Paprika IgG4 Ab [Mass/volume] in Serum |
|
63114-3
|
Paprika IgG Ab [Mass/volume] in Serum |
|
41421-9
|
Paragonimus sp Ab [Presence] in Serum by Immunoblot |
|
7977-2
|
Paragonimus sp Ab [Units/volume] in Serum |
|
51465-3
|
Paragonimus sp Ab [Titer] in Pleural fluid |
|
51450-5
|
Paragonimus sp Ab [Titer] in Pleural fluid by Immunoassay |
|
22436-0
|
Paragonimus sp Ab [Titer] in Serum |
|
5267-0
|
Paragonimus sp Ab [Titer] in Serum by Complement fixation |
|
51449-7
|
Paragonimus sp Ab [Titer] in Serum by Immunoassay |
|
24503-5
|
Parakeet droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
17416-9
|
Parakeet droppings Ab [Units/volume] in Serum |
|
7564-8
|
Parakeet droppings IgE Ab [Units/volume] in Serum |
|
17417-7
|
Parakeet droppings IgG Ab [Units/volume] in Serum |
|
55605-0
|
Parakeet feather IgE Ab [Presence] in Serum |
|
7565-5
|
Parakeet feather IgE Ab [Units/volume] in Serum |
|
58915-0
|
Parakeet feather IgG Ab [Mass/volume] in Serum |
|
24502-7
|
Parakeet serum Ab [Presence] in Serum by Immune diffusion (ID) |
|
17418-5
|
Parakeet serum Ab [Units/volume] in Serum |
|
7566-3
|
Parakeet serum IgE Ab [Units/volume] in Serum |
|
50386-2
|
Parakeet+Parrot droppings IgE Ab/IgE total in Serum |
|
3904-0
|
Paraldehyde [Mass/volume] in Blood |
|
3905-7
|
Paraldehyde [Mass/volume] in Serum or Plasma |
|
55563-1
|
Paraldehyde [Moles/volume] in Serum or Plasma |
|
18391-3
|
Paraldehyde [Mass/volume] in Urine |
|
53715-9
|
Paraneoplastic Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
43104-9
|
Paraneoplastic Ab panel - Serum |
|
34142-0
|
Paraneoplastic Ab [Presence] in Serum by Immunoblot |
|
61177-2
|
Paraneoplastic Ab [Presence] in Serum by Immunofluorescence |
|
60129-4
|
Paraoxon [Mass/volume] in Blood |
|
60130-2
|
Paraoxon [Mass/volume] in Body fluid |
|
27279-9
|
Paraoxon [Mass/volume] in Serum or Plasma |
|
60131-0
|
Paraoxon [Mass/mass] in Tissue |
|
21443-7
|
Paraoxon [Mass/volume] in Urine |
|
5708-3
|
Paraquat [Mass/volume] in Blood |
|
20929-6
|
Paraquat [Mass/volume] in Gastric fluid |
|
59070-3
|
Paraquat [Presence] in Serum or Plasma |
|
5709-1
|
Paraquat [Mass/volume] in Serum or Plasma |
|
50893-7
|
Paraquat [Moles/volume] in Serum or Plasma |
|
20930-4
|
Paraquat [Mass/mass] in Tissue |
|
52961-0
|
Paraquat [Presence] in Urine |
|
9827-7
|
Paraquat [Mass/volume] in Urine |
|
24429-3
|
Parasite identified in Blood |
|
91900-1
|
Parasite [Presence] in Blood by Light microscopy |
|
17784-0
|
Parasite identified in Blood by Light microscopy |
|
40656-1
|
Parasite identified in Blood by Thick film |
|
38416-4
|
Parasite identified in Body fluid by Inspection |
|
42807-8
|
Parasite identified in Isolate |
|
53609-4
|
Parasite identified in Bone marrow by Light microscopy |
|
20933-8
|
Parasite identified in Serum by Light microscopy |
|
92892-9
|
Microbiology - parasitic studies |
|
38402-4
|
Parasite identified in Tissue |
|
41446-6
|
Parasite identified in Unspecified specimen by Culture |
|
20932-0
|
Parasite identified in Unspecified specimen by Inspection |
|
20931-2
|
Parasites [#/volume] in Gastric fluid |
|
38613-6
|
Parathion [Mass/volume] in Air |
|
60132-8
|
Parathion [Mass/volume] in Blood |
|
60133-6
|
Parathion [Mass/volume] in Body fluid |
|
53649-0
|
Parathion [Mass/volume] in Gastric fluid |
|
2728-4
|
Parathion [Mass/volume] in Serum or Plasma |
|
60134-4
|
Parathion [Mass/mass] in Tissue |
|
17419-3
|
Parathion [Mass/volume] in Urine |
|
87659-9
|
Parathion [Mass/mass] in Unspecified specimen |
|
90741-0
|
Parathyrin.1-84 [Mass/volume] in Serum or Plasma by Immunoassay |
|
86582-4
|
Parechovirus A RNA [Presence] in Blood by NAA with probe detection |
|
82193-4
|
Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
86586-5
|
Parechovirus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
51669-0
|
Parechovirus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87689-6
|
Parent Patient Activation Measure - 10 [PAM] Parent |
|
87675-5
|
Parent Patient Activation Measure - 13 [PAM] Parent |
|
52054-4
|
Parenteral nutrition attachment |
|
46043-6
|
Parenteral or enteral intake Set |
|
88651-5
|
Parenteral therapy note |
|
60135-1
|
Pargyline [Mass/volume] in Serum or Plasma |
|
82521-6
|
Paritaprevir [Susceptibility] by Genotype method |
|
41071-2
|
PARK2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40476-4
|
PARK2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77629-4
|
PARK7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7213-2
|
Parmesan Cheese triggered histamine release [Units/volume] in Blood |
|
7212-4
|
Parmesan Cheese IgE Ab [Units/volume] in Serum |
|
56346-0
|
Parmesan Cheese IgG4 Ab [Mass/volume] in Serum |
|
63089-7
|
Parmesan Cheese IgG Ab [Mass/volume] in Serum |
|
51719-3
|
Paromomycin [Susceptibility] |
|
72978-0
|
PARoxetine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72977-2
|
PARoxetine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60136-9
|
PARoxetine [Mass/volume] in Blood |
|
60137-7
|
PARoxetine [Mass/volume] in Body fluid |
|
59950-6
|
PARoxetine [Moles/volume] in Gastric fluid |
|
73215-6
|
PARoxetine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73214-9
|
PARoxetine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13577-2
|
PARoxetine [Presence] in Serum or Plasma |
|
9699-0
|
PARoxetine [Mass/volume] in Serum or Plasma |
|
14867-6
|
PARoxetine [Moles/volume] in Serum or Plasma |
|
60138-5
|
PARoxetine [Mass/mass] in Tissue |
|
72658-8
|
PARoxetine [Mass/volume] in Serum or Plasma --trough |
|
72784-2
|
PARoxetine [Mass/volume] in Urine by Confirmatory method |
|
27109-8
|
PARoxetine [Presence] in Urine |
|
92650-1
|
PARoxetine [Presence] in Urine by Confirmatory method |
|
39591-3
|
PARoxetine [Mass/volume] in Urine |
|
59949-8
|
PARoxetine [Moles/volume] in Urine |
|
32102-6
|
PARoxetine [Presence] in Unspecified specimen |
|
60327-4
|
PARoxetine [Moles/volume] in Unspecified specimen |
|
72785-9
|
PARoxetine/Creatinine [Mass Ratio] in Urine |
|
55164-8
|
Paroxysmal nocturnal panel - Blood |
|
24501-9
|
Parrot droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
17420-1
|
Parrot droppings Ab [Units/volume] in Serum |
|
6201-8
|
Parrot droppings IgE Ab [Units/volume] in Serum |
|
43637-8
|
Parrot droppings IgG Ab [Presence] in Serum |
|
55606-8
|
Parrot feather IgE Ab [Presence] in Serum |
|
6202-6
|
Parrot feather IgE Ab [Units/volume] in Serum |
|
50353-2
|
Parrot feather IgE Ab/IgE total in Serum |
|
51548-6
|
Parrot feather IgG Ab [Presence] in Serum |
|
56347-8
|
Parrot feather IgG4 Ab [Mass/volume] in Serum |
|
58913-5
|
Parrot feather IgG Ab [Mass/volume] in Serum |
|
51860-5
|
Parrot serum proteins+feathers+droppings IgG Ab [Presence] in Serum |
|
78368-8
|
Parrot serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum |
|
24500-1
|
Parrot serum Ab [Presence] in Serum by Immune diffusion (ID) |
|
17421-9
|
Parrot serum Ab [Units/volume] in Serum |
|
7567-1
|
Parrot serum IgE Ab [Units/volume] in Serum |
|
6203-4
|
Parsley IgE Ab [Units/volume] in Serum |
|
61295-2
|
Parsley IgE Ab/IgE total in Serum |
|
7568-9
|
Parsley IgG Ab [Units/volume] in Serum |
|
56348-6
|
Parsley IgG4 Ab [Mass/volume] in Serum |
|
63094-7
|
Parsley IgG Ab [Mass/volume] in Serum |
|
7569-7
|
Parsnip IgE Ab [Units/volume] in Serum |
|
56349-4
|
Parsnip IgG4 Ab [Mass/volume] in Serum |
|
63150-7
|
Parsnip IgG Ab [Mass/volume] in Serum |
|
46071-7
|
Participation in assessment Set |
|
48685-2
|
Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
54182-1
|
Para aminosalicylate [Susceptibility] by Disk diffusion (KB) |
|
9786-5
|
Microscopic observation [Identifier] in Blood or Marrow by Periodic acid-Schiff stain |
|
6675-3
|
Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain |
|
674-2
|
Microscopic observation [Identifier] in Unspecified specimen by Periodic acid-Schiff stain |
|
10946-2
|
Passion fruit IgE Ab [Units/volume] in Serum |
|
61293-7
|
Passion fruit IgE Ab/IgE total in Serum |
|
41360-9
|
Passive range of motion panel Quantitative |
|
80434-4
|
Past employer state |
|
52067-6
|
Past filing limit justification |
|
46005-5
|
Past roles Set |
|
84339-1
|
Pastoral care Team Note |
|
84349-0
|
Pastoral care Consult note |
|
84348-2
|
Pastoral care Counseling note |
|
84347-4
|
Pastoral care Education note |
|
84346-6
|
Pastoral care Group counseling note |
|
68469-6
|
Pastoral care Hospital Consult note |
|
84343-3
|
Pastoral care Hospital Note |
|
84344-1
|
Pastoral care Initial evaluation note |
|
84342-5
|
Pastoral care Long term care facility Note |
|
34906-8
|
Pastoral care Note |
|
84341-7
|
Pastoral care Outpatient Note |
|
84338-3
|
Pastoral care Telephone encounter Note |
|
84337-5
|
Pastoral care Plan of care note |
|
80671-1
|
Pastoral care Progress note |
|
84345-8
|
Pastoral care Patient's home Note |
|
78675-6
|
Pastoral care Referral note |
|
84340-9
|
Pastoral care Risk assessment and screening note |
|
48301-6
|
Patent blue V triggered leukotriene release [Mass/volume] by Leukocytes |
|
78740-8
|
Pathologic casts [#/area] in Urine by Automated count |
|
34122-2
|
Pathology procedure note |
|
83321-0
|
Pathology report intraoperative observation in Specimen Document |
|
59465-5
|
Pathologist review of results |
|
14869-2
|
Pathologist review of Blood tests |
|
90947-3
|
Pathology case identifier [Identifier] |
|
60570-9
|
Pathology Consult note |
|
60571-7
|
Pathology Consult note.synoptic |
|
34819-3
|
Pathology Evaluation and management note |
|
84336-7
|
Pathology Letter |
|
83592-6
|
Pathology Nurse Note |
|
84335-9
|
Pathology Outpatient Note |
|
84334-2
|
Pathology Telephone encounter Note |
|
11526-1
|
Pathology study |
|
86946-1
|
Patient Activation Measure - 10 [PAM] |
|
86933-9
|
Patient Activation Measure - 13 [PAM] |
|
75877-1
|
Patient activity scale [PAS] |
|
75876-3
|
Patient activity scale II [PASII] |
|
83331-9
|
Patient Centered Assessment Method panel [PCAM] |
|
79191-3
|
Patient demographics panel |
|
58120-7
|
Patient Health Questionnaire 2 item (PHQ-2) [PHQ.CMS] |
|
89206-7
|
Patient Health Questionnaire-9: Modified for Teens [Reported.PHQ.Teen] |
|
89204-2
|
Patient Health Questionnaire-9: Modified for Teens total score [Reported.PHQ.Teen] |
|
35090-0
|
Patient history |
|
52463-7
|
Patient Identification Number or Provider Account Number |
|
86533-7
|
Patient Living will |
|
85198-0
|
Patient Long term care facility Living will |
|
51855-5
|
Patient Note |
|
35091-8
|
Patient physical |
|
92664-2
|
Power of attorney and Living will |
|
89196-0
|
Patient reported outcome measure panel |
|
74080-3
|
Patient safety event report - hospital - medication or other substance - version 1.2 [AHRQ] |
|
55750-4
|
Patient safety report Document |
|
89862-7
|
Patient-Oriented Eczema Measure [POEM] |
|
84436-5
|
Pattern Comparison Processing Speed Test [NIH Toolbox] |
|
75994-4
|
Pulmonary artery wedge pressure |
|
60994-1
|
Pulmonary artery wedge Diastolic blood pressure |
|
60995-8
|
Pulmonary artery wedge Systolic blood pressure |
|
38407-3
|
PAX3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35296-3
|
PAX3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48680-3
|
PAX5 Ag [Presence] in Tissue by Immune stain |
|
74490-4
|
PAX5 and BCL2 Ag [Identifier] in Tissue by Immune stain |
|
74492-0
|
PAX5 and CD43 Ag [Identifier] in Tissue by Immune stain |
|
74493-8
|
PAX5 and CD5 Ag [Identifier] in Tissue by Immune stain |
|
59064-6
|
PAX6 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
73910-2
|
PAX8 Ag [Presence] in Tissue by Immune stain |
|
52034-6
|
Payer letter |
|
52556-8
|
Payment sources |
|
6883-3
|
Glucose.protein bound [Mass/volume] in Serum or Plasma |
|
10878-7
|
Iodine.protein bound [Mass/volume] in Serum or Plasma |
|
18489-5
|
Valproate.protein bound [Mass/volume] in Serum or Plasma |
|
87486-7
|
PB-22 3-carboxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
17472-2
|
Polybrominated biphenyl [Mass/volume] in Serum or Plasma |
|
12245-7
|
Porphobilinogen [Presence] in 24 hour Urine |
|
27382-1
|
Porphobilinogen [Mass/volume] in 24 hour Urine |
|
2810-0
|
Porphobilinogen [Mass/time] in 24 hour Urine |
|
34356-6
|
Porphobilinogen [Moles/volume] in 24 hour Urine |
|
14882-5
|
Porphobilinogen [Moles/time] in 24 hour Urine |
|
12810-8
|
Porphobilinogen deaminase [Enzymatic activity/volume] in Blood |
|
2812-6
|
Porphobilinogen deaminase [Enzymatic activity/volume] in Red Blood Cells |
|
49228-0
|
Porphobilinogen deaminase [Enzymatic activity/mass] in Red Blood Cells |
|
56483-1
|
Porphobilinogen [Mass/mass] in Stool |
|
12916-3
|
Porphobilinogen synthase [Enzymatic activity/volume] in Blood |
|
2813-4
|
Porphobilinogen synthase [Enzymatic activity/volume] in Red Blood Cells |
|
79465-1
|
Porphobilinogen synthase [Enzymatic activity/mass] in Red Blood Cells |
|
12917-1
|
Porphobilinogen synthase [Enzymatic activity/volume] in Serum or Plasma |
|
2809-2
|
Porphobilinogen [Presence] in Urine |
|
24446-7
|
Porphobilinogen [Mass/volume] in Urine |
|
2811-8
|
Porphobilinogen [Moles/volume] in Urine |
|
74441-7
|
Porphobilinogen/Creatinine [Molar ratio] in 24 hour Urine |
|
13797-6
|
Porphobilinogen/Creatinine [Mass Ratio] in Urine |
|
34357-4
|
Porphobilinogen/Creatinine [Molar ratio] in Urine |
|
33307-0
|
Phosphatidylcholine Ab [Presence] in Serum |
|
93363-0
|
Plasma cell DNA content and proliferation panel - Bone marrow by Flow cytometry (FC) |
|
14010-3
|
Phosphatidylcholine IgA Ab [Units/volume] in Serum by Immunoassay |
|
14242-2
|
Phosphatidylcholine IgA Ab [Presence] in Serum |
|
13075-7
|
Phosphatidylcholine IgA Ab [Units/volume] in Serum |
|
14008-7
|
Phosphatidylcholine IgG Ab [Units/volume] in Serum by Immunoassay |
|
14243-0
|
Phosphatidylcholine IgG Ab [Presence] in Serum |
|
13073-2
|
Phosphatidylcholine IgG Ab [Units/volume] in Serum |
|
14009-5
|
Phosphatidylcholine IgM Ab [Units/volume] in Serum by Immunoassay |
|
14244-8
|
Phosphatidylcholine IgM Ab [Presence] in Serum |
|
13074-0
|
Phosphatidylcholine IgM Ab [Units/volume] in Serum |
|
84135-3
|
Primary care Interdisciplinary Patient's home Plan of care note |
|
2784-7
|
Phosphatidylcholine.saturated [Mass/volume] in Amniotic fluid |
|
76765-7
|
Phosphatidylcholine.saturated [Moles/volume] in Amniotic fluid |
|
50618-8
|
Phosphatidylcholine.saturated/Surfactant.total in Amniotic fluid |
|
30165-5
|
Phosphatidylcholine/Albumin [Mass Ratio] in Amniotic fluid |
|
63303-2
|
Parietal cell Ab [Presence] in Gastric fluid by Immunofluorescence |
|
56147-2
|
Parietal cell Ab [Units/volume] in Serum by Immunoassay |
|
14241-4
|
Parietal cell Ab [Presence] in Serum |
|
26969-6
|
Parietal cell Ab [Presence] in Serum by Immunofluorescence |
|
8087-9
|
Parietal cell Ab [Units/volume] in Serum |
|
42527-2
|
Parietal cell Ab [Titer] in Cerebral spinal fluid |
|
63304-0
|
Parietal cell Ab [Titer] in Gastric fluid by Immunofluorescence |
|
27320-1
|
Parietal cell Ab [Titer] in Serum |
|
5271-2
|
Parietal cell Ab [Titer] in Serum by Immunofluorescence |
|
76312-8
|
PCA dose number.max 1 hour Infusion pump |
|
76313-6
|
PCA dose volume.max Infusion pump |
|
31556-4
|
Parietal cell IgG Ab [Presence] in Serum |
|
29963-6
|
Parietal cell IgG Ab [Presence] in Serum by Immunofluorescence |
|
40960-7
|
Parietal cell IgG Ab [Units/volume] in Serum |
|
48406-3
|
Parietal cell IgG Ab [Titer] in Serum |
|
76314-4
|
PCA lockout time Infusion pump |
|
90842-6
|
PCA-1 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
90841-8
|
PCA-1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
84923-2
|
PCA-1 Ab [Units/volume] in Serum by Immunoblot |
|
84924-0
|
PCA-1 Ab [Presence] in Serum by Immunofluorescence |
|
53713-4
|
PCA-1 Ab [Titer] in Cerebral spinal fluid |
|
53717-5
|
PCA-1 Ab [Titer] in Serum |
|
69953-8
|
PCA-1 IgG Ab [Presence] in Serum by Immunoassay |
|
90843-4
|
PCA-2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
84925-7
|
PCA-2 Ab [Presence] in Serum by Immunofluorescence |
|
35143-7
|
PCA-2 Ab [Titer] in Cerebral spinal fluid |
|
33925-9
|
PCA-2 Ab [Titer] in Serum |
|
69361-4
|
PCA3 score in Urine by Molecular genetics method |
|
51796-1
|
PCA-Tr Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
90844-2
|
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
90845-9
|
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
88734-9
|
PCA-Tr Ab [Units/volume] in Serum by Line blot |
|
63440-2
|
PCA-Tr Ab [Presence] in Serum by Immunoblot |
|
84926-5
|
PCA-Tr Ab [Presence] in Serum by Immunofluorescence |
|
51748-2
|
PCA-Tr Ab [Titer] in Cerebral spinal fluid |
|
90846-7
|
PCA-Tr Ab [Titer] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay |
|
56551-5
|
PCA-Tr Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
33926-7
|
PCA-Tr Ab [Titer] in Serum |
|
56550-7
|
PCA-Tr Ab [Titer] in Serum by Immunofluorescence |
|
82999-4
|
PCA-Tr IgG Ab [Presence] in Serum or Plasma by Line blot |
|
38752-2
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Air |
|
61175-6
|
Polychlorinated biphenyl.Aroclor 1242 [Mass/volume] in Serum or Plasma |
|
61176-4
|
Polychlorinated biphenyl.Aroclor 1248 [Mass/volume] in Serum or Plasma |
|
12991-6
|
Polychlorinated biphenyl.Aroclor 1254 [Mass/volume] in Serum or Plasma |
|
12990-8
|
Polychlorinated biphenyl.Aroclor 1260 [Mass/volume] in Serum or Plasma |
|
43213-8
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Blood |
|
27015-7
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Body fluid |
|
74410-2
|
Polychlorinated biphenyl (PCB) panel - Serum or Plasma by Confirmatory method |
|
73993-8
|
Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Confirmatory method |
|
73994-6
|
Polychlorinated biphenyl (PCB) [Presence] in Serum or Plasma by Screen method |
|
5716-6
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Serum or Plasma |
|
18251-9
|
Polychlorinated biphenyl (PCB) [Presence] in Tissue |
|
16179-4
|
Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue |
|
5717-4
|
Polychlorinated biphenyl (PCB) [Mass/volume] in Urine |
|
47873-5
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Amniotic fluid cells |
|
47877-6
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Chorionic villus sample |
|
47874-3
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Fibroblast |
|
47876-8
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Placenta |
|
47875-0
|
Propionyl CoA Carboxylase [Enzymatic activity/mass] in Leukocytes |
|
53887-6
|
PCCA gene+PCCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77748-2
|
PCDH15 gene c.733C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
77126-1
|
PCDH15 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77125-3
|
PCDH15 gene full mutation analysis in Blood or Tissue by Sequencing |
|
76137-9
|
Platelet component distribution width [Mass/volume] in Blood by calculation |
|
33050-6
|
Pseudocholinesterase phenotype [Identifier] in Serum or Plasma |
|
78939-6
|
Percutaneous coronary intervention device panel |
|
80527-5
|
Percutaneous coronary intervention individual lesion details panel |
|
78914-9
|
Percutaneous coronary intervention panel |
|
93753-2
|
Porcine cytomegalovirus DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87382-8
|
Porcine cytomegalovirus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
38714-2
|
Pentachloronitrobenzene [Mass/volume] in Air |
|
2018-0
|
Carbon dioxide [Partial pressure] in Amniotic fluid |
|
11557-6
|
Carbon dioxide [Partial pressure] in Blood |
|
2019-8
|
Carbon dioxide [Partial pressure] in Arterial blood |
|
2020-6
|
Carbon dioxide [Partial pressure] in Capillary blood |
|
14003-8
|
Carbon dioxide [Partial pressure] in Cord blood |
|
28644-3
|
Carbon dioxide [Partial pressure] in Arterial cord blood |
|
28645-0
|
Carbon dioxide [Partial pressure] in Venous cord blood |
|
19212-0
|
Carbon dioxide [Partial pressure] in Mixed venous blood |
|
2021-4
|
Carbon dioxide [Partial pressure] in Venous blood |
|
2022-2
|
Carbon dioxide [Partial pressure] in Cerebral spinal fluid |
|
59165-1
|
Carbon dioxide [Partial pressure] in Dialysis fluid |
|
2023-0
|
Carbon dioxide [Partial pressure] in Body fluid |
|
53458-6
|
Carbon dioxide [Partial pressure] in Nonbiological fluid |
|
47599-6
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Cord blood |
|
49694-3
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood |
|
49695-0
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Venous cord blood |
|
50981-0
|
Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Mixed venous blood |
|
32306-3
|
Carbon dioxide [Partial pressure] in Urine |
|
75418-4
|
PCORI patient-reported outcomes common measures - core and recommended [PROMIS] |
|
75421-8
|
PCORI patient-reported outcomes core adult measures [PROMIS] |
|
75420-0
|
PCORI patient-reported outcomes core pediatric measures [PROMIS] |
|
75419-2
|
PCORI patient-reported outcomes recommended measures [PROMIS] |
|
85057-8
|
PCORnet Common Data Model set - version 3.0 [PCORnet] |
|
58042-3
|
Phencyclidine [Presence] in Blood by Confirmatory method |
|
51692-2
|
Phencyclidine [Presence] in Blood by Screen method |
|
91040-6
|
Phencyclidine [Presence] in Body fluid by Screen method |
|
8228-9
|
Phencyclidine [Presence] in Gastric fluid |
|
8229-7
|
Phencyclidine [Presence] in Gastric fluid by Confirmatory method |
|
8230-5
|
Phencyclidine [Presence] in Gastric fluid by Screen method |
|
8227-1
|
Phencyclidine [Mass/volume] in Gastric fluid |
|
40394-9
|
Phencyclidine [Presence] in Hair |
|
40807-0
|
Phencyclidine [Presence] in Hair by Screen method |
|
10370-5
|
Phencyclidine [Mass/mass] in Hair |
|
92816-8
|
Phencyclidine [Mass/mass] in Meconium by Confirmatory method |
|
8232-1
|
Phencyclidine [Presence] in Meconium |
|
8233-9
|
Phencyclidine [Presence] in Meconium by Confirmatory method |
|
8234-7
|
Phencyclidine [Presence] in Meconium by Screen method |
|
26829-2
|
Phencyclidine [Mass/mass] in Meconium by Screen method |
|
8231-3
|
Phencyclidine [Mass/volume] in Meconium |
|
26859-9
|
Phencyclidine [Mass/mass] in Meconium |
|
26994-4
|
Phencyclidine [Mass/volume] in Milk |
|
72765-1
|
Phencyclidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74660-2
|
Phencyclidine [Presence] in Saliva (oral fluid) by Confirmatory method |
|
40808-8
|
Phencyclidine [Presence] in Saliva (oral fluid) by Screen method |
|
3935-4
|
Phencyclidine [Presence] in Serum or Plasma |
|
8235-4
|
Phencyclidine [Presence] in Serum or Plasma by Confirmatory method |
|
8236-2
|
Phencyclidine [Presence] in Serum or Plasma by Screen method |
|
3934-7
|
Phencyclidine [Mass/volume] in Serum or Plasma |
|
59956-3
|
Phencyclidine [Moles/volume] in Serum or Plasma |
|
12355-4
|
Phencyclidine [Presence] in Stool |
|
91035-6
|
Phencyclidine [Presence] in Tissue by Screen method |
|
16254-5
|
Phencyclidine [Mass/volume] in Urine by Confirmatory method |
|
3936-2
|
Phencyclidine [Presence] in Urine |
|
18392-1
|
Phencyclidine [Presence] in Urine by Confirmatory method |
|
14311-5
|
Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL |
|
8237-0
|
Phencyclidine [Presence] in Urine by SAMHSA confirm method |
|
8238-8
|
Phencyclidine [Presence] in Urine by SAMHSA screen method |
|
19659-2
|
Phencyclidine [Presence] in Urine by Screen method |
|
14310-7
|
Phencyclidine [Presence] in Urine by Screen method >25 ng/mL |
|
72825-3
|
Phencyclidine [Mass/volume] in Urine by Screen method |
|
3937-0
|
Phencyclidine [Mass/volume] in Urine |
|
52951-1
|
Phencyclidine [Moles/volume] in Urine |
|
8240-4
|
Phencyclidine [Presence] in Unknown substance |
|
8241-2
|
Phencyclidine [Presence] in Unknown substance by Confirmatory method |
|
8242-0
|
Phencyclidine [Presence] in Unknown substance by Screen method |
|
8239-6
|
Phencyclidine [Mass/volume] in Unknown substance |
|
27131-2
|
Phencyclidine [Presence] in Vitreous fluid |
|
27356-5
|
Phencyclidine [Mass/volume] in Vitreous fluid |
|
32107-5
|
Phencyclidine [Presence] in Unspecified specimen |
|
10915-7
|
Phencyclidine [Mass/volume] in Unspecified specimen |
|
57869-0
|
Phencyclidine [Moles/volume] in Unspecified specimen |
|
58397-1
|
Phencyclidine/Creatinine [Mass Ratio] in Urine |
|
38672-2
|
P-cresol [Mass/volume] in Air |
|
79524-5
|
P-cresol [Moles/volume] in Serum or Plasma |
|
79507-0
|
P-cresol/Creatinine [Molar ratio] in Urine |
|
56158-9
|
PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
90887-1
|
Porcine circovirus type 3 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing |
|
23766-9
|
Porcine circovirus Ag [Presence] in Tissue by Immunofluorescence |
|
23767-7
|
Porcine circovirus Ag [Presence] in Tissue by Immune stain |
|
90889-7
|
Porcine circovirus type 2 IgG Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
90326-0
|
Porcine circovirus type 2d DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
90327-8
|
Porcine circovirus type 2d DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
90888-9
|
Porcine circovirus type 3 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
90328-6
|
Porcine circovirus type 3 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
93755-7
|
Porcine circovirus type 3 DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
74577-8
|
Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Fibroblast |
|
74578-6
|
Pyruvate dehydrogenase complex [Enzymatic activity/mass] in Tissue |
|
41872-3
|
PDCD10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
90329-4
|
Porcine deltacoronavirus IgG Ab/Positive control in Unspecified specimen by Immunoassay |
|
76340-9
|
Porcine deltacoronavirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
76339-1
|
Porcine deltacoronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82431-8
|
Platelet-derived growth factor receptor Ab [Units/volume] in Serum by Line blot |
|
82432-6
|
Platelet-derived growth factor receptor Ab [Presence] in Serum by Line blot |
|
72315-5
|
Platelet-derived growth factor receptor IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
71357-8
|
PDGFRA gene exon 18 targeted mutation analysis in Blood or Tissue by Sequencing |
|
55092-1
|
PDGFRA gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
77170-9
|
PDGFRA gene p.Asp842Val [Presence] in Blood or Tissue by Molecular genetics method |
|
74120-7
|
PDGFR-alpha Ag [Presence] in Tissue by Immune stain |
|
78220-1
|
PDGFRB gene rearrangements [Presence] in Blood or Tissue by FISH |
|
49557-2
|
PDGFR-beta Ag [Presence] in Tissue by Immune stain |
|
2910-8
|
Pyruvate dehydrogenase.cytochrome [Enzymatic activity/volume] in Serum or Plasma |
|
74579-4
|
Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Fibroblast |
|
74575-2
|
Pyruvate dehydrogenase E1 [Enzymatic activity/mass] in Tissue |
|
70251-4
|
Pyruvate dehydrogenase IgG Ab [Units/volume] in Serum by Immunoassay |
|
2911-6
|
Pyruvate dehydrogenase.lipoamide [Enzymatic activity/mass] in Tissue |
|
75403-6
|
PDHA1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
81798-1
|
Pregnanediolone/Creatinine [Molar ratio] in Urine |
|
82897-0
|
Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82896-2
|
Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
85147-7
|
PD-L1 by clone 22C3 in Tissue by Immune stain Report |
|
83052-1
|
PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain |
|
85148-5
|
PD-L1 by clone 28-8 in Tissue by Immune stain Report |
|
83056-2
|
PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative |
|
83055-4
|
PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain |
|
85149-3
|
PD-L1 by clone SP142 in Tissue by Immune stain Report |
|
83057-0
|
PD-L1 by clone SP142 [Presence] in Tissue by Immune stain |
|
82852-5
|
Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in 24 hour Urine |
|
82853-3
|
Prenanediolone+pregnanetriol/Androsterone+etiocholanolone [Molar ratio] in Urine |
|
82855-8
|
Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82854-1
|
Prenanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
94078-3
|
PDX1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
33588-5
|
Phosphatidylethanolamine Ab [Units/volume] in Serum by Immunoassay |
|
33308-8
|
Phosphatidylethanolamine Ab [Presence] in Serum |
|
33611-5
|
Phosphatidylethanolamine Ab [Units/volume] in Serum |
|
17448-2
|
Phosphatidylethanolamine IgA Ab [Presence] in Serum |
|
13078-1
|
Phosphatidylethanolamine IgA Ab [Units/volume] in Serum |
|
17449-0
|
Phosphatidylethanolamine IgG Ab [Presence] in Serum |
|
13076-5
|
Phosphatidylethanolamine IgG Ab [Units/volume] in Serum |
|
17450-8
|
Phosphatidylethanolamine IgM Ab [Presence] in Serum |
|
13077-3
|
Phosphatidylethanolamine IgM Ab [Units/volume] in Serum |
|
49576-2
|
Phosphatidylethanolamine/Surfactants.total in Amniotic fluid |
|
7574-7
|
Pea triggered histamine release [Units/volume] in Blood |
|
6204-2
|
Pea IgE Ab [Units/volume] in Serum |
|
61300-0
|
Pea IgE Ab/IgE total in Serum |
|
7570-5
|
Pea IgG Ab [Units/volume] in Serum |
|
56277-7
|
Pea IgG4 Ab [Mass/volume] in Serum |
|
60389-4
|
Pea IgG Ab [Mass/volume] in Serum |
|
79166-5
|
Peach natural (nPru p) 3 IgE Ab [Units/volume] in Serum |
|
58776-6
|
Peach recombinant (rPru p) 1 IgE Ab [Units/volume] in Serum |
|
59391-3
|
Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum |
|
58775-8
|
Peach recombinant (rPru p) 4 IgE Ab [Units/volume] in Serum |
|
7576-2
|
Peach triggered histamine release [Units/volume] in Blood |
|
6205-9
|
Peach IgE Ab [Units/volume] in Serum |
|
43591-7
|
Peach IgE Ab/IgE total in Serum |
|
7575-4
|
Peach IgG Ab [Units/volume] in Serum |
|
56350-2
|
Peach IgG4 Ab [Mass/volume] in Serum |
|
60390-2
|
Peach IgG Ab [Mass/volume] in Serum |
|
43145-2
|
Peak flow meter device panel |
|
94120-3
|
Oxygen consumption (VO2)/Heart rate --peak during exercise |
|
60845-5
|
Peak power frequency on EEG |
|
65769-2
|
Peanut native (nAra h) 1 IgE Ab [Units/volume] in Serum |
|
65770-0
|
Peanut native (nAra h) 2 IgE Ab [Units/volume] in Serum |
|
65771-8
|
Peanut native (nAra h) 3 IgE Ab [Units/volume] in Serum |
|
58779-0
|
Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum |
|
58778-2
|
Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum |
|
58777-4
|
Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum |
|
90880-6
|
Peanut recombinant (rAra h) 6 IgE Ab [Units/volume] in Serum |
|
63477-4
|
Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum |
|
64965-7
|
Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum |
|
7577-0
|
Peanut triggered histamine release [Units/volume] in Blood |
|
6206-7
|
Peanut IgE Ab [Units/volume] in Serum |
|
61219-2
|
Peanut IgE Ab/IgE total in Serum |
|
6732-2
|
Peanut IgG Ab [Units/volume] in Serum |
|
56351-0
|
Peanut IgG4 Ab [Mass/volume] in Serum |
|
35542-0
|
Peanut IgG Ab [Mass/volume] in Serum |
|
48218-2
|
Peanut triggered leukotriene release [Mass/volume] by Leukocytes |
|
6207-5
|
Pear IgE Ab [Units/volume] in Serum |
|
61307-5
|
Pear IgE Ab/IgE total in Serum |
|
7578-8
|
Pear IgG Ab [Units/volume] in Serum |
|
56352-8
|
Pear IgG4 Ab [Mass/volume] in Serum |
|
60391-0
|
Pear IgG Ab [Mass/volume] in Serum |
|
7579-6
|
Pear Pollen IgE Ab [Units/volume] in Serum |
|
7402-1
|
Pecan or Hickory Nut triggered histamine release [Units/volume] in Blood |
|
6208-3
|
Pecan or Hickory Nut IgE Ab [Units/volume] in Serum |
|
39594-7
|
Pecan or Hickory Nut IgE Ab/IgE total in Serum |
|
7580-4
|
Pecan or Hickory Nut IgG Ab [Units/volume] in Serum |
|
56353-6
|
Pecan or Hickory Nut IgG4 Ab [Mass/volume] in Serum |
|
63108-5
|
Pecan or Hickory Nut IgG Ab [Mass/volume] in Serum |
|
6209-1
|
Pecan or Hickory Tree IgE Ab [Units/volume] in Serum |
|
61240-8
|
Pecan or Hickory Tree IgE Ab/IgE total in Serum |
|
56354-4
|
Pecan or Hickory Tree IgG4 Ab [Mass/volume] in Serum |
|
81159-6
|
US Pediatric Cervical and thoracic and lumbar spine |
|
81158-8
|
US Pediatric Head |
|
81160-4
|
US.doppler Pediatric limited Head |
|
81164-6
|
US Pediatric limited Hip - bilateral |
|
43144-5
|
Pedometer device panel |
|
55413-9
|
Pedometer tracking panel |
|
78507-1
|
Pediatrics Admission history and physical note |
|
68718-6
|
Pediatric cardiology Diagnostic study note |
|
68719-4
|
Pediatric cardiology Discharge summary |
|
68721-0
|
Pediatric cardiology History and physical note |
|
68727-7
|
Pediatric cardiology Hospital Consult note |
|
68728-5
|
Pediatric cardiology Hospital Letter |
|
68722-8
|
Pediatric cardiology Note |
|
68723-6
|
Pediatric cardiology Preoperative evaluation and management note |
|
68724-4
|
Pediatric cardiology procedure note |
|
68725-1
|
Pediatric cardiology Progress note |
|
68726-9
|
Pediatric cardiology Transfer summary note |
|
78726-7
|
Pediatrics Consult note |
|
68729-3
|
Pediatric critical care medicine Hospital procedure note |
|
68731-9
|
Pediatric dermatology History and physical note |
|
68892-9
|
Pediatric dermatology Hospital Consult note |
|
68893-7
|
Pediatric dermatology Hospital Letter |
|
68889-5
|
Pediatric dermatology Note |
|
68732-7
|
Pediatric dermatology Preoperative evaluation and management note |
|
68890-3
|
Pediatric dermatology procedure note |
|
68891-1
|
Pediatric dermatology Progress note |
|
93963-7
|
Pediatrics Diagnostic study note |
|
78578-2
|
Pediatrics Discharge instructions |
|
68815-0
|
Pediatrics Discharge summary |
|
78590-7
|
Pediatrics Discharge teaching note |
|
78615-2
|
Pediatrics Education note |
|
68733-5
|
Pediatric endocrinology Discharge summary |
|
68735-0
|
Pediatric endocrinology History and physical note |
|
68897-8
|
Pediatric endocrinology Hospital Consult note |
|
68898-6
|
Pediatric endocrinology Hospital Letter |
|
68894-5
|
Pediatric endocrinology Note |
|
68736-8
|
Pediatric endocrinology Preoperative evaluation and management note |
|
68895-2
|
Pediatric endocrinology procedure note |
|
68896-0
|
Pediatric endocrinology Progress note |
|
68737-6
|
Pediatric endocrinology Transfer summary note |
|
78634-3
|
Pediatrics Flowsheet |
|
68738-4
|
Pediatric gastroenterology Discharge summary |
|
68740-0
|
Pediatric gastroenterology History and physical note |
|
68746-7
|
Pediatric gastroenterology Hospital Consult note |
|
68747-5
|
Pediatric gastroenterology Hospital Letter |
|
68741-8
|
Pediatric gastroenterology Note |
|
68742-6
|
Pediatric gastroenterology Preoperative evaluation and management note |
|
68743-4
|
Pediatric gastroenterology procedure note |
|
68744-2
|
Pediatric gastroenterology Progress note |
|
68745-9
|
Pediatric gastroenterology Transfer summary note |
|
68817-6
|
Pediatrics History and physical note |
|
68748-3
|
Pediatric hematology-oncology Diagnostic study note |
|
68749-1
|
Pediatric hematology-oncology Discharge summary |
|
68751-7
|
Pediatric hematology-oncology History and physical note |
|
68757-4
|
Pediatric hematology-oncology Hospital Consult note |
|
68758-2
|
Pediatric hematology-oncology Hospital Letter |
|
68752-5
|
Pediatric hematology-oncology Note |
|
68753-3
|
Pediatric hematology-oncology Preoperative evaluation and management note |
|
68754-1
|
Pediatric hematology-oncology procedure note |
|
68755-8
|
Pediatric hematology-oncology Progress note |
|
68756-6
|
Pediatric hematology-oncology Transfer summary note |
|
68821-8
|
Pediatrics Hospital Consult note |
|
68822-6
|
Pediatrics Hospital Diagnostic study note |
|
68823-4
|
Pediatrics Hospital Discharge summary |
|
68825-9
|
Pediatrics Hospital History and physical note |
|
68826-7
|
Pediatrics Hospital Letter |
|
68827-5
|
Pediatrics Hospital Note |
|
68828-3
|
Pediatrics Hospital Preoperative evaluation and management note |
|
68829-1
|
Pediatrics Hospital procedure note |
|
68830-9
|
Pediatrics Hospital Progress note |
|
68884-6
|
Pediatrics Hospital Transfer summary note |
|
68760-8
|
Pediatric infectious diseases History and physical note |
|
68765-7
|
Pediatric infectious diseases Hospital Consult note |
|
68766-5
|
Pediatric infectious diseases Hospital Letter |
|
68761-6
|
Pediatric infectious diseases Note |
|
68762-4
|
Pediatric infectious diseases Preoperative evaluation and management note |
|
68763-2
|
Pediatric infectious diseases Progress note |
|
68764-0
|
Pediatric infectious diseases Transfer summary note |
|
78644-2
|
Pediatrics Initial evaluation note |
|
68767-3
|
Pediatric nephrology Diagnostic study note |
|
68768-1
|
Pediatric nephrology Discharge summary |
|
68770-7
|
Pediatric nephrology History and physical note |
|
68869-7
|
Pediatric nephrology Hospital Consult note |
|
68870-5
|
Pediatric nephrology Hospital Letter |
|
68866-3
|
Pediatric nephrology Letter |
|
68867-1
|
Pediatric nephrology Note |
|
68771-5
|
Pediatric nephrology Preoperative evaluation and management note |
|
68868-9
|
Pediatric nephrology procedure note |
|
68772-3
|
Pediatric nephrology Transfer summary note |
|
68818-4
|
Pediatrics Note |
|
89879-1
|
Pediatrics Outpatient Note |
|
68773-1
|
Pediatric otolaryngology Discharge summary |
|
68775-6
|
Pediatric otolaryngology History and physical note |
|
68874-7
|
Pediatric otolaryngology Hospital Consult note |
|
68875-4
|
Pediatric otolaryngology Hospital Letter |
|
68871-3
|
Pediatric otolaryngology Note |
|
68776-4
|
Pediatric otolaryngology Preoperative evaluation and management note |
|
68872-1
|
Pediatric otolaryngology procedure note |
|
68873-9
|
Pediatric otolaryngology Progress note |
|
68777-2
|
Pediatric otolaryngology Transfer summary note |
|
80771-9
|
Pediatrics Plan of care note |
|
68819-2
|
Pediatrics Preoperative evaluation and management note |
|
68820-0
|
Pediatrics procedure note |
|
68778-0
|
Pediatric pulmonology Diagnostic study note |
|
68779-8
|
Pediatric pulmonology Discharge summary |
|
68781-4
|
Pediatric pulmonology History and physical note |
|
68787-1
|
Pediatric pulmonology Hospital Consult note |
|
68788-9
|
Pediatric pulmonology Hospital Diagnostic study note |
|
68789-7
|
Pediatric pulmonology Hospital Letter |
|
68782-2
|
Pediatric pulmonology Note |
|
68783-0
|
Pediatric pulmonology Preoperative evaluation and management note |
|
68784-8
|
Pediatric pulmonology procedure note |
|
68785-5
|
Pediatric pulmonology Progress note |
|
68786-3
|
Pediatric pulmonology Transfer summary note |
|
78670-7
|
Pediatrics Referral note |
|
68854-9
|
Pediatric rehabilitation medicine Note |
|
68791-3
|
Pediatric rheumatology History and physical note |
|
68879-6
|
Pediatric rheumatology Hospital Consult note |
|
68880-4
|
Pediatric rheumatology Hospital Letter |
|
68876-2
|
Pediatric rheumatology Note |
|
68792-1
|
Pediatric rheumatology Preoperative evaluation and management note |
|
68877-0
|
Pediatric rheumatology procedure note |
|
68878-8
|
Pediatric rheumatology Progress note |
|
68793-9
|
Pediatric rheumatology Transfer summary note |
|
78724-2
|
Pediatric surgery Admission history and physical note |
|
78544-4
|
Pediatric surgery Checklist |
|
68794-7
|
Pediatric surgery Diagnostic study note |
|
68795-4
|
Pediatric surgery Discharge summary |
|
78606-1
|
Pediatric surgery Education note |
|
78627-7
|
Pediatric surgery Flowsheet |
|
68797-0
|
Pediatric surgery History and physical note |
|
68802-8
|
Pediatric surgery Hospital Consult note |
|
68803-6
|
Pediatric surgery Hospital Letter |
|
82836-8
|
Pediatric surgery Initial evaluation note |
|
68881-2
|
Pediatric surgery Note |
|
78725-9
|
Pediatric surgery Surgical operation note |
|
80767-7
|
Pediatric surgery Plan of care note |
|
68798-8
|
Pediatric surgery Preoperative evaluation and management note |
|
68799-6
|
Pediatric surgery procedure note |
|
68800-2
|
Pediatric surgery Progress note |
|
78673-1
|
Pediatric surgery Referral note |
|
68801-0
|
Pediatric surgery Transfer summary note |
|
89888-2
|
Pediatrics Telehealth Note |
|
68883-8
|
Pediatrics Transfer summary note |
|
68855-6
|
Pediatric transplant hepatology Diagnostic study note |
|
68856-4
|
Pediatric transplant hepatology Discharge summary |
|
68858-0
|
Pediatric transplant hepatology History and physical note |
|
68864-8
|
Pediatric transplant hepatology Hospital Consult note |
|
68865-5
|
Pediatric transplant hepatology Hospital Letter |
|
68859-8
|
Pediatric transplant hepatology Note |
|
68860-6
|
Pediatric transplant hepatology Preoperative evaluation and management note |
|
68861-4
|
Pediatric transplant hepatology procedure note |
|
68862-2
|
Pediatric transplant hepatology Progress note |
|
68863-0
|
Pediatric transplant hepatology Transfer summary note |
|
68804-4
|
Pediatric urology Diagnostic study note |
|
68805-1
|
Pediatric urology Discharge summary |
|
68807-7
|
Pediatric urology History and physical note |
|
68812-7
|
Pediatric urology Hospital Consult note |
|
68813-5
|
Pediatric urology Hospital Letter |
|
68882-0
|
Pediatric urology Note |
|
68808-5
|
Pediatric urology Preoperative evaluation and management note |
|
68809-3
|
Pediatric urology procedure note |
|
68810-1
|
Pediatric urology Progress note |
|
68811-9
|
Pediatric urology Transfer summary note |
|
86695-4
|
Porcine epidemic diarrhea virus Ab/Positive control in Serum by Immunoassay |
|
85357-2
|
PEDV prototype and S INDEL strain S gene panel - Unspecified specimen by NAA with probe detection |
|
85356-4
|
PEDV prototype strain S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
74752-7
|
Porcine epidemic diarrhea virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
76338-3
|
Porcine epidemic diarrhea virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
85355-6
|
PEDV S INDEL strain S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
88064-1
|
Porcine epidemic diarrhea virus S1 gene [Nucleotide sequence] in Isolate by Sequencing |
|
86201-1
|
Porcine epidemic diarrhea virus gene sequence and phylogenetic analysis in Unspecified specimen Document |
|
86928-9
|
Porcine epidemic diarrhea virus whole genome [Nucleotide sequence] in Isolate by Sequencing |
|
76248-4
|
PEEP Respiratory system --on ventilator |
|
85106-3
|
Peer Rejection Survey version 2.0 - parent report - fixed length form - ages 3-12 [NIH Toolbox] |
|
69976-9
|
Maximum expiratory gas flow Respiratory system airway --post bronchodilation |
|
69975-1
|
Maximum expiratory gas flow Respiratory system airway --pre bronchodilation |
|
3906-5
|
Pefloxacin [Mass/volume] in Serum or Plasma |
|
91148-7
|
Pain intensity, Enjoyment of life, General activity scale [PEG] |
|
83141-2
|
9-Hole Pegboard Dexterity Test [NIH Toolbox] |
|
6199-4
|
Pellitory (Parietaria judaica) IgE Ab [Units/volume] in Serum |
|
48250-5
|
Pellitory (Parietaria judaica) triggered leukotriene release [Mass/volume] by Leukocytes |
|
6200-0
|
Pellitory (Parietaria officinalis) IgE Ab [Units/volume] in Serum |
|
48251-3
|
Pellitory (Parietaria officinalis) triggered leukotriene release [Mass/volume] by Leukocytes |
|
56882-4
|
Pellitory (Parietaria judaica) recombinant (rPar j) 2 IgE Ab [Units/volume] in Serum |
|
7760-2
|
Wall pellitory IgE Ab [Units/volume] in Serum |
|
42480-4
|
Pelvis Narrative transabdominal US |
|
12388-5
|
Phenylethylmalonamide [Mass/volume] in Serum or Plasma |
|
29289-6
|
Phenylethylmalonamide [Presence] in Urine |
|
29295-3
|
Phenylethylmalonamide [Mass/volume] in Urine |
|
3910-7
|
Pemoline [Mass/time] in 24 hour Urine |
|
60139-3
|
Pemoline [Mass/volume] in Blood |
|
3907-3
|
Pemoline [Mass/volume] in Serum or Plasma |
|
33349-2
|
Pemoline [Mass/volume] in Urine by Confirmatory method |
|
3908-1
|
Pemoline [Presence] in Urine |
|
33348-4
|
Pemoline [Mass/volume] in Urine by Screen method |
|
3909-9
|
Pemoline [Mass/volume] in Urine |
|
74440-9
|
Pemptoporphyrin [Moles/mass] in Stool |
|
60140-1
|
Penciclovir [Mass/volume] in Blood |
|
60141-9
|
Penciclovir [Mass/volume] in Serum or Plasma |
|
60142-7
|
Pendimethalin [Mass/volume] in Blood |
|
60143-5
|
Pendimethalin [Mass/volume] in Serum or Plasma |
|
60144-3
|
Pendimethalin [Mass/volume] in Urine |
|
82893-9
|
Penfluridol [Mass/volume] in Serum or Plasma |
|
79410-7
|
Penfluridol [Mass/volume] in Serum or Plasma --trough |
|
72976-4
|
Penicillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72975-6
|
Penicillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
6851-0
|
Penicillin G IgE Ab [Units/volume] in Serum |
|
49729-7
|
Penicillin G IgG Ab [Mass/volume] in Serum |
|
48201-8
|
Penicillin G triggered leukotriene release [Mass/volume] by Leukocytes |
|
3913-1
|
Penicillin G [Mass/volume] in Serum or Plasma |
|
73213-1
|
Penicillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73212-3
|
Penicillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
85428-1
|
Penicillin [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC) |
|
85429-9
|
Penicillin [Susceptibility] for pneumonia by Minimum inhibitory concentration (MIC) |
|
3911-5
|
Penicillin [Mass/volume] in Serum or Plasma |
|
3912-3
|
Penicillin [Mass/volume] in Urine |
|
6210-9
|
Penicillin V IgE Ab [Units/volume] in Serum |
|
39553-3
|
Penicillin V IgE Ab/IgE total in Serum |
|
48200-0
|
Penicillin V triggered leukotriene release [Mass/volume] by Leukocytes |
|
3914-9
|
Penicillin V [Mass/volume] in Serum or Plasma |
|
25267-6
|
Penicillin [Mass/volume] in Unspecified specimen |
|
87594-8
|
Penicillin [Mass/mass] in Unspecified specimen |
|
17427-6
|
Penicillium sp Ab [Units/volume] in Serum |
|
57034-1
|
Penicillium sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
74805-3
|
Penicillium sp IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
51544-5
|
Penicillium sp IgG Ab [Presence] in Serum |
|
7583-8
|
Penicillium sp IgG Ab [Units/volume] in Serum |
|
53801-7
|
Penile vessels by US.doppler |
|
40392-3
|
Pentacarboxylate [Moles/time] in 24 hour Urine |
|
14870-0
|
Pentacarboxylate [Moles/volume] in Plasma |
|
14871-8
|
Pentacarboxylate [Moles/volume] in Stool |
|
45311-8
|
Pentacarboxylate [Moles/mass] in Stool |
|
14872-6
|
Pentacarboxylate [Moles/volume] in Urine |
|
45317-5
|
Pentacarboxylate/Creatinine [Molar ratio] in Urine |
|
38614-4
|
Pentachlorophenol [Mass/volume] in Air |
|
17429-2
|
Pentachlorophenol [Mass/volume] in Blood |
|
20937-9
|
Pentachlorophenol [Mass/mass] in Fat |
|
12338-0
|
Pentachlorophenol [Presence] in Serum or Plasma |
|
5710-9
|
Pentachlorophenol [Mass/volume] in Serum or Plasma |
|
20936-1
|
Pentachlorophenol [Mass/mass] in Tissue |
|
5711-7
|
Pentachlorophenol [Mass/volume] in Urine |
|
26987-8
|
Pentachlorophenol/Creatinine [Mass Ratio] in Urine |
|
42002-6
|
Pentacarboxylporphyrins [Mass/volume] in 24 hour Urine |
|
74989-5
|
Pentacarboxylporphyrins [Moles/volume] in Serum or Plasma |
|
50894-5
|
Pentacarboxylporphyrins [Moles/mass] in Stool |
|
93510-6
|
Pentacarboxylporphyrin III [Moles/time] in 24 hour Urine |
|
74086-0
|
Pentacarboxylporphyrin III [Moles/mass] in Stool |
|
74089-4
|
Pentacarboxylporphyrin III/Creatinine [Molar ratio] in Urine |
|
93509-8
|
Pentacarboxylporphyrin I [Moles/time] in 24 hour Urine |
|
75107-3
|
Pentadecanoate [Entitic substance] in Red Blood Cells |
|
48366-9
|
Pentadecanoate [Moles/volume] in Serum or Plasma |
|
48119-2
|
Pentadecanoate/Creatinine [Molar ratio] in Urine |
|
17430-0
|
Pentane [Mass/volume] in Blood |
|
60145-0
|
Pentane [Mass/volume] in Body fluid |
|
60146-8
|
Pentane [Mass/volume] in Serum or Plasma |
|
60147-6
|
Pentane [Mass/mass] in Tissue |
|
60148-4
|
Pentane [Mass/volume] in Urine |
|
3919-8
|
Pentazocine [Mass/time] in 24 hour Urine |
|
60149-2
|
Pentazocine [Mass/volume] in Blood |
|
60150-0
|
Pentazocine [Mass/volume] in Body fluid |
|
40393-1
|
Pentazocine [Presence] in Gastric fluid |
|
59952-2
|
Pentazocine [Moles/volume] in Gastric fluid |
|
3915-6
|
Pentazocine [Presence] in Serum or Plasma |
|
3916-4
|
Pentazocine [Mass/volume] in Serum or Plasma |
|
55564-9
|
Pentazocine [Moles/volume] in Serum or Plasma |
|
3917-2
|
Pentazocine [Presence] in Urine |
|
16219-8
|
Pentazocine [Presence] in Urine by Confirmatory method |
|
3918-0
|
Pentazocine [Mass/volume] in Urine |
|
59951-4
|
Pentazocine [Moles/volume] in Urine |
|
60328-2
|
Pentazocine [Moles/volume] in Unspecified specimen |
|
3922-2
|
Pentetrazol [Mass/time] in 24 hour Urine |
|
3920-6
|
Pentetrazol [Presence] in Urine |
|
3921-4
|
Pentetrazol [Mass/volume] in Urine |
|
60151-8
|
PENTobarbital [Mass/volume] in Blood |
|
60152-6
|
PENTobarbital [Mass/volume] in Body fluid |
|
12488-3
|
PENTobarbital [Presence] in Gastric fluid |
|
17431-8
|
PENTobarbital [Mass/volume] in Gastric fluid |
|
26918-3
|
PENTobarbital [Mass/mass] in Hair |
|
27308-6
|
PENTobarbital [Mass/mass] in Meconium |
|
72635-6
|
PENTobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72630-7
|
PENTobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
3923-0
|
PENTobarbital [Presence] in Serum or Plasma |
|
35630-3
|
PENTobarbital [Mass/volume] in Serum or Plasma by Screen method |
|
82969-7
|
PENTobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3924-8
|
PENTobarbital [Mass/volume] in Serum or Plasma |
|
32103-4
|
PENTobarbital [Moles/volume] in Serum or Plasma |
|
12499-0
|
PENTobarbital [Presence] in Stool |
|
27243-5
|
PENTobarbital [Mass/mass] in Stool |
|
60153-4
|
PENTobarbital [Mass/mass] in Tissue |
|
16240-4
|
PENTobarbital [Mass/volume] in Urine by Confirmatory method |
|
3925-5
|
PENTobarbital [Presence] in Urine |
|
16193-5
|
PENTobarbital [Presence] in Urine by Confirmatory method |
|
19655-0
|
PENTobarbital [Presence] in Urine by Screen method |
|
3926-3
|
PENTobarbital [Mass/volume] in Urine |
|
32104-2
|
PENTobarbital [Presence] in Unspecified specimen |
|
57866-6
|
PENTobarbital [Moles/volume] in Unspecified specimen |
|
64132-4
|
PENTobarbital/Creatinine [Mass Ratio] in Urine |
|
2734-2
|
Pentoses [Mass/time] in 24 hour Urine |
|
60154-2
|
Pentoxifylline [Mass/volume] in Blood |
|
10892-8
|
Pentoxifylline [Mass/volume] in Serum or Plasma |
|
60155-9
|
Pentoxifylline [Mass/volume] in Urine |
|
38408-1
|
PEO gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35357-3
|
PEO gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
2788-8
|
Phosphoenolpyruvate carboxykinase [Enzymatic activity/volume] in Serum |
|
6213-3
|
Pepper tree IgE Ab [Units/volume] in Serum |
|
56460-9
|
Pepper tree IgG4 Ab [Mass/volume] in Serum |
|
80831-1
|
Pepsin A Panel - Lower respiratory specimen |
|
26044-8
|
Pepsin IgE Ab [Units/volume] in Serum |
|
80828-7
|
Pepsin A+Pepsinogen A [Mass/volume] in Lower respiratory specimen by Immunoassay |
|
2735-9
|
Pepsinogen [Mass/volume] in Blood |
|
2736-7
|
Pepsinogen I [Mass/volume] in Serum or Plasma |
|
2737-5
|
Pepsinogen I [Mass/volume] in Urine |
|
2738-3
|
Pepsinogen II [Mass/volume] in Serum or Plasma |
|
2739-1
|
Pepsinogen [Mass/volume] in Serum or Plasma |
|
2740-9
|
Pepsins [Enzymatic activity/volume] in Gastric fluid |
|
2741-7
|
Pepsins [Enzymatic activity/volume] in Urine |
|
49858-4
|
Peptide YY [Mass/volume] in Serum or Plasma |
|
82367-4
|
Peripheral deiodinase activity [Moles/time] in Serum or Plasma by Calculated.SPINA |
|
7374-2
|
Perennial rye grass triggered histamine release [Units/volume] in Blood |
|
7369-2
|
Perennial rye grass IgE Ab [Units/volume] in Serum |
|
61282-0
|
Perennial rye grass IgE Ab/IgE total in Serum |
|
7370-0
|
Perennial rye grass IgG Ab [Units/volume] in Serum |
|
56357-7
|
Perennial rye grass IgG4 Ab [Mass/volume] in Serum |
|
58923-4
|
Perennial rye grass IgG Ab [Mass/volume] in Serum |
|
48261-2
|
Perennial rye grass triggered leukotriene release [Mass/volume] by Leukocytes |
|
56726-3
|
Perennial rye grass recombinant profilin IgE Ab [Units/volume] in Serum |
|
88895-8
|
Perampanel [Mass/volume] - Serum or Plasma |
|
88989-9
|
Perazine [Mass/volume] in Serum or Plasma |
|
76642-8
|
Percutaneous coronary intervention Study report |
|
89544-1
|
Pulmonary Embolism Rule-out Criteria panel PERC |
|
91528-0
|
Perceived Stress Survey - fixed length form - age 18+ [NIH Toolbox] |
|
6214-1
|
Perch IgE Ab [Units/volume] in Serum |
|
50355-7
|
Perch IgE Ab/IgE total in Serum |
|
7598-6
|
Perch IgG Ab [Units/volume] in Serum |
|
56356-9
|
Perch IgG4 Ab [Mass/volume] in Serum |
|
63088-9
|
Perch IgG Ab [Mass/volume] in Serum |
|
37424-9
|
Perchlorate [Mass/volume] in Unspecified specimen by HPLC |
|
60156-7
|
Perfluorooctanoate [Mass/volume] in Blood |
|
60157-5
|
Perfluorooctanoate [Mass/volume] in Serum or Plasma |
|
74121-5
|
Perforin Ag [Presence] in Tissue by Immune stain |
|
35128-8
|
Perforin [Units/volume] in Leukocytes |
|
72510-1
|
Performance rate Reporting Period Population Calculated |
|
89197-8
|
Performance-based measure panel |
|
60158-3
|
Pergolide [Mass/volume] in Blood |
|
11248-2
|
Pergolide [Mass/volume] in Serum or Plasma |
|
60159-1
|
Pergolide [Mass/volume] in Urine |
|
79446-1
|
Pericyazine [Mass/volume] in Serum or Plasma |
|
57867-4
|
Pericyazine [Moles/volume] in Unspecified specimen |
|
28629-4
|
Perimetry study |
|
86603-8
|
Periodontal attachment - recommended CDA R1 set |
|
74030-8
|
Periodontal service attachment |
|
74029-0
|
Periodontal attachment - recommended CDA set |
|
29752-3
|
Perioperative records |
|
66111-6
|
Peritoneum Pathology biopsy report |
|
11018-9
|
Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain |
|
35289-8
|
Peroxide hemolysis of Red Blood Cells |
|
60160-9
|
Perphenazine [Mass/volume] in Blood |
|
59955-5
|
Perphenazine [Moles/volume] in Gastric fluid |
|
73211-5
|
Perphenazine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73210-7
|
Perphenazine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26846-6
|
Perphenazine [Presence] in Serum or Plasma |
|
3927-1
|
Perphenazine [Mass/volume] in Serum or Plasma |
|
59953-0
|
Perphenazine [Moles/volume] in Serum or Plasma |
|
74949-9
|
Perphenazine [Mass/volume] in Serum or Plasma --trough |
|
32105-9
|
Perphenazine [Presence] in Urine |
|
3928-9
|
Perphenazine [Mass/volume] in Urine |
|
59954-8
|
Perphenazine [Moles/volume] in Urine |
|
32106-7
|
Perphenazine [Presence] in Unspecified specimen |
|
57868-2
|
Perphenazine [Moles/volume] in Unspecified specimen |
|
81745-2
|
Personal advance care plan R1.0 - recommended CDA sections |
|
48150-7
|
Perseitol/Creatinine [Molar ratio] in Urine |
|
10947-0
|
Persimmon IgE Ab [Units/volume] in Serum |
|
81334-5
|
Patient Personal advance care plan |
|
94066-8
|
Person-Centered Primary Care Measure [PCPCM] |
|
91003-4
|
Personnel contact information panel |
|
91905-0
|
Personnel Response team leader information panel |
|
92026-4
|
Personnel Supervisor contact information panel |
|
89694-4
|
Pulmonary Embolism Severity Index panel [PESI] |
|
35499-3
|
Pesticide and Insecticide panel [Mass/volume] - Serum or Plasma |
|
35501-6
|
Pesticide and Insecticide panel [Mass/volume] - Urine and Serum or Plasma |
|
35500-8
|
Pesticide and Insecticide panel [Mass/volume] - Urine |
|
13020-3
|
Pesticides [Identifier] in Blood |
|
13021-1
|
Pesticides [Identifier] in Gastric fluid |
|
54093-0
|
Pesticides [Presence] in Gastric fluid by Screen method |
|
13019-5
|
Pesticides [Identifier] in Serum or Plasma |
|
13018-7
|
Pesticides [Identifier] in Urine |
|
23764-4
|
Pesticides [Identifier] in Unspecified specimen |
|
78747-3
|
Peritoneal equilibration test panel - Peritoneal dialysis fluid |
|
81551-4
|
PET+CT Bone from skull base to mid-thigh W 18F-NaF IV |
|
87907-2
|
PET+CT Brain for amyloidosis |
|
92927-3
|
PET+CT Brain for tau protein |
|
86976-8
|
PET+CT Brain metabolic |
|
81559-7
|
PET+CT Unspecified body region for simulation limited |
|
81553-0
|
PET+CT Guidance limited for localization of tumor of Unspecified body region-- W 18F-FDG IV |
|
87905-6
|
PET+CT Guidance for localization of tumor of Head and Neck-- W 18F-FDG IV |
|
82800-4
|
PET+CT Heart W contrast IV |
|
82801-2
|
PET+CT Heart WO contrast |
|
81554-8
|
PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV |
|
89712-4
|
PET+CT Guidance for limited for localization of tumor of Unspecified body region-- W 18F-FDG IV and W contrast IV |
|
87915-5
|
PET+CT Guidance for localization of tumor of Skull vertex to mid-thigh-- W 18F-FDG IV and W contrast IV |
|
81552-2
|
PET+CT Whole body Bone W 18F-NaF IV |
|
76660-0
|
Phosphatidylethanol [Presence] in Blood by Screen method |
|
74661-0
|
Phosphatidylethanol [Mass/volume] in Blood |
|
54326-4
|
Phosphoethanolamine [Moles/volume] in DBS |
|
50950-5
|
Phosphoethanolamine IgA Ab [Presence] in Serum or Plasma |
|
50954-7
|
Phosphoethanolamine IgG Ab [Presence] in Serum or Plasma |
|
50953-9
|
Phosphoethanolamine IgM Ab [Presence] in Serum or Plasma |
|
44352-3
|
Phosphoethanolamine/Creatinine [Mass Ratio] in 24 hour Urine |
|
44351-5
|
Phosphoethanolamine/Creatinine [Molar ratio] in 24 hour Urine |
|
23361-9
|
Porcine enterovirus Ab [Presence] in Serum |
|
23363-5
|
Porcine enterovirus Ab [Presence] in Serum by Immunoassay |
|
23362-7
|
Porcine enterovirus Ab [Presence] in Serum by Neutralization test |
|
31944-2
|
Porcine enterovirus Ag [Presence] in Unspecified specimen |
|
23364-3
|
Porcine enterovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23360-1
|
Porcine enterovirus Ag [Presence] in Unspecified specimen by Neutralization test |
|
88217-5
|
Parechovirus RNA [Presence] in Aspirate by NAA with probe detection |
|
91825-0
|
Parechovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88218-3
|
Parechovirus RNA [Presence] in Stool by NAA with probe detection |
|
88219-1
|
Parechovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
60525-3
|
Parechovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
81838-5
|
PEX1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81835-1
|
PEX7 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
6001-2
|
Platelet factor 3 [Units/volume] in Platelet poor plasma |
|
40686-8
|
Platelet factor 3 [Units/volume] in Platelet rich plasma |
|
6003-8
|
Platelet factor 4 Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
50747-5
|
Platelet factor 4 Ag [Presence] in Platelet poor plasma by Immunoassay |
|
34701-3
|
Heparin induced platelet Ab [Presence] in Serum |
|
45155-9
|
Heparin induced platelet Ab [Units/volume] in Serum |
|
57761-9
|
Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay |
|
73818-7
|
Heparin induced platelet IgG Ab in Serum or Plasma by Immunoassay |
|
73819-5
|
Heparin induced platelet IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
33594-3
|
Platelet factor 4 [Presence] in Platelet poor plasma |
|
6002-0
|
Platelet factor 4 [Units/volume] in Platelet poor plasma |
|
68982-8
|
PFGE panel - Isolate |
|
2791-2
|
Phosphofructokinase [Enzymatic activity/volume] in Blood |
|
44052-9
|
Phosphofructokinase [Enzymatic activity/mass] in Blood |
|
11058-5
|
Phosphofructokinase [Enzymatic activity/volume] in Red Blood Cells |
|
72664-6
|
Phosphofructokinase [Enzymatic activity/mass] in Red Blood Cells |
|
2792-0
|
Phosphofructokinase [Enzymatic activity/volume] in Serum |
|
81458-2
|
Pulmonary function test panel |
|
2785-4
|
Phosphatidylglycerol [Presence] in Amniotic fluid |
|
27420-9
|
Phosphatidylglycerol [Units/volume] in Amniotic fluid |
|
2786-2
|
Phosphatidylglycerol [Mass/volume] in Amniotic fluid |
|
59807-8
|
Phosphatidylglycerol [Moles/volume] in Amniotic fluid |
|
17451-6
|
Phosphatidylglycerol IgA Ab [Presence] in Serum |
|
13081-5
|
Phosphatidylglycerol IgA Ab [Units/volume] in Serum |
|
17452-4
|
Phosphatidylglycerol IgG Ab [Presence] in Serum |
|
13079-9
|
Phosphatidylglycerol IgG Ab [Units/volume] in Serum |
|
17453-2
|
Phosphatidylglycerol IgM Ab [Presence] in Serum |
|
13080-7
|
Phosphatidylglycerol IgM Ab [Units/volume] in Serum |
|
11059-3
|
Phosphoglycerate kinase [Enzymatic activity/volume] in Red Blood Cells |
|
44053-7
|
Phosphoglycerate kinase [Enzymatic activity/mass] in Red Blood Cells |
|
2798-7
|
Phosphoglycerate kinase [Enzymatic activity/volume] in Serum |
|
27378-9
|
pH of 24 hour Urine |
|
50897-8
|
pH of 24 hour Urine by Test strip |
|
53651-6
|
pH of 2 hour Urine |
|
53652-4
|
pH of 4 hour Urine |
|
2743-3
|
pH of Amniotic fluid |
|
53653-2
|
pH of Bile fluid |
|
11558-4
|
pH of Blood |
|
2744-1
|
pH of Arterial blood |
|
2745-8
|
pH of Capillary blood |
|
33913-5
|
pH of Capillary blood from Fetus |
|
14873-4
|
pH of Cord blood |
|
28646-8
|
pH of Arterial cord blood |
|
28647-6
|
pH of Venous cord blood |
|
19213-8
|
pH of Mixed venous blood |
|
2746-6
|
pH of Venous blood |
|
53600-3
|
pH of Blood product unit |
|
10582-5
|
pH of Cervical mucus |
|
9347-6
|
pH combined acid of Gastric fluid |
|
2747-4
|
pH of Cerebral spinal fluid |
|
53654-0
|
pH of Dialysis fluid |
|
2748-2
|
pH of Body fluid |
|
50896-0
|
pH of Body fluid by Test strip |
|
55976-5
|
pH of Nonbiological fluid |
|
9348-4
|
pH free acid of Gastric fluid |
|
2749-0
|
pH of Gastric fluid |
|
80830-3
|
pH of Lower respiratory specimen |
|
93843-1
|
Primary hyperoxaluria multigene analysis in Blood or Tissue by Molecular genetics method |
|
42728-6
|
pH of Ocular fluid |
|
33417-7
|
pH of Pericardial fluid |
|
68382-1
|
pH of Pericardial fluid by Test strip |
|
2750-8
|
pH of Pleural fluid |
|
50895-2
|
pH of Pleural fluid by Test strip |
|
2751-6
|
pH of Peritoneal fluid |
|
68459-7
|
pH of Peritoneal fluid by Test strip |
|
56963-2
|
pH of Saliva (oral fluid) |
|
2753-2
|
pH of Serum or Plasma |
|
2752-4
|
pH of Semen |
|
2754-0
|
pH of Synovial fluid |
|
68381-3
|
pH of Synovial fluid by Test strip |
|
2755-7
|
pH of Stool |
|
49701-6
|
pH of Blood adjusted to patient's actual temperature |
|
49698-4
|
pH of Arterial cord blood adjusted to patient's actual temperature |
|
49699-2
|
pH of Venous cord blood adjusted to patient's actual temperature |
|
50980-2
|
pH of Mixed venous blood adjusted to patient's actual temperature |
|
9349-2
|
pH total acid of Gastric fluid |
|
55968-2
|
pH of Total parental nutrition |
|
2756-5
|
pH of Urine |
|
5803-2
|
pH of Urine by Test strip |
|
48037-6
|
pH of Vaginal fluid |
|
72269-4
|
pH of Vaginal fluid by Test strip |
|
42670-0
|
pH of Vitreous fluid |
|
9481-3
|
pH of Water |
|
17433-4
|
pH of Unspecified specimen |
|
57742-9
|
Phadiatop infant IgE Ab [Units/volume] in Serum |
|
57036-6
|
Phadiatop inhalant allergen IgE Ab [Units/volume] in Serum |
|
7599-4
|
Phadiatop IgE Ab [Units/volume] in Serum |
|
51962-9
|
Pharmacogenetic DNA analysis panel |
|
90006-8
|
Pharmacogenomics Consult note |
|
93964-5
|
Pharmacogenomics Diagnostic study note |
|
90005-0
|
Pharmacogenomics Outpatient Note |
|
90007-6
|
Pharmacogenomics Progress note |
|
90008-4
|
Pharmacogenomics Telehealth Note |
|
85153-5
|
Pharmacology Admission evaluation note |
|
88360-3
|
Pharmacology Alert |
|
34820-1
|
Pharmacology Consult note |
|
34869-8
|
Pharmacology Counseling note |
|
78583-2
|
Pharmacology Discharge instructions |
|
85154-3
|
Pharmacology Discharge summary |
|
78589-9
|
Pharmacology Discharge teaching note |
|
75467-1
|
Pharmacology Evaluation and management of anticoagulation note |
|
85155-0
|
Pharmacology Evaluation and management of hyperlipidemia note |
|
85156-8
|
Pharmacology Evaluation and management of hypertension note |
|
78601-2
|
Pharmacology Education note |
|
68586-7
|
Pharmacology Hospital Consult note |
|
68587-5
|
Pharmacology Hospital Medication management note |
|
85157-6
|
Pharmacology Hospital Note |
|
82837-6
|
Pharmacology Initial evaluation note |
|
85158-4
|
Pharmacology Letter |
|
85159-2
|
Pharmacology Long term care facility Admission evaluation note |
|
85160-0
|
Pharmacology Long term care facility Medication management note |
|
85161-8
|
Pharmacology Long term care facility Note |
|
75468-9
|
Pharmacology Medication management note |
|
34821-9
|
Pharmacology Note |
|
85162-6
|
Pharmacology Nurse Outpatient Evaluation and management of anticoagulation note |
|
85163-4
|
Pharmacology Outpatient Counseling note |
|
85164-2
|
Pharmacology Outpatient Evaluation and management of anticoagulation note |
|
85165-9
|
Pharmacology Outpatient Evaluation and management of hyperlipidemia note |
|
85166-7
|
Pharmacology Outpatient Medication management note |
|
75469-7
|
Pharmacology Outpatient Note |
|
34132-1
|
Pharmacology Outpatient Progress note |
|
75470-5
|
Pharmacology Telephone encounter Note |
|
80797-4
|
Pharmacology Plan of care note |
|
80569-7
|
Pharmacology Progress note |
|
85167-5
|
Pharmacology Patient's home Medication management note |
|
85168-3
|
Pharmacology Patient's home Note |
|
57152-1
|
Pharmacology Referral note |
|
85169-1
|
Pharmacology Team Note |
|
85170-9
|
Pharmacology Technician Note |
|
93024-8
|
Pharmacist Consult note |
|
73709-8
|
Prescription request Pharmacy Document from Pharmacist |
|
93023-0
|
Pharmacist Plan of care note |
|
82118-1
|
Pharmacogenomics result panel |
|
79621-9
|
Phenylalanine and Tyrosine panel - DBS |
|
13409-8
|
Phenylalanine [Mass/volume] in Amniotic fluid |
|
26981-1
|
Phenylalanine [Moles/volume] in Amniotic fluid |
|
49484-9
|
Phenylalanine [Presence] in Blood |
|
12803-3
|
Phenylalanine [Presence] in Blood by Guthrie test |
|
2762-3
|
Phenylalanine [Mass/volume] in Blood |
|
29571-7
|
Phenylalanine [Presence] in DBS |
|
29572-5
|
Phenylalanine [Mass/volume] in DBS |
|
29573-3
|
Phenylalanine [Moles/volume] in DBS |
|
32263-6
|
Phenylalanine [Moles/volume] in Body fluid |
|
55970-8
|
Phenylalanine [Moles/mass] in Hair |
|
74303-9
|
Phenylalanine [Moles/volume] in DBS --post therapeutic diet |
|
2764-9
|
Phenylalanine [Presence] in Serum or Plasma |
|
27362-3
|
Phenylalanine [Units/volume] in Serum or Plasma |
|
2765-6
|
Phenylalanine [Mass/volume] in Serum or Plasma |
|
14875-9
|
Phenylalanine [Moles/volume] in Serum or Plasma |
|
47723-2
|
Phenylalanine/Amino acids.total in Amniotic fluid |
|
47722-4
|
Phenylalanine/Amino acids.total in Cerebral spinal fluid |
|
47721-6
|
Phenylalanine/Amino acids.total in Hair |
|
47724-0
|
Phenylalanine/Amino acids.total in Serum or Plasma |
|
47725-7
|
Phenylalanine/Amino acids.total in Unspecified specimen |
|
32264-4
|
Phenylalanine [Moles/volume] in Vitreous fluid |
|
44348-1
|
Phenylalanine/Creatinine [Mass Ratio] in 24 hour Urine |
|
47981-6
|
Phenylalanine/Creatinine [Ratio] in 24 hour Urine |
|
44349-9
|
Phenylalanine/Creatinine [Mass Ratio] in Urine |
|
74300-5
|
Phenylalanine/Tyrosine [Molar ratio] in DBS --post therapeutic diet |
|
41170-2
|
Phenylalanine+Tyrosine [Presence] in Blood |
|
16105-9
|
Pheasant IgE Ab [Units/volume] in Serum |
|
3929-7
|
Phenacetin [Mass/volume] in Serum or Plasma |
|
55565-6
|
Phenacetin [Moles/volume] in Serum or Plasma |
|
12368-7
|
Phenacetin [Presence] in Urine |
|
60161-7
|
Phenacemide [Mass/volume] in Blood |
|
11249-0
|
Phenacemide [Mass/volume] in Serum or Plasma |
|
60162-5
|
Phenacemide [Mass/volume] in Urine |
|
3933-9
|
Phenazocine [Mass/time] in 24 hour Urine |
|
3931-3
|
Phenazocine [Presence] in Urine |
|
3932-1
|
Phenazocine [Mass/volume] in Urine |
|
17434-2
|
Phenazopyridine [Mass/volume] in Serum or Plasma |
|
3941-2
|
Phendimetrazine [Mass/time] in 24 hour Urine |
|
26711-2
|
Phendimetrazine [Mass/mass] in Meconium |
|
27102-3
|
Phendimetrazine [Mass/volume] in Milk |
|
29613-7
|
Phendimetrazine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3938-8
|
Phendimetrazine [Mass/volume] in Serum or Plasma |
|
27303-7
|
Phendimetrazine [Mass/mass] in Stool |
|
3939-6
|
Phendimetrazine [Presence] in Urine |
|
3940-4
|
Phendimetrazine [Mass/volume] in Urine |
|
27178-3
|
Phendimetrazine [Mass/volume] in Vitreous fluid |
|
9778-2
|
Phenelzine [Mass/volume] in Serum or Plasma |
|
55566-4
|
Phenelzine [Moles/volume] in Serum or Plasma |
|
41471-4
|
Phenethicillin [Mass/volume] in Serum or Plasma |
|
12331-5
|
Phenethylamine [Presence] in Urine |
|
26045-5
|
Pheneturide [Moles/volume] in Serum or Plasma |
|
3942-0
|
Pheniramine [Mass/volume] in Serum or Plasma |
|
55567-2
|
Pheniramine [Moles/volume] in Serum or Plasma |
|
78876-0
|
Pheniramine [Presence] in Urine |
|
17435-9
|
Pheniramine [Mass/volume] in Urine |
|
3946-1
|
Phenmetrazine [Mass/time] in 24 hour Urine |
|
43177-5
|
Phenmetrazine [Presence] in Hair by Screen method |
|
26712-0
|
Phenmetrazine [Mass/mass] in Meconium |
|
27101-5
|
Phenmetrazine [Mass/volume] in Milk |
|
29614-5
|
Phenmetrazine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3943-8
|
Phenmetrazine [Mass/volume] in Serum or Plasma |
|
27290-6
|
Phenmetrazine [Mass/mass] in Stool |
|
20555-9
|
Phenmetrazine [Mass/volume] in Urine by Confirmatory method |
|
3944-6
|
Phenmetrazine [Presence] in Urine |
|
16220-6
|
Phenmetrazine [Presence] in Urine by Confirmatory method |
|
19662-6
|
Phenmetrazine [Presence] in Urine by Screen method |
|
3945-3
|
Phenmetrazine [Mass/volume] in Urine |
|
27250-0
|
Phenmetrazine [Mass/volume] in Vitreous fluid |
|
72974-9
|
PHENobarbital induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72973-1
|
PHENobarbital induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72396-5
|
PHENobarbital [Mass/volume] in Blood by Confirmatory method |
|
29223-5
|
PHENobarbital [Mass/volume] in Body fluid |
|
3951-1
|
PHENobarbital Free [Mass/volume] in Serum or Plasma |
|
12484-2
|
PHENobarbital [Presence] in Gastric fluid |
|
17436-7
|
PHENobarbital [Mass/volume] in Gastric fluid |
|
47124-3
|
PHENobarbital [Moles/volume] in Gastric fluid |
|
26905-0
|
PHENobarbital [Mass/mass] in Hair |
|
73209-9
|
PHENobarbital induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73208-1
|
PHENobarbital induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
27235-1
|
PHENobarbital [Mass/mass] in Meconium |
|
27051-2
|
PHENobarbital [Mass/volume] in Milk |
|
72453-4
|
PHENobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72628-1
|
PHENobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
60468-6
|
PHENobarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
|
3947-9
|
PHENobarbital [Presence] in Serum or Plasma |
|
35631-1
|
PHENobarbital [Mass/volume] in Serum or Plasma by Screen method |
|
82970-5
|
PHENobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3948-7
|
PHENobarbital [Mass/volume] in Serum or Plasma |
|
14874-2
|
PHENobarbital [Moles/volume] in Serum or Plasma |
|
12501-3
|
PHENobarbital [Presence] in Stool |
|
27240-1
|
PHENobarbital [Mass/mass] in Stool |
|
74926-7
|
PHENobarbital [Mass/volume] in Serum or Plasma --trough |
|
16241-2
|
PHENobarbital [Mass/volume] in Urine by Confirmatory method |
|
3949-5
|
PHENobarbital [Presence] in Urine |
|
16192-7
|
PHENobarbital [Presence] in Urine by Confirmatory method |
|
19666-7
|
PHENobarbital [Presence] in Urine by Screen method |
|
3950-3
|
PHENobarbital [Mass/volume] in Urine |
|
39487-4
|
PHENobarbital [Moles/volume] in Urine |
|
27191-6
|
PHENobarbital [Mass/volume] in Vitreous fluid |
|
32108-3
|
PHENobarbital [Presence] in Unspecified specimen |
|
64133-2
|
PHENobarbital/Creatinine [Mass Ratio] in Urine |
|
38615-1
|
Phenol [Mass/volume] in Air |
|
2757-3
|
Phenol [Mass/volume] in Blood |
|
2758-1
|
Phenol [Mass/volume] in Urine |
|
56647-1
|
Phenol/Creatinine [Ratio] in 24 hour Urine |
|
44347-3
|
Phenol/Creatinine [Molar ratio] in 24 hour Urine |
|
13487-4
|
Phenol/Creatinine [Mass Ratio] in Urine |
|
44346-5
|
Phenol/Creatinine [Molar ratio] in Urine |
|
17438-3
|
Phenolphthalein [Mass/volume] in Blood |
|
50357-3
|
Phenolphthalein [Presence] in Serum or Plasma |
|
60163-3
|
Phenolphthalein [Mass/volume] in Serum or Plasma |
|
55568-0
|
Phenolphthalein [Moles/volume] in Serum or Plasma |
|
26868-0
|
Phenolphthalein [Presence] in Stool |
|
16183-6
|
Phenolphthalein [Mass/volume] in Stool |
|
10883-7
|
Phenolphthalein [Mass/mass] in Stool |
|
12317-4
|
Phenolphthalein [Presence] in Urine |
|
17437-5
|
Phenolphthalein [Mass/volume] in Urine |
|
49105-0
|
Phenolphthalein [Mass/volume] in Unspecified specimen |
|
45140-1
|
Phenols [Mass/time] in 24 hour Urine |
|
17439-1
|
Phenols [Mass/volume] in Blood |
|
20938-7
|
Phenols [Mass/volume] in Gastric fluid |
|
59825-0
|
Phenols [Presence] in Urine |
|
2759-9
|
Phenols [Mass/volume] in Urine |
|
49106-8
|
Phenols [Mass/volume] in Unspecified specimen |
|
2760-7
|
Phenolsulphonphthalein [Mass/volume] in Urine |
|
9808-7
|
Phenothiazines [Presence] in Gastric fluid |
|
3952-9
|
Phenothiazines [Presence] in Serum or Plasma |
|
17440-9
|
Phenothiazines [Units/volume] in Serum or Plasma |
|
42528-0
|
Phenothiazines [Mass/volume] in Serum or Plasma |
|
20556-7
|
Phenothiazines [Mass/volume] in Urine by Confirmatory method |
|
3953-7
|
Phenothiazines [Presence] in Urine |
|
16221-4
|
Phenothiazines [Presence] in Urine by Confirmatory method |
|
19670-9
|
Phenothiazines [Presence] in Urine by Screen method |
|
17441-7
|
Phenothiazines [Units/volume] in Urine |
|
3954-5
|
Phenothiazines [Mass/volume] in Urine |
|
34178-4
|
Phenothiazines [Presence] in Unspecified specimen |
|
35109-8
|
Phenprocoumon [Mass/volume] in Serum or Plasma |
|
60164-1
|
Phensuximide [Mass/volume] in Blood |
|
3955-2
|
Phensuximide [Mass/volume] in Serum or Plasma |
|
39488-2
|
Phensuximide [Moles/volume] in Serum or Plasma |
|
60165-8
|
Phensuximide [Mass/volume] in Urine |
|
3959-4
|
Phentermine [Mass/time] in 24 hour Urine |
|
3956-0
|
Phentermine [Mass/volume] in Blood |
|
40395-6
|
Phentermine [Presence] in Gastric fluid |
|
43178-3
|
Phentermine [Presence] in Hair by Screen method |
|
26713-8
|
Phentermine [Mass/mass] in Meconium |
|
26990-2
|
Phentermine [Mass/volume] in Milk |
|
92644-4
|
Phentermine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
29608-7
|
Phentermine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
32579-5
|
Phentermine [Mass/volume] in Serum or Plasma |
|
55569-8
|
Phentermine [Moles/volume] in Serum or Plasma |
|
27305-2
|
Phentermine [Mass/mass] in Stool |
|
20557-5
|
Phentermine [Mass/volume] in Urine by Confirmatory method |
|
3957-8
|
Phentermine [Presence] in Urine |
|
16222-2
|
Phentermine [Presence] in Urine by Confirmatory method |
|
19674-1
|
Phentermine [Presence] in Urine by Screen method |
|
3958-6
|
Phentermine [Mass/volume] in Urine |
|
27234-4
|
Phentermine [Mass/volume] in Vitreous fluid |
|
64134-0
|
Phentermine/Creatinine [Mass Ratio] in Urine |
|
93340-8
|
PhenX - complete blood count protocol 220501 |
|
93000-8
|
PhenX - body proportions protocol 220201 |
|
93149-3
|
PhenX - bone age protocol 220301 |
|
75062-0
|
Phenylacetate [Moles/volume] in Serum or Plasma |
|
50358-1
|
Phenylacetate/Creatinine [Molar ratio] in 24 hour Urine |
|
13791-9
|
Phenylacetate/Creatinine [Mass Ratio] in Urine |
|
25124-9
|
Phenylacetate/Creatinine [Molar ratio] in Urine |
|
53205-1
|
Phenylacetylcarnitine (PheC2) [Moles/volume] in DBS |
|
90237-9
|
Phenylacetylcarnitine (PheC2) [Moles/volume] in Serum or Plasma |
|
68454-8
|
Phenylbutazone [Moles/volume] in Gastric fluid |
|
56878-2
|
Phenylbutazone IgE Ab [Units/volume] in Serum |
|
3960-2
|
Phenylbutazone [Mass/volume] in Serum or Plasma |
|
25500-0
|
Phenylbutazone [Moles/volume] in Serum or Plasma |
|
68379-7
|
Phenylbutazone [Moles/volume] in Urine |
|
68962-0
|
Phenylbutazone [Moles/volume] in Unspecified specimen |
|
17442-5
|
Phenylephrine [Mass/volume] in Serum or Plasma |
|
3962-8
|
Phenylephrine [Mass/volume] in Urine |
|
11250-8
|
Phenylethylmalonate [Mass/volume] in Serum or Plasma |
|
12537-7
|
Phenylglyoxylate [Mass/volume] in Urine |
|
56648-9
|
Phenylglyoxylate/Creatinine [Ratio] in 24 hour Urine |
|
13830-5
|
Phenylglyoxylate/Creatinine [Mass Ratio] in Urine |
|
2761-5
|
Phenylketones [Presence] in Blood |
|
2769-8
|
Phenylketones [Presence] in Urine |
|
72437-7
|
Phenyllactate [Moles/volume] in Serum or Plasma |
|
32583-7
|
Phenyllactate [Presence] in Urine |
|
50359-9
|
Phenyllactate/Creatinine [Molar ratio] in 24 hour Urine |
|
13792-7
|
Phenyllactate/Creatinine [Mass Ratio] in Urine |
|
25125-6
|
Phenyllactate/Creatinine [Molar ratio] in Urine |
|
2770-6
|
Phenylpyruvate [Mass/volume] in Blood |
|
2771-4
|
Phenylpyruvate [Mass/volume] in Plasma |
|
72436-9
|
Phenylpyruvate [Moles/volume] in Serum or Plasma |
|
2772-2
|
Phenylpyruvate [Presence] in Urine |
|
2773-0
|
Phenylpyruvate [Mass/volume] in Urine |
|
50361-5
|
Phenylpyruvate/Creatinine [Molar ratio] in 24 hour Urine |
|
13794-3
|
Phenylpyruvate/Creatinine [Mass Ratio] in Urine |
|
25126-4
|
Phenylpyruvate/Creatinine [Molar ratio] in Urine |
|
15373-4
|
Phenyltoloxamine [Mass/volume] in Blood |
|
14189-5
|
Phenyltoloxamine [Mass/volume] in Urine |
|
72972-3
|
Phenytoin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72971-5
|
Phenytoin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
29224-3
|
Phenytoin [Mass/volume] in Body fluid |
|
14190-3
|
Phenytoin Free [Mass/volume] in Saliva (oral fluid) |
|
3969-3
|
Phenytoin Free [Mass/volume] in Serum or Plasma |
|
74983-8
|
Phenytoin Free [Mass/volume] in Serum or Plasma --trough |
|
34540-5
|
Phenytoin free and total panel - Serum or Plasma |
|
73206-5
|
Phenytoin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73207-3
|
Phenytoin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14073-1
|
Phenytoin [Mass/volume] in Saliva (oral fluid) |
|
3967-7
|
Phenytoin [Presence] in Serum or Plasma |
|
35632-9
|
Phenytoin [Mass/volume] in Serum or Plasma by Screen method |
|
3968-5
|
Phenytoin [Mass/volume] in Serum or Plasma |
|
14877-5
|
Phenytoin [Moles/volume] in Serum or Plasma |
|
74976-2
|
Phenytoin [Mass/volume] in Serum or Plasma --trough |
|
12310-9
|
Phenytoin [Presence] in Urine |
|
17444-1
|
Phenytoin [Mass/volume] in Urine |
|
43831-7
|
Phenytoin [Presence] in Unspecified specimen |
|
45154-2
|
Phenylalanine hydroxylase Ab [Units/volume] in Serum |
|
87383-6
|
Porcine hemagglutinating encephalomyelitis virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
53888-4
|
PHEX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
25168-6
|
Perhexiline [Mass/volume] in Serum or Plasma |
|
93875-3
|
Phosphohistone H3 [Presence] in Tissue by Immune stain |
|
14169-7
|
Peptide histidine isoleucine [Mass/volume] in Plasma |
|
34522-3
|
Phosphorylase kinase [Enzymatic activity/volume] in Red Blood Cells |
|
91074-5
|
Phlebovirus sp RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
73720-5
|
Pholcodine IgE Ab [Units/volume] in Serum |
|
3970-1
|
Pholedrine [Mass/volume] in Urine |
|
17446-6
|
Phoma sp IgE Ab [Units/volume] in Serum |
|
24517-5
|
Phoma sp IgG Ab [Units/volume] in Serum |
|
85209-5
|
Telephone encounter Evaluation and management of smoking cessation note |
|
78290-4
|
Telephone encounter Initial evaluation note |
|
34748-4
|
Telephone encounter Note |
|
75499-4
|
Telephone encounter Triage note |
|
12547-6
|
Phorate [Mass/volume] in Serum or Plasma |
|
21457-7
|
Phorate [Mass/volume] in Urine |
|
87633-4
|
Phorate [Mass/mass] in Unspecified specimen |
|
38715-9
|
Phosgene [Mass/volume] in Air |
|
35673-3
|
Phosphate [Mass/volume] in Urine collected for unspecified duration |
|
80611-7
|
Phosphate [Moles/volume] in Urine collected for unspecified duration |
|
57348-5
|
Phosphate [Mass/volume] in 12 hour Urine |
|
54922-0
|
Phosphate [Mass/time] in 12 hour Urine |
|
51604-7
|
Phosphate [Moles/time] in 12 hour Urine |
|
58993-7
|
Phosphate [Mass/time] in 18 hour Urine |
|
59167-7
|
Phosphate [Moles/time] in 24 hour Stool |
|
21458-5
|
Phosphate [Mass/volume] in 24 hour Urine |
|
2779-7
|
Phosphate [Mass/time] in 24 hour Urine |
|
35263-3
|
Phosphate [Mass or Moles] in 24 hour Urine |
|
25973-9
|
Phosphate [Moles/volume] in 24 hour Urine |
|
14881-7
|
Phosphate [Moles/time] in 24 hour Urine |
|
57349-3
|
Phosphate [Mass/volume] in 2 hour Urine |
|
38717-5
|
Phosphate [Mass/volume] in Air |
|
14408-9
|
Phosphate [Mass/volume] in Amniotic fluid |
|
2774-8
|
Phosphate [Mass/volume] in Blood |
|
24519-1
|
Phosphate [Moles/volume] in Blood |
|
50058-7
|
Phosphate renal clearance in Urine and Serum or Plasma collected for unspecified duration |
|
2776-3
|
Phosphate renal clearance in 24 hour Urine and Serum or Plasma |
|
13542-6
|
Phosphate [Mass/volume] in Cerebral spinal fluid |
|
59037-2
|
Phosphate [Mass/volume] in Peritoneal dialysis fluid |
|
49006-0
|
Phosphate [Moles/volume] in Peritoneal dialysis fluid |
|
2775-5
|
Phosphate [Mass/volume] in Dialysis fluid |
|
35220-3
|
Phosphate [Mass or Moles/volume] in Dialysis fluid |
|
34938-1
|
Phosphate [Moles/volume] in Dialysis fluid |
|
58019-1
|
Phosphate [Mass/volume] in Nonbiological fluid |
|
12242-4
|
Phosphate [Mass/volume] in Body fluid |
|
25501-8
|
Phosphate [Moles/volume] in Body fluid |
|
14407-1
|
Phosphate [Mass/volume] in Gastric fluid |
|
86916-4
|
Phosphate goal [Mass/volume] Serum or Plasma |
|
76656-8
|
Phosphate [Mass/mass] in Hair |
|
50898-6
|
Phosphate [Moles/mass] in Hair |
|
48617-5
|
Phosphate [Mass/volume] in Serum or Plasma --post dialysis |
|
55972-4
|
Phosphate [Moles/volume] in Serum or Plasma --post dialysis |
|
14404-8
|
Phosphate [Mass/volume] in Pleural fluid |
|
48641-5
|
Phosphate [Mass/volume] in Serum or Plasma --pre dialysis |
|
14405-5
|
Phosphate [Mass/volume] in Peritoneal fluid |
|
55973-2
|
Phosphate [Moles/volume] in Peritoneal fluid |
|
27123-9
|
Phosphate [Mass/mass] in Red Blood Cells |
|
24520-9
|
Phosphate [Moles/volume] in Red Blood Cells |
|
74889-7
|
Phosphate [Moles/volume] in Saliva (oral fluid) |
|
2777-1
|
Phosphate [Mass/volume] in Serum or Plasma |
|
35221-1
|
Phosphate [Mass or Moles/volume] in Serum or Plasma |
|
14879-1
|
Phosphate [Moles/volume] in Serum or Plasma |
|
14406-3
|
Phosphate [Mass/volume] in Synovial fluid |
|
17447-4
|
Phosphate [Presence] in Stool |
|
88713-3
|
Phosphate [Mass/volume] in Stool |
|
10884-5
|
Phosphate [Mass/mass] in Stool |
|
59161-0
|
Phosphate [Moles/volume] in Stool |
|
14878-3
|
Phosphate [Presence] in Stone |
|
30544-1
|
Phosphate [Mass/volume] in Total parental nutrition |
|
2780-5
|
Phosphate [Presence] in Urine |
|
2778-9
|
Phosphate [Mass/volume] in Urine |
|
35222-9
|
Phosphate [Mass or Moles/volume] in Urine |
|
13539-2
|
Phosphate [Moles/volume] in Urine |
|
22733-0
|
Phosphate [Moles/volume] in Unspecified specimen |
|
13795-0
|
Phosphate/Creatinine [Mass Ratio] in 24 hour Urine |
|
33306-2
|
Phosphatidate Ab [Presence] in Serum |
|
47030-2
|
Phosphatidate IgA Ab [Units/volume] in Serum by Immunoassay |
|
13072-4
|
Phosphatidate IgA Ab [Units/volume] in Serum |
|
13070-8
|
Phosphatidate IgG Ab [Units/volume] in Serum |
|
47300-9
|
Phosphatidate IgM Ab [Units/volume] in Serum by Immunoassay |
|
13071-6
|
Phosphatidate IgM Ab [Units/volume] in Serum |
|
20940-3
|
Phosphide [Mass/mass] in Feed |
|
20939-5
|
Phosphide [Mass/mass] in Gastrointestinal content |
|
38716-7
|
Phosphine [Mass/volume] in Air |
|
2797-9
|
Phosphoglucomutase [Enzymatic activity/volume] in Serum |
|
2799-5
|
Phosphoglyceromutase [Enzymatic activity/volume] in Serum |
|
7600-0
|
Phospholipase IgE Ab [Units/volume] in Serum |
|
3285-4
|
Phospholipid Ab [Units/volume] in Serum by Immunoassay |
|
19140-3
|
Phospholipid Ab [Presence] in Serum |
|
7800-6
|
Phospholipid Ab [Units/volume] in Serum |
|
17459-9
|
Phospholipid IgA Ab [Units/volume] in Serum by Immunoassay |
|
31561-4
|
Phospholipid IgA Ab [Units/volume] in Serum |
|
55395-8
|
Phospholipid IgA and IgG and IgM panel - Serum |
|
3286-2
|
Phospholipid IgG Ab [Units/volume] in Serum by Immunoassay |
|
20428-9
|
Phospholipid IgG Ab [Presence] in Serum |
|
7801-4
|
Phospholipid IgG Ab [Units/volume] in Serum |
|
3287-0
|
Phospholipid IgM Ab [Units/volume] in Serum by Immunoassay |
|
20429-7
|
Phospholipid IgM Ab [Presence] in Serum |
|
7802-2
|
Phospholipid IgM Ab [Units/volume] in Serum |
|
2567-6
|
Phospholipid phosphorus [Mass/volume] in Serum |
|
2568-4
|
Phospholipid [Mass/volume] in Serum or Plasma |
|
15089-6
|
Phospholipid [Moles/volume] in Serum or Plasma |
|
44830-8
|
Phosphorylase [Enzymatic activity/volume] in Blood |
|
79464-4
|
Phosphorylase [Enzymatic activity/mass] in Red Blood Cells |
|
54489-0
|
Phosphoserine [Moles/volume] in DBS |
|
50951-3
|
Phosphoserine IgA Ab [Presence] in Serum or Plasma |
|
50952-1
|
Phosphoserine IgG Ab [Presence] in Serum or Plasma |
|
50955-4
|
Phosphoserine IgM Ab [Presence] in Serum or Plasma |
|
72170-4
|
Photographic image |
|
43246-8
|
PHOX2B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
44249-1
|
PHQ-9 quick depression assessment panel [Reported.PHQ] |
|
80982-2
|
Phytanoyl CoA hydroxlase [Enzymatic activity/mass] in Fibroblast |
|
82294-0
|
Physical activity guideline used |
|
60869-5
|
Physiological dead space [Volume] Respiratory system --on ventilator |
|
76001-7
|
Physiological dead space [Volume] Respiratory system |
|
60870-3
|
Physiological dead space/Tidal volume Respiratory system --on ventilator |
|
76002-5
|
Physiological dead space/Tidal volume Respiratory system |
|
51850-6
|
Physical findings of Head and Ears and Eyes and Nose and Throat |
|
85910-8
|
Physical findings of Teeth and gum Narrative |
|
75293-1
|
Physical findings of nutrition assessment |
|
87517-9
|
Physical abuse was reported |
|
82287-4
|
Physical activity panel |
|
46006-3
|
Physical functioning and stuctural problems section Set |
|
78439-7
|
Phenytoin free and total trough panel - Serum or Plasma |
|
81763-5
|
Phytanate and pristanate panel - Serum or Plasma |
|
47726-5
|
Phytanate (C16:0(CH3)4)/Creatinine [Molar ratio] in Urine |
|
26047-1
|
Phytate [Moles/volume] in Serum or Plasma |
|
9622-2
|
Phytonadione [Mass/volume] in Serum or Plasma |
|
58793-1
|
Phytonadione [Moles/volume] in Serum or Plasma |
|
33589-3
|
Phosphatidylinositol Ab [Units/volume] in Serum by Immunoassay |
|
33309-6
|
Phosphatidylinositol Ab [Presence] in Serum |
|
33612-3
|
Phosphatidylinositol Ab [Units/volume] in Serum |
|
33637-0
|
Phagocytic index of Blood by Flow cytometry (FC) |
|
17454-0
|
Phosphatidylinositol IgA Ab [Presence] in Serum |
|
13084-9
|
Phosphatidylinositol IgA Ab [Units/volume] in Serum |
|
17455-7
|
Phosphatidylinositol IgG Ab [Presence] in Serum |
|
13082-3
|
Phosphatidylinositol IgG Ab [Units/volume] in Serum |
|
17456-5
|
Phosphatidylinositol IgM Ab [Presence] in Serum |
|
13083-1
|
Phosphatidylinositol IgM Ab [Units/volume] in Serum |
|
49218-1
|
Phosphatidylinositol/Surfactant.total in Amniotic fluid |
|
2787-0
|
Phosphatidylinositol [Mass/volume] in Serum |
|
49574-7
|
Phosphatidylinositol+Phosphatidylserine/Surfactant.total in Amniotic fluid |
|
92735-0
|
Pibrentasvir [Susceptibility] by Genotype method |
|
7602-6
|
Pickleweed IgE Ab [Units/volume] in Serum |
|
17462-3
|
Picloram [Mass/volume] in Urine |
|
68460-5
|
Picornavirus Ag [Presence] in Isolate by Immunofluorescence |
|
10706-0
|
Picornavirus [Identifier] in Stool by Electron microscopy |
|
84437-3
|
Picture Sequence Memory Test [NIH Toolbox] |
|
35575-0
|
Pigeon antibody panel - Serum |
|
24505-0
|
Pigeon droppings Ab [Presence] in Serum by Immune diffusion (ID) |
|
17463-1
|
Pigeon droppings Ab [Units/volume] in Serum |
|
6217-4
|
Pigeon droppings IgE Ab [Units/volume] in Serum |
|
38418-0
|
Pigeon droppings IgG Ab [Presence] in Serum |
|
7603-4
|
Pigeon droppings IgG Ab [Units/volume] in Serum |
|
38368-7
|
Pigeon droppings IgG Ab [Mass/volume] in Serum |
|
17464-9
|
Pigeon feather IgE Ab [Presence] in Serum |
|
10948-8
|
Pigeon feather IgE Ab [Units/volume] in Serum |
|
51549-4
|
Pigeon feather IgG Ab [Presence] in Serum |
|
58912-7
|
Pigeon feather IgG Ab [Mass/volume] in Serum |
|
51859-7
|
Pigeon serum proteins+feathers+droppings IgG Ab [Presence] in Serum |
|
78367-0
|
Pigeon serum proteins+feathers+droppings IgG Ab [Mass/volume] in Serum |
|
42529-8
|
Pigeon serum Ab [Presence] in Cerebral spinal fluid |
|
6733-0
|
Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID) |
|
17465-6
|
Pigeon serum IgE Ab [Presence] in Serum |
|
19752-5
|
Pigeon serum IgG Ab [Presence] in Serum |
|
74755-0
|
Placental growth factor [Mass/volume] in Serum |
|
7606-7
|
Pigweed triggered histamine release [Units/volume] in Blood |
|
7605-9
|
Pigweed IgG Ab [Units/volume] in Serum |
|
48298-4
|
Pigweed triggered leukotriene release [Mass/volume] by Leukocytes |
|
60033-8
|
PIK3CA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60034-6
|
PIK3CA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
83062-0
|
PIK3CA gene [VCF] in Cancer specimen by Sequencing |
|
79519-5
|
Pimelate [Moles/volume] in Serum or Plasma |
|
79494-1
|
Pimelate/Creatinine [Molar ratio] in Urine |
|
54474-2
|
Pimeloylcarnitine (C7-DC) [Moles/volume] in Amniotic fluid |
|
54473-4
|
Pimeloylcarnitine (C7-DC) [Moles/volume] in Cerebral spinal fluid |
|
54475-9
|
Pimeloylcarnitine (C7-DC) [Moles/volume] in DBS |
|
54476-7
|
Pimeloylcarnitine (C7-DC) [Moles/volume] in Urine |
|
54488-2
|
Pimeloylcarnitine (C7-DC)/Creatinine [Molar ratio] in Urine |
|
12410-7
|
Pimozide [Mass/volume] in Serum or Plasma |
|
74981-2
|
Pimozide [Mass/volume] in Serum or Plasma --trough |
|
87779-5
|
Pimozide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
7434-4
|
Pinchot Juniper IgE Ab [Units/volume] in Serum |
|
3971-9
|
Pindolol [Mass/volume] in Serum or Plasma |
|
7609-1
|
Pine IgE Ab [Units/volume] in Serum |
|
10954-6
|
Pine Nut IgE Ab [Units/volume] in Serum |
|
61330-7
|
Pine Nut IgE Ab/IgE total in Serum |
|
6218-2
|
Pineapple IgE Ab [Units/volume] in Serum |
|
61216-8
|
Pineapple IgE Ab/IgE total in Serum |
|
7612-5
|
Pineapple IgG Ab [Units/volume] in Serum |
|
56358-5
|
Pineapple IgG4 Ab [Mass/volume] in Serum |
|
60394-4
|
Pineapple IgG Ab [Mass/volume] in Serum |
|
47968-3
|
PINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
47255-5
|
Procollagen type I.N-terminal propeptide [Mass/volume] in Serum |
|
77370-5
|
Procollagen type I.N-terminal propeptide [Mass/volume] in Serum or Plasma by Immunoassay |
|
7135-7
|
Pinto Bean IgE Ab [Units/volume] in Serum |
|
7136-5
|
Pinto Bean IgG Ab [Units/volume] in Serum |
|
56359-3
|
Pinto Bean IgG4 Ab [Mass/volume] in Serum |
|
60355-5
|
Pinto Bean IgG Ab [Mass/volume] in Serum |
|
73205-7
|
Pioglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73204-0
|
Pioglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73201-6
|
Piperacillin+Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73200-8
|
Piperacillin+Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35115-5
|
Pipamperone [Mass/volume] in Serum or Plasma |
|
54490-8
|
Pipecolate [Moles/volume] in Amniotic fluid |
|
2805-0
|
Pipecolate [Mass/volume] in Cerebral spinal fluid |
|
54327-2
|
Pipecolate [Moles/volume] in Cerebral spinal fluid |
|
54328-0
|
Pipecolate [Moles/volume] in DBS |
|
2806-8
|
Pipecolate [Mass/volume] in Serum or Plasma |
|
32334-5
|
Pipecolate [Moles/volume] in Serum or Plasma |
|
2807-6
|
Pipecolate [Mass/volume] in Urine |
|
32335-2
|
Pipecolate [Moles/volume] in Urine |
|
33659-4
|
Pipecolate/Creatinine [Ratio] in Urine |
|
47727-3
|
Pipecolate/Creatinine [Molar ratio] in Urine |
|
72970-7
|
Piperacillin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72969-9
|
Piperacillin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73202-4
|
Piperacillin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73203-2
|
Piperacillin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3972-7
|
Piperacillin [Mass/volume] in Serum or Plasma |
|
25268-4
|
Piperacillin [Mass/volume] in Unspecified specimen |
|
54199-5
|
Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54198-7
|
Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54197-9
|
Piperacillin+Sulbactam [Susceptibility] |
|
3975-0
|
Pipradrol [Mass/time] in 24 hour Urine |
|
3973-5
|
Pipradrol [Presence] in Urine |
|
3974-3
|
Pipradrol [Mass/volume] in Urine |
|
10549-4
|
Pirmenol [Mass/volume] in Serum or Plasma |
|
56703-2
|
Piroxicam IgE Ab [Units/volume] in Serum |
|
11251-6
|
Piroxicam [Mass/volume] in Serum or Plasma |
|
7613-3
|
Pistachio IgE Ab [Units/volume] in Serum |
|
40832-8
|
Pistachio IgE Ab/IgE total in Serum |
|
56360-1
|
Pistachio IgG4 Ab [Mass/volume] in Serum |
|
63110-1
|
Pistachio IgG Ab [Mass/volume] in Serum |
|
7614-1
|
Pitosporium triggered histamine release [Units/volume] in Blood |
|
63551-6
|
Pituitary Ab [Titer] in Serum by Immunofluorescence |
|
52759-8
|
Prekallikrein (Fletcher Factor) activity actual/normal in Platelet poor plasma by Coagulation assay |
|
11227-6
|
Pyruvate kinase [Presence] in Blood |
|
71713-2
|
Pyruvate kinase [Enzymatic activity/substance] in Red Blood Cells |
|
6004-6
|
Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
13594-7
|
Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasma |
|
6005-3
|
Prekallikrein (Fletcher Factor) [Units/volume] in Platelet poor plasma |
|
4669-8
|
Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma |
|
77626-0
|
Pyruvate kinase [Entitic Catalytic Activity] in Red Blood Cells |
|
2912-4
|
Pyruvate kinase [Enzymatic activity/volume] in Red Blood Cells |
|
32552-2
|
Pyruvate kinase [Enzymatic activity/mass] in Red Blood Cells |
|
2913-2
|
Pyruvate kinase [Enzymatic activity/volume] in Serum or Plasma |
|
74542-2
|
Pyruvate kinase/Glucose-6-Phosphate dehydrogenase [Enzymatic activity ratio] in Red Blood Cells |
|
46207-7
|
PKD1 gene+PKD2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
44421-6
|
PKD1 gene+PKD2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49215-7
|
PKHD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48968-2
|
PKHD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48029-3
|
PKLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
46746-4
|
Phenylketonuria and variants/Biopterin defects newborn screen interpretation |
|
33771-7
|
PL-12 Ab [Presence] in Serum |
|
56745-3
|
PL-12 Ab [Presence] in Serum by Immunoblot |
|
33772-5
|
PL-7 Ab [Presence] in Serum |
|
56744-6
|
PL-7 Ab [Presence] in Serum by Immunoblot |
|
82924-2
|
PL-7 IgG Ab [Presence] in Serum by Immunoassay |
|
43369-8
|
PlA1 Ab [Presence] in Platelet rich plasma |
|
58983-8
|
Honey bee phospholipase A2 native (nApi m) 1 IgE Ab [Units/volume] in Serum |
|
60421-5
|
Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum |
|
73737-9
|
Phospholipase A2 receptor IgG Ab [Units/volume] in Serum by Immunoassay |
|
82926-7
|
Phospholipase A2 receptor IgG Ab [Presence] in Serum by Line blot |
|
82991-1
|
Phospholipase A2 receptor IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
81201-6
|
Phospholipase A2 receptor IgG Ab [Titer] in Serum by Immunofluorescence |
|
42138-8
|
US Guidance for localization of placenta |
|
10959-5
|
Plaice IgE Ab [Units/volume] in Serum |
|
18776-5
|
Plan of care note |
|
20942-9
|
Plant identified [Type] in Plant |
|
5967-5
|
Plasmin inhibitor Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
5966-7
|
Plasmin inhibitor Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5965-9
|
Plasmin inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
|
48681-1
|
Plasma cell Ag [Presence] in Tissue by Immune stain |
|
75658-5
|
Plasma cells/100 leukocytes in Bronchial specimen |
|
5279-5
|
Plasmodium sp Ab [Units/volume] in Serum |
|
25632-1
|
Plasmodium sp Ab [Titer] in Serum |
|
25731-1
|
Plasmodium sp Ab [Titer] in Serum by Immunofluorescence |
|
51865-4
|
Plasmodium sp Ag [Identifier] in Blood |
|
70569-9
|
Plasmodium sp Ag [Identifier] in Blood by Rapid immunoassay |
|
50687-3
|
Plasmodium sp Ag [Presence] in Blood |
|
46094-9
|
Plasmodium sp Ag [Presence] in Blood by Immunoassay |
|
51587-4
|
Plasmodium sp [Presence] in Blood by Light microscopy |
|
32206-5
|
Plasmodium sp identified in Blood by Light microscopy |
|
637-9
|
Plasmodium sp identified in Blood by Thick film |
|
10710-2
|
Plasmodium sp identified in Blood by Thin film |
|
47260-5
|
Plasmodium sp DNA [Identifier] in Blood by NAA with probe detection |
|
47085-6
|
Plasmodium sp DNA [Presence] in Blood by NAA with probe detection |
|
53383-6
|
Plasmodium sp IgG Ab [Titer] in Serum |
|
52980-0
|
Plasmodium sp IgG Ab [Titer] in Serum by Immunofluorescence |
|
53556-7
|
Erythrocytes.Plasmodium sp infected/100 erythrocytes in Blood |
|
48427-9
|
Erythrocytes.Plasmodium sp infected/1000 erythrocytes in Blood |
|
50688-1
|
Plasmodium sp lactate dehydrogenase [Identifier] in Blood |
|
53248-1
|
Plasmodium sp lactate dehydrogenase [Presence] in Blood |
|
41451-6
|
Plasmodium stage [Identifier] in Blood by Light microscopy |
|
17280-9
|
Plasmodium sp identified in Tissue by Thick film |
|
83665-0
|
Plastic surgery Attending Admission evaluation note |
|
83666-8
|
Plastic surgery Attending Note |
|
83667-6
|
Plastic surgery Attending Preoperative evaluation and management note |
|
83743-5
|
Plastic surgery Fellow Note |
|
83606-4
|
Plastic surgery Nurse Outpatient Note |
|
83771-6
|
Plastic surgery Resident Note |
|
83850-8
|
Plastic surgery Admission evaluation note |
|
78727-5
|
Plastic surgery Admission history and physical note |
|
78545-1
|
Plastic surgery Checklist |
|
34826-8
|
Plastic surgery Consult note |
|
93966-0
|
Plastic surgery Diagnostic study note |
|
68591-7
|
Plastic surgery Discharge summary |
|
78614-5
|
Plastic surgery Education note |
|
78633-5
|
Plastic surgery Flowsheet |
|
68592-5
|
Plastic surgery History and physical note |
|
68597-4
|
Plastic surgery Hospital Consult note |
|
68598-2
|
Plastic surgery Hospital Letter |
|
83851-6
|
Plastic surgery Hospital Note |
|
82832-7
|
Plastic surgery Initial evaluation note |
|
68593-3
|
Plastic surgery Letter |
|
34827-6
|
Plastic surgery Note |
|
83852-4
|
Plastic surgery Outpatient Note |
|
34870-6
|
Plastic surgery Surgical operation note |
|
83855-7
|
Plastic surgery Telephone encounter Note |
|
80776-8
|
Plastic surgery Plan of care note |
|
83853-2
|
Plastic surgery Postoperative evaluation and management note |
|
68594-1
|
Plastic surgery Preoperative evaluation and management note |
|
83854-0
|
Plastic surgery procedure note |
|
68595-8
|
Plastic surgery Progress note |
|
57155-4
|
Plastic surgery Referral note |
|
68596-6
|
Plastic surgery Transfer summary note |
|
43302-9
|
Platelet glycoprotein Ab [Presence] in Serum by Immunoassay |
|
63479-0
|
Platelet glycoprotein Ia/IIa Ab [Presence] in Blood by Immunoassay |
|
47084-9
|
Platelet glycoprotein Ia/IIa Ab [Presence] in Serum by Immunoassay |
|
48502-9
|
Platelet glycoprotein Ia/IIa IgG Ab [Presence] in Blood by Immunoassay |
|
63478-2
|
Platelet glycoprotein Ib/Ix Ab [Presence] in Blood by Immunoassay |
|
48506-0
|
Platelet glycoprotein Ib/Ix Ab [Presence] in Serum by Immunoassay |
|
48503-7
|
Platelet glycoprotein Ib/Ix IgG Ab [Presence] in Blood by Immunoassay |
|
48594-6
|
Platelet glycoprotein IIb/IIIa Ab [Presence] in Blood by Immunoassay |
|
53815-7
|
Platelet glycoprotein IIb/IIIa Ab [Units/volume] in Blood |
|
50365-6
|
Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum |
|
48505-2
|
Platelet glycoprotein IIb/IIIa Ab [Presence] in Serum by Immunoassay |
|
48504-5
|
Platelet glycoprotein IIb/IIIa IgG Ab [Presence] in Blood by Immunoassay |
|
87757-1
|
Platelet glycoprotein IV Ab [Presence] in Serum or Plasma by Immunoassay |
|
60829-9
|
Pressure.plateau Respiratory system airway |
|
26515-7
|
Platelets [#/volume] in Blood |
|
777-3
|
Platelets [#/volume] in Blood by Automated count |
|
49497-1
|
Platelets [#/volume] in Blood by Estimate |
|
62244-9
|
Platelets [#/volume] in Blood from Fetus by Automated count |
|
778-1
|
Platelets [#/volume] in Blood by Manual count |
|
74464-9
|
Platelets [#/volume] in Capillary blood by Manual count |
|
47284-5
|
Platelets [#/volume] in Cord blood |
|
55802-3
|
Platelets [#/volume] in Cord blood by Estimate |
|
40574-6
|
Platelets [#/volume] in Body fluid by Automated count |
|
26516-5
|
Platelets [#/volume] in Plasma |
|
13056-7
|
Platelets [#/volume] in Plasma by Automated count |
|
74775-8
|
Platelets [#/volume] in Platelet rich plasma by Automated count |
|
24375-8
|
Platelet Ab [Presence] in Serum |
|
41616-4
|
Platelet Ab [Presence] in Serum by Flow cytometry (FC) |
|
57440-0
|
Platelet Ab [Presence] in Serum by Immunofluorescence |
|
5379-3
|
Platelet Ab [Units/volume] in Serum |
|
22759-5
|
Platelet Ab [Titer] in Serum |
|
48805-6
|
Platelet aggregation panel - Platelet rich plasma |
|
91124-8
|
Platelet function with adenosine diphosphate induction panel - Blood by Resonance TEG |
|
35460-5
|
Platelet genotype [Identifier] in Amniotic fluid |
|
34977-9
|
Platelet genotype [Identifier] in Blood |
|
93320-0
|
Platelet surface glycoprotein disorders panel - Blood by Flow cytometry (FC) |
|
31185-2
|
Platelet IgA Ab [Presence] in Serum |
|
13062-5
|
Platelet IgA Ab [Units/volume] in Serum |
|
15400-5
|
Platelet IgG Ab [Presence] in Serum |
|
6927-8
|
Platelet IgG Ab [Presence] in Serum by Flow cytometry (FC) |
|
11570-9
|
Platelet IgG Ab [Units/volume] in Serum |
|
31186-0
|
Platelet IgM Ab [Presence] in Serum |
|
13061-7
|
Platelet IgM Ab [Units/volume] in Serum |
|
73556-3
|
Platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55206-7
|
Platelet mass [Volume Fraction] in Blood |
|
58406-0
|
Platelet morphology panel - Blood |
|
53800-9
|
Platelets panel - Blood by Automated count |
|
52909-9
|
Platinum [Moles/time] in 24 hour Urine |
|
10916-5
|
Platinum [Mass/volume] in Blood |
|
51202-0
|
Platinum [Mass/volume] in Body fluid |
|
5713-3
|
Platinum [Mass/mass] in Hair |
|
50900-0
|
Platinum [Moles/mass] in Hair |
|
60166-6
|
Platinum [Mass/mass] in Nail |
|
60167-4
|
Platinum [Mass/volume] in Red Blood Cells |
|
5714-1
|
Platinum [Mass/volume] in Serum or Plasma |
|
60168-2
|
Platinum [Mass/mass] in Tissue |
|
50899-4
|
Platinum [Moles/mass] in Tissue |
|
5715-8
|
Platinum [Mass/volume] in Urine |
|
52897-6
|
Platinum [Moles/volume] in Urine |
|
9400-3
|
Platinum [Mass/volume] in Unspecified specimen |
|
52924-8
|
Platinum/Creatinine [Molar ratio] in 24 hour Urine |
|
52925-5
|
Platinum/Creatinine [Molar ratio] in Urine |
|
76523-0
|
Plethysmogram Arterial blood Pulse oximetry |
|
66123-1
|
Pleura Pathology biopsy report |
|
5991-5
|
Plasminogen Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
4668-0
|
Plasminogen Ag [Mass/volume] in Platelet poor plasma |
|
5970-9
|
Plasminogen [Units/volume] in Platelet poor plasma by Chromogenic method |
|
74814-5
|
Plasma cells.centroblasts/100 leukocytes in Blood by Manual count |
|
74820-2
|
Plasma cells.centrocytes/100 leukocytes in Blood by Manual count |
|
53890-0
|
PLOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77071-9
|
PLOD2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77070-1
|
PLOD2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
77113-9
|
PLOD3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77112-1
|
PLOD3 gene full mutation analysis in Blood or Tissue by Sequencing |
|
79324-0
|
Pyridoxal phosphate and pyridoxal and pyridoxine panel - Cerebral spinal fluid |
|
79325-7
|
Pyridoxal phosphate and pyridoxal and pyridoxine panel - Serum or Plasma |
|
42179-2
|
PLP1 gene duplication [Presence] in Blood or Tissue by Molecular genetics method |
|
39089-8
|
PLP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
6853-6
|
Plum IgE Ab [Units/volume] in Serum |
|
43592-5
|
Plum IgE Ab/IgE total in Serum |
|
7617-4
|
Plum IgG Ab [Units/volume] in Serum |
|
56361-9
|
Plum IgG4 Ab [Mass/volume] in Serum |
|
60395-1
|
Plum IgG Ab [Mass/volume] in Serum |
|
7618-2
|
Plum Pollen IgE Ab [Units/volume] in Serum |
|
17468-0
|
Plutonium [Mass/volume] in Urine |
|
88735-6
|
PM-SCL-100 Ab [Units/volume] in Serum by Line blot |
|
81732-0
|
PM-SCL-100 Ab [Presence] in Serum by Line blot |
|
82925-9
|
PM-SCL-100 IgG Ab [Presence] in Serum by Line blot |
|
61120-2
|
PM-SCL-100 IgG Ab [Units/volume] in Serum |
|
89926-0
|
Physical medicine and rehab Adult day care center Note |
|
83707-0
|
Physical medicine and rehab Administrative note |
|
83708-8
|
Physical medicine and rehab Admission evaluation note |
|
83709-6
|
Physical medicine and rehabilitation Attending Note |
|
83710-4
|
Physical medicine and rehabilitation Case manager Note |
|
83711-2
|
Physical medicine and rehab Conference note |
|
34822-7
|
Physical medicine and rehab Consult note |
|
85894-4
|
Physical medicine and rehab Counseling note |
|
93965-2
|
Physical medicine and rehab Diagnostic study note |
|
83712-0
|
Physical medicine and rehab Discharge summary |
|
83714-6
|
Physical medicine and rehab Education note |
|
78619-4
|
Physical medicine and rehab Flowsheet |
|
83715-3
|
Physical medicine and rehab History and physical note |
|
83718-7
|
Physical medicine and rehab Hospital Admission evaluation note |
|
83719-5
|
Physical medicine and rehab Hospital Note |
|
83717-9
|
Physical medicine and rehab Initial evaluation note |
|
83713-8
|
Physical medicine and rehabilitation Interdisciplinary Note |
|
83734-4
|
Physical medicine and rehabilitation Interdisciplinary Plan of care note |
|
83720-3
|
Physical medicine and rehab Long term care facility Consult note |
|
83721-1
|
Physical medicine and rehab Long term care facility Note |
|
83726-0
|
Physical medicine and rehabilitation Physician Initial evaluation note |
|
83727-8
|
Physical medicine and rehabilitation Physician Note |
|
34823-5
|
Physical medicine and rehab Note |
|
83722-9
|
Physical medicine and rehabilitation Nurse Consult note |
|
83723-7
|
Physical medicine and rehabilitation Nurse Note |
|
83724-5
|
Physical medicine and rehab Outpatient Initial evaluation note |
|
83725-2
|
Physical medicine and rehab Outpatient Note |
|
83733-6
|
Physical medicine and rehab Telephone encounter Note |
|
80786-7
|
Physical medicine and rehab Plan of care note |
|
83728-6
|
Physical medicine and rehab procedure note |
|
89030-1
|
Physical medicine and rehab Progress note |
|
83716-1
|
Physical medicine and rehab Patient's home Note |
|
57153-9
|
Physical medicine and rehab Referral note |
|
83729-4
|
Physical medicine and rehabilitation Resident Note |
|
83730-2
|
Physical medicine and rehab Risk assessment and screening note |
|
90757-6
|
Physical medicine and rehabilitation Social worker Hospital Note |
|
90758-4
|
Physical medicine and rehabilitation Social worker Outpatient hospital Note |
|
83731-0
|
Physical medicine and rehabilitation Team Conference note |
|
83732-8
|
Physical medicine and rehabilitation Team Note |
|
89889-0
|
Physical medicine and rehab Telehealth Note |
|
17471-4
|
PM-1 Ab [Units/volume] in Serum by Immunofluorescence |
|
14131-7
|
PM-1 Ab [Presence] in Serum |
|
17470-6
|
PM-1 Ab [Presence] in Serum by Immunofluorescence |
|
17469-8
|
PM-1 Ab [Units/volume] in Serum |
|
59399-6
|
PM-1 Ab [Titer] in Serum by Immunofluorescence |
|
76685-7
|
Platelet dry mass distribution width [Entitic mass] in Blood by calculation |
|
2725-0
|
Para methylhippurate [Mass/volume] in Urine |
|
82891-3
|
Para methylhippurate [Moles/volume] in Urine |
|
82892-1
|
Para methylhippurate/Creatinine [Molar ratio] in Urine |
|
56753-7
|
PML Ab [Presence] in Serum by Immunoblot |
|
82923-4
|
PML IgG Ab [Presence] in Serum by Line blot |
|
71796-7
|
Promyelocytic leukemia protein distribution pattern [Interpretation] in Blood or Tissue Qualitative by Immunofluorescence |
|
78971-9
|
Phosphomannomutase 1 [Enzymatic activity/mass] in Fibroblast |
|
78970-1
|
Phosphomannomutase 1 [Enzymatic activity/mass] in Leukocytes |
|
76026-4
|
Phosphomannomutase 2 [Enzymatic activity/mass] in Fibroblast |
|
81818-7
|
PMM2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
60127-8
|
Paramethadione [Mass/volume] in Blood |
|
10999-1
|
Paramethadione [Mass/volume] in Serum or Plasma |
|
60128-6
|
Paramethadione [Mass/volume] in Urine |
|
75384-8
|
PMP22 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
21727-3
|
PMP22 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50328-4
|
PMS-2 Ag [Presence] in Tissue by Immune stain |
|
79419-8
|
PMS2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
79417-2
|
PMS2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
88736-4
|
PM-SCL-75 Ab [Units/volume] in Serum by Line blot |
|
81733-8
|
PM-SCL-75 Ab [Presence] in Serum by Line blot |
|
72724-8
|
PM-SCL-75 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
47283-7
|
Platelet mean volume [Entitic volume] in Cord blood |
|
10506-4
|
Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
|
46078-2
|
Pneumococcal vaccine Set |
|
10712-8
|
Pneumocystis sp identified in Lung tissue |
|
18308-7
|
Pneumocystis sp identified in Lung tissue by Immune stain |
|
13326-4
|
Pneumocystis sp identified in Unspecified specimen by Light microscopy |
|
90735-2
|
PNH GPI-Linked WBC and RBC Ag Panel - Blood |
|
38749-8
|
P-nitrobiphenyl [Mass/volume] in Air |
|
38750-6
|
Para nitrophenol [Mass/volume] in Air |
|
35482-9
|
Para nitrophenol [Mass/volume] in Serum or Plasma |
|
2726-8
|
Para nitrophenol [Presence] in Urine |
|
2727-6
|
Para nitrophenol [Mass/volume] in Urine |
|
13790-1
|
Para nitrophenol/Creatinine [Mass Ratio] in Urine |
|
25123-1
|
Para nitrophenol/Creatinine [Molar ratio] in Urine |
|
53891-8
|
PNKD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35141-1
|
Purine nucleoside phosphorylase [Enzymatic activity/volume] in Cerebral spinal fluid |
|
79466-9
|
Purine nucleoside phosphorylase [Enzymatic activity/substance] in Red Blood Cells |
|
79467-7
|
Purine nucleoside phosphorylase [Enzymatic activity/volume] in DBS |
|
38179-8
|
Peripheral neuropathy gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41070-4
|
Peripheral neuropathy gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
47740-6
|
Purine nucleoside phosphorylase [Enzymatic activity/mass] in Red Blood Cells |
|
2899-3
|
Purine nucleoside phosphorylase [Enzymatic activity/mass] in Tissue |
|
47741-4
|
Purine nucleoside phosphorylase [Entitic Catalytic Activity] in Leukocytes |
|
11556-8
|
Oxygen [Partial pressure] in Blood |
|
2703-7
|
Oxygen [Partial pressure] in Arterial blood |
|
2704-5
|
Oxygen [Partial pressure] in Capillary blood |
|
14864-3
|
Oxygen [Partial pressure] in Cord blood |
|
28648-4
|
Oxygen [Partial pressure] in Arterial cord blood |
|
28649-2
|
Oxygen [Partial pressure] in Venous cord blood |
|
19211-2
|
Oxygen [Partial pressure] in Mixed venous blood |
|
2705-2
|
Oxygen [Partial pressure] in Venous blood |
|
3147-6
|
Oxygen [Partial pressure] in Exhaled gas |
|
2706-0
|
Oxygen [Partial pressure] in Body fluid |
|
3148-4
|
Oxygen [Partial pressure] in Gas |
|
3149-2
|
Oxygen [Partial pressure] in Inhaled gas |
|
65343-6
|
Oxygen [Partial pressure] saturation adjusted to 0.5 in Blood |
|
49696-8
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial cord blood |
|
49697-6
|
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous cord blood |
|
13129-2
|
Pancreatic oncofetal Ag [Units/volume] in Serum or Plasma |
|
93764-9
|
Porcine astrovirus type 3 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
83856-5
|
Podiatry Administrative note |
|
83857-3
|
Podiatry Admission evaluation note |
|
90793-1
|
Podiatry Attending Note |
|
90792-3
|
Podiatry Attending Preoperative evaluation and management note |
|
34828-4
|
Podiatry Consult note |
|
78577-4
|
Podiatry Diagnostic study note |
|
78611-1
|
Podiatry Education note |
|
78630-1
|
Podiatry Flowsheet |
|
83858-1
|
Podiatry History and physical note |
|
83859-9
|
Podiatry Hospital Note |
|
18737-7
|
Podiatry Initial evaluation note |
|
34829-2
|
Podiatry Note |
|
83607-2
|
Podiatry Nurse Note |
|
83608-0
|
Podiatry Nurse Outpatient Note |
|
75480-4
|
Podiatry Outpatient Note |
|
83860-7
|
Podiatry Outpatient Risk assessment and screening note |
|
28624-5
|
Podiatry Operation note |
|
83864-9
|
Podiatry Telephone encounter Note |
|
80775-0
|
Podiatry Plan of care note |
|
83861-5
|
Podiatry Postoperative evaluation and management note |
|
83862-3
|
Podiatry Preoperative evaluation and management note |
|
28625-2
|
Podiatry procedure note |
|
11509-7
|
Podiatry Progress note |
|
57156-2
|
Podiatry Referral note |
|
90790-7
|
Podiatry Resident Note |
|
83863-1
|
Podiatry Risk assessment and screening note |
|
83865-6
|
Podiatry Transfer summary note |
|
3903-2
|
Para hydroxyamphetamine [Mass/time] in 24 hour Urine |
|
20554-2
|
Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method |
|
3901-6
|
Para hydroxyamphetamine [Presence] in Urine |
|
19652-7
|
Para hydroxyamphetamine [Presence] in Urine by Confirmatory method |
|
19651-9
|
Para hydroxyamphetamine [Presence] in Urine by Screen method |
|
3902-4
|
Para hydroxyamphetamine [Mass/volume] in Urine |
|
92942-2
|
Poison control record Document |
|
7619-0
|
Poison ivy IgE Ab [Units/volume] in Serum |
|
48976-5
|
POLG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
11191-4
|
Pollock IgE Ab [Units/volume] in Serum |
|
17473-0
|
Polymyxin B [Mass/volume] in Serum or Plasma |
|
25269-2
|
Polymyxin B [Mass/volume] in Unspecified specimen |
|
53521-1
|
Polymorphonuclear cells [#/volume] in Semen |
|
76497-7
|
Polymorphonuclear cells [#] in Cerebral spinal fluid by Manual count |
|
75659-3
|
Polymorphonuclear cells [#] in Pericardial fluid by Manual count |
|
75661-9
|
Polymorphonuclear cells [#] in Pleural fluid by Manual count |
|
75660-1
|
Polymorphonuclear cells [#] in Peritoneal fluid by Manual count |
|
75662-7
|
Polymorphonuclear cells [#] in Synovial fluid by Manual count |
|
49787-5
|
Polymorphonuclear cells/100 leukocytes in Pericardial fluid |
|
49966-5
|
Polymorphonuclear cells/100 leukocytes in Pericardial fluid by Manual count |
|
90568-7
|
Polysomnography panel |
|
28633-6
|
Polysomnography (sleep) study |
|
33779-0
|
IgG+IgM+IgA heavy chain Ag [Presence] in Tissue by Immune stain |
|
12300-0
|
Polythiazide [Presence] in Urine |
|
88350-4
|
Polytrauma Case manager Note |
|
88351-2
|
Polytrauma Consult note |
|
88352-0
|
Polytrauma Education note |
|
88353-8
|
Polytrauma History and physical note |
|
88354-6
|
Polytrauma Note |
|
88355-3
|
Polytrauma Nurse Note |
|
88356-1
|
Polytrauma Telephone encounter Note |
|
21471-8
|
Pomegranate IgE Ab [Units/volume] in Serum |
|
81840-1
|
POMGNT1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
63414-7
|
Pompe disease newborn screening panel |
|
51757-3
|
POMT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
51758-1
|
POMT2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
78378-7
|
PON1 gene c.575A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
72492-2
|
Paraoxonase-arylesterase 1 (PON1) [Enzymatic activity/volume] in Serum |
|
7610-9
|
Pondorosa Pine IgE Ab [Units/volume] in Serum |
|
51900-9
|
Population Summary note |
|
7623-2
|
Poppy Seed IgE Ab [Units/volume] in Serum |
|
56362-7
|
Poppy Seed IgG4 Ab [Mass/volume] in Serum |
|
63115-0
|
Poppy Seed IgG Ab [Mass/volume] in Serum |
|
82285-8
|
Population RMR |
|
31570-5
|
Porcine influenza virus A Ab [Units/volume] in Serum |
|
42977-9
|
Porcine influenza virus A Ab [Titer] in Serum |
|
23768-5
|
Porcine influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition |
|
23769-3
|
Porcine influenza virus A Ag [Presence] in Tissue by Immune stain |
|
16103-4
|
Porcine Gelatin IgE Ab [Units/volume] in Serum |
|
7624-0
|
Pork triggered histamine release [Units/volume] in Blood |
|
6219-0
|
Pork IgE Ab [Units/volume] in Serum |
|
61347-1
|
Pork IgE Ab/IgE total in Serum |
|
6734-8
|
Pork IgG Ab [Units/volume] in Serum |
|
56442-7
|
Pork IgG4 Ab [Mass/volume] in Serum |
|
35543-8
|
Pork IgG Ab [Mass/volume] in Serum |
|
48212-5
|
Pork triggered leukotriene release [Mass/volume] by Leukocytes |
|
74910-1
|
Porphyrin fractions and creatinine panel [Molar ratio] - 24 hour Urine |
|
43116-3
|
Porphyrin fractions panel - 24 hour Urine |
|
58732-9
|
Porphyrin fractions panel [Mass/volume] - Serum or Plasma |
|
77009-9
|
Porphyrin fractions panel [Moles/volume] - Serum or Plasma |
|
74835-0
|
Porphyrin fractions panel - Stool |
|
74445-8
|
Porphyrin fractions panel [Moles/mass] - Stool |
|
93707-8
|
Porphyrin fractions panel - Urine |
|
56970-7
|
Porphyrins [Mass/volume] in 24 hour Urine |
|
50901-8
|
Porphyrins [Moles/volume] in 24 hour Urine |
|
40396-4
|
Porphyrins [Moles/time] in 24 hour Urine |
|
56554-9
|
Porphyrins [Mass/time] in 72 hour Stool |
|
17476-3
|
Porphyrins [Units/volume] in Red Blood Cells |
|
2814-2
|
Porphyrins [Mass/volume] in Red Blood Cells |
|
39784-4
|
Porphyrins [Moles/volume] in Red Blood Cells |
|
2815-9
|
Porphyrins [Mass/volume] in Serum or Plasma |
|
33311-2
|
Porphyrins [Moles/volume] in Serum or Plasma |
|
2816-7
|
Porphyrins [Presence] in Stool |
|
56512-7
|
Porphyrins [Mass/mass] in Stool |
|
39774-5
|
Porphyrins [Moles/mass] in Stool |
|
2818-3
|
Porphyrins [Presence] in Urine |
|
11225-0
|
Porphyrins [Mass/volume] in Urine |
|
39771-1
|
Porphyrins [Moles/volume] in Urine |
|
44353-1
|
Porphyrins/Creatinine [Mass Ratio] in 24 hour Urine |
|
38160-8
|
Porphyrins/Creatinine [Mass Ratio] in Urine |
|
57378-2
|
Porphyrins/Creatinine [Molar ratio] in Urine |
|
93037-0
|
Portable medical order form |
|
23773-5
|
Porcine rotavirus Ag [Presence] in Tissue by Immunofluorescence |
|
80545-7
|
Posaconazole [Mass/mass] in Hair |
|
54186-2
|
Posaconazole [Susceptibility] by Gradient strip |
|
54189-6
|
Posaconazole [Susceptibility] by Disk diffusion (KB) |
|
54187-0
|
Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
53731-6
|
Posaconazole [Mass/volume] in Serum or Plasma |
|
54188-8
|
Posaconazole [Susceptibility] |
|
84910-9
|
Positive Affect Survey - fixed length form - ages 13-17 [NIH Toolbox] |
|
84802-8
|
Positive Affect Survey - parent report - fixed length form - ages 3-12 [NIH Toolbox] |
|
84799-6
|
Positive Affect Survey - self report - CAT item bank - ages 18+ [NIH Toolbox] |
|
84800-2
|
Positive Affect Survey - self report - fixed length form - ages 18+ [NIH Toolbox] |
|
85135-2
|
Positive Affect Survey version 2.0 - fixed length form - ages 8-12 [NIH Toolbox] |
|
85115-4
|
Positive Affect Survey version 2.0 - parent report - CAT item bank - ages 3-7 [NIH Toolbox] |
|
84801-0
|
Positive Affect Survey version 2.0 - self report - CAT item bank - ages 13-17 [NIH Toolbox] |
|
85109-7
|
Positive Peer Interaction Survey version 2.0 - parent report - fixed length form - ages 3-12 [NIH Toolbox] |
|
45401-7
|
Postal code [Location] |
|
67860-7
|
Postoperative evaluation and management note |
|
6940-1
|
Potassium [Moles/time] in unspecified time Stool |
|
32550-6
|
Potassium [Molar amount] in Urine collected for unspecified duration |
|
35677-4
|
Potassium [Moles/volume] in Urine collected for unspecified duration |
|
57355-0
|
Potassium [Moles/volume] in 12 hour Urine |
|
57380-8
|
Potassium [Moles/time] in 12 hour Urine |
|
58996-0
|
Potassium [Moles/time] in 18 hour Urine |
|
53123-6
|
Potassium [Moles/time] in 1 hour Urine |
|
59162-8
|
Potassium [Moles/volume] in 24 hour Stool |
|
27441-5
|
Potassium [Moles/mass] in 24 hour Stool |
|
6792-6
|
Potassium [Moles/time] in 24 hour Stool |
|
51720-1
|
Potassium [Mass/time] in 24 hour Urine |
|
21476-7
|
Potassium [Moles/volume] in 24 hour Urine |
|
2829-0
|
Potassium [Moles/time] in 24 hour Urine |
|
57379-0
|
Potassium [Moles/volume] in 2 hour Urine |
|
18372-3
|
Potassium [Moles/time] in 6 hour Urine |
|
2826-6
|
Potassium [Moles/time] in 72 hour Stool |
|
49788-3
|
Potassium [Moles/volume] in Amniotic fluid |
|
32713-0
|
Potassium [Moles/volume] in Arterial blood |
|
39790-1
|
Potassium [Moles/volume] in Capillary blood |
|
75940-7
|
Potassium [Mass/volume] in Blood |
|
41656-0
|
Potassium [Moles/volume] in Mixed venous blood |
|
6298-4
|
Potassium [Moles/volume] in Blood |
|
39789-3
|
Potassium [Moles/volume] in Venous blood |
|
2830-8
|
Potassium renal clearance in 24 hour Urine and Serum or Plasma |
|
2819-1
|
Potassium [Moles/volume] in Cerebral spinal fluid |
|
39785-1
|
Potassium [Moles/volume] in Peritoneal dialysis fluid |
|
2820-9
|
Potassium [Moles/volume] in Dialysis fluid |
|
2821-7
|
Potassium [Moles/volume] in Body fluid |
|
2822-5
|
Potassium [Moles/volume] in Gastric fluid |
|
86919-8
|
Potassium goal [Moles/volume] Serum or Plasma |
|
79710-0
|
Potassium [Mass/mass] in Hair |
|
50902-6
|
Potassium [Moles/mass] in Hair |
|
17795-6
|
Potassium [Moles/volume] in Hyperal solution |
|
60218-5
|
Potassium [Moles/volume] in Mother's milk |
|
51618-7
|
Potassium [Moles/volume] in Serum or Plasma --pre dialysis |
|
49789-1
|
Potassium [Moles/volume] in Peritoneal fluid |
|
82722-0
|
Potassium [Mass/volume] in Red Blood Cells |
|
2824-1
|
Potassium [Moles/volume] in Red Blood Cells |
|
2825-8
|
Potassium [Moles/volume] in Saliva (oral fluid) |
|
77142-8
|
Potassium [Moles/volume] in Serum, Plasma or Blood |
|
22760-3
|
Potassium [Mass/volume] in Serum or Plasma |
|
42569-4
|
Potassium [Mass or Moles/volume] in Serum or Plasma |
|
2823-3
|
Potassium [Moles/volume] in Serum or Plasma |
|
14172-1
|
Potassium [Moles/volume] in Synovial fluid |
|
15202-5
|
Potassium [Moles/volume] in Stool |
|
25506-7
|
Potassium [Moles/mass] in Stool |
|
2827-4
|
Potassium [Moles/volume] in Sweat |
|
59733-6
|
Potassium [Mass/mass] in Tissue |
|
30549-0
|
Potassium [Moles/volume] in Total parental nutrition |
|
2828-2
|
Potassium [Moles/volume] in Urine |
|
12814-0
|
Potassium [Moles/volume] in Vitreous fluid |
|
9482-1
|
Potassium [Mass/volume] in Water |
|
32336-0
|
Potassium [Moles/volume] in Unspecified specimen |
|
13798-4
|
Potassium/Creatinine [Mass Ratio] in 24 hour Urine |
|
56143-1
|
Potassium/Creatinine [Molar ratio] in 24 hour Urine |
|
11148-4
|
Potassium/Creatinine [Mass Ratio] in Urine |
|
43222-9
|
Potassium/Creatinine [Ratio] in Urine |
|
33949-9
|
Potassium/Creatinine [Molar ratio] in Urine |
|
7626-5
|
Potato triggered histamine release [Units/volume] in Blood |
|
6220-8
|
Potato IgE Ab [Units/volume] in Serum |
|
7625-7
|
Potato IgG Ab [Units/volume] in Serum |
|
56429-4
|
Potato IgG4 Ab [Mass/volume] in Serum |
|
35544-6
|
Potato IgG Ab [Mass/volume] in Serum |
|
49873-3
|
POU3F4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
7631-5
|
Povertyweed IgE Ab [Units/volume] in Serum |
|
56364-3
|
Povertyweed IgG4 Ab [Mass/volume] in Serum |
|
64298-3
|
Power of attorney |
|
52055-1
|
Power operated vehicle attachment |
|
26646-0
|
Powassan virus Ab [Presence] in Serum |
|
74824-4
|
Powassan virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
42975-3
|
Powassan virus Ab [Titer] in Serum |
|
40504-3
|
Powassan virus Ab [Titer] in Serum by Complement fixation |
|
40513-4
|
Powassan virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
53384-4
|
Powassan virus Ab [Presence] in Unspecified specimen |
|
50037-1
|
Powassan virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
29842-2
|
Powassan virus IgG Ab [Presence] in Cerebral spinal fluid |
|
29804-2
|
Powassan virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
29854-7
|
Powassan virus IgG Ab [Presence] in Serum |
|
29817-4
|
Powassan virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
31573-9
|
Powassan virus IgG Ab [Units/volume] in Serum |
|
42974-6
|
Powassan virus IgG Ab [Titer] in Serum |
|
29564-2
|
Powassan virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
42973-8
|
Powassan virus IgG Ab [Titer] in Unspecified specimen |
|
30177-0
|
Powassan virus IgG Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
29830-7
|
Powassan virus IgG Ab [Presence] in Unspecified specimen |
|
29791-1
|
Powassan virus IgG Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
31574-7
|
Powassan virus IgG Ab [Units/volume] in Unspecified specimen |
|
29843-0
|
Powassan virus IgM Ab [Presence] in Cerebral spinal fluid |
|
29805-9
|
Powassan virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
29855-4
|
Powassan virus IgM Ab [Presence] in Serum |
|
29818-2
|
Powassan virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
31575-4
|
Powassan virus IgM Ab [Units/volume] in Serum |
|
42972-0
|
Powassan virus IgM Ab [Titer] in Serum |
|
29565-9
|
Powassan virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
42971-2
|
Powassan virus IgM Ab [Titer] in Unspecified specimen |
|
30179-6
|
Powassan virus IgM Ab [Titer] in Unspecified specimen by Immunofluorescence |
|
29831-5
|
Powassan virus IgM Ab [Presence] in Unspecified specimen |
|
29792-9
|
Powassan virus IgM Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
31576-2
|
Powassan virus IgM Ab [Units/volume] in Unspecified specimen |
|
47475-9
|
Powassan virus polyvalent E Ab [Presence] in Unspecified specimen |
|
43687-3
|
Powassan virus polyvalent E Ab [Presence] in Unspecified specimen by Immunoassay |
|
34456-4
|
Powassan virus RNA [Presence] in Blood by NAA with probe detection |
|
34457-2
|
Powassan virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
55144-0
|
Powassan virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
3966-9
|
Phenylpropanolamine [Mass/time] in 24 hour Urine |
|
14876-7
|
Phenylpropanolamine [Presence] in Gastric fluid |
|
26714-6
|
Phenylpropanolamine [Mass/mass] in Meconium |
|
26991-0
|
Phenylpropanolamine [Mass/volume] in Milk |
|
3963-6
|
Phenylpropanolamine [Presence] in Serum or Plasma |
|
29601-2
|
Phenylpropanolamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3964-4
|
Phenylpropanolamine [Mass/volume] in Serum or Plasma |
|
27442-3
|
Phenylpropanolamine [Mass/mass] in Stool |
|
3965-1
|
Phenylpropanolamine [Presence] in Urine |
|
17443-3
|
Phenylpropanolamine [Mass/volume] in Urine |
|
27251-8
|
Phenylpropanolamine [Mass/volume] in Vitreous fluid |
|
32333-7
|
Phenylpropanolamine [Presence] in Unspecified specimen |
|
57870-8
|
Phenylpropanolamine [Moles/volume] in Unspecified specimen |
|
61090-7
|
Alpha-Phenyl-2-Piperidine acetate [Presence] in Gastric fluid |
|
32153-9
|
Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Serum or Plasma |
|
72790-9
|
Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by Confirmatory method |
|
61058-4
|
Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine |
|
33507-5
|
Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine |
|
61059-2
|
Alpha-Phenyl-2-Piperidine acetate [Presence] in Unspecified specimen |
|
72791-7
|
Alpha-Phenyl-2-Piperidine acetate/Creatinine [Mass Ratio] in Urine |
|
38751-4
|
1,4-Benzenediamine [Mass/volume] in Air |
|
79472-7
|
Phenylpropionylglycine [Moles/volume] in Serum or Plasma |
|
32582-9
|
Phenylpropionylglycine [Presence] in Urine |
|
44350-7
|
Phenylpropionylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
50360-7
|
Phenylpropionylglycine/Creatinine [Molar ratio] in 24 hour Urine |
|
13793-5
|
Phenylpropionylglycine/Creatinine [Mass Ratio] in Urine |
|
24441-8
|
Phenylpropionylglycine/Creatinine [Molar ratio] in Urine |
|
87385-1
|
Porcine parainfluenza virus 1 F gene [Nucleotide sequence] in Isolate by Sequencing |
|
87384-4
|
Porcine parainfluenza virus 1 HN gene [Nucleotide sequence] in Isolate by Sequencing |
|
90330-2
|
Porcine parainfluenza virus 1 RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
87386-9
|
Porcine parainfluenza virus 1 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87387-7
|
Porcine parainfluenza virus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48267-9
|
Benzylpenicilloyl-polylysine triggered leukotriene release [Mass/volume] by Leukocytes |
|
80202-5
|
Clotting time of depleted plasma with 1:1 phospholipid by Coagulation assay --after addition of factor X activated |
|
23351-0
|
Peste des petits ruminants virus Ab [Presence] in Serum |
|
23354-4
|
Peste des petits ruminants virus Ab [Presence] in Serum by Immunoassay |
|
31560-6
|
Peste des petits ruminants virus Ab [Units/volume] in Serum |
|
23350-2
|
Peste des petits ruminants virus Ab [Titer] in Serum |
|
23352-8
|
Peste des petits ruminants virus Ab [Titer] in Serum by Neutralization test |
|
23355-1
|
Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoassay |
|
23357-7
|
Peste des petits ruminants virus Ag [Presence] in Tissue by Immune diffusion (ID) |
|
23356-9
|
Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoelectrophoresis |
|
34887-0
|
Peste des petits ruminants virus Ag [Presence] in Tissue by Immunofluorescence |
|
23359-3
|
Peste des petits ruminants virus RNA [Presence] in Tissue by NAA with probe detection |
|
23358-5
|
Peste des petits ruminants virus RNA [Presence] in Tissue by Probe |
|
59246-9
|
Palmitoyl protein thioesterase [Enzymatic activity/volume] in DBS |
|
74365-8
|
Palmitoyl protein thioesterase [Enzymatic activity/mass] in Fibroblast |
|
34587-6
|
Palmitoyl protein thioesterase [Enzymatic activity/volume] in Serum or Plasma |
|
74935-8
|
Palmitoyl protein thioesterase [Enzymatic activity/mass] in Leukocytes |
|
93703-7
|
Palmitoyl protein thioesterase 1 and Tripeptidyl peptidase 1 panel - Fibroblast |
|
93704-5
|
Palmitoyl protein thioesterase 1 and Tripeptidyl peptidase 1 panel - Leukocytes |
|
41069-6
|
PPT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34647-8
|
PPT1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
86736-6
|
Porcine parvovirus type 1 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86741-6
|
Porcine parvovirus type 2 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
23366-8
|
Porcine parvovirus Ab [Presence] in Serum |
|
23365-0
|
Porcine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition |
|
31571-3
|
Porcine parvovirus Ab [Units/volume] in Serum |
|
23770-1
|
Porcine parvovirus Ab [Titer] in Serum |
|
86734-1
|
Porcine parvovirus Ab [Titer] in Serum by Hemagglutination inhibition |
|
23771-9
|
Porcine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
|
86735-8
|
Porcine parvovirus DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86733-3
|
Porcine parvovirus [Presence] in Unspecified specimen by Organism specific culture |
|
40557-1
|
Progesterone receptor Ag [Presence] in Tissue by Immune stain |
|
10861-3
|
Progesterone receptor [Mass/mass] in Tissue |
|
31207-4
|
Progesterone receptor [Moles/mass] in Tissue |
|
14230-7
|
Cells.progesterone receptor/100 cells in Tissue by Immune stain |
|
76148-6
|
Pradofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87800-9
|
Pradofloxacin [Susceptibility] |
|
3976-8
|
Practolol [Mass/volume] in Urine |
|
73199-2
|
Pravastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73198-4
|
Pravastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3977-6
|
Prazepam [Mass/volume] in Serum or Plasma |
|
48356-0
|
Prazepam [Moles/volume] in Serum or Plasma |
|
17479-7
|
Prazepam [Mass/volume] in Urine by Confirmatory method |
|
19679-0
|
Prazepam [Presence] in Urine by Confirmatory method |
|
19678-2
|
Prazepam [Presence] in Urine by Screen method |
|
12311-7
|
Prazepam [Mass/volume] in Urine |
|
14191-1
|
Prazosin [Mass/volume] in Serum or Plasma |
|
23372-6
|
Porcine respiratory coronavirus Ab [Presence] in Serum |
|
23374-2
|
Porcine respiratory coronavirus Ab [Presence] in Serum by Immunoassay |
|
23373-4
|
Porcine respiratory coronavirus Ab [Presence] in Serum by Neutralization test |
|
23377-5
|
Porcine respiratory coronavirus Ag [Presence] in Small intestine Tissue by Immune stain |
|
23376-7
|
Porcine respiratory coronavirus Ag [Presence] in Unspecified specimen by Immune stain |
|
23378-3
|
Porcine respiratory coronavirus RNA [Presence] in Unspecified specimen by Probe |
|
53229-1
|
Prealbumin [Mass/time] in 24 hour Urine |
|
33467-2
|
Prealbumin [Mass/volume] in Cord blood |
|
6793-4
|
Prealbumin [Mass/volume] in Serum or Plasma by Immunoassay |
|
46130-1
|
Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry |
|
14338-8
|
Prealbumin [Mass/volume] in Serum or Plasma |
|
77192-3
|
Prealbumin [Moles/volume] in Serum or Plasma |
|
82286-6
|
Predicted RMR |
|
12727-4
|
Prednisolone [Mass/volume] in Serum or Plasma |
|
46955-1
|
Prednisolone [Mass/volume] in Urine |
|
18252-7
|
Prednisone [Mass/time] in 24 hour Urine |
|
73197-6
|
Prednisone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73196-8
|
Prednisone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
49709-9
|
Prednisone [Presence] in Serum or Plasma |
|
12434-7
|
Prednisone [Mass/volume] in Serum or Plasma |
|
55570-6
|
Prednisone [Moles/volume] in Serum or Plasma |
|
46956-9
|
Prednisone [Mass/volume] in Urine |
|
46054-3
|
Preferred activity settings Set |
|
93186-5
|
Preferred language and interpreter need |
|
54899-0
|
Preferred language |
|
46056-8
|
Prefers change in daily routine Set |
|
13894-1
|
Pregnenolone [Mass/time] in 24 hour Urine |
|
2837-3
|
Pregnenolone [Mass/volume] in Serum or Plasma |
|
25507-5
|
Pregnenolone [Moles/volume] in Serum or Plasma |
|
2831-6
|
Pregnancy specific protein 1 [Mass/volume] in Serum |
|
17480-5
|
Pregnenolone [Mass/volume] in Urine |
|
47414-8
|
Pregabalin [Mass/volume] in Serum or Plasma |
|
48349-5
|
Pregabalin [Moles/volume] in Serum or Plasma |
|
64125-8
|
Pregabalin [Mass/volume] in Urine by Confirmatory method |
|
92651-9
|
Pregabalin [Presence] in Urine by Confirmatory method |
|
64137-3
|
Pregabalin [Presence] in Urine by Screen method |
|
64136-5
|
Pregabalin/Creatinine [Mass Ratio] in Urine |
|
87764-7
|
Pregabalin/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
90767-5
|
Pregnancy summary Document |
|
2834-0
|
Pregnanediol [Mass/time] in 24 hour Urine |
|
34358-2
|
Pregnanediol [Moles/volume] in 24 hour Urine |
|
14885-8
|
Pregnanediol [Moles/time] in 24 hour Urine |
|
2832-4
|
Pregnanediol [Mass/volume] in Amniotic fluid |
|
2833-2
|
Pregnanediol [Mass/volume] in Urine |
|
15091-2
|
Pregnanediol [Moles/volume] in Urine |
|
34359-0
|
Pregnanediol/Creatinine [Molar ratio] in Urine |
|
82895-4
|
Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82894-7
|
Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
83131-3
|
Pregnanolone [Moles/time] in 24 hour Urine |
|
83132-1
|
Pregnanolone [Moles/volume] in Urine |
|
2836-5
|
Pregnanetriol [Mass/time] in 24 hour Urine |
|
34360-8
|
Pregnanetriol [Moles/volume] in 24 hour Urine |
|
14886-6
|
Pregnanetriol [Moles/time] in 24 hour Urine |
|
2835-7
|
Pregnanetriol [Mass/volume] in Urine |
|
15092-0
|
Pregnanetriol [Moles/volume] in Urine |
|
39566-5
|
Pregnanetriol/Creatinine [Mass Ratio] in 24 hour Urine |
|
30512-8
|
Pregnanetriol/Creatinine [Mass Ratio] in Urine |
|
34361-6
|
Pregnanetriol/Creatinine [Molar ratio] in Urine |
|
82898-8
|
Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82899-6
|
Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
50643-6
|
Pregnanetriolone [Mass/time] in 24 hour Urine |
|
34362-4
|
Pregnanetriolone [Moles/volume] in 24 hour Urine |
|
25732-9
|
Pregnanetriolone [Moles/time] in 24 hour Urine |
|
34363-2
|
Pregnanetriolone [Moles/volume] in Urine |
|
30513-6
|
Pregnanetriolone/Creatinine [Mass Ratio] in Urine |
|
34364-0
|
Pregnanetriolone/Creatinine [Molar ratio] in Urine |
|
82901-0
|
Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82900-2
|
Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
74207-2
|
Prehospital summary Document |
|
76517-2
|
Premature infant |
|
81679-3
|
Preoperative measures for patient safety panel |
|
67862-3
|
Preoperative evaluation and management note |
|
64288-4
|
Prescription for eyewear |
|
57828-6
|
Prescription list |
|
76003-3
|
Pressure Respiratory system airway --during inspiration on ventilator |
|
75942-3
|
Airway pressure --during inspiration |
|
75943-1
|
Airway pressure --during respiratory pause |
|
76268-2
|
Pressure.ambient Room |
|
76169-2
|
Pressure.baseline Respiratory system airway --on ventilator |
|
91150-3
|
Pressure injury stage NPUAP |
|
60952-9
|
Mean airway pressure --during inspiration |
|
90982-0
|
Pressure Ulcer Scale for Healing (PUSH) Tool 3.0 [PUSH] |
|
72527-5
|
Pressure ulcer stage NPUAP |
|
93850-6
|
Pretomanid [Susceptibility] |
|
75460-6
|
Preventive medicine Nurse Note |
|
83867-2
|
Preventive medicine Annual evaluation note |
|
83868-0
|
Preventive medicine Consult note |
|
83869-8
|
Preventive medicine Counseling note |
|
75481-2
|
Preventive medicine Education note |
|
89432-9
|
Preventive medicine Group counseling note |
|
75482-0
|
Preventive medicine Note |
|
75483-8
|
Preventive medicine Outpatient Note |
|
75484-6
|
Preventive medicine Risk assessment and screening note |
|
41067-0
|
PRF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal |
|
34493-7
|
PRF1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method |
|
41068-8
|
PRF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34491-1
|
PRF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
34668-4
|
Prilocaine [Mass/volume] in Serum or Plasma |
|
55571-4
|
Prilocaine [Moles/volume] in Serum or Plasma |
|
93780-5
|
Primary mediastinal large B-cell lymphoma [Likelihood] in Tissue |
|
75485-3
|
Primary care Administrative note |
|
83870-6
|
Primary care Admission evaluation note |
|
83871-4
|
Primary care Annual evaluation note |
|
83706-2
|
Primary care Attending Initial evaluation note |
|
75473-9
|
Primary care Attending Note |
|
83703-9
|
Primary care Attending Patient's home Note |
|
83872-2
|
Primary care Case manager Note |
|
83873-0
|
Primary care Consult note |
|
83874-8
|
Primary care Custodial care facility Note |
|
68831-7
|
Primary care Discharge summary |
|
75486-1
|
Primary care Education note |
|
78624-4
|
Primary care Flowsheet |
|
89434-5
|
Primary care Group counseling note |
|
68833-3
|
Primary care History and physical note |
|
68837-4
|
Primary care Hospital Consult note |
|
68838-2
|
Primary care Hospital Letter |
|
87272-1
|
Primary care Immunization note |
|
83875-5
|
Primary care Initial evaluation note |
|
75487-9
|
Primary care Letter |
|
83786-4
|
Primary care Physician History and physical note |
|
75479-6
|
Primary care Physician Note |
|
75488-7
|
Primary care Medication management note |
|
68834-1
|
Primary care Note |
|
83560-3
|
Primary care Nurse practitioner Note |
|
75461-4
|
Primary care Nurse Note |
|
83625-4
|
Primary care Nurse Patient's home Note |
|
83642-9
|
Primary care Nurse Triage note |
|
83749-2
|
Primary care Physician assistant Note |
|
75489-5
|
Primary care Telephone encounter Note |
|
80777-6
|
Primary care Plan of care note |
|
68835-8
|
Primary care Preoperative evaluation and management note |
|
68836-6
|
Primary care procedure note |
|
88692-9
|
Primary care Patient's home Admission evaluation note |
|
84130-4
|
Primary care Patient's home Annual evaluation note |
|
84131-2
|
Primary care Patient's home Consult note |
|
84132-0
|
Primary care Patient's home Discharge summary |
|
84133-8
|
Primary care Patient's home Medication management note |
|
84134-6
|
Primary care Patient's home Note |
|
84136-1
|
Primary care Patient's home Plan of care note |
|
78671-5
|
Primary care Referral note |
|
83772-4
|
Primary care Resident Note |
|
83876-3
|
Primary care Risk assessment and screening note |
|
90759-2
|
Primary care Social worker Note |
|
75495-2
|
Primary care Team Note |
|
83877-1
|
Primary care Triage note |
|
83878-9
|
Primary care Urgent care center Note |
|
91704-7
|
Primary contact information panel Facility |
|
86255-7
|
Primary diagnosis ICD code |
|
78436-3
|
Primidone and PHENobarbital trough panel - Serum or Plasma |
|
29225-0
|
Primidone [Mass/volume] in Body fluid |
|
47125-0
|
Primidone [Moles/volume] in Gastric fluid |
|
73195-0
|
Primidone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73194-3
|
Primidone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3978-4
|
Primidone [Mass/volume] in Serum or Plasma |
|
14887-4
|
Primidone [Moles/volume] in Serum or Plasma |
|
74912-7
|
Primidone [Mass/volume] in Serum or Plasma --trough |
|
12387-7
|
Primidone [Mass/volume] in Urine |
|
87767-0
|
Primidone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
10547-8
|
Primidone+PHENobarbital [Mass/volume] in Serum or Plasma |
|
34365-7
|
Primidone+PHENobarbital [Moles/volume] in Serum or Plasma |
|
6221-6
|
Primrose IgE Ab [Units/volume] in Serum |
|
52539-4
|
Prior postal code [Location] |
|
7632-3
|
Privet IgE Ab [Units/volume] in Serum |
|
7633-1
|
Privet IgG Ab [Units/volume] in Serum |
|
63204-2
|
Privet IgG Ab [Mass/volume] in Serum |
|
50682-4
|
PRKCG gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
81869-0
|
PRNP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
81868-2
|
PRNP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
57309-7
|
PRNP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
27824-2
|
Prothrombin Fragment 1.2 Ag [Moles/volume] in Serum or Plasma by Immunoassay |
|
5900-6
|
Prothrombin Fragment 1.2 [Units/volume] in Serum or Plasma |
|
25742-8
|
Prothrombin Fragment 1.2 [Moles/volume] in Serum or Plasma |
|
3981-8
|
Probenecid [Mass/time] in 24 hour Urine |
|
27100-7
|
Probenecid [Mass/volume] in Serum or Plasma |
|
3979-2
|
Probenecid [Presence] in Urine |
|
17481-3
|
Probenecid [Units/volume] in Urine |
|
3980-0
|
Probenecid [Mass/volume] in Urine |
|
46105-3
|
Problem conditions Set |
|
93815-9
|
PROC gene full mutation analysis in Blood or Tissue by Sequencing |
|
88699-4
|
Procainamide and N-acetylprocainamide panel - Serum or Plasma |
|
17805-3
|
Procainamide [Mass/volume] in Body fluid |
|
73193-5
|
Procainamide induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73192-7
|
Procainamide induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3982-6
|
Procainamide [Mass/volume] in Serum or Plasma |
|
14888-2
|
Procainamide [Moles/volume] in Serum or Plasma |
|
72657-0
|
Procainamide [Mass/volume] in Serum or Plasma --trough |
|
17482-1
|
Procainamide [Mass/volume] in Urine |
|
3983-4
|
Procainamide+N-acetylprocainamide [Mass/volume] in Serum or Plasma |
|
14889-0
|
Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma |
|
9700-6
|
Procaine [Mass/volume] in Serum or Plasma |
|
55572-2
|
Procaine [Moles/volume] in Serum or Plasma |
|
12301-8
|
Procaine [Presence] in Urine |
|
75241-0
|
Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay |
|
33959-8
|
Procalcitonin [Mass/volume] in Serum or Plasma |
|
64293-4
|
Procedure consent Document |
|
28570-0
|
Procedure note |
|
75768-2
|
Prochlorperazine [Presence] in Blood or Urine by Screen method |
|
61105-3
|
Prochlorperazine [Moles/volume] in Gastric fluid |
|
26830-0
|
Prochlorperazine [Presence] in Serum or Plasma |
|
3509-7
|
Prochlorperazine [Mass/volume] in Serum or Plasma |
|
39470-0
|
Prochlorperazine [Moles/volume] in Serum or Plasma |
|
3510-5
|
Prochlorperazine [Presence] in Urine |
|
61103-8
|
Prochlorperazine [Moles/volume] in Urine |
|
61104-6
|
Prochlorperazine [Moles/volume] in Unspecified specimen |
|
10337-4
|
Procollagen type I [Mass/volume] in Serum |
|
25733-7
|
Procollagen type III [Units/volume] in Serum |
|
56627-3
|
Procollagen type III [Mass/volume] in Serum |
|
57756-9
|
Procollagen type III.N-terminal propeptide [Units/volume] in Serum |
|
71792-6
|
Procollagen type III.N-terminal propeptide [Mass/volume] in Serum |
|
47728-1
|
Procollagen type III/Creatinine [Ratio] in Urine |
|
35573-5
|
Procollagen+Collagen [Identifier] in Fibroblast by Electrophoresis |
|
92993-5
|
PROCR gene full mutation analysis in Blood or Tissue by Sequencing |
|
9387-2
|
Procyclidine [Mass/volume] in Serum or Plasma |
|
32110-9
|
Procyclidine [Moles/volume] in Serum or Plasma |
|
12290-3
|
Procyclidine [Presence] in Urine |
|
27103-1
|
Procyclidine [Mass/volume] in Urine |
|
12820-7
|
Progesterone [Mass/volume] in 24 hour Urine |
|
14173-9
|
Progesterone Free [Mass/time] in 24 hour Urine |
|
72889-9
|
Progesterone Free [Mass/volume] in Serum or Plasma |
|
72890-7
|
Progesterone Free/Progesterone.total in Serum or Plasma |
|
2838-1
|
Progesterone [Mass/volume] in Saliva (oral fluid) |
|
24109-1
|
Progesterone [Moles/volume] in Saliva (oral fluid) |
|
83109-9
|
Progesterone [Mass/volume] in Serum or Plasma by Immunoassay |
|
83110-7
|
Progesterone [Moles/volume] in Serum or Plasma by Immunoassay |
|
2839-9
|
Progesterone [Mass/volume] in Serum or Plasma |
|
35223-7
|
Progesterone [Mass or Moles/volume] in Serum or Plasma |
|
14890-8
|
Progesterone [Moles/volume] in Serum or Plasma |
|
17483-9
|
Progesterone [Mass/volume] in Urine |
|
46063-4
|
Programs Set |
|
68607-1
|
Progress letter |
|
11506-3
|
Progress note |
|
48497-2
|
Pro-hepcidin [Mass/volume] in Serum or Plasma |
|
10451-3
|
Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |
|
2840-7
|
Proinsulin [Mass/volume] in Serum or Plasma |
|
27882-0
|
Proinsulin [Moles/volume] in Serum or Plasma |
|
45338-1
|
Proinsulin/Insulin [Ratio] in Serum or Plasma |
|
80893-1
|
Projected heparin concentration to reach target ACT [Units/volume] in Blood by calculation |
|
21380-1
|
Prolactin [Mass/time] in 24 hour Urine |
|
10507-2
|
Prolactin Ag [Presence] in Tissue by Immune stain |
|
78993-3
|
Prolactin isoforms panel - Serum or Plasma |
|
20434-7
|
Prolactin [Units/volume] in Serum or Plasma by 3rd IS |
|
49220-7
|
Prolactin [Mass/volume] in Serum or Plasma by 3rd IS |
|
83111-5
|
Prolactin [Units/volume] in Serum or Plasma by Immunoassay |
|
20568-2
|
Prolactin [Mass/volume] in Serum or Plasma by Immunoassay |
|
15081-3
|
Prolactin [Units/volume] in Serum or Plasma |
|
2842-3
|
Prolactin [Mass/volume] in Serum or Plasma |
|
2841-5
|
Prolactin [Mass/volume] in Semen |
|
42607-2
|
Prolactin monomeric [Mass/volume] in Serum or Plasma |
|
50366-4
|
Prolactin monomeric/Prolactin.total in Serum or Plasma |
|
47732-3
|
Proline [Moles/volume] in DBS |
|
47734-9
|
Proline/Amino acids.total in Amniotic fluid |
|
47736-4
|
Proline/Amino acids.total in DBS |
|
47733-1
|
Proline/Amino acids.total in Hair |
|
47735-6
|
Proline/Amino acids.total in Serum or Plasma |
|
47737-2
|
Proline/Amino acids.total in Unspecified specimen |
|
44398-6
|
Proline/Creatinine [Mass Ratio] in 24 hour Urine |
|
3986-7
|
Prolintane [Mass/time] in 24 hour Urine |
|
3984-2
|
Prolintane [Presence] in Urine |
|
3985-9
|
Prolintane [Mass/volume] in Urine |
|
75769-0
|
Promazine [Presence] in Blood or Urine by Screen method |
|
59959-7
|
Promazine [Moles/volume] in Gastric fluid |
|
13578-0
|
Promazine [Presence] in Serum or Plasma |
|
12411-5
|
Promazine [Mass/volume] in Serum or Plasma |
|
59957-1
|
Promazine [Moles/volume] in Serum or Plasma |
|
74819-4
|
Promazine [Presence] in Urine by Screen method |
|
3987-5
|
Promazine [Mass/volume] in Urine |
|
59958-9
|
Promazine [Moles/volume] in Urine |
|
60329-0
|
Promazine [Moles/volume] in Unspecified specimen |
|
75346-7
|
Promethazine [Mass/volume] in Blood by Confirmatory method |
|
75813-6
|
Promethazine [Presence] in Blood or Urine by Screen method |
|
75270-9
|
Promethazine [Presence] in Serum or Plasma or Urine by Screen method |
|
26736-9
|
Promethazine [Presence] in Serum or Plasma |
|
3988-3
|
Promethazine [Mass/volume] in Serum or Plasma |
|
55573-0
|
Promethazine [Moles/volume] in Serum or Plasma |
|
11000-7
|
Promethazine [Presence] in Urine |
|
3989-1
|
Promethazine [Mass/volume] in Urine |
|
89679-5
|
PROMIS cancer item bank - emotional distress - anxiety - version 1.0 |
|
89670-4
|
PROMIS cancer item bank - emotional distress - depression - version 1.0 |
|
89677-9
|
PROMIS cancer item bank - fatigue - version 1.0 |
|
89674-6
|
PROMIS cancer item bank - pain interference - version 1.1 |
|
89689-4
|
PROMIS cancer item bank - physical function - version 1.1 |
|
76787-1
|
PROMIS item bank - ability to participate in social roles and activities - version 2.0 |
|
76899-4
|
PROMIS item bank - alcohol - alcohol use - version 1.0 |
|
76938-0
|
PROMIS item bank - alcohol - negative consequences - version 1.0 |
|
76940-6
|
PROMIS item bank - alcohol - negative expectancies - version 1.0 |
|
76889-5
|
PROMIS item bank - alcohol - positive expectancies - version 1.0 |
|
76939-8
|
PROMIS item bank - alcohol - positive outcomes - version 1.0 |
|
89920-3
|
PROMIS item bank - anger - version 1.1 |
|
90761-8
|
PROMIS item bank - applied cognitive - general concerns - version 1.0 |
|
81492-1
|
PROMIS item bank - cognitive function - abilities subset - version 2.0 |
|
81524-1
|
PROMIS item bank - cognitive function - version 2.0 |
|
76788-9
|
PROMIS item bank - companionship - version 2.0 |
|
90409-4
|
PROMIS item bank - dyspnea functional limitations - version 1.0 |
|
92148-6
|
PROMIS item bank - dyspnea severity - version 1.0 |
|
76789-7
|
PROMIS item bank - emotional support - version 2.0 |
|
76790-5
|
PROMIS item bank - informational support - version 2.0 |
|
76791-3
|
PROMIS item bank - instrumental support - version 2.0 |
|
91613-0
|
PROMIS item bank - mobility - version 2.0 |
|
89923-7
|
PROMIS item bank - pain interference - version 1.1 |
|
91722-9
|
PROMIS item bank - physical function - version 2.0 |
|
79062-6
|
PROMIS item bank - physical function w mobility aids - version 1.0 |
|
76774-9
|
PROMIS item bank - satisfaction with social roles and activities - version 2.0 |
|
92392-0
|
PROMIS item bank - self-efficacy for managing daily activities - version 1.0 |
|
92330-0
|
PROMIS item bank - self-efficacy for managing emotions - version 1.0 |
|
92419-1
|
PROMIS item bank - self-efficacy for managing medications and treatments - version 1.0 |
|
92394-6
|
PROMIS item bank - self-efficacy for managing social interactions - version 1.0 |
|
92449-8
|
PROMIS item bank - self-efficacy for managing symptoms - version 1.0 |
|
92214-6
|
PROMIS item bank - smoking - coping expectancies for all smokers - version 1.0 |
|
92297-1
|
PROMIS item bank - smoking - negative psychosocial expectancies for all smokers - version 1.0 |
|
92306-0
|
PROMIS item bank - smoking - nicotine dependence for all smokers - version v1.0 |
|
92324-3
|
PROMIS item bank - smoking - social motivations for all smokers - version 1.0 |
|
76806-9
|
PROMIS item bank - social isolation - version 2.0 |
|
91611-4
|
PROMIS item bank - upper extremity - version 2.0 |
|
91988-6
|
PROMIS parent proxy item bank - anxiety - version 2.0 |
|
91426-7
|
PROMIS parent proxy item bank - asthma impact - version 2.0 |
|
90170-2
|
PROMIS parent proxy item bank - cognitive function - version 1.0 |
|
91407-7
|
PROMIS parent proxy item bank - depressive symptoms - version 2.0 |
|
91933-2
|
PROMIS parent proxy item bank - fatigue version 2.0 |
|
90615-6
|
PROMIS parent proxy item bank - life satisfaction - version 1.0 |
|
92080-1
|
PROMIS parent proxy item bank - meaning purpose - version 1.0 |
|
90704-8
|
PROMIS parent proxy item bank - mobility - version 2.0 |
|
91204-8
|
PROMIS parent proxy item bank - pain behavior - version 1.0 |
|
89949-2
|
PROMIS parent proxy item bank - pain interference - version 2.0 |
|
90679-2
|
PROMIS parent proxy item bank - peer relationships - version 2.0 |
|
91215-4
|
PROMIS parent proxy item bank - physical activity - version 1.0 |
|
92077-7
|
PROMIS parent proxy item bank - physical stress experiences - version 1.0 |
|
91307-9
|
PROMIS parent proxy item bank - positive affect - version 1.0 |
|
91367-3
|
PROMIS parent proxy item bank - psychological stress experiences - version 1.0 |
|
91338-4
|
PROMIS parent proxy item bank - strength impact - version 1.0 |
|
92586-7
|
PROMIS parent proxy short form - anxiety 8a - version 2.0 |
|
90934-1
|
PROMIS parent proxy short form - cognitive function 7a - version 1.0 |
|
92587-5
|
PROMIS parent proxy short form - fatigue 10a - version 2.0 |
|
90936-6
|
PROMIS parent proxy short form - life satisfaction 4a - version 1.0 |
|
90938-2
|
PROMIS parent proxy short form - life satisfaction 8a - version 1.0 |
|
92583-4
|
PROMIS parent proxy short form - meaning and purpose 4a - version 1.0 |
|
92582-6
|
PROMIS parent proxy short form - meaning and purpose 8a - version 1.0 |
|
90940-8
|
PROMIS parent proxy short form - mobility 8a - version 2.0 |
|
90942-4
|
PROMIS parent proxy short form - pain interference 8a - version 2.0 |
|
90944-0
|
PROMIS parent proxy short form - peer relationship 7a - version 2.0 |
|
92585-9
|
PROMIS parent proxy short form - physical stress experiences 4a - version 1.0 |
|
92584-2
|
PROMIS parent proxy short form - physical stress experiences 8a - version 1.0 |
|
91540-5
|
PROMIS pediatric item bank - anxiety - version 2.0 |
|
91538-9
|
PROMIS pediatric item bank - asthma impact - version 2.0 |
|
90217-1
|
PROMIS pediatric item bank - cognitive function - version 1.0 |
|
91536-3
|
PROMIS pediatric item bank - depressive symptoms - version 2.0 |
|
91534-8
|
PROMIS pediatric item bank - fatigue - version 2.0 |
|
90616-4
|
PROMIS pediatric item bank - life satisfaction - version 1.0 |
|
91454-9
|
PROMIS pediatric item bank - meaning and purpose - version 1.0 |
|
90883-0
|
PROMIS pediatric item bank - mobility - version 2.0 |
|
91936-5
|
PROMIS pediatric item bank - pain behavior - version 1.0 |
|
89935-1
|
PROMIS pediatric item bank - pain interference - version 2.0 |
|
90706-3
|
PROMIS pediatric item bank - peer relationships - version 2.0 |
|
91228-7
|
PROMIS pediatric item bank - physical activity - version 1.0 |
|
78161-7
|
PROMIS pediatric item bank - physical function - upper extremity - version 2.0 |
|
91452-3
|
PROMIS pediatric item bank - physical stress experiences - version 1.0 |
|
91355-8
|
PROMIS pediatric item bank - positive affect - version 1.0 |
|
91324-4
|
PROMIS pediatric item bank - psychological stress experiences - version 1.0 |
|
91512-4
|
PROMIS pediatric item bank - strength impact - version 1.0 |
|
90933-3
|
PROMIS pediatric short form - cognitive function 7a - version 1.0 |
|
90949-9
|
PROMIS pediatric short form - depressive symptoms 8a - version 2.0 |
|
77875-3
|
PROMIS pediatric short form - emotional distress - anxiety 8b - version 1.1 |
|
90951-5
|
PROMIS pediatric short form - life satisfaction 4a - version 1.0 |
|
90953-1
|
PROMIS pediatric short form - life satisfaction 8a - version 1.0 |
|
90955-6
|
PROMIS pediatric short form - mobility 8a - version 2.0 |
|
92581-8
|
PROMIS pediatric short form - pain behavior 8a - version 1.0 |
|
90957-2
|
PROMIS pediatric short form - pain interference 8a - version 2.0 |
|
90959-8
|
PROMIS pediatric short form - peer relationships 8a - version 2.0 |
|
76731-9
|
PROMIS short form - ability to participate in social roles and activities 8a - version 2.0 |
|
77003-2
|
PROMIS short form - alcohol - alcohol use 7a - version 1.0 |
|
77004-0
|
PROMIS short form - alcohol - negative consequences 7a - version 1.0 |
|
77005-7
|
PROMIS short form - alcohol - negative expectancies 7a - version 1.0 |
|
77007-3
|
PROMIS short form - alcohol - positive consequences 7a - version 1.0 |
|
77006-5
|
PROMIS short form - alcohol - positive expectancies 7a - version 1.0 |
|
90961-4
|
PROMIS short form - applied cognition - general concerns 4a - version 1.0 |
|
90963-0
|
PROMIS short form - applied cognition - general concerns 6a - version 1.0 |
|
90965-5
|
PROMIS short form - applied cognition - general concerns 8a - version 1.0 |
|
81525-8
|
PROMIS short form - cognitive function - abilities subset 4a - version 2.0 |
|
81526-6
|
PROMIS short form - cognitive function - abilities subset 6a - version 2.0 |
|
81527-4
|
PROMIS short form - cognitive function - abilities subset 8a - version 2.0 |
|
81528-2
|
PROMIS short form - cognitive function 4a - version 2.0 |
|
81529-0
|
PROMIS short form - cognitive function 6a - version 2.0 |
|
81530-8
|
PROMIS short form - cognitive function 8a - version 2.0 |
|
76732-7
|
PROMIS short form - companionship 4a - version 2.0 |
|
76733-5
|
PROMIS short form - companionship 6a - version 2.0 |
|
90967-1
|
PROMIS short form - dyspnea functional limitations 10a - version 1.0 |
|
92578-4
|
PROMIS short form - dyspnea severity 10a - version 1.0 |
|
90969-7
|
PROMIS short form - emotional distress - anger 5a - version 1.1 |
|
76735-0
|
PROMIS short form - emotional support 4a - version 2.0 |
|
76734-3
|
PROMIS short form - emotional support 6a - version 2.0 |
|
76736-8
|
PROMIS short form - emotional support 8a - version 2.0 |
|
85524-7
|
PROMIS short form - global - version 1.2 |
|
85523-9
|
PROMIS short form - global - version 1.2 raw score |
|
76792-1
|
PROMIS short form - informational support 4a - version 2.0 |
|
76793-9
|
PROMIS short form - informational support 6a - version 2.0 |
|
76794-7
|
PROMIS short form - informational support 8a - version 2.0 |
|
76795-4
|
PROMIS short form - instrumental support 4a - version 2.0 |
|
76796-2
|
PROMIS short form - instrumental support 6a - version 2.0 |
|
76797-0
|
PROMIS short form - instrumental support 8a - version 2.0 |
|
75259-2
|
PROMIS short form - pain intensity 3a - version 1.0 |
|
90971-3
|
PROMIS short form - pain interference 4a - version 1.0 |
|
90973-9
|
PROMIS short form - pain interference 6a - version 1.0 |
|
75870-6
|
PROMIS short form - pain interference 8a - version 1.0 |
|
92580-0
|
PROMIS short form - physical function 10a - version 2.0 |
|
92579-2
|
PROMIS short form - physical function 10b - version 2.0 |
|
76702-0
|
PROMIS short form - physical function 20a - version 1.0 |
|
76700-4
|
PROMIS short form - physical function 4a - version 1.0 |
|
76804-4
|
PROMIS short form - physical function 6b - version 1.2 |
|
76805-1
|
PROMIS short form - physical function 8b - version 1.2 |
|
79063-4
|
PROMIS short form - physical function w mobility aids - version 1.0 |
|
76704-6
|
PROMIS short form - satisfaction with participation in social roles 4a - version 1.0 |
|
76701-2
|
PROMIS short form - satisfaction with participation in social roles 8a - version 1.0 |
|
76798-8
|
PROMIS short form - satisfaction with social roles and activities 4a - version 2.0 |
|
76799-6
|
PROMIS short form - satisfaction with social roles and activities 6a - version 2.0 |
|
76800-2
|
PROMIS short form - satisfaction with social roles and activities 8a - version 2.0 |
|
92597-4
|
PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 |
|
92596-6
|
PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 |
|
92595-8
|
PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 |
|
92594-1
|
PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 |
|
92593-3
|
PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 |
|
92592-5
|
PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 |
|
92591-7
|
PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 |
|
92590-9
|
PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 |
|
92589-1
|
PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 |
|
92588-3
|
PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 |
|
75258-4
|
PROMIS short form - sleep disturbance 4a - version 1.0 |
|
76703-8
|
PROMIS short form - sleep disturbance 6a - version 1.0 |
|
92604-8
|
PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 |
|
92603-0
|
PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 |
|
92602-2
|
PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 |
|
92601-4
|
PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0 |
|
92600-6
|
PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0 |
|
92599-0
|
PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0 |
|
92598-2
|
PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0 |
|
76801-0
|
PROMIS short form - social isolation 4a - version 2.0 |
|
76802-8
|
PROMIS short form - social isolation 6a - version 2.0 |
|
76803-6
|
PROMIS short form - social isolation 8a - version 2.0 |
|
92605-5
|
PROMIS short form - upper extremity 7a - version 2.0 |
|
66135-5
|
Promyelocytes [#/volume] in Blood from Fetus by Manual count |
|
14894-0
|
Propylene glycol [Presence] in Serum or Plasma |
|
12552-6
|
Propylene glycol [Mass/volume] in Serum or Plasma |
|
22668-8
|
Propylene glycol [Moles/volume] in Serum or Plasma |
|
18341-8
|
Propylene glycol [Mass/volume] in Urine |
|
32126-5
|
Propylene glycol [Moles/volume] in Urine |
|
22742-1
|
Propylene glycol [Moles/volume] in Unspecified specimen |
|
36920-7
|
PROP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
6905-4
|
Propafenone [Mass/volume] in Serum or Plasma |
|
25511-7
|
Propafenone [Moles/volume] in Serum or Plasma |
|
13022-9
|
Propane [Mass/volume] in Blood |
|
17379-9
|
Propanol [Mass/volume] in Blood |
|
73931-8
|
Propanol [Mass/volume] in Urine |
|
45147-6
|
Propiomazine [Presence] in Serum or Plasma |
|
12802-5
|
Propiomazine [Mass/volume] in Serum or Plasma |
|
38721-7
|
Propionaldehyde [Mass/volume] in Air |
|
54331-4
|
Propionylcarnitine (C3) [Moles/volume] in Amniotic fluid |
|
54330-6
|
Propionylcarnitine (C3) [Moles/volume] in Cerebral spinal fluid |
|
53160-8
|
Propionylcarnitine (C3) [Moles/volume] in DBS |
|
69774-8
|
Propionylcarnitine (C3) [Moles/volume] in Urine |
|
53162-4
|
Propionylcarnitine (C3)/Carnitine.free (C0) [Molar ratio] in DBS |
|
53164-0
|
Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
59197-4
|
Propionylcarnitine (C3)/Palmitoylcarnitine (C16) [Molar ratio] in Serum or Plasma |
|
53163-2
|
Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
59198-2
|
Propionylcarnitine (C3)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
54329-8
|
Propionylcarnitine (C3)/Creatinine [Molar ratio] in Urine |
|
53161-6
|
Propionylcarnitine (C3)/Methionine [Molar ratio] in DBS |
|
54332-2
|
Propionylglycine [Moles/volume] in Cerebral spinal fluid |
|
47878-4
|
Propionylglycine [Moles/volume] in Plasma |
|
32584-5
|
Propionylglycine [Presence] in Urine |
|
44399-4
|
Propionylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
|
50367-2
|
Propionylglycine/Creatinine [Molar ratio] in 24 hour Urine |
|
13800-8
|
Propionylglycine/Creatinine [Mass Ratio] in Urine |
|
24442-6
|
Propionylglycine/Creatinine [Molar ratio] in Urine |
|
59561-1
|
Propofol glucuronide [Mass/volume] in Urine |
|
48285-1
|
Propofol triggered leukotriene release [Mass/volume] by Leukocytes |
|
34673-4
|
Propofol [Mass/volume] in Serum or Plasma |
|
38616-9
|
Propoxur [Mass/volume] in Air |
|
9694-1
|
Propoxur [Mass/volume] in Serum or Plasma |
|
21480-9
|
Propoxur [Mass/volume] in Urine |
|
87753-0
|
Propoxur [Mass/mass] in Unspecified specimen |
|
72401-3
|
Propoxyphene [Presence] in Blood by Screen method |
|
9809-5
|
Propoxyphene [Presence] in Gastric fluid |
|
9737-8
|
Propoxyphene [Mass/volume] in Gastric fluid |
|
59961-3
|
Propoxyphene [Moles/volume] in Gastric fluid |
|
11234-2
|
Propoxyphene [Mass/mass] in Hair |
|
73190-1
|
Propoxyphene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73191-9
|
Propoxyphene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73567-0
|
Propoxyphene [Presence] in Meconium by Screen method |
|
11027-0
|
Propoxyphene [Mass/volume] in Meconium |
|
27067-8
|
Propoxyphene [Mass/mass] in Meconium |
|
73660-3
|
Propoxyphene panel - Saliva (oral fluid) |
|
87817-3
|
Propoxyphene [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72622-4
|
Propoxyphene [Presence] in Saliva (oral fluid) |
|
72617-4
|
Propoxyphene [Presence] in Saliva (oral fluid) by Screen method |
|
72621-6
|
Propoxyphene [Mass/volume] in Saliva (oral fluid) |
|
3542-8
|
Propoxyphene [Presence] in Serum or Plasma |
|
16748-6
|
Propoxyphene [Presence] in Serum or Plasma by Confirmatory method |
|
59734-4
|
Propoxyphene [Presence] in Serum or Plasma by Screen method |
|
35649-3
|
Propoxyphene [Mass/volume] in Serum or Plasma by Screen method |
|
3543-6
|
Propoxyphene [Mass/volume] in Serum or Plasma |
|
32125-7
|
Propoxyphene [Moles/volume] in Serum or Plasma |
|
12357-0
|
Propoxyphene [Presence] in Stool |
|
27281-5
|
Propoxyphene [Mass/mass] in Stool |
|
16242-0
|
Propoxyphene [Mass/volume] in Urine by Confirmatory method |
|
19141-1
|
Propoxyphene [Presence] in Urine |
|
16200-8
|
Propoxyphene [Presence] in Urine by Confirmatory method |
|
19429-0
|
Propoxyphene [Presence] in Urine by Screen method |
|
3545-1
|
Propoxyphene [Mass/volume] in Urine |
|
59960-5
|
Propoxyphene [Moles/volume] in Urine |
|
27190-8
|
Propoxyphene [Mass/volume] in Vitreous fluid |
|
48963-3
|
Propoxyphene [Mass/volume] in Unspecified specimen by Confirmatory method |
|
43811-9
|
Propoxyphene [Presence] in Unspecified specimen |
|
48964-1
|
Propoxyphene [Mass/volume] in Unspecified specimen |
|
60330-8
|
Propoxyphene [Moles/volume] in Unspecified specimen |
|
58398-9
|
Propoxyphene/Creatinine [Mass Ratio] in Urine |
|
73189-3
|
Propoxyphene+Acetaminophen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73188-5
|
Propoxyphene+Acetaminophen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
10533-8
|
Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |
|
72618-2
|
Propoxyphene + Norpropoxyphene [Presence] in Saliva (oral fluid) |
|
47415-5
|
Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma by Confirmatory method |
|
9626-3
|
Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma |
|
55574-8
|
Propoxyphene + Norpropoxyphene [Moles/volume] in Serum or Plasma |
|
19435-7
|
Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
|
19434-0
|
Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method |
|
19433-2
|
Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method |
|
16749-4
|
Propoxyphene + Norpropoxyphene [Units/volume] in Urine |
|
19436-5
|
Propoxyphene + Norpropoxyphene [Mass/volume] in Urine |
|
77335-8
|
Propoxyphene + Norpropoxyphene [Moles/volume] in Unspecified specimen |
|
3990-9
|
Propranolol [Mass/time] in 24 hour Urine |
|
14893-2
|
Propranolol [Moles/time] in 24 hour Urine |
|
21481-7
|
Propranolol [Mass/volume] in Gastric fluid |
|
59962-1
|
Propranolol [Moles/volume] in Gastric fluid |
|
73187-7
|
Propranolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73186-9
|
Propranolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
3991-7
|
Propranolol [Presence] in Serum or Plasma |
|
35633-7
|
Propranolol [Mass/volume] in Serum or Plasma by Screen method |
|
3992-5
|
Propranolol [Mass/volume] in Serum or Plasma |
|
14891-6
|
Propranolol [Moles/volume] in Serum or Plasma |
|
3993-3
|
Propranolol [Presence] in Urine |
|
3994-1
|
Propranolol [Mass/volume] in Urine |
|
14892-4
|
Propranolol [Moles/volume] in Urine |
|
60331-6
|
Propranolol [Moles/volume] in Unspecified specimen |
|
38722-5
|
Propyleneimine [Mass/volume] in Air |
|
3998-2
|
Propylhexedrine [Mass/time] in 24 hour Urine |
|
3995-8
|
Propylhexedrine [Mass/volume] in Blood |
|
3996-6
|
Propylhexedrine [Presence] in Urine |
|
3997-4
|
Propylhexedrine [Mass/volume] in Urine |
|
9388-0
|
Propylthiouracil [Mass/volume] in Serum or Plasma |
|
27173-4
|
Propylthiouracil [Mass/volume] in Urine |
|
54923-8
|
Propyphenazone IgE Ab [Units/volume] in Serum |
|
48279-4
|
Propyphenazone triggered leukotriene release [Mass/volume] by Leukocytes |
|
11226-8
|
Prorenin [Units/volume] in Plasma |
|
92994-3
|
PROS1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
48161-4
|
PROS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
14004-6
|
Prostaglandin A [Mass/time] in 24 hour Urine |
|
14054-1
|
Prostaglandin D2 [Mass/time] in 24 hour Urine |
|
48785-0
|
Prostaglandin D2 [Mass/volume] in Body fluid |
|
12839-7
|
Prostaglandin D2 [Mass/volume] in Serum or Plasma |
|
12838-9
|
Prostaglandin D2 [Mass/volume] in Urine |
|
2851-4
|
Prostaglandin E [Mass/volume] in Plasma |
|
17493-8
|
Prostaglandin E [Mass/volume] in Serum or Plasma |
|
12837-1
|
Prostaglandin E1 [Mass/volume] in 24 hour Urine |
|
14005-3
|
Prostaglandin E1 [Mass/time] in 24 hour Urine |
|
70093-0
|
Prostaglandin E1 [Mass/volume] in Cerebral spinal fluid |
|
70092-2
|
Prostaglandin E1 [Mass/volume] in Body fluid |
|
2852-2
|
Prostaglandin E1 [Mass/volume] in Serum or Plasma |
|
12836-3
|
Prostaglandin E2 [Mass/volume] in 24 hour Urine |
|
14006-1
|
Prostaglandin E2 [Mass/time] in 24 hour Urine |
|
70091-4
|
Prostaglandin E2 [Mass/volume] in Cerebral spinal fluid |
|
2853-0
|
Prostaglandin E2 [Mass/volume] in Serum or Plasma |
|
2854-8
|
Prostaglandin F [Mass/volume] in Plasma |
|
10583-3
|
Prostaglandin F1 alpha [Moles/volume] in Semen |
|
2855-5
|
Prostaglandin F2 [Mass/volume] in Serum or Plasma |
|
14007-9
|
Prostaglandin F2 alpha [Mass/time] in 24 hour Urine |
|
70094-8
|
Prostaglandin F2 alpha [Mass/volume] in Cerebral spinal fluid |
|
70095-5
|
Prostaglandin F2 alpha [Mass/volume] in Body fluid |
|
14174-7
|
Prostaglandin F2 alpha [Mass/volume] in Serum or Plasma |
|
17494-6
|
Prostaglandin F2 alpha [Mass/volume] in Urine |
|
12840-5
|
Prostaglandin F2 alpha [Moles/volume] in Urine |
|
2856-3
|
Prostaglandin [Mass/volume] in Serum or Plasma |
|
17495-3
|
Prostaglandins [Mass/volume] in Urine |
|
58022-5
|
Prostanozol [Presence] in Urine |
|
66117-3
|
Prostate Pathology biopsy report |
|
35663-4
|
Protein [Mass/volume] in Urine collected for unspecified duration |
|
55394-1
|
Protein and Glucose panel - Cerebral spinal fluid |
|
34546-2
|
Protein and Glucose panel [Mass/volume] - Cerebral spinal fluid |
|
54246-4
|
Protein and Glucose panel [Mass/volume] - Body fluid |
|
45060-1
|
Protein and Glucose panel - Urine by Test strip |
|
12842-1
|
Protein [Mass/volume] in 12 hour Urine |
|
26801-1
|
Protein [Mass/time] in 12 hour Urine |
|
58992-9
|
Protein [Mass/time] in 18 hour Urine |
|
53121-0
|
Protein [Mass/time] in 1 hour Urine |
|
21482-5
|
Protein [Mass/volume] in 24 hour Urine |
|
2889-4
|
Protein [Mass/time] in 24 hour Urine |
|
18373-1
|
Protein [Mass/time] in 6 hour Urine |
|
2878-7
|
Protein [Mass/volume] in Amniotic fluid |
|
27819-2
|
Protein C actual/normal in Platelet poor plasma by Coagulation assay |
|
27818-4
|
Protein C actual/normal in Platelet poor plasma by Chromogenic method |
|
27820-0
|
Protein C Ag actual/normal in Platelet poor plasma by Immunoassay |
|
6009-5
|
Protein C Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
4672-2
|
Protein C Ag [Mass/volume] in Platelet poor plasma |
|
27438-1
|
Protein C Ag/Coagulation factor VII Ag Ag [Mass Ratio] in Platelet poor plasma by Immunoassay |
|
6011-1
|
Protein C cofactor [Units/volume] in Platelet poor plasma |
|
6010-3
|
Protein C inhibitor [Mass/volume] in Platelet poor plasma by Immunoassay |
|
4671-4
|
Protein C [Mass/volume] in Plasma |
|
6006-1
|
Protein C [Units/volume] in Platelet poor plasma by Chromogenic method |
|
6007-9
|
Protein C [Units/volume] in Platelet poor plasma by Coagulation assay |
|
13050-0
|
Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma |
|
49639-8
|
Protein C/Coagulation factor X [Mass Ratio] in Platelet poor plasma |
|
6008-7
|
Protein C+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
2879-5
|
Protein [Presence] in Cerebral spinal fluid |
|
2880-3
|
Protein [Mass/volume] in Cerebral spinal fluid |
|
12843-9
|
Protein [Mass/volume] in Peritoneal dialysis fluid |
|
5920-4
|
Protein [Mass/volume] in Dialysis fluid |
|
55295-0
|
Protein electrophoresis and Immunoglobulins panel - Serum |
|
90991-1
|
Protein electrophoresis and M protein isotype panel - Serum or Plasma |
|
81231-3
|
Protein electrophoresis panel - 24 hour Urine |
|
24352-7
|
Protein electrophoresis panel - Cerebral spinal fluid |
|
88698-6
|
Protein electrophoresis panel - Body fluid |
|
24351-9
|
Protein electrophoresis panel - Serum or Plasma |
|
77381-2
|
Protein electrophoresis panel in Urine collected for unspecified duration |
|
34539-7
|
Protein electrophoresis panel - Urine |
|
2881-1
|
Protein [Mass/volume] in Body fluid |
|
14387-5
|
Protein [Mass/volume] in Gastric fluid |
|
2859-7
|
Protein kinase [Enzymatic activity/volume] in Serum |
|
80832-9
|
Protein [Mass/volume] in Lower respiratory specimen |
|
2860-5
|
Protein nitrogen [Mass/time] in 24 hour Urine |
|
12851-2
|
Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis |
|
70265-4
|
Protein in pericardial fluid/Protein in serum |
|
33407-8
|
Protein [Mass/volume] in Pericardial fluid |
|
2882-9
|
Protein [Mass/volume] in Pleural fluid |
|
70267-0
|
Protein in peritoneal fluid/Protein in serum |
|
2883-7
|
Protein [Mass/volume] in Peritoneal fluid |
|
27822-6
|
Protein S actual/normal in Platelet poor plasma by Coagulation assay |
|
87557-5
|
Protein S Ag and protein S Ag.free panel - Platelet poor plasma by Immunoassay |
|
27823-4
|
Protein S Ag actual/normal in Platelet poor plasma by Immunoassay |
|
72337-9
|
Protein S Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
18345-9
|
Protein S Ag/Coagulation factor VII Ag Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
|
49640-6
|
Protein S Ag/Coagulation factor X Ag Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
|
27821-8
|
Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay |
|
4677-1
|
Protein S Free Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
5889-1
|
Protein S Free [Units/volume] in Platelet poor plasma by Coagulation assay |
|
5893-3
|
Protein S [Units/volume] in Platelet poor plasma by Chromogenic method |
|
5892-5
|
Protein S [Units/volume] in Platelet poor plasma by Coagulation assay |
|
13052-6
|
Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay |
|
5891-7
|
Protein S+Acarboxy Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
5890-9
|
Protein S+Acarboxy Free Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
77359-8
|
Protein [Mass/volume] in Saliva (oral fluid) |
|
2885-2
|
Protein [Mass/volume] in Serum or Plasma |
|
2884-5
|
Protein [Mass/volume] in Semen |
|
2886-0
|
Protein [Mass/volume] in Synovial fluid |
|
47739-8
|
Protein [Mass/volume] in Stool |
|
29748-1
|
Protein [Mass/mass] in Tissue |
|
76665-9
|
Protein [Mass/volume] in Cerebral spinal fluid --1st tube |
|
76666-7
|
Protein [Mass/volume] in Cerebral spinal fluid --2nd tube |
|
76667-5
|
Protein [Mass/volume] in Cerebral spinal fluid --3rd tube |
|
76668-3
|
Protein [Mass/volume] in Cerebral spinal fluid --4th tube |
|
53525-2
|
Protein [Presence] in Urine by SSA method |
|
5804-0
|
Protein [Mass/volume] in Urine by Test strip |
|
2888-6
|
Protein [Mass/volume] in Urine |
|
32337-8
|
Protein [Mass/volume] in Unspecified specimen |
|
60678-0
|
Protein/Creatinine [Mass Ratio] in 12 hour Urine |
|
13801-6
|
Protein/Creatinine [Mass Ratio] in 24 hour Urine |
|
30154-9
|
Protein/Creatinine [Mass Ratio] in Serum or Plasma |
|
2890-2
|
Protein/Creatinine [Mass Ratio] in Urine |
|
34366-5
|
Protein/Creatinine [Ratio] in Urine |
|
11192-2
|
Protamine IgE Ab [Units/volume] in Serum |
|
87434-7
|
Protein and creatinine panel - Urine |
|
50043-9
|
Protein carbonyl/Protein [Ratio] in Serum or Plasma |
|
93746-6
|
Protein catabolic rate based on 24 hour Urine [Calculated] |
|
48811-4
|
Protein fractions 3 panel - Serum or Plasma |
|
75299-8
|
Protein intake 24 hour Estimated |
|
82156-1
|
Protein intake 24 hour Measured |
|
81904-5
|
Protein intake panel |
|
75290-7
|
Protein need [Mass/time] 24 hour Estimated |
|
56037-5
|
Protein phosphatase 3 [Enzymatic activity/volume] in Leukocytes |
|
57697-5
|
Protein Z Ag [Mass/volume] in Plasma by Immunoassay |
|
63309-9
|
Proteinase 3 Ab [Presence] in Body fluid by Immunoassay |
|
63539-1
|
Proteinase 3 Ab [Units/volume] in Body fluid |
|
46267-1
|
Proteinase 3 Ab [Units/volume] in Serum by Immunoassay |
|
63310-7
|
Proteinase 3 Ab [Presence] in Serum by Immunoassay |
|
63311-5
|
Proteinase 3 Ab [Presence] in Serum by Immunofluorescence |
|
89505-2
|
Proteinase 3 Ab [Presence] in Serum by Line blot |
|
6968-2
|
Proteinase 3 Ab [Units/volume] in Serum |
|
69957-9
|
Proteinase 3 IgG Ab [Presence] in Serum by Immunoassay |
|
48408-9
|
Proteinase 3 IgG Ab [Units/volume] in Serum |
|
74106-6
|
Proteinase 3 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
29644-2
|
Proteinase 3 [Presence] in Serum by Immunoassay |
|
22468-3
|
Rickettsia (Proteus OX19) Ab [Presence] in Serum |
|
5303-3
|
Rickettsia (Proteus OX19) Ab [Presence] in Serum by Latex agglutination |
|
31593-7
|
Rickettsia (Proteus OX19) Ab [Units/volume] in Serum |
|
22469-1
|
Rickettsia (Proteus OX19) Ab [Titer] in Serum |
|
21489-0
|
Rickettsia (Proteus OX19) Ab [Titer] in Serum by Latex agglutination |
|
22470-9
|
Rickettsia (Proteus OX2) Ab [Presence] in Serum |
|
5304-1
|
Rickettsia (Proteus OX2) Ab [Presence] in Serum by Latex agglutination |
|
22471-7
|
Rickettsia (Proteus OX2) Ab [Titer] in Serum |
|
21490-8
|
Rickettsia (Proteus OX2) Ab [Titer] in Serum by Latex agglutination |
|
22472-5
|
Rickettsia (Proteus OXK) Ab [Presence] in Serum |
|
5305-8
|
Rickettsia (Proteus OXK) Ab [Presence] in Serum by Latex agglutination |
|
31594-5
|
Rickettsia (Proteus OXK) Ab [Units/volume] in Serum |
|
22473-3
|
Rickettsia (Proteus OXK) Ab [Titer] in Serum |
|
21491-6
|
Rickettsia (Proteus OXK) Ab [Titer] in Serum by Latex agglutination |
|
88267-0
|
Proteus sp atpD gene [Presence] by Probe in Positive blood culture |
|
92962-0
|
Proteus sp DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85776-3
|
Proteus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92961-2
|
Proteus sp DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
40457-4
|
Prothrombin Ab [Units/volume] in Serum or Plasma |
|
3289-6
|
Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay |
|
3288-8
|
Prothrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
40595-1
|
Prothrombin IgG Ab [Units/volume] in Serum or Plasma |
|
40596-9
|
Prothrombin IgM Ab [Units/volume] in Serum or Plasma |
|
77161-8
|
Prothrombin activity [Units/volume] in Platelet poor plasma by Coagulation assay --immediately after addition of factor II depleted plasma |
|
5902-2
|
Prothrombin time (PT) |
|
93025-5
|
Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] |
|
50368-0
|
Protoporphyrin [Mass/volume] in 24 hour Urine |
|
50372-2
|
Protoporphyrin [Mass/time] in 24 hour Urine |
|
76341-7
|
Protoporphyrin [Moles/volume] in Blood |
|
41017-5
|
Protoporphyrin [Moles/volume] in Red Blood Cells |
|
50371-4
|
Protoporphyrin [Mass/volume] in Urine |
|
10713-6
|
Prototheca identified in Unspecified specimen by Culture |
|
38401-6
|
Protozoa identified in Unspecified specimen |
|
47126-8
|
Protriptyline [Moles/volume] in Gastric fluid |
|
4000-6
|
Protriptyline [Presence] in Serum or Plasma |
|
3999-0
|
Protriptyline [Mass/volume] in Serum or Plasma |
|
14898-1
|
Protriptyline [Moles/volume] in Serum or Plasma |
|
4002-2
|
Protriptyline [Mass/volume] in Serum or Plasma --trough |
|
4001-4
|
Protriptyline [Presence] in Urine |
|
26978-7
|
Protriptyline [Mass/volume] in Urine |
|
47127-6
|
Protriptyline [Moles/volume] in Urine |
|
77330-9
|
Protriptyline [Moles/volume] in Unspecified specimen |
|
80405-4
|
Provider Certification [Type] |
|
86803-4
|
Provider Death Registration - recommended CDA R1 sections |
|
86808-3
|
Provider death registration Document |
|
87720-9
|
Provider Postal code |
|
92021-5
|
Provider supplied facility fetal death report Document |
|
92020-7
|
Provider supplied facility live birth report Document |
|
92019-9
|
Provider supplied mother's fetal death report Document |
|
92018-1
|
Provider supplied mother's live birth report Document |
|
33012-6
|
Provolone Cheese IgE Ab [Units/volume] in Serum |
|
47867-7
|
Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Fibroblast |
|
47866-9
|
Phosphoribosylpyrophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells |
|
22451-9
|
PRRSV Ab [Presence] in Serum |
|
23367-6
|
PRRSV Ab [Presence] in Serum by Complement fixation |
|
15495-5
|
PRRSV Ab [Presence] in Serum by Immunoassay |
|
15496-3
|
PRRSV Ab [Presence] in Serum by Immunofluorescence |
|
23368-4
|
PRRSV Ab [Presence] in Serum by Neutralization test |
|
31572-1
|
PRRSV Ab [Units/volume] in Serum |
|
42976-1
|
PRRSV Ab [Titer] in Serum |
|
23772-7
|
PRRSV Ab [Titer] in Serum by Immunofluorescence |
|
74313-8
|
PRRSV Ab/Positive control in Unspecified specimen by Immunoassay |
|
23370-0
|
PRRSV Ag [Presence] in Tissue by Immune stain |
|
74305-4
|
PRRSV Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23369-2
|
PRRSV Ag [Presence] in Unspecified specimen by Immune stain |
|
85586-6
|
PRRSV European and North American strains IgG panel - Serum by Immunofluorescence |
|
85551-0
|
PRRSV European and North American strains neutralizing antibody panel - Serum by Neutralization test |
|
74317-9
|
PRRSV European strain RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
74306-2
|
PRRSV ORF5 gene sequence homology to Fostera in Isolate by Sequencing |
|
90332-8
|
PRRSV IgA Ab/Positive control in Unspecified specimen by Immunoassay |
|
90331-0
|
PRRSV IgA+IgM/Positive control in Unspecified specimen by Immunoassay |
|
90333-6
|
PRRSV IgM Ab/Positive control in Unspecified specimen by Immunoassay |
|
74308-8
|
PRRSV ORF5 gene sequence homology to Ingelvac ATP in Isolate by Sequencing |
|
74309-6
|
PRRSV ORF5 gene sequence homology to Ingelvac MLV in Isolate by Sequencing |
|
74307-0
|
PRRSV ORF5 gene sequence homology to Lelystad in Isolate by Sequencing |
|
74318-7
|
PRRSV North American strain RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
74304-7
|
PRRSV neutralizing antibody [Titer] in Serum by Neutralization test |
|
74316-1
|
PRRSV ORF5 gene RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
74311-2
|
PRRSV ORF5 gene sequence [Nucleotide sequence] in Isolate by Sequencing |
|
74315-3
|
PRRSV RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
23371-8
|
PRRSV RNA [Presence] in Semen by NAA with probe detection |
|
74312-0
|
PRRSV [Presence] in Unspecified specimen by Organism specific culture |
|
21692-9
|
PRSS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7634-9
|
Prune IgE Ab [Units/volume] in Serum |
|
38519-5
|
Microscopic observation [Identifier] in Blood or Marrow by Prussian blue stain |
|
22452-7
|
Pseudorabies virus Ab [Presence] in Serum |
|
15497-1
|
Pseudorabies virus Ab [Presence] in Serum by Immunoassay |
|
15498-9
|
Pseudorabies virus Ab [Presence] in Serum by Latex agglutination |
|
23382-5
|
Pseudorabies virus Ab [Presence] in Serum by Neutralization test |
|
31577-0
|
Pseudorabies virus Ab [Units/volume] in Serum |
|
22453-5
|
Pseudorabies virus Ab [Titer] in Serum |
|
15499-7
|
Pseudorabies virus Ab [Titer] in Serum by Neutralization test |
|
23774-3
|
Pseudorabies virus Ag [Presence] in Tissue by Immunofluorescence |
|
31945-9
|
Pseudorabies virus Ag [Presence] in Unspecified specimen |
|
23384-1
|
Pseudorabies virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23385-8
|
Pseudorabies virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23383-3
|
Pseudorabies virus Ag [Presence] in Unspecified specimen by Immune stain |
|
23386-6
|
Pseudorabies virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
22454-3
|
Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum |
|
15500-2
|
Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay |
|
23387-4
|
Pseudorabies virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
29890-1
|
Pseudorabies virus G1 gene deletion Ab [Presence] in Serum |
|
29888-5
|
Pseudorabies virus G1 gene deletion Ab [Presence] in Serum by Immunoassay |
|
22455-0
|
Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum |
|
15501-0
|
Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay |
|
22456-8
|
Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum |
|
15502-8
|
Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay |
|
22457-6
|
Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum |
|
15503-6
|
Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay |
|
41066-2
|
PRX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34507-4
|
PRX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
33310-4
|
Phosphatidylserine Ab [Presence] in Serum |
|
32031-7
|
Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay |
|
30500-3
|
Phosphatidylserine IgA Ab [Presence] in Serum |
|
13069-0
|
Phosphatidylserine IgA Ab [Units/volume] in Serum |
|
43101-5
|
Phosphatidylserine IgA and IgG and IgM panel - Serum |
|
32032-5
|
Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay |
|
11568-3
|
Phosphatidylserine IgG Ab [Presence] in Serum |
|
9326-0
|
Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay |
|
14245-5
|
Phosphatidylserine IgG Ab [Units/volume] in Serum |
|
34951-4
|
Phosphatidylserine IgG and IgM panel - Serum |
|
32033-3
|
Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay |
|
11569-1
|
Phosphatidylserine IgM Ab [Presence] in Serum |
|
9327-8
|
Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay |
|
14246-3
|
Phosphatidylserine IgM Ab [Units/volume] in Serum |
|
51802-7
|
Phosphatidylserine IgM Ab [Titer] in Serum by Immunofluorescence |
|
74123-1
|
Phospho-S6 ribosomal protein Ag [Presence] in Tissue by Immune stain |
|
59230-3
|
Prostate specific Ag [Mass/volume] in Cerebral spinal fluid |
|
47738-0
|
Prostate specific Ag [Mass/volume] in Body fluid |
|
59231-1
|
Prostate Specific Ag Free [Mass/volume] in Cerebral spinal fluid |
|
59239-4
|
Prostate Specific Ag Free [Mass/volume] in Body fluid |
|
59232-9
|
Prostate Specific Ag Free [Mass/volume] in Pleural fluid |
|
59224-6
|
Prostate Specific Ag Free [Mass/volume] in Peritoneal fluid |
|
83113-1
|
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma by Immunoassay |
|
19201-3
|
Prostate Specific Ag Free [Units/volume] in Serum or Plasma |
|
10886-0
|
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
|
19203-9
|
Prostate Specific Ag Free [Moles/volume] in Serum or Plasma |
|
19204-7
|
Prostate Specific Ag Free [Units/volume] in Semen |
|
19205-4
|
Prostate Specific Ag Free [Mass/volume] in Semen |
|
19206-2
|
Prostate Specific Ag Free [Moles/volume] in Semen |
|
59221-2
|
Prostate specific Ag [Mass/volume] in Pleural fluid |
|
53764-7
|
Prostate specific Ag panel - Serum or Plasma |
|
59223-8
|
Prostate specific Ag [Mass/volume] in Peritoneal fluid |
|
35741-8
|
Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
|
83112-3
|
Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay |
|
19195-7
|
Prostate specific Ag [Units/volume] in Serum or Plasma |
|
2857-1
|
Prostate specific Ag [Mass/volume] in Serum or Plasma |
|
19197-3
|
Prostate specific Ag [Moles/volume] in Serum or Plasma |
|
19198-1
|
Prostate specific Ag [Units/volume] in Semen |
|
19199-9
|
Prostate specific Ag [Mass/volume] in Semen |
|
19200-5
|
Prostate specific Ag [Moles/volume] in Semen |
|
10508-0
|
Prostate specific Ag [Presence] in Tissue by Immune stain |
|
34611-4
|
Prostate specific Ag [Mass/volume] in Urine |
|
48167-1
|
Prostate specific Ag/Creatinine [Mass Ratio] in Urine |
|
21729-9
|
PSAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81870-8
|
PSEN1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
35299-7
|
PSEN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81871-6
|
PSEN2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77628-6
|
PSEN2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
89691-0
|
Pseudocasts [#/area] in Urine by Computer assisted method |
|
4005-5
|
Pseudoephedrine [Mass/time] in 24 hour Urine |
|
61089-9
|
Pseudoephedrine [Presence] in Gastric fluid |
|
73185-1
|
Pseudoephedrine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73184-4
|
Pseudoephedrine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
61056-8
|
Pseudoephedrine [Presence] in Serum or Plasma |
|
90446-6
|
Pseudoephedrine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
9389-8
|
Pseudoephedrine [Mass/volume] in Serum or Plasma |
|
55575-5
|
Pseudoephedrine [Moles/volume] in Serum or Plasma |
|
4003-0
|
Pseudoephedrine [Presence] in Urine |
|
4004-8
|
Pseudoephedrine [Mass/volume] in Urine |
|
61057-6
|
Pseudoephedrine [Presence] in Unspecified specimen |
|
48645-6
|
Pseudomonas sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
78692-1
|
Pseudouridine/Creatinine [Molar ratio] in Urine |
|
46202-8
|
Psittacid herpesvirus 1 Ab [Presence] in Serum |
|
43340-9
|
Psittacid herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
|
16146-3
|
Psilocin [Mass/volume] in Serum or Plasma |
|
20558-3
|
Psilocin [Mass/volume] in Urine by Confirmatory method |
|
18414-3
|
Psilocin [Presence] in Urine |
|
19683-2
|
Psilocin [Presence] in Urine by Confirmatory method |
|
19682-4
|
Psilocin [Presence] in Urine by Screen method |
|
18415-0
|
Psilocin [Mass/volume] in Urine |
|
19688-1
|
Psilocybin [Mass/volume] in Urine by Confirmatory method |
|
17504-2
|
Psilocybin [Presence] in Urine |
|
19687-3
|
Psilocybin [Presence] in Urine by Confirmatory method |
|
19686-5
|
Psilocybin [Presence] in Urine by Screen method |
|
6930-2
|
Psilocybin [Mass/volume] in Urine |
|
17505-9
|
Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma |
|
90018-3
|
Psoriasis care satisfaction questionnaire [PsoSat] |
|
88888-3
|
Pancreatic stone protein [Mass/volume] in Serum, Plasma or Blood by Rapid immunoassay |
|
85359-8
|
Phosphatidylserine-prothrombin complex IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
85358-0
|
Phosphatidylserine-prothrombin complex IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
87389-3
|
Porcine sapelovirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87390-1
|
Porcine sapelovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87388-5
|
Porcine sapelovirus [Presence] in Unspecified specimen by Organism specific culture |
|
83897-9
|
Psychology Administrative note |
|
34791-4
|
Psychology Consult note |
|
34866-4
|
Psychology Counseling note |
|
83899-5
|
Psychology Custodial care facility Note |
|
93968-6
|
Psychology Diagnostic study note |
|
83898-7
|
Psychology Discharge summary |
|
83900-1
|
Psychology Education note |
|
78641-8
|
Psychology Flowsheet |
|
34793-0
|
Psychology Group counseling note |
|
83901-9
|
Psychology History and physical note |
|
83903-5
|
Psychology Hospital Note |
|
18738-5
|
Psychology Initial evaluation note |
|
83904-3
|
Psychology Long term care facility Note |
|
34792-2
|
Psychology Note |
|
83905-0
|
Psychology Outpatient Note |
|
83908-4
|
Psychology Telephone encounter Note |
|
80770-1
|
Psychology Plan of care note |
|
89812-2
|
Psychology procedure note |
|
11510-5
|
Psychology Progress note |
|
83902-7
|
Psychology Patient's home Note |
|
57158-8
|
Psychology Referral note |
|
83906-8
|
Psychology Risk assessment and screening note |
|
83879-7
|
Psychiatry Administrative note |
|
83880-5
|
Psychiatry Admission evaluation note |
|
34788-0
|
Psychiatry Consult note |
|
34865-6
|
Psychiatry Counseling note |
|
93967-8
|
Psychiatry Diagnostic study note |
|
59259-2
|
Psychiatry Discharge summary |
|
83884-7
|
Psychiatry Emergency department Note |
|
83883-9
|
Psychiatry Education note |
|
78625-1
|
Psychiatry Flowsheet |
|
34790-6
|
Psychiatry Group counseling note |
|
68599-0
|
Psychiatry History and physical note |
|
34102-4
|
Psychiatry Hospital Consult note |
|
83885-4
|
Psychiatry Hospital Group counseling note |
|
83886-2
|
Psychiatry Hospital History and physical note |
|
83887-0
|
Psychiatry Hospital Note |
|
28635-1
|
Psychiatry Initial evaluation note |
|
93899-3
|
Psychiatry Letter |
|
83888-8
|
Psychiatry Long term care facility Consult note |
|
83889-6
|
Psychiatry Medication management note |
|
28628-6
|
Psychiatry Note |
|
83890-4
|
Psychiatry Outpatient Group counseling note |
|
68601-4
|
Psychiatry Outpatient Note |
|
46024-6
|
Psychiatric or mood diseases or conditions Set |
|
83894-6
|
Psychiatry Telephone encounter Note |
|
80765-1
|
Psychiatry Plan of care note |
|
83891-2
|
Psychiatry procedure note |
|
28627-8
|
Psychiatry Progress note |
|
57157-0
|
Psychiatry Referral note |
|
85872-0
|
Psychiatry Restraint note |
|
83892-0
|
Psychiatry Risk assessment and screening note |
|
90716-2
|
Psychiatry Telehealth Note |
|
83896-1
|
Psychiatry Triage note |
|
83668-4
|
Psychiatry Attending Admission evaluation note |
|
83669-2
|
Psychiatry Attending Hospital Note |
|
75474-7
|
Psychiatry Attending Note |
|
83881-3
|
Psychiatry Case manager Note |
|
83882-1
|
Psychiatry Interdisciplinary Note |
|
83895-3
|
Psychiatry Interdisciplinary Plan of care note |
|
83561-1
|
Psychiatry Nurse practitioner Note |
|
83609-8
|
Psychiatry Nurse Consult note |
|
83610-6
|
Psychiatry Nurse Hospital Note |
|
83611-4
|
Psychiatry Nurse Note |
|
88347-0
|
Psychiatry Nurse procedure note |
|
83773-2
|
Psychiatry Resident Note |
|
11527-9
|
Psychiatry study |
|
83893-8
|
Psychiatry Team Note |
|
90789-9
|
Psychology Intern Note |
|
83907-6
|
Psychology Team Note |
|
93686-4
|
Psychosine [Moles/volume] in Cerebral spinal fluid |
|
93688-0
|
Psychosine [Moles/volume] in DBS |
|
93687-2
|
Psychosine [Moles/mass] in Red Blood Cells |
|
46002-2
|
Psychosocial well-being section |
|
7635-6
|
Psyllium seed IgE Ab [Units/volume] in Serum |
|
49045-8
|
PT and aPTT and Fibrinogen panel - Platelet poor plasma by Coagulation assay |
|
34529-8
|
PT and aPTT panel - Platelet poor plasma by Coagulation assay |
|
33357-5
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --1 hour post incubation |
|
33895-4
|
Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --2 hours post incubation |
|
84332-6
|
Physical therapy Administrative note |
|
5964-2
|
Prothrombin time (PT) in Blood by Coagulation assay |
|
46417-2
|
Prothrombin time (PT) in Capillary blood by Coagulation assay |
|
81577-9
|
PT Brain for amyloidosis |
|
81578-7
|
PT Brain metabolic |
|
44138-6
|
PT Brain |
|
76456-3
|
Physical therapy conclusion of care panel |
|
34824-3
|
Physical therapy Consult note |
|
78582-4
|
Physical therapy Discharge instructions |
|
84331-8
|
Physical therapy Discharge summary |
|
78591-5
|
Physical therapy Discharge teaching note |
|
78604-6
|
Physical therapy Education note |
|
57823-7
|
PT Esophagus |
|
78637-6
|
Physical therapy Flowsheet |
|
92562-8
|
Physical therapy goals panel |
|
82126-4
|
PT Guidance for radiation treatment of Unspecified body region |
|
58742-8
|
PT Head and Neck |
|
92563-6
|
Physical therapy health concerns panel |
|
68590-9
|
Physical therapy Hospital Consult note |
|
84328-4
|
Physical therapy Hospital Discharge summary |
|
84327-6
|
Physical therapy Hospital Initial evaluation note |
|
84326-8
|
Physical therapy Hospital Note |
|
81564-7
|
PT Heart for sarcoidosis |
|
81565-4
|
PT Heart for tissue viability |
|
44137-8
|
PT Heart |
|
76453-0
|
Physical therapy initial visit panel |
|
18735-1
|
Physical therapy Initial evaluation note |
|
84325-0
|
Physical therapy Interdisciplinary Note |
|
84314-4
|
Physical therapy Interdisciplinary Plan of care note |
|
84324-3
|
Physical therapy Long term care facility Consult note |
|
84323-5
|
Physical therapy Long term care facility Note |
|
57822-9
|
PT Lung |
|
84322-7
|
Physical therapy Medication management note |
|
93321-8
|
PT mixing study panel - Platelet poor plasma by Coagulation assay |
|
28579-1
|
Physical therapy Note |
|
83605-6
|
Physical therapy Nurse Note |
|
84321-9
|
Physical therapy Outpatient Discharge summary |
|
84320-1
|
Physical therapy Outpatient Education note |
|
84319-3
|
Physical therapy Outpatient Initial evaluation note |
|
84318-5
|
Physical therapy Outpatient Note |
|
84315-1
|
Physical therapy Telephone encounter Note |
|
52752-3
|
Prothrombin time (PT) PIVKA insensitive actual/normal in Capillary blood by Coagulation assay |
|
52753-1
|
Prothrombin time (PT) PIVKA insensitive actual/normal in Platelet poor plasma by Coagulation assay |
|
52760-6
|
Prothrombin time (PT) PIVKA sensitive actual/normal in Capillary blood by Coagulation assay |
|
52761-4
|
Prothrombin time (PT) PIVKA sensitive actual/normal in Platelet poor plasma by Coagulation assay |
|
88893-3
|
Prothrombin time (PT) PIVKA sensitive in Platelet poor plasma |
|
80762-8
|
Physical therapy Plan of care note |
|
34528-0
|
PT panel - Platelet poor plasma by Coagulation assay |
|
92564-4
|
Physical therapy plan of care panel |
|
61190-5
|
Prothrombin time (PT) in Platelet poor plasma from Fetus by Coagulation assay |
|
78662-4
|
Physical therapy procedure note |
|
11508-9
|
Physical therapy Progress note |
|
84330-0
|
Physical therapy Patient's home Initial evaluation note |
|
84329-2
|
Physical therapy Patient's home Note |
|
91149-5
|
Physical therapy Reevaluation note |
|
76455-5
|
Physical therapy reexamination panel |
|
57154-7
|
Physical therapy Referral note |
|
90791-5
|
Physical therapy Resident Note |
|
84317-7
|
Physical therapy Risk assessment and screening note |
|
58741-0
|
PT Skull base to mid-thigh |
|
76454-8
|
Physical therapy subsequent visit panel |
|
78005-6
|
Physical therapy Summary registry report |
|
84316-9
|
Physical therapy Team Note |
|
44139-4
|
PT Whole body |
|
44136-0
|
PT Unspecified body region |
|
81579-5
|
PT perfusion Brain |
|
81568-8
|
PT perfusion Heart W multiple states of exercise |
|
81569-6
|
PT perfusion Heart W single state of exercise |
|
82809-5
|
PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV and W contrast IV |
|
82808-7
|
PET+CT Guidance for localization of tumor of Skull base to mid-thigh-- W 18F-FDG IV and WO contrast |
|
82807-9
|
PET+CT Guidance for localization of tumor of Skull vertex to mid-thigh-- W 18F-FDG IV and WO contrast |
|
81555-5
|
PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV |
|
82806-1
|
PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV and W contrast IV |
|
82805-3
|
PET+CT Guidance for localization of tumor of Whole body-- W 18F-FDG IV and WO contrast |
|
72260-3
|
Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay |
|
38922-1
|
PTCH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38909-8
|
PTCH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
47969-1
|
PTEN gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
83063-8
|
PTEN gene [VCF] in Cancer specimen by Sequencing |
|
80168-8
|
Pterins panel - Cerebral spinal fluid |
|
80169-6
|
Pterins panel - Serum or Plasma |
|
80170-4
|
Pterins panel - Urine |
|
35567-7
|
Parathyrin [Mass/volume] in Serum or Plasma --10 minutes post excision |
|
13928-7
|
Parathyrin Ab [Presence] in Serum |
|
63301-6
|
Parathyrin Ab [Presence] in Serum by Immunofluorescence |
|
12799-3
|
Parathyrin Ab [Units/volume] in Serum |
|
63302-4
|
Parathyrin Ab [Titer] in Serum by Immunofluorescence |
|
35566-9
|
Parathyrin [Mass/volume] in Serum or Plasma --baseline |
|
24347-7
|
Parathyrin.mid molecule and Calcium panel - Serum or Plasma |
|
2729-2
|
Parathyrin related protein [Mass/volume] in Serum or Plasma |
|
15087-0
|
Parathyrin related protein [Moles/volume] in Serum or Plasma |
|
32045-7
|
Parathyrin.biointact [Mass/volume] in Serum or Plasma |
|
47093-0
|
Parathyrin.biointact [Moles/volume] in Serum or Plasma |
|
2730-0
|
Parathyrin.C-terminal [Mass/volume] in Serum or Plasma |
|
15088-8
|
Parathyrin.C-terminal [Moles/volume] in Serum or Plasma |
|
24346-9
|
Parathyrin.intact and Calcium panel - Serum or Plasma |
|
47178-9
|
Parathyrin.intact [Moles/volume] in Serum or Plasma --baseline |
|
59835-9
|
Parathyrin.intact [Mass/volume] in Body fluid |
|
86917-2
|
Parathyrin.intact goal [Mass/volume] Serum or Plasma |
|
72203-3
|
Parathyrin.intact intraoperative panel - Serum or Plasma |
|
49036-7
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --post excision |
|
2731-8
|
Parathyrin.intact [Mass/volume] in Serum or Plasma |
|
35219-5
|
Parathyrin.intact [Mass or Moles/volume] in Serum or Plasma |
|
14866-8
|
Parathyrin.intact [Moles/volume] in Serum or Plasma |
|
50525-5
|
Parathyrin.intact [Mass/volume] in Serum or Plasma --1st specimen |
|
88106-0
|
Parathyrin.intact [Mass/volume] in Tissue fine needle aspirate |
|
2732-6
|
Parathyrin.mid molecule [Mass/volume] in Serum or Plasma |
|
29390-2
|
Parathyrin.mid molecule [Moles/volume] in Serum or Plasma |
|
2733-4
|
Parathyrin.N-terminal [Mass/volume] in Serum or Plasma |
|
41065-4
|
PTPN11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34679-1
|
PTPN11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53791-0
|
PTPN11 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53792-8
|
PTPN11 gene mutations tier 3 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81142-2
|
PTPN22 gene.c.1858C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
84161-9
|
Patient's home Administrative note |
|
84162-7
|
Patient's home Admission evaluation note |
|
88693-7
|
Patient's home Discharge summary |
|
88694-5
|
Patient's home Discharge teaching note |
|
34107-3
|
Patient's home Education note |
|
85203-8
|
Patient's home History and physical note |
|
34118-0
|
Patient's home Initial evaluation note |
|
85470-3
|
Patient's home Medication management note |
|
75503-3
|
Patient's home Note |
|
84165-0
|
Patient's home Plan of care note |
|
34129-7
|
Patient's home Progress note |
|
85205-3
|
Patient's home Referral note |
|
85204-6
|
Patient's home Risk assessment and screening note |
|
87391-9
|
Porcine teschovirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
87392-7
|
Porcine teschovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
87399-2
|
Porcine teschovirus [Presence] in Unspecified specimen by Organism specific culture |
|
55751-2
|
Public health Case report |
|
83909-2
|
Public health Consult note |
|
78642-6
|
Public health Form |
|
80421-1
|
Public health Mandatory reporting form |
|
83910-0
|
Public health Note |
|
78674-9
|
Public health Referral note |
|
31578-8
|
Pullularia sp Ab [Presence] in Serum |
|
24504-3
|
Pullularia sp Ab [Presence] in Serum by Immune diffusion (ID) |
|
7637-2
|
Pullularia sp IgE Ab [Units/volume] in Serum |
|
7638-0
|
Pullularia sp IgG Ab [Units/volume] in Serum |
|
76285-6
|
Pulmonary capillary Blood pressure |
|
76286-4
|
Pulmonary capillary Diastolic blood pressure |
|
76287-2
|
Pulmonary capillary Mean blood pressure |
|
76288-0
|
Pulmonary capillary Systolic blood pressure |
|
64077-1
|
Pulmonary Attending Hospital Note |
|
68478-7
|
Pulmonary Attending Hospital Progress note |
|
83787-2
|
Pulmonary Attending Note |
|
83788-0
|
Pulmonary Attending Outpatient Note |
|
83789-8
|
Pulmonary Attending procedure note |
|
83911-8
|
Pulmonary Admission evaluation note |
|
34103-2
|
Pulmonary Consult note |
|
80792-5
|
Pulmonary Diagnostic study note |
|
80793-3
|
Pulmonary Education note |
|
80794-1
|
Pulmonary Flowsheet |
|
64062-3
|
Pulmonary Hospital Admission evaluation note |
|
64063-1
|
Pulmonary Hospital Progress note |
|
83914-2
|
Pulmonary Hospital Transfer summary note |
|
80795-8
|
Pulmonary Initial evaluation note |
|
34830-0
|
Pulmonary Note |
|
83915-9
|
Pulmonary Outpatient Note |
|
83916-7
|
Pulmonary Telephone encounter Note |
|
80796-6
|
Pulmonary Plan of care note |
|
85944-7
|
Pulmonary Preoperative evaluation and management note |
|
80798-2
|
Pulmonary procedure note |
|
80819-6
|
Pulmonary Progress note |
|
83912-6
|
Pulmonary Patient's home Consult note |
|
83913-4
|
Pulmonary Patient's home Note |
|
57177-8
|
Pulmonary Referral note |
|
46025-3
|
Pulmonary diseases or conditions Set |
|
83744-3
|
Pulmonary Fellow Note |
|
64078-9
|
Pulmonary Medical student Hospital Admission evaluation note |
|
64080-5
|
Pulmonary Medical student Hospital Consult note |
|
64079-7
|
Pulmonary Medical student Hospital Progress note |
|
83638-7
|
Pulmonary Nurse Note |
|
83639-5
|
Pulmonary Nurse Outpatient Note |
|
83640-3
|
Pulmonary Nurse procedure note |
|
83774-0
|
Pulmonary Resident Note |
|
74782-4
|
Pulse intensity Dorsal pedal artery - right by palpation |
|
6854-4
|
Pumpkin IgE Ab [Units/volume] in Serum |
|
39597-0
|
Pumpkin IgE Ab/IgE total in Serum |
|
56468-2
|
Pumpkin IgG4 Ab [Mass/volume] in Serum |
|
63116-8
|
Pumpkin IgG Ab [Mass/volume] in Serum |
|
11193-0
|
Pumpkin Seed IgE Ab [Units/volume] in Serum |
|
61252-3
|
Pumpkin Seed IgE Ab/IgE total in Serum |
|
75944-9
|
Pupil reaction [Time] Left eye |
|
75945-6
|
Pupil reaction [Time] Right eye |
|
87515-3
|
Pupillary response Pupil - bilateral --at admission |
|
52075-9
|
Purchase invoice |
|
79668-0
|
Purine and Pyrimidine panel - Cerebral spinal fluid |
|
79665-6
|
Purine and Pyrimidine panel - Serum or Plasma |
|
79673-0
|
Purine and Pyrimidine panel - Urine |
|
85379-6
|
Purine/Pyrimidine [Ratio] in Red Blood Cells by Spectrophotometry |
|
54924-6
|
Purkinje cells Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63312-3
|
Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
56736-2
|
Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
14247-1
|
Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31579-6
|
Purkinje cells Ab [Units/volume] in Cerebral spinal fluid |
|
45172-4
|
Purkinje cells Ab [Units/volume] in Serum by Immunofluorescence |
|
27214-6
|
Purkinje cells Ab [Presence] in Serum |
|
12853-8
|
Purkinje cells Ab [Presence] in Serum by Immunoblot |
|
14249-7
|
Purkinje cells Ab [Presence] in Serum by Immunofluorescence |
|
27068-6
|
Purkinje cells Ab [Units/volume] in Serum |
|
14248-9
|
Purkinje cells Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
6970-8
|
Purkinje cells Ab [Titer] in Serum |
|
51721-9
|
Purkinje cells Ab [Titer] in Serum by Immunofluorescence |
|
14250-5
|
Purkinje cells IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
31580-4
|
Purkinje cells IgG Ab [Units/volume] in Serum |
|
7778-4
|
Pussy Willow IgE Ab [Units/volume] in Serum |
|
7897-2
|
Hantavirus puumala IgG Ab [Units/volume] in Serum |
|
70059-1
|
Hantavirus puumala IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
22308-1
|
Hantavirus puumala IgG Ab [Titer] in Serum |
|
21322-3
|
Hantavirus puumala IgG Ab [Titer] in Serum by Immunofluorescence |
|
16928-4
|
Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum |
|
7898-0
|
Hantavirus puumala IgM Ab [Units/volume] in Serum |
|
70058-3
|
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
22309-9
|
Hantavirus puumala IgM Ab [Titer] in Serum |
|
21323-1
|
Hantavirus puumala IgM Ab [Titer] in Serum by Immunofluorescence |
|
88220-9
|
Hantavirus puumala RNA [Presence] in Blood by NAA with probe detection |
|
88216-7
|
Hantavirus puumala RNA [Presence] in Urine by NAA with probe detection |
|
40709-8
|
Polio virus Ab [Units/volume] in Cerebral spinal fluid |
|
68320-1
|
Polio virus Ab panel [Titer] - Serum |
|
41506-7
|
Polio virus Ab panel [Titer] - Serum by Neutralization test |
|
16284-2
|
Polio virus Ab [Units/volume] in Serum |
|
42980-3
|
Polio virus Ab [Titer] in Serum |
|
27261-7
|
Polio virus Ab [Titer] in Serum by Complement fixation |
|
40783-3
|
Polio virus IgG Ab [Titer] in Cerebral spinal fluid --2nd specimen |
|
40708-0
|
Polio virus IgG Ab [Titer] in Serum --2nd specimen |
|
40782-5
|
Polio virus IgM Ab [Titer] in Cerebral spinal fluid --1st specimen |
|
40781-7
|
Polio virus IgM Ab [Titer] in Serum --1st specimen |
|
60546-9
|
Polio virus identified [Type] in Isolate by Organism specific culture |
|
53645-8
|
Polio virus identified in Stool by Organism specific culture |
|
73907-8
|
Polio virus identified in Unspecified specimen by Organism specific culture |
|
31564-8
|
Polio virus 1 Ab [Units/volume] in Cerebral spinal fluid |
|
31565-5
|
Polio virus 1 Ab [Units/volume] in Body fluid |
|
30546-6
|
Polio virus 1 Ab [Presence] in Serum |
|
7985-5
|
Polio virus 1 Ab [Units/volume] in Serum |
|
24243-8
|
Polio virus 1 Ab [Titer] in Serum --1st specimen |
|
24169-5
|
Polio virus 1 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24244-6
|
Polio virus 1 Ab [Titer] in Serum --2nd specimen |
|
24170-3
|
Polio virus 1 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22445-1
|
Polio virus 1 Ab [Titer] in Cerebral spinal fluid |
|
18397-0
|
Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
42981-1
|
Polio virus 1 Ab [Titer] in Body fluid |
|
31063-1
|
Polio virus 1 Ab [Titer] in Body fluid by Complement fixation |
|
22446-9
|
Polio virus 1 Ab [Titer] in Serum |
|
5282-9
|
Polio virus 1 Ab [Titer] in Serum by Complement fixation |
|
5281-1
|
Polio virus 1 Ab [Titer] in Serum by Neutralization test |
|
31566-3
|
Polio virus 2 Ab [Units/volume] in Cerebral spinal fluid |
|
31567-1
|
Polio virus 2 Ab [Units/volume] in Body fluid |
|
30547-4
|
Polio virus 2 Ab [Presence] in Serum |
|
7986-3
|
Polio virus 2 Ab [Units/volume] in Serum |
|
24245-3
|
Polio virus 2 Ab [Titer] in Serum --1st specimen |
|
24171-1
|
Polio virus 2 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24246-1
|
Polio virus 2 Ab [Titer] in Serum --2nd specimen |
|
24172-9
|
Polio virus 2 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22447-7
|
Polio virus 2 Ab [Titer] in Cerebral spinal fluid |
|
18398-8
|
Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
42978-7
|
Polio virus 2 Ab [Titer] in Body fluid |
|
31064-9
|
Polio virus 2 Ab [Titer] in Body fluid by Complement fixation |
|
22448-5
|
Polio virus 2 Ab [Titer] in Serum |
|
5284-5
|
Polio virus 2 Ab [Titer] in Serum by Complement fixation |
|
5283-7
|
Polio virus 2 Ab [Titer] in Serum by Neutralization test |
|
31568-9
|
Polio virus 3 Ab [Units/volume] in Cerebral spinal fluid |
|
31569-7
|
Polio virus 3 Ab [Units/volume] in Body fluid |
|
30548-2
|
Polio virus 3 Ab [Presence] in Serum |
|
7987-1
|
Polio virus 3 Ab [Units/volume] in Serum |
|
24247-9
|
Polio virus 3 Ab [Titer] in Serum --1st specimen |
|
24173-7
|
Polio virus 3 Ab [Titer] in Serum by Neutralization test --1st specimen |
|
24248-7
|
Polio virus 3 Ab [Titer] in Serum --2nd specimen |
|
24174-5
|
Polio virus 3 Ab [Titer] in Serum by Neutralization test --2nd specimen |
|
22449-3
|
Polio virus 3 Ab [Titer] in Cerebral spinal fluid |
|
18399-6
|
Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
42979-5
|
Polio virus 3 Ab [Titer] in Body fluid |
|
31065-6
|
Polio virus 3 Ab [Titer] in Body fluid by Complement fixation |
|
22450-1
|
Polio virus 3 Ab [Titer] in Serum |
|
5286-0
|
Polio virus 3 Ab [Titer] in Serum by Complement fixation |
|
5285-2
|
Polio virus 3 Ab [Titer] in Serum by Neutralization test |
|
76126-2
|
Premature ventricular contractions [#] |
|
84438-1
|
Picture Vocabulary Test - English [NIH Toolbox] |
|
44617-9
|
PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77196-4
|
Pulse wave velocity |
|
10887-8
|
Pyridinoline [Mass/time] in 24 hour Urine |
|
25977-0
|
Pyridinoline [Moles/volume] in 24 hour Urine |
|
34368-1
|
Pyridinoline [Moles/time] in 24 hour Urine |
|
9381-5
|
Pyridinoline [Mass/time] in 2 hour Urine |
|
55255-4
|
Pyridinoline panel - Urine |
|
34367-3
|
Pyridinoline [Moles/volume] in Urine |
|
48987-2
|
Pyridinoline.free/Creatinine [Molar ratio] in Urine |
|
13803-2
|
Pyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
|
25130-6
|
Pyridinoline/Creatinine [Molar ratio] in 24 hour Urine |
|
13804-0
|
Pyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
|
25131-4
|
Pyridinoline/Creatinine [Molar ratio] in 2 hour Urine |
|
13802-4
|
Pyridinoline/Creatinine [Mass Ratio] in Urine |
|
25129-8
|
Pyridinoline/Creatinine [Molar ratio] in Urine |
|
35647-7
|
Pyridinoline+Deoxypyridinoline/Creatinine [Molar ratio] in Urine collected for unspecified duration |
|
41064-7
|
PYGM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35294-8
|
PYGM gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
40930-0
|
PYGM gene p.Arg50Ter+Gly205Ser [Presence] in Blood or Tissue by Molecular genetics method |
|
57313-9
|
Pyrazole IgE Ab [Units/volume] in Serum |
|
7640-6
|
Pyrethrum triggered histamine release [Units/volume] in Blood |
|
7639-8
|
Pyrethrum IgE Ab [Units/volume] in Serum |
|
12412-3
|
Pyridine [Mass/volume] in Serum or Plasma |
|
9390-6
|
Pyridostigmine [Mass/volume] in Serum or Plasma |
|
75042-2
|
Pyridoxal [Moles/volume] in Cerebral spinal fluid |
|
74442-5
|
Pyridoxal phosphate [Moles/volume] in Blood |
|
75056-2
|
Pyridoxal phosphate [Moles/volume] in Cerebral spinal fluid |
|
30552-4
|
Pyridoxal phosphate [Mass/volume] in Serum or Plasma |
|
62236-5
|
Pyridoxal phosphate [Moles/volume] in Serum or Plasma |
|
30572-2
|
Pyridoxal [Mass/volume] in Serum or Plasma |
|
75041-4
|
Pyridoxal [Moles/volume] in Serum or Plasma |
|
4006-3
|
Pyrilamine [Mass/volume] in Blood |
|
4007-1
|
Pyrilamine [Presence] in Serum or Plasma |
|
4008-9
|
Pyrilamine [Mass/volume] in Serum or Plasma |
|
4009-7
|
Pyrilamine [Presence] in Urine |
|
4010-5
|
Pyrilamine [Mass/volume] in Urine |
|
34669-2
|
Pyrimethamine [Mass/volume] in Serum or Plasma |
|
4013-9
|
Pyrovalerone [Mass/time] in 24 hour Urine |
|
4011-3
|
Pyrovalerone [Presence] in Urine |
|
4012-1
|
Pyrovalerone [Mass/volume] in Urine |
|
14176-2
|
Pyrroles [Mass/volume] in Urine |
|
2906-6
|
Pyruvate [Mass/volume] in Arterial blood |
|
51750-8
|
Pyruvate [Moles/volume] in Arterial blood |
|
2905-8
|
Pyruvate [Mass/volume] in Blood |
|
14121-8
|
Pyruvate [Moles/volume] in Blood |
|
51751-6
|
Pyruvate [Moles/volume] in Venous blood |
|
47879-2
|
Pyruvate carboxylase [Enzymatic activity/mass] in Amniotic fluid cells |
|
47880-0
|
Pyruvate carboxylase [Enzymatic activity/mass] in Fibroblast |
|
47882-6
|
Pyruvate carboxylase [Enzymatic activity/mass] in Placenta |
|
2909-0
|
Pyruvate carboxylase [Enzymatic activity/mass] in Tissue |
|
47881-8
|
Pyruvate carboxylase [Enzymatic activity/mass] in Leukocytes |
|
2907-4
|
Pyruvate [Mass/volume] in Cerebral spinal fluid |
|
14122-6
|
Pyruvate [Moles/volume] in Cerebral spinal fluid |
|
2914-0
|
Pyruvate oxidase [Enzymatic activity/volume] in Serum or Plasma |
|
12247-3
|
Pyruvate [Mass/volume] in Serum or Plasma |
|
32338-6
|
Pyruvate [Moles/volume] in Serum or Plasma |
|
30481-6
|
Pyruvate [Presence] in Urine |
|
2908-2
|
Pyruvate [Mass/volume] in Urine |
|
44400-0
|
Pyruvate/Creatinine [Mass Ratio] in 24 hour Urine |
|
13805-7
|
Pyruvate/Creatinine [Mass Ratio] in Urine |
|
25132-2
|
Pyruvate/Creatinine [Molar ratio] in Urine |
|
11001-5
|
Pyrazinamide [Mass/volume] in Serum or Plasma |
|
25270-0
|
Pyrazinamide [Mass/volume] in Unspecified specimen |
|
43163-5
|
Quaternary ammonium compound [Mass/volume] in Unspecified specimen |
|
76635-2
|
Q-T interval corrected based on Bazett formula |
|
76634-5
|
Q-T interval corrected based on Fridericia formula |
|
7367-6
|
Quack grass IgE Ab [Units/volume] in Serum |
|
48550-8
|
Quality Audit Marker (QAM) panel |
|
93088-3
|
Quality of Working Life Questionnaire for Cancer Survivors [Quality of Working Life Questionnaire for Cancer Survivors] |
|
9391-4
|
Quazepam [Mass/volume] in Serum or Plasma |
|
6222-4
|
Queen Palm IgE Ab [Units/volume] in Serum |
|
50370-6
|
Queen Palm IgE Ab/IgE total in Serum |
|
56365-0
|
Queen Palm IgG4 Ab [Mass/volume] in Serum |
|
74468-0
|
Questionnaire form definition Document |
|
74465-6
|
Questionnaire response Document |
|
72968-1
|
QUEtiapine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72967-3
|
QUEtiapine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59964-7
|
QUEtiapine [Moles/volume] in Gastric fluid |
|
73183-6
|
QUEtiapine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73182-8
|
QUEtiapine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59175-0
|
QUEtiapine metabolite [Presence] in Urine |
|
89981-5
|
QUEtiapine [Presence] in Serum or Plasma by Screen method |
|
26776-5
|
QUEtiapine [Mass/volume] in Serum or Plasma |
|
55576-3
|
QUEtiapine [Moles/volume] in Serum or Plasma |
|
74936-6
|
QUEtiapine [Mass/volume] in Serum or Plasma --trough |
|
59174-3
|
QUEtiapine [Presence] in Urine |
|
59963-9
|
QUEtiapine [Moles/volume] in Urine |
|
60332-4
|
QUEtiapine [Moles/volume] in Unspecified specimen |
|
17506-7
|
Quinacrine [Mass/volume] in Serum or Plasma |
|
73181-0
|
Quinapril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73180-2
|
Quinapril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12546-8
|
Quinethazone [Presence] in Serum or Plasma |
|
12348-9
|
Quinethazone [Presence] in Urine |
|
9392-2
|
Quinethazone [Mass/volume] in Urine |
|
72966-5
|
quiNIDine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72965-7
|
quiNIDine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4014-7
|
quiNIDine [Mass/volume] in Blood |
|
29226-8
|
quiNIDine [Mass/volume] in Body fluid |
|
9779-0
|
quiNIDine Free [Mass/volume] in Serum or Plasma |
|
73178-6
|
quiNIDine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73179-4
|
quiNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
21483-3
|
quiNIDine [Mass/volume] in Serum or Plasma --peak |
|
6694-4
|
quiNIDine [Mass/volume] in Serum or Plasma |
|
14899-9
|
quiNIDine [Moles/volume] in Serum or Plasma |
|
4017-0
|
quiNIDine [Mass/volume] in Serum or Plasma --trough |
|
4015-4
|
quiNIDine [Presence] in Urine |
|
17507-5
|
quiNIDine [Mass/volume] in Urine |
|
43832-5
|
quiNIDine [Presence] in Unspecified specimen |
|
4016-2
|
quiNIDine+Quinine [Presence] in Serum or Plasma |
|
18393-9
|
quiNIDine+Quinine [Presence] in Urine |
|
72964-0
|
quiNINE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72963-2
|
quiNINE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4018-8
|
quiNINE [Mass/volume] in Blood |
|
9810-3
|
quiNINE [Presence] in Gastric fluid |
|
59967-0
|
quiNINE [Moles/volume] in Gastric fluid |
|
33989-5
|
quiNINE induced platelet Ab [Presence] in Serum |
|
73177-8
|
quiNINE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73176-0
|
quiNINE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4019-6
|
quiNINE [Mass/volume] in Serum or Plasma |
|
59965-4
|
quiNINE [Moles/volume] in Serum or Plasma |
|
4020-4
|
quiNINE [Presence] in Urine |
|
17508-3
|
quiNINE [Units/volume] in Urine |
|
27218-7
|
quiNINE [Mass/volume] in Urine |
|
59966-2
|
quiNINE [Moles/volume] in Urine |
|
43833-3
|
quiNINE [Presence] in Unspecified specimen |
|
57871-6
|
quiNINE [Moles/volume] in Unspecified specimen |
|
25743-6
|
Quinoa IgE Ab [Units/volume] in Serum |
|
75077-8
|
Quinolinate [Moles/volume] in Serum or Plasma |
|
48121-8
|
Quinolinate/Creatinine [Molar ratio] in Urine |
|
38724-1
|
Quinoline [Mass/volume] in Air |
|
48296-8
|
Quinoline yellow triggered leukotriene release [Mass/volume] by Leukocytes |
|
79586-4
|
R- and S-beta aminoisobutyrate and D- and L-serine panel - Cerebral spinal fluid |
|
79583-1
|
R- and S-beta aminoisobutyrate and D- and L-serine panel - Serum or Plasma |
|
79605-2
|
R- and S-beta aminoisobutyrate and D- and L-serine panel - Urine |
|
49159-7
|
Rickettsia africae IgG Ab [Titer] in Body fluid |
|
48903-9
|
Rickettsia africae IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49161-3
|
Rickettsia africae IgG Ab [Titer] in Serum |
|
48858-5
|
Rickettsia africae IgG Ab [Titer] in Serum by Immunofluorescence |
|
49160-5
|
Rickettsia africae IgM Ab [Titer] in Body fluid |
|
48902-1
|
Rickettsia africae IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49162-1
|
Rickettsia africae IgM Ab [Titer] in Serum |
|
48857-7
|
Rickettsia africae IgM Ab [Titer] in Serum by Immunofluorescence |
|
29681-4
|
Rickettsia akari Ab [Presence] in Serum |
|
29708-5
|
Rickettsia akari Ab [Presence] in Serum by Immunofluorescence |
|
31595-2
|
Rickettsia akari Ab [Units/volume] in Serum |
|
29680-6
|
Rickettsia akari Ab [Titer] in Serum |
|
29707-7
|
Rickettsia akari Ab [Titer] in Serum by Immunofluorescence |
|
49158-9
|
Rickettsia akari IgG Ab [Titer] in Body fluid |
|
48904-7
|
Rickettsia akari IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49157-1
|
Rickettsia akari IgG Ab [Titer] in Serum |
|
48859-3
|
Rickettsia akari IgG Ab [Titer] in Serum by Immunofluorescence |
|
49156-3
|
Rickettsia akari IgM Ab [Titer] in Body fluid |
|
48905-4
|
Rickettsia akari IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49155-5
|
Rickettsia akari IgM Ab [Titer] in Serum |
|
48860-1
|
Rickettsia akari IgM Ab [Titer] in Serum by Immunofluorescence |
|
26651-0
|
Rhizopus arrhizus Ab [Presence] in Serum |
|
29669-9
|
Rickettsia australis Ab [Presence] in Serum |
|
29649-1
|
Rickettsia australis Ab [Presence] in Serum by Immunofluorescence |
|
31596-0
|
Rickettsia australis Ab [Units/volume] in Serum |
|
29668-1
|
Rickettsia australis Ab [Titer] in Serum |
|
29648-3
|
Rickettsia australis Ab [Titer] in Serum by Immunofluorescence |
|
26624-7
|
Rickettsia conorii Ab [Presence] in Serum |
|
29702-8
|
Rickettsia conorii Ab [Presence] in Serum by Immunofluorescence |
|
31597-8
|
Rickettsia conorii Ab [Units/volume] in Serum |
|
29678-0
|
Rickettsia conorii Ab [Titer] in Serum |
|
29665-7
|
Rickettsia conorii Ab [Titer] in Serum by Immunofluorescence |
|
51804-3
|
Rickettsia conorii IgG Ab [Units/volume] in Serum by Immunoassay |
|
87924-7
|
Rickettsia conorii IgG Ab [Presence] in Serum by Immunoassay |
|
13199-5
|
Rickettsia conorii IgG Ab [Units/volume] in Serum |
|
58809-5
|
Rickettsia conorii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49154-8
|
Rickettsia conorii IgG Ab [Titer] in Body fluid |
|
48907-0
|
Rickettsia conorii IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
21492-4
|
Rickettsia conorii IgG Ab [Titer] in Serum |
|
25749-3
|
Rickettsia conorii IgG Ab [Titer] in Serum by Immunofluorescence |
|
51805-0
|
Rickettsia conorii IgM Ab [Units/volume] in Serum by Immunoassay |
|
87923-9
|
Rickettsia conorii IgM Ab [Presence] in Serum by Immunoassay |
|
13200-1
|
Rickettsia conorii IgM Ab [Units/volume] in Serum |
|
49153-0
|
Rickettsia conorii IgM Ab [Titer] in Body fluid |
|
48906-2
|
Rickettsia conorii IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
21493-2
|
Rickettsia conorii IgM Ab [Titer] in Serum |
|
25750-1
|
Rickettsia conorii IgM Ab [Titer] in Serum by Immunofluorescence |
|
31587-9
|
Rhodococcus equi Ab [Presence] in Serum |
|
26735-1
|
Rhodococcus equi Ab [Presence] in Serum by Immune diffusion (ID) |
|
31586-1
|
Rhodococcus equi Ab [Units/volume] in Serum |
|
23775-0
|
Rhodococcus equi Ab [Titer] in Serum |
|
29671-5
|
Rickettsia honei Ab [Presence] in Serum |
|
29651-7
|
Rickettsia honei Ab [Presence] in Serum by Immunofluorescence |
|
31598-6
|
Rickettsia honei Ab [Units/volume] in Serum |
|
29670-7
|
Rickettsia honei Ab [Titer] in Serum |
|
29650-9
|
Rickettsia honei Ab [Titer] in Serum by Immunofluorescence |
|
6229-9
|
Rhizopus nigricans IgE Ab [Units/volume] in Serum |
|
61308-3
|
Rhizopus nigricans IgE Ab/IgE total in Serum |
|
18411-9
|
Rhizopus nigricans IgG Ab [Units/volume] in Serum |
|
35552-9
|
Rhizopus nigricans IgG Ab [Mass/volume] in Serum |
|
49149-8
|
Rickettsia parkeri IgG Ab [Titer] in Body fluid |
|
48909-6
|
Rickettsia parkeri IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
49151-4
|
Rickettsia parkeri IgG Ab [Titer] in Serum |
|
48862-7
|
Rickettsia parkeri IgG Ab [Titer] in Serum by Immunofluorescence |
|
49150-6
|
Rickettsia parkeri IgM Ab [Titer] in Body fluid |
|
48908-8
|
Rickettsia parkeri IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
49152-2
|
Rickettsia parkeri IgM Ab [Titer] in Serum |
|
48861-9
|
Rickettsia parkeri IgM Ab [Titer] in Serum by Immunofluorescence |
|
6542-5
|
Rickettsia prowazekii Ab [Units/volume] in Serum by Complement fixation |
|
29683-0
|
Rickettsia prowazekii Ab [Presence] in Serum |
|
29710-1
|
Rickettsia prowazekii Ab [Presence] in Serum by Immunofluorescence |
|
7995-4
|
Rickettsia prowazekii Ab [Units/volume] in Serum |
|
29682-2
|
Rickettsia prowazekii Ab [Titer] in Serum |
|
29709-3
|
Rickettsia prowazekii Ab [Titer] in Serum by Immunofluorescence |
|
31599-4
|
Rickettsia prowazekii IgG Ab [Units/volume] in Serum |
|
49148-0
|
Rickettsia prowazekii IgG Ab [Titer] in Body fluid |
|
48911-2
|
Rickettsia prowazekii IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
25603-2
|
Rickettsia prowazekii IgG Ab [Titer] in Serum |
|
25751-9
|
Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunofluorescence |
|
31600-0
|
Rickettsia prowazekii IgM Ab [Units/volume] in Serum |
|
49147-2
|
Rickettsia prowazekii IgM Ab [Titer] in Body fluid |
|
48910-4
|
Rickettsia prowazekii IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
25604-0
|
Rickettsia prowazekii IgM Ab [Titer] in Serum |
|
25752-7
|
Rickettsia prowazekii IgM Ab [Titer] in Serum by Immunofluorescence |
|
7996-2
|
Rickettsia prowazekii RNA [Presence] in Serum by NAA with probe detection |
|
26670-0
|
Rhizomucor pusillus Ab [Presence] in Serum |
|
31604-2
|
Rickettsia rickettsii Ab [Presence] in Serum |
|
29706-9
|
Rickettsia rickettsii Ab [Presence] in Serum by Immunofluorescence |
|
31603-4
|
Rickettsia rickettsii Ab [Units/volume] in Serum |
|
29737-4
|
Rickettsia rickettsii Ab [Titer] in Serum |
|
29705-1
|
Rickettsia rickettsii Ab [Titer] in Serum by Immunofluorescence |
|
6543-3
|
Rickettsia rickettsii Ag [Identifier] in Tissue by Immunofluorescence |
|
48868-4
|
Rickettsia rickettsii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
18429-1
|
Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid |
|
42968-8
|
Rickettsia rickettsii IgG Ab [Presence] in Serum |
|
41476-3
|
Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay |
|
8003-6
|
Rickettsia rickettsii IgG Ab [Units/volume] in Serum |
|
47477-5
|
Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid |
|
47069-0
|
Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49145-6
|
Rickettsia rickettsii IgG Ab [Titer] in Body fluid |
|
48913-8
|
Rickettsia rickettsii IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
22482-4
|
Rickettsia rickettsii IgG Ab [Titer] in Serum |
|
5307-4
|
Rickettsia rickettsii IgG Ab [Titer] in Serum by Immunofluorescence |
|
35563-6
|
Rickettsia rickettsii IgG and IgM panel - Serum |
|
18430-9
|
Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid |
|
42969-6
|
Rickettsia rickettsii IgM Ab [Presence] in Serum |
|
41475-5
|
Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay |
|
8004-4
|
Rickettsia rickettsii IgM Ab [Units/volume] in Serum |
|
47478-3
|
Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid |
|
47070-8
|
Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
49146-4
|
Rickettsia rickettsii IgM Ab [Titer] in Body fluid |
|
48912-0
|
Rickettsia rickettsii IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
22483-2
|
Rickettsia rickettsii IgM Ab [Titer] in Serum |
|
5308-2
|
Rickettsia rickettsii IgM Ab [Titer] in Serum by Immunofluorescence |
|
8005-1
|
Rickettsia rickettsii RNA [Presence] in Serum by NAA with probe detection |
|
11482-7
|
Rickettsia rickettsii RNA [Presence] in Tissue by NAA with probe detection |
|
29736-6
|
Rickettsia sibirica Ab [Presence] in Serum |
|
29704-4
|
Rickettsia sibirica Ab [Presence] in Serum by Immunofluorescence |
|
31605-9
|
Rickettsia sibirica Ab [Units/volume] in Serum |
|
29679-8
|
Rickettsia sibirica Ab [Titer] in Serum |
|
29703-6
|
Rickettsia sibirica Ab [Titer] in Serum by Immunofluorescence |
|
17539-8
|
Rickettsia typhi Ab [Units/volume] in Serum by Latex agglutination |
|
29685-5
|
Rickettsia typhi Ab [Presence] in Serum |
|
29712-7
|
Rickettsia typhi Ab [Presence] in Serum by Immunofluorescence |
|
22486-5
|
Rickettsia typhi Ab [Units/volume] in Serum |
|
29684-8
|
Rickettsia typhi Ab [Titer] in Serum |
|
29711-9
|
Rickettsia typhi Ab [Titer] in Serum by Immunofluorescence |
|
41876-4
|
Rickettsia typhi and Rickettsia spotted fever group IgG and IgM panel - Serum |
|
17540-6
|
Rickettsia typhi IgA Ab [Units/volume] in Serum by Immunofluorescence |
|
22487-3
|
Rickettsia typhi IgA Ab [Units/volume] in Serum |
|
29321-7
|
Rickettsia typhi IgG Ab [Presence] in Body fluid |
|
22488-1
|
Rickettsia typhi IgG Ab [Presence] in Serum |
|
17541-4
|
Rickettsia typhi IgG Ab [Presence] in Serum by Immunoassay |
|
56881-6
|
Rickettsia typhi IgG Ab [Presence] in Serum by Immunofluorescence |
|
8007-7
|
Rickettsia typhi IgG Ab [Units/volume] in Serum |
|
24279-2
|
Rickettsia typhi IgG Ab [Titer] in Serum --1st specimen |
|
24205-7
|
Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24280-0
|
Rickettsia typhi IgG Ab [Titer] in Serum --2nd specimen |
|
24206-5
|
Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
47479-1
|
Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid |
|
47065-8
|
Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
31076-3
|
Rickettsia typhi IgG Ab [Titer] in Body fluid |
|
48914-6
|
Rickettsia typhi IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
22489-9
|
Rickettsia typhi IgG Ab [Titer] in Serum |
|
5324-9
|
Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence |
|
29322-5
|
Rickettsia typhi IgM Ab [Presence] in Body fluid |
|
31611-7
|
Rickettsia typhi IgM Ab [Units/volume] in Body fluid |
|
33001-9
|
Rickettsia typhi IgM Ab [Presence] in Serum |
|
8008-5
|
Rickettsia typhi IgM Ab [Units/volume] in Serum |
|
47480-9
|
Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid |
|
47067-4
|
Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
31077-1
|
Rickettsia typhi IgM Ab [Titer] in Body fluid |
|
48915-3
|
Rickettsia typhi IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
22490-7
|
Rickettsia typhi IgM Ab [Titer] in Serum |
|
5325-6
|
Rickettsia typhi IgM Ab [Titer] in Serum by Immunofluorescence |
|
93511-4
|
Rickettsia rickettsii and Coxiella burnetii phase 1 and Coxiella burnetii phase 2 IgG panel - Serum |
|
75635-3
|
Rheumatoid arthritis disease activity panel - Serum or Plasma by VectraDA |
|
17532-3
|
Rheumatoid arthritis nuclear Ab [Presence] in Serum |
|
9839-2
|
Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
|
17533-1
|
Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immunofluorescence |
|
11571-7
|
Rheumatoid arthritis nuclear Ab [Units/volume] in Serum |
|
56977-2
|
Rheumatoid arthritis nuclear Ab [Titer] in Serum by Immunofluorescence |
|
60996-6
|
Right atrial pressure |
|
60997-4
|
Right atrial pressure Diastolic |
|
60998-2
|
Right atrial pressure Systolic |
|
50960-4
|
Rabbit Ab [Presence] in Serum |
|
50961-2
|
Rabbit Ab [Titer] in Serum |
|
7641-4
|
Rabbit Bush IgE Ab [Units/volume] in Serum |
|
43422-5
|
Rabbit dander IgE Ab [Units/volume] in Serum |
|
6223-2
|
Rabbit epithelium IgE Ab [Units/volume] in Serum |
|
39606-9
|
Rabbit epithelium IgE Ab/IgE total in Serum |
|
56367-6
|
Rabbit epithelium IgG4 Ab [Mass/volume] in Serum |
|
39805-7
|
Rabbit hair IgE Ab [Units/volume] in Serum |
|
56366-8
|
Rabbit IgG4 Ab [Mass/volume] in Serum |
|
63113-5
|
Rabbit IgG Ab [Mass/volume] in Serum |
|
7642-2
|
Rabbit meat IgE Ab [Units/volume] in Serum |
|
10960-3
|
Rabbit serum proteins IgE Ab [Units/volume] in Serum |
|
10961-1
|
Rabbit urine proteins IgE Ab [Units/volume] in Serum |
|
73174-5
|
RABEprazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73175-2
|
RABEprazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
70856-0
|
Rabies virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
6523-5
|
Rabies virus Ab [Units/volume] in Cerebral spinal fluid by Neutralization test |
|
70857-8
|
Rabies virus Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
70859-4
|
Rabies virus Ab [Presence] in Cerebral spinal fluid by Neutralization test |
|
6522-7
|
Rabies virus Ab [Units/volume] in Cerebral spinal fluid |
|
43590-9
|
Rabies virus Ab [Units/volume] in Serum by Immunoassay |
|
6524-3
|
Rabies virus Ab [Units/volume] in Serum by Neutralization test |
|
30553-2
|
Rabies virus Ab [Presence] in Serum |
|
41507-5
|
Rabies virus Ab [Presence] in Serum by Immunoassay |
|
70858-6
|
Rabies virus Ab [Presence] in Serum by Neutralization test |
|
5288-6
|
Rabies virus Ab [Units/volume] in Serum |
|
6525-0
|
Rabies virus Ab [Units/volume] in Tissue by Neutralization test |
|
22458-4
|
Rabies virus Ab [Units/volume] in Tissue |
|
14128-3
|
Rabies virus Ab [Titer] in Serum |
|
43980-2
|
Rabies virus Ab [Titer] in Serum by Neutralization test |
|
6527-6
|
Rabies virus Ab [Units/volume] in Unspecified specimen by Neutralization test |
|
6526-8
|
Rabies virus Ab [Units/volume] in Unspecified specimen |
|
31946-7
|
Rabies virus Ag [Presence] in Brain |
|
23389-0
|
Rabies virus Ag [Presence] in Brain by Immunoassay |
|
23390-8
|
Rabies virus Ag [Presence] in Brain by Immune stain |
|
88211-8
|
Rabies virus Ag [Presence] in Cerebral spinal fluid by Immunoassay |
|
91075-2
|
Rabies virus Ag [Presence] in Saliva (oral fluid) by Immunoassay |
|
6529-2
|
Rabies virus Ag [Units/volume] in Tissue by Immunofluorescence |
|
91076-0
|
Rabies virus Ag [Presence] in Tissue by Immunoassay |
|
6528-4
|
Rabies virus Ag [Presence] in Tissue by Immunofluorescence |
|
6533-4
|
Rabies virus Ag [Units/volume] in Unspecified specimen by Immunofluorescence |
|
31947-5
|
Rabies virus Ag [Presence] in Unspecified specimen |
|
6532-6
|
Rabies virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23391-6
|
Rabies virus Ag [Presence] in Unspecified specimen by Immune stain |
|
31948-3
|
Rabies virus Ag [Units/volume] in Unspecified specimen |
|
23388-2
|
Rabies virus [Presence] in Brain by Light microscopy |
|
70860-2
|
Rabies virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
70861-0
|
Rabies virus IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
41128-0
|
Rabies virus IgG Ab [Presence] in Serum |
|
86587-3
|
Rabies virus IgG Ab [Presence] in Serum by Immunoassay |
|
40742-9
|
Rabies virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
58023-3
|
Rabies virus IgG Ab [Units/volume] in Serum |
|
70862-8
|
Rabies virus IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
70863-6
|
Rabies virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
70865-1
|
Rabies virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
70864-4
|
Rabies virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
86588-1
|
Rabies virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
60270-6
|
Rabies virus RNA [Presence] in Isolate by NAA with probe detection |
|
88215-9
|
Rabies virus RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
|
88214-2
|
Rabies virus RNA [Presence] in Tissue by NAA with probe detection |
|
51646-8
|
Rabies virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
51647-6
|
Rabies virus RNA [Presence] in Unspecified specimen by Probe |
|
70866-9
|
Rabies virus strain identified in Unspecified specimen by Immunofluorescence |
|
70867-7
|
Rabies virus strain identified in Unspecified specimen by Sequencing |
|
6536-7
|
Rabies virus identified in Tissue by Organism specific culture |
|
6539-1
|
Rabies virus identified in Unspecified specimen by Organism specific culture |
|
86805-9
|
Race and ethnicity information Document |
|
72826-1
|
Race OMB.1997 |
|
59362-4
|
Race or ethnicity OMB.1997 |
|
73569-6
|
Radiation exposure and protection information [Description] Document Diagnostic imaging |
|
83697-3
|
Radiation oncology Attending Note |
|
83593-4
|
Radiation oncology Nurse Education note |
|
83594-2
|
Radiation oncology Nurse Note |
|
34831-8
|
Radiation oncology Consult note |
|
78572-5
|
Radiation oncology Diagnostic study note |
|
78595-6
|
Radiation oncology Education note |
|
78628-5
|
Radiation oncology Flowsheet |
|
83917-5
|
Radiation oncology Hospital Note |
|
68603-0
|
Radiation oncology Hospital Summary note |
|
78653-3
|
Radiation oncology Initial evaluation note |
|
34832-6
|
Radiation oncology Note |
|
83918-3
|
Radiation oncology Outpatient Note |
|
83919-1
|
Radiation oncology Telephone encounter Note |
|
80785-9
|
Radiation oncology Plan of care note |
|
78656-6
|
Radiation oncology procedure note |
|
78665-7
|
Radiation oncology Progress note |
|
57159-6
|
Radiation oncology Referral note |
|
68602-2
|
Radiation oncology Summary note |
|
83775-7
|
Radiation oncology Resident Note |
|
83920-9
|
Radiation oncology Therapist Note |
|
85255-8
|
Radiology Administrative note |
|
85256-6
|
Radiology Attending Note |
|
73575-3
|
Radiology Consult note |
|
68604-8
|
Radiology Diagnostic study note |
|
85257-4
|
Radiology Education note |
|
93152-7
|
Radiology Initial evaluation note |
|
75490-3
|
Radiology Note |
|
85258-2
|
Radiology Nurse Education note |
|
85259-0
|
Radiology Nurse Note |
|
85260-8
|
Radiology Nurse procedure note |
|
85263-2
|
Radiology Telephone encounter Note |
|
90351-8
|
Radiology Postoperative evaluation and management note |
|
86450-4
|
Radiology Preoperative evaluation and management note |
|
85261-6
|
Radiology procedure note |
|
93151-9
|
Radiology Team Conference note |
|
85262-4
|
Radiology Technician Note |
|
7643-0
|
Radish IgE Ab [Units/volume] in Serum |
|
7644-8
|
Radish IgG Ab [Units/volume] in Serum |
|
56368-4
|
Radish IgG4 Ab [Mass/volume] in Serum |
|
60397-7
|
Radish IgG Ab [Mass/volume] in Serum |
|
82537-2
|
RAF1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
73750-2
|
RAI1 gene 17p11.2 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal |
|
51759-9
|
RAI1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
17510-9
|
Raisin IgE Ab [Units/volume] in Serum |
|
90295-7
|
RalA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
73173-7
|
Raloxifene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73172-9
|
Raloxifene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72525-9
|
Raltegravir [Susceptibility] by Genotype method |
|
72835-2
|
Raltegravir [Mass/volume] in Serum or Plasma |
|
59314-5
|
Ramelteon [Mass/volume] in Blood |
|
59316-0
|
Ramelteon [Mass/volume] in Body fluid |
|
59313-7
|
Ramelteon M-II [Mass/volume] in Blood |
|
59315-2
|
Ramelteon M-II [Mass/volume] in Body fluid |
|
59317-8
|
Ramelteon M-II [Mass/volume] in Serum or Plasma |
|
59319-4
|
Ramelteon M-II [Mass/mass] in Tissue |
|
59321-0
|
Ramelteon M-II [Mass/volume] in Urine |
|
59318-6
|
Ramelteon [Mass/volume] in Serum or Plasma |
|
59320-2
|
Ramelteon [Mass/mass] in Tissue |
|
59322-8
|
Ramelteon [Mass/volume] in Urine |
|
72962-4
|
Ramipril induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72961-6
|
Ramipril induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73171-1
|
Ramipril induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73170-3
|
Ramipril induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72960-8
|
raNITIdine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72959-0
|
raNITIdine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14900-5
|
raNITIdine [Presence] in Gastric fluid |
|
73168-7
|
raNITIdine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73169-5
|
raNITIdine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14901-3
|
raNITIdine [Presence] in Serum or Plasma |
|
6950-0
|
raNITIdine [Mass/volume] in Serum or Plasma |
|
14902-1
|
raNITIdine [Presence] in Urine |
|
32127-3
|
raNITIdine [Presence] in Unspecified specimen |
|
11194-8
|
Rape Pollen IgE Ab [Units/volume] in Serum |
|
11195-5
|
Rapeseed IgE Ab [Units/volume] in Serum |
|
79428-9
|
Rapid response team Consult note |
|
89814-8
|
Rapid response team procedure note |
|
89813-0
|
Rapid response team Progress note |
|
43427-4
|
Microscopic observation [Identifier] in Tissue by Rapid stain |
|
78217-7
|
RARA gene rearrangements [Presence] in Blood or Tissue by FISH |
|
7658-8
|
Raspberry triggered histamine release [Units/volume] in Blood |
|
7656-2
|
Raspberry IgE Ab [Units/volume] in Serum |
|
7657-0
|
Raspberry IgG Ab [Units/volume] in Serum |
|
56373-4
|
Raspberry IgG4 Ab [Mass/volume] in Serum |
|
63083-0
|
Raspberry IgG Ab [Mass/volume] in Serum |
|
6224-0
|
Rat epithelium IgE Ab [Units/volume] in Serum |
|
56374-2
|
Rat epithelium IgG4 Ab [Mass/volume] in Serum |
|
19753-3
|
Rat epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum |
|
7659-6
|
Rat hair IgE Ab [Units/volume] in Serum |
|
7660-4
|
Rat muliialgro IgE Ab [Units/volume] in Serum |
|
6225-7
|
Rat serum proteins IgE Ab [Units/volume] in Serum |
|
6226-5
|
Rat urine proteins IgE Ab [Units/volume] in Serum |
|
61346-3
|
Rat urine proteins IgE Ab/IgE total in Serum |
|
42795-5
|
Retinoblastoma protein [Presence] in Tissue by Immune stain |
|
47416-3
|
RB1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21731-5
|
RB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
55779-3
|
Erythrocytes [#/volume] in Amniotic fluid |
|
789-8
|
Erythrocytes [#/volume] in Blood by Automated count |
|
47280-3
|
Erythrocytes [#/volume] in Cord blood |
|
57841-9
|
Erythrocytes [#/volume] in Dialysis fluid by Automated count |
|
53517-9
|
Erythrocytes [#/volume] in Dialysis fluid by Manual count |
|
26455-6
|
Erythrocytes [#/volume] in Body fluid |
|
82588-5
|
Erythrocytes [#/volume] in Bone marrow by Automated count |
|
57842-7
|
Erythrocytes [#/volume] in Pericardial fluid by Automated count |
|
57843-5
|
Erythrocytes [#/volume] in Peritoneal fluid by Automated count |
|
43245-0
|
Erythrocytes [#/volume] in Semen by Light microscopy |
|
68435-7
|
Erythrocytes [#/volume] in Vitreous fluid by Automated count |
|
51910-8
|
Erythrocytes [#/area] in Bronchoalveolar lavage by Microscopy high power field |
|
75237-8
|
Erythrocytes [#/area] in Synovial fluid by Microscopy high power field |
|
59830-0
|
Erythrocytes in 3 hour Urine sediment by Light microscopy |
|
51790-4
|
RBC casts [#/area] in Urine sediment by Microscopy high power field |
|
90738-6
|
Erythrocytes.CD59 complete loss/100 erythrocytes in Blood |
|
88113-6
|
Erythrocytes [Presence] in Cerebral spinal fluid by Gram stain |
|
68901-8
|
Erythrocytes [Presence] in Dialysis fluid |
|
38285-3
|
Erythrocytes [Presence] in Duodenal fluid |
|
72695-0
|
Erythrocyte enzyme panel - Red Blood Cells |
|
57960-7
|
Erythrocytes [Morphology] in Body fluid by Light microscopy |
|
58408-6
|
Erythrocyte morphology panel - Blood |
|
72338-7
|
Erythrocytes [Presence] in Prostatic fluid by Light microscopy |
|
76673-3
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --1st tube |
|
46087-3
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --2nd tube |
|
46091-5
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --3rd tube |
|
46092-3
|
Erythrocytes [#/volume] in Cerebral spinal fluid by Manual count --4th tube |
|
85378-8
|
Erythrocytes.EMA mean fluorescence intensity actual/normal in Blood by Flow cytometry (FC) |
|
73930-0
|
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78878-6
|
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72469-0
|
RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73922-7
|
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood |
|
78880-2
|
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method |
|
72468-2
|
RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
73951-6
|
RCS-4 (synthetic cannabinoid) [Presence] in Blood |
|
76138-7
|
Reticulocyte distribution width [Ratio] in Blood by calculation |
|
64284-3
|
Readiness for duty assessment |
|
64294-2
|
Readiness for duty letter |
|
43813-5
|
Reagin Ab [Presence] in Cord blood |
|
22459-2
|
Reagin Ab [Presence] in Cerebral spinal fluid |
|
22460-0
|
Reagin Ab [Units/volume] in Cerebral spinal fluid |
|
22463-4
|
Reagin Ab [Presence] in Serum from Donor |
|
22461-8
|
Reagin Ab [Presence] in Serum |
|
22462-6
|
Reagin Ab [Units/volume] in Serum |
|
46203-6
|
Reagin Ab [Titer] in Cerebral spinal fluid |
|
11084-1
|
Reagin Ab [Titer] in Serum |
|
47476-7
|
Reagin Ab [Titer] in Unspecified specimen |
|
22464-2
|
Reagin Ab [Presence] in Unspecified specimen |
|
53577-3
|
Reason for study |
|
45968-5
|
Reasons for assessment (basic) Set |
|
50943-0
|
Reasons for assessment (full) Set |
|
88896-6
|
Reboxetine [Mass/volume] in Serum or Plasma |
|
48352-9
|
Reboxetine [Moles/volume] in Serum or Plasma |
|
34833-4
|
Recreational therapy Consult note |
|
83922-5
|
Recreational therapy Custodial care facility Note |
|
78581-6
|
Recreational therapy Discharge instructions |
|
83921-7
|
Recreational therapy Discharge summary |
|
78588-1
|
Recreational therapy Discharge teaching note |
|
83923-3
|
Recreational therapy Education note |
|
78635-0
|
Recreational therapy Flowsheet |
|
68605-5
|
Recreational therapy Hospital Education note |
|
83924-1
|
Recreational therapy Hospital Note |
|
78646-7
|
Recreational therapy Initial evaluation note |
|
83925-8
|
Recreational therapy Interdisciplinary Note |
|
83926-6
|
Recreational therapy Long term care facility Consult note |
|
83927-4
|
Recreational therapy Long term care facility Note |
|
34834-2
|
Recreational therapy Note |
|
83928-2
|
Recreational therapy Outpatient Note |
|
80784-2
|
Recreational therapy Plan of care note |
|
78664-0
|
Recreational therapy Progress note |
|
57160-4
|
Recreational therapy Referral note |
|
83929-0
|
Recreational therapy Risk assessment and screening note |
|
3242-5
|
Recalcification time in Platelet poor plasma by Coagulation assay |
|
88727-3
|
Recoverin Ab [Units/volume] in Serum by Line blot |
|
83003-4
|
Recoverin IgG Ab [Presence] in Serum or Plasma by Line blot |
|
46074-1
|
Recreational therapy Set |
|
65755-1
|
Rectum Pathology biopsy report |
|
7062-3
|
Red Alder IgE Ab [Units/volume] in Serum |
|
56461-7
|
Red Alder IgG4 Ab [Mass/volume] in Serum |
|
7087-0
|
Red Ant IgE Ab [Units/volume] in Serum |
|
7146-4
|
Red Beet IgE Ab [Units/volume] in Serum |
|
56375-9
|
Red Beet IgG4 Ab [Mass/volume] in Serum |
|
63201-8
|
Red Beet IgG Ab [Mass/volume] in Serum |
|
93739-1
|
Red cabbage IgE Ab [Units/volume] in Serum |
|
7195-1
|
Red Cedar IgE Ab [Units/volume] in Serum |
|
48244-8
|
Red Cedar triggered leukotriene release [Mass/volume] by Leukocytes |
|
19754-1
|
Red Currant IgE Ab [Units/volume] in Serum |
|
17511-7
|
Red dye IgE Ab [Units/volume] in Serum |
|
6117-6
|
Red Imported Fire Ant IgE Ab [Units/volume] in Serum |
|
61315-8
|
Red Imported Fire Ant IgE Ab/IgE total in Serum |
|
56260-3
|
Red Imported Fire Ant IgG4 Ab [Mass/volume] in Serum |
|
7129-0
|
Red Kidney Bean IgE Ab [Units/volume] in Serum |
|
7130-8
|
Red Kidney Bean IgG Ab [Units/volume] in Serum |
|
56297-5
|
Red Kidney Bean IgG4 Ab [Mass/volume] in Serum |
|
60354-8
|
Red Kidney Bean IgG Ab [Mass/volume] in Serum |
|
7480-7
|
Red Maple triggered histamine release [Units/volume] in Blood |
|
7479-9
|
Red Maple IgE Ab [Units/volume] in Serum |
|
24150-5
|
Red Maple IgG Ab [Units/volume] in Serum |
|
7514-3
|
Red mulberry IgE Ab [Units/volume] in Serum |
|
24142-2
|
Red mulberry IgG Ab [Units/volume] in Serum |
|
7534-1
|
Red Oak IgE Ab [Units/volume] in Serum |
|
7595-2
|
Red Pepper triggered histamine release [Units/volume] in Blood |
|
6227-3
|
Red Pepper IgE Ab [Units/volume] in Serum |
|
56462-5
|
Red Pepper IgG4 Ab [Mass/volume] in Serum |
|
7661-2
|
Red Snapper IgE Ab [Units/volume] in Serum |
|
7662-0
|
Red Snapper IgG Ab [Units/volume] in Serum |
|
56376-7
|
Red Snapper IgG4 Ab [Mass/volume] in Serum |
|
60404-1
|
Red Snapper IgG Ab [Mass/volume] in Serum |
|
7368-4
|
Red top grass triggered histamine release [Units/volume] in Blood |
|
6228-1
|
Red top grass IgE Ab [Units/volume] in Serum |
|
43941-4
|
Red top grass IgE Ab/IgE total in Serum |
|
56377-5
|
Red top grass IgG4 Ab [Mass/volume] in Serum |
|
7481-5
|
Red+Silver Maple IgE Ab [Units/volume] in Serum |
|
17512-5
|
Redfish IgE Ab [Units/volume] in Serum |
|
38364-6
|
Haloperidol reduced [Mass/volume] in Serum or Plasma |
|
11060-1
|
Reducing substances [Presence] in Stool |
|
57796-5
|
Reducing substances [Presence] in Stool by Post hydrolysis |
|
32211-5
|
Reducing substances [Mass/volume] in Stool |
|
59242-8
|
Reducing substances [Moles/volume] in Stool |
|
5809-9
|
Reducing substances [Presence] in Urine |
|
32147-1
|
Reducing substances [Mass/volume] in Urine |
|
59234-5
|
Reducing substances [Moles/volume] in Urine |
|
7663-8
|
Redwood Dust IgE Ab [Units/volume] in Serum |
|
7664-6
|
Redwood IgE Ab [Units/volume] in Serum |
|
51991-8
|
Reference lab test panel |
|
81294-1
|
Genetic form configuration controls Nominal |
|
57133-1
|
Referral note |
|
15232-2
|
Regional Allergen Mix A (Common ragweed+Mugwort+Japenese cedar+Orchard grass+Timothy) IgE Ab [Presence] in Serum by Multidisk |
|
15258-7
|
Regional Allergen Mix B (Common ragweed+Goosefoot or Lambs quarters+Bermuda grass+Perennial rye grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
|
15256-1
|
Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Presence] in Serum by Multidisk |
|
82103-3
|
Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
|
15257-9
|
Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
|
82105-8
|
Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Units/volume] in Serum by Multidisk |
|
51525-4
|
Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
|
82107-4
|
Regional Allergen Mix 3 (Common Ragweed+Goosefoot+Bermuda grass+Perennial rye grass+English Plantain+Bahia grass) IgE Ab [Units/volume] in Serum by Multidisk |
|
15259-5
|
Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Presence] in Serum by Multidisk |
|
82109-0
|
Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
|
51526-2
|
Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Presence] in Serum by Multidisk |
|
37988-3
|
Regional Allergy Mix 5 (Aspergillus fumigatus+Cockroach+Cat dander+European house dust mite) IgE Ab [Units/volume] in Serum by Multidisk |
|
82359-1
|
Reproductive endocrinology and infertility Consult note |
|
82360-9
|
Reproductive endocrinology and infertility Diagnostic study note |
|
82361-7
|
Reproductive endocrinology and infertility Education note |
|
82362-5
|
Reproductive endocrinology and infertility Flowsheet |
|
82363-3
|
Reproductive endocrinology and infertility Initial evaluation note |
|
82364-1
|
Reproductive endocrinology and infertility Plan of care note |
|
82366-6
|
Reproductive endocrinology and infertility procedure note |
|
82365-8
|
Reproductive endocrinology and infertility Progress note |
|
82358-3
|
Reproductive endocrinology and infertility Referral note |
|
10950-4
|
Reindeer epithelium IgE Ab [Units/volume] in Serum |
|
75930-8
|
Relative humidity setting Infant microenvironment.incubator |
|
75929-0
|
Relative humidity Infant microenvironment.incubator |
|
64292-6
|
Release of information consent Document |
|
49628-1
|
Remnant lipoprotein [Mass/volume] in Serum or Plasma |
|
90044-9
|
Epithelial cells.renal [Presence] in Urine sediment |
|
24362-6
|
Renal function 2000 panel - Serum or Plasma |
|
56577-0
|
Renin [Enzymatic activity/volume] in Plasma --1.5 hours post XXX challenge |
|
78517-0
|
Renin [Mass/volume] in Plasma --2 hours post XXX challenge |
|
2916-5
|
Renin renal clearance in 24 hour Urine and Serum or Plasma |
|
30895-7
|
Renin [Units/volume] in Plasma |
|
2915-7
|
Renin [Enzymatic activity/volume] in Plasma |
|
35570-1
|
Renin [Mass/volume] in Plasma |
|
92826-7
|
Renin [Units/volume] in Plasma --supine |
|
17516-6
|
Renin [Enzymatic activity/volume] in Plasma --supine |
|
2917-3
|
Renin [Mass/volume] in Plasma --supine |
|
92825-9
|
Renin [Units/volume] in Plasma --upright |
|
2918-1
|
Renin [Enzymatic activity/volume] in Plasma --upright |
|
47883-4
|
Renin [Mass/volume] in Plasma --upright |
|
56975-6
|
Renin [Mass/volume] in Plasma --upright+30 minutes post XXX challenge |
|
31581-2
|
Reovirus Ab [Units/volume] in Cerebral spinal fluid |
|
31582-0
|
Reovirus Ab [Units/volume] in Body fluid |
|
5293-6
|
Reovirus Ab [Units/volume] in Serum |
|
29354-8
|
Reovirus Ab [Titer] in Cerebral spinal fluid |
|
29413-2
|
Reovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
29415-7
|
Reovirus Ab [Titer] in Body fluid |
|
29355-5
|
Reovirus Ab [Titer] in Body fluid by Complement fixation |
|
22465-9
|
Reovirus Ab [Titer] in Serum |
|
11012-2
|
Reovirus Ab [Titer] in Serum by Complement fixation |
|
48328-9
|
Repaglinide [Presence] in Serum or Plasma |
|
38542-7
|
Repaglinide [Mass/volume] in Serum or Plasma |
|
73689-2
|
Repaglinide [Mass/volume] in Urine |
|
52056-9
|
Repair of durable medical equipment attachment |
|
25015-9
|
Replacement of percutaneous gastrojejunostomy Upper GI tract Document |
|
80563-0
|
Report |
|
72509-3
|
Reporting rate Reporting Period Population Calculated |
|
73983-9
|
Report.section heading Unspecified body region |
|
88085-6
|
Reportability response report Document Public health |
|
82267-6
|
Reported Activity metabolic rate/Measured RMR [Relative energy/Time] |
|
82272-6
|
Reported Activity metabolic rate/Population RMR [Relative energy/Time] |
|
82275-9
|
Reported Activity metabolic rate/Predicted RMR [Relative energy/Time] |
|
82263-5
|
Reported activity metabolic rate/Standard RMR [Relative energy/Time] |
|
91879-7
|
Reporter Information |
|
77966-0
|
Reporting state |
|
6683-7
|
Reptilase time |
|
75477-0
|
Resident Note |
|
83931-6
|
Research Consult note |
|
83932-4
|
Research Discharge summary |
|
83933-2
|
Research Evaluation and management of hypertension note |
|
83934-0
|
Research Initial evaluation note |
|
83935-7
|
Research Medication management note |
|
68839-0
|
Research Note |
|
83936-5
|
Research Nurse Note |
|
83937-3
|
Research Outpatient Note |
|
83939-9
|
Research Telephone encounter Note |
|
83938-1
|
Research procedure note |
|
68840-8
|
Research Progress note |
|
77602-1
|
Research study consent |
|
46079-0
|
Resident assessment protocol summary section |
|
45971-9
|
Residential history 5 years prior to entry Set |
|
46637-5
|
Residual physical functional capacity (RFC) assessment form [RFC] |
|
81453-3
|
Residual volume --post bronchodilation |
|
81452-5
|
Residual volume --pre bronchodilation |
|
94125-2
|
Residual volume/Predicted by Plethysmograph body box |
|
81455-8
|
Residual volume/Total capacity --post bronchodilation |
|
81454-1
|
Residual volume/Total capacity --pre bronchodilation |
|
75632-0
|
Resistin [Mass/volume] in Serum or Plasma |
|
81541-5
|
Resource identifier [URI] for Patient education material |
|
48841-1
|
Respiratory allergen panel, US - Alaska a - Serum |
|
48932-8
|
Respiratory allergen panel, US - Alaska b - Serum |
|
48835-3
|
Respiratory allergen panel, US - Arid southwest - Serum |
|
48931-0
|
Respiratory allergen panel, US - AZ, Southeastern CA, Western NM - Serum |
|
48837-9
|
Respiratory allergen panel, US - California central valley - Serum |
|
48840-3
|
Respiratory allergen panel, US - Cascade Pacific northwest a - Serum |
|
48929-4
|
Respiratory allergen panel, US - Cascade Pacific northwest b - Serum |
|
48831-2
|
Respiratory allergen panel, US - Central midwest a - Serum |
|
48925-2
|
Respiratory allergen panel, US - Central midwest b - Serum |
|
49020-1
|
Respiratory allergen panel, US - Coastal California - Serum |
|
48832-0
|
Respiratory allergen panel, US - Great plains states a - Serum |
|
48926-0
|
Respiratory allergen panel, US - Great plains states b - Serum |
|
48828-8
|
Respiratory allergen panel, US - Greater Ohio valley a - Serum |
|
48923-7
|
Respiratory allergen panel, US - Greater Ohio valley b - Serum |
|
49021-9
|
Respiratory allergen panel, US - Greater Ohio valley c - Serum |
|
48933-6
|
Respiratory allergen panel, US - Hawaii - Serum |
|
48839-5
|
Respiratory allergen panel, US - Inland northwest a - Serum |
|
48928-6
|
Respiratory allergen panel, US - Inland northwest b - Serum |
|
48838-7
|
Respiratory allergen panel, US - Intermountain west a - Serum |
|
48930-2
|
Respiratory allergen panel, US - Intermountain west b - Serum |
|
49018-5
|
Respiratory allergen panel, US - Intermountain west c - Serum |
|
48825-4
|
Respiratory allergen panel, US - Mid Atlantic states - Serum |
|
48919-5
|
Respiratory allergen panel, US - Central Florida - Serum |
|
48824-7
|
Respiratory allergen panel, US - North Atlantic states a - Serum |
|
48916-1
|
Respiratory allergen panel, US - North Atlantic states b - Serum |
|
49017-7
|
Respiratory allergen panel, US - North Atlantic states c - Serum |
|
48830-4
|
Respiratory allergen panel, US - Northern midwest states a - Serum |
|
48924-5
|
Respiratory allergen panel, US - Northern midwest states b - Serum |
|
49022-7
|
Respiratory allergen panel, US - Northern midwest states c - Serum |
|
48918-7
|
Respiratory allergen panel, US - NC, PA, SC, VA, WV - Serum |
|
49019-3
|
Respiratory allergen panel, US - Puerto Rico - Serum |
|
48834-6
|
Respiratory allergen panel, US - Rocky mountain states a - Serum |
|
48927-8
|
Respiratory allergen panel, US - Rocky mountain states b - Serum |
|
48826-2
|
Respiratory allergen panel, US - South Atlantic states a - Serum |
|
48917-9
|
Respiratory allergen panel, US - South Atlantic states b - Serum |
|
48829-6
|
Respiratory allergen panel, US - South central states - Serum |
|
48836-1
|
Respiratory allergen panel, US - Southern coastal California - Serum |
|
48920-3
|
Respiratory allergen panel, US - Southern Florida - Serum |
|
48921-1
|
Respiratory allergen panel, US - Southeast coast - Serum |
|
48827-0
|
Respiratory allergen panel, US - Subtropical Florida - Serum |
|
48833-8
|
Respiratory allergen panel, US - Southwestern grassland states - Serum |
|
48922-9
|
Respiratory allergen panel, US - West south central states - Serum |
|
81655-3
|
Respiratory pathogens DNA and RNA identified in Respiratory specimen by NAA with probe detection |
|
91776-5
|
Respiratory Mycoplasma identified in Lower respiratory specimen by Organism specific culture |
|
684-1
|
Respiratory Mycoplasma identified in Sputum by Organism specific culture |
|
685-8
|
Respiratory Mycoplasma identified in Throat by Organism specific culture |
|
686-6
|
Respiratory Mycoplasma identified in Unspecified specimen by Organism specific culture |
|
50219-5
|
Respiratory pathogens DNA and RNA 12a panel - Unspecified specimen by NAA with probe detection |
|
60566-7
|
Respiratory pathogens DNA and RNA 12b panel - Unspecified specimen by NAA with probe detection |
|
76091-8
|
Respiratory pathogens DNA and RNA 4 panel - Nasopharynx by NAA with probe detection |
|
77029-7
|
Respiratory pathogens DNA and RNA 14 panel - Nasopharynx by NAA with probe detection |
|
82127-2
|
Respiratory pathogens DNA and RNA identified in Pleural fluid by NAA with probe detection |
|
92958-8
|
Respiratory pathogens DNA and RNA panel - Lower respiratory specimen by NAA with non-probe detection |
|
82159-5
|
Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with non-probe detection |
|
78922-2
|
Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with probe detection |
|
92143-7
|
Respiratory pathogens DNA and RNA panel - Respiratory specimen by NAA with probe detection |
|
76771-5
|
Respiratory pathogens RNA 8 panel - Unspecified specimen by NAA with probe detection |
|
76269-0
|
Respiratory quotient Respiratory system |
|
76170-0
|
Respiratory rate by Acoustic measurement |
|
76171-8
|
Respiratory rate by Airway flow measurement |
|
76172-6
|
Respiratory rate by Carbon dioxide measurement |
|
89279-4
|
Respiratory rate --during anesthesia |
|
76270-8
|
Respiratory rate by Impedance.transthoracic |
|
76173-4
|
Respiratory rate by Non-airway pressure measurement |
|
76174-2
|
Respiratory rate by Pulse oximetry.plethysmograph |
|
89292-7
|
Respiratory rate --W pain |
|
34837-5
|
Respiratory therapy Consult note |
|
78569-1
|
Respiratory therapy Counseling note |
|
78580-8
|
Respiratory therapy Discharge instructions |
|
85433-1
|
Respiratory therapy Discharge summary |
|
78586-5
|
Respiratory therapy Discharge teaching note |
|
78609-5
|
Respiratory therapy Education note |
|
78640-0
|
Respiratory therapy Flowsheet |
|
68470-4
|
Respiratory therapy Hospital Initial evaluation note |
|
83943-1
|
Respiratory therapy Hospital Note |
|
68479-5
|
Respiratory therapy Hospital Progress note |
|
83940-7
|
Respiratory therapy Intensive care unit Note |
|
78728-3
|
Respiratory therapy Initial evaluation note |
|
83944-9
|
Respiratory therapy Long term care facility Note |
|
34838-3
|
Respiratory therapy Note |
|
83945-6
|
Respiratory therapy Outpatient Note |
|
83946-4
|
Respiratory therapy Telephone encounter Note |
|
80772-7
|
Respiratory therapy Plan of care note |
|
78658-2
|
Respiratory therapy procedure note |
|
83941-5
|
Respiratory therapy Patient's home Consult note |
|
83942-3
|
Respiratory therapy Patient's home Note |
|
57162-0
|
Respiratory therapy Referral note |
|
54245-6
|
Respiratory virus Ag [Identifier] in Unspecified specimen by Immunofluorescence |
|
50548-7
|
Respiratory virus DNA+RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
12413-1
|
Resperine [Mass/volume] in Serum or Plasma |
|
12414-9
|
Resperine [Mass/volume] in Urine |
|
88058-3
|
Respiratory measurements Document |
|
87964-3
|
Respiratory pathogens panel - Bronchoalveolar lavage by Immunofluorescence |
|
88137-5
|
Respiratory pathogens panel - Nasopharynx by Immunofluorescence |
|
88129-2
|
Respiratory pathogens panel - Throat by Immunofluorescence |
|
55101-0
|
Respiratory pathogens panel - Unspecified specimen by Organism specific culture |
|
85212-9
|
Respite note |
|
75949-8
|
Response entropy [Score] Cerebral cortex Electroencephalogram (EEG) |
|
45985-9
|
Responsibility/legal guardian Set |
|
70007-0
|
Restraint note |
|
40693-4
|
RET gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21733-1
|
RET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
90927-5
|
RET gene rearrangements in Blood or Tissue by FISH |
|
50262-5
|
Reticulocytes panel - Blood |
|
60474-4
|
Reticulocytes [#/volume] in Blood by Automated count |
|
42758-3
|
Reticulocytes [#/volume] in Blood by calculation |
|
40665-2
|
Reticulocytes [#/volume] in Blood by Manual count |
|
76140-3
|
Reticulocytes.hypochromic/100 erythrocytes in Blood by Automated count |
|
4679-7
|
Reticulocytes/100 erythrocytes in Blood |
|
17849-1
|
Reticulocytes/100 erythrocytes in Blood by Automated count |
|
17521-6
|
Reticulin Ab [Presence] in Serum |
|
57414-5
|
Reticulin Ab [Presence] in Serum by Immunofluorescence |
|
5296-9
|
Reticulin Ab [Units/volume] in Serum |
|
9398-9
|
Reticulin Ab [Titer] in Serum |
|
51722-7
|
Reticulin Ab [Titer] in Serum by Immunofluorescence |
|
14273-7
|
Reticulin IgA Ab [Presence] in Serum |
|
9720-4
|
Reticulin IgA Ab [Titer] in Serum |
|
17522-4
|
Reticulin IgA Ab [Titer] in Serum by Immunofluorescence |
|
31585-3
|
Reticulin IgG Ab [Presence] in Serum |
|
26970-4
|
Reticulin IgG Ab [Presence] in Serum by Immunofluorescence |
|
31584-6
|
Reticulin IgG Ab [Units/volume] in Serum |
|
17523-2
|
Reticulin IgG Ab [Titer] in Serum |
|
17524-0
|
Reticulin IgG Ab [Titer] in Serum by Immunofluorescence |
|
2919-9
|
Reticulin [Mass/volume] in Serum |
|
87673-0
|
Retinal+retinol+retinoic acid [Mass/mass] in Unspecified specimen |
|
17525-7
|
Retinoate esters [Mass/volume] in Serum or Plasma |
|
2921-5
|
Retinoate [Mass/volume] in Serum or Plasma |
|
18362-4
|
Alpha-2-Retinol binding protein [Mass/time] in 24 hour Urine |
|
1836-6
|
Alpha-2-Retinol binding protein [Mass/volume] in Serum or Plasma |
|
33782-4
|
Alpha-2-Retinol binding protein [Mass/volume] in Urine |
|
38496-6
|
Retinyl palmitate [Mass/volume] in Serum or Plasma |
|
17530-7
|
Retrovirus identified in Unspecified specimen by Organism specific culture |
|
22103-6
|
Reticuloendotheliosis virus Ab [Presence] in Serum |
|
15454-2
|
Reticuloendotheliosis virus Ab [Presence] in Serum by Immunoassay |
|
89549-0
|
Revised Geneva Score panel |
|
93083-4
|
Revised Prenatal Distress Questionnaire (NuPDQ) - Concurrent Self-Administered Version |
|
46437-0
|
Rheumatoid Factor and Cyclic Citrullinated Peptide IgG panel [Units/volume] - Serum |
|
42703-9
|
RF Less than 1 hour |
|
86406-6
|
RF Unspecified body region Less than 1 hour Views during surgery |
|
42702-1
|
RF Greater than 1 hour |
|
25065-4
|
RF 15 minutes |
|
25068-8
|
RF 1 hour |
|
30642-3
|
RF Unspecified body region Single view |
|
43471-2
|
RF 2 hour |
|
25066-2
|
RF 30 minutes |
|
25067-0
|
RF 45 minutes |
|
43472-0
|
RF 90 minutes |
|
46341-4
|
RF Abdomen Views |
|
37183-1
|
RF Ankle Arthrogram |
|
37184-9
|
RF Ankle - bilateral Arthrogram |
|
37185-6
|
RF Ankle - left Arthrogram |
|
37942-0
|
RF Ankle - right Arthrogram |
|
86373-8
|
RF AV fistula Views W contrast via additional puncture |
|
86391-0
|
RF AV fistula Views W contrast via existing catheter |
|
86382-9
|
RF Biliary ducts Limited Views during surgery |
|
86383-7
|
RF Biliary ducts Views W contrast IV |
|
86376-1
|
RF Biliary ducts Views W contrast via existing catheter |
|
24574-6
|
RF Biliary ducts and Gallbladder Views during surgery W contrast biliary duct |
|
24575-3
|
RF Biliary ducts and Gallbladder Views W contrast percutaneous transhepatic |
|
30647-2
|
RF Biliary ducts and Gallbladder Views W contrast via T-tube |
|
38092-3
|
RF Urinary bladder Views W chain and contrast intra bladder |
|
86401-7
|
RF Urinary bladder Views W contrast intra bladder |
|
37569-1
|
RF Urinary bladder Views W contrast via suprapubic tube |
|
42014-1
|
RF Urinary bladder and Urethra Views W contrast |
|
38100-4
|
RF Urinary bladder and Urethra Views W contrast antegrade |
|
43559-4
|
RF Urinary bladder and Urethra Views W contrast intra bladder during voiding |
|
25017-5
|
RF Urinary bladder and Urethra Views W contrast intra bladder |
|
25020-9
|
RF Urinary bladder and Urethra Views W contrast retrograde via urethra |
|
69076-8
|
RF guidance for percutaneous biopsy of Bone |
|
38125-1
|
RF Cervical and thoracic and lumbar spine Limited Views W contrast IT |
|
30808-0
|
RF Cervical and thoracic and lumbar spine Views W contrast IT |
|
24620-7
|
RF Catheter Views for patency check W contrast via catheter |
|
86398-5
|
RF Cerebral cisterns Views W contrast IT |
|
86439-7
|
RF Cerebral sinuses Views W contrast IV |
|
24656-1
|
RF Chest Single view during surgery |
|
24655-3
|
RF Chest Image intensifier during surgery |
|
30631-6
|
RF Chest Views |
|
37199-7
|
RF Chest Views W contrast PO |
|
24668-6
|
RF Colon Single view for transit Post solid contrast |
|
86381-1
|
RF Colon Screening W air and barium contrast PR |
|
44226-9
|
RF Colon Views for reduction W barium contrast PR |
|
30636-5
|
RF Colon Views for reduction W contrast PR |
|
41797-2
|
RF Colon Limited Views W air and barium contrast PR |
|
46357-0
|
RF Colon Views W air contrast PR |
|
24666-0
|
RF Colon Views W air and barium contrast PR |
|
44227-7
|
RF Colon Views W barium contrast PR |
|
24667-8
|
RF Colon Views W contrast PR |
|
37567-5
|
RF Colon Views W contrast via colostomy |
|
42681-7
|
RF Colon Views W gastrografin PR |
|
24669-4
|
RF Colon Views W water soluble contrast PR |
|
36640-1
|
RF Cervical spine Views |
|
42335-0
|
RF Cervical spine Limited Views W contrast IT |
|
37192-2
|
RF Cervical spine Views W contrast intradisc |
|
24947-4
|
RF Cervical spine Views W contrast IT |
|
38103-8
|
RF Spine Cervical and Spine Lumbar Views W contrast IT |
|
30632-4
|
RF Diaphragm for motion |
|
37186-4
|
RF Elbow Arthrogram |
|
37187-2
|
RF Elbow - bilateral Arthrogram |
|
37188-0
|
RF Elbow - left Arthrogram |
|
37947-9
|
RF Elbow - right Arthrogram |
|
38104-6
|
RF Spine epidural space Views W contrast IT |
|
30633-2
|
RF Esophagus Views W barium contrast PO |
|
24678-5
|
RF Esophagus Views W contrast PO |
|
24679-3
|
RF Esophagus Views W gastrografin PO |
|
86437-1
|
RF Fistula Diagnostic W contrast intra fistula |
|
86385-2
|
RF Gallbladder Views W contrast PO |
|
86384-5
|
RF Gallbladder Views W contrast and fatty meal PO |
|
86378-7
|
RF Gastrointestinal tract Views for fistula |
|
24998-7
|
RF Placement check of gastrostomy tube W contrast via GI tube |
|
42422-6
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Breast |
|
42423-4
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Chest |
|
44223-6
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Ovary |
|
35890-3
|
RF Guidance for biopsy of Abdomen |
|
69241-8
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Abdomen |
|
42017-4
|
RF Guidance for percutaneous replacement of cholecystostomy of Abdomen |
|
35885-3
|
RF Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region |
|
69242-6
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Appendix |
|
30892-4
|
RF Guidance for placement of catheter in Biliary ducts and Pancreatic duct-- W contrast retrograde |
|
43478-7
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 1.5 hours post contrast retrograde intrabiliary |
|
43474-6
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 15m post contrast retrograde intrabiliary |
|
43477-9
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 1H post contrast retrograde intrabiliary |
|
43473-8
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 2H post contrast retrograde intrabiliary |
|
43475-3
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 30M post contrast retrograde intrabiliary |
|
43476-1
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- 45M post contrast retrograde intrabiliary |
|
30815-5
|
RF Guidance for endoscopy of Biliary ducts and Pancreatic duct-- W contrast retrograde |
|
36761-5
|
RF Guidance for balloon dilatation of Biliary ducts-- W contrast |
|
44214-5
|
RF Guidance for endoscopy of Biliary ducts-- W contrast retrograde |
|
46372-9
|
RF Guidance for percutaneous drainage and placement of drainage catheter of Biliary ducts |
|
72545-7
|
RF Guidance for percutaneous replacement of drainage tube of Biliary ducts and Gallbladder |
|
24782-5
|
RF Guidance for percutaneous placement of nephroureteral stent of Kidney - bilateral-- W contrast via stent |
|
86397-7
|
RF Guidance for drainage and placement of suprapubic catheter of Urinary bladder |
|
86404-1
|
RF Guidance for fluid aspiration of Urinary bladder |
|
69306-9
|
RF Guidance for aspiration of cyst of Bone |
|
75669-2
|
RF Guidance for biopsy of Bone marrow |
|
38154-1
|
RF Guidance for superficial biopsy of Bone |
|
41803-8
|
RF Guidance for biopsy of Breast |
|
25069-6
|
RF Guidance for biopsy of Unspecified body region |
|
35912-5
|
RF Guidance for placement of catheter in Unspecified body region |
|
24570-4
|
RF Guidance for removal of calculus from Biliary duct common-- W contrast retrograde intra biliary |
|
35889-5
|
RF Guidance for bronchoscopy of Chest |
|
35894-5
|
RF Guidance for biopsy of Chest |
|
69078-4
|
RF Guidance for drainage and placement of drainage catheter of Chest |
|
69127-9
|
RF Guidance for biopsy of Chest Pleura |
|
39362-9
|
RF Guidance for placement of tube in Chest |
|
69073-5
|
RF Guidance for core needle biopsy of Unspecified body region |
|
72541-6
|
RF Guidance for denervation of Spine Cervical Facet Joint |
|
30812-2
|
RF Guidance for injection of Spine Cervical Facet Joint |
|
70918-8
|
RF Guidance for injection of Cervical spine |
|
70923-8
|
RF Guidance for percutaneous vertebroplasty of Cervical spine |
|
24671-0
|
RF Guidance for aspiration of cyst of Unspecified body region |
|
43558-6
|
RF Guidance for change of dialysis catheter in Unspecified body region-- W contrast IV |
|
43537-0
|
RF Guidance for drainage and placement of drainage catheter of Unspecified body region |
|
24680-1
|
RF Guidance for dilation of Esophagus |
|
86403-3
|
RF Guidance for placement of catheter in Fallopian tube |
|
30628-2
|
RF Guidance for removal of foreign body of Unspecified body region |
|
86436-3
|
RF Guidance for treatment of Fistula-- W contrast intra fistula |
|
44215-2
|
RF Guidance for fine needle aspiration of Unspecified body region |
|
64999-6
|
RF Guidance for placement of catheter in Fallopian tube - right-- transcervical |
|
30818-9
|
RF Guidance for placement of catheter in Fallopian tubes-- transcervical |
|
64998-8
|
RF Guidance for placement of catheter in Fallopian tube - left-- transcervical |
|
86377-9
|
RF Guidance for advancement of feeding tube of Gastrointestinal tract |
|
24716-3
|
RF Guidance for placement of decompression tube in Gastrointestinal tract |
|
86413-2
|
RF Guidance for placement of long feeding tube in Gastrointestinal tract |
|
30637-3
|
RF Guidance for placement of tube in Gastrointestinal tract |
|
86407-4
|
RF Guidance of Unspecified body region |
|
35888-7
|
RF Guidance for arthrocentesis of Hip |
|
69133-7
|
RF Guidance for drainage and placement of drainage catheter of Hip |
|
30638-1
|
RF Guidance for injection of Hip |
|
75750-0
|
RF Guidance for biopsy of Intervertebral disc |
|
75749-2
|
RF Guidance for fluid aspiration of Intervertebral disc |
|
25078-7
|
RF Guidance for placement of stent in Intrahepatic portal system |
|
36771-4
|
RF Guidance for injection of Joint |
|
24771-8
|
RF Guidance for arthrocentesis of Joint space |
|
44222-8
|
RF Guidance for procedure of Joint space |
|
72544-0
|
RF Guidance for percutaneous device removal of nephrostomy tube of Kidney - bilateral-- W contrast |
|
86441-3
|
RF Guidance for manometry of Kidney and Ureter and Urinary bladder |
|
88834-7
|
RF Guidance for dilation of nephrostomy tract, ureter, or urethra |
|
35899-4
|
RF Guidance for biopsy of Kidney |
|
44217-8
|
RF Guidance for fine needle aspiration of Kidney |
|
86425-6
|
RF Guidance for manometry of Kidney |
|
39361-1
|
RF Guidance for drainage of abscess and placement of drainage catheter of Liver |
|
35900-0
|
RF Guidance for percutaneous biopsy of Liver |
|
44225-1
|
RF Guidance for biopsy of Liver-- W contrast IV |
|
44220-2
|
RF Guidance for fine needle aspiration of Liver |
|
24718-9
|
RF Guidance for transjugular biopsy of Liver-- W contrast IV |
|
41799-8
|
RF Guidance for placement of tube in Liver |
|
72542-4
|
RF Guidance for denervation of Lumbar Spine Facet Joint |
|
30817-1
|
RF Guidance for injection of Lumbar Spine Facet Joint |
|
70919-6
|
RF Guidance for injection of Lumbar spine |
|
72552-3
|
RF Guidance for kyphoplasty of Lumbar spine |
|
70924-6
|
RF Guidance for percutaneous vertebroplasty of Lumbar spine |
|
24973-0
|
RF Guidance for fluid aspiration of Lumbar spine space |
|
30634-0
|
RF Guidance for biopsy of Lung |
|
69243-4
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Lung |
|
69226-9
|
RF Guidance for biopsy of Muscle |
|
72554-9
|
RF Guidance for trigger point injection of Muscle |
|
69120-4
|
RF Guidance for drainage of abscess and placement of drainage catheter of Neck |
|
39027-8
|
RF Guidance for needle localization of Unspecified body region |
|
86400-9
|
RF Guidance for placement of needle in Unspecified body region |
|
69121-2
|
RF Guidance for aspiration of cyst of Ovary |
|
69122-0
|
RF Guidance for drainage of abscess and placement of drainage catheter of Pancreas |
|
35902-6
|
RF Guidance for biopsy of Pancreas |
|
44218-6
|
RF Guidance for fine needle aspiration of Pancreas |
|
42421-8
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Unspecified body region |
|
24621-5
|
RF Guidance for percutaneous drainage and placement of drainage catheter of Unspecified body region |
|
44213-7
|
RF Guidance for endoscopy of Pancreatic duct-- W contrast retrograde |
|
69074-3
|
RF Guidance for biopsy of Pelvis |
|
69244-2
|
RF Guidance for percutaneous drainage of abscess and placement of drainage catheter of Pelvis |
|
62450-2
|
RF Guidance for placement of catheter in Peritoneum |
|
41800-4
|
RF Guidance for drainage and placement of drainage catheter of Pharynx |
|
69123-8
|
RF Guidance for drainage of abscess and placement of chest tube of Pleural space |
|
37887-7
|
RF Guidance for fluid aspiration of Pleural space |
|
75747-6
|
RF Guidance for drainage of abscess and placement of chest tube of Pleural space - bilateral |
|
75751-8
|
RF Guidance for drainage of abscess and placement of chest tube of Pleural space - left |
|
75817-7
|
RF Guidance for drainage of abscess and placement of chest tube of Pleural space - right |
|
72539-0
|
RF Guidance for denervation of Peripheral nerve |
|
30629-0
|
RF Guidance for procedure of Unspecified body region |
|
41802-0
|
RF Guidance for biopsy of Prostate |
|
69075-0
|
RF Guidance for biopsy of Salivary gland |
|
48435-2
|
RF Guidance for injection of Salivary gland - bilateral |
|
35927-3
|
RF Guidance for injection of Sacroiliac Joint |
|
30646-4
|
RF Guidance for change of tube in Sinus tract-- W contrast |
|
46392-7
|
RF Guidance for injection of Sinuses |
|
26322-8
|
RF Guidance for injection of Spine facet joint - bilateral |
|
26323-6
|
RF Guidance for injection of Spine facet joint - left |
|
26324-4
|
RF Guidance for injection of Spine facet joint - right |
|
72540-8
|
RF Guidance for denervation of Spine facet joint |
|
24931-8
|
RF Guidance for injection of Spine facet joint |
|
37427-2
|
RF Guidance for injection of Spine |
|
35936-4
|
RF Guidance for percutaneous vertebroplasty of Spine |
|
35907-5
|
RF Guidance for biopsy of Spleen |
|
35925-7
|
RF Guidance for endoscopy of Stomach |
|
35926-5
|
RF Guidance for gastrostomy of Stomach |
|
46294-5
|
RF Guidance for percutaneous replacement of drainage tube of Stomach |
|
24996-1
|
RF Guidance for percutaneous replacement of gastrostomy of Stomach |
|
24995-3
|
RF Guidance for placement of tube in Stomach |
|
37494-2
|
RF Guidance for injection of Tendon |
|
69129-5
|
RF Guidance for biopsy of Thyroid gland |
|
44216-0
|
RF Guidance for fine needle aspiration of Thyroid gland |
|
44221-0
|
RF Guidance for deep aspiration.fine needle of Tissue |
|
69124-6
|
RF Guidance for superficial aspiration.fine needle of Tissue |
|
30814-8
|
RF Guidance for injection of Spine Thoracic Facet Joint |
|
72543-2
|
RF Guidance for denervation of Thoracic spine intercostal nerve |
|
70920-4
|
RF Guidance for injection of Thoracic spine |
|
72553-1
|
RF Guidance for kyphoplasty of Thoracic spine |
|
70925-3
|
RF Guidance for percutaneous vertebroplasty of Thoracic spine |
|
86405-8
|
RF Guidance for exchange of tube of Unspecified body region |
|
44224-4
|
RF Guidance for placement of tube in Unspecified body region |
|
72549-9
|
RF Guidance for removal of tunneled CV catheter |
|
86438-9
|
RF Guidance for check of feeding tube of Gastrointestinal tract upper |
|
39047-6
|
RF Hip Single view during surgery |
|
24764-3
|
RF Hip Arthrogram |
|
26070-3
|
RF Hip - bilateral Arthrogram |
|
26071-1
|
RF Hip - left Arthrogram |
|
26072-9
|
RF Hip - right Arthrogram |
|
63314-9
|
Rheumatoid factor IgA [Units/volume] in Body fluid by Immunoassay |
|
33313-8
|
Rheumatoid factor IgA [Units/volume] in Serum |
|
33314-6
|
Rheumatoid factor IgG [Units/volume] in Serum |
|
63315-6
|
Rheumatoid factor IgM [Units/volume] in Body fluid by Immunoassay |
|
9338-5
|
Rheumatoid factor IgM [Units/volume] in Serum by Immunoassay |
|
11573-3
|
Rheumatoid factor IgM [Units/volume] in Serum |
|
33577-8
|
Rheumatoid factor IgM [Titer] in Serum by Nephelometry |
|
37585-7
|
RF Jejunum Views W contrast |
|
37191-4
|
RF Joint Arthrogram |
|
65799-9
|
RF Kidney - bilateral Single view for cyst |
|
24781-7
|
RF Guidance for exchange of nephrostomy tube of Kidney - bilateral-- W contrast |
|
24779-1
|
RF Guidance for percutaneous placement of nephrostomy tube of Kidney - bilateral-- W contrast via tube |
|
46376-0
|
RF Kidney - bilateral Views W contrast antegrade |
|
39349-6
|
RF Kidney - bilateral Views W contrast retrograde |
|
24780-9
|
RF Kidney - bilateral Views W contrast via nephrostomy tube |
|
24783-3
|
RF Kidney - bilateral Views for urodynamics |
|
86380-3
|
RF Kidney and Ureter and Urinary bladder Views for fistula |
|
86392-8
|
RF Kidney and Ureter and Urinary bladder Limited Views W contrast IV |
|
86387-8
|
RF Kidney and Ureter and Urinary bladder Views W contrast antegrade |
|
86372-0
|
RF Kidney and Ureter and Urinary bladder Views W contrast IV |
|
86388-6
|
RF Kidney and Ureter and Urinary bladder Views W contrast retrograde |
|
86390-2
|
RF Kidney and Ureter and Urinary bladder Views W contrast via nephrostomy tube |
|
86389-4
|
RF Kidney and Ureter and Urinary bladder Views during surgery W contrast retrograde |
|
88833-9
|
RF Kidney - bilateral and Ureter Views W contrast retrograde intra ureter |
|
86393-6
|
RF Kidney - bilateral and Ureter - bilateral and Urinary bladder Views W contrast retrograde |
|
88832-1
|
RF Kidney - left and Ureter Views W contrast retrograde intra ureter |
|
65800-5
|
RF Kidney - left Single view for cyst |
|
38872-8
|
RF Kidney - left Views W contrast via nephrostomy tube |
|
65801-3
|
RF Kidney - right Single view for cyst |
|
38112-9
|
RF Kidney - right Views W contrast via nephrostomy tube |
|
88831-3
|
RF Kidney - right and Ureter Views W contrast retrograde intra ureter |
|
24800-5
|
RF Knee Arthrogram |
|
26073-7
|
RF Knee - bilateral Arthrogram |
|
26074-5
|
RF Knee - left Arthrogram |
|
26075-2
|
RF Knee - right Arthrogram |
|
30810-6
|
RF Lacrimal duct Views W contrast intra lacrimal duct |
|
38098-0
|
RF Lacrimal duct - bilateral Views W contrast intra lacrimal duct |
|
38099-8
|
RF Lacrimal duct - left Views W contrast intra lacrimal duct |
|
38827-2
|
RF Lacrimal duct - right Views W contrast intra lacrimal duct |
|
48465-9
|
RF Larynx Views |
|
75670-0
|
RF Lumbar spine epidural space Views W contrast epidural |
|
37193-0
|
RF Lumbar spine Views W contrast intradisc |
|
24974-8
|
RF Lumbar spine Views W contrast IT |
|
24845-0
|
RF Neck Views W contrast intra larynx |
|
38116-0
|
RF Parotid gland Views W contrast intra salivary duct |
|
38097-2
|
RF Parotid gland - left Views W contrast intra salivary duct |
|
38826-4
|
RF Parotid gland - right Views W contrast intra salivary duct |
|
86408-2
|
RF Pelvis Views for urinary pouch |
|
37586-5
|
RF Penis Views W contrast intra corpus cavernosum |
|
86410-8
|
RF Pharynx and Cervical esophagus Views W barium contrast PO |
|
24661-1
|
RF Pleural space Views W contrast intra pleural space |
|
37151-8
|
Portable RF Unspecified body region Views |
|
30811-4
|
RF Posterior fossa Views W contrast IT |
|
86411-6
|
RF Posterior fossa - bilateral Views W contrast IT |
|
86430-6
|
RF Posterior fossa - unilateral Views W contrast IT |
|
24894-8
|
RF Rectum and Urinary bladder Views W contrast PR and intra bladder during defecation and voiding |
|
24893-0
|
RF Rectum Single view post contrast PR during defecation |
|
86409-0
|
RF Rectum Views for rectal dysfunction W barium contrast PR |
|
26067-9
|
RF Salivary gland - bilateral Views W contrast intra salivary duct |
|
26068-7
|
RF Salivary gland - left Views W contrast intra salivary duct |
|
26069-5
|
RF Salivary gland - right Views W contrast intra salivary duct |
|
24902-9
|
RF Salivary gland Views W contrast intra salivary duct |
|
86379-5
|
RF Small bowel Views for loop diversion |
|
69272-3
|
RF Small bowel Views W contrast via ileostomy |
|
24924-3
|
RF Small bowel Views W contrast PO |
|
24923-5
|
RF Small bowel Views W positive contrast via enteroclysis tube |
|
86440-5
|
RF Seminal vesicle Views W contrast intra seminal vesicle |
|
86402-5
|
RF Shoulder Arthrogram limited |
|
24910-2
|
RF Shoulder Arthrogram |
|
26076-0
|
RF Shoulder - bilateral Arthrogram |
|
26077-8
|
RF Shoulder - left Arthrogram |
|
26078-6
|
RF Shoulder - right Arthrogram |
|
24911-0
|
RF Shunt Views |
|
37647-5
|
RF Sacroiliac Joint Arthrogram |
|
37189-8
|
RF Sacroiliac joint - bilateral Arthrogram |
|
37190-6
|
RF Sacroiliac joint - left Arthrogram |
|
37785-3
|
RF Sacroiliac joint - right Arthrogram |
|
24912-8
|
RF Sinus tract Views W contrast intra sinus tract |
|
38094-9
|
RF Spinal cavity Views W contrast |
|
24927-6
|
RF Spine Views W contrast intradisc |
|
37572-5
|
RF Spine Views W contrast IT |
|
24552-2
|
RF Stent Views W contrast intra stent |
|
48698-5
|
RF Submandibular gland - bilateral Views W contrast intra salivary duct |
|
42460-6
|
RF Submandibular gland - left Views W contrast intra salivary duct |
|
48696-9
|
RF Submandibular gland - right Views W contrast intra salivary duct |
|
38153-3
|
RF Submandibular gland Views W contrast intra salivary duct |
|
37973-5
|
RF Testicular vessels Views W contrast |
|
37901-6
|
RF Temporomandibular joint Arthrogram |
|
37409-0
|
RF Temporomandibular joint - bilateral Arthrogram |
|
37410-8
|
RF Temporomandibular joint - left Arthrogram |
|
37818-2
|
RF Temporomandibular joint - right Arthrogram |
|
48464-2
|
RF Trachea Views |
|
75816-9
|
RF Spine.thoracic epidural space Views W contrast epidural |
|
38120-2
|
RF Thoracic spine Limited Views W contrast IT |
|
70933-7
|
RF Thoracic spine Views W contrast intradisc |
|
24985-4
|
RF Thoracic spine Views W contrast IT |
|
43788-9
|
RF Tube Views for patency W contrast via tube |
|
39144-1
|
RF Gastrointestinal tract upper Single view W air contrast PO |
|
24715-5
|
RF Gastrointestinal tract upper Single view W contrast PO |
|
86420-7
|
RF Gastrointestinal tract upper Views W air contrast PO and W barium contrast PO |
|
86386-0
|
RF Gastrointestinal tract upper Views W barium contrast PO |
|
42459-8
|
RF Gastrointestinal tract upper Views W contrast PO |
|
42684-1
|
RF Gastrointestinal tract upper Views W gastrografin PO |
|
42012-5
|
RF Gastrointestinal tract upper Views W water soluble contrast PO |
|
42470-5
|
RF Gastrointestinal tract upper and Gallbladder Single view W contrast PO |
|
41795-6
|
RF Upper gastrointestinal tract and Small bowel Single view W air contrast PO |
|
30809-8
|
RF Upper gastrointestinal tract and Small bowel Single view W contrast PO |
|
86427-2
|
RF Upper gastrointestinal tract and Small bowel Views W air contrast PO and W barium contrast PO |
|
43574-3
|
RF Upper gastrointestinal tract and Small bowel Views W barium contrast PO |
|
42469-7
|
RF Gastrointestinal tract upper and Small bowel and Gallbladder Single view W contrast PO |
|
86443-9
|
RF Ureter Views W contrast intra ureter |
|
25016-7
|
RF Urethra Views W contrast intra urethra |
|
25022-5
|
RF Uterus and Fallopian tubes Views W contrast IU |
|
75853-2
|
RF Vagina Views W contrast VG |
|
39151-6
|
RF Vas deferens Views W contrast intra vas deferens |
|
86395-1
|
RF videography Hypopharynx and Esophagus Views for swallowing function W speech and W barium contrast PO |
|
24681-9
|
RF videography Hypopharynx and Esophagus Views |
|
24682-7
|
RF videography Hypopharynx and Esophagus Views W liquid and paste contrast PO during swallowing |
|
30630-8
|
RF videography Cerebral cisterns Views W contrast |
|
43538-8
|
RF videography Cervical spine Views |
|
24752-8
|
RF videography Heart Views |
|
43536-2
|
RF videography Lumbar spine Views |
|
24855-9
|
RF videography Oropharynx Views |
|
49512-7
|
RF Unspecified body region Views |
|
24631-4
|
RF Unspecified body region Views for central venous catheter placement check |
|
37063-5
|
RF Unspecified body region Views for foreign body |
|
30650-6
|
RF Unspecified body region Views for shunt |
|
25070-4
|
RF Unspecified body region Views during surgery |
|
37565-9
|
RF Unspecified body region Views W barium contrast via fistula |
|
37566-7
|
RF Unspecified body region Views W contrast via catheter |
|
37568-3
|
RF Unspecified body region Views W contrast via fistula |
|
37576-6
|
RF Unspecified body region Views W gastrografin via fistula |
|
86399-3
|
RF Guidance for Views and Guidance for injection of non-vascular shunt of Unspecified body region |
|
25034-0
|
RF Wrist Arthrogram |
|
37570-9
|
RF Wrist - bilateral Arthrogram |
|
37571-7
|
RF Wrist - left Arthrogram |
|
37641-8
|
RF Wrist - right Arthrogram |
|
25014-2
|
RFA Two vessels Views W contrast |
|
25005-0
|
RFA Three vessels Views W contrast |
|
43479-5
|
RFA Abdominal Aorta Runoff W contrast IA |
|
30837-9
|
RFA Abdominal Aorta Views W contrast IA |
|
30839-5
|
RFA Abdominal lymphatic vessels Views W contrast intra lymphatic |
|
30840-3
|
RFA Abdominal lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
69066-9
|
RFA Abdominal vessels Views W contrast IV |
|
37598-0
|
RFA Abdominal and pelvic lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
37597-2
|
RFA Abdominal and pelvic lymphatic vessels Views W contrast intra lymphatic |
|
37596-4
|
RFA Abdominal and pelvic lymphatic vessels - left Views W contrast intra lymphatic |
|
38811-6
|
RFA Abdominal and pelvic lymphatic vessels - right Views W contrast intra lymphatic |
|
25030-8
|
RFA Abdominal arteries Views W contrast IA |
|
37380-3
|
RFA Aortic arch and Brachial artery Views W contrast IA |
|
37379-5
|
RFA Aortic arch and Upper Extremity artery Views W contrast IA |
|
30832-0
|
RFA Adrenal artery Views W contrast IA |
|
30831-2
|
RFA Adrenal artery - bilateral Views W contrast IA |
|
37387-8
|
RFA Adrenal artery - left Views W contrast IA |
|
37939-6
|
RFA Adrenal artery - right Views W contrast IA |
|
30843-7
|
RFA Adrenal vein Views W contrast IV |
|
30844-5
|
RFA Adrenal vein - bilateral Views W contrast IV |
|
86461-1
|
RFA Adrenal vessel Views |
|
37602-0
|
RFA Adrenal vein - left Views W contrast IV |
|
37940-4
|
RFA Adrenal vein - right Views W contrast IV |
|
38861-1
|
RFA Ankle arteries - left Views W contrast IA |
|
37941-2
|
RFA Ankle arteries - right Views W contrast IA |
|
69054-5
|
RFA Aortic arch Views W contrast IA |
|
37594-9
|
RFA Carotid artery and Vertebral artery Views W contrast IA |
|
37587-3
|
RFA Aortic arch and Carotid artery - bilateral and Vertebral artery - bilateral Views W contrast IA |
|
37588-1
|
RFA Common carotid artery - bilateral Views W contrast IA |
|
37589-9
|
RFA Common carotid artery - left Views W contrast IA |
|
37590-7
|
RFA Common carotid artery - right Views W contrast IA |
|
37591-5
|
RFA Aortic arch and External carotid artery - bilateral Views W contrast IA |
|
37592-3
|
RFA Aortic arch and External carotid artery - left Views W contrast IA |
|
37593-1
|
RFA Aortic arch and External carotid artery - right Views W contrast IA |
|
37382-9
|
RFA Aortic arch and Subclavian artery Views W contrast IA |
|
37383-7
|
RFA Aortic arch and Subclavian artery - left Views W contrast IA |
|
38800-9
|
RFA Aortic arch and Subclavian artery - right Views W contrast IA |
|
37385-2
|
RFA Aortic arch and Vertebral artery - left Views W contrast IA |
|
37386-0
|
RFA Aortic arch and Vertebral artery - right Views W contrast IA |
|
30838-7
|
RFA Aorta and Femoral artery - bilateral Runoff W contrast IA |
|
37364-7
|
RFA Aorta and Femoral artery - left Runoff W contrast IA |
|
38799-3
|
RFA Aorta and Femoral artery - right Runoff W contrast IA |
|
24569-6
|
RFA AV shunt Views W contrast IV |
|
24551-4
|
RFA AV fistula Views W contrast IA |
|
58746-9
|
RFA AV fistula Views W contrast IV |
|
39363-7
|
RFA AV fistula Views W contrast retrograde |
|
37411-6
|
RFA Azygos vein Views W contrast IV |
|
24576-1
|
RFA Urinary bladder arteries Views W contrast IA |
|
30828-8
|
RFA Brachial artery Views W contrast IA |
|
69077-6
|
RFA Brachiocephalic artery Views W contrast IA |
|
37388-6
|
RFA Brachial artery - bilateral Views W contrast IA |
|
37389-4
|
RFA Bronchial artery Views W contrast IA |
|
37595-6
|
RFA Coronary arteries Views for graft W contrast IA |
|
37174-0
|
RFA Coronary arteries Views W contrast IA |
|
39098-9
|
RFA Carotid artery.cervical.bilateral Views W contrast IA |
|
38863-7
|
RFA Carotid artery.cervical - left Views W contrast IA |
|
39094-8
|
RFA Carotid artery.cervical Views W contrast IA |
|
37945-3
|
RFA Carotid artery.cervical - right Views W contrast IA |
|
30821-3
|
RFA Carotid artery.external Views W contrast IA |
|
30820-5
|
RFA Carotid artery.external - bilateral Views W contrast IA |
|
37390-2
|
RFA Carotid artery.external - left Views W contrast IA |
|
37948-7
|
RFA Carotid artery.external - right Views W contrast IA |
|
38864-5
|
RFA Carotid artery.internal - left Views W contrast IA |
|
37952-9
|
RFA Carotid artery.internal - right Views W contrast IA |
|
38865-2
|
RFA Carotid artery and Cerebral artery internal - left Views W contrast IA |
|
37953-7
|
RFA Carotid artery and Cerebral artery internal - right Views W contrast IA |
|
39095-5
|
RFA Carotid artery and Cerebral artery Views W contrast IA |
|
38862-9
|
RFA Carotid artery and Cerebral artery - left Views W contrast IA |
|
37944-6
|
RFA Carotid artery and Cerebral artery - right Views W contrast IA |
|
37391-0
|
RFA Carotid arteries and Vertebral artery Views W contrast IA |
|
37392-8
|
RFA Carotid arteries and Vertebral artery - bilateral Views W contrast IA |
|
37393-6
|
RFA Carotid arteries and Vertebral artery - left Views W contrast IA |
|
37943-8
|
RFA Carotid arteries and Vertebral artery - right Views W contrast IA |
|
39097-1
|
RFA Carotid artery - bilateral and Cerebral artery - bilateral Views W contrast IA |
|
37381-1
|
RFA Carotid artery Views W contrast IA |
|
24617-3
|
RFA Carotid arteries Views W contrast IA |
|
26079-4
|
RFA Carotid arteries - bilateral Views W contrast IA |
|
26080-2
|
RFA Carotid arteries - left Views W contrast IA |
|
26081-0
|
RFA Carotid arteries -right Views W contrast IA |
|
86434-8
|
RFA Carotid arteries - unilateral Views W contrast IA |
|
37403-3
|
RFA Celiac artery and Gastric artery - left and Superior mesenteric artery Views W contrast IA |
|
24622-3
|
RFA Celiac artery Views W contrast IA |
|
37394-4
|
RFA Celiac artery and Superior mesenteric artery and Inferior mesenteric artery Views W contrast IA |
|
86431-4
|
RFA Cerebral arteries - bilateral and Cervical arteries - bilateral Views W contrast IA |
|
86432-2
|
RFA Cerebral arteries - unilateral and Cervical arteries - unilateral Views W contrast IA |
|
37173-2
|
RFA Cerebral artery Views W contrast IA |
|
86417-3
|
RFA Cerebral arteries Bilateral Views W contrast IA |
|
86429-8
|
RFA Cerebral arteries - unilateral Views W contrast IA |
|
37195-5
|
RFA Cerebral vein Views W contrast IV |
|
94091-6
|
RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty |
|
30819-7
|
RFA Epidural veins Views W contrast IV |
|
94095-7
|
RFA Extremity vessels Unilateral Views W contrast IV |
|
30848-6
|
RFA Extremity arteries Views W contrast IA |
|
30849-4
|
RFA Extremity arteries - bilateral Views W contrast IA |
|
37395-1
|
RFA Extremity arteries - left Views W contrast IA |
|
37949-5
|
RFA Extremity arteries - right Views W contrast IA |
|
86428-0
|
RFA Extremity arteries - unilateral Views W contrast IA |
|
39055-9
|
RFA Extremity veins Views W contrast IV |
|
37412-4
|
RFA Extremity veins - bilateral Views W contrast IV |
|
37413-2
|
RFA Extremity veins - left Views W contrast IV |
|
37950-3
|
RFA Extremity veins - right Views W contrast IV |
|
86396-9
|
RFA Extremity veins - unilateral Views W contrast IV |
|
30850-2
|
RFA Extremity lymphatic vessels Views W contrast intra lymphatic |
|
30851-0
|
RFA Extremity lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
37599-8
|
RFA Extremity lymphatic vessels - left Views W contrast intra lymphatic |
|
38812-4
|
RFA Extremity lymphatic vessels - right Views W contrast intra lymphatic |
|
42157-8
|
RFA Extremity vessels Views W contrast IV |
|
24699-1
|
RFA Femoral artery Runoff W contrast IA |
|
49511-9
|
RFA Femoral artery Runoff WO and W contrast IA |
|
37175-7
|
RFA Femoral artery Views W contrast IA |
|
37176-5
|
RFA Femoral artery and Popliteal artery Views W contrast IA |
|
26178-4
|
RFA Femoral artery - bilateral Runoff W contrast IA |
|
26179-2
|
RFA Femoral artery - left Runoff W contrast IA |
|
26180-0
|
RFA Femoral artery - right Runoff W contrast IA |
|
37416-5
|
RFA Femoral vein Views W contrast IV |
|
37397-7
|
RFA Gastric artery Views W contrast IA |
|
37398-5
|
RFA Gastric artery - left Views W contrast IA |
|
38801-7
|
RFA Gastric artery right Views W contrast IA |
|
37399-3
|
RFA Gastroduodenal artery Views W contrast IA |
|
25028-2
|
RFA Guidance for placement of catheter for infusion of thrombolytic in Vessel-- W contrast intravascular |
|
69067-7
|
RFA Guidance for angioplasty of Unspecified body region-- W contrast |
|
24554-8
|
RFA Guidance for embolization of Artery-- W contrast IA |
|
24555-5
|
RFA Guidance for placement of stent in Artery |
|
65798-1
|
RFA Guidance for placement of stent in Artery - right |
|
65797-3
|
RFA Guidance for placement of stent in Artery - left |
|
36760-7
|
RFA Guidance for angioplasty of AV shunt-- W contrast |
|
24568-8
|
RFA Guidance for atherectomy of AV fistula-- W contrast IV |
|
24580-3
|
RFA Guidance for angioplasty of Brachiocephalic artery-- W contrast IA |
|
36766-4
|
RFA Guidance for atherectomy of Coronary arteries-- W contrast IA |
|
24614-0
|
RFA Guidance for angioplasty of Carotid artery extracranial-- W contrast IA |
|
24615-7
|
RFA Guidance for angioplasty of Carotid artery.intracranial-- W contrast IA |
|
24684-3
|
RFA Guidance for embolectomy of Extracranial vessels-- W contrast IA |
|
35881-2
|
RFA Guidance for angioplasty of Extremity artery-- W contrast IA |
|
36762-3
|
RFA Guidance for angioplasty of Extremity vessel-- W contrast |
|
24698-3
|
RFA Guidance for angioplasty of Femoral artery-- W contrast IA |
|
36763-1
|
RFA Guidance for angioplasty of Femoral artery and Popliteal artery-- W contrast IA |
|
36764-9
|
RFA Guidance for atherectomy of Femoral vessel and Popliteal artery-- W contrast |
|
25077-9
|
RFA Guidance for placement of catheter in Hepatic artery-- W contrast IA |
|
24553-0
|
RFA Guidance for embolectomy of Intracranial vessel-- W contrast IV |
|
24766-8
|
RFA Guidance for angioplasty of Iliac artery-- W contrast IA |
|
69135-2
|
RFA Guidance for atherectomy of Iliac artery-- W contrast |
|
69134-5
|
RFA Guidance for placement of stent in Iliac artery |
|
26370-7
|
RFA Guidance for angioplasty of Iliac artery - bilateral-- W contrast IA |
|
26371-5
|
RFA Guidance for angioplasty of Iliac artery - left-- W contrast IA |
|
62491-6
|
RFA Guidance for placement of prosthesis in Iliac artery - left-- W contrast IA |
|
26372-3
|
RFA Guidance for angioplasty of Iliac artery - right-- W contrast IA |
|
62492-4
|
RFA Guidance for placement of prosthesis in Iliac artery - right-- W contrast IA |
|
86464-5
|
RFA Guidance for repair of aneurysm or dissection of Infrarenal aorta |
|
42334-3
|
RFA Guidance for injection of Internal thoracic artery - left |
|
35882-0
|
RFA Guidance for angioplasty of Inferior vena cava-- W contrast IV |
|
25026-6
|
RFA Guidance for placement of venous filter in Inferior vena cava-- W contrast IV |
|
37426-4
|
RFA Guidance for angioplasty of Lower extremity vein-- W contrast IV |
|
44219-4
|
RFA Guidance for fine needle aspiration of Lymph node |
|
24832-8
|
RFA Guidance for angioplasty of Mesenteric artery-- W contrast IA |
|
24887-2
|
RFA Guidance for embolectomy of Pulmonary arteries-- W contrast IA |
|
69252-5
|
RFA Guidance for percutaneous transluminal angioplasty of Pulmonary arteries-- W contrast IA |
|
30649-8
|
RFA Guidance for Additional angioplasty of Peripheral artery-- W contrast IA |
|
24882-3
|
RFA Guidance for percutaneous transluminal angioplasty of Popliteal artery-- W contrast IA |
|
41801-2
|
RFA Guidance for placement of catheter in Portal vein-- W contrast IV |
|
51391-1
|
RFA Guidance for placement of TIPS of Portal vein and Hepatic vein |
|
69248-3
|
RFA Guidance for percutaneous transluminal angioplasty of Renal artery-- W contrast IA |
|
25081-1
|
RFA Guidance for angioplasty of Renal vessel-- W contrast IA |
|
69253-3
|
RFA Guidance for atherectomy of Renal vessels-- W contrast |
|
24543-1
|
RFA Guidance for angioplasty of Thoracic and abdominal aorta-- W contrast IA |
|
35883-8
|
RFA Guidance for atherectomy of Thoracic and abdominal aorta-- W contrast IA |
|
43793-9
|
RFA Guidance for angioplasty of Tibioperoneal arteries-- W contrast IA |
|
43794-7
|
RFA Guidance for angioplasty of Tibioperoneal arteries - bilateral-- W contrast IA |
|
43795-4
|
RFA Guidance for angioplasty of Tibioperoneal arteries - left-- W contrast IA |
|
43792-1
|
RFA Guidance for angioplasty of Tibioperoneal arteries - right-- W contrast IA |
|
69301-0
|
RFA Guidance for percutaneous transluminal angioplasty of Upper extremity vein-- W contrast IV |
|
30641-5
|
RFA Guidance for Additional angioplasty of Vein-- W contrast IV |
|
30640-7
|
RFA Guidance for angioplasty of Vein-- W contrast IV |
|
24755-1
|
RFA Guidance for atherectomy of Vein-- W contrast IV |
|
24624-9
|
RFA Guidance for change of CV catheter in Vein-- W contrast IV |
|
72546-5
|
RFA Guidance for removal of CV catheter lumen obstruction of Vein |
|
72547-3
|
RFA Guidance for removal of CV catheter pericatheter obstruction of Vein |
|
24625-6
|
RFA Guidance for placement of CV catheter in Vein-- W contrast IV |
|
72548-1
|
RFA Guidance for removal of CV catheter from Vein-- W contrast IV |
|
24626-4
|
RFA Guidance for reposition of CV catheter in Vein-- W contrast IV |
|
72550-7
|
RFA Guidance for repair of CV catheter with port or pump of Vein |
|
72551-5
|
RFA Guidance for repair of CV catheter without port or pump of Vein |
|
72538-2
|
RFA Guidance for removal of peripherally-inserted central venous catheter from Vein |
|
25024-1
|
RFA Guidance for placement of peripherally-inserted central venous catheter in Vein |
|
42018-2
|
RFA Guidance for percutaneous transluminal angioplasty of Vein-- W contrast IA |
|
24756-9
|
RFA Guidance for placement of stent in Vein |
|
43763-2
|
RFA Guidance for thrombectomy of Vein-- W contrast IV |
|
26298-0
|
RFA Guidance for atherectomy of Vein - bilateral-- W contrast IV |
|
26331-9
|
RFA Guidance for change of CV catheter in Vein - bilateral-- W contrast IV |
|
26310-3
|
RFA Guidance for placement of CV catheter in Vein - bilateral-- W contrast IV |
|
26295-6
|
RFA Guidance for reposition of CV catheter in Vein - bilateral-- W contrast IV |
|
26304-6
|
RFA Guidance for placement of peripherally-inserted central venous catheter in Vein - bilateral |
|
26301-2
|
RFA Guidance for placement of stent in Vein - bilateral |
|
43761-6
|
RFA Guidance for thrombectomy of Vein - bilateral-- W contrast IV |
|
26299-8
|
RFA Guidance for atherectomy of Vein - left-- W contrast IV |
|
26332-7
|
RFA Guidance for change of CV catheter in Vein - left-- W contrast IV |
|
26311-1
|
RFA Guidance for placement of CV catheter in Vein - left-- W contrast IV |
|
26296-4
|
RFA Guidance for reposition of CV catheter in Vein - left-- W contrast IV |
|
26305-3
|
RFA Guidance for placement of peripherally-inserted central venous catheter in Vein - left |
|
26302-0
|
RFA Guidance for placement of stent in Vein - left |
|
43762-4
|
RFA Guidance for thrombectomy of Vein - left-- W contrast IV |
|
26300-4
|
RFA Guidance for atherectomy of Vein - right-- W contrast IV |
|
26333-5
|
RFA Guidance for change of CV catheter in Vein - right-- W contrast IV |
|
26312-9
|
RFA Guidance for placement of CV catheter in Vein - right-- W contrast IV |
|
26297-2
|
RFA Guidance for reposition of CV catheter in Vein - right-- W contrast IV |
|
26306-1
|
RFA Guidance for placement of peripherally-inserted central venous catheter in Vein - right |
|
26303-8
|
RFA Guidance for placement of stent in Vein - right |
|
43764-0
|
RFA Guidance for thrombectomy of Vein - right-- W contrast IV |
|
36765-6
|
RFA Guidance for atherectomy of Vessel-- W contrast |
|
25073-8
|
RFA Guidance for removal of foreign body from Vessel |
|
39138-3
|
RFA Guidance for vascular access of Vessel |
|
25029-0
|
RFA Guidance for placement of catheter for vasoconstrictor infusion in Vessels |
|
30836-1
|
RFA Guidance for angioplasty of Visceral artery-- W contrast IA |
|
62448-6
|
RFA Head artery - left and Neck artery - left Views W contrast IA |
|
62449-4
|
RFA Head artery - right and Neck artery - right Views W contrast IA |
|
30823-9
|
RFA Head artery and Neck artery Views W contrast IA |
|
30822-1
|
RFA Head artery - bilateral and Neck artery - bilateral Views W contrast IA |
|
25076-1
|
RFA Hepatic artery Views W contrast IA |
|
39093-0
|
RFA Hepatic veins Views W contrast IV |
|
39096-3
|
RFA Hepatic veins Views for hemodynamics W contrast IV |
|
30824-7
|
RFA Intercranial vessel and Neck Vessel Views W contrast |
|
43782-2
|
RFA Iliac artery Views W contrast IA |
|
24862-5
|
RFA Iliac artery Internal Views W contrast IA |
|
37177-3
|
RFA Iliac artery - bilateral Views W contrast IA |
|
37178-1
|
RFA Iliac artery - left Views W contrast IA |
|
37739-0
|
RFA Iliac artery - right Views W contrast IA |
|
37179-9
|
RFA Inferior mesenteric artery Views W contrast IA |
|
37421-5
|
RFA Inferior mesenteric vein Views W contrast IV |
|
37401-7
|
RFA Internal maxillary artery Views W contrast IA |
|
37419-9
|
RFA Intraosseous veins Views W contrast IV |
|
37404-1
|
RFA Internal pudendal artery Views W contrast IA |
|
30829-6
|
RFA Internal thoracic artery Views W contrast IA |
|
64995-4
|
RFA Internal thoracic artery - left Views W contrast IA |
|
65000-2
|
RFA Internal thoracic artery - right Views W contrast IA |
|
30845-2
|
RFA Inferior vena cava Views W contrast IV |
|
86435-5
|
RFA Jugular vein - bilateral Views W contrast IV |
|
86426-4
|
RFA Jugular vein - unilateral Views W contrast IV |
|
37487-6
|
RFA Lower extremity arteries Views W contrast IA |
|
47986-5
|
RFA Lower extremity arteries - left Views W contrast IA |
|
47987-3
|
RFA Lower extremity arteries - right Views W contrast IA |
|
37574-1
|
RFA Lower extremity vessels Views W contrast IV |
|
38853-8
|
RFA Lower extremity vessels - left Views W contrast |
|
37765-5
|
RFA Lower extremity vessels - right Views W contrast |
|
37414-0
|
RFA Lower extremity veins - bilateral Views W contrast IV |
|
37196-3
|
RFA Lower extremity veins - left Views W contrast IV |
|
37767-1
|
RFA Lower extremity veins - right Views W contrast IV |
|
86433-0
|
RFA Lumbar spine intercostal arteries Views W contrast IA |
|
24827-8
|
RFA Lymphatic vessels Views W contrast intra lymphatic |
|
37600-4
|
RFA Lymphatic vessels - left Views W contrast intra lymphatic |
|
38813-2
|
RFA Lymphatic vessels - right Views W contrast intra lymphatic |
|
24833-6
|
RFA Mesenteric artery Views W contrast IA |
|
30825-4
|
RFA Orbit veins Views W contrast IV |
|
37422-3
|
RFA Orbit veins - left Views W contrast IV |
|
37958-6
|
RFA Orbit veins - right Views W contrast IV |
|
39057-5
|
RFA Pulmonary arteries Views W contrast IA |
|
30830-4
|
RFA Pulmonary artery - bilateral Views W contrast IA |
|
37182-3
|
RFA Pulmonary arteries - left Views W contrast IA |
|
24860-9
|
RFA Pancreatic artery Views W contrast IA |
|
37779-6
|
RFA Right pulmonary arteries Views W contrast IA |
|
86412-4
|
RFA Pedal lymphatic vessels Views W contrast intra lymphatic |
|
86374-6
|
RFA Pedal lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
86375-3
|
RFA Pedal lymphatic vessels - unilateral Views W contrast intra lymphatic |
|
39510-3
|
RFA Pelvic lymphatic vessels Views W contrast intra lymphatic |
|
37601-2
|
RFA Pelvic lymphatic vessels - bilateral Views W contrast intra lymphatic |
|
30833-8
|
RFA Pelvis arteries Views W contrast IA |
|
37935-4
|
RFA Pelvis arteries and Lower extremity arteries - bilateral Views W contrast IA |
|
37615-2
|
RFA Pelvis vessels Views W contrast |
|
30648-0
|
RFA Peripheral artery Views for angioplasty W contrast IA |
|
24874-0
|
RFA Peripheral arteries Views W contrast IA |
|
37936-2
|
RFA Peripheral vessels Views W contrast |
|
24685-0
|
RFA Peripheral veins Views W contrast IV |
|
44240-0
|
RFA Peripheral arteries - bilateral Views W contrast IA |
|
30852-8
|
RFA XXX>Peripheral veins - bilateral Views W contrast IV |
|
30816-3
|
RFA Peritoneum Views W contrast percutaneous intraperitoneal |
|
69249-1
|
RFA Popliteal artery Views W contrast IA |
|
37181-5
|
RFA Popliteal artery - left Views W contrast IA |
|
37778-8
|
RFA Popliteal artery - right Views W contrast IA |
|
69250-9
|
RFA Portal vein Views W contrast IV |
|
30841-1
|
RFA Portal vein Views W contrast transhepatic |
|
30842-9
|
RFA Portal vein Views for hemodynamics W contrast transhepatic |
|
86418-1
|
RFA Pulmonary arteries - unilateral Views W contrast IA |
|
25079-5
|
RFA Renal arteries Views W contrast IA |
|
86414-0
|
RFA Renal arteries - unilateral Views W contrast IA |
|
30834-6
|
RFA Renal artery - bilateral Views W contrast IA |
|
62446-0
|
RFA Renal artery - left Views W contrast IA |
|
62447-8
|
RFA Renal artery - right Views W contrast IA |
|
30847-8
|
RFA Renal vein Views W contrast IV |
|
43783-0
|
RFA Renal vein Views for renin sampling W contrast IV |
|
30846-0
|
RFA Renal vein - bilateral Views W contrast IV |
|
25080-3
|
RFA Renal vein - bilateral Views for renin sampling W contrast IV |
|
37640-0
|
RFA Renal vessels Views W contrast |
|
64140-7
|
RFA Renal vessels - left Views W contrast |
|
64141-5
|
RFA Renal vessels - right Views W contrast |
|
37423-1
|
RFA Renal vein - left Views W contrast IV |
|
37959-4
|
RFA Renal vein - right Views W contrast IV |
|
86415-7
|
RFA Renal vein - unilateral Views W contrast IV |
|
37969-3
|
RFA Sinus vein Views W contrast IV |
|
37180-7
|
RFA Superior mesenteric artery Views W contrast IA |
|
37402-5
|
RFA Superior mesenteric artery and Inferior mesenteric artery Views W contrast IA |
|
37972-7
|
RFA Superior mesenteric vein Views W contrast IV |
|
24925-0
|
RFA Spinal artery Views W contrast IA |
|
26082-8
|
RFA Spinal artery - bilateral Views W contrast IA |
|
26083-6
|
RFA Spinal artery - left Views W contrast IA |
|
26084-4
|
RFA Spinal artery - right Views W contrast IA |
|
86460-3
|
RFA Spine vessel Views |
|
24992-0
|
RFA Splenic artery Views W contrast IA |
|
37970-1
|
RFA Splenic vein Views W contrast IV |
|
24991-2
|
RFA Splenic vein and Portal vein Views W contrast IA |
|
24581-1
|
RFA Subclavian artery and Brachial artery Views W contrast IA |
|
37886-9
|
RFA Subclavian artery Views W contrast IA |
|
37405-8
|
RFA Subclavian artery - bilateral Views W contrast IA |
|
37406-6
|
RFA Subclavian artery - left Views W contrast IA |
|
37966-9
|
RFA Subclavian artery - right Views W contrast IA |
|
37971-9
|
RFA Subclavian vein Views W contrast IV |
|
30645-6
|
RFA Superior vena cava Views W contrast IV |
|
24658-7
|
RFA Thoracic and abdominal aorta Views W contrast IA |
|
86394-4
|
RFA Thoracic Aorta Views W contrast IA |
|
38119-4
|
RFA Thoracic artery Views W contrast IA |
|
37489-2
|
RFA Tibioperoneal arteries Views W contrast IA |
|
37977-6
|
RFA Upper extremity arteries Views W contrast IA |
|
37396-9
|
RFA Upper extremity arteries - bilateral Views W contrast IA |
|
37488-4
|
RFA Upper extremity arteries - left Views W contrast IA |
|
37967-7
|
RFA Upper extremity arteries - right Views W contrast IA |
|
37976-8
|
RFA Upper extremity vessels Views W contrast |
|
24550-6
|
RFA Upper extremity veins Views W contrast IV |
|
37415-7
|
RFA Upper extremity veins - bilateral Views W contrast IV |
|
38859-5
|
RFA Upper extremity veins - left Views W contrast IV |
|
37824-0
|
RFA Upper extremity veins - right Views W contrast IV |
|
37979-2
|
RFA Uterine artery Views W contrast IA |
|
37384-5
|
RFA Vertebral artery Views W contrast IA |
|
37407-4
|
RFA Vertebral artery - bilateral Views W contrast IA |
|
37490-0
|
RFA Vertebral artery - left Views W contrast IA |
|
37968-5
|
RFA Vertebral artery - right Views W contrast IA |
|
25023-3
|
RFA Vein Views W contrast IV |
|
26064-6
|
RFA Vein - bilateral Views W contrast IV |
|
26065-3
|
RFA Vein - left Views W contrast IV |
|
26066-1
|
RFA Vein - right Views W contrast IV |
|
25025-8
|
RFA Vena cava Views W contrast IV |
|
86442-1
|
RFA Vertebral artery - unilateral Views W contrast IA |
|
37980-0
|
RFA Vertebral vessels Views W contrast |
|
30639-9
|
RFA Vessel Single view W contrast |
|
25063-9
|
RFA Vessel Single view W contrast IA |
|
25064-7
|
RFA Vessel Views for angioplasty W contrast IA |
|
42156-0
|
RFA Vessels Views W contrast IA |
|
43554-5
|
RFA Vessels - left Views W contrast IV |
|
86419-9
|
RFA Visceral arteries Views W contrast IA |
|
37981-8
|
RFA Visceral vessels Views W contrast |
|
94094-0
|
RFA Unspecified body region Limited Views for therapy or embolization or infusion W contrast via existing catheter |
|
68965-3
|
Rg Ag [Presence] on Red Blood Cells |
|
58071-2
|
Rg sup(a) Ag [Presence] on Red Blood Cells |
|
93951-2
|
Rh antigens and K Ag panel - Blood |
|
93915-7
|
Rh antigens and K Ag panel - Blood from Blood product unit |
|
93947-0
|
Rh antigens and K Ag panel - Cord blood |
|
93939-7
|
Rh antigens and K Ag during infancy panel - Blood |
|
93929-8
|
Rh antigens and K Ag post hematopoietic stem cell transplant panel - Blood |
|
93922-3
|
Rh antigens and K Ag post transfusion reaction panel - Blood |
|
17531-5
|
Rh [Type] in Amniotic fluid |
|
10331-7
|
Rh [Type] in Blood |
|
52792-9
|
Father's Rh Type |
|
14908-8
|
Rh [Type] in Blood from Newborn |
|
14906-2
|
Rh [Type] in Cord blood |
|
88027-8
|
Rh group Ag [Type] on Red Blood Cells |
|
1314-4
|
Rh immune globulin screen [interpretation] |
|
46276-2
|
Rh [Type] in Blood--after transfusion reaction |
|
85505-6
|
Presumptive Rh [Type] in Saliva (oral fluid) by Molecular genetics method |
|
65332-9
|
Rh32 Ab [Presence] in Serum or Plasma |
|
46731-6
|
RHC gene mutations found [Type] in Amniotic fluid by Molecular genetics method |
|
34741-9
|
RHCE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
42316-0
|
RHD gene mutations found [Type] in Amniotic fluid by Molecular genetics method |
|
35465-4
|
RHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
42325-1
|
RHD+RHC gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
|
23574-7
|
Viral hemorrhagic disease virus Ab [Presence] in Serum |
|
23577-0
|
Viral hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay |
|
31699-2
|
Viral hemorrhagic disease virus Ab [Units/volume] in Serum |
|
23575-4
|
Viral hemorrhagic disease virus Ab [Titer] in Serum |
|
23578-8
|
Viral hemorrhagic disease virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
23576-2
|
Viral hemorrhagic disease virus Ab [Titer] in Serum by Immunoassay |
|
34886-2
|
Viral hemorrhagic disease virus Ab [Titer] in Serum by Neutralization test |
|
23581-2
|
Viral hemorrhagic disease virus Ag [Presence] in Tissue by Agglutination |
|
23580-4
|
Viral hemorrhagic disease virus Ag [Presence] in Tissue by Immunoassay |
|
23579-6
|
Viral hemorrhagic disease virus Ag [Presence] in Tissue by Immunofluorescence |
|
23582-0
|
Viral hemorrhagic disease virus Ag [Presence] in Tissue by Immune stain |
|
23573-9
|
Viral hemorrhagic disease virus [Presence] in Tissue by Electron microscopy |
|
48030-1
|
RHE gene mutations found [Type] in Amniotic fluid by Molecular genetics method |
|
29351-4
|
Rheumatoid factor [Presence] in Cerebral spinal fluid |
|
14034-3
|
Rheumatoid factor [Units/volume] in Cerebral spinal fluid |
|
17534-9
|
Rheumatoid factor [Units/volume] in Body fluid by Immunoassay |
|
15203-3
|
Rheumatoid factor [Units/volume] in Body fluid by Nephelometry |
|
31046-6
|
Rheumatoid factor [Presence] in Body fluid |
|
45156-7
|
Rheumatoid factor [Presence] in Body fluid by Latex agglutination |
|
25745-1
|
Rheumatoid factor [Presence] in Body fluid by Sheep Cell Agglutination |
|
63313-1
|
Rheumatoid factor [Units/volume] in Body fluid by Sheep Cell Agglutination |
|
30231-5
|
Rheumatoid factor [Units/volume] in Body fluid |
|
53562-5
|
Rheumatoid factor [Units/volume] in Pleural fluid |
|
6928-6
|
Rheumatoid factor [Units/volume] in Serum by Immunoassay |
|
15205-8
|
Rheumatoid factor [Units/volume] in Serum by Nephelometry |
|
33910-1
|
Rheumatoid factor [Presence] in Serum |
|
5297-7
|
Rheumatoid factor [Presence] in Serum by Latex agglutination |
|
5298-5
|
Rheumatoid factor [Presence] in Serum by Sheep Cell Agglutination |
|
11572-5
|
Rheumatoid factor [Units/volume] in Serum or Plasma |
|
15206-6
|
Rheumatoid factor [Units/volume] in Synovial fluid by Nephelometry |
|
6823-9
|
Rheumatoid factor [Presence] in Synovial fluid by Latex agglutination |
|
13634-1
|
Rheumatoid factor [Units/volume] in Synovial fluid |
|
43932-3
|
Rheumatoid factor [Titer] in Body fluid |
|
25746-9
|
Rheumatoid factor [Titer] in Body fluid by Sheep Cell Agglutination |
|
17857-4
|
Rheumatoid factor [Titer] in Serum |
|
5299-3
|
Rheumatoid factor [Titer] in Serum by Latex agglutination |
|
15204-1
|
Rheumatoid factor [Titer] in Serum by Nephelometry |
|
5300-9
|
Rheumatoid factor [Titer] in Serum by Sheep Cell Agglutination |
|
13930-3
|
Rheumatoid factor [Titer] in Synovial fluid by Agglutination |
|
53924-7
|
Rheumatoid factor [Titer] in Synovial fluid by Latex agglutination |
|
13929-5
|
Rheumatoid factor [Titer] in Synovial fluid by Sheep Cell Agglutination |
|
83698-1
|
Rheumatology Attending Note |
|
34839-1
|
Rheumatology Consult note |
|
78571-7
|
Rheumatology Diagnostic study note |
|
85434-9
|
Rheumatology Discharge summary |
|
78600-4
|
Rheumatology Education note |
|
83745-0
|
Rheumatology Fellow Note |
|
78639-2
|
Rheumatology Flowsheet |
|
83947-2
|
Rheumatology Hospital Note |
|
78652-5
|
Rheumatology Initial evaluation note |
|
34840-9
|
Rheumatology Note |
|
83595-9
|
Rheumatology Nurse Note |
|
83596-7
|
Rheumatology Nurse Outpatient Note |
|
83948-0
|
Rheumatology Outpatient Note |
|
83949-8
|
Rheumatology Telephone encounter Note |
|
80774-3
|
Rheumatology Plan of care note |
|
78660-8
|
Rheumatology procedure note |
|
78666-5
|
Rheumatology Progress note |
|
57163-8
|
Rheumatology Referral note |
|
83776-5
|
Rheumatology Resident Note |
|
89900-5
|
Rheumatology Telehealth Note |
|
83950-6
|
Rheumatology Transfer summary note |
|
40993-8
|
Rhinovirus Ag [Identifier] in Unspecified specimen by Neutralization test |
|
88213-4
|
Rhinovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
91131-3
|
Rhinovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
92130-4
|
Rhinovirus RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
91793-0
|
Rhinovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
40990-4
|
Rhinovirus RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
7993-9
|
Rhinovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
55222-4
|
Microscopic observation [Identifier] in Aspirate by Rhodamine-auramine fluorochrome stain |
|
53522-9
|
Microscopic observation [Identifier] in Bronchial specimen by Rhodamine-auramine fluorochrome stain |
|
53906-4
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Rhodamine-auramine fluorochrome stain |
|
53914-8
|
Microscopic observation [Identifier] in Endometrium by Rhodamine-auramine fluorochrome stain |
|
53912-2
|
Microscopic observation [Identifier] in Body fluid by Rhodamine-auramine fluorochrome stain |
|
53916-3
|
Microscopic observation [Identifier] in Gastric fluid by Rhodamine-auramine fluorochrome stain |
|
53918-9
|
Microscopic observation [Identifier] in Bone marrow by Rhodamine-auramine fluorochrome stain |
|
53915-5
|
Microscopic observation [Identifier] in Pericardial fluid by Rhodamine-auramine fluorochrome stain |
|
53907-2
|
Microscopic observation [Identifier] in Pleural fluid by Rhodamine-auramine fluorochrome stain |
|
53910-6
|
Microscopic observation [Identifier] in Peritoneal fluid by Rhodamine-auramine fluorochrome stain |
|
53913-0
|
Microscopic observation [Identifier] in Synovial fluid by Rhodamine-auramine fluorochrome stain |
|
53904-9
|
Microscopic observation [Identifier] in Sputum by Rhodamine-auramine fluorochrome stain |
|
6677-9
|
Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain |
|
53905-6
|
Microscopic observation [Identifier] in Urine by Rhodamine-auramine fluorochrome stain |
|
676-7
|
Microscopic observation [Identifier] in Unspecified specimen by Rhodamine-auramine fluorochrome stain |
|
7665-3
|
Rhodotorula spp IgE Ab [Units/volume] in Serum |
|
7667-9
|
Rhubarb IgE Ab [Units/volume] in Serum |
|
56378-3
|
Rhubarb IgG4 Ab [Mass/volume] in Serum |
|
63105-1
|
Rhubarb IgG Ab [Mass/volume] in Serum |
|
41469-8
|
Ribavirin [Mass/volume] in Serum or Plasma |
|
47884-2
|
Ribitol/Creatinine [Molar ratio] in Urine |
|
2926-4
|
Ribose [Mass/volume] in Serum |
|
32268-5
|
Ribose [Presence] in Urine |
|
63322-2
|
Ribosomal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63320-6
|
Ribosomal Ab [Presence] in Body fluid by Immunofluorescence |
|
31590-3
|
Ribosomal Ab [Presence] in Serum |
|
25747-7
|
Ribosomal Ab [Presence] in Serum by Immunoassay |
|
53009-7
|
Ribosomal Ab [Presence] in Serum by Immunofluorescence |
|
89504-5
|
Ribosomal Ab [Presence] in Serum by Line blot |
|
31589-5
|
Ribosomal Ab [Units/volume] in Serum |
|
63323-0
|
Ribosomal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63321-4
|
Ribosomal Ab [Titer] in Body fluid by Immunofluorescence |
|
13635-8
|
Ribosomal Ab [Titer] in Serum |
|
25748-5
|
Ribosomal Ab [Titer] in Serum by Immunofluorescence |
|
63324-8
|
Ribosomal IgG Ab [Presence] in Serum by Immunoassay |
|
63325-5
|
Ribosomal IgG Ab [Titer] in Serum by Immunoassay |
|
63327-1
|
Ribosomal P Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
89534-2
|
Ribosomal P Ab [Presence] in Cerebral spinal fluid by Line blot |
|
21487-4
|
Ribosomal P Ab [Units/volume] in Cerebral spinal fluid |
|
63541-7
|
Ribosomal P Ab [Presence] in Body fluid |
|
63326-3
|
Ribosomal P Ab [Presence] in Body fluid by Immunoassay |
|
47301-7
|
Ribosomal P Ab [Units/volume] in Serum by Immunoassay |
|
31592-9
|
Ribosomal P Ab [Presence] in Serum |
|
56732-1
|
Ribosomal P Ab [Presence] in Serum by Immunoblot |
|
13636-6
|
Ribosomal P Ab [Units/volume] in Serum |
|
45226-8
|
Ribosomal P IgG Ab [Presence] in Serum |
|
53892-6
|
Ribosomal P IgG Ab [Units/volume] in Serum |
|
2927-2
|
Ribulose [Mass/volume] in Serum |
|
7669-5
|
Rice triggered histamine release [Units/volume] in Blood |
|
6230-7
|
Rice IgE Ab [Units/volume] in Serum |
|
61291-1
|
Rice IgE Ab/IgE total in Serum |
|
7668-7
|
Rice IgG Ab [Units/volume] in Serum |
|
26428-3
|
Rice IgG4 Ab [Units/volume] in Serum |
|
56379-1
|
Rice IgG4 Ab [Mass/volume] in Serum |
|
35545-3
|
Rice IgG Ab [Mass/volume] in Serum |
|
41640-4
|
Ricin toxin IgG Ab [Presence] in Serum by Immunofluorescence |
|
41639-6
|
Ricin toxin IgM Ab [Presence] in Serum by Immunofluorescence |
|
41641-2
|
Ricin toxin [Presence] in Unspecified specimen by Immunofluorescence |
|
35493-6
|
Ricin [Presence] in Unspecified specimen |
|
54934-5
|
Ricinine [Mass/volume] in Urine |
|
5309-0
|
Rickettsia spotted fever group Ab [Units/volume] in Serum by Immunoassay |
|
22474-1
|
Rickettsia spotted fever group Ab [Presence] in Serum |
|
23776-8
|
Rickettsia spotted fever group Ab [Presence] in Serum by Immunofluorescence |
|
5310-8
|
Rickettsia spotted fever group Ab [Presence] in Serum by Latex agglutination |
|
7997-0
|
Rickettsia spotted fever group Ab [Units/volume] in Serum |
|
22475-8
|
Rickettsia spotted fever group Ab [Titer] in Serum |
|
5311-6
|
Rickettsia spotted fever group Ab [Titer] in Serum by Immunofluorescence |
|
54033-6
|
Rickettsia spotted fever group Ag [Presence] in Tissue by Immune stain |
|
48870-0
|
Rickettsia spotted fever group DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5312-4
|
Rickettsia spotted fever group IgG Ab [Units/volume] in Serum by Immunoassay |
|
32999-5
|
Rickettsia spotted fever group IgG Ab [Presence] in Serum |
|
7998-8
|
Rickettsia spotted fever group IgG Ab [Units/volume] in Serum |
|
24281-8
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum --1st specimen |
|
24207-3
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24282-6
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum --2nd specimen |
|
24208-1
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22476-6
|
Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid |
|
21494-0
|
Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22477-4
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum |
|
5313-2
|
Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence |
|
31601-8
|
Rickettsia spotted fever group IgM Ab [Units/volume] in Cerebral spinal fluid |
|
5314-0
|
Rickettsia spotted fever group IgM Ab [Units/volume] in Serum by Immunoassay |
|
33000-1
|
Rickettsia spotted fever group IgM Ab [Presence] in Serum |
|
7999-6
|
Rickettsia spotted fever group IgM Ab [Units/volume] in Serum |
|
70135-9
|
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
70136-7
|
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22478-2
|
Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid |
|
21495-7
|
Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22479-0
|
Rickettsia spotted fever group IgM Ab [Titer] in Serum |
|
5315-7
|
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence |
|
17537-2
|
Rickettsia spotted fever group RNA [Presence] in Serum by NAA with probe detection |
|
17538-0
|
Rickettsia spotted fever group RNA [Presence] in Serum by Probe |
|
22491-5
|
Rickettsia typhus group Ab [Presence] in Serum |
|
5316-5
|
Rickettsia typhus group Ab [Presence] in Serum by Immunoassay |
|
5317-3
|
Rickettsia typhus group Ab [Presence] in Serum by Latex agglutination |
|
8000-2
|
Rickettsia typhus group Ab [Units/volume] in Serum |
|
22492-3
|
Rickettsia typhus group Ab [Titer] in Serum |
|
5318-1
|
Rickettsia typhus group Ab [Titer] in Serum by Immunofluorescence |
|
60272-2
|
Rickettsia typhus group DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
48871-8
|
Rickettsia typhus group DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5319-9
|
Rickettsia typhus group IgG Ab [Units/volume] in Serum by Immunoassay |
|
30555-7
|
Rickettsia typhus group IgG Ab [Presence] in Serum |
|
8001-0
|
Rickettsia typhus group IgG Ab [Units/volume] in Serum |
|
70131-8
|
Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
70132-6
|
Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22480-8
|
Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid |
|
21496-5
|
Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22493-1
|
Rickettsia typhus group IgG Ab [Titer] in Serum |
|
5320-7
|
Rickettsia typhus group IgG Ab [Titer] in Serum by Immunofluorescence |
|
31602-6
|
Rickettsia typhus group IgM Ab [Units/volume] in Cerebral spinal fluid |
|
5321-5
|
Rickettsia typhus group IgM Ab [Units/volume] in Serum by Immunoassay |
|
32714-8
|
Rickettsia typhus group IgM Ab [Presence] in Serum |
|
8002-8
|
Rickettsia typhus group IgM Ab [Units/volume] in Serum |
|
70133-4
|
Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
70134-2
|
Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22481-6
|
Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid |
|
21497-3
|
Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22494-9
|
Rickettsia typhus group IgM Ab [Titer] in Serum |
|
5322-3
|
Rickettsia typhus group IgM Ab [Titer] in Serum by Immunofluorescence |
|
49128-2
|
Rickettsia typhus group identified in Unspecified specimen by Sequencing |
|
42342-6
|
Rickettsia (Proteus) Ab panel - Serum |
|
7994-7
|
Rickettsia sp Ab [Units/volume] in Serum |
|
22484-0
|
Rickettsia sp Ab [Titer] in Serum |
|
5306-6
|
Rickettsia sp Ab [Titer] in Serum by Complement fixation |
|
5878-4
|
Rickettsia sp identified in Blood by Organism specific culture |
|
20949-4
|
Rickettsia sp [Presence] in Blood by Light microscopy |
|
53608-6
|
Rickettsia sp DNA [Presence] in Blood by NAA with probe detection |
|
67726-0
|
Rickettsia sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
48869-2
|
Rickettsia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
48863-5
|
Rickettsia sp DNA [Identifier] in Unspecified specimen by RFLP |
|
6544-1
|
Rickettsia sp identified in Genital specimen by Organism specific culture |
|
35877-0
|
Rickettsia sp IgG Ab [Units/volume] in Serum |
|
35740-0
|
Rickettsia sp IgG and IgM panel - Serum |
|
35876-2
|
Rickettsia sp IgM Ab [Units/volume] in Serum |
|
6545-8
|
Rickettsia sp identified in Sputum by Organism specific culture |
|
70130-0
|
Rickettsia typhus group and Rickettsia spotted fever group acute and convalescent IgG and IgM panel - Serum by Immunofluorescence |
|
6546-6
|
Rickettsia sp identified in Unspecified specimen by Organism specific culture |
|
49127-4
|
Rickettsia sp identified in Unspecified specimen by Sequencing |
|
54183-9
|
Rifabutin [Susceptibility] by Disk diffusion (KB) |
|
24032-5
|
Rifabutin [Mass/volume] in Serum or Plasma |
|
80546-5
|
rifAMPin [Mass/volume] in DBS |
|
73166-1
|
rifAMPin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73167-9
|
rifAMPin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
89489-9
|
rifAMPin [Susceptibility] by Genotype method |
|
4021-2
|
rifAMPin [Mass/volume] in Serum or Plasma |
|
76627-9
|
Rifapentine [Susceptibility] by Method for Slow-growing mycobacteria |
|
68463-9
|
Rilpivirine [Susceptibility] by Genotype method |
|
72557-2
|
Rilpivirine [Susceptibility] by Phenotype method |
|
80547-3
|
Rilpivirine [Mass/volume] in Serum or Plasma |
|
73165-3
|
Risedronate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73164-6
|
Risedronate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
75492-9
|
Risk assessment and screening note |
|
71482-4
|
Risk assessment Document |
|
91024-0
|
Risk assessment report Document Public health |
|
78440-5
|
risperiDONE trough and 9-Hydroxyrisperidone panel - Serum or Plasma |
|
72958-2
|
risperiDONE induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72957-4
|
risperiDONE induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73163-8
|
risperiDONE induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73162-0
|
risperiDONE induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
32128-1
|
risperiDONE [Presence] in Serum or Plasma |
|
9393-0
|
risperiDONE [Mass/volume] in Serum or Plasma |
|
39799-2
|
risperiDONE [Moles/volume] in Serum or Plasma |
|
72656-2
|
risperiDONE [Mass/volume] in Serum or Plasma --trough |
|
77880-3
|
risperiDONE [Mass/volume] in Urine by Confirmatory method |
|
32129-9
|
risperiDONE [Presence] in Urine |
|
32130-7
|
risperiDONE [Presence] in Unspecified specimen |
|
55157-2
|
risperiDONE and 9-Hydroxyrisperidone panel - Serum or Plasma |
|
9394-8
|
risperiDONE+9-Hydroxyrisperidone [Mass/volume] in Serum or Plasma |
|
39800-8
|
risperiDONE+9-Hydroxyrisperidone [Moles/volume] in Serum or Plasma |
|
51929-8
|
Ritonavir [Mass/volume] in Serum or Plasma --peak |
|
29122-9
|
Ritonavir [Units/volume] in Serum or Plasma |
|
31027-6
|
Ritonavir [Mass/volume] in Serum or Plasma |
|
51930-6
|
Ritonavir [Mass/volume] in Serum or Plasma --trough |
|
82466-4
|
riTUXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
82467-2
|
riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay |
|
68979-4
|
Rivaroxaban [Units/volume] in Platelet poor plasma by Chromogenic method |
|
74871-5
|
Rivaroxaban [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
74215-5
|
Rivaroxaban [Mass/volume] in Serum or Plasma by LC/MS/MS |
|
72624-0
|
Rivaroxaban [Mass/volume] in Serum or Plasma |
|
34427-5
|
Methadone.R [Mass/volume] in Serum or Plasma |
|
48365-1
|
Methadone.R [Moles/volume] in Serum or Plasma |
|
82279-1
|
RMR panel |
|
81821-1
|
RMRP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
83952-2
|
Registered nurse Hospital Note |
|
75491-1
|
Registered nurse Note |
|
59400-2
|
RNA Ab [Units/volume] in Serum by Immunoassay |
|
18272-5
|
RNA Ab [Units/volume] in Serum |
|
54156-5
|
RNA polymerase I Ab [Presence] in Serum by Immunofluorescence |
|
54157-3
|
RNA polymerase I Ab [Titer] in Serum by Immunofluorescence |
|
13347-0
|
RNA polymerase I+II+III Ab [Presence] in Serum |
|
63329-7
|
RNA polymerase III Ab [Units/volume] in Serum by Immunoassay |
|
89503-7
|
RNA polymerase III Ab [Units/volume] in Serum by Line blot |
|
63328-9
|
RNA polymerase III Ab [Presence] in Serum by Immunoassay |
|
89513-6
|
RNA polymerase III Ab [Presence] in Serum by Line blot |
|
53893-4
|
RNA polymerase III Ab [Units/volume] in Serum |
|
79182-2
|
RNA polymerase III IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
88737-2
|
RNA polymerase III RP11 Ab [Units/volume] in Serum by Line blot |
|
81737-9
|
RNA polymerase III RP11 Ab [Presence] in Serum by Line blot |
|
72317-1
|
RNA polymerase III RP11 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
88738-0
|
RNA polymerase III RP155 Ab [Units/volume] in Serum by Line blot |
|
81738-7
|
RNA polymerase III RP155 Ab [Presence] in Serum by Line blot |
|
72316-3
|
RNA polymerase III RP155 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
2925-6
|
Ribonuclease [Enzymatic activity/volume] in Serum |
|
88115-1
|
Round cells [Presence] in Semen by Light microscopy |
|
86291-2
|
Retinal nerve fiber layer panel Retina by OCT |
|
64982-2
|
Cockroach recombinant (rBla g) 1 IgE Ab [Units/volume] in Serum |
|
64983-0
|
Cockroach recombinant (rBla g) 2 IgE Ab [Units/volume] in Serum |
|
66444-1
|
Cockroach recombinant (rBla g) 4 IgE Ab [Units/volume] in Serum |
|
64984-8
|
Cockroach recombinant (rBla g) 5 IgE Ab [Units/volume] in Serum |
|
6078-0
|
Cockroach IgE Ab [Units/volume] in Serum |
|
61230-9
|
Cockroach IgE Ab/IgE total in Serum |
|
24139-8
|
Cockroach IgG Ab [Units/volume] in Serum |
|
56266-0
|
Cockroach IgG4 Ab [Mass/volume] in Serum |
|
48238-0
|
Cockroach triggered leukotriene release [Mass/volume] by Leukocytes |
|
73721-3
|
Rocuronium IgE Ab [Units/volume] in Serum |
|
48286-9
|
Rocuronium triggered leukotriene release [Mass/volume] by Leukocytes |
|
73160-4
|
Rofecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73161-2
|
Rofecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
69570-0
|
Risk of ovarian malignancy algorithm score in Serum or Plasma --postmenopausal |
|
69569-2
|
Risk of ovarian malignancy algorithm score in Serum or Plasma --premenopausal |
|
33014-2
|
Romano Cheese IgE Ab [Units/volume] in Serum |
|
45403-3
|
Room number [Location] |
|
51203-8
|
Ropivacaine [Mass/volume] in Serum or Plasma |
|
7214-0
|
Roquefort Cheese IgE Ab [Units/volume] in Serum |
|
89440-2
|
Rose Dyspnea Scale |
|
6231-5
|
Rose Hip IgE Ab [Units/volume] in Serum |
|
30043-4
|
Rosemary IgE Ab [Units/volume] in Serum |
|
73159-6
|
Rosiglitazone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73158-8
|
Rosiglitazone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73157-0
|
Rosuvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73156-2
|
Rosuvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80376-7
|
Rotavirus and Adenovirus Ag panel - Stool by Rapid immunoassay |
|
6233-1
|
Rough Pigweed IgE Ab [Units/volume] in Serum |
|
56463-3
|
Rough Pigweed IgG4 Ab [Mass/volume] in Serum |
|
63189-5
|
Rough Pigweed IgG Ab [Mass/volume] in Serum |
|
90028-2
|
Routine Assessment of Patient Index Data 3 [RAPID3] |
|
82289-0
|
Rating of perceived exertion [Score] |
|
77120-4
|
RPGR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77119-6
|
RPGR gene full mutation analysis in Blood or Tissue by Sequencing |
|
77118-8
|
RPGRIP1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77117-0
|
RPGRIP1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
82225-4
|
Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Fibroblast |
|
82224-7
|
Ribose-5-phosphate isomerase [Enzymatic activity/mass] in Lymphoblasts |
|
87925-4
|
Reagin Ab [Titer] in Cerebral spinal fluid by RPR |
|
47360-3
|
Reagin Ab [Presence] in Serum from Donor by RPR |
|
20507-0
|
Reagin Ab [Presence] in Serum by RPR |
|
20508-8
|
Reagin Ab [Units/volume] in Serum by RPR |
|
31147-2
|
Reagin Ab [Titer] in Serum by RPR |
|
59068-7
|
RPS19 gene targeted mutation analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
41063-9
|
RPS6KA3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35290-6
|
RPS6KA3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53793-6
|
RPS6KA3 gene mutations tier 1 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53794-4
|
RPS6KA3 gene mutations tier 2 found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
23411-2
|
Rinderpest virus Ab [Presence] in Serum |
|
23410-4
|
Rinderpest virus Ab [Presence] in Serum by Immunoassay |
|
23407-0
|
Rinderpest virus Ab [Presence] in Serum by Neutralization test |
|
31613-3
|
Rinderpest virus Ab [Units/volume] in Serum |
|
23408-8
|
Rinderpest virus Ab [Titer] in Serum |
|
23409-6
|
Rinderpest virus Ab [Titer] in Serum by Neutralization test |
|
31952-5
|
Rinderpest virus Ag [Presence] in Exudate |
|
23415-3
|
Rinderpest virus Ag [Presence] in Exudate by Immune diffusion (ID) |
|
23414-6
|
Rinderpest virus Ag [Presence] in Exudate by Immunoelectrophoresis |
|
23412-0
|
Rinderpest virus Ag [Units/volume] in Tissue by Immunoassay |
|
23416-1
|
Rinderpest virus Ag [Units/volume] in Unspecified specimen by Immunoassay |
|
31953-3
|
Rinderpest virus Ag [Presence] in Unspecified specimen |
|
23413-8
|
Rinderpest virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
31954-1
|
Rinderpest virus Ag [Units/volume] in Unspecified specimen |
|
23417-9
|
Rinderpest virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
76644-4
|
R-R interval.coefficient of variation by EKG |
|
76643-6
|
R-R interval.standard deviation (Heart rate variability) by EKG |
|
94080-9
|
RRM2B gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
85597-3
|
Renal replacement therapy goals panel NKDEP |
|
26672-6
|
Ross River virus Ab [Presence] in Serum |
|
31614-1
|
Ross River virus IgG Ab [Presence] in Serum |
|
24117-4
|
Ross River virus IgG Ab [Presence] in Serum by Immunoassay |
|
31615-8
|
Ross River virus IgM Ab [Presence] in Serum |
|
24120-8
|
Ross River virus IgM Ab [Presence] in Serum by Immunoassay |
|
81117-4
|
Ross River virus RNA [Presence] in Serum by NAA with probe detection |
|
38914-8
|
RS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38925-4
|
RS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
88204-3
|
Respiratory syncytial virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88595-4
|
Respiratory syncytial virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91795-5
|
Respiratory syncytial virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
30075-6
|
Respiratory syncytial virus A RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
52975-0
|
Respiratory syncytial virus Ab [Units/volume] in Serum by Complement fixation |
|
33390-6
|
Respiratory syncytial virus Ab [Presence] in Serum |
|
7990-5
|
Respiratory syncytial virus Ab [Units/volume] in Serum |
|
30147-3
|
Respiratory syncytial virus Ab [Presence] in Serum --1st specimen |
|
24298-2
|
Respiratory syncytial virus Ab [Titer] in Serum --1st specimen |
|
24224-8
|
Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation --1st specimen |
|
30148-1
|
Respiratory syncytial virus Ab [Presence] in Serum --2nd specimen |
|
24299-0
|
Respiratory syncytial virus Ab [Titer] in Serum --2nd specimen |
|
24225-5
|
Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation --2nd specimen |
|
33382-3
|
Respiratory syncytial virus Ab [Titer] in Cerebral spinal fluid |
|
22466-7
|
Respiratory syncytial virus Ab [Titer] in Serum |
|
5294-4
|
Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation |
|
5295-1
|
Respiratory syncytial virus Ab [Titer] in Serum by Immunofluorescence |
|
77389-5
|
Respiratory syncytial virus Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
|
88909-7
|
Respiratory syncytial virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
33045-6
|
Respiratory syncytial virus Ag [Presence] in Nose |
|
32040-8
|
Respiratory syncytial virus Ag [Presence] in Nose by Immunofluorescence |
|
68966-1
|
Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunoassay |
|
72885-7
|
Respiratory syncytial virus Ag [Presence] in Nasopharynx by Rapid immunoassay |
|
77390-3
|
Respiratory syncytial virus Ag [Presence] in Nasopharynx by Immunofluorescence |
|
31949-1
|
Respiratory syncytial virus Ag [Presence] in Throat |
|
5874-3
|
Respiratory syncytial virus Ag [Presence] in Throat by Immunoassay |
|
5875-0
|
Respiratory syncytial virus Ag [Presence] in Throat by Immunofluorescence |
|
50329-2
|
Respiratory syncytial virus Ag [Presence] in Tissue by Immune stain |
|
31950-9
|
Respiratory syncytial virus Ag [Presence] in Unspecified specimen |
|
5876-8
|
Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
5877-6
|
Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
88202-7
|
Respiratory syncytial virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
88597-0
|
Respiratory syncytial virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
91794-8
|
Respiratory syncytial virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
30076-4
|
Respiratory syncytial virus B RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88527-7
|
Respiratory syncytial virus identified [Presence] in Cornea or Conjunctiva by Organism specific culture |
|
69929-8
|
Respiratory syncytial virus IgA Ab [Presence] in Serum by Immunoassay |
|
31583-8
|
Respiratory syncytial virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
41012-6
|
Respiratory syncytial virus IgG Ab [Presence] in Serum |
|
40989-6
|
Respiratory syncytial virus IgG Ab [Presence] in Serum by Immunoassay |
|
7991-3
|
Respiratory syncytial virus IgG Ab [Units/volume] in Serum |
|
17517-4
|
Respiratory syncytial virus IgG Ab [Titer] in Cerebral spinal fluid |
|
17518-2
|
Respiratory syncytial virus IgG Ab [Titer] in Serum |
|
9573-7
|
Respiratory syncytial virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
49037-5
|
Respiratory syncytial virus IgG and IgM panel [Units/volume] - Serum |
|
69962-9
|
Respiratory syncytial virus IgM Ab [Presence] in Serum by Immunoassay |
|
7992-1
|
Respiratory syncytial virus IgM Ab [Units/volume] in Serum |
|
17519-0
|
Respiratory syncytial virus IgM Ab [Titer] in Cerebral spinal fluid |
|
22467-5
|
Respiratory syncytial virus IgM Ab [Titer] in Serum |
|
9574-5
|
Respiratory syncytial virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
91782-3
|
Respiratory syncytial virus identified [Presence] in Lower respiratory specimen by Organism specific culture |
|
14129-1
|
Respiratory syncytial virus [Presence] in Nose by Organism specific culture |
|
76088-4
|
Respiratory syncytial virus RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection |
|
88528-5
|
Respiratory syncytial virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
60271-4
|
Respiratory syncytial virus RNA [Presence] in Isolate by NAA with probe detection |
|
92957-0
|
Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
91133-9
|
Respiratory syncytial virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82176-9
|
Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
76089-2
|
Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with probe detection |
|
92131-2
|
Respiratory syncytial virus RNA [Presence] in Respiratory specimen by NAA with probe detection |
|
85479-4
|
Respiratory syncytial virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
40987-0
|
Respiratory syncytial virus RNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
40988-8
|
Respiratory syncytial virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91785-6
|
Respiratory syncytial virus identified [Presence] in Upper respiratory specimen by Organism specific culture |
|
17520-8
|
Respiratory syncytial virus identified in Unspecified specimen by Organism specific culture |
|
55100-2
|
Respiratory syncytial virus [Presence] in Unspecified specimen by Organism specific culture |
|
85701-1
|
Rubella surveillance panel |
|
29968-5
|
Rubidium [Mass/volume] in 24 hour Urine |
|
29969-3
|
Rubidium [Mass/time] in 24 hour Urine |
|
5718-2
|
Rubidium [Mass/volume] in Blood |
|
5719-0
|
Rubidium [Mass/mass] in Hair |
|
60169-0
|
Rubidium [Mass/volume] in Red Blood Cells |
|
5720-8
|
Rubidium [Mass/volume] in Serum or Plasma |
|
5721-6
|
Rubidium [Mass/volume] in Urine |
|
29970-1
|
Rubidium/Creatinine [Mass Ratio] in 24 hour Urine |
|
9576-0
|
Rubella virus Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
39581-4
|
Rubella virus Ab [Presence] in Cerebral spinal fluid |
|
40666-0
|
Rubella virus Ab [Presence] in Cerebral spinal fluid by Latex agglutination |
|
17549-7
|
Rubella virus Ab [Units/volume] in Cerebral spinal fluid |
|
5330-6
|
Rubella virus Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
51931-4
|
Rubella virus Ab [Units/volume] in Serum by Immunoassay |
|
17550-5
|
Rubella virus Ab [Units/volume] in Serum by Latex agglutination |
|
22496-4
|
Rubella virus Ab [Presence] in Serum |
|
5331-4
|
Rubella virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
43810-1
|
Rubella virus Ab [Presence] in Serum by Immunoassay |
|
89040-0
|
Rubella virus Ab [Presence] in Serum by Immunofluorescence |
|
5332-2
|
Rubella virus Ab [Presence] in Serum by Latex agglutination |
|
8013-5
|
Rubella virus Ab [Units/volume] in Serum |
|
42967-0
|
Rubella virus Ab [Titer] in Cerebral spinal fluid |
|
40542-3
|
Rubella virus Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
|
22497-2
|
Rubella virus Ab [Titer] in Serum |
|
50694-9
|
Rubella virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
5333-0
|
Rubella virus Ab [Titer] in Serum by Latex agglutination |
|
31955-8
|
Rubella virus Ag [Presence] in Cerebral spinal fluid |
|
14523-5
|
Rubella virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31956-6
|
Rubella virus Ag [Presence] in Cervix |
|
14529-2
|
Rubella virus Ag [Presence] in Cervix by Immunofluorescence |
|
31957-4
|
Rubella virus Ag [Presence] in Eye |
|
14526-8
|
Rubella virus Ag [Presence] in Eye by Immunofluorescence |
|
31959-0
|
Rubella virus Ag [Presence] in Nose |
|
14527-6
|
Rubella virus Ag [Presence] in Nose by Immunofluorescence |
|
31960-8
|
Rubella virus Ag [Presence] in Penis |
|
14532-6
|
Rubella virus Ag [Presence] in Penis by Immunofluorescence |
|
31961-6
|
Rubella virus Ag [Presence] in Skin |
|
14525-0
|
Rubella virus Ag [Presence] in Skin by Immunofluorescence |
|
31962-4
|
Rubella virus Ag [Presence] in Sputum |
|
14528-4
|
Rubella virus Ag [Presence] in Sputum by Immunofluorescence |
|
31963-2
|
Rubella virus Ag [Presence] in Throat |
|
14524-3
|
Rubella virus Ag [Presence] in Throat by Immunofluorescence |
|
31964-0
|
Rubella virus Ag [Presence] in Urine sediment |
|
14531-8
|
Rubella virus Ag [Presence] in Urine sediment by Immunofluorescence |
|
31965-7
|
Rubella virus Ag [Presence] in Urethra |
|
14533-4
|
Rubella virus Ag [Presence] in Urethra by Immunofluorescence |
|
31958-2
|
Rubella virus Ag [Presence] in Vaginal fluid |
|
14530-0
|
Rubella virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
|
31966-5
|
Rubella virus Ag [Presence] in Unspecified specimen |
|
12251-5
|
Rubella virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
85795-3
|
Rubella virus E1 gene and genotype panel - Unspecified specimen |
|
52986-7
|
Rubella virus IgG Ab avidity [Ratio] in Serum by Immunoassay |
|
34421-8
|
Rubella virus IgG Ab avidity [Ratio] in Serum |
|
17551-3
|
Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
39013-8
|
Rubella virus IgG Ab [Presence] in Cerebral spinal fluid |
|
40668-6
|
Rubella virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13281-1
|
Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
74415-1
|
Rubella virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29343-1
|
Rubella virus IgG Ab [Units/volume] in Body fluid |
|
25514-1
|
Rubella virus IgG Ab [Presence] in Serum |
|
63462-6
|
Rubella virus IgG Ab [Presence] in Serum by Latex agglutination |
|
8014-3
|
Rubella virus IgG Ab [Units/volume] in Serum |
|
5334-8
|
Rubella virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
40667-8
|
Rubella virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
13279-5
|
Rubella virus IgG Ab [Units/volume] in Serum --1st specimen |
|
13280-3
|
Rubella virus IgG Ab [Units/volume] in Serum --2nd specimen |
|
46110-3
|
Rubella virus IgG Ab [Titer] in Cerebral spinal fluid |
|
41763-4
|
Rubella virus IgG Ab [Titer] in Serum |
|
34953-0
|
Rubella virus IgG and IgM panel - Cerebral spinal fluid |
|
34952-2
|
Rubella virus IgG and IgM panel - Serum |
|
17552-1
|
Rubella virus IgM Ab [Presence] in Cerebral spinal fluid |
|
40669-4
|
Rubella virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13282-9
|
Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
69765-6
|
Rubella virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
31047-4
|
Rubella virus IgM Ab [Units/volume] in Body fluid |
|
5335-5
|
Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
31616-6
|
Rubella virus IgM Ab [Presence] in Serum |
|
25420-1
|
Rubella virus IgM Ab [Presence] in Serum by Latex agglutination |
|
8015-0
|
Rubella virus IgM Ab [Units/volume] in Serum |
|
24116-6
|
Rubella virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
46109-5
|
Rubella virus IgM Ab [Titer] in Cerebral spinal fluid |
|
49107-6
|
Rubella virus IgM Ab [Titer] in Serum |
|
91823-5
|
Rubella virus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
60274-8
|
Rubella virus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
91792-2
|
Rubella virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
86589-9
|
Rubella virus RNA [Presence] in Urine by NAA with probe detection |
|
54091-4
|
Rubella virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6548-2
|
Rubella virus identified in Serum by Organism specific culture |
|
59323-6
|
Rufinamide [Mass/volume] in Serum or Plasma |
|
87768-8
|
Rufinamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
48428-7
|
Rumenate (C18:2 cis-9 trans-11) [Moles/volume] in Serum or Plasma |
|
13177-1
|
Russian olive IgE Ab [Units/volume] in Serum |
|
5329-8
|
Rotavirus Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE) |
|
71705-8
|
Rotavirus Ab [Units/volume] in Serum by Immunoassay |
|
71765-2
|
Rotavirus Ab [Presence] in Serum by Immunoassay |
|
5328-0
|
Rotavirus Ab [Units/volume] in Serum |
|
22495-6
|
Rotavirus Ab [Titer] in Serum |
|
9575-2
|
Rotavirus Ab [Titer] in Serum by Complement fixation |
|
71764-5
|
Rotavirus Ab [Titer] in Serum by Immunoassay |
|
17547-1
|
Rotavirus Ag [Presence] in Stool |
|
5879-2
|
Rotavirus Ag [Presence] in Stool by Agglutination |
|
5880-0
|
Rotavirus Ag [Presence] in Stool by Immunoassay |
|
72174-6
|
Rotavirus Ag [Presence] in Stool by Rapid immunoassay |
|
71702-5
|
Rotavirus dsRNA [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) |
|
71701-7
|
Rotavirus dsRNA [Identifier] in Stool by Polyacrylamide gel electrophoresis (PAGE) |
|
8012-7
|
Rotavirus dsRNA [Presence] in Stool by NAA with probe detection |
|
71704-1
|
Rotavirus IgA Ab [Units/volume] in Serum by Immunoassay |
|
71762-9
|
Rotavirus IgA Ab [Presence] in Serum by Immunoassay |
|
71763-7
|
Rotavirus IgA Ab [Titer] in Serum by Immunoassay |
|
25754-3
|
Rotavirus IgG Ab [Units/volume] in Serum by Immunoassay |
|
25593-5
|
Rotavirus IgG Ab [Presence] in Serum |
|
25753-5
|
Rotavirus IgG Ab [Presence] in Serum by Immunoassay |
|
25599-2
|
Rotavirus IgG Ab [Units/volume] in Serum |
|
71703-3
|
Rotavirus IgG Ab [Titer] in Serum by Immunoassay |
|
25756-8
|
Rotavirus IgM Ab [Units/volume] in Serum by Immunoassay |
|
25601-6
|
Rotavirus IgM Ab [Presence] in Serum |
|
25755-0
|
Rotavirus IgM Ab [Presence] in Serum by Immunoassay |
|
25600-8
|
Rotavirus IgM Ab [Units/volume] in Serum |
|
71761-1
|
Rotavirus identified in Isolate by Sequencing |
|
71759-5
|
Rotavirus RNA [Identifier] in Isolate by NAA with probe detection |
|
60273-0
|
Rotavirus RNA [Presence] in Isolate by NAA with probe detection |
|
71700-9
|
Rotavirus RNA [Identifier] in Stool by NAA with probe detection |
|
62859-4
|
Rotavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17548-9
|
Rotavirus RNA [Presence] in Unspecified specimen by Probe |
|
8011-9
|
Rotavirus [Presence] in Stool by Electron microscopy |
|
71760-3
|
Rotavirus identified in Stool by Sequencing |
|
6547-4
|
Rotavirus identified in Unspecified specimen by Organism specific culture |
|
40992-0
|
Rhinovirus+Enterovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
92956-2
|
Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection |
|
92885-3
|
Rhinovirus+Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
82175-1
|
Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
88721-6
|
Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection |
|
40991-2
|
Rhinovirus+Enterovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82212-2
|
Rotavirus A RNA [Presence] in Stool by NAA with non-probe detection |
|
92693-1
|
Rotavirus A RNA [Presence] in Stool by NAA with probe detection |
|
87713-4
|
Rotavirus A VP4 gene [Nucleotide sequence] in Isolate by Sequencing |
|
80675-2
|
Rotavirus A VP6 gene [Presence] in Stool by NAA with probe detection |
|
87712-6
|
Rotavirus A VP7 gene [Nucleotide sequence] in Isolate by Sequencing |
|
87711-8
|
Rotavirus B VP7 gene [Nucleotide sequence] in Isolate by Sequencing |
|
87710-0
|
Rotavirus C VP7 gene [Nucleotide sequence] in Isolate by Sequencing |
|
86688-9
|
Rotavirus C [Presence] in Unspecified specimen by Organism specific culture |
|
23397-3
|
Rift valley fever virus Ab [Presence] in Serum |
|
23399-9
|
Rift valley fever virus Ab [Presence] in Serum by Immunoassay |
|
31612-5
|
Rift valley fever virus Ab [Units/volume] in Serum |
|
23400-5
|
Rift valley fever virus Ab [Titer] in Serum |
|
23398-1
|
Rift valley fever virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
23396-5
|
Rift valley fever virus Ab [Titer] in Serum by Neutralization test |
|
23402-1
|
Rift valley fever virus Ag [Presence] in Blood by Neutralization test |
|
71778-5
|
Rift valley fever virus Ag [Presence] in Serum by Immunoassay |
|
23406-2
|
Rift valley fever virus Ag [Presence] in Serum by Immune diffusion (ID) |
|
23405-4
|
Rift valley fever virus Ag [Presence] in Tissue by Immune diffusion (ID) |
|
23404-7
|
Rift valley fever virus Ag [Presence] in Tissue by Immunofluorescence |
|
23401-3
|
Rift valley fever virus Ag [Presence] in Tissue by Neutralization test |
|
31951-7
|
Rift valley fever virus Ag [Presence] in Unspecified specimen |
|
23403-9
|
Rift valley fever virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
71780-1
|
Rift valley fever virus IgG Ab [Presence] in Serum by Immunoassay |
|
71784-3
|
Rift valley fever virus IgG Ab [Titer] in Serum by Immunoassay |
|
71781-9
|
Rift valley fever virus IgM Ab [Presence] in Serum by Immunoassay |
|
71779-3
|
Rift valley fever virus IgM Ab [Titer] in Serum by Immunoassay |
|
5904-8
|
Russell viper venom time in Platelet poor plasma by Coagulation assay |
|
52063-5
|
Prescription for durable medical equipment (DME) |
|
57832-8
|
Prescription for diagnostic or specialist care |
|
57829-4
|
Prescription for medical equipment or product |
|
57833-6
|
Prescription for medication |
|
57831-0
|
Prescription for rehabilitation |
|
7673-7
|
Rye triggered histamine release [Units/volume] in Blood |
|
7674-5
|
Rye IgE Ab [Units/volume] in Serum |
|
61312-5
|
Rye IgE Ab/IgE total in Serum |
|
7675-2
|
Rye IgG Ab [Units/volume] in Serum |
|
56443-5
|
Rye IgG4 Ab [Mass/volume] in Serum |
|
51933-0
|
Rye IgG Ab [Mass/volume] in Serum |
|
48222-4
|
Rye triggered leukotriene release [Mass/volume] by Leukocytes |
|
23419-5
|
Salmonella abortus equi Ab [Presence] in Serum |
|
23418-7
|
Salmonella abortus equi Ab [Presence] in Serum by Agglutination |
|
23421-1
|
Salmonella abortus ovis Ab [Presence] in Serum |
|
23420-3
|
Salmonella abortus ovis Ab [Presence] in Serum by Complement fixation |
|
92521-4
|
S Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92483-7
|
S Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1320-1
|
S Ag [Presence] on Red Blood Cells |
|
88273-8
|
Streptococcus agalactiae hsp60 gene [Presence] by Probe in Positive blood culture |
|
70070-8
|
Streptococcus anginosus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88274-6
|
Streptococcus anginosus group gyrB gene [Presence] by Probe in Positive blood culture |
|
88551-7
|
Scedosporium apiospermum DNA [Presence] in Aspirate by NAA with probe detection |
|
88549-1
|
Scedosporium apiospermum DNA [Presence] in Isolate by NAA with probe detection |
|
88550-9
|
Scedosporium apiospermum DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88548-3
|
Scedosporium apiospermum DNA [Presence] in Tissue by NAA with probe detection |
|
88557-4
|
Scedosporium apiospermum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22515-1
|
Salmonella arizonae Ab [Presence] in Serum |
|
15504-4
|
Salmonella arizonae Ab [Presence] in Serum by Agglutination |
|
7712-3
|
Spondylocladium atrovirens IgE Ab [Units/volume] in Serum |
|
6550-8
|
Staphylococcus aureus Ab [Units/volume] in Serum |
|
92953-9
|
Staphylococcus aureus DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85765-6
|
Staphylococcus aureus DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92701-2
|
Staphylococcus aureus DNA [Presence] in Nose by NAA with probe detection |
|
92952-1
|
Staphylococcus aureus DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61404-0
|
Staphylococcus aureus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
71786-8
|
Staphylococcus aureus exfoliative toxin A eta gene [Presence] in Unspecified specimen by NAA with probe detection |
|
71787-6
|
Staphylococcus aureus exfoliative toxin B etb gene [Presence] in Unspecified specimen by NAA with probe detection |
|
44878-7
|
Staphylococcus aureus enterotoxin A sea gene [Presence] in Unspecified specimen by NAA with probe detection |
|
25821-0
|
Staphylococcus aureus enterotoxin A IgE Ab [Units/volume] in Serum |
|
23934-3
|
Staphylococcus aureus enterotoxin B Ab [Presence] in Serum |
|
44880-3
|
Staphylococcus aureus enterotoxin B seb gene [Presence] in Unspecified specimen by NAA with probe detection |
|
25822-8
|
Staphylococcus aureus enterotoxin B IgE Ab [Units/volume] in Serum |
|
23933-5
|
Staphylococcus aureus enterotoxin B [Presence] in Unspecified specimen |
|
41855-8
|
Staphylococcus aureus enterotoxin B [Presence] in Unspecified specimen by Immunofluorescence |
|
72823-8
|
Staphylococcus aureus enterotoxin C sec gene [Presence] in Unspecified specimen by NAA with probe detection |
|
25824-4
|
Staphylococcus aureus enterotoxin C IgE Ab [Units/volume] in Serum |
|
72822-0
|
Staphylococcus aureus enterotoxin D sed gene [Presence] in Unspecified specimen by NAA with probe detection |
|
25826-9
|
Staphylococcus aureus enterotoxin D IgE Ab [Units/volume] in Serum |
|
44879-5
|
Staphylococcus aureus enterotoxin E see gene [Presence] in Unspecified specimen by NAA with probe detection |
|
82574-5
|
Staphylococcus aureus enterotoxin E IgE Ab [Units/volume] in Serum |
|
90882-2
|
Staphylococcus aureus enterotoxin E IgE Ab RAST class [Presence] in Serum |
|
33865-7
|
Staphylococcus aureus enterotoxin [Identifier] in Unspecified specimen |
|
86319-1
|
Staphylococcus aureus [Presence] in Food by Culture |
|
88269-6
|
Staphylococcus aureus gyrB gene [Presence] by Probe in Positive blood culture |
|
7719-8
|
Staphylococcus aureus IgE Ab [Units/volume] in Serum |
|
48816-3
|
Staphylococcus aureus Panton-Valentine leukocidin gene [Presence] in Unspecified specimen by NAA with probe detection |
|
5033-6
|
Staphylococcus aureus rRNA [Presence] in Unspecified specimen by Probe |
|
44881-1
|
Staphylococcus aureus toxic shock syndrome toxin gene [Presence] in Unspecified specimen by NAA with probe detection |
|
23936-8
|
Staphylococcus aureus toxic shock syndrome toxin 1 Ab [Presence] in Serum |
|
51856-3
|
Staphylococcus aureus TSST-1 IgE Ab [Units/volume] in Serum |
|
23935-0
|
Staphylococcus aureus toxic shock syndrome toxin 1 [Presence] in Unspecified specimen |
|
50683-2
|
Staphylococcus aureus toxic shock syndrome toxin 1+Staphylococcus aureus enterotoxin B Ab [Presence] in Serum |
|
85764-9
|
Staphylococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
73558-9
|
Staphylococcus aureus and Staphylococcus sp.coagulase negative rRNA [Identifier] by FISH in Positive blood culture |
|
6252-1
|
Stemphylium botryosum IgE Ab [Units/volume] in Serum |
|
39601-0
|
Stemphylium botryosum IgE Ab/IgE total in Serum |
|
18412-7
|
Stemphylium botryosum IgG Ab [Units/volume] in Serum |
|
35553-7
|
Stemphylium botryosum IgG Ab [Mass/volume] in Serum |
|
11602-0
|
Shigella boydii Ab [Units/volume] in Serum |
|
22537-5
|
Shigella boydii Ab [Titer] in Serum |
|
9712-1
|
Shigella boydii Ab [Titer] in Serum by Complement fixation |
|
42256-8
|
Shigella boydii Ag [Presence] in Isolate |
|
31634-9
|
Stachybotrys chartarum IgA Ab [Units/volume] in Serum |
|
26820-1
|
Stachybotrys chartarum IgA Ab [Mass/volume] in Serum |
|
29616-0
|
Stachybotrys chartarum IgE Ab [Units/volume] in Serum |
|
42815-1
|
Stachybotrys chartarum IgE Ab [Mass/volume] in Serum |
|
51541-1
|
Stachybotrys chartarum IgG Ab [Presence] in Serum |
|
25779-0
|
Stachybotrys chartarum IgG Ab [Units/volume] in Serum |
|
42816-9
|
Stachybotrys chartarum IgG Ab [Mass/volume] in Serum |
|
93757-3
|
Salmonella choleraesuis+infantis+typhimurium Ab/Positive control in Unspecified specimen by Immunoassay |
|
10963-7
|
Spondylocladium citrovirens IgE Ab [Units/volume] in Serum |
|
70071-6
|
Streptococcus constellatus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
11596-4
|
Shigella dysenteriae Ab [Units/volume] in Serum |
|
22538-3
|
Shigella dysenteriae Ab [Titer] in Serum |
|
9713-9
|
Shigella dysenteriae Ab [Titer] in Serum by Complement fixation |
|
42257-6
|
Shigella dysenteriae Ag [Presence] in Isolate |
|
70068-2
|
Streptococcus dysgalactiae subspecies equisimilis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
82199-1
|
Salmonella enterica+bongori DNA [Presence] in Stool by NAA with non-probe detection |
|
61370-3
|
Salmonella enterica DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
34423-4
|
Salmonella enteritidis H Ab [Titer] in Serum |
|
34431-7
|
Salmonella enteritidis H Ab [Titer] in Serum by Agglutination |
|
23425-2
|
Salmonella enteritidis IgG Ab [Presence] in Egg yolk |
|
23423-7
|
Salmonella enteritidis IgG Ab [Presence] in Egg yolk by Immunoassay |
|
23422-9
|
Salmonella enteritidis IgG Ab [Presence] in Serum |
|
23424-5
|
Salmonella enteritidis IgG Ab [Presence] in Serum by Immunoassay |
|
23602-6
|
Salmonella enteritidis [Presence] in Stool by Organism specific culture |
|
34891-2
|
Salmonella enteritidis [Presence] in Unspecified specimen by Organism specific culture |
|
61405-7
|
Staphylococcus epidermidis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
88270-4
|
Staphylococcus epidermidis hsp60 gene [Presence] by Probe in Positive blood culture |
|
11600-4
|
Shigella flexneri Ab [Units/volume] in Serum |
|
22539-1
|
Shigella flexneri Ab [Titer] in Serum |
|
9714-7
|
Shigella flexneri Ab [Titer] in Serum by Complement fixation |
|
42258-4
|
Shigella flexneri Ag [Presence] in Isolate |
|
41127-2
|
Salmonella gallinarum Ab [Presence] in Blood |
|
23426-0
|
Salmonella gallinarum Ab [Presence] in Blood by Agglutination |
|
23427-8
|
Salmonella gallinarum Ab [Presence] in Serum |
|
23429-4
|
Salmonella gallinarum Ab [Presence] in Serum by Agglutination |
|
23428-6
|
Salmonella gallinarum Ab [Presence] in Serum by Immunoassay |
|
23431-0
|
Salmonella gallinarum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23432-8
|
Salmonella gallinarum rRNA [Presence] in Unspecified specimen by Probe |
|
26657-7
|
Schistosoma haematobium Ab [Presence] in Serum |
|
41422-7
|
Schistosoma haematobium Ab [Presence] in Serum by Immunoblot |
|
70018-7
|
Staphylococcus haemolyticus DNA [Presence] in Blood by NAA with probe detection |
|
20962-7
|
Serpulina hyodysenteria [Presence] in Spiral colon by Organism specific culture |
|
20963-5
|
Serpulina hyodysenteria [Presence] in Stool by Organism specific culture |
|
70069-0
|
Streptococcus intermedius DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41423-5
|
Schistosoma japonicum Ab [Presence] in Serum by Immunoblot |
|
8018-4
|
Schistosoma japonicum Ab [Units/volume] in Serum |
|
22535-9
|
Schistosoma japonicum Ab [Titer] in Serum |
|
6626-6
|
Schistosoma japonicum Ab [Titer] in Serum by Complement fixation |
|
6241-4
|
Dry-rot Fungus IgE Ab [Units/volume] in Serum |
|
63165-5
|
Dry-rot Fungus IgG Ab [Mass/volume] in Serum |
|
88271-2
|
Staphylococcus lugdunensis sodA gene [Presence] by Probe in Positive blood culture |
|
61403-2
|
Stenotrophomonas maltophilia DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
77943-9
|
Schistosoma mansoni+haematobium+intercalatum [Titer] in Serum by Hemagglutination |
|
22536-7
|
Schistosoma mansoni Ab [Presence] in Serum |
|
6627-4
|
Schistosoma mansoni Ab [Presence] in Serum by Immunoassay |
|
8019-2
|
Schistosoma mansoni Ab [Units/volume] in Serum |
|
41424-3
|
Schistosoma mansoni Ab [Presence] in Unspecified specimen by Immunoblot |
|
92955-4
|
Serratia marcescens DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85777-1
|
Serratia marcescens DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92954-7
|
Serratia marcescens DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
61402-4
|
Serratia marcescens DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5367-8
|
Streptobacillus moniliformis Ab [Units/volume] in Serum |
|
75754-2
|
Streptobacillus moniliformis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22532-6
|
Sarcocystis neurona Ab [Presence] in Blood |
|
20958-5
|
Sarcocystis neurona Ab [Presence] in Blood by Immunoblot |
|
22533-4
|
Sarcocystis neurona Ab [Presence] in Body fluid |
|
20956-9
|
Sarcocystis neurona Ab [Presence] in Body fluid by Immunoblot |
|
22534-2
|
Sarcocystis neurona Ab [Presence] in Serum |
|
20957-7
|
Sarcocystis neurona Ab [Presence] in Serum by Immunoblot |
|
39022-9
|
Sarcocystis neurona Ab [Presence] in Serum by Immunofluorescence |
|
20959-3
|
Sarcocystis neurona Ag [Presence] in Tissue by Immune stain |
|
22516-9
|
Salmonella paratyphi A Ab [Presence] in Serum |
|
11264-9
|
Salmonella paratyphi A Ab [Presence] in Serum by Agglutination |
|
32212-3
|
Salmonella paratyphi A Ab [Titer] in Serum |
|
22517-7
|
Salmonella paratyphi A H Ab [Presence] in Serum |
|
5339-7
|
Salmonella paratyphi A H Ab [Presence] in Serum by Latex agglutination |
|
22518-5
|
Salmonella paratyphi A H Ab [Titer] in Serum |
|
21511-1
|
Salmonella paratyphi A H Ab [Titer] in Serum by Agglutination |
|
21512-9
|
Salmonella paratyphi A H Ab [Titer] in Serum by Immunofluorescence |
|
22519-3
|
Salmonella paratyphi A O Ab [Presence] in Serum |
|
5340-5
|
Salmonella paratyphi A O Ab [Presence] in Serum by Latex agglutination |
|
33316-1
|
Salmonella paratyphi A O Ab [Titer] in Serum |
|
33470-6
|
Salmonella paratyphi A O Ab [Titer] in Serum by Agglutination |
|
22520-1
|
Salmonella paratyphi B Ab [Presence] in Serum |
|
11265-6
|
Salmonella paratyphi B Ab [Presence] in Serum by Agglutination |
|
32213-1
|
Salmonella paratyphi B Ab [Titer] in Serum |
|
22521-9
|
Salmonella paratyphi B H Ab [Presence] in Serum |
|
5341-3
|
Salmonella paratyphi B H Ab [Presence] in Serum by Latex agglutination |
|
31618-2
|
Salmonella paratyphi B H Ab [Units/volume] in Serum |
|
22522-7
|
Salmonella paratyphi B H Ab [Titer] in Serum |
|
21513-7
|
Salmonella paratyphi B H Ab [Titer] in Serum by Agglutination |
|
21514-5
|
Salmonella paratyphi B H Ab [Titer] in Serum by Immunofluorescence |
|
22523-5
|
Salmonella paratyphi B O Ab [Presence] in Serum |
|
5342-1
|
Salmonella paratyphi B O Ab [Presence] in Serum by Latex agglutination |
|
31619-0
|
Salmonella paratyphi B O Ab [Units/volume] in Serum |
|
42964-7
|
Salmonella paratyphi B O Ab [Titer] in Serum |
|
27938-0
|
Salmonella paratyphi B O Ab [Titer] in Serum by Agglutination |
|
48686-0
|
Salmonella paratyphi C Ab [Titer] in Serum |
|
22524-3
|
Salmonella paratyphi C H Ab [Presence] in Serum |
|
5343-9
|
Salmonella paratyphi C H Ab [Presence] in Serum by Latex agglutination |
|
42963-9
|
Salmonella paratyphi C H Ab [Titer] in Serum |
|
34369-9
|
Salmonella paratyphi C H Ab [Titer] in Serum by Agglutination |
|
22525-0
|
Salmonella paratyphi C O Ab [Presence] in Serum |
|
5344-7
|
Salmonella paratyphi C O Ab [Presence] in Serum by Latex agglutination |
|
42962-1
|
Salmonella paratyphi C O Ab [Titer] in Serum |
|
34370-7
|
Salmonella paratyphi C O Ab [Titer] in Serum by Agglutination |
|
30913-8
|
S-phase cells/100 cells in Unspecified specimen by Flow cytometry (FC) |
|
53932-0
|
Streptococcus pneumoniae 14 serotypes and Corynebacterium diphtheriae toxin and Clostridium tetani toxin Ab.IgG panel - Serum |
|
85759-9
|
Streptococcus pneumoniae Danish serotypes 11A+11D DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85749-0
|
Streptococcus pneumoniae Danish serotypes 22A+22F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85755-7
|
Streptococcus pneumoniae Danish serotypes 33A+33F+37 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85754-0
|
Streptococcus pneumoniae Danish serotypes 6A+6B+6C+6D DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86019-7
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum |
|
86020-5
|
Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum |
|
86032-0
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86033-8
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --1st specimen |
|
86034-6
|
Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --1st specimen |
|
86035-3
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86036-1
|
Streptococcus pneumoniae Danish serotype 19F Ab [Units/volume] in Serum --2nd specimen |
|
86037-9
|
Streptococcus pneumoniae Danish serotype 19F Ab [Mass/volume] in Serum --2nd specimen |
|
85745-8
|
Streptococcus pneumoniae Danish serotype 19F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86031-2
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86023-9
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum by Immunoassay |
|
86021-3
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86022-1
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum |
|
86024-7
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum |
|
86027-0
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86026-2
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --1st specimen |
|
86025-4
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --1st specimen |
|
86030-4
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86029-6
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Units/volume] in Serum --2nd specimen |
|
86028-8
|
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
51668-2
|
Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Pseudomonas aeruginosa DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
62493-2
|
Streptococcus pneumoniae DNA and Haemophilus influenza DNA and Streptococcus agalactiae DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
42361-6
|
Streptococcus pneumoniae 12 serotypes IgG panel [Mass/volume] - Serum |
|
42360-8
|
Streptococcus pneumoniae 14 serotypes IgG panel A [Mass/volume] - Serum |
|
42359-0
|
Streptococcus pneumoniae 14 serotypes IgG panel B [Mass/volume] - Serum |
|
42366-5
|
Streptococcus pneumoniae 23 serotypes IgG panel [Mass/volume] - Serum |
|
42365-7
|
Streptococcus pneumoniae 4 serotypes IgG panel [Mass/volume] - Serum |
|
42364-0
|
Streptococcus pneumoniae 6 serotypes IgG panel [Mass/volume] - Serum |
|
42363-2
|
Streptococcus pneumoniae 7 serotypes IgG panel A [Mass/volume] - Serum |
|
42362-4
|
Streptococcus pneumoniae 7 serotypes IgG panel B [Mass/volume] - Serum |
|
17648-7
|
Streptococcus pneumoniae Ab [Units/volume] in Serum by Immunoassay |
|
10717-7
|
Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
|
8030-9
|
Streptococcus pneumoniae Ab [Presence] in Serum |
|
6552-4
|
Streptococcus pneumoniae Ab [Presence] in Serum by Immunoassay |
|
17647-9
|
Streptococcus pneumoniae Ab [Units/volume] in Serum |
|
25531-5
|
Streptococcus pneumoniae Ab [Mass/volume] in Serum |
|
20489-1
|
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid |
|
86590-7
|
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Rapid immunoassay |
|
6553-2
|
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
14322-2
|
Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
|
73685-0
|
Streptococcus pneumoniae Ag [Presence] in Isolate by Latex agglutination |
|
11086-6
|
Streptococcus pneumoniae Ag [Presence] in Serum |
|
31968-1
|
Streptococcus pneumoniae Ag [Presence] in Sputum |
|
6554-0
|
Streptococcus pneumoniae Ag [Presence] in Sputum by Immunofluorescence |
|
24027-5
|
Streptococcus pneumoniae Ag [Presence] in Urine |
|
77949-6
|
Streptococcus pneumoniae Ag [Presence] in Urine by Rapid immunoassay |
|
31969-9
|
Streptococcus pneumoniae Ag [Presence] in Unspecified specimen |
|
6555-7
|
Streptococcus pneumoniae Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
17652-9
|
Streptococcus pneumoniae Ag [Presence] in Unspecified specimen by Latex agglutination |
|
51407-5
|
Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum by Immunoassay |
|
51472-9
|
Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum |
|
51408-3
|
Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum by Immunoassay |
|
51473-7
|
Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum |
|
85953-8
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum |
|
85952-0
|
Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum |
|
85966-0
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
85967-8
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --1st specimen |
|
85965-2
|
Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --1st specimen |
|
85969-4
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
85970-2
|
Streptococcus pneumoniae Danish serotype 1 Ab [Units/volume] in Serum --2nd specimen |
|
85968-6
|
Streptococcus pneumoniae Danish serotype 1 Ab [Mass/volume] in Serum --2nd specimen |
|
85747-4
|
Streptococcus pneumoniae Danish serotype 1 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85964-5
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
85957-9
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
85955-3
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
85956-1
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum |
|
85954-6
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum |
|
85958-7
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
85960-3
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --1st specimen |
|
85959-5
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --1st specimen |
|
85961-1
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
85963-7
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Units/volume] in Serum --2nd specimen |
|
85962-9
|
Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86104-7
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86099-9
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86098-1
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum |
|
86101-3
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86100-5
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --1st specimen |
|
86103-9
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86102-1
|
Streptococcus pneumoniae Danish serotype 10A IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86128-6
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86123-7
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86122-9
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum |
|
86125-2
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86124-5
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --1st specimen |
|
86127-8
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86126-0
|
Streptococcus pneumoniae Danish serotype 11A IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85988-4
|
Streptococcus pneumoniae Danish serotype 12F Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
85973-6
|
Streptococcus pneumoniae Danish serotype 12F Ab [Presence] in Serum |
|
85972-8
|
Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum |
|
85971-0
|
Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum |
|
85984-3
|
Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --1st specimen |
|
85985-0
|
Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --1st specimen |
|
85986-8
|
Streptococcus pneumoniae Danish serotype 12F Ab [Units/volume] in Serum --2nd specimen |
|
85987-6
|
Streptococcus pneumoniae Danish serotype 12F Ab [Mass/volume] in Serum --2nd specimen |
|
85976-9
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum by Immunoassay |
|
85974-4
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
85975-1
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum |
|
85977-7
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum |
|
85980-1
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
85979-3
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --1st specimen |
|
85978-5
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --1st specimen |
|
85983-5
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
85982-7
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Units/volume] in Serum --2nd specimen |
|
85981-9
|
Streptococcus pneumoniae Danish serotype 12F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86007-2
|
Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
|
86008-0
|
Streptococcus pneumoniae Danish serotype 14 Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
85990-0
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum |
|
85989-2
|
Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum |
|
86002-3
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86003-1
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --1st specimen |
|
86001-5
|
Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --1st specimen |
|
86005-6
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86006-4
|
Streptococcus pneumoniae Danish serotype 14 Ab [Units/volume] in Serum --2nd specimen |
|
86004-9
|
Streptococcus pneumoniae Danish serotype 14 Ab [Mass/volume] in Serum --2nd specimen |
|
85746-6
|
Streptococcus pneumoniae Danish serotype 14 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85994-2
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum by Immunoassay |
|
85992-6
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
85993-4
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum |
|
85991-8
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum |
|
85995-9
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
85997-5
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --1st specimen |
|
85996-7
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --1st specimen |
|
85998-3
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86000-7
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Units/volume] in Serum --2nd specimen |
|
85999-1
|
Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
47347-0
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
47356-1
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay |
|
40973-0
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum |
|
47357-9
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47501-2
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --1st specimen |
|
47346-2
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
47502-0
|
Streptococcus pneumoniae Danish serotype 15B IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85751-6
|
Streptococcus pneumoniae Danish serotype 16F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86015-5
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86010-6
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86009-8
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum |
|
86012-2
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86011-4
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --1st specimen |
|
86014-8
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86013-0
|
Streptococcus pneumoniae Danish serotype 17F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
13136-7
|
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum |
|
26755-9
|
Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum |
|
13157-3
|
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --1st specimen |
|
27151-0
|
Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --1st specimen |
|
13158-1
|
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --2nd specimen |
|
27121-3
|
Streptococcus pneumoniae Danish serotype 18C Ab [Mass/volume] in Serum --2nd specimen |
|
25285-8
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
9611-5
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum by Immunoassay |
|
40913-6
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay |
|
17635-4
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum |
|
27395-3
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum |
|
40914-4
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
31647-1
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --1st specimen |
|
30490-7
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --1st specimen |
|
40912-8
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
25289-0
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Units/volume] in Serum --2nd specimen |
|
30491-5
|
Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86018-9
|
Streptococcus pneumoniae Danish serotype 18F Ab [Units/volume] in Serum --1st specimen |
|
86017-1
|
Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86016-3
|
Streptococcus pneumoniae Danish serotype 18F IgG Ab [Mass/volume] in Serum |
|
85760-7
|
Streptococcus pneumoniae Danish serotype 19A DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
47348-8
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
40915-1
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
40974-8
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum |
|
40916-9
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47503-8
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --1st specimen |
|
40917-7
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
47504-6
|
Streptococcus pneumoniae Danish serotype 19A IgG Ab [Mass/volume] in Serum --2nd specimen |
|
42367-3
|
Streptococcus pneumoniae Danish serotype 19B IgG Ab [Mass/volume] in Serum |
|
85744-1
|
Streptococcus pneumoniae Danish serotype 2 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86044-5
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86038-7
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86039-5
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum |
|
86040-3
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86041-1
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86042-9
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86043-7
|
Streptococcus pneumoniae Danish serotype 2 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86051-0
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86046-0
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86045-2
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum |
|
86048-6
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86047-8
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --1st specimen |
|
86050-2
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86049-4
|
Streptococcus pneumoniae Danish serotype 20A IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86058-5
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86053-6
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86052-8
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum |
|
86055-1
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86054-4
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --1st specimen |
|
86057-7
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86056-9
|
Streptococcus pneumoniae Danish serotype 22F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85750-8
|
Streptococcus pneumoniae Danish serotype 23A DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86059-3
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum |
|
86060-1
|
Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum |
|
86072-6
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86073-4
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --1st specimen |
|
86074-2
|
Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --1st specimen |
|
86075-9
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86076-7
|
Streptococcus pneumoniae Danish serotype 23F Ab [Units/volume] in Serum --2nd specimen |
|
86077-5
|
Streptococcus pneumoniae Danish serotype 23F Ab [Mass/volume] in Serum --2nd specimen |
|
85743-3
|
Streptococcus pneumoniae Danish serotype 23F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86071-8
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86063-5
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum by Immunoassay |
|
86061-9
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86062-7
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum |
|
86064-3
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum |
|
86067-6
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86066-8
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --1st specimen |
|
86065-0
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --1st specimen |
|
86070-0
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86069-2
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Units/volume] in Serum --2nd specimen |
|
86068-4
|
Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86097-3
|
Streptococcus pneumoniae Danish serotype 3 Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86079-1
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum |
|
86078-3
|
Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum |
|
86092-4
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86093-2
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --1st specimen |
|
86091-6
|
Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --1st specimen |
|
86095-7
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86096-5
|
Streptococcus pneumoniae Danish serotype 3 Ab [Units/volume] in Serum --2nd specimen |
|
86094-0
|
Streptococcus pneumoniae Danish serotype 3 Ab [Mass/volume] in Serum --2nd specimen |
|
85742-5
|
Streptococcus pneumoniae Danish serotype 3 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86090-8
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86083-3
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum by Immunoassay |
|
86081-7
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86082-5
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum |
|
86080-9
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum |
|
86084-1
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86086-6
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --1st specimen |
|
86085-8
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86087-4
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86089-0
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Units/volume] in Serum --2nd specimen |
|
86088-2
|
Streptococcus pneumoniae Danish serotype 3 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
47350-4
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
47349-6
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
40969-8
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum |
|
47351-2
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47509-5
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --1st specimen |
|
47352-0
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
47510-3
|
Streptococcus pneumoniae Danish serotype 33F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86106-2
|
Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum |
|
86105-4
|
Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum |
|
86119-5
|
Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --1st specimen |
|
86118-7
|
Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --1st specimen |
|
86121-1
|
Streptococcus pneumoniae Danish serotype 4 Ab [Units/volume] in Serum --2nd specimen |
|
86120-3
|
Streptococcus pneumoniae Danish serotype 4 Ab [Mass/volume] in Serum --2nd specimen |
|
85741-7
|
Streptococcus pneumoniae Danish serotype 4 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86117-9
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86110-4
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum by Immunoassay |
|
86108-8
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86109-6
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum |
|
86107-0
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum |
|
86111-2
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86113-8
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --1st specimen |
|
86112-0
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86114-6
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86116-1
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Units/volume] in Serum --2nd specimen |
|
86115-3
|
Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85740-9
|
Streptococcus pneumoniae Danish serotype 5 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86135-1
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86129-4
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86130-2
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum |
|
86131-0
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86132-8
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86133-6
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86134-4
|
Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86139-3
|
Streptococcus pneumoniae Danish serotype 6A Ab [Units/volume] in Serum --2nd specimen |
|
86140-1
|
Streptococcus pneumoniae Danish serotype 6A Ab [Mass/volume] in Serum --2nd specimen |
|
86138-5
|
Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86137-7
|
Streptococcus pneumoniae Danish serotype 6A IgG Ab [Units/volume] in Serum |
|
86136-9
|
Streptococcus pneumoniae Danish serotype 6A IgG Ab [Mass/volume] in Serum |
|
86338-1
|
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum |
|
86342-3
|
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum |
|
86341-5
|
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Units/volume] in Serum --1st specimen |
|
86343-1
|
Streptococcus pneumoniae Danish serotype 6A+6B Ab [Mass/volume] in Serum --1st specimen |
|
86340-7
|
Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum by Immunoassay |
|
86339-9
|
Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab [Units/volume] in Serum |
|
13133-4
|
Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum |
|
34172-7
|
Streptococcus pneumoniae Danish serotype 6B Ab [Mass/volume] in Serum |
|
13145-8
|
Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --1st specimen |
|
13146-6
|
Streptococcus pneumoniae Danish serotype 6B Ab [Units/volume] in Serum --2nd specimen |
|
25280-9
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
40905-2
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay |
|
25295-7
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum |
|
27118-9
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum |
|
40906-0
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
25279-1
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --1st specimen |
|
30498-0
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --1st specimen |
|
40907-8
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
31639-8
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Units/volume] in Serum --2nd specimen |
|
30499-8
|
Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85753-2
|
Streptococcus pneumoniae Danish serotypes 6C+6D DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86142-7
|
Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum by Immunoassay |
|
86141-9
|
Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum |
|
85748-2
|
Streptococcus pneumoniae Danish serotypes 7A+7F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
17640-4
|
Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
|
22555-7
|
Streptococcus pneumoniae Danish serotype 7F Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
13167-2
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum |
|
26754-2
|
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum |
|
17638-8
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
13147-4
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --1st specimen |
|
27150-2
|
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --1st specimen |
|
17639-6
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
13148-2
|
Streptococcus pneumoniae Danish serotype 7F Ab [Units/volume] in Serum --2nd specimen |
|
27120-5
|
Streptococcus pneumoniae Danish serotype 7F Ab [Mass/volume] in Serum --2nd specimen |
|
25278-3
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
8028-3
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum by Immunoassay |
|
40911-0
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay |
|
22552-4
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum |
|
25296-5
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum |
|
27433-2
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
31645-5
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --1st specimen |
|
30501-1
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --1st specimen |
|
27427-4
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
31646-3
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Units/volume] in Serum --2nd specimen |
|
30502-9
|
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum --2nd specimen |
|
86143-5
|
Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum |
|
86144-3
|
Streptococcus pneumoniae Danish serotype 8 Ab [Presence] in Serum by Immunoassay |
|
86145-0
|
Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum |
|
86146-8
|
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum |
|
86159-1
|
Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --1st specimen |
|
86158-3
|
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --1st specimen |
|
86161-7
|
Streptococcus pneumoniae Danish serotype 8 Ab [Units/volume] in Serum --2nd specimen |
|
86160-9
|
Streptococcus pneumoniae Danish serotype 8 Ab [Mass/volume] in Serum --2nd specimen |
|
86157-5
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86150-0
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum by Immunoassay |
|
86148-4
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86149-2
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum |
|
86147-6
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum |
|
86151-8
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86153-4
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --1st specimen |
|
86152-6
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --1st specimen |
|
86154-2
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86156-7
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Units/volume] in Serum --2nd specimen |
|
86155-9
|
Streptococcus pneumoniae Danish serotype 8 IgG Ab [Mass/volume] in Serum --2nd specimen |
|
85752-4
|
Streptococcus pneumoniae Danish serotypes 9A+9V DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
86181-5
|
Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
|
86180-7
|
Streptococcus pneumoniae Danish serotype 9N Ab [Ratio] in Serum --1st specimen/2nd specimen |
|
86165-8
|
Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum |
|
86162-5
|
Streptococcus pneumoniae Danish serotype 9N Ab [Presence] in Serum by Immunoassay |
|
86163-3
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum |
|
86164-1
|
Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum |
|
86177-3
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
86178-1
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --1st specimen |
|
86179-9
|
Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --1st specimen |
|
86182-3
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
86183-1
|
Streptococcus pneumoniae Danish serotype 9N Ab [Units/volume] in Serum --2nd specimen |
|
86184-9
|
Streptococcus pneumoniae Danish serotype 9N Ab [Mass/volume] in Serum --2nd specimen |
|
86176-5
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
86168-2
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum by Immunoassay |
|
86166-6
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay |
|
86167-4
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum |
|
86169-0
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum |
|
86172-4
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
86171-6
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --1st specimen |
|
86170-8
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --1st specimen |
|
86175-7
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
86174-0
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Units/volume] in Serum --2nd specimen |
|
86173-2
|
Streptococcus pneumoniae Danish serotype 9N IgG Ab [Mass/volume] in Serum --2nd specimen |
|
47037-7
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
|
47508-7
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
40926-8
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay |
|
31650-5
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Units/volume] in Serum |
|
30153-1
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum |
|
40918-5
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
47506-1
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --1st specimen |
|
40919-3
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
47507-9
|
Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum --2nd specimen |
|
92949-7
|
Streptococcus pneumoniae DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85768-0
|
Streptococcus pneumoniae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
53917-1
|
Streptococcus pneumoniae DNA [Presence] in Blood by NAA with probe detection |
|
82187-6
|
Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
92125-4
|
Streptococcus pneumoniae DNA [Presence] in Respiratory specimen by NAA with probe detection |
|
92948-9
|
Streptococcus pneumoniae DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
49672-9
|
Streptococcus pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
5368-6
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay |
|
43236-9
|
Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum by Immunoassay |
|
8031-7
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum |
|
46205-1
|
Streptococcus pneumoniae IgG Ab [Mass/volume] in Serum |
|
17650-3
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
22562-3
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --1st specimen |
|
17651-1
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
22564-9
|
Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen |
|
8032-5
|
Streptococcus pneumoniae IgM Ab [Units/volume] in Serum |
|
85688-0
|
Streptococcus pneumoniae lytA gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
5035-1
|
Streptococcus pneumoniae rRNA [Presence] in Unspecified specimen by Probe |
|
88722-4
|
Streptococcus pneumoniae serotype [Type] in Isolate |
|
73674-4
|
Streptococcus pneumoniae serotype [Type] in Isolate by Agglutination |
|
85496-8
|
Streptococcus pneumoniae serotype [Identifier] in Unspecified specimen by NAA with probe detection |
|
88275-3
|
Streptococcus pneumoniae gryB gene [Presence] by Probe in Positive blood culture |
|
88591-3
|
Scedosporium prolificans DNA [Presence] in Aspirate by NAA with probe detection |
|
88553-3
|
Scedosporium prolificans DNA [Presence] in Isolate by NAA with probe detection |
|
88556-6
|
Scedosporium prolificans DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88554-1
|
Scedosporium prolificans DNA [Presence] in Tissue by NAA with probe detection |
|
88552-5
|
Scedosporium prolificans DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
22526-8
|
Salmonella pullorum Ab [Presence] in Serum |
|
15505-1
|
Salmonella pullorum Ab [Presence] in Serum by Agglutination |
|
23434-4
|
Salmonella pullorum Ab [Presence] in Serum by Immunoassay |
|
23433-6
|
Salmonella pullorum Ab [Presence] in Serum by Immune diffusion (ID) |
|
31620-8
|
Salmonella pullorum Ab [Units/volume] in Serum |
|
42961-3
|
Salmonella pullorum Ab [Titer] in Serum |
|
23777-6
|
Salmonella pullorum Ab [Titer] in Serum by Agglutination |
|
23435-1
|
Salmonella pullorum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23436-9
|
Salmonella pullorum rRNA [Presence] in Unspecified specimen by Probe |
|
31970-7
|
Streptococcus pyogenes Ag [Presence] in Serum |
|
11269-8
|
Streptococcus pyogenes Ag [Presence] in Serum by Agglutination |
|
18481-2
|
Streptococcus pyogenes Ag [Presence] in Throat |
|
78012-2
|
Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay |
|
6557-3
|
Streptococcus pyogenes Ag [Presence] in Throat by Immunofluorescence |
|
31971-5
|
Streptococcus pyogenes Ag [Presence] in Unspecified specimen |
|
6558-1
|
Streptococcus pyogenes Ag [Presence] in Unspecified specimen by Immunoassay |
|
6559-9
|
Streptococcus pyogenes Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
92947-1
|
Streptococcus pyogenes DNA [NCncRange] in Bronchoalveolar lavage Qualitative by NAA with non-probe detection |
|
85769-8
|
Streptococcus pyogenes DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
92946-3
|
Streptococcus pyogenes DNA [NCncRange] in Sputum Qualitative by NAA with non-probe detection |
|
60489-2
|
Streptococcus pyogenes DNA [Presence] in Throat by NAA with probe detection |
|
49610-9
|
Streptococcus pyogenes DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
68954-7
|
Streptococcus pyogenes rRNA [Presence] in Throat by Probe |
|
5036-9
|
Streptococcus pyogenes rRNA [Presence] in Unspecified specimen by Probe |
|
11268-0
|
Streptococcus pyogenes [Presence] in Throat by Organism specific culture |
|
17656-0
|
Streptococcus pyogenes [Presence] in Unspecified specimen by Organism specific culture |
|
55163-0
|
Streptococcus pyogenes enzyme Ab panel - Serum Qualitative |
|
22566-4
|
Streptococcus pyogenes enzyme Ab [Presence] in Serum |
|
5172-2
|
Streptococcus pyogenes enzyme Ab [Presence] in Serum by Latex agglutination |
|
12259-8
|
Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination |
|
31658-8
|
Streptococcus pyogenes enzyme Ab [Units/volume] in Serum |
|
22567-2
|
Streptococcus pyogenes enzyme Ab [Titer] in Serum |
|
5173-0
|
Streptococcus pyogenes enzyme Ab [Titer] in Serum by Latex agglutination |
|
88276-1
|
Streptococcus pyogenes hsp60 gene [Presence] by Probe in Positive blood culture |
|
72268-6
|
Streptococcus pyogenes exotoxin B speB gene [Presence] in Unspecified specimen by NAA with probe detection |
|
42521-5
|
Saccharopolyspora rectivirgula Ab [Presence] in Cerebral spinal fluid |
|
22412-1
|
Saccharopolyspora rectivirgula Ab [Presence] in Serum |
|
6818-9
|
Saccharopolyspora rectivirgula Ab [Presence] in Serum by Immune diffusion (ID) |
|
5246-4
|
Saccharopolyspora rectivirgula Ab [Units/volume] in Serum |
|
21389-2
|
Saccharopolyspora rectivirgula IgE Ab [Units/volume] in Serum |
|
19749-1
|
Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum |
|
25479-7
|
Saccharopolyspora rectivirgula IgG Ab [Units/volume] in Serum |
|
34410-1
|
Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum by Immune diffusion (ID) |
|
26948-0
|
Saccharopolyspora rectivirgula IgG Ab [Mass/volume] in Serum |
|
6251-3
|
Sporobolomyces roseus IgE Ab [Units/volume] in Serum |
|
6138-2
|
Setomelanomma rostrata IgE Ab [Units/volume] in Serum |
|
49899-8
|
Setomelanomma rostrata IgE Ab/IgE total in Serum |
|
35555-2
|
Setomelanomma rostrata IgG Ab [Mass/volume] in Serum |
|
9787-3
|
Sarcoptes scabiei identified in Skin by Light microscopy |
|
51471-1
|
Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid |
|
49860-0
|
Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid by Latex agglutination |
|
31633-1
|
Sporothrix schenckii Ab [Units/volume] in Cerebral spinal fluid |
|
26864-9
|
Sporothrix schenckii Ab [Units/volume] in Serum by Latex agglutination |
|
13273-8
|
Sporothrix schenckii Ab [Presence] in Serum |
|
5364-5
|
Sporothrix schenckii Ab [Units/volume] in Serum |
|
27859-8
|
Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid |
|
38345-5
|
Sporothrix schenckii Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
|
27937-2
|
Sporothrix schenckii Ab [Titer] in Serum |
|
48339-6
|
Sporothrix schenckii Ag [Presence] in Tissue by Immune stain |
|
13243-1
|
Sporothrix schenckii IgA Ab [Units/volume] in Serum |
|
13241-5
|
Sporothrix schenckii IgG Ab [Units/volume] in Serum |
|
13242-3
|
Sporothrix schenckii IgM Ab [Units/volume] in Serum |
|
7720-6
|
Stemphylium solani IgE Ab [Units/volume] in Serum |
|
11611-1
|
Shigella sonnei Ab [Units/volume] in Serum |
|
22540-9
|
Shigella sonnei Ab [Titer] in Serum |
|
9715-4
|
Shigella sonnei Ab [Titer] in Serum by Complement fixation |
|
42259-2
|
Shigella sonnei Ag [Presence] in Isolate |
|
58046-4
|
Strongyloides stercoralis Ab [Titer] in Serum |
|
88913-9
|
Strongyloides stercoralis DNA [Presence] in Stool by NAA with probe detection |
|
8035-8
|
Strongyloides stercoralis IgG Ab [Presence] in Serum |
|
6632-4
|
Strongyloides stercoralis IgG Ab [Presence] in Serum by Immunoassay |
|
86740-8
|
Streptococcus suis Ag [Presence] in Unspecified specimen by Immune stain |
|
86739-0
|
Streptococcus suis DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
24430-1
|
Streptococcus suis serotype [Identifier] in Isolate by Agglutination |
|
70021-1
|
Salmonella typhi DNA [Presence] in Blood by NAA with probe detection |
|
22529-2
|
Salmonella typhi H Ab [Presence] in Serum |
|
5345-4
|
Salmonella typhi H Ab [Presence] in Serum by Latex agglutination |
|
42960-5
|
Salmonella typhi H Ab [Titer] in Serum |
|
34371-5
|
Salmonella typhi H Ab [Titer] in Serum by Agglutination |
|
13284-5
|
Salmonella typhi H D Ab [Presence] in Serum |
|
17565-3
|
Salmonella typhi H D Ab [Presence] in Serum by Latex agglutination |
|
31621-6
|
Salmonella typhi H D Ab [Units/volume] in Serum |
|
14227-3
|
Salmonella typhi H D Ab [Titer] in Serum |
|
47388-4
|
Salmonella typhi H D Ab [Titer] in Serum by Agglutination |
|
53956-9
|
Salmonella typhi [Identifier] in Isolate by Agglutination |
|
17566-1
|
Salmonella typhi O Ab [Presence] in Serum |
|
5346-2
|
Salmonella typhi O Ab [Presence] in Serum by Latex agglutination |
|
42959-7
|
Salmonella typhi O Ab [Titer] in Serum |
|
34372-3
|
Salmonella typhi O Ab [Titer] in Serum by Agglutination |
|
13285-2
|
Salmonella typhi O D Ab [Presence] in Serum |
|
17564-6
|
Salmonella typhi O D Ab [Presence] in Serum by Latex agglutination |
|
31622-4
|
Salmonella typhi O D Ab [Units/volume] in Serum |
|
46204-4
|
Salmonella typhi O D Ab [Titer] in Serum |
|
23930-1
|
Salmonella typhi O D Ab [Titer] in Serum by Agglutination |
|
23931-9
|
Salmonella typhi O D [Titer] in Serum by Immunofluorescence |
|
57769-2
|
Salmonella typhi O Vi Ab [Presence] in Serum |
|
22531-8
|
Salmonella typhimurium Ab [Presence] in Serum |
|
15506-9
|
Salmonella typhimurium Ab [Presence] in Serum by Agglutination |
|
31623-2
|
Salmonella typhimurium Ab [Units/volume] in Serum |
|
42958-9
|
Salmonella typhimurium Ab [Titer] in Serum |
|
23778-4
|
Salmonella typhimurium Ab [Titer] in Serum by Agglutination |
|
34424-2
|
Salmonella typhimurium H Ab [Titer] in Serum |
|
34432-5
|
Salmonella typhimurium H Ab [Titer] in Serum by Agglutination |
|
42533-0
|
Saccharomonospora viridis Ab [Presence] in Cerebral spinal fluid |
|
22572-2
|
Saccharomonospora viridis Ab [Presence] in Serum |
|
15209-0
|
Saccharomonospora viridis Ab [Presence] in Serum by Immune diffusion (ID) |
|
5336-3
|
Saccharomonospora viridis Ab [Units/volume] in Serum |
|
17557-0
|
Saccharomonospora viridis IgG Ab [Units/volume] in Serum |
|
10510-6
|
S-100 Ag [Presence] in Tissue by Immune stain |
|
47274-6
|
S100 calcium binding protein B [Mass/volume] in Cerebral spinal fluid |
|
47275-3
|
S100 calcium binding protein B [Mass/volume] in Serum |
|
85045-3
|
Staphylococcus aureus glycopeptide resistant based on vancomycin and teicoplanin IC [Identifier] by ARD gradient strip |
|
85044-6
|
Staphylococcus aureus glycopeptide resistance panel |
|
79448-7
|
Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus panel - Nose by NAA with probe detection |
|
2929-8
|
Saccharides [Presence] in Urine |
|
81781-7
|
Saccharopine [Moles/volume] in Cerebral spinal fluid |
|
81823-7
|
SACS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
46000-6
|
Sad, apethetic, anxious appearance Set |
|
85140-2
|
Sadness Survey - CAT item bank - age 18+ [NIH Toolbox] |
|
85136-0
|
Sadness Survey version 2.0 - fixed length form - ages 8-17 [NIH Toolbox] |
|
85118-8
|
Sadness Survey version 2.0 - parent report - fixed length form - ages 3-7 [NIH Toolbox] |
|
82439-1
|
SUMO-activating enzyme subunit 1 Ab [Units/volume] in Serum by Line blot |
|
82440-9
|
SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot |
|
82992-9
|
SUMO-activating enzyme subunit 1 IgG Ab [Presence] in Serum by Line blot |
|
82441-7
|
SUMO-activating enzyme subunit 2 Ab [Units/volume] in Serum by Line blot |
|
82442-5
|
SUMO-activating enzyme subunit 2 Ab [Presence] in Serum by Line blot |
|
82214-8
|
Safety issue assessment note |
|
88033-6
|
Safety checklist Ventilator Document |
|
7676-0
|
Safflower IgE Ab [Units/volume] in Serum |
|
7677-8
|
Safflower IgG Ab [Units/volume] in Serum |
|
56382-5
|
Safflower IgG4 Ab [Mass/volume] in Serum |
|
63117-6
|
Safflower IgG Ab [Mass/volume] in Serum |
|
19755-8
|
Saffron IgE Ab [Units/volume] in Serum |
|
7681-0
|
Common Sagebrush IgE Ab [Units/volume] in Serum |
|
7682-8
|
Common Sagebrush IgG Ab [Units/volume] in Serum |
|
63193-7
|
Common Sagebrush IgG Ab [Mass/volume] in Serum |
|
7678-6
|
Sage IgE Ab [Units/volume] in Serum |
|
7680-2
|
Sage IgG Ab [Units/volume] in Serum |
|
56464-1
|
Sage IgG4 Ab [Mass/volume] in Serum |
|
60399-3
|
Sage IgG Ab [Mass/volume] in Serum |
|
80174-6
|
S-adenosylhomocysteine [Moles/volume] in Cerebral spinal fluid |
|
80175-3
|
S-adenosylhomocysteine [Moles/volume] in Serum or Plasma |
|
80176-1
|
S-adenosylhomocysteine/Creatinine [Molar ratio] in Urine |
|
75147-9
|
Succinylaminoimidazole carboxamide riboside [Moles/volume] in Cerebral spinal fluid |
|
75146-1
|
Succinylaminoimidazole carboxamide riboside [Moles/volume] in Serum or Plasma |
|
63553-2
|
Succinylaminoimidazole carboxamide riboside [Presence] in Urine |
|
75138-8
|
Succinylaminoimidazole carboxamide riboside/Creatinine [Molar ratio] in Urine |
|
59735-1
|
Salicylamide [Mass/volume] in Blood |
|
34198-2
|
Salicylamide [Mass/volume] in Serum or Plasma --peak |
|
4022-0
|
Salicylamide [Mass/volume] in Serum or Plasma |
|
55577-1
|
Salicylamide [Moles/volume] in Serum or Plasma |
|
34197-4
|
Salicylamide [Mass/volume] in Serum or Plasma --trough |
|
59736-9
|
Salicylamide [Mass/volume] in Urine |
|
17559-6
|
Salicylates [Presence] in Blood |
|
60201-1
|
Salicylates [Mass/volume] in Blood |
|
29227-6
|
Salicylates [Mass/volume] in Body fluid |
|
80963-2
|
Salicylates free [Mass/volume] in Serum or Plasma |
|
17560-4
|
Salicylates [Presence] in Gastric fluid |
|
29352-2
|
Salicylates [Mass/volume] in Gastric fluid |
|
47128-4
|
Salicylates [Moles/volume] in Gastric fluid |
|
46978-3
|
Salicylates [Mass/volume] in Serum or Plasma by Confirmatory method |
|
4023-8
|
Salicylates [Presence] in Serum or Plasma |
|
35597-4
|
Salicylates [Mass/volume] in Serum or Plasma by Screen method |
|
70216-7
|
Salicylates [Moles/volume] in Serum or Plasma by Screen method |
|
4024-6
|
Salicylates [Mass/volume] in Serum or Plasma |
|
14909-6
|
Salicylates [Moles/volume] in Serum or Plasma |
|
72677-8
|
Salicylates [Mass/volume] in Serum or Plasma --trough |
|
4025-3
|
Salicylates [Presence] in Urine |
|
4026-1
|
Salicylates [Mass/volume] in Urine |
|
22701-7
|
Salicylates [Moles/volume] in Urine |
|
35130-4
|
Salicylates [Presence] in Unspecified specimen |
|
22732-2
|
Salicylates [Moles/volume] in Unspecified specimen |
|
90238-7
|
Salicylcarnitine [Moles/volume] in Serum or Plasma |
|
42610-6
|
Salicylurate [Mass/volume] in Serum or Plasma |
|
79489-1
|
Salicylurate [Moles/volume] in Serum or Plasma |
|
42612-2
|
Salicylurate [Mass/volume] in Urine |
|
79478-4
|
Salicylurate/Creatinine [Molar ratio] in Urine |
|
53206-9
|
Salicylylcarnitine (SalC) [Moles/volume] in DBS |
|
87593-0
|
Salinomycin [Mass/mass] in Unspecified specimen |
|
5337-1
|
Salivary gland Ab [Units/volume] in Serum |
|
9721-2
|
Salivary gland Ab [Titer] in Serum |
|
53021-2
|
Salivary gland Ab [Titer] in Serum by Immunofluorescence |
|
43686-5
|
Salivary gland IgA Ab [Units/volume] in Saliva (oral fluid) |
|
43371-4
|
Salmonella and Shigella sp identified in Stool by Organism specific culture |
|
42255-0
|
Salmonella and Shigella sp identified in Unspecified specimen by Organism specific culture |
|
48806-4
|
Salmonella sp+Shigella sp+Escherichia coli enterotoxic identified in Stool by Organism specific culture |
|
6237-2
|
Salmon IgE Ab [Units/volume] in Serum |
|
39548-3
|
Salmon IgE Ab/IgE total in Serum |
|
7685-1
|
Salmon IgG Ab [Units/volume] in Serum |
|
56383-3
|
Salmon IgG4 Ab [Mass/volume] in Serum |
|
60400-9
|
Salmon IgG Ab [Mass/volume] in Serum |
|
17561-2
|
Salmon roe IgE Ab [Units/volume] in Serum |
|
17562-0
|
Salmonella sp Ab [Presence] in Serum |
|
11603-8
|
Salmonella sp Ab [Units/volume] in Serum |
|
22527-6
|
Salmonella sp Ab [Titer] in Serum |
|
5338-9
|
Salmonella sp Ab [Titer] in Serum by Latex agglutination |
|
87393-5
|
Salmonella sp Ab/Positive control in Serum by Immunoassay |
|
87394-3
|
Salmonella sp DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
49612-5
|
Salmonella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20952-8
|
Salmonella sp identified in Egg by Organism specific culture |
|
9672-7
|
Salmonella sp IgA Ab [Units/volume] in Serum |
|
9673-5
|
Salmonella sp IgG Ab [Units/volume] in Serum |
|
9674-3
|
Salmonella sp IgM Ab [Units/volume] in Serum |
|
59846-6
|
Salmonella sp identified [Type] in Isolate |
|
73672-8
|
Salmonella sp phage type in Isolate |
|
65756-9
|
Salmonella sp serovar [Type] in Isolate |
|
20951-0
|
Salmonella sp serotype [Identifier] in Isolate by Agglutination |
|
80678-6
|
Salmonella sp invA+fliC genes [Presence] in Stool by NAA with probe detection |
|
20955-1
|
Salmonella sp identified in Stool by Organism specific culture |
|
20953-6
|
Salmonella sp identified in Tissue by Organism specific culture |
|
17563-8
|
Salmonella sp identified in Unspecified specimen by Organism specific culture |
|
6238-0
|
Salt grass IgE Ab [Units/volume] in Serum |
|
56465-8
|
Salt grass IgG4 Ab [Mass/volume] in Serum |
|
7686-9
|
Saltbush IgE Ab [Units/volume] in Serum |
|
7196-9
|
Saltcedar IgE Ab [Units/volume] in Serum |
|
65784-1
|
Saltwort native (nSal k) 1 IgE Ab [Units/volume] in Serum |
|
6234-9
|
Saltwort IgE Ab [Units/volume] in Serum |
|
61311-7
|
Saltwort IgE Ab/IgE total in Serum |
|
7671-1
|
Saltwort IgG Ab [Units/volume] in Serum |
|
56380-9
|
Saltwort IgG4 Ab [Mass/volume] in Serum |
|
63187-9
|
Saltwort IgG Ab [Mass/volume] in Serum |
|
48252-1
|
Saltwort triggered leukotriene release [Mass/volume] by Leukocytes |
|
59324-4
|
Salvinorin A [Mass/volume] in Blood |
|
59326-9
|
Salvinorin A [Mass/volume] in Serum or Plasma |
|
59328-5
|
Salvinorin A [Mass/volume] in Urine |
|
59325-1
|
Salvinorin B [Mass/volume] in Blood |
|
59327-7
|
Salvinorin B [Mass/volume] in Serum or Plasma |
|
59329-3
|
Salvinorin B [Mass/volume] in Urine |
|
80179-5
|
S-adenosylmethionine and S-adenosylhomocystine panel - Cerebral spinal fluid |
|
80178-7
|
S-adenosylmethionine and S-adenosylhomocystine panel - Serum or Plasma |
|
80177-9
|
S-adenosylmethionine [Moles/volume] in Cerebral spinal fluid |
|
78966-9
|
S-adenosylmethionine [Moles/volume] in Serum or Plasma |
|
80182-9
|
S-adenosylmethionine/Creatinine [Molar ratio] in Urine |
|
20564-1
|
Oxygen saturation in Blood |
|
2708-6
|
Oxygen saturation in Arterial blood |
|
51733-4
|
Oxygen saturation Calculated from oxygen partial pressure in Arterial blood |
|
2709-4
|
Oxygen saturation in Capillary blood |
|
51732-6
|
Oxygen saturation Calculated from oxygen partial pressure in Capillary blood |
|
74105-8
|
Oxygen saturation Calculated from oxygen partial pressure in Mixed venous blood |
|
2711-0
|
Oxygen saturation in Venous blood |
|
51731-8
|
Oxygen saturation Calculated from oxygen partial pressure in Venous blood |
|
71853-6
|
Oxygen saturation [Pure mass fraction] in Blood |
|
71849-4
|
Oxygen saturation [Pure mass fraction] in Cord blood |
|
89277-8
|
Oxygen saturation in Arterial blood by Pulse oximetry --during anesthesia |
|
89272-9
|
Oxygen saturation in Arterial blood by Pulse oximetry --during apnea |
|
89276-0
|
Oxygen saturation in Arterial blood by Pulse oximetry --W exercise |
|
43146-0
|
Oxygen saturation device panel |
|
82937-4
|
SAP and XIAP [Interpretation] in Leukocytes by Flow cytometry (FC) |
|
55227-3
|
Sapeli IgE Ab [Units/volume] in Serum |
|
82213-0
|
Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with non-probe detection |
|
92694-9
|
Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection |
|
72111-8
|
Sapovirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
29123-7
|
Saquinavir [Units/volume] in Serum or Plasma |
|
19051-2
|
Saquinavir [Mass/volume] in Serum or Plasma |
|
51932-2
|
Saquinavir [Mass/volume] in Serum or Plasma --trough |
|
49621-6
|
Saquinavir+Ritonavir [Susceptibility] by Genotype method |
|
58024-1
|
Saquinavir+Ritonavir [Susceptibility] by Phenotype method |
|
93016-4
|
Scale for the Assessment and Rating of Ataxia [SARA] |
|
44401-8
|
Sarcosine/Creatinine [Mass Ratio] in 24 hour Urine |
|
30989-8
|
Sardine (Sardinops melanosticta) IgE Ab [Units/volume] in Serum |
|
11197-1
|
Sardine (pilchard) IgE Ab [Units/volume] in Serum |
|
56384-1
|
Sardine (pilchard) IgG4 Ab [Mass/volume] in Serum |
|
63134-1
|
Sardine (pilchard) IgG Ab [Mass/volume] in Serum |
|
7688-5
|
Sardine IgG Ab [Units/volume] in Serum |
|
77107-1
|
SARS2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77106-3
|
SARS2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
60426-4
|
SARS coronavirus Ab [Titer] in Serum |
|
42957-1
|
SARS coronavirus IgG Ab [Presence] in Serum |
|
41460-7
|
SARS coronavirus IgG Ab [Presence] in Serum by Immunoassay |
|
42956-3
|
SARS coronavirus IgM Ab [Presence] in Serum |
|
41991-1
|
SARS coronavirus IgM Ab [Presence] in Serum by Immunoassay |
|
60275-5
|
SARS coronavirus RNA [Presence] in Isolate by NAA with probe detection |
|
60534-5
|
SARS coronavirus RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
41458-1
|
SARS coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
33969-7
|
SARS coronavirus Urbani Ab [Units/volume] in Serum by Immunoassay |
|
33972-1
|
SARS coronavirus Urbani Ab [Presence] in Serum |
|
33968-9
|
SARS coronavirus Urbani Ab [Presence] in Serum by Immunoassay |
|
33970-5
|
SARS coronavirus Urbani Ab [Presence] in Serum by Immunofluorescence |
|
33973-9
|
SARS coronavirus Urbani Ab [Units/volume] in Serum |
|
33974-7
|
SARS coronavirus Urbani Ab [Titer] in Serum |
|
33971-3
|
SARS coronavirus Urbani Ab [Titer] in Serum by Immunofluorescence |
|
33966-3
|
SARS coronavirus Urbani RNA [Presence] in Nose by NAA with probe detection |
|
33967-1
|
SARS coronavirus Urbani RNA [Presence] in Serum or Plasma by NAA with probe detection |
|
33975-4
|
SARS coronavirus Urbani RNA [Presence] in Sputum by NAA with probe detection |
|
33965-5
|
SARS coronavirus Urbani RNA [Presence] in Stool by NAA with probe detection |
|
33964-8
|
SARS coronavirus Urbani RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
41459-9
|
SARS coronavirus [Presence] in Unspecified specimen |
|
17567-9
|
Sasapyrine [Mass/volume] in Serum or Plasma |
|
49592-9
|
Satratoxin IgM Ab [Units/volume] in Serum by Immunoassay |
|
51470-3
|
Satratoxin IgM Ab [Units/volume] in Serum |
|
7689-3
|
Savinase IgE Ab [Units/volume] in Serum |
|
41764-2
|
SBDS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
80628-1
|
1,1'-Sulfonylbis-2-Methylthioethane [Mass/volume] in Urine |
|
14269-5
|
Sec-butyl acetate [Mass/volume] in Blood |
|
65333-7
|
Sc sup(1) Ab [Presence] in Serum or Plasma |
|
92520-6
|
Sc sup(1) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92482-9
|
Sc sup(1) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
65334-5
|
Sc sup(2) Ab [Presence] in Serum or Plasma |
|
92519-8
|
Sc sup(2) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92481-1
|
Sc sup(2) Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
47276-1
|
Complement Sc5b-9 Ab [Presence] in Serum or Plasma |
|
13117-7
|
Complement Sc5b-9 Ab [Units/volume] in Serum or Plasma |
|
93244-2
|
Complement Sc5b-9 [Mass/volume] in Serum or Plasma by Immunoassay |
|
36911-6
|
SCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21769-5
|
SCA genes CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49641-4
|
SCA1 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49642-2
|
SCA1 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21765-3
|
SCA1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49643-0
|
SCA10 gene allele 1.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49644-8
|
SCA10 gene allele 2.ATTCT repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
34494-5
|
SCA10 gene ATTCT repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
48031-9
|
SCA10 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
34203-0
|
SCA12 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49015-1
|
SCA15 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49645-5
|
SCA2 gene allele 1 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49646-3
|
SCA2 gene allele 2 CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21766-1
|
SCA2 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
49651-3
|
SCA7 gene allele 1.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
49652-1
|
SCA7 gene allele 2.CAG repeats [Entitic number] in Blood or Tissue by Molecular genetics method |
|
21767-9
|
SCA7 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
27984-4
|
SCA8 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
11184-9
|
Scad IgE Ab [Units/volume] in Serum |
|
61320-8
|
Scad IgE Ab/IgE total in Serum |
|
7691-9
|
Scallop IgE Ab [Units/volume] in Serum |
|
39088-0
|
Scallop IgE Ab/IgE total in Serum |
|
7692-7
|
Scallop IgG Ab [Units/volume] in Serum |
|
56385-8
|
Scallop IgG4 Ab [Mass/volume] in Serum |
|
60401-7
|
Scallop IgG Ab [Mass/volume] in Serum |
|
29923-0
|
Scandium [Mass/volume] in 24 hour Urine |
|
29924-8
|
Scandium [Mass/time] in 24 hour Urine |
|
29925-5
|
Scandium/Creatinine [Mass Ratio] in 24 hour Urine |
|
59228-7
|
Squamous cell carcinoma Ag [Mass/volume] in Cerebral spinal fluid |
|
48165-5
|
Squamous cell carcinoma Ag [Mass/volume] in Body fluid |
|
19209-6
|
Squamous cell carcinoma Ag [Units/volume] in Pleural fluid |
|
59222-0
|
Squamous cell carcinoma Ag [Mass/volume] in Pleural fluid |
|
19210-4
|
Squamous cell carcinoma Ag [Moles/volume] in Pleural fluid |
|
59225-3
|
Squamous cell carcinoma Ag [Mass/volume] in Peritoneal fluid |
|
19207-0
|
Squamous cell carcinoma Ag [Units/volume] in Serum or Plasma |
|
9679-2
|
Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma |
|
19208-8
|
Squamous cell carcinoma Ag [Moles/volume] in Serum or Plasma |
|
72892-3
|
MRSA SCCmec and mecA genes panel - Nose by NAA with probe detection |
|
86622-8
|
MRSA SCCmec and mecA+mecC genes panel - Nose |
|
80153-0
|
Soluble CD27 [Units/volume] in Cerebral spinal fluid |
|
80155-5
|
Soluble CD27 [Units/volume] in Serum or Plasma |
|
800-3
|
Schistocytes [Presence] in Blood by Light microscopy |
|
8020-0
|
Schistosoma sp Ab [Presence] in Serum |
|
6631-6
|
Schistosoma sp Ab [Presence] in Serum by Complement fixation |
|
6630-8
|
Schistosoma sp Ab [Presence] in Serum by Hemagglutination |
|
6629-0
|
Schistosoma sp Ab [Presence] in Serum by Immunoassay |
|
6628-2
|
Schistosoma sp Ab [Presence] in Serum by Immunofluorescence |
|
5347-0
|
Schistosoma sp Ab [Units/volume] in Serum |
|
34594-2
|
Schistosoma sp Ab [Titer] in Serum |
|
25422-7
|
Schistosoma sp Ab [Titer] in Serum by Immunofluorescence |
|
7693-5
|
Schistosoma sp IgE Ab [Units/volume] in Serum |
|
27260-9
|
Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31624-0
|
Schistosoma sp IgG Ab [Units/volume] in Cerebral spinal fluid |
|
25757-6
|
Schistosoma sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
33317-9
|
Schistosoma sp IgG Ab [Presence] in Serum |
|
13277-9
|
Schistosoma sp IgG Ab [Units/volume] in Serum |
|
13278-7
|
Schistosoma sp IgM Ab [Units/volume] in Serum |
|
76767-3
|
Schistosoma sp identified in Semen by Light microscopy |
|
11085-8
|
Schistosoma sp identified in Stool by Concentration |
|
10715-1
|
Schistosoma sp identified in Urine sediment by Light microscopy |
|
10716-9
|
Schistosoma sp identified in Unspecified specimen by Organism specific culture |
|
62333-0
|
Severe combined immunodeficiency (SCID) newborn screening panel |
|
83989-4
|
Spinal cord injury medicine Admission evaluation note |
|
83990-2
|
Spinal cord injury medicine Annual evaluation note |
|
83790-6
|
Spinal cord injury medicine Attending Note |
|
83991-0
|
Spinal cord injury medicine Conference note |
|
83992-8
|
Spinal cord injury medicine Consult note |
|
83993-6
|
Spinal cord injury medicine Discharge summary |
|
83994-4
|
Spinal cord injury medicine Education note |
|
83746-8
|
Spinal cord injury medicine Fellow Hospital Note |
|
83995-1
|
Spinal cord injury medicine History and physical note |
|
83999-3
|
Spinal cord injury medicine Hospital Note |
|
83998-5
|
Spinal cord injury medicine Initial evaluation note |
|
84000-9
|
Spinal cord injury medicine Interdisciplinary Note |
|
84011-6
|
Spinal cord injury medicine Interdisciplinary Plan of care note |
|
83791-4
|
Spinal cord injury medicine Physician Note |
|
84001-7
|
Spinal cord injury medicine Note |
|
84002-5
|
Spinal cord injury medicine Nurse Note |
|
84003-3
|
Spinal cord injury medicine Nurse Outpatient Note |
|
84004-1
|
Spinal cord injury medicine Outpatient Annual evaluation note |
|
84005-8
|
Spinal cord injury medicine Outpatient Note |
|
83750-0
|
Spinal cord injury medicine Physician assistant Note |
|
84010-8
|
Spinal cord injury medicine Telephone encounter Note |
|
84006-6
|
Spinal cord injury medicine procedure note |
|
83996-9
|
Spinal cord injury medicine Patient's home Consult note |
|
83997-7
|
Spinal cord injury medicine Patient's home Note |
|
83777-3
|
Spinal cord injury medicine Resident Hospital Note |
|
84007-4
|
Spinal cord injury medicine Risk assessment and screening note |
|
84008-2
|
Spinal cord injury medicine Team Note |
|
84009-0
|
Spinal cord injury medicine Telehealth Note |
|
41765-9
|
SCN1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81872-4
|
SCN5A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
55139-0
|
SCN5A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43748-3
|
SCO1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
43749-1
|
SCO2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
11252-4
|
Scopolamine [Mass/volume] in Serum or Plasma |
|
11002-3
|
Scopolamine [Presence] in Urine |
|
17571-1
|
Scopolamine [Mass/volume] in Urine |
|
7694-3
|
Scorpion IgE Ab [Units/volume] in Serum |
|
7695-0
|
Scotch broom IgE Ab [Units/volume] in Serum |
|
34571-0
|
aPTT.lupus sensitive (LA screen) |
|
6303-2
|
dRVVT (LA screen) |
|
81829-4
|
SDHA gene full mutation analysis in Blood or Tissue by Sequencing |
|
82530-7
|
SDHB gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
41062-1
|
SDHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34510-8
|
SDHB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82532-3
|
SDHB and SDHC and SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
82531-5
|
SDHC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
38923-9
|
SDHC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38911-4
|
SDHC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
82529-9
|
SDHD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
41061-3
|
SDHD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34511-6
|
SDHD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
52057-7
|
Seat lift mechanism attachment |
|
52058-5
|
Seating system attachment |
|
88479-1
|
Seattle Angina Questionnaire - 7 items [SAQ] |
|
75084-4
|
Sebacate (C8) [Moles/volume] in Serum or Plasma |
|
53460-2
|
Sebacylcarnitine (C10-DC) [Moles/volume] in Amniotic fluid |
|
53465-1
|
Sebacylcarnitine (C10-DC) [Moles/volume] in Cerebral spinal fluid |
|
53212-7
|
Sebacylcarnitine (C10-DC) [Moles/volume] in DBS |
|
74609-9
|
Sebacylcarnitine (C10-DC) [Enzymatic activity/mass] in Fibroblast |
|
53472-7
|
Sebacylcarnitine (C10-DC) [Moles/volume] in Serum or Plasma |
|
53493-3
|
Sebacylcarnitine (C10-DC) [Moles/volume] in Urine |
|
53509-6
|
Sebacylcarnitine (C10-DC)/Creatinine [Molar ratio] in Urine |
|
72397-3
|
Secobarbital [Mass/volume] in Blood by Confirmatory method |
|
12489-1
|
Secobarbital [Presence] in Gastric fluid |
|
17573-7
|
Secobarbital [Mass/volume] in Gastric fluid |
|
26930-8
|
Secobarbital [Mass/mass] in Hair |
|
27002-5
|
Secobarbital [Mass/mass] in Meconium |
|
27049-6
|
Secobarbital [Mass/volume] in Milk |
|
72452-6
|
Secobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72629-9
|
Secobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
|
4027-9
|
Secobarbital [Presence] in Serum or Plasma |
|
35634-5
|
Secobarbital [Mass/volume] in Serum or Plasma by Screen method |
|
82968-9
|
Secobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
4028-7
|
Secobarbital [Mass/volume] in Serum or Plasma |
|
25520-8
|
Secobarbital [Moles/volume] in Serum or Plasma |
|
12500-5
|
Secobarbital [Presence] in Stool |
|
27242-7
|
Secobarbital [Mass/mass] in Stool |
|
16238-8
|
Secobarbital [Mass/volume] in Urine by Confirmatory method |
|
4029-5
|
Secobarbital [Presence] in Urine |
|
16194-3
|
Secobarbital [Presence] in Urine by Confirmatory method |
|
19692-3
|
Secobarbital [Presence] in Urine by Screen method |
|
19695-6
|
Secobarbital [Mass/volume] in Urine |
|
72928-5
|
Secobarbital [Moles/volume] in Urine |
|
26679-1
|
Secobarbital [Mass/volume] in Vitreous fluid |
|
32111-7
|
Secobarbital [Presence] in Unspecified specimen |
|
64135-7
|
Secobarbital/Creatinine [Mass Ratio] of Urine |
|
2933-0
|
Secretin [Mass/volume] in Plasma |
|
48151-5
|
Sedoheptitol/Creatinine [Molar ratio] in Urine |
|
78967-7
|
Sedoheptulose/Creatinine [Molar ratio] in Urine |
|
74153-8
|
Seizure Disorder action plan |
|
55427-9
|
Seizure disorder tracking panel |
|
12415-6
|
Selegiline [Mass/volume] in Serum or Plasma |
|
30927-8
|
Selenium [Mass/volume] in Urine collected for unspecified duration |
|
47976-6
|
Selenium [Mass/volume] in 24 hour Urine |
|
5727-3
|
Selenium [Mass/time] in 24 hour Urine |
|
52908-1
|
Selenium [Moles/time] in 24 hour Urine |
|
5722-4
|
Selenium [Mass/volume] in Blood |
|
78696-2
|
Selenium [Moles/volume] in Blood |
|
20961-9
|
Selenium [Mass/mass] in Feed |
|
58026-6
|
Selenium [Mass/volume] in Nonbiological fluid |
|
17574-5
|
Selenium [Mass/volume] in Body fluid |
|
20960-1
|
Selenium [Mass/mass] in Gastric fluid |
|
29499-1
|
Selenium [Mass/mass] in Hair |
|
50904-2
|
Selenium [Moles/mass] in Hair |
|
59737-7
|
Selenium [Mass/mass] in Nail |
|
5723-2
|
Selenium [Mass/volume] in Red Blood Cells |
|
52913-1
|
Selenium [Moles/volume] in Red Blood Cells |
|
5724-0
|
Selenium [Mass/volume] in Serum or Plasma |
|
25521-6
|
Selenium [Moles/volume] in Serum or Plasma |
|
54925-3
|
Selenium [Mass/volume] in Semen |
|
5725-7
|
Selenium [Mass/mass] in Tissue |
|
52889-3
|
Selenium [Moles/mass] in Tissue |
|
5726-5
|
Selenium [Mass/volume] in Urine |
|
50903-4
|
Selenium [Moles/volume] in Urine |
|
9483-9
|
Selenium [Mass/volume] in Water |
|
23779-2
|
Selenium [Mass/volume] in Unspecified specimen |
|
29917-2
|
Selenium/Creatinine [Mass Ratio] in 24 hour Urine |
|
44402-6
|
Selenium/Creatinine [Molar ratio] in 24 hour Urine |
|
13467-6
|
Selenium/Creatinine [Mass Ratio] in Urine |
|
52923-0
|
Selenium/Creatinine [Molar ratio] in Urine |
|
83180-0
|
Self-care activities panel |
|
77576-7
|
Self-care and mobility panel APTA |
|
91530-6
|
Self-Efficacy Survey version 2.0 - CAT item bank - ages 13-17 [NIH Toolbox] |
|
85127-9
|
Self-Efficacy Survey version 2.0 - CAT item bank - ages 8-12 [NIH Toolbox] |
|
54231-6
|
Semen analysis fertility panel |
|
50677-4
|
Semen analysis post vasectomy panel |
|
13361-1
|
Semen analysis panel |
|
6240-6
|
Seminal fluid IgE Ab [Units/volume] in Serum |
|
81236-2
|
Send document that conforms to C-CDA R1.1 template |
|
81907-8
|
Send document that conforms to C-CDA R2.0 template |
|
81237-0
|
Send document that conforms to C-CDA R2.1 template |
|
81238-8
|
Send document that conforms to CDP Set 1 R1.0 template |
|
81239-6
|
Send document that conforms to CDP Set 1 R1.1 template |
|
86630-1
|
Send document that conforms to Level 3 EMS R1 template |
|
86626-9
|
Send document that conforms to Level 3 EMS R2 template |
|
86629-3
|
Send document that conforms to Oncology Treatment Plan Summary R1.2 template |
|
86628-5
|
Send document that conforms to Oncology Treatment Plan Summary R1.2.1 template |
|
86627-7
|
Send document that conforms to Oncology Treatment Plan Summary R1.3 template |
|
46003-0
|
Sense of initiative/involvement Set |
|
46026-1
|
Sensory diseases or conditions Set |
|
49941-8
|
Sepiapterin [Moles/volume] in Cerebral spinal fluid |
|
75044-8
|
Sepiapterin/Creatinine [Molar ratio] in Urine |
|
65810-4
|
SEPT9 gene methylation [Presence] in Plasma by Molecular genetics method |
|
77067-7
|
SEPT9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48014-5
|
Sequence variation panel - Blood or Tissue by Molecular genetics method |
|
48017-8
|
Sequencing methodology panel - Blood or Tissue by Molecular genetics method |
|
79424-8
|
Serial sputum smears for diagnosing pulmonary tuberculosis panel - by Acid fast stain - Ziehl-Neelsen |
|
10951-2
|
Sericin IgE Ab [Units/volume] in Serum |
|
47742-2
|
Serine [Moles/volume] in DBS |
|
47745-5
|
Serine/Amino acids.total in Amniotic fluid |
|
47744-8
|
Serine/Amino acids.total in Cerebral spinal fluid |
|
47747-1
|
Serine/Amino acids.total in DBS |
|
47743-0
|
Serine/Amino acids.total in Hair |
|
47746-3
|
Serine/Amino acids.total in Serum or Plasma |
|
47748-9
|
Serine/Amino acids.total in Unspecified specimen |
|
44403-4
|
Serine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56642-2
|
Serine/Creatinine [Ratio] in 24 hour Urine |
|
56978-0
|
Serotonin [Mass/volume] in 24 hour Urine |
|
18253-5
|
Serotonin [Mass/time] in 24 hour Urine |
|
25981-2
|
Serotonin [Moles/volume] in 24 hour Urine |
|
32339-4
|
Serotonin [Moles/time] in 24 hour Urine |
|
10511-4
|
Serotonin Ag [Presence] in Tissue by Immune stain |
|
2939-7
|
Serotonin [Mass/volume] in Blood |
|
25524-0
|
Serotonin [Moles/volume] in Blood |
|
71804-9
|
Serotonin [Entitic substance] in Platelets |
|
2940-5
|
Serotonin [Mass/volume] in Plasma |
|
26035-6
|
Serotonin [Moles/volume] in Plasma |
|
42671-8
|
Serotonin [Entitic mass] in Platelets |
|
2941-3
|
Serotonin [Mass/volume] in Platelets |
|
68501-6
|
Serotonin release.heparin.unfractionated and low molecular weight panel - Serum |
|
27057-9
|
Serotonin [Mass/volume] in Serum |
|
14910-4
|
Serotonin [Moles/volume] in Serum |
|
17003-5
|
Serotonin [Mass/volume] in Urine |
|
34373-1
|
Serotonin [Moles/volume] in Urine |
|
34374-9
|
Serotonin/Creatinine [Molar ratio] in Urine |
|
38409-9
|
SERPINA1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
21723-2
|
SERPINA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21724-0
|
SERPINA1 gene p.Glu264Val [Presence] in Blood or Tissue by Molecular genetics method |
|
21725-7
|
SERPINA1 gene p.Glu342Lys [Presence] in Blood or Tissue by Molecular genetics method |
|
69363-0
|
SERPINA10 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93814-2
|
SERPINC1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
52757-2
|
SERPINE1 gene c.-675 4G+5G [Presence] in Blood or Tissue by Molecular genetics method |
|
52758-0
|
SERPINE1 gene c.-844A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
48028-5
|
SERPINE1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60577-4
|
SERPINE1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
77081-8
|
SERPINF1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77080-0
|
SERPINF1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
75380-6
|
SERPING1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
88990-7
|
Sertindole [Mass/volume] in Serum or Plasma |
|
72956-6
|
Sertraline induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72955-8
|
Sertraline induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73155-4
|
Sertraline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73154-7
|
Sertraline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13579-8
|
Sertraline [Presence] in Serum or Plasma |
|
6906-2
|
Sertraline [Mass/volume] in Serum or Plasma |
|
14911-2
|
Sertraline [Moles/volume] in Serum or Plasma |
|
78438-9
|
Sertraline trough and Norsertraline panel - Serum or Plasma |
|
74911-9
|
Sertraline [Mass/volume] in Serum or Plasma --trough |
|
92638-6
|
Sertraline [Mass/volume] in Urine by Confirmatory method |
|
32112-5
|
Sertraline [Presence] in Urine |
|
92652-7
|
Sertraline [Presence] in Urine by Confirmatory method |
|
74662-8
|
Sertraline [Mass/volume] in Urine |
|
32113-3
|
Sertraline [Presence] in Unspecified specimen |
|
83339-2
|
Service coordination panel [PCAM] |
|
81635-5
|
Service AndOr equipment AndOr product note |
|
7697-6
|
Sesame Seed triggered histamine release [Units/volume] in Blood |
|
6242-2
|
Sesame Seed IgE Ab [Units/volume] in Serum |
|
61313-3
|
Sesame Seed IgE Ab/IgE total in Serum |
|
7696-8
|
Sesame Seed IgG Ab [Units/volume] in Serum |
|
56386-6
|
Sesame Seed IgG4 Ab [Mass/volume] in Serum |
|
60402-5
|
Sesame Seed IgG Ab [Mass/volume] in Serum |
|
48219-0
|
Sesame Seed triggered leukotriene release [Mass/volume] by Leukocytes |
|
60782-0
|
Sevoflurane gas delivered during case [Volume] from Gas delivery system |
|
61027-9
|
Sevoflurane gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76018-1
|
Sevoflurane liquid delivered during case [Volume] from Gas delivery system |
|
76019-9
|
Sevoflurane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
|
60779-6
|
Gas delivery system inspiratory Sevoflurane setting [VFr/PPres] |
|
60807-5
|
Sevoflurane [VFr/PPres] Airway adaptor --during expiration |
|
76107-2
|
Sevoflurane [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
60907-3
|
Sevoflurane [VFr/PPres] Airway adaptor --during inspiration |
|
60864-6
|
Sevoflurane [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
60908-1
|
Sevoflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60863-8
|
Sevoflurane [VFr/PPres] Airway adaptor |
|
60781-2
|
Sevoflurane [VFr/PPres] Gas delivery system |
|
46098-0
|
Sex |
|
76689-9
|
Sex assigned at birth |
|
76690-7
|
Sexual orientation |
|
90260-1
|
Rickettsia spotted fever group Ab.IgG and IgM panel [Titer] - Serum |
|
74756-8
|
Soluble fms-like tyrosine kinase-1 [Mass/volume] in Serum |
|
74764-2
|
Soluble fms-like tyrosine kinase-1 and placental growth factor panel - Serum or Plasma |
|
41060-5
|
SFTPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40961-5
|
SFTPB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
40962-3
|
SFTPC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41059-7
|
SFTPC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74541-4
|
Surfactant pulmonary-associated protein D [Mass/volume] in Serum |
|
26647-8
|
Semliki forest virus Ab [Presence] in Serum |
|
74826-9
|
Semliki forest virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
42955-5
|
Semliki forest virus Ab [Titer] in Serum |
|
40512-6
|
Semliki forest virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
46226-7
|
SGCA gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
47970-9
|
SGCB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
48977-3
|
SGCG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
31661-2
|
Sulfate-3-Glucuronyl paragloboside Ab [Presence] in Serum |
|
31662-0
|
Sulfate-3-Glucuronyl paragloboside Ab [Units/volume] in Serum |
|
31162-1
|
Sulfate-3-Glucuronyl paragloboside Ab [Titer] in Serum |
|
31663-8
|
Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Cerebral spinal fluid |
|
31664-6
|
Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Cerebral spinal fluid |
|
31665-3
|
Sulfate-3-Glucuronyl paragloboside IgM Ab [Presence] in Serum |
|
31666-1
|
Sulfate-3-Glucuronyl paragloboside IgM Ab [Units/volume] in Serum |
|
76032-2
|
SGSH gene full mutation analysis in Blood or Tissue by Sequencing |
|
47971-7
|
SGSH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
35742-6
|
SH2D1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41058-9
|
SH2D1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53895-9
|
SH3BP2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49704-0
|
SH3TC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7404-7
|
Shagbark Hickory IgE Ab [Units/volume] in Serum |
|
11198-9
|
Shark IgE Ab [Units/volume] in Serum |
|
65359-2
|
Sex hormone binding globulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge |
|
2942-1
|
Sex hormone binding globulin [Mass/volume] in Serum or Plasma |
|
13967-5
|
Sex hormone binding globulin [Moles/volume] in Serum or Plasma |
|
7698-4
|
Sheep epithelium triggered histamine release [Units/volume] in Blood |
|
6243-0
|
Sheep epithelium IgE Ab [Units/volume] in Serum |
|
61344-8
|
Sheep epithelium IgE Ab/IgE total in Serum |
|
19756-6
|
Sheep milk IgE Ab [Units/volume] in Serum |
|
76413-4
|
Sheep prion protein codon 112 [Type] in Blood by Genotype method |
|
76414-2
|
Sheep prion protein codon 136 [Type] in Blood by Genotype method |
|
76412-6
|
Sheep prion protein codon 141 [Type] in Blood by Genotype method |
|
76415-9
|
Sheep prion protein codon 154 [Type] in Blood by Genotype method |
|
76416-7
|
Sheep prion protein codon 171 [Type] in Blood by Genotype method |
|
7699-2
|
Sheep Sorrel triggered histamine release [Units/volume] in Blood |
|
6244-8
|
Sheep Sorrel IgE Ab [Units/volume] in Serum |
|
61309-1
|
Sheep Sorrel IgE Ab/IgE total in Serum |
|
24143-0
|
Sheep Sorrel IgG Ab [Units/volume] in Serum |
|
56387-4
|
Sheep Sorrel IgG4 Ab [Mass/volume] in Serum |
|
19757-4
|
Sheep whey IgE Ab [Units/volume] in Serum |
|
6245-5
|
Sheep wool IgE Ab [Units/volume] in Serum |
|
61314-1
|
Sheep wool IgE Ab/IgE total in Serum |
|
7405-4
|
Shellbark Hickory IgE Ab [Units/volume] in Serum |
|
33764-2
|
Shiga toxin stx gene [Identifier] in Unspecified specimen by NAA with probe detection |
|
43589-1
|
Shigella sp Ab [Presence] in Serum |
|
5350-4
|
Shigella sp Ab [Units/volume] in Serum |
|
46455-2
|
Shigella sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
20964-3
|
Shigella sp identified in Feed by Organism specific culture |
|
49056-5
|
Shigella sp serotype [Identifier] in Isolate by Agglutination |
|
70242-3
|
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection |
|
82300-5
|
Shigella sp [Presence] in Stool by Culture |
|
17576-0
|
Shigella sp identified in Unspecified specimen by Organism specific culture |
|
46454-5
|
Shigella sp [Presence] in Unspecified specimen by Organism specific culture |
|
55429-5
|
Short blood count panel - Blood |
|
55417-0
|
Short blood pressure panel |
|
55398-2
|
Short Fibrin D-dimer FEU and DDU panel - Platelet poor plasma |
|
10956-1
|
Short Leaf Pine IgE Ab [Units/volume] in Serum |
|
55397-4
|
Short myasthenia gravis panel - Serum |
|
7653-9
|
Short+Giant Ragweed IgG Ab [Units/volume] in Serum |
|
48202-6
|
Short+Giant Ragweed triggered leukotriene release [Mass/volume] by Leukocytes |
|
56047-4
|
Shoulder Horizontal adduction Active Range of Motion Quantitative |
|
56046-6
|
Shoulder Horizontal adduction Passive Range of Motion Quantitative |
|
41299-9
|
Shoulder - left Abduction Active Range of Motion Quantitative |
|
41300-5
|
Shoulder - left Abduction Passive Range of Motion Quantitative |
|
41297-3
|
Shoulder - left Extension Active Range of Motion Quantitative |
|
41298-1
|
Shoulder - left Extension Passive Range of Motion Quantitative |
|
41305-4
|
Shoulder - left External rotation Active Range of Motion Quantitative |
|
41306-2
|
Shoulder - left External rotation Passive Range of Motion Quantitative |
|
41295-7
|
Shoulder - left Flexion Active Range of Motion Quantitative |
|
41296-5
|
Shoulder - left Flexion Passive Range of Motion Quantitative |
|
56048-2
|
Shoulder - left Horizontal adduction Active Range of Motion Quantitative |
|
56045-8
|
Shoulder - left Horizontal adduction Passive Range of Motion Quantitative |
|
41303-9
|
Shoulder - left Internal rotation Active Range of Motion Quantitative |
|
41304-7
|
Shoulder - left Internal rotation Passive Range of Motion Quantitative |
|
41311-2
|
Shoulder - right Abduction Active Range of Motion Quantitative |
|
41312-0
|
Shoulder - right Abduction Passive Range of Motion Quantitative |
|
41309-6
|
Shoulder - right Extension Active Range of Motion Quantitative |
|
41310-4
|
Shoulder - right Extension Passive Range of Motion Quantitative |
|
41317-9
|
Shoulder - right External rotation Active Range of Motion Quantitative |
|
41318-7
|
Shoulder - right External rotation Passive Range of Motion Quantitative |
|
41307-0
|
Shoulder - right Flexion Active Range of Motion Quantitative |
|
41308-8
|
Shoulder - right Flexion Passive Range of Motion Quantitative |
|
56044-1
|
Shoulder - right Horizontal adduction Active Range of Motion Quantitative |
|
56043-3
|
Shoulder - right Horizontal adduction Passive Range of Motion Quantitative |
|
41315-3
|
Shoulder - right Internal rotation Active Range of Motion Quantitative |
|
41316-1
|
Shoulder - right Internal rotation Passive Range of Motion Quantitative |
|
34500-9
|
SHOX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
66451-6
|
Shrimp native (nPen i) 11 IgE Ab [Units/volume] in Serum |
|
65794-0
|
Shrimp native (nPen m) 1 IgE Ab [Units/volume] in Serum |
|
65786-6
|
Shrimp native (nPen m) 2 IgE Ab [Units/volume] in Serum |
|
65787-4
|
Shrimp native (nPen m) 4 IgE Ab [Units/volume] in Serum |
|
7701-6
|
Shrimp triggered histamine release [Units/volume] in Blood |
|
6246-3
|
Shrimp IgE Ab [Units/volume] in Serum |
|
7700-8
|
Shrimp IgG Ab [Units/volume] in Serum |
|
56388-2
|
Shrimp IgG4 Ab [Mass/volume] in Serum |
|
60403-3
|
Shrimp IgG Ab [Mass/volume] in Serum |
|
48214-1
|
Shrimp triggered leukotriene release [Mass/volume] by Leukocytes |
|
58986-1
|
Shrimp tropomyosin recombinant (rPen a) 1 IgE Ab [Units/volume] in Serum |
|
77200-4
|
SI gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75045-5
|
Sialate [Moles/volume] in Amniotic fluid |
|
75046-3
|
Sialate [Moles/volume] in Cerebral spinal fluid |
|
2943-9
|
Sialate [Mass/volume] in Plasma |
|
75047-1
|
Sialate [Moles/volume] in Serum or Plasma |
|
34598-3
|
Sialate [Presence] in Urine |
|
2944-7
|
Sialate [Mass/volume] in Urine |
|
40452-5
|
Sialate/Creatinine [Ratio] in Urine |
|
76024-9
|
Sialate/Creatinine [Molar ratio] in Urine |
|
24099-4
|
Sialidase [Enzymatic activity/mass] in Fibroblast |
|
2945-4
|
Sialidase [Enzymatic activity/volume] in Serum |
|
2946-2
|
Sialidase [Enzymatic activity/mass] in Tissue |
|
75057-0
|
Sialidase [Enzymatic activity/mass] in Leukocytes |
|
40453-3
|
Sialooligosaccharides [Presence] in Urine |
|
34526-4
|
Sialooligosaccharides/Creatinine [Ratio] in Urine |
|
59332-7
|
Sibutramine [Mass/volume] in Blood |
|
59335-0
|
Sibutramine [Mass/volume] in Serum or Plasma |
|
59338-4
|
Sibutramine [Mass/volume] in Urine |
|
75376-4
|
Siderocytes per HPF [Presence] in Blood by Light microscopy |
|
45137-7
|
IgA.secretory [Mass/volume] in Body fluid |
|
44590-8
|
IgA.secretory [Presence] in Saliva (oral fluid) |
|
33636-2
|
IgA.secretory [Units/volume] in Saliva (oral fluid) |
|
26849-0
|
IgA.secretory [Mass/volume] in Saliva (oral fluid) |
|
12725-8
|
IgA.secretory [Units/volume] in Serum or Plasma |
|
14163-0
|
IgA.secretory [Mass/volume] in Serum or Plasma |
|
68933-1
|
IgA.secretory [Mass/volume] in Sweat |
|
68932-3
|
IgA.secretory [Mass/volume] in Tear |
|
75950-6
|
Signal quality index EEG device Calculated |
|
72954-1
|
Sildenafil citrate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72953-3
|
Sildenafil citrate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73153-9
|
Sildenafil citrate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73152-1
|
Sildenafil citrate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
28075-0
|
Sildenafil citrate [Mass/volume] in Serum or Plasma |
|
55578-9
|
Sildenafil citrate [Moles/volume] in Serum or Plasma |
|
43164-3
|
Silica [Mass/volume] in Water |
|
18254-3
|
Silicate [Mass/volume] in Body fluid |
|
5729-9
|
Silicate [Mass/volume] in Serum or Plasma |
|
5730-7
|
Silicate [Mass/mass] in Tissue |
|
5731-5
|
Silicate [Mass/volume] in Urine |
|
50907-5
|
Silicon [Moles/time] in 24 hour Urine |
|
5728-1
|
Silicon [Mass/volume] in Blood |
|
60170-8
|
Silicon [Mass/volume] in Body fluid |
|
51204-6
|
Silicon [Mass/mass] in Hair |
|
50905-9
|
Silicon [Moles/mass] in Hair |
|
60171-6
|
Silicon [Mass/volume] in Red Blood Cells |
|
10829-0
|
Silicon [Mass/volume] in Serum or Plasma |
|
25526-5
|
Silicon [Moles/volume] in Serum or Plasma |
|
52888-5
|
Silicon [Moles/mass] in Tissue |
|
46981-7
|
Silicon [Mass/volume] in Urine |
|
50906-7
|
Silicon [Moles/volume] in Urine |
|
9401-1
|
Silicon [Mass/volume] in Unspecified specimen |
|
44404-2
|
Silicon/Creatinine [Mass Ratio] in Urine |
|
39612-7
|
Silicone IgA Ab [Units/volume] in Serum by Immunoassay |
|
9675-0
|
Silicone IgA Ab [Units/volume] in Serum |
|
9676-8
|
Silicone IgE Ab [Units/volume] in Serum |
|
39614-3
|
Silicone IgE Ab [Units/volume] in Serum by Immunoassay |
|
39611-9
|
Silicone IgG Ab [Units/volume] in Serum by Immunoassay |
|
9677-6
|
Silicone IgG Ab [Units/volume] in Serum |
|
39613-5
|
Silicone IgM Ab [Units/volume] in Serum by Immunoassay |
|
9678-4
|
Silicone IgM Ab [Units/volume] in Serum |
|
6247-1
|
Silk IgE Ab [Units/volume] in Serum |
|
19758-2
|
Silk waste IgE Ab [Units/volume] in Serum |
|
30928-6
|
Silver [Mass/volume] in Urine collected for unspecified duration |
|
29977-6
|
Silver [Mass/volume] in 24 hour Urine |
|
6931-0
|
Silver [Mass/time] in 24 hour Urine |
|
50910-9
|
Silver [Moles/volume] in 24 hour Urine |
|
47129-2
|
Silver [Moles/time] in 24 hour Urine |
|
65776-7
|
Silver birch native (nBet v) 1 IgE Ab [Units/volume] in Serum |
|
30984-9
|
Silver Birch recombinant (rBet v) 1 IgE Ab [Units/volume] in Serum |
|
61229-1
|
Silver Birch recombinant (rBet v) 1 IgE Ab/IgE total in Serum |
|
34425-9
|
Silver Birch recombinant (rBet v) 1 + 2 IgE Ab [Units/volume] in Serum |
|
30985-6
|
Silver Birch recombinant (rBet v) 2 IgE Ab [Units/volume] in Serum |
|
51524-7
|
Silver Birch recombinant (rBet v) 2 + 4 IgE Ab [Units/volume] in Serum |
|
34250-1
|
Silver Birch recombinant (rBet v) 4 IgE Ab [Units/volume] in Serum |
|
82572-9
|
Silver Birch recombinant (rBet v) 6 IgE Ab [Units/volume] in Serum |
|
15283-5
|
Silver Birch IgE Ab [Units/volume] in Serum |
|
61228-3
|
Silver Birch IgE Ab/IgE total in Serum |
|
51537-9
|
Silver Birch IgG Ab [Presence] in Serum |
|
25349-2
|
Silver Birch IgG Ab [Units/volume] in Serum |
|
26409-3
|
Silver Birch IgG4 Ab [Units/volume] in Serum |
|
48249-7
|
Silver Birch triggered leukotriene release [Mass/volume] by Leukocytes |
|
5732-3
|
Silver [Mass/volume] in Blood |
|
82462-3
|
Silver [Moles/volume] in Blood |
|
17582-8
|
Silver [Mass/volume] in Dialysis fluid |
|
59738-5
|
Silver [Mass/volume] in Body fluid |
|
80145-6
|
Silver [Moles/volume] in Body fluid |
|
5733-1
|
Silver [Mass/mass] in Hair |
|
50908-3
|
Silver [Moles/mass] in Hair |
|
11199-7
|
Silver IgE Ab [Units/volume] in Serum |
|
14133-3
|
Silver Maple IgE Ab [Units/volume] in Serum |
|
59739-3
|
Silver [Mass/mass] in Nail |
|
59740-1
|
Silver [Mass/volume] in Red Blood Cells |
|
52896-8
|
Silver [Moles/volume] in Red Blood Cells |
|
5734-9
|
Silver [Mass/volume] in Serum or Plasma |
|
25527-3
|
Silver [Moles/volume] in Serum or Plasma |
|
59741-9
|
Silver [Mass/mass] in Tissue |
|
78892-7
|
Silver [Moles/mass] in Tissue |
|
5735-6
|
Silver [Mass/volume] in Urine |
|
50909-1
|
Silver [Moles/volume] in Urine |
|
29978-4
|
Silver/Creatinine [Mass Ratio] in 24 hour Urine |
|
52904-0
|
Silver/Creatinine [Molar ratio] in 24 hour Urine |
|
13476-7
|
Silver/Creatinine [Mass Ratio] in Urine |
|
52905-7
|
Silver/Creatinine [Molar ratio] in Urine |
|
82522-4
|
Simeprevir [Susceptibility] by Genotype method |
|
73151-3
|
Simethicone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73150-5
|
Simethicone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
81250-3
|
Discrete genetic variant panel |
|
75843-3
|
Simplified disease activity index [SDAI] |
|
72952-5
|
Simvastatin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72951-7
|
Simvastatin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73149-7
|
Simvastatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73148-9
|
Simvastatin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26648-6
|
Sindbis virus Ab [Presence] in Serum |
|
74845-9
|
Sindbis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
42954-8
|
Sindbis virus Ab [Titer] in Serum |
|
40503-5
|
Sindbis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
29247-4
|
Sirolimus [Mass/volume] in Blood |
|
80548-1
|
Sirolimus [Mass/volume] in DBS |
|
72676-0
|
Sirolimus [Mass/volume] in Plasma --trough |
|
92842-4
|
Situational report |
|
23437-7
|
Swine influenza virus Ab [Presence] in Serum |
|
23438-5
|
Swine influenza virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
23781-8
|
Swine influenza virus Ag [Presence] in Tissue by Immunofluorescence |
|
23782-6
|
Swine influenza virus Ag [Presence] in Tissue by Immune stain |
|
66878-0
|
Skin Ab [Titer] in Serum |
|
72284-3
|
Skin assessment panel |
|
46046-9
|
Skin condition section |
|
66882-2
|
Skin IgG Ab [Presence] in Serum by Guinea pig esophagus substrate |
|
66881-4
|
Skin IgG Ab [Presence] in Serum by Monkey esophagus substrate |
|
66879-8
|
Skin IgG Ab [Titer] in Serum by Guinea pig esophagus substrate |
|
66883-0
|
Skin IgG Ab [Titer] in Serum by Monkey esophagus substrate |
|
65754-4
|
Skin Pathology biopsy report |
|
60839-8
|
Skin temperature --in microenvironment |
|
75951-4
|
Skin temperature setting Infant microenvironment |
|
46050-1
|
Skin treatments Set |
|
10957-9
|
Slash Pine IgE Ab [Units/volume] in Serum |
|
81874-0
|
SLC12A3 gene full mutation analysis in Blood or Tissue by Sequencing |
|
81824-5
|
SLC12A6 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81834-4
|
SLC17A5 gene full mutation analysis in Blood or Tissue by Sequencing |
|
34514-0
|
SLC22A18 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41056-3
|
SLC22A18 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60497-5
|
SLC22A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
61107-9
|
SLC25A13 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53725-8
|
SLC25A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
81832-8
|
SLC26A2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41055-5
|
SLC26A4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40468-1
|
SLC26A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53722-5
|
SLC26A4 gene p.Glu384Gly [Presence] in Blood by Molecular genetics method |
|
53723-3
|
SLC26A4 gene.p.Leu236Pro [Presence] in Blood by Molecular genetics method |
|
53724-1
|
SLC26A4 gene p.Thr416Pro [Presence] in Blood by Molecular genetics method |
|
71355-2
|
SLC26A5 gene c.-53-2A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
81828-6
|
SLC37A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
72696-8
|
SLC40A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
50330-0
|
SLC6A4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
93412-5
|
SLCO1B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
85866-2
|
Sleep medicine Consult note |
|
85865-4
|
Sleep medicine Diagnostic study note |
|
85864-7
|
Sleep medicine Note |
|
90711-3
|
Sleep medicine Outpatient Note |
|
90712-1
|
Sleep medicine Telehealth Consult note |
|
90713-9
|
Sleep medicine Telehealth Note |
|
89035-0
|
Sleep medicine Physician Note |
|
45999-0
|
Sleep-cycle issues Set |
|
7654-7
|
Slender Ragweed IgE Ab [Units/volume] in Serum |
|
22507-8
|
Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid |
|
8021-8
|
Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
17558-8
|
Saint Louis encephalitis virus Ab [Units/volume] in Cerebral spinal fluid |
|
8022-6
|
Saint Louis encephalitis virus Ab [Units/volume] in Serum by Complement fixation |
|
20806-6
|
Saint Louis encephalitis virus Ab [Presence] in Serum |
|
74825-1
|
Saint Louis encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
8023-4
|
Saint Louis encephalitis virus Ab [Presence] in Serum by Immunoassay |
|
8024-2
|
Saint Louis encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
|
5365-2
|
Saint Louis encephalitis virus Ab [Units/volume] in Serum |
|
24275-0
|
Saint Louis encephalitis virus Ab [Titer] in Serum --1st specimen |
|
24201-6
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24276-8
|
Saint Louis encephalitis virus Ab [Titer] in Serum --2nd specimen |
|
24202-4
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
22509-4
|
Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
9577-8
|
Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
29796-0
|
Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
22510-2
|
Saint Louis encephalitis virus Ab [Titer] in Serum |
|
40502-7
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
40514-2
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
9578-6
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
|
29809-1
|
Saint Louis encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
29822-4
|
Saint Louis encephalitis virus Ab [Titer] in Unspecified specimen |
|
29783-8
|
Saint Louis encephalitis virus Ab [Titer] in Unspecified specimen by Neutralization test |
|
31617-4
|
Saint Louis encephalitis virus Ab [Units/volume] in Unspecified specimen |
|
6549-0
|
Saint Louis encephalitis virus Ag [Units/volume] in Serum |
|
13230-8
|
Saint Louis encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
62435-3
|
Saint Louis encephalitis virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
43232-8
|
Saint Louis encephalitis virus IgG Ab [Presence] in Serum |
|
8016-8
|
Saint Louis encephalitis virus IgG Ab [Units/volume] in Serum |
|
22511-0
|
Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
21509-5
|
Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22512-8
|
Saint Louis encephalitis virus IgG Ab [Titer] in Serum |
|
10906-6
|
Saint Louis encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
9634-7
|
Saint Louis encephalitis virus IgG Ab [Titer] in Unspecified specimen |
|
42966-2
|
Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid |
|
42006-7
|
Saint Louis encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
13231-6
|
Saint Louis encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
49144-9
|
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid |
|
48507-8
|
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
62434-6
|
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid by Immunofluorescence |
|
42965-4
|
Saint Louis encephalitis virus IgM Ab [Presence] in Serum |
|
42005-9
|
Saint Louis encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
8017-6
|
Saint Louis encephalitis virus IgM Ab [Units/volume] in Serum |
|
22513-6
|
Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
21510-3
|
Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22514-4
|
Saint Louis encephalitis virus IgM Ab [Titer] in Serum |
|
10907-4
|
Saint Louis encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
9635-4
|
Saint Louis encephalitis virus IgM Ab [Titer] in Unspecified specimen |
|
34458-0
|
Saint Louis encephalitis virus RNA [Presence] in Blood by NAA with probe detection |
|
34459-8
|
Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
27950-5
|
Saint Louis encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe |
|
8025-9
|
Saint Louis encephalitis virus RNA [Presence] in Serum by NAA with probe detection |
|
55145-7
|
Saint Louis encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
37984-2
|
Saint Louis encephalitis virus RNA [Presence] in Unspecified specimen by Probe |
|
83987-8
|
Speech-language pathology Team Note |
|
63210-9
|
Actin smooth muscle Ab [Presence] in Serum by Immunoassay |
|
63211-7
|
Actin smooth muscle Ab [Presence] in Serum by Immunofluorescence |
|
89520-1
|
Actin smooth muscle Ab [Presence] in Serum by Line blot |
|
40563-9
|
Actin smooth muscle Ag [Presence] in Tissue by Immune stain |
|
81774-2
|
Actin smooth muscle IgG Ab [Presence] in Serum |
|
44706-0
|
Actin smooth muscle IgG Ab [Units/volume] in Serum |
|
92005-8
|
Spinal muscular atrophy newborn screening panel |
|
77624-5
|
SMAD4 gene full mutation analysis in Blood or Tissue by Sequencing |
|
53896-7
|
SMC1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
34994-4
|
Smear morphology panel - Blood |
|
20431-3
|
Microscopic observation [Identifier] in Unspecified specimen by Smear |
|
7702-4
|
Smelt IgE Ab [Units/volume] in Serum |
|
33778-2
|
SmIg Ag [Presence] in Tissue by Immune stain |
|
25613-1
|
Smoky Brown Cockroach IgE Ab [Units/volume] in Serum |
|
48682-9
|
Smooth muscle myosin heavy chain Ag [Presence] in Tissue by Immune stain |
|
54453-6
|
Semen analysis test method |
|
92002-5
|
SMN1 gene [Cycle Threshold #] in DBS by NAA with probe detection |
|
35462-1
|
SMN1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41053-0
|
SMN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49857-6
|
SMN1 gene+SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
54449-4
|
SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
88031-0
|
Smokeless tobacco status |
|
7063-1
|
Smooth Alder IgE Ab [Units/volume] in Serum |
|
41873-1
|
Smooth Alder IgG Ab [Units/volume] in Serum |
|
63203-4
|
Smooth Alder IgG Ab [Mass/volume] in Serum |
|
63357-8
|
Smooth muscle Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63355-2
|
Smooth muscle Ab [Presence] in Body fluid by Immunofluorescence |
|
14252-1
|
Smooth muscle Ab [Presence] in Serum |
|
26971-2
|
Smooth muscle Ab [Presence] in Serum by Immunofluorescence |
|
31629-9
|
Smooth muscle Ab [Units/volume] in Serum |
|
17593-5
|
Smooth muscle Ab [Presence] in Sweat |
|
42530-6
|
Smooth muscle Ab [Titer] in Cerebral spinal fluid |
|
63358-6
|
Smooth muscle Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
63356-0
|
Smooth muscle Ab [Titer] in Body fluid by Immunofluorescence |
|
8095-2
|
Smooth muscle Ab [Titer] in Serum |
|
5358-7
|
Smooth muscle Ab [Titer] in Serum by Immunofluorescence |
|
30557-3
|
Smooth muscle IgG Ab [Presence] in Serum |
|
47977-4
|
Smooth muscle IgG Ab [Titer] in Serum |
|
32641-3
|
SMPD1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
34518-1
|
SMPD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41292-4
|
Soluble mesothelin related proteins [Moles/volume] in Serum or Plasma |
|
68437-3
|
Smudge cells [#/volume] in Blood by Manual count |
|
77203-8
|
Smut fungi (Ustilago nuda+Ustilago tritici+Ustilago maydis+Tilletia tritici) IgE Ab [Units/volume] in Serum |
|
75952-2
|
SNAP index Cerebral cortex Electroencephalogram (EEG) |
|
21735-6
|
SNCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21736-4
|
SNCA gene p.Ala30Pro [Presence] in Blood or Tissue by Molecular genetics method |
|
21737-2
|
SNCA gene p.Ala53Thr [Presence] in Blood or Tissue by Molecular genetics method |
|
52039-5
|
Skilled Nursing Facility (SNF) record |
|
72654-7
|
SNRPN gene 15q11 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal |
|
33549-7
|
Hantavirus sin nombre Ab [Presence] in Serum |
|
26654-4
|
Hantavirus sin nombre IgG Ab [Presence] in Serum |
|
31408-8
|
Hantavirus sin nombre IgG Ab [Units/volume] in Serum |
|
23867-5
|
Hantavirus sin nombre IgG Ab [Titer] in Serum |
|
26650-2
|
Hantavirus sin nombre IgM Ab [Presence] in Serum |
|
31409-6
|
Hantavirus sin nombre IgM Ab [Units/volume] in Serum |
|
23868-3
|
Hantavirus sin nombre IgM Ab [Titer] in Serum |
|
76506-5
|
Social connection and isolation panel |
|
83334-3
|
Social environmental panel [PCAM] |
|
76512-3
|
Social isolation score [NHANES] |
|
45396-9
|
Social Security number [Identifier] |
|
45966-9
|
Social Security and Medicare numbers |
|
87295-2
|
Social Security Number was requested |
|
85112-1
|
Social Withdrawal Survey version 2.0 - parent report - fixed length form - ages 3-12 [NIH Toolbox] |
|
45333-2
|
Superoxide dismutase [Enzymatic activity/volume] in Blood |
|
44410-9
|
Superoxide dismutase [Presence] in Plasma |
|
2978-5
|
Superoxide dismutase [Enzymatic activity/volume] in Plasma |
|
56479-9
|
Superoxide dismutase [Enzymatic activity/mass] in Red Blood Cells |
|
49710-7
|
SOD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
32553-0
|
Sodium [Molar amount] in Urine collected for unspecified duration |
|
35678-2
|
Sodium [Moles/volume] in Urine collected for unspecified duration |
|
74353-4
|
Sodium and Potassium panel [Moles/volume] - Blood |
|
34548-8
|
Sodium and Potassium panel [Moles/volume] - Serum or Plasma |
|
57370-9
|
Sodium [Moles/volume] in 12 hour Urine |
|
18377-2
|
Sodium [Moles/time] in 12 hour Urine |
|
58994-5
|
Sodium [Moles/time] in 18 hour Urine |
|
53122-8
|
Sodium [Moles/time] in 1 hour Urine |
|
59163-6
|
Sodium [Moles/volume] in 24 hour Stool |
|
27257-5
|
Sodium [Moles/mass] in 24 hour Stool |
|
27419-1
|
Sodium [Moles/time] in 24 hour Stool |
|
92572-7
|
Sodium [Molar amount] in 24 hour Dialysis fluid |
|
2952-0
|
Sodium [Molar amount] in 24 hour Stool |
|
21526-9
|
Sodium [Mass/volume] in 24 hour Urine |
|
21527-7
|
Sodium [Mass/time] in 24 hour Urine |
|
21525-1
|
Sodium [Moles/volume] in 24 hour Urine |
|
2956-1
|
Sodium [Moles/time] in 24 hour Urine |
|
26763-3
|
Sodium [Mass/time] in 2 hour Urine |
|
57382-4
|
Sodium [Moles/volume] in 2 hour Urine |
|
74685-9
|
Sodium [Moles/volume] in 4 hour Urine |
|
18376-4
|
Sodium [Moles/time] in 6 hour Urine |
|
2953-8
|
Sodium [Molar amount] in 72 hour Stool |
|
49791-7
|
Sodium [Moles/volume] in Amniotic fluid |
|
56711-5
|
Sodium benzoate IgE Ab [Units/volume] in Serum |
|
48289-3
|
Sodium benzoate triggered leukotriene release [Mass/volume] by Leukocytes |
|
32717-1
|
Sodium [Moles/volume] in Arterial blood |
|
39792-7
|
Sodium [Moles/volume] in Capillary blood |
|
41657-8
|
Sodium [Moles/volume] in Mixed venous blood |
|
2947-0
|
Sodium [Moles/volume] in Blood |
|
39791-9
|
Sodium [Moles/volume] in Venous blood |
|
2957-9
|
Sodium renal clearance in 24 hour Urine and Serum or Plasma |
|
26761-7
|
Sodium renal clearance in 2 hour Urine and Serum or Plasma |
|
2948-8
|
Sodium [Moles/volume] in Cerebral spinal fluid |
|
39787-7
|
Sodium [Moles/volume] in Peritoneal dialysis fluid |
|
2949-6
|
Sodium [Moles/volume] in Dialysis fluid |
|
2950-4
|
Sodium [Moles/volume] in Body fluid |
|
50911-7
|
Sodium [Moles/volume] in Gastric fluid |
|
51205-3
|
Sodium [Mass/mass] in Hair |
|
50912-5
|
Sodium [Moles/mass] in Hair |
|
17796-4
|
Sodium [Moles/volume] in Hyperal solution |
|
13895-8
|
Sodium [Moles/volume] in Milk |
|
60220-1
|
Sodium [Moles/volume] in Mother's milk |
|
48290-1
|
Sodium nitrite triggered leukotriene release [Mass/volume] by Leukocytes |
|
74688-3
|
Sodium [Moles/volume] in Serum or Plasma --post dialysis |
|
49790-9
|
Sodium [Moles/volume] in Peritoneal fluid |
|
82812-9
|
Sodium [Mass/volume] in Red Blood Cells |
|
12907-2
|
Sodium [Moles/volume] in Red Blood Cells |
|
48292-7
|
Sodium salicylate triggered leukotriene release [Mass/volume] by Leukocytes |
|
56979-8
|
Sodium [Moles/volume] in Saliva (oral fluid) |
|
77139-4
|
Sodium [Moles/volume] in Serum, Plasma or Blood |
|
42570-2
|
Sodium [Mass or Moles/volume] in Serum or Plasma |
|
2951-2
|
Sodium [Moles/volume] in Serum or Plasma |
|
15207-4
|
Sodium [Moles/volume] in Stool |
|
14055-8
|
Sodium [Moles/mass] in Stool |
|
2954-6
|
Sodium [Moles/volume] in Sweat |
|
30558-1
|
Sodium [Moles/volume] in Total parental nutrition |
|
2955-3
|
Sodium [Moles/volume] in Urine |
|
12908-0
|
Sodium [Moles/volume] in Vitreous fluid |
|
9485-4
|
Sodium [Mass/volume] in Water |
|
32340-2
|
Sodium [Moles/volume] in Unspecified specimen |
|
13809-9
|
Sodium/Creatinine [Mass Ratio] in 24 hour Urine |
|
56980-6
|
Sodium/Creatinine [Ratio] in 24 hour Urine |
|
44405-9
|
Sodium/Creatinine [Molar ratio] in 24 hour Urine |
|
11149-2
|
Sodium/Creatinine [Mass Ratio] in Urine |
|
43223-7
|
Sodium/Creatinine [Ratio] in Urine |
|
33951-5
|
Sodium/Creatinine [Molar ratio] in Urine |
|
44406-7
|
Sodium/Potassium [Molar ratio] in 24 hour Urine |
|
28003-2
|
Sodium/Potassium [Molar ratio] in Serum or Plasma |
|
2958-7
|
Sodium/Potassium [Molar ratio] in Sweat |
|
2959-5
|
Sodium/Potassium [Molar ratio] in Urine |
|
82382-3
|
Sofosbuvir [Susceptibility] by Genotype method |
|
55927-8
|
Interleukin 1 receptor alpha chain soluble [Mass/volume] in Serum or Plasma |
|
9654-5
|
Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma |
|
76039-7
|
Interleukin 2 Receptor Soluble [Mass/volume] in Serum or Plasma |
|
34408-5
|
Interleukin 2 Receptor Soluble [Moles/volume] in Serum or Plasma |
|
44422-4
|
Interleukin 2 receptor alpha chain soluble [Units/volume] in Serum or Plasma |
|
7709-9
|
Sole IgE Ab [Units/volume] in Serum |
|
7710-7
|
Sole IgG Ab [Units/volume] in Serum |
|
56389-0
|
Sole IgG4 Ab [Mass/volume] in Serum |
|
60405-8
|
Sole IgG Ab [Mass/volume] in Serum |
|
32219-8
|
Soluble liver Ab [Units/volume] in Serum by Immunoassay |
|
13925-3
|
Soluble liver Ab [Presence] in Serum |
|
42199-0
|
Soluble liver Ab [Presence] in Serum by Immunoassay |
|
56722-2
|
Soluble liver Ab [Presence] in Serum by Immunoblot |
|
12734-0
|
Soluble liver Ab [Units/volume] in Serum |
|
38420-6
|
Soluble liver IgG Ab [Units/volume] in Serum by Immunoassay |
|
78433-0
|
Soluble liver IgG Ab [Presence] in Serum by Line blot |
|
20965-0
|
Somatic cells [#/volume] in Milk |
|
2486-9
|
Somatomedins [Mass/volume] in Serum or Plasma |
|
10512-2
|
Somatostatin Ag [Presence] in Tissue by Immune stain |
|
2960-3
|
Somatostatin [Presence] in Plasma |
|
2961-1
|
Somatostatin [Mass/volume] in Plasma |
|
49792-5
|
Somatostatin [Moles/volume] in Plasma |
|
85038-8
|
Somatotropin monitoring panel |
|
73679-3
|
SORAfenib [Mass/volume] in Serum or Plasma |
|
48152-3
|
Sorbitol/Creatinine [Molar ratio] in Urine |
|
7375-9
|
Sorghum grass IgE Ab [Units/volume] in Serum |
|
82536-4
|
SOS1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
53727-4
|
SOS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
4032-9
|
Sotalol [Mass/time] in 24 hour Urine |
|
73146-3
|
Sotalol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73147-1
|
Sotalol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12416-4
|
Sotalol [Mass/volume] in Serum or Plasma |
|
55579-7
|
Sotalol [Moles/volume] in Serum or Plasma |
|
72675-2
|
Sotalol [Mass/volume] in Serum or Plasma --trough |
|
4030-3
|
Sotalol [Presence] in Urine |
|
4031-1
|
Sotalol [Mass/volume] in Urine |
|
7655-4
|
Southern Ragweed IgE Ab [Units/volume] in Serum |
|
73911-0
|
SOX10 Ag [Presence] in Tissue by Immune stain |
|
89007-9
|
SOX-2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
73719-7
|
Soybean native (nGly m) 5 IgE Ab [Units/volume] in Serum |
|
65772-6
|
Soybean native (nGly m) 6 IgE Ab [Units/volume] in Serum |
|
63476-6
|
Soybean recombinant (rGly m) 4 IgE Ab [Units/volume] in Serum |
|
7137-3
|
Soybean triggered histamine release [Units/volume] in Blood |
|
7138-1
|
Soybean dust IgE Ab [Units/volume] in Serum |
|
6248-9
|
Soybean IgE Ab [Units/volume] in Serum |
|
61271-3
|
Soybean IgE Ab/IgE total in Serum |
|
6735-5
|
Soybean IgG Ab [Units/volume] in Serum |
|
56390-8
|
Soybean IgG4 Ab [Mass/volume] in Serum |
|
35546-1
|
Soybean IgG Ab [Mass/volume] in Serum |
|
48217-4
|
Soybean triggered leukotriene release [Mass/volume] by Leukocytes |
|
2966-0
|
Specific gravity of 24 hour Urine |
|
44933-0
|
Specific gravity of 24 hour Urine by Refractometry |
|
14345-3
|
Specific gravity of Amniotic fluid by Refractometry |
|
14346-1
|
Specific gravity of Cerebral spinal fluid by Refractometry |
|
2964-5
|
Specific gravity of Body fluid |
|
35414-2
|
Specific gravity of Body fluid by Refractometry |
|
14347-9
|
Specific gravity of Gastric fluid by Refractometry |
|
60027-0
|
Specific gravity of Pericardial fluid |
|
68384-7
|
Specific gravity of Pericardial fluid by Refractometry |
|
14349-5
|
Specific gravity of Pleural fluid by Refractometry |
|
14348-7
|
Specific gravity of Peritoneal fluid by Refractometry |
|
53555-9
|
Specific gravity of Red Blood Cells |
|
17598-4
|
Specific gravity of Synovial fluid |
|
14350-3
|
Specific gravity of Synovial fluid by Refractometry |
|
14351-1
|
Specific gravity of Stool by Refractometry |
|
2965-2
|
Specific gravity of Urine |
|
5810-7
|
Specific gravity of Urine by Refractometry |
|
5811-5
|
Specific gravity of Urine by Test strip |
|
14352-9
|
Specific gravity of Water by Refractometry |
|
33513-3
|
Specific gravity of Unspecified specimen |
|
77217-8
|
Salivary gland protein 1 and Carbonic anhydrase 6 and Parotid secretory protein IgA and IgG and IgM panel - Serum by Immunoassay |
|
54024-5
|
sp100 Ab [Presence] in Serum |
|
59066-1
|
sp100 Ab [Presence] in Serum by Immunoassay |
|
56754-5
|
sp100 Ab [Presence] in Serum by Immunoblot |
|
82932-5
|
sp100 IgG Ab [Presence] in Serum by Line blot |
|
7501-0
|
Spanish Moss IgE Ab [Units/volume] in Serum |
|
80191-0
|
Spasm stress test panel |
|
81875-7
|
SPAST gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
34516-5
|
SPAST gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41052-2
|
SPAST gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
53897-5
|
SPAST gene + KIAA0196 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
82799-8
|
Spatial clot growth analysis panel - Platelet poor plasma |
|
90041-5
|
Specimen collection setting type |
|
74384-9
|
Specimen container [Type] |
|
81147-1
|
Specimen source patient identification [Interpretation] Narrative |
|
85793-8
|
Specimen source subject [Type] |
|
46061-8
|
Special care Set |
|
46059-2
|
Special treatments and procedures section |
|
46073-3
|
Special treatments and procedures Set |
|
46060-0
|
Special treatments, procedures and programs Set |
|
91982-9
|
Specific airway resistance measured/predicted by Plethysmograph body box |
|
58400-3
|
Specimen pH acceptable of Urine |
|
80662-0
|
Volume of Peritoneal dialysis fluid |
|
68992-7
|
Specimen-related information panel |
|
69238-4
|
SPECT Urinary bladder and Urethra W contrast intra bladder during voiding |
|
39813-1
|
SPECT Bone limited |
|
39821-4
|
SPECT Bone marrow limited |
|
39906-3
|
SPECT Bone marrow multiple areas |
|
39823-0
|
SPECT Bone marrow |
|
39905-5
|
SPECT Bone multiple areas |
|
46366-1
|
SPECT guidance for percutaneous biopsy of Bone |
|
41772-5
|
SPECT Bone W In-111 tagged WBC IV |
|
39879-2
|
SPECT Bone |
|
24578-7
|
SPECT Bones |
|
39637-4
|
SPECT Brain for blood flow |
|
81557-1
|
SPECT Brain W florbetapir IV |
|
39638-2
|
SPECT Brain W I-123 IV |
|
39632-5
|
SPECT Brain |
|
44152-7
|
SPECT Brain W Tc-99m bicisate IV |
|
39640-8
|
SPECT Brain W Tc-99m DTPA IV |
|
39641-6
|
SPECT Brain W Tc-99m glucoheptonate IV |
|
39631-7
|
SPECT Brain W Tc-99m HMPAO IV |
|
81558-9
|
SPECT Brain W Tc-99m IV |
|
39639-0
|
SPECT Brain W Tl-201 IV |
|
39644-0
|
SPECT Breast |
|
39684-6
|
SPECT Unspecified body region for abscess W Ga-67 IV |
|
39811-5
|
SPECT Unspecified body region for abscess |
|
81556-3
|
SPECT Unspecified body region for infection or inflammation |
|
39770-3
|
SPECT Gastrointestinal tract |
|
39621-8
|
SPECT Guidance for abscess localization of Unspecified body region |
|
46384-4
|
SPECT Guidance for superficial biopsy of Bone |
|
46373-7
|
SPECT Guidance for placement of tube in Chest |
|
39759-6
|
SPECT Guidance limited for localization of tumor |
|
39622-6
|
SPECT Guidance for abscess localization of Whole body |
|
39762-0
|
SPECT Guidance for localization of tumor of Whole body |
|
39862-8
|
SPECT Heart blood pool at rest and W radionuclide IV |
|
39656-4
|
SPECT Heart for infarct |
|
39655-6
|
SPECT Heart for infarct W Tc-99m Sestamibi IV |
|
39654-9
|
SPECT Heart for infarct W Tc-99m PYP IV |
|
46396-8
|
SPECT Heart gated at rest and W Tc-99m Sestamibi IV |
|
39916-2
|
SPECT Heart gated |
|
39930-3
|
SPECT Heart gated W stress and W radionuclide IV |
|
46395-0
|
SPECT Heart gated and ejection fraction at rest and W stress and W radionuclide IV |
|
39913-9
|
SPECT Heart gated and ejection fraction |
|
39918-8
|
SPECT Heart gated and wall motion |
|
43659-2
|
SPECT Heart perfusion qualitative at rest and W radionuclide IV |
|
49568-9
|
SPECT Heart perfusion at rest and W stress and W Tl-201 IV and W Tc-99m Sestamibi IV |
|
39724-0
|
SPECT Heart perfusion at rest and W stress and W radionuclide IV |
|
39723-2
|
SPECT Heart perfusion at rest and W stress and W Tl-201 IV |
|
39725-7
|
SPECT Heart perfusion at rest and W adenosine and W Tl-201 IV |
|
39718-2
|
SPECT Heart perfusion at rest and W radionuclide IV |
|
39729-9
|
SPECT Heart perfusion at rest and W Tl-201 IV |
|
39700-0
|
SPECT Heart perfusion W adenosine and W radionuclide IV |
|
49567-1
|
SPECT Heart perfusion W adenosine and W Tc-99m Sestamibi IV |
|
39712-5
|
SPECT Heart perfusion |
|
39734-9
|
SPECT Heart perfusion W stress and W radionuclide IV |
|
39736-4
|
SPECT Heart perfusion W stress and W Tc-99m Sestamibi IV |
|
39710-9
|
SPECT Heart perfusion W Tc-99m Sestamibi IV |
|
39711-7
|
SPECT Heart perfusion W Tl-201 IV |
|
49569-7
|
SPECT Heart perfusion and wall motion at rest and W stress and W Tl-201 IV and W Tc-99m Sestamibi IV |
|
39662-2
|
SPECT Heart at rest and W stress and W Tc-99m Sestamibi IV |
|
39658-0
|
SPECT Heart at rest and W radionuclide IV |
|
49566-3
|
SPECT Heart at rest and W Tc-99m Sestamibi IV |
|
44154-3
|
SPECT Heart W dipyridamole and W Tc-99m Sestamibi IV |
|
39648-1
|
SPECT Heart W dipyridamole IV |
|
81561-3
|
SPECT Heart W multiple states of exercise |
|
39649-9
|
SPECT Heart |
|
81562-1
|
SPECT Heart W single state of exercise |
|
39668-9
|
SPECT Heart W stress and W radionuclide IV |
|
44151-9
|
SPECT Heart W Tc-99m Sestamibi IV |
|
39647-3
|
SPECT Heart W Tc-99m Tetrofosmin IV |
|
39872-7
|
SPECT Heart wall motion |
|
39938-6
|
SPECT Joint |
|
39852-9
|
SPECT Kidney - bilateral |
|
39851-1
|
SPECT Kidney - bilateral W Tc-99m Mertiatide IV |
|
42310-3
|
SPECT Kidney |
|
44153-5
|
SPECT Kidney W Tc-99m glucoheptonate IV |
|
43655-0
|
SPECT Liver for blood flow |
|
47378-5
|
SPECT Liver blood pool |
|
81613-2
|
SPECT Liver for hemangioma |
|
39692-9
|
SPECT Liver |
|
39691-1
|
SPECT Liver W Tc-99m tagged RBC IV |
|
24817-9
|
SPECT Liver W Tc-99m IV |
|
69229-3
|
SPECT Liver W Tc-99m SC IV |
|
43652-7
|
SPECT Liver and Spleen for blood flow |
|
39876-8
|
SPECT Liver and Spleen |
|
39681-2
|
SPECT Unspecified body region limited W Ga-67 IV |
|
39898-2
|
SPECT Lung ventilation |
|
39838-8
|
SPECT Lung ventilation and perfusion |
|
39740-6
|
SPECT Parathyroid gland |
|
41838-4
|
SPECT Prostate W In-111 Satumomab IV |
|
39743-0
|
SPECT Prostate W Tc-99m capromab pendatide IV |
|
43662-6
|
SPECT Renal vessels for blood flow W Tc-99m glucoheptonate IV |
|
69235-0
|
SPECT Scrotum and testicle for blood flow |
|
39628-3
|
SPECT Small bowel for Meckel's diverticulum |
|
43670-9
|
SPECT Spleen for blood flow |
|
69234-3
|
SPECT Spleen W Tc-99m tagged RBC IV |
|
43673-3
|
SPECT Thyroid gland for blood flow |
|
39755-4
|
SPECT Thyroid gland W I-131 IV |
|
39682-0
|
SPECT Unspecified body region W Ga-67 IV |
|
39881-8
|
SPECT Whole body Bone 3 phase |
|
39825-5
|
SPECT Whole body Bone marrow |
|
39816-4
|
SPECT Whole body Bone |
|
39748-9
|
SPECT Whole body for tumor W Tc-99m Sestamibi IV |
|
39675-4
|
SPECT Whole body for infection W Ga-67 IV |
|
39678-8
|
SPECT Whole body for tumor W Ga-67 IV |
|
69237-6
|
SPECT Whole body for tumor |
|
42292-3
|
SPECT Whole body for tumor W Tl-201 IV |
|
39680-4
|
SPECT Whole body W Ga-67 IV |
|
39839-6
|
SPECT Whole body W I-131 MIBG IV |
|
81560-5
|
SPECT Whole body W In-111 capromab pendetide IV |
|
39844-6
|
SPECT Whole body W In-111 Satumomab IV |
|
81547-2
|
SPECT Whole body W In-111 pentetreotide IV |
|
46297-8
|
SPECT Whole body |
|
41837-6
|
SPECT Whole body W Tc-99m Arcitumomab IV |
|
43526-3
|
SPECT Unspecified body region |
|
81548-0
|
SPECT Unspecified body region W tagged WBC IV |
|
89631-6
|
SPECT+CT Guidance for localization of tumor of Whole body |
|
81549-8
|
SPECT+CT Lymph node |
|
81550-6
|
SPECT+CT Parathyroid gland |
|
90312-0
|
SPECT+CT Skeletal system |
|
89842-9
|
SPECT+CT Whole body |
|
52059-3
|
Speech generating device attachment |
|
83984-5
|
Speech-language pathology Consult note |
|
78570-9
|
Speech-language pathology Counseling note |
|
78584-0
|
Speech-language pathology Discharge instructions |
|
68841-6
|
Speech-language pathology Discharge summary |
|
78592-3
|
Speech-language pathology Discharge teaching note |
|
78613-7
|
Speech-language pathology Education note |
|
78632-7
|
Speech-language pathology Flowsheet |
|
68843-2
|
Speech-language pathology History and physical note |
|
68846-5
|
Speech-language pathology Hospital Consult note |
|
68847-3
|
Speech-language pathology Hospital Letter |
|
18740-1
|
Speech-language pathology Initial evaluation note |
|
83985-2
|
Speech-language pathology Long term care facility Note |
|
28571-8
|
Speech-language pathology Note |
|
83988-6
|
Speech-language pathology Telephone encounter Note |
|
80782-6
|
Speech-language pathology Plan of care note |
|
68844-0
|
Speech-language pathology Preoperative evaluation and management note |
|
78654-1
|
Speech-language pathology procedure note |
|
11512-1
|
Speech-language pathology Progress note |
|
57165-3
|
Speech-language pathology Referral note |
|
83986-0
|
Speech-language pathology Risk assessment and screening note |
|
34845-8
|
Speech-language pathology+Audiology Consult note |
|
34846-6
|
Speech-language pathology+Audiology Note |
|
33002-7
|
Spelt IgE Ab [Units/volume] in Serum |
|
9780-8
|
Spermatozoa [#/volume] in Semen |
|
31630-7
|
Spermatozoa Ab [Presence] in Cervical mucus |
|
5360-3
|
Spermatozoa Ab [Units/volume] in Cervical mucus |
|
31631-5
|
Spermatozoa Ab [Presence] in Serum |
|
5362-9
|
Spermatozoa Ab [Units/volume] in Serum |
|
31632-3
|
Spermatozoa Ab [Presence] in Semen |
|
5361-1
|
Spermatozoa Ab [Units/volume] in Semen |
|
30559-9
|
Spermatozoa Ab [Units/volume] in Unspecified specimen |
|
33217-1
|
Spermatozoa Agglutinated [Presence] in Semen |
|
18400-2
|
Spermatozoa IgA Ab [Units/volume] in Cervical mucus |
|
47007-0
|
Spermatozoa IgA Ab/100 spermatozoa in Serum by Immunobead |
|
32625-6
|
Spermatozoa IgA Ab [Presence] in Serum |
|
9723-8
|
Spermatozoa IgA Ab [Units/volume] in Serum |
|
32718-9
|
Spermatozoa IgA Ab [Presence] in Semen |
|
18402-8
|
Spermatozoa IgA Ab [Units/volume] in Semen |
|
45061-9
|
Spermatozoa IgA and IgG and IgM panel - Serum |
|
18401-0
|
Spermatozoa IgG Ab [Units/volume] in Cervical mucus |
|
47006-2
|
Spermatozoa IgG Ab/100 spermatozoa in Serum by Immunobead |
|
32626-4
|
Spermatozoa IgG Ab [Presence] in Serum |
|
9724-6
|
Spermatozoa IgG Ab [Units/volume] in Serum |
|
32719-7
|
Spermatozoa IgG Ab [Presence] in Semen |
|
18403-6
|
Spermatozoa IgG Ab [Units/volume] in Semen |
|
34614-8
|
Spermatozoa IgM Ab [Units/volume] in Cervical mucus |
|
47005-4
|
Spermatozoa IgM Ab/100 spermatozoa in Serum by Immunobead |
|
33318-7
|
Spermatozoa IgM Ab [Presence] in Serum |
|
9725-3
|
Spermatozoa IgM Ab [Units/volume] in Serum |
|
32720-5
|
Spermatozoa IgM Ab [Presence] in Semen |
|
18404-4
|
Spermatozoa IgM Ab [Units/volume] in Semen |
|
44248-3
|
Spermatozoa Immotile [#/area] in Vaginal fluid |
|
48372-7
|
Spermatozoa Isolated Head/100 spermatozoa in Semen |
|
48812-2
|
Spermatozoa morphology panel |
|
42531-4
|
Spermatozoa Motile [#/volume] in Semen |
|
43155-1
|
Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post concentration |
|
43378-9
|
Spermatozoa Motile [#/volume] in Semen --post washing |
|
71387-5
|
Spermatozoa Motile [#] in Semen --post ejaculate |
|
13942-8
|
Spermatozoa Motile [Presence] in Semen by Light microscopy |
|
44247-5
|
Spermatozoa Motile [#/area] in Vaginal fluid by Wet preparation |
|
81141-4
|
Spermatozoa motility [Score] in Semen by Automated |
|
42676-7
|
Spermatozoa Normal Motile [#/volume] in Semen |
|
43154-4
|
Spermatozoa [Presence] in Semen by Light microscopy --post concentration |
|
35436-5
|
Spermatozoa [Presence] in Semen by Light microscopy --post reanastomosis |
|
51623-7
|
Spermatozoa [#/volume] in Semen --post vasectomy |
|
12256-4
|
Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy |
|
29990-9
|
Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy |
|
10601-3
|
Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |
|
10600-5
|
Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |
|
10599-9
|
Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |
|
9704-8
|
Spermatozoa [Morphology] in Semen |
|
8248-7
|
Spermatozoa [Presence] in Urine sediment by Light microscopy |
|
48373-5
|
Spermatozoa Angled Midpiece/100 spermatozoa in Semen |
|
48374-3
|
Spermatozoa Isolated Tail/100 spermatozoa in Semen |
|
48375-0
|
Spermatozoa Short Tail/100 spermatozoa in Semen |
|
53113-7
|
Spermatids/100 spermatozoa in Semen |
|
81876-5
|
SPG11 gene deletion+duplication and mutation analysis in Blood or Tissue by Molecular genetics method |
|
81877-3
|
SPG3A gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
38532-8
|
SPG3A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48069-9
|
Spherocytes.micro [Presence] in Blood by Light microscopy |
|
49575-4
|
Sphingomyelin/Surfactant.total in Amniotic fluid |
|
75953-0
|
Spike count Cerebral cortex Electroencephalogram (EEG) |
|
6856-9
|
Spinach IgE Ab [Units/volume] in Serum |
|
61317-4
|
Spinach IgE Ab/IgE total in Serum |
|
7711-5
|
Spinach IgG Ab [Units/volume] in Serum |
|
56391-6
|
Spinach IgG4 Ab [Mass/volume] in Serum |
|
60406-6
|
Spinach IgG Ab [Mass/volume] in Serum |
|
92910-9
|
Spinal surgery Consult note |
|
34497-8
|
SPINK1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41051-4
|
SPINK1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
10630-2
|
Spinnbarkeit [Length] in Cervical mucus |
|
6249-7
|
Spiny lobster IgE Ab [Units/volume] in Serum |
|
6250-5
|
Spiny Pigweed IgE Ab [Units/volume] in Serum |
|
56392-4
|
Spiny Pigweed IgG4 Ab [Mass/volume] in Serum |
|
56707-3
|
Spiramycin IgE Ab [Units/volume] in Serum |
|
5363-7
|
Spirillum minus Ab [Units/volume] in Serum |
|
18759-1
|
Spirometry study |
|
72950-9
|
Spironolactone induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72949-1
|
Spironolactone induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4035-2
|
Spironolactone [Mass/time] in 24 hour Urine |
|
73144-8
|
Spironolactone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73145-5
|
Spironolactone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14074-9
|
Spironolactone [Mass/volume] in Serum or Plasma |
|
12318-2
|
Spironolactone [Presence] in Urine |
|
4034-5
|
Spironolactone [Mass/volume] in Urine |
|
66118-1
|
Spleen Pathology biopsy report |
|
85758-1
|
Streptococcus pneumoniae Danish serotypes 12A+12F+44+46 DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85756-5
|
Streptococcus pneumoniae Danish serotypes 18A+18B+18C+18F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
85757-3
|
Streptococcus pneumoniae Danish serotypes 15A+15F DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
63174-7
|
Spondylocladium sp IgG Ab [Mass/volume] in Serum |
|
33700-6
|
Spore [Identifier] in Unspecified specimen by Malachite green stain |
|
78738-2
|
Sports medicine Consult note |
|
78703-6
|
Sports medicine Diagnostic study note |
|
78602-0
|
Sports medicine Education note |
|
78623-6
|
Sports medicine Flowsheet |
|
78704-4
|
Sports medicine Initial evaluation note |
|
89882-5
|
Sports medicine Outpatient Note |
|
80781-8
|
Sports medicine Plan of care note |
|
79267-1
|
Sports medicine procedure note |
|
78705-1
|
Sports medicine Progress note |
|
78700-2
|
Sports medicine Referral note |
|
89901-3
|
Sports medicine Telehealth Note |
|
6857-7
|
Spruce IgE Ab [Units/volume] in Serum |
|
61298-6
|
Spruce IgE Ab/IgE total in Serum |
|
79326-5
|
Squalene [Moles/volume] in Serum or Plasma |
|
7713-1
|
Squash IgE Ab [Units/volume] in Serum |
|
6858-5
|
Squid IgE Ab [Units/volume] in Serum |
|
61281-2
|
Squid IgE Ab/IgE total in Serum |
|
56240-5
|
Squid IgG4 Ab [Mass/volume] in Serum |
|
63121-8
|
Squid IgG Ab [Mass/volume] in Serum |
|
60475-1
|
Serotonin release 0.2 IU/mL heparin.low molecular weight [Units/volume] in Serum |
|
77728-4
|
Serotonin release 0.2 IU/mL heparin.unfractionated [Units/volume] in Serum |
|
74005-0
|
Serotonin release 0.5 IU/mL heparin.unfractionated [Units/volume] in Serum |
|
88459-3
|
Serotonin release 1.0 IU/mL heparin.low molecular weight [Units/volume] in Serum |
|
88460-1
|
Serotonin release 50 IU/mL heparin.low molecular weight [Units/volume] in Serum |
|
50738-4
|
Serotonin release.heparin.low molecular weight panel - Serum |
|
50737-6
|
Serotonin release.heparin.porcine panel - Serum |
|
50739-2
|
Serotonin release.heparin.porcine and low molecular weight panel - Serum |
|
50736-8
|
Serotonin release.heparin.unfractionated panel - Serum |
|
91980-3
|
Specific airway resistance by Plethysmograph body box |
|
33921-8
|
Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma |
|
53010-5
|
Signal Recognition Particle (SRP) Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
53031-1
|
Signal Recognition Particle (SRP) Ab [Units/volume] in Serum or Plasma |
|
53011-3
|
Signal Recognition Particle (SRP) Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
82936-6
|
Signal Recognition Particle (SRP) IgG Ab [Presence] in Serum by Line blot |
|
82257-7
|
SRY gene deletion in Blood or Tissue by FISH |
|
57310-5
|
SRY gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93810-0
|
SS18 gene rearrangements in Tissue by FISH |
|
34523-1
|
Succinate semialdehyde dehydrogenase [Enzymatic activity/mass] in Leukocytes |
|
94020-5
|
Somatic symptom disorder screening report |
|
66484-7
|
DNA single strand Ab [Units/volume] in Serum by Immunoassay |
|
5132-6
|
DNA single strand Ab [Units/volume] in Serum |
|
42201-4
|
DNA single strand IgG Ab [Units/volume] in Serum by Immunoassay |
|
10360-6
|
DNA single strand IgG Ab [Units/volume] in Serum |
|
10361-4
|
DNA single strand IgM Ab [Units/volume] in Serum |
|
26649-4
|
Snowshoe hare virus Ab [Presence] in Serum |
|
74827-7
|
Snowshoe hare virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
74828-5
|
Snowshoe hare virus Ab [Presence] in Serum by Neutralization test |
|
42952-2
|
Snowshoe hare virus Ab [Titer] in Serum |
|
40511-8
|
Snowshoe hare virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
40510-0
|
Snowshoe hare virus Ab [Titer] in Serum by Immunofluorescence |
|
53385-1
|
Snowshoe hare virus Ab [Presence] in Unspecified specimen |
|
50038-9
|
Snowshoe hare virus Ab [Presence] in Unspecified specimen by Neutralization test |
|
57853-4
|
Snowshoe hare virus IgG Ab [Presence] in Serum by Immunoassay |
|
74829-3
|
Snowshoe hare virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
55379-2
|
Snowshoe hare virus IgM Ab [Presence] in Serum by Immunoassay |
|
74846-7
|
Snowshoe hare virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
42953-0
|
Snowshoe hare virus IgM Ab [Titer] in Serum |
|
40509-2
|
Snowshoe hare virus IgM Ab [Titer] in Serum by Neutralization test |
|
60962-8
|
ST amplitude.derived lead V1 |
|
60963-6
|
ST amplitude.derived lead V2 |
|
60964-4
|
ST amplitude.derived lead V3 |
|
60965-1
|
ST amplitude.derived lead V4 |
|
60966-9
|
ST amplitude.derived lead V5 |
|
60967-7
|
ST amplitude.derived lead V6 |
|
60960-2
|
ST amplitude.lead AI |
|
60961-0
|
ST amplitude.lead AS |
|
76056-1
|
ST amplitude.lead aVF |
|
76057-9
|
ST amplitude.lead aVL |
|
76058-7
|
ST amplitude.lead aVR |
|
60968-5
|
ST amplitude.lead ES |
|
76053-8
|
ST amplitude.lead I |
|
76054-6
|
ST amplitude.lead II |
|
76055-3
|
ST amplitude.lead III |
|
60969-3
|
ST amplitude.lead MCL |
|
60970-1
|
ST amplitude.lead MCL1 |
|
60971-9
|
ST amplitude.lead MCL6 |
|
76047-0
|
ST amplitude.lead V1 |
|
76048-8
|
ST amplitude.lead V2 |
|
76049-6
|
ST amplitude.lead V3 |
|
76050-4
|
ST amplitude.lead V4 |
|
76051-2
|
ST amplitude.lead V5 |
|
76052-0
|
ST amplitude.lead V6 |
|
91546-2
|
ST deviation (Maximum value during study) by EKG |
|
82754-3
|
State of travel |
|
67569-4
|
Streptococcus pyogenes M protein emm gene [Type] in Isolate by Sequencing |
|
63426-1
|
Bacterial heat-stable enterotoxin ST gene [Presence] in Unspecified specimen by NAA with probe detection |
|
16921-9
|
St. Augustine grass IgE Ab [Units/volume] in Serum |
|
90239-5
|
ST2.soluble [Mass/volume] in Serum by Immunoassay |
|
46036-0
|
Stability of conditions Set |
|
82284-1
|
Standard RMR |
|
52060-1
|
Standers/standing frame attachment |
|
83142-0
|
Standing Balance Test [NIH Toolbox] |
|
4038-6
|
Stanozolol [Mass/time] in 24 hour Urine |
|
4036-0
|
Stanozolol [Presence] in Urine |
|
4037-8
|
Stanozolol [Mass/volume] in Urine |
|
88272-0
|
Staphylococcus sp tuf gene [Presence] by Probe in Positive blood culture |
|
20968-4
|
Staphylococcus sp identified in Cheese by Organism specific culture |
|
90076-1
|
Staphylococcus sp identified in Isolate by Organism specific culture |
|
20967-6
|
Staphylococcus sp identified in Milk by Organism specific culture |
|
20966-8
|
Staphylococcus sp identified in Unspecified specimen by Organism specific culture |
|
48417-0
|
Staphylolysin Ab [Units/volume] in Body fluid |
|
5366-0
|
Staphylolysin Ab [Units/volume] in Serum |
|
48418-8
|
Staphylolysin Ab [Titer] in Serum |
|
2967-8
|
Starch granules [Presence] in Stool by Light microscopy |
|
59386-3
|
Starch [Mass/mass] in Stool by Infrared spectroscopy |
|
10924-9
|
Starfruit IgE Ab [Units/volume] in Serum |
|
91352-5
|
STarT Back Screening risk level |
|
91349-1
|
STarT Back Screening Tool panel |
|
75954-8
|
State entropy [Score] Cerebral cortex Electroencephalogram (EEG) |
|
46499-0
|
State of residence |
|
45398-5
|
State provider number for Facility |
|
29124-5
|
Stavudine [Units/volume] in Serum or Plasma |
|
49227-2
|
Stavudine [Mass/volume] in Serum or Plasma |
|
54335-5
|
Stearoylcarnitine (C18) [Moles/volume] in Amniotic fluid |
|
54334-8
|
Stearoylcarnitine (C18) [Moles/volume] in Cerebral spinal fluid |
|
53241-6
|
Stearoylcarnitine (C18) [Moles/volume] in DBS |
|
69775-5
|
Stearoylcarnitine (C18) [Moles/volume] in Urine |
|
54333-0
|
Stearoylcarnitine (C18)/Creatinine [Molar ratio] in Urine |
|
31029-2
|
Stenbolone [Mass/volume] in Urine |
|
2969-4
|
Stercobilin [Presence] in Stool |
|
52029-6
|
Sterilization consent Document |
|
73885-6
|
Steroid fractions panel - 24 hour Urine |
|
79221-8
|
Steroid fractions panel - Serum or Plasma |
|
73886-4
|
Steroid fractions panel - Urine |
|
79220-0
|
Steroid fractions interpretation in Serum or Plasma Narrative |
|
75858-1
|
Sterols panel [Mass/volume] - Serum or Plasma |
|
74888-9
|
Sterols panel [Moles/volume] - Serum or Plasma |
|
74807-9
|
Transferrin receptor.soluble/log Ferritin index [Mass Ratio] in Serum or Plasma |
|
30248-9
|
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma |
|
33210-6
|
Transferrin receptor.soluble [Moles/volume] in Serum or Plasma |
|
91134-7
|
Sexually transmitted pathogens panel - Unspecified specimen by NAA with probe detection |
|
74887-1
|
Stigmastanol [Moles/volume] in Serum or Plasma |
|
74886-3
|
Stigmasterol [Moles/volume] in Serum or Plasma |
|
17611-5
|
Stimulants [Identifier] in Serum or Plasma |
|
12553-4
|
Stimulants [Identifier] in Urine |
|
59339-2
|
Stiripentol [Mass/volume] in Blood |
|
59340-0
|
Stiripentol [Mass/volume] in Serum or Plasma |
|
59341-8
|
Stiripentol [Mass/volume] in Urine |
|
53795-1
|
STK11 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
8026-7
|
Stain method [Type] in Unspecified specimen |
|
66114-0
|
Stomach Pathology biopsy report |
|
49255-3
|
Calculus analysis [Interpretation] in Stone Narrative by Infrared spectroscopy |
|
74446-6
|
Stone analysis panel |
|
56161-3
|
Calculus analysis with calculus photography [Interpretation] in Stone |
|
48265-3
|
Dust Allergen Mix B (Acarus siro+Lepidoglyphus destructor+Tyrophagus putrescentiae+Glycyphagus domesticus) triggered leukotriene release [Mass/volume] by Leukocytes |
|
5227-4
|
Streptococcal hyaluronidase Ab [Presence] in Serum |
|
9716-2
|
Streptococcal hyaluronidase Ab [Titer] in Serum |
|
7722-2
|
Strawberry triggered histamine release [Units/volume] in Blood |
|
6257-0
|
Strawberry IgE Ab [Units/volume] in Serum |
|
61266-3
|
Strawberry IgE Ab/IgE total in Serum |
|
7721-4
|
Strawberry IgG Ab [Units/volume] in Serum |
|
56393-2
|
Strawberry IgG4 Ab [Mass/volume] in Serum |
|
40835-1
|
Strawberry IgG Ab [Mass/volume] in Serum |
|
5133-4
|
Streptococcal DNAse B [Units/volume] in Serum |
|
14207-5
|
Streptococcal DNAse B [Titer] in Serum |
|
58713-9
|
Streptococcal DNAse B and ASO antibodies panel - Serum |
|
77741-7
|
Streptavidin [Presence] in Serum or Plasma by Immunoblot |
|
6819-7
|
Streptococcus sp Ab [Presence] in Serum |
|
6820-5
|
Streptococcus sp Ab [Titer] in Serum |
|
85766-4
|
Streptococcus sp DNA [Presence] by NAA with non-probe detection in Positive blood culture |
|
70015-3
|
Streptococcus sp DNA [Presence] in Blood by NAA with probe detection |
|
43390-4
|
Streptococcus sp identified in Isolate |
|
43389-6
|
Streptococcus sp identified in Isolate by Organism specific culture |
|
49016-9
|
Streptococcus sp exoenzyme Ab [Units/volume] in Serum |
|
88277-9
|
Streptococcus sp tuf gene [Presence] by Probe in Positive blood culture |
|
38353-9
|
Streptococcus sp identified in Unspecified specimen by Organism specific culture |
|
5369-4
|
Streptokinase Ab [Units/volume] in Serum |
|
34375-6
|
Streptokinase Ab [Titer] in Serum |
|
4681-3
|
Streptokinase [Enzymatic activity/volume] in Plasma |
|
4682-1
|
Streptokinase [Titer] in Serum |
|
2970-2
|
Streptomyces proteinase [Presence] in Serum |
|
48177-0
|
Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
4039-4
|
Streptomycin [Mass/volume] in Serum or Plasma |
|
59282-4
|
Stress cardiac echo study report |
|
13931-1
|
Striated muscle Ab [Presence] in Serum |
|
31659-6
|
Striated muscle Ab [Units/volume] in Serum |
|
8097-8
|
Striated muscle Ab [Titer] in Serum |
|
5372-8
|
Striated muscle Ab [Titer] in Serum by Immunofluorescence |
|
49692-7
|
Striated muscle IgG Ab [Presence] in Serum by Immunofluorescence |
|
31660-4
|
Striated muscle IgG Ab [Units/volume] in Serum |
|
42217-0
|
Striated muscle IgG Ab [Titer] in Serum |
|
29998-2
|
Striated muscle IgG Ab [Titer] in Serum by Immunofluorescence |
|
5373-6
|
Strongyloides sp Ab [Units/volume] in Serum by Hemagglutination |
|
10718-5
|
Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |
|
8034-1
|
Strongyloides sp Ab [Units/volume] in Serum |
|
34376-4
|
Strongyloides sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
80660-4
|
Strongyloides sp IgG Ab [Presence] in Serum by Immunoassay |
|
41125-6
|
Strongyloides sp IgG Ab [Units/volume] in Serum |
|
87995-7
|
Strongyloides sp identified in Stool by Organism specific culture |
|
29971-9
|
Strontium [Mass/volume] in 24 hour Urine |
|
29972-7
|
Strontium [Mass/time] in 24 hour Urine |
|
50915-8
|
Strontium [Moles/time] in 24 hour Urine |
|
60172-4
|
Strontium [Mass/volume] in Blood |
|
51206-1
|
Strontium [Mass/volume] in Body fluid |
|
76647-7
|
Strontium [Mass/mass] in Hair |
|
50913-3
|
Strontium [Moles/mass] in Hair |
|
60173-2
|
Strontium [Mass/volume] in Red Blood Cells |
|
5736-4
|
Strontium [Mass/volume] in Serum or Plasma |
|
60174-0
|
Strontium [Mass/mass] in Tissue |
|
14100-2
|
Strontium [Presence] in Urine |
|
12705-0
|
Strontium [Mass/volume] in Urine |
|
50914-1
|
Strontium [Moles/volume] in Urine |
|
29973-5
|
Strontium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52921-4
|
Strontium/Creatinine [Molar ratio] in 24 hour Urine |
|
17658-6
|
Strontium/Creatinine [Mass Ratio] in Urine |
|
52922-2
|
Strontium/Creatinine [Molar ratio] in Urine |
|
81297-4
|
Structural variant panel |
|
5741-4
|
Strychnine [Mass/time] in 24 hour Urine |
|
14102-8
|
Strychnine [Mass/volume] in Blood |
|
20969-2
|
Strychnine [Presence] in Gastric fluid |
|
14101-0
|
Strychnine [Mass/volume] in Gastric fluid |
|
59970-4
|
Strychnine [Moles/volume] in Gastric fluid |
|
5737-2
|
Strychnine [Presence] in Serum or Plasma |
|
17659-4
|
Strychnine [Units/volume] in Serum or Plasma |
|
5738-0
|
Strychnine [Mass/volume] in Serum or Plasma |
|
59968-8
|
Strychnine [Moles/volume] in Serum or Plasma |
|
20972-6
|
Strychnine [Mass/mass] in Tissue |
|
5739-8
|
Strychnine [Presence] in Urine |
|
17660-2
|
Strychnine [Units/volume] in Urine |
|
5740-6
|
Strychnine [Mass/volume] in Urine |
|
59969-6
|
Strychnine [Moles/volume] in Urine |
|
20970-0
|
Strychnine [Presence] in Unspecified specimen |
|
23780-0
|
Strychnine [Mass/volume] in Unspecified specimen |
|
57872-4
|
Strychnine [Moles/volume] in Unspecified specimen |
|
21620-0
|
STS gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
86371-2
|
Study Interpretation of outside study |
|
29756-4
|
Peritoneoscopy study |
|
38269-7
|
Study report Skeletal system DXA |
|
38618-5
|
Styrene [Mass/volume] in Air |
|
8243-8
|
Styrene [Mass/volume] in Blood |
|
54940-2
|
Styrene [Mass/volume] in Serum or Plasma |
|
29897-6
|
Styrene [Mass/volume] in Urine |
|
38725-8
|
Styrene-7,8-Oxide [Mass/volume] in Air |
|
75073-7
|
Suberate [Moles/volume] in Serum or Plasma |
|
26831-8
|
Suberate [Presence] in Urine |
|
49960-8
|
Suberate.unsaturated/Creatinine [Molar ratio] in Urine |
|
44408-3
|
Suberate/Creatinine [Molar ratio] in 24 hour Urine |
|
13810-7
|
Suberate/Creatinine [Mass Ratio] in Urine |
|
25135-5
|
Suberate/Creatinine [Molar ratio] in Urine |
|
69778-9
|
Suberylcarnitine (C8-DC) [Moles/volume] in Amniotic fluid |
|
69777-1
|
Suberylcarnitine (C8-DC) [Moles/volume] in Cerebral spinal fluid |
|
53210-1
|
Suberylcarnitine (C8-DC) [Moles/volume] in DBS |
|
74591-9
|
Suberylcarnitine (C8-DC) [Enzymatic activity/mass] in Fibroblast |
|
69779-7
|
Suberylcarnitine (C8-DC) [Moles/volume] in Urine |
|
69776-3
|
Suberylcarnitine (C8-DC)/Creatinine [Molar ratio] in Urine |
|
79511-2
|
Suberylglycine [Moles/volume] in Serum or Plasma |
|
79895-9
|
Subjective refraction measurements panel |
|
52038-7
|
Subscriber Information including retroactive and presumptive eligibility |
|
89562-3
|
Substance abuse symptoms score [CUBS] |
|
34630-4
|
Substance P [Mass/volume] in Cerebral spinal fluid |
|
2971-0
|
Substance P [Mass/volume] in Serum or Plasma |
|
58454-0
|
Subtelomere analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81878-1
|
Subtelomere analysis in Blood or Tissue by Molecular genetics method |
|
49039-1
|
Subtelomere analysis [Identifier] in Blood or Tissue by FISH Nominal |
|
82258-5
|
Subtelomere analysis in Bone marrow by FISH |
|
72653-9
|
Subtelomere analysis.short arm [Interpretation] in Blood or Tissue by FISH Narrative |
|
72652-1
|
Subtelomere analysis.long arm [Interpretation] in Blood or Tissue by FISH Narrative |
|
74588-5
|
Succinate cytochrome C reductase [Enzymatic activity/mass] in Fibroblast |
|
35498-5
|
Succinate cytochrome C reductase [Enzymatic activity/mass] in Tissue |
|
74587-7
|
Succinate cytochrome C reductase/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
35494-4
|
Succinate dehydrogenase [Enzymatic activity/mass] in Tissue |
|
74589-3
|
Succinate dehydrogenase/Citrate synthase [Enzymatic activity ratio] in Tissue |
|
35871-3
|
Succinate [Moles/volume] in Serum or Plasma |
|
26798-9
|
Succinate [Presence] in Urine |
|
2972-8
|
Succinate [Mass/volume] in Urine |
|
44409-1
|
Succinate/Creatinine [Molar ratio] in 24 hour Urine |
|
13812-3
|
Succinate/Creatinine [Mass Ratio] in Urine |
|
25136-3
|
Succinate/Creatinine [Molar ratio] in Urine |
|
38912-2
|
Succinylacetone [Moles/volume] in Amniotic fluid |
|
53231-7
|
Succinylacetone [Moles/volume] in DBS |
|
74301-3
|
Succinylacetone [Moles/volume] in DBS --post therapeutic diet |
|
74957-2
|
Succinylacetone [Moles/volume] in Plasma |
|
75079-4
|
Succinylacetone [Moles/volume] in Serum or Plasma |
|
42677-5
|
Succinylacetone [Molar amount] in DBS |
|
42682-5
|
Succinyladenosine [Moles/volume] in Cerebral spinal fluid |
|
75145-3
|
Succinyladenosine [Moles/volume] in Serum or Plasma |
|
11201-1
|
Succinylcholine IgE Ab [Units/volume] in Serum |
|
48193-7
|
Succinylcholine triggered leukotriene release [Mass/volume] by Leukocytes |
|
17661-0
|
Succinylcholine [Mass/volume] in Serum or Plasma |
|
12429-7
|
Succinylcholine [Mass/volume] in Urine |
|
17662-8
|
Succinylpurines [Presence] in Urine |
|
73143-0
|
Sucralfate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73142-2
|
Sucralfate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
14178-8
|
Sucrase [Enzymatic activity/mass] in Tissue |
|
30372-7
|
Sucrase [Enzymatic activity/mass] in Small intestine Tissue |
|
13534-3
|
Sucrose hemolysis [Presence] of Blood |
|
40433-5
|
Sucrose hemolysis of Red Blood Cells from Control |
|
12260-6
|
Sucrose hemolysis [Presence] of Red Blood Cells |
|
76134-6
|
Sucrose [Moles/time] in 5 hour Urine --post XXX g sugar solution PO |
|
40672-8
|
Sucrose [Presence] in Stool |
|
51612-0
|
Sucrose [Presence] in Urine |
|
50916-6
|
Sucrose [Moles/volume] in Urine |
|
2974-4
|
Sucrose [Mass/volume] in Unspecified specimen |
|
74443-3
|
Sucrose/Creatinine [Molar ratio] in 5 hour Urine --post XXX g sugar solution PO |
|
76132-0
|
Sucrose/Creatinine [Molar ratio] in Urine |
|
88107-8
|
Suctioning frequency |
|
94021-3
|
Substance use disorder screening report |
|
11019-7
|
Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain |
|
32815-3
|
Microscopic observation [Identifier] in Unspecified specimen by Sudan black B stain |
|
10763-1
|
Microscopic observation [Identifier] in Body fluid by Sudan black stain |
|
10813-4
|
Microscopic observation [Identifier] in Tissue by Sudan black stain |
|
7376-7
|
Sudan grass IgE Ab [Units/volume] in Serum |
|
9395-5
|
SUFentanil [Mass/volume] in Serum or Plasma |
|
18435-8
|
SUFentanil [Presence] in Urine |
|
9396-3
|
SUFentanil [Mass/volume] in Urine |
|
86610-3
|
SUFentanil/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
76133-8
|
Sugar absorption test panel [Molar ratio] - 5 hour Urine |
|
7147-2
|
Sugar Beet IgE Ab [Units/volume] in Serum |
|
24165-3
|
Sugar Beet Seed (Beta vulgaris seed) IgE Ab [Units/volume] in Serum |
|
7723-0
|
Sugar Cane IgE Ab [Units/volume] in Serum |
|
7724-8
|
Sugar Cane IgG Ab [Units/volume] in Serum |
|
56394-0
|
Sugar Cane IgG4 Ab [Mass/volume] in Serum |
|
35531-3
|
Sugar Cane IgG Ab [Mass/volume] in Serum |
|
74447-4
|
Sugars and polyols panel [Molar ratio] - Urine |
|
77050-3
|
SUGCT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77049-5
|
SUGCT gene full mutation analysis in Blood or Tissue by Sequencing |
|
87626-8
|
Suicide prevention note |
|
89560-7
|
Suicide risk score [CUBS] |
|
87804-1
|
Sulfachloropyridazine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87802-5
|
Sulfachloropyridazine [Susceptibility] |
|
59742-7
|
sulfADIAZINE [Mass/volume] in Blood |
|
17663-6
|
sulfADIAZINE IgE Ab [Units/volume] in Serum |
|
6907-0
|
sulfADIAZINE [Mass/volume] in Serum or Plasma |
|
27216-1
|
sulfADIAZINE [Mass/volume] in Urine |
|
87799-3
|
Sulfadimethoxine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87803-3
|
Sulfadimethoxine [Susceptibility] |
|
17664-4
|
Sulfalazine IgE Ab [Units/volume] in Serum |
|
17665-1
|
Sulfamedraxozole IgE Ab [Units/volume] in Serum |
|
87592-2
|
Sulfamethazine [Mass/mass] in Unspecified specimen |
|
60175-7
|
Sulfamethizole [Mass/volume] in Blood |
|
60176-5
|
Sulfamethizole [Mass/volume] in Serum or Plasma |
|
60177-3
|
Sulfamethizole [Mass/volume] in Urine |
|
72948-3
|
Sulfamethoxazole induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72947-5
|
Sulfamethoxazole induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80549-9
|
Sulfamethoxazole [Mass/volume] in DBS |
|
80974-9
|
Sulfamethoxazole free [Mass/volume] in Serum or Plasma |
|
59972-0
|
Sulfamethoxazole [Moles/volume] in Gastric fluid |
|
40694-2
|
Sulfamethoxazole IgE Ab [Presence] in Serum |
|
50031-4
|
Sulfamethoxazole IgE Ab [Units/volume] in Serum |
|
73140-6
|
Sulfamethoxazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73141-4
|
Sulfamethoxazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48281-0
|
Sulfamethoxazole triggered leukotriene release [Mass/volume] by Leukocytes |
|
10342-4
|
Sulfamethoxazole [Mass/volume] in Serum or Plasma |
|
39772-9
|
Sulfamethoxazole [Moles/volume] in Serum or Plasma |
|
72674-5
|
Sulfamethoxazole [Mass/volume] in Serum or Plasma --trough |
|
59971-2
|
Sulfamethoxazole [Moles/volume] in Urine |
|
25271-8
|
Sulfamethoxazole [Mass/volume] in Unspecified specimen |
|
60333-2
|
Sulfamethoxazole [Moles/volume] in Unspecified specimen |
|
14075-6
|
Sulfapyridine [Mass/volume] in Serum or Plasma |
|
55580-5
|
Sulfapyridine [Moles/volume] in Serum or Plasma |
|
73139-8
|
sulfaSALAzine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73138-0
|
sulfaSALAzine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
12390-1
|
sulfaSALAzine [Mass/volume] in Serum or Plasma |
|
55581-3
|
sulfaSALAzine [Moles/volume] in Serum or Plasma |
|
43754-1
|
Sulfate [Mass/volume] in Urine collected for unspecified duration |
|
12920-5
|
Sulfate [Mass/volume] in 24 hour Urine |
|
39576-4
|
Sulfate [Mass/time] in 24 hour Urine |
|
26888-8
|
Sulfate [Moles/volume] in 24 hour Urine |
|
26889-6
|
Sulfate [Moles/time] in 24 hour Urine |
|
17666-9
|
Sulfate [Mass/volume] in Dialysis fluid |
|
20973-4
|
Sulfate [Mass/volume] in Gastric fluid |
|
20974-2
|
Sulfate [Mass/volume] in Serum or Plasma |
|
2975-1
|
Sulfate [Mass/volume] in Urine |
|
47780-2
|
Sulfate [Moles/volume] in Urine |
|
87615-1
|
Sulfate [Mass/mass] in Unspecified specimen |
|
87796-9
|
Sulfathiazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87797-7
|
Sulfathiazole [Susceptibility] |
|
87591-4
|
Sulfathiazole [Mass/mass] in Unspecified specimen |
|
34689-0
|
Sulfatidase [Enzymatic activity/volume] in Leukocytes |
|
31667-9
|
Sulfatide Ab [Presence] in Serum |
|
82445-8
|
Sulfatide Ab [Presence] in Serum by Line blot |
|
31668-7
|
Sulfatide Ab [Units/volume] in Serum |
|
17669-3
|
Sulfatide IgG Ab [Units/volume] in Serum by Immunoassay |
|
17668-5
|
Sulfatide IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
31670-3
|
Sulfatide IgG Ab [Presence] in Serum |
|
27894-5
|
Sulfatide IgG Ab [Presence] in Serum by Immunoassay |
|
89500-3
|
Sulfatide IgG Ab [Presence] in Serum by Line blot |
|
31669-5
|
Sulfatide IgG Ab [Units/volume] in Serum |
|
21545-9
|
Sulfatide IgG Ab [Titer] in Cerebral spinal fluid |
|
10866-2
|
Sulfatide IgG Ab [Titer] in Serum |
|
42218-8
|
Sulfatide IgG and IgM panel - Serum |
|
17671-9
|
Sulfatide IgM Ab [Units/volume] in Serum by Immunoassay |
|
17670-1
|
Sulfatide IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
44753-2
|
Sulfatide IgM Ab [Presence] in Serum |
|
82447-4
|
Sulfatide IgM Ab [Presence] in Serum by Line blot |
|
31671-1
|
Sulfatide IgM Ab [Units/volume] in Serum |
|
21546-7
|
Sulfatide IgM Ab [Titer] in Cerebral spinal fluid |
|
10867-0
|
Sulfatide IgM Ab [Titer] in Serum |
|
34646-0
|
Sulfatides [Presence] in Urine |
|
58682-6
|
Sulfatides [Mass/volume] in Urine |
|
9350-0
|
Sulfhydryls [Presence] in Urine |
|
9646-1
|
Sulfide [Mass/volume] in Blood |
|
17672-7
|
Sulfide [Mass/volume] in Urine |
|
17673-5
|
Sulfisoxazole IgE Ab [Units/volume] in Serum |
|
73137-2
|
Sulfisoxazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73136-4
|
Sulfisoxazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
9701-4
|
Sulfisoxazole [Mass/volume] in Serum or Plasma |
|
2977-7
|
Sulfite oxidase [Enzymatic activity/volume] in Plasma |
|
58457-3
|
Sulfites [Presence] in Urine by Test strip |
|
47781-0
|
Sulfocysteine [Moles/volume] in Amniotic fluid |
|
54336-3
|
Sulfocysteine [Moles/volume] in Cerebral spinal fluid |
|
54337-1
|
Sulfocysteine [Moles/volume] in DBS |
|
4041-0
|
Sulfonamide [Presence] in Serum or Blood |
|
17674-3
|
Sulfonamide [Units/volume] in Serum or Plasma |
|
4040-2
|
Sulfonamide [Mass/volume] in Serum or Plasma |
|
75650-2
|
Sulfonamide [Moles/volume] in Serum or Plasma |
|
17675-0
|
Sulfonamide [Units/volume] in Urine |
|
4042-8
|
Sulfonamide [Mass/volume] in Urine |
|
15374-2
|
Sulfonylurea [Presence] in Serum or Plasma |
|
18255-0
|
Sulfonylurea [Mass/volume] in Serum or Plasma |
|
47391-8
|
Sulfonylurea [Presence] in Urine |
|
18256-8
|
Sulfonylurea [Mass/volume] in Urine |
|
15368-4
|
Hypoglycemics.sulfonyluric [Identifier] in Serum or Plasma |
|
34633-8
|
Hypoglycemics.sulfonyluric [Identifier] in Urine |
|
35116-3
|
Sulforidazine [Mass/volume] in Serum or Plasma |
|
73135-6
|
Sulindac induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73134-9
|
Sulindac induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
17676-8
|
Sulindac sulfide metabolite [Mass/volume] in Serum or Plasma |
|
12417-2
|
Sulindac [Mass/volume] in Serum or Plasma |
|
57315-4
|
Sulphonamide IgE Ab [Units/volume] in Serum |
|
35117-1
|
Sulpiride [Mass/volume] in Serum or Plasma |
|
74915-0
|
Sulpiride [Mass/volume] in Serum or Plasma --trough |
|
33961-4
|
Sulthiame [Mass/volume] in Serum or Plasma |
|
34377-2
|
Sulthiame [Moles/volume] in Serum or Plasma |
|
59743-5
|
SUMAtriptan [Mass/volume] in Blood |
|
28076-8
|
SUMAtriptan [Mass/volume] in Serum or Plasma |
|
59744-3
|
SUMAtriptan [Mass/volume] in Urine |
|
89997-1
|
SUMF1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
46612-8
|
Summary conclusions Set |
|
68608-9
|
Summary note |
|
47046-8
|
Summary of death note |
|
34133-9
|
Summary of episode note |
|
75219-6
|
Summary registry report |
|
7714-9
|
Summer Squash IgE Ab [Units/volume] in Serum |
|
7715-6
|
Summer Squash IgG Ab [Units/volume] in Serum |
|
7726-3
|
Sunflower Pollen IgE Ab [Units/volume] in Serum |
|
63195-2
|
Sunflower Pollen IgG Ab [Mass/volume] in Serum |
|
7727-1
|
Sunflower Seed triggered histamine release [Units/volume] in Blood |
|
6258-8
|
Sunflower Seed IgE Ab [Units/volume] in Serum |
|
61272-1
|
Sunflower Seed IgE Ab/IgE total in Serum |
|
56395-7
|
Sunflower Seed IgG4 Ab [Mass/volume] in Serum |
|
60407-4
|
Sunflower Seed IgG Ab [Mass/volume] in Serum |
|
48192-9
|
Sunset yellow FCF triggered leukotriene release [Mass/volume] by Leukocytes |
|
81232-1
|
Supersaturation panel - 24 hour Urine |
|
47047-6
|
Supervisory note |
|
91909-2
|
Expiration date of Supply |
|
52061-9
|
Support surface attachment |
|
43750-9
|
SURF1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
30562-3
|
Surfactant/Albumin [Mass Ratio] in Amniotic fluid |
|
83670-0
|
Surgery Attending Admission evaluation note |
|
68480-3
|
Surgery Attending Hospital Progress note |
|
83671-8
|
Surgery Attending Intensive care unit Admission evaluation note |
|
83672-6
|
Surgery Attending Intensive care unit Note |
|
34773-2
|
Surgery Attending Note |
|
83674-2
|
Surgery Attending Outpatient Note |
|
83673-4
|
Surgery Attending Surgical operation note |
|
83675-9
|
Surgery Attending Postoperative evaluation and management note |
|
85948-8
|
Surgery Attending Preoperative evaluation and management note |
|
83843-3
|
Surgery Case manager Note |
|
83842-5
|
Surgery Interdisciplinary Note |
|
83792-2
|
Surgery Intern Admission evaluation note |
|
64066-4
|
Surgery Medical student Hospital Admission evaluation note |
|
64068-0
|
Surgery Medical student Hospital Consult note |
|
64067-2
|
Surgery Medical student Hospital Progress note |
|
83562-9
|
Surgery Nurse practitioner Note |
|
80799-0
|
Surgical oncology Admission history and physical note |
|
80800-6
|
Surgical oncology Checklist |
|
80801-4
|
Surgical oncology Consult note |
|
80802-2
|
Surgical oncology Education note |
|
80803-0
|
Surgical oncology Flowsheet |
|
82839-2
|
Surgical oncology Initial evaluation note |
|
80807-1
|
Surgical oncology Surgical operation note |
|
80804-8
|
Surgical oncology Plan of care note |
|
80805-5
|
Surgical oncology Preoperative evaluation and management note |
|
80806-3
|
Surgical oncology Referral note |
|
80808-9
|
Surgical oncology Transfer summary note |
|
83778-1
|
Surgery Resident Admission evaluation note |
|
83779-9
|
Surgery Resident Note |
|
34873-0
|
Surgery Admission evaluation note |
|
78247-4
|
Surgery Admission history and physical note |
|
78503-0
|
Surgery Checklist |
|
34847-4
|
Surgery Consult note |
|
85898-5
|
Surgery Diagnostic study note |
|
84017-3
|
Surgery Discharge summary |
|
78280-5
|
Surgery Education note |
|
78292-0
|
Surgery Flowsheet |
|
34774-0
|
Surgery History and physical note |
|
68606-3
|
Surgery Hospital Postoperative evaluation and management note |
|
64057-3
|
Surgery Hospital Progress note |
|
84012-4
|
Surgery Intensive care unit Admission evaluation note |
|
84013-2
|
Surgery Intensive care unit Discharge summary |
|
84014-0
|
Surgery Intensive care unit Note |
|
84015-7
|
Surgery Intensive care unit procedure note |
|
84016-5
|
Surgery Intensive care unit Transfer summary note |
|
34848-2
|
Surgery Note |
|
83612-2
|
Surgery Nurse Hospital Note |
|
83613-0
|
Surgery Nurse Note |
|
83615-5
|
Surgery Nurse Outpatient Note |
|
85947-0
|
Surgery Nurse Outpatient Preoperative evaluation and management note |
|
83616-3
|
Surgery Nurse Outpatient procedure note |
|
83614-8
|
Surgery Nurse Surgical operation note |
|
34880-5
|
Surgery Nurse Postoperative evaluation and management note |
|
34881-3
|
Surgery Nurse Preoperative evaluation and management note |
|
83617-1
|
Surgery Nurse procedure note |
|
84018-1
|
Surgery Outpatient Discharge summary |
|
84019-9
|
Surgery Outpatient History and physical note |
|
75493-7
|
Surgery Outpatient Note |
|
84020-7
|
Surgery Outpatient Surgical operation note |
|
85945-4
|
Surgery Outpatient Postoperative evaluation and management note |
|
85946-2
|
Surgery Outpatient Preoperative evaluation and management note |
|
84021-5
|
Surgery Outpatient procedure note |
|
34874-8
|
Surgery Surgical operation note |
|
88652-3
|
Surgery Parenteral therapy note |
|
84022-3
|
Surgery Telephone encounter Note |
|
80753-7
|
Surgery Plan of care note |
|
34875-5
|
Surgery Postoperative evaluation and management note |
|
34876-3
|
Surgery Preoperative evaluation and management note |
|
78322-5
|
Surgery procedure note |
|
57166-1
|
Surgery Referral note |
|
78729-1
|
Surgery Transfer summary note |
|
78446-2
|
Surgical critical care Flowsheet |
|
80790-9
|
Surgical critical care Plan of care note |
|
11529-5
|
Surgical pathology study |
|
90745-1
|
Surgical procedures requiring active SNF care [CMS Assessment] |
|
17413-6
|
Papova virus SV 40 Ab [Units/volume] in Serum |
|
49418-7
|
Papova virus SV 40 DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
49422-9
|
Papova virus SV 40 DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
49421-1
|
Papova virus SV 40 DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49420-3
|
Papova virus SV 40 DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
49424-5
|
Papova virus SV 40 DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49426-0
|
Papova virus SV 40 DNA [#/volume] (viral load) in Stool by NAA with probe detection |
|
49419-5
|
Papova virus SV 40 DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49423-7
|
Papova virus SV 40 DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49425-2
|
Papova virus SV 40 DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
23441-9
|
Swine vesicular disease virus Ab [Presence] in Serum |
|
23442-7
|
Swine vesicular disease virus Ab [Presence] in Serum by Immunoassay |
|
23443-5
|
Swine vesicular disease virus Ab [Presence] in Serum by Immunoelectrophoresis |
|
23440-1
|
Swine vesicular disease virus Ab [Presence] in Serum by Neutralization test |
|
31972-3
|
Swine vesicular disease virus Ag [Presence] in Skin |
|
23445-0
|
Swine vesicular disease virus Ag [Presence] in Skin by Complement fixation |
|
23447-6
|
Swine vesicular disease virus Ag [Presence] in Skin by Immunoassay |
|
31973-1
|
Swine vesicular disease virus Ag [Presence] in Unspecified specimen |
|
23446-8
|
Swine vesicular disease virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23444-3
|
Swine vesicular disease virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23448-4
|
Swine vesicular disease virus RNA [Presence] in Tissue by NAA with probe detection |
|
90751-9
|
Social worker Adult day care center Note |
|
83954-8
|
Social worker Admission evaluation note |
|
83955-5
|
Social worker Annual evaluation note |
|
80672-9
|
Social worker Conference note |
|
34841-7
|
Social worker Consult note |
|
34872-2
|
Social worker Counseling note |
|
83957-1
|
Social worker Custodial care facility Note |
|
83956-3
|
Social worker Discharge summary |
|
83958-9
|
Social worker Emergency department Note |
|
78607-9
|
Social worker Education note |
|
34843-3
|
Social worker Group counseling note |
|
83959-7
|
Social worker History and physical note |
|
83965-4
|
Social worker Hospital Note |
|
18739-3
|
Social worker Initial evaluation note |
|
83967-0
|
Social worker Long term care facility Consult note |
|
83968-8
|
Social worker Long term care facility Discharge summary |
|
83969-6
|
Social worker Long term care facility Initial evaluation note |
|
83970-4
|
Social worker Long term care facility Note |
|
83971-2
|
Social worker Long term care facility Referral note |
|
83972-0
|
Social worker Long term care facility Respite note |
|
83973-8
|
Social worker Long term care facility Risk assessment and screening note |
|
28653-4
|
Social worker Note |
|
83975-3
|
Social worker Outpatient Group counseling note |
|
83976-1
|
Social worker Outpatient Note |
|
83977-9
|
Social worker Outreach note |
|
34844-1
|
Social worker Telephone encounter Note |
|
80788-3
|
Social worker Plan of care note |
|
28656-7
|
Social worker Progress note |
|
83960-5
|
Social worker Patient's home Consult note |
|
83961-3
|
Social worker Patient's home Discharge summary |
|
83962-1
|
Social worker Patient's home Initial evaluation note |
|
83963-9
|
Social worker Patient's home Note |
|
83964-7
|
Social worker Patient's home Referral note |
|
57164-6
|
Social worker Referral note |
|
83978-7
|
Social worker Respite note |
|
83979-5
|
Social worker Risk assessment and screening note |
|
65335-2
|
Sw sup(a) Ab [Presence] in Serum or Plasma |
|
91531-4
|
Social worker Telehealth Note |
|
83981-1
|
Social worker Transfer summary note |
|
83982-9
|
Social worker Transplant candidate evaluation note |
|
7377-5
|
Sweet Vernal grass triggered histamine release [Units/volume] in Blood |
|
6261-2
|
Sweet Vernal grass IgE Ab [Units/volume] in Serum |
|
61217-6
|
Sweet Vernal grass IgE Ab/IgE total in Serum |
|
56398-1
|
Sweet Vernal grass IgG4 Ab [Mass/volume] in Serum |
|
30163-0
|
Sweat Bee IgE Ab [Units/volume] in Serum |
|
21206-8
|
Sweet Clover IgE Ab [Units/volume] in Serum |
|
6260-4
|
Sweet gum IgE Ab [Units/volume] in Serum |
|
49916-0
|
Sweet gum IgE Ab/IgE total in Serum |
|
7629-9
|
Sweet potato triggered histamine release [Units/volume] in Blood |
|
7627-3
|
Sweet potato IgE Ab [Units/volume] in Serum |
|
57987-0
|
Sweet potato IgE Ab/IgE total in Serum |
|
7628-1
|
Sweet potato IgG Ab [Units/volume] in Serum |
|
56397-3
|
Sweet potato IgG4 Ab [Mass/volume] in Serum |
|
60396-9
|
Sweet potato IgG Ab [Mass/volume] in Serum |
|
7409-6
|
Swine triggered histamine release [Units/volume] in Blood |
|
6262-0
|
Swine epithelium IgE Ab [Units/volume] in Serum |
|
7410-4
|
Swine epithelium IgG Ab [Units/volume] in Serum |
|
19759-0
|
Swine serum albumin IgE Ab [Units/volume] in Serum |
|
10952-0
|
Swine urine proteins IgE Ab [Units/volume] in Serum |
|
7215-7
|
Swiss Cheese IgE Ab [Units/volume] in Serum |
|
7216-5
|
Swiss Cheese IgG Ab [Units/volume] in Serum |
|
56399-9
|
Swiss Cheese IgG4 Ab [Mass/volume] in Serum |
|
63103-6
|
Swiss Cheese IgG Ab [Mass/volume] in Serum |
|
7728-9
|
Swordfish IgE Ab [Units/volume] in Serum |
|
7729-7
|
Swordfish IgG Ab [Units/volume] in Serum |
|
56466-6
|
Swordfish IgG4 Ab [Mass/volume] in Serum |
|
88873-5
|
Sympathomimetics [Presence] in Serum, Plasma or Blood by Confirmatory method |
|
12369-5
|
Sympathomimetics [Identifier] in Urine |
|
29656-6
|
Sympathomimetics [Presence] in Urine |
|
45272-2
|
Sympathomimetics [Presence] in Urine by Confirmatory method |
|
27993-5
|
Sympathomimetics [Mass/volume] in Urine |
|
80891-5
|
Symptom score [AUASI] |
|
43141-1
|
Synthetic glucocorticoid panel [Mass/volume] - Serum or Plasma |
|
46959-3
|
Synthetic glucocorticoid panel [Mass/volume] - Urine |
|
10514-8
|
Synaptophysin Ag [Presence] in Tissue by Immune stain |
|
79399-2
|
Synovial fluid analysis panel - Synovial fluid |
|
72478-1
|
Synthetic cannabinoids panel - Urine by Confirmatory method |
|
48072-3
|
Synthetic glucocorticoid drug [Mass/volume] in Unknown substance |
|
93474-5
|
Synthetic opioids panel - Urine by Confirmatory method |
|
76322-7
|
Systolic time ratio |
|
88702-6
|
Systemic sclerosis panel - Serum by Immunoassay |
|
23459-1
|
Theileria annulata Ab [Presence] in Serum |
|
23460-9
|
Theileria annulata Ab [Presence] in Serum by Immunofluorescence |
|
31680-2
|
Theileria annulata Ab [Units/volume] in Serum |
|
23461-7
|
Theileria annulata Ab [Titer] in Serum |
|
23462-5
|
Theileria annulata Ab [Titer] in Serum by Immunofluorescence |
|
23463-3
|
Theileria annulata rRNA [Presence] in Serum by Probe |
|
5397-5
|
Trypanosoma brucei Ab [Units/volume] in Serum |
|
42947-2
|
Trypanosoma brucei Ab [Titer] in Serum |
|
34383-0
|
Trypanosoma brucei Ab [Titer] in Serum by Immunofluorescence |
|
23507-7
|
Trypanosoma brucei DNA [Presence] in Blood by NAA with probe detection |
|
26617-1
|
Trypanosoma brucei gambiense Ab [Presence] in Serum |
|
41427-6
|
Trypanosoma brucei gambiense Ab [Presence] in Serum by Agglutination |
|
26618-9
|
Trypanosoma brucei rhodesiense Ab [Presence] in Serum |
|
42946-4
|
Trypanosoma brucei rhodesiense Ab [Titer] in Serum |
|
41428-4
|
Trypanosoma brucei rhodesiense Ab [Titer] in Serum by Immunofluorescence |
|
42532-2
|
Thermoactinomyces candidus Ab [Presence] in Cerebral spinal fluid |
|
21560-8
|
Thermoactinomyces candidus Ab [Presence] in Serum |
|
5376-9
|
Thermoactinomyces candidus Ab [Units/volume] in Serum |
|
17715-4
|
Toxocara canis Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
13274-6
|
Toxocara canis Ab [Units/volume] in Cerebral spinal fluid |
|
60470-2
|
Toxocara canis Ab [Units/volume] in Body fluid |
|
5386-8
|
Toxocara canis Ab [Units/volume] in Serum by Immunoassay |
|
8038-2
|
Toxocara canis Ab [Units/volume] in Serum |
|
42950-6
|
Toxocara canis Ab [Titer] in Unspecified specimen |
|
41425-0
|
Toxocara canis Ab [Titer] in Unspecified specimen by Immunoassay |
|
49861-8
|
Toxocara canis Ab [Units/volume] in Unspecified specimen by Immunoassay |
|
53386-9
|
Toxocara canis Ab [Units/volume] in Unspecified specimen |
|
9717-0
|
Toxocara canis IgA Ab [Units/volume] in Serum by Immunoassay |
|
24028-3
|
Toxocara canis IgA Ab [Presence] in Serum |
|
13276-1
|
Toxocara canis IgA Ab [Units/volume] in Serum |
|
53585-6
|
Toxocara canis IgE Ab [Units/volume] in Serum |
|
9718-8
|
Toxocara canis IgG Ab [Units/volume] in Serum by Immunoassay |
|
24029-1
|
Toxocara canis IgG Ab [Presence] in Serum |
|
40674-4
|
Toxocara canis IgG Ab [Presence] in Serum by Immunoassay |
|
22575-5
|
Toxocara canis IgG Ab [Units/volume] in Serum |
|
9719-6
|
Toxocara canis IgM Ab [Units/volume] in Serum by Immunoassay |
|
24030-9
|
Toxocara canis IgM Ab [Presence] in Serum |
|
40675-1
|
Toxocara canis IgM Ab [Presence] in Serum by Immunoassay |
|
13275-3
|
Toxocara canis IgM Ab [Units/volume] in Serum |
|
45229-2
|
Toxocara cati Ab [Presence] in Serum |
|
10448-9
|
T-cell Ag [Presence] in Tissue by Immune stain |
|
48409-7
|
T cell crossmatch [Presence] in Blood from Donor |
|
46720-9
|
T cell crossmatch [Presence] in Blood |
|
23508-5
|
Trypanosoma congolense DNA [Presence] in Blood by NAA with probe detection |
|
60553-5
|
Trypanosoma cruzi Ab [Presence] in Serum from Donor |
|
23785-9
|
Trypanosoma cruzi Ab [Presence] in Serum |
|
57320-4
|
Trypanosoma cruzi Ab [Presence] in Serum by Immunoassay |
|
8045-7
|
Trypanosoma cruzi Ab [Units/volume] in Serum |
|
77952-0
|
Trypanosoma cruzi Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
22599-5
|
Trypanosoma cruzi Ab [Titer] in Serum |
|
5398-3
|
Trypanosoma cruzi Ab [Titer] in Serum by Complement fixation |
|
25813-7
|
Trypanosoma cruzi Ab [Titer] in Serum by Immunofluorescence |
|
49801-4
|
Trypanosoma cruzi DNA [Presence] in Blood by NAA with probe detection |
|
88232-4
|
Trypanosoma cruzi DNA [Presence] in Tissue by NAA with probe detection |
|
90247-8
|
Trypanosoma cruzi IgG Ab [Presence] in Serum from Donor by Immunoassay |
|
59387-1
|
Trypanosoma cruzi IgG Ab [Units/volume] in Serum by Immunoassay |
|
32725-4
|
Trypanosoma cruzi IgG Ab [Presence] in Serum |
|
87994-0
|
Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunoassay |
|
44816-7
|
Trypanosoma cruzi IgG Ab [Presence] in Serum by Immunofluorescence |
|
13291-0
|
Trypanosoma cruzi IgG Ab [Units/volume] in Serum |
|
89995-5
|
Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Immunoassay |
|
89994-8
|
Trypanosoma cruzi IgG Ab [Presence] in Serum or Plasma from Donor by Rapid immunoassay |
|
14094-7
|
Trypanosoma cruzi IgG Ab [Titer] in Serum |
|
59393-9
|
Trypanosoma cruzi IgG Ab [Titer] in Serum by Immunofluorescence |
|
30104-4
|
Trypanosoma cruzi IgG Ab [Titer] in Unspecified specimen |
|
31691-9
|
Trypanosoma cruzi IgG Ab [Units/volume] in Unspecified specimen |
|
35682-4
|
Trypanosoma cruzi IgG and IgM panel - Serum |
|
51827-4
|
Trypanosoma cruzi IgM Ab [Units/volume] in Serum by Immunoassay |
|
32726-2
|
Trypanosoma cruzi IgM Ab [Presence] in Serum |
|
87997-3
|
Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunoassay |
|
26989-4
|
Trypanosoma cruzi IgM Ab [Presence] in Serum by Immunofluorescence |
|
13290-2
|
Trypanosoma cruzi IgM Ab [Units/volume] in Serum |
|
15397-3
|
Trypanosoma cruzi IgM Ab [Titer] in Serum |
|
30105-1
|
Trypanosoma cruzi IgM Ab [Titer] in Unspecified specimen |
|
22105-1
|
Theileria equi Ab [Presence] in Serum |
|
20690-4
|
Theileria equi Ab [Presence] in Serum by Complement fixation |
|
23464-1
|
Theileria equi Ab [Presence] in Serum by Immunoassay |
|
23466-6
|
Theileria equi Ab [Presence] in Serum by Immunofluorescence |
|
23465-8
|
Theileria equi rRNA [Presence] in Blood by Probe |
|
23454-2
|
Taylorella equigenitalis Ab [Presence] in Serum |
|
23453-4
|
Taylorella equigenitalis Ab [Presence] in Serum by Complement fixation |
|
31672-9
|
Taylorella equigenitalis Ab [Units/volume] in Serum |
|
42951-4
|
Taylorella equigenitalis Ab [Titer] in Serum |
|
23783-4
|
Taylorella equigenitalis Ab [Titer] in Serum by Complement fixation |
|
31976-4
|
Taylorella equigenitalis Ag [Presence] in Unspecified specimen |
|
23456-7
|
Taylorella equigenitalis Ag [Presence] in Unspecified specimen by Agglutination |
|
23455-9
|
Taylorella equigenitalis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23458-3
|
Taylorella equigenitalis DNA [Presence] in Genital specimen by NAA with probe detection |
|
23603-4
|
Taylorella equigenitalis [Presence] in Genital specimen by Organism specific culture |
|
23515-0
|
Trypanosoma equiperdum Ab [Presence] in Serum |
|
23511-9
|
Trypanosoma equiperdum Ab [Presence] in Serum by Complement fixation |
|
23512-7
|
Trypanosoma equiperdum Ab [Presence] in Serum by Immunoassay |
|
23514-3
|
Trypanosoma equiperdum Ab [Presence] in Serum by Immune diffusion (ID) |
|
23513-5
|
Trypanosoma equiperdum Ab [Presence] in Serum by Immunofluorescence |
|
31692-7
|
Trypanosoma equiperdum Ab [Units/volume] in Serum |
|
23517-6
|
Trypanosoma equiperdum Ab [Titer] in Serum |
|
23510-1
|
Trypanosoma equiperdum Ab [Titer] in Serum by Complement fixation |
|
23509-3
|
Trypanosoma equiperdum [Presence] in Body fluid by Light microscopy |
|
23524-2
|
Trypanosoma evansi Ab [Units/volume] in Serum by Immunoassay |
|
23522-6
|
Trypanosoma evansi Ab [Presence] in Serum |
|
23523-4
|
Trypanosoma evansi Ab [Presence] in Serum by Agglutination |
|
23526-7
|
Trypanosoma evansi Ab [Presence] in Serum by Immunofluorescence |
|
23521-8
|
Trypanosoma evansi Ab [Units/volume] in Serum |
|
31979-8
|
Trypanosoma evansi Ag [Presence] in Blood |
|
23528-3
|
Trypanosoma evansi Ag [Presence] in Blood by Immunoassay |
|
23518-4
|
Trypanosoma evansi [Presence] in Aspirate by Thick film |
|
23519-2
|
Trypanosoma evansi [Presence] in Aspirate by Thin film |
|
23520-0
|
Trypanosoma evansi [Presence] in Aspirate by Wet preparation |
|
23529-1
|
Trypanosoma evansi DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23530-9
|
Trypanosoma evansi rRNA [Presence] in Unspecified specimen by Probe |
|
23500-2
|
Tritrichomonas foetus Ab [Presence] in Genital mucus |
|
23501-0
|
Tritrichomonas foetus Ab [Presence] in Genital mucus by Agglutination |
|
23503-6
|
Tritrichomonas foetus Ag [Presence] in Placenta by Immune stain |
|
23502-8
|
Tritrichomonas foetus Ag [Presence] in Tissue from Fetus by Immune stain |
|
23505-1
|
Tritrichomonas foetus DNA [Presence] in Genital fluid by NAA with probe detection |
|
23504-4
|
Tritrichomonas foetus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23604-2
|
Tritrichomonas foetus [Presence] in Body fluid by Organism specific culture |
|
23606-7
|
Tritrichomonas foetus [Presence] in Genital fluid by Organism specific culture |
|
23605-9
|
Tritrichomonas foetus [Presence] in Placenta by Organism specific culture |
|
20976-7
|
Tritrichomonas foetus [Presence] in Preputial wash by Organism specific culture |
|
49109-2
|
Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
13287-8
|
Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid |
|
22577-1
|
Toxoplasma gondii Ab [Presence] in Serum |
|
23485-6
|
Toxoplasma gondii Ab [Presence] in Serum by Agglutination |
|
5387-6
|
Toxoplasma gondii Ab [Presence] in Serum by Sabin dye test |
|
23486-4
|
Toxoplasma gondii Ab [Presence] in Serum by Latex agglutination |
|
11598-0
|
Toxoplasma gondii Ab [Units/volume] in Serum |
|
87361-2
|
Toxoplasma gondii Ab/Negative control in Serum or Plasma by Immunoassay |
|
42949-8
|
Toxoplasma gondii Ab [Titer] in Serum |
|
23784-2
|
Toxoplasma gondii Ab [Titer] in Serum by Hemagglutination |
|
14923-7
|
Toxoplasma gondii Ab [Units/volume] in Unspecified specimen |
|
35305-2
|
Toxoplasma gondii AC Ab [Units/volume] in Serum by Agglutination |
|
41124-9
|
Toxoplasma gondii AC Ab [Units/volume] in Serum |
|
86737-4
|
Toxoplasma gondii Ag [Presence] in Tissue by Immune stain |
|
90301-3
|
Toxoplasma gondii [Presence] in Amniotic fluid by Organism specific culture |
|
89599-5
|
Toxoplasma gondii [Presence] in Cerebral spinal fluid by Organism specific culture |
|
53611-0
|
Toxoplasma gondii [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
49444-3
|
Toxoplasma gondii DNA [#/volume] in Amniotic fluid by NAA with probe detection |
|
49445-0
|
Toxoplasma gondii DNA [#/volume] in Bronchoalveolar lavage by NAA with probe detection |
|
49447-6
|
Toxoplasma gondii DNA [#/volume] in Blood by NAA with probe detection |
|
62465-0
|
Toxoplasma gondii DNA [#/volume] in Cerebral spinal fluid by NAA with probe detection |
|
49446-8
|
Toxoplasma gondii DNA [#/volume] in Bone marrow by NAA with probe detection |
|
49449-2
|
Toxoplasma gondii DNA [#/volume] in Serum or Plasma by NAA with probe detection |
|
49443-5
|
Toxoplasma gondii DNA [#/volume] in Urine by NAA with probe detection |
|
49448-4
|
Toxoplasma gondii DNA [#/volume] in Unspecified specimen by NAA with probe detection |
|
27999-2
|
Toxoplasma gondii DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
16279-2
|
Toxoplasma gondii DNA [Presence] in Blood by NAA with probe detection |
|
87993-2
|
Toxoplasma gondii DNA [Presence] in Cord blood by NAA with probe detection |
|
42626-2
|
Toxoplasma gondii DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
10725-0
|
Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification |
|
57441-8
|
Toxoplasma gondii DNA [Presence] in Body fluid by NAA with probe detection |
|
87989-0
|
Toxoplasma gondii DNA [Presence] in Bone marrow by NAA with probe detection |
|
88164-9
|
Toxoplasma gondii DNA [Presence] in Ocular fluid by NAA with probe detection |
|
87983-3
|
Toxoplasma gondii DNA [Presence] in Placenta by NAA with probe detection |
|
87984-1
|
Toxoplasma gondii DNA [Presence] in Tissue by NAA with probe detection |
|
29904-0
|
Toxoplasma gondii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
35287-2
|
Toxoplasma gondii HS Ab [Units/volume] in Serum by Agglutination |
|
41123-1
|
Toxoplasma gondii HS Ab [Units/volume] in Serum |
|
33265-0
|
Toxoplasma gondii IgA Ab [Units/volume] in Cerebral spinal fluid |
|
10723-5
|
Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay |
|
33459-9
|
Toxoplasma gondii IgA Ab [Presence] in Serum |
|
74830-1
|
Toxoplasma gondii IgA Ab [Presence] in Serum by Immunoassay |
|
22578-9
|
Toxoplasma gondii IgA Ab [Units/volume] in Serum |
|
60428-0
|
Toxoplasma gondii IgA Ab [Titer] in Serum |
|
14922-9
|
Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay |
|
22579-7
|
Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum |
|
10724-3
|
Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay |
|
27354-0
|
Toxoplasma gondii IgE Ab [Presence] in Serum |
|
74847-5
|
Toxoplasma gondii IgE Ab [Presence] in Serum by Immunoassay |
|
17716-2
|
Toxoplasma gondii IgE Ab [Units/volume] in Serum |
|
56990-5
|
Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay |
|
47389-2
|
Toxoplasma gondii IgG Ab avidity [Presence] in Serum |
|
56991-3
|
Toxoplasma gondii IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay |
|
34422-6
|
Toxoplasma gondii IgG Ab avidity [Ratio] in Serum |
|
30038-4
|
Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31685-1
|
Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid |
|
30568-0
|
Toxoplasma gondii IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
9741-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid |
|
54087-2
|
Toxoplasma gondii IgG Ab [Presence] in DBS |
|
33320-3
|
Toxoplasma gondii IgG Ab [Units/volume] in Body fluid |
|
93858-9
|
Toxoplasma gondii IgG panel - Serum from Donor |
|
47390-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum by Sabin dye test |
|
22580-5
|
Toxoplasma gondii IgG Ab [Presence] in Serum |
|
21570-7
|
Toxoplasma gondii IgG Ab [Presence] in Serum by Sabin dye test |
|
40677-7
|
Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoassay |
|
35281-5
|
Toxoplasma gondii IgG Ab [Presence] in Serum by Immunofluorescence |
|
8039-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum |
|
5388-4
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
24242-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum --1st specimen |
|
13286-0
|
Toxoplasma gondii IgG Ab [Units/volume] in Serum --2nd specimen |
|
40786-6
|
Toxoplasma gondii IgG Ab [Titer] in Serum --2nd specimen |
|
22581-3
|
Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid |
|
21569-9
|
Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22582-1
|
Toxoplasma gondii IgG Ab [Titer] in Serum |
|
12261-4
|
Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay |
|
5389-2
|
Toxoplasma gondii IgG Ab [Titer] in Serum by Immunofluorescence |
|
86738-2
|
Toxoplasma gondii IgG Ab [Presence] in Unspecified specimen by Immunoassay |
|
57770-0
|
Toxoplasma gondii IgG and IgM panel - Serum |
|
88746-3
|
Toxoplasma gondii IgG and IgM panel - Serum or Plasma by Immunoassay |
|
17717-0
|
Toxoplasma gondii IgG+IgM Ab [Presence] in Serum |
|
83123-0
|
Toxoplasma gondii IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
31178-7
|
Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31181-1
|
Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid |
|
30569-8
|
Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
18348-3
|
Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid |
|
54088-0
|
Toxoplasma gondii IgM Ab [Presence] in DBS |
|
33321-1
|
Toxoplasma gondii IgM Ab [Units/volume] in Body fluid |
|
5390-0
|
Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay |
|
25542-2
|
Toxoplasma gondii IgM Ab [Presence] in Serum |
|
33336-9
|
Toxoplasma gondii IgM Ab [Presence] in Serum by Agglutination |
|
8040-8
|
Toxoplasma gondii IgM Ab [Units/volume] in Serum |
|
40678-5
|
Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
35282-3
|
Toxoplasma gondii IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
40785-8
|
Toxoplasma gondii IgM Ab [Titer] in Serum --1st specimen |
|
22583-9
|
Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid |
|
21571-5
|
Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22584-7
|
Toxoplasma gondii IgM Ab [Titer] in Serum |
|
12262-2
|
Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay |
|
5391-8
|
Toxoplasma gondii IgM Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
87982-5
|
Toxoplasma gondii [Presence] in Bone marrow by Organism specific culture |
|
88161-5
|
Toxoplasma gondii [Presence] in Ocular fluid by Organism specific culture |
|
89632-4
|
Toxoplasma gondii [Presence] in Placenta by Organism specific culture |
|
30158-0
|
Toxoplasma gondii [Presence] in Stool |
|
10727-6
|
Toxoplasma gondii identified in Tissue |
|
14838-7
|
Toxoplasma gondii [Presence] in Tissue by Organism specific culture |
|
10726-8
|
Toxoplasma gondii [Presence] in Tissue by Giemsa stain |
|
42343-4
|
Toxoplasma gondii identified in Unspecified specimen by Other stain |
|
31974-9
|
Taenia hydatigena Ag [Presence] in Stool |
|
23449-2
|
Taenia hydatigena Ag [Presence] in Stool by Immunoassay |
|
26037-2
|
Trichophyton mentagrophytes var goetzii IgE Ab [Units/volume] in Serum |
|
63167-1
|
Trichophyton mentagrophytes IgG Ab [Mass/volume] in Serum |
|
25801-2
|
Trichophyton mentagrophytes var interdigitale IgE Ab [Units/volume] in Serum |
|
23470-8
|
Theileria mutans Ab [Presence] in Serum |
|
23468-2
|
Theileria mutans Ab [Presence] in Serum by Immunoassay |
|
23469-0
|
Theileria mutans Ab [Presence] in Serum by Immunofluorescence |
|
31681-0
|
Theileria mutans Ab [Units/volume] in Serum |
|
23471-6
|
Theileria mutans Ab [Titer] in Serum |
|
23467-4
|
Theileria mutans Ab [Titer] in Serum by Immunofluorescence |
|
23473-2
|
Theileria mutans DNA [Presence] in Serum by NAA with probe detection |
|
23472-4
|
Theileria mutans rRNA [Presence] in Serum by Probe |
|
13288-6
|
Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence |
|
22585-4
|
Treponema pallidum Ab [Units/volume] in Blood |
|
49800-6
|
Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid by Hemagglutination |
|
22586-2
|
Treponema pallidum Ab [Presence] in Cerebral spinal fluid |
|
50689-9
|
Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Hemagglutination |
|
9826-9
|
Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
51474-5
|
Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid |
|
39015-3
|
Treponema pallidum Ab [Units/volume] in Body fluid by Hemagglutination |
|
47511-1
|
Treponema pallidum Ab [Units/volume] in Body fluid |
|
46206-9
|
Treponema pallidum Ab [Presence] in Serum from Donor |
|
43238-5
|
Treponema pallidum Ab [Presence] in Serum from Donor by Immunofluorescence |
|
63464-2
|
Treponema pallidum Ab [Units/volume] in Serum by Immunoassay |
|
17724-6
|
Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence |
|
5392-6
|
Treponema pallidum Ab [Units/volume] in Serum by Immobilization |
|
17725-3
|
Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination |
|
22587-0
|
Treponema pallidum Ab [Presence] in Serum |
|
24312-1
|
Treponema pallidum Ab [Presence] in Serum by Agglutination |
|
8041-6
|
Treponema pallidum Ab [Presence] in Serum by Hemagglutination |
|
24110-9
|
Treponema pallidum Ab [Presence] in Serum by Immunoassay |
|
57032-5
|
Treponema pallidum Ab [Presence] in Serum by Immunoblot |
|
5393-4
|
Treponema pallidum Ab [Presence] in Serum by Immunofluorescence |
|
17723-8
|
Treponema pallidum Ab [Presence] in Serum by Immobilization |
|
11597-2
|
Treponema pallidum Ab [Units/volume] in Serum |
|
51475-2
|
Treponema pallidum Ab [Titer] in Cerebral spinal fluid |
|
50695-6
|
Treponema pallidum Ab [Titer] in Cerebral spinal fluid by Hemagglutination |
|
22590-4
|
Treponema pallidum Ab [Titer] in Serum |
|
26009-1
|
Treponema pallidum Ab [Titer] in Serum by Hemagglutination |
|
34382-2
|
Treponema pallidum Ab [Titer] in Serum by Immunofluorescence |
|
5394-2
|
Treponema pallidum Ab [Titer] in Serum by Latex agglutination |
|
71793-4
|
Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination |
|
41122-3
|
Treponema pallidum Ab [Units/volume] in Unspecified specimen |
|
53605-2
|
Treponema pallidum DNA [Presence] in Blood by NAA with probe detection |
|
49799-0
|
Treponema pallidum DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91846-6
|
Treponema pallidum DNA [Presence] in Genital specimen by NAA with probe detection |
|
41163-7
|
Treponema pallidum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
47051-8
|
Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
58031-6
|
Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid |
|
58751-9
|
Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
47512-9
|
Treponema pallidum IgG Ab [Units/volume] in Cerebral spinal fluid |
|
47513-7
|
Treponema pallidum IgG Ab [Presence] in Serum from Donor |
|
47361-1
|
Treponema pallidum IgG Ab [Presence] in Serum from Donor by Immunoassay |
|
51838-1
|
Treponema pallidum IgG Ab [Units/volume] in Serum by Immunoassay |
|
17727-9
|
Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
6561-5
|
Treponema pallidum IgG Ab [Presence] in Serum |
|
47238-1
|
Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay |
|
40679-3
|
Treponema pallidum IgG Ab [Presence] in Serum by Immunoblot |
|
17726-1
|
Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence |
|
22592-0
|
Treponema pallidum IgG Ab [Units/volume] in Serum |
|
34954-8
|
Treponema pallidum IgG and IgM panel - Serum |
|
68502-4
|
Treponema pallidum IgG and IgM panel - Serum Qualitative by Immunofluorescence |
|
34147-9
|
Treponema pallidum IgG+IgM Ab [Presence] in Serum |
|
47236-5
|
Treponema pallidum IgG+IgM Ab [Presence] in Serum by Immunoassay |
|
47063-3
|
Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
69946-2
|
Treponema pallidum IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
47514-5
|
Treponema pallidum IgM Ab [Units/volume] in Cerebral spinal fluid |
|
51839-9
|
Treponema pallidum IgM Ab [Units/volume] in Serum by Immunoassay |
|
17728-7
|
Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
6562-3
|
Treponema pallidum IgM Ab [Presence] in Serum |
|
47237-3
|
Treponema pallidum IgM Ab [Presence] in Serum by Immunoassay |
|
40680-1
|
Treponema pallidum IgM Ab [Presence] in Serum by Immunoblot |
|
17729-5
|
Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence |
|
22594-6
|
Treponema pallidum IgM Ab [Units/volume] in Serum |
|
76766-5
|
Treponema pallidum polA gene [Presence] in Genital specimen by NAA with probe detection |
|
29310-0
|
Treponema pallidum [Presence] in Unspecified specimen by Immunofluorescence |
|
23474-0
|
Theileria parva Ab [Presence] in Serum |
|
23477-3
|
Theileria parva Ab [Presence] in Serum by Immunoassay |
|
23475-7
|
Theileria parva Ab [Presence] in Serum by Immunofluorescence |
|
31682-8
|
Theileria parva Ab [Units/volume] in Serum |
|
23478-1
|
Theileria parva Ab [Titer] in Serum |
|
23476-5
|
Theileria parva Ab [Titer] in Serum by Immunofluorescence |
|
23480-7
|
Theileria parva DNA [Presence] in Serum by NAA with probe detection |
|
23479-9
|
Theileria parva rRNA [Presence] in Serum by Probe |
|
11203-7
|
Trichosporon pullulans IgE Ab [Units/volume] in Serum |
|
6256-2
|
Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum |
|
48232-3
|
Tyrophagus putrescentiae triggered leukotriene release [Mass/volume] by Leukocytes |
|
69939-7
|
Trichophyton rubrum DNA [Presence] in Nail by NAA with probe detection |
|
6860-1
|
Trichophyton rubrum IgE Ab [Units/volume] in Serum |
|
35556-0
|
Trichophyton rubrum IgG Ab [Mass/volume] in Serum |
|
21561-6
|
Thermoactinomyces sacchari Ab [Presence] in Serum |
|
35318-5
|
Thermoactinomyces sacchari Ab [Presence] in Serum by Immune diffusion (ID) |
|
5377-7
|
Thermoactinomyces sacchari Ab [Units/volume] in Serum |
|
5374-4
|
Taenia saginata Ab [Units/volume] in Serum by Immunoassay |
|
8036-6
|
Taenia saginata Ab [Units/volume] in Serum |
|
58455-7
|
Taenia solium Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
5375-1
|
Taenia solium adult Ab [Units/volume] in Serum by Immunoassay |
|
10719-3
|
Taenia solium adult Ab [Units/volume] in Serum by Immunoblot |
|
8037-4
|
Taenia solium adult Ab [Units/volume] in Serum |
|
48804-9
|
Taenia solium Ag [Presence] in Stool |
|
56486-4
|
Taenia solium IgG Ab [Units/volume] in Serum by Immunoassay |
|
44804-3
|
Taenia solium IgG Ab [Units/volume] in Serum by Immunoblot |
|
56485-6
|
Taenia solium IgG Ab [Presence] in Serum by Immunoassay |
|
57455-8
|
Taenia solium IgG Ab [Units/volume] in Serum |
|
56665-3
|
Taenia solium IgG Ab [Titer] in Serum by Immunofluorescence |
|
49798-2
|
Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
56480-7
|
Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
35349-0
|
Taenia solium larva Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
16708-0
|
Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid |
|
5120-1
|
Taenia solium larva Ab [Units/volume] in Serum by Hemagglutination |
|
22238-0
|
Taenia solium larva Ab [Presence] in Serum |
|
56984-8
|
Taenia solium larva Ab [Presence] in Serum by Immunoassay |
|
9600-8
|
Taenia solium larva Ab [Presence] in Serum by Immunoblot |
|
7850-1
|
Taenia solium larva Ab [Units/volume] in Serum |
|
41462-3
|
Taenia solium larva Ab [Presence] in Unspecified specimen by Immunoblot |
|
88920-4
|
Taenia solium larva Ag [Presence] in Serum by Immunoassay |
|
53602-9
|
Taenia solium larva Ag [Units/volume] in Serum |
|
88912-1
|
Taenia solium larva DNA [Presence] in Blood by NAA with probe detection |
|
59388-9
|
Taenia solium larva DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
88911-3
|
Taenia solium larva DNA [Presence] in Tissue by NAA with probe detection |
|
7844-4
|
Taenia solium larva IgA Ab [Presence] in Cerebral spinal fluid |
|
7845-1
|
Taenia solium larva IgA Ab [Presence] in Serum |
|
7846-9
|
Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid |
|
88919-6
|
Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
6373-5
|
Taenia solium larva IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
35391-2
|
Taenia solium larva IgG Ab [Units/volume] in Cerebral spinal fluid |
|
25389-8
|
Taenia solium larva IgG Ab [Units/volume] in Serum by Immunoassay |
|
7847-7
|
Taenia solium larva IgG Ab [Presence] in Serum |
|
6374-3
|
Taenia solium larva IgG Ab [Presence] in Serum by Immunoblot |
|
25337-7
|
Taenia solium larva IgG Ab [Units/volume] in Serum |
|
7848-5
|
Taenia solium larva IgM Ab [Presence] in Cerebral spinal fluid |
|
16706-4
|
Taenia solium larva IgM Ab [Units/volume] in Cerebral spinal fluid |
|
7849-3
|
Taenia solium larva IgM Ab [Presence] in Serum |
|
16707-2
|
Taenia solium larva IgM Ab [Units/volume] in Serum |
|
41426-8
|
Trichinella spiralis Ab [Units/volume] in Serum by Immunoassay |
|
22595-3
|
Trichinella spiralis Ab [Presence] in Serum |
|
19253-4
|
Trichinella spiralis Ab [Presence] in Serum by Immunoassay |
|
17732-9
|
Trichinella spiralis Ab [Presence] in Serum by Latex agglutination |
|
8042-4
|
Trichinella spiralis Ab [Units/volume] in Serum |
|
22596-1
|
Trichinella spiralis Ab [Titer] in Serum |
|
25993-7
|
Trichinella spiralis Ab [Titer] in Serum by Immunofluorescence |
|
5395-9
|
Trichinella spiralis Ab [Titer] in Serum by Latex agglutination |
|
87985-8
|
Trichinella spiralis DNA [Presence] in Tissue by NAA with probe detection |
|
17733-7
|
Trichinella spiralis IgA Ab [Presence] in Serum |
|
13922-0
|
Trichinella spiralis IgA Ab [Presence] in Serum by Immunoassay |
|
25423-5
|
Trichinella spiralis IgG Ab [Units/volume] in Serum by Immunoassay |
|
8043-2
|
Trichinella spiralis IgG Ab [Presence] in Serum |
|
6563-1
|
Trichinella spiralis IgG Ab [Presence] in Serum by Immunoassay |
|
17734-5
|
Trichinella spiralis IgG Ab [Units/volume] in Serum |
|
53387-7
|
Trichinella spiralis IgG Ab [Titer] in Serum |
|
52979-2
|
Trichinella spiralis IgG Ab [Titer] in Serum by Immunofluorescence |
|
17735-2
|
Trichinella spiralis IgM Ab [Presence] in Serum |
|
13923-8
|
Trichinella spiralis IgM Ab [Presence] in Serum by Immunoassay |
|
23499-7
|
Trichinella spiralis [Presence] in Tissue by Light microscopy |
|
79347-1
|
Sulfate.total/Creatinine [Molar ratio] in Urine |
|
54927-9
|
Tetranychus urticae IgE Ab [Units/volume] in Serum |
|
31978-0
|
Trichomonas vaginalis Ag [Presence] in Genital specimen |
|
6566-4
|
Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunoassay |
|
6567-2
|
Trichomonas vaginalis Ag [Presence] in Genital specimen by Immunofluorescence |
|
41511-7
|
Trichomonas vaginalis Ag [Presence] in Vaginal fluid |
|
90303-9
|
Trichomonas vaginalis [Presence] in Cervix by Light microscopy |
|
14366-9
|
Trichomonas vaginalis [Presence] in Cervix by Wet preparation |
|
90302-1
|
Trichomonas vaginalis DNA [Presence] in Cervix by NAA with probe detection |
|
91844-1
|
Trichomonas vaginalis DNA [Presence] in Genital specimen by NAA with probe detection |
|
92685-7
|
Trichomonas vaginalis DNA [Presence] in Urine by NAA with probe detection |
|
92700-4
|
Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe |
|
54144-1
|
Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe with signal amplification |
|
69937-1
|
Trichomonas vaginalis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
6564-9
|
Trichomonas vaginalis [Presence] in Genital specimen by Complement fixation |
|
91790-6
|
Trichomonas vaginalis [Presence] in Genital specimen by Organism specific culture |
|
91845-8
|
Trichomonas vaginalis [Presence] in Genital specimen by Light microscopy |
|
6565-6
|
Trichomonas vaginalis [Presence] in Genital specimen by Wet preparation |
|
72277-7
|
Trichomonas vaginalis [Presence] in Prostatic fluid by Light microscopy |
|
70166-4
|
Trichomonas vaginalis rRNA [Presence] in Cervix by NAA with probe detection |
|
6568-0
|
Trichomonas vaginalis rRNA [Presence] in Genital specimen by Probe |
|
70167-2
|
Trichomonas vaginalis rRNA [Presence] in Urine by NAA with probe detection |
|
70165-6
|
Trichomonas vaginalis rRNA [Presence] in Vaginal fluid by NAA with probe detection |
|
46154-1
|
Trichomonas vaginalis rRNA [Presence] in Unspecified specimen by NAA with probe detection |
|
81316-2
|
Trichomonas vaginalis [Presence] in Urine sediment by Organism specific culture |
|
14368-5
|
Trichomonas vaginalis [Presence] in Urethra by Wet preparation |
|
90285-8
|
Trichomonas vaginalis [Presence] in Vaginal fluid by Organism specific culture |
|
90286-6
|
Trichomonas vaginalis [Presence] in Vaginal fluid by Light microscopy |
|
14367-7
|
Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation |
|
44244-2
|
Trichomonas vaginalis [#/area] in Vaginal fluid by Wet preparation |
|
76705-3
|
Trichomonas vaginalis [Presence] in Unspecified specimen by Gram stain |
|
32766-8
|
Trichomonas vaginalis [Presence] in Unspecified specimen by Wet preparation |
|
39569-9
|
Trichoderma viride Ab [Mass/volume] in Serum |
|
6267-9
|
Trichoderma viride IgE Ab [Units/volume] in Serum |
|
26986-0
|
Trichoderma viride IgG Ab [Presence] in Serum |
|
30071-5
|
Trichoderma viride IgG Ab [Units/volume] in Serum |
|
49687-7
|
Trichoderma viride IgG Ab [Mass/volume] in Serum |
|
56406-2
|
Trichoderma viride IgG4 Ab [Mass/volume] in Serum |
|
42534-8
|
Thermoactinomyces vulgaris Ab [Presence] in Cerebral spinal fluid |
|
22573-0
|
Thermoactinomyces vulgaris Ab [Presence] in Serum |
|
6821-3
|
Thermoactinomyces vulgaris Ab [Presence] in Serum by Immune diffusion (ID) |
|
5378-5
|
Thermoactinomyces vulgaris Ab [Units/volume] in Serum |
|
56728-9
|
Thermoactinomyces vulgaris IgE Ab [Units/volume] in Serum |
|
19761-6
|
Thermoactinomyces vulgaris IgG Ab [Presence] in Serum |
|
25538-0
|
Thermoactinomyces vulgaris IgG Ab [Units/volume] in Serum |
|
34190-9
|
Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum |
|
40473-1
|
Thermoactinomyces vulgaris 1 Ab [Presence] in Serum |
|
35317-7
|
Thermoactinomyces vulgaris 1 Ab [Presence] in Serum by Immune diffusion (ID) |
|
30111-9
|
Thermoactinomyces vulgaris 2 Ab [Presence] in Serum |
|
59071-1
|
Tropheryma whippelii Ab [Presence] in Serum |
|
42602-3
|
Tropheryma whippelii DNA [Presence] in Blood by NAA with probe detection |
|
42536-3
|
Tropheryma whippelii DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
89650-6
|
Tropheryma whippelii DNA [Presence] in Implanted device by NAA with probe detection |
|
88140-9
|
Tropheryma whippelii DNA [Presence] in Ocular fluid by NAA with probe detection |
|
91057-0
|
Tropheryma whippelii DNA [Presence] in Stool by NAA with probe detection |
|
29607-9
|
Tropheryma whippelii DNA [Presence] in Tissue by NAA with probe detection |
|
46725-8
|
Tropheryma whippelii DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
70276-1
|
t(1;11)(p32;q23)(EPS15,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
81849-2
|
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Blood or Tissue by Molecular genetics method |
|
81848-4
|
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Bone marrow by Molecular genetics method |
|
77030-5
|
t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript in Blood or Tissue by FISH |
|
72312-2
|
t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
62203-5
|
t(10;11)(p12;q23)(MLLT10,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
77037-0
|
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript in Blood or Tissue by FISH |
|
21801-6
|
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
72368-4
|
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
72725-5
|
t(11;14)(q13.2;q32)(MYEOV,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal |
|
70283-7
|
t(11;17)(q23;q21)(MLL,MLLT6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70284-5
|
t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
87826-4
|
t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by Molecular genetics method |
|
77036-2
|
t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by FISH |
|
70285-2
|
t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
77039-6
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript in Blood or Tissue by FISH |
|
48821-3
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
72218-1
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72217-3
|
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
70286-0
|
t(12;22)(p13;q12.1)(ETV6,MN1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
77033-9
|
t(14;16)(q32;q23)(IGH,MAF) fusion transcript in Blood or Tissue by FISH |
|
77038-8
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript in Blood or Tissue by FISH |
|
21809-9
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method |
|
21810-7
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method |
|
60584-0
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Cerebral spinal fluid by Molecular genetics method |
|
49794-1
|
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Bone marrow by Molecular genetics method |
|
77035-4
|
t(14;18)(q32;q21)(IGH,MALT1) fusion transcript in Blood or Tissue by FISH |
|
90043-1
|
t(14;20)(q32;q12)(IGH,MAFB) fusion transcript in Blood or Tissue by FISH |
|
72216-5
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72212-4
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
72215-7
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72211-6
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
72214-0
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72213-2
|
t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
77031-3
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript in Blood or Tissue by FISH |
|
21551-7
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75011-7
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
72274-4
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
82903-6
|
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
70287-8
|
t(16;21)(p11.2;q22.3)(FUS,ERG) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70288-6
|
t(17;19)(q22;p13.3)(HLF,TCF3) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
79209-3
|
t(2;3)(q13;p25)(PAX8,PPARG) fusion transcript [Presence] in Tissue by Molecular genetics method |
|
90305-4
|
t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript in Blood or Tissue by Molecular genetics method |
|
70278-7
|
t(3;21)(q26;q22.3)(MECOM,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70277-9
|
t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75012-5
|
t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
72313-0
|
t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72726-3
|
t(4;14)(p16;q32)(FGFR3,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal |
|
70279-5
|
t(5;17)(q25.1;q21.1)(NPM1,RARA) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70280-3
|
t(6;11)(q27;q23)(MLLT4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
77042-0
|
t(6;9)(p22;q34)(DEK,NUP214) fusion transcript in Blood or Tissue by FISH |
|
77032-1
|
t(8;14)(q24;q32)(MYC,IGH) fusion transcript in Blood or Tissue by FISH |
|
77040-4
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript in Blood or Tissue by FISH |
|
21819-8
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75013-3
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
72207-4
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
72208-2
|
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
70282-9
|
t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75014-1
|
t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
50014-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by Molecular genetics method |
|
51867-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by FISH |
|
75892-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript break points [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
21822-2
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method |
|
75020-8
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Bone marrow by Molecular genetics method |
|
82904-4
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
21823-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method |
|
46434-7
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
82905-1
|
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Bone marrow by Molecular genetics method |
|
70281-1
|
t(9;9)(q34;q34)(NUP214,SET) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
52135-1
|
t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel - Blood or Tissue by Molecular genetics method |
|
75015-8
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
69381-2
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method |
|
75016-6
|
t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
69382-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method |
|
54926-1
|
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method |
|
75018-2
|
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75017-4
|
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
49795-8
|
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
75019-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
69963-7
|
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
|
49796-6
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [#/volume] in Blood or Tissue by Molecular genetics method |
|
42714-6
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
49797-4
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method |
|
74041-5
|
BCR-ABL1 p210 Major Molecular Response (MMR) [Presence] in Blood or Tissue by Molecular genetics method --post treatment |
|
69380-4
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) in Blood or Tissue by Molecular genetics method |
|
55147-3
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
63422-0
|
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2+e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
70275-3
|
t(X;11)(q13.1;q23)(FOXO4,MLL) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
|
72665-3
|
Trans,trans-muconic acid [Mass/volume] in Urine |
|
87567-4
|
T-2 toxin [Mass/mass] in Unspecified specimen |
|
43172-6
|
Triiodothyronine (T3) Ab [Presence] in Serum |
|
5396-7
|
Triiodothyronine (T3) Ab [Units/volume] in Serum |
|
26879-7
|
Triiodothyronine (T3) [Mass/volume] in Saliva (oral fluid) |
|
83124-8
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma by Immunoassay |
|
83125-5
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma by Immunoassay |
|
3053-6
|
Triiodothyronine (T3) [Mass/volume] in Serum or Plasma |
|
35231-0
|
Triiodothyronine (T3) [Mass or Moles/volume] in Serum or Plasma |
|
14930-2
|
Triiodothyronine (T3) [Moles/volume] in Serum or Plasma |
|
29239-1
|
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis |
|
83127-1
|
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Immunoassay |
|
83126-3
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma by Immunoassay |
|
3051-0
|
Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma |
|
35230-2
|
Triiodothyronine (T3) Free [Mass or Moles/volume] in Serum or Plasma |
|
14928-6
|
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma |
|
3052-8
|
Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma |
|
14929-4
|
Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma |
|
3050-2
|
Triiodothyronine resin uptake (T3RU) in Serum or Plasma |
|
3054-4
|
Triiodothyronine (T3).true [Mass/volume] in Serum or Plasma |
|
38356-2
|
Thyroxine (T4) Ab [Presence] in Serum |
|
9580-2
|
Thyroxine (T4) Ab [Units/volume] in Serum |
|
11062-7
|
Thyroxine (T4).albumin bound [Mass/volume] in Serum or Plasma |
|
20451-1
|
Thyroxine (T4) [Presence] in Blood |
|
3025-4
|
Thyroxine (T4) [Mass/volume] in Blood |
|
38506-2
|
Thyroxine (T4) [Presence] in DBS |
|
31144-9
|
Thyroxine (T4) [Mass/volume] in DBS |
|
31145-6
|
Thyroxine (T4) [Moles/volume] in DBS |
|
73557-1
|
Thyroxine (T4) free [Mass/volume] in Cord blood |
|
53349-7
|
Thyroxine (T4) free [Mass/volume] in DBS |
|
53350-5
|
Thyroxine (T4) free [Moles/volume] in DBS |
|
6892-4
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis |
|
70217-5
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis |
|
83122-2
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Immunoassay |
|
83121-4
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Immunoassay |
|
3024-7
|
Thyroxine (T4) free [Mass/volume] in Serum or Plasma |
|
35228-6
|
Thyroxine (T4) free [Mass or Moles/volume] in Serum or Plasma |
|
14920-3
|
Thyroxine (T4) free [Moles/volume] in Serum or Plasma |
|
24348-5
|
Free T4 and TSH panel - Serum or Plasma |
|
14014-5
|
Thyroxine (T4).prealbumin bound [Mass/volume] in Serum or Plasma |
|
27000-9
|
Thyroxine (T4) [Mass/volume] in Saliva (oral fluid) |
|
83119-8
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma by Immunoassay |
|
83120-6
|
Thyroxine (T4) [Moles/volume] in Serum or Plasma by Immunoassay |
|
3026-2
|
Thyroxine (T4) [Mass/volume] in Serum or Plasma |
|
35226-0
|
Thyroxine (T4) [Mass or Moles/volume] in Serum or Plasma |
|
14921-1
|
Thyroxine (T4) [Moles/volume] in Serum or Plasma |
|
14016-0
|
Thyroxine.thyroxine binding globulin bound [Mass/volume] in Serum or Plasma |
|
3028-8
|
Thyroxine (T4)/Triiodothyronine (T3) uptake index [Mass Ratio] in Serum or Plasma |
|
3020-5
|
Thyroxine binding globulin [Mass/volume] in Blood |
|
48073-1
|
Thyroxine binding globulin panel [Mass/volume] - Serum or Plasma by Electrophoresis |
|
3021-3
|
Thyroxine binding globulin [Mass/volume] in Serum or Plasma |
|
35227-8
|
Thyroxine binding globulin [Mass or Moles/volume] in Serum or Plasma |
|
27980-2
|
Thyroxine binding globulin [Moles/volume] in Serum or Plasma |
|
90422-7
|
TACI cells/100 CD19 cells in Blood |
|
9359-1
|
Tacrine [Mass/volume] in Serum or Plasma |
|
72946-7
|
Tacrolimus induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72945-9
|
Tacrolimus induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
92730-1
|
Tacrolimus [Mass/volume] in Blood --1 hour post dose |
|
92729-3
|
Tacrolimus [Mass/volume] in Blood --2 hours post dose |
|
59823-5
|
Tacrolimus [Mass/volume] in Serum or Plasma --2 hours post dose |
|
92728-5
|
Tacrolimus [Mass/volume] in Blood --4 hours post dose |
|
59822-7
|
Tacrolimus [Mass/volume] in Serum or Plasma --4 hours post dose |
|
74096-9
|
Tacrolimus [Mass/volume] in Blood by Immunoassay |
|
76494-4
|
Tacrolimus [Moles/volume] in Blood by Immunoassay |
|
74097-7
|
Tacrolimus [Mass/volume] in Blood by LC/MS/MS |
|
92727-7
|
Tacrolimus [AUC] in Blood |
|
11253-2
|
Tacrolimus [Mass/volume] in Blood |
|
80550-7
|
Tacrolimus [Mass/volume] in DBS |
|
73133-1
|
Tacrolimus induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73132-3
|
Tacrolimus induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
32721-3
|
Tacrolimus [Mass/volume] in Serum or Plasma |
|
77348-1
|
Tacrolimus [Mass/volume] in Blood --trough |
|
33929-1
|
Tacrolimus [Mass/volume] in Serum or Plasma --trough |
|
59342-6
|
Tadalafil [Mass/volume] in Blood |
|
59343-4
|
Tadalafil [Mass/volume] in Serum or Plasma |
|
59344-2
|
Tadalafil [Mass/volume] in Urine |
|
31975-6
|
Taenia sp Ag [Presence] in Stool |
|
23450-0
|
Taenia sp Ag [Presence] in Stool by Immunoassay |
|
88910-5
|
Taenia sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23452-6
|
Taenia sp eggs [Presence] in Stool by NAA with probe detection |
|
23451-8
|
Taenia sp eggs [Presence] in Stool by Probe |
|
77683-1
|
Thrombin activatable fibrinolysis inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
|
12490-9
|
Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma |
|
59347-5
|
Tamoxifen [Mass/volume] in Blood |
|
73131-5
|
Tamoxifen induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73130-7
|
Tamoxifen induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13909-7
|
Tamoxifen [Mass/volume] in Serum or Plasma |
|
73129-9
|
Tamsulosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73128-1
|
Tamsulosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
75362-4
|
Tapentadol glucuronide [Mass/volume] in Urine by Screen method |
|
79145-9
|
Tapentadol [Presence] in Blood by Confirmatory method |
|
79146-7
|
Tapentadol [Presence] in Blood by Screen method |
|
59352-5
|
Tapentadol [Mass/volume] in Blood |
|
59353-3
|
Tapentadol [Mass/volume] in Body fluid |
|
87819-9
|
Tapentadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87818-1
|
Tapentadol [Presence] in Saliva (oral fluid) by Screen method |
|
75347-5
|
Tapentadol [Mass/volume] in Serum, Plasma or Blood |
|
59354-1
|
Tapentadol [Mass/volume] in Serum or Plasma |
|
59355-8
|
Tapentadol [Mass/mass] in Tissue |
|
58402-9
|
Tapentadol [Mass/volume] in Urine by Confirmatory method |
|
58401-1
|
Tapentadol [Presence] in Urine by Confirmatory method |
|
72485-6
|
Tapentadol [Presence] in Urine by Screen method |
|
65807-0
|
Tapentadol [Mass/volume] in Urine |
|
61429-7
|
Tapentadol/Creatinine [Mass Ratio] in Urine |
|
7733-9
|
Tapioca IgE Ab [Units/volume] in Serum |
|
7734-7
|
Tapioca IgG Ab [Units/volume] in Serum |
|
77633-6
|
TARDBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60749-9
|
Target enflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60756-4
|
Target halothane [VFr/PPres] Airway adaptor --at end expiration |
|
60763-0
|
Target isoflurane [VFr/PPres] Airway adaptor --at end expiration |
|
60796-0
|
Target oxygen [VFr/PPres] Airway adaptor --at end expiration |
|
60776-2
|
Target sevoflurane [VFr/PPres] Airway adaptor --at end expiration |
|
34138-8
|
Targeted history and physical note |
|
11202-9
|
Tarragon IgE Ab [Units/volume] in Serum |
|
56709-9
|
Tartrazine IgE Ab [Units/volume] in Serum |
|
48293-5
|
Tartrazine triggered leukotriene release [Mass/volume] by Leukocytes |
|
14182-0
|
Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
77064-4
|
TAT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77063-6
|
TAT gene full mutation analysis in Blood or Tissue by Sequencing |
|
49558-0
|
TAU 3 Ag [Presence] in Tissue by Immune stain |
|
49559-8
|
TAU 4 Ag [Presence] in Tissue by Immune stain |
|
30160-6
|
Tau protein [Mass/volume] in Cerebral spinal fluid |
|
34159-4
|
Tau protein [Presence] in Body fluid |
|
32559-7
|
Tau protein [Mass/volume] in Serum |
|
41027-4
|
Tau protein/Amyloid beta 42 peptide [Ratio] in Cerebral spinal fluid |
|
47782-8
|
Taurine [Moles/volume] in DBS |
|
44411-7
|
Taurine/Creatinine [Mass Ratio] in 24 hour Urine |
|
72944-2
|
Tazobactam induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72943-4
|
Tazobactam induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73127-3
|
Tazobactam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73126-5
|
Tazobactam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
31383-3
|
European tick borne encephalitis virus Ab [Units/volume] in Serum |
|
26061-2
|
European tick borne encephalitis virus Ab [Titer] in Serum |
|
26058-8
|
European tick borne encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
69927-2
|
European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
69928-0
|
European tick borne encephalitis virus IgG Ab index [Units/volume] in Serum and CSF by Immunoassay |
|
26059-6
|
European tick borne encephalitis virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
69926-4
|
European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay |
|
26062-0
|
European tick borne encephalitis virus IgG Ab [Units/volume] in Serum |
|
69924-9
|
European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
69925-6
|
European tick borne encephalitis virus IgM Ab index [Units/volume] in Serum and CSF by Immunoassay |
|
26060-4
|
European tick borne encephalitis virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
69923-1
|
European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
26063-8
|
European tick borne encephalitis virus IgM Ab [Units/volume] in Serum |
|
86519-6
|
European tick borne encephalitis virus RNA [Presence] in Serum by NAA with probe detection |
|
77617-9
|
Toe brachial index - left |
|
77618-7
|
Toe brachial index - right |
|
57449-1
|
Tubular basement membrane Ab [Units/volume] in Serum |
|
57661-1
|
Tubular basement membrane Ab [Titer] in Serum by Immunofluorescence |
|
48822-1
|
Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay |
|
48823-9
|
Tubular basement membrane IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
56547-3
|
Tubular basement membrane IgG Ab [Titer] in Serum by Immunofluorescence |
|
89657-1
|
Microscopic observation [Identifier] in Lower respiratory specimen by Toluidine blue O stain |
|
81424-4
|
Microscopic observation [Identifier] in Bone marrow by Toluidine blue O stain |
|
677-5
|
Microscopic observation [Identifier] in Unspecified specimen by Toluidine blue O stain |
|
33981-2
|
TBP gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
|
54165-6
|
Tumor necrosis factor binding protein [Units/volume] in Serum |
|
14270-3
|
Tert-butyl acetate [Mass/volume] in Blood |
|
38924-7
|
TBX5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
38913-0
|
TBX5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
75992-8
|
Transcutaneous monitor Heater power |
|
76005-8
|
Transcutaneous monitor sensor temperature |
|
17736-0
|
Trichloroacetate [Mass/volume] in Blood |
|
13898-2
|
Trichloroacetate [Mass/volume] in Serum or Plasma |
|
93327-5
|
Taurocholate [Moles/volume] in Serum or Plasma |
|
3041-1
|
Trichloroacetate [Mass/volume] in Urine |
|
26770-8
|
Trichloroacetate/Creatinine [Mass Ratio] in Urine |
|
56646-3
|
Trichloroacetate/Creatinine [Ratio] in Urine |
|
93328-3
|
Taurochenodeoxycholate [Moles/volume] in Serum or Plasma |
|
38707-6
|
Trichloroethane [Mass/volume] in Air |
|
13938-6
|
Trichloroethane [Mass/volume] in Blood |
|
56783-4
|
Trichloroethane [Moles/volume] in Blood |
|
13637-4
|
Trichloroethane [Mass/volume] in Serum or Plasma |
|
17737-8
|
Trichloroethane [Mass/volume] in Urine |
|
80716-4
|
T-cell activated (CD38+HLA-DR+) subsets panel - Blood |
|
65758-5
|
T-cell helper (CD4) subset panel - Blood |
|
80719-8
|
T-cell naive and memory and effector (CD27 and CD45RA) subsets [Interpretation] in Blood Narrative |
|
80720-6
|
T-cell naive and memory and effector (CD27 and CD45RA) subsets panel - Blood |
|
90413-6
|
T-cell regulatory (Treg) subsets panel - Blood |
|
65759-3
|
T-cell subsets CD4 and CD8 panel - Blood |
|
13024-5
|
Trichlorofluoroethane [Mass/volume] in Blood |
|
13023-7
|
Trichlorofluoromethane [Mass/volume] in Blood |
|
49481-5
|
TCL-1A Ag [Presence] in Tissue by Immune stain |
|
60195-5
|
Trichlormethiazide [Mass/volume] in Blood |
|
60196-3
|
Trichlormethiazide [Mass/volume] in Serum or Plasma |
|
12349-7
|
Trichlormethiazide [Presence] in Urine |
|
9653-7
|
Trichlormethiazide [Mass/volume] in Urine |
|
38533-6
|
TCOF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
74682-6
|
Trichloroethanol.free [Mass/volume] in Blood |
|
23540-8
|
Turkey enteritis coronavirus [Presence] in Serum by Immunofluorescence |
|
17740-2
|
Trichlorophenoxyacetate [Presence] in Blood |
|
17741-0
|
Trichlorophenoxyacetate [Mass/volume] in Serum or Plasma |
|
46960-1
|
TCR alpha beta Ag [Presence] in Tissue by Immune stain |
|
50975-2
|
TCR alpha beta cells [#/volume] in Blood |
|
46961-9
|
TCR gamma delta Ag [Presence] in Tissue by Immune stain |
|
50976-0
|
TCR gamma delta cells [#/volume] in Blood |
|
21751-3
|
TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
60582-4
|
TCRB gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
|
60581-6
|
TCRB gene rearrangements [Presence] in Body fluid by Molecular genetics method |
|
60583-2
|
TCRB gene rearrangements [Presence] in Bone marrow by Molecular genetics method |
|
56880-8
|
TCRB gene+TCRD gene+TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
46998-1
|
TCRB and HC gene rearrangements in Blood or Tissue by Molecular genetics method |
|
21752-1
|
TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
21753-9
|
TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
|
60579-0
|
TCRG gene rearrangements [Presence] in Cerebral spinal fluid by Molecular genetics method |
|
60578-2
|
TCRG gene rearrangements [Presence] in Body fluid by Molecular genetics method |
|
60580-8
|
TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method |
|
19720-2
|
Trichlorothiazide [Mass/volume] in Urine by Confirmatory method |
|
17742-8
|
Trichlorothiazide [Presence] in Urine |
|
19719-4
|
Trichlorothiazide [Presence] in Urine by Confirmatory method |
|
19718-6
|
Trichlorothiazide [Presence] in Urine by Screen method |
|
19721-0
|
Trichlorothiazide [Mass/volume] in Urine |
|
13025-2
|
Trichlorotrifluoroethane [Mass/volume] in Blood |
|
38625-0
|
Trichloroethylene [Mass/volume] in Air |
|
21579-8
|
Trichloroethylene [Mass/volume] in Blood |
|
9793-1
|
Trichloroethylene [Mass/volume] in Urine |
|
93326-7
|
Taurodeoxycholate [Moles/volume] in Serum or Plasma |
|
78351-4
|
Tetradecadienoate (C14:2) [Entitic substance] in Red Blood Cells |
|
69793-8
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Amniotic fluid |
|
69792-0
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Cerebral spinal fluid |
|
53190-5
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS |
|
74603-2
|
Tetradecadienoylcarnitine (C14:2) [Enzymatic activity/mass] in Fibroblast |
|
69794-6
|
Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Urine |
|
69791-2
|
Tetradecadienoylcarnitine (C14:2)/Creatinine [Molar ratio] in Urine |
|
50333-4
|
Tetradecanedioate/Creatinine [Mass Ratio] in Urine |
|
50061-1
|
Tetradecanedioate/Creatinine [Molar ratio] in Urine |
|
54340-5
|
Tetradecanoylcarnitine (C14) [Moles/volume] in Amniotic fluid |
|
54339-7
|
Tetradecanoylcarnitine (C14) [Moles/volume] in Cerebral spinal fluid |
|
53192-1
|
Tetradecanoylcarnitine (C14) [Moles/volume] in DBS |
|
74606-5
|
Tetradecanoylcarnitine (C14) [Enzymatic activity/mass] in Fibroblast |
|
54338-9
|
Tetradecanoylcarnitine (C14)/Creatinine [Molar ratio] in Urine |
|
50062-9
|
Tetradecenedioate/Creatinine [Molar ratio] in Urine |
|
53191-3
|
Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS |
|
74605-7
|
Tetradecenoylcarnitine (C14:1) [Enzymatic activity/mass] in Fibroblast |
|
88025-2
|
Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in DBS |
|
88011-2
|
Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0) [Molar ratio] in Serum or Plasma |
|
53194-7
|
Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS |
|
59194-1
|
Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Serum or Plasma |
|
70159-9
|
Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS |
|
53195-4
|
Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS |
|
53193-9
|
Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS |
|
88010-4
|
Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Serum or Plasma |
|
81780-9
|
Tetradecenoylcarnitine (C14:1)/Creatinine [Molar ratio] in Urine |
|
17712-1
|
Toluene diisocyanate [Mass/volume] in Blood |
|
57439-2
|
Terminal deoxyribonucleotidyl transferase cells [Presence] in Body fluid |
|
2983-5
|
Terminal deoxyribonucleotidyl transferase [Enzymatic activity/volume] in Plasma |
|
11021-3
|
Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain |
|
32816-1
|
Microscopic observation [Identifier] in Unspecified specimen by Terminal deoxynucleotidyl transferase stain |
|
6264-6
|
Tea IgE Ab [Units/volume] in Serum |
|
7735-4
|
Tea IgG Ab [Units/volume] in Serum |
|
56401-3
|
Tea IgG4 Ab [Mass/volume] in Serum |
|
49723-0
|
Tea IgG Ab [Mass/volume] in Serum |
|
84023-1
|
Team Conference note |
|
84025-6
|
Team Custodial care facility Note |
|
84024-9
|
Team Discharge summary |
|
84028-0
|
Team Letter |
|
84029-8
|
Team Long term care facility Conference note |
|
84030-6
|
Team Long term care facility Note |
|
84031-4
|
Team Long term care facility Referral note |
|
75494-5
|
Team Note |
|
84032-2
|
Team Outpatient Note |
|
84033-0
|
Team Telephone encounter Note |
|
84034-8
|
Team Plan of care note |
|
84026-4
|
Team Patient's home Conference note |
|
84027-2
|
Team Patient's home Note |
|
69552-8
|
Thromboelastography after addtion of heparinase panel - Blood |
|
67790-6
|
Thromboelastography panel - Blood |
|
52765-5
|
Thromboelastography without activation panel - Blood |
|
10858-9
|
Teichoate Ab [Presence] in Serum |
|
31673-7
|
Teichoate Ab [Units/volume] in Serum |
|
22571-4
|
Teichoate Ab [Titer] in Serum |
|
10358-0
|
Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |
|
80968-1
|
Teicoplanin free [Mass/volume] in Serum or Plasma |
|
34378-0
|
Teicoplanin [Mass/volume] in Serum or Plasma --peak |
|
25534-9
|
Teicoplanin [Moles/volume] in Serum or Plasma --peak |
|
4043-6
|
Teicoplanin [Mass/volume] in Serum or Plasma |
|
34379-8
|
Teicoplanin [Mass/volume] in Serum or Plasma --trough |
|
25535-6
|
Teicoplanin [Moles/volume] in Serum or Plasma --trough |
|
72860-0
|
Telaprevir [Susceptibility] by Genotype method |
|
85051-1
|
Telavancin [Susceptibility] by Gradient strip |
|
72894-9
|
Telavancin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
88886-7
|
Telavancin [Susceptibility] |
|
85208-7
|
Telehealth Consult note |
|
85207-9
|
Telehealth Education note |
|
85206-1
|
Telehealth Initial evaluation note |
|
75496-0
|
Telehealth Note |
|
75497-8
|
Telehealth Progress note |
|
75498-6
|
Telehealth Summary note |
|
85863-9
|
Teleimaging Note |
|
29915-6
|
Tellurium [Mass/time] in 24 hour Urine |
|
52886-9
|
Tellurium [Moles/time] in 24 hour Urine |
|
16140-6
|
Tellurium [Mass/volume] in Blood |
|
60178-1
|
Tellurium [Mass/mass] in Hair |
|
60179-9
|
Tellurium [Mass/mass] in Nail |
|
60180-7
|
Tellurium [Mass/volume] in Red Blood Cells |
|
12706-8
|
Tellurium [Mass/volume] in Serum or Plasma |
|
60181-5
|
Tellurium [Mass/mass] in Tissue |
|
17681-8
|
Tellurium [Presence] in Urine |
|
5742-2
|
Tellurium [Mass/volume] in Urine |
|
52895-0
|
Tellurium [Moles/volume] in Urine |
|
29939-6
|
Tellurium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52920-6
|
Tellurium/Creatinine [Molar ratio] in 24 hour Urine |
|
52919-8
|
Tellurium/Creatinine [Molar ratio] in Urine |
|
73125-7
|
Telmisartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73124-0
|
Telmisartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
35463-9
|
Telomere analysis [Identifier] in Blood or Tissue Nominal |
|
59746-8
|
Temazepam [Mass/volume] in Blood by Confirmatory method |
|
59745-0
|
Temazepam [Mass/volume] in Blood |
|
59748-4
|
Temazepam [Mass/volume] in Body fluid by Confirmatory method |
|
59747-6
|
Temazepam [Mass/volume] in Body fluid |
|
61091-5
|
Temazepam [Presence] in Gastric fluid |
|
94106-2
|
Temazepam glucuronide [Presence] in Urine by Screen method |
|
26834-2
|
Temazepam [Mass/mass] in Hair |
|
59749-2
|
Temazepam [Mass/mass] in Meconium by Confirmatory method |
|
26937-3
|
Temazepam [Mass/mass] in Meconium |
|
72738-8
|
Temazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
72634-9
|
Temazepam [Presence] in Saliva (oral fluid) |
|
57302-2
|
Temazepam [Mass/volume] in Saliva (oral fluid) |
|
59750-0
|
Temazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
13580-6
|
Temazepam [Presence] in Serum or Plasma |
|
10343-2
|
Temazepam [Mass/volume] in Serum or Plasma |
|
29654-1
|
Temazepam [Moles/volume] in Serum or Plasma |
|
59751-8
|
Temazepam [Mass/mass] in Stool by Confirmatory method |
|
16184-4
|
Temazepam [Mass/volume] in Stool |
|
27249-2
|
Temazepam [Mass/mass] in Stool |
|
59752-6
|
Temazepam [Mass/mass] in Tissue |
|
20559-1
|
Temazepam [Mass/volume] in Urine by Confirmatory method |
|
61060-0
|
Temazepam [Presence] in Urine |
|
16206-5
|
Temazepam [Presence] in Urine by Confirmatory method |
|
19698-0
|
Temazepam [Presence] in Urine by Screen method |
|
12382-8
|
Temazepam [Mass/volume] in Urine |
|
26898-7
|
Temazepam [Mass/volume] in Vitreous fluid |
|
61061-8
|
Temazepam [Presence] in Unspecified specimen |
|
48965-8
|
Temazepam [Mass/volume] in Unspecified specimen |
|
77329-1
|
Temazepam [Moles/volume] in Unspecified specimen |
|
58369-0
|
Temazepam/Creatinine [Mass Ratio] in Urine |
|
60182-3
|
Temephos [Mass/volume] in Urine |
|
54190-4
|
Temocillin [Susceptibility] by Gradient strip |
|
11534-5
|
Temperature charts |
|
75961-3
|
Temperature control mode Infant microenvironment |
|
76006-6
|
Temperature difference |
|
75955-5
|
Temperature Infant microenvironment.incubator |
|
75957-1
|
Temperature setting Infant microenvironment.incubator |
|
75956-3
|
Temperature sensor [Resistance] Infant microenvironment |
|
38374-5
|
Tenofovir [Mass/volume] in Serum or Plasma |
|
68910-9
|
Teratozoospermia index in Semen |
|
72942-6
|
Terazosin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72941-8
|
Terazosin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60183-1
|
Terazosin [Mass/volume] in Blood |
|
73123-2
|
Terazosin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73122-4
|
Terazosin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60184-9
|
Terazosin [Mass/volume] in Serum or Plasma |
|
31174-6
|
Terbufos [Mass/volume] in Blood |
|
35481-1
|
Terbufos [Mass/volume] in Serum or Plasma |
|
21554-1
|
Terbufos [Mass/volume] in Urine |
|
87754-8
|
Terbufos [Mass/mass] in Unspecified specimen |
|
9702-2
|
Terbutaline [Mass/volume] in Serum or Plasma |
|
29634-3
|
Terbutaline [Presence] in Urine |
|
12418-0
|
Terfenadine [Mass/volume] in Serum or Plasma |
|
12419-8
|
Terfenadine [Mass/volume] in Urine |
|
44828-2
|
Teriflunomide [Mass/volume] in Serum or Plasma |
|
7736-2
|
Termamyl IgE Ab [Units/volume] in Serum |
|
17682-6
|
Terpineol [Presence] in Blood |
|
46009-7
|
Test for balance Set |
|
13932-9
|
Testes IgG Ab [Titer] in Serum |
|
35092-6
|
Urology testicular ultrasound |
|
66124-9
|
Testis Pathology biopsy report |
|
58027-4
|
Testolactone [Presence] in Urine |
|
12922-1
|
Testosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
|
26826-8
|
Testosterone [Mass/volume] in 24 hour Urine |
|
2989-2
|
Testosterone [Mass/time] in 24 hour Urine |
|
25986-1
|
Testosterone [Moles/volume] in 24 hour Urine |
|
15095-3
|
Testosterone [Moles/time] in 24 hour Urine |
|
2992-6
|
Testosterone [Mass/volume] in Amniotic fluid |
|
93730-0
|
Testosterone [Moles/volume] in Amniotic fluid |
|
30123-4
|
Testosterone.bound [Mass/volume] in Serum or Plasma |
|
59233-7
|
Testosterone [Moles/volume] in Cerebral spinal fluid |
|
59240-2
|
Testosterone [Moles/volume] in Body fluid |
|
17685-9
|
Testosterone Free [Mass/volume] in Dialysis fluid |
|
49043-3
|
Testosterone Free/Testosterone.total in Serum or Plasma by Detection limit <= 1.0 ng/dL |
|
70240-7
|
Testosterone Free [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L |
|
49042-5
|
Testosterone Free [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL |
|
25987-9
|
Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
2991-8
|
Testosterone Free [Mass/volume] in Serum or Plasma |
|
35225-2
|
Testosterone Free [Mass or Moles/volume] in Serum or Plasma |
|
14914-6
|
Testosterone Free [Moles/volume] in Serum or Plasma |
|
58952-3
|
Testosterone free and total panel [Mass/volume] - Serum or Plasma |
|
58716-2
|
Testosterone.free+weakly bound and total panel - Serum or Plasma |
|
59219-6
|
Testosterone [Moles/volume] in Pleural fluid |
|
59229-5
|
Testosterone [Moles/volume] in Peritoneal fluid |
|
27306-0
|
Testosterone [Presence] in Saliva (oral fluid) |
|
2984-3
|
Testosterone [Mass/volume] in Saliva (oral fluid) |
|
48357-8
|
Testosterone [Moles/volume] in Saliva (oral fluid) |
|
70239-9
|
Testosterone [Moles/volume] in Serum or Plasma by Detection limit <= 3.47 pmol/L |
|
49041-7
|
Testosterone [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL |
|
83116-4
|
Testosterone [Mass/volume] in Serum or Plasma by Immunoassay |
|
83115-6
|
Testosterone [Moles/volume] in Serum or Plasma by Immunoassay |
|
2986-8
|
Testosterone [Mass/volume] in Serum or Plasma |
|
35224-5
|
Testosterone [Mass or Moles/volume] in Serum or Plasma |
|
14913-8
|
Testosterone [Moles/volume] in Serum or Plasma |
|
2985-0
|
Testosterone [Mass/volume] in Semen |
|
10631-0
|
Testosterone [Moles/volume] in Semen |
|
2987-6
|
Testosterone [Presence] in Urine |
|
2988-4
|
Testosterone [Mass/volume] in Urine |
|
15094-6
|
Testosterone [Moles/volume] in Urine |
|
17686-7
|
Testosterone.weakly bound [Mass/volume] in Serum or Plasma |
|
76352-4
|
Testosterone/Cortisol [Molar ratio] in Serum or Plasma |
|
26827-6
|
Testosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
13486-6
|
Testosterone/Creatinine [Mass Ratio] in Urine |
|
34380-6
|
Testosterone/Creatinine [Molar ratio] in Urine |
|
17687-5
|
Testosterone/Epitestosterone [Mass Ratio] in Serum or Plasma |
|
31030-0
|
Testosterone/Epitestosterone [Mass Ratio] in Urine |
|
51005-7
|
Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma by High sensitivity method |
|
2990-0
|
Testosterone.free+weakly bound [Mass/volume] in Serum or Plasma |
|
41018-3
|
Testosterone.free+weakly bound [Moles/volume] in Serum or Plasma |
|
4044-4
|
Tetracaine [Mass/volume] in Serum or Plasma |
|
38753-0
|
Tetrachloroethane [Mass/volume] in Air |
|
17697-4
|
Tetrachloroethane [Mass/volume] in Blood |
|
49855-0
|
Tetracycline IgE Ab [Units/volume] in Serum |
|
73121-6
|
Tetracycline induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73120-8
|
Tetracycline induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48271-1
|
Tetracycline triggered leukotriene release [Mass/volume] by Leukocytes |
|
4045-1
|
Tetracycline [Mass/volume] in Serum or Plasma |
|
25272-6
|
Tetracycline [Mass/volume] in Unspecified specimen |
|
87590-6
|
Tetracycline [Mass/mass] in Unspecified specimen |
|
17698-2
|
Tetraethyl lead [Mass/volume] in Blood |
|
35579-2
|
Tetrahydrofuran [Mass/volume] in Urine |
|
58028-2
|
Tetrahydrogestrinone [Presence] in Urine |
|
10932-2
|
Tetramin IgE Ab [Units/volume] in Serum |
|
80649-7
|
Tetramethylenedisulfotetramine [Mass/volume] in Urine |
|
72487-2
|
TF gene full mutation analysis in Blood or Tissue by Sequencing |
|
77091-7
|
TFB1M gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77090-9
|
TFB1M gene full mutation analysis in Blood or Tissue by Sequencing |
|
23487-2
|
Transmissible gastroenteritis virus Ab [Presence] in Serum |
|
23491-4
|
Transmissible gastroenteritis virus Ab [Presence] in Serum by Immunoassay |
|
23488-0
|
Transmissible gastroenteritis virus Ab [Presence] in Serum by Neutralization test |
|
31686-9
|
Transmissible gastroenteritis virus Ab [Units/volume] in Serum |
|
23489-8
|
Transmissible gastroenteritis virus Ab [Titer] in Serum |
|
23492-2
|
Transmissible gastroenteritis virus Ab [Titer] in Serum by Neutralization test |
|
23494-8
|
Transmissible gastroenteritis virus Ag [Presence] in Stool by Immunoassay |
|
23497-1
|
Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence |
|
23496-3
|
Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immune stain |
|
31977-2
|
Transmissible gastroenteritis virus Ag [Presence] in Unspecified specimen |
|
23495-5
|
Transmissible gastroenteritis virus Ag [Presence] in Unspecified specimen by Immune stain |
|
23493-0
|
Transmissible gastroenteritis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
23498-9
|
Transmissible gastroenteritis virus RNA [Presence] in Unspecified specimen by Probe |
|
74129-8
|
Transforming growth factor alpha Ag [Presence] in Tissue by Immune stain |
|
53840-5
|
TGFB3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
49853-5
|
Transforming growth factor beta 1 [Mass/volume] in Serum or Plasma |
|
47972-5
|
TGFBR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
53899-1
|
TGFBR1 gene+TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
47973-3
|
TGFBR2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
69573-4
|
Tiglylcarnitine+methylcrotonylcarnitine (C5:1) [Moles/volume] in Serum or Plasma |
|
48602-7
|
TGM1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
40430-1
|
TH gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41050-6
|
TH gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
73839-3
|
11-Dehydrotetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
|
73840-1
|
11-Dehydrotetrahydrocorticosterone [Moles/time] in 24 hour Urine |
|
73838-5
|
11-Dehydrotetrahydrocorticosterone [Moles/volume] in Urine |
|
81797-3
|
11-Dehydrotetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
|
13618-4
|
Tetrahydroaldosterone [Mass/time] in 24 hour Urine |
|
32570-4
|
Tetrahydroaldosterone/Creatinine [Mass Ratio] in 24 hour Urine |
|
30515-1
|
Tetrahydroaldosterone/Creatinine [Mass Ratio] in Urine |
|
30929-4
|
Thallium [Mass/volume] in Urine collected for unspecified duration |
|
21558-2
|
Thallium [Mass/volume] in 24 hour Urine |
|
5746-3
|
Thallium [Mass/time] in 24 hour Urine |
|
50918-2
|
Thallium [Moles/volume] in 24 hour Urine |
|
42224-6
|
Thallium [Moles/time] in 24 hour Urine |
|
32114-1
|
Thallium [Presence] in Blood |
|
5743-0
|
Thallium [Mass/volume] in Blood |
|
25173-6
|
Thallium [Moles/volume] in Blood |
|
51207-9
|
Thallium [Mass/volume] in Body fluid |
|
15408-8
|
Thallium [Mass/mass] in Hair |
|
50917-4
|
Thallium [Moles/mass] in Hair |
|
15409-6
|
Thallium [Mass/mass] in Nail |
|
60185-6
|
Thallium [Mass/volume] in Red Blood Cells |
|
47130-0
|
Thallium [Moles/volume] in Red Blood Cells |
|
5744-8
|
Thallium [Mass/volume] in Serum or Plasma |
|
25537-2
|
Thallium [Moles/volume] in Serum or Plasma |
|
20975-9
|
Thallium [Mass/mass] in Tissue |
|
5745-5
|
Thallium [Mass/volume] in Urine |
|
42225-3
|
Thallium [Moles/volume] in Urine |
|
87614-4
|
Thallium [Mass/mass] in Unspecified specimen |
|
29938-8
|
Thallium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52918-0
|
Thallium/Creatinine [Molar ratio] in 24 hour Urine |
|
13469-2
|
Thallium/Creatinine [Mass Ratio] in Urine |
|
42226-1
|
Thallium/Creatinine [Molar ratio] in Urine |
|
9579-4
|
Tetrahydrocorticosterone [Mass/time] in 24 hour Urine |
|
73887-2
|
Tetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
|
73888-0
|
Tetrahydrocorticosterone [Moles/time] in 24 hour Urine |
|
73889-8
|
Tetrahydrocorticosterone [Moles/volume] in Urine |
|
82907-7
|
Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in 24 hour Urine |
|
82906-9
|
Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone [Molar ratio] in Urine |
|
50644-4
|
Tetrahydrocorticosterone/Creatinine [Mass Ratio] in Urine |
|
81796-5
|
Tetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
|
92995-0
|
THBD gene full mutation analysis in Blood or Tissue by Sequencing |
|
74794-9
|
Thyroid hormone binding ratio (THBR) in Serum or Plasma |
|
58047-2
|
Tetrahydrocannabinol [Presence] in Blood by Confirmatory method |
|
8163-8
|
Tetrahydrocannabinol [Presence] in Gastric fluid |
|
8164-6
|
Tetrahydrocannabinol [Presence] in Gastric fluid by Confirmatory method |
|
8165-3
|
Tetrahydrocannabinol [Presence] in Gastric fluid by Screen method |
|
8162-0
|
Tetrahydrocannabinol [Mass/volume] in Gastric fluid |
|
80551-5
|
Tetrahydrocannabinol [Mass/mass] in Hair |
|
8167-9
|
Tetrahydrocannabinol [Presence] in Meconium |
|
8168-7
|
Tetrahydrocannabinol [Presence] in Meconium by Confirmatory method |
|
8169-5
|
Tetrahydrocannabinol [Presence] in Meconium by Screen method |
|
8166-1
|
Tetrahydrocannabinol [Mass/volume] in Meconium |
|
26893-8
|
Tetrahydrocannabinol [Mass/mass] in Meconium |
|
44049-5
|
Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method |
|
73935-9
|
Tetrahydrocannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method |
|
3528-7
|
Tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
|
12351-3
|
Tetrahydrocannabinol [Presence] in Stool |
|
18432-5
|
Tetrahydrocannabinol [Presence] in Stool by Screen method |
|
26731-0
|
Tetrahydrocannabinol [Mass/mass] in Stool |
|
14313-1
|
Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
|
3426-4
|
Tetrahydrocannabinol [Presence] in Urine |
|
19416-7
|
Tetrahydrocannabinol [Presence] in Urine by Confirmatory method |
|
17872-3
|
Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL |
|
8174-5
|
Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method |
|
8175-2
|
Tetrahydrocannabinol [Presence] in Urine by SAMHSA screen method |
|
19415-9
|
Tetrahydrocannabinol [Presence] in Urine by Screen method |
|
21557-4
|
Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL |
|
21556-6
|
Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL |
|
14312-3
|
Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL |
|
3530-3
|
Tetrahydrocannabinol [Mass/volume] in Urine |
|
27193-2
|
Tetrahydrocannabinol [Mass/volume] in Vitreous fluid |
|
43834-1
|
Tetrahydrocannabinol [Presence] in Unspecified specimen |
|
13478-3
|
Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
|
16116-6
|
Tetrahydrocortisone [Mass/time] in 24 hour Urine |
|
73893-0
|
Tetrahydrocortisone [Moles/volume] in 24 hour Urine |
|
56657-0
|
Tetrahydrocortisone [Moles/time] in 24 hour Urine |
|
12325-7
|
Tetrahydrocortisone [Presence] in Urine |
|
4046-9
|
Tetrahydrocortisone [Mass/volume] in Urine |
|
73894-8
|
Tetrahydrocortisone [Moles/volume] in Urine |
|
30514-4
|
Tetrahydrocortisone/Creatinine [Mass Ratio] in Urine |
|
81795-7
|
Tetrahydrocortisone/Creatinine [Molar ratio] in Urine |
|
2996-7
|
Tetrahydrodeoxycortisol [Mass/time] in 24 hour Urine |
|
73842-7
|
Tetrahydrodeoxycortisol [Moles/volume] in 24 hour Urine |
|
73843-5
|
Tetrahydrodeoxycortisol [Moles/time] in 24 hour Urine |
|
73841-9
|
Tetrahydrodeoxycortisol [Moles/volume] in Urine |
|
81793-2
|
Tetrahydrodeoxycortisol/Creatinine [Molar ratio] in 24 hour Urine |
|
44412-5
|
Tetrahydrodeoxycortisol/Creatinine [Mass Ratio] in Urine |
|
93325-9
|
Taurohyodeoxycholate [Moles/volume] in Serum or Plasma |
|
82860-8
|
11-Deoxytetrahydrocorticosterone [Moles/volume] in 24 hour Urine |
|
82859-0
|
11-Deoxytetrahydrocorticosterone [Moles/time] in 24 hour Urine |
|
82858-2
|
11-Deoxytetrahydrocorticosterone [Moles/volume] in Urine |
|
83130-5
|
11-Deoxytetrahydrocorticosterone/Creatinine [Molar ratio] in Urine |
|
75058-8
|
Thymidine phosphorylase [Enzymatic activity/volume] in DBS |
|
33988-7
|
Thymidine phosphorylase [Enzymatic activity/mass] in Leukocytes |
|
17699-0
|
Thebaine [Mass/volume] in Serum or Plasma |
|
23482-3
|
Theileria sp [Presence] in Blood by Giemsa stain |
|
23483-1
|
Theileria sp [Presence] in Tissue by Giemsa stain |
|
12302-6
|
Theobromine [Presence] in Serum or Plasma |
|
31169-6
|
Theobromine [Mass/volume] in Serum or Plasma |
|
12303-4
|
Theobromine [Presence] in Urine |
|
4047-7
|
Theophylline [Mass/volume] in Blood |
|
13581-4
|
Theophylline [Mass/volume] in Cerebral spinal fluid |
|
13582-2
|
Theophylline [Mass/volume] in Body fluid |
|
80967-3
|
Theophylline free [Mass/volume] in Serum or Plasma |
|
21559-0
|
Theophylline [Mass/volume] in Gastric fluid |
|
32115-8
|
Theophylline [Moles/volume] in Serum or Plasma --peak |
|
4048-5
|
Theophylline [Mass/volume] in Saliva (oral fluid) |
|
35596-6
|
Theophylline [Mass/volume] in Serum or Plasma by Screen method |
|
4049-3
|
Theophylline [Mass/volume] in Serum or Plasma |
|
35238-5
|
Theophylline [Mass or Moles/volume] in Serum or Plasma |
|
14915-3
|
Theophylline [Moles/volume] in Serum or Plasma |
|
72673-7
|
Theophylline [Mass/volume] in Serum or Plasma --trough |
|
32116-6
|
Theophylline [Moles/volume] in Serum or Plasma --trough |
|
33323-7
|
Theophylline [Presence] in Urine by Screen method |
|
17700-6
|
Theophylline [Mass/volume] in Urine |
|
46081-6
|
Theophylline [Moles/volume] in Urine |
|
87789-4
|
Theophylline/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
86922-2
|
Therapeutic goals panel |
|
46064-2
|
Therapies Set |
|
46072-5
|
Therapy supplement for Medicare PPS section |
|
10638-5
|
Thermophilic Actinomycetes colony count [#/volume] in Unspecified specimen by Organism specific culture |
|
10639-3
|
Thermophilic Actinomycetes identified in Unspecified specimen by Organism specific culture |
|
13198-7
|
Thermoactinomyces Ab [Units/volume] in Serum |
|
31683-6
|
Thermoactinomyces IgG Ab [Units/volume] in Serum |
|
26949-8
|
Thermoactinomyces IgG Ab [Mass/volume] in Serum |
|
60851-3
|
Theta frequency relative power on EEG |
|
2995-9
|
Tetrahydrocortisol [Mass/time] in 24 hour Urine |
|
73891-4
|
Tetrahydrocortisol [Moles/volume] in 24 hour Urine |
|
73892-2
|
Tetrahydrocortisol [Moles/time] in 24 hour Urine |
|
73890-6
|
Tetrahydrocortisol [Moles/volume] in Urine |
|
82908-5
|
Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82909-3
|
Tetrahydrocortisol/5-Alpha tetrahydrocortisol [Molar ratio] in Urine |
|
50645-1
|
Tetrahydrocortisol/Creatinine [Mass Ratio] in Urine |
|
81794-0
|
Tetrahydrocortisol/Creatinine [Molar ratio] in Urine |
|
82857-4
|
Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in 24 hour Urine |
|
82856-6
|
Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone [Molar ratio] in Urine |
|
75048-9
|
Tetrahydrofolate [Moles/volume] in Cerebral spinal fluid |
|
2997-5
|
Tetrahydrofolate [Mass/volume] in Plasma |
|
54184-7
|
Thiacetazone [Susceptibility] by Disk diffusion (KB) |
|
54204-3
|
Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54169-8
|
Thiamphenicol [Susceptibility] |
|
12492-5
|
Thiamylal [Presence] in Serum or Plasma |
|
12343-0
|
Thiazides [Identifier] in Urine |
|
20414-9
|
Thiazides [Mass/volume] in Urine by Confirmatory method |
|
19306-0
|
Thiazides [Presence] in Urine by Confirmatory method |
|
19303-7
|
Thiazides [Presence] in Urine by Screen method |
|
17701-4
|
Thiazides [Mass/volume] in Urine |
|
60186-4
|
Thiethylperazine [Mass/volume] in Blood |
|
60187-2
|
Thiethylperazine [Mass/volume] in Serum or Plasma |
|
60188-0
|
Thiethylperazine [Mass/volume] in Urine |
|
77653-4
|
Microscopic observation [Identifier] in Anorectal Cyto stain.thin prep |
|
50389-6
|
Microscopic observation [Identifier] in Bronchial brush by Cyto stain.thin prep |
|
18500-9
|
Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep |
|
39086-4
|
Microscopic observation [Identifier] in Vaginal fluid by Cyto stain.thin prep |
|
38427-1
|
Thiocyanate [Mass/time] in 24 hour Urine |
|
3001-5
|
Thiocyanate [Mass/volume] in Blood |
|
59974-6
|
Thiocyanate [Moles/volume] in Gastric fluid |
|
3003-1
|
Thiocyanate [Presence] in Serum or Plasma |
|
3002-3
|
Thiocyanate [Mass/volume] in Serum or Plasma |
|
14916-1
|
Thiocyanate [Moles/volume] in Serum or Plasma |
|
3004-9
|
Thiocyanate [Mass/volume] in Urine |
|
59973-8
|
Thiocyanate [Moles/volume] in Urine |
|
60334-0
|
Thiocyanate [Moles/volume] in Unspecified specimen |
|
21562-4
|
Thiocyanate/Creatinine [Mass Ratio] in Urine |
|
29243-3
|
Thiodiglycolate [Mass/volume] in Urine |
|
29244-1
|
Thiodiglycolate/Creatinine [Mass Ratio] in Urine |
|
34381-4
|
Thioguanine [Mass/volume] in Serum or Plasma |
|
74908-5
|
3-ketoacyl-CoA thiolase [Enzymatic activity/mass] in Fibroblast |
|
56697-6
|
Thiopental IgE Ab [Units/volume] in Serum |
|
4050-1
|
Thiopental [Mass/volume] in Serum or Plasma |
|
32117-4
|
Thiopental [Moles/volume] in Serum or Plasma |
|
16223-0
|
Thiopental [Presence] in Urine by Confirmatory method |
|
12370-3
|
Thiopental [Mass/volume] in Urine |
|
75770-8
|
Thioridazine [Presence] in Blood or Urine by Screen method |
|
31087-0
|
Thioridazine [Mass/volume] in Gastric fluid |
|
47131-8
|
Thioridazine [Moles/volume] in Gastric fluid |
|
13583-0
|
Thioridazine [Presence] in Serum or Plasma |
|
4052-7
|
Thioridazine [Mass/volume] in Serum or Plasma |
|
14917-9
|
Thioridazine [Moles/volume] in Serum or Plasma |
|
20560-9
|
Thioridazine [Mass/volume] in Urine by Confirmatory method |
|
12319-0
|
Thioridazine [Presence] in Urine |
|
19707-9
|
Thioridazine [Presence] in Urine by Confirmatory method |
|
19706-1
|
Thioridazine [Presence] in Urine by Screen method |
|
4053-5
|
Thioridazine [Mass/volume] in Urine |
|
47132-6
|
Thioridazine [Moles/volume] in Urine |
|
9647-9
|
Thiosulfate [Mass/volume] in Blood |
|
3005-6
|
Thiosulfate renal clearance in 24 hour Urine and Serum or Plasma |
|
21564-0
|
Thiosulfate [Mass/volume] in Serum or Plasma |
|
12420-6
|
Thiosulfate [Mass/volume] in Urine |
|
75049-7
|
Thiosulfate [Moles/volume] in Urine |
|
12421-4
|
Thiosulfate/Creatinine [Mass Ratio] in Urine |
|
32274-3
|
Thiosulfate/Creatinine [Ratio] in Urine |
|
29404-1
|
Thiothixene [Mass/volume] in Gastric fluid |
|
89980-7
|
Thiothixene [Presence] in Serum or Plasma by Screen method |
|
6696-9
|
Thiothixene [Mass/volume] in Serum or Plasma |
|
12320-8
|
Thiothixene [Presence] in Urine |
|
29403-3
|
Thiothixene [Mass/volume] in Urine |
|
57873-2
|
Thiothixene [Moles/volume] in Unspecified specimen |
|
76525-5
|
Thoracic fluid conductivity [Fluid Conductance] Chest |
|
76652-7
|
Thorium [Mass/mass] in Hair |
|
50920-8
|
Thorium [Moles/mass] in Hair |
|
12707-6
|
Thorium [Mass/volume] in Serum or Plasma |
|
50919-0
|
Thorium [Moles/mass] in Tissue |
|
17703-0
|
Thorium [Mass/volume] in Urine |
|
47974-1
|
THRB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48032-7
|
THRB gene p.Ala317Thr [Presence] in Blood or Tissue by Molecular genetics method |
|
48153-1
|
Threitol/Creatinine [Molar ratio] in Urine |
|
48154-9
|
Threo-4,5-Dihydrohexanoate/Creatinine [Molar ratio] in Urine |
|
48155-6
|
Threo-4,5-Dihydrohexanolactone/Creatinine [Molar ratio] in Urine |
|
48156-4
|
Threo-4-Deoxytetronate/Creatinine [Molar ratio] in Urine |
|
34692-4
|
Threoamino alcohol [Mass/volume] in Serum or Plasma |
|
47784-4
|
Threonine [Moles/volume] in DBS |
|
47787-7
|
Threonine/Amino acids.total in Amniotic fluid |
|
47786-9
|
Threonine/Amino acids.total in Cerebral spinal fluid |
|
47789-3
|
Threonine/Amino acids.total in DBS |
|
47785-1
|
Threonine/Amino acids.total in Hair |
|
47788-5
|
Threonine/Amino acids.total in Serum or Plasma |
|
47790-1
|
Threonine/Amino acids.total in Unspecified specimen |
|
44413-3
|
Threonine/Creatinine [Mass Ratio] in 24 hour Urine |
|
56641-4
|
Threonine/Creatinine [Ratio] in 24 hour Urine |
|
87148-3
|
Guidance for injection of thrombin for pseudoaneurysm |
|
3243-3
|
Thrombin time |
|
90878-0
|
Thromboembolism Telephone encounter Note |
|
90877-2
|
Thromboembolism procedure note |
|
90876-4
|
Thromboembolism Progress note |
|
90879-8
|
Thromboembolism Team Conference note |
|
4686-2
|
Thromboglobulin [Mass/volume] in Plasma |
|
43237-7
|
Thrombopoietin [Mass/volume] in Platelet poor plasma by Immunoassay |
|
82861-6
|
11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in 24 hour Urine |
|
82862-4
|
11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol [Molar ratio] in Urine |
|
93339-0
|
THSD7A IgG Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
93689-8
|
THSD7A IgG Ab [Titer] in Serum or Plasma by Cell binding assay immunofluorescent assay |
|
81742-9
|
Th-To Ab [Units/volume] in Serum by Line blot |
|
81743-7
|
Th-To Ab [Presence] in Serum by Line blot |
|
72314-8
|
Th-To IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
7737-0
|
Thyme IgE Ab [Units/volume] in Serum |
|
41851-7
|
Thyme IgG Ab [Units/volume] in Serum |
|
56402-1
|
Thyme IgG4 Ab [Mass/volume] in Serum |
|
63125-9
|
Thyme IgG Ab [Mass/volume] in Serum |
|
75156-0
|
Thymidine [Moles/volume] in Cerebral spinal fluid |
|
44934-8
|
Thymidine kinase [Enzymatic activity/volume] in Serum |
|
48162-2
|
Thymidine [Moles/volume] in Serum or Plasma |
|
75153-7
|
Thymine [Moles/volume] in Cerebral spinal fluid |
|
75121-4
|
Thymine [Moles/volume] in Serum or Plasma |
|
48157-2
|
Thymine/Creatinine [Molar ratio] in Urine |
|
90231-2
|
Thymoma and myasthenia gravis antibody panel - Serum |
|
86950-3
|
Thymus IgG Ab [Titer] in Serum or Plasma by Immunofluorescence |
|
82368-2
|
Thyroid secretory capacity [Moles/time] in Serum or Plasma by Calculated.SPINA |
|
57780-9
|
Thyroglobulin and Thyrogobulin Ab panel - Serum or Plasma |
|
87556-7
|
Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma |
|
63360-2
|
Thyroglobulin Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63359-4
|
Thyroglobulin Ab [Units/volume] in Body fluid by Immunoassay |
|
53921-3
|
Thyroglobulin Ab [Units/volume] in Lymph node fine needle aspirate |
|
15210-8
|
Thyroglobulin Ab [Presence] in Serum |
|
5380-1
|
Thyroglobulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA) |
|
56536-6
|
Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
8098-6
|
Thyroglobulin Ab [Units/volume] in Serum or Plasma |
|
53919-7
|
Thyroglobulin Ab [Units/volume] in Tissue fine needle aspirate |
|
38504-7
|
Thyroglobulin Ab [Titer] in Serum by Immunofluorescence |
|
5381-9
|
Thyroglobulin Ab [Titer] in Serum by Latex agglutination |
|
10515-5
|
Thyroglobulin Ag [Presence] in Tissue by Immune stain |
|
56635-6
|
Thyroglobulin IgG Ab [Units/volume] in Serum |
|
83117-2
|
Thyroglobulin IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
17705-5
|
Thyroglobulin IgM Ab [Units/volume] in Serum |
|
53920-5
|
Thyroglobulin [Mass/volume] in Lymph node fine needle aspirate |
|
38505-4
|
Thyroglobulin recovery in Serum or Plasma |
|
48387-5
|
Thyroglobulin recovery [Presence] in Serum or Plasma |
|
3013-0
|
Thyroglobulin [Mass/volume] in Serum or Plasma |
|
14918-7
|
Thyroglobulin [Moles/volume] in Serum or Plasma |
|
53922-1
|
Thyroglobulin [Mass/volume] in Tissue fine needle aspirate |
|
63412-1
|
Thyroid colloidal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
63407-1
|
Thyroid colloidal Ab [Presence] in Serum by Immunofluorescence |
|
17797-2
|
Thyroid colloidal Ab [Units/volume] in Serum |
|
63413-9
|
Thyroid colloidal Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
34642-9
|
Thyroid colloidal Ab [Titer] in Serum |
|
66120-7
|
Thyroid Pathology biopsy report |
|
63362-8
|
Thyroperoxidase Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
63361-0
|
Thyroperoxidase Ab [Units/volume] in Body fluid by Immunoassay |
|
56477-3
|
Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
32042-4
|
Thyroperoxidase Ab [Presence] in Serum or Plasma |
|
5382-7
|
Thyroperoxidase Ab [Units/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
|
8099-4
|
Thyroperoxidase Ab [Units/volume] in Serum or Plasma |
|
14296-8
|
Thyroperoxidase Ab [Moles/volume] in Serum or Plasma |
|
17706-3
|
Thyroperoxidase Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
|
32786-6
|
Thyroperoxidase Ab [Titer] in Serum or Plasma |
|
5383-5
|
Thyroperoxidase Ab [Titer] in Serum or Plasma by Latex agglutination |
|
83118-0
|
Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
18332-7
|
Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma |
|
17707-1
|
Thyroperoxidase IgM Ab [Units/volume] in Serum or Plasma |
|
3018-9
|
Thyrotropin releasing hormone [Mass/volume] in Plasma |
|
70096-3
|
Thyrotropin releasing hormone [Mass/volume] in Urine |
|
90224-7
|
Thyroxine and Thyroxine.free panel - Serum or Plasma |
|
21565-7
|
tiaGABine [Mass/volume] in Serum or Plasma |
|
87769-6
|
tiaGABine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
87589-8
|
Tiamulin [Mass/mass] in Unspecified specimen |
|
90977-0
|
Tianeptine [Mass/volume] in Serum or Plasma |
|
2500-7
|
Iron binding capacity [Mass/volume] in Serum or Plasma |
|
35215-3
|
Iron binding capacity [Mass or Moles/volume] in Serum or Plasma |
|
14800-7
|
Iron binding capacity [Moles/volume] in Serum or Plasma |
|
4054-3
|
Ticarcillin [Mass/volume] in Serum or Plasma |
|
25254-4
|
Ticarcillin [Mass/volume] in Unspecified specimen |
|
82755-0
|
Geographic location where tick bite occurred |
|
45350-6
|
Tick identification panel |
|
45342-3
|
Tick identified in Unspecified specimen |
|
87547-6
|
Borrelia burgdorferi Ab and Anaplasma phagocytophilum, Babesia microti and Ehrlichia chaffeensis IgG panel - Serum |
|
38726-6
|
Titanium tetrachloride [Mass/volume] in Air |
|
11003-1
|
Ticlopidine [Mass/volume] in Serum or Plasma |
|
17709-7
|
Ticlopidine [Presence] in Urine |
|
88739-8
|
TIF1-gamma Ab [Units/volume] in Serum by Line blot |
|
82448-2
|
TIF1-gamma Ab [Presence] in Serum by Line blot |
|
82995-2
|
TIF1-gamma IgG Ab [Presence] in Serum by Line blot |
|
53170-7
|
Tiglylcarnitine (C5:1) [Moles/volume] in DBS |
|
51416-6
|
Tiglylcarnitine (C5:1) [Moles/volume] in Serum or Plasma |
|
81770-0
|
Tiglylcarnitine (C5:1)/Creatinine [Molar ratio] in Urine |
|
54342-1
|
Tiglylglycine [Moles/volume] in Cerebral spinal fluid |
|
47954-3
|
Tiglylglycine [Moles/volume] in Plasma |
|
30484-0
|
Tiglylglycine [Presence] in Urine |
|
13816-4
|
Tiglylglycine/Creatinine [Mass Ratio] in Urine |
|
24444-2
|
Tiglylglycine/Creatinine [Molar ratio] in Urine |
|
32572-0
|
Tilapia IgE Ab [Units/volume] in Serum |
|
88375-1
|
Tildipirosin [Susceptibility] by Disk diffusion (KB) |
|
88377-7
|
Tildipirosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87588-0
|
Tilmicosin [Mass/mass] in Unspecified specimen |
|
46053-5
|
Time awake Set |
|
76299-7
|
Time interval between start of doses Infusion pump |
|
89423-8
|
Time to rise from chair, walk 10 feet and back, and return to sitting [TUG] |
|
73119-0
|
Timolol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73118-2
|
Timolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4056-8
|
Timolol [Mass/volume] in Serum or Plasma |
|
55582-1
|
Timolol [Moles/volume] in Serum or Plasma |
|
30994-8
|
Timothy recombinant (rPhl p) 1 IgE Ab [Units/volume] in Serum |
|
34429-1
|
Timothy recombinant (rPhl p) 1 + 5b IgE Ab [Units/volume] in Serum |
|
31000-3
|
Timothy recombinant (rPhl p) 11 IgE Ab [Units/volume] in Serum |
|
34428-3
|
Timothy recombinant (rPhl p) 12 IgE Ab [Units/volume] in Serum |
|
30995-5
|
Timothy recombinant (rPhl p) 2 IgE Ab [Units/volume] in Serum |
|
30996-3
|
Timothy recombinant (rPhl p) 5 IgE Ab [Units/volume] in Serum |
|
58981-2
|
Timothy recombinant (rPhl p) 5b IgE Ab [Units/volume] in Serum |
|
30998-9
|
Timothy recombinant (rPhl p) 6 IgE Ab [Units/volume] in Serum |
|
30999-7
|
Timothy recombinant (rPhl p) 7 IgE Ab [Units/volume] in Serum |
|
34430-9
|
Timothy recombinant (rPhl p) 7 + 12 IgE Ab [Units/volume] in Serum |
|
7738-8
|
Timothy triggered histamine release [Units/volume] in Blood |
|
6265-3
|
Timothy IgE Ab [Units/volume] in Serum |
|
61296-0
|
Timothy IgE Ab/IgE total in Serum |
|
51535-3
|
Timothy IgG Ab [Presence] in Serum |
|
10953-8
|
Timothy IgG Ab [Units/volume] in Serum |
|
26430-9
|
Timothy IgG4 Ab [Units/volume] in Serum |
|
56403-9
|
Timothy IgG4 Ab [Mass/volume] in Serum |
|
81782-5
|
Timothy IgG Ab [Mass/volume] in Serum |
|
48260-4
|
Timothy triggered leukotriene release [Mass/volume] by Leukocytes |
|
30997-1
|
Timothy native (nPhl p) 4 IgE Ab [Units/volume] in Serum |
|
74101-7
|
Tissue inhibitor of metalloproteinases 1 [Mass/volume] in Serum or Plasma by Immunoassay |
|
29979-2
|
Tin [Mass/volume] in 24 hour Urine |
|
29980-0
|
Tin [Mass/time] in 24 hour Urine |
|
50923-2
|
Tin [Moles/time] in 24 hour Urine |
|
5747-1
|
Tin [Mass/volume] in Blood |
|
80650-5
|
Tin [Moles/volume] in Blood |
|
51208-7
|
Tin [Mass/volume] in Body fluid |
|
51209-5
|
Tin [Mass/mass] in Hair |
|
50922-4
|
Tin [Moles/mass] in Hair |
|
60189-8
|
Tin [Mass/mass] in Nail |
|
60190-6
|
Tin [Mass/volume] in Red Blood Cells |
|
5748-9
|
Tin [Mass/volume] in Serum or Plasma |
|
60191-4
|
Tin [Mass/mass] in Tissue |
|
12708-4
|
Tin [Mass/volume] in Urine |
|
50921-6
|
Tin [Moles/volume] in Urine |
|
29981-8
|
Tin/Creatinine [Mass Ratio] in 24 hour Urine |
|
52916-4
|
Tin/Creatinine [Molar ratio] in 24 hour Urine |
|
17710-5
|
Tin/Creatinine [Mass Ratio] in Urine |
|
52917-2
|
Tin/Creatinine [Molar ratio] in Urine |
|
54928-7
|
Tinidazole [Susceptibility] |
|
49667-9
|
Tipranavir [Susceptibility] by Phenotype method |
|
57383-2
|
Tipranavir [Mass/volume] in Serum |
|
49622-4
|
Tipranavir+Ritonavir [Susceptibility] by Genotype method |
|
73117-4
|
Tirofiban induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73116-6
|
Tirofiban induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
66121-5
|
Tissue Pathology biopsy report |
|
81671-0
|
Tissue perfusion assessment panel |
|
63441-0
|
Tissue polypeptide Ag [Units/volume] in Serum or Plasma |
|
14179-6
|
Tissue polypeptide Ag [Mass/volume] in Serum or Plasma |
|
29928-9
|
Titanium [Mass/volume] in 24 hour Urine |
|
29929-7
|
Titanium [Mass/time] in 24 hour Urine |
|
59753-4
|
Titanium [Mass/volume] in Blood |
|
76495-1
|
Titanium [Moles/volume] in Blood |
|
51210-3
|
Titanium [Mass/volume] in Body fluid |
|
59754-2
|
Titanium [Mass/mass] in Hair |
|
50926-5
|
Titanium [Moles/mass] in Hair |
|
59755-9
|
Titanium [Mass/volume] in Red Blood Cells |
|
52894-3
|
Titanium [Moles/volume] in Red Blood Cells |
|
8244-6
|
Titanium [Mass/volume] in Serum or Plasma |
|
50924-0
|
Titanium [Moles/volume] in Serum or Plasma |
|
59756-7
|
Titanium [Mass/mass] in Tissue |
|
50925-7
|
Titanium [Moles/mass] in Tissue |
|
5749-7
|
Titanium [Mass/volume] in Urine |
|
49108-4
|
Titanium [Mass/volume] in Unspecified specimen |
|
29930-5
|
Titanium/Creatinine [Mass Ratio] in 24 hour Urine |
|
88740-6
|
Titin Ab [Units/volume] in Serum by Line blot |
|
82449-0
|
Titin Ab [Presence] in Serum by Line blot |
|
83000-0
|
Titin IgG Ab [Presence] in Serum or Plasma by Line blot |
|
56489-8
|
Acidity.titratable [Moles/time] in 24 hour Urine |
|
14583-9
|
Acidity.titratable [Mass/volume] in Gastric fluid |
|
26813-6
|
Acidity.titratable [Moles/volume] in Gastric fluid |
|
1716-0
|
Acidity.titratable [Mass/volume] in Urine |
|
74092-8
|
Acidity.titratable [Moles/volume] in Urine |
|
59757-5
|
tiZANidine [Mass/volume] in Blood |
|
47975-8
|
tiZANidine [Mass/volume] in Serum or Plasma |
|
87774-6
|
tiZANidine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
89085-5
|
Total lung capacity measured/predicted by Plethysmograph body box |
|
81450-9
|
Total lung capacity --pre bronchodilation |
|
93324-2
|
Taurolithocholate [Moles/volume] in Serum or Plasma |
|
65336-0
|
Tm Ab [Presence] in Serum or Plasma |
|
7746-1
|
Trimellitic anhydride (TMA) IgE Ab [Units/volume] in Serum |
|
61321-6
|
Trimellitic anhydride (TMA) IgE Ab/IgE total in Serum |
|
17744-4
|
Trimellitic anhydride (TMA) IgG Ab [Units/volume] in Serum |
|
61142-6
|
Trimellitic anhydride (TMA) IgG Ab [Mass/volume] in Serum |
|
17745-1
|
Trimellitic anhydride (TMA) IgM Ab [Units/volume] in Serum |
|
90360-9
|
Trimethylamine N-oxide [Moles/volume] in Serum or Plasma by LC/MS/MS |
|
93765-6
|
Trimethylamine N-oxide [Molar amount] in Serum |
|
94077-5
|
Tumor mutation burden [Interpretation] |
|
77751-6
|
TMEM216 gene c.218G>T [Presence] in Blood or Tissue by Molecular genetics method |
|
79329-9
|
Trimethyllysine [Moles/volume] in Cerebral spinal fluid |
|
79330-7
|
Trimethyllysine [Moles/volume] in DBS |
|
79328-1
|
Trimethyllysine [Moles/volume] in Serum or Plasma |
|
79331-5
|
Trimethyllysine/Creatinine [Molar ratio] in Urine |
|
60204-5
|
Trimethadione [Mass/volume] in Blood |
|
4078-2
|
Trimethadione [Mass/volume] in Serum or Plasma |
|
60205-2
|
Trimethadione [Mass/volume] in Urine |
|
80629-9
|
1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Blood |
|
54099-7
|
1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Urine |
|
80406-2
|
Date and time of initial encounter |
|
69488-5
|
TNFRSF13B gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
69487-7
|
TNFRSF13B gene full mutation analysis in Blood or Tissue by Sequencing |
|
57758-5
|
TNFRSF13B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
57754-4
|
TNFRSF13B gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
40463-2
|
TNFRSF1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41049-8
|
TNFRSF1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75629-6
|
Tumor necrosis factor receptor superfamily member 1A [Mass/volume] in Serum or Plasma |
|
75620-5
|
TNM clinical staging before treatment panel Cancer |
|
75621-3
|
TNM pathologic staging after surgery panel Cancer |
|
81880-7
|
TNNT2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
81881-5
|
TNNT3 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
88003-9
|
TOAST Classification of subtypes of acute ischemic stroke |
|
72166-2
|
Tobacco smoking status |
|
7740-4
|
Tobacco triggered histamine release [Units/volume] in Blood |
|
6859-3
|
Tobacco IgE Ab [Units/volume] in Serum |
|
7739-6
|
Tobacco IgG Ab [Units/volume] in Serum |
|
56404-7
|
Tobacco IgG4 Ab [Mass/volume] in Serum |
|
63180-4
|
Tobacco IgG Ab [Mass/volume] in Serum |
|
88029-4
|
Tobacco use duration |
|
88028-6
|
Tobacco use panel |
|
52962-8
|
Tobramycin [Mass/volume] in Cerebral spinal fluid |
|
13584-8
|
Tobramycin [Mass/volume] in Body fluid |
|
80966-5
|
Tobramycin free [Mass/volume] in Serum or Plasma |
|
56705-7
|
Tobramycin IgE Ab [Units/volume] in Serum |
|
73115-8
|
Tobramycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73114-1
|
Tobramycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59380-6
|
Tobramycin [Mass/volume] in Serum or Plasma --post dialysis |
|
4057-6
|
Tobramycin [Mass/volume] in Serum or Plasma --peak |
|
22751-2
|
Tobramycin [Moles/volume] in Serum or Plasma --peak |
|
31094-6
|
Tobramycin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
|
31096-1
|
Tobramycin [Mass/volume] in Serum or Plasma --random post extended interval dosing |
|
4058-4
|
Tobramycin [Mass/volume] in Serum or Plasma --random |
|
22750-4
|
Tobramycin [Moles/volume] in Serum or Plasma --random |
|
35670-9
|
Tobramycin [Mass/volume] in Serum or Plasma |
|
50927-3
|
Tobramycin [Moles/volume] in Serum or Plasma |
|
31095-3
|
Tobramycin [Mass/volume] in Serum or Plasma --trough post extended interval dosing |
|
4059-2
|
Tobramycin [Mass/volume] in Serum or Plasma --trough |
|
35239-3
|
Tobramycin [Mass or Moles/volume] in Serum or Plasma --trough |
|
22752-0
|
Tobramycin [Moles/volume] in Serum or Plasma --trough |
|
17808-7
|
Tobramycin [Mass/volume] in Urine |
|
4060-0
|
Tocainide [Mass/volume] in Serum or Plasma |
|
39794-3
|
Tocainide [Moles/volume] in Serum or Plasma |
|
87672-2
|
Tocopherol+tocotrienol [Mass/mass] in Unspecified specimen |
|
74544-8
|
Tocopherols [Entitic substance] in Red Blood Cells |
|
47791-9
|
Tocopherols [Mass/volume] in Serum or Plasma |
|
29747-3
|
Tocopherols [Moles/volume] in Serum or Plasma |
|
60833-1
|
Toe temperature |
|
39567-3
|
Tolazamide [Mass/volume] in 24 hour Urine |
|
21566-5
|
Tolazamide [Presence] in Serum or Plasma |
|
9629-7
|
Tolazamide [Mass/volume] in Serum or Plasma |
|
27166-8
|
Tolazamide [Mass/volume] in Urine |
|
48323-0
|
Tolazamide [Presence] in Unspecified specimen |
|
6951-8
|
Tolazamide [Mass/volume] in Unspecified specimen |
|
39568-1
|
Tolbutamide [Mass/volume] in 24 hour Urine |
|
21567-3
|
Tolbutamide [Presence] in Serum or Plasma |
|
4061-8
|
Tolbutamide [Mass/volume] in Serum or Plasma |
|
32118-2
|
Tolbutamide [Moles/volume] in Serum or Plasma |
|
27170-0
|
Tolbutamide [Mass/volume] in Urine |
|
48321-4
|
Tolbutamide [Presence] in Unspecified specimen |
|
6952-6
|
Tolbutamide [Mass/volume] in Unspecified specimen |
|
12441-2
|
Tolmetin [Mass/volume] in Serum or Plasma |
|
73112-5
|
Tolterodine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73113-3
|
Tolterodine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
38621-9
|
Toluene [Mass/volume] in Air |
|
9637-0
|
Toluene [Mass/volume] in Blood |
|
5750-5
|
Toluene [Mass/volume] in Serum or Plasma |
|
9638-8
|
Toluene [Mass/volume] in Urine |
|
7742-0
|
Tomato triggered histamine release [Units/volume] in Blood |
|
6266-1
|
Tomato IgE Ab [Units/volume] in Serum |
|
40841-9
|
Tomato IgE Ab/IgE total in Serum |
|
6736-3
|
Tomato IgG Ab [Units/volume] in Serum |
|
56405-4
|
Tomato IgG4 Ab [Mass/volume] in Serum |
|
35547-9
|
Tomato IgG Ab [Mass/volume] in Serum |
|
48213-3
|
Tomato triggered leukotriene release [Mass/volume] by Leukocytes |
|
79896-7
|
Tonometry measurements panel |
|
28630-2
|
Tonometry study |
|
63070-7
|
TOP2A gene 17q21-22 deletion and duplication mutation analysis [Presence] in Tissue by FISH |
|
72940-0
|
Topiramate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72939-2
|
Topiramate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60192-2
|
Topiramate [Mass/volume] in Blood |
|
80965-7
|
Topiramate free [Mass/volume] in Serum or Plasma |
|
73111-7
|
Topiramate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73110-9
|
Topiramate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
49516-8
|
Topiramate [Mass/volume] in Serum or Plasma --peak |
|
17713-9
|
Topiramate [Mass/volume] in Serum or Plasma |
|
25541-4
|
Topiramate [Moles/volume] in Serum or Plasma |
|
49517-6
|
Topiramate [Mass/volume] in Serum or Plasma --trough |
|
60193-0
|
Topiramate [Mass/volume] in Urine |
|
87770-4
|
Topiramate/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
73678-5
|
Topotecan [Mass/volume] in Serum or Plasma --trough |
|
34489-5
|
TOR1A gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
|
34495-2
|
TOR1A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38411-5
|
TOR1A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
24314-7
|
TORCH 1996 panel - Serum |
|
34665-0
|
TORCH panel - Cerebral spinal fluid |
|
10722-7
|
Torovirus [Identifier] in Stool by Electron microscopy |
|
78018-9
|
Toscana virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
77951-2
|
Toscana virus IgG Ab [Presence] in Serum by Immunoassay |
|
78019-7
|
Toscana virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
77950-4
|
Toscana virus IgM Ab [Presence] in Serum by Immunoassay |
|
88598-8
|
Toscana virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
86591-5
|
Toscana virus RNA [Presence] in Serum by NAA with probe detection |
|
33767-5
|
Acidity.total [Moles/volume] in Gastric fluid |
|
4531-0
|
Complement total hemolytic [Units/volume] in Blood |
|
13834-7
|
Total IgE [Units/volume] in Serum by Radioallergosorbent test (RAST) |
|
82323-7
|
Total interval score [HOOSJR] |
|
82332-8
|
Total interval score [KOOSJR] |
|
86335-7
|
Total interval score change [HOOSJR] |
|
86336-5
|
Total interval score change [KOOSJR] |
|
77595-7
|
Total physical activity score [IPAQ] |
|
75941-5
|
Total power of power spectrum on EEG |
|
84772-3
|
Total score [BSDS] |
|
75698-1
|
Total score [COOP.WONCA] |
|
75810-2
|
Total score [COOP] |
|
76504-0
|
Total score [HARK] |
|
84773-1
|
Total score [MDQ] |
|
82237-9
|
Total score [NDI] |
|
88175-5
|
Total score [PAM] |
|
89436-0
|
Total score [Rose Dyspnea Scale] |
|
91351-7
|
Total score [STarT Back] |
|
88176-3
|
Total score Caregiver [PAM] |
|
91392-1
|
Total score ORT |
|
88174-8
|
Total score Parent [PAM] |
|
74795-6
|
Total thyroxine binding capacity in Serum or Plasma |
|
38622-7
|
Toxaphene [Mass/volume] in Air |
|
17714-7
|
Toxaphene [Mass/volume] in Serum or Plasma |
|
87632-6
|
Toxaphene [Mass/mass] in Unspecified specimen |
|
10692-2
|
Mushroom.toxic identified in Food by Light microscopy |
|
10691-4
|
Mushroom.toxic identified by Inspection |
|
10693-0
|
Mushroom.toxic identified in Vomitus by Light microscopy |
|
10708-6
|
Toxic Plant identified in Vomitus by Light microscopy |
|
10707-8
|
Toxic Plant identified in Plant specimen by Inspection |
|
32148-9
|
Toxic substance identified in Urine |
|
29587-3
|
Toxicology panel - Blood |
|
77743-3
|
Toxocara sp Ab [Presence] in Ocular fluid by Immunoassay |
|
43225-2
|
Toxocara sp Ab [Units/volume] in Serum by Immunoassay |
|
26660-1
|
Toxocara sp Ab [Presence] in Serum |
|
40830-2
|
Toxocara sp Ab [Units/volume] in Serum |
|
21739-8
|
TP53 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
35744-2
|
TP73L gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
5989-9
|
Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis |
|
5988-1
|
Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis |
|
5990-7
|
Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis |
|
5973-3
|
Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis |
|
5972-5
|
Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis |
|
5971-7
|
Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay |
|
5986-5
|
Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method |
|
5987-3
|
Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method |
|
43636-0
|
Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method |
|
5983-2
|
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis |
|
5982-4
|
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis |
|
5981-6
|
Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay |
|
11063-5
|
Triosephosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
|
44054-5
|
Triosephosphate isomerase [Enzymatic activity/mass] in Red Blood Cells |
|
3058-5
|
Triosephosphate isomerase [Enzymatic activity/volume] in Serum |
|
93193-1
|
TPMT gene and NUDT15 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
91139-6
|
Thiopurine methyltransferase activity panel - Red Blood Cells |
|
53819-9
|
Thiopurine methyltransferase [Enzymatic activity/volume] in Blood |
|
49654-7
|
TPMT gene c.238G>C [Presence] in Blood or Tissue by Molecular genetics method |
|
71356-0
|
TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
49655-4
|
TPMT gene c.460G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
49653-9
|
TPMT gene c.719A>G [Presence] in Blood or Tissue by Molecular genetics method |
|
79468-5
|
Thiopurine methyltransferase [Enzymatic activity/substance] in Red Blood Cells |
|
36922-3
|
TPMT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41048-0
|
TPMT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
80738-8
|
TPMT gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
21563-2
|
Thiopurine methyltransferase [Enzymatic activity/volume] in Red Blood Cells |
|
43421-7
|
Thiopurine methyltransferase [Enzymatic activity/mass] in Red Blood Cells |
|
81812-0
|
TPP1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
19185-8
|
Tissue polypeptide specific Ag [Units/volume] in Pleural fluid |
|
19184-1
|
Tissue polypeptide specific Ag [Units/volume] in Serum or Plasma |
|
25799-8
|
Tissue polypeptide specific Ag [Units/volume] in Urine |
|
65337-8
|
Tr sup(a) Ab [Presence] in Serum or Plasma |
|
78216-9
|
TRA+TRD gene rearrangements [Presence] in Blood or Tissue by FISH |
|
76770-7
|
Trace elements panel - Hair |
|
21740-6
|
TRAF3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
7743-8
|
Tragacanth IgE Ab [Units/volume] in Serum |
|
79147-5
|
traMADol [Presence] in Blood by Confirmatory method |
|
79148-3
|
traMADol [Presence] in Blood by Screen method |
|
73932-6
|
traMADol [Mass/volume] in Blood |
|
73109-1
|
traMADol induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73108-3
|
traMADol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
93720-1
|
traMADol [Mass/mass] in Meconium by Confirmatory method |
|
72740-4
|
traMADol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
74110-8
|
traMADol [Presence] in Saliva (oral fluid) by Screen method |
|
12437-0
|
traMADol [Mass/volume] in Serum or Plasma |
|
48355-2
|
traMADol [Moles/volume] in Serum or Plasma |
|
20561-7
|
traMADol [Mass/volume] in Urine by Confirmatory method |
|
43219-5
|
traMADol [Presence] in Urine |
|
17718-8
|
traMADol [Presence] in Urine by Confirmatory method |
|
19710-3
|
traMADol [Presence] in Urine by Screen method |
|
17719-6
|
traMADol [Mass/volume] in Urine |
|
58404-5
|
traMADol/Creatinine [Mass Ratio] in Urine |
|
33046-4
|
Tranquilizers [Presence] in Serum or Plasma by Screen method |
|
33047-2
|
Tranquilizers [Presence] in Urine by Screen method |
|
50669-1
|
Transfuse antithrombin [Volume] |
|
46136-8
|
Transitional cells [#/area] in Urine sediment by Microscopy low power field |
|
54427-0
|
Transfuse frozen erythrocytes newborn units [Volume] |
|
17721-2
|
Trans nonachlor [Mass/volume] in Blood |
|
23937-6
|
Trans nonachlor [Mass/volume] in Serum or Plasma |
|
17720-4
|
Trans nonachlor [Mass/volume] in Urine |
|
78887-7
|
Trans-3-Hydroxycotinine [Mass/volume] in Saliva (oral fluid) |
|
35140-3
|
Trans-3-Hydroxycotinine [Mass/volume] in Serum or Plasma |
|
33916-8
|
Trans-3-Hydroxycotinine [Mass/volume] in Urine |
|
75059-6
|
Transaldolase [Enzymatic activity/mass] in Fibroblast |
|
73731-2
|
Transaldolase [Enzymatic activity/mass] in Lymphoblasts |
|
3029-6
|
Transcobalamin I [Mass/volume] in Serum |
|
59211-3
|
Transcobalamin I+Transcobalamin III [Moles/volume] in Serum |
|
3030-4
|
Transcobalamin II [Mass/volume] in Serum |
|
32341-0
|
Transcobalamin II [Moles/volume] in Serum |
|
3031-2
|
Transcobalamin III [Mass/volume] in Serum |
|
3032-0
|
Transcobalamin [Mass/volume] in Serum |
|
18378-0
|
Transcortin [Mass/volume] in Cerebral spinal fluid |
|
3033-8
|
Transcortin [Mass/volume] in Serum |
|
68315-1
|
Transcortin and Cortisol.free panel - Serum or Plasma |
|
14924-5
|
Transfusion reaction [Interpretation] in Plasma or RBC Narrative |
|
74199-1
|
Transferred from another acute care facility [NTDS] |
|
18761-7
|
Transfer summary note |
|
74977-0
|
Transferrin [Mass/time] in 24 hour Urine |
|
3034-6
|
Transferrin [Mass/volume] in Serum or Plasma |
|
35229-4
|
Transferrin [Mass or Moles/volume] in Serum or Plasma |
|
22674-6
|
Transferrin [Moles/volume] in Serum or Plasma |
|
3035-3
|
Transferrin [Mass/volume] in Urine |
|
86271-4
|
Transferrin.gastrointestinal [Mass/volume] in Stool by Immunoassay |
|
89428-7
|
Blood or blood product transfusion consent Document |
|
34609-8
|
Transketolase [Enzymatic activity/mass] in Blood |
|
3036-1
|
Transketolase [Enzymatic activity/volume] in Serum |
|
76522-2
|
Transmission Arterial blood Pulse oximetry |
|
76520-6
|
Transmission.infrared Arterial blood Pulse oximetry |
|
76521-4
|
Transmission.red Arterial blood Pulse oximetry |
|
48368-5
|
trans-Octadecanoate (C18:0) [Moles/volume] in Serum or Plasma |
|
83676-7
|
Transplant surgery Attending Note |
|
83841-7
|
Transplant surgery Case manager Note |
|
83780-7
|
Transplant surgery Resident Note |
|
78731-7
|
Transplant surgery Admission history and physical note |
|
78539-4
|
Transplant surgery Checklist |
|
84035-5
|
Transplant surgery Consult note |
|
78598-0
|
Transplant surgery Education note |
|
78629-3
|
Transplant surgery Flowsheet |
|
68849-9
|
Transplant surgery History and physical note |
|
68852-3
|
Transplant surgery Hospital Consult note |
|
68853-1
|
Transplant surgery Hospital Letter |
|
70238-1
|
Transplant surgery Hospital Progress note |
|
82835-0
|
Transplant surgery Initial evaluation note |
|
68848-1
|
Transplant surgery Note |
|
84036-3
|
Transplant surgery Outpatient Note |
|
78244-1
|
Transplant surgery Surgical operation note |
|
84037-1
|
Transplant surgery Telephone encounter Note |
|
80763-6
|
Transplant surgery Plan of care note |
|
68850-7
|
Transplant surgery Preoperative evaluation and management note |
|
68851-5
|
Transplant surgery procedure note |
|
78677-2
|
Transplant surgery Referral note |
|
78683-0
|
Transplant surgery Transfer summary note |
|
77596-5
|
Transportation summary Document |
|
75920-9
|
Transthoracic impedance |
|
48369-3
|
trans-Vaccenate (C18:1w7) [Moles/volume] in Serum or Plasma |
|
47979-0
|
Tranylcypromine [Presence] in Serum or Plasma |
|
10344-0
|
Tranylcypromine [Mass/volume] in Serum or Plasma |
|
55583-9
|
Tranylcypromine [Moles/volume] in Serum or Plasma |
|
58030-8
|
Tranylcypromine [Presence] in Urine |
|
4062-6
|
Tranylcypromine [Mass/volume] in Urine |
|
11020-5
|
Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain |
|
32824-5
|
Microscopic observation [Identifier] in Unspecified specimen by Tartrate-resistant acid phosphatase stain |
|
53894-2
|
TRAPPC2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
60801-8
|
Trapped lung volume --at end expiration |
|
78732-5
|
Trauma Consult note |
|
93969-4
|
Trauma Diagnostic study note |
|
89815-5
|
Trauma Initial evaluation note |
|
89036-8
|
Trauma Note |
|
90708-9
|
Trauma Outpatient Note |
|
78240-9
|
Trauma Surgical operation note |
|
89817-1
|
Trauma procedure note |
|
87513-8
|
Trauma Process of care measures Document |
|
89816-3
|
Trauma Progress note |
|
74198-3
|
Trauma Summary registry report |
|
89561-5
|
Trauma symptoms score [CUBS] |
|
82752-7
|
Date travel started |
|
40402-0
|
traZODone [Presence] in Gastric fluid |
|
59976-1
|
traZODone [Moles/volume] in Gastric fluid |
|
4063-4
|
traZODone [Presence] in Serum or Plasma |
|
35635-2
|
traZODone [Mass/volume] in Serum or Plasma by Screen method |
|
4064-2
|
traZODone [Mass/volume] in Serum or Plasma |
|
14925-2
|
traZODone [Moles/volume] in Serum or Plasma |
|
72672-9
|
traZODone [Mass/volume] in Serum or Plasma --trough |
|
92637-8
|
traZODone [Mass/volume] in Urine by Confirmatory method |
|
4065-9
|
traZODone [Presence] in Urine |
|
92653-5
|
traZODone [Presence] in Urine by Confirmatory method |
|
16281-8
|
traZODone [Units/volume] in Urine |
|
27059-5
|
traZODone [Mass/volume] in Urine |
|
59975-3
|
traZODone [Moles/volume] in Urine |
|
60335-7
|
traZODone [Moles/volume] in Unspecified specimen |
|
82481-3
|
TRBV28 gene segment/TRBV gene segments.total in Blood |
|
91547-0
|
Treadmill angina [Identifier] |
|
88057-5
|
Treatment for abnormal Pap test |
|
87534-4
|
Challenges for treatment plan maintenance panel |
|
46062-6
|
Treatments Set |
|
62320-7
|
T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection |
|
92008-2
|
T-cell receptor excision circle [Multiple of the median] in DBS |
|
92007-4
|
T-cell receptor excision circle [Z-score] in DBS |
|
15269-4
|
Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multidisk |
|
71371-9
|
Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Units/volume] in Serum by Multidisk |
|
24512-6
|
Tree Allergen Mix C (Berry juniper+Oneseed juniper+Rocky mountain juniper) IgE Ab [Units/volume] in Serum by Multidisk |
|
15263-7
|
Tree Allergen Mix D (Cottonwood+Elm+Maple+Oak+Pecan tree) IgE Ab [Presence] in Serum by Multidisk |
|
15265-2
|
Tree Allergen Mix E (American sycamore+Cottonwood+White oak+Willow+White elm) IgE Ab [Presence] in Serum by Multidisk |
|
15262-9
|
Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multidisk |
|
30184-6
|
Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Units/volume] in Serum by Multidisk |
|
15260-3
|
Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Presence] in Serum by Multidisk |
|
82111-6
|
Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Units/volume] in Serum by Multidisk |
|
23797-4
|
Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Presence] in Serum by Multidisk |
|
82031-6
|
Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Units/volume] in Serum by Multidisk |
|
15264-5
|
Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Presence] in Serum by Multidisk |
|
82032-4
|
Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Units/volume] in Serum by Multidisk |
|
51527-0
|
Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk |
|
24491-3
|
Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk |
|
15266-0
|
Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk |
|
69959-5
|
Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk |
|
15267-8
|
Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multidisk |
|
82035-7
|
Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Units/volume] in Serum by Multidisk |
|
15268-6
|
Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Presence] in Serum by Multidisk |
|
30182-0
|
Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Units/volume] in Serum by Multidisk |
|
15270-2
|
Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Presence] in Serum by Multidisk |
|
50653-5
|
Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Units/volume] in Serum by Multidisk |
|
7744-6
|
Tree of Heaven IgE Ab [Units/volume] in Serum |
|
3038-7
|
Trehalase [Enzymatic activity/volume] in Urine |
|
73565-4
|
Trenbolone [Presence] in Urine |
|
10893-6
|
Trenbolone [Mass/volume] in Urine |
|
89253-9
|
Trend |
|
26658-5
|
Treponema sp Ab [Presence] in Serum |
|
6465-9
|
Microscopic observation [Identifier] in Duodenal fluid by Trichrome stain |
|
6469-1
|
Microscopic observation [Identifier] in Stool by Trichrome stain |
|
6473-3
|
Microscopic observation [Identifier] in Tissue by Trichrome stain |
|
678-3
|
Microscopic observation [Identifier] in Unspecified specimen by Trichrome stain |
|
75500-9
|
Triage note |
|
41767-5
|
Triamcinolone acetonide [Mass/volume] in Serum or Plasma |
|
46958-5
|
Triamcinolone acetonide [Mass/volume] in Urine |
|
73107-5
|
Triamcinolone induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73106-7
|
Triamcinolone induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41766-7
|
Triamcinolone [Mass/volume] in Serum or Plasma |
|
46957-7
|
Triamcinolone [Mass/volume] in Urine |
|
4067-5
|
Triamterene [Mass/time] in 24 hour Urine |
|
60194-8
|
Triamterene [Mass/volume] in Blood |
|
73104-2
|
Triamterene induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73105-9
|
Triamterene induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
10551-0
|
Triamterene [Mass/volume] in Serum or Plasma |
|
4068-3
|
Triamterene [Presence] in Urine |
|
17730-3
|
Triamterene [Units/volume] in Urine |
|
4066-7
|
Triamterene [Mass/volume] in Urine |
|
91664-3
|
Triangle bur ragweed (Ambrosia deltoidea) IgE Ab [Units/volume] in Serum |
|
59759-1
|
Triazolam [Mass/volume] in Blood by Confirmatory method |
|
59758-3
|
Triazolam [Mass/volume] in Blood |
|
59761-7
|
Triazolam [Mass/volume] in Body fluid by Confirmatory method |
|
59760-9
|
Triazolam [Mass/volume] in Body fluid |
|
61092-3
|
Triazolam [Presence] in Gastric fluid |
|
26945-6
|
Triazolam [Mass/mass] in Hair |
|
73102-6
|
Triazolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73103-4
|
Triazolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
26913-4
|
Triazolam [Mass/mass] in Meconium |
|
78883-6
|
Triazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
59762-5
|
Triazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
61064-2
|
Triazolam [Presence] in Serum or Plasma |
|
4069-1
|
Triazolam [Mass/volume] in Serum or Plasma |
|
14926-0
|
Triazolam [Moles/volume] in Serum or Plasma |
|
12384-4
|
Triazolam [Presence] in Stool |
|
27286-4
|
Triazolam [Mass/mass] in Stool |
|
59764-1
|
Triazolam [Mass/mass] in Tissue by Confirmatory method |
|
59763-3
|
Triazolam [Mass/mass] in Tissue |
|
16232-1
|
Triazolam [Mass/volume] in Urine by Confirmatory method |
|
14192-9
|
Triazolam [Presence] in Urine |
|
16224-8
|
Triazolam [Presence] in Urine by Confirmatory method |
|
19714-5
|
Triazolam [Presence] in Urine by Screen method |
|
4070-9
|
Triazolam [Mass/volume] in Urine |
|
26686-6
|
Triazolam [Mass/volume] in Vitreous fluid |
|
61093-1
|
Triazolam [Presence] in Unspecified specimen |
|
48966-6
|
Triazolam [Mass/volume] in Unspecified specimen |
|
77327-5
|
Triazolam [Moles/volume] in Unspecified specimen |
|
26661-9
|
Trichinella sp Ab [Presence] in Serum |
|
33587-7
|
Trichinella sp IgA Ab [Units/volume] in Serum |
|
32723-9
|
Trichinella sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
56992-1
|
Trichinella sp IgG Ab [Presence] in Serum by Immunofluorescence |
|
32768-4
|
Trichinella sp IgG Ab [Units/volume] in Serum |
|
27426-6
|
Trichinella sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
31687-7
|
Trichinella sp IgM Ab [Units/volume] in Serum |
|
10728-4
|
Trichomonas sp identified in Genital specimen by Organism specific culture |
|
32724-7
|
Trichomonas sp [Presence] in Urine by Light microscopy |
|
68458-9
|
Trichomonas sp identified in Unspecified specimen by Organism specific culture |
|
7745-3
|
Trichophyton sp IgE Ab [Units/volume] in Serum |
|
49116-7
|
Trichosporon sp DNA [Units/volume] in Serum by NAA with probe detection |
|
49593-7
|
Trichothecene IgA Ab [Units/volume] in Serum by Immunoassay |
|
53388-5
|
Trichothecene IgA Ab [Units/volume] in Serum |
|
49597-8
|
Trichothecene IgE Ab [Units/volume] in Serum by Immunoassay |
|
53389-3
|
Trichothecene IgE Ab [Units/volume] in Serum |
|
49594-5
|
Trichothecene IgG Ab [Units/volume] in Serum by Immunoassay |
|
53390-1
|
Trichothecene IgG Ab [Units/volume] in Serum |
|
49595-2
|
Trichothecene IgM Ab [Units/volume] in Serum by Immunoassay |
|
53391-9
|
Trichothecene IgM Ab [Units/volume] in Serum |
|
60197-1
|
Triclopyr [Mass/volume] in Serum or Plasma |
|
80146-4
|
Tricyclic antidepressants [Presence] in Blood by Screen method |
|
80147-2
|
Tricyclic antidepressants [Presence] in Body fluid by Screen method |
|
29228-4
|
Tricyclic antidepressants [Mass/volume] in Body fluid |
|
78893-5
|
Tricyclic antidepressants [Presence] in Gastric fluid |
|
78891-9
|
Tricyclic antidepressants [Presence] in Hair |
|
4073-3
|
Tricyclic antidepressants [Presence] in Serum or Plasma |
|
80148-0
|
Tricyclic antidepressants [Presence] in Serum or Plasma by Screen method |
|
10552-8
|
Tricyclic antidepressants [Mass/volume] in Serum or Plasma |
|
15111-8
|
Tricyclic antidepressants [Moles/volume] in Serum or Plasma |
|
16181-0
|
Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method |
|
11004-9
|
Tricyclic antidepressants [Presence] in Urine |
|
19315-1
|
Tricyclic antidepressants [Presence] in Urine by Confirmatory method |
|
6799-1
|
Tricyclic antidepressants [Presence] in Urine by Immunoassay |
|
19312-8
|
Tricyclic antidepressants [Presence] in Urine by Screen method |
|
80149-8
|
Tricyclic antidepressants [Presence] in Urine by Screen method >1000 ng/mL |
|
78889-3
|
Tricyclic antidepressants [Presence] in Urine by Screen method >300 ng/mL |
|
20663-1
|
Tricyclic antidepressants [Mass/volume] in Urine by Screen method |
|
50543-8
|
Tricyclic antidepressants [Mass/volume] in Urine |
|
34176-8
|
Tricyclic antidepressants [Presence] in Unspecified specimen |
|
58403-7
|
Tricyclic antidepressants/Creatinine [Mass Ratio] in Urine |
|
38731-6
|
Triethylamine [Mass/volume] in Air |
|
38732-4
|
Trifluralin [Mass/volume] in Air |
|
60198-9
|
Trifluralin [Mass/volume] in Blood |
|
60199-7
|
Trifluralin [Mass/volume] in Serum or Plasma |
|
60200-3
|
Trifluralin [Mass/volume] in Urine |
|
75771-6
|
Trifluoperazine [Presence] in Blood or Urine by Screen method |
|
13585-5
|
Trifluoperazine [Presence] in Serum or Plasma |
|
4074-1
|
Trifluoperazine [Mass/volume] in Serum or Plasma |
|
39795-0
|
Trifluoperazine [Moles/volume] in Serum or Plasma |
|
12321-6
|
Trifluoperazine [Presence] in Urine |
|
89965-8
|
Trifluoperazine [Presence] in Urine by Screen method |
|
45146-8
|
Triflupromazine [Presence] in Serum or Plasma |
|
12422-2
|
Triflupromazine [Mass/volume] in Serum or Plasma |
|
12322-4
|
Triflupromazine [Presence] in Urine |
|
35362-3
|
Triglyceride in Chylomicrons [Presence] in Serum or Plasma |
|
35363-1
|
Triglyceride in Chylomicrons [Mass/volume] in Serum or Plasma |
|
77360-6
|
Triglyceride [Mass/mass] in 24 hour Stool |
|
77361-4
|
Triglyceride [Mass/time] in 24 hour Stool |
|
59571-0
|
Triglyceride [Moles/time] in 24 hour Urine |
|
14445-1
|
Triglyceride [Mass/volume] in Amniotic fluid |
|
3043-7
|
Triglyceride [Mass/volume] in Blood |
|
70218-3
|
Triglyceride [Moles/volume] in Blood |
|
14446-9
|
Triglyceride [Mass/volume] in Cerebral spinal fluid |
|
59036-4
|
Triglyceride [Mass/volume] in Peritoneal dialysis fluid |
|
12228-3
|
Triglyceride [Mass/volume] in Body fluid |
|
29766-3
|
Triglyceride [Moles/volume] in Body fluid |
|
53527-8
|
Triglyceride in HDL 2 [Moles/volume] in Serum or Plasma |
|
53528-6
|
Triglyceride in HDL 3 [Moles/volume] in Serum or Plasma |
|
53526-0
|
Triglyceride in VLDL [Moles/volume] in Serum or Plasma |
|
1644-4
|
Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting |
|
30524-3
|
Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting |
|
3048-6
|
Triglyceride [Mass/volume] in Serum or Plasma --fasting |
|
47210-0
|
Triglyceride [Moles/volume] in Serum or Plasma --fasting |
|
70259-7
|
Triglyceride in pericardial fluid/Triglyceride in serum |
|
69947-0
|
Triglyceride [Moles/volume] in Pericardial fluid |
|
70269-6
|
Triglyceride in pleural fluid/Triglyceride in serum |
|
9619-8
|
Triglyceride [Mass/volume] in Pleural fluid |
|
39801-6
|
Triglyceride [Moles/volume] in Pleural fluid |
|
30570-6
|
Triglyceride [Percentile] |
|
70260-5
|
Triglyceride in peritoneal fluid/Triglyceride in serum |
|
14447-7
|
Triglyceride [Mass/volume] in Peritoneal fluid |
|
66769-1
|
Triglyceride [Moles/volume] in Peritoneal fluid |
|
28554-4
|
Triglyceride [Presence] in Serum or Plasma |
|
2571-8
|
Triglyceride [Mass/volume] in Serum or Plasma |
|
35217-9
|
Triglyceride [Mass or Moles/volume] in Serum or Plasma |
|
14927-8
|
Triglyceride [Moles/volume] in Serum or Plasma |
|
14448-5
|
Triglyceride [Mass/volume] in Semen |
|
14449-3
|
Triglyceride [Mass/volume] in Synovial fluid |
|
51605-4
|
Triglyceride [Moles/volume] in Synovial fluid |
|
14450-1
|
Triglyceride [Mass/volume] in Urine |
|
59572-8
|
Triglyceride [Moles/volume] in Urine |
|
22731-4
|
Triglyceride [Moles/volume] in Unspecified specimen |
|
55607-6
|
Triglyceride/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
|
3044-5
|
Triglyceride+ester in HDL [Mass/volume] in Serum or Plasma |
|
3045-2
|
Triglyceride+ester in IDL [Mass/volume] in Serum or Plasma |
|
3046-0
|
Triglyceride+ester in LDL [Mass/volume] in Serum or Plasma |
|
3047-8
|
Triglyceride+ester in VLDL [Mass/volume] in Serum or Plasma |
|
9703-0
|
Trihexyphenidyl [Mass/volume] in Serum or Plasma |
|
10345-7
|
Trihexyphenidyl [Mass/volume] in Urine |
|
4077-4
|
Trimeperidine [Mass/time] in 24 hour Urine |
|
4075-8
|
Trimeperidine [Presence] in Urine |
|
4076-6
|
Trimeperidine [Mass/volume] in Urine |
|
79149-1
|
Trimeprazine [Mass/volume] in Body fluid |
|
80150-6
|
Trimeprazine [Mass/mass] in Hair |
|
17746-9
|
Trimeprazine [Presence] in Serum or Plasma |
|
12423-0
|
Trimeprazine [Mass/volume] in Serum or Plasma |
|
39482-5
|
Trimeprazine [Moles/volume] in Serum or Plasma |
|
12323-2
|
Trimeprazine [Presence] in Urine |
|
78888-5
|
Trimeprazine [Mass/volume] in Urine |
|
17748-5
|
Trimethylamine [Presence] in Urine |
|
3056-9
|
Trimethylamine [Mass/volume] in Urine |
|
21580-6
|
Trimethobenzamide [Mass/volume] in Unspecified specimen |
|
72938-4
|
Trimethoprim induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72937-6
|
Trimethoprim induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80552-3
|
Trimethoprim [Mass/volume] in DBS |
|
80973-1
|
Trimethoprim free [Mass/volume] in Serum or Plasma |
|
18258-4
|
Trimethoprim IgE Ab [Units/volume] in Serum |
|
73100-0
|
Trimethoprim induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73101-8
|
Trimethoprim induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
48195-2
|
Trimethoprim triggered leukotriene release [Mass/volume] by Leukocytes |
|
4079-0
|
Trimethoprim [Presence] in Serum or Plasma |
|
11005-6
|
Trimethoprim [Mass/volume] in Serum or Plasma |
|
55584-7
|
Trimethoprim [Moles/volume] in Serum or Plasma |
|
4080-8
|
Trimethoprim [Presence] in Urine |
|
17747-7
|
Trimethoprim [Mass/volume] in Urine |
|
57767-6
|
Trimipramine and Nortrimipramine panel - Serum or Plasma |
|
25812-9
|
Trimipramine+Nortrimipramine [Moles/volume] in Serum or Plasma |
|
77337-4
|
Trimipramine+Nortrimipramine [Moles/volume] in Unspecified specimen |
|
40403-8
|
Trimipramine [Presence] in Gastric fluid |
|
29402-5
|
Trimipramine [Mass/volume] in Gastric fluid |
|
47133-4
|
Trimipramine [Moles/volume] in Gastric fluid |
|
4082-4
|
Trimipramine [Presence] in Serum or Plasma |
|
4083-2
|
Trimipramine [Mass/volume] in Serum or Plasma |
|
14931-0
|
Trimipramine [Moles/volume] in Serum or Plasma |
|
4084-0
|
Trimipramine [Presence] in Urine |
|
12443-8
|
Trimipramine [Mass/volume] in Urine |
|
47134-2
|
Trimipramine [Moles/volume] in Urine |
|
60336-5
|
Trimipramine [Moles/volume] in Unspecified specimen |
|
16466-5
|
Bile acid.trihydroxy [Mass/volume] in Serum or Plasma |
|
38188-9
|
Bile acid.trihydroxy [Moles/volume] in Serum or Plasma |
|
3057-7
|
Triokinase [Enzymatic activity/volume] in Plasma |
|
60206-0
|
Tripelennamine [Mass/volume] in Blood |
|
40404-6
|
Tripelennamine [Presence] in Gastric fluid |
|
75764-1
|
Tripelennamine [Presence] in Serum or Plasma or Urine by Screen method |
|
4085-7
|
Tripelennamine [Mass/volume] in Serum or Plasma |
|
55585-4
|
Tripelennamine [Moles/volume] in Serum or Plasma |
|
14193-7
|
Tripelennamine [Presence] in Urine |
|
27280-7
|
Tripelennamine [Mass/volume] in Urine |
|
34674-2
|
Tripeptide aminopeptidase [Enzymatic activity/volume] in Serum or Plasma |
|
72498-9
|
Tripeptidyl peptidase I [Enzymatic activity/volume] in DBS |
|
74576-0
|
Tripeptidyl peptidase I [Enzymatic activity/mass] in Fibroblast |
|
76038-9
|
Tripeptidyl peptidase I [Enzymatic activity/mass] in Leukocytes |
|
46137-6
|
Triple phosphate crystals [#/area] in Urine sediment by Microscopy high power field |
|
50585-9
|
Triple bolus stimulation panel - Serum or Plasma |
|
75765-8
|
Triprolidine [Presence] in Serum or Plasma or Urine by Screen method |
|
12424-8
|
Triprolidine [Mass/volume] in Serum or Plasma |
|
39585-5
|
Tritium [Presence] in 24 hour Urine |
|
28074-3
|
Tritium [Presence] in Urine |
|
85214-5
|
Transplant candidate evaluation note |
|
17749-3
|
Tromethamine [Mass/volume] in Serum or Plasma |
|
57316-2
|
Tropomyosin IgE Ab [Units/volume] in Serum |
|
57305-5
|
Tropomyosin IgE Ab [Mass/volume] in Serum |
|
42757-5
|
Troponin I.cardiac [Mass/volume] in Blood |
|
49563-0
|
Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
|
16255-2
|
Troponin I.cardiac [Units/volume] in Serum or Plasma |
|
76399-5
|
Troponin I.cardiac [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
10839-9
|
Troponin I.cardiac [Mass/volume] in Serum or Plasma |
|
48426-1
|
Troponin T.cardiac [Presence] in Blood |
|
48425-3
|
Troponin T.cardiac [Mass/volume] in Blood |
|
6597-9
|
Troponin T.cardiac [Mass/volume] in Venous blood |
|
67151-1
|
Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method |
|
33204-9
|
Troponin T.cardiac [Presence] in Serum or Plasma |
|
6598-7
|
Troponin T.cardiac [Mass/volume] in Serum or Plasma |
|
6268-7
|
Trout IgE Ab [Units/volume] in Serum |
|
61289-5
|
Trout IgE Ab/IgE total in Serum |
|
7747-9
|
Trout IgG Ab [Units/volume] in Serum |
|
56407-0
|
Trout IgG4 Ab [Mass/volume] in Serum |
|
60409-0
|
Trout IgG Ab [Mass/volume] in Serum |
|
38927-0
|
TRPS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
38931-2
|
TRPS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85215-2
|
Transplant donor evaluation note |
|
25424-3
|
Trypanosoma sp Ab [Units/volume] in Serum by Immunofluorescence |
|
23533-3
|
Trypanosoma sp Ab [Presence] in Serum |
|
23532-5
|
Trypanosoma sp Ab [Presence] in Serum by Agglutination |
|
23531-7
|
Trypanosoma sp Ab [Presence] in Serum by Immunoassay |
|
23534-1
|
Trypanosoma sp Ab [Presence] in Serum by Immunofluorescence |
|
5399-1
|
Trypanosoma sp Ab [Units/volume] in Serum |
|
31980-6
|
Trypanosoma sp Ag [Presence] in Blood |
|
23535-8
|
Trypanosoma sp Ag [Presence] in Blood by Immunoassay |
|
10859-7
|
Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain |
|
23536-6
|
Trypanosoma sp identified in Blood by Concentration |
|
10730-0
|
Trypanosoma sp identified in Blood by Organism specific culture |
|
10729-2
|
Trypanosoma sp identified in Blood by Light microscopy |
|
10731-8
|
Trypanosoma sp identified in Blood by Thick film |
|
10732-6
|
Trypanosoma sp identified in Blood by Thin film |
|
10733-4
|
Trypanosoma sp identified in Blood by Wet preparation |
|
14839-5
|
Trypanosoma sp identified in Buffy Coat by Light microscopy |
|
14840-3
|
Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation |
|
74545-5
|
Tryptophan-related indole profiling panel - Platelet rich plasma |
|
3062-7
|
Trypsin [Enzymatic activity/time] in 24 hour Stool |
|
10517-1
|
Trypsin Ag [Presence] in Tissue by Immune stain |
|
3059-3
|
Trypsin [Enzymatic activity/volume] in Duodenal fluid |
|
3060-1
|
Trypsin [Enzymatic activity/volume] in Serum or Plasma |
|
33325-2
|
Trypsin [Mass/volume] in Serum or Plasma |
|
26960-5
|
Trypsin [Presence] in Stool |
|
3063-5
|
Trypsin [Enzymatic activity/volume] in Stool |
|
33669-3
|
Trypsin [Titer] in Stool |
|
3064-3
|
Trypsin+Trypsinogen [Mass/volume] in Serum or Plasma |
|
51935-5
|
Trypsinogen I Free [Presence] in DBS |
|
48633-2
|
Trypsinogen I Free [Mass/volume] in DBS |
|
3067-6
|
Trypsinogen I Free [Mass/volume] in Serum or Plasma |
|
3065-0
|
Trypsinogen [Presence] in Serum or Plasma |
|
17750-1
|
Trypsinogen [Enzymatic activity/volume] in Serum or Plasma |
|
3066-8
|
Trypsinogen [Mass/volume] in Serum or Plasma |
|
17751-9
|
Tryptamine [Mass/volume] in Serum or Plasma |
|
45334-0
|
Tryptase [Mass/volume] in Body fluid |
|
7748-7
|
Tryptase IgE Ab [Units/volume] in Serum |
|
12733-2
|
Tryptase [Enzymatic activity/volume] in Serum or Plasma |
|
21582-2
|
Tryptase [Mass/volume] in Serum or Plasma |
|
51834-0
|
Tryptase [Moles/volume] in Serum or Plasma |
|
60539-4
|
Tryptase.beta [Mass/volume] in Serum or Plasma |
|
41870-7
|
Tryptase.mature [Enzymatic activity/volume] in Serum or Plasma |
|
53159-0
|
Tryptophan [Moles/volume] in DBS |
|
74767-5
|
Tryptophan [Moles/volume] in Platelet rich plasma |
|
3070-0
|
Tryptophan [Mass/volume] in Serum or Plasma |
|
44414-1
|
Tryptophan/Creatinine [Mass Ratio] in 24 hour Urine |
|
77364-8
|
Tryptophan, kynurenin and 3-hydroxykynurenin panel - Serum or Plasma |
|
88004-7
|
Trisomy 18 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency [Likelihood] in Fetus |
|
87410-7
|
Thymidine synthase activity interpretation in Blood or Tissue Qualitative |
|
34650-2
|
TSC gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41047-2
|
TSC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48979-9
|
TSC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
48980-7
|
TSC2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
81882-3
|
TSC2 and PKD1 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
74037-3
|
Transmissible spongiform encephalopathy [Identifier] in Brain by Light microscopy |
|
38275-4
|
Transmissible spongiform encephalopathy [Presence] in Brain by Light microscopy |
|
77623-7
|
Thyrotropin [Units/volume] in Serum or Plasma --2.5 hours post XXX challenge |
|
35134-6
|
Thyrotropin Ab [Presence] in Serum |
|
5384-3
|
Thyrotropin Ab [Units/volume] in Serum |
|
10516-3
|
Thyrotropin Ag [Presence] in Tissue by Immune stain |
|
45173-2
|
Thyrotropin.alpha subunit [Mass/volume] in Serum or Plasma |
|
13897-4
|
Thyrotropin.beta subunit [Mass/volume] in Serum or Plasma |
|
14919-5
|
Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum |
|
40673-6
|
Thyrotropin binding inhibitory immunoglobulins [Units/volume] in Serum |
|
3017-1
|
Thyrotropin binding inhibitory immunoglobulins [Mass/volume] in Serum |
|
20452-9
|
Thyrotropin [Presence] in Blood |
|
3015-5
|
Thyrotropin [Units/volume] in Blood |
|
69561-9
|
Thyrotropin [Units/volume] in Cord blood |
|
14255-4
|
Thyrotropin blocking Ab [Units/volume] in Serum |
|
29574-1
|
Thyrotropin [Presence] in DBS |
|
29575-8
|
Thyrotropin [Units/volume] in DBS |
|
63363-6
|
Thyrotropin receptor Ab [Units/volume] in Blood from Fetus |
|
63364-4
|
Thyrotropin receptor Ab [Units/volume] in Cord blood |
|
63366-9
|
Thyrotropin receptor Ab [Units/volume] in Cerebral spinal fluid |
|
63365-1
|
Thyrotropin receptor Ab [Units/volume] in Body fluid |
|
57416-0
|
Thyrotropin receptor Ab [Units/volume] in Serum by Immunoassay |
|
82659-4
|
Thyrotropin receptor Ab [Presence] in Serum |
|
5385-0
|
Thyrotropin receptor Ab [Units/volume] in Serum |
|
26998-5
|
Thyrotropin [Units/volume] in Saliva (oral fluid) |
|
11580-8
|
Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L |
|
11579-0
|
Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L |
|
3016-3
|
Thyrotropin [Units/volume] in Serum or Plasma |
|
27975-2
|
Thyrotropin [Mass/volume] in Serum or Plasma |
|
14297-6
|
Thyrotropin [Moles/volume] in Serum or Plasma |
|
30166-3
|
Thyroid stimulating immunoglobulins actual/normal in Serum |
|
17708-9
|
Thyroid stimulating immunoglobulins [Presence] in Serum |
|
30567-2
|
Thyroid stimulating immunoglobulins [Units/volume] in Serum |
|
3014-8
|
Thyroid stimulating immunoglobulins [Mass/volume] in Serum |
|
32214-9
|
Thyroid stimulating immunoglobulins [Moles/volume] in Serum |
|
46224-2
|
Thrombin time in Platelet poor plasma by Coagulation assay --after addition of heparinase |
|
12533-6
|
Thiazolidine-2-Thione-4-Carboxylic acid [Mass/volume] in Urine |
|
12534-4
|
Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine [Mass Ratio] in Urine |
|
38620-1
|
Tetrachloroethylene [Mass/volume] in Air |
|
11100-5
|
Tetrachloroethylene [Mass/volume] in Blood |
|
56626-5
|
Tetrachloroethylene [Moles/volume] in Blood |
|
17432-6
|
Tetrachloroethylene [Mass/volume] in Serum or Plasma |
|
43206-2
|
Tetrachloroethylene [Mass/volume] in Urine |
|
40564-7
|
Thyroid transcription factor 1 Ag [Presence] in Tissue by Immune stain |
|
35681-6
|
Tissue transglutaminase Ab panel - Serum |
|
53023-8
|
Tissue transglutaminase Ab [Presence] in Serum |
|
54929-5
|
Tissue transglutaminase Ab [Titer] in Serum by Immunofluorescence |
|
46128-5
|
Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay |
|
35285-6
|
Tissue transglutaminase IgA Ab [Presence] in Serum |
|
35280-7
|
Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay |
|
31017-7
|
Tissue transglutaminase IgA Ab [Units/volume] in Serum |
|
69726-8
|
Tissue transglutaminase IgA + Gliadin peptides IgA and IgG panel - Serum |
|
55727-2
|
Tissue transglutaminase IgA and IgG panel - Serum |
|
56537-4
|
Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay |
|
53026-1
|
Tissue transglutaminase IgG Ab [Presence] in Serum |
|
32998-7
|
Tissue transglutaminase IgG Ab [Units/volume] in Serum |
|
35880-4
|
Tissue transglutaminase IgM Ab [Units/volume] in Serum |
|
75381-4
|
TTR gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
48033-5
|
TTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
49708-1
|
TTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
92887-9
|
Torque teno virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
92886-1
|
Torque teno virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
32365-9
|
Torque teno virus DNA [Presence] in Serum or Plasma by NAA with probe detection |
|
93323-4
|
Tauroursodeoxycholate [Moles/volume] in Serum or Plasma |
|
89422-0
|
Timed Up and Go test and physical findings of gait panel CDC |
|
87798-5
|
Tulathromycin [Susceptibility] |
|
6269-5
|
Tulip IgE Ab [Units/volume] in Serum |
|
40690-0
|
Tumor Ag 90 [Units/volume] in Serum |
|
85232-7
|
Tumor board Consult note |
|
85231-9
|
Tumor board Note |
|
77753-2
|
Tumor morphology panel Cancer |
|
7750-3
|
Tuna triggered histamine release [Units/volume] in Blood |
|
6270-3
|
Tuna IgE Ab [Units/volume] in Serum |
|
39547-5
|
Tuna IgE Ab/IgE total in Serum |
|
7749-5
|
Tuna IgG Ab [Units/volume] in Serum |
|
56408-8
|
Tuna IgG4 Ab [Mass/volume] in Serum |
|
60410-8
|
Tuna IgG Ab [Mass/volume] in Serum |
|
59765-8
|
Tungsten [Mass/volume] in Blood |
|
76655-0
|
Tungsten [Mass/mass] in Hair |
|
59766-6
|
Tungsten [Mass/volume] in Red Blood Cells |
|
12483-4
|
Tungsten [Presence] in Serum or Plasma |
|
17753-5
|
Tungsten [Mass/volume] in Serum or Plasma |
|
54941-0
|
Tungsten [Mass/volume] in Urine |
|
74002-7
|
Tungsten/Creatinine [Mass Ratio] in 24 hour Urine |
|
74793-1
|
Thyroid hormone uptake (T-uptake) in Serum or Plasma |
|
87442-0
|
Turbidity of Water |
|
7752-9
|
Turkey triggered histamine release [Units/volume] in Blood |
|
55608-4
|
Turkey feather IgE Ab [Presence] in Serum |
|
7753-7
|
Turkey feather IgE Ab [Units/volume] in Serum |
|
7751-1
|
Turkey IgG Ab [Units/volume] in Serum |
|
56409-6
|
Turkey IgG4 Ab [Mass/volume] in Serum |
|
60411-6
|
Turkey IgG Ab [Mass/volume] in Serum |
|
6271-1
|
Turkey meat IgE Ab [Units/volume] in Serum |
|
40845-0
|
Turkey meat IgE Ab/IgE total in Serum |
|
30041-8
|
Turmeric IgE Ab [Units/volume] in Serum |
|
7754-5
|
Turnip IgE Ab [Units/volume] in Serum |
|
12549-2
|
Turpentine [Mass/volume] in Serum or Plasma |
|
12555-9
|
Turpentine [Mass/volume] in Urine |
|
86949-5
|
Trichomonas vaginalis and Mycoplasma genitalium DNA panel - Unspecified specimen |
|
81094-5
|
Tricuspid valve Effective regurgitant orifice area by US.doppler+Calculated by volumetric method |
|
81093-7
|
Tricuspid valve Effective regurgitant orifice area by US.doppler+Calculated by PISA method |
|
81091-1
|
Tricuspid valve Orifice area by US 2D |
|
81092-9
|
Tricuspid valve Orifice area by US.doppler |
|
31688-5
|
Trivittatus virus Ab [Units/volume] in Cerebral spinal fluid |
|
31689-3
|
Trivittatus virus Ab [Units/volume] in Serum |
|
29834-9
|
Trivittatus virus Ab [Titer] in Cerebral spinal fluid |
|
29795-2
|
Trivittatus virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
29846-3
|
Trivittatus virus Ab [Titer] in Serum |
|
29808-3
|
Trivittatus virus Ab [Titer] in Serum by Neutralization test |
|
29821-6
|
Trivittatus virus Ab [Titer] in Unspecified specimen |
|
29782-0
|
Trivittatus virus Ab [Titer] in Unspecified specimen by Neutralization test |
|
31690-1
|
Trivittatus virus Ab [Units/volume] in Unspecified specimen |
|
35356-5
|
TWIST1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41046-4
|
TWIST1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
3011-4
|
Thromboxane alpha 2 [Mass/volume] in Serum |
|
3012-2
|
Thromboxane beta 2 [Mass/volume] in Serum or Plasma |
|
82910-1
|
Thromboxane beta 2 [Moles/volume] in Serum or Plasma |
|
12548-4
|
Tybamate [Mass/volume] in Serum or Plasma |
|
87587-2
|
Tylosin [Mass/mass] in Unspecified specimen |
|
87586-4
|
Tylvalosin [Mass/mass] in Unspecified specimen |
|
94079-1
|
TYMP gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal |
|
43585-9
|
TYMP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
34532-2
|
Blood type and Indirect antibody screen panel - Blood |
|
34531-4
|
Blood type and Crossmatch panel - Blood |
|
81663-7
|
Diet [Type] |
|
46048-5
|
Type of ulcer Set |
|
35293-0
|
TYR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41045-6
|
TYR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
3075-9
|
Tyramine [Mass/volume] in Cerebral spinal fluid |
|
3076-7
|
Tyramine [Mass/volume] in Urine |
|
3082-5
|
Tyrosine aminotransferase [Mass/volume] in Plasma |
|
77087-5
|
TYROBP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77086-7
|
TYROBP gene full mutation analysis in Blood or Tissue by Sequencing |
|
30069-9
|
Tyrosine [Moles/volume] in Amniotic fluid |
|
45032-0
|
Tyrosine [Mass/volume] in DBS |
|
35571-9
|
Tyrosine [Moles/volume] in DBS |
|
74302-1
|
Tyrosine [Moles/volume] in DBS --post therapeutic diet |
|
3078-3
|
Tyrosine [Presence] in Serum or Plasma |
|
27361-5
|
Tyrosine [Units/volume] in Serum or Plasma |
|
3079-1
|
Tyrosine [Mass/volume] in Serum or Plasma |
|
20660-7
|
Tyrosine [Moles/volume] in Serum or Plasma |
|
47794-3
|
Tyrosine/Amino acids.total in Amniotic fluid |
|
47793-5
|
Tyrosine/Amino acids.total in Cerebral spinal fluid |
|
47796-8
|
Tyrosine/Amino acids.total in DBS |
|
47792-7
|
Tyrosine/Amino acids.total in Hair |
|
47795-0
|
Tyrosine/Amino acids.total in Serum or Plasma |
|
47797-6
|
Tyrosine/Amino acids.total in Unspecified specimen |
|
44415-8
|
Tyrosine/Creatinine [Mass Ratio] in 24 hour Urine |
|
74481-3
|
Tyrosine/Phenylalanine [Molar ratio] in DBS |
|
74299-9
|
Tyrosine/Phenylalanine [Molar ratio] in DBS --post therapeutic diet |
|
32186-9
|
Microscopic observation [Identifier] in Penis by Tzanck smear |
|
32187-7
|
Microscopic observation [Identifier] in Skin by Tzanck smear |
|
45043-7
|
Microscopic observation [Identifier] in Unspecified specimen by Tzanck smear |
|
92518-0
|
U Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92480-3
|
U Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1328-4
|
U Ag [Presence] on Red Blood Cells |
|
11204-5
|
Ulocladium chartarum IgE Ab [Units/volume] in Serum |
|
2197-2
|
Dehydroepiandrosterone (DHEA).unconjugated [Mass/time] in 24 hour Urine |
|
2196-4
|
Dehydroepiandrosterone (DHEA).unconjugated [Mass/volume] in Serum or Plasma |
|
2246-7
|
Estradiol (E2).unconjugated [Mass/time] in 24 hour Urine |
|
34288-1
|
Estradiol (E2).unconjugated [Moles/volume] in 24 hour Urine |
|
15062-3
|
Estradiol (E2).unconjugated [Moles/time] in 24 hour Urine |
|
34289-9
|
Estradiol (E2).unconjugated [Moles/volume] in Urine |
|
34290-7
|
Estradiol (E2).unconjugated/Creatinine [Molar ratio] in Urine |
|
2249-1
|
Estriol (E3).unconjugated [Mass/volume] in Amniotic fluid |
|
27259-1
|
Estriol (E3).unconjugated [Presence] in Serum or Plasma |
|
2250-9
|
Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma |
|
15064-9
|
Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma |
|
2262-4
|
Estrone (E1).unconjugated [Mass/time] in 24 hour Urine |
|
2260-8
|
Estrone (E1).unconjugated [Mass/volume] in Amniotic fluid |
|
2261-6
|
Estrone (E1).unconjugated [Mass/volume] in Serum or Plasma |
|
91843-3
|
Ureaplasma parvum DNA [Presence] in Genital specimen by NAA with probe detection |
|
69933-0
|
Ureaplasma parvum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
69934-8
|
Ureaplasma urealyticum+Ureaplasma parvum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
91842-5
|
Ureaplasma urealyticum DNA [Presence] in Genital specimen by NAA with probe detection |
|
51988-4
|
Ureaplasma urealyticum DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
17852-5
|
Ureaplasma urealyticum [Presence] in Unspecified specimen by Organism specific culture |
|
57662-9
|
U1 small nuclear ribonucleoprotein Ab [Units/volume] in Serum by Immunoassay |
|
53022-0
|
U1 small nuclear ribonucleoprotein Ab [Presence] in Serum |
|
63367-7
|
U1 small nuclear ribonucleoprotein Ab [Titer] in Serum by Immunoassay |
|
56548-1
|
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoassay |
|
40467-3
|
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum by Immunoblot |
|
38369-5
|
U1 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum |
|
33983-8
|
U1 small nuclear ribonucleoprotein IgG Ab [Units/volume] in Serum |
|
63316-4
|
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay |
|
53032-9
|
U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum |
|
82450-8
|
U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot |
|
59026-5
|
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum |
|
81768-4
|
U1 small nuclear ribonucleoprotein 70kD IgG Ab [Units/volume] in Serum by Immunoassay |
|
88741-4
|
U1 small nuclear ribonucleoprotein A Ab [Units/volume] in Serum by Line blot |
|
54032-8
|
U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum |
|
82451-6
|
U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot |
|
88742-2
|
U1 small nuclear ribonucleoprotein C Ab [Units/volume] in Serum by Line blot |
|
54023-7
|
U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum |
|
82452-4
|
U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot |
|
68549-5
|
U2 small nuclear ribonucleoprotein Ab [Presence] in Serum |
|
45157-5
|
U2 small nuclear ribonucleoprotein IgG Ab [Presence] in Serum |
|
93459-6
|
U-47700 [Mass/volume] in Urine by Confirmatory method |
|
53281-2
|
Urinalysis type of cast panel [#/volume] - Urine by Computer assisted method |
|
53330-7
|
Urinalysis type of cast panel [#/area] - Urine by Computer assisted method |
|
53277-0
|
Urinalysis type of cast panel - Urine by Computer assisted method |
|
58077-9
|
Urinalysis complete W Reflex Culture panel - Urine |
|
53295-2
|
Urinalysis type of crystal panel [#/volume] - Urine by Computer assisted method |
|
53305-9
|
Urinalysis type of crystal panel [#/area] - Urine by Computer assisted method |
|
53325-7
|
Urinalysis type of crystal panel - Urine by Computer assisted method |
|
24357-6
|
Urinalysis macro (dipstick) panel - Urine |
|
50556-0
|
Urinalysis dipstick panel - Urine by Automated test strip |
|
57019-2
|
Urinalysis dipstick W Reflex Culture panel - Urine |
|
57020-0
|
Urinalysis dipstick W Reflex Microscopic panel - Urine |
|
53273-9
|
Urinalysis type of non-squamous epithelial cells panel [#/volume] - Urine by Computer assisted method |
|
53276-2
|
Urinalysis type of non-squamous epithelial cells panel [#/area] - Urine by Computer assisted method |
|
53270-5
|
Urinalysis type of non-squamous epithelial cells panel - Urine by Computer assisted method |
|
50554-5
|
Urinalysis microscopic panel [#/volume] - Urine by Automated count |
|
53293-7
|
Urinalysis microscopic panel [#/area] - Urine sediment by Automated count |
|
53315-8
|
Urinalysis microscopic panel - Urine Qualitative by Automated |
|
24365-9
|
Urinalysis microscopic panel - Urine sediment |
|
53351-3
|
Urinalysis other formed elements panel [#/volume] - Urine by Computer assisted method |
|
53353-9
|
Urinalysis other formed elements panel [#/area] - Urine by Computer assisted method |
|
53333-1
|
Urinalysis other formed elements panel - Urine by Computer assisted method |
|
53264-8
|
Urinalysis yeast variants panel [#/volume] - Urine by Computer assisted method |
|
53267-1
|
Urinalysis yeast variants panel [#/area] - Urine by Computer assisted method |
|
53263-0
|
Urinalysis yeast variants panel - Urine by Computer assisted method |
|
35291-4
|
UBE3A gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
|
51987-6
|
Coenzyme Q10 [Presence] in Serum or Plasma |
|
18209-7
|
Coenzyme Q10 [Units/volume] in Serum or Plasma |
|
27923-2
|
Coenzyme Q10 [Mass/volume] in Serum or Plasma |
|
75050-5
|
Coenzyme Q10 [Moles/volume] in Serum or Plasma |
|
81157-0
|
Coenzyme Q10.reduced [Mass/volume] in Serum or Plasma |
|
81156-2
|
Coenzyme Q10.reduced/Coenzyme Q10 in Serum or Plasma |
|
74122-3
|
Ubiquitin Ag [Presence] in Tissue by Immune stain |
|
3099-9
|
Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/volume] in Plasma |
|
79469-3
|
Uridine diphosphate glucose-4-Epimerase [Enzymatic activity/mass] in Red Blood Cells |
|
10518-9
|
Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
|
3275-5
|
Heparin unfractionated [Mass/time] in 24 hour Urine |
|
80892-3
|
Heparin unfractionated [Units/volume] in Blood by Heparin protamine titration |
|
3274-8
|
Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic method |
|
3273-0
|
Heparin unfractionated [Units/volume] in Platelet poor plasma by Coagulation assay |
|
93844-9
|
UGT1A1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
34509-0
|
UGT1A1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41044-9
|
UGT1A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
93845-6
|
UGT1A1 gene TA repeats and c.211G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
|
72508-5
|
UGT1A1 gene c.A(TA)7TAA(*28) [Presence] in Blood or Tissue by Molecular genetics method |
|
72881-6
|
UGT2B15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
2501-5
|
Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma |
|
35216-1
|
Iron binding capacity.unsaturated [Mass or Moles/volume] in Serum or Plasma |
|
22753-8
|
Iron binding capacity.unsaturated [Moles/volume] in Serum or Plasma |
|
63429-5
|
Bacterial beta-glucuronidase uidA gene [Presence] in Unspecified specimen by NAA with probe detection |
|
46047-7
|
Ulcers Set |
|
61002-2
|
Umbilical artery blood pressure |
|
61011-3
|
Umbilical vein blood pressure |
|
61003-0
|
Umbilical vein Diastolic blood pressure |
|
61004-8
|
Umbilical vein Mean blood pressure |
|
61005-5
|
Umbilical vein Systolic blood pressure |
|
60490-0
|
UMOD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
79470-1
|
Uridine monophosphate synthetase [Enzymatic activity/mass] in Red Blood Cells |
|
43358-1
|
UNC13D gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
85521-3
|
Undersea and hyperbaric medicine Note |
|
46004-8
|
Unsettled releationships Set |
|
5985-7
|
Plasminogen activator urokinase type [Units/volume] in Platelet poor plasma |
|
21464-3
|
Plasminogen activator urokinase type [Presence] in Tissue |
|
5984-0
|
Plasminogen activator urokinase type [Units/volume] in Urine |
|
77717-7
|
Unified Parkinson's Disease Rating Scale (UPDRS) panel |
|
7755-2
|
Upholstery dust IgE Ab [Units/volume] in Serum |
|
88846-1
|
Urinary cell count CNAMTS panel - 3 hour Urine |
|
73955-7
|
UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood |
|
72471-6
|
UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method |
|
73945-8
|
UR-144 (synthetic cannabinoid) [Presence] in Blood |
|
73957-3
|
UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood |
|
72472-4
|
UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
53451-1
|
Uracil arabinoside [Mass/volume] in Serum or Plasma |
|
75128-9
|
Uracil [Moles/volume] in Cerebral spinal fluid |
|
75152-9
|
Uracil [Moles/volume] in Serum or Plasma |
|
30485-7
|
Uracil [Presence] in Urine |
|
13819-8
|
Uracil/Creatinine [Mass Ratio] in Urine |
|
25140-5
|
Uracil/Creatinine [Molar ratio] in Urine |
|
41165-2
|
Uranium 235/Uranium 238 [Mass Ratio] in 24 hour Urine |
|
41286-6
|
Uranium 235/Uranium 238 [Mass Ratio] in Urine |
|
21585-5
|
Uranium [Mass/volume] in 24 hour Urine |
|
21586-3
|
Uranium [Mass/time] in 24 hour Urine |
|
50930-7
|
Uranium [Moles/time] in 24 hour Urine |
|
5751-3
|
Uranium [Mass/volume] in Blood |
|
77185-7
|
Uranium [Mass/mass] in Dentin |
|
51211-1
|
Uranium [Mass/volume] in Body fluid |
|
77186-5
|
Uranium [Mass/mass] in Hair |
|
50929-9
|
Uranium [Moles/mass] in Hair |
|
5752-1
|
Uranium [Mass/volume] in Urine |
|
50928-1
|
Uranium [Moles/volume] in Urine |
|
49670-3
|
Uranium.depleted panel - 24 hour Urine |
|
29989-1
|
Uranium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52902-4
|
Uranium/Creatinine [Molar ratio] in 24 hour Urine |
|
39540-0
|
Uranium/Creatinine [Mass Ratio] in Urine |
|
52903-2
|
Uranium/Creatinine [Molar ratio] in Urine |
|
32555-5
|
Urate [Molar amount] in Urine collected for unspecified duration |
|
57332-9
|
Urate [Mass/volume] in 12 hour Urine |
|
57387-3
|
Urate [Mass/time] in 12 hour Urine |
|
58990-3
|
Urate [Mass/time] in 18 hour Urine |
|
21587-1
|
Urate [Mass/volume] in 24 hour Urine |
|
3087-4
|
Urate [Mass/time] in 24 hour Urine |
|
35253-4
|
Urate [Mass or Moles/volume] in 24 hour Urine |
|
25997-8
|
Urate [Moles/volume] in 24 hour Urine |
|
14935-1
|
Urate [Moles/time] in 24 hour Urine |
|
57386-5
|
Urate [Mass/volume] in 2 hour Urine |
|
17755-0
|
Urate [Mass/time] in 2 hour Urine |
|
17756-8
|
Urate [Mass/time] in 4 hour Urine |
|
18379-8
|
Urate [Mass/time] in 6 hour Urine |
|
3083-3
|
Urate [Mass/volume] in Amniotic fluid |
|
74979-6
|
Urate [Moles/volume] in Bronchoalveolar lavage |
|
49961-6
|
Urate renal clearance in Urine and Serum or Plasma collected for unspecified duration |
|
3088-2
|
Urate renal clearance in 24 hour Urine and Serum or Plasma |
|
46138-4
|
Urate crystals [#/area] in Urine sediment by Microscopy high power field |
|
59839-1
|
Urate crystals [Presence] in Tissue by Light microscopy |
|
13902-2
|
Urate [Mass/volume] in Cerebral spinal fluid |
|
75139-6
|
Urate [Moles/volume] in Cerebral spinal fluid |
|
49003-7
|
Urate [Mass/volume] in Peritoneal dialysis fluid |
|
53612-8
|
Urate [Mass/volume] in Body fluid |
|
25548-9
|
Urate [Moles/volume] in Body fluid |
|
60469-4
|
Urate [Mass/volume] in Pleural fluid |
|
3084-1
|
Urate [Mass/volume] in Serum or Plasma |
|
35232-8
|
Urate [Mass or Moles/volume] in Serum or Plasma |
|
14933-6
|
Urate [Moles/volume] in Serum or Plasma |
|
3085-8
|
Urate [Mass/volume] in Synovial fluid |
|
39788-5
|
Urate [Moles/volume] in Synovial fluid |
|
14932-8
|
Urate [Presence] in Stone |
|
3086-6
|
Urate [Mass/volume] in Urine |
|
35233-6
|
Urate [Mass or Moles/volume] in Urine |
|
14934-4
|
Urate [Moles/volume] in Urine |
|
32343-6
|
Urate [Moles/volume] in Unspecified specimen |
|
13820-6
|
Urate/Creatinine [Mass Ratio] in 24 hour Urine |
|
75642-9
|
Urate/Creatinine [Molar ratio] in 24 hour Urine |
|
3089-0
|
Urate/Creatinine [Mass Ratio] in Urine |
|
34385-5
|
Urate/Creatinine [Molar ratio] in Urine |
|
32556-3
|
Urea [Molar amount] in Urine collected for unspecified duration |
|
55609-2
|
Urea [Moles/volume] in Urine collected for unspecified duration |
|
57389-9
|
Urea [Mass/volume] in 12 hour Urine |
|
57385-7
|
Urea [Mass/time] in 12 hour Urine |
|
74082-9
|
Urea [Moles/time] in 12 hour Urine |
|
58991-1
|
Urea [Mass/time] in 18 hour Urine |
|
53137-6
|
Urea [Moles/time] in 1 hour Urine |
|
57388-1
|
Urea [Mass/volume] in 24 hour Peritoneal dialysis fluid |
|
39779-4
|
Urea [Moles/volume] in 24 hour Dialysis fluid |
|
40405-3
|
Urea [Moles/time] in 24 hour Dialysis fluid |
|
40406-1
|
Urea [Moles/time] in 24 hour Body fluid |
|
59168-5
|
Urea [Moles/time] in 24 hour Stool |
|
63481-6
|
Urea [Mass/volume] in 24 hour Urine |
|
48999-7
|
Urea [Mass/time] in 24 hour Urine |
|
25998-6
|
Urea [Moles/volume] in 24 hour Urine |
|
25550-5
|
Urea [Moles/time] in 24 hour Urine |
|
45303-5
|
Urea [Moles/volume] in Dialysis fluid --2 hour specimen |
|
45304-3
|
Urea [Moles/volume] in Dialysis fluid --4 hour specimen |
|
3090-8
|
Urea [Mass/volume] in Amniotic fluid |
|
72927-7
|
Urea [Moles/volume] in Arterial blood |
|
20977-5
|
Urea [Mass/volume] in Blood |
|
72926-9
|
Urea [Moles/volume] in Venous blood |
|
29891-9
|
Helicobacter pylori [Presence] in Stomach by urea breath test |
|
29892-7
|
Helicobacter pylori [Quantitative] in Stomach by urea breath test |
|
3098-1
|
Urea renal clearance in 24 hour Urine and Serum or Plasma |
|
50063-7
|
Urea renal clearance/1.73 sq M in Urine and Serum or Plasma collected for unspecified duration |
|
59187-5
|
Urea renal clearance/1.73 sq M in 24 hour Urine and Serum or Plasma |
|
58831-9
|
Urea [Moles/volume] in Cerebral spinal fluid |
|
58885-5
|
Urea [Mass/volume] in Peritoneal dialysis fluid |
|
39780-2
|
Urea [Moles/volume] in Peritoneal dialysis fluid |
|
45302-7
|
Urea [Moles/volume] in Dialysis fluid |
|
20979-1
|
Urea [Mass/mass] in Feed |
|
57392-3
|
Urea [Mass/volume] in Body fluid |
|
25549-7
|
Urea [Moles/volume] in Body fluid |
|
20978-3
|
Urea [Mass/volume] in Gastric fluid |
|
12268-9
|
Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
|
48622-5
|
Urea nitrogen [Mass/volume] in Peritoneal fluid --24 hours post peritoneal dialysis |
|
12266-3
|
Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
|
12267-1
|
Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
|
14393-3
|
Urea nitrogen [Mass/volume] in Amniotic fluid |
|
48791-8
|
Urea nitrogen peritoneal dialysis clearance/1.73 sq M |
|
14000-4
|
Urea nitrogen [Mass/volume] in Cerebral spinal fluid |
|
17757-6
|
Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid |
|
14936-9
|
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid |
|
5918-8
|
Urea nitrogen [Mass/volume] in Dialysis fluid |
|
35241-9
|
Urea nitrogen [Mass or Moles/volume] in Dialysis fluid |
|
3093-2
|
Urea nitrogen [Mass/volume] in Body fluid |
|
14397-4
|
Urea nitrogen [Mass/volume] in Gastric fluid |
|
79265-5
|
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid --overnight dwell |
|
14394-1
|
Urea nitrogen [Mass/volume] in Pleural fluid |
|
12265-5
|
Urea nitrogen [Mass/volume] in Peritoneal fluid |
|
14396-6
|
Urea nitrogen [Mass/volume] in Synovial fluid |
|
17758-4
|
Urea nitrogen [Mass/volume] in Vitreous fluid |
|
57752-8
|
Urea [Mass/volume] in Peritoneal dialysis fluid --overnight |
|
56995-4
|
Urea [Mass/volume] in Pleural fluid |
|
77010-7
|
Urea [Molar ratio] in Serum or Plasma --post dialysis/pre dialysis |
|
49802-2
|
Urea [Mass/volume] in Peritoneal fluid |
|
39781-0
|
Urea [Moles/volume] in Peritoneal fluid |
|
54456-9
|
Urea reduction ratio in Serum or Plasma |
|
77136-0
|
Urea [Moles/volume] in Serum, Plasma or Blood |
|
3091-6
|
Urea [Mass/volume] in Serum or Plasma |
|
42571-0
|
Urea [Mass or Moles/volume] in Serum or Plasma |
|
22664-7
|
Urea [Moles/volume] in Serum or Plasma |
|
47798-4
|
Urea [Moles/volume] in Stool |
|
3092-4
|
Urea [Mass/volume] in Urine |
|
22700-9
|
Urea [Moles/volume] in Urine |
|
75364-0
|
Urea [Moles/volume] in Vitreous fluid |
|
23786-7
|
Urea [Mass/volume] in Unspecified specimen |
|
87613-6
|
Urea [Mass/mass] in Unspecified specimen |
|
22738-9
|
Urea [Moles/volume] in Unspecified specimen |
|
56996-2
|
Urea/Creatinine [Mass Ratio] in 24 hour Urine |
|
25999-4
|
Urea/Creatinine [Molar ratio] in 24 hour Urine |
|
39783-6
|
Urea/Creatinine [Molar ratio] in Serum or Plasma |
|
40487-1
|
Urea/Creatinine [Ratio] in Urine |
|
68547-9
|
Ureaplasma sp DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
32368-3
|
Ureaplasma sp identified in Unspecified specimen by Organism specific culture |
|
66491-2
|
Urease [Presence] in Tissue --2nd specimen |
|
66492-0
|
Urease [Presence] in Tissue --3rd specimen |
|
32637-1
|
Urease [Presence] in Tissue |
|
81776-7
|
Ureidopropionate/Creatinine [Molar ratio] in Urine |
|
85211-1
|
Urgent care center Discharge instructions |
|
75504-1
|
Urgent care center Note |
|
85210-3
|
Urgent care center Triage note |
|
75130-5
|
Uridine [Moles/volume] in Cerebral spinal fluid |
|
75159-4
|
Uridine [Moles/volume] in Serum or Plasma |
|
3100-5
|
Uridyl transferase [Enzymatic activity/volume] in Red Blood Cells |
|
3101-3
|
Uridyl transferase [Enzymatic activity/mass] in Tissue |
|
24356-8
|
Urinalysis complete panel - Urine |
|
50564-4
|
Urinalysis panel - Urine by Auto |
|
90077-9
|
Urinary pathogens identified in Isolate by Organism specific culture |
|
81323-8
|
Urine collection associated observations panel - 24 hour Urine |
|
32344-4
|
Urobilin [Presence] in Stool |
|
3102-1
|
Urobilin [Mass/volume] in Stool |
|
3103-9
|
Urobilin [Presence] in Urine |
|
3104-7
|
Urobilin [Mass/volume] in Urine |
|
6893-2
|
Urobilinogen [Mass/time] in 24 hour Stool |
|
28007-3
|
Urobilinogen [Units] in 24 hour Urine |
|
12269-7
|
Urobilinogen [Presence] in 24 hour Urine |
|
3108-8
|
Urobilinogen [Mass/time] in 24 hour Urine |
|
3109-6
|
Urobilinogen [Mass/time] in 2 hour Urine |
|
17761-8
|
Urobilinogen [Mass/time] in 48 hour Stool |
|
25551-3
|
Urobilinogen [Presence] in Body fluid |
|
3105-4
|
Urobilinogen [Presence] in Stool |
|
38507-0
|
Urobilinogen [Units/mass] in Stool |
|
3106-2
|
Urobilinogen [Mass/volume] in Stool |
|
21588-9
|
Urobilinogen [Mass/mass] in Stool |
|
82575-2
|
Urobilinogen [Moles/mass] in Stool |
|
13658-0
|
Urobilinogen [Presence] in Urine |
|
5818-0
|
Urobilinogen [Presence] in Urine by Test strip |
|
62487-4
|
Urobilinogen [Presence] in Urine by Automated test strip |
|
60025-4
|
Urobilinogen [Moles/volume] in Urine by Automated test strip |
|
19161-9
|
Urobilinogen [Units/volume] in Urine by Test strip |
|
20405-7
|
Urobilinogen [Mass/volume] in Urine by Test strip |
|
34928-2
|
Urobilinogen [Moles/volume] in Urine by Test strip |
|
32727-0
|
Urobilinogen [Units/volume] in Urine |
|
3107-0
|
Urobilinogen [Mass/volume] in Urine |
|
35236-9
|
Urobilinogen [Mass or Moles/volume] in Urine |
|
34927-4
|
Urobilinogen [Moles/volume] in Urine |
|
18381-4
|
Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood |
|
3114-6
|
Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Plasma |
|
18476-2
|
Uroporphyrinogen decarboxylase [Presence] in Red Blood Cells |
|
18380-6
|
Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells |
|
49596-0
|
Uroporphyrinogen decarboxylase [Units/volume] in Red Blood Cells |
|
80521-8
|
Uroflowmetry Study report |
|
80525-9
|
Uroflowmetry panel |
|
84038-9
|
Urology Administrative note |
|
84039-7
|
Urology Admission evaluation note |
|
78733-3
|
Urology Admission history and physical note |
|
83699-9
|
Urology Attending Admission evaluation note |
|
83700-5
|
Urology Attending Note |
|
83701-3
|
Urology Attending Preoperative evaluation and management note |
|
78734-1
|
Urology Checklist |
|
34851-6
|
Urology Consult note |
|
78576-6
|
Urology Diagnostic study note |
|
84040-5
|
Urology Discharge summary |
|
78603-8
|
Urology Education note |
|
78622-8
|
Urology Flowsheet |
|
84041-3
|
Urology History and physical note |
|
84042-1
|
Urology Hospital Note |
|
78645-9
|
Urology Initial evaluation note |
|
84043-9
|
Urology Interdisciplinary Note |
|
34852-4
|
Urology Note |
|
83563-7
|
Urology Nurse practitioner Note |
|
83597-5
|
Urology Nurse Note |
|
83598-3
|
Urology Nurse Outpatient Note |
|
83599-1
|
Urology Nurse procedure note |
|
75501-7
|
Urology Outpatient Note |
|
84044-7
|
Urology Outpatient procedure note |
|
34877-1
|
Urology Surgical operation note |
|
83751-8
|
Urology Physician assistant Note |
|
84046-2
|
Urology Telephone encounter Note |
|
80783-4
|
Urology Plan of care note |
|
84045-4
|
Urology Postoperative evaluation and management note |
|
78735-8
|
Urology Preoperative evaluation and management note |
|
78659-0
|
Urology procedure note |
|
75220-4
|
Urology Progress note |
|
57168-7
|
Urology Referral note |
|
83781-5
|
Urology Resident Note |
|
89033-5
|
Urology Telehealth Consult note |
|
89903-9
|
Urology Telehealth Note |
|
78736-6
|
Urology Transfer summary note |
|
3110-4
|
Uronate [Mass/volume] in Urine |
|
41032-4
|
Uroporphyrin [Mass/time] in unspecified time Stool |
|
50932-3
|
Uroporphyrin/Porphyrins.total in 24 hour Urine |
|
56484-9
|
Uroporphyrin [Mass/mass] in Stool |
|
45319-1
|
Uroporphyrin/Creatinine [Molar ratio] in Urine |
|
79126-9
|
Uroporphyrin 1 isomer [Mass/time] in 24 hour Urine |
|
50931-5
|
Uroporphyrin 1 isomer [Moles/mass] in Stool |
|
79127-7
|
Uroporphyrin 1 isomer/Creatinine [Mass Ratio] in Urine |
|
58684-2
|
Uroporphyrin 1 isomer/Creatinine [Molar ratio] in Urine |
|
79128-5
|
Uroporphyrin 3 isomer [Mass/time] in 24 hour Urine |
|
45312-6
|
Uroporphyrin 3 isomer [Moles/mass] in Stool |
|
79129-3
|
Uroporphyrin 3 isomer/Creatinine [Mass Ratio] in Urine |
|
45318-3
|
Uroporphyrin 3 isomer/Creatinine [Molar ratio] in Urine |
|
12811-6
|
Uroporphyrinogen III synthase [Enzymatic activity/volume] in Blood |
|
3115-3
|
Uroporphyrinogen III synthase [Enzymatic activity/volume] in Plasma |
|
11066-8
|
Uroporphyrinogen III synthase [Enzymatic activity/volume] in Red Blood Cells |
|
73098-6
|
Ursodeoxycholate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73099-4
|
Ursodeoxycholate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
55159-8
|
Ursodeoxycholate [Moles/volume] in Serum or Plasma |
|
81162-0
|
US Guidance for needle localization Breast - left and MG Views Breast specimen |
|
81163-8
|
US Guidance for needle localization Breast - right and MG Views Breast specimen |
|
24558-9
|
US Abdomen |
|
69276-4
|
US Abdominal Aorta |
|
79374-5
|
US Abdominal Aorta for screening |
|
49513-5
|
Fetal Abdomen Narrative Study observation, multiple fetuses US |
|
30704-1
|
US Abdomen limited |
|
24532-4
|
US Abdomen RUQ |
|
39494-0
|
US Abdominal wall |
|
69277-2
|
US Adrenal gland |
|
24542-3
|
US Anus |
|
24548-0
|
US Appendix |
|
46375-2
|
US Artery |
|
39040-1
|
US AV fistula |
|
80852-7
|
US Axilla |
|
72529-1
|
US Axilla - left |
|
72528-3
|
US Axilla - right |
|
38021-2
|
US Biliary ducts and Gallbladder |
|
25019-1
|
US Urinary bladder |
|
69280-6
|
US Urinary bladder limited |
|
69388-7
|
US Urinary bladder post void |
|
44163-4
|
US Brachial plexus |
|
24601-7
|
US Breast |
|
30853-6
|
US Breast duct W contrast intra duct |
|
24599-3
|
US Breast limited |
|
42132-1
|
US Breast screening |
|
24596-9
|
US Breast specimen |
|
26214-7
|
US Breast - bilateral |
|
26286-5
|
US Breast - bilateral limited |
|
26215-4
|
US Breast - left |
|
26288-1
|
US Breast - left limited |
|
26216-2
|
US Breast - right |
|
26290-7
|
US Breast - right limited |
|
24616-5
|
US Carotid arteries |
|
38015-4
|
US Carotid arteries limited |
|
26217-0
|
US Carotid arteries - bilateral |
|
26218-8
|
US Carotid arteries - left |
|
42149-5
|
US Carotid arteries - left limited |
|
26219-6
|
US Carotid arteries -right |
|
42151-1
|
US Carotid arteries -right limited |
|
43552-9
|
US Carotid arteries - unilateral |
|
46374-5
|
US Cerebral arteries |
|
24630-6
|
US Chest |
|
69281-4
|
US Chest limited |
|
38016-2
|
US Chest wall |
|
70926-1
|
US Cervical spine |
|
69400-0
|
US Guidance for chorionic villus sampling |
|
24672-8
|
US Diaphragm for motion |
|
24818-7
|
US Diaphragm and Liver |
|
80855-0
|
US Extremity musculoskeletal tissue |
|
80854-3
|
US Extremity musculoskeletal tissue limited |
|
24693-4
|
US Extremity |
|
44173-3
|
US Extremity artery limited |
|
69293-9
|
US Extremity artery - left |
|
69297-0
|
US Extremity artery - right |
|
39526-9
|
US Extremity limited |
|
42145-3
|
US Extremity vein - left |
|
42144-6
|
US Extremity vein - right |
|
41835-0
|
US Extremity veins - left |
|
41816-0
|
US Extremity veins - right |
|
26223-8
|
US Extremity - bilateral |
|
26225-3
|
US Extremity - left |
|
62451-0
|
US Extremity - left limited |
|
26230-3
|
US Extremity - right |
|
62452-8
|
US Extremity - right limited |
|
69286-3
|
US Eye limited |
|
24853-4
|
US Eye+Orbit - bilateral |
|
69389-5
|
US Femoral artery and Popliteal artery |
|
69399-4
|
US Femoral vein and Popliteal vein |
|
38134-3
|
US Femoral vessels |
|
38128-5
|
US Femoral vessels - bilateral |
|
38037-8
|
US Femur - left |
|
38048-5
|
US Femur - right |
|
39527-7
|
US Unspecified body region for foreign body |
|
80869-1
|
US for pregnancy in first trimester |
|
80866-7
|
US for pregnancy in second or third trimester |
|
80868-3
|
US for pregnancy with fetal abnormality |
|
11525-3
|
US for pregnancy |
|
39032-8
|
US for transplanted kidney |
|
69300-2
|
US for transplanted kidney limited |
|
39454-4
|
US for transplanted liver |
|
39509-5
|
US for transplanted pancreas |
|
24711-4
|
US Gallbladder |
|
38020-4
|
US Gallbladder limited |
|
38022-0
|
US Gallbladder W cholecystokinin |
|
39415-5
|
US Gastrointestinal tract |
|
39450-2
|
US Gastrointestinal tract W contrast PO |
|
24719-7
|
US Groin |
|
80898-0
|
US Groin and Pseudoaneurysm |
|
39416-3
|
US Genitourinary tract |
|
44169-1
|
US Guidance for drainage of abscess and placement of drainage catheter of Peritoneal space |
|
41809-5
|
US Guidance for drainage and placement of drainage catheter of Retroperitoneum |
|
44166-7
|
US Guidance for drainage of abscess and placement of drainage catheter of Subphrenic space |
|
37913-1
|
US Guidance for biopsy of Abdomen |
|
24559-7
|
US Guidance for drainage and placement of drainage catheter of Abdomen |
|
58743-6
|
US Guidance for ablation of tissue of Unspecified body region |
|
39451-0
|
US Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region |
|
42705-4
|
US Guidance for drainage of abscess and placement of drainage catheter of Appendix |
|
43565-1
|
US Guidance for deep biopsy of Bone |
|
42135-4
|
US Guidance for superficial biopsy of Bone |
|
37914-9
|
US Guidance for biopsy of Breast |
|
30653-0
|
US Guidance for aspiration of cyst of Breast |
|
42448-1
|
US Guidance for excisional biopsy of Breast |
|
30652-2
|
US Guidance for fine needle biopsy of Breast |
|
44160-0
|
US Guidance for fine needle aspiration of Breast |
|
24600-9
|
US Guidance for needle localization of Breast |
|
80841-0
|
US Guidance for placement of needle in Breast |
|
42456-4
|
US Guidance for placement of needle wire in Breast |
|
30651-4
|
US Guidance for percutaneous biopsy.core needle of Breast |
|
43756-6
|
US Guidance for fluid aspiration of Breast |
|
37912-3
|
US Guidance for biopsy of Breast - bilateral |
|
38012-1
|
US Guidance for aspiration of cyst of Breast - bilateral |
|
43759-0
|
US Guidance for localization of Breast - bilateral |
|
26313-7
|
US Guidance for needle localization of Breast - bilateral |
|
69278-0
|
US Guidance for fluid aspiration of Breast - bilateral |
|
42449-9
|
US Guidance for biopsy of Breast - left |
|
42450-7
|
US Guidance for aspiration of cyst of Breast - left |
|
80842-8
|
US Guidance for additional aspiration of cyst of Breast - left |
|
80844-4
|
US Guidance for fine needle biopsy of Breast - left |
|
38026-1
|
US Guidance for fine needle aspiration of Breast - left |
|
43758-2
|
US Guidance for localization of Breast - left |
|
26314-5
|
US Guidance for needle localization of Breast - left |
|
38023-8
|
US Guidance for percutaneous biopsy.core needle of Breast - left |
|
69292-1
|
US Guidance for fluid aspiration of Breast - left |
|
80843-6
|
US Guidance for vacuum biopsy of Breast - left |
|
42457-2
|
US Guidance for biopsy of Breast - right |
|
42458-0
|
US Guidance for aspiration of cyst of Breast - right |
|
80846-9
|
US Guidance for additional aspiration of cyst of Breast - right |
|
80848-5
|
US Guidance for fine needle biopsy of Breast - right |
|
38033-7
|
US Guidance for fine needle aspiration of Breast - right |
|
43760-8
|
US Guidance for localization of Breast - right |
|
26318-6
|
US Guidance for needle localization of Breast - right |
|
38025-3
|
US Guidance for percutaneous biopsy.core needle of Breast - right |
|
69296-2
|
US Guidance for fluid aspiration of Breast - right |
|
80847-7
|
US Guidance for vacuum biopsy of Breast - right |
|
25059-7
|
US Guidance for biopsy of Unspecified body region |
|
38766-2
|
US Guidance for biopsy of transplanted kidney |
|
38765-4
|
US Guidance for biopsy of transplanted liver |
|
80880-8
|
US Guidance for injection of Carpal tunnel |
|
37915-6
|
US Guidance for biopsy of Chest |
|
38142-6
|
US Guidance for drainage and placement of drainage catheter of Chest |
|
37921-4
|
US Guidance for needle localization of Chest |
|
42333-5
|
US Guidance for biopsy of Chest Pleura |
|
42140-4
|
US Guidance for placement of tube in Chest |
|
38024-6
|
US Guidance for core needle biopsy of Unspecified body region |
|
69391-1
|
US Guidance for cordocentesis |
|
70915-4
|
US Guidance for aspiration of CSF of Cervical spine |
|
30698-5
|
US Guidance for aspiration of cyst of Unspecified body region |
|
46282-0
|
US Guidance for aspiration or injection of cyst of Unspecified body region |
|
24670-2
|
US Guidance for biopsy of cyst of Unspecified body region |
|
30699-3
|
US Guidance for drainage and placement of drainage catheter of Unspecified body region |
|
80853-5
|
US Guidance for injection of Elbow |
|
42463-0
|
US Guidance for biopsy of Endomyocardium |
|
69387-9
|
US Guidance for biopsy of Epididymis |
|
24692-6
|
US Guidance for drainage and placement of drainage catheter of Extremity |
|
72537-4
|
US Guidance for vascular sclerotherapy of Extremity vein - bilateral |
|
72533-3
|
US Guidance for ambulatory phlebectomy of Extremity vein - left |
|
72535-8
|
US Guidance for laser ablation of Extremity vein - left |
|
72645-5
|
US Guidance for vascular sclerotherapy of Extremity vein - left |
|
72532-5
|
US Guidance for ambulatory phlebectomy of Extremity vein - right |
|
72534-1
|
US Guidance for laser ablation of Extremity vein - right |
|
72644-8
|
US Guidance for vascular sclerotherapy of Extremity vein - right |
|
72536-6
|
US Guidance for vascular sclerotherapy of Extremity veins - bilateral |
|
72643-0
|
US Guidance for vascular sclerotherapy of Extremity veins - left |
|
72642-2
|
US Guidance for vascular sclerotherapy of Extremity veins - right |
|
26325-1
|
US Guidance for drainage and placement of drainage catheter of Extremity - bilateral |
|
26326-9
|
US Guidance for drainage and placement of drainage catheter of Extremity - left |
|
26327-7
|
US Guidance for drainage and placement of drainage catheter of Extremity - right |
|
37608-7
|
US Guidance for localization of foreign body of Eye |
|
38018-8
|
US Guidance for fine needle aspiration of Unspecified body region |
|
80882-4
|
US Guidance of Unspecified body region-- during surgery |
|
72530-9
|
US Guidance for injection of Joint |
|
26340-0
|
US Guidance for biopsy of Kidney - bilateral |
|
26328-5
|
US Guidance for drainage and placement of drainage catheter of Kidney - bilateral |
|
44156-8
|
US Guidance for ablation of tissue of Kidney |
|
44167-5
|
US Guidance for drainage of abscess and placement of drainage catheter of Kidney |
|
24772-6
|
US Guidance for biopsy of Kidney |
|
38126-9
|
US Guidance for aspiration of cyst of Kidney |
|
42478-8
|
US Guidance for drainage of cyst and placement of drainage catheter of Kidney |
|
24896-3
|
US Guidance for drainage and placement of drainage catheter of Kidney |
|
44159-2
|
US Guidance for fine needle aspiration of Kidney |
|
75672-6
|
US Guidance for placement of nephrostomy tube in Kidney |
|
48434-5
|
US Guidance for fluid aspiration of Kidney |
|
26341-8
|
US Guidance for biopsy of Kidney - left |
|
26329-3
|
US Guidance for drainage and placement of drainage catheter of Kidney - left |
|
26342-6
|
US Guidance for biopsy of Kidney - right |
|
26330-1
|
US Guidance for drainage and placement of drainage catheter of Kidney - right |
|
44155-0
|
US Guidance for ablation of tissue of Liver |
|
42133-9
|
US Guidance for drainage of abscess and placement of drainage catheter of Liver |
|
24816-1
|
US Guidance for biopsy of Liver |
|
44158-4
|
US Guidance for fine needle aspiration of Liver |
|
69279-8
|
US Guidance for core needle biopsy of Lymph node |
|
69287-1
|
US Guidance for fluid aspiration of Lymph node |
|
43797-0
|
US Guidance for superficial biopsy of Lymph node |
|
70916-2
|
US Guidance for aspiration of CSF of Lumbar spine |
|
44161-8
|
US Guidance for biopsy of Lung |
|
92678-2
|
US Guidance for elastography of Lung |
|
92679-0
|
US Guidance for elastography of lesion of Lung |
|
92680-8
|
US Guidance for additional elastography of lesion of Lung |
|
42137-0
|
US Guidance for biopsy of Mediastinum |
|
37917-2
|
US Guidance for percutaneous biopsy of Muscle |
|
43564-4
|
US Guidance for superficial biopsy of Muscle |
|
37918-0
|
US Guidance for biopsy of Neck |
|
38032-9
|
US Guidance for needle localization of Unspecified body region |
|
64993-9
|
US Guidance for placement of needle in Unspecified body region |
|
46369-5
|
US Guidance for biopsy of Ovary |
|
39452-8
|
US Guidance for fluid aspiration of Ovary |
|
37919-8
|
US Guidance for biopsy of Pancreas |
|
38133-5
|
US Guidance for aspiration of cyst of Pancreas |
|
44172-5
|
US Guidance for drainage and placement of drainage catheter of Pancreas |
|
44157-6
|
US Guidance for fine needle aspiration of Pancreas |
|
62494-0
|
US Guidance for percutaneous drainage and placement of drainage catheter of Unspecified body region |
|
30878-3
|
US Guidance for fluid aspiration of Unspecified body region |
|
44168-3
|
US Guidance for drainage of abscess and placement of drainage catheter of Pelvis |
|
46370-3
|
US Guidance for biopsy of Pelvis |
|
24868-2
|
US Guidance for drainage and placement of drainage catheter of Pelvis |
|
30703-3
|
US Guidance for fluid aspiration of Pericardial space |
|
42706-2
|
US Guidance for injection of Pleural space |
|
24662-9
|
US Guidance for fluid aspiration of Pleural space |
|
46288-7
|
US Guidance for biopsy of Prostate |
|
24883-1
|
US Guidance for percutaneous biopsy of Prostate |
|
41798-0
|
US Guidance for drainage and placement of drainage catheter of Prostate |
|
38017-0
|
US Guidance for FNA of Prostate |
|
44162-6
|
US Guidance for biopsy of Retroperitoneum |
|
82124-9
|
US Guidance for radiation treatment of Unspecified body region |
|
43487-8
|
US Guidance for placement of radiation therapy fields in Unspecified body region |
|
37920-6
|
US Guidance for biopsy of Salivary gland |
|
38132-7
|
US Guidance for biopsy of Scrotum and testicle |
|
69396-0
|
US Guidance for biopsy of Spinal cord |
|
38127-7
|
US Guidance for aspiration of CSF of Spine |
|
38030-3
|
US Guidance for biopsy of Spleen |
|
25009-2
|
US Guidance for biopsy of Thyroid gland |
|
46285-3
|
US Guidance for core needle biopsy of Thyroid gland |
|
42447-3
|
US Guidance for aspiration of cyst of Thyroid gland |
|
38019-6
|
US Guidance for fine needle aspiration of Thyroid gland |
|
30702-5
|
US Guidance for injection of Thyroid gland |
|
42134-7
|
US Guidance for fluid aspiration of Thyroid gland |
|
38135-0
|
US Guidance for deep aspiration.fine needle of Tissue |
|
38136-8
|
US Guidance for superficial aspiration.fine needle of Tissue |
|
70917-0
|
US Guidance for aspiration of CSF of Thoracic spine |
|
30644-9
|
US Guidance for placement of tunneled CV catheter |
|
42141-2
|
US Guidance for removal of tunneled CV catheter |
|
24537-3
|
US Guidance for aspiration of amniotic fluid of Uterus |
|
39139-1
|
US Guidance for vascular access of Unspecified body region |
|
30643-1
|
US Guidance for placement of CV catheter in Vein |
|
81165-3
|
US Guidance for peripheral venous access of Vein |
|
24731-2
|
US Head |
|
24732-0
|
US Head during surgery |
|
38034-5
|
US Head limited |
|
44164-2
|
US Head and Neck |
|
80858-4
|
US Head and neck soft tissue |
|
85475-2
|
US Heart Transesophageal |
|
59281-6
|
US Heart Transthoracic |
|
24760-1
|
US Hip |
|
30711-6
|
US Hip developmental joint assessment |
|
30712-4
|
US Hip WO developmental joint assessment |
|
43566-9
|
US Hip and Thigh |
|
26250-1
|
US Hip - bilateral |
|
26251-9
|
US Hip - left |
|
26252-7
|
US Hip - right |
|
42148-7
|
US Heart |
|
42707-0
|
US Heart limited |
|
38129-3
|
US Iliac vessels - bilateral |
|
38137-6
|
US Iliac vessels - left |
|
38141-8
|
US Iliac vessels - right |
|
43774-9
|
US Kidney - bilateral |
|
69402-6
|
US Kidney - bilateral and Urinary bladder |
|
38036-0
|
US Kidney |
|
38035-2
|
US Kidney limited |
|
38038-6
|
US Kidney - left |
|
38049-3
|
US Kidney - right |
|
30709-0
|
US Lower extremity |
|
48693-6
|
US Lower extremity artery |
|
41812-9
|
US Lower extremity artery limited |
|
38130-1
|
US Lower extremity artery - bilateral |
|
41834-3
|
US Lower extremity artery - left |
|
41815-2
|
US Lower extremity artery - right |
|
80861-8
|
US Lower extremity soft tissue |
|
46363-8
|
US Lower extremity vein |
|
46364-6
|
US Lower extremity vein - bilateral |
|
48692-8
|
US Lower extremity vein - left |
|
48691-0
|
US Lower extremity vein - right |
|
69385-3
|
US Lower extremity veins - bilateral |
|
69392-9
|
US Lower extremity veins - left |
|
80860-0
|
US Lower extremity veins - unilateral limited |
|
38013-9
|
US Lower extremity - bilateral |
|
38040-2
|
US Lower extremity - left |
|
38039-4
|
US Lower extremity - left limited |
|
38051-9
|
US Lower extremity - right |
|
38050-1
|
US Lower extremity - right limited |
|
28614-6
|
US Liver |
|
30706-6
|
US Liver during surgery |
|
80838-6
|
US Liver limited |
|
39522-8
|
US guidance for percutaneous biopsy of Lymph node |
|
69393-7
|
US Lumbar spine |
|
38043-6
|
US Mastoid |
|
38044-4
|
US Mediastinum |
|
69394-5
|
US Mesenteric arteries |
|
80834-5
|
US for multiple gestation pregnancy in first trimester |
|
80836-0
|
US for multiple gestation pregnancy in second or third trimester |
|
80833-7
|
US for multiple gestation pregnancy limited |
|
80837-8
|
US for multiple gestation pregnancy with fetal abnormality |
|
24842-7
|
US Neck |
|
25060-5
|
US Unspecified body region No charge |
|
69390-3
|
US Ovary |
|
80871-7
|
US Ovary for torsion |
|
24859-1
|
US Pancreas |
|
80839-4
|
US Pancreas limited |
|
38045-1
|
US Parathyroid gland |
|
38138-4
|
US Parotid gland |
|
24869-0
|
US Pelvis |
|
80862-6
|
US Pelvis for in vitro fertilization |
|
38046-9
|
US Pelvis limited |
|
42455-6
|
US Pelvis transabdominal and transvaginal |
|
24677-7
|
US Pelvis transvaginal |
|
38140-0
|
US Penis |
|
80875-8
|
US Penis soft tissue |
|
38139-2
|
US Penis vessels |
|
24881-5
|
US Popliteal space |
|
26262-6
|
US Popliteal space - bilateral |
|
26263-4
|
US Popliteal space - left |
|
26264-2
|
US Popliteal space - right |
|
80870-9
|
US for pregnancy limited |
|
24884-9
|
US Prostate transrectal |
|
80876-6
|
US Prostate transrectal for volume measurement |
|
24889-8
|
US Pylorus for pyloric stenosis |
|
24892-2
|
US Rectum |
|
69294-7
|
US Renal artery |
|
69295-4
|
US Renal vessels |
|
24531-6
|
US Retroperitoneum |
|
38047-7
|
US Retroperitoneum limited |
|
38053-5
|
US Sacrum |
|
69298-8
|
US Salivary gland |
|
25002-7
|
US Scrotum and testicle |
|
80877-4
|
US Scrotum and testicle for torsion |
|
69299-6
|
US Scrotum and testicle limited |
|
26271-7
|
US Scrotum and Testicle - bilateral |
|
26272-5
|
US Scrotum and Testicle - left |
|
26273-3
|
US Scrotum and Testicle - right |
|
24907-8
|
US Shoulder |
|
26265-9
|
US Shoulder - bilateral |
|
26267-5
|
US Shoulder - left |
|
26269-1
|
US Shoulder - right |
|
24926-8
|
US Spine |
|
24990-4
|
US Spleen |
|
80840-2
|
US Spleen limited |
|
38131-9
|
US Subclavian vessels - bilateral |
|
42468-9
|
US Surgical specimen |
|
24547-2
|
US Thoracic and abdominal aorta |
|
38011-3
|
US Thoracic and abdominal aorta limited |
|
80835-2
|
US transabdominal and transvaginal for multiple gestation pregnancy in first trimester |
|
80867-5
|
US transabdominal and transvaginal for pregnancy in first trimester |
|
39453-6
|
US Tendon |
|
25010-0
|
US Thyroid gland |
|
70927-9
|
US Thoracic spine |
|
80865-9
|
US transvaginal for pregnancy |
|
30710-8
|
US Upper extremity |
|
48448-5
|
US Upper extremity artery |
|
41813-7
|
US Upper extremity artery limited |
|
38014-7
|
US Upper extremity artery - bilateral |
|
41833-5
|
US Upper extremity artery - left |
|
41814-5
|
US Upper extremity artery - right |
|
80881-6
|
US Upper extremity soft tissue |
|
48690-2
|
US Upper extremity vein - bilateral |
|
48689-4
|
US Upper extremity vein - left |
|
48688-6
|
US Upper extremity vein - right |
|
69395-2
|
US Upper extremity veins |
|
80895-6
|
US Upper extremity veins - bilateral |
|
80879-0
|
US Upper extremity veins - unilateral limited |
|
38041-0
|
US Upper extremity - left |
|
38052-7
|
US Upper extremity - right |
|
25061-3
|
US Unspecified body region |
|
30705-8
|
US Uterus and Fallopian tubes |
|
42143-8
|
US Uterus and Fallopian tubes W saline IU |
|
39036-9
|
US Vein |
|
39045-0
|
US Vein limited |
|
39030-2
|
US Vein - bilateral |
|
38054-3
|
US Visceral artery |
|
25036-5
|
US Wrist |
|
26278-2
|
US Wrist - bilateral |
|
26280-8
|
US Wrist - left |
|
26282-4
|
US Wrist - right |
|
30701-7
|
US Unspecified body region during surgery |
|
81894-8
|
Liver ultrasound attenuation by transient elastography |
|
77615-3
|
Liver stiffness by US.transient elastography |
|
77128-7
|
USH1C gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
77127-9
|
USH1C gene full mutation analysis in Blood or Tissue by Sequencing |
|
53901-5
|
USH2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
87409-9
|
Ustekinumab Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
88992-3
|
Ustekinumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
87408-1
|
Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
74162-9
|
Usual industry duration |
|
35093-4
|
Urology urinary tract ultrasound |
|
66113-2
|
Uterus Pathology biopsy report |
|
24465-7
|
Urea nitrogen [Mass/time] in 12 hour Urine |
|
12967-6
|
Urea nitrogen [Mass/volume] in 24 hour Urine |
|
3096-5
|
Urea nitrogen [Mass/time] in 24 hour Urine |
|
33355-9
|
Urea nitrogen [Moles/volume] in 24 hour Urine |
|
14939-3
|
Urea nitrogen [Moles/time] in 24 hour Urine |
|
51735-9
|
Urea nitrogen renal clearance in 24 hour Urine and Serum or Plasma |
|
13506-1
|
Urea nitrogen renal clearance in Urine and Serum or Plasma |
|
3095-7
|
Urea nitrogen [Mass/volume] in Urine |
|
35235-1
|
Urea nitrogen [Mass or Moles/volume] in Urine |
|
14938-5
|
Urea nitrogen [Moles/volume] in Urine |
|
13821-4
|
Urea nitrogen/Creatinine [Mass Ratio] in 24 hour Urine |
|
44416-6
|
Urea nitrogen/Creatinine [Mass Ratio] in Urine |
|
92517-2
|
V Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92479-5
|
V Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
1334-2
|
V Ag [Presence] on Red Blood Cells |
|
82200-7
|
Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with non-probe detection |
|
92686-5
|
Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with probe detection |
|
31698-4
|
Vibrio cholerae Ab [Units/volume] in Serum |
|
5405-6
|
Vibrio cholerae Ab [Mass/volume] in Serum |
|
53942-9
|
Vibrio cholerae toxin ctx gene [Presence] in Unspecified specimen by NAA with probe detection |
|
82201-5
|
Vibrio cholerae DNA [Presence] in Stool by NAA with non-probe detection |
|
61371-1
|
Vibrio cholerae DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
53941-1
|
Vibrio cholerae toxin Ag [Presence] in Isolate |
|
41857-4
|
Vibrio parahaemolyticus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
38932-0
|
VA Compensation and Pension (C and P) examination acromegaly |
|
38933-8
|
VA Compensation and Pension (C and P) examination aid and attendance/housebound |
|
38934-6
|
VA Compensation and Pension (C and P) examination arrhythmias |
|
38936-1
|
VA Compensation and Pension (C and P) examination audio |
|
38937-9
|
VA Compensation and Pension (C and P) examination bones fractures/bone disease |
|
38938-7
|
VA Compensation and Pension (C and P) examination brain/spinal cord |
|
38939-5
|
VA Compensation and Pension (C and P) examination chronic fatigue syndrome |
|
38940-3
|
VA Compensation and Pension (C and P) examination cold injury protocol |
|
38941-1
|
VA Compensation and Pension (C and P) examination cranial nerves |
|
38942-9
|
VA Compensation and Pension (C and P) examination Cushings syndrome |
|
38943-7
|
VA Compensation and Pension (C and P) examination dental/oral |
|
38944-5
|
VA Compensation and Pension (C and P) examination diabetes mellitus |
|
38956-9
|
VA Compensation and Pension (C and P) examination disability in gulf war veterans |
|
38946-0
|
VA Compensation and Pension (C and P) examination ear disease |
|
38949-4
|
VA Compensation and Pension (C and P) examination epilepsy/narcolepsy |
|
38950-2
|
VA Compensation and Pension (C and P) examination esophagus/hiatal hernia |
|
38966-8
|
VA Compensation and Pension (C and P) examination extremity joints |
|
38951-0
|
VA Compensation and Pension (C and P) examination eye |
|
38952-8
|
VA Compensation and Pension (C and P) examination feet |
|
38953-6
|
VA Compensation and Pension (C and P) examination fibromyalgia |
|
38954-4
|
VA Compensation and Pension (C and P) examination general medical |
|
38969-2
|
VA Compensation and Pension (C and P) examination general mental disorders |
|
38955-1
|
VA Compensation and Pension (C and P) examination genitourinary |
|
38957-7
|
VA Compensation and Pension (C and P) examination gynecological conditions/disorders of the breast |
|
38958-5
|
VA Compensation and Pension (C and P) examination hand/thumb/fingers |
|
38959-3
|
VA Compensation and Pension (C and P) examination heart |
|
38960-1
|
VA Compensation and Pension (C and P) examination hemic disorders |
|
38961-9
|
VA Compensation and Pension (C and P) examination HIV-related illness |
|
38962-7
|
VA Compensation and Pension (C and P) examination hypertension |
|
38963-5
|
VA Compensation and Pension (C and P) examination infectious/immune/nutritional disabilities |
|
38964-3
|
VA Compensation and Pension (C and P) examination initial evaluation post-traumatic stress disorder |
|
38965-0
|
VA Compensation and Pension (C and P) examination large/small intestines |
|
38967-6
|
VA Compensation and Pension (C and P) examination liver/gall bladder/pancreas |
|
38968-4
|
VA Compensation and Pension (C and P) examination lymphatic disorders |
|
38947-8
|
VA Compensation and Pension (C and P) examination mental health eating disorders |
|
38935-3
|
VA Compensation and Pension (C and P) examination miscellaneous arteries/veins |
|
38945-2
|
VA Compensation and Pension (C and P) examination miscellaneous digestive conditions |
|
38948-6
|
VA Compensation and Pension (C and P) examination miscellaneous endocrine diseases |
|
38972-6
|
VA Compensation and Pension (C and P) examination miscellaneous neurological disorders |
|
38980-9
|
VA Compensation and Pension (C and P) examination miscellaneous respiratory diseases |
|
38970-0
|
VA Compensation and Pension (C and P) examination mouth/lips/tongue |
|
38971-8
|
VA Compensation and Pension (C and P) examination muscles |
|
38973-4
|
VA Compensation and Pension (C and P) examination nose/sinus/larynx/pharynx |
|
38979-1
|
VA Compensation and Pension (C and P) examination obstructive/restrictive/interstitial respiratory diseases |
|
38974-2
|
VA Compensation and Pension (C and P) examination peripheral nerves |
|
38975-9
|
VA Compensation and Pension (C and P) examination prisoner of war protocol |
|
38976-7
|
VA Compensation and Pension (C and P) examination pulmonary tuberculosis/mycobacterial diseases |
|
38977-5
|
VA Compensation and Pension (C and P) examination rectum/anus |
|
38978-3
|
VA Compensation and Pension (C and P) examination residuals of amputations |
|
38981-7
|
VA Compensation and Pension (C and P) examination review evaluation post-traumatic stress disorder |
|
38982-5
|
VA Compensation and Pension (C and P) examination scars |
|
38983-3
|
VA Compensation and Pension (C and P) examination sense of smell/taste |
|
38984-1
|
VA Compensation and Pension (C and P) examination skin diseases other than scars |
|
38985-8
|
VA Compensation and Pension (C and P) examination social/industrial survey |
|
38986-6
|
VA Compensation and Pension (C and P) examination spine |
|
38987-4
|
VA Compensation and Pension (C and P) examination stomach/duodenum/peritoneal adhesions |
|
38988-2
|
VA Compensation and Pension (C and P) examination thyroid/parathyroid diseases |
|
85217-8
|
VA Compensation and Pension (C and P) multiple examination |
|
78352-2
|
Vaccenate (C18:1w7) [Entitic substance] in Red Blood Cells |
|
5400-7
|
Vaccinia virus Ab [Units/volume] in Serum |
|
35390-4
|
Vaccinia virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
92703-8
|
Vaginal pathogens panel - Vaginal fluid by NAA with probe detection |
|
54145-8
|
Bacterial vaginosis and vaginitis DNA panel - Vaginal fluid by Probe with signal amplification |
|
46999-9
|
Bacterial vaginosis and vaginitis rRNA panel - Vaginal fluid by Probe |
|
73096-0
|
valACYclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73097-8
|
valACYclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73094-5
|
Valdecoxib induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73095-2
|
Valdecoxib induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
93466-1
|
Valerylfentanyl [Mass/volume] in Urine by Confirmatory method |
|
73093-7
|
valGANciclovir induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73092-9
|
valGANciclovir induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
74960-6
|
valGANciclovir [Mass/volume] in Plasma --trough |
|
41169-4
|
Valine [Presence] in Blood |
|
47799-2
|
Valine [Moles/volume] in DBS |
|
74884-8
|
Valine [Moles/volume] in DBS --post therapeutic diet |
|
47802-4
|
Valine/Amino acids.total in Amniotic fluid |
|
47801-6
|
Valine/Amino acids.total in Cerebral spinal fluid |
|
47804-0
|
Valine/Amino acids.total in DBS |
|
47800-8
|
Valine/Amino acids.total in Hair |
|
47803-2
|
Valine/Amino acids.total in Serum or Plasma |
|
47805-7
|
Valine/Amino acids.total in Unspecified specimen |
|
44417-4
|
Valine/Creatinine [Mass Ratio] in 24 hour Urine |
|
53151-7
|
Valine/Phenylalanine [Molar ratio] in DBS |
|
7535-8
|
Valley Oak IgE Ab [Units/volume] in Serum |
|
72936-8
|
Valproate induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72935-0
|
Valproate induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
29229-2
|
Valproate [Mass/volume] in Body fluid |
|
15375-9
|
Valproate Free [Mass/volume] in Saliva (oral fluid) |
|
4087-3
|
Valproate Free [Mass/volume] in Serum or Plasma |
|
73091-1
|
Valproate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73090-3
|
Valproate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73677-7
|
Valproate [Mass/volume] in Serum or Plasma --peak |
|
4086-5
|
Valproate [Mass/volume] in Serum or Plasma |
|
14946-8
|
Valproate [Moles/volume] in Serum or Plasma |
|
4088-1
|
Valproate [Mass/volume] in Serum or Plasma --trough |
|
17762-6
|
Valproate [Mass/volume] in Urine |
|
57775-9
|
Valproate.free and Valproate panel - Serum or Plasma |
|
73088-7
|
Valsartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73089-5
|
Valsartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
88252-2
|
Vancomycin resistance vanA gene [Presence] by Probe in Positive blood culture |
|
48814-8
|
Vancomycin resistance vanA gene [Presence] by Molecular method |
|
85787-0
|
Vancomycin resistance vanA + vanB genes [Presence] by NAA with non-probe detection in Positive blood culture |
|
29931-3
|
Vanadium [Mass/volume] in 24 hour Urine |
|
29932-1
|
Vanadium [Mass/time] in 24 hour Urine |
|
50937-2
|
Vanadium [Moles/time] in 24 hour Urine |
|
5753-9
|
Vanadium [Mass/volume] in Blood |
|
50933-1
|
Vanadium [Moles/volume] in Blood |
|
51212-9
|
Vanadium [Mass/volume] in Body fluid |
|
5754-7
|
Vanadium [Mass/mass] in Hair |
|
50934-9
|
Vanadium [Moles/mass] in Hair |
|
5755-4
|
Vanadium [Mass/volume] in Red Blood Cells |
|
50935-6
|
Vanadium [Moles/volume] in Red Blood Cells |
|
5756-2
|
Vanadium [Mass/volume] in Serum or Plasma |
|
52893-5
|
Vanadium [Moles/volume] in Serum or Plasma |
|
60207-8
|
Vanadium [Mass/mass] in Tissue |
|
5757-0
|
Vanadium [Mass/volume] in Urine |
|
50936-4
|
Vanadium [Moles/volume] in Urine |
|
29933-9
|
Vanadium/Creatinine [Mass Ratio] in 24 hour Urine |
|
52900-8
|
Vanadium/Creatinine [Molar ratio] in 24 hour Urine |
|
13831-3
|
Vanadium/Creatinine [Mass Ratio] in Urine |
|
52901-6
|
Vanadium/Creatinine [Molar ratio] in Urine |
|
88253-0
|
Vancomycin resistance vanB gene [Presence] by Probe in Positive blood culture |
|
72421-1
|
Vancomycin resistance vanB gene [Presence] by Molecular method |
|
72837-8
|
Vancomycin resistance vanC1 gene [Presence] by Molecular method |
|
72836-0
|
Vancomycin resistance vanC2+vanC3 genes [Presence] by Molecular method |
|
72934-3
|
Vancomycin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72933-5
|
Vancomycin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13586-3
|
Vancomycin [Mass/volume] in Cerebral spinal fluid |
|
13587-1
|
Vancomycin [Mass/volume] in Body fluid |
|
50938-0
|
Vancomycin [Moles/volume] in Body fluid |
|
4089-9
|
Vancomycin Free [Mass/volume] in Serum or Plasma |
|
73086-1
|
Vancomycin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73087-9
|
Vancomycin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
59381-4
|
Vancomycin [Mass/volume] in Serum or Plasma --post dialysis |
|
39092-2
|
Vancomycin [Mass/volume] in Cerebral spinal fluid --peak |
|
4090-7
|
Vancomycin [Mass/volume] in Serum or Plasma --peak |
|
39796-8
|
Vancomycin [Moles/volume] in Serum or Plasma --peak |
|
4091-5
|
Vancomycin [Mass/volume] in Serum or Plasma --random |
|
20578-1
|
Vancomycin [Mass/volume] in Serum or Plasma |
|
31012-8
|
Vancomycin [Moles/volume] in Serum or Plasma |
|
4092-3
|
Vancomycin [Mass/volume] in Serum or Plasma --trough |
|
39797-6
|
Vancomycin [Moles/volume] in Serum or Plasma --trough |
|
75753-4
|
Vancomycin resistance vanD gene [Presence] by Molecular method |
|
7756-0
|
Vanilla IgE Ab [Units/volume] in Serum |
|
61324-0
|
Vanilla IgE Ab/IgE total in Serum |
|
6861-9
|
Vanilla IgG Ab [Units/volume] in Serum |
|
56410-4
|
Vanilla IgG4 Ab [Mass/volume] in Serum |
|
60412-4
|
Vanilla IgG Ab [Mass/volume] in Serum |
|
75076-0
|
Vanillate [Moles/volume] in Serum or Plasma |
|
48158-0
|
Vanillate/Creatinine [Molar ratio] in Urine |
|
79512-0
|
Vanilloylglycine [Moles/volume] in Serum or Plasma |
|
79483-4
|
Vanilloylglycine/Creatinine [Molar ratio] in Urine |
|
77631-0
|
VAPB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
59357-4
|
Vardenafil [Mass/volume] in Blood |
|
59359-0
|
Vardenafil [Mass/volume] in Serum or Plasma |
|
59361-6
|
Vardenafil [Mass/volume] in Urine |
|
43743-4
|
Variant lymphocytes [#/volume] in Blood by Automated count |
|
66144-7
|
Variant lymphocytes [#/volume] in Blood from Fetus by Manual count |
|
40573-8
|
Variant lymphocytes [#/volume] in Body fluid by Manual count |
|
41856-6
|
Variola virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
80666-1
|
Vascular neurology Consult note |
|
89034-3
|
Vascular neurology Initial evaluation note |
|
80668-7
|
Vascular neurology Surgical operation note |
|
80669-5
|
Vascular neurology procedure note |
|
80667-9
|
Vascular neurology Progress note |
|
83677-5
|
Vascular surgery Attending Admission evaluation note |
|
83678-3
|
Vascular surgery Attending Note |
|
83679-1
|
Vascular surgery Attending Preoperative evaluation and management note |
|
83564-5
|
Vascular surgery Nurse practitioner Note |
|
83618-9
|
Vascular surgery Nurse Note |
|
83619-7
|
Vascular surgery Nurse Outpatient Note |
|
83752-6
|
Vascular surgery Physician assistant Note |
|
83782-3
|
Vascular surgery Resident Note |
|
89825-4
|
Vascular surgery Team Conference note |
|
83840-9
|
Vascular surgery Technician Note |
|
84047-0
|
Vascular surgery Admission evaluation note |
|
78510-5
|
Vascular surgery Admission history and physical note |
|
78542-8
|
Vascular surgery Checklist |
|
34853-2
|
Vascular surgery Consult note |
|
85440-6
|
Vascular surgery Discharge summary |
|
78597-2
|
Vascular surgery Education note |
|
78620-2
|
Vascular surgery Flowsheet |
|
84048-8
|
Vascular surgery History and physical note |
|
84049-6
|
Vascular surgery Hospital Note |
|
82838-4
|
Vascular surgery Initial evaluation note |
|
84050-4
|
Vascular surgery Note |
|
34854-0
|
Vascular surgery Outpatient Note |
|
84051-2
|
Vascular surgery Outpatient Postoperative evaluation and management note |
|
78243-3
|
Vascular surgery Surgical operation note |
|
84054-6
|
Vascular surgery Telephone encounter Note |
|
80768-5
|
Vascular surgery Plan of care note |
|
84052-0
|
Vascular surgery Postoperative evaluation and management note |
|
78737-4
|
Vascular surgery Preoperative evaluation and management note |
|
84053-8
|
Vascular surgery procedure note |
|
85441-4
|
Vascular surgery Progress note |
|
57169-5
|
Vascular surgery Referral note |
|
78680-6
|
Vascular surgery Transfer summary note |
|
26928-2
|
Vasopressin [Presence] in 24 hour Urine |
|
94128-6
|
Vasopressin challenge post water deprivation panel - Urine and Serum or Plasma |
|
14949-2
|
Vasopressin [Moles/volume] in Plasma |
|
3126-0
|
Vasopressin [Mass/volume] in Serum or Plasma |
|
13903-0
|
Vasopressin [Mass/volume] in Urine |
|
81441-8
|
Vital capacity [Volume] Respiratory system --post bronchodilation |
|
75627-0
|
Vascular cell adhesion molecule 1 [Mass/volume] in Serum or Plasma |
|
24754-4
|
Administration of vasodilator into catheter Vein |
|
26376-4
|
Administration of vasodilator into catheter Vein - bilateral |
|
26377-2
|
Administration of vasodilator into catheter Vein - left |
|
26378-0
|
Administration of vasodilator into catheter Vein - right |
|
51783-9
|
Reagin Ab [Presence] in Cord blood by VDRL |
|
5290-2
|
Reagin Ab [Presence] in Cerebral spinal fluid by VDRL |
|
5289-4
|
Reagin Ab [Units/volume] in Cerebral spinal fluid by VDRL |
|
31146-4
|
Reagin Ab [Titer] in Cerebral spinal fluid by VDRL |
|
21030-2
|
Reagin Ab [Presence] in Serum from Donor by VDRL |
|
5292-8
|
Reagin Ab [Presence] in Serum by VDRL |
|
5291-0
|
Reagin Ab [Units/volume] in Serum by VDRL |
|
50690-7
|
Reagin Ab [Titer] in Serum by VDRL |
|
14904-7
|
Reagin Ab [Presence] in Unspecified specimen by VDRL |
|
47235-7
|
Reagin Ab [Titer] in Unspecified specimen by VDRL |
|
94119-5
|
Expired minute volume/Carbon dioxide production during exercise |
|
7758-6
|
Veal triggered histamine release [Units/volume] in Blood |
|
7757-8
|
Veal IgE Ab [Units/volume] in Serum |
|
48288-5
|
Vecuronium triggered leukotriene release [Mass/volume] by Leukocytes |
|
90794-9
|
Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma |
|
86899-2
|
Vedolizumab Ab [Mass/volume] in Serum or Plasma by Immunoassay |
|
86898-4
|
Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay |
|
90805-3
|
Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough |
|
23554-9
|
Venezuelan equine encephalitis virus subtype [Identifier] in Unspecified specimen by Immunofluorescence |
|
23553-1
|
Venezuelan equine encephalitis virus subtype [Identifier] in Unspecified specimen by NAA with probe detection |
|
23552-3
|
Venezuelan equine encephalitis virus subtype [Identifier] in Unspecified specimen by Neutralization test |
|
23544-0
|
Venezuelan equine encephalitis virus Ab [Presence] in Serum |
|
23541-6
|
Venezuelan equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
|
23542-4
|
Venezuelan equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
23545-7
|
Venezuelan equine encephalitis virus Ab [Presence] in Serum by Neutralization test |
|
6571-4
|
Venezuelan equine encephalitis virus Ab [Units/volume] in Serum |
|
22607-6
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum |
|
23787-5
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
23543-2
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
43341-7
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Immunoassay |
|
20980-9
|
Venezuelan equine encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
31983-0
|
Venezuelan equine encephalitis virus Ag [Presence] in Serum |
|
6572-2
|
Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunoassay |
|
6573-0
|
Venezuelan equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence |
|
31984-8
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen |
|
23551-5
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23550-7
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Hemagglutination inhibition |
|
23549-9
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23548-1
|
Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
8050-7
|
Venezuelan equine encephalitis virus IgG Ab [Units/volume] in Serum |
|
23546-5
|
Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum |
|
23547-3
|
Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
8051-5
|
Venezuelan equine encephalitis virus IgM Ab [Units/volume] in Serum |
|
49482-3
|
Vascular endothelial growth factor Ag [Presence] in Tissue by Immune stain |
|
34694-0
|
Vascular endothelial growth factor [Mass/volume] in Serum or Plasma |
|
75628-8
|
Vascular endothelial growth factor A [Mass/volume] in Serum or Plasma |
|
82911-9
|
Vascular endothelial growth factor D [Mass/volume] in Serum or Plasma |
|
58082-9
|
Vel Ag [Presence] on Red Blood Cells |
|
75986-0
|
Velocity index Aorta Non-invasive impedance cardiography (NI-ICG) |
|
82520-8
|
Velpatasvir [Susceptibility] by Genotype method |
|
6272-9
|
Velvet grass IgE Ab [Units/volume] in Serum |
|
56411-2
|
Velvet grass IgG4 Ab [Mass/volume] in Serum |
|
48257-0
|
Velvet grass triggered leukotriene release [Mass/volume] by Leukocytes |
|
82307-0
|
Vendor device information panel |
|
7759-4
|
Venison IgE Ab [Units/volume] in Serum |
|
56412-0
|
Venison IgG4 Ab [Mass/volume] in Serum |
|
63098-8
|
Venison IgG Ab [Mass/volume] in Serum |
|
72932-7
|
Venlafaxine induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72931-9
|
Venlafaxine induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
60208-6
|
Venlafaxine [Mass/volume] in Blood |
|
60209-4
|
Venlafaxine [Mass/volume] in Body fluid |
|
59978-7
|
Venlafaxine [Moles/volume] in Gastric fluid |
|
73085-3
|
Venlafaxine induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73084-6
|
Venlafaxine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
13588-9
|
Venlafaxine [Presence] in Serum or Plasma |
|
9630-5
|
Venlafaxine [Mass/volume] in Serum or Plasma |
|
34386-3
|
Venlafaxine [Moles/volume] in Serum or Plasma |
|
60210-2
|
Venlafaxine [Mass/mass] in Tissue |
|
32120-8
|
Venlafaxine [Presence] in Urine |
|
18467-1
|
Venlafaxine [Mass/volume] in Urine |
|
59977-9
|
Venlafaxine [Moles/volume] in Urine |
|
32121-6
|
Venlafaxine [Presence] in Unspecified specimen |
|
60337-3
|
Venlafaxine [Moles/volume] in Unspecified specimen |
|
72775-0
|
Venlafaxine/Creatinine [Mass Ratio] in Urine |
|
75987-8
|
Venous blood temperature |
|
88035-1
|
Ventilator alarm settings Document |
|
76296-3
|
Ventilator airway circuit leakage volume |
|
76526-3
|
Ventilation rate by Carbon dioxide measurement |
|
88034-4
|
Ventilator settings Document |
|
88036-9
|
Ventilator alarm events Document |
|
94124-5
|
Ventilatory threshold [Volume Rate Content] |
|
73083-8
|
Verapamil induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73082-0
|
Verapamil induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
4093-1
|
Verapamil [Presence] in Serum or Plasma |
|
4094-9
|
Verapamil [Mass/volume] in Serum or Plasma |
|
55586-2
|
Verapamil [Moles/volume] in Serum or Plasma |
|
4095-6
|
Verapamil [Presence] in Urine |
|
17767-5
|
Verapamil [Mass/volume] in Urine |
|
45998-2
|
Verbal expressions of distress Set |
|
20981-7
|
Verotoxin identified in Isolate |
|
88869-3
|
Veterinary toxicology panel [Presence] - Unspecified specimen |
|
88868-5
|
Veterinary toxicology quantitative panel - Unspecified specimen |
|
30073-1
|
Voltage-gated calcium channel Ab [Presence] in Serum |
|
31024-3
|
Voltage-gated calcium channel Ab [Moles/volume] in Serum |
|
41261-9
|
Voltage-gated calcium channel IgG Ab [Presence] in Serum |
|
12724-1
|
Voltage-gated calcium channel IgG Ab [Units/volume] in Serum |
|
41201-5
|
Voltage-gated calcium channel IgG Ab [Moles/volume] in Serum |
|
33979-6
|
Voltage-gated calcium channel N type binding Ab [Moles/volume] in Serum |
|
33980-4
|
Voltage-gated calcium channel P/Q type binding Ab [Moles/volume] in Serum |
|
68913-3
|
Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid |
|
68943-0
|
Voltage-gated potassium channel Ab [Units/volume] in Serum |
|
41871-5
|
Voltage-gated potassium channel Ab [Moles/volume] in Serum |
|
82533-1
|
VHL gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
69489-3
|
VHL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
|
82528-1
|
VHL gene full mutation analysis in Blood or Tissue by Sequencing |
|
34502-5
|
VHL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
41043-1
|
VHL gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
60347-2
|
Viable CD34 cells [#/volume] in Body fluid |
|
6578-9
|
Vibrio sp identified in Blood by Organism specific culture |
|
80680-2
|
Vibrio cholerae toxin ctxA gene [Presence] in Stool by NAA with probe detection |
|
49609-1
|
Vibrio sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
6579-7
|
Vibrio sp identified in Stool by Organism specific culture |
|
6580-5
|
Vibrio sp identified in Water by Organism specific culture |
|
6581-3
|
Vibrio sp identified in Unspecified specimen by Organism specific culture |
|
92050-4
|
Video EEG study report |
|
30042-6
|
Vigabatrin [Mass/volume] in Serum or Plasma |
|
25816-0
|
Vigabatrin [Moles/volume] in Serum or Plasma |
|
74939-0
|
Vigabatrin [Mass/volume] in Serum or Plasma --trough |
|
90978-8
|
Vilazodone [Mass/volume] in Serum or Plasma |
|
89988-0
|
Vilazodone [Mass/volume] in Urine by Confirmatory method |
|
75235-2
|
Vilazodone [Presence] in Urine |
|
89989-8
|
Vilazodone [Presence] in Urine by Screen method |
|
47038-5
|
Villin Ag [Presence] in Tissue by Immune stain |
|
55345-3
|
VIM gene methylation [Presence] in Stool by Molecular genetics method |
|
54011-2
|
Vimentin Ab [Presence] in Serum by Immunofluorescence |
|
54012-0
|
Vimentin Ab [Titer] in Serum by Immunofluorescence |
|
10519-7
|
Vimentin Ag [Presence] in Tissue by Immune stain |
|
87420-6
|
Vinculin Ab [Units/volume] in Serum by Immunoassay |
|
54013-8
|
Vinculin Ab [Presence] in Serum by Immunofluorescence |
|
54014-6
|
Vinculin Ab [Titer] in Serum by Immunofluorescence |
|
38733-2
|
Vinyl acetate [Mass/volume] in Air |
|
38734-0
|
Vinyl bromide [Mass/volume] in Air |
|
38626-8
|
Vinyl chloride [Mass/volume] in Air |
|
17768-3
|
Vinyl chloride [Mass/volume] in Blood |
|
13640-8
|
Vinyl chloride [Mass/volume] in Urine |
|
18259-2
|
Vasoactive intestinal peptide [Mass/time] in 24 hour Urine |
|
46962-7
|
Vasoactive intestinal peptide Ag [Presence] in Tissue by Immune stain |
|
55205-9
|
Vasoactive intestinal peptide [Mass/volume] in Cerebral spinal fluid |
|
51989-2
|
Vasoactive intestinal peptide [Presence] in Serum or Plasma |
|
3125-2
|
Vasoactive intestinal peptide [Mass/volume] in Serum or Plasma |
|
53523-7
|
Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma |
|
10735-9
|
Viral sequencing [Identifier] in Serum by Sequencing |
|
615-5
|
Viral strain [Type] in Isolate by Viral subtyping |
|
92893-7
|
Microbiology - viral studies |
|
29578-2
|
Viral susceptibility panel |
|
6164-8
|
Virginia Live Oak IgE Ab [Units/volume] in Serum |
|
56413-8
|
Virginia Live Oak IgG4 Ab [Mass/volume] in Serum |
|
10958-7
|
Virginia Scrub Pine IgE Ab [Units/volume] in Serum |
|
87585-6
|
Virginiamycin [Mass/mass] in Unspecified specimen |
|
11484-3
|
Virus identified in Amniotic fluid by Culture |
|
5883-4
|
Virus identified in Blood by Culture |
|
14489-9
|
Virus identified in Blood by Immunofluorescence |
|
5884-2
|
Virus identified in Cerebral spinal fluid by Culture |
|
10736-7
|
Virus identified in Cerebral spinal fluid by Electron microscopy |
|
14488-1
|
Virus identified in Cerebral spinal fluid by Immunofluorescence |
|
14452-7
|
Virus identified in Cervix by Culture |
|
14493-1
|
Virus identified in Cervix by Immunofluorescence |
|
14451-9
|
Virus identified in Eye by Culture |
|
14492-3
|
Virus identified in Eye by Immunofluorescence |
|
40479-8
|
Virus identified in Body fluid by Culture |
|
40480-6
|
Virus identified in Genital specimen by Culture |
|
42808-6
|
Virus identified in Isolate |
|
6608-4
|
Virus identified in Isolate by Culture |
|
86337-3
|
Virus identified in Isolate by Shell vial culture |
|
87709-2
|
Virus identified in Lower respiratory specimen by Culture |
|
72374-2
|
Virus identified in Lung tissue by Culture |
|
14454-3
|
Virus identified in Nose by Culture |
|
72373-4
|
Virus identified in Nasopharynx by Culture |
|
14459-2
|
Virus identified in Penis by Culture |
|
14497-2
|
Virus identified in Penis by Immunofluorescence |
|
14455-0
|
Virus identified in Pleural fluid by Culture |
|
14456-8
|
Virus identified in Peritoneal fluid by Culture |
|
5885-9
|
Virus identified in Skin by Culture |
|
6583-9
|
Virus identified in Semen by Culture |
|
14490-7
|
Virus identified in Semen by Immunofluorescence |
|
14458-4
|
Virus identified in Sputum by Culture |
|
14496-4
|
Virus identified in Sputum by Immunofluorescence |
|
5886-7
|
Virus identified in Stool by Culture |
|
10737-5
|
Virus identified in Stool by Electron microscopy |
|
5887-5
|
Virus identified in Throat by Culture |
|
14491-5
|
Virus identified in Throat by Immunofluorescence |
|
5888-3
|
Virus identified in Tissue by Culture |
|
10738-3
|
Virus identified in Tissue by Electron microscopy |
|
89655-5
|
Virus identified in Tissue by Shell vial culture |
|
14457-6
|
Virus identified in Urine by Culture |
|
14495-6
|
Virus identified in Urine sediment by Immunofluorescence |
|
14460-0
|
Virus identified in Urethra by Culture |
|
14498-0
|
Virus identified in Urethra by Immunofluorescence |
|
14453-5
|
Virus identified in Vaginal fluid by Culture |
|
14494-9
|
Virus identified in Vaginal fluid by Immunofluorescence |
|
41461-5
|
Virus identified in Unspecified specimen |
|
6584-7
|
Virus identified in Unspecified specimen by Culture |
|
10739-1
|
Virus identified in Unspecified specimen by Electron microscopy |
|
12272-1
|
Virus identified in Unspecified specimen by Immunofluorescence |
|
50024-9
|
Virus identified in Unspecified specimen by Shell vial culture |
|
4690-4
|
Viscosity of Blood |
|
79333-1
|
Viscosity of Cervical mucus Qualitative |
|
3127-8
|
Viscosity of Body fluid |
|
4691-2
|
Viscosity of Plasma |
|
3128-6
|
Viscosity of Serum |
|
9631-3
|
Viscosity of Semen |
|
32789-0
|
Viscosity of Semen Qualitative |
|
14950-0
|
Viscosity of Synovial fluid Qualitative |
|
45994-1
|
Vision patterns section |
|
86530-3
|
Visit notification note |
|
28631-0
|
Visual acuity study |
|
45995-8
|
Visual limitations and dificulties Set |
|
2922-3
|
Retinol [Mass/volume] in Blood |
|
17526-5
|
Retinyl esters [Mass/volume] in Serum or Plasma |
|
20947-8
|
Retinol [Mass/mass] in Feed |
|
17527-3
|
Retinol Free [Mass/volume] in Serum or Plasma |
|
20946-0
|
Retinol [Mass/mass] in Liver |
|
2923-1
|
Retinol [Mass/volume] in Serum or Plasma |
|
14905-4
|
Retinol [Moles/volume] in Serum or Plasma |
|
20948-6
|
Retinol [Mass/mass] in Tissue |
|
27149-4
|
Thiamine [Presence] in Blood |
|
2998-3
|
Thiamine [Mass/volume] in Blood |
|
32554-8
|
Thiamine [Moles/volume] in Blood |
|
49115-9
|
Thiamine.free [Mass/volume] in Blood |
|
74444-1
|
Thiamine pyrophosphate [Moles/volume] in Blood |
|
3000-7
|
Thiamine pyrophosphate [Mass/volume] in Serum |
|
2999-1
|
Thiamine [Mass/volume] in Serum or Plasma |
|
20468-5
|
Thiamine [Moles/volume] in Serum or Plasma |
|
26916-7
|
Cobalamin (Vitamin B12) [Presence] in Blood |
|
16695-9
|
Cobalamin (Vitamin B12) [Mass/volume] in Blood |
|
2169-1
|
Cobalamin (Vitamin B12) renal clearance in 24 hour Urine and Serum or Plasma |
|
54377-7
|
Cobalamin (Vitamin B12) [Mass/volume] in Body fluid |
|
54376-9
|
Cobalamin (Vitamin B12) [Moles/volume] in Body fluid |
|
35201-3
|
Cobalamin (Vitamin B12) [Mass or Moles/volume] in Serum |
|
2132-9
|
Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma |
|
14685-2
|
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma |
|
55850-2
|
Cobalamin (Vitamin B12) [Mass/volume] in Urine |
|
54378-5
|
Cobalamin (Vitamin B12) [Moles/volume] in Urine |
|
2171-7
|
Cobalamin (Vitamin B12).unsaturated Binding Capacity [Mass/volume] in Serum or Plasma |
|
15052-4
|
Cobalamin (Vitamin B12).unsaturated Binding Capacity [Moles/volume] in Serum or Plasma |
|
1888-7
|
Aquacobalamin [Mass/volume] in Serum or Plasma |
|
55883-3
|
Hydroxocobalamin [Mass/volume] in Body fluid |
|
55882-5
|
Hydroxocobalamin [Moles/volume] in Body fluid |
|
2440-6
|
Hydroxocobalamin [Mass/volume] in Serum or Plasma |
|
55881-7
|
Hydroxocobalamin [Moles/volume] in Serum or Plasma |
|
55885-8
|
Hydroxocobalamin [Mass/volume] in Urine |
|
55884-1
|
Hydroxocobalamin [Moles/volume] in Urine |
|
18374-9
|
Riboflavin [Mass/volume] in 24 hour Urine |
|
27099-1
|
Riboflavin [Presence] in Blood |
|
6695-1
|
Riboflavin [Mass/volume] in Blood |
|
73723-9
|
Riboflavin [Moles/volume] in Blood |
|
2924-9
|
Riboflavin [Mass/volume] in Serum or Plasma |
|
49038-3
|
Riboflavin [Moles/volume] in Serum or Plasma |
|
26915-9
|
Pyridoxine [Presence] in Blood |
|
2901-7
|
Pyridoxine congeners [Mass/volume] in Serum or Plasma |
|
75043-0
|
Pyridoxine [Moles/volume] in Cerebral spinal fluid |
|
2900-9
|
Pyridoxine [Mass/volume] in Serum or Plasma |
|
39786-9
|
Pyridoxine [Moles/volume] in Serum or Plasma |
|
1905-9
|
Ascorbate [Mass/time] in 24 hour Urine |
|
34246-9
|
Ascorbate [Moles/volume] in 24 hour Urine |
|
15033-4
|
Ascorbate [Moles/time] in 24 hour Urine |
|
1902-6
|
Ascorbate [Mass/volume] in Blood |
|
1903-4
|
Ascorbate [Mass/volume] in Serum or Plasma |
|
14622-5
|
Ascorbate [Moles/volume] in Serum or Plasma |
|
59398-8
|
Ascorbate [Mass/volume] in Semen |
|
56779-2
|
Ascorbate [Moles/volume] in Semen |
|
1904-2
|
Ascorbate [Presence] in Urine |
|
16408-7
|
Ascorbate [Mass/volume] in Urine |
|
34247-7
|
Ascorbate [Moles/volume] in Urine |
|
12482-6
|
Ascorbate [Mass/volume] in Leukocytes |
|
60286-2
|
Ascorbate [Moles/volume] in Unspecified specimen |
|
34248-5
|
Ascorbate/Creatinine [Molar ratio] in Urine |
|
54351-2
|
Ascorbate+Dehydroascorbate [Mass/volume] in Serum or Plasma |
|
54350-4
|
Ascorbate+Dehydroascorbate [Moles/volume] in Serum or Plasma |
|
35365-6
|
Vitamin D+Metabolites [Mass/volume] in Serum or Plasma |
|
49590-3
|
Calcidiol and Calciferol panel - Serum or Plasma |
|
43134-6
|
Calcidiol and Calciferol and Calcitriol panel [Mass/volume] - Serum or Plasma |
|
72105-0
|
Vital signs and oximetry - admission, home health, interim, discharge [CARE] |
|
34566-0
|
Vital signs with method details panel |
|
34565-2
|
Vital signs, weight and height panel |
|
85353-1
|
Vital signs, weight, height, head circumference, oxygen saturation and BMI panel |
|
67795-5
|
Vital signs, weight, height, head circumference and oximetry panel HITSP |
|
74728-7
|
Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.CCDAr1.1 |
|
2236-8
|
Calciferol (Vit D2) [Mass/volume] in Serum or Plasma |
|
47094-8
|
Calciferol (Vit D2) [Moles/volume] in Serum or Plasma |
|
1990-1
|
Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma |
|
33958-0
|
Cholecalciferol (Vit D3) [Moles/volume] in Serum or Plasma |
|
87671-4
|
Cholecalciferol (Vit D3) [Mass/mass] in Unspecified specimen |
|
81942-5
|
Vitamin intake panel |
|
3130-2
|
Vitronectin [Mass/volume] in Plasma |
|
72507-7
|
VKORC1 gene c.1173C>T [Presence] in Blood or Tissue by Molecular genetics method |
|
72512-7
|
VKORC1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
50722-8
|
VKORC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
75101-6
|
Fatty acids.very long chain C22:0 (Docosanoate) [Entitic substance] in Red Blood Cells |
|
74615-6
|
Fatty acids.very long chain C22:0 (Docosanoate) [Mass/mass] in Fibroblast |
|
53859-5
|
Fatty acids.very long chain C22:0 (Docosanoate) [Mass/volume] in Serum or Plasma |
|
43677-4
|
Fatty acid very long chain (C22-C26) panel - Serum or Plasma |
|
75104-0
|
Fatty acids.very long chain C24:0 (Tetracosanoate) [Entitic substance] in Red Blood Cells |
|
74613-1
|
Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/mass] in Fibroblast |
|
53860-3
|
Fatty acids.very long chain C24:0 (Tetracosanoate) [Mass/volume] in Serum or Plasma |
|
74583-6
|
Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast |
|
50060-3
|
Fatty acids.very long chain C24:0 (Tetracosanoate)/Creatinine [Molar ratio] in Urine |
|
75096-8
|
Fatty acids.very long chain C26:0 (Hexacosanoate) [Entitic substance] in Red Blood Cells |
|
74614-9
|
Fatty acids.very long chain C26:0 (Hexacosanoate) [Mass/mass] in Fibroblast |
|
74582-8
|
Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Fibroblast |
|
54294-4
|
Fatty acids.very long chain C26:0 (Hexacosanoate)/Creatinine [Molar ratio] in Urine |
|
75105-7
|
Fatty acids.very long chain C26:1 (Hexacosenoate) [Entitic substance] in Red Blood Cells |
|
75109-9
|
Fatty acids.very long chain.C22:1n9 (Erucate) [Entitic substance] in Red Blood Cells |
|
79701-9
|
Fatty acids.very long chain.C22:1n9 (Erucate) [Moles/volume] in Serum or Plasma |
|
41999-4
|
Lipoprotein.pre-beta [Presence] in Body fluid |
|
43728-5
|
Lipoprotein.pre-beta.subparticle.large [Moles/volume] in Serum or Plasma |
|
56777-6
|
Lipoprotein.pre-beta/Lipoprotein.beta [Mass Ratio] in Serum or Plasma |
|
50192-4
|
Cholesterol in VLDL 1+2+3 [Mass/volume] in Serum or Plasma |
|
49624-0
|
Cholesterol in VLDL 1+2 [Mass/volume] in Serum or Plasma |
|
46986-6
|
Cholesterol in VLDL 3 [Mass/volume] in Serum or Plasma |
|
66126-4
|
Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation |
|
48618-3
|
Cholesterol in VLDL [Mass/volume] in Serum or Plasma ultracentrifugate |
|
43099-1
|
Vanillylmandelate and Creatinine panel - 24 hour Urine |
|
90250-2
|
Vanillylmandelate and Homovanillate panel - Urine |
|
48644-9
|
Vanillylmandelate, Homovanillate and Creatinine panel - 24 hour Urine |
|
26706-2
|
Vanillylmandelate [Mass/volume] in 24 hour Urine |
|
3122-9
|
Vanillylmandelate [Mass/time] in 24 hour Urine |
|
26003-4
|
Vanillylmandelate [Moles/volume] in 24 hour Urine |
|
14947-6
|
Vanillylmandelate [Moles/time] in 24 hour Urine |
|
79400-8
|
Vanillylmandelate [Moles/volume] in Cerebral spinal fluid |
|
3121-1
|
Vanillylmandelate [Mass/volume] in Serum |
|
75064-6
|
Vanillylmandelate [Moles/volume] in Serum or Plasma |
|
9624-8
|
Vanillylmandelate [Mass/volume] in Urine |
|
15097-9
|
Vanillylmandelate [Moles/volume] in Urine |
|
30571-4
|
Vanillylmandelate/Creatinine [Mass Ratio] in 24 hour Urine |
|
26004-2
|
Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine |
|
3124-5
|
Vanillylmandelate/Creatinine [Mass Ratio] in Urine |
|
14948-4
|
Vanillylmandelate/Creatinine [Molar ratio] in Urine |
|
44418-2
|
Vanillylmandelate/Creatine [Mass Ratio] in 24 hour Urine |
|
56645-5
|
Vanillylmandelate/Creatine [Ratio] in 24 hour Urine |
|
3123-7
|
Vanillylmandelate/Creatine [Mass Ratio] in Urine |
|
74028-2
|
Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDS |
|
62849-5
|
Venlafaxine+Norvenlafaxine [Mass/volume] in Serum or Plasma |
|
48350-3
|
Venlafaxine+Norvenlafaxine [Moles/volume] in Serum or Plasma |
|
72678-6
|
Venlafaxine+Norvenlafaxine [Mass/volume] in Serum or Plasma --trough |
|
94122-9
|
Oxygen consumption (VO2)/Body weight [Volume Rate Content] --peak during exercise |
|
84313-6
|
Vocational rehabilitation Admission evaluation note |
|
84312-8
|
Vocational rehabilitation Consult note |
|
84311-0
|
Vocational rehabilitation Counseling note |
|
84309-4
|
Vocational rehabilitation Custodial care facility Note |
|
84310-2
|
Vocational rehabilitation Discharge summary |
|
85935-5
|
Vocational rehabilitation Education note |
|
84308-6
|
Vocational rehabilitation Initial evaluation note |
|
86213-6
|
Vocational rehabilitation Medical clearance note |
|
75502-5
|
Vocational rehabilitation Note |
|
84306-0
|
Vocational rehabilitation Plan of care note |
|
85936-3
|
Vocational rehabilitation Risk assessment and screening note |
|
80524-2
|
Voiding time by Uroflowmetry |
|
13004-7
|
Hydrocarbons.halogenated.volatile [Identifier] in Blood |
|
75959-7
|
Volume expired per minute Respiratory system |
|
75960-5
|
Inspired minute Volume |
|
4096-4
|
Volatile drugs negative [Identifier] in Urine by Screen method |
|
14951-8
|
Volatile drugs positive [Identifier] in Serum or Plasma by Screen method |
|
4097-2
|
Volatile drugs positive [Identifier] in Urine by Screen method |
|
41266-8
|
Volatiles and gases [Identifier] in Blood |
|
74133-0
|
Volatiles and gases [Presence] in Blood |
|
41214-8
|
Volatiles and gases [Identifier] in Gastric fluid by Screen method |
|
50025-6
|
Volatiles panel - Serum or Plasma |
|
24350-1
|
Volatiles panel - Urine |
|
32044-0
|
Volatiles and gases [Identifier] in Serum or Plasma |
|
12983-3
|
Volatiles and gases [Identifier] in Urine |
|
40474-9
|
Volatiles and gases [Identifier] in Unspecified specimen |
|
91889-6
|
Volunteer contact information panel |
|
48593-8
|
von Willebrand panel - Platelet poor plasma |
|
80553-1
|
Voriconazole [Mass/volume] in DBS |
|
73081-2
|
Voriconazole induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73080-4
|
Voriconazole induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
80651-3
|
Voriconazole N-oxide [Mass/volume] in Serum or Plasma |
|
38370-3
|
Voriconazole [Mass/volume] in Serum or Plasma |
|
73676-9
|
Voriconazole [Mass/volume] in Serum or Plasma --trough |
|
90979-6
|
Vortioxetine [Mass/volume] in Serum or Plasma |
|
89986-4
|
Vortioxetine [Mass/volume] in Urine by Confirmatory method |
|
89987-2
|
Vortioxetine [Presence] in Urine by Screen method |
|
92734-3
|
Voxilaprevir [Susceptibility] by Genotype method |
|
48600-1
|
VPS13B gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
76274-0
|
Ventilation-perfusion index Respiratory system |
|
59150-3
|
Vancomycin resistant enterococcus [Presence] in Anal by Organism specific culture |
|
59152-9
|
Vancomycin resistant enterococcus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
59151-1
|
Vancomycin resistant enterococcus [Presence] in Urine by Organism specific culture |
|
13316-5
|
Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture |
|
92516-4
|
VS Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method |
|
92478-7
|
VS Ag inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
|
93913-2
|
VS Ag [Presence] on Red Blood Cells |
|
47517-8
|
Vesicular stomatitis Alagoas virus Ab [Titer] in Serum |
|
45124-5
|
Vesicular stomatitis Alagoas virus Ab [Titer] in Serum by Neutralization test |
|
45125-2
|
Vesicular stomatitis Alagoas virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
45126-0
|
Vesicular stomatitis Alagoas virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
23561-4
|
Vesicular stomatitis Indiana virus Ab [Presence] in Serum |
|
23564-8
|
Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Complement fixation |
|
23563-0
|
Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Immunoassay |
|
23562-2
|
Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Neutralization test |
|
31696-8
|
Vesicular stomatitis Indiana virus Ab [Units/volume] in Serum |
|
42945-6
|
Vesicular stomatitis Indiana virus Ab [Titer] in Serum |
|
23788-3
|
Vesicular stomatitis Indiana virus Ab [Titer] in Serum by Complement fixation |
|
23789-1
|
Vesicular stomatitis Indiana virus Ab [Titer] in Serum by Neutralization test |
|
45118-7
|
Vesicular stomatitis Indiana virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
45120-3
|
Vesicular stomatitis Indiana virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
78531-1
|
Vesicular stomatitis Indiana virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
39023-7
|
Vesicular stomatitis Indiana virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23565-5
|
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum |
|
23568-9
|
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Complement fixation |
|
23566-3
|
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Immunoassay |
|
23567-1
|
Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Neutralization test |
|
31697-6
|
Vesicular stomatitis New Jersey virus Ab [Units/volume] in Serum |
|
42944-9
|
Vesicular stomatitis New Jersey virus Ab [Titer] in Serum |
|
23790-9
|
Vesicular stomatitis New Jersey virus Ab [Titer] in Serum by Complement fixation |
|
23791-7
|
Vesicular stomatitis New Jersey virus Ab [Titer] in Serum by Neutralization test |
|
45128-6
|
Vesicular stomatitis New Jersey virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
45127-8
|
Vesicular stomatitis New Jersey virus Ag [Presence] in Unspecified specimen by Immunoassay |
|
78530-3
|
Vesicular stomatitis New Jersey virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
39024-5
|
Vesicular stomatitis New Jersey virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
23555-6
|
Vesicular stomatitis virus Ab [Presence] in Serum |
|
31985-5
|
Vesicular stomatitis virus Ag [Presence] in Skin |
|
23559-8
|
Vesicular stomatitis virus Ag [Presence] in Skin by Complement fixation |
|
23557-2
|
Vesicular stomatitis virus Ag [Presence] in Skin by Immunoassay |
|
31986-3
|
Vesicular stomatitis virus Ag [Presence] in Throat |
|
23560-6
|
Vesicular stomatitis virus Ag [Presence] in Throat by Complement fixation |
|
23558-0
|
Vesicular stomatitis virus Ag [Presence] in Throat by Immunoassay |
|
23570-5
|
Vesicular stomatitis virus serotype [Identifier] in Tissue by Complement fixation |
|
23571-3
|
Vesicular stomatitis virus serotype [Identifier] in Tissue by Immunoassay |
|
23569-7
|
Vesicular stomatitis virus serotype [Identifier] in Unspecified specimen by Complement fixation |
|
23572-1
|
Vesicular stomatitis virus serotype [Identifier] in Unspecified specimen by Immunoassay |
|
76222-9
|
Tidal volume Ventilator --on ventilator |
|
75958-9
|
Tidal volume expired Respiratory system airway |
|
76007-4
|
Tidal volume expired Respiratory system airway --on ventilator |
|
58083-7
|
Vw Ag [Presence] on Red Blood Cells |
|
27816-8
|
von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay |
|
6012-9
|
von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
|
41867-3
|
von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma |
|
50377-1
|
von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay |
|
89366-9
|
von Willebrand factor collagen binding adhesion inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method |
|
93371-3
|
von Willebrand factor (vWf) cleaving protease activity [Enzymatic activity/volume] in Platelet poor plasma by Chromogenic method |
|
53622-7
|
von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Chromogenic method |
|
34590-0
|
von Willebrand factor (vWf) cleaving protease inhibitor [Presence] in Platelet poor plasma |
|
40824-5
|
von Willebrand factor (vWf) cleaving protease inhibitor [Units/volume] in Platelet poor plasma |
|
34589-2
|
von Willebrand factor (vWf) cleaving protease [Presence] in Platelet poor plasma |
|
40970-6
|
VWF gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
41768-3
|
VWF gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
24376-6
|
von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoassay |
|
6013-7
|
von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot |
|
32217-2
|
von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma |
|
41210-6
|
VWF gene p.Arg816Trp [Presence] in Blood or Tissue by Molecular genetics method |
|
41209-8
|
VWF gene.p.Arg854Gln [Presence] in Blood or Tissue by Molecular genetics method |
|
41268-4
|
VWF gene.p.Thr791Met [Presence] in Blood by Molecular genetics method |
|
89367-7
|
von Willebrand factor.ristocetin cofactor inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay |
|
74808-7
|
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay --immediately after 1:1 addition of normal plasma |
|
68324-3
|
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay |
|
73978-9
|
von Willebrand factor (vWf).activity [Units/volume] in Platelet poor plasma by Immunoassay |
|
6014-5
|
von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation |
|
4680-5
|
von Willebrand factor (vWf) ristocetin cofactor [Units/volume] in Platelet poor plasma |
|
81643-9
|
von Willebrand factor (vWf) ristocetin cofactor/von Willebrand factor (vWf) Ag [Ratio] in Platelet poor plasma |
|
80632-3
|
2-Methylpropyl methylphosphonate [Mass/volume] in Blood |
|
54101-1
|
2-Methylpropyl methylphosphonate [Mass/volume] in Urine |
|
9636-2
|
Varicella zoster virus Ab [Presence] in Cerebral spinal fluid |
|
31694-3
|
Varicella zoster virus Ab [Units/volume] in Cerebral spinal fluid |
|
52978-4
|
Varicella zoster virus Ab [Units/volume] in Serum by Complement fixation |
|
47419-7
|
Varicella zoster virus Ab [Units/volume] in Serum by Immunoassay |
|
22600-1
|
Varicella zoster virus Ab [Presence] in Serum |
|
43978-6
|
Varicella zoster virus Ab [Presence] in Serum by Immunoassay |
|
12271-3
|
Varicella zoster virus Ab [Presence] in Serum by Latex agglutination |
|
8046-5
|
Varicella zoster virus Ab [Units/volume] in Serum |
|
21592-1
|
Varicella zoster virus Ab [Titer] in Cerebral spinal fluid |
|
33327-8
|
Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
|
26723-7
|
Varicella zoster virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
21594-7
|
Varicella zoster virus Ab [Titer] in Serum |
|
5401-5
|
Varicella zoster virus Ab [Titer] in Serum by Complement fixation |
|
44771-4
|
Varicella zoster virus Ab [Titer] in Serum by Immunofluorescence |
|
5402-3
|
Varicella zoster virus Ab [Titer] in Serum by Latex agglutination |
|
89589-6
|
Varicella zoster virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
67812-8
|
Varicella zoster virus Ag [Presence] in Isolate by Immunofluorescence |
|
91774-0
|
Varicella zoster virus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
31981-4
|
Varicella zoster virus Ag [Presence] in Skin |
|
5881-8
|
Varicella zoster virus Ag [Presence] in Skin by Immunofluorescence |
|
86592-3
|
Varicella zoster virus Ag [Presence] in Tissue by Immunofluorescence |
|
31982-2
|
Varicella zoster virus Ag [Presence] in Unspecified specimen |
|
5882-6
|
Varicella zoster virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
86509-7
|
Varicella zoster virus clade [Type] in Unspecified specimen by Molecular genetics method |
|
88135-9
|
Varicella zoster virus [Presence] in Cornea or Conjunctiva by Organism specific culture |
|
49454-2
|
Varicella zoster virus DNA [#/volume] (viral load) in Amniotic fluid by NAA with probe detection |
|
49455-9
|
Varicella zoster virus DNA [#/volume] (viral load) in Bronchoalveolar lavage by NAA with probe detection |
|
92848-1
|
Varicella zoster virus DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
47002-1
|
Varicella zoster virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
49453-4
|
Varicella zoster virus DNA [#/volume] (viral load) in Bone marrow by NAA with probe detection |
|
47003-9
|
Varicella zoster virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
49450-0
|
Varicella zoster virus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
|
49452-6
|
Varicella zoster virus DNA [#/volume] (viral load) in Urine by NAA with probe detection |
|
49451-8
|
Varicella zoster virus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection |
|
86593-1
|
Varicella zoster virus DNA [Presence] in Amniotic fluid by NAA with probe detection |
|
88536-8
|
Varicella zoster virus DNA [Presence] in Aspirate by NAA with probe detection |
|
29248-2
|
Varicella zoster virus DNA [Presence] in Blood by NAA with probe detection |
|
88132-6
|
Varicella zoster virus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
82188-4
|
Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
21598-8
|
Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
35399-5
|
Varicella zoster virus DNA [Presence] in Eye by NAA with probe detection |
|
87961-9
|
Varicella zoster virus DNA [Presence] in Body fluid by NAA with probe detection |
|
88565-7
|
Varicella zoster virus DNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
88134-2
|
Varicella zoster virus DNA [Presence] in Ocular fluid by NAA with probe detection |
|
8049-9
|
Varicella zoster virus DNA [Presence] in Serum by NAA with probe detection |
|
92888-7
|
Varicella zoster virus DNA [Presence] in Skin by NAA with probe detection |
|
35400-1
|
Varicella zoster virus DNA [Presence] in Tissue by NAA with probe detection |
|
91791-4
|
Varicella zoster virus DNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
11483-5
|
Varicella zoster virus DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
58755-0
|
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
17765-9
|
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
|
42537-1
|
Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid |
|
17764-2
|
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
53534-4
|
Varicella zoster virus IgG Ab [Presence] in Body fluid by Immunoassay |
|
29249-0
|
Varicella zoster virus IgG Ab [Units/volume] in Body fluid |
|
5403-1
|
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
17763-4
|
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence |
|
19162-7
|
Varicella zoster virus IgG Ab [Presence] in Serum |
|
15410-4
|
Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay |
|
41512-5
|
Varicella zoster virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
8047-3
|
Varicella zoster virus IgG Ab [Units/volume] in Serum |
|
14306-5
|
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
22603-5
|
Varicella zoster virus IgG Ab [Units/volume] in Serum --1st specimen |
|
14307-3
|
Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
22604-3
|
Varicella zoster virus IgG Ab [Units/volume] in Serum --2nd specimen |
|
22601-9
|
Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid |
|
21595-4
|
Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22602-7
|
Varicella zoster virus IgG Ab [Titer] in Serum |
|
6569-8
|
Varicella zoster virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
35679-0
|
Varicella zoster virus IgG and IgM panel - Cerebral spinal fluid |
|
45063-5
|
Varicella zoster virus IgG and IgM panel - Serum |
|
81234-7
|
Varicella zoster virus IgG and IgM panel - Serum or Plasma Qualitative |
|
69930-6
|
Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
31695-0
|
Varicella zoster virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
74414-4
|
Varicella zoster virus IgM Ab [Units/volume] in Body fluid by Immunoassay |
|
53535-1
|
Varicella zoster virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
5404-9
|
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
17766-7
|
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunofluorescence |
|
21597-0
|
Varicella zoster virus IgM Ab [Presence] in Serum |
|
29662-4
|
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay |
|
43588-3
|
Varicella zoster virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
8048-1
|
Varicella zoster virus IgM Ab [Units/volume] in Serum |
|
57322-0
|
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
57323-8
|
Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
|
22605-0
|
Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid |
|
21596-2
|
Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22606-8
|
Varicella zoster virus IgM Ab [Titer] in Serum |
|
6570-6
|
Varicella zoster virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
91784-9
|
Varicella zoster virus [Presence] in Lower respiratory specimen by Organism specific culture |
|
88136-7
|
Varicella zoster virus [Presence] in Ocular fluid by Organism specific culture |
|
73656-1
|
Varicella zoster virus ORF28 genotype [Identifier] |
|
73657-9
|
Varicella zoster virus ORF36 genotype [Identifier] |
|
10734-2
|
Varicella zoster virus identified in Skin by Electron microscopy |
|
43693-1
|
Varicella zoster virus identified in Skin by Shell vial culture |
|
86502-2
|
Varicella zoster virus strain DNA [Type] in Unspecified specimen by NAA with probe detection |
|
81235-4
|
Varicella zoster virus surveillance panel |
|
10860-5
|
Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture |
|
22617-5
|
Wuchereria bancrofti Ab [Presence] in Serum |
|
6633-2
|
Wuchereria bancrofti Ab [Presence] in Serum by Immunoassay |
|
11582-4
|
Wuchereria bancrofti Ab [Units/volume] in Serum |
|
59850-8
|
Wuchereria bancrofti Ag [Units/volume] in Serum by Immunoassay |
|
25555-4
|
Wuchereria bancrofti Ag [Presence] in Serum |
|
41463-1
|
Wuchereria bancrofti+Brugia malayi Ag [Presence] in Serum by Immunoassay |
|
88182-1
|
Wuchereria bancrofti+Brugia malayi IgG1 Ab [Presence] in Serum by Immunoassay |
|
88181-3
|
Wuchereria bancrofti+Brugia malayi IgG2 Ab [Presence] in Serum by Immunoassay |
|
88180-5
|
Wuchereria bancrofti+Brugia malayi IgG3 Ab [Presence] in Serum by Immunoassay |
|
88179-7
|
Wuchereria bancrofti+Brugia malayi IgG4 Ab [Presence] in Serum by Immunoassay |
|
93453-9
|
W-15 [Mass/volume] in Urine by Confirmatory method |
|
93454-7
|
W-18 [Mass/volume] in Urine by Confirmatory method |
|
93452-1
|
W-19 [Mass/volume] in Urine by Confirmatory method |
|
46075-8
|
Walking when most self sufficient Set |
|
7761-0
|
Walleye Pike IgE Ab [Units/volume] in Serum |
|
7762-8
|
Walnut triggered histamine release [Units/volume] in Blood |
|
6273-7
|
Walnut IgE Ab [Units/volume] in Serum |
|
41198-3
|
Walnut IgE Ab/IgE total in Serum |
|
7767-7
|
Walnut IgG Ab [Units/volume] in Serum |
|
56414-6
|
Walnut IgG4 Ab [Mass/volume] in Serum |
|
63120-0
|
Walnut IgG Ab [Mass/volume] in Serum |
|
72930-1
|
Warfarin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
72929-3
|
Warfarin induced neutrophil IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
29383-7
|
Warfarin [Mass/volume] in Gastric fluid |
|
59980-3
|
Warfarin [Moles/volume] in Gastric fluid |
|
93196-4
|
Warfarin response genotype panel - Blood or Tissue by Molecular genetics method |
|
73078-8
|
Warfarin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
73079-6
|
Warfarin induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
|
41184-3
|
Warfarin [Presence] in Serum or Plasma |
|
4098-0
|
Warfarin [Mass/volume] in Serum or Plasma |
|
39798-4
|
Warfarin [Moles/volume] in Serum or Plasma |
|
55401-4
|
Warfarin tracking panel - Platelet poor plasma |
|
12282-0
|
Warfarin [Presence] in Urine |
|
29382-9
|
Warfarin [Mass/volume] in Urine |
|
59979-5
|
Warfarin [Moles/volume] in Urine |
|
74107-4
|
Warfarin [Presence] in Unspecified specimen by Screen method |
|
87605-2
|
Warfarin [Mass/mass] in Unspecified specimen |
|
60338-1
|
Warfarin [Moles/volume] in Unspecified specimen |
|
57759-3
|
WAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
57755-1
|
WAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
|
13176-3
|
Wasp venom IgE Ab [Units/volume] in Serum |
|
13178-9
|
Wasp venom IgG Ab [Units/volume] in Serum |
|
26432-5
|
Wasp venom IgG4 Ab [Units/volume] in Serum or Plasma |
|
92186-6
|
Watch team report Document |
|
7769-3
|
Water Chestnut IgE Ab [Units/volume] in Serum |
|
94129-4
|
Water deprivation challenge panel - Urine and Serum or Plasma |
|
7400-5
|
Water Hemp IgE Ab [Units/volume] in Serum |
|
59016-6
|
Water [Mass/mass] in Stool by Infrared spectroscopy |
|
7770-1
|
Watermelon IgE Ab [Units/volume] in Serum |
|
57940-9
|
Watermelon IgE Ab/IgE total in Serum |
|
7771-9
|
Watermelon IgG Ab [Units/volume] in Serum |
|
56415-3
|
Watermelon IgG4 Ab [Mass/volume] in Serum |
|
41205-6
|
Watermelon IgG Ab [Mass/volume] in Serum |
|
6015-2
|
Wattle IgE Ab [Units/volume] in Serum |
|
56458-3
|
Wattle IgG4 Ab [Mass/volume] in Serum |
|
7140-7
|
Wax Bean IgE Ab [Units/volume] in Serum |
|
44098-2
|
Microscopic observation [Identifier] in Unspecified specimen by Wayson stain |
|
26464-8
|
Leukocytes [#/volume] in Blood |
|
6690-2
|
Leukocytes [#/volume] in Blood by Automated count |
|
47281-1
|
Leukocytes [#/volume] in Cord blood |
|
92635-2
|
Leukocytes [#/volume] in Buffy Coat |
|
49928-5
|
Leukocytes [#/volume] in Peritoneal dialysis fluid |
|
57847-6
|
Leukocytes [#/volume] in Dialysis fluid by Manual count |
|
57845-0
|
Leukocytes [#/volume] in Body fluid by Automated count |
|
82587-7
|
Leukocytes [#/volume] in Bone marrow by Automated count |
|
57846-8
|
Leukocytes [#/volume] in Pericardial fluid by Automated count |
|
72348-6
|
Leukocytes [#/volume] in Prostatic fluid by Manual count |
|
13349-6
|
Leukocytes [#/volume] in Stool by Manual count |
|
58805-3
|
Leukocytes [#/volume] in Urine by Automated test strip |
|
68434-0
|
Leukocytes [#/volume] in Vitreous fluid by Automated count |
|
49224-9
|
Leukocytes [#/area] in Semen by Microscopy high power field |
|
63555-7
|
Leukocytes [#/volume] by Microscopy high power field in Urine sediment collected for unspecified duration |
|
60433-0
|
Leukocytes by Light microscopy in Urine sediment collected for unspecified duration |
|
63554-0
|
Leukocytes in 24 hour Urine sediment by Microscopy |
|
59829-2
|
Leukocytes in 3 hour Urine sediment by Light microscopy |
|
88114-4
|
Leukocytes [Presence] in Cerebral spinal fluid by Gram stain |
|
58407-8
|
Leukocyte morphology panel - Blood |
|
70126-8
|
Leukocytes [#/volume] corrected for nucleated erythrocytes in Pleural fluid |
|
66145-4
|
Leukocytes other [#/volume] in Blood from Fetus by Manual count |
|
68428-2
|
Leukocytes other [#/volume] in Pericardial fluid by Manual count |
|
68430-8
|
Leukocytes other [#/volume] in Pleural fluid by Manual count |
|
68429-0
|
Leukocytes other [#/volume] in Peritoneal fluid by Manual count |
|
68431-6
|
Leukocytes other [#/volume] in Synovial fluid by Manual count |
|
68433-2
|
Leukocytes other [#/volume] in Vitreous fluid by Manual count |
|
68432-4
|
Leukocytes other/100 leukocytes in Vitreous fluid by Manual count |
|
48973-2
|
Leukocytes [Presence] in Stool by Methylene blue stain --2nd specimen |
|
42327-7
|
Leukocytes [Presence] in Stool by Methylene blue stain |
|
13655-6
|
Leukocytes [Presence] in Stool by Light microscopy |
|
76674-1
|
Leukocytes [#/volume] in Cerebral spinal fluid --1st tube |
|
46088-1
|
Leukocytes [#/volume] in Cerebral spinal fluid --2nd tube |
|
46089-9
|
Leukocytes [#/volume] in Cerebral spinal fluid --3rd tube |
|
46090-7
|
Leukocytes [#/volume] in Cerebral spinal fluid --4th tube |
|
82611-5
|
Wearable device external physiologic monitoring panel |
|
15271-0
|
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Presence] in Serum by Multidisk |
|
24480-6
|
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Units/volume] in Serum by Multidisk |
|
61202-8
|
Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab/IgE total in Serum by Multidisk |
|
15272-8
|
Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Presence] in Serum by Multidisk |
|
24493-9
|
Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
|
15261-1
|
Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Presence] in Serum by Multidisk |
|
73710-6
|
Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Units/volume] in Serum by Multidisk |
|
15273-6
|
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Presence] in Serum by Multidisk |
|
82041-5
|
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Units/volume] in Serum by Multidisk |
|
46709-2
|
Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Mass/volume] in Serum by Multidisk |
|
15274-4
|
Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
|
63197-8
|
Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk |
|
15275-1
|
Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Presence] in Serum by Multidisk |
|
63198-6
|
Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Units/volume] in Serum by Multidisk |
|
15276-9
|
Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
|
82045-6
|
Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Units/volume] in Serum by Multidisk |
|
7309-8
|
Weeping Fig IgE Ab [Units/volume] in Serum |
|
22610-0
|
Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid |
|
20986-6
|
Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation |
|
20984-1
|
Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
|
31705-7
|
Western equine encephalitis virus Ab [Units/volume] in Cerebral spinal fluid |
|
22611-8
|
Western equine encephalitis virus Ab [Presence] in Serum |
|
23583-8
|
Western equine encephalitis virus Ab [Presence] in Serum by Agglutination |
|
20985-8
|
Western equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
|
23586-1
|
Western equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
20983-3
|
Western equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
|
23585-3
|
Western equine encephalitis virus Ab [Presence] in Serum by Neutralization test |
|
5406-4
|
Western equine encephalitis virus Ab [Units/volume] in Serum |
|
24285-9
|
Western equine encephalitis virus Ab [Titer] in Serum --1st specimen |
|
24211-5
|
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
|
24286-7
|
Western equine encephalitis virus Ab [Titer] in Serum --2nd specimen |
|
24212-3
|
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
|
17769-1
|
Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid |
|
9314-6
|
Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
41175-1
|
Western equine encephalitis virus Ab [Titer] in Body fluid |
|
17770-9
|
Western equine encephalitis virus Ab [Titer] in Serum |
|
41183-5
|
Western equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
|
23584-6
|
Western equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
9581-0
|
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
|
20982-5
|
Western equine encephalitis virus Ab [Titer] in Serum by Neutralization test |
|
23792-5
|
Western equine encephalitis virus Ab [Presence] in Unspecified specimen |
|
31987-1
|
Western equine encephalitis virus Ag [Presence] in Serum |
|
6585-4
|
Western equine encephalitis virus Ag [Presence] in Serum by Immunoassay |
|
6586-2
|
Western equine encephalitis virus Ag [Presence] in Serum by Immunofluorescence |
|
31988-9
|
Western equine encephalitis virus Ag [Presence] in Unspecified specimen |
|
23591-1
|
Western equine encephalitis virus Ag [Presence] in Unspecified specimen by Complement fixation |
|
23590-3
|
Western equine encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
23589-5
|
Western equine encephalitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
|
41260-1
|
Western equine encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid |
|
31706-5
|
Western equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
41244-5
|
Western equine encephalitis virus IgG Ab [Presence] in Serum |
|
8052-3
|
Western equine encephalitis virus IgG Ab [Units/volume] in Serum |
|
22613-4
|
Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
|
9315-3
|
Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22614-2
|
Western equine encephalitis virus IgG Ab [Titer] in Serum |
|
6957-5
|
Western equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
34955-5
|
Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid |
|
69036-2
|
Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
|
69041-2
|
Western equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence |
|
41259-3
|
Western equine encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid |
|
34956-3
|
Western equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
23587-9
|
Western equine encephalitis virus IgM Ab [Presence] in Serum |
|
23588-7
|
Western equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
|
8053-1
|
Western equine encephalitis virus IgM Ab [Units/volume] in Serum |
|
22615-9
|
Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
|
9316-1
|
Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
22616-7
|
Western equine encephalitis virus IgM Ab [Titer] in Serum |
|
6958-3
|
Western equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
26690-8
|
Western equine encephalitis virus RNA [Presence] in Cerebral spinal fluid by Probe |
|
54036-9
|
Western equine encephalitis virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
43143-7
|
Weighing device panel |
|
55418-8
|
Weight and Height tracking panel |
|
46040-2
|
Weight change Set |
|
76543-8
|
Weight management summary report |
|
3141-9
|
Body weight Measured |
|
77249-1
|
Weight management summary - recommended IHE set |
|
79348-9
|
Body weight --used for drug calculation |
|
75292-3
|
Body weight - Reported --usual |
|
59283-2
|
Well child visit note |
|
93667-4
|
WellRx Questionnaire - revised |
|
89546-6
|
Wells pulmonary embolism risk calculator panel |
|
65338-6
|
WES sup(b) Ab [Presence] in Serum or Plasma |
|
7255-3
|
Western Cottonwood IgE Ab [Units/volume] in Serum |
|
7435-1
|
Western Juniper IgE Ab [Units/volume] in Serum |
|
6275-2
|
Western Ragweed IgE Ab [Units/volume] in Serum |
|
56372-6
|
Western Ragweed IgG4 Ab [Mass/volume] in Serum |
|
24146-3
|
Western Water Hemp IgG Ab [Units/volume] in Serum |
|
56416-1
|
Western Water Hemp IgG4 Ab [Mass/volume] in Serum |
|
24511-8
|
Western wheatgrass IgE Ab [Units/volume] in Serum |
|
7611-7
|
Western White Pine IgE Ab [Units/volume] in Serum |
|
47531-9
|
Wet mount panel - Vaginal fluid |
|
14318-0
|
Microscopic observation [Identifier] in Cervix by Wet preparation |
|
6466-7
|
Microscopic observation [Identifier] in Duodenal fluid by Wet preparation |
|
23901-2
|
Microscopic observation [Identifier] in Body fluid by Wet preparation |
|
14317-2
|
Microscopic observation [Identifier] in Genital specimen by Wet preparation |
|
6470-9
|
Microscopic observation [Identifier] in Stool by Wet preparation |
|
6680-3
|
Microscopic observation [Identifier] in Tissue by Wet preparation |
|
57851-8
|
Microscopic observation [Identifier] in Urethra by Wet preparation |
|
14319-8
|
Microscopic observation [Identifier] in Vaginal fluid by Wet preparation |
|
680-9
|
Microscopic observation [Identifier] in Unspecified specimen by Wet preparation |
|
41042-3
|
WFS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
40475-6
|
WFS1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
74219-7
|
Weight difference pre dialysis and post dialysis panel |
|
66452-4
|
Wheat native (nTri a) 18 IgE Ab [Units/volume] in Serum |
|
51008-1
|
Wheat native (nTri a) 19 IgE Ab [Units/volume] in Serum |
|
82583-6
|
Wheat native (nTri a) 19+20+21 IgE Ab [Units/volume] in Serum |
|
65774-2
|
Wheat native (nTri a) aA/TI IgE Ab [Units/volume] in Serum |
|
64966-5
|
Wheat recombinant (rTri a) 14 IgE Ab [Units/volume] in Serum |
|
58752-7
|
Wheat recombinant (rTri a) 19 IgE Ab [Units/volume] in Serum |
|
7772-7
|
Wheat triggered histamine release [Units/volume] in Blood |
|
11161-7
|
Wheat Bran IgE Ab [Units/volume] in Serum |
|
25354-2
|
Wheat Bran IgG Ab [Units/volume] in Serum |
|
26411-9
|
Wheat Bran IgG4 Ab [Units/volume] in Serum |
|
21603-6
|
Wheat dust IgE Ab [Units/volume] in Serum |
|
7379-1
|
Wheat grass IgG Ab [Units/volume] in Serum |
|
6276-0
|
Wheat IgE Ab [Units/volume] in Serum |
|
41207-2
|
Wheat IgE Ab/IgE total in Serum |
|
6737-1
|
Wheat IgG Ab [Units/volume] in Serum |
|
56417-9
|
Wheat IgG4 Ab [Mass/volume] in Serum |
|
35537-0
|
Wheat IgG Ab [Mass/volume] in Serum |
|
48223-2
|
Wheat triggered leukotriene release [Mass/volume] by Leukocytes |
|
7708-1
|
Wheat smut IgE Ab [Units/volume] in Serum |
|
7672-9
|
Wheat Stem Rust IgE Ab [Units/volume] in Serum |
|
10939-7
|
Whiff IgE Ab [Units/volume] in Serum |
|
7064-9
|
White Alder IgE Ab [Units/volume] in Serum |
|
7098-7
|
White Ash triggered histamine release [Units/volume] in Blood |
|
6278-6
|
White Ash IgE Ab [Units/volume] in Serum |
|
42594-2
|
White Ash IgE Ab/IgE total in Serum |
|
24140-6
|
White Ash IgG Ab [Units/volume] in Serum |
|
56420-3
|
White Ash IgG4 Ab [Mass/volume] in Serum |
|
63184-6
|
White Ash IgG Ab [Mass/volume] in Serum |
|
6279-4
|
White Bean IgE Ab [Units/volume] in Serum |
|
57913-6
|
White Bean IgE Ab/IgE total in Serum |
|
7141-5
|
White Bean IgG Ab [Units/volume] in Serum |
|
56421-1
|
White Bean IgG4 Ab [Mass/volume] in Serum |
|
63079-8
|
White Bean IgG Ab [Mass/volume] in Serum |
|
41874-9
|
White Birch IgE Ab [Units/volume] in Serum |
|
61227-5
|
White Birch IgE Ab/IgE total in Serum |
|
56422-9
|
White Birch IgG4 Ab [Mass/volume] in Serum |
|
21148-2
|
White Cedar IgE Ab [Units/volume] in Serum |
|
7301-5
|
White Elm triggered histamine release [Units/volume] in Blood |
|
6109-3
|
White Elm IgE Ab [Units/volume] in Serum |
|
61322-4
|
White Elm IgE Ab/IgE total in Serum |
|
13183-9
|
White Elm IgG Ab [Units/volume] in Serum |
|
56174-6
|
White Elm IgG4 Ab [Mass/volume] in Serum |
|
58032-4
|
White Elm IgG Ab [Mass/volume] in Serum |
|
7407-0
|
White Hickory IgE Ab [Units/volume] in Serum |
|
24137-2
|
White Hickory IgG Ab [Units/volume] in Serum |
|
56423-7
|
White Hickory IgG4 Ab [Mass/volume] in Serum |
|
6281-0
|
White mulberry IgE Ab [Units/volume] in Serum |
|
61286-1
|
White mulberry IgE Ab/IgE total in Serum |
|
7513-5
|
White mulberry IgG Ab [Units/volume] in Serum |
|
56425-2
|
White mulberry IgG4 Ab [Mass/volume] in Serum |
|
63202-6
|
White mulberry IgG Ab [Mass/volume] in Serum |
|
7537-4
|
White Oak triggered histamine release [Units/volume] in Blood |
|
6189-5
|
White Oak IgE Ab [Units/volume] in Serum |
|
50369-8
|
White Oak IgE Ab/IgE total in Serum |
|
7536-6
|
White Oak IgG Ab [Units/volume] in Serum |
|
56426-0
|
White Oak IgG4 Ab [Mass/volume] in Serum |
|
63182-0
|
White Oak IgG Ab [Mass/volume] in Serum |
|
48247-1
|
White Oak triggered leukotriene release [Mass/volume] by Leukocytes |
|
7596-0
|
White Pepper IgE Ab [Units/volume] in Serum |
|
7597-8
|
White Pepper IgG Ab [Units/volume] in Serum |
|
7622-4
|
White Poplar triggered histamine release [Units/volume] in Blood |
|
21473-4
|
White Poplar IgE Ab [Units/volume] in Serum |
|
56428-6
|
White Poplar IgG4 Ab [Mass/volume] in Serum |
|
24159-6
|
White+Black Pepper IgE Ab [Units/volume] in Serum |
|
24158-8
|
White+Black Pepper IgG Ab [Units/volume] in Serum |
|
6280-2
|
Whitefaced Hornet IgE Ab [Units/volume] in Serum |
|
61259-8
|
Whitefaced Hornet IgE Ab/IgE total in Serum |
|
7417-9
|
Whitefaced Hornet IgG Ab [Units/volume] in Serum |
|
41193-4
|
Whitefaced Hornet IgG4 Ab [Presence] in Serum |
|
56424-5
|
Whitefaced Hornet IgG4 Ab [Mass/volume] in Serum |
|
49745-3
|
Whitefaced Hornet IgG Ab [Mass/volume] in Serum |
|
7775-0
|
Whitefish IgE Ab [Units/volume] in Serum |
|
7776-8
|
Whitefish IgG Ab [Units/volume] in Serum |
|
56430-2
|
Whitefish IgG4 Ab [Mass/volume] in Serum |
|
61127-7
|
Whitefish IgG Ab [Mass/volume] in Serum |
|
17771-7
|
Whitefish roe IgE Ab [Units/volume] in Serum |
|
7293-4
|
Whole Egg triggered histamine release [Units/volume] in Blood |
|
7291-8
|
Whole Egg IgE Ab [Units/volume] in Serum |
|
41288-2
|
Whole Egg IgE Ab/IgE total in Serum |
|
7292-6
|
Whole Egg IgG Ab [Units/volume] in Serum |
|
56255-3
|
Whole Egg IgG4 Ab [Mass/volume] in Serum |
|
45201-1
|
Whole Egg IgG Ab [Mass/volume] in Serum |
|
86205-2
|
Whole exome sequence analysis in Blood or Tissue by Molecular genetics method |
|
86206-0
|
Whole genome sequence analysis in Blood or Tissue by Molecular genetics method |
|
7542-4
|
Wild Oats IgE Ab [Units/volume] in Serum |
|
7777-6
|
Wild Rice IgE Ab [Units/volume] in Serum |
|
16922-7
|
Wild rye grass IgE Ab [Units/volume] in Serum |
|
6284-4
|
Wild Silk IgE Ab [Units/volume] in Serum |
|
6285-1
|
Willow IgE Ab [Units/volume] in Serum |
|
61310-9
|
Willow IgE Ab/IgE total in Serum |
|
50186-6
|
Wine vinegar IgE Ab [Units/volume] in Serum |
|
56431-0
|
Wine vinegar IgG4 Ab [Mass/volume] in Serum |
|
63139-0
|
Wine vinegar IgG Ab [Mass/volume] in Serum |
|
7779-2
|
Wingscale IgE Ab [Units/volume] in Serum |
|
7780-0
|
Winterfat IgE Ab [Units/volume] in Serum |
|
81339-4
|
Witness and notary Document |
|
86214-4
|
Womens health Annual evaluation note |
|
85871-2
|
Womens health Consult note |
|
85869-6
|
Womens health Education note |
|
85868-8
|
Womens health Group counseling note |
|
85867-0
|
Womens health History and physical note |
|
85870-4
|
Womens health Note |
|
85892-8
|
Womens health Nurse practitioner Note |
|
85862-1
|
Womens health Nurse Note |
|
85861-3
|
Womens health Nurse Outpatient Note |
|
85860-5
|
Womens health Outpatient History and physical note |
|
85859-7
|
Womens health Outpatient Letter |
|
85858-9
|
Womens health Outpatient Note |
|
85855-5
|
Womens health Telephone encounter Note |
|
85857-1
|
Womens health procedure note |
|
85856-3
|
Womens health Risk assessment and screening note |
|
72372-6
|
Wound bed and edge panel |
|
72286-8
|
Wound dressing panel |
|
72292-6
|
Wound exudate panel |
|
76585-9
|
Wound microorganism gene identification panel by NAA with probe detection |
|
72287-6
|
Wound size panel |
|
72299-1
|
Wound tunneling and undermining panel |
|
39558-2
|
West Nile virus Ab [Presence] in Cerebral spinal fluid |
|
41206-4
|
West Nile virus Ab [Units/volume] in Cerebral spinal fluid |
|
41194-2
|
West Nile virus Ab [Units/volume] in Serum by Immunoassay |
|
41232-0
|
West Nile virus Ab [Presence] in Serum |
|
75404-4
|
West Nile virus Ab [Presence] in Serum by Hemagglutination inhibition |
|
39555-8
|
West Nile virus Ab [Units/volume] in Serum |
|
41224-7
|
West Nile virus Ab [Titer] in Cerebral spinal fluid |
|
29570-9
|
West Nile virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
41225-4
|
West Nile virus Ab [Titer] in Serum |
|
55380-0
|
West Nile virus Ab [Titer] in Serum by Hemagglutination inhibition |
|
29568-3
|
West Nile virus Ab [Titer] in Serum by Neutralization test |
|
29781-2
|
West Nile virus Ab [Titer] in Unspecified specimen |
|
29779-6
|
West Nile virus Ab [Titer] in Unspecified specimen by Neutralization test |
|
33468-0
|
West Nile virus Ab [Presence] in Unspecified specimen |
|
36897-7
|
West Nile virus Ab [Presence] in Unspecified specimen by Immunoassay |
|
31700-8
|
West Nile virus Ab [Units/volume] in Unspecified specimen |
|
50015-7
|
West Nile virus Ag [Presence] in Blood or Marrow from Donor |
|
32371-7
|
West Nile virus Ag [Presence] in Tissue by Immune stain |
|
41643-8
|
West Nile virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
60028-8
|
West Nile virus IgG Ab avidity [Presence] in Serum by Immunoassay |
|
60029-6
|
West Nile virus IgG Ab avidity [Presence] in Serum by Immunofluorescence |
|
39572-3
|
West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
41236-1
|
West Nile virus IgG Ab [Presence] in Cerebral spinal fluid |
|
77953-8
|
West Nile virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
29537-8
|
West Nile virus IgG Ab [Units/volume] in Cerebral spinal fluid |
|
38997-3
|
West Nile virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
31701-6
|
West Nile virus IgG Ab [Presence] in Serum |
|
29566-7
|
West Nile virus IgG Ab [Presence] in Serum by Immunoassay |
|
60030-4
|
West Nile virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
29535-2
|
West Nile virus IgG Ab [Units/volume] in Serum |
|
33328-6
|
West Nile virus IgG Ab [Titer] in Cerebral spinal fluid |
|
41196-7
|
West Nile virus IgG Ab [Titer] in Body fluid |
|
33329-4
|
West Nile virus IgG Ab [Titer] in Serum |
|
31702-4
|
West Nile virus IgG Ab [Presence] in Unspecified specimen |
|
30178-8
|
West Nile virus IgG Ab [Presence] in Unspecified specimen by Immunoassay |
|
55402-2
|
West Nile virus IgG and IgM panel - Serum |
|
41211-4
|
West Nile virus IgG+IgM Ab [Presence] in Serum |
|
39573-1
|
West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
31703-2
|
West Nile virus IgM Ab [Presence] in Cerebral spinal fluid |
|
29569-1
|
West Nile virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
29538-6
|
West Nile virus IgM Ab [Units/volume] in Cerebral spinal fluid |
|
62436-1
|
West Nile virus IgM Ab [Presence] in Body fluid by Immunoassay |
|
38166-5
|
West Nile virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
31704-0
|
West Nile virus IgM Ab [Presence] in Serum |
|
29567-5
|
West Nile virus IgM Ab [Presence] in Serum by Immunoassay |
|
29536-0
|
West Nile virus IgM Ab [Units/volume] in Serum |
|
33330-2
|
West Nile virus IgM Ab [Titer] in Cerebral spinal fluid |
|
43342-5
|
West Nile virus IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay |
|
41195-9
|
West Nile virus IgM Ab [Titer] in Body fluid |
|
33331-0
|
West Nile virus IgM Ab [Titer] in Serum |
|
43343-3
|
West Nile virus IgM Ab [Titer] in Serum by Immunoassay |
|
29780-4
|
West Nile virus IgM Ab [Presence] in Unspecified specimen |
|
29778-8
|
West Nile virus IgM Ab [Presence] in Unspecified specimen by Immunoassay |
|
41642-0
|
West Nile virus IgM Ab [Presence] in Unspecified specimen by Immunofluorescence |
|
81097-8
|
West Nile virus Kunjin strain Ab [Presence] in Serum |
|
81096-0
|
West Nile virus Kunjin strain IgM Ab [Presence] in Serum |
|
81650-4
|
West Nile virus Kunjin strain RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
36901-7
|
West Nile virus NS5 Ab [Presence] in Unspecified specimen |
|
36898-5
|
West Nile virus NS5 Ab [Presence] in Unspecified specimen by Immunoassay |
|
36900-9
|
West Nile virus polyvalent E Ab [Presence] in Unspecified specimen |
|
36896-9
|
West Nile virus polyvalent E Ab [Presence] in Unspecified specimen by Immunoassay |
|
34460-6
|
West Nile virus RNA [Presence] in Blood by NAA with probe detection |
|
34461-4
|
West Nile virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
87395-0
|
West Nile virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection |
|
41212-2
|
West Nile virus RNA [Presence] in Serum from Donor by NAA with probe detection |
|
32361-8
|
West Nile virus RNA [Presence] in Serum by NAA with probe detection |
|
74857-4
|
West Nile virus RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
|
32370-9
|
West Nile virus RNA [Presence] in Tissue by NAA with probe detection |
|
34892-0
|
West Nile virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
37985-9
|
West Nile virus RNA [Presence] in Unspecified specimen by Probe |
|
93955-3
|
Wound, Ostomy, and Continence Care Consult note |
|
93970-2
|
Wound, Ostomy, and Continence Care Diagnostic study note |
|
93954-6
|
Wound, Ostomy, and Continence Care Outpatient Note |
|
74160-3
|
Work days per week |
|
74161-1
|
Work hours per week |
|
74159-5
|
Work schedule NIOSH |
|
16930-0
|
Helminth IgE Ab [Units/volume] in Serum |
|
10671-6
|
Helminth identified in Unspecified specimen |
|
14789-2
|
Helminth identified in Unspecified specimen by Macro/micro identification |
|
90300-5
|
Helminth identified in Unspecified specimen by NAA with probe detection |
|
14790-0
|
Helminth identified in Unspecified specimen by Permanent mount |
|
10672-4
|
Helminth+Arthropod identified in Unspecified specimen |
|
14788-4
|
Helminth+Arthropod identified in Unspecified specimen by Rearing/Culture |
|
6286-9
|
Wormwood IgE Ab [Units/volume] in Serum |
|
7781-8
|
Wormwood IgG Ab [Units/volume] in Serum |
|
56432-8
|
Wormwood IgG4 Ab [Mass/volume] in Serum |
|
39135-9
|
Wound assessment panel |
|
89254-7
|
Wound bed panel |
|
84303-7
|
Wound care management Consult note |
|
89820-5
|
Wound care management Initial evaluation note |
|
46215-0
|
Wound care management Note |
|
89818-9
|
Wound care management Telephone encounter Note |
|
89821-3
|
Wound care management Progress note |
|
84302-9
|
Wound care management Nurse Note |
|
89819-7
|
Wound care management Team Conference note |
|
89256-2
|
Wound edge panel |
|
89257-0
|
Wound tunneling panel |
|
89258-8
|
Wound undermining panel |
|
58073-8
|
Wr sup(a) Ag [Presence] on Red Blood Cells |
|
65339-4
|
Wr sup(b) Ab [Presence] in Serum or Plasma |
|
10355-6
|
Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
|
682-5
|
Microscopic observation [Identifier] in Unspecified specimen by Wright Giemsa stain |
|
53786-0
|
Microscopic observation [Identifier] in Stool by Wright stain |
|
6681-1
|
Microscopic observation [Identifier] in Tissue by Wright stain |
|
681-7
|
Microscopic observation [Identifier] in Unspecified specimen by Wright stain |
|
6679-5
|
Microscopic observation [Identifier] in Tissue by Warthin-Starry stain |
|
679-1
|
Microscopic observation [Identifier] in Unspecified specimen by Warthin-Starry stain |
|
53728-2
|
WS2A gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
50331-8
|
WT-1 Ag [Presence] in Tissue by Immune stain |
|
72503-6
|
WT1 gene exon 1+2 transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
|
21742-2
|
WT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
77606-2
|
Weight-for-length Per age and sex |
|
35455-5
|
X chromosome inactivation [Identifier] in Blood or Tissue Narrative |
|
48730-6
|
X linked heterotaxy [Identifier] in Blood or Tissue by FISH Narrative |
|
85267-3
|
X-linked adrenoleukodystrophy (X-ALD) newborn screening panel |
|
41213-0
|
Xanthan gum IgE Ab [Units/volume] in Serum |
|
41227-0
|
Xanthine [Moles/time] in 24 hour Urine |
|
75129-7
|
Xanthine [Moles/volume] in Cerebral spinal fluid |
|
43250-0
|
Xanthine derivatives [Presence] in Urine |
|
58036-5
|
Xanthine/Total in Stone |
|
41228-8
|
Xanthine [Presence] in Serum |
|
3131-0
|
Xanthine [Mass/volume] in Serum |
|
75144-6
|
Xanthine [Moles/volume] in Serum or Plasma |
|
3132-8
|
Xanthine [Mass/volume] in Urine |
|
72897-2
|
Xanthine [Moles/volume] in Urine |
|
41230-4
|
Xanthine [Presence] in Unspecified specimen |
|
38371-1
|
Xanthine/Creatinine [Molar ratio] in Urine |
|
13532-7
|
Xanthochromia [Presence] of Cerebral spinal fluid Qualitative |
|
80184-5
|
Xanthopterin [Moles/volume] in Cerebral spinal fluid |
|
80183-7
|
Xanthopterin [Moles/volume] in Serum or Plasma |
|
80185-2
|
Xanthopterin/Creatinine [Molar ratio] in Urine |
|
41220-5
|
Xanthurenate [Presence] in 24 hour Urine |
|
41240-3
|
Xanthurenate [Presence] in Serum or Plasma |
|
41615-6
|
Xanthurenate [Mass/volume] in Serum or Plasma |
|
41248-6
|
Xanthurenate [Presence] in Urine |
|
3133-6
|
Xanthurenate [Mass/volume] in Urine |
|
41231-2
|
Xanthurenate+Kynurenate [Presence] in 24 hour Urine |
|
41221-3
|
Xanthurenate+Kynurenate [Mass/time] in 24 hour Urine |
|
76118-9
|
Xenon [VFr/PPres] Airway adaptor --during expiration |
|
76108-0
|
Xenon [VFr/PPres] Gas delivery system.expiratory limb --during expiration |
|
76121-3
|
Xenon [VFr/PPres] Airway adaptor --during inspiration |
|
76109-8
|
Xenon [VFr/PPres] Gas delivery system.inspiratory limb --during inspiration |
|
76116-3
|
Xenon [VFr/PPres] Airway adaptor --at end expiration |
|
76124-7
|
Xenon gas delivered during case [Volume] from Gas delivery system |
|
76125-4
|
Xenon gas delivered.total [Volume] in Reporting period from Gas delivery system |
|
76094-2
|
Xenon [VFr/PPres] Airway adaptor |
|
76114-8
|
Xenon [VFr/PPres] Gas delivery system |
|
1341-7
|
Xg sup(a) Ag [Presence] on Red Blood Cells |
|
41218-9
|
Xipamid [Presence] in Urine |
|
88023-7
|
XLR-11 N-(4-hydroxypentyl) (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method |
|
82295-7
|
Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by FISH |
|
81873-2
|
Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
36550-2
|
XR Abdomen Single view |
|
41793-1
|
XR Abdomen Single view during surgery |
|
36641-9
|
XR Abdomen 2 Views |
|
83015-8
|
XR Abdomen 2 Views for renal calculus |
|
36293-9
|
XR Abdomen 3 Views |
|
24799-9
|
XR Abdomen AP |
|
24561-3
|
XR Abdomen AP left lateral-decubitus |
|
24563-9
|
XR Abdomen AP right lateral-decubitus |
|
24796-5
|
XR Abdomen AP and AP left lateral-decubitus |
|
24794-0
|
XR Abdomen AP and Lateral |
|
69065-1
|
XR Abdomen AP and Lateral crosstable |
|
38084-0
|
XR Abdomen AP and Left posterior oblique |
|
37119-5
|
XR Abdomen AP and Oblique |
|
24797-3
|
XR Abdomen AP and Oblique prone |
|
79350-5
|
XR Abdomen GE 3 Views |
|
83016-6
|
XR Abdomen GE 3 Views AP and Oblique and Cone |
|
24562-1
|
XR Abdomen Left lateral-decubitus and Right lateral-decubitus |
|
36591-6
|
XR Abdomen Lateral |
|
36984-3
|
XR Abdomen Lateral crosstable |
|
36995-9
|
XR Abdomen Left lateral |
|
38069-1
|
XR Abdomen Left posterior oblique |
|
36607-0
|
XR Abdomen Oblique |
|
37015-5
|
XR Abdomen PA prone |
|
36996-7
|
XR Abdomen Right lateral |
|
37131-0
|
XR Abdomen Right lateral and Left lateral |
|
37138-5
|
XR Abdomen Right oblique and Left oblique |
|
39323-1
|
XR Abdomen Right posterior oblique |
|
37085-8
|
XR Abdomen Supine and Lateral-decubitus |
|
24798-1
|
XR Abdomen Supine and Upright |
|
37046-0
|
XR Abdomen Upright |
|
42019-0
|
XR Abdomen upright and left lateral decubitus |
|
37636-8
|
XR Abdomen Views |
|
72256-1
|
XR Abdomen Views for motility W radioopaque markers |
|
37297-9
|
XR Abdomen and Fetal Single view for fetal age |
|
39327-2
|
XR Abdomen and Fetal Views for fetal age |
|
37467-8
|
XR Acromioclavicular Joint 10 degree cephalic angle |
|
24536-5
|
XR Acromioclavicular Joint Views |
|
37577-4
|
XR Acromioclavicular Joint Views W weight |
|
37582-4
|
XR Acromioclavicular Joint Views WO weight |
|
37579-0
|
XR Acromioclavicular Joint Views WO and W weight |
|
37848-9
|
XR Acromioclavicular Joint Zanca |
|
26136-2
|
XR Acromioclavicular joint - bilateral Views |
|
37578-2
|
XR Acromioclavicular joint - bilateral Views W weight |
|
69055-2
|
XR Acromioclavicular joint - bilateral Views WO weight |
|
37580-8
|
XR Acromioclavicular joint - bilateral Views WO and W weight |
|
37056-9
|
XR Acromioclavicular joint - bilateral Zanca |
|
36665-8
|
XR Acromioclavicular joint - left 2 Views |
|
36583-3
|
XR Acromioclavicular joint - left AP |
|
26137-0
|
XR Acromioclavicular joint - left Views |
|
37581-6
|
XR Acromioclavicular joint - left Views WO and W weight |
|
37057-7
|
XR Acromioclavicular joint - left Zanca |
|
37661-6
|
XR Acromioclavicular joint - right 2 Views |
|
37662-4
|
XR Acromioclavicular joint - right AP |
|
26138-8
|
XR Acromioclavicular joint - right Views |
|
37663-2
|
XR Acromioclavicular joint - right Views WO and W weight |
|
37810-9
|
XR Acromioclavicular joint - right Zanca |
|
37635-0
|
XR Acetabulum 3 Views |
|
24535-7
|
XR Acetabulum Views |
|
26133-9
|
XR Acetabulum - bilateral Views |
|
37064-3
|
XR Acetabulum - left 2 Views |
|
26134-7
|
XR Acetabulum - left Views |
|
37664-0
|
XR Acetabulum - right 2 Views |
|
26135-4
|
XR Acetabulum - right Views |
|
36644-3
|
XR and RF Chest 2 Views and Views |
|
36321-8
|
XR and RF Chest 4 Views and Views |
|
39066-6
|
XR and RF Chest AP and Lateral and Views |
|
47367-8
|
XR and RF Chest GE 4 Views and Views |
|
36751-6
|
XR and RF Chest PA and Lateral and Views |
|
36551-0
|
XR Ankle Single view |
|
83018-2
|
XR Ankle 1 or 2 Views |
|
24540-7
|
XR Ankle 2 Views |
|
36294-7
|
XR Ankle 3 Views |
|
36317-6
|
XR Ankle 4 Views |
|
36571-8
|
XR Ankle AP |
|
30779-3
|
XR Ankle AP and Lateral |
|
37095-7
|
XR Ankle AP and Lateral and Mortise |
|
39072-4
|
XR Ankle AP and Lateral and oblique |
|
44210-3
|
XR Ankle GE 3 Views |
|
36592-4
|
XR Ankle Lateral |
|
37007-2
|
XR Ankle Mortise |
|
24541-5
|
XR Ankle Views |
|
37486-8
|
XR Ankle Broden Views W manual stress |
|
37201-1
|
XR Ankle Views W standing |
|
37556-8
|
XR Ankle Views W manual stress |
|
51395-2
|
XR Ankle and Foot - left Views |
|
51394-5
|
XR Ankle and Foot - right Views |
|
26385-5
|
XR Ankle - bilateral 2 Views |
|
36295-4
|
XR Ankle - bilateral 3 Views |
|
42273-3
|
XR Ankle - bilateral 6 Views |
|
36684-9
|
XR Ankle - bilateral AP and Lateral |
|
39330-6
|
XR Ankle - bilateral AP and Lateral W standing |
|
37096-5
|
XR Ankle - bilateral AP and Lateral and Mortise |
|
36720-1
|
XR Ankle - bilateral AP and Lateral and oblique |
|
42417-6
|
XR Ankle - bilateral AP and Lateral and Oblique and (View W manual stress) |
|
48480-8
|
XR Ankle - bilateral GE 3 Views |
|
49570-5
|
XR Ankle - bilateral GE 6 Views |
|
37134-4
|
XR Ankle - bilateral Lateral and Mortise |
|
26097-6
|
XR Ankle - bilateral Views |
|
37202-9
|
XR Ankle - bilateral Views W standing |
|
37557-6
|
XR Ankle - bilateral Views W manual stress |
|
69307-7
|
XR Ankle - left Single view |
|
26386-3
|
XR Ankle - left 2 Views |
|
38841-3
|
XR Ankle - left 2 Views W standing |
|
38840-5
|
XR Ankle - left 2 Views W manual stress |
|
36296-2
|
XR Ankle - left 3 Views |
|
69138-6
|
XR Ankle - left 3 Views W standing |
|
36685-6
|
XR Ankle - left AP and Lateral |
|
42380-6
|
XR Ankle - left AP and Lateral W standing |
|
37097-3
|
XR Ankle - left AP and Lateral and Mortise |
|
36721-9
|
XR Ankle - left AP and Lateral and oblique |
|
69137-8
|
XR Ankle - left AP and Lateral and oblique W standing |
|
42418-4
|
XR Ankle - left AP and Lateral and Oblique and (View W manual stress) |
|
46390-1
|
XR Ankle - left GE 3 Views |
|
37135-1
|
XR Ankle - left Lateral and Mortise |
|
42382-2
|
XR Ankle - left Lateral and Mortise and Broden W manual stress |
|
37475-1
|
XR Ankle - left Mortise W manual stress |
|
26098-4
|
XR Ankle - left Views |
|
37474-4
|
XR Ankle - left Lateral Views W manual stress |
|
37203-7
|
XR Ankle - left Views W standing |
|
37558-4
|
XR Ankle - left Views W manual stress |
|
69314-3
|
XR Ankle - right Single view |
|
26387-1
|
XR Ankle - right 2 Views |
|
37675-6
|
XR Ankle - right 2 Views W standing |
|
37672-3
|
XR Ankle - right 2 Views W manual stress |
|
37665-7
|
XR Ankle - right 3 Views |
|
69254-1
|
XR Ankle - right 3 Views W standing |
|
37667-3
|
XR Ankle - right AP and Lateral |
|
39368-6
|
XR Ankle - right AP and Lateral W standing |
|
37666-5
|
XR Ankle - right AP and Lateral and Mortise |
|
37668-1
|
XR Ankle - right AP and Lateral and oblique |
|
39371-0
|
XR Ankle - right AP and Lateral and oblique W standing |
|
39369-4
|
XR Ankle - right AP and Lateral and Oblique and (View W manual stress) |
|
46347-1
|
XR Ankle - right GE 3 Views |
|
37670-7
|
XR Ankle - right Lateral and Mortise |
|
37671-5
|
XR Ankle - right Mortise W manual stress |
|
26099-2
|
XR Ankle - right Views |
|
37669-9
|
XR Ankle - right Lateral Views W manual stress |
|
37676-4
|
XR Ankle - right Views W standing |
|
37673-1
|
XR Ankle - right Views W manual stress |
|
39370-2
|
XR Ankle - right Views and (View W manual stress) |
|
39372-8
|
XR Ankle - right Views and Mortise |
|
24573-8
|
XR Biliary ducts and Gallbladder Views W contrast IV |
|
85151-9
|
XR Bone age |
|
24577-9
|
XR Bone Views during surgery |
|
43518-0
|
XR Bones Survey Views |
|
83020-8
|
XR Bones Complete Survey Views |
|
37365-4
|
XR Bones Survey Views for metastasis |
|
38089-9
|
XR Bones Limited Survey Views for metastasis |
|
43519-8
|
XR Bones Limited Survey Views |
|
37362-1
|
XR Bones Bone age Views |
|
24579-5
|
XR Long bones Survey Views |
|
39518-6
|
XR Long bones Limited Survey Views |
|
69158-4
|
XR Breast Diagnostic for implant |
|
69159-2
|
XR Breast Screening for implant |
|
43784-8
|
XR Cervical and thoracic and lumbar spine 2 Views |
|
39067-4
|
XR Cervical and thoracic and lumbar spine AP and Lateral |
|
83028-1
|
XR Cervical and thoracic and lumbar spine GE 2 Views |
|
38008-9
|
XR Cervical and thoracic and lumbar spine Views |
|
37361-3
|
XR Cervical and thoracic spine AP and Lateral |
|
37481-9
|
XR Cervical and thoracic spine Views |
|
36554-4
|
XR Chest Single view |
|
41790-7
|
XR Chest Single view during surgery |
|
38001-4
|
XR Chest Single view W expiration |
|
38002-2
|
XR Chest Single view W inspiration |
|
36643-5
|
XR Chest 2 Views |
|
37067-6
|
XR Chest 2 Views W nipple markers |
|
42009-1
|
XR Chest 2 Views and Apical lordotic |
|
43467-0
|
XR Chest 2 Views and Right oblique and Left oblique |
|
83024-0
|
XR Chest 2 Views and Views Lateral-decubitus |
|
36298-8
|
XR Chest 3 Views |
|
36320-0
|
XR Chest 4 Views |
|
36572-6
|
XR Chest AP |
|
43561-0
|
XR Chest AP and Abdomen Upright |
|
30734-8
|
XR Chest AP lateral-decubitus |
|
24637-1
|
XR Chest AP left lateral-decubitus |
|
43466-2
|
XR Chest AP right lateral-decubitus |
|
24653-8
|
XR Chest AP and AP right lateral-decubitus |
|
36687-2
|
XR Chest AP and Lateral |
|
39070-8
|
XR Chest AP and Lateral and Apical lordotic |
|
39074-0
|
XR Chest AP and Lateral and Right oblique and Left oblique |
|
24642-1
|
XR Chest AP and PA upright |
|
24640-5
|
XR Chest Apical lordotic |
|
46348-9
|
XR Chest GE 2 and PA and Lateral |
|
47368-6
|
XR Chest GE 4 and PA and Lateral |
|
44211-1
|
XR Chest GE 4 Views |
|
36620-3
|
XR Chest Left anterior oblique |
|
39051-8
|
XR Chest Lateral |
|
39341-3
|
XR Chest Lateral and PA W inspiration and expiration |
|
30737-1
|
XR Chest Left lateral |
|
24639-7
|
XR Chest Left lateral upright |
|
37008-0
|
XR Chest Left oblique |
|
30740-5
|
XR Chest Oblique |
|
42011-7
|
XR Chest PA and Abdomen AP |
|
43463-9
|
XR Chest PA and Abdomen Supine and Upright |
|
43532-1
|
XR Chest PA and Abdomen Upright |
|
24648-8
|
XR Chest PA upright |
|
36750-8
|
XR Chest PA and AP lateral-decubitus |
|
36759-9
|
XR Chest PA and Apical lordotic |
|
42272-5
|
XR Chest PA and Lateral |
|
24647-0
|
XR Chest PA and Lateral upright |
|
37143-5
|
XR Chest PA and Lateral and AP lateral-decubitus |
|
37144-3
|
XR Chest PA and Lateral and AP left lateral-decubitus |
|
37145-0
|
XR Chest PA and Lateral and AP right lateral-decubitus |
|
37146-8
|
XR Chest PA and Lateral and Left oblique |
|
30741-3
|
XR Chest PA and Lateral and Lordotic upright |
|
30744-7
|
XR Chest PA and Lateral and Oblique |
|
24643-9
|
XR Chest PA and Lateral and Oblique upright |
|
36758-1
|
XR Chest PA and Lateral and Oblique and Apical lordotic |
|
37147-6
|
XR Chest PA and Lateral and Right oblique |
|
30742-1
|
XR Chest PA and Lateral and Right oblique and Left oblique |
|
37141-9
|
XR Chest PA and Right lateral |
|
24646-2
|
XR Chest PA and Right lateral and Right oblique and Left oblique upright |
|
37150-0
|
XR Chest PA and Right oblique and Left oblique |
|
24650-4
|
XR Chest Right lateral-decubitus and Left lateral-decubitus |
|
38068-3
|
XR Chest Right anterior oblique |
|
37010-6
|
XR Chest Right oblique |
|
41792-3
|
XR Chest Right oblique and Left oblique |
|
24651-2
|
XR Chest Right oblique and Left oblique upright |
|
42414-3
|
XR Chest Right oblique and Left oblique W nipple markers |
|
83017-4
|
XR Chest View and Abdomen Supine and Upright |
|
30745-4
|
XR Chest Views |
|
24635-5
|
XR Chest PA upright Views W inspiration and expiration |
|
37200-3
|
XR Chest Views W contrast PO |
|
30736-3
|
XR Chest Views W inspiration and expiration |
|
38093-1
|
XR Chest Views W nipple markers |
|
42699-9
|
XR Chest and Abdomen Single view |
|
42269-1
|
XR Chest and Abdomen Views |
|
83019-0
|
XR Chest and Abdomen and Pelvis View babygram |
|
36555-1
|
XR Clavicle Single view |
|
36645-0
|
XR Clavicle 2 Views |
|
69079-2
|
XR Clavicle 45 degree cephalic angle |
|
36573-4
|
XR Clavicle AP |
|
24664-5
|
XR Clavicle Views |
|
37469-4
|
XR Clavicle - bilateral 45 degree cephalic angle |
|
26106-5
|
XR Clavicle - bilateral Views |
|
36646-8
|
XR Clavicle - left 2 Views |
|
37470-2
|
XR Clavicle - left 45 degree cephalic angle |
|
37121-1
|
XR Clavicle - left AP and Serendipity |
|
26107-3
|
XR Clavicle - left Views |
|
37679-8
|
XR Clavicle - right 2 Views |
|
38803-3
|
XR Clavicle - right 45 degree cephalic angle |
|
37680-6
|
XR Clavicle - right AP and Serendipity |
|
26108-1
|
XR Clavicle - right Views |
|
36647-6
|
XR Coccyx 2 Views |
|
36688-0
|
XR Coccyx AP and Lateral |
|
83025-7
|
XR Coccyx GE 2 Views |
|
30883-3
|
XR Coccyx Views |
|
25062-1
|
XR Unspecified body region Comparison view |
|
24940-9
|
XR Cervical spine Single view |
|
36669-0
|
XR Cervical spine 2 Views |
|
43539-6
|
XR Cervical spine 2 or 3 Views |
|
24941-7
|
XR Cervical spine 3 Views |
|
36331-7
|
XR Cervical spine 4 Views |
|
83023-2
|
XR Cervical spine 4 or 5 Views |
|
24939-1
|
XR Cervical spine 5 Views |
|
69080-0
|
XR Cervical spine 5 Views W flexion and W extension |
|
69081-8
|
XR Cervical spine 5 Views and Swimmers |
|
42691-6
|
XR Cervical spine 6 Views |
|
36680-7
|
XR Cervical spine 7 Views |
|
30725-6
|
XR Cervical spine AP |
|
24942-5
|
XR Cervical spine AP and Lateral |
|
36734-2
|
XR Cervical spine AP and Lateral and oblique |
|
37099-9
|
XR Cervical spine AP and Lateral and Oblique and Odontoid |
|
38083-2
|
XR Cervical spine AP and Lateral and Oblique and Odontoid and Swimmers |
|
37103-9
|
XR Cervical spine AP and Lateral and Odontoid |
|
37098-1
|
XR Cervical spine AP and Oblique and (Lateral W flexion and W extension) |
|
37100-5
|
XR Cervical spine AP and Oblique and Odontoid and (Lateral W flexion and W extension) |
|
37104-7
|
XR Cervical spine AP and Odontoid and (Lateral W flexion and W extension) |
|
37120-3
|
XR Cervical spine AP and Odontoid and Lateral crosstable |
|
79351-3
|
XR Cervical spine GE 2 Views |
|
44212-9
|
XR Cervical spine GE 4 Views |
|
79352-1
|
XR Cervical spine GE 6 Views |
|
24943-3
|
XR Cervical spine Lateral |
|
36997-5
|
XR Cervical spine Lateral W extension |
|
36998-3
|
XR Cervical spine Lateral W flexion |
|
36989-2
|
XR Cervical spine Lateral crosstable |
|
37139-3
|
XR Cervical spine Oblique and (Lateral W flexion and W extension) |
|
24944-1
|
XR Cervical spine Swimmers |
|
83021-6
|
XR Cervical spine 2 or 3 views and (Views W flexion and W extension) |
|
24946-6
|
XR Cervical spine Views |
|
37133-6
|
XR Cervical spine Lateral Views W flexion and W extension |
|
42710-4
|
XR Cervical spine Limited Views |
|
36748-2
|
XR Cervical spine Oblique Views |
|
24945-8
|
XR Cervical spine Views W flexion and W extension |
|
42164-4
|
XR Cervical spine Views and Oblique |
|
24948-2
|
XR Spine Cervical Odontoid and Cervical axis AP |
|
83022-4
|
XR Cervical spine 2 or 3 views and (Views W flexion and W extension) and Views oblique |
|
43785-5
|
XR Spine cervicothoracic junction AP and Lateral |
|
43781-4
|
XR Spine cervicothoracic junction Views |
|
36556-9
|
XR Elbow Single view |
|
83026-5
|
XR Elbow 1 or 2 Views |
|
36648-4
|
XR Elbow 2 Views |
|
36299-6
|
XR Elbow 3 Views |
|
36689-8
|
XR Elbow AP and Lateral |
|
36722-7
|
XR Elbow AP and Lateral and oblique |
|
79353-9
|
XR Elbow GE 3 Views |
|
83027-3
|
XR Elbow GE 4 Views |
|
36979-3
|
XR Elbow Jones |
|
37998-2
|
XR Elbow Radial head capitellar |
|
24676-9
|
XR Elbow Views |
|
36608-8
|
XR Elbow Oblique Views |
|
46381-0
|
XR Elbow and Radius and Ulna Views |
|
36649-2
|
XR Elbow - bilateral 2 Views |
|
36300-2
|
XR Elbow - bilateral 3 Views |
|
36322-6
|
XR Elbow - bilateral 4 Views |
|
36690-6
|
XR Elbow - bilateral AP and Lateral |
|
36723-5
|
XR Elbow - bilateral AP and Lateral and oblique |
|
48481-6
|
XR Elbow - bilateral GE 3 Views |
|
37999-0
|
XR Elbow - bilateral Radial head capitellar |
|
26109-9
|
XR Elbow - bilateral Views |
|
36740-9
|
XR Elbow - bilateral Oblique Views |
|
69056-0
|
XR Elbow - bilateral Views and Obliques |
|
46389-3
|
XR Elbow - bilateral Views and Radial head capitellar |
|
69308-5
|
XR Elbow - left Single view |
|
36650-0
|
XR Elbow - left 2 Views |
|
38844-7
|
XR Elbow - left 2 Oblique Views |
|
36301-0
|
XR Elbow - left 3 Views |
|
36323-4
|
XR Elbow - left 4 Views |
|
36691-4
|
XR Elbow - left AP and Lateral |
|
36724-3
|
XR Elbow - left AP and Lateral and oblique |
|
46344-8
|
XR Elbow - left GE 3 Views |
|
36980-1
|
XR Elbow - left Jones |
|
38000-6
|
XR Elbow - left Radial head capitellar |
|
26110-7
|
XR Elbow - left Views |
|
41826-9
|
XR Elbow - left Limited Views |
|
36741-7
|
XR Elbow - left Oblique Views |
|
69315-0
|
XR Elbow - right Single view |
|
37681-4
|
XR Elbow - right 2 Views |
|
37686-3
|
XR Elbow - right 2 Oblique Views |
|
37682-2
|
XR Elbow - right 3 Views |
|
37683-0
|
XR Elbow - right 4 Views |
|
37684-8
|
XR Elbow - right AP and Lateral |
|
37685-5
|
XR Elbow - right AP and Lateral and oblique |
|
46345-5
|
XR Elbow - right GE 3 Views |
|
38777-9
|
XR Elbow - right Jones |
|
38006-3
|
XR Elbow - right Radial head capitellar |
|
26111-5
|
XR Elbow - right Views |
|
41785-7
|
XR Elbow - right Limited Views |
|
37687-1
|
XR Elbow - right Oblique Views |
|
39373-6
|
XR Elbow - right Views and Oblique |
|
37198-9
|
XR Esophagus Views W contrast PO |
|
42153-7
|
XR Extremity Single view |
|
37637-6
|
XR Extremity Views |
|
44199-8
|
XR Facial bones 1 or 2 Views |
|
36297-0
|
XR Facial bones 3 Views |
|
36318-4
|
XR Facial bones 4 Views |
|
36675-7
|
XR Facial bones 5 Views |
|
48479-0
|
XR Facial bones GE 3 Views |
|
37164-1
|
XR Facial bones Lateral and Caldwell and Waters |
|
37165-8
|
XR Facial bones Lateral and Caldwell and Waters and Submentovertex |
|
37166-6
|
XR Facial bones Lateral and Caldwell and Waters and Submentovertex and Towne |
|
24695-9
|
XR Facial bones Views |
|
36737-5
|
XR Facial bones Limited Views |
|
83029-9
|
XR Facial bones and Zygomatic arch 1 or 2 Views |
|
37303-5
|
XR Facial bones and Zygomatic arch Views |
|
36559-3
|
XR Femur Single view |
|
36652-6
|
XR Femur 2 Views |
|
36302-8
|
XR Femur 3 Views |
|
36575-9
|
XR Femur AP |
|
36693-0
|
XR Femur AP and Lateral |
|
36593-2
|
XR Femur Lateral |
|
36609-6
|
XR Femur Oblique |
|
24704-9
|
XR Femur Views |
|
24700-7
|
XR Femur and Tibia Views for leg length |
|
39490-8
|
XR Femur and Tibia - right Views for leg length |
|
36653-4
|
XR Femur - bilateral 2 Views |
|
36694-8
|
XR Femur - bilateral AP and Lateral |
|
26118-0
|
XR Femur - bilateral Views |
|
36560-1
|
XR Femur - left Single view |
|
36654-2
|
XR Femur - left 2 Views |
|
36324-2
|
XR Femur - left 4 Views |
|
36695-5
|
XR Femur - left AP and Lateral |
|
26120-6
|
XR Femur - left Views |
|
38845-4
|
XR Femur - left Views W standing |
|
37689-7
|
XR Femur - right Single view |
|
37690-5
|
XR Femur - right 2 Views |
|
37691-3
|
XR Femur - right 4 Views |
|
37692-1
|
XR Femur - right AP and Lateral |
|
26122-2
|
XR Femur - right Views |
|
37693-9
|
XR Femur - right Views W standing |
|
37060-1
|
XR Fetal Views |
|
36655-9
|
XR Finger 2 Views |
|
36303-6
|
XR Finger 3 Views |
|
36725-0
|
XR Finger AP and Lateral and oblique |
|
79354-7
|
XR Finger GE 2 Views |
|
39078-1
|
XR Finger PA and Lateral and Oblique |
|
24706-4
|
XR Finger Views |
|
36596-5
|
XR Finger second Lateral |
|
36612-0
|
XR Finger second Oblique |
|
30780-1
|
XR Finger second Views |
|
37521-2
|
XR Finger second - bilateral Views |
|
43489-4
|
XR Finger second - left GE 3 Views |
|
37522-0
|
XR Finger second - left Views |
|
43494-4
|
XR Finger second - right GE 3 Views |
|
38144-2
|
XR Finger second - right Views |
|
36578-3
|
XR Finger third AP |
|
36597-3
|
XR Finger third Lateral |
|
36613-8
|
XR Finger third Oblique |
|
30781-9
|
XR Finger third Views |
|
37523-8
|
XR Finger third - bilateral Views |
|
43490-2
|
XR Finger third - left GE 3 Views |
|
37524-6
|
XR Finger third - left Views |
|
43495-1
|
XR Finger third - right GE 3 Views |
|
38145-9
|
XR Finger third - right Views |
|
36577-5
|
XR Finger fourth AP |
|
36595-7
|
XR Finger fourth Lateral |
|
36611-2
|
XR Finger fourth Oblique |
|
30782-7
|
XR Finger fourth Views |
|
37519-6
|
XR Finger fourth - bilateral Views |
|
43491-0
|
XR Finger fourth - left GE 3 Views |
|
37520-4
|
XR Finger fourth - left Views |
|
43496-9
|
XR Finger fourth - right GE 3 Views |
|
38146-7
|
XR Finger fourth - right Views |
|
36576-7
|
XR Finger fifth AP |
|
36594-0
|
XR Finger fifth Lateral |
|
36610-4
|
XR Finger fifth Oblique |
|
30783-5
|
XR Finger fifth Views |
|
37517-0
|
XR Finger fifth - bilateral Views |
|
43492-8
|
XR Finger fifth - left GE 3 Views |
|
37518-8
|
XR Finger fifth - left Views |
|
43497-7
|
XR Finger fifth - right GE 3 Views |
|
38147-5
|
XR Finger fifth - right Views |
|
36726-8
|
XR Finger - bilateral AP and Lateral and oblique |
|
26124-8
|
XR Finger - bilateral Views |
|
36656-7
|
XR Finger - left 2 Views |
|
36304-4
|
XR Finger - left 3 Views |
|
36727-6
|
XR Finger - left AP and Lateral and oblique |
|
26125-5
|
XR Finger - left Views |
|
37694-7
|
XR Finger - right 2 Views |
|
37695-4
|
XR Finger - right 3 Views |
|
37696-2
|
XR Finger - right AP and Lateral and oblique |
|
26126-3
|
XR Finger - right Views |
|
36561-9
|
XR Foot Single view |
|
83030-7
|
XR Foot 1 or 2 Views |
|
30784-3
|
XR Foot 2 Views |
|
36305-1
|
XR Foot 3 Views |
|
79355-4
|
XR Foot 3 Views W standing |
|
36579-1
|
XR Foot AP |
|
39069-0
|
XR Foot AP and Lateral |
|
39068-2
|
XR Foot AP and Lateral W standing |
|
36728-4
|
XR Foot AP and Lateral and oblique |
|
39076-5
|
XR Foot AP and Oblique |
|
44188-1
|
XR Foot GE 3 Views |
|
36976-9
|
XR Foot Harris |
|
37001-5
|
XR Foot Lateral W standing |
|
36614-6
|
XR Foot Oblique |
|
42398-8
|
XR Foot Oblique and (AP and Lateral W standing) |
|
24709-8
|
XR Foot Views |
|
30785-0
|
XR Foot Views W forced dorsiflexion |
|
24708-0
|
XR Foot Views W standing |
|
36657-5
|
XR Foot - bilateral 2 Views |
|
37068-4
|
XR Foot - bilateral 2 Views W standing |
|
36306-9
|
XR Foot - bilateral 3 Views |
|
36947-0
|
XR Foot - bilateral 3 Views W standing |
|
36580-9
|
XR Foot - bilateral AP |
|
36696-3
|
XR Foot - bilateral AP and Lateral |
|
39331-4
|
XR Foot - bilateral AP and Lateral W standing |
|
36729-2
|
XR Foot - bilateral AP and Lateral and oblique |
|
48478-2
|
XR Foot - bilateral GE 3 Views |
|
26127-1
|
XR Foot - bilateral Views |
|
26094-3
|
XR Foot - bilateral Views W standing |
|
69309-3
|
XR Foot - left Single view |
|
38846-2
|
XR Foot - left 2 Views |
|
37069-2
|
XR Foot - left 2 Views W standing |
|
36307-7
|
XR Foot - left 3 Views |
|
43499-3
|
XR Foot - left 3 or 4 Views |
|
36948-8
|
XR Foot - left 3 Views W standing |
|
36697-1
|
XR Foot - left AP and Lateral |
|
39332-2
|
XR Foot - left AP and Lateral W standing |
|
36730-0
|
XR Foot - left AP and Lateral and oblique |
|
39334-8
|
XR Foot - left AP and Lateral and oblique W standing |
|
48477-4
|
XR Foot - left GE 3 Views |
|
36598-1
|
XR Foot - left Lateral |
|
36615-3
|
XR Foot - left Oblique |
|
26128-9
|
XR Foot - left Views |
|
38003-0
|
XR Foot - left Views AP W standing |
|
26095-0
|
XR Foot - left Views W standing |
|
37559-2
|
XR Foot - left Views W manual stress |
|
69316-8
|
XR Foot - right Single view |
|
37697-0
|
XR Foot - right 2 Views |
|
37698-8
|
XR Foot - right 2 Views W standing |
|
37699-6
|
XR Foot - right 3 Views |
|
43483-7
|
XR Foot - right 3 or 4 Views |
|
37700-2
|
XR Foot - right 3 Views W standing |
|
37701-0
|
XR Foot - right AP and Lateral |
|
39374-4
|
XR Foot - right AP and Lateral W standing |
|
37702-8
|
XR Foot - right AP and Lateral and oblique |
|
39375-1
|
XR Foot - right AP and Lateral and oblique W standing |
|
48476-6
|
XR Foot - right GE 3 Views |
|
37703-6
|
XR Foot - right Lateral |
|
37704-4
|
XR Foot - right Oblique |
|
26129-7
|
XR Foot - right Views |
|
38815-7
|
XR Foot - right Views AP W standing |
|
26096-8
|
XR Foot - right Views W standing |
|
37705-1
|
XR Foot - right Views W manual stress |
|
42409-3
|
XR Foot sesamoid bones AP and Lateral |
|
42399-6
|
XR Foot sesamoid bones Views |
|
42395-4
|
XR Foot sesamoid bones - bilateral Axial |
|
42400-2
|
XR Foot sesamoid bones - bilateral Views |
|
42396-2
|
XR Foot sesamoid bones - left Axial |
|
43641-0
|
XR Foot sesamoid bones - left Views |
|
42434-1
|
XR Foot sesamoid bones - right Views |
|
24713-0
|
XR Gallbladder Views 48H post contrast PO |
|
24712-2
|
XR Gallbladder Views W contrast PO |
|
42383-0
|
XR Gallbladder Views W contrast PO and W contrast PO |
|
37575-8
|
XR Gallbladder Views W contrast and fatty meal PO |
|
39149-0
|
XR Gastrointestinal tract and Pulmonary system Single view for foreign body |
|
37532-9
|
XR Great toe - bilateral Views |
|
37533-7
|
XR Great toe - left Views |
|
37584-0
|
XR Great toe - left Views W standing |
|
38152-5
|
XR Great toe - right Views |
|
38810-8
|
XR Great toe - right Views W standing |
|
46371-1
|
XR Guidance for change of percutaneous tube in Unspecified body region-- W contrast |
|
36563-5
|
XR Hand Single view |
|
79356-2
|
XR Hand 1 or 2 Views |
|
24721-3
|
XR Hand 2 Views |
|
24722-1
|
XR Hand 3 Views |
|
69130-3
|
XR Hand AP and Lateral |
|
24723-9
|
XR Hand Arthritis |
|
36965-2
|
XR Hand Ball Catcher |
|
79357-0
|
XR Hand GE 3 Views |
|
36599-9
|
XR Hand Lateral |
|
36616-1
|
XR Hand Oblique |
|
36621-1
|
XR Hand PA |
|
36755-7
|
XR Hand PA and Lateral and Oblique |
|
39079-9
|
XR Hand PA and Oblique |
|
28582-5
|
XR Hand Views |
|
26388-9
|
XR Hand - bilateral 2 Views |
|
26379-8
|
XR Hand - bilateral 3 Views |
|
48474-1
|
XR Hand - bilateral AP and Lateral |
|
69057-8
|
XR Hand - bilateral AP and Lateral and oblique |
|
26355-8
|
XR Hand - bilateral Arthritis |
|
37471-0
|
XR Hand - bilateral Bora |
|
36966-0
|
XR Hand - bilateral Brewerton |
|
36600-5
|
XR Hand - bilateral Lateral |
|
36622-9
|
XR Hand - bilateral PA |
|
36752-4
|
XR Hand - bilateral PA and Lateral |
|
37142-7
|
XR Hand - bilateral PA and Lateral and Ball Catcher |
|
36756-5
|
XR Hand - bilateral PA and Lateral and Oblique |
|
36629-4
|
XR Hand - bilateral Views |
|
69310-1
|
XR Hand - left Single view |
|
26389-7
|
XR Hand - left 2 Views |
|
26380-6
|
XR Hand - left 3 Views |
|
38847-0
|
XR Hand - left AP and Lateral |
|
38848-8
|
XR Hand - left AP and Lateral and oblique |
|
26356-6
|
XR Hand - left Arthritis |
|
37472-8
|
XR Hand - left Bora |
|
36967-8
|
XR Hand - left Brewerton |
|
47370-2
|
XR Hand - left GE 3 Views |
|
36601-3
|
XR Hand - left Lateral |
|
36623-7
|
XR Hand - left PA |
|
36753-2
|
XR Hand - left PA and Lateral |
|
36757-3
|
XR Hand - left PA and Lateral and Oblique |
|
36630-2
|
XR Hand - left Views |
|
41830-1
|
XR Hand - left Limited Views |
|
69318-4
|
XR Hand - right Single view |
|
26390-5
|
XR Hand - right 2 Views |
|
26381-4
|
XR Hand - right 3 Views |
|
37710-1
|
XR Hand - right AP and Lateral |
|
37711-9
|
XR Hand - right AP and Lateral and oblique |
|
26357-4
|
XR Hand - right Arthritis |
|
38804-1
|
XR Hand - right Bora |
|
38775-3
|
XR Hand - right Brewerton |
|
47371-0
|
XR Hand - right GE 3 Views |
|
37712-7
|
XR Hand - right Lateral |
|
37714-3
|
XR Hand - right PA |
|
37713-5
|
XR Hand - right PA and Lateral |
|
37715-0
|
XR Hand - right PA and Lateral and Oblique |
|
37716-8
|
XR Hand - right Views |
|
41789-9
|
XR Hand - right Limited Views |
|
91720-3
|
XR Head to Abdomen Views for shunt patency |
|
36564-3
|
XR Calcaneus Single view |
|
36661-7
|
XR Calcaneus 2 Views |
|
36731-8
|
XR Calcaneus AP and Lateral and oblique |
|
24612-4
|
XR Calcaneus Views |
|
37996-6
|
XR Calcaneus Broden Views |
|
37022-1
|
XR Calcaneus Ski jump Views |
|
37205-2
|
XR Calcaneus Views W standing |
|
37058-5
|
XR Calcaneus - bilateral Single view W standing |
|
48433-7
|
XR Calcaneus - bilateral 2 Views |
|
36686-4
|
XR Calcaneus - bilateral AP and Lateral |
|
36975-1
|
XR Calcaneus - bilateral Harris |
|
26100-8
|
XR Calcaneus - bilateral Views |
|
37995-8
|
XR Calcaneus - bilateral Broden Views |
|
37021-3
|
XR Calcaneus - bilateral Ski jump Views |
|
69311-9
|
XR Calcaneus - left Single view |
|
36662-5
|
XR Calcaneus - left 2 Views |
|
36701-1
|
XR Calcaneus - left AP and Lateral |
|
36977-7
|
XR Calcaneus - left Harris |
|
26101-6
|
XR Calcaneus - left Views |
|
37997-4
|
XR Calcaneus - left Broden Views |
|
37023-9
|
XR Calcaneus - left Ski jump Views |
|
37206-0
|
XR Calcaneus - left Views W standing |
|
69319-2
|
XR Calcaneus - right Single view |
|
37718-4
|
XR Calcaneus - right 2 Views |
|
37719-2
|
XR Calcaneus - right AP and Lateral |
|
38776-1
|
XR Calcaneus - right Harris |
|
26102-4
|
XR Calcaneus - right Views |
|
38814-0
|
XR Calcaneus - right Broden Views |
|
38778-7
|
XR Calcaneus - right Ski jump Views |
|
37720-0
|
XR Calcaneus - right Views W standing |
|
83033-1
|
XR Hip single view during surgery |
|
24761-9
|
XR Hip Single view |
|
36663-3
|
XR Hip 2 Views |
|
36581-7
|
XR Hip AP |
|
36702-9
|
XR Hip AP and Lateral |
|
37091-6
|
XR Hip AP and Lateral frog |
|
37086-6
|
XR Hip AP and Lateral crosstable |
|
69132-9
|
XR Hip Danelius Miller |
|
36973-6
|
XR Hip Friedman |
|
79361-2
|
XR Hip GE 2 Views |
|
83032-3
|
XR Hip GE 2 Views preoperative |
|
36981-9
|
XR Hip Judet |
|
36602-1
|
XR Hip Lateral |
|
30786-8
|
XR Hip Lateral frog |
|
36985-0
|
XR Hip Lateral crosstable |
|
36617-9
|
XR Hip Oblique |
|
37039-5
|
XR Hip True lateral |
|
24762-7
|
XR Hip Views |
|
47372-8
|
XR Hip Views during surgery |
|
69131-1
|
XR Hip Views and Danelius Miller |
|
37049-4
|
XR Hip Von Rosen |
|
26400-2
|
XR Hip - bilateral Single view |
|
37059-3
|
XR Hip - bilateral Single view W standing |
|
69058-6
|
XR Hip - bilateral 2 Views |
|
36308-5
|
XR Hip - bilateral 3 Views |
|
36703-7
|
XR Hip - bilateral AP and Lateral |
|
37092-4
|
XR Hip - bilateral AP and Lateral frog |
|
79358-8
|
XR Hip - bilateral GE 4 Views |
|
36982-7
|
XR Hip - bilateral Judet |
|
36993-4
|
XR Hip - bilateral Lateral frog |
|
36986-8
|
XR Hip - bilateral Lateral crosstable |
|
36618-7
|
XR Hip - bilateral Oblique |
|
26130-5
|
XR Hip - bilateral Views |
|
69059-4
|
XR Hip - bilateral Views and Lateral crosstable |
|
26401-0
|
XR Hip - left Single view |
|
38065-9
|
XR Hip - left Single view during surgery |
|
37207-8
|
XR Hip - left Single view W standing |
|
36664-1
|
XR Hip - left 2 Views |
|
36309-3
|
XR Hip - left 3 Views |
|
36582-5
|
XR Hip - left AP |
|
36704-5
|
XR Hip - left AP and Lateral |
|
42404-4
|
XR Hip - left AP and Lateral Views for measurement |
|
37093-2
|
XR Hip - left AP and Lateral frog |
|
37087-4
|
XR Hip - left AP and Lateral crosstable |
|
69141-0
|
XR Hip - left Danelius Miller |
|
79359-6
|
XR Hip - left GE 2 Views |
|
36983-5
|
XR Hip - left Judet |
|
36603-9
|
XR Hip - left Lateral |
|
36994-2
|
XR Hip - left Lateral frog |
|
38066-7
|
XR Hip - left Lateral during surgery |
|
36987-6
|
XR Hip - left Lateral crosstable |
|
37545-1
|
XR Hip - left Oblique crosstable |
|
37040-3
|
XR Hip - left True lateral |
|
26131-3
|
XR Hip - left Views |
|
69140-2
|
XR Hip - left Views and Danelius Miller |
|
69139-4
|
XR Hip - left Views and Lateral crosstable |
|
26402-8
|
XR Hip - right Single view |
|
38818-1
|
XR Hip - right Single view during surgery |
|
37731-7
|
XR Hip - right Single view W standing |
|
37721-8
|
XR Hip - right 2 Views |
|
37722-6
|
XR Hip - right 3 Views |
|
37726-7
|
XR Hip - right AP |
|
39512-9
|
XR Hip - right AP and Danelius Miller |
|
37725-9
|
XR Hip - right AP and Lateral |
|
37724-2
|
XR Hip - right AP and Lateral frog |
|
37723-4
|
XR Hip - right AP and Lateral crosstable |
|
39514-5
|
XR Hip - right Danelius Miller |
|
79360-4
|
XR Hip - right GE 2 Views |
|
37732-5
|
XR Hip - right Judet |
|
37730-9
|
XR Hip - right Lateral |
|
37729-1
|
XR Hip - right Lateral frog |
|
38819-9
|
XR Hip - right Lateral during surgery |
|
37727-5
|
XR Hip - right Lateral crosstable |
|
37728-3
|
XR Hip - right Oblique crosstable |
|
38772-0
|
XR Hip - right True lateral |
|
26132-1
|
XR Hip - right Views |
|
39513-7
|
XR Hip - right Views and Danelius Miller |
|
39377-7
|
XR Hip - right Views and Lateral crosstable |
|
36565-0
|
XR Humerus Single view |
|
42008-3
|
XR Humerus Single view during surgery |
|
24765-0
|
XR Humerus 2 Views |
|
36706-0
|
XR Humerus AP and Lateral |
|
37485-0
|
XR Humerus AP and Transthoracic |
|
37319-1
|
XR Humerus bicipital groove Views |
|
37321-7
|
XR Humerus bicipital groove - bilateral Views |
|
37320-9
|
XR Humerus bicipital groove - left Views |
|
38797-7
|
XR Humerus bicipital groove - right Views |
|
79362-0
|
XR Humerus GE 2 Views |
|
37031-2
|
XR Humerus Transthoracic |
|
28567-6
|
XR Humerus Views |
|
26391-3
|
XR Humerus - bilateral 2 Views |
|
36707-8
|
XR Humerus - bilateral AP and Lateral |
|
37032-0
|
XR Humerus - bilateral Transthoracic |
|
37062-7
|
XR Humerus - bilateral Views |
|
69312-7
|
XR Humerus - left Single view |
|
26392-1
|
XR Humerus - left 2 Views |
|
36708-6
|
XR Humerus - left AP and Lateral |
|
37033-8
|
XR Humerus - left Transthoracic |
|
36632-8
|
XR Humerus - left Views |
|
36744-1
|
XR Humerus - left Oblique Views |
|
69320-0
|
XR Humerus - right Single view |
|
26393-9
|
XR Humerus - right 2 Views |
|
37736-6
|
XR Humerus - right AP and Lateral |
|
38007-1
|
XR Humerus - right Transthoracic |
|
37738-2
|
XR Humerus - right Views |
|
37737-4
|
XR Humerus - right Oblique Views |
|
36628-6
|
XR Internal auditory canal Views |
|
30787-6
|
XR Joint Single view |
|
43480-3
|
XR Joint Lateral Views W manual stress |
|
43481-1
|
XR Joint Views W flexion and W extension |
|
24778-3
|
XR Kidney - bilateral 3 Serial Views WO and W contrast IV |
|
24788-2
|
XR Kidney - bilateral Views W contrast IV |
|
43485-2
|
XR Kidney Views during surgery W contrast retrograde |
|
37137-7
|
XR Kidney Limited Views W contrast IV |
|
38101-2
|
XR Kidney Views W contrast antegrade |
|
37607-9
|
XR Kidney Views W contrast IV |
|
38105-3
|
XR Kidney Views W contrast retrograde |
|
38102-0
|
XR Kidney Views W contrast antegrade via pyelostomy |
|
42405-1
|
XR Knee (AP W standing) and (Lateral W extension) |
|
44198-0
|
XR Knee 1 or 2 Views |
|
83035-6
|
XR Knee 1 or 2 Views during surgery |
|
24806-2
|
XR Knee 2 Views |
|
30788-4
|
XR Knee 3 Views |
|
30789-2
|
XR Knee 4 Views |
|
36584-1
|
XR Knee AP |
|
24807-0
|
XR Knee AP W standing |
|
36709-4
|
XR Knee AP and Lateral |
|
24805-4
|
XR Knee AP and Lateral W standing |
|
37090-8
|
XR Knee AP and Lateral crosstable |
|
39071-6
|
XR Knee AP and Lateral and Merchants |
|
37115-3
|
XR Knee AP and Lateral and Oblique and Tunnel |
|
39073-2
|
XR Knee AP and Lateral and Right oblique and Left oblique |
|
37106-2
|
XR Knee AP and Lateral and Sunrise |
|
37111-2
|
XR Knee AP and Lateral and Sunrise and tunnel |
|
37112-0
|
XR Knee AP and Lateral and Tunnel |
|
24808-8
|
XR Knee AP and PA W standing |
|
91598-3
|
XR Knee GE 2 Views |
|
79364-6
|
XR Knee GE 4 Views |
|
44195-6
|
XR Knee GE 5 Views |
|
36978-5
|
XR Knee Holmblad |
|
36604-7
|
XR Knee Lateral |
|
36988-4
|
XR Knee Lateral crosstable |
|
37004-9
|
XR Knee Laurin |
|
24801-3
|
XR Knee Merchants |
|
38086-5
|
XR Knee Merchants 30 and 45 and 60 degrees |
|
37154-2
|
XR Knee Oblique and Sunrise |
|
37155-9
|
XR Knee Oblique and Sunrise and Tunnel |
|
37476-9
|
XR Knee PA 45 degree flexion |
|
37477-7
|
XR Knee PA 45 degree flexion W standing |
|
37018-9
|
XR Knee Rosenberg W standing |
|
43780-6
|
XR Knee Sunrise |
|
69136-0
|
XR Knee Sunrise and Tunnel |
|
30790-0
|
XR Knee Tunnel |
|
28565-0
|
XR Knee Views |
|
36619-5
|
XR Knee Oblique Views |
|
24809-6
|
XR Knee Views W standing |
|
37560-0
|
XR Knee Views W manual stress |
|
36566-8
|
XR Knee - bilateral Single view |
|
26394-7
|
XR Knee - bilateral 2 Views |
|
36945-4
|
XR Knee - bilateral 2 Views W standing |
|
69060-2
|
XR Knee - bilateral 2 Views and Sunrise |
|
69061-0
|
XR Knee - bilateral 2 Views and Tunnel |
|
36310-1
|
XR Knee - bilateral 3 Views |
|
36325-9
|
XR Knee - bilateral 4 Views |
|
69062-8
|
XR Knee - bilateral 4 Views W standing |
|
69063-6
|
XR Knee - bilateral 4 Views and Sunrise and Tunnel |
|
36678-1
|
XR Knee - bilateral 6 Views |
|
36682-3
|
XR Knee - bilateral 8 Views |
|
36585-8
|
XR Knee - bilateral AP |
|
26358-2
|
XR Knee - bilateral AP W standing |
|
36590-8
|
XR Knee - bilateral AP and Lateral |
|
26364-0
|
XR Knee - bilateral AP and Lateral W standing |
|
79363-8
|
XR Knee - bilateral AP and Lateral and Merchants and (Views W standing) |
|
36732-6
|
XR Knee - bilateral AP and Lateral and oblique |
|
37102-1
|
XR Knee - bilateral AP and Lateral and Oblique and Sunrise |
|
37118-7
|
XR Knee - bilateral AP and Lateral and Oblique and Sunrise and Tunnel |
|
37107-0
|
XR Knee - bilateral AP and Lateral and Sunrise |
|
37116-1
|
XR Knee - bilateral AP and Lateral and Sunrise and tunnel |
|
37113-8
|
XR Knee - bilateral AP and Lateral and Tunnel |
|
26361-6
|
XR Knee - bilateral AP and PA W standing |
|
44197-2
|
XR Knee - bilateral GE 5 Views W standing |
|
36605-4
|
XR Knee - bilateral Lateral |
|
36999-1
|
XR Knee - bilateral Lateral W extension |
|
26283-2
|
XR Knee - bilateral Merchants |
|
37020-5
|
XR Knee - bilateral Rosenberg W standing |
|
37027-0
|
XR Knee - bilateral Sunrise |
|
38088-1
|
XR Knee - bilateral Sunrise 20 and 40 and 60 degrees |
|
37163-3
|
XR Knee - bilateral Sunrise and Tunnel |
|
69064-4
|
XR Knee - bilateral Sunrise and (Views W standing) |
|
37041-1
|
XR Knee - bilateral Tunnel |
|
36635-1
|
XR Knee - bilateral Views |
|
37540-2
|
XR Knee - bilateral Holmblad Views W standing |
|
36745-8
|
XR Knee - bilateral Oblique Views |
|
46378-6
|
XR Knee - bilateral PA Views W standing and W flexion |
|
26085-1
|
XR Knee - bilateral Views W standing |
|
37561-8
|
XR Knee - bilateral Views W manual stress |
|
51387-9
|
XR Knee - bilateral Views and (AP W standing) |
|
36567-6
|
XR Knee - left Single view |
|
47373-6
|
XR Knee - left 1 or 2 Views |
|
26395-4
|
XR Knee - left 2 Views |
|
38871-0
|
XR Knee - left 2 Oblique Views |
|
38851-2
|
XR Knee - left 2 Views W standing |
|
69142-8
|
XR Knee - left 2 Views and Sunrise |
|
41819-4
|
XR Knee - left 2 Views and Tunnel |
|
69143-6
|
XR Knee - left 2 views and (Tunnel W standing) |
|
36311-9
|
XR Knee - left 3 Views |
|
36326-7
|
XR Knee - left 4 Views |
|
38852-0
|
XR Knee - left 4 Views W standing |
|
69144-4
|
XR Knee - left 4 views and (AP W standing) |
|
69145-1
|
XR Knee - left 4 views and Tunnel |
|
36676-5
|
XR Knee - left 5 Views |
|
48462-6
|
XR Knee - left AP |
|
26359-0
|
XR Knee - left AP W standing |
|
36710-2
|
XR Knee - left AP and Lateral |
|
26365-7
|
XR Knee - left AP and Lateral W standing |
|
69146-9
|
XR Knee - left AP and Lateral crosstable |
|
36733-4
|
XR Knee - left AP and Lateral and oblique |
|
69147-7
|
XR Knee - left AP and Lateral and Right oblique and Left oblique |
|
37108-8
|
XR Knee - left AP and Lateral and Sunrise |
|
37117-9
|
XR Knee - left AP and Lateral and Sunrise and tunnel |
|
37114-6
|
XR Knee - left AP and Lateral and Tunnel |
|
26362-4
|
XR Knee - left AP and PA W standing |
|
43498-5
|
XR Knee - left GE 3 Views |
|
47374-4
|
XR Knee - left GE 4 Views |
|
36606-2
|
XR Knee - left Lateral |
|
37000-7
|
XR Knee - left Lateral W extension |
|
37002-3
|
XR Knee - left Lateral W standing |
|
26284-0
|
XR Knee - left Merchants |
|
37014-8
|
XR Knee - left PA W standing |
|
37019-7
|
XR Knee - left Rosenberg W standing |
|
43779-8
|
XR Knee - left Sunrise |
|
38087-3
|
XR Knee - left Sunrise 20 and 40 and 60 degrees |
|
37156-7
|
XR Knee - left Sunrise and Tunnel |
|
39345-4
|
XR Knee - left Sunrise and (Tunnel W standing) |
|
69149-3
|
XR Knee - left Sunrise and (Views W standing) |
|
37042-9
|
XR Knee - left Tunnel |
|
37043-7
|
XR Knee - left Tunnel W standing |
|
36636-9
|
XR Knee - left Views |
|
37484-3
|
XR Knee - left Views AP W manual stress |
|
36746-6
|
XR Knee - left Oblique Views |
|
26086-9
|
XR Knee - left Views W standing |
|
37562-6
|
XR Knee - left Views W manual stress |
|
69148-5
|
XR Knee - left Views and Tunnel |
|
37741-6
|
XR Knee - right Single view |
|
47375-1
|
XR Knee - right 1 or 2 Views |
|
26396-2
|
XR Knee - right 2 Views |
|
39382-7
|
XR Knee - right 2 views and (Tunnel W standing) |
|
38108-7
|
XR Knee - right 2 Oblique Views |
|
37762-2
|
XR Knee - right 2 Views W standing |
|
42430-9
|
XR Knee - right 2 views and (Views W standing) |
|
39378-5
|
XR Knee - right 2 Views and Oblique |
|
39379-3
|
XR Knee - right 2 Views and Sunrise |
|
39380-1
|
XR Knee - right 2 Views and Sunrise and Tunnel |
|
39381-9
|
XR Knee - right 2 Views and Tunnel |
|
37742-4
|
XR Knee - right 3 Views |
|
39383-5
|
XR Knee - right 3 Views and Sunrise |
|
37743-2
|
XR Knee - right 4 Views |
|
37763-0
|
XR Knee - right 4 Views W standing |
|
39384-3
|
XR Knee - right 4 views and (AP W standing) |
|
39385-0
|
XR Knee - right 4 Views and Oblique |
|
39387-6
|
XR Knee - right 4 Views and Sunrise and Tunnel |
|
39386-8
|
XR Knee - right 4 views and Tunnel |
|
37744-0
|
XR Knee - right 5 Views |
|
48463-4
|
XR Knee - right AP |
|
26360-8
|
XR Knee - right AP W standing |
|
37745-7
|
XR Knee - right AP and Lateral |
|
26366-5
|
XR Knee - right AP and Lateral W standing |
|
37748-1
|
XR Knee - right AP and Lateral and oblique |
|
39388-4
|
XR Knee - right AP and Lateral and Right oblique and Left oblique |
|
37749-9
|
XR Knee - right AP and Lateral and Sunrise |
|
37740-8
|
XR Knee - right AP and Lateral and Sunrise and tunnel |
|
37747-3
|
XR Knee - right AP and Lateral and Tunnel |
|
26363-2
|
XR Knee - right AP and PA W standing |
|
43482-9
|
XR Knee - right GE 3 Views |
|
47376-9
|
XR Knee - right GE 4 Views |
|
37751-5
|
XR Knee - right Lateral |
|
37750-7
|
XR Knee - right Lateral W extension |
|
37754-9
|
XR Knee - right Lateral W standing |
|
47377-7
|
XR Knee - right LE 4 Views |
|
26285-7
|
XR Knee - right Merchants |
|
42431-7
|
XR Knee - right PA 30 degree flexion W standing |
|
37755-6
|
XR Knee - right PA W standing |
|
37752-3
|
XR Knee - right Rosenberg W standing |
|
69256-6
|
XR Knee - right Sunrise |
|
38824-9
|
XR Knee - right Sunrise 20 and 40 and 60 degrees |
|
42432-5
|
XR Knee - right Sunrise and (Views W standing) |
|
37759-8
|
XR Knee - right Sunrise and Tunnel |
|
69255-8
|
XR Knee - right Sunrise and (Tunnel W standing) |
|
37761-4
|
XR Knee - right Tunnel |
|
37756-4
|
XR Knee - right Tunnel W standing |
|
37758-0
|
XR Knee - right Views |
|
37746-5
|
XR Knee - right Views AP W manual stress |
|
37757-2
|
XR Knee - right Oblique Views |
|
26087-7
|
XR Knee - right Views W standing |
|
37753-1
|
XR Knee - right Views W manual stress |
|
39390-0
|
XR Knee - right Views and Oblique |
|
39391-8
|
XR Knee - right Views and Sunrise |
|
39389-2
|
XR Knee - right Views and Tunnel |
|
36651-8
|
XR Lower extremity 2 Views |
|
36574-2
|
XR Lower extremity AP |
|
36692-2
|
XR Lower extremity AP and Lateral |
|
83036-4
|
XR Lower extremity GE 2 Views |
|
24686-8
|
XR Lower extremity Views |
|
37204-5
|
XR Lower extremity Views W standing |
|
36557-7
|
XR Lower extremity - bilateral Single view |
|
44205-3
|
XR Lower extremity - bilateral Single view W standing |
|
44177-4
|
XR Lower extremity - bilateral AP W standing |
|
26112-3
|
XR Lower extremity - bilateral Views |
|
36558-5
|
XR Lower extremity - left Single view |
|
38850-4
|
XR Lower extremity - left Single view W standing |
|
38849-6
|
XR Lower extremity - left AP W standing |
|
26113-1
|
XR Lower extremity - left Views |
|
37764-8
|
XR Lower extremity - right Single view |
|
37734-1
|
XR Lower extremity - right Single view W standing |
|
69257-4
|
XR Lower extremity - right 2 Views |
|
37733-3
|
XR Lower extremity - right AP W standing |
|
69258-2
|
XR Lower extremity - right AP and Lateral |
|
26114-9
|
XR Lower extremity - right Views |
|
37515-4
|
XR Spine lumbosacral junction Lateral spot |
|
37516-2
|
XR Spine lumbosacral junction Lateral spot W standing |
|
37300-1
|
XR Spine lumbosacral junction True AP |
|
46340-6
|
XR Spine lumbosacral junction Views |
|
42411-9
|
XR Lumbar spine (AP^W R-bending and W L-bending) and (Lateral^W flexion and W extension) |
|
42401-0
|
XR Lumbar spine Lumbar (AP W R-bending and W L-bending and WO bending) and Lateral |
|
30773-6
|
XR Lumbar spine Single view |
|
83037-2
|
XR Lumbar spine Single view during surgery |
|
36670-8
|
XR Lumbar spine 2 Views |
|
48469-1
|
XR Lumbar spine 2 or 3 Views |
|
36946-2
|
XR Lumbar spine 2 Views W standing |
|
30775-1
|
XR Lumbar spine 3 Views |
|
36949-6
|
XR Lumbar spine 3 Views W standing |
|
36332-5
|
XR Lumbar spine 4 Views |
|
30797-5
|
XR Lumbar spine 5 Views |
|
39063-3
|
XR Lumbar spine 5 Views W flexion and W extension |
|
37073-4
|
XR Lumbar spine 5 Views W standing |
|
36681-5
|
XR Lumbar spine 7 Views |
|
30777-7
|
XR Lumbar spine AP |
|
42378-0
|
XR Lumbar spine AP W left bending |
|
42379-8
|
XR Lumbar spine AP W right bending |
|
24970-6
|
XR Lumbar spine AP and Lateral |
|
39333-0
|
XR Lumbar spine AP and Lateral W standing |
|
36735-9
|
XR Lumbar spine AP and Lateral and oblique |
|
37101-3
|
XR Lumbar spine AP and Lateral and Oblique and Spot |
|
42410-1
|
XR Lumbar spine AP and Lateral and Oblique and Spot W standing |
|
37105-4
|
XR Lumbar spine AP and Lateral and Spot |
|
47382-7
|
XR Lumbar spine GE 4 Views |
|
44196-4
|
XR Lumbar spine GE 5 Views W right bending and W left bending |
|
83038-0
|
XR Lumbar spine Greater than 4 views and (Greater than 1 view W R-bending and W L-bending) |
|
24969-8
|
XR Lumbar spine Lateral |
|
37003-1
|
XR Lumbar spine Lateral W standing |
|
36990-0
|
XR Lumbar spine Lateral crosstable |
|
37009-8
|
XR Lumbar spine Left oblique |
|
30778-5
|
XR Lumbar spine Oblique |
|
44178-2
|
XR Lumbar spine oblique and (views W right bending and W left bending) |
|
37011-4
|
XR Lumbar spine Right oblique |
|
24972-2
|
XR Lumbar spine Views |
|
42403-6
|
XR Lumbar spine Views AP W right bending and W left bending |
|
42408-5
|
XR Lumbar spine Views AP W right bending and W left bending and WO bending |
|
42406-9
|
XR Lumbar spine Views AP W and WO left bending |
|
42407-7
|
XR Lumbar spine Views AP W and WO right bending |
|
37132-8
|
XR Lumbar spine Lateral Views W flexion and W extension |
|
39340-5
|
XR Lumbar spine Lateral Views W standing and W flexion and W extension |
|
43791-3
|
XR Lumbar spine Oblique Views |
|
24971-4
|
XR Lumbar spine Views W flexion and W extension |
|
42413-5
|
XR Lumbar spine Views W right bending and W left bending |
|
37208-6
|
XR Lumbar spine Views W standing |
|
42163-6
|
XR Lumbar spine Views and Oblique |
|
37259-9
|
XR Spine Lumbar and Sacrum 3 Views |
|
48473-3
|
XR Spine Lumbar and Sacrum 4 Views |
|
37355-5
|
XR Spine Lumbar and Sacrum 5 Views |
|
79371-1
|
XR Spine Lumbar and Sacrum GE 2 Views |
|
79372-9
|
XR Spine Lumbar and Sacrum GE 4 Views |
|
79349-7
|
XR Spine Lumbar and Sacrum GE 6 Views |
|
37340-7
|
XR Spine Lumbar and Sacrum Views |
|
37260-7
|
XR Spine Lumbar and Sacrum and Coccyx 3 Views |
|
37356-3
|
XR Spine Lumbar and Sacrum and Coccyx 5 Views |
|
37341-5
|
XR Spine Lumbar and Sacrum and Coccyx Views |
|
37261-5
|
XR Lumbar spine and Sacrum and SI joint and Coccyx 3 Views |
|
37357-1
|
XR Lumbar spine and Sacrum and SI joint and Coccyx 5 Views |
|
37342-3
|
XR Lumbar spine and Sacrum and SI joint and Coccyx Views |
|
37257-3
|
XR Spine Lumbar and Sacroiliac Joint 3 Views |
|
37353-0
|
XR Spine Lumbar and Sacroiliac Joint 5 Views |
|
24975-5
|
XR Spine.lumbar and Sacroiliac joint - bilateral Views |
|
24825-2
|
XR Lung Views W contrast intrabronchial |
|
30813-0
|
XR Lung - bilateral Views W contrast intrabronchial |
|
64996-2
|
XR Lung - left Views W contrast intrabronchial |
|
64997-0
|
XR Lung - right Views W contrast intrabronchial |
|
43521-4
|
XR Mandible 1 or 2 Views |
|
36312-7
|
XR Mandible 3 Views |
|
36327-5
|
XR Mandible 4 Views |
|
36711-0
|
XR Mandible AP and Lateral |
|
47379-3
|
XR Mandible GE 4 Views |
|
47380-1
|
XR Mandible LE 3 Views |
|
36754-0
|
XR Mandible PA and Lateral |
|
37148-4
|
XR Mandible PA and Lateral and Oblique and Towne |
|
24829-4
|
XR Mandible Views |
|
36738-3
|
XR Mandible Limited Views |
|
36747-4
|
XR Mandible Oblique Views |
|
36838-1
|
XR Mastoid 3 Views |
|
36839-9
|
XR Mastoid 4 Views |
|
36890-2
|
XR Mastoid 5 Views |
|
47381-9
|
XR Mastoid GE 3 Views |
|
37153-4
|
XR Mastoid Stenver and Arcelin |
|
24830-2
|
XR Mastoid Views |
|
36893-6
|
XR Mastoid Limited Views |
|
47983-2
|
XR Mastoid - bilateral 1 or 2 Views |
|
83039-8
|
XR Mastoid - bilateral GE 3 Views |
|
37541-0
|
XR Mastoid - bilateral Law and Mayer and Stenver and Towne |
|
26139-6
|
XR Mastoid - bilateral Views |
|
42007-5
|
XR Mastoid - bilateral Limited Views |
|
48489-9
|
XR Mastoid - left 1 or 2 Views |
|
48470-9
|
XR Mastoid - left 3 Views |
|
26140-4
|
XR Mastoid - left Views |
|
48488-1
|
XR Mastoid - right 1 or 2 Views |
|
48471-7
|
XR Mastoid - right 3 Views |
|
26141-2
|
XR Mastoid - right Views |
|
36637-7
|
XR Maxilla Views |
|
37604-6
|
XR Nasal bones 3 Views |
|
37605-3
|
XR Nasal bones Lateral and Waters |
|
24834-4
|
XR Nasal bones Views |
|
38118-6
|
XR Neck 2 Lateral Views |
|
42439-0
|
XR Neck AP |
|
42438-2
|
XR Neck AP and Lateral |
|
24843-5
|
XR Neck Lateral |
|
42441-6
|
XR Neck Magnification |
|
37639-2
|
XR Neck Views |
|
37332-4
|
XR Olecranon - left Views |
|
38798-5
|
XR Olecranon - right Views |
|
37609-5
|
XR Optic foramen 4 Views |
|
24846-8
|
XR Optic foramen Views |
|
26142-0
|
XR Optic foramen - bilateral Views |
|
26143-8
|
XR Optic foramen - left Views |
|
26144-6
|
XR Optic foramen - right Views |
|
36886-0
|
XR Orbit Views |
|
44208-7
|
XR Orbit Views for foreign body |
|
43529-7
|
XR Orbit and Facial bones Views |
|
37612-9
|
XR Orbit - bilateral 4 Views |
|
48747-0
|
XR Orbit - bilateral GE 4 Views |
|
24854-2
|
XR Orbit - bilateral Views |
|
30720-7
|
XR Orbit - bilateral Views for foreign body |
|
37613-7
|
XR Orbit - bilateral Waters |
|
36887-8
|
XR Orbit - left Views |
|
42311-1
|
XR Orbit - left Views for foreign body |
|
38774-6
|
XR Orbit - right Views |
|
42312-9
|
XR Orbit - right Views for foreign body |
|
37614-5
|
XR Patella Single view |
|
24861-7
|
XR Patella 2 Views |
|
69239-2
|
XR Patella Sunrise |
|
30791-8
|
XR Patella Views |
|
26397-0
|
XR Patella - bilateral 2 Views |
|
36712-8
|
XR Patella - bilateral AP and Lateral |
|
37109-6
|
XR Patella - bilateral AP and Lateral and Sunrise |
|
69069-3
|
XR Patella - bilateral Sunrise |
|
36638-5
|
XR Patella - bilateral Views |
|
69152-7
|
XR Patella - left Single view |
|
26398-8
|
XR Patella - left 2 Views |
|
36713-6
|
XR Patella - left AP and Lateral |
|
37110-4
|
XR Patella - left AP and Lateral and Sunrise |
|
37149-2
|
XR Patella - left PA and Lateral and Sunrise |
|
36639-3
|
XR Patella - left Views |
|
69260-8
|
XR Patella - right Single view |
|
26399-6
|
XR Patella - right 2 Views |
|
69261-6
|
XR Patella - right 3 Views |
|
37776-2
|
XR Patella - right AP and Lateral |
|
38786-0
|
XR Patella - right AP and Lateral and Sunrise |
|
38790-2
|
XR Patella - right PA and Lateral and Sunrise |
|
37777-0
|
XR Patella - right Views |
|
37616-0
|
XR Pelvis Single view |
|
43522-2
|
XR Pelvis 1 or 2 Views |
|
37633-5
|
XR Pelvis Single view W standing |
|
37617-8
|
XR Pelvis 2 Views |
|
30766-0
|
XR Pelvis 3 Views |
|
36705-2
|
XR Pelvis and Hip AP and Lateral |
|
30770-2
|
XR Pelvis and Hip AP and Lateral frog |
|
37089-0
|
XR Pelvis and Hip AP and Lateral crosstable |
|
92677-4
|
XR Pelvis and Hip GE 4 Views |
|
30767-8
|
XR Pelvis and Hip Views |
|
42167-7
|
XR Pelvis and Hip - bilateral AP and Lateral frog |
|
30768-6
|
XR Pelvis and Hip - bilateral Views |
|
30769-4
|
XR Pelvis and Hip - bilateral Maximum abduction Views |
|
37583-2
|
XR Pelvis and Hip - bilateral Views and Lateral frog |
|
42685-8
|
XR Pelvis and Hip - left 2 Views |
|
37094-0
|
XR Pelvis and Hip - left AP and Lateral frog |
|
37088-2
|
XR Pelvis and Hip - left AP and Lateral crosstable |
|
36631-0
|
XR Pelvis and Hip - left Views |
|
42686-6
|
XR Pelvis and Hip - right 2 Views |
|
38785-2
|
XR Pelvis and Hip - right AP and Lateral frog |
|
38784-5
|
XR Pelvis and Hip - right AP and Lateral crosstable |
|
38771-2
|
XR Pelvis and Hip - right Views |
|
37622-8
|
XR Pelvis AP |
|
83031-5
|
XR Pelvis AP and Hip - bilateral GE 2 Views |
|
37634-3
|
XR Pelvis AP 20 degree cephalic angle |
|
42420-0
|
XR Pelvis AP W standing |
|
37618-6
|
XR Pelvis AP and Inlet |
|
37623-6
|
XR Pelvis AP and Inlet and Outlet |
|
39065-8
|
XR Pelvis AP and Inlet and Outlet and Oblique |
|
37619-4
|
XR Pelvis AP and Judet |
|
37620-2
|
XR Pelvis AP and Lateral |
|
37624-4
|
XR Pelvis AP and Lateral and oblique |
|
37621-0
|
XR Pelvis AP and Oblique |
|
37625-1
|
XR Pelvis Ferguson |
|
43543-8
|
XR Pelvis GE 3 Views |
|
37628-5
|
XR Pelvis Inlet |
|
30771-0
|
XR Pelvis Inlet and Outlet |
|
37627-7
|
XR Pelvis Inlet and Outlet and Oblique |
|
37629-3
|
XR Pelvis Lateral |
|
37626-9
|
XR Pelvis Lateral frog |
|
37631-9
|
XR Pelvis Outlet |
|
24871-6
|
XR Pelvis Pelvimetry |
|
30885-8
|
XR Pelvis symphysis pubis Views |
|
28561-9
|
XR Pelvis Views |
|
37630-1
|
XR Pelvis Oblique Views |
|
39360-3
|
XR Pelvis Views and Inlet and Outlet |
|
39511-1
|
XR Pelvis Views and Oblique |
|
37256-5
|
XR Pelvis and Spine Lumbar 3 Views |
|
37351-4
|
XR Pelvis and Spine Lumbar 5 Views |
|
47984-0
|
XR Pelvis and Spine Lumbar Views |
|
24745-2
|
XR Petrous part of temporal bone Views |
|
36588-2
|
Portable XR Abdomen AP |
|
24560-5
|
Portable XR Abdomen AP left lateral-decubitus |
|
24564-7
|
Portable XR Abdomen AP upright |
|
24792-4
|
Portable XR Abdomen AP and AP left lateral-decubitus |
|
24793-2
|
Portable XR Abdomen AP and Lateral |
|
30763-7
|
Portable XR Abdomen AP and Lateral crosstable |
|
37076-7
|
Portable XR Abdomen Supine and Lateral-decubitus |
|
24795-7
|
Portable XR Abdomen Supine and Upright |
|
30765-2
|
Portable XR Acetabulum Views |
|
30764-5
|
Portable XR Acetabulum - bilateral Views |
|
41823-6
|
Portable XR Ankle - left Views |
|
41782-4
|
Portable XR Ankle - right Views |
|
44203-8
|
Portable XR Cervical and thoracic and lumbar spine Views |
|
36589-0
|
Portable XR Chest AP single view |
|
30735-5
|
Portable XR Chest AP lateral-decubitus |
|
24636-3
|
Portable XR Chest AP left lateral-decubitus |
|
24652-0
|
Portable XR Chest AP right lateral-decubitus |
|
43778-0
|
Portable XR Chest AP supine |
|
36960-3
|
Portable XR Chest AP upright |
|
24654-6
|
Portable XR Chest AP and AP right lateral-decubitus |
|
30738-9
|
Portable XR Chest Left lateral |
|
24638-9
|
Portable XR Chest Left lateral upright |
|
24641-3
|
Portable XR Chest Left oblique |
|
30739-7
|
Portable XR Chest Oblique |
|
24644-7
|
Portable XR Chest PA and Lateral upright |
|
30743-9
|
Portable XR Chest PA and Lateral and Right oblique and Left oblique |
|
24645-4
|
Portable XR Chest PA and Right lateral and Right oblique and Left oblique upright |
|
24649-6
|
Portable XR Chest Right lateral-decubitus and Left lateral-decubitus |
|
30733-0
|
Portable XR Chest Right oblique and Left oblique |
|
30746-2
|
Portable XR Chest Views |
|
24632-2
|
Portable XR Chest Views AP |
|
24634-8
|
Portable XR Chest Views W inspiration and expiration |
|
30724-9
|
Portable XR Cervical spine Single view |
|
30727-2
|
Portable XR Cervical spine AP |
|
30726-4
|
Portable XR Cervical spine AP and Lateral |
|
37079-1
|
Portable XR Cervical spine AP and Lateral and Odontoid |
|
44187-3
|
Portable XR Cervical spine AP and Oblique and Odontoid and (Lateral W flexion and W extension) |
|
36991-8
|
Portable XR Cervical spine Lateral crosstable |
|
37171-6
|
Portable XR Cervical spine Views |
|
30729-8
|
Portable XR Spine Cervical Odontoid and Cervical axis AP |
|
44184-0
|
Portable XR Elbow 2 Views |
|
41827-7
|
Portable XR Elbow - left Views |
|
41786-5
|
Portable XR Elbow - right Views |
|
41773-3
|
Portable XR Facial bones Views |
|
44185-7
|
Portable XR Femur AP and Lateral |
|
41818-6
|
Portable XR Femur - left Views |
|
41778-2
|
Portable XR Femur - right Views |
|
44186-5
|
Portable XR Foot AP and Lateral |
|
44182-4
|
Portable XR Hand 2 Views |
|
44193-1
|
Portable XR Hand GE 3 Views |
|
43570-1
|
Portable XR Hand Views |
|
41829-3
|
Portable XR Hand - left Views |
|
41788-1
|
Portable XR Hand - right Views |
|
44176-6
|
Portable XR Hip Single view |
|
37077-5
|
Portable XR Hip AP and Lateral crosstable |
|
37168-2
|
Portable XR Hip Views |
|
37075-9
|
Portable XR Hip Views AP |
|
41817-8
|
Portable XR Hip - left AP and Lateral |
|
37169-0
|
Portable XR Hip - left Views |
|
41777-4
|
Portable XR Hip - right AP and Lateral |
|
38796-9
|
Portable XR Hip - right Views |
|
37170-8
|
Portable XR Humerus Views |
|
41825-1
|
Portable XR Humerus - left Views |
|
41784-0
|
Portable XR Humerus - right Views |
|
44202-0
|
Portable XR Knee 1 or 2 Views |
|
41820-2
|
Portable XR Knee - left Views |
|
41779-0
|
Portable XR Knee - right Views |
|
30774-4
|
Portable XR Lumbar spine Single view |
|
36674-0
|
Portable XR Lumbar spine 2 Views |
|
30776-9
|
Portable XR Lumbar spine 3 Views |
|
37078-3
|
Portable XR Lumbar spine AP and Lateral |
|
36992-6
|
Portable XR Lumbar spine Lateral crosstable |
|
37172-4
|
Portable XR Lumbar spine Views |
|
41774-1
|
Portable XR Neck Lateral |
|
30792-6
|
Portable XR Patella Views |
|
41775-8
|
Portable XR Pelvis Single view |
|
44201-2
|
Portable XR Pelvis 1 or 2 Views |
|
41776-6
|
Portable XR Pelvis and Hip - right AP and Lateral frog |
|
44192-3
|
Portable XR Pelvis GE 3 Views |
|
30772-8
|
Portable XR Pelvis Views |
|
44183-2
|
Portable XR Radius and Ulna 2 Views |
|
30747-0
|
Portable XR Ribs Views |
|
41831-9
|
Portable XR Ribs - left Views |
|
41791-5
|
Portable XR Ribs - right Views |
|
44239-2
|
Portable XR Ribs - unilateral GE 3 Views and Chest PA |
|
30749-6
|
Portable XR Shoulder Single view |
|
46391-9
|
Portable XR Shoulder Views |
|
41824-4
|
Portable XR Shoulder - left Views |
|
41783-2
|
Portable XR Shoulder - right Views |
|
30722-3
|
Portable XR Skull Single view |
|
30723-1
|
Portable XR Skull Views |
|
70932-9
|
Portable XR Thoracic spine Single view |
|
30755-3
|
Portable XR Thoracic spine AP |
|
30754-6
|
Portable XR Thoracic spine AP and Lateral |
|
30757-9
|
Portable XR Thoracic spine Lateral |
|
30759-5
|
Portable XR Thoracic spine Oblique |
|
41828-5
|
Portable XR Wrist - left Views |
|
41787-3
|
Portable XR Wrist - right Views |
|
30731-4
|
Portable XR Zygomatic arch Views |
|
30730-6
|
Portable XR Zygomatic arch - bilateral Views |
|
36658-3
|
XR Radius and Ulna 2 Views |
|
36698-9
|
XR Radius and Ulna AP and Lateral |
|
24891-4
|
XR Radius and Ulna Views |
|
36659-1
|
XR Radius and Ulna - bilateral 2 Views |
|
36699-7
|
XR Radius and Ulna - bilateral AP and Lateral |
|
26146-1
|
XR Radius and Ulna - bilateral Views |
|
36742-5
|
XR Radius and Ulna - bilateral Oblique Views |
|
36660-9
|
XR Radius and Ulna - left 2 Views |
|
36700-3
|
XR Radius and Ulna - left AP and Lateral |
|
26148-7
|
XR Radius and Ulna - left Views |
|
36743-3
|
XR Radius and Ulna - left Oblique Views |
|
69317-6
|
XR Radius and Ulna - right Single view |
|
37707-7
|
XR Radius and Ulna - right 2 Views |
|
37708-5
|
XR Radius and Ulna - right AP and Lateral |
|
26150-3
|
XR Radius and Ulna - right Views |
|
37709-3
|
XR Radius and Ulna - right Oblique Views |
|
39376-9
|
XR Radius and Ulna - right Views and Oblique |
|
39060-9
|
XR Ribs 2 Views |
|
48468-3
|
XR Ribs - bilateral 2 Views and Chest PA |
|
39062-5
|
XR Ribs 3 Views |
|
37937-0
|
XR Ribs anterior Views |
|
39064-1
|
XR Ribs Anterior and Lateral |
|
38868-6
|
XR Ribs anterior and posterior - left Views |
|
37962-8
|
XR Ribs anterior and posterior - right Views |
|
38073-3
|
XR Ribs anterior - bilateral Views |
|
38074-1
|
XR Ribs anterior - left Views |
|
37963-6
|
XR Ribs anterior - right Views |
|
39050-0
|
XR Ribs AP |
|
44191-5
|
XR Ribs GE 3 Views and Chest PA |
|
39053-4
|
XR Ribs Lateral |
|
39489-0
|
XR Ribs lower posterior Views |
|
42381-4
|
XR Ribs lower posterior - left Views |
|
39493-2
|
XR Ribs lower posterior - right Views |
|
38866-0
|
XR Ribs lower - left Views |
|
37938-8
|
XR Ribs posterior Views |
|
39352-0
|
XR Ribs posterior - bilateral Views |
|
38869-4
|
XR Ribs posterior - left Views |
|
37964-4
|
XR Ribs posterior - right Views |
|
39351-2
|
XR Ribs upper anterior and posterior - left Views |
|
39491-6
|
XR Ribs upper anterior and posterior - right Views |
|
39353-8
|
XR Ribs upper posterior - left Views |
|
39492-4
|
XR Ribs upper posterior - right Views |
|
38867-8
|
XR Ribs upper - left Views |
|
37961-0
|
XR Ribs upper - right Views |
|
24899-7
|
XR Ribs Views |
|
42165-1
|
XR Ribs Views and Chest PA |
|
37960-2
|
XR Ribs lower - right Views |
|
69071-9
|
XR Ribs - bilateral and Chest Views |
|
42687-4
|
XR Ribs - bilateral 2 Views |
|
36313-5
|
XR Ribs - bilateral 3 Views |
|
36328-3
|
XR Ribs - bilateral 4 Views |
|
39099-7
|
XR Ribs - bilateral 4 Views and Chest PA |
|
69070-1
|
XR Ribs - bilateral Anterior and Lateral |
|
36958-7
|
XR Ribs - bilateral AP |
|
79365-3
|
XR Ribs - bilateral GE 3 Views |
|
48485-7
|
XR Ribs - bilateral GE 3 Views and Chest PA |
|
26151-1
|
XR Ribs - bilateral Views |
|
41811-1
|
XR Ribs - bilateral Views and Chest PA |
|
39326-4
|
XR Ribs - left and Chest Views |
|
42313-7
|
XR Ribs - left Single view |
|
37066-8
|
XR Ribs - left 2 Views |
|
36314-3
|
XR Ribs - left 3 Views |
|
38856-1
|
XR Ribs - left Anterior and Lateral |
|
36959-5
|
XR Ribs - left AP |
|
48486-5
|
XR Ribs - left GE 3 Views and Chest PA |
|
38857-9
|
XR Ribs - left Lateral |
|
26152-9
|
XR Ribs - left Views |
|
41832-7
|
XR Ribs - left Views and Chest PA |
|
42314-5
|
XR Ribs - right Single view |
|
37780-4
|
XR Ribs - right 2 Views |
|
37781-2
|
XR Ribs - right 3 Views |
|
37782-0
|
XR Ribs - right Anterior and Lateral |
|
37783-8
|
XR Ribs - right AP |
|
48484-0
|
XR Ribs - right GE 3 Views and Chest PA |
|
37784-6
|
XR Ribs - right Lateral |
|
26153-7
|
XR Ribs - right Views |
|
42010-9
|
XR Ribs - right Views and Chest PA |
|
79366-1
|
XR Ribs - unilateral and Chest 2 Views |
|
83040-6
|
XR Ribs - unilateral 2 Views |
|
83041-4
|
XR Ribs - unilateral 2 Views and Chest Single view |
|
83042-2
|
XR Ribs - unilateral 2 Views and Chest AP |
|
37651-7
|
XR Sacrum 2 Views |
|
37652-5
|
XR Sacrum AP and Lateral |
|
83044-8
|
XR Sacrum GE 2 Views |
|
30884-1
|
XR Sacrum Views |
|
69264-0
|
XR Sacrum Views W standing |
|
44179-0
|
XR Sacrum and Coccyx 2 Views |
|
39061-7
|
XR Sacrum and Coccyx 3 Views |
|
79367-9
|
XR Sacrum and Coccyx GE 2 Views |
|
24665-2
|
XR Sacrum and Coccyx Views |
|
39058-3
|
XR Salivary gland Views |
|
37881-0
|
XR Sternoclavicular Joint 3 Views |
|
37882-8
|
XR Sternoclavicular Joint 4 Views |
|
37880-2
|
XR Sternoclavicular Joint AP |
|
37846-3
|
XR Sternoclavicular Joint Serendipity |
|
48482-4
|
XR Sternoclavicular joint - bilateral GE 3 Views |
|
37298-7
|
XR Sternoclavicular joint - bilateral Serendipity |
|
37323-3
|
XR Sternoclavicular joint - bilateral Views |
|
37299-5
|
XR Sternoclavicular joint - left Serendipity |
|
37324-1
|
XR Sternoclavicular joint - left Views |
|
37808-3
|
XR Sternoclavicular joint - right Serendipity |
|
37965-1
|
XR Sternoclavicular joint - right Views |
|
37654-1
|
XR Scapula Single view |
|
37655-8
|
XR Scapula 2 Views |
|
39048-4
|
XR Scapula AP |
|
83045-5
|
XR Scapula AP and Lateral |
|
39366-0
|
XR Scapula Lateral and outlet |
|
24903-7
|
XR Scapula Views |
|
37656-6
|
XR Scapula Y |
|
36714-4
|
XR Scapula - bilateral AP and Lateral |
|
26154-5
|
XR Scapula - bilateral Views |
|
37055-1
|
XR Scapula - bilateral Y |
|
36666-6
|
XR Scapula - left 2 Views |
|
36715-1
|
XR Scapula - left AP and Lateral |
|
37124-5
|
XR Scapula - left AP and Y |
|
26155-2
|
XR Scapula - left Views |
|
37054-4
|
XR Scapula - left Y |
|
37787-9
|
XR Scapula - right 2 Views |
|
37788-7
|
XR Scapula - right AP and Lateral |
|
37789-5
|
XR Scapula - right AP and Y |
|
26156-0
|
XR Scapula - right Views |
|
37790-3
|
XR Scapula - right Y |
|
30748-8
|
XR Shoulder Single view |
|
37840-6
|
XR Shoulder 2 Views |
|
24908-6
|
XR Shoulder 3 Views |
|
69265-7
|
XR Shoulder 4 Views |
|
30750-4
|
XR Shoulder 5 Views |
|
37842-2
|
XR Shoulder AP |
|
39402-3
|
XR Shoulder AP internal rotation and AP external rotation |
|
39321-5
|
XR Shoulder AP internal rotation and AP external rotation and Axillary |
|
39401-5
|
XR Shoulder AP and Grashey and Axillary |
|
37841-4
|
XR Shoulder AP and Lateral |
|
37839-8
|
XR Shoulder AP and Lateral and Axillary |
|
39077-3
|
XR Shoulder AP and Transthoracic |
|
69266-5
|
XR Shoulder AP and Y |
|
37849-7
|
XR Shoulder Axillary |
|
39403-1
|
XR Shoulder Axillary and Transcapular |
|
37843-0
|
XR Shoulder Garth |
|
79370-3
|
XR Shoulder GE 2 Views |
|
37844-8
|
XR Shoulder Grashey |
|
69267-3
|
XR Shoulder Grashey and Axillary and Y |
|
37845-5
|
XR Shoulder Outlet |
|
39516-0
|
XR Shoulder Stryker Notch |
|
39517-8
|
XR Shoulder Stryker Notch and West Point |
|
24909-4
|
XR Shoulder Views |
|
30751-2
|
XR Shoulder West Point |
|
37847-1
|
XR Shoulder Y |
|
36568-4
|
XR Shoulder - bilateral Single view |
|
36667-4
|
XR Shoulder - bilateral 2 Views |
|
37468-6
|
XR Shoulder - bilateral 30 degree caudal angle |
|
26382-2
|
XR Shoulder - bilateral 3 Views |
|
36329-1
|
XR Shoulder - bilateral 4 Views |
|
36586-6
|
XR Shoulder - bilateral AP |
|
39329-8
|
XR Shoulder - bilateral AP internal rotation and AP external rotation |
|
39336-3
|
XR Shoulder - bilateral AP internal rotation and AP external rotation and Axillary |
|
39337-1
|
XR Shoulder - bilateral AP internal rotation and AP external rotation and Axillary and Outlet |
|
39344-7
|
XR Shoulder - bilateral AP internal rotation and AP external rotation and Axillary and Y |
|
39343-9
|
XR Shoulder - bilateral AP internal rotation and AP external rotation and Y |
|
39346-2
|
XR Shoulder - bilateral AP internal rotation and West Point |
|
37080-9
|
XR Shoulder - bilateral AP and Axillary |
|
37081-7
|
XR Shoulder - bilateral AP and Axillary and Outlet |
|
39339-7
|
XR Shoulder - bilateral AP and Axillary and Outlet and 30 degree caudal angle |
|
37126-0
|
XR Shoulder - bilateral AP and Axillary and Y |
|
36716-9
|
XR Shoulder - bilateral AP and Lateral |
|
46349-7
|
XR Shoulder - bilateral AP and Transthoracic |
|
36963-7
|
XR Shoulder - bilateral Axillary |
|
37127-8
|
XR Shoulder - bilateral Axillary and Y |
|
37035-3
|
XR Shoulder - bilateral Grashey |
|
37161-7
|
XR Shoulder - bilateral Grashey and Axillary and Outlet and Zanca |
|
39350-4
|
XR Shoulder - bilateral Grashey and Outlet and Serendipity |
|
37012-2
|
XR Shoulder - bilateral Outlet |
|
37152-6
|
XR Shoulder - bilateral Outlet and Y |
|
37024-7
|
XR Shoulder - bilateral Stryker Notch |
|
37047-8
|
XR Shoulder - bilateral Velpeau axillary |
|
26157-8
|
XR Shoulder - bilateral Views |
|
37050-2
|
XR Shoulder - bilateral West Point |
|
36569-2
|
XR Shoulder - left Single view |
|
36668-2
|
XR Shoulder - left 2 Views |
|
26383-0
|
XR Shoulder - left 3 Views |
|
69154-3
|
XR Shoulder - left 3 Views and Axillary |
|
69155-0
|
XR Shoulder - left 3 Views and Y |
|
36330-9
|
XR Shoulder - left 4 Views |
|
36677-3
|
XR Shoulder - left 5 Views |
|
36679-9
|
XR Shoulder - left 6 Views |
|
36587-4
|
XR Shoulder - left AP |
|
39328-0
|
XR Shoulder - left AP internal rotation and AP external rotation |
|
39335-5
|
XR Shoulder - left AP internal rotation and AP external rotation and Axillary |
|
39338-9
|
XR Shoulder - left AP internal rotation and AP external rotation and Axillary and Y |
|
39348-8
|
XR Shoulder - left AP internal rotation and AP external rotation and Y |
|
39325-6
|
XR Shoulder - left AP internal rotation and Grashey and Axillary and Outlet |
|
39347-0
|
XR Shoulder - left AP internal rotation and West Point |
|
37082-5
|
XR Shoulder - left AP and Axillary and Outlet |
|
37083-3
|
XR Shoulder - left AP and Axillary and Outlet and Zanca |
|
37084-1
|
XR Shoulder - left AP and Axillary and Y |
|
69153-5
|
XR Shoulder - left AP and Grashey and Axillary |
|
37122-9
|
XR Shoulder - left AP and Stryker Notch |
|
38082-4
|
XR Shoulder - left AP and Transthoracic |
|
37123-7
|
XR Shoulder - left AP and West Point |
|
36961-1
|
XR Shoulder - left AP and West Point and Outlet |
|
37125-2
|
XR Shoulder - left AP and Y |
|
36964-5
|
XR Shoulder - left Axillary |
|
37128-6
|
XR Shoulder - left Axillary and Y |
|
36974-4
|
XR Shoulder - left Garth |
|
79368-7
|
XR Shoulder - left GE 2 Views |
|
37473-6
|
XR Shoulder - left Grashey |
|
37160-9
|
XR Shoulder - left Grashey and Axillary |
|
37158-3
|
XR Shoulder - left Grashey and Axillary and Outlet |
|
37538-6
|
XR Shoulder - left Grashey and Axillary and Y |
|
37157-5
|
XR Shoulder - left Grashey and Outlet |
|
37162-5
|
XR Shoulder - left Grashey and Outlet and Serendipity |
|
37167-4
|
XR Shoulder - left Grashey and West Point |
|
69156-8
|
XR Shoulder - left Grashey and Y |
|
37136-9
|
XR Shoulder - left Lateral and Y |
|
37013-0
|
XR Shoulder - left Outlet |
|
37140-1
|
XR Shoulder - left Outlet and Y |
|
37025-4
|
XR Shoulder - left Stryker Notch |
|
37034-6
|
XR Shoulder - left Transthoracic |
|
37048-6
|
XR Shoulder - left Velpeau axillary |
|
26158-6
|
XR Shoulder - left Views |
|
42412-7
|
XR Shoulder - left 90 degree abduction Views |
|
38004-8
|
XR Shoulder - left Grashey Views WO and W weight |
|
37051-0
|
XR Shoulder - left West Point |
|
38858-7
|
XR Shoulder - left Y |
|
37792-9
|
XR Shoulder - right Single view |
|
37793-7
|
XR Shoulder - right 2 Views |
|
26384-8
|
XR Shoulder - right 3 Views |
|
39393-4
|
XR Shoulder - right 3 Views and Axillary |
|
39394-2
|
XR Shoulder - right 3 Views and Y |
|
37794-5
|
XR Shoulder - right 4 Views |
|
37795-2
|
XR Shoulder - right 5 Views |
|
37796-0
|
XR Shoulder - right 6 Views |
|
37798-6
|
XR Shoulder - right AP |
|
39395-9
|
XR Shoulder - right AP internal rotation and AP external rotation |
|
39397-5
|
XR Shoulder - right AP internal rotation and AP external rotation and West Point |
|
39396-7
|
XR Shoulder - right AP internal rotation and West Point |
|
38781-1
|
XR Shoulder - right AP and Axillary and Outlet |
|
38782-9
|
XR Shoulder - right AP and Axillary and Outlet and Zanca |
|
38783-7
|
XR Shoulder - right AP and Axillary and Y |
|
69262-4
|
XR Shoulder - right AP and Grashey and Axillary |
|
37797-8
|
XR Shoulder - right AP and Stryker Notch |
|
38822-3
|
XR Shoulder - right AP and Transthoracic |
|
38787-8
|
XR Shoulder - right AP and West Point |
|
37799-4
|
XR Shoulder - right AP and West Point and Outlet |
|
38788-6
|
XR Shoulder - right AP and Y |
|
37800-0
|
XR Shoulder - right Axillary |
|
37807-5
|
XR Shoulder - right Axillary and Y |
|
37801-8
|
XR Shoulder - right Garth |
|
79369-5
|
XR Shoulder - right GE 2 Views |
|
38805-8
|
XR Shoulder - right Grashey |
|
38793-6
|
XR Shoulder - right Grashey and Axillary |
|
37806-7
|
XR Shoulder - right Grashey and Axillary and Outlet |
|
38789-4
|
XR Shoulder - right Grashey and Axillary and Y |
|
38791-0
|
XR Shoulder - right Grashey and Outlet |
|
38794-4
|
XR Shoulder - right Grashey and Outlet and Serendipity |
|
38795-1
|
XR Shoulder - right Grashey and West Point |
|
43790-5
|
XR Shoulder - right Grashey and Y |
|
37803-4
|
XR Shoulder - right Lateral and Y |
|
37802-6
|
XR Shoulder - right Outlet |
|
37804-2
|
XR Shoulder - right Outlet and Y |
|
37791-1
|
XR Shoulder - right Stryker Notch |
|
38779-5
|
XR Shoulder - right Transthoracic |
|
39392-6
|
XR Shoulder - right Internal rotation and External rotation and Axillary |
|
38780-3
|
XR Shoulder - right Velpeau axillary |
|
26159-4
|
XR Shoulder - right Views |
|
38816-5
|
XR Shoulder - right Grashey Views WO and W weight |
|
37809-1
|
XR Shoulder - right West Point |
|
37805-9
|
XR Shoulder - right Y |
|
48467-5
|
XR Sacroiliac Joint 1 or 2 Views |
|
44181-6
|
XR Sacroiliac Joint 2 or 3 Views |
|
37648-3
|
XR Sacroiliac Joint 3 Views |
|
37649-1
|
XR Sacroiliac Joint AP and Oblique |
|
37650-9
|
XR Sacroiliac Joint Ferguson |
|
44189-9
|
XR Sacroiliac Joint GE 3 Views |
|
24900-3
|
XR Sacroiliac Joint Views |
|
37646-7
|
XR Sacroiliac Joint Limited Views |
|
83043-0
|
XR Sacroiliac joint - bilateral 1 or 2 Views |
|
48746-2
|
XR Sacroiliac joint - bilateral GE 3 Views |
|
36633-6
|
XR Sacroiliac joint - bilateral Views |
|
36634-4
|
XR Sacroiliac joint - left Views |
|
37786-1
|
XR Sacroiliac joint - right Views |
|
37851-3
|
XR Sinuses Single view |
|
43523-0
|
XR Sinuses 1 or 2 Views |
|
37853-9
|
XR Sinuses 2 Views |
|
37854-7
|
XR Sinuses 3 Views |
|
39404-9
|
XR Sinuses 3 Views and Submentovertex |
|
37855-4
|
XR Sinuses 4 Views |
|
37856-2
|
XR Sinuses 5 Views |
|
37857-0
|
XR Sinuses Caldwell |
|
37852-1
|
XR Sinuses Caldwell and Waters |
|
43486-0
|
XR Sinuses GE 3 Views |
|
37858-8
|
XR Sinuses Lateral |
|
37864-6
|
XR Sinuses Lateral and Caldwell and Waters |
|
37862-0
|
XR Sinuses Lateral and Waters |
|
30721-5
|
XR Sinuses PA and Lateral |
|
37860-4
|
XR Sinuses PA and Lateral and Caldwell and Waters |
|
37859-6
|
XR Sinuses PA and Lateral and Waters |
|
37861-2
|
XR Sinuses Submentovertex |
|
24916-9
|
XR Sinuses Views |
|
44209-5
|
XR Sinuses Limited Views |
|
37863-8
|
XR Sinuses Waters |
|
38117-8
|
XR Sinuses Waters upright |
|
24917-7
|
XR Skull Single view |
|
37867-9
|
XR Skull 2 Views |
|
24918-5
|
XR Skull 3 Views |
|
37868-7
|
XR Skull 4 Views |
|
24922-7
|
XR Skull 5 Views |
|
69269-9
|
XR Skull AP |
|
24919-3
|
XR Skull AP and Lateral |
|
46377-8
|
XR Skull GE 3 Views |
|
48487-3
|
XR Skull GE 4 Views |
|
43524-8
|
XR Skull GE 5 Views |
|
24920-1
|
XR Skull Lateral |
|
37872-9
|
XR Skull Lateral crosstable |
|
37871-1
|
XR Skull Lateral and Caldwell and Waters and Towne |
|
37869-5
|
XR Skull Lateral and Towne |
|
43470-4
|
XR Skull LE 3 Views |
|
83046-3
|
XR Skull LE 3 AP and Lateral Views |
|
69270-7
|
XR Skull PA |
|
69271-5
|
XR Skull PA and Lateral and Waters and Towne |
|
39519-4
|
XR Skull PA and Right lateral and Left lateral |
|
39521-0
|
XR Skull PA and Right lateral and Left lateral and Caldwell and Towne |
|
39520-2
|
XR Skull PA and Right lateral and Left lateral and Towne |
|
37026-2
|
XR Skull Submentovertex |
|
93605-4
|
XR Skull to Coccyx 2 or 3 Views |
|
93606-2
|
XR Skull to Coccyx 4 or 5 Views |
|
93607-0
|
XR Skull to Coccyx GE 6 Views |
|
37870-3
|
XR Skull Towne |
|
28564-3
|
XR Skull Views |
|
48466-7
|
XR Skull Limited Views |
|
24921-9
|
XR Skull Waters |
|
48695-1
|
XR Skull base Single view |
|
48697-7
|
XR Skull base Views |
|
37338-1
|
XR Skull and Facial bones and Mandible Views |
|
43787-1
|
XR Skull and Facial bones and Mandible Views for dental measurement |
|
37875-2
|
XR Spine Single view |
|
37879-4
|
XR Spine 2 Views |
|
37876-0
|
XR Spine 4 Views |
|
37877-8
|
XR Spine AP |
|
24928-4
|
XR Spine AP and Lateral |
|
44194-9
|
XR Spine GE 4 Views W right bending and W left bending |
|
39052-6
|
XR Spine Lateral |
|
42442-4
|
XR Spine Lateral W standing |
|
37878-6
|
XR Spine Lateral crosstable |
|
42689-0
|
XR Spine Oblique |
|
28613-8
|
XR Spine Views |
|
48748-8
|
XR Spine Oblique Views |
|
42690-8
|
XR Spine Views W flexion and W extension |
|
30713-2
|
XR Spine Views W right bending and W left bending |
|
42435-8
|
XR Sella turcica 2 Views |
|
42436-6
|
XR Sella turcica Lateral and Towne |
|
42159-4
|
XR Sella turcica Views |
|
37883-6
|
XR Sternum 2 Views |
|
83047-1
|
XR Sternum GE 2 Views |
|
39406-4
|
XR Sternum Lateral and right anterior oblique |
|
39405-6
|
XR Sternum Lateral and right oblique and left oblique |
|
37884-4
|
XR Sternum PA and Lateral and Oblique |
|
24994-6
|
XR Sternum Views |
|
72876-6
|
XR Surgical specimen Views |
|
42425-9
|
XR Thoracic and lumbar spine AP Views for scoliosis W standing and W right bending and W left bending and WO bending |
|
38121-0
|
XR Thoracic and lumbar spine Single view |
|
24984-7
|
XR Thoracic and lumbar spine 2 Views |
|
37658-2
|
XR Thoracic and lumbar spine 2 Views for scoliosis |
|
39049-2
|
XR Thoracic and lumbar spine AP |
|
30714-0
|
XR Thoracic and lumbar spine AP for scoliosis |
|
42428-3
|
XR Thoracic and lumbar spine AP for scoliosis W standing in brace |
|
42426-7
|
XR Thoracic and lumbar spine AP for scoliosis W sitting |
|
37659-0
|
XR Thoracic and lumbar spine AP for scoliosis W standing |
|
42429-1
|
XR Thoracic and lumbar spine AP for scoliosis W standing and W right bending |
|
38123-6
|
XR Thoracic and lumbar spine AP and Lateral |
|
30715-7
|
XR Thoracic and lumbar spine AP and lateral for scoliosis |
|
42424-2
|
XR Thoracic and lumbar spine AP and lateral for scoliosis W sitting |
|
39367-8
|
XR Thoracic and lumbar spine AP and lateral for scoliosis W standing |
|
44206-1
|
XR Thoracic and lumbar spine for scoliosis single view |
|
30716-5
|
XR Thoracic and lumbar spine Lateral Views for scoliosis |
|
42427-5
|
XR Thoracic and lumbar spine Lateral for scoliosis W sitting |
|
37660-8
|
XR Thoracic and lumbar spine Lateral for scoliosis W standing |
|
42692-4
|
XR Thoracic and lumbar spine Views |
|
43569-3
|
XR Thoracic and lumbar spine AP Views for scoliosis upright and supine |
|
24930-0
|
XR Thoracic and lumbar spine Views for scoliosis |
|
24929-2
|
XR Thoracic and lumbar spine Views for scoliosis W flexion and W extension |
|
30717-3
|
XR Thoracic and lumbar spine Views for scoliosis W standing |
|
38124-4
|
XR Thoracic and lumbar spine Views W standing |
|
42472-1
|
XR Thoracic and lumbar spine AP Views for scoliosis in traction |
|
46386-9
|
XR Teeth Bitewing Views |
|
37888-5
|
XR Thumb 3 Views |
|
37890-1
|
XR Thumb AP |
|
37889-3
|
XR Thumb AP and Lateral |
|
37891-9
|
XR Thumb Lateral |
|
37892-7
|
XR Thumb Oblique |
|
25006-8
|
XR Thumb Views |
|
26160-2
|
XR Thumb - bilateral Views |
|
37563-4
|
XR Thumb - bilateral Views W manual stress |
|
36315-0
|
XR Thumb - left 3 Views |
|
36736-7
|
XR Thumb - left AP and Lateral and oblique |
|
43488-6
|
XR Thumb - left GE 3 Views |
|
26161-0
|
XR Thumb - left Views |
|
37564-2
|
XR Thumb - left Views W manual stress |
|
37812-5
|
XR Thumb - right 3 Views |
|
37813-3
|
XR Thumb - right AP and Lateral and oblique |
|
43493-6
|
XR Thumb - right GE 3 Views |
|
26162-8
|
XR Thumb - right Views |
|
37814-1
|
XR Thumb - right Views W manual stress |
|
37894-3
|
XR Tibia and Fibula Single view |
|
37895-0
|
XR Tibia and Fibula 2 Views |
|
37897-6
|
XR Tibia and Fibula AP |
|
37896-8
|
XR Tibia and Fibula AP and Lateral |
|
83048-9
|
XR Tibia and Fibula GE 3 Views |
|
37893-5
|
XR Tibia and Fibula Lateral |
|
25011-8
|
XR Tibia and Fibula Views |
|
36894-4
|
XR Tibia and Fibula Oblique Views |
|
37899-2
|
XR Tibia and Fibula Views W standing |
|
36671-6
|
XR Tibia and Fibula - bilateral 2 Views |
|
36717-7
|
XR Tibia and Fibula - bilateral AP and Lateral |
|
26163-6
|
XR Tibia and Fibula - bilateral Views |
|
69313-5
|
XR Tibia and Fibula - left Single view |
|
36672-4
|
XR Tibia and Fibula - left 2 Views |
|
38874-4
|
XR Tibia and Fibula - left 2 Oblique Views |
|
36718-5
|
XR Tibia and Fibula - left AP and Lateral |
|
26164-4
|
XR Tibia and Fibula - left Views |
|
36749-0
|
XR Tibia and Fibula - left Oblique Views |
|
69321-8
|
XR Tibia and Fibula - right Single view |
|
37815-8
|
XR Tibia and Fibula - right 2 Views |
|
38114-5
|
XR Tibia and Fibula - right 2 Oblique Views |
|
37816-6
|
XR Tibia and Fibula - right AP and Lateral |
|
26165-1
|
XR Tibia and Fibula - right Views |
|
37817-4
|
XR Tibia and Fibula - right Oblique Views |
|
39398-3
|
XR Tibia and Fibula - right Views and Oblique |
|
37513-9
|
XR Tibia - bilateral 10 degree caudal angle |
|
37514-7
|
XR Tibia - left 10 degree caudal angle |
|
38806-6
|
XR Tibia - right 10 degree caudal angle |
|
69273-1
|
XR Spine thoracolumbar junction 2 Views |
|
37974-3
|
XR Spine thoracolumbar junction AP and Lateral |
|
37975-0
|
XR Spine thoracolumbar junction Views |
|
25000-1
|
XR Temporomandibular joint Views |
|
37350-6
|
XR Temporomandibular joint - bilateral 5 Views |
|
37546-9
|
XR Temporomandibular joint - bilateral Open and Closed mouth |
|
37325-8
|
XR Temporomandibular joint - bilateral Views |
|
48491-5
|
XR Temporomandibular joint - left Open and Closed mouth |
|
30889-0
|
XR Temporomandibular joint - left Views |
|
48490-7
|
XR Temporomandibular joint - right Open and Closed mouth |
|
30890-8
|
XR Temporomandibular joint - right Views |
|
48699-3
|
XR Temporomandibular joint - unilateral Open and Closed mouth |
|
37534-5
|
XR Toe second - left Views |
|
38148-3
|
XR Toe second - right Views |
|
37535-2
|
XR Toe third - left Views |
|
38149-1
|
XR Toe third - right Views |
|
37531-1
|
XR Toe fourth - left Views |
|
38150-9
|
XR Toe fourth - right Views |
|
37530-3
|
XR Toe fifth - left Views |
|
38151-7
|
XR Toe fifth - right Views |
|
79373-7
|
XR Toe GE 2 Views |
|
37902-4
|
XR Toes 2 Views |
|
39075-7
|
XR Toes AP and Oblique |
|
25013-4
|
XR Toes Views |
|
37348-0
|
XR Toes - bilateral 2 Views |
|
26166-9
|
XR Toes - bilateral Views |
|
36673-2
|
XR Toes - left 2 Views |
|
36316-8
|
XR Toes - left 3 Views |
|
36719-3
|
XR Toes - left AP and Lateral |
|
26167-7
|
XR Toes - left Views |
|
37209-4
|
XR Toes - left Views W standing |
|
37821-6
|
XR Toes - right 2 Views |
|
37820-8
|
XR Toes - right 3 Views |
|
37822-4
|
XR Toes - right AP and Lateral |
|
26168-5
|
XR Toes - right Views |
|
37823-2
|
XR Toes - right Views W standing |
|
30762-9
|
XR tomography Abdomen |
|
35939-8
|
XR tomography Ankle |
|
35943-0
|
XR tomography Ankle - left |
|
37674-9
|
XR tomography Ankle - right |
|
24657-9
|
XR tomography Chest |
|
35959-6
|
XR tomography Clavicle |
|
36068-5
|
XR tomography Cervical spine |
|
35963-8
|
XR tomography Elbow |
|
35964-6
|
XR tomography Elbow - bilateral |
|
35967-9
|
XR tomography Elbow - left |
|
37688-9
|
XR tomography Elbow - right |
|
35970-3
|
XR tomography Extremity |
|
35985-1
|
XR tomography Femur |
|
35986-9
|
XR tomography Femur - bilateral |
|
35988-5
|
XR tomography Femur - left |
|
38768-8
|
XR tomography Femur - right |
|
35992-7
|
XR tomography Foot |
|
35995-0
|
XR tomography Foot - left |
|
37706-9
|
XR tomography Foot - right |
|
36001-6
|
XR tomography Gallbladder |
|
36003-2
|
XR tomography Hand |
|
36006-5
|
XR tomography Hand - left |
|
37717-6
|
XR tomography Hand - right |
|
36011-5
|
XR tomography Calcaneus |
|
36012-3
|
XR tomography Hip |
|
36015-6
|
XR tomography Hip - bilateral |
|
36019-8
|
XR tomography Hip - left |
|
37735-8
|
XR tomography Hip - right |
|
36024-8
|
XR tomography Humerus |
|
24767-6
|
XR tomography Internal auditory canal |
|
26253-5
|
XR tomography Internal auditory canal - bilateral |
|
26254-3
|
XR tomography Internal auditory canal - left |
|
26255-0
|
XR tomography Internal auditory canal - right |
|
24789-0
|
XR tomography Kidney - bilateral |
|
30760-3
|
XR tomography Kidney - bilateral 3 views W contrast IV |
|
24790-8
|
XR tomography Kidney - bilateral W contrast IV |
|
39359-5
|
XR tomography Kidney - bilateral WO contrast |
|
24787-4
|
XR tomography Kidney - bilateral WO contrast and 10M post contrast IV |
|
24784-1
|
XR tomography Kidney - bilateral WO and W contrast IV |
|
36032-1
|
XR tomography Kidney |
|
36038-8
|
XR tomography Knee |
|
36039-6
|
XR tomography Knee - bilateral |
|
36042-0
|
XR tomography Knee - left |
|
37760-6
|
XR tomography Knee - right |
|
36044-6
|
XR tomography Larynx |
|
35972-9
|
XR tomography Lower extremity |
|
35977-8
|
XR tomography Lower extremity - left |
|
37766-3
|
XR tomography Lower extremity - right |
|
36069-3
|
XR tomography Lumbar spine |
|
36048-7
|
XR tomography Mandible |
|
24828-6
|
XR tomography Mandible Panoramic |
|
36776-3
|
XR tomography Mastoid |
|
37233-4
|
XR tomography Mediastinum |
|
37606-1
|
XR tomography Nasal bones |
|
37611-1
|
XR tomography Orbit - bilateral |
|
37632-7
|
XR tomography Pelvis |
|
37653-3
|
XR tomography Sacrum |
|
37850-5
|
XR tomography Shoulder |
|
36065-1
|
XR tomography Shoulder - left |
|
37811-7
|
XR tomography Shoulder - right |
|
37866-1
|
XR tomography Sinuses |
|
37874-5
|
XR tomography Skull |
|
42437-4
|
XR tomography Sella turcica |
|
37885-1
|
XR tomography Sternum |
|
37898-4
|
XR tomography Tibia and Fibula |
|
30719-9
|
XR tomography Temporomandibular joint |
|
37227-6
|
XR tomography Temporomandibular joint - bilateral |
|
37229-2
|
XR tomography Temporomandibular joint - left |
|
37819-0
|
XR tomography Temporomandibular joint - right |
|
37911-5
|
XR tomography Thoracic spine |
|
39408-0
|
XR tomography Thoracic spine AP |
|
39409-8
|
XR tomography Thoracic spine lateral |
|
37923-0
|
XR tomography Upper extremity |
|
25071-2
|
XR tomography Unspecified body region |
|
37932-1
|
XR tomography Wrist |
|
37429-8
|
XR tomography Wrist - bilateral |
|
37432-2
|
XR tomography Wrist - left |
|
37644-2
|
XR tomography Wrist - right |
|
44238-4
|
XR Trachea Views |
|
37904-0
|
XR Thoracic spine Single view |
|
37905-7
|
XR Thoracic spine 2 Views |
|
69274-9
|
XR Thoracic spine 2 Views W standing |
|
37906-5
|
XR Thoracic spine 3 Views |
|
42443-2
|
XR Thoracic spine 3 Views W standing |
|
48472-5
|
XR Thoracic spine 3 Views and Swimmers |
|
37907-3
|
XR Thoracic spine 4 Views |
|
39413-0
|
XR Thoracic spine 4 Views and Oblique |
|
39407-2
|
XR Thoracic spine 5 Views and Oblique |
|
30752-0
|
XR Thoracic spine AP |
|
39410-6
|
XR Thoracic spine AP W left bending |
|
39411-4
|
XR Thoracic spine AP W right bending |
|
30753-8
|
XR Thoracic spine AP and Lateral |
|
37908-1
|
XR Thoracic spine AP and Lateral and oblique |
|
38009-7
|
XR Thoracic spine AP and Lateral and Swimmers |
|
30756-1
|
XR Thoracic spine Lateral |
|
37909-9
|
XR Thoracic spine Lateral W hyperextension |
|
37910-7
|
XR Thoracic spine Lateral W standing |
|
37903-2
|
XR Thoracic spine Lateral crosstable |
|
30758-7
|
XR Thoracic spine Oblique |
|
24983-9
|
XR Thoracic spine Views |
|
42445-7
|
XR Thoracic spine Views AP W left bending and WO bending |
|
42444-0
|
XR Thoracic spine Views AP W right bending and W left bending and WO bending |
|
42446-5
|
XR Thoracic spine Views AP W right bending and WO bending |
|
38010-5
|
XR Thoracic spine Lateral Views W flexion and W extension |
|
48749-6
|
XR Thoracic spine Oblique Views |
|
69275-6
|
XR Thoracic spine Views W standing |
|
39414-8
|
XR Thoracic spine Views and Oblique |
|
39412-2
|
XR Thoracic spine Views and Swimmers |
|
37922-2
|
XR Upper extremity 2 Views |
|
83049-7
|
XR Upper extremity GE 2 Views |
|
24689-2
|
XR Upper extremity Views |
|
26115-6
|
XR Upper extremity - bilateral Views |
|
26116-4
|
XR Upper extremity - left Views |
|
26117-2
|
XR Upper extremity - right Views |
|
43468-8
|
XR Unspecified body region Views |
|
43469-6
|
XR Unspecified body region Views for foreign body |
|
42402-8
|
XR Unspecified body region Post morten Views |
|
39056-7
|
XR Unspecified body region Views W manual stress |
|
42160-2
|
XR Unspecified body region Views for shunt patency |
|
37924-8
|
XR Wrist Single view |
|
83050-5
|
XR Wrist 1 or 2 Views |
|
69302-8
|
XR Wrist Single view W clenched fist |
|
37925-5
|
XR Wrist 2 Views |
|
37926-3
|
XR Wrist 3 Views |
|
38155-8
|
XR Wrist 4 Views |
|
38156-6
|
XR Wrist 6 Views |
|
30793-4
|
XR Wrist AP and Lateral |
|
37927-1
|
XR Wrist AP and Lateral and oblique |
|
37928-9
|
XR Wrist Brewerton |
|
44190-7
|
XR Wrist GE 3 Views |
|
37930-5
|
XR Wrist Lateral |
|
37931-3
|
XR Wrist PA |
|
42812-8
|
XR Wrist scaphoid single view |
|
69303-6
|
XR Wrist Ulnar deviation and Radial deviation |
|
24619-9
|
XR Wrist Views |
|
37929-7
|
XR Wrist Lateral Views W flexion and W extension |
|
38107-9
|
XR Wrist Scaphoid Views |
|
69304-4
|
XR Wrist Ulnar deviation Views |
|
48737-1
|
XR Wrist and Hand 3 Views |
|
24724-7
|
XR Wrist and Hand Bone age Views |
|
48738-9
|
XR Wrist - bilateral and Hand - bilateral 3 Views |
|
26352-5
|
XR Wrist - bilateral and Hand - bilateral Bone age Views |
|
51392-9
|
XR Wrist - left and Hand - left Views |
|
26353-3
|
XR Wrist - left and Hand - left Bone age Views |
|
51388-7
|
XR Wrist - right and Hand - right Views |
|
26354-1
|
XR Wrist - right and Hand - right Bone age Views |
|
42419-2
|
XR Wrist - bilateral Single view |
|
36968-6
|
XR Wrist - bilateral Single view W clenched fist |
|
37482-7
|
XR Wrist - bilateral 2 Views |
|
37454-6
|
XR Wrist - bilateral 3 Views |
|
37070-0
|
XR Wrist - bilateral 4 Views |
|
48483-2
|
XR Wrist - bilateral GE 3 Views |
|
36624-5
|
XR Wrist - bilateral PA |
|
37547-7
|
XR Wrist - bilateral PA and Lateral |
|
37549-3
|
XR Wrist - bilateral PA and Lateral and Oblique |
|
42813-6
|
XR Wrist - bilateral scaphoid single view |
|
37045-2
|
XR Wrist - bilateral Ulnar deviation |
|
69072-7
|
XR Wrist - bilateral Ulnar deviation and Radial deviation |
|
26169-3
|
XR Wrist - bilateral Views |
|
36739-1
|
XR Wrist - bilateral Limited Views |
|
37544-4
|
XR Wrist - bilateral Oblique Views |
|
37304-3
|
XR Wrist - bilateral Scaphoid Views |
|
43796-2
|
XR Wrist - bilateral Carpal tunnel Views |
|
36570-0
|
XR Wrist - left Single view |
|
37483-5
|
XR Wrist - left 2 Views |
|
38843-9
|
XR Wrist - left 2 Carpal tunnel Views |
|
37455-3
|
XR Wrist - left 3 Views |
|
69151-9
|
XR Wrist - left 3 Scaphoid Views |
|
37071-8
|
XR Wrist - left 4 Views |
|
37072-6
|
XR Wrist - left 5 Views |
|
37074-2
|
XR Wrist - left 6 Views |
|
36683-1
|
XR Wrist - left 8 Views |
|
38860-3
|
XR Wrist - left AP and Lateral |
|
38842-1
|
XR Wrist - left Carpal tunnel |
|
46346-3
|
XR Wrist - left GE 3 Views |
|
36971-0
|
XR Wrist - left Lateral W extension |
|
36972-8
|
XR Wrist - left Lateral W flexion |
|
39324-9
|
XR Wrist - left PA W clenched fist |
|
37548-5
|
XR Wrist - left PA and Lateral |
|
37550-1
|
XR Wrist - left PA and Lateral and Oblique |
|
42814-4
|
XR Wrist - left scaphoid single view |
|
37044-5
|
XR Wrist - left Ulnar deviation |
|
37555-0
|
XR Wrist - left Ulnar deviation and Radial deviation |
|
26170-1
|
XR Wrist - left Views |
|
69157-6
|
XR Wrist - left Lateral Views W flexion and W extension |
|
38838-9
|
XR Wrist - left Limited Views |
|
38839-7
|
XR Wrist - left Oblique Views |
|
37302-7
|
XR Wrist - left Scaphoid Views |
|
37825-7
|
XR Wrist - right Single view |
|
37826-5
|
XR Wrist - right 2 Views |
|
37678-0
|
XR Wrist - right 2 Carpal tunnel Views |
|
37827-3
|
XR Wrist - right 3 Views |
|
39399-1
|
XR Wrist - right 3 Views and Carpal tunnel |
|
39364-5
|
XR Wrist - right 3 Views and Radial deviation |
|
39365-2
|
XR Wrist - right 3 Views and Ulnar deviation |
|
37828-1
|
XR Wrist - right 4 Views |
|
37829-9
|
XR Wrist - right 5 Views |
|
37830-7
|
XR Wrist - right 6 Views |
|
37831-5
|
XR Wrist - right 8 Views |
|
37832-3
|
XR Wrist - right AP and Lateral |
|
37677-2
|
XR Wrist - right Carpal tunnel |
|
46343-0
|
XR Wrist - right GE 3 Views |
|
37833-1
|
XR Wrist - right Lateral W extension |
|
37834-9
|
XR Wrist - right Lateral W flexion |
|
69263-2
|
XR Wrist - right PA W clenched fist |
|
37835-6
|
XR Wrist - right PA and Lateral |
|
37836-4
|
XR Wrist - right PA and Lateral and Oblique |
|
42811-0
|
XR Wrist - right scaphoid single view |
|
37645-9
|
XR Wrist - right Ulnar deviation |
|
38808-2
|
XR Wrist - right Ulnar deviation and Radial deviation |
|
26171-9
|
XR Wrist - right Views |
|
39515-2
|
XR Wrist - right Lateral Views W flexion and W extension |
|
37642-6
|
XR Wrist - right Limited Views |
|
37643-4
|
XR Wrist - right Oblique Views |
|
38115-2
|
XR Wrist - right Scaphoid Views |
|
39400-7
|
XR Wrist - right Views and Carpal tunnel |
|
69305-1
|
XR Zygomatic arch 2 Views |
|
37933-9
|
XR Zygomatic arch 3 Views |
|
37934-7
|
XR Zygomatic arch 4 Views |
|
25074-6
|
XR Zygomatic arch Views |
|
26172-7
|
XR Zygomatic arch - bilateral Views |
|
26173-5
|
XR Zygomatic arch - left Views |
|
26174-3
|
XR Zygomatic arch - right Views |
|
42397-0
|
XR.stereoscopic Chest Frontal Views |
|
42471-3
|
XR.stereoscopic Pelvis Single view |
|
42473-9
|
XR.stereoscopic Sinuses Waters |
|
42474-7
|
XR.stereoscopic Skull Single view |
|
77727-6
|
XXX allergen triggered histamine release [Units/volume] in Blood |
|
61406-5
|
XXX blood group Ab [Titer] in Serum or Plasma |
|
48132-5
|
Xylitol/Creatinine [Molar ratio] in Urine |
|
12274-7
|
Xylose [Mass/time] in 5 hour Urine |
|
3134-4
|
Xylose [Mass/volume] in Blood |
|
29999-0
|
Xylose [Mass/volume] in Serum or Plasma |
|
32347-7
|
Xylose [Moles/volume] in Serum or Plasma |
|
47806-5
|
Xylose [Presence] in Urine |
|
3135-1
|
Xylose [Mass/volume] in Urine |
|
25556-2
|
Xylose [Moles/volume] in Urine |
|
75051-3
|
Xylose/Creatinine [Molar ratio] in Urine |
|
3136-9
|
Xylulose [Mass/volume] in Serum |
|
71359-4
|
Y chromosome AZFa region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
71360-2
|
Y chromosome AZFb region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
71361-0
|
Y chromosome AZFc region deletion [Identifier] in Blood or Tissue by Molecular genetics method Narrative |
|
35456-3
|
Y chromosome deletion [Identifier] in Blood or Tissue Nominal |
|
40948-2
|
Yersinia enterocolitica O:3 Ab [Presence] in Cerebral spinal fluid |
|
40932-6
|
Yersinia enterocolitica O:3 Ab [Presence] in Serum |
|
5407-2
|
Yersinia enterocolitica O:3 Ab [Units/volume] in Serum |
|
6959-1
|
Yersinia enterocolitica O:3 Ab [Titer] in Serum |
|
40577-9
|
Yersinia enterocolitica O:3 Ab [Titer] in Serum by Agglutination |
|
40953-2
|
Yersinia enterocolitica O:3 Ab [Titer] in Serum by Complement fixation |
|
30100-2
|
Yersinia enterocolitica O:3 Ab [Titer] in Unspecified specimen |
|
77956-1
|
Yersinia enterocolitica O:3 IgG Ab [Presence] in Serum by Agglutination |
|
40949-0
|
Yersinia enterocolitica O:5 Ab [Presence] in Cerebral spinal fluid |
|
40933-4
|
Yersinia enterocolitica O:5 Ab [Presence] in Serum |
|
6960-9
|
Yersinia enterocolitica O:5 Ab [Titer] in Serum |
|
48312-3
|
Yersinia enterocolitica O:5 Ab [Titer] in Serum by Agglutination |
|
30101-0
|
Yersinia enterocolitica O:5 Ab [Titer] in Unspecified specimen |
|
31707-3
|
Yersinia enterocolitica O:5 Ab [Units/volume] in Unspecified specimen |
|
42943-1
|
Yersinia enterocolitica O:5,27 Ab [Titer] in Serum |
|
40575-3
|
Yersinia enterocolitica O:5,27 Ab [Titer] in Serum by Agglutination |
|
40950-8
|
Yersinia enterocolitica O:8 Ab [Presence] in Cerebral spinal fluid |
|
40934-2
|
Yersinia enterocolitica O:8 Ab [Presence] in Serum |
|
5408-0
|
Yersinia enterocolitica O:8 Ab [Units/volume] in Serum |
|
6961-7
|
Yersinia enterocolitica O:8 Ab [Titer] in Serum |
|
40576-1
|
Yersinia enterocolitica O:8 Ab [Titer] in Serum by Agglutination |
|
40954-0
|
Yersinia enterocolitica O:8 Ab [Titer] in Serum by Complement fixation |
|
30102-8
|
Yersinia enterocolitica O:8 Ab [Titer] in Unspecified specimen |
|
40951-6
|
Yersinia enterocolitica O:9 Ab [Presence] in Cerebral spinal fluid |
|
40935-9
|
Yersinia enterocolitica O:9 Ab [Presence] in Serum |
|
5409-8
|
Yersinia enterocolitica O:9 Ab [Units/volume] in Serum |
|
6962-5
|
Yersinia enterocolitica O:9 Ab [Titer] in Serum |
|
48313-1
|
Yersinia enterocolitica O:9 Ab [Titer] in Serum by Agglutination |
|
40955-7
|
Yersinia enterocolitica O:9 Ab [Titer] in Serum by Complement fixation |
|
30103-6
|
Yersinia enterocolitica O:9 Ab [Titer] in Unspecified specimen |
|
77957-9
|
Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination |
|
43930-7
|
Yersinia enterocolitica Ab [Presence] in Cerebral spinal fluid |
|
40941-7
|
Yersinia enterocolitica Ab [Presence] in Serum |
|
31708-1
|
Yersinia enterocolitica Ab [Units/volume] in Serum |
|
6963-3
|
Yersinia enterocolitica Ab [Titer] in Serum |
|
40498-8
|
Yersinia enterocolitica Ab [Titer] in Serum by Agglutination |
|
58797-2
|
Yersinia enterocolitica Ab [Titer] in Serum by Complement fixation |
|
82202-3
|
Yersinia enterocolitica DNA [Presence] in Stool by NAA with non-probe detection |
|
6964-1
|
Yersinia enterocolitica IgA Ab [Units/volume] in Serum by Immunoassay |
|
40945-8
|
Yersinia enterocolitica IgA Ab [Presence] in Serum |
|
22619-1
|
Yersinia enterocolitica IgA Ab [Units/volume] in Serum |
|
6965-8
|
Yersinia enterocolitica IgG Ab [Units/volume] in Serum by Immunoassay |
|
40946-6
|
Yersinia enterocolitica IgG Ab [Presence] in Serum |
|
22620-9
|
Yersinia enterocolitica IgG Ab [Units/volume] in Serum |
|
6966-6
|
Yersinia enterocolitica IgM Ab [Units/volume] in Serum by Immunoassay |
|
22621-7
|
Yersinia enterocolitica IgM Ab [Units/volume] in Serum |
|
73673-6
|
Yersinia enterocolitica serotype [Type] in Isolate by Agglutination |
|
82298-1
|
Yersinia enterocolitica [Presence] in Unspecified specimen by Culture |
|
33706-3
|
Yersinia pestis Ab [Presence] in Serum |
|
33689-1
|
Yersinia pestis Ab [Presence] in Serum by Hemagglutination inhibition |
|
33707-1
|
Yersinia pestis Ab [Titer] in Serum |
|
33690-9
|
Yersinia pestis Ab [Titer] in Serum by Immunoassay |
|
47518-6
|
Yersinia pestis Ab [Presence] in Unspecified specimen |
|
45045-2
|
Yersinia pestis Ab [Presence] in Unspecified specimen by Hemagglutination |
|
33688-3
|
Yersinia pestis Ag [Presence] in Isolate by Immunofluorescence |
|
33687-5
|
Yersinia pestis Ag [Presence] in Unspecified specimen by Immunofluorescence |
|
33692-5
|
Yersinia pestis DNA [Presence] in Isolate by NAA with probe detection |
|
33691-7
|
Yersinia pestis DNA [Presence] in Unspecified specimen by NAA with probe detection |
|
33686-7
|
Yersinia pestis [Presence] in Isolate by Organism specific culture |
|
33693-3
|
Yersinia pestis [Presence] in Isolate by Phage lysis |
|
33685-9
|
Yersinia pestis [Presence] in Unspecified specimen by Organism specific culture |
|
40497-0
|
Yersinia pseudotuberculosis 1 Ab [Titer] in Serum |
|
40496-2
|
Yersinia pseudotuberculosis 2 Ab [Titer] in Serum |
|
40495-4
|
Yersinia pseudotuberculosis 3 Ab [Titer] in Serum |
|
43586-7
|
Yersinia pseudotuberculosis Ab [Presence] in Cerebral spinal fluid |
|
40936-7
|
Yersinia pseudotuberculosis Ab [Presence] in Serum |
|
5410-6
|
Yersinia pseudotuberculosis Ab [Units/volume] in Serum |
|
6967-4
|
Yersinia pseudotuberculosis Ab [Titer] in Serum |
|
40494-7
|
Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination |
|
7782-6
|
Yam IgE Ab in Serum |
|
14369-3
|
Yeast [Presence] in Cervix by Wet preparation |
|
53571-6
|
Yeast identified in Genital specimen by Organism specific culture |
|
18483-8
|
Yeast [Presence] in Genital specimen by Organism specific culture |
|
12275-4
|
Yeast [Presence] in Genital specimen by Wet preparation |
|
90078-7
|
Yeast identified in Isolate by Organism specific culture |
|
91779-9
|
Yeast identified in Upper respiratory specimen by Organism specific culture |
|
87831-4
|
Yeast [Presence] in Urine |
|
14371-9
|
Yeast [Presence] in Urethra by Wet preparation |
|
14370-1
|
Yeast [Presence] in Vaginal fluid by Wet preparation |
|
44246-7
|
Yeast [#/area] in Vaginal fluid by Wet preparation |
|
18482-0
|
Yeast [Presence] in Unspecified specimen by Organism specific culture |
|
74759-2
|
Yeast [Presence] in Unspecified specimen by Gram stain |
|
32765-0
|
Yeast [Presence] in Unspecified specimen by Wet preparation |
|
7142-3
|
Yellow Bean IgG Ab [Units/volume] in Serum |
|
7283-5
|
Yellow Dock triggered histamine release [Units/volume] in Blood |
|
6738-9
|
Yellow Dock IgE Ab [Units/volume] in Serum |
|
13186-2
|
Yellow Dock IgG Ab [Units/volume] in Serum |
|
63192-9
|
Yellow Dock IgG Ab [Mass/volume] in Serum |
|
17774-1
|
Yellow dye IgE Ab [Units/volume] in Serum |
|
6288-5
|
Yellow Hornet IgE Ab [Units/volume] in Serum |
|
39544-2
|
Yellow Hornet IgE Ab/IgE total in Serum |
|
6739-7
|
Yellow Hornet IgG Ab [Units/volume] in Serum |
|
41192-6
|
Yellow Hornet IgG4 Ab [Presence] in Serum |
|
56433-6
|
Yellow Hornet IgG4 Ab [Mass/volume] in Serum |
|
49740-4
|
Yellow Hornet IgG Ab [Mass/volume] in Serum |
|
6740-5
|
Yellow Jacket IgE Ab [Units/volume] in Serum |
|
41203-1
|
Yellow Jacket IgE Ab/IgE total in Serum |
|
40943-3
|
Yellow Jacket IgE Ab [Mass/volume] in Serum |
|
7768-5
|
Yellow Jacket IgG Ab [Units/volume] in Serum |
|
40952-4
|
Yellow Jacket IgG4 Ab [Presence] in Serum |
|
57000-2
|
Yellow Jacket IgG4 Ab [Units/volume] in Serum |
|
56434-4
|
Yellow Jacket IgG4 Ab [Mass/volume] in Serum |
|
41229-6
|
Yellow Jacket IgG Ab [Mass/volume] in Serum |
|
48184-6
|
Yellow Jacket triggered leukotriene release [Mass/volume] by Leukocytes |
|
7716-4
|
Yellow Squash IgE Ab [Units/volume] in Serum |
|
7717-2
|
Yellow Squash IgG Ab [Units/volume] in Serum |
|
43098-3
|
Yersinia sp Ab panel - Serum |
|
40931-8
|
Yersinia sp Ab [Presence] in Serum |
|
40956-5
|
Yersinia sp Ab [Presence] in Serum by Complement fixation |
|
5411-4
|
Yersinia sp Ab [Units/volume] in Serum |
|
40940-9
|
Yersinia sp Ab [Titer] in Serum |
|
20987-4
|
Yersinia sp identified in Dairy product by Organism specific culture |
|
48646-4
|
Yersinia sp DNA [Identifier] in Unspecified specimen by NAA with probe detection |
|
57001-0
|
Yersinia sp IgA Ab [Units/volume] in Serum by Immunoassay |
|
41400-3
|
Yersinia sp IgA Ab [Presence] in Serum by Immunoblot |
|
17775-8
|
Yersinia sp IgA Ab [Units/volume] in Serum |
|
40938-3
|
Yersinia sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
41401-1
|
Yersinia sp IgG Ab [Presence] in Serum by Immunoblot |
|
17776-6
|
Yersinia sp IgG Ab [Units/volume] in Serum |
|
40939-1
|
Yersinia sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
48410-5
|
Yersinia sp IgM Ab [Presence] in Serum by Immunoblot |
|
17777-4
|
Yersinia sp IgM Ab [Units/volume] in Serum |
|
42942-3
|
Yersinia sp IgM Ab [Titer] in Serum |
|
40942-5
|
Yersinia sp IgM Ab [Titer] in Serum by Immunoassay |
|
55728-0
|
Yersinia sp IgG and IgM panel - Serum |
|
28549-4
|
Yersinia sp identified in Stool by Organism specific culture |
|
701-3
|
Yersinia sp identified in Unspecified specimen by Organism specific culture |
|
73664-5
|
Yersinia adhesion protein YadA [Presence] in Isolate |
|
7786-7
|
Yew IgE Ab [Units/volume] in Serum |
|
41239-5
|
Yellow fever virus Ab [Presence] in Cerebral spinal fluid |
|
6588-8
|
Yellow fever virus Ab [Units/volume] in Serum by Hemagglutination inhibition |
|
6591-2
|
Yellow fever virus Ab [Units/volume] in Serum by Neutralization test |
|
41249-4
|
Yellow fever virus Ab [Presence] in Serum |
|
8054-9
|
Yellow fever virus Ab [Units/volume] in Serum |
|
41247-8
|
Yellow fever virus Ab [Titer] in Serum --1st specimen |
|
41246-0
|
Yellow fever virus Ab [Titer] in Serum --2nd specimen |
|
71783-5
|
Yellow fever virus Ab [Titer] in Cerebral spinal fluid by Neutralization test |
|
22618-3
|
Yellow fever virus Ab [Titer] in Serum |
|
6587-0
|
Yellow fever virus Ab [Titer] in Serum by Complement fixation |
|
6589-6
|
Yellow fever virus Ab [Titer] in Serum by Immunofluorescence |
|
6590-4
|
Yellow fever virus Ab [Titer] in Serum by Latex agglutination |
|
6592-0
|
Yellow fever virus IgG Ab [Units/volume] in Serum by Immunoassay |
|
41217-1
|
Yellow fever virus IgG Ab [Presence] in Serum |
|
77954-6
|
Yellow fever virus IgG Ab [Presence] in Serum by Immunofluorescence |
|
8055-6
|
Yellow fever virus IgG Ab [Units/volume] in Serum |
|
71782-7
|
Yellow fever virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
6593-8
|
Yellow fever virus IgM Ab [Units/volume] in Serum by Immunoassay |
|
41216-3
|
Yellow fever virus IgM Ab [Presence] in Serum |
|
77955-3
|
Yellow fever virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
8056-4
|
Yellow fever virus IgM Ab [Units/volume] in Serum |
|
77959-5
|
Yellow fever virus ns5 gene [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
90459-9
|
Yellow fever virus RNA [Presence] in Blood by NAA with probe detection |
|
8057-2
|
Yellow fever virus RNA [Presence] in Serum by NAA with probe detection |
|
58075-3
|
Yk sup(a) Ag [Presence] on Red Blood Cells |
|
48663-9
|
YKL-40 [Mass/volume] in Serum |
|
7787-5
|
Yogurt IgE Ab [Units/volume] in Serum |
|
7788-3
|
Yogurt IgG Ab [Units/volume] in Serum |
|
56435-1
|
Yogurt IgG4 Ab [Mass/volume] in Serum |
|
63141-6
|
Yogurt IgG Ab [Mass/volume] in Serum |
|
40944-1
|
Yohimbine [Mass/volume] in Serum or Plasma |
|
90744-4
|
Youth Risk Behavior Survey - body weight panel [CDC] |
|
1347-4
|
Yt sup(a) Ag [Presence] on Red Blood Cells |
|
1353-2
|
Yt sup(b) Ag [Presence] on Red Blood Cells |
|
51778-9
|
YY1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
29125-2
|
Zalcitabine [Units/volume] in Serum or Plasma |
|
32574-6
|
Zaleplon [Mass/volume] in Serum or Plasma |
|
74663-6
|
Zaleplon [Mass/volume] in Urine |
|
87776-1
|
Zaleplon/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
75029-9
|
Zanamivir [Susceptibility] by Genotype method |
|
49113-4
|
ZAP70 Ag [Presence] in Tissue by Immune stain |
|
46722-5
|
ZAP70 cells [Presence] in Blood |
|
53619-3
|
ZAP70 cells [Presence] in Bone marrow |
|
53618-5
|
ZAP70 cells [Presence] in Unspecified specimen |
|
87564-1
|
Zearalenone [Mass/mass] in Unspecified specimen |
|
87565-8
|
Zearalenol [Mass/mass] in Unspecified specimen |
|
90847-5
|
Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Cerebral spinal fluid by Line blot |
|
88743-0
|
Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Serum by Line blot |
|
38915-5
|
Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum |
|
83002-6
|
Zinc finger protein of the cerebellum 4 IgG Ab [Presence] in Serum or Plasma by Line blot |
|
29126-0
|
Zidovudine [Units/volume] in Serum or Plasma |
|
6894-0
|
Zidovudine [Mass/volume] in Serum or Plasma |
|
81149-7
|
Zika virus envelope E gene [Presence] in Amniotic fluid by NAA with probe detection |
|
80826-1
|
Zika virus envelope E gene [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
80825-3
|
Zika virus envelope E gene [Presence] in Serum by NAA with probe detection |
|
81148-9
|
Zika virus envelope E gene [Presence] in Urine by NAA with probe detection |
|
87439-6
|
Zika virus IgA+IgG+IgM Ab [Interpretation] in Unspecified specimen Qualitative by Immunoassay |
|
91080-2
|
Zika virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
89590-4
|
Zika virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
80618-2
|
Zika virus IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
|
80823-8
|
Zika virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay |
|
82731-1
|
Zika virus IgM Ab [Presence] in Serum by Immunofluorescence |
|
80619-0
|
Zika virus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
80824-6
|
Zika virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
91678-3
|
Zika virus IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
89591-2
|
Zika virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
87622-7
|
Zika virus IgM Ab [Presence] in Unspecified specimen by Immunoassay |
|
80821-2
|
Zika virus neutralizing antibody [Presence] in Cerebral spinal fluid by Neutralization test |
|
80822-0
|
Zika virus neutralizing antibody [Presence] in Serum by Neutralization test |
|
80624-0
|
Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --1st specimen |
|
80622-4
|
Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
|
80625-7
|
Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test --2nd specimen |
|
80623-2
|
Zika virus neutralizing antibody [Titer] in Serum by Neutralization test --2nd specimen |
|
80621-6
|
Zika virus neutralizing antibody [Titer] in Cerebral spinal fluid by Neutralization test |
|
80620-8
|
Zika virus neutralizing antibody [Titer] in Serum by Neutralization test |
|
86321-7
|
Zika virus neutralizing antibody [Titer] in Unspecified specimen by Neutralization test |
|
86320-9
|
Zika virus neutralizing antibody [Presence] in Unspecified specimen by Neutralization test |
|
83069-5
|
Zika virus non-structural protein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
89368-5
|
Zika virus non-structural protein 1 IgM panel - Serum or Plasma by Immunoassay |
|
89369-3
|
Zika virus non-structural protein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
85621-1
|
Zika virus RNA [Presence] in Amniotic fluid by NAA with probe detection |
|
91078-6
|
Zika virus RNA [Presence] in Blood by NAA with probe detection |
|
90462-3
|
Zika virus RNA [Presence] in Cord blood by NAA with probe detection |
|
86594-9
|
Zika virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
91079-4
|
Zika virus RNA [Presence] in Placenta by NAA with probe detection |
|
86190-6
|
Zika virus RNA [Presence] in Plasma from Donor by NAA with probe detection |
|
85622-9
|
Zika virus RNA [Presence] in Serum by NAA with probe detection |
|
85623-7
|
Zika virus RNA [Presence] in Urine by NAA with probe detection |
|
79190-5
|
Zika virus RNA [Presence] in Unspecified specimen by NAA with probe detection |
|
4099-8
|
Zimelidine [Mass/volume] in Serum or Plasma |
|
48431-1
|
Zinc [Molar amount] in unspecified time Semen |
|
30930-2
|
Zinc [Mass/volume] in Urine collected for unspecified duration |
|
21610-1
|
Zinc [Mass/volume] in 24 hour Urine |
|
5765-3
|
Zinc [Mass/time] in 24 hour Urine |
|
34388-9
|
Zinc [Moles/volume] in 24 hour Urine |
|
22689-4
|
Zinc [Moles/time] in 24 hour Urine |
|
27106-4
|
Zinc [Presence] in Blood |
|
8245-3
|
Zinc [Mass/volume] in Blood |
|
58037-3
|
Zinc [Mass/volume] in Cerebral spinal fluid |
|
32348-5
|
Zinc [Moles/volume] in Cerebral spinal fluid |
|
5760-4
|
Zinc [Mass/volume] in Dialysis fluid |
|
11028-8
|
Zinc [Mass/volume] in Body fluid |
|
40947-4
|
Zinc [Presence] in Hair |
|
13652-3
|
Zinc [Mass/mass] in Hair |
|
50939-8
|
Zinc [Moles/mass] in Hair |
|
29245-8
|
Zinc [Mass/mass] in Nail |
|
20988-2
|
Zinc phosphide [Mass/mass] in Gastrointestinal content |
|
20989-0
|
Zinc phosphide [Mass/mass] in Unspecified specimen |
|
5761-2
|
Zinc [Mass/volume] in Red Blood Cells |
|
27125-4
|
Zinc [Mass/mass] in Red Blood Cells |
|
25557-0
|
Zinc [Moles/volume] in Red Blood Cells |
|
40937-5
|
Zinc [Presence] in Serum or Plasma |
|
5763-8
|
Zinc [Mass/volume] in Serum or Plasma |
|
14955-9
|
Zinc [Moles/volume] in Serum or Plasma |
|
5762-0
|
Zinc [Mass/volume] in Semen |
|
10633-6
|
Zinc [Moles/volume] in Semen |
|
10917-3
|
Zinc [Mass/mass] in Stool |
|
18260-0
|
Zinc [Presence] in Tissue |
|
16180-2
|
Zinc [Mass/mass] in Tissue |
|
52910-7
|
Zinc [Moles/mass] in Tissue |
|
40957-3
|
Zinc [Presence] in Urine |
|
5764-6
|
Zinc [Mass/volume] in Urine |
|
34387-1
|
Zinc [Moles/volume] in Urine |
|
9487-0
|
Zinc [Mass/volume] in Water |
|
17778-2
|
Zinc [Mass/volume] in Leukocytes |
|
10918-1
|
Zinc [Mass/volume] in Unspecified specimen |
|
43973-7
|
Zinc [Moles/volume] in Unspecified specimen |
|
27201-3
|
Zinc/Creatinine [Mass Ratio] in 24 hour Urine |
|
50940-6
|
Zinc/Creatinine [Molar ratio] in 24 hour Urine |
|
13473-4
|
Zinc/Creatinine [Mass Ratio] in Urine |
|
34389-7
|
Zinc/Creatinine [Molar ratio] in Urine |
|
59767-4
|
Ziprasidone [Mass/volume] in Blood |
|
89979-9
|
Ziprasidone [Presence] in Serum or Plasma by Screen method |
|
33946-5
|
Ziprasidone [Mass/volume] in Serum or Plasma |
|
77877-9
|
Ziprasidone [Mass/volume] in Urine by Confirmatory method |
|
89964-1
|
Ziprasidone [Presence] in Urine by Screen method |
|
87780-3
|
Ziprasidone/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
76658-4
|
Zirconium [Mass/mass] in Hair |
|
27032-2
|
Zirconium [Mass/volume] in Serum or Plasma |
|
77187-3
|
Zirconium [Mass/volume] in Urine |
|
77188-1
|
Zirconium [Moles/volume] in Urine |
|
6974-0
|
Zirconium [Mass/volume] in Unspecified specimen |
|
77189-9
|
Zirconium/Creatinine [Molar ratio] in Urine |
|
76083-5
|
Microscopic observation [Presence] in Bronchoalveolar lavage by Acid fast stain.Ziehl-Neelsen |
|
58943-2
|
Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain.Ziehl-Neelsen |
|
58944-0
|
Microscopic observation [Identifier] in Body fluid by Acid fast stain.Ziehl-Neelsen |
|
642-9
|
Microscopic observation [Identifier] in Gastric fluid by Acid fast stain.Ziehl-Neelsen |
|
58942-4
|
Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Ziehl-Neelsen |
|
58945-7
|
Microscopic observation [Identifier] in Peritoneal fluid by Acid fast stain.Ziehl-Neelsen |
|
63433-7
|
Microscopic observation [Identifier] in Synovial fluid by Acid fast stain.Ziehl-Neelsen |
|
79375-2
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--2nd specimen |
|
79376-0
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen--3rd specimen |
|
647-8
|
Microscopic observation [Identifier] in Sputum by Acid fast stain.Ziehl-Neelsen |
|
6657-1
|
Microscopic observation [Identifier] in Tissue by Acid fast stain.Ziehl-Neelsen |
|
652-8
|
Microscopic observation [Identifier] in Urine by Acid fast stain.Ziehl-Neelsen |
|
656-9
|
Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain.Ziehl-Neelsen |
|
76651-9
|
Zinc transporter 8 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
82453-2
|
Zo Ab [Presence] in Serum by Line blot |
|
60211-0
|
Zolazepam [Mass/volume] in Blood |
|
60212-8
|
Zolazepam [Mass/volume] in Serum or Plasma |
|
60213-6
|
Zolazepam [Mass/volume] in Urine |
|
60214-4
|
ZOLMitriptan [Mass/volume] in Blood |
|
34443-2
|
ZOLMitriptan [Mass/volume] in Serum or Plasma |
|
60215-1
|
ZOLMitriptan [Mass/volume] in Urine |
|
74664-4
|
Zolpidem [Mass/volume] in Blood |
|
72768-5
|
Zolpidem phenyl-4-carboxylate [Mass/volume] in Urine by Confirmatory method |
|
94103-9
|
Zolpidem phenyl-4-carboxylate [Presence] in Urine by Screen method |
|
72769-3
|
Zolpidem phenyl-4-carboxylate/Creatinine [Mass Ratio] in Urine |
|
87821-5
|
Zolpidem [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
87820-7
|
Zolpidem [Presence] in Saliva (oral fluid) by Screen method |
|
6953-4
|
Zolpidem [Mass/volume] in Serum or Plasma |
|
25559-6
|
Zolpidem [Moles/volume] in Serum or Plasma |
|
72770-1
|
Zolpidem [Mass/volume] in Urine by Confirmatory method |
|
33338-5
|
Zolpidem [Presence] in Urine |
|
53787-8
|
Zolpidem [Presence] in Urine by Confirmatory method |
|
94104-7
|
Zolpidem [Presence] in Urine by Screen method |
|
33339-3
|
Zolpidem [Mass/volume] in Urine |
|
33340-1
|
Zolpidem [Moles/volume] in Urine |
|
72771-9
|
Zolpidem/Creatinine [Mass Ratio] in Urine |
|
60216-9
|
Zomepirac [Mass/volume] in Blood |
|
12545-0
|
Zomepirac [Mass/volume] in Serum or Plasma |
|
29620-2
|
Zonisamide [Mass/volume] in Serum or Plasma |
|
87771-2
|
Zonisamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
|
59982-9
|
Zopiclone [Moles/volume] in Gastric fluid |
|
74392-2
|
Zopiclone [Mass/mass] in Hair |
|
80554-9
|
Zopiclone [Mass/volume] in Serum or Plasma |
|
48379-2
|
Zopiclone [Moles/volume] in Serum or Plasma |
|
59176-8
|
Zopiclone [Presence] in Urine |
|
59981-1
|
Zopiclone [Moles/volume] in Urine |
|
60339-9
|
Zopiclone [Moles/volume] in Unspecified specimen |
|
89043-4
|
Zopiclone-N-oxide [Mass/volume] in Urine |
|
88991-5
|
Zotepine [Mass/volume] in Serum or Plasma |
|
2893-6
|
Protoporphyrin.zinc [Presence] in Blood |
|
33007-6
|
Protoporphyrin.zinc [Mass/volume] in Blood |
|
2894-4
|
Protoporphyrin.zinc [Presence] in Red Blood Cells |
|
2895-1
|
Protoporphyrin.zinc [Mass/volume] in Red Blood Cells |
|
34417-6
|
Protoporphyrin.zinc [Mass/mass] in Red Blood Cells |
|
71797-5
|
Protoporphyrin.zinc [Moles/volume] in Red Blood Cells |
|
29763-0
|
Protoporphyrin.zinc [Molar ratio] in Red Blood Cells |
|
4539-3
|
Erythrocyte sedimentation rate Zeta by Zetafuge |
|
7718-0
|
Zucchini IgE Ab [Units/volume] in Serum |
|
18425-9
|
Zucchini IgG Ab [Units/volume] in Serum |
|
56436-9
|
Zucchini IgG4 Ab [Mass/volume] in Serum |
|
60414-0
|
Zucchini IgG Ab [Mass/volume] in Serum |
|
48412-1
|
Zygomycete sp Ag [Presence] in Tissue by Immune stain |
|
55198-6
|
Zygosity DNA [Identifier] in Buccal by Molecular genetics method Nominal |